PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Gahm, C; Holmin, S; Wiklund, PN; Brundin, L; Mathiesen, T				Gahm, Caroline; Holmin, Staffan; Wiklund, Peter N.; Brundin, Lou; Mathiesen, Tiit			Neuroprotection by selective inhibition of inducible nitric oxide synthase after experimental brain contusion	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; iNOS; L-NIL; neuronal degeneration; nitrotyrosine; traumatic brain injury	PERIVASCULAR TYROSINE NITRATION; DNA-DAMAGE; CELL-DEATH; NEURONAL DEGENERATION; SUPEROXIDE-DISMUTASE; MICE DEFICIENT; FREE-RADICALS; RAT-BRAIN; IN-SITU; INJURY	The inflammatory response is thought to be important for secondary damage following traumatic brain injury (TBI). The inducible nitric oxide synthase (iNOS) isoform is a mediator in inflammatory reactions and may catalyze substantial synthesis of NO in the injured brain. This study was undertaken to analyze neuronal degeneration and survival, cellular apoptosis and formation of nitrotyrosine following treatment with the iNOS-inhibitor L-N-iminoethyl-lysine (L-NIL) in a model of brain contusion. A brain contusion was produced using a weight-drop device in 30 rats. The animals received treatment with L-NIL or NaCl at 15 min and 12 h after the injury and were sacrificed at 24 h or 6 days after trauma. iNOS activity was measured at 24 h post-trauma by the conversion of L-[U-C-14]arginine to L-[U-C-14]citrulline and immunohistochemistry for iNOS. Peroxynitrite formation was indirectly assessed by nitrotyrosine (NT) immunohistochemistry. Neuronal degeneration and survival were assessed by Fluoro-Jade (FJ) and NeuN stainings, and cellular death by TUNEL staining. iNOS activity but not iNOS immunoreactivity was significantly reduced in animals that received L-NIL. Neuronal degeneration (FJ) and NT immunoreactivity were significantly reduced at 24 h. Neuronal survival was unchanged at 24 h but increased at 6 days in L-NIL-treated animals. Cellular apoptosis of ED-1 and NeuN positive cells was significantly reduced following L-NIL treatment at 6 days after trauma. We demonstrated neuroprotection by selective inhibition of iNOS after trauma. L-NIL appeared to protect the injured brain by limiting peroxynitrite formation. Our findings support a putative harmful role of iNOS induction early after TBI.	Karolinska Univ Hosp, Dept Clin Neurosci, Sect Clin CNS Res, S-17176 Stockholm, Sweden; Karolinska Univ Hosp, Dept Clin Neurosci, Sect Otorhinolaryngol, S-17176 Stockholm, Sweden; Karolinska Univ Hosp, Dept Surg, Urol Sect, S-17176 Stockholm, Sweden; Karolinska Univ Hosp, Ctr Mol Med, Neuroimmunol Unit, S-17176 Stockholm, Sweden		Gahm, C (corresponding author), Karolinska Univ Hosp, Dept Clin Neurosci, Sect Clin CNS Res, S-17176 Stockholm, Sweden.	caroline.gahm@karolinska.se	mathiesen, tiit/ABC-3627-2021	Holmin, Staffan/0000-0002-1628-1615; Brundin, Lou/0000-0003-4408-7817; Wiklund, Peter/0000-0001-6497-4697; Mathiesen, Tiit/0000-0001-9463-1919			Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Beckman J.S., 1994, METHODS ENZYMOL, V233, P229, DOI [DOI 10.1016/S0076-6879(94)33026-3, 10.1016/s0076-6879(94)33026-3]; Bolanos JP, 1997, J NEUROCHEM, V68, P2227; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; Bryk R, 1998, BIOCHEMISTRY-US, V37, P4844, DOI 10.1021/bi972065t; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Coeroli L, 1998, J NEUROCHEM, V70, P2516; Conti AC, 1998, J NEUROSCI, V18, P5663; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Eguchi Y, 1997, CANCER RES, V57, P1835; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; GANSTER R, 2000, NITRIC OXIDE BIOL PA, V1, P129; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gorlach C, 2000, PFLUG ARCH EUR J PHY, V440, P309; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; HALL ED, 1989, CRIT CARE CLIN, V5, P793; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; HOGG N, 1993, FEBS LETT, V326, P199, DOI 10.1016/0014-5793(93)81790-7; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Ischiropoulos H, 1996, J CLIN INVEST, V97, P2260, DOI 10.1172/JCI118667; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; KLEINERT H, 2000, NITRIC OXIDE BIOL PA, V1, P105; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; MINCGOLOMB D, 1994, BRIT J PHARMACOL, V112, P720, DOI 10.1111/j.1476-5381.1994.tb13136.x; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; RINK A, 1995, AM J PATHOL, V147, P1575; SALGO MG, 1995, ARCH BIOCHEM BIOPHYS, V322, P500, DOI 10.1006/abbi.1995.1493; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Stoffel M, 2000, ACTA NEUROCHIR SUPPL, V76, P357; Szabo C, 1997, NITRIC OXIDE-BIOL CH, V1, P373, DOI 10.1006/niox.1997.0143; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Zhang YW, 2004, CANCER CELL, V6, P5, DOI 10.1016/j.ccr.2004.07.003	59	55	58	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2006	23	9					1343	1354		10.1089/neu.2006.23.1343			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	085LP	WOS:000240605900006	16958586				2022-02-06	
J	Zazryn, T; Cameron, P; McCrory, P				Zazryn, T.; Cameron, P.; McCrory, P.			A prospective cohort study of injury in amateur and professional boxing	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RUGBY-LEAGUE; FOOTBALL; BOXERS; HEAD; EPIDEMIOLOGY; CONCUSSIONS; STATE; ELITE	Background: There is concern over the potential for a high incidence of injury in boxing. This is despite a lack of prospective data evaluating the risk for modern day participants. Updated, reliable data with a focus on potential exposure to injury for both amateur and, especially, professional boxers is required. Aim: To determine the epidemiology of injury and exposure of amateur and professional boxers in Victoria, Australia. Methods: A prospective cohort study with one year follow up was carried out over 2004 - 2005. Thirty three amateur and 14 active professional boxers registered with either Boxing Victoria Inc ( amateurs) or the Professional Boxing and Combat Sports Board of Victoria ( professionals) volunteered. Exposure at training and competition was measured, and any injuries sustained during this participation were recorded. Results: Twenty one injuries were sustained by the cohort during the follow up period. Most were to the head region (71%; 95% confidence interval 23.7 to 89.4), with concussion being the most common (33%). An overall injury rate of 2.0 injuries per 1000 hours of boxing was calculated. Conclusion: The high exposure experienced by the boxers ( as a result of considerable training time) indicated that boxing has acute injury rates comparable to, and often lower than, those found in other contact and non-contact sports. Further, acute injuries during training appear to be less common and severe than those sustained in bouts.	Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; Univ Melbourne, Brain Res Inst, Melbourne, Vic, Australia		Cameron, P (corresponding author), Monash Univ, Cent & Eastern Clin Sch, Alfred Hosp, Dept Epidemiol & Prevent Med, Commercial Rd, Melbourne, Vic 3004, Australia.	peter.cameron@med.monash.edu.au	McCrory, Paul/Q-8688-2019	Cameron, Peter/0000-0002-1443-557X			[Anonymous], 1992, J NEUROIMAGING; Boxing Jordan B, 1996, EPIDEMIOLOGY SPORTS, P113; Braham R, 2004, J SCI MED SPORT, V7, P96, DOI 10.1016/S1440-2440(04)80048-3; BUTLER RJ, 1993, J NEUROL NEUROSUR PS, V56, P1055, DOI 10.1136/jnnp.56.10.1055; CANTU R, 1995, BOXING MED; Carson JD, 1999, CLIN J SPORT MED, V9, P75, DOI 10.1097/00042752-199904000-00006; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Critchley GR, 1999, BRIT J SPORT MED, V33, P174, DOI 10.1136/bjsm.33.3.174; deLoes M, 1997, SPORTS MED, V24, P172, DOI 10.2165/00007256-199724030-00005; ESTWANIK J J, 1984, Physician and Sportsmedicine, V12, P123; Finch C, 2002, AUST NZ J PUBL HEAL, V26, P462, DOI 10.1111/j.1467-842X.2002.tb00348.x; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; GIBBS N, 1993, AM J SPORT MED, V21, P696, DOI 10.1177/036354659302100510; Gissane C, 2003, OCCUP MED-OXFORD, V53, P512, DOI 10.1093/occmed/kqg103; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; JORDAN B, 1993, MED ASPECTS BOXING, P4; JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974; JORDAN BD, 1988, PHYSICIAN SPORTSMED, V16, P87, DOI 10.1080/00913847.1988.11709407; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; JORDAN BD, 1993, MED ASPECTS BOXING, P177; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Kolt GS, 1999, BRIT J SPORT MED, V33, P312, DOI 10.1136/bjsm.33.5.312; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; MCCOWN IA, 1959, AM J SURG, V98, P509, DOI 10.1016/0002-9610(59)90545-8; Morgan BE, 2001, AM J SPORT MED, V29, P426, DOI 10.1177/03635465010290040701; Orchard J, 1998, J SCI MED SPORT, V1, P82; Pieter W, 1999, J SPORT MED PHYS FIT, V39, P147; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Porter MD, 1996, CLIN J SPORT MED, V6, P90, DOI 10.1097/00042752-199604000-00005; *PROF BOX COMB SPO, 2002, RUL SCOR KICKB BOX C; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; SCOTT I, 2001, COUNTING INJURIES OU; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shawdon A, 1994, Aust J Sci Med Sport, V26, P59; STEWART WF, 1994, AM J EPIDEMIOL, V139, P573, DOI 10.1093/oxfordjournals.aje.a117047; WELCH MJ, 1986, PHYSICIAN SPORTSMED, V14, P81, DOI 10.1080/00913847.1986.11709169; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321	40	55	59	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2006	40	8					670	674		10.1136/bjsm.2006.025924			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	066BW	WOS:000239205600005	16807306	Green Published			2022-02-06	
J	Javouhey, E; Guerin, AC; Chiron, M				Javouhey, E; Guerin, AC; Chiron, M			Incidence and risk factors of severe traumatic brain injury resulting from road accidents: A population-based study	ACCIDENT ANALYSIS AND PREVENTION			English	Article						traumatic brain injury; road traffic accident; risk factors; epidemiology; logistic regression	MORTALITY; FRANCE; AGE; EPIDEMIOLOGY; MANAGEMENT; HEMATOMA; DEATHS	A population-based study was carried out in 1996-2001 to provide the incidence and to identify the risk factors of severe traumatic brain injury (TBI) resulting from a road accident. The severe TBI was defined as an injury to the brain or the skull, excluding scalp injuries, with an abbreviated injury scale (AIS) severity score greater than 2. The severe TBI of 1238 patients were described. The annual incidence and mortality of severe TBI were, respectively, 13.7 per 100,000 and 5.3 per 100,000. The fatality rate increased from 20% in childhood to 71% over 75-year-old. Compared to restrained car occupants, the odds ratio for having a severe TBI was 18.1 (95% confidence interval, CI = 12.8-25.5) for un-helmeted motorcyclists, 9.2 (95% CI = 7.5-11.3) for pedestrians, 6.4 (95% CI = 4.7-8.8) for un-helmeted cyclists, 3.9 (95% CI = 3.1-4.8) for unrestrained car occupants and 2.8 (95% CI = 2.2-3.5) for helmeted motorcyclists. Even after adjustment for several severity factors, male gender and age above 55 were both risk factors. Prevention programs aiming at improving the head protection should be promoted. The circumstances of the accident should be taken into account to predict a severe TBI. (c) 2005 Elsevier Ltd. All rights reserved.	Univ Lyon 1, UMRESTTE Epidemiol Res & Surveillance Unit Transp, Joint Unit Inrets, French Natl Inst Transport & Safety Res, F-69675 Bron, France; InVS Natl Inst Publ Hlth Surveillance, F-69675 Bron, France		Javouhey, E (corresponding author), Univ Lyon 1, UMRESTTE Epidemiol Res & Surveillance Unit Transp, Joint Unit Inrets, French Natl Inst Transport & Safety Res, 25 Ave Francois Mitterrand,Case 24, F-69675 Bron, France.	etienne.javouhey@inrets.fr; anne-celine.guerin@inrets.fr; mireille.chiron@inrets.fr	Javouhey, Etienne/G-3651-2013				Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Farin A, 2004, ACT NEUR S, V89, P101; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Laumon B, 2002, REV EPIDEMIOL SANTE, V50, P277; Martin JL, 2004, REV EPIDEMIOL SANTE, V52, P357, DOI 10.1016/S0398-7620(04)99065-7; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; *ONISR, 2004, SEC ROUT FRANC BIL A; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Servadei F, 2002, J Neurosurg Sci, V46, P111; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Turner C, 2004, ACCIDENT ANAL PREV, V36, P93, DOI 10.1016/S0001-4575(02)00131-8	24	55	57	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAR	2006	38	2					225	233		10.1016/j.aap.2005.08.001			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	011JZ	WOS:000235265700002	16242108				2022-02-06	
J	Kapreli, E; Athanasopoulos, S				Kapreli, Eleni; Athanasopoulos, Spyridon			The anterior cruciate ligament deficiency as a model of brain plasticity	MEDICAL HYPOTHESES			English	Article							KNEE-JOINT EFFUSION; INDUCED MOVEMENT THERAPY; UPPER-LIMB AMPUTATION; NERVOUS-SYSTEM; NON-COPERS; SOMATOSENSORY CORTEX; QUADRICEPS STRENGTH; CORTICAL ACTIVATION; DYNAMIC STABILITY; FUNCTIONAL MRI	This paper describes a plausible mechanism for the development of brain plastic changes due to a peripheral joint injury, such as anterior cruciate ligament (ACL) rupture. Evidence for the hypothesis is based on mainly three indications derived from the literature review: (a) the existence of two different categories of ACL patients, the copers and non-copers, presenting different features of functional deficiencies, (b) the demand of a sufficient post-traumatic time (more than 6 months) for the dysfunction development and (c) the fact that the dysfunction is not limited to the injured limb but also concerns the non-injured one. Considering the fact that ACL contains mechanoreceptors, which inform the central nervous system (CNS) about joint sense position and kinaesthesia, it can be suggested that this kind of injury might be regarded as a neurophysiological dysfunction, not being a simple musculoskeletal injury. The rupture of the ACL could lead to the cessation/depletion or differentiation of the ascending afferent pathway from the injured joint towards CNS, inducing to the joint de-afferentation and consequently CNS reorganization and joint de-efferentation. In case of presumable evidence of the proposed hypothesis, its clinical application could concern several aspects of the intervention procedures. For example, a number of clinical findings, such as the functional differences presented between two separate clinical groups of patients (copers and non-copers) could be justified or the rehabilitation strategies might have to be revised, provided that certain therapeutic components have influence on facilitating brain plastic changes that induce to beneficial functional outcomes. (c) 2006 Elsevier Ltd. All rights reserved.	TEI Lamia, Dept Physiotherapy, Athens 35100, Greece; Univ Athens, Sports Physiotherapy Lab, Dept Sports Med & Biol Exercise, Daphne 17237, Greece		Kapreli, E (corresponding author), TEI Lamia, Dept Physiotherapy, 3rd Km Old Natl Rd Lamia, Athens 35100, Greece.	ekapreti@teitam.gr	Kapreli, Eleni/ABB-8982-2020				Alkjaer T, 2003, EUR J APPL PHYSIOL, V89, P301, DOI 10.1007/s00421-002-0787-x; Alkjaer T, 2002, CLIN BIOMECH, V17, P586, DOI 10.1016/S0268-0033(02)00098-0; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; BERCHUCK M, 1990, J BONE JOINT SURG AM, V72A, P871, DOI 10.2106/00004623-199072060-00012; Boerboom AL, 2001, KNEE SURG SPORT TR A, V9, P211, DOI 10.1007/s001670100196; Borsa PA, 1997, AM J SPORT MED, V25, P336, DOI 10.1177/036354659702500311; Cameron M, 1997, AM J SPORT MED, V25, P751, DOI 10.1177/036354659702500605; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chmielewski TL, 2002, GAIT POSTURE, V16, P87, DOI 10.1016/S0966-6362(01)00202-8; Chmielewski TL, 2005, J ELECTROMYOGR KINES, V15, P83, DOI 10.1016/j.jelekin.2004.07.003; Chmielewski TL, 2005, J ORTHOP RES, V23, P54, DOI 10.1016/j.orthres.2004.05.011; Chmielewski TL, 2001, CLIN BIOMECH, V16, P586, DOI 10.1016/S0268-0033(01)00050-X; Courtney C, 2005, GAIT POSTURE, V22, P69, DOI 10.1016/j.gaitpost.2004.07.002; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Dettmers C, 1999, NEUROSCI LETT, V263, P41, DOI 10.1016/S0304-3940(99)00105-6; Eastlack ME, 1999, MED SCI SPORT EXER, V31, P210, DOI 10.1097/00005768-199902000-00002; ELMQVIST LG, 1988, EUR J APPL PHYSIOL O, V58, P203, DOI 10.1007/BF00636627; Fischer-Rasmussen T, 2000, SCAND J MED SCI SPOR, V10, P85, DOI 10.1034/j.1600-0838.2000.010002085.x; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Fu, 2000, PROPRIOCEPTION NEURO; GRIGG P, 1986, J NEUROPHYSIOL, V55, P635, DOI 10.1152/jn.1986.55.4.635; Guido J, 1997, J ORTHOP SPORT PHYS, V25, P208, DOI 10.2519/jospt.1997.25.3.208; Holder-Powell HM, 1999, ARCH PHYS MED REHAB, V80, P717, DOI 10.1016/S0003-9993(99)90179-X; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Hopkins JT, 2000, ARCH PHYS MED REHAB, V81, P1199, DOI 10.1053/apmr.2000.6298; Ikeda H, 2002, INT ORTHOP, V26, P374, DOI 10.1007/s00264-002-0402-0; Irie K, 2003, KNEE, V10, P93, DOI 10.1016/S0968-0160(02)00083-2; Jerosch J, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P171; Jerosch J, 1996, ARCH ORTHOP TRAUM SU, V115, P162, DOI 10.1007/BF00434546; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Konishi Y, 2002, SCAND J MED SCI SPOR, V12, P371, DOI 10.1034/j.1600-0838.2002.01293.x; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Lattanzio PJ, 1998, ORTHOPEDICS, V21, P463; Lephart SM, 1997, AM J SPORT MED, V25, P130, DOI 10.1177/036354659702500126; LEVINE JD, 1985, J NEUROSCI, V5, P1380; Levy CE, 2001, AM J PHYS MED REHAB, V80, P4, DOI 10.1097/00002060-200101000-00003; Lewek M, 2002, CLIN BIOMECH, V17, P56, DOI 10.1016/S0268-0033(01)00097-3; Liepert J, 1995, ELECTROMYOGR MOTOR C, V97, P382, DOI 10.1016/0924-980X(95)00194-P; Liepert J, 1998, NEUROSCI LETT, V250, P5, DOI 10.1016/S0304-3940(98)00386-3; Lysholm M, 1998, SCAND J MED SCI SPOR, V8, P432; MCNAIR PJ, 1995, ARCH PHYS MED REHAB, V76, P566, DOI 10.1016/S0003-9993(95)80512-5; NITZ AJ, 1997, FUNCTIONAL MOVEMENT; O'Connell M, 1998, GAIT POSTURE, V8, P136, DOI 10.1016/S0966-6362(98)00023-X; Patel RR, 2003, AM J SPORT MED, V31, P68, DOI 10.1177/03635465030310012301; Reddy H, 2001, EXP BRAIN RES, V138, P484, DOI 10.1007/s002210100732; Roberts D, 1999, J ORTHOP SPORT PHYS, V29, P587, DOI 10.2519/jospt.1999.29.10.587; Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5; Rudolph KS, 2004, J ELECTROMYOGR KINES, V14, P565, DOI 10.1016/j.jelekin.2004.03.002; Rudolph KS, 2001, KNEE SURG SPORT TR A, V9, P62, DOI 10.1007/s001670000166; Rudolph KS, 1998, J ELECTROMYOGR KINES, V8, P349, DOI 10.1016/S1050-6411(97)00042-4; Schwenkreis P, 2001, CLIN NEUROPHYSIOL, V112, P627, DOI 10.1016/S1388-2457(01)00486-2; Shelbourne K D, 1998, Am J Knee Surg, V11, P136; SnyderMackler L, 1997, AM J SPORT MED, V25, P191, DOI 10.1177/036354659702500209; Solomonow M, 2001, SCAND J MED SCI SPOR, V11, P64, DOI 10.1034/j.1600-0838.2001.011002064.x; STRATFORD P, 1987, PHYS THER, V67, P1533, DOI 10.1093/ptj/67.10.1533; TIBONE JE, 1993, CLIN ORTHOP RELAT R, V288, P35; Torry MR, 2000, CLIN BIOMECH, V15, P147, DOI 10.1016/S0268-0033(99)00083-2; Urbach D, 1999, MED SCI SPORT EXER, V31, P1691, DOI 10.1097/00005768-199912000-00001; Valeriani M, 1996, BRAIN, V119, P1751, DOI 10.1093/brain/119.5.1751; Valeriani M, 1999, ACTA NEUROL SCAND, V99, P303, DOI 10.1111/j.1600-0404.1999.tb00680.x; Weiss T, 2000, EXP BRAIN RES, V134, P199, DOI 10.1007/s002210000456; Williams GN, 2003, J ORTHOPAED RES, V21, P1131, DOI 10.1016/S0736-0266(03)00106-2; WOJTYS EM, 1994, AM J SPORT MED, V22, P89, DOI 10.1177/036354659402200116; YOUNG A, 1993, ANN RHEUM DIS, V52, P829, DOI 10.1136/ard.52.11.829; Zanette G, 1997, ELECTROMYOGR MOTOR C, V105, P269, DOI 10.1016/S0924-980X(97)00024-6; ZATTERSTROM R, 1994, AM J SPORT MED, V22, P531, DOI 10.1177/036354659402200416	66	55	57	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses		2006	67	3					645	650		10.1016/j.mehy.2006.01.063			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	069RK	WOS:000239465700033	16698187				2022-02-06	
J	Lister, JP; Tonkiss, J; Blatt, GJ; Kemper, TL; DeBassio, WA; Galler, JR; Rosene, DL				Lister, James P.; Tonkiss, John; Blatt, Gene J.; Kemper, Thomas L.; DeBassio, William A.; Galler, Janina R.; Rosene, Douglas L.			Asymmetry of neuron numbers in the hippocampal formation of prenatally malnourished and normally nourished rats: A stereological investigation	HIPPOCAMPUS			English	Article						CA1; cerebral dominance; hippocampus; nutrition; stereology; subiculum	TRAUMATIC BRAIN-INJURY; PROTEIN-MALNUTRITION; POSTNATAL-DEVELOPMENT; PYRAMIDAL CELLS; AGED RATS; CA1; MEMORY; ESTIMATORS; FEMALE; REGION	There is considerable evidence for lateralization of hippocampal function and hemispheric asymmetry in humans. In the rat, studies have reported asymmetries in the thicknesses of layers, the volumes of hippocampal subfields, and the density of cells at specific points along the septotemporal axis. To determine if there is an asymmetry of neuron numbers and whether prenatal malnutrition affects any asymmetries, 90-day old male Sprague-Dawley rats that were either normally nourished or malnourished prenatally were perfused with 4% paraformaldehyde and the brains cut into 30-mu m sections. One interrupted series of sections through the entire hippocampus was analyzed stereologically to estimate the total number of neurons in the hilus of the dentate gyrus, the CA3/CA2 stratum pyramidale (SP), the CA1 SP, and the SP of the prosubiculum/subiculum of both hemispheres. Significant asymmetries (P < 0.05) were found in the CA1 and CA3/CA2 subfields, with the right hemisphere containing 21 and 6% fewer neurons, respectively. Malnutrition reduced neuron numbers in the CA1 subfield by 12%, but did not alter the hemispheric asymmetry. Our findings agree with previous reports of left dominant asymmetries in the rat brain and suggest that this may result from differences in total numbers of neurons. (c) 2006 Wiley-Liss, Inc.	Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Ctr Behav Dev & Mental Retardat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Lister, JP (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 715 Albany St W701, Boston, MA 02118 USA.	listerj@bu.edu	Rosene, Douglas L/G-1973-2015	Kemper, Thomas/0000-0002-4623-4094; Tonkiss, John/0000-0002-6498-7815; Rosene, Douglas/0000-0001-8719-1441; DeBassio, William/0000-0002-0073-5627	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD022539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH069686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG000001] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01-AG00001] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01-HD22539] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1R01-MH069686] Funding Source: Medline		BAYER SA, 1974, J COMP NEUROL, V158, P55, DOI 10.1002/cne.901580105; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Bronzino JD, 1997, EXP NEUROL, V148, P317, DOI 10.1006/exnr.1997.6653; CINTRA L, 1990, BRAIN RES, V532, P271, DOI 10.1016/0006-8993(90)91769-D; Cintra L, 1997, HIPPOCAMPUS, V7, P184, DOI 10.1002/(SICI)1098-1063(1997)7:2<184::AID-HIPO5>3.0.CO;2-N; Cintra L, 1997, HIPPOCAMPUS, V7, P192, DOI 10.1002/(SICI)1098-1063(1997)7:2<192::AID-HIPO6>3.3.CO;2-G; DIAMOND MC, 1983, EXP NEUROL, V81, P1, DOI 10.1016/0014-4886(83)90153-X; DIAMOND MC, 1982, EXP NEUROL, V76, P553, DOI 10.1016/0014-4886(82)90124-8; DIAZCINTRA S, 1991, J COMP NEUROL, V310, P356, DOI 10.1002/cne.903100306; DIAZCINTRA S, 1994, BRAIN RES, V662, P117, DOI 10.1016/0006-8993(94)90803-6; GALLER JR, 1991, J NUTR, V121, P762, DOI 10.1093/jn/121.5.762; Galler JR, 1996, NUTR PEDIAT BASIC SC, P196; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Granados-Rojas L, 2002, BRAIN RES, V933, P164, DOI 10.1016/S0006-8993(02)02314-4; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Halpern ME, 2003, TRENDS NEUROSCI, V26, P308, DOI 10.1016/S0166-2236(03)00129-2; Hedreen JC, 1998, ANAT REC, V250, P366; JENNRICH R, 1988, BMDP STAT SOFTWARE M, P485; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; KOLB B, 1982, EXP NEUROL, V78, P348, DOI 10.1016/0014-4886(82)90053-X; Lister JP, 2005, HIPPOCAMPUS, V15, P393, DOI 10.1002/hipo.20065; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Milner B, 1972, Clin Neurosurg, V19, P421; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Nunez JL, 2003, ENDOCRINOLOGY, V144, P2350, DOI 10.1210/en.2002-220840; Ragbetli MC, 2002, INT J NEUROSCI, V112, P81, DOI 10.1080/00207450212016; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Rasmussen T, 1996, NEUROBIOL AGING, V17, P143, DOI 10.1016/0197-4580(95)02032-2; Rosene D.L., 1987, CEREB CORTEX, V6, P345, DOI DOI 10.1007/978-1-4615-6616-8_9; ROSENE DL, 1986, J HISTOCHEM CYTOCHEM, V34, P1301, DOI 10.1177/34.10.3745909; SLOMIANKA L, 1987, BRAIN RES, V436, P69, DOI 10.1016/0006-8993(87)91557-5; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319; STOKES KA, 1981, PHYSIOL BEHAV, V26, P163, DOI 10.1016/0031-9384(81)90005-6; Tang AC, 2003, ASYMMETRICAL BRAIN, P37; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; TONKISS J, 1993, ANN NY ACAD SCI, V678, P215; TONKISS J, 1990, BEHAV BRAIN RES, V40, P95, DOI 10.1016/0166-4328(90)90002-V; Tuunanen J, 2000, EPILEPSY RES, V39, P171, DOI 10.1016/S0920-1211(99)00123-0; VALDES JJ, 1981, PHYSIOL BEHAV, V27, P381, DOI 10.1016/0031-9384(81)90284-5; VANEDEN CG, 1984, DEV BRAIN RES, V12, P146, DOI 10.1016/0165-3806(84)90186-X; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Verstynen T, 2001, NEUROREPORT, V12, P3019, DOI 10.1097/00001756-200110080-00008; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	45	55	55	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus		2006	16	11					946	958		10.1002/hipo.20221			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102SL	WOS:000241833500005	16983649				2022-02-06	
J	Shavelle, RM; DeVivo, MJ; Strauss, DJ; Paculdo, DR; Lammertse, DP; Day, SM				Shavelle, Robert M.; DeVivo, Michael J.; Strauss, David J.; Paculdo, David R.; Lammertse, Daniel P.; Day, Steven M.			Long-term survival of persons ventilator dependent after spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						spinal cord injuries; model systems; tetraplegia; ventilator dependence; mortality; life expectancies; national spinal cord injury statistical center	TRAUMATIC BRAIN-INJURY; LIFE EXPECTANCY; CEREBRAL-PALSY; MORTALITY; TRENDS; DEATH; CHILDREN; SYSTEMS; CARE	Background/Objective: Identify factors related to long-term survival, and quantify their effect on mortality and life expectancy. Setting: Model spinal cord injury systems of care across the United States. Study Design: Survival analysis of persons with traumatic spinal cord injury who are ventilator dependent at discharge from inpatient rehabilitation and who survive at least I year after injury. Methods: Logistic regression analysis on a data set of 1,986 person-years occurring among 319 individuals injured from 1973 through 2003. Results: The key factors related to long-term survival were age, time since injury, neurologic level, and degree of completeness of injury. The life expectancies were modestly lower than previous estimates. Pneumonia and other respiratory conditions remain the leading cause of death but account for only 31% of deaths of known causes. Conclusions: Whereas previous research has suggested a dramatic improvement in survival over the last few decades in this population, this is only the case during the critical first few years after injury. There was no evidence for such a trend in the subsequent period.	Life Expectancy Project, San Francisco, CA 94122 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA; Craig Hosp, Denver, CO USA		Shavelle, RM (corresponding author), Life Expectancy Project, 1439 17th Ave, San Francisco, CA 94122 USA.	shavelle@lifeexpectancy.com	Day, Steven/P-1002-2019	Paculdo, David/0000-0002-2184-4603; Lammertse, Daniel/0000-0003-4590-2481; Day, Marc/0000-0002-1711-3963; Day, Steven/0000-0001-8305-5813			AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Spinal Injury Association, 2002, INT STAND NEUR CLASS; Anderson TW, 2002, LIFE EXPECTANCY COUR; ARIAS E, 2004, NATL VITAL STAT REPO, V52; Baguley I, 2000, BRAIN INJURY, V14, P505; Brown AW, 2004, NEUROREHABILITATION, V19, P37; CARTER RE, 1993, PARAPLEGIA, V31, P150, DOI 10.1038/sc.1993.28; CARTER RE, 1979, PARAPLEGIA, V17, P140, DOI 10.1038/sc.1979.28; Collett D., 1994, MODELLING SURVIVAL D; Devivo Michael J., 1995, P289; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P156; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; DEVIVO MJ, 1995, CHEST, V108, P226, DOI 10.1378/chest.108.1.226; Frankel H L, 1969, Paraplegia, V7, P179; FUHRER MJ, 1987, ARCH PHYS MED REHAB, V68, P353; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hosmer D, 1989, APPL LOGISTIC REGRES; Kirshblum S, 1999, ARCH PHYS MED REHAB, V80, P1101, DOI 10.1016/S0003-9993(99)90068-0; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Marsolais EB, 2005, J SPINAL CORD MED, V28, P259; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; SCHOEN R, 1988, MODELLING MULTIGROUP; Shavelle RM, 2006, BRAIN INJURY MED PRI; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; Strauss D, 1998, DEV MED CHILD NEUROL, V40, P369; Strauss D, 1997, J PEDIATR-US, V131, P712, DOI 10.1016/S0022-3476(97)70098-2; Strauss D, 2000, J Insur Med, V32, P217; Strauss David J, 2005, J Insur Med, V37, P20; Strauss DJ, 2006, ARCH PHYS MED REHAB, V87, P1079, DOI 10.1016/j.apmr.2006.04.022; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Strauss DJ, 1998, PEDIATR NEUROL, V18, P143, DOI 10.1016/S0887-8994(97)00172-0; WHITENECK G, 1989, MANAGEMENT HIGH QUAD, P353; WICKS AB, 1986, CHEST, V90, P406, DOI 10.1378/chest.90.3.406	38	55	56	0	5	AMER PARAPLEGIA SOC	JACKSON HWIGHTS	75-20 ASTORIA BLVD, JACKSON HWIGHTS, NY 11370-1177 USA	1079-0268			J SPINAL CORD MED	J. Spinal Cord. Med.		2006	29	5					511	519		10.1080/10790268.2006.11753901			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	121GC	WOS:000243145100006	17274490	Green Published			2022-02-06	
J	Garcia, M; Bondada, V; Geddes, JW				Garcia, M; Bondada, V; Geddes, JW			Mitochondrial localization of mu-calpain	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						apoptosis; apoptosis inducing factor; Bax; calcium; cell death; cortex; necrosis; neuroblastoma; permeability transition; protease	ACTIVATED NEUTRAL PROTEINASE; APOPTOTIC CELL-DEATH; TRAUMATIC BRAIN-INJURY; RAT-BRAIN; CALPAIN/CALPASTATIN NETWORK; PLATELET CALPAIN; AXONAL DAMAGE; CYTOCHROME-C; BAX-CLEAVAGE; BID CLEAVAGE	Calcium-dependent cysteine proteases, calpains, have physiological roles in cell motility and differentiation but also play a pathological role following insult or disease. The ubiquitous calpains are widely considered to be cytosolic enzymes, although there has been speculation of a mitochondrial calpain. Within a highly enriched fraction of mitochondria obtained from rat cortex and SH-SY5Y human neuroblastoma cells, immunoblotting demonstrated enrichment of the 80 kDa mu-calpain large subunit and 28 kDa small subunit. In rat cortex, antibodies against domains II and III of the large mu-calpain subunit also detected a 40 kDa fragment, similar to the autolytic fragment generated following incubation of human erythrocyte mu-calpain with Ca2+. Mitochondrial proteins including apoptosis inducing factor and mitochondrial Bax are calpain substrates, but the mechanism by which calpains gain access to these proteins is uncertain. Mitochondrial localization of mu-calpain places the enzyme in proximity to its mitochondrial substrates and to Ca2+ released from mitochondrial stores. (c) 2005 Elsevier Inc. All rights reserved.	Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Geddes, JW (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA.	jgeddes@uky.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG010836] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG10836] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS045726] Funding Source: Medline		Aki T, 2002, J BIOCHEM, V132, P921, DOI 10.1093/oxfordjournals.jbchem.a003305; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; ARIYOSHI H, 1993, BIOCHEM MOL BIOL INT, V30, P63; BANIK NL, 1991, J NEUROSCI RES, V29, P346, DOI 10.1002/jnr.490290310; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Branca D, 2004, BIOCHEM BIOPH RES CO, V322, P1098, DOI 10.1016/j.bbrc.2004.07.126; Brini M, 2003, CELL CALCIUM, V34, P399, DOI 10.1016/S0143-4160(03)00145-3; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Caro AA, 2002, ARCH BIOCHEM BIOPHYS, V408, P162, DOI 10.1016/S0003-9861(02)00544-1; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; CHAKRABARTI AK, 1988, J NEUROSCI RES, V20, P351, DOI 10.1002/jnr.490200309; COOLICAN SA, 1984, J BIOL CHEM, V259, P1627; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Croall DE, 2000, METH MOL B, V144, P33; Daniel KG, 2003, INT J MOL MED, V12, P247; Ding WX, 2002, BIOCHEM BIOPH RES CO, V291, P321, DOI 10.1006/bbrc.2002.6453; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Gabrijelcic-Geiger D, 2001, BIOL CHEM, V382, P1733, DOI 10.1515/BC.2001.209; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gil-Parrado S, 2002, J BIOL CHEM, V277, P27217, DOI 10.1074/jbc.M202945200; Gil-Parrado S, 2003, J BIOL CHEM, V278, P16336, DOI 10.1074/jbc.M208657200; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Hewitt KE, 1998, J NEUROSCI RES, V54, P223, DOI 10.1002/(SICI)1097-4547(19981015)54:2<223::AID-JNR10>3.0.CO;2-5; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Hood JL, 2003, BIOCHEM BIOPH RES CO, V310, P1200, DOI 10.1016/j.bbrc.2003.09.142; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; KUMAMOTO T, 1995, ACTA NEUROPATHOL, V89, P399; LANE RD, 1992, EXP CELL RES, V203, P5, DOI 10.1016/0014-4827(92)90033-5; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Oh SH, 2004, BIOCHEM PHARMACOL, V68, P1845, DOI 10.1016/j.bcp.2004.06.021; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Pang Z, 2003, J NEUROPATH EXP NEUR, V62, P633, DOI 10.1093/jnen/62.6.633; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rutledge TW, 2002, J BIOL CHEM, V277, P37009, DOI 10.1074/jbc.M204526200; SAIDO TC, 1993, J BIOL CHEM, V268, P7422; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; Saris NEL, 2005, BIOCHEMISTRY-MOSCOW+, V70, P187, DOI 10.1007/s10541-005-0100-9; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; SCHWAB C, 1994, HIPPOCAMPUS, V4, P210, DOI 10.1002/hipo.450040212; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tagliarino C, 2003, CANCER BIOL THER, V2, P141, DOI 10.4161/cbt.2.2.237; TAKEUCHI KH, 1992, J NEUROCHEM, V58, P1526, DOI 10.1111/j.1471-4159.1992.tb11374.x; TAYLOR RG, 1991, BIOMED BIOCHIM ACTA, V50, P491; Thompson VF, 2000, METH MOL B, V144, P3; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Zalewska T, 1998, MOL CHEM NEUROPATHOL, V33, P185, DOI 10.1007/BF02815181	57	55	58	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	DEC 16	2005	338	2					1241	1247		10.1016/j.bbrc.2005.10.081			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	986LM	WOS:000233451100076	16259951				2022-02-06	
J	Quintana, A; Giralt, M; Rojas, S; Penkowa, M; Campbell, IL; Hidalgo, J; Molinero, A				Quintana, A; Giralt, M; Rojas, S; Penkowa, M; Campbell, IL; Hidalgo, J; Molinero, A			Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; knockout type-1 TNF receptor; knockout type-2 TNF receptor; gene expression; apoptosis	ASTROCYTE-TARGETED EXPRESSION; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; TRANSGENIC MICE; NERVOUS-SYSTEM; FACTOR-ALPHA; TISSUE INHIBITOR; GENE-EXPRESSION; COLD INJURY	Tumor necrosis factor-alpha (TNF-alpha) is one of the mediators dramatically increased after traumatic brain injury that leads to the activation, proliferation, and hypertrophy of mononuclear, phagocytic cells and gliosis. Eventually, TNF-alpha can induce both apoptosis and necrosis via intracellular signaling. This cytokine exerts its functions via interaction with two receptors: type-1 receptor (TNFR1) and type-2 receptor (TNFR2). In this work, the inflammatory response after a freeze injury (cryolesion) in the cortex was studied in wild-type (WT) animals and in mice lacking TNFR1 (TNFR1 KO) or TNFR2 (TNFR2 KO). Lack of TNFR1, but not of TNFR2, significantly decreased the inflammatory response and tissue damage elicited by the cryolesion at both 3 and 7 days postlesion, with decreased gliosis, lower IL-1 beta immunostaining, and a reduction of apoptosis markers. Cryolesion produced a clear induction of the proinflammatory cytokines interleukin (IL)-1 alpha, IL-1 beta, IL-6, and TNF-alpha; this induction was significantly lower in the TNFR1 KO mice. Host response genes (ICAM-1, A20, EB22/5, and GFAP) were also induced by the cryolesion, but to a lesser extent in TNFR1 KO mice. Lack of TNIFR1 signaling also affected the expression of apoptosis/cell death-related genes (Fas, Rip, p53), matrix metalloproteinases (MMP3, MMP9, MMP12), and their inhibitors (TIMP1), suggesting a role of TNFR1 in extracellular matrix remodeling after injury. However, GDNF, NGF, and BDNF expression were not affected by TNFR1 deficiency. Overall, these results suggest that TNFR1 is involved in the early establishment of the inflammatory response and that its deficiency causes a decreased inflammatory response and tissue damage following brain injury. (c) 2005 Wiley-Liss, Inc.	Autonomous Univ Barcelona, Fac Sci, Inst Neurosci, E-08193 Barcelona, Spain; Autonomous Univ Barcelona, Dept Cellular Biol Physiol & Immunol, Anim Physiol Unit, E-08193 Barcelona, Spain; Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen, Denmark; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia		Molinero, A (corresponding author), Autonomous Univ Barcelona, Fac Sci, Inst Neurosci, E-08193 Barcelona, Spain.	amalia.molinero@uab.es	Hidalgo, Juan/C-9082-2011; Quintana, Albert/N-5544-2015; molinero, amalia/K-2147-2014; Giralt, Mercedes/K-1626-2014	Hidalgo, Juan/0000-0003-0921-1122; Quintana, Albert/0000-0003-1674-7160; molinero, amalia/0000-0001-8661-8570; Giralt, Mercedes/0000-0002-1806-1528	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH062231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036979] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH62231] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36979] Funding Source: Medline		Akassoglou K, 2003, P NATL ACAD SCI USA, V100, P709, DOI 10.1073/pnas.0236046100; Aloe L, 1999, BRAIN RES, V840, P125, DOI 10.1016/S0006-8993(99)01748-5; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; BLUETHMANN H, 1994, J LEUKOCYTE BIOL, V56, P565, DOI 10.1002/jlb.56.5.565; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; CAMPBELL IL, 1994, J IMMUNOL, V153, P3622; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; Carrasco J, 2003, NEUROBIOL DIS, V13, P22, DOI 10.1016/S0969-9961(03)00015-9; Carrasco J, 2000, EXP NEUROL, V163, P46, DOI 10.1006/exnr.1999.7335; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cook JL, 1998, BRAIN RES PROTOC, V3, P1, DOI 10.1016/S1385-299X(98)00012-9; Culpan D, 2003, NEUROSCI LETT, V350, P61, DOI 10.1016/S0304-3940(03)00854-1; Cuzner ML, 1999, J NEUROIMMUNOL, V94, P1, DOI 10.1016/S0165-5728(98)00241-0; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Ethell DW, 2003, J CLIN IMMUNOL, V23, P439, DOI 10.1023/B:JOCI.0000010420.96419.a8; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; HOBBS MV, 1993, J IMMUNOL, V150, P3602; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; Lambertsen KL, 2005, J CEREBR BLOOD F MET, V25, P119, DOI 10.1038/sj.jcbfm.9600014; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Little AR, 2002, NEUROSCIENCE, V115, P307, DOI 10.1016/S0306-4522(02)00359-7; Lucas R, 1997, EUR J IMMUNOL, V27, P1719, DOI 10.1002/eji.1830270719; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Molinero A, 2003, J NEUROPATH EXP NEUR, V62, P315, DOI 10.1093/jnen/62.3.315; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Pagenstecher A, 1997, J IMMUNOL METHODS, V206, P1, DOI 10.1016/S0022-1759(97)00077-X; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 2003, GLIA, V42, P287, DOI 10.1002/glia.10208; Penkowa M, 2000, J CEREBR BLOOD F MET, V20, P1174, DOI 10.1097/00004647-200008000-00003; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Probert L, 2001, GLIA, V36, P212, DOI 10.1002/glia.1110; Raivich G, 2003, J NEUROSCI RES, V72, P726, DOI 10.1002/jnr.10621; Raivich G, 2002, EXP NEUROL, V178, P186, DOI 10.1006/exnr.2002.8024; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Sayer FT, 2002, EXP NEUROL, V175, P282, DOI 10.1006/exnr.2002.7901; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Stalder A K, 1999, Methods Mol Med, V22, P53, DOI 10.1385/0-89603-612-X:53; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Trembovler V, 2003, NEUROSCI LETT, V353, P115, DOI 10.1016/j.neulet.2003.09.023; Wang QX, 2000, CHINESE MED J-PEKING, V113, P281; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x; Yang LB, 2002, J NEUROSCI, V22, P3025, DOI 10.1523/JNEUROSCI.22-08-03025.2002; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	76	55	60	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC 1	2005	82	5					701	716		10.1002/jnr.20680			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994BN	WOS:000234004900012	16267827				2022-02-06	
J	Shaw, SE; Morris, DM; Uswatte, G; Mckay, S; Meythaller, JM; Taub, E				Shaw, SE; Morris, DM; Uswatte, G; Mckay, S; Meythaller, JM; Taub, E			Constraint-induced movement therapy for recovery of upper-limb function following traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						behavioral therapy; constraint-induced movement therapy; functional abilities; massed practice; motor function; motor impairment; neurological injury; physical rehabilitation; training; traumatic brain injury	MOTOR FUNCTION-TEST; LEARNED NONUSE; CHRONIC STROKE; CORTICAL REORGANIZATION; FORCED USE; REHABILITATION; PLASTICITY; INTENSITY; DEFICITS; OUTCOMES	A volunteer sample of 22 participants with chronic traumatic brain injury (TBI) (onset > 1 year) and relative hemiplegia that revealed moderate disability in the more-affected upper limb (UL) participated. Constraint-induced (CI) movement therapy (CI therapy) was employed for a 2-week period; treatments included massed practice, shaping of the more-affected UL, behavioral contracts, and other behavioral techniques for affecting transfer to a real-world setting. We used the Wolf Motor Function Test, the Fugl-Meyer Motor Performance Assessment, and the Motor Activity Log to measure outcomes. All outcome measures improved significantly as a result of the intervention. More-adherent participants had more improvement compared with less-adherent participants. These preliminary results suggest that Cl therapy may be effective for improving UL motor function following chronic TBI.	Univ Alabama, Dept Phys Therapy, Birmingham, AL 35294 USA; Univ Alabama, Dept Psychol, Birmingham, AL 35294 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Birmingham VA Med Ctr, Dept Vet Affairs, Res Serv, Birmingham, AL USA		Shaw, SE (corresponding author), Univ Alabama, Dept Phys Therapy, RMSB 360,1530 3rd Ave S, Birmingham, AL 35294 USA.	sshaw@uab.edu	Uswatte, Gitendra/C-4913-2009		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR 403541-12] Funding Source: Medline		Alon G, 2003, ARCH PHYS MED REHAB, V84, P119, DOI 10.1053/apmr.2003.50073; [Anonymous], 1944, ARMY INDIVIDUAL TEST; ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Bauder H, 1999, PSYCHOPHYSIOLOGY, V36, pS31; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; BLEECKER ML, 1988, NEUROLOGY, V38, P1565, DOI 10.1212/WNL.38.10.1565; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Cohen J., 1997, STAT POWER ANAL BEHA, P19; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; FULK GD, 2001, PHYS REHABILITATION, P783; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Hamster K., 1983, MULTILINGUAL APHASIA; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; Levy CE, 2001, AM J PHYS MED REHAB, V80, P4, DOI 10.1097/00002060-200101000-00003; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; McCrea PH, 2002, DISABIL REHABIL, V24, P534, DOI 10.1080/09638280110115393; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; MORGAN WG, 1974, BEHAV THER, V5, P271, DOI 10.1016/S0005-7894(74)80144-9; Morris DM, 1997, NEUROREHABILITATION, V9, P29, DOI 10.3233/NRE-1997-9104; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Page S, 2003, BRAIN INJURY, V17, P675, DOI 10.1080/0269905031000107160; STEVENS J, 2001, APPL MULTIVARIATE ST, P222; Taub E, 2003, J REHABIL MED, V35, P34, DOI 10.1080/16501960310010124; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; Taub E, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P475, DOI 10.1037/10361-022; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Uswatte G, 2005, REHABIL PSYCHOL, V50, P34, DOI 10.1037/0090-5550.50.1.34; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; van Wijck FMJ, 2001, NEUROREHAB NEURAL RE, V15, P23, DOI 10.1177/154596830101500104; Wechsler D., 1997, WECHSLER MEMORY SCAL; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	45	55	60	1	9	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.	NOV-DEC	2005	42	6					769	778		10.1682/JRRD.2005.06.0094			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	047MQ	WOS:000237883800007	16680614	Bronze			2022-02-06	
J	O'Keeffe, FM; Dockree, PM; Robertson, IH				O'Keeffe, FM; Dockree, PM; Robertson, IH			Poor insight in traumatic brain injury mediated by impaired error processing? Evidence from electrodermal activity	COGNITIVE BRAIN RESEARCH			English	Article						error awareness; electrodermal activity; traumatic brain injury; no-go task	SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; FRONTAL DAMAGE; NEURAL SYSTEM; PERFORMANCE; AWARENESS; LESIONS; DYSFUNCTION; FAILURES; BEHAVIOR	Impaired deficit awareness is common following traumatic brain injury (TBI) and is a major obstacle to rehabilitation. We have previously confirmed the presence of impaired error awareness in TBI using a highly discriminating go/no-go procedure. In the present study, we extend this work to try to identify more closely the nature of the error awareness deficit using measures of electrodermal activity (EDA). Sixteen participants with TBI and sixteen age-, sex-, and education-matched controls performed the Sustained Attention to Response Task(SART), while EDA was recorded. TBI detected significantly fewer errors compared to controls. EDA was significantly attenuated for TBI participants even to errors of which they were aware: error detection rates and EDA amplitude were also correlated. These findings suggest that poor insight following TBI may result, in part, from impaired error processing abilities. (C) 2004 Elsevier B.V. All rights reserved.	Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland		Robertson, IH (corresponding author), Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland.	Ian.Robertson@tcd.ie		Robertson, Ian H/0000-0001-8637-561X			ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROOKS N, 1984, CLOSED HEAD INJURY P; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050110034325; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAMASIO AR, 1994, DESCARTES ERROR EMOT, P211; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; GOLDBERG E, 1991, AWARENESS DEFICIT BR, P152; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; MATTHEWS G, 1990, BRIT J PSYCHOL, V81, P17, DOI 10.1111/j.2044-8295.1990.tb02343.x; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCAVINUE L, IN PRESS NEUROPSYCHO; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Connor C, 2004, BRAIN COGNITION, V54, P133, DOI 10.1016/S0278-2626(03)00268-9; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Rollnik JD, 2004, CLIN NEUROPHYSIOL, V115, P145, DOI 10.1016/j.clinph.2003.05.001; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Scheffers MK, 1996, PSYCHOPHYSIOLOGY, V33, P42, DOI 10.1111/j.1469-8986.1996.tb02107.x; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; STERN R, 2001, PSYCHOPHYSIOLOGICAL, P206; STUSS D, 2001, FRONTAL LOBES NEUROP; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; Ullsperger M, 2002, NEUROPSYCHOLOGY, V16, P548, DOI 10.1037//0894-4105.16.4.548; Umilta C, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P37; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Zahn TP, 1999, INT J PSYCHOPHYSIOL, V33, P113, DOI 10.1016/S0167-8760(99)00030-6; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2; ZAIDEL E, 1987, DUALITY UNITY BRAIN; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmer H, 2000, Z EXP PSYCHOL, V47, P129; [No title captured]	58	55	55	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0926-6410			COGNITIVE BRAIN RES	Cognit. Brain Res.	DEC	2004	22	1					101	112		10.1016/j.cogbrainres.2004.07.012			12	Computer Science, Artificial Intelligence; Neurosciences; Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	881VU	WOS:000225898300012	15561506				2022-02-06	
J	Heep, A; Stoffel-Wagner, B; Bartmann, P; Benseler, S; Schaller, C; Groneck, P; Obladen, M; Felderhoff-Mueser, U				Heep, A; Stoffel-Wagner, B; Bartmann, P; Benseler, S; Schaller, C; Groneck, P; Obladen, M; Felderhoff-Mueser, U			Vascular endothelial growth factor and transforming growth factor-beta 1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus	PEDIATRIC RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; FACTOR-BETA; SUBARACHNOID HEMORRHAGE; PRETERM INFANTS; IN-VIVO; SERUM; TGF-BETA-1; COLLAGEN; IL-6; ERYTHROPOIETIN	The expression of specific growth factors such as vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1) is of importance during brain development and in the pathogenesis of neurodegenerative disorders. VEGF and TGF-beta1 was studied in the cerebrospinal fluid (CSF) of neonates with posthemorrhagic hydrocephalus (PHHC) and nonhemorrhagic hydrocephalus. For determining the interference of inflammatory cytokine interaction with the expression of VEGF and TGF-beta1, IL-6 and IL-10 CSF concentrations were measured. Eighteen neonates who had PHHC and underwent serial reservoir puncture and nine neonates who had congenital nonhemorrhagic hydrocephalus (CHC) and underwent first shunt surgery were included in the study. CSF samples of 11 neonates with lumbar puncture for the exclusion of meningitis served as control subjects. VEGF, TGF-beta1, IL-6, and IL-10 concentrations in the CSF were measured by ELISA technique. VEGF concentrations in the CSF of patients with PHHC were significantly higher (median: 377 pg/mL; range: 101-1301 pg/mL) when compared with patients with CHC (median: 66 pg/mL; range: 3-1991; p < 0.001) and control subjects (median: 2 pg/mL; range: 0-12 pg/mL; p < 0.0001). TGF-beta1 CSF concentrations did not differ from control infants in all groups. Median IL-6 and IL-10 concentrations in the CSF were found to be low in all patient groups. Increased release of VEGF in the CSF of neonates with PHHC and nonhemorrhagic hydrocephalus may serve as an indicator of brain injury from progressive ventricular dilation. TGF-beta1 CSF concentrations are not elevated in the phase of acute fibroproliferative reactions in patients with PHHC.	Univ Bonn, Dept Neonatol, D-53113 Bonn, Germany; Univ Bonn, Dept Clin Biochem, D-53105 Bonn, Germany; Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Cologne Childrens Hosp, Dept Neonatol, D-50735 Cologne, Germany; Free Univ Berlin, Med Ctr, Dept Neonatol, D-13353 Berlin, Germany		Heep, A (corresponding author), Univ Bonn, Dept Neonatol, Adenauerallee 19, D-53113 Bonn, Germany.	a.heep@uni-bonn.de	Felderhoff-Muser, Ursula/AAU-9682-2020				Arai Y, 1998, PEDIATR NEUROL, V19, P45, DOI 10.1016/S0887-8994(98)00018-6; Baumeister FAM, 2000, INFECTION, V28, P234, DOI 10.1007/s150100070043; Bell MJ, 1997, ACT NEUR S, V70, P96; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bocker-Meffert S, 2002, INVEST OPHTH VIS SCI, V43, P2021; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Heep A., 2000, Biology of the Neonate, V78, P153; Heep A, 2004, EUR J PEDIATR, V163, P44, DOI 10.1007/s00431-003-1333-5; Heep A, 2002, ARCH DIS CHILD-FETAL, V87, pF34, DOI 10.1136/fn.87.1.F34; Heep A, 2001, CHILD NERV SYST, V17, P47, DOI 10.1007/s003810000363; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ilzecka J, 2002, CYTOKINE, V20, P239, DOI 10.1006/cyto.2002.2005; JOHNSON MD, 1992, LAB INVEST, V67, P360; Jones KL, 2003, PEDIATRICS, V111, P358, DOI 10.1542/peds.111.2.358; KIM RC, 1989, NEUROSURGERY, V24, P771, DOI 10.1227/00006123-198905000-00022; KITAZAWA K, 1994, STROKE, V25, P1400, DOI 10.1161/01.STR.25.7.1400; Koehne P, 2002, CHILD NERV SYST, V18, P137, DOI 10.1007/s00381-002-0567-2; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Leviton A, 2002, NEUROPEDIATRICS, V33, P281, DOI 10.1055/s-2002-37089; Maskin B, 2001, MEDICINA-BUENOS AIRE, V61, P573; Massicotte EM, 1999, J NEUROSURG, V91, P80, DOI 10.3171/jns.1999.91.1.0080; Moinuddin SM, 2000, NEUROL RES, V22, P215, DOI 10.1080/01616412.2000.11741064; Nakazato F, 2002, NEUROL MED-CHIR, V42, P151, DOI 10.2176/nmc.42.151; Paneth N, 1999, J PEDIATR-US, V134, P527, DOI 10.1016/S0022-3476(99)70231-3; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Rollnik JD, 1997, ACTA NEUROL SCAND, V96, P101; Savman K, 1998, PEDIATR RES, V43, P746; Scheufler KM, 2003, J CEREBR BLOOD F MET, V23, P99, DOI 10.1097/01.WCB.0000037547.46809.83; Schromm AB, 1998, J IMMUNOL, V161, P5464; Segura I, 2002, FASEB J, V16, DOI 10.1096/fj.01-0819com; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Ueberham U, 2003, NEUROSCIENCE, V116, P1, DOI 10.1016/S0306-4522(02)00670-X; Volpe J J, 2001, NEUROLOGY NEWBORN, P428; Whitelaw A, 1999, PEDIATR RES, V46, P576, DOI 10.1203/00006450-199911000-00014; XIAO L, 2002, HUMAN YI KE DA XUE X, V28, P123; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	46	55	63	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	NOV	2004	56	5					768	774		10.1203/01.PDR.0000141524.32142.53			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	864WD	WOS:000224662800017	15319463	Bronze			2022-02-06	
J	Maxwell, WL; Pennington, K; MacKinnon, MA; Smith, DH; McIntosh, TK; Wilson, JTL; Graham, DI				Maxwell, WL; Pennington, K; MacKinnon, MA; Smith, DH; McIntosh, TK; Wilson, JTL; Graham, DI			Differential responses in three thalamic nuclei in moderately disabled, severely disabled and vegetative patients after blunt head injury	BRAIN			English	Article						human thalamus; stereology; traumatic brain injury; thalamus; loss of neurons	TRAUMATIC BRAIN-INJURY; UNBIASED STEREOLOGICAL ESTIMATION; ALZHEIMERS-DISEASE; CORTICAL ATROPHY; DEGENERATION; CELLS; HIPPOCAMPUS; ABLATION; NEURONS; PROTEIN	In vivo imaging techniques have indicated for many years that there is loss of white matter after human traumatic brain injury (TBI) and that the loss is inversely related to cognitive outcome. However, correlated, quantitative evidence for loss of neurons from either the cerebral cortex or the diencephalon is largely lacking. There is some evidence in models of TBI that neuronal loss occurs within the thalamus, but no systematic studies of such loss have been undertaken in the thalamus of humans after blunt head injury. We have undertaken a stereological analysis of changes in numbers of neurons within the dorsomedial, ventral posterior and lateral posterior thalamic nuclei in patients assessed by the Glasgow Outcome Scale as moderately disabled (n = 9), severely disabled (n = 12) and vegetative (n = 10) head-injured patients who survived between 6 h and 3 years, and controls (n = 9). In histological sections at the level of the lateral geniculate body, the cross-sectional area of each nucleus and the number and the mean size of neurons within each nucleus was quantified. A statistically significant loss of cross-sectional area and number of neurons occurred in the dorsomedial nucleus in moderately disabled, and both the dorsomedial and ventral posterior thalamic nuclei in severely disabled and vegetative head-injured patients. However, there was no change in neuronal cell size. In the lateral posterior nucleus, despite a reduction in mean cell size, there was not a significant change in either nuclear area or number of neurons in cases of moderately disabled, severely disabled or vegetative patients. We posit, although detailed neuropsychological outcome for the patients included within this study was not available, that neuronal loss in the dorsomedial thalamus in moderately and severely disabled and vegetative patients may be the structural basis for the clinical assessment in the Glasgow Outcome Scale. In severely disabled and vegetative pati-ents, loss of neurons from the ventral posterior thalamic nucleus may also reflect loss of response to afferent stimuli.	Univ Glasgow, Inst Biomed & Life Sci, Lab Human Anat, Glasgow G12 8QQ, Lanark, Scotland; So Gen Hosp, Inst Neurol Sci, Acad Unit Neuropathol, Glasgow G51 4TF, Lanark, Scotland; Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Univ Penn, Div Neurosurg, Head Injury Res Ctr, Philadelphia, PA 19104 USA		Maxwell, WL (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Lab Human Anat, Thomson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	w.maxwell@bio.gla.ac.uk	Wilson, Lindsay/O-8883-2019; Ritter, Stefanie L/D-9312-2012; Wilson, Lindsay/A-3659-2009; smith, douglas/A-1321-2007	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Pennington, Kyla/0000-0002-4323-606X			Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Benes FM, 2001, TRENDS NEUROSCI, V24, P11, DOI 10.1016/S0166-2236(00)01660-X; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; CARRERAS M, 1969, ARCH ITAL BIOL, V107, P570; CHMIELOWSKA J, 1995, J COMP NEUROL, V360, P377, DOI 10.1002/cne.903600302; Conti AC, 1998, J NEUROSCI, V18, P5663; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Howard C.V., 1998, UNBIASED STEREOLOGY, V1; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jennett B., 1997, HEAD INJURY, P439; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Jones E.G., 1985, THALAMUS; Juhasz C, 1999, NEUROLOGY, V53, P2037, DOI 10.1212/WNL.53.9.2037; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouton P. R., 2002, PRINCIPLES PRACTICES; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RAUSELL E, 1992, J NEUROSCI, V12, P4088; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stamatakis EA, 2002, J NUCL MED, V43, P476; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; WONGRILEY MT, 1972, J COMP NEUROL, V146, P519, DOI 10.1002/cne.901460407; XUEREB JH, 1991, BRAIN, V114, P1363; [No title captured]	45	55	56	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	NOV	2004	127		11				2470	2478		10.1093/brain/awh294			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	865LD	WOS:000224703700010	15456707	Bronze			2022-02-06	
J	Bloom, GA; Horton, AS; McCrory, P; Johnston, KM				Bloom, GA; Horton, AS; McCrory, P; Johnston, KM			Sport psychology and concussion: new impacts to explore	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SUPPORT GROUPS; SOCIAL SUPPORT; INJURY; STRESS; PROGRAM		McGill Univ, McGill Sport Med Ctr, Dept Neurosurg Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada; Univ Melbourne, Melbourne, Vic, Australia		Johnston, KM (corresponding author), McGill Univ, McGill Sport Med Ctr, Dept Neurosurg Kinesiol & Phys Educ, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	Karen.Johnston@mcgill.ca	McCrory, Paul/Q-8688-2019				ACORN S, 1993, J ADV NURS, V18, P39, DOI 10.1046/j.1365-2648.1993.18010039.x; BONNO C, 1987, PREGNANCY LOSS MED T, P225; BREWER BW, 1995, CLIN J SPORT MED, V5, P241, DOI 10.1097/00042752-199510000-00006; Brewer BW., 1991, J APPL SPORT PSYCHOL, V3, P183, DOI [10.1080/10413209108406443, DOI 10.1080/10413209108406443]; Broatch JW, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199612005-00008; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; DEANS G, 1988, BRIT J CANCER, V58, P670, DOI 10.1038/bjc.1988.284; DIPASQUALE JA, 1990, CANCER NURS, V13, P278; Gilbourne D, 1998, J APPL SPORT PSYCHOL, V10, P124, DOI 10.1080/10413209808406381; Gould D, 1997, SPORT PSYCHOL, V11, P361, DOI 10.1123/tsp.11.4.361; Granito Vincent J. Jr., 1995, Journal of Athletic Training, V30, P328; Green SL, 2001, J APPL SPORT PSYCHOL, V13, P40, DOI 10.1080/10413200109339003; Horton A., 2002, MED SCI SPORTS EXERC, V34, P99; Ievleva L., 1991, SPORT PSYCHOL, V5, P25, DOI [DOI 10.1123/TSP.5.1.25, 10.1123/tsp.5.1.25]; KATES N, 1995, CAN J PSYCHIAT, V40, P367, DOI 10.1177/070674379504000702; Lynch GP, 1988, SPORT PSYCHOL, V2, P161; PETIPAS AJ, 1995, SPORT PSYCHOL INTERV, P225; Quinn AM, 1999, J APPL SPORT PSYCHOL, V11, P210, DOI 10.1080/10413209908404201; Ribble D, 1989, Holist Nurs Pract, V3, P52; Smith AM, 1996, SPORTS MED, V22, P391, DOI 10.2165/00007256-199622060-00006; Taylor S., 1997, PSYCHOL APPROACHES S; Udry E, 1996, J SPORT REHABIL, V5, P151, DOI 10.1123/jsr.5.2.151; Udry E, 1997, J SPORT EXERCISE PSY, V19, P368, DOI 10.1123/jsep.19.4.368; Wiese D. M., 1987, SPORT PSYCHOL, V1, P318, DOI DOI 10.1123/TSP.1.4.318; [No title captured]	25	55	55	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	OCT 1	2004	38	5					519	521		10.1136/bjsm.2004.011999			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	856PE	WOS:000224056300003	15388529	Bronze, Green Published			2022-02-06	
J	Hoffman, R; Al'Absi, M				Hoffman, R; Al'Absi, M			The effect of acute stress on subsequent neuropsychological test performance (2003)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neuropsychology; cortisol; memory; attention; cardiovascular	TRAUMATIC BRAIN-INJURY; CORTISOL REACTIVITY; ADRENOCORTICAL RESPONSES; POSTCONCUSSIVE SYMPTOMS; MENTAL STRESS; HEAD-INJURY; ANXIETY; TASK; MEMORY; SEX	Acute mental stressors have been implicated as variables that may deleteriously affect neuropsychological test performance by increasing distractibility and decreasing working memory function. This study examined 25 subjects with no known neurological or psychiatric impairment on a brief battery of neuropsychological measures on alternate days following either rest or induced mental stress in a counterbalanced design. The test battery consisted of the Rey Auditory-Verbal Learning Test, the Rey Complex Figure, and three Wechsler Memory Scale-III subtests (Logical Memory, Digit Span, and Visual Memory Span). The Ss average age was 24.8 years (S.D. = 10.1) and average education was 15.0 years (S.D. = 1.6). The mental stressor employed was a videotaped public-speaking exercise that has been shown in previous work to induce negative mood, cardiovascular reactivity, and perceived mental stress. Ss demonstrated statistically significant (P < .05) increases in negative mood, heart rate, diastolic blood pressure, and systolic blood pressure as well as elevated cortisol concentration following induced stress, suggesting substantially increased adrenocortical reactivity and cardiovascular stress response. There were, however, no statistically significant differences in any of the neuropsychological measures when stress versus rest days were compared. The results suggest that acute mental stressors may have no measurable effect on subsequent performance on selected neuropsychological tests in a normal population. Further work is suggested to determine whether pre-existing anxiety-related psychopathology or pre-existing neurological compromise might interact with induced mental stress to cause decrements in neuropsychological test performance. (C) 2003 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ Minnesota, Dept Behav Sci, Sch Med, Duluth, MN 55812 USA		Hoffman, R (corresponding author), Univ Minnesota, Dept Behav Sci, Sch Med, 10 Univ Dr, Duluth, MN 55812 USA.	rhoffman@d.umn.edu					Al'Absi M, 2002, PSYCHOPHYSIOLOGY, V39, P95, DOI 10.1017/S0048577202001543; al'Absi M, 1998, PSYCHOSOM MED, V60, P521, DOI 10.1097/00006842-199807000-00021; ALABSI M, 1994, PSYCHOSOM MED, V56, P245, DOI 10.1097/00006842-199405000-00011; BOHNEN N, 1990, BIOL PSYCHOL, V31, P107, DOI 10.1016/0301-0511(90)90011-K; BOHNEN N, 1991, J PSYCHOSOM RES, V35, P141, DOI 10.1016/0022-3999(91)90068-Y; BOHNEN N, 1992, INT J NEUROSCI, V64, P97, DOI 10.3109/00207459209000536; BUCKELEW SP, 1986, PERCEPT MOTOR SKILL, V63, P711, DOI 10.2466/pms.1986.63.2.711; Cernak I, 1999, BRAIN INJURY, V13, P1005; CHAVEZ EL, 1983, PERCEPT MOTOR SKILL, V56, P923, DOI 10.2466/pms.1983.56.3.923; COCKBURN J, 1994, BRIT J PSYCHOL, V85, P273, DOI 10.1111/j.2044-8295.1994.tb02523.x; DABSI M, 1997, PSYCHOPHYSIOLOGY, V34, P266; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P192; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Holdwick DJ, 1999, ARCH CLIN NEUROPSYCH, V14, P273, DOI 10.1016/S0887-6177(98)00021-3; Juzwin, 1991, NEUROPSY NEUROPSY BE, V4, P110; KING GD, 1978, J CONSULT CLIN PSYCH, V46, P375, DOI 10.1037/0022-006X.46.2.375; LEZAK MD, 1976, NEUROPSYCHOLOGICAL A; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Meyers J. E., 1995, CLIN NEUROPSYCHOL, V9, P63, DOI [10.1080/13854049508402059, DOI 10.1080/13854049508402059]; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Taylor L B, 1969, Clin Neurosurg, V16, P269; TAYLOR LB, 1979, FUNCTIONAL NEUROSURG; VINGERHOETS G, 1995, CLIN NEUROPSYCHOL, V9, P198, DOI 10.1080/13854049508401603; Waldstein SR, 1997, ARCH CLIN NEUROPSYCH, V12, P567	30	55	60	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2004	19	4					497	506		10.1016/j.acn.2003.07.005			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	830DL	WOS:000222101700004	15163451	Bronze			2022-02-06	
J	Katz, DI; White, DK; Alexander, MP; Klein, RB				Katz, DI; White, DK; Alexander, MP; Klein, RB			Recovery of ambulation after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting of the American-Physical-Therapy-Association	FEB 13-15, 2003	Tampa, FL	Amer Phys Therapy Assoc		brain injuries; gait disorders; neurologic; recovery of function; rehabilitation	STROKE PATIENTS; COPENHAGEN STROKE; WALKING FUNCTION; HEAD-INJURY; REHABILITATION; GAIT; POSTSTROKE; OUTCOMES; PARESIS; ARM	Objectives: To identify variables that are predictive of independent ambulation after traumatic brain injury (TBI) and to define the time course of recovery. Design: Retrospective review of consecutive admissions of patients with severe TBI over a 32-month period. Setting: Brain injury unit in all acute, inpatient rehabilitation hospital. Participants: Of 264 patients screened, 116 met criteria that included the ability to participate in motor and functional evaluation on admission to acute rehabilitation, and the absence of other neurologic disorders or fractures that affect one's ability to ambulate. Intervention: Inpatient rehabilitation on a specialized TBI unit by an interdisciplinary team. Main Outcome Measures: Recovery of independent ambulation and time to recover independent ambulation. Results: Of eligible patients, 73.3% achieved independent ambulation by latest follow-up (up to 5.1 mo). Patients who achieved independent ambulation were significantly younger (P<.05), had better gait scores on admission (P<.05), and tended to be less severely injured-based on duration of post-traumatic amnesia (PTA: P=.058)-than those who did not ambulate independently. There were no differences in recovery based on neuropathologic profile. Mean time to independent ambulation standard deviation was 5.7+/-4.3 weeks; of those achieving independent ambulation, 82.4% did so by 2 months and 94.1 % by 3 months. If not independent by 3 months postinjury, patients had a 13.9% chance of recovery. Multivariate regression analysis generated prediction models for time to independent ambulation, using admission FIM instrument scores and age (38% of variance); initial gait score, loss of consciousness; and age (40% of variance); or initial gait score and PTA (58% of variance), when restricted to just those patients With diffuse axonal injury. Conclusions: Most patients with severe TBI achieved independent ambulation; the vast majority did so within 3 months postinjury. Functional measures, injury severity measures, and age call help guide prognosis and expectations for time to recover.	Health S Braintree Rehabil Hosp, Braintree, MA 02184 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA USA; Youville Lifecare Rehabil Hosp, Cambridge, MA USA; Boston Univ, Memory Disorders Res Ctr, Boston, MA USA; Boston Univ, Harold Goodglass Aphasia Res Ctr, Boston, MA USA		Katz, DI (corresponding author), Health S Braintree Rehabil Hosp, 250 Pond St, Braintree, MA 02184 USA.	dkatz@bu.edu	White, Daniel Kenta/AAE-8449-2021	White, Daniel Kenta/0000-0003-3792-4621; Katz, Douglas/0000-0002-7502-8505			Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Friedman P J, 1990, Int Disabil Stud, V12, P119; HAGGARD P, 1995, J NEUROL NEUROSUR PS, V58, P433, DOI 10.1136/jnnp.58.4.433; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P27, DOI 10.1016/S0003-9993(95)80038-7; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; KATZ DI, 1999, REHABILITATION ADULT, P89; Kwakkel G, 2002, J NEUROL NEUROSUR PS, V72, P473; MacPherson Valerie, 1992, Brain Injury, V6, P489, DOI 10.3109/02699059209008146; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; OLSEN TS, 1990, STROKE, V21, P247, DOI 10.1161/01.STR.21.2.247; Patel AT, 2000, ARCH PHYS MED REHAB, V81, P1357, DOI 10.1053/apmr.2000.9397; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; POVLISHOCK JT, 1992, J NEUROTRAUMA, V9, P189; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Sullivan KJ, 2002, ARCH PHYS MED REHAB, V83, P683, DOI 10.1053/apmr.2002.32488; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade D T, 1988, Int Disabil Stud, V10, P64; Wandel A, 2000, ARCH PHYS MED REHAB, V81, P736, DOI 10.1016/S0003-9993(00)90102-3	28	55	56	0	8	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2004	85	6					865	869		10.1016/j.apmr.2003.11.020			5	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	826NK	WOS:000221835600001	15179637				2022-02-06	
J	Hansson, MJ; Mansson, R; Mattiasson, G; Ohlsson, J; Karlsson, J; Keep, MF; Elmer, E				Hansson, MJ; Mansson, R; Mattiasson, G; Ohlsson, J; Karlsson, J; Keep, MF; Elmer, E			Brain-derived respiring mitochondria exhibit homogeneous, complete and cyclosporin-sensitive permeability transition	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; cell death; flow cytometry; ischaemia; neurodegeneration; traumatic brain injury	TRANSIENT FOREBRAIN ISCHEMIA; CYTOCHROME-C RELEASE; IMMUNOSUPPRESSANT FK506; MEMBRANE TRANSITION; HEART-MITOCHONDRIA; DOSE-RESPONSE; AXONAL INJURY; CELL-DEATH; CALCIUM; DAMAGE	The mitochondrial permeability transition (mPT) is increasingly implicated in neuronal cell death. In the present study, isolated respiring brain mitochondria were examined for their ability to undergo calcium-induced mPT and their sensitivity to mPT inhibition by cyclosporin A (CsA). Previous studies have suggested a heterogeneous response to calcium, a limitation of CsA inhibition, and a relative resistance in the ability of respiring brain mitochondria to undergo mPT. Using fluorometric and electron microscopic analyses, we found that virtually the whole population of respiring brain mitochondria readily undergo mPT and swell upon calcium exposure. Further, brain mitochondria were highly sensitive to CsA which potentiated morphological recovery after transient swelling as well as completely blocked mPT induction in the presence of a low concentration of ADP. Using flow cytometry, which allows analysis of individual mitochondria, we demonstrate that both brain and liver mitochondria display homogeneous responses to calcium-induced mPT. We conclude that the mPT is one likely target for the broad in vivo neuroprotective effects displayed by CsA when allowed to penetrate the blood-brain barrier, and that development of compounds inhibiting mPT may prove beneficial for the treatment of severe brain disease.	Lund Univ, Wallenberg Neurosci Ctr, Expt Brain Res Lab, S-22100 Lund, Sweden; Ryhov Hosp, Dept Internal Med, Jonkoping, Sweden; Malmo Univ Hosp, Dept Neurol, Malmo, Sweden; Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Community Environm Hlth Program, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Div Neurosurg, Albuquerque, NM 87131 USA		Hansson, MJ (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Expt Brain Res Lab, S-22100 Lund, Sweden.	magnus.hansson@expbr.lu.se	Hansson, Magnus/G-4486-2014; Elmer, Eskil/F-9341-2014	Hansson, Magnus/0000-0002-0201-0638; Elmer, Eskil/0000-0001-7901-1826			Andreyev A, 1999, CELL DEATH DIFFER, V6, P825, DOI 10.1038/sj.cdd.4400565; Andreyev AY, 1998, FEBS LETT, V439, P373, DOI 10.1016/S0014-5793(98)01394-5; Anneser JMH, 2001, NEUROREPORT, V12, P2663, DOI 10.1097/00001756-200108280-00015; Berman SB, 2000, EXP NEUROL, V164, P415, DOI 10.1006/exnr.2000.7438; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Borel J F, 1996, Adv Pharmacol, V35, P115, DOI 10.1016/S1054-3589(08)60276-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Butcher SP, 1997, J NEUROSCI, V17, P6939; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1988, BIOCHEM J, V255, P357; Drake M, 1996, ACTA PHYSIOL SCAND, V158, P155, DOI 10.1046/j.1365-201X.1996.535298000.x; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; FOLBERGROVA J, 1990, J NEUROCHEM, V55, P1690, DOI 10.1111/j.1471-4159.1990.tb04957.x; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Gillessen T, 2002, BIOMED PHARMACOTHER, V56, P186, DOI 10.1016/S0753-3322(02)00184-1; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Keep M, 2001, BRAIN RES, V894, P327, DOI 10.1016/S0006-8993(01)02012-1; Keep Marcus F., 2003, P343; Keep Marcus F., 2003, P3; Kristal BS, 2000, DEV NEUROSCI-BASEL, V22, P376, DOI 10.1159/000017463; Kristal BS, 1997, J NEUROCHEM, V69, P524; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Kristian T, 1998, EXP BRAIN RES, V120, P503, DOI 10.1007/s002210050424; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Kuroda S, 1999, BRAIN RES, V835, P148, DOI 10.1016/S0006-8993(99)01535-8; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li PA, 1997, BRAIN RES, V753, P133, DOI 10.1016/S0006-8993(97)00005-X; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mattiasson G, 2003, J NEUROCHEM, V87, P532, DOI 10.1046/j.1471-4159.2003.02026.x; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Nieminen AL, 1996, NEUROSCIENCE, V75, P993; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schinder AF, 1996, J NEUROSCI, V16, P6125; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; VINK R, 1988, J BIOL CHEM, V263, P757; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; White RJ, 1996, J NEUROSCI, V16, P5688; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; Yoshimoto T, 2001, BRAIN RES, V899, P148, DOI 10.1016/S0006-8993(01)02220-X; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	77	55	56	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAY	2004	89	3					715	729		10.1111/j.1471-4159.2004.02400.x			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	812QV	WOS:000220854900019	15086528	Bronze			2022-02-06	
J	da Costa, RMEM; de Carvalho, LAV				da Costa, RMEM; de Carvalho, LAV			The acceptance of virtual reality devices for cognitive rehabilitation: a report of positive results with schizophrenia	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						virtual reality; virtual environment; cognitive rehabilitation; schizophrenia		This study presents a process of virtual environment development supported by a cognitive model that is specific to cognitive deficits of diverse disorders or traumatic brain injury, and evaluates the acceptance of computer devices by a group of schizophrenic patients. The subjects that participated in this experiment accepted to work with computers and immersive glasses and demonstrated a high level of interest in the proposed tasks. No problems of illness have been observed. This experiment indicated that further research projects must be carried out to verify the value of virtual reality technology for cognitive rehabilitation of psychiatric patients. The results of the current study represent a small but necessary step in the realization of that potential. (C) 2003 Elsevier Ireland Ltd. All rights reserved.	UERJ, IME, Dept Informat & Ciencia Compt, BR-20550013 Rio De Janeiro, RJ, Brazil; UFRJ, COPPE, Programa Eng Sistemas & Comp, BR-21945270 Rio De Janeiro, RJ, Brazil		da Costa, RMEM (corresponding author), UERJ, IME, Dept Informat & Ciencia Compt, Rua Sao Francisco Xavier 524 6 Andar,Bl B, BR-20550013 Rio De Janeiro, RJ, Brazil.	rcosta@ime.uerj.br; alfredo@cos.ufrj.br	Costa, Rosa Maria/H-4053-2018	Costa, Rosa Maria/0000-0001-6165-1649			BURDA PC, 1994, COMPUT HUM BEHAV, V10, P359, DOI 10.1016/0747-5632(94)90061-2; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Dautenhahn K., 2000, P 3 INT C DIS VIRT R, P153; DIAMONT JJ, 1989, COGNITIVE REHABILITA; FURLAN JD, 1998, MODELAGEM OBJETOS AT; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Jeste D. V., 1996, NEUROPSYCHIATRY, P325; KIRNER T, 1998, P 2 IEEE INT S APPL; LEWIS CH, 1997, VIRTUAL REALITY NEUR; NINISS H, 2000, P 3 INT C DIS VIRT R, P9; North M., 1998, CLIN PSYCHOL NEUROSC; Pantelidis VS., 1995, VR SCH, V1, P9; PARENTE R., 1996, RETRAINING COGNITION; PRESSMAN RS, 1997, SOFTWARE ENG; RIZZO A, 2001, APPL VIRTUAL ENV MEN; ROSE FD, 1996, BRIT J THERAPY REHAB, V3; ROUSSOS M, 1997, THESIS U ILLINOIS CH; SCHWARTZKROIN P, 1989, TXB PHYSL, V1, P718; Silverstein SM, 1998, PSYCHIAT QUART, V69, P169, DOI 10.1023/A:1022197109569; STUART R, 1996, DESIGN VIRTUAL ENV; Wiederhold BK., 1998, VIRTUAL ENV CLIN PSY; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876	22	55	57	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	MAR	2004	73	3					173	182		10.1016/S0169-2607(03)00066-X			10	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	801XX	WOS:000220129700001	14980398				2022-02-06	
J	Mathias, JL; Bigler, ED; Jones, NR; Bowden, SC; Barrett-Woodbridge, M; Brown, GC; Taylor, AJ				Mathias, JL; Bigler, ED; Jones, NR; Bowden, SC; Barrett-Woodbridge, M; Brown, GC; Taylor, AJ			Neuropsychological and information processing performance and its relationship to white matter changes following moderate and severe traumatic brain injury: A preliminary study	APPLIED NEUROPSYCHOLOGY			English	Article; Proceedings Paper	5th World Congress on Traumatic Brain Injury	MAY, 2003	STOCKHOLM, SWEDEN			information processing speed; interhemispheric processing; white matter; traumatic brain injury; neuropsychological performance; corpus callosum	CLOSED-HEAD-INJURY; CORPUS-CALLOSUM; SEX-DIFFERENCES; AXONAL INJURY; REACTION-TIME; MILD; ATTENTION; ATROPHY; DISCONNECTION; INTELLIGENCE	Reductions in information processing speed have frequently been reported following moderate and severe traumatic brain injuries (TBIs), consistent with the effects of diffuse white matter damage. Although the corpus callosum (CC) is a common site for diffuse damage following TBI, the effects of this damage on information processing speed have not been adequately examined. This study assessed a TBI group and a matched control group on tests of attention, memory, fluency, and set shifting ability, together with reaction time (RT) tasks requiring the inter- and intrahemispheric processing of visual and tactile information. The RT tasks were designed to target the cognitive functions that are likely to be affected by diffuse white matter damage, including damage to the CC. The TBI group demonstrated deficits in verbal and visual fluency and verbal memory. They were also slower on the visual and tactile RT tasks, were more affected by task complexity, and slower on RT tasks requiring the interhemispheric transfer of information. In fact, one of the interhemispheric tactile RT tasks proved to be the most discriminating of all the cognitive and RT measures. MRIs completed on a subset of TBI participants indicated that the mean CC measurements were 5% to 19% smaller than a normative control group, with the most atrophied areas being the isthmus and anterior midbody. Although white matter atrophy was moderately related to visual and tactile RT performance, and total hippocampal volume related to memory performance, CC area was not related to many of the tasks that were designed to tap interhemispheric processing. None of the standard cognitive tests correlated with outcome in the TBI group, but 1 of the tactile RT measures was significantly related to 2 measures of outcome.	Univ Adelaide, Dept Psychol, Adelaide, SA 5005, Australia; Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Univ Utah, Dept Psychiat & Radiol, Salt Lake City, UT USA; Univ Adelaide, Dept Neurosurg, Adelaide, SA 5005, Australia; Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia; Royal Adelaide Hosp, Dept Radiol, Adelaide, SA, Australia		Mathias, JL (corresponding author), Univ Adelaide, Dept Psychol, Adelaide, SA 5005, Australia.	jane.mathias@psychology.adelaide.edu.au	Brown, Gregory/D-3983-2013; Mathias, J L/L-6295-2013	Brown, Gregory/0000-0001-7994-2743; Mathias, Jane/0000-0001-8957-8594			ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson DR., 1982, TESTING FIELD VISION; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bagley LJ, 1999, AM J NEURORADIOL, V20, P977; Banich M.T., 1997, NEUROPSYCHOLOGY NEUR; Banich M.T., 1994, NEUROPSYCHOLOGY, V8, P263; BANICH MT, 1992, J EXP PSYCHOL HUMAN, V18, P763, DOI 10.1037/0096-1523.18.3.763; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; BERGESON AG, IN PRESS CLIN NEUROP; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BRAUNSTEIN P, 1989, STEREOCHEMISTRY ORGA, V3, P1; CECH KM, 1998, J NEUROSURG, V88, P795; CLARKE JM, 1994, BEHAV BRAIN RES, V64, P185, DOI 10.1016/0166-4328(94)90131-7; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corballis MC, 2002, NEUROPSYCHOLOGIA, V40, P423, DOI 10.1016/S0028-3932(01)00097-5; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; CURRY LM, 1991, PHILADELPHIA HEAD IN; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Deloche Gerard, 1993, Brain Injury, V7, P363, DOI 10.3109/02699059309034963; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; EVANS RW, 1985, PERCEPT MOTOR SKILL, V61, P699, DOI 10.2466/pms.1985.61.3.699; Freeman J, 2000, BRIT J CLIN PSYCHOL, V39, P95, DOI 10.1348/014466500163130; Freeman J, 2001, BRIT J CLIN PSYCHOL, V40, P221, DOI 10.1348/014466501163562; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gean AD, 1994, IMAGING HEAD TRAUMA; GEFFEN G, 1985, NEUROPSYCHOLOGIA, V23, P497, DOI 10.1016/0028-3932(85)90004-1; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V2, P823; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holden C, 2003, SCIENCE, V299, P192, DOI 10.1126/science.299.5604.192; HOPKINS RO, 2003, J INT NEUROPSYCH SOC, V9, P234; IACOBONI M, 1995, BRAIN, V118, P779, DOI 10.1093/brain/118.3.779; JENNETT B, 1975, LANCET, V1, P480; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Klaas PA, 1999, J CLIN EXP NEUROPSYC, V21, P837, DOI 10.1076/jcen.21.6.837.851; Levander MB, 1998, BRAIN INJURY, V12, P165, DOI 10.1080/026990598122791; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Milders M, 1999, J CLIN EXP NEUROPSYC, V21, P171, DOI 10.1076/jcen.21.2.171.932; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; OTOOLE BI, 1990, ACCIDENT ANAL PREV, V22, P211, DOI 10.1016/0001-4575(90)90013-B; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; QUINN K, 1986, NEUROPSYCHOLOGIA, V24, P793, DOI 10.1016/0028-3932(86)90078-3; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Robertson I., 1994, TEST EVERYDAY ATTENT; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schmidt M., 1996, REY AUDITORY VERBAL; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VUILLEUMIER P, 1995, CLIN NEUROL NEUROSUR, V97, P39, DOI 10.1016/0303-8467(94)00056-C; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	88	55	56	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2004	11	3					134	152		10.1207/s15324826an1103_2			19	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychology	883SL	WOS:000226035900002	15590348				2022-02-06	
J	Sakoh, M; Gjedde, A				Sakoh, M; Gjedde, A			Neuroprotection in hypothermia linked to redistribution of oxygen in brain	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						cerebral blood flow; cerebral metabolic rate of oxygen	CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; ACUTE STROKE; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; ARTERY OCCLUSION; POSTISCHEMIC HYPOTHERMIA; GLUCOSE-METABOLISM; FOCAL ISCHEMIA; CANINE BRAIN	Hypothermia improves the outcome of acute ischemic stroke, traumatic injury, and inflammation of brain tissue. We tested the hypothesis that hypothermia reduces the energy metabolism of brain tissue to a level that is commensurate with the prevailing blood flow and hence allows adequate distribution of oxygen to the entire tissue. To determine the effect of 32degreesC hypothermia on brain tissue, we measured the sequential changes of physiological variables by means of PET in pigs. Cerebral blood flow and oxygen consumption (cerebral metabolic rate of oxygen) declined to 50% of the baseline in 3 and 5 h, respectively, thus elevating the oxygen extraction fraction to 140% of the baseline at 3 h. The results are consistent with the claim that cooling of the brain to 32degreesC couples both energy metabolism and blood flow to a lower rate of work of the entire tissue.	Aarhus Univ Hosp, PET Ctr, DK-8000 Aarhus, Denmark; Aarhus Univ, Ctr Functionally Integrat Neurosci, DK-8000 Aarhus, Denmark; Ehime Univ, Sch Med, Dept Neurol Surg, Matsuyama, Ehime 7910295, Japan		Gjedde, A (corresponding author), Aarhus Univ Hosp, PET Ctr, 44 Norrebrogade, DK-8000 Aarhus, Denmark.	albert@gjedde.nu	Gjedde, Albert/U-3751-2019; Gjedde, Albert/I-2452-2019	Gjedde, Albert/0000-0002-3756-7401; 			Angstwurm K, 2000, J CEREBR BLOOD F MET, V20, P834, DOI 10.1097/00004647-200005000-00010; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Aubert A, 2002, NEUROIMAGE, V17, P1162, DOI 10.1006/nimg.2002.1224; Bacher A, 1998, ANESTHESIOLOGY, V88, P403, DOI 10.1097/00000542-199802000-00019; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Canevari L, 1999, BRAIN RES, V817, P241, DOI 10.1016/S0006-8993(98)01278-5; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Clifton G, 2000, J NEUROSURG, V93, P718; COETZEE A, 1990, SCAND J CLIN LAB INV, V50, P149, DOI 10.3109/00365519009087504; CROUGHWELL N, 1992, J THORAC CARDIOV SUR, V103, P549; Danielsen E, 1998, SCAND J LAB ANIM SCI, V25, P127; DEMPSEY RJ, 1987, NEUROSURGERY, V21, P177, DOI 10.1227/00006123-198708000-00007; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; Gjedde A, 1978, Ugeskr Laeger, V140, P1408; Gjedde A, 2002, NEUROIMAGE, V17, P1876, DOI 10.1006/nimg.2002.1272; Gjedde A, 2002, J CEREBR BLOOD F MET, V22, P1, DOI 10.1097/00004647-200201000-00001; GJEDDE A, 2002, BRAIN ACTIVATION CBF, P223; GJEDDE A, 1991, A BENZON S, V31, P177; Gjedde Albert, 1997, P23; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; GUTIERREZ G, 1986, J APPL PHYSIOL, V60, P751, DOI 10.1152/jappl.1986.60.3.751; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Henderson RD, 2001, J NEUROSURG, V95, P964, DOI 10.3171/jns.2001.95.6.0964; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; Hyder F, 1998, J APPL PHYSIOL, V85, P554, DOI 10.1152/jappl.1998.85.2.554; ILLIEVICH UM, 1994, ANESTHESIOLOGY, V80, P177, DOI 10.1097/00000542-199401000-00025; Iwama T, 1997, J NEUROSURG, V87, P440, DOI 10.3171/jns.1997.87.3.0440; JIANG Q, 1994, J CEREBR BLOOD F MET, V14, P732, DOI 10.1038/jcbfm.1994.94; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; KARIBE H, 1994, BRAIN RES, V649, P12, DOI 10.1016/0006-8993(94)91043-X; KASSISSIA IG, 1995, CIRC RES, V77, P1201, DOI 10.1161/01.RES.77.6.1201; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P10, DOI 10.1164/ajrccm.151.1.7812538; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; MICHENFELDER JD, 1970, ANESTHESIOLOGY, V33, P430, DOI 10.1097/00000542-197010000-00013; MICHENFELDER JD, 1977, STROKE, V8, P87, DOI 10.1161/01.STR.8.1.87; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; Mori K, 1999, NEUROL RES, V21, P585, DOI 10.1080/01616412.1999.11740981; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; OHTA S, 1992, J CEREBR BLOOD F MET, V12, P179, DOI 10.1038/jcbfm.1992.28; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P765, DOI 10.1097/00004647-199609000-00002; Ooboshi H, 2000, BRAIN RES, V884, P23, DOI 10.1016/S0006-8993(00)02861-4; Poulsen PH, 1997, J NEUROSCI METH, V77, P199, DOI 10.1016/S0165-0270(97)00127-1; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Sakoh M, 2000, STROKE, V31, P1958, DOI 10.1161/01.STR.31.8.1958; Sakoh M, 2000, J NEUROSURG, V93, P647, DOI 10.3171/jns.2000.93.4.0647; Schwab M, 1998, ACTA NEUROBIOL EXP, V58, P29; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; SESSLER DI, 1995, J NEUROSURG ANESTH, V7, P38, DOI 10.1097/00008506-199501000-00008; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; TOUZANI O, 1995, STROKE, V26, P2112, DOI 10.1161/01.STR.26.11.2112; Ueda T, 1999, J CEREBR BLOOD F MET, V19, P99, DOI 10.1097/00004647-199901000-00011; Vafaee MS, 2000, J CEREBR BLOOD F MET, V20, P747, DOI 10.1097/00004647-200004000-00012; VALABREGUE R, IN PRESS J CEREB BLO; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	62	55	57	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	JUL	2003	285	1					H17	H25		10.1152/ajpheart.01112.2002			9	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Physiology	687AX	WOS:000183354600003	12793975				2022-02-06	
J	Schultke, E; Kendall, E; Kamencic, H; Ghong, Z; Griebel, RW; Juurlink, BHJ				Schultke, E; Kendall, E; Kamencic, H; Ghong, Z; Griebel, RW; Juurlink, BHJ			Quercetin promotes functional recovery following acute spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						functional recovery; iron chelation; MRI; neurotrauma; rat; spinal cord	LIPID-PEROXIDATION; HUMAN-ERYTHROCYTES; OXIDATIVE STRESS; IRON RELEASE; FLAVONOIDS; INHIBITION; APOPTOSIS; ANTIOXIDANT; METHYLPREDNISOLONE; TRAUMA	We tested the hypothesis that quercetin, a potent Fe2+-chelating flavonoid, would decrease secondary damage following spinal cord trauma. MRI studies using the relaxation of the T1 proton signal caused by Fe2+ ions and the dose-dependent reversal of this effect by addition of quercetin in aqueous solution were used to guide us to the dosage of quercetin to be used in animal experimentations. Forty-four male Wistar rats were used in two experimental series to test the hypothesis that administration of quercetin improves recovery of motor function after acute traumatic spinal cord injury. Animals were subjected to laminectomy and subjected to an extradural 40-g force clip compression for 5 see at T7. Quercetin or saline was administered intraperitoneally 1 h after injury and then every 12 hr thereafter. Recovery of motor function was assessed using BBB scores at weekly intervals for 4 weeks. A dose of 2.5 mumoles quercetin/kg body weight did not result in significantly better functional outcome, whereas doses ranging from 5 to 100 mumoles quercetin/kg body weight resulted in a significantly better functional outcome with half or more of the animals walking, although with deficit; in contrast, no animals walked in the group of saline-treated animals. No significant differences in behavioral outcome were seen amongst the doses ranging from 5 to 100 mumol/kg, nor was there a difference if animals were treated for 4 or 10 days. Therapeutic outcome was coincident with more efficient iron clearance, suggesting that one possible mechanism whereby quercetin decreases secondary damage is through iron chelation.	Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada; Univ Saskatchewan, Dept Med Imaging, Saskatoon, SK S7N 5E5, Canada; Univ Saskatchewan, Dept Surg, Div Neurosurg, Saskatoon, SK S7N 5E5, Canada		Juurlink, BHJ (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	juurlink@duke.usask.ca	Schultke, Elisabeth/M-3959-2013	Kendall, Edward/0000-0002-9638-9254			AFANASEV IB, 1989, BIOCHEM PHARMACOL, V38, P1763, DOI 10.1016/0006-2952(89)90410-3; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BENHUR E, 1993, PHOTOCHEM PHOTOBIOL, V57, P984, DOI 10.1111/j.1751-1097.1993.tb02959.x; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Cheng IF, 2000, BIOMETALS, V13, P77, DOI 10.1023/A:1009229429250; Comporti M, 2002, FREE RADICAL BIO MED, V32, P568, DOI 10.1016/S0891-5849(02)00759-1; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Cotelle N, 1996, FREE RADICAL BIO MED, V20, P35, DOI 10.1016/0891-5849(95)02014-4; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cuevas P, 2001, NEUROL RES, V23, P207, DOI 10.1179/016164101101198352; Farooque M, 1999, NEUROREPORT, V10, P131, DOI 10.1097/00001756-199901180-00024; Fehlings MG, 2001, SPINE, V26, pS99; FEHLINGS MG, 2000, CONT MANAGEMENT SPIN, P35; Fernandez MT, 2002, J INORG BIOCHEM, V92, P105, DOI 10.1016/S0162-0134(02)00511-1; FERRALI M, 1992, BIOCHEM J, V285, P295, DOI 10.1042/bj2850295; FERRANDIZ ML, 1991, AGENTS ACTIONS, V32, P283, DOI 10.1007/BF01980887; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; Galey J B, 1997, Adv Pharmacol, V38, P167; GRIFFITHS LA, 1972, ANGIOLOGICA, V9, P162; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Hall E D, 2001, J Spinal Cord Med, V24, P142; Hall ED, 1995, J NEUROL SCI, V134, P79, DOI 10.1016/0022-510X(95)00211-J; Halliwell B., 1989, FREE RADICALS BIOL M, VSecond; HIDER RC, 1994, ADV EXP MED BIOL, V356, P343; HOLLMAN RC, 1996, FREE RADIC BIOL MED, V21, P232; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Huk I, 1998, BRIT J SURG, V85, P1080; Hurlbert RJ, 2001, SPINE, V26, pS39, DOI 10.1097/00007632-200112151-00009; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Koc RK, 1999, SPINAL CORD, V37, P29, DOI 10.1038/sj.sc.3100732; Koszyca B, 2002, J CLIN NEUROSCI, V9, P298, DOI 10.1054/jocn.2001.0969; Mallory FB, 1961, PATHOLOGICAL TECHNIQ; Matz PG, 2000, BRAIN RES, V858, P312, DOI 10.1016/S0006-8993(99)02454-3; MIDDLETON E, 1992, BIOCHEM PHARMACOL, V43, P1167, DOI 10.1016/0006-2952(92)90489-6; MOREL I, 1993, BIOCHEM PHARMACOL, V45, P13, DOI 10.1016/0006-2952(93)90371-3; NOCKELS R, 1992, J NEUROTRAUM, V9, pS211; Pelzer LE, 1998, FARMACO, V53, P421, DOI 10.1016/S0014-827X(98)00046-9; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; RATTY AK, 1988, BIOCHEM MED METAB B, V39, P69, DOI 10.1016/0885-4505(88)90060-6; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Romanova D, 2001, NEOPLASMA, V48, P104; SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K; SCHULTKE E, 2000, SOC NEUR ABSTR, V27, P516; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sestili P, 1998, FREE RADICAL BIO MED, V25, P196, DOI 10.1016/S0891-5849(98)00040-9; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Sobottka AM, 2000, ARCH PHARM, V333, P205, DOI 10.1002/1521-4184(20007)333:7<205::AID-ARDP205>3.3.CO;2-P; SORATA Y, 1984, BIOCHIM BIOPHYS ACTA, V799, P313, DOI 10.1016/0304-4165(84)90276-9; Sugihara N, 1999, FREE RADICAL BIO MED, V27, P1313, DOI 10.1016/S0891-5849(99)00167-7; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; TATOR CH, 1991, NEUROCHIRURGIE, V37, P291; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; THOMPSON JH, 1966, IRISH J MED SCI, V484, P127; vanAcker SABE, 1996, FREE RADICAL BIO MED, V20, P331, DOI 10.1016/0891-5849(95)02047-0; Vasiljeva O V, 2000, Membr Cell Biol, V14, P47; Vymazal J, 1996, MAGN RESON MED, V35, P56, DOI 10.1002/mrm.1910350108; Weidner N, 1999, EXP NEUROL, V160, P40, DOI 10.1006/exnr.1999.7200; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459	71	55	58	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2003	20	6					583	591		10.1089/089771503767168500			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	697DL	WOS:000183926900006	12906742				2022-02-06	
J	Nathoo, N; Chetty, R; Van Dellen, JR; Connolly, C; Naidoo, R				Nathoo, N; Chetty, R; Van Dellen, JR; Connolly, C; Naidoo, R			Apolipoprotein E polymorphism and outcome after closed traumatic brain injury: influence of ethnic and regional differences	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; apolipoprotein E; polymorphism; outcome	CEREBRAL AMYLOID ANGIOPATHY; HEAD-INJURY; HIGH-FREQUENCY; INTRACEREBRAL HEMORRHAGE; ALZHEIMER-DISEASE; EPSILON-4 ALLELE; E GENOTYPE; POPULATIONS; ASSOCIATION; STROKE	Object. The presence of the apolipoprotein E-epsilon4 (APOE-epsilon4) allele is reported to be associated with poor outcome after traumatic brain injury (TBI). This study was performed to determine if the presence of the APOE-epsilon4 allele influenced outcome in a cohort of black patients with TBI who had homogeneous neuropathological findings. Methods. Venous blood was collected at the time of admission to determine the APOE genotype in black Zulu-speaking patients who presented with traumatic cerebral contusions. The frequency of the APOE-epsilon4 allele's appearance was correlated with outcome at a minimum of 6 months of follow up. Univariate and multivariate analyses were performed to determine independent risk factors and to control for confounding factors. In 110 black Zulu-speaking patients with traumatic cerebral contusions, genotypes for APOE were analyzed. Eleven of 45 (24.4%) with the APOE-epsilon4 allele experienced a poor outcome, compared with 10 (15.4%) of 65 without this allele (p = 0.34). Both patients with homozygous APOE-epsilon4 alleles experienced a good outcome (Glasgow Outcome Score 5). Univariate and multivariate analysis revealed no significant relationship in patients with the APOE-epsilon4 allele with regard to age, admission Glasgow Comas Scale score, contusion volume, type of neurosurgical management, and outcome. The risk of a poor outcome was, however, greater in patients with the APOE-epsilon4 allele (relative risk 1.59; 95% confidence interval 0.74-3.42). Conclusions. The authors recorded no relationship between APOE-epsilon4 allele status and outcome after TBI in black patients. Given the high regional susceptibility to the APOE gene, further studies, possibly even community-based investigations and studies conducted in other geographic areas, are probably warranted.	Univ Natal, Wentworth Hosp, Nelson R Mandela Sch Med, Dept Neurosurg, Natal, RN, Brazil; Univ Natal, Wentworth Hosp, Nelson R Mandela Sch Med, Dept Pathol, Natal, RN, Brazil; Univ Natal, Wentworth Hosp, Nelson R Mandela Sch Med, Dept Mol Biol, Natal, RN, Brazil; MRC S Africa, Div Biostat, Durban, South Africa; W London Neurosci Ctr, London, England; Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Sch Med, London, England		Nathoo, N (corresponding author), Cleveland Clin Fdn, Dept Neurosurg, 9500 Euclid Ave, Cleveland, OH 44195 USA.						ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Basun H, 1996, STROKE, V27, P1310, DOI 10.1161/01.STR.27.8.1310; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chikosi AB, 2000, HYPERTENS PREGNANCY, V19, P309, DOI 10.1081/PRG-100101992; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Greenberg SM, 1996, STROKE, V27, P1333, DOI 10.1161/01.STR.27.8.1333; HIXSON JE, 1990, J LIPID RES, V31, P545; JENNETT B, 1975, LANCET, V1, P480; KAMBOH MI, 1989, DIS MARKERS, V7, P49; KAY AD, 2002, NEUROPATHOL APPL NEU, V28, P152; LECLERCQ PD, 2002, NEUROPATHOL APPL NEU, V28, P161; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Loktionov A, 1999, ATHEROSCLEROSIS, V145, P125, DOI 10.1016/S0021-9150(99)00022-2; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; McCarron MO, 2000, ARCH NEUROL-CHICAGO, V57, P1480, DOI 10.1001/archneur.57.10.1480; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nicoll JAR, 1996, ANN NEUROL, V39, P682, DOI 10.1002/ana.410390521; Niskakangas T, 2001, STROKE, V32, P1181, DOI 10.1161/01.STR.32.5.1181; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; SANDHOLZER C, 1995, HUM GENET, V95, P46; SEPEHRNIA B, 1988, AM J HUM GENET, V43, P847; SMITH C, 2002, NEUROPATHOL APPL NEU, V28, P15; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Zekraoui L, 1997, HUM BIOL, V69, P575	33	55	62	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	2003	98	2					302	306		10.3171/jns.2003.98.2.0302			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	643RB	WOS:000180873300007	12593615				2022-02-06	
J	Forducey, PG; Ruwe, WD; Dawson, SJ; Scheideman-Miller, C; McDonald, NB; Hantla, MR				Forducey, PG; Ruwe, WD; Dawson, SJ; Scheideman-Miller, C; McDonald, NB; Hantla, MR			Using telerehabilitation to promote TBI recovery and transfer of knowledge	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; DISABILITIES; STROKE; URBAN; STATE	Advances in the design and delivery of trauma care and acute medical management have increased the number of survivors of traumatic brain injury (TBI), producing societal consequences and medical challenges. Although access to health care for rural patients remains a critical challenge, teletherapy may represent a viable means for the delivery of therapeutic services to such patients. A case study is presented in which teletherapy was successfully utilized to improve the functional outcomes, both physical and cognitive, of a patient with a severe TBI. A physical therapist from a metropolitan rehabilitation center employed teletherapy to provide Neuro Developmental Treatment for a patient and to mentor staff in a nursing home located over 100 miles from the metro area. The patient, who participated in 48 physical teletherapy sessions over a 24-week period, demonstrated improvements in physical functioning and neuropsychological status. During the course of therapy, goals were adjusted upward to match the patient's improvements. This case study provides confirmatory evidence that teletherapy represents an effective and efficient means for providing rehabilitation services for patients in rural communities, as well as for facilitating mentoring relationships between seasoned professionals and trainees located in rural settings.	INTEGRIS Jim Thorpe Rehabil Ctr, Oklahoma City, OK USA		Forducey, PG (corresponding author), INTEGRIS Jim Thorpe Rehabil Ctr, 4219 S Westerna Ave, Oklahoma City, OK USA.						Artunian J, 1997, Rehab Manag, V10, P54; ARTUNIAN J, 1997, REHAB MANAGEMENT, V10, P58; ARTUNIAN J, 1997, REHAB MANAGEMENT, V10, P56; Auchincloss AH, 2002, J RURAL HEALTH, V18, P319, DOI 10.1111/j.1748-0361.2002.tb00894.x; Bobath B., 1990, ADULT HEMIPLEGIA EVA; BORSTAD AL, 2001, P STAT SCI C TEL APP, P3; Bull CN, 2001, J RURAL HEALTH, V17, P356, DOI 10.1111/j.1748-0361.2001.tb00288.x; Burns RB, 1998, ASSIST TECHNOL, V10, P126, DOI 10.1080/10400435.1998.10131970; *CDC, TRAUM BRAIN INJ US R; CLARK PG, 2002, NEUROLOGY REPORT, V26, P86; Conner K, 1999, Rehab Manag, V12, P72; CONNER K, 1999, REHAB MANAGEMENT, V12, P74; DAWSON SJ, 1999, PHYSICAL THERAPY CAS, V3, P84; Eldar R, 2001, J RURAL HEALTH, V17, P341, DOI 10.1111/j.1748-0361.2001.tb00285.x; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P3, DOI 10.1037/0090-5550.47.1.3; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Nudo RJ, 1999, CURR OPIN NEUROBIOL, V9, P740, DOI 10.1016/S0959-4388(99)00027-6; Ogden R., 1917, PSYCHOBIOLOGY, V1, P33, DOI [10.1037/h0074814, DOI 10.1037/H0074814]; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; Rogers FB, 2001, J TRAUMA, V50, P604, DOI 10.1097/00005373-200104000-00003; SCHEIDEMANMILLE.CL, 2002, UNPUB RURAL POST ACU; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; Snow C, 1996, Mod Healthc, V26, P102; SNOW C, 1996, MODERN HEALTHCARE, V26, P102; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vesmarovich S, 1999, Adv Wound Care, V12, P264; 1998, NIH CONSENSUS STATEM, V16, P1	31	55	57	2	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2003	18	2					103	111					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	743ZU	WOS:000186604100003	12867673				2022-02-06	
J	Mussack, T; Biberthaler, P; Kanz, KG; Heckl, U; Gruber, R; Linsenmaier, U; Mutschler, W; Jochum, M				Mussack, T; Biberthaler, P; Kanz, KG; Heckl, U; Gruber, R; Linsenmaier, U; Mutschler, W; Jochum, M			Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients	SHOCK			English	Article						traumatic brain injury; minor head injury; S-100B; NSE; cerebral computed tomography; ROC analysis; alcohol intoxication; screening test	COMPUTED-TOMOGRAPHY; NEUROBIOCHEMICAL MARKERS; TEMPORAL PROFILE; SERUM LEVELS; TRAUMA; MANAGEMENT; PROTEIN; S100-BETA; SEVERITY; RELEASE	The neuroproteins S-100B and neuron-specific enolase (NSE) released into the circulation are suggested to be reliable markers for primary brain damage. However, safe identification of relevant post-traumatic complications after minor head injury (MHI) is often hampered by acute intoxication of the patients. The objective of this study was to determine the diagnostic validity of immediate plasma measurements of S-100B and NSE in comparison with neurological examinations and cerebral computed tomography (CCT) findings in alcohol-intoxicated MHI patients. One hundered thrity-nine MHI individuals were enrolled in this prospective study during Munich's Oktoberfest 2000. Plasma levels of S-100B and NSE as well as serum alcohol and glucose values were determined by fully automated assays immediately after admission. The results were compared with Glasgow Coma Scale score, a brief neurological examination, and the CCT findings. Without being influenced by alcohol, median S-100B levels of the CCT+ group were significantly increased compared with those of the CCT- group (P < 0.001). NSE, alcohol, and glucose levels showed no significant group differences. As calculated by the ROC analysis, a cutoff value of 0.21 ng/mL with an area under the curve of 0.864 clearly differentiates between CCT+ and CCT- patients at a sensitivity of 100%, a specificity of 50.0%, and a positive likelihood ratio of 2.0. Although acute alcohol intoxication did not confound plasma measurements of S-100B and NSE, only S-100B levels below the cutoff level of 0.21 ng/mL seem to indicate absence of primary brain damage. Thus, in addition to routine neurological examinations, S-100B measurements immediately after admission might help to reduce CCT scans in alcohol-intoxicated patients early after MHI.	Klinikum Univ Munich, Chirurg Klin & Poliklin Innenstadt, D-80336 Munich, Germany; Klinikum Univ Munich, Med Klin & Poliklin Innenstadt, Munich, Germany; Klinikum Univ Munich, Inst Klin Radiol, Munich, Germany; Klinikum Univ Munich, Abt Klin Chem & Klin Biochem, Munich, Germany		Mussack, T (corresponding author), Klinikum Univ Munich, Chirurg Klin & Poliklin Innenstadt, Nussbaumstr 20, D-80336 Munich, Germany.						Baethmann A, 1999, ACT NEUR S, V73, P93; Baethmann A, 1998, ACT NEUR S, V71, P107; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Fogel W, 1997, CRIT CARE MED, V25, P1133, DOI 10.1097/00003246-199707000-00012; Griner P F, 1981, Ann Intern Med, V94, P557; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hammon JW, 2000, J THORAC CARDIOV SUR, V119, P130, DOI 10.1016/S0022-5223(00)70227-3; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; KAHN HJ, 1991, MODERN PATHOL, V4, P698; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Lehr D, 1997, J TRAUMA, V42, pS71, DOI 10.1097/00005373-199705001-00015; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mussack T, 2000, ACT NEUR S, V76, P393; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	36	55	61	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	NOV	2002	18	5					395	400		10.1097/00024382-200211000-00002			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	617VW	WOS:000179382400002	12412616				2022-02-06	
J	Van Laere, KJ; Warwick, J; Versijpt, J; Goethals, I; Audenaert, K; Van Heerden, B; Dierckx, R				Van Laere, KJ; Warwick, J; Versijpt, J; Goethals, I; Audenaert, K; Van Heerden, B; Dierckx, R			Analysis of clinical brain SPECT data based on anatomic standardization and reference to normal data: An ROC-based comparison of visual, semiquantitative, and voxel-based methods	JOURNAL OF NUCLEAR MEDICINE			English	Article						SPECT; statistical parametric mapping; traumatic brain injury; cognitive impairment; anatomic standardization	F-18 FDG PET; OBSERVER-PERFORMANCE; VALIDATION; IMAGES; INJURY; ACTIVATION; DESIGN; FMRI; MRI; SPM	The technique of anatomic standardization and comparison with normal templates is increasingly used in clinical brain SPECT practice and allows automated, operator-in dependent volume-of-interest (VOI) or voxel-based analysis of whole-brain data. In 2 distinct clinical populations with severe traumatic brain Injury and cognitive impairment, this study compared 3 widely available approaches that use normal templates to evaluate SPECT brain perfusion deficits. Methods: In total, 74 subjects were studied. These included 14 patients with severe, traumatic brain injury (group 1; 10 males, 4 females; mean age +/- SD, 27.6 +/- 8.2 y) and 15 patients with cognitive impairment (group 2; 7 males, 8 females; mean age, 75.8 +/- 8.6 y). These data were compared with those from, respectively, 25 and 20 age- and sex-adjusted healthy volunteers. All data were analyzed in 4 ways. Three semiquantitative statistical algorithms were used: statistical parametric mapping (SPM) using SPM99, brain registration and analysis of SPECT studies (BRASS) using a voxelwise region-growing technique, and a predefined VOI approach. These results were compared with visual analysis based on consensus reading by 3 experienced nuclear medicine physicians. Receiver operating characteristic (ROC) analysis was performed at various statistical cutoffs. Moreover, as a measure of regional agreement, relative regional agreement between methods was assessed. Results: In both study groups, BRASS voxel-based analysis was most accurate, as defined by the area under the ROC curve (0.97 for group 1 and 0.96 for group 2). VOI assessment was slightly more accurate than visual consensus analysis, whereas SPM showed, overall, a lower area under the ROC curve. SPM analysis was also significantly less sensitive at thresholds corresponding to low false-positive fractions. Regional analysis showed 83%-92% agreement between ail methods. Conclusion: Under clinical conditions, classification of brain SPECT studies can greatly be aided by anatomic standardization techniques and reference to normal data. Under the investigated circumstances, SPM was found to have a lower sensitivity than VOI or voxelwise region-growing techniques, especially at low false-positive fractions.	State Univ Ghent Hosp, Div Nucl Med, B-9000 Ghent, Belgium; Univ Stellenbosch, Tygerberg Hosp, Dept Nucl Med, ZA-7600 Matieland, South Africa; State Univ Ghent Hosp, Dept Psychiat, B-9000 Ghent, Belgium		Van Laere, KJ (corresponding author), State Univ Ghent Hosp, Div Nucl Med, P7,De Pintelaan 185, B-9000 Ghent, Belgium.		Versijpt, Jan/F-5531-2013	Versijpt, Jan/0000-0002-8710-5715; Warwick, James/0000-0002-2810-0543			Acton PD, 1998, EUR J NUCL MED, V25, P663; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Burdette JH, 1996, RADIOLOGY, V198, P837, DOI 10.1148/radiology.198.3.8628880; CHAKRABORTY DP, 1990, RADIOLOGY, V174, P873, DOI 10.1148/radiology.174.3.2305073; Drzezga A, 1999, J NUCL MED, V40, P737; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Hendel RC, 1999, CIRCULATION, V99, P2742, DOI 10.1161/01.CIR.99.21.2742; ICHISE M, 1994, J NUCL MED, V35, P217; Ishii K, 2001, J NUCL MED, V42, P548; Jagust W, 2001, NEUROLOGY, V56, P950, DOI 10.1212/WNL.56.7.950; Lahorte P, 2000, NEUROIMAGE, V12, P757, DOI 10.1006/nimg.2000.0658; Liow JS, 2000, J NUCL MED, V41, P612; MASDEU JC, 1995, J NEUROIMAGING, V5, pS53; Metz CE, 1998, STAT MED, V17, P1033, DOI 10.1002/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.0.CO;2-Z; METZ CE, 1989, INVEST RADIOL, V24, P234, DOI 10.1097/00004424-198903000-00012; MILLER JW, 1992, PROG NEUROBIOL, V39, P155, DOI 10.1016/0301-0082(92)90009-4; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Pickut BA, 1997, J NUCL MED, V38, P929; Radau PE, 2000, J NUCL MED, V41, P220; Senda M, 1998, NEUROIMAGE, V8, P283, DOI 10.1006/nimg.1998.0370; Shiina G, 1998, AM J NEURORADIOL, V19, P297; Signorini M, 1999, NEUROIMAGE, V9, P63, DOI 10.1006/nimg.1998.0381; Stamatakis EA, 1999, NEUROIMAGE, V10, P397, DOI 10.1006/nimg.1999.0477; Sugiura M, 1999, J NUCL MED, V40, P317; Swensson RG, 1996, MED PHYS, V23, P1709, DOI 10.1118/1.597758; Talairach J., 1988, COPLANAR STEREOTACTI; Van Laere K, 2001, J NUCL MED, V42, P361; Van Laere K, 2001, EUR J NUCL MED, V28, P873, DOI 10.1007/s002590100549; Van Laere K, 2000, J NUCL MED, V41, P2051; Van Laere K, 2001, EUR J NUCL MED, V28, P435, DOI 10.1007/s002590000461; Van Laere K, 2001, EUR J NUCL MED, V28, P90, DOI 10.1007/s002590000407; VANLAERE K, 2002, IN PRESS NEUROIMAGE; Waldemar G, 1997, Int Psychogeriatr, V9 Suppl 1, P223, DOI 10.1017/S1041610297004924; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; [No title captured]	39	55	55	0	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505			J NUCL MED	J. Nucl. Med.	APR	2002	43	4					458	469					12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	540BA	WOS:000174907300011	11937588				2022-02-06	
J	Soustiel, JF; Shik, V; Shreiber, R; Tavor, Y; Goldsher, D				Soustiel, JF; Shik, V; Shreiber, R; Tavor, Y; Goldsher, D			Basilar vasospasm diagnosis - Investigation of a modified "Lindegaard index" based on imaging studies and blood velocity measurements of the basilar artery	STROKE			English	Article						basilar artery; cerebral angiography; subarachnoid hemorrhage; tomography, x-ray computed; ultrasonography, Doppler, transcranial; vasospasm	TRANSCRANIAL DOPPLER ULTRASOUND; SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; FLOW VELOCITIES; VERTEBROBASILAR VASOSPASM; CEREBROVASCULAR SPASM; ULTRASONOGRAPHY; HEMODYNAMICS; HYPEREMIA	Background and Purpose-Numerous studies have shown that cerebral vasospasm is one of the leading causes of death and neurological disability after subarachnoid hemorrhage. Most of these studies, however, have focused on anterior circulation vessels. Since the introduction of the transcranial Doppler (TCD), increasing attention has been given to basilar artery (BA) vasospasm, especially in traumatic subarachnoid hemorrhage. As shown for the anterior circulation, however, the significance of elevated flow velocities (FVs) in the posterior vessels may be ambiguous, so vasospasm may not be reliably differentiated from hyperemia. The purpose of the present study was to evaluate the potential additional value of an intracranial/extracranial FV ratio in the posterior circulation to cope with this shortcoming of the TCD in the diagnosis of BA vasospasm. Methods-FV in the extracranial vertebral artery (VA) was measured in 20 healthy volunteers. Normative values of all intracranial/extracranial VA FV ratio (IVA/EVA) and a BA/extracranial VA FV ratio (BA/EVA) were calculated. Thirty-four patients with subarachnoid hemorrhage were then evaluated with TCD and CT angiography (CTA). The value of the IVA/EVA and BA/EVA ratios in the diagnosis and assessment of vertebrobasilar vasospasm was investigated. Results-The extracranial VA could be insonated in all subjects at depths ranging from 45 to 55 mm. The average FV for the extracranial VA was 26 cm/s. The ratios between intracranial and extracranial VA FVs were 1.6 on both sides, whereas the ratio between the BA FVs and the mean extracranial VA FVs was slightly higher at 1.7. Fourteen patients (41.2%) had CTA evidence of BA vasospasm. Vasospasm was severe in 7 patients, moderate in 1, and mild in the remaining. An FV threshold of 80 cm/s was indicative of BA vasospasm in 92.8% with 3 false-positive results that could be related to vertebrobasilar hyperemia. Comparative analysis between CTA and TCD findings showed that BA/EVA was >2 in all patients with BA vasospasm (100% sensitivity) and <2 in all but I patient without BA vasospasm (95% specificity). Furthermore, the BA/EVA ratio showed a close correlation with BA diameter (r=-0.8139, P<0.0001) and was >3 in all patients with severe vasospasm. Conclusions-The results of the present study showed that the BA/EVA ratio may contribute to all improved discrimination between BA vasospasm and vertebrobasilar hyperemia and enhance the accuracy and reliability of TCD in the diagnosis of BA vasospasm. Our data further suggest that the BA/EVA ratio may provide an approximation of vasospasm severity and help in identifying patients who are likely to suffer from heinodynamically significant vasospasm.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Neuroradiol, IL-31096 Haifa, Israel		Soustiel, JF (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Neurosurg, POB 9602, IL-31096 Haifa, Israel.						AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Aaslid R, 1999, ACT NEUR S, V72, P47; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ECHLIN FA, 1965, J NEUROSURG, V23, P1, DOI 10.3171/jns.1965.23.1.0001; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fujioka KA., 1992, TRANSCRANIAL DOPPLER, P9; Hadani M, 1997, J NEUROTRAUM, V14, P629, DOI 10.1089/neu.1997.14.629; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; LAUMER R, 1993, NEUROSURGERY, V33, P1, DOI 10.1227/00006123-199307000-00001; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MOORE WS, 1979, J SURG RES, V26, P1, DOI 10.1016/0022-4804(79)90071-4; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; SLOAN MA, 1994, STROKE, V25, P2187, DOI 10.1161/01.STR.25.11.2187; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Soustiel JF, 2001, STROKE, V32, P629, DOI 10.1161/01.STR.32.3.629; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	23	55	57	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JAN	2002	33	1					72	77		10.1161/hs0102.100484			6	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	509KV	WOS:000173147700016	11779892	Bronze			2022-02-06	
J	van Santbrink, H; Schouten, JW; Steyerberg, EW; Avezaat, CJJ; Maas, AIR				van Santbrink, H; Schouten, JW; Steyerberg, EW; Avezaat, CJJ; Maas, AIR			Serial transcranial Doppler measurements in Traumatic Brain Injury with special focus on the early posttraumatic period	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; transcranial Doppler Sonography; prognosis; outcome; brain tissue PO2	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; ARTERIAL SPASM; ULTRASOUND; VELOCITY; VASOSPASM; PRESSURE; TOMOGRAPHY; OXYGEN	Background. Cerebral ischemia is considered a key factor in the development of secondary damage after Traumatic Brain Injury (TBI). Studies on Cerebral Blood Flow (CBF) have documented decreased flow in over 50% of patients with TBI, studied in the acute phase. Transcranial Doppler (TCD) sonography is a non-invasive technique, permitting frequent or continuous measurements of blood flow velocity in the basal cerebral arteries. Objectives. To investigate the potential of TCD to detect decreased blood flow velocity in the early phase after TBI; To investigate whether flow velocity differs between hemispheres in patients with focal lesions versus those with more diffuse injuries; To investigate if decreased blood flow velocity is indicative of cerebral ischemia, as evidenced by measurements of brain tissue pO(2) Methods. TCD examinations were performed in 57 patients with severe TBI (GCS less than or equal to 8) daily over a period of 10 days, with particular attention focused on the first 72 hours, during which period examinations were performed more frequently. A low flow velocity state (LFVS) was defined as a flow velocity less than or equal to 35 cm/sec in one or both MCA's within 72 hours after trauma. PbrO(2) was measured in 33 patients with an intraparenchymal Clark type electrode (Licox). Patients were differentiated into those with primarily unilateral pathology on the admission CT scan versus those with primarily more diffuse or bilateral pathology. Outcome was evaluated at six months after injury, according to the Glasgow Outcome Scale (GOS). Results. A low flow velocity state was observed in 63% of patients studied. Decreased flow was most pronounced during the first eight hours after injury and was accompanied by high pulsatility indices, especially at the side of the lesion. Flow velocity increased significantly after this time period. Initial Vmca values had a strong correlation with ipsilateral measured PbrO(2) values (R = 0.73). The occurrence of a LFVS was associated with poorer outcome (odds ratio 3.9). Conclusions. TCD studies show reduction of cerebral blood flow velocity in the acute phase after traumatic brain injury. Decreased flow velocity is most pronounced ipsilateral to focal pathology. A low flow velocity state is probably due to high peripheral resistance, and is indicative of ischemia, as demonstrated by the association with decreased PbrO(2). A low flow velocity state is of prognostic value and identifies patients at increased risk for ischemia. Early TCD studies are recommended in TBI.	Erasmus MC, Dept Neurosurg, NL-3015 GD Rotterdam, Netherlands; Erasmus MC, Ctr Clin Decis Sci, Dept Publ Hlth, NL-3015 GD Rotterdam, Netherlands		Maas, AIR (corresponding author), Erasmus MC, Dept Neurosurg, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.		Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Steyerberg, Ewout/0000-0002-7787-0122			AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRINK WA, 2000, NEUROSURGERY, V46, P868; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; CHAN KH, 1992, NEUROSURGERY, V30, P697; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; GROLIMUND P, 1988, LANCET          0521, P1173; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Muizelaar JP, 1997, STROKE, V28, P1998, DOI 10.1161/01.STR.28.10.1998; RINGELSTEIN EB, 1990, ULTRASOUND MED BIOL, V16, P745, DOI 10.1016/0301-5629(90)90039-F; ROMNER B, 1991, British Journal of Neurosurgery, V5, P31, DOI 10.3109/02688699108998444; SAUNDERS FW, 1988, SURG NEUROL, V29, P401, DOI 10.1016/0090-3019(88)90049-3; SEILER RW, 1986, J NEUROSURG, V64, P594, DOI 10.3171/jns.1986.64.4.0594; Shigemori M, 1992, Acta Neurochir Suppl (Wien), V55, P6; SHIGEMORI M, 1990, ACTA NEUROCHIR, V107, P5, DOI 10.1007/BF01402605; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; VANSANTBRINK H, 1994, SERIAL TRANSCRANIAL, P585; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626	29	55	58	0	3	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		2002	144	11					1141	1149		10.1007/s00701-002-1012-8			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	616KZ	WOS:000179304100003	12434170				2022-02-06	
J	Kim, BT; Raghavendra, VL; Sailor, KA; Bowen, KK; Dempsey, RJ				Kim, BT; Raghavendra, VL; Sailor, KA; Bowen, KK; Dempsey, RJ			Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats	JOURNAL OF NEUROSURGERY			English	Article						glial cell line-derived neurotrophic factor; neuron death; neuroprotection; traumatic brain injury; rat	CONTROLLED CORTICAL IMPACT; NERVE GROWTH-FACTOR; BARRIER BREAKDOWN; HEAD-INJURY; DEATH; EXPRESSION; ASTROCYTES; RECEPTOR; GDNF; ISCHEMIA	Object. The purpose of this study was to evaluate whether glial cell line-derived neurotrophic factor (GDNF) can protect against hippocampal neuronal death after traumatic brain injury (TBI). Methods. Male Sprague-Dawley rats were subjected to moderate TBI with a controlled cortical impact device while in a state of halothane-induced anesthesia. Then, GDNF or artificial cerebrospinal fluid ([aCSF]; vehicle) was infused into the frontal horn of the left lateral ventricle. In eight brain-injured and eight sham-operated rats, GDNF was infused continuously for 7 days (200 ng/day intracerebroventricularly at a rate of 8.35 ng/0.5 mul/hour). An equal volume of vehicle was infused at the same rate into the remaining eight brain-injured and eight sham-operated rats. Seven days postinjury, all rats were killed. Their brains were sectioned and stained with cresyl violet, and the hippocampal neuronal loss was evaluated in the CA2 and CA3 regions with the aid of microscopy. A parallel set of sections from each brain was subjected to immunoreaction with antibodies against glial fibrillary acidic protein (GFAP; astroglia marker). In the aCSF-treated group, TBI resulted in a significant neuronal loss in the CA2 (60%, p < 0.05) and CA3 regions (68%, p < 0.05) compared with the sham-operated control animals. Compared with control rats infused with aCSF, GDNF infusion significantly decreased the TBI-induced neuronal loss in both the CA2 (58%, p < 0.05) and CA3 regions (51%, P < 0.05). There was no difference in the number of GFAP-positive astroglial cells in the GDNF-infused rats in the TBI and sham-operated groups compared with the respective vehicle-treated groups. Conclusions. The authors found that GDNF treatment following TBI is neuroprotective.	Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI 53792 USA; William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; Soonchunhyang Univ Hosp, Dept Neurosurg, Seoul, South Korea		Dempsey, RJ (corresponding author), Univ Wisconsin, Dept Neurol Surg, H4-336 CSC,600 Highland Ave, Madison, WI 53792 USA.			Sailor, Kurt/0000-0002-9574-6838			Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Glazner GW, 1998, J COMP NEUROL, V391, P42, DOI 10.1002/(SICI)1096-9861(19980202)391:1<42::AID-CNE4>3.0.CO;2-R; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDSAY RM, 1995, NATURE, V373, P289, DOI 10.1038/373289a0; Lu X, 1997, J COMP NEUROL, V388, P484; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Miyazaki H, 1999, NEUROSCIENCE, V89, P643, DOI 10.1016/S0306-4522(98)00592-2; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Sawada H, 2000, J NEUROCHEM, V74, P1175; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Wang Y, 1997, J NEUROSCI, V17, P4341; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yang SY, 1998, J NEUROSURG, V89, P297, DOI 10.3171/jns.1998.89.2.0297	32	55	60	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2001	95	4					674	679		10.3171/jns.2001.95.4.0674			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	478NQ	WOS:000171352600017	11596962				2022-02-06	
J	Hermanns, S; Reiprich, P; Muller, HW				Hermanns, S; Reiprich, P; Muller, HW			A reliable method to reduce collagen scar formation in the lesioned rat spinal cord	JOURNAL OF NEUROSCIENCE METHODS			English	Article						spinal cord injury; collagen scar; 2,2 '-bipyridine; axonal regeneration; [2,2 '-bipyridine]-5,5 '-dicarboxylic acid; connective tissue growth factor	TISSUE GROWTH-FACTOR; NEURITE OUTGROWTH; AXONAL REGENERATION; BASAL LAMINA; ADULT-RAT; CNS AXONS; INJURY; BRAIN; PROTEOGLYCANS; INHIBITORS	Following traumatic injury, the formation of a glial scar and deposition of extracellular matrix (ECM) contributes to the regeneration failure in the adult mammalian central nervous system (CNS). Using a postcommissural fornix transection as a brain lesion model in rat, we have previously shown that the collagenous basement membrane (BM) at the lesion site is a major impediment for axon regeneration. Deposition of BM in this lesion model can be delayed by administration of the iron chelator 2,2'-bipyridine (BPY), an inhibitor of prolyl 4-hydroxylase (PH), a key enzyme of collagen biosynthesis. To examine whether this potential therapeutic approach is transferable to other CNS regions, we have chosen the mechanically lesioned rat spinal cord to investigate the effects of BPY administration on BM formation. Due to the close proximity of the lesion zone to meningeal fibroblasts, a cell-type secreting large amounts of collagen IV, BM deposition was much more extensive in the spinal cord than in the brain lesion. Neither immediate injections nor continuous application of BPY resulted in a detectable reduction of BM formation in the spinal cord. Only a combination of anti-scarring treatments including (i) injection of the more potent PH inhibitor [2,2'-bipyridine]-5,5'-dicarboxylic acid (BPY-DCA), (ii) selective inhibition of fibroblast proliferation and ECM production by S-Br-cAMP, and (iii) continuous application of BPY-DCA, reduced the lesion-induced BM significantly. The present results clearly demonstrate, that the exclusive application of BPY according to a protocol designed for treatment of brain lesions is not sufficient to reduce BM formation in the lesioned adult rat spinal cord. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Dusseldorf, Dept Neurol, Mol Neurobiol Lab, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Inst Physiol, D-40225 Dusseldorf, Germany		Muller, HW (corresponding author), Univ Dusseldorf, Dept Neurol, Mol Neurobiol Lab, Moorenstr 5, D-40225 Dusseldorf, Germany.		Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661			Becker T, 2000, GLIA, V29, P330, DOI 10.1002/(SICI)1098-1136(20000215)29:4<330::AID-GLIA4>3.0.CO;2-L; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Bovolenta P, 1997, EUR J NEUROSCI, V9, P977, DOI 10.1111/j.1460-9568.1997.tb01448.x; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Grill R, 1997, J NEUROSCI, V17, P5560; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; GUTH L, 1980, J NEUROSURG, V52, P73, DOI 10.3171/jns.1980.52.1.0073; HALES NJ, 1993, J MED CHEM, V36, P3853, DOI 10.1021/jm00076a014; Hermanns S, 2001, BRAIN RES PROTOC, V7, P162, DOI 10.1016/S1385-299X(01)00059-9; IKEDA H, 1992, HEPATOLOGY, V15, P282, DOI 10.1002/hep.1840150218; KIVIRIKKO KI, 1985, ANN NY ACAD SCI, V460, P187, DOI 10.1111/j.1749-6632.1985.tb51167.x; KOWALSKI TF, 1979, ANN NEUROL, V6, P78, DOI 10.1002/ana.410060121; KUHL U, 1984, DIFFERENTIATION, V28, P164, DOI 10.1111/j.1432-0436.1984.tb00279.x; MATINIAN LA, 1973, ENZYME THERAPY ORGAN, P94; Moon LDF, 2000, EXP NEUROL, V161, P49, DOI 10.1006/exnr.1999.7230; Novikova L, 1996, NEUROSCI LETT, V220, P203, DOI 10.1016/S0304-3940(96)13267-5; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700; SMITH AL, 1995, J NEUROSCI METH, V60, P211, DOI 10.1016/0165-0270(95)00014-L; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x; STICHEL CC, 1994, GLIA, V10, P89, DOI 10.1002/glia.440100203; Stichel CC, 1999, NEUROSCIENCE, V93, P321, DOI 10.1016/S0306-4522(99)00112-8; Weidner N, 1999, EXP NEUROL, V160, P40, DOI 10.1006/exnr.1999.7200	29	55	56	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2001	110	1-2					141	146		10.1016/S0165-0270(01)00427-7			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	482VM	WOS:000171598000017	11564534				2022-02-06	
J	Maas, AIR				Maas, AIR			Neuroprotective agents in traumatic brain injury	EXPERT OPINION ON INVESTIGATIONAL DRUGS			English	Article						clinical trials; head injury; neuroprotection; traumatic brain injury	SEVERE HEAD-INJURY; NERVOUS-SYSTEM TRAUMA; RANDOMIZED CONTROLLED TRIALS; B-2 RECEPTOR ANTAGONIST; FLUID-PERCUSSION INJURY; CORTICAL IMPACT INJURY; CEREBRAL-ISCHEMIA; RAT-BRAIN; SUBARACHNOID HEMORRHAGE; LIPID-PEROXIDATION	The role of neuroprotection in traumatic brain injury (TBI) is reviewed. Basic research and experimental investigations have identified many different compounds with potential neuroprotective effect. However, none of the Phase III trials performed in TBI have been successful in convincingly demonstrating efficacy in the overall population. A common misconception is that consequently these agents are ineffective. The negative results as reported in the overall population may in part be caused by specific aspects of the head injury population as well as by aspects of clinical trial design and analysis. The heterogeneity of the TBI population causes specific problems, such as a risk of imbalances between placebo and treated groups but also causes problems m;hen a possible treatment effect is evaluated in relation to the prognostic effect present. Trials of neuroprotective agents should be targeted first of all to a population in which the mechanism at which the agent is directed is likely to be present and secondly to a population in which the chances of demonstrating efficacy are realistic, e.g., to patients with an intermediate prognosis. The possibilities for concomitant or sequential administration of different neuroprotective agents at different times deserve consideration. The potential for neuroprotection in TBI remains high and we should not be discouraged by recent failures obtained up until now. Rather, prior to initiating new trials, careful consideration of experimental evidence is required in order to optimise chances for mechanistic targeting and lessons learned from previous experience need to be taken to heart in the design of future studies.	Erasmus Univ, Med Ctr, Dept Neurosurg, NL-3015 GD Rotterdam, Netherlands		Maas, AIR (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosurg, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	maas@neur.azr.nl	Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Alexiou T, 2000, NEUROSCI RES COMMUN, V26, P1, DOI 10.1002/(SICI)1520-6769(200001/02)26:1<1::AID-NRC1>3.0.CO;2-Q; ALLESSANDRI B, 1999, J NEUROTRAUM, V16, P981; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P103, DOI 10.1111/j.1399-6576.1995.tb04285.x; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Barzo P, 1997, ACT NEUR S, V70, P119; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; BENTZER P, 1999, J NEUROTRAUM, V16, P979; BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CARON MH, 1996, NEUROTRAUMA, P163; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; FAN L, 1995, MOL BRAIN RES, V30, P125; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Jain KK, 2000, EXPERT OPIN INV DRUG, V9, P695, DOI 10.1517/13543784.9.4.695; Jennett B., 1991, NIMODIPINE PHARM CLI, P225; Jolkkonen J, 1999, EUR J PHARMACOL, V372, P31, DOI 10.1016/S0014-2999(99)00186-7; KAKARIEKA A, 1994, J NEURAL TRANSM-SUPP, P13; KAKARIEKA A, 1997, TRAUMATIC SUBARACHNO; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Katayama Y, 1998, ACT NEUR S, V71, P289; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; Kawamata T, 1997, ACT NEUR S, V70, P191; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kroppenstedt SN, 1999, J NEUROTRAUM, V16, P629, DOI 10.1089/neu.1999.16.629; LANG DA, 1991, ACTA NEUROCHIR, V109, P5, DOI 10.1007/BF01405689; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2000, CNS DRUGS, V13, P139, DOI 10.2165/00023210-200013020-00007; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; MAHMOOD A, IN PRESS J NEUROSURG; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Park KI, 1999, J NEUROTRAUM, V16, P675, DOI 10.1089/neu.1999.16.675; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Pruneau D, 1999, J NEUROTRAUM, V16, P1057, DOI 10.1089/neu.1999.16.1057; PRUNEAU D, 1999, IMMUNOPHARMACOLOGY, P1285; REILLY PL, 1975, LANCET, V2, P375; REISS P, 1999, J NEUROTRAUM, V16, P1016; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHAPIRA Y, 1989, Neurological Research, V11, P169; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Soares HD, 1995, J NEUROSCI, V15, P8223; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Teasdale GM, 1999, ACT NEUR S, V73, P111; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Uenishi H, 1999, ANN NY ACAD SCI, V890, P385, DOI 10.1111/j.1749-6632.1999.tb08018.x; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; YAMASAKI Y, 1994, ACTA NEUROCHIR, P300; Yates D, 2000, BRIT MED J, V321, P128, DOI 10.1136/bmj.321.7254.128; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Young Byron, 1998, Journal of Neurotrauma, V15, P48; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	98	55	58	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1354-3784	1744-7658		EXPERT OPIN INV DRUG	Expert Opin. Investig. Drugs	APR	2001	10	4					753	767		10.1517/13543784.10.4.753			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	419ZP	WOS:000167979700014	11281824				2022-02-06	
J	Saatman, KE; Bareyre, FM; Grady, MS; McIntosh, TK				Saatman, KE; Bareyre, FM; Grady, MS; McIntosh, TK			Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						calpain; cytoskeleton; head injury; histology; microtubule-associated protein-2; MAP-2; spectrin	MICROTUBULE-ASSOCIATED PROTEIN-2; FOCAL CEREBRAL-ISCHEMIA; CLOSED-HEAD INJURY; RAT HIPPOCAMPUS; NEURONAL INJURY; MAGNETIC-RESONANCE; TRAUMA; ACID; NEURODEGENERATION; PROTECTS	Traumatic brain injury results in a profound decline in intracellular magnesium ion levels that may jeopardize critical cellular functions. We examined the consequences of preinjury magnesium deficiency and post-traumatic magnesium treatment on injury-induced cytoskeletal damage and cell death at 24 h after injury. Adult male rats were fed either a normal (n = 24) or magnesium-deficient diet (n = 16) for 2 wk prior to anesthesia and lateral fluid percussion brain injury (n = 31) or sham injury (n = 9). Normally fed animals were then randomized to receive magnesium chloride (125 mu mol, i.v., n = 10) or vehicle solution (n = 11) at 10 min postinjury. Magnesium treatment reduced cortical cell loss (p < 0.05), cortical alterations in microtubule-associated protein-2 (MAP-2) (p < 0.05), and both cortical and hippocampal calpain mediated spectrin breakdown (p < 0.05 for each region) when compared to vehicle treatment. Conversely, magnesium deficiency prior to brain injury led to a greater area of cortical cell loss (p < 0.05 compared to vehicle treatment). Moreover, brain injury to magnesium-deficient rats resulted in cytoskeletal alterations within the cortex and hippocampus that were not observed in vehicle- or magnesium-treated animals. These data suggest that cortical cell death and cytoskeletal disruptions in cortical and hippocampal neurons may be sensitive to magnesium status after experimental brain injury, and may be mediated in part through modulation of calpains.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		Saatman, KE (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 105C Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803, R01-NS26818] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, P50NS008803] Funding Source: NIH RePORTER		Altura B T, 1984, Magnesium, V3, P195; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Bartus RT, 1997, NEUROSCIENTIST, V3, P314, DOI 10.1177/107385849700300513; CLARK GD, 1987, NEUROSCIENCE, V21, P665, DOI 10.1016/0306-4522(87)90027-3; Conti AC, 1998, J NEUROSCI, V18, P5663; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Eguchi Y, 1997, J NEUROTRAUM, V14, P109, DOI 10.1089/neu.1997.14.109; Emery DL, 2000, J COMP NEUROL, V424, P521; FAVARON M, 1985, FEBS LETT, V183, P260, DOI 10.1016/0014-5793(85)80789-4; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FISCHER S, 1993, EUR J PHARMACOL, V232, P121, DOI 10.1016/0014-2999(93)90736-2; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, MAGNESIUM RES, V12, P269; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KASS IS, 1988, ANESTHESIOLOGY, V69, P710, DOI 10.1097/00000542-198811000-00012; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; KOSTYUK FG, 1981, BIOCHIM BIOPHYS ACTA, V650, P128; Kristal BS, 1997, J NEUROCHEM, V69, P524; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; POLLARD H, 1994, NEUROSCIENCE, V61, P773, DOI 10.1016/0306-4522(94)90401-4; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Posmantur RM, 2000, EXP NEUROL, V161, P15, DOI 10.1006/exnr.1999.7244; PRESCOTT AR, 1988, J CELL SCI, V89, P321; Regan RF, 1998, J NEUROCHEM, V70, P77; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SEELIG JM, 1983, AM J PHYSIOL, V202, pH22; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; Smallwood I.M, 1996, HDB ORGANIC SOLVENT, P1; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Tang P, 1998, EPILEPSIA, V39, P577, DOI 10.1111/j.1528-1157.1998.tb01424.x; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; TSUDA T, 1991, NEUROSCIENCE, V44, P335, DOI 10.1016/0306-4522(91)90058-V; VINK R, 1989, BRAIN RES, V490, P144, DOI 10.1016/0006-8993(89)90440-X; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1991, Magnesium and Trace Elements, V10, P1; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Volpe Pompeo, 1993, Magnesium Research, V6, P267; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; WOLF G, 1990, NEUROSCI LETT, V117, P207, DOI 10.1016/0304-3940(90)90145-Y; Zhang AM, 1996, BRAIN RES, V728, P204, DOI 10.1016/S0006-8993(96)00401-5; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang ZG, 1999, J CEREBR BLOOD F MET, V19, P68, DOI 10.1097/00004647-199901000-00008	79	55	56	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	FEB	2001	60	2					183	194		10.1093/jnen/60.2.183			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	402VD	WOS:000167008100008	11273006	Bronze			2022-02-06	
J	Gozzoli, V; Schottker, P; Suter, PM; Ricou, B				Gozzoli, V; Schottker, P; Suter, PM; Ricou, B			Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling	ARCHIVES OF INTERNAL MEDICINE			English	Article							ORGAN FAILURE; SEPSIS	Background: Antipyresis is a common clinical practice in intensive care, although it is unknown if fever is harmful, beneficial, or a negligible adverse effect of infection and inflammation. Methods: In a randomized study, rectal temperature and discomfort were assessed in 38 surgical intensive care unit patients without neurotrauma or severe hypoxemia and with fever (temperature greater than or equal to 38.5 degreesC) and systemic inflammatory response syndrome. Eighteen patients received external cooling while 20 received no antipyretic treatment. Results: Temperature and discomfort decreased similarly in both groups after 24 hours. No significant differences in recurrence of fever, incidence of infection, antibiotic therapy, intensive care unit and hospital length of stay, or mortality were noted between the groups. Conclusions: These results suggest that the systematic suppression of fever may not be useful in patients without severe cranial trauma or significant hypoxemia. Letting fever take its natural course does not seem to harm patients with systemic inflammatory response syndrome or influence the discomfort level and may save costs.	Univ Hosp Geneva, Div Surg Intens Care, Dept Anaesthesiol Pharmacol & Surg Intens Care, CH-1211 Geneva 14, Switzerland		Ricou, B (corresponding author), Univ Hosp Geneva, Div Surg Intens Care, Dept Anaesthesiol Pharmacol & Surg Intens Care, CH-1211 Geneva 14, Switzerland.						BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P10, DOI 10.1164/ajrccm.151.1.7812538; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Poblete B, 1997, BRIT J ANAESTH, V78, P123, DOI 10.1093/bja/78.2.123; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	6	55	55	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0003-9926			ARCH INTERN MED	Arch. Intern. Med.	JAN 8	2001	161	1					121	123		10.1001/archinte.161.1.121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387LN	WOS:000166124200015	11146708				2022-02-06	
J	Riess, P; Bareyre, FM; Saatman, KE; Cheney, JA; Lifshitz, J; Raghupathi, R; Grady, MS; Neugebauer, E; McIntosh, TK				Riess, P; Bareyre, FM; Saatman, KE; Cheney, JA; Lifshitz, J; Raghupathi, R; Grady, MS; Neugebauer, E; McIntosh, TK			Effects of chronic, post-injury Cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						head injury; immunosuppressant; CsA; behavior	TRANSIENT FOREBRAIN ISCHEMIA; PERMEABILITY TRANSITION; COGNITIVE IMPAIRMENT; AXONAL DAMAGE; RAT; DYSFUNCTION; PROTECTS; DEFICITS; THERAPY; NEURONS	Purpose: Cyclosporin A (CsA) is widely used in clinical situations to attenuate graft rejection following organ and central nervous system transplantation. Previous studies demonstrated that CsA administration is neuroprotective in models of traumatic brain injury (TBI). However, no studies, to date, have evaluated the influence of post-injury CsA administration on behavioral recovery after TBI. Methods: Rats (n = 33) were anesthetized and subjected to severe, lateral fluid percussion brain injury. Fifteen minutes thereafter, animals were randomized to receive the first of 28 daily injections of either CsA (10 mg/kg, ip) or saline. Sham-operated animals (n = 14) were anesthetized and surgically prepared without injury and treated daily either with CsA or saline. Motor and sensorimotor functions were assessed at one day before and two days after injury, and weekly thereafter up to 4 wks post-injury. Cognition was assessed at 1 and 4 wks post-injury using a Morris Water Maze test. Results: Injured animals showed significant impairments in motor, sensorimotor and cognitive function over the 4-week post-injury period. Injured animals treated with CsA showed a significant improvement in motor function assessed using a composite neuroscore (at day 28) and in sensorimotor function assessed using a sticky paper test (at days 2, 14, and 28) (p < 0.05, when compared to vehicle treated, injured animals). No beneficial effects on cognitive function were observed following CsA administration. Conclusion: These data suggest that daily post-injury treatment with CsA improves certain aspects of motor and sensorimotor function following experimental TBI.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA; Univ Cologne, Dept Surg 2, Biochem & Expt Div, D-51109 Cologne, Germany		McIntosh, TK (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	mcintosh@seas.upenn.edu	Raghupathi, Ramesh/AAX-5538-2021		NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER		AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; BEGLEY DJ, 1990, J NEUROCHEM, V55, P1222, DOI 10.1111/j.1471-4159.1990.tb03128.x; BRUNDIN P, 1989, EXP BRAIN RES, V75, P195; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; CHRISTIANS U, 1993, PHARMACOL THERAPEUT, V57, P291, DOI 10.1016/0163-7258(93)90059-M; Czech KA, 1997, EXP NEUROL, V147, P66, DOI 10.1006/exnr.1997.6589; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; Drachman DB, 1996, MUSCLE NERVE, V19, P1239; ELLIOTT JF, 1984, SCIENCE, V226, P1439, DOI 10.1126/science.6334364; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Gogarten W, 1998, J NEUROSURG ANESTH, V10, P101, DOI 10.1097/00008506-199804000-00006; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; HEWITT CW, 1990, J CLIN LAB IMMUNOL, V31, P23; Jiang HS, 1999, TRANSPLANT INT, V12, P92, DOI 10.1007/s001470050192; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kuroda S, 1999, BRAIN RES, V835, P148, DOI 10.1016/S0006-8993(99)01535-8; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU SL, 1994, J NEUROTRAUM, V11, P73, DOI 10.1089/neu.1994.11.73; LopezLozano JJ, 1997, TRANSPL P, V29, P977, DOI 10.1016/S0041-1345(96)00333-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIDHA R, 1992, MICROSURG, V13, P273, DOI 10.1002/micr.1920130516; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; MOVSOWITZ C, 1990, J ORTHOPAED RES, V8, P635, DOI 10.1002/jor.1100080503; O'Dell DM, 2000, RESTOR NEUROL NEUROS, V16, P127; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; REEM GH, 1983, SCIENCE, V221, P63, DOI 10.1126/science.6407112; RYFFEL B, 1983, ARCH TOXICOL, V53, P107; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smallwood I.M, 1996, HDB ORGANIC SOLVENT, P1; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soares HD, 1995, J NEUROSCI, V15, P8223; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sunio A, 1997, EXP NEUROL, V146, P46, DOI 10.1006/exnr.1997.6484; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; Tao R, 1998, RESTOR NEUROL NEUROS, V12, P239; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; THOMSON AW, 1983, IMMUNOLOGY, V48, P291; TROJANOWSKI JQ, 1993, EXP NEUROL, V122, P283, DOI 10.1006/exnr.1993.1128; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0	57	55	56	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2001	18	1					1	8					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491RR	WOS:000172123100001	11673665				2022-02-06	
J	Azouvi, P				Azouvi, P			Neuroimaging correlates of cognitive and functional outcome after traumatic brain injury	CURRENT OPINION IN NEUROLOGY			English	Article							CLOSED-HEAD-INJURY; MILD; MRI; SPECT; ADOLESCENTS; PERFORMANCE; ATTENTION; CHILDREN; MEMORY	Magnetic resonance imaging (MRI) may provide an estimate of the severity of diffuse axonal injury by quantitative measurements of atrophy of white matter tracts (such as corpus callosum) and of ventricular enlargement (particularly the third ventricle). However, most MRI studies failed to reveal consistent relationships between the pattern of neuropsychological impairments and the site and extent of focal structural lesions after traumatic brain injury. Functional neuroimaging techniques, such as positron emission tomography or functional MRI, may reveal areas of cerebral dysfunction in regions that look structurally intact on MRI. Studies using these techniques have suggested that the cognitive and behavioural disturbances of traumatic brain injury could be related to a defective activation of a prefrontal-cingulate network. Curr Opin Neurol 13:665-669. (C) 2000 Lippincott Williams & Wilkins.	Univ Paris 05, Dept Neurol Rehabil, Raymond Poincare Hosp, F-92380 Garches, France		Azouvi, P (corresponding author), Univ Paris 05, Dept Neurol Rehabil, Raymond Poincare Hosp, F-92380 Garches, France.						Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Bigler E D, 1999, Appl Neuropsychol, V6, P217, DOI 10.1207/s15324826an0604_4; CAZALIS F, 2000, J INT NEUROPSYCH SOC, V6, P379; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gerring J, 2000, BRAIN INJURY, V14, P205; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Plum F, 1998, PHILOS T ROY SOC B, V353, P1929, DOI 10.1098/rstb.1998.0345; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214	20	55	58	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2000	13	6					665	669		10.1097/00019052-200012000-00009			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	425HG	WOS:000168284700009	11148667				2022-02-06	
J	Horsburgh, K; McCulloch, J; Nilsen, M; Roses, AD; Nicoll, JAR				Horsburgh, K; McCulloch, J; Nilsen, M; Roses, AD; Nicoll, JAR			Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						Alzheimer's disease; genotype; injury; trauma	TRANSIENT FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN INJURY; E-DEFICIENT MICE; E EPSILON-4 ALLELE; HEAD-INJURY; ALZHEIMER-DISEASE; FOCAL ISCHEMIA; E GENOTYPE; RAT; EXPRESSION	Apolipoprotein E (apoE, protein; APOE, gene) is expressed as three isoforms in humans (E2, E3, E4). The APOE-epsilon4 allele is associated with a poor outcome in patients after head injury of which ischaemic brain damage is a contributor of mortality and morbidity. The aim of the study was to determine whether mice expressing human APOE-epsilon4 displayed more extensive ischaemic neuronal damage 72 h after transient global ischaemia compared with mice which express human APOE-epsilon3. APOE-epsilon3 and -epsilon4 transgenic mice, under the control of a human promoter, were used which express human APOE in neurons and glia. Ischaemic neuronal damage in the CA1 pyramidal cell layer in the APOE-epsilon4 transgenic mice was significantly greater than in the APOE-epsilon3 mice after global ischaemia (36.4 +/- 8.9%, 18.2 +/- 7.3%; P < 0.05). This was associated with more extensive neuronal apoE immunoreactivity in the CA1 pyramidal cell layer in the APOE-<epsilon>4 transgenic mice compared with APOE-epsilon3 transgenic mice. In contrast, in the caudate nucleus, there were similar levels of ischaemic neuronal damage in the APOE-epsilon3 and -epsilon4 transgenic mice (39.2 +/- 10.1%; 44.6 +/- 8.4%, P = 0.32). In the caudate, similar numbers of neurons were immunostained for apoE in the APOE-epsilon3 and -epsilon4 transgenic mice. The present study demonstrated that the APOE-epsilon4 allele is associated with an increased vulnerability of a specific brain region to the effects of global ischaemia, which is closely associated with an increase in neuronal apoE. The data extend previous work and are consistent with an association of the APOE-epsilon4 allele with a poor outcome after acute brain injury in humans.	Univ Glasgow, Wellcome Surg Inst, Glasgow G61 1QH, Lanark, Scotland; Univ Glasgow, Dept Neuropathol, Glasgow, Lanark, Scotland; Glaxo Wellcome Res & Dev Ltd, Res Triangle Pk, NC USA		Horsburgh, K (corresponding author), Univ Glasgow, Wellcome Surg Inst, Garscube Estate,Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.		Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246; Horsburgh, Karen/0000-0002-9620-3691			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Buttini M, 1999, J NEUROSCI, V19, P4867; Cambon K, 2000, NEUROSCIENCE, V97, P685, DOI 10.1016/S0306-4522(00)00065-8; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Fleming LM, 1996, EXP NEUROL, V138, P252, DOI 10.1006/exnr.1996.0064; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GILL R, 1992, BRAIN RES, V580, P35, DOI 10.1016/0006-8993(92)90924-X; Graham D.I., 1992, GREENFIELDS NEUROPAT, P153; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HALL ED, 1995, EXP NEUROL, V135, P17, DOI 10.1006/exnr.1995.1062; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V201, P1567, DOI 10.1006/bbrc.1994.1883; Horsburgh K, 1997, BRAIN RES, V763, P103, DOI 10.1016/S0006-8993(97)00411-3; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Horsburgh K, 1996, NEUROPATH APPL NEURO, V22, P342, DOI 10.1111/j.1365-2990.1996.tb01113.x; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; Horsburgh K, 1996, ALZHEIMER RES, V2, P37; HORSBURGH K, 1999, J CEREB BLOOD FLO S1, V19, P589; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Masliah E, 1996, APOLIPOPROTEIN E ALZ, P59; McCarron MO, 1998, STROKE, V29, P1882, DOI 10.1161/01.STR.29.9.1882; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NELLGARD B, 1992, J CEREBR BLOOD F MET, V12, P2, DOI 10.1038/jcbfm.1992.2; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teter B, 1999, J NEUROCHEM, V73, P2613, DOI 10.1046/j.1471-4159.1999.0732613.x; Xu PT, 1998, NEUROSCI LETT, V246, P65, DOI 10.1016/S0304-3940(98)00247-X; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9	43	55	57	0	4	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2000	12	12					4309	4317		10.1046/j.1460-9568.2000.01339.x			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	387FV	WOS:000166113000014	11122341				2022-02-06	
J	Wagner, AK; Sasser, HC; Hammond, FM; Wiercisiewski, D; Alexander, J				Wagner, AK; Sasser, HC; Hammond, FM; Wiercisiewski, D; Alexander, J			Intentional traumatic brain injury: Epidemiology, risk factors, and associations with injury severity and mortality	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						violence; traumatic brain injury; injury severity; epidemiology; risk factors; outcome	GUNSHOT WOUNDS; VIOLENCE; POPULATION; HEAD	Background: Intentional injury is associated with significant morbidity and mortality and has been associated with certain demographic and socioeconomic groups, Less is known about the relationship of intentional traumatic brain injury (TBI) to injury severity, mortality, and demographic and socioeconomic profile, The objective of this study was to delineate demographic and event-related factors associated with intentional TBI and to evaluate the predictive value of intentional TBI on injury severity and mortality. Methods: Prospective data were obtained for 2,637 adults sustaining TBIs between January 1994 and September 1998, Descriptive, univariate, and multivariate analyses were conducted to determine the predictive value of intentional TBI on injury severity and mortality. Results: Gender, minority status, age, substance abuse, and residence in a zip code with low average income were associated with intentional TBI, Multivariate analysis found minority status and substance abuse to be predictive of intentional injury after adjusting for other demographic variables studied. Intentional TBI was predictive of mortality and anatomic severity of injury to the head. Penetrating intentional TBI was predictive of injury severity with all injury severity markers studied. Conclusion: Many demographic variables are risk factors for intentional TBT, and such injury is a risk factor for both injury severity and mortality, Future studies are needed to definitively link intentional TBI to disability and functional outcome.	Carolinas Hlth Care Syst, Charlotte, NC USA; Charlotte Inst Rehabil, Charlotte, NC USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Kaufmann Bldg Suite 901, Pittsburgh, PA 15213 USA.						BAKER S, 1993, MED HLTH ANN 1993, P331; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BONTKE CF, 1996, PHYSICAL MED REHABIL, P1029; CENTERWALL BS, 1984, AM J PUBLIC HEALTH, V74, P813, DOI 10.2105/AJPH.74.8.813; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; Drubach D A, 1993, Md Med J, V42, P989; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; KOOP CE, 1992, JAMA-J AM MED ASSOC, V267, P3075, DOI 10.1001/jama.267.22.3075; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; MERCY JA, 1993, HEALTH AFFAIR, V12, P7, DOI 10.1377/hlthaff.12.4.7; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; SPRADEO FR, 1989, J HEAD TRAUMA REHAB, V4, P75; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WAGNER A, 2000, J TRAUMA, V49; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Zafonte RD, 1997, BRAIN INJURY, V11, P403	21	55	56	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2000	49	3					404	410		10.1097/00005373-200009000-00004			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	355DA	WOS:000089369300003	11003315				2022-02-06	
J	Herrmann, M; Curio, N; Petz, T; Synowitz, H; Wagner, S; Bartels, C; Wallesch, CW				Herrmann, M; Curio, N; Petz, T; Synowitz, H; Wagner, S; Bartels, C; Wallesch, CW			Coping with illness after brain diseases - a comparison between patients with malignant brain tumors, stroke, Parkinson's disease and traumatic brain injury	DISABILITY AND REHABILITATION			English	Article							PRIMARY SUPPORT PERSONS; HEAD-INJURY; DEPRESSION; IMPAIRMENT	Purpose : This study investigates coping styles in patients suffering from different brain disorders (malignant brain tumors, stroke, Parkinson's disease and traumatic brain injury). Method: In a combined analysis of four prospective studies we investigated 21 patients with malignant glioma at the end radiochemotherapy, 30 patients one year after ischemic stroke, 54 patients suffering from various stages of Parkinson's disease, and 58 patients 6 to 8.5 months after traumatic brain injury. The assessment of coping with illness was based on the Freiburg Questionnaire on Coping with illness.(1) Results : With few exceptions, coping styles did not differ across the various brain pathologies. Differences occurred with respect to 'active, problem-oriented coping' (decreased in stroke patients), and coping by search for religious relief or quest for sense (increased in patients with Parkinson's disease). Conclusion : Differences in coping styles could be mainly related to age and social factors. Individual coping strategies seem only to be little related to the type of brain pathology.	Otto Von Guericke Univ, Div Neuropsychol & Behav Neurol, Magdeburg, Germany; Otto Von Guericke Univ, Dept Neurosurg, Magdeburg, Germany; Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany		Herrmann, M (corresponding author), Otto Von Guericke Univ, Div Neuropsychol & Behav Neurol, Magdeburg, Germany.		Herrmann, Manfred/H-3931-2011	Herrmann, Manfred/0000-0003-1872-8406			Angeleri F, 1997, J CLIN PSYCHIAT, V58, P261, DOI 10.4088/JCP.v58n0605; ASTROM M, 1993, STROKE, V24, P976, DOI 10.1161/01.STR.24.7.976; BOYLE EA, 1991, ARCH NEUROL-CHICAGO, V48, P1150, DOI 10.1001/archneur.1991.00530230058022; CASAS MS, 1989, J REHABIL, V55, P37; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Ehmann T S, 1990, J Geriatr Psychiatry Neurol, V3, P85, DOI 10.1177/089198879000300206; Fahn S., 1987, RECENT DEV PARKINSON, P153; FALLER H, 1994, PSYCHOTHER PSYCH MED, V44, P207; Field D, 1983, Int Rehabil Med, V5, P96; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HERRMANN M, 1995, STROKE, V26, P850, DOI 10.1161/01.STR.26.5.850; Herrmann M, 1997, DISABIL REHABIL, V19, P6, DOI 10.3109/09638289709166439; HERRMANN M, 1993, J NEUROL NEUROSUR PS, V56, P672, DOI 10.1136/jnnp.56.6.672; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Herrmann Manfred, 1995, Top Stroke Rehabil, V2, P5; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; KARNOFSKY DA, 1951, ARCH INTERN MED, V87, P477, DOI 10.1001/archinte.1951.03810040002001; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; MAHONEY F I, 1965, Md State Med J, V14, P61; MULLER A, 1998, NEUROLOGICAL REHABIL, V4, P71; Muthny F, 1989, PSYCHOSOZIALE ONKOLO, P86; Muthny F.A., 1989, FREIBURGER FRAGEBOGE, V1st ed.; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1997, NEUROLOGICAL REHABIL, P423; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; RIDLEY B, 1989, SOC SCI MED, V29, P555, DOI 10.1016/0277-9536(89)90201-3; SCHULZ R, 1988, PSYCHOL AGING, V3, P131, DOI 10.1037/0882-7974.3.2.131; SINYOR D, 1986, STROKE, V17, P1102, DOI 10.1161/01.STR.17.6.1102; STARKSTEIN SE, 1992, TXB NEUROPSYCHIATRY, P449; TOMPKINS CA, 1988, J CONSULT CLIN PSYCH, V56, P502, DOI 10.1037/0022-006X.56.4.502	30	55	55	1	8	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	AUG	2000	22	12					539	546		10.1080/096382800416788			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	352QC	WOS:000089228500002	11005743				2022-02-06	
J	Petrov, T; Page, AB; Owen, CR; Rafols, JA				Petrov, T; Page, AB; Owen, CR; Rafols, JA			Expression of the inducible nitric oxide synthase in distinct cellular types after traumatic brain injury: an in situ hybridization anal immunocytochemical study	ACTA NEUROPATHOLOGICA			English	Article						endothelial cells; macrophages; neurons; cytoprotection; cytotoxicity	CENTRAL-NERVOUS-SYSTEM; IN-VIVO EXPRESSION; SPINAL-CORD INJURY; RAT; ACTIVATION; NEURONS; CELLS; PATHOPHYSIOLOGY; PERMEABILITY; INVOLVEMENT	The Marmarou's acceleration traumatic brain injury (TBI) model, in situ hybridization and immunocytochemistry were utilized to study the temporal expression of the inducible form of nitric oxide synthase (iNOS) mRNA and protein in different cellular compartments of the rat brain. Four hours following TBI, expression of iNOS was observed in the endothelial cells of cerebral blood vessels, macrophages and many cortical and hippocampal neurons. In the cortex labeled neuronal and nonneuronal cells were primarily found in the superficial layers. In the hippocampus the strongest neuronal labeling was observed in the CA1 and CA3 (lateral part) regions. By 24 h post TBI endothelial cells no longer expressed iNOS mRNA, and the macrophage and neuronal INOS expression was reduced by 30-50%. The reduction was assessed by automated quantitation of the silver grains that occupy individual cellular profiles using an image analysis system. Immunocytochemistry revealed de novo iNOS synthesis in non-neuronal cells at the different time points, thus paralleling the changes in iNOS mRNA expression. In contrast, iNOS immunoreactivity in neurons was not observed before 24 h post TBI, suggesting failure of iNOS protein translation at 4 h after trauma. The results demonstrate complex spatial and temporal patterns of iNOS expression in discrete cellular populations, indicating different times of nitric oxide synthesis (and release) following TBI. Uncoupling of iNOS mRNA and protein synthesis in neurons suggests differential synthesis of nitric oxide in these cells as compared to non-neuronal cellular populations after trauma.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.						Aono K, 1997, J CELL BIOCHEM, V65, P349, DOI 10.1002/(SICI)1097-4644(19970601)65:3<349::AID-JCB5>3.0.CO;2-S; ASSREUY J, 1993, BRIT J PHARMACOL, V108, P833, DOI 10.1111/j.1476-5381.1993.tb12886.x; AVELLINO AM, 1995, EXP NEUROL, V136, P183, DOI 10.1006/exnr.1995.1095; Bethea JR, 1998, J NEUROSCI, V18, P3251; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; BOULDIN TW, 1990, NEUROTOXICOLOGY, V11, P23; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CAZABON SM, 1998, INTRO BLOOD BRAIN BA, P338; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; DEBELDER AJ, 1993, LANCET, V341, P84, DOI 10.1016/0140-6736(93)92559-C; DEGRACIA DJ, 1997, CEREB BLOOD FLOW MET, V17, P1291; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Heneka MT, 1998, J NEUROCHEM, V71, P88; Jhamandas JH, 1996, NEUROREPORT, V7, P2843, DOI 10.1097/00001756-199611250-00006; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; KRAUSE GS, 1993, STROKE, V24, P747, DOI 10.1161/01.STR.24.5.747; LASKIN DL, 1994, J LEUKOCYTE BIOL, V56, P751, DOI 10.1002/jlb.56.6.751; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MincGolomb D, 1996, J NEUROCHEM, V66, P1504; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONTAGUE PR, 1994, SCIENCE, V263, P973, DOI 10.1126/science.7508638; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; Oda H, 1997, J NEUROCHEM, V69, P669; PETROV T, 1995, NEUROPHARMACOLOGY, V34, P509, DOI 10.1016/0028-3908(95)00002-N; Petrov T., 1999, Society for Neuroscience Abstracts, V25, P822; PETROV T, 1996, CAN J PHYSL PHARM, V7, pRA21; POGUN S, 1994, SYNAPSE, V18, P21, DOI 10.1002/syn.890180104; POPOVICH PG, 1994, BRAIN RES, V633, P348, DOI 10.1016/0006-8993(94)91560-1; POSTMANTUR RM, 1996, J NEUROPATHOL EXP NE, V55, P68; RADOMSKI MW, 1995, ANN MED, V27, P321, DOI 10.3109/07853899509002585; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Sharma AC, 1998, NEUROL RES, V20, P632; SHUKLA A, 1995, NEUROREPORT, V6, P1629, DOI 10.1097/00001756-199508000-00010; Strijbos PJLM, 1996, J NEUROSCI, V16, P5004; Suzuki N, 1999, ARCH ORAL BIOL, V44, P67, DOI 10.1016/S0003-9969(98)00089-2; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Tamatani M, 1998, J NEUROCHEM, V71, P1588; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WHITTLE BJR, 1995, HISTOCHEM J, V27, P727; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1	45	55	57	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	AUG	2000	100	2					196	204		10.1007/s004019900167			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	336MV	WOS:000088307600013	10963368				2022-02-06	
J	Keeling, KL; Hicks, RR; Mahesh, J; Billings, BB; Kotwall, GJ				Keeling, KL; Hicks, RR; Mahesh, J; Billings, BB; Kotwall, GJ			Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragments of the third component (C3) of the complement system	JOURNAL OF NEUROIMMUNOLOGY			English	Article						myeloperoxidase; brain trauma; head injury; inflammation; complement	MICROTUBULE-ASSOCIATED PROTEIN-2; CONTROLLED CORTICAL IMPACT; POLYMORPHONUCLEAR LEUKOCYTES; MYELOPEROXIDASE ACTIVITY; ADHESION MOLECULES; ALZHEIMERS-DISEASE; HEAD-INJURY; FACTOR-B; INFLAMMATION; TISSUE	Traumatic brain injury can lead to locally destructive secondary events mediated by several inflammatory components. Following lateral fluid-percussion (FP) brain injury in rats, we examined cortical and hippocampal sections for neutrophil infiltration and accumulation of complement component C3. Neutrophil influx into the brain after injury was detected by an improved myeloperoxidase (MPO) microassay and manual cell counting, while C3 accumulation was detected using immunocytochemistry. MPO levels were elevated in the injured cortical tissue, whereas C3 immunoreactivity was increased in both injured cortical and ipsilateral hippocampal sections. These results show that the FP model of head injury leads to an intense local inflammatory reaction and subsequent tissue destruction. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; Univ Kentucky, Div Phys Therapy, Lexington, KY 40536 USA		Kotwall, GJ (corresponding author), Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.						ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; ANDREWS PC, 1982, ANAL BIOCHEM, V127, P346, DOI 10.1016/0003-2697(82)90185-3; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; BECKER P, 1987, ANAESTHESIST, V36, P301; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BOKISCH VA, 1975, P NATL ACAD SCI USA, V72, P1989, DOI 10.1073/pnas.72.6.1989; BOWMAN CM, 1983, AM REV RESPIR DIS, V128, P469, DOI 10.1164/arrd.1983.128.3.469; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BRETZ U, 1974, J CELL BIOL, V63, P251, DOI 10.1083/jcb.63.1.251; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Daly J, 1998, NEUROBIOL AGING, V19, P619, DOI 10.1016/S0197-4580(98)00100-6; Dixon C. E., 1995, CENTRAL NERVOUS SYST, P255; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Grady MS, 1999, J NEUROTRAUM, V16, P13, DOI 10.1089/neu.1999.16.13; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X; KLEBANOFF SJ, 1975, SEMIN HEMATOL, V12, P117; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Kuebler WM, 1996, INT J MICROCIRC, V16, P89, DOI 10.1159/000179155; LEVISTRAUSS M, 1987, J IMMUNOL, V139, P2361; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCKENZIE R, 1992, J INFECT DIS, V166, P1245, DOI 10.1093/infdis/166.6.1245; MercerJones MA, 1997, SHOCK, V8, P193, DOI 10.1097/00024382-199709000-00007; Morgan BP, 1997, IMMUNOPHARMACOLOGY, V38, P43; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; ROTHER K, 1988, COMPLEMENT SYSTEM; SCHIERWAGEN C, 1990, J PHARMACOL METHOD, V23, P179, DOI 10.1016/0160-5402(90)90061-O; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soares HD, 1995, J NEUROSCI, V15, P8223; SPIEGEL K, 1997, NEUROINFLAMMATION ME, P129; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TONNESEN MG, 1988, MOL CELLULAR BIOL WO, P149; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141	57	55	55	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728			J NEUROIMMUNOL	J. Neuroimmunol.	JUN 1	2000	105	1					20	30		10.1016/S0165-5728(00)00183-1			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	310HV	WOS:000086821200003	10713360				2022-02-06	
J	Vanier, M; Mazaux, JM; Lambert, J; Dassa, C; Levin, HS				Vanier, M; Mazaux, JM; Lambert, J; Dassa, C; Levin, HS			Assessment of neuropsychologic impairments after head injury: Interrater reliability and factorial and criterion validity of the neurobehavioral rating scale-revised	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	25th Meeting of the International-Neuropsychological-Society	FEB 05-08, 1997	ORLANDO, FL	Int Neuropsychol Soc		factorial validity; Neurobehavioral Rating Scale-Revised (NRS-R); traumatic brain injuries; screening measure; neuropsychologic dimensions; rehabilitation	TRAUMATIC BRAIN INJURY; BEHAVIORAL SEQUELAE; MEMORY; DYSFUNCTION; VALIDATION; DEPRESSION; RELATIVES; SEVERITY; DEFICITS; AUTONOMY	Objective: To study interrater reliability and factorial and criterion validity of the Neurobehavioral Rating Scale-Revised (NRS-R). Design: Validity study on persons with traumatic brain injury (TBI) and test-retest reliability study on a randomly selected subset of patients. Factor analyses, kappa statistics, intraclass correlation coefficients, and Cronbach's alphas were used. Setting: Inpatients from 15 French hospitals, mainly rehabilitation units. Other recruitment sites included a neurology hospital unit and a psychiatry hospital specifically devoted to TBI rehabilitation. Patients: Two hundred eighty-six TBI patients ages 16 to 70 years (convenience sample). Results: For the reliability study, the average of percentages of agreement among the items was 74.3% and the average of kappa statistics was .40. Factor analyses disclosed a maximum likelihood extraction of 5 correlated factors (F), explaining 42.2% of total variance: (F1) deficits in intentional behavior and in memory, (F2) lowering of emotional state, (F3) emotional and behavioral hyperactivation, (F4) lowering of arousal state and of attention, and (F5) language and speech problems. Results support the criterion validity of the factors. Reliability of the factor scores and internal consistencies of factors were very good. Conclusions: Results describe some important properties of the NRS-R and, through an understanding of its underlying structure and relationships with the patients' clinical characteristics, contribute to the conceptual framework of neuropsychologic impairments after TBI.	Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Social & Prevent Med, Montreal, PQ H3C 3J7, Canada; CHU Bordeaux, Serv Reeduc Fonctionelle Neurol, Bordeaux, France; Baylor Coll Med, Houston, TX 77030 USA		Vanier, M (corresponding author), Univ Montreal, Fac Med, Ecole Readaptat, CP 6128 Succ Centreville, Montreal, PQ H3C 3J7, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		Alaoui P., 1998, Annales de Readaptation et de Medecine Physique, V41, P171, DOI 10.1016/S0168-6054(98)80001-9; ALEXANDER MP, 1987, NEUROBEHAVIORAL RECO; *AM PSYCH ASS, 1985, STAND ED PSYCH TEST; AZOUVI P, 1991, TRAUMATISME CRANIEN, P179; Benton AL, 1991, FRONTAL LOBE FUNCTIO; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKS DN, 1990, TRAUMATIC BRAIN INJU, P77; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Dahlstrom W. G., 1972, MMPI HDB, V1; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Epstein Richard S., 1994, P285; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Feldt L. S., 1989, ED MEASUREMENT, V3rd, P105; Fleiss J.L., 1981, STAT METHODS RATES P; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; Gerbing DW, 1996, STRUCT EQU MODELING, V3, P62, DOI 10.1080/10705519609540030; GIROIRE JM, 1988, NEUROPSYCHOLOGIE MEM, P70; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; GOLDSTEIN FC, 1989, INTEGRATING THEORY P, P217; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; HAMILTON JM, 1995, BRAIN INJURY, V9, P479, DOI 10.3109/02699059509008207; HARTLEY L, 1989, J SPEECH LANGUAGE PA, V13, P51; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; Heilman K. M., 1991, FRONTAL LOBE FUNCTIO; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1977, CORTEX, V13, P119, DOI 10.1016/S0010-9452(77)80003-8; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1973, WORKING BRAIN; LURIA AR, 1967, TROUBLES RESOLUTION; Marsh H.W., 1999, STAT STRATEGIES SMAL, P251; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MAZAUX JM, 1991, TRAUMATISME CRANIEN, P185; MORRISON J, 1995, DSM 4 MADE EASY CLIN; NEARY D, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P304; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pollens RD, 1988, COGNITIVE REHABILITA, V6, P26; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Silver Jonathan M., 1994, P313; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TRUELLE JL, 1994, BRAIN INJURY NEUROPS, P281; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANIER M, 1991, TRAUMATISME CRANIEN, P166; VANZOMEREN AH, 1990, TRAUMATIC BRAIN INJU, P33; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186; Wood R. L. L., 1984, CLOSED HEAD INJURY P; [No title captured]; [No title captured]	74	55	58	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2000	81	6					796	806		10.1016/S0003-9993(00)90114-X			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	320EN	WOS:000087389000020	10857527				2022-02-06	
J	Isaki, E; Turkstra, L				Isaki, E; Turkstra, L			Communication abilities and work re-entry following traumatic brain injury	BRAIN INJURY			English	Article							SUPPORTED EMPLOYMENT; RETURN; REHABILITATION; PREDICTION; OUTCOMES	This exploratory study was completed to determine if communication measures could discriminate employed from unemployed individuals with traumatic brain injury (TBI). Twenty adults with TBI participated, 10 employed and 10 unemployed; subjects in both groups were 1-4 years post-injury, with comparable severity of injury and type of work. Subjects were administered communication tests measuring auditory processing, effects of speaking under time pressure, production of oral language, and functional verbal reasoning ability. An aphasia test and a functional outcome measure were also administered. Results revealed that a combination of three tests, one test of functional verbal reasoning and two tests of auditory processing, correctly classified 85% of subjects as employed or unemployed. Tasks that were impairment- and disability-based appear to be more related to outcome than impairment-level tasks alone. Impairment and disability level communication tasks may provide functional and practical information, which could assist in work re-entry.	Nat Ctr Neurogen Commun Disorders, Tucson, AZ USA; Case Western Reserve Univ, Cleveland, OH 44106 USA		Isaki, E (corresponding author), Univ Hawaii, Div SPA, 1410 Lower Campus Rd, Honolulu, HI 96822 USA.		Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P60DC001409] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-00163, DC-01409] Funding Source: Medline		BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CONBOY TJ, 1986, REHABIL PSYCHOL, V31, P203, DOI 10.1037//0090-5550.31.4.203; CRISP R, 1992, J REHABIL, V58, P27; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; DENCKLA M B, 1974, Cortex, V10, P186; FRASER RT, 1995, NEUROREHABILITATION, V5, P39, DOI 10.3233/NRE-1995-5104; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GLOSSER G, 1990, BRAIN LANG, V6, P271; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hartley L. L, 1995, COGNITIVE COMMUNICAT; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KEITH RW, 1994, SCANA TEST AUDITORY; Kertesz A., 1982, W APHASIA BATTERY TE; MACDONALD S, IN PRESS FUNCTIONAL; MURRAY LL, 1995, DISS ABSTR INT, V56, P2592; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SCHALEN W, 1994, BRAIN INJURY, V8, P37, DOI 10.3109/02699059409150957; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spreen O, 1991, COMPENDIUM NEUROPSYC; *STAT CORP, 1997, STAT 5 0 COMP SOFTW; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 1980, INT CLASS IMP DIS HA; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; 1988, ASHA, V30, P79; [No title captured]	33	55	55	0	8	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2000	14	5					441	453					13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	316MQ	WOS:000087171500005	10834339				2022-02-06	
J	Kanaki, T; Bujo, H; Hirayama, S; Ishii, I; Morisaki, N; Schneider, WJ; Saito, Y				Kanaki, T; Bujo, H; Hirayama, S; Ishii, I; Morisaki, N; Schneider, WJ; Saito, Y			Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						LDL receptor; atherosclerosis; smooth muscle cell; THP-1	DENSITY-LIPOPROTEIN RECEPTOR; PROTEIN ALPHA(2)-MACROGLOBULIN RECEPTOR; SMOOTH-MUSCLE PHENOTYPE; HEAD-ACTIVATOR; DECREASED EXPRESSION; ENDOCYTIC RECEPTOR; SCAVENGER RECEPTOR; SORTING RECEPTOR; VLDL RECEPTOR; CELLS	Receptors belonging to the LDL receptor (LDLR) family are thought to play key roles in lipoprotein metabolism in a variety of tissues, including the arterial wall. Here, we report that the expression of a 250-kDa mosaic LDLR family member, which we called LR11 for the presence of 11 ligand-binding repeats, is markedly induced during the process of atherogenesis in 2 animal models. Analysis by reverse transcription-polymerase chain reaction and RNase protection assays revealed that LR11 transcript levels rise in rabbit aortas displaying atheromatous lesions after the rabbits have been fed a high-cholesterol diet. Immunohistochemistry demonstrated that the highest induction of LR11 occurs in intimal smooth muscle cells (SMCs), followed by medial SMCs close to the intimal border of the atheromatous lesions. Experimental intimal hyperplasia by endothelial denudation showed that LR11 mRNA levels were also increased in the arteries after balloon injury, with the transcripts localized primarily in the hyperplastic intimal layer. In agreement with the correlation of LR11 induction during increased cell, proliferation, cultured SMCs showed an increase in LR11 expression in the proliferative phase. Furthermore, Northern and Western blot analyses showed that medium conditioned by the monocyte-macrophage cell line THP-1 enhanced LR11 expression in cultured SMCs. These findings suggest that upregulation of LR11 might be contributing to the pathological roles of intimal and medial SMCs during arteriosclerotic lesion development and provide the first insight into the as yet unknown functional significance of this intriguing LDLR family member.	Chiba Univ, Sch Med, Dept Internal Med 2, Chuo Ku, Chiba 260, Japan; Chiba Univ, Fac Pharmaceut Sci, Lab Clin Pharmacol, Chiba 260, Japan; Bioctr, Dept Mol Genet, Vienna, Austria; Univ Vienna, Vienna, Austria		Bujo, H (corresponding author), Chiba Univ, Sch Med, Dept Internal Med 2, Chuo Ku, 1-8-1 Inohana, Chiba 260, Japan.						Bochaton-Piallat ML, 1998, CIRC RES, V82, P1086, DOI 10.1161/01.RES.82.10.1086; BUJO H, 1995, J BIOL CHEM, V270, P23546, DOI 10.1074/jbc.270.40.23546; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; CAMPBELL JH, 1992, EXP CELL RES, V200, P156, DOI 10.1016/S0014-4827(05)80084-9; deVries TJ, 1996, CANCER RES, V56, P1432; Franke I, 1997, EUR J BIOCHEM, V244, P940, DOI 10.1111/j.1432-1033.1997.00940.x; GODYNA S, 1995, J CELL BIOL, V129, P1403, DOI 10.1083/jcb.129.5.1403; Hajjar DP, 1997, J BIOL CHEM, V272, P22975, DOI 10.1074/jbc.272.37.22975; HASEL KW, 1991, MOL CELL BIOL, V11, P3484, DOI 10.1128/MCB.11.7.3484; Hermans-Borgmeyer I, 1998, MECH DEVELOP, V70, P65, DOI 10.1016/S0925-4773(97)00177-9; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Ishikawa Y, 1998, ARTERIOSCL THROM VAS, V18, P665, DOI 10.1161/01.ATV.18.4.665; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Kanaki T, 1998, DNA CELL BIOL, V17, P647, DOI 10.1089/dna.1998.17.647; KANCHA RK, 1994, ONCOL RES, V6, P365; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P13070, DOI 10.1074/jbc.270.22.13070; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Li YH, 1997, BIOCHEM BIOPH RES CO, V240, P122, DOI 10.1006/bbrc.1997.7619; LOPES MBS, 1994, FEBS LETT, V338, P301, DOI 10.1016/0014-5793(94)80288-2; LUOMA J, 1994, J CLIN INVEST, V93, P2014, DOI 10.1172/JCI117195; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; MIKHAILENKO I, 1995, J BIOL CHEM, V270, P9543, DOI 10.1074/jbc.270.16.9543; MOERWALD S, 1997, ARTERIOSCLER THROMB, V17, P996; MOESTRUP SK, 1994, BBA-REV BIOMEMBRANES, V1197, P197, DOI 10.1016/0304-4157(94)90005-1; Multhaupt HAB, 1996, AM J PATHOL, V148, P1985; Nakazato K, 1996, AM J PATHOL, V149, P1831; Niemann S, 1996, NEUROSCI LETT, V207, P49, DOI 10.1016/0304-3940(96)12485-X; ORLANDI A, 1994, ARTERIOSCLER THROMB, V14, P982, DOI 10.1161/01.ATV.14.6.982; QUACH TT, 1992, DEV BRAIN RES, V68, P97; Raines EW, 1996, BIOESSAYS, V18, P271, DOI 10.1002/bies.950180405; RENNICK RE, 1988, ATHEROSCLEROSIS, V71, P35, DOI 10.1016/0021-9150(88)90300-0; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sambrook J, 1989, MOL CLONING LAB MANU; Schneider WJ, 1997, CURR OPIN LIPIDOL, V8, P315, DOI 10.1097/00041433-199710000-00011; Schneider Wolfgang J., 1995, Current Opinion in Lipidology, V6, P92, DOI 10.1097/00041433-199504000-00006; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; SUZUKI J, 1995, BIOCHEM BIOPH RES CO, V206, P835, DOI 10.1006/bbrc.1995.1119; TAKAHASHI K, 1993, J CLIN INVEST, V92, P2060, DOI 10.1172/JCI116802; TAMURA K, 1993, ONCOGENE, V8, P2113; Ueno H, 1997, CIRCULATION, V96, P2272; vanLeeuwen RTJ, 1996, FIBRINOLYSIS, V10, P59, DOI 10.1016/S0268-9499(96)80081-6; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; Wei GL, 1997, CIRC RES, V80, P418, DOI 10.1161/01.res.0000435858.35902.ea; Wyne KL, 1996, ARTERIOSCL THROM VAS, V16, P407, DOI 10.1161/01.ATV.16.3.407; Yamamoto M, 1997, CANCER RES, V57, P2799; Yamamoto T, 1996, CURR OPIN LIPIDOL, V7, P298, DOI 10.1097/00041433-199610000-00007; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; YlaHerttuala S, 1996, CURR OPIN LIPIDOL, V7, P292, DOI 10.1097/00041433-199610000-00006	49	55	55	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-5642			ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	NOV	1999	19	11					2687	2695		10.1161/01.ATV.19.11.2687			9	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	256LA	WOS:000083725700015	10559012	Bronze			2022-02-06	
J	McMahon, CG; Yates, DW; Campbell, FM; Hollis, S; Woodford, M				McMahon, CG; Yates, DW; Campbell, FM; Hollis, S; Woodford, M			Unexpected contribution of moderate traumatic brain injury to death after major trauma	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							HEMORRHAGIC-SHOCK; SEVERITY SCORE; CARE; SUPPRESSION; ENGLAND; ALCOHOL; RATS	Background: The cardiovascular reflex responses to injury and simple hemorrhage are coordinated in the central nervous system. Coincidental brain injury, which is present in 64% of trauma patients who die, could impair these homeostatic responses. The occurrence of hemorrhagic shock in the patient with head injury is also known to increase mortality. Therefore, there is a potential bidirectional interaction between traumatic brain injury and peripheral injury, which would result in an increased mortality when these two injuries coexist. Our objective was to test the hypothesis that moderate traumatic brain injury is an independent predictor of outcome in patients with multisystem trauma. Methods: We carried out an analysis of the UK Trauma Audit and Research Network Database. Moderate traumatic brain injury was defined as an Abbreviated Injury Scale score of 3, The study population included 2,717 patients with multisystem injury: 378 patients had a moderate brain injury with peripheral injury, and 2,339 patients had extracranial injury alone, Mortality rates for both groups were compared at increasing injury severity. Results: Moderate brain injury alone was associated with a mortality rate of 4.2%. However, when combined with extracranial injury, the risk of death was double that attributable to extracranial injury alone (odds ratio, 2.08; 95% confidence interval, 1.57-2.77). Conclusion: This study confirms that the coexistence of moderate traumatic brain injury with extracranial injury is associated with a doubling of the predicted mortality rate throughout the injury severity ranges studied.	Univ Lancaster, Lancaster LA1 4YW, England; Univ Manchester, Hope Hosp, Salford M6 8HD, Lancs, England		McMahon, CG (corresponding author), Univ Manchester, Hope Hosp, Clin Sci Bldg, Salford M6 8HD, Lancs, England.		McMahon, C Geraldine/M-8684-2019	McMahon, C Geraldine/0000-0002-9870-3104			ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barcroft H, 1944, LANCET, V1, P489; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BULL JP, 1991, INJURY, V21, P127; Campbell FM, 1996, THESIS U MANCHESTER; FLAMM ES, 1977, J TRAUMA, V47, P328; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GREEN AR, 1995, PSYCHOPHARMACOLOGY, V119, P247, DOI 10.1007/BF02246288; HOLLIS S, 1995, J TRAUMA, V38, P766; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; MCMAHON G, 1997, J ACCID EMERG MED, V14, P130; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; *ROYAL COLL SURG E, 1988, MAN PAT MAJ INJ REP; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; *SPSS, 1996, STAT PACK SOC SCI WI; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; YATES DW, 1987, J ROY SOC MED, V80, P486, DOI 10.1177/014107688708000810; YATES DW, 1992, BRIT MED J, V305, P737, DOI 10.1136/bmj.305.6856.737; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	23	55	58	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	1999	47	5					891	895		10.1097/00005373-199911000-00013			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	254QM	WOS:000083623700013	10568718				2022-02-06	
J	Levi, RB; Drotar, D; Yeates, KO; Taylor, HG				Levi, RB; Drotar, D; Yeates, KO; Taylor, HG			Posttraumatic stress symptoms in children following orthopedic or traumatic brain injury	JOURNAL OF CLINICAL CHILD PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; SEVERITY; DISASTER; SEQUELAE; DISORDER; ADOLESCENTS; SUPPORT; AMNESIA; SCALE	Examined posttraumatic stress (PTS) symptoms in children following pediatric traumatic brain injury (TBI). Children (ages 6-12) with TBI (n = 81) and orthopedic injury (OI; n = 59) were assessed 6 and 12 months postinjury. Parents of children with severe TBI reported higher levels of child PTS symptoms than did parents of children with moderate TBI or OI at the 6- and 12-month follow-ups. Group differences in child-reported PTS symptoms emerged at the 12-month follow-up with higher symptom levels reported by children with severe TBI than by those with moderate TBI or OI. At both follow-ups, rates of clinically significant symptom levels were higher in the severe TBI group than in the moderate TBI or OI groups. The group differences in parent and child reports were significant even after taking ethnicity, social disadvantage, and age at injury into account. Parent and child reports of child PTS symptoms were related to family socioeconomic status. Implications for clinical intervention with children and families following pediatric TBI are discussed.	Case Western Reserve Univ, Dept Psychol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Ohio State Univ, Coll Med, Columbus, OH 43210 USA; Columbus Childrens Hosp, Columbus, OH USA		Levi, RB (corresponding author), Case Western Reserve Univ, Dept Psychol, 10900 Euclid Ave, Cleveland, OH 44106 USA.		Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-390611, 18830] Funding Source: Medline		ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Achenbach TM, 1991, MANUAL CHILD BEHAV C; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; BENEDEK ED, 1985, PSYCHIAT ANN, V15, P168, DOI 10.3928/0048-5713-19850301-08; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bruce D. A., 1995, TRAUMATIC HEAD INJUR, P40; BURKE JD, 1982, AM J PSYCHIAT, V139, P1010; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cohen J., 1983, APPL MULTIPLE REGRES; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; EARLS F, 1988, J AM ACAD CHILD PSY, V27, P90, DOI 10.1097/00004583-198801000-00014; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; Frederick C., 1985, POSTTRAUMATIC STRESS, P71; Frederick CJ., 1992, CHILD POSTTRAUMATIC; Hobfoll, 1991, ANXIETY RES, V4, P187, DOI [10.1080/08917779108248773, DOI 10.1080/08917779108248773]; Hobfoll S. E., 1988, ECOLOGY STRESS; JACOBSON MS, 1986, PEDIATRICS, V77, P236; Keppel-Benson J. M., 1993, CHILDREN DISASTERS, P29; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LaGreca AM, 1996, J CONSULT CLIN PSYCH, V64, P712, DOI 10.1037/0022-006X.66.6.883; LEE ML, 1994, J PSYCHOSOC ONCOL, V12, P43; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Levin HS., 1982, NEUROBEHAVIORAL CONS; LYONS JA, 1987, J DEV BEHAV PEDIATR, V8, P349; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MCCAFFREY RJ, 1985, BEHAV THER, V16, P406, DOI 10.1016/S0005-7894(85)80007-1; McNally R. J., 1991, PSYCHOL ASSESSMENT, V3, P531, DOI [DOI 10.1037/1040-3590.3.4.531, 10.1037/1040-3590.3.4.531]; MOOS R, 1988, LIFE STRESSORS SOCIA; *NAT HEAD INJ FDN, 1985, ED MAN ED NEED KNOW; PYNOOS R, 1986, J AM ACAD CHILD ADOL, V44, P1057; Pynoos Robert S., 1996, P331; PYNOOS RS, 1987, ARCH GEN PSYCHIAT, V44, P1057; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; PYNOOS RS, 1990, PSYCHIAT DISORDERS C, P48; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SHAFFER D, 1995, TRAUMATIC HEAD INJUR, P55; SILVER JM, 1992, AM PSYCHIAT PRESS TX, P363; SNOW JH, 1994, PEDIATRIC TRAUMATIC; STALLARD P, 1994, CHILDREN SOC, V8, P89; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Stuber ML, 1996, PSYCHOSOMATICS, V37, P254, DOI 10.1016/S0033-3182(96)71564-5; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; TERR LC, 1991, AM J PSYCHIAT, V148, P10; Van Der Kolk Bessel A., 1996, P279; VOGEL JM, 1993, J CLIN CHILD PSYCHOL, V22, P464, DOI 10.1207/s15374424jccp2204_7; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; WETHINGTON E, 1986, J HEALTH SOC BEHAV, V27, P78, DOI 10.2307/2136504; Wolfe J, 1991, PSYCHOL ASSESSMENT J, V3, P573, DOI DOI 10.1037/1040-3590.3.4.573; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yule W., 1993, CHILDREN DISASTERS, P105; [No title captured]; [No title captured]	69	55	55	0	4	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0047-228X			J CLIN CHILD PSYCHOL	J. Clin. Child Psychol.	JUN	1999	28	2					232	243		10.1207/s15374424jccp2802_10			12	Psychology, Clinical; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	197TW	WOS:000080382600010	10353082				2022-02-06	
J	Thatcher, RW; Biver, C; McAlaster, R; Salazar, A				Thatcher, RW; Biver, C; McAlaster, R; Salazar, A			Biophysical linkage between MRI and EEG coherence in closed head injury	NEUROIMAGE			English	Article						EEG coherence; MRI; H-1 proton relaxation times; cognition; traumatic brain injury	MAGNETIC-RESONANCE IMAGES; RELAXATION-TIMES; BRAIN; TISSUE; NMR; SEGMENTATION; DEPENDENCE; SEQUENCES; MODEL; T1	Using conventional MRI procedures, nuclear magnetic resonance (NMR) of brain water proton (H-1) T2 relaxation times and EEG coherence were obtained from two independent groups of closed head injured (CHI) patients and a group of normal control subjects. Statistically significant intercorrelations were observed between III T2 relaxation times of the cortical gray and white matter and EEG coherence. The analyses showed that lengthened H-1 T2 relaxation times of the cortical gray and white matter were related to: (1) decreased EEG coherence between short interelectrode distances (e.g., 7 cm) and increased EEG coherence between long interelectrode distances (e.g., 28 cm), (2) differences in EEG frequency in which T2 relaxation time was most strongly related to the gray matter in the delta and theta frequencies in CHI patients, and (3) increased T2 relaxation time and decreased short-distance EEG; coherence were related to reduced cognitive function. The results were interpreted in terms of reduced integrity of protein/lipid neural membranes and the efficiency and effectiveness of short- and long-distance neural synchronization following traumatic brain injury. (C) 1998 Academic Press.	VA Med Ctr, Res & Dev Serv, Bay Pines, FL 33744 USA; Univ S Florida, Coll Med, Dept Neurol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Radiol, Tampa, FL 33612 USA; Def & Vet Head Injury Program, Washington, DC USA		Thatcher, RW (corresponding author), VA Med Ctr, Res & Dev Serv, Bay Pines, FL 33744 USA.						Bendat J. S., 1980, ENG APPL CORRELATION; BENSAID AM, 1994, P SOC PHOTO-OPT INS, V2167, P454, DOI 10.1117/12.175079; Berryman A. A., 1981, POPULATION SYSTEMS G; BEZDEK JC, 1993, MED PHYS, V20, P1033, DOI 10.1118/1.597000; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; BRAITENBERG V, 1978, ARCHITECTECTONICS CE; Braitenberg V., 1991, ANATOMY CORTEX STAT; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; Cohen J., 1983, APPL MULTIPLE REGRES; DANIEL JC, 1997, DEFENSE VETERANS HEA; DARWIN RH, 1986, RADIOLOGY, V160, P375, DOI 10.1148/radiology.160.2.3726116; DECERTAINES JD, 1993, MAGN RESON IMAGING, V11, P841, DOI 10.1016/0730-725X(93)90201-N; DIXON RL, 1982, MED PHYS, V9, P807, DOI 10.1118/1.595189; FEIN G, 1988, ELECTROEN CLIN NEURO, V69, P581, DOI 10.1016/0013-4694(88)90171-X; HENRIKSEN O, 1993, MAG RESON IMAG, V11, P811; HICKEY DS, 1986, BRIT J RADIOL, V59, P565, DOI 10.1259/0007-1285-59-702-565; KJOS BO, 1985, AM J ROENTGENOL, V144, P1165, DOI 10.2214/ajr.144.6.1165; KOENIG SH, 1991, MAGNET RESON MED, V20, P285, DOI 10.1002/mrm.1910200210; MILLS CM, 1984, RADIOLOGY, V150, P87, DOI 10.1148/radiology.150.1.6689792; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NICHOLSON C, 1980, NEUROSCI RES PROGRAM, V18, P181; Nunez P, 1981, ELECT FIELDS BRAIN; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Otnes RK, 1972, DIGITAL TIME SERIES; PASCUALMARQUI RD, 1988, INT J NEUROSCI, V40, P89, DOI 10.3109/00207458808985730; Petsche H, 1996, INT J PSYCHOPHYSIOL, V24, P145, DOI 10.1016/S0167-8760(96)00050-5; RAPPELSBERGER P, 1989, Brain Topography, V2, P63, DOI 10.1007/BF01128844; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHOENIGER JS, 1994, J MAGN RESON SER B, V103, P261, DOI 10.1006/jmrb.1994.1039; SZAFER A, 1995, MAGNET RESON MED, V33, P687; Thatcher R W, 1995, J Neuroimaging, V5, P35; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; THATCHER RW, 1994, DEV PSYCHOPATHOL, V6, P565, DOI 10.1017/S0954579400004697; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; THATCHER RW, 1998, DYNAMICAL SYSTEMS DE; VANBAAL C, 1997, THESIS VRIJE U NETHE; VELLEMAN PF, 1995, DATA DESK VERSION 5; Wehrli F. W, 1992, MAGNETIC RESONANCE I, P3; Wright JJ, 1997, BIOL CYBERN, V76, P181, DOI 10.1007/s004220050331; [No title captured]	47	55	56	1	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	NOV	1998	8	4					307	326		10.1006/nimg.1998.0365			20	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	144GV	WOS:000077306700001	9811550				2022-02-06	
J	Azkue, JJ; Zimmermann, M; Hsieh, TF; Herdegen, T				Azkue, JJ; Zimmermann, M; Hsieh, TF; Herdegen, T			Peripheral nerve insult induces NMDA receptor-mediated, delayed degeneration in spinal neurons	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						rat; neurodegeneration; excitotoxicity; glutamate receptors	TRAUMATIC BRAIN INJURY; PROGRAMMED CELL-DEATH; CORD DORSAL HORN; CEREBRAL-ISCHEMIA; APOPTOSIS; RAT; GLUTAMATE; NEURECTOMY; ASPARTATE; NECROSIS	Injury of a peripheral nerve gives rise to adaptive functional and structural alterations in spinal neurons. We report that the rearrangement of the spinal circuitry in response to sciatic nerve transection in adult rats involves a delayed mode of degeneration of lumbar spinal cord neurons. Nuclear fragmentation was detected by the TUNEL technique 7 days after sciatic neurectomy but not after 3 or 14 days. Dying cells were preferentially located in the ipsilateral superficial dorsal horn and expressed the neuronal cytoskeletal marker SMI-31, Degeneration was prevented by continous systemic treatment with the NMDA receptor-antagonist MK-801. These data are supportive that apoptosis is induced in spinal neurons in a transsynaptic manner by an early signal from injured afferent fibres via activation of spinal NMDA receptors.	Univ Heidelberg, Inst Physiol 2, Abt Physiol Zent Nervensyst, D-69120 Heidelberg, Germany; Univ Kiel Klinikum, Inst Pharmakol, D-24105 Kiel, Germany		Azkue, JJ (corresponding author), Univ Basque Country, Sch Med & Dent, Dept Neurosci, POB 699, Bilbao 48080, Spain.	ONBAZBAJ@lg.ehu.es					ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; ARENDS MJ, 1990, AM J PATHOL, V136, P593; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Capurso SA, 1997, J NEUROSCI, V17, P7372; CASTROLOPES JM, 1995, BRAIN RES, V679, P289, DOI 10.1016/0006-8993(95)00262-O; CASTROLOPES JM, 1993, BRAIN RES, V620, P287, DOI 10.1016/0006-8993(93)90167-L; DEVOR M, 1981, J NEUROSCI, V1, P679, DOI 10.1523/JNEUROSCI.01-07-00679.1981; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gass P, 1995, PROG NEUROBIOL, V47, P257, DOI 10.1016/0301-0082(95)00022-4; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; Larm JA, 1997, J NEUROCHEM, V69, P617; Li YQ, 1996, CANCER RES, V56, P5417; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; RINK A, 1995, AM J PATHOL, V147, P1575; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; ZHANG X, 1995, J NEUROSCI, V15, P2733	21	55	59	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUN	1998	10	6					2204	2206		10.1046/j.1460-9568.1998.00260.x			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZR740	WOS:000074009000028	9753107				2022-02-06	
J	Williams, SE; Ris, MD; Ayyangar, R; Schefft, BK; Berch, D				Williams, SE; Ris, MD; Ayyangar, R; Schefft, BK; Berch, D			Recovery in pediatric brain injury: Is psychostimulant medication beneficial?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED-HEAD-INJURY; MULTIMETHOD CLINICAL PROTOCOL; ATTENTION DEFICIT DISORDER; INTELLECTUAL ABILITY; CHILDREN; METHYLPHENIDATE; SEQUELAE; HYPERACTIVITY; PERFORMANCE; APPROPRIATE	Objective: To assess the effects of methylphenidate on attention, memory, behavior, processing speed, and psychomotor skills of children with closed head injuries. Design: Double-blind, placebo-controlled, crossover design. Setting: An outpatient facility of a children's hospital medical center. Patients: Ten pediatric subjects identified through chart review. Subjects met baseline scores for hyperactivity (Conner's Hyperactivity Index greater than or equal to 60) and intellectual functioning (Verbal Intelligence Quotient greater than or equal to 70) and achieved minimal scores on two psychometric tests. Ail subjects evidenced head injury by focal lesions on computed tomography scan and/or sequelae reported at the time of injury. Severity of injury ranged from mild to severe. All subjects were medically stable at the time of testing. Mean time post injury was 2 years, 8 months. Intervention: Administration of methylphenidate and placebo. Main Outcome Measures: Percentage change in scores was calculated to assess differences between baseline and end of methylphenidate/placebo trials. Results: No significant differences between methylphenidate and placebo on measures assessing behavior, attention, memory, and processing speed. Conclusions: The results of the study call into question the effectiveness of methylphenidate in the pediatric head injury population.	Stanford Univ, Med Ctr, Sch Med, Div Child Psychiat,Dept Psychiat, Stanford, CA 94305 USA; Univ Cincinnati, Coll Med, Neuropsychol Program, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Dept Phys Med & Rehabil, Cincinnati, OH USA; Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA		Williams, SE (corresponding author), Stanford Univ, Med Ctr, Sch Med, Div Child Psychiat,Dept Psychiat, 401 Quarry Rd, Stanford, CA 94305 USA.	sharonw@leland.Stanford.edu					ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Barkley R. A., 1990, ATTENTION DEFICIT HY; BARKLEY RA, 1977, J CHILD PSYCHOL PSYC, V18, P137, DOI 10.1111/j.1469-7610.1977.tb00425.x; BARKLEY RA, 1988, J CLIN CHILD PSYCHOL, V17, P14, DOI 10.1207/s15374424jccp1701_3; Barkley RA, 1991, COMPREHENSIVE MENTAL, V1, P27; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BEERY K, 1989, DEV TEST VISUAL MOTO; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRUMAGHIM JT, 1987, PSYCHOPHYSIOLOGY, V24, P361, DOI 10.1111/j.1469-8986.1987.tb00310.x; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Conners C.K., 1989, CONNERS RATING SCALE; DENCKLA M B, 1974, Cortex, V10, P186; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; EVANS RW, 1987, J HEAD TRAUMA REHAB, V1, P34; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; FISCHER M, 1991, J CLIN CHILD PSYCHOL, V20, P232, DOI 10.1207/s15374424jccp2003_2; Fletcher J, 1987, NEUROBEHAVIORAL RECO; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FRANKOWSKI KF, 1985, CENTRAL NERVOUS SYST; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; HANNAY HJ, 1988, J CLIN EXPT NEUROPSY, V11, P444; HAYES RL, 1992, J HEAD TRAUMA REHAB, V7, P16; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KLORMAN R, 1990, PSYCHOPHYSIOLOGY, V27, P328, DOI 10.1111/j.1469-8986.1990.tb00391.x; KRAUS MF, 1995, INT J PSYCHIAT MED, V25, P39, DOI 10.2190/BXRM-3M58-WBC5-A7EL; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MATTES JA, 1980, COMPR PSYCHIAT, V21, P358, DOI 10.1016/0010-440X(80)90017-6; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; ODOUGHERTY M, 1984, J ABNORM PSYCHOL, V93, P1878; Reitan R, 1969, MANUAL ADM NEUROPSYC; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; SWANSON JM, 1985, PSYCHOPHARMACOL BULL, V21, P887; SYKES DH, 1971, J CHILD PSYCHOL PSYC, V12, P129, DOI 10.1111/j.1469-7610.1971.tb01056.x; TIFFIN J, 1948, INSTRUCTIONS NORMATI; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; ZAMETKIN AJ, 1987, J AM ACAD CHILD PSY, V26, P676, DOI 10.1097/00004583-198709000-00011; [No title captured]	44	55	55	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1998	13	3					73	81		10.1097/00001199-199806000-00007			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZT046	WOS:000074042200007	9582180				2022-02-06	
J	Yehuda, R; Resnick, HS; Schmeidler, J; Yang, RK; Pitman, RK				Yehuda, R; Resnick, HS; Schmeidler, J; Yang, RK; Pitman, RK			Predictors of cortisol and 3-methoxy-4-hydroxyphenylglycol responses in the acute aftermath of rape	BIOLOGICAL PSYCHIATRY			English	Article						posttraumatic stress disorder; rape; cortisol; catecholamines; 3-methoxy-4-hydroxyphenylglycol; prior history; risk factors	POSTTRAUMATIC-STRESS-DISORDER; VIETNAM COMBAT VETERANS; URINARY CORTISOL; CATECHOLAMINE EXCRETION; PLASMA-CORTISOL; BRAIN-REGIONS; NOREPINEPHRINE; SUPPRESSION; SECRETION; RAT	Background: Prospective studies of trauma survivors can provide information about the relationship between rape characteristics and the development of subsequent symptoms. Methods: The present study examined the relationship of prior assault, rape severity, posttraumatic stress disorder (PTSD) symptoms following rape, and subsequent PTSD diagnosis, to the acute cortisol and 3-methoxy,-4-hydroxyphenylglycol (MHPG) response to this traumatic event in 20 women. Results: Women with a history of prior physical or sexual assault showed a significantly attenuated cortisol response to the acute stress of rape compared to women without such a history. MHPG appeared to be associated with injury-related rape characteristics, and symptoms of active avoidance, but not prior history. PTSD status at the 3-month follow-up was predicted by both a prior history of assault and high injury rape, but was not directly predicted by either cortisol or MHPG levels. MHPG and cortisol were nor correlated in the sample as a whole, but were correlated among individuals who did not subsequently develop PTSD (p = .04). Conclusions: The results suggest that different neuroendocrine systems may mediate different components of the response to traumatic stress. Published 1998 Society of Biological Psychiatry.	CUNY Mt Sinai Sch Med, Vet Affairs Med Ctr, Dept Psychiat, Bronx, NY 10468 USA; Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; VA Med Ctr, Res Serv, Manchester, NH USA; Harvard Univ, Sch Med, Boston, MA USA		Yehuda, R (corresponding author), CUNY Mt Sinai Sch Med, Vet Affairs Med Ctr, Dept Psychiat, 130 W Kingsbridge Rd, Bronx, NY 10468 USA.				NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH048559, R03MH049536, R01MH049555] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH49555, MH-48559, MH49536] Funding Source: Medline		ANISMAN H, 1991, PSYCHOPHARMACOLOGY B, V44, P775; ANTELMAN SM, 1992, PSYCHOPHARMACOLOGY, V107, P331, DOI 10.1007/BF02245157; BOHUS B, 1984, ADV SERIES NEUROSCIE, P337; BROWN MR, 1986, LIFE SCI, V39, P1003, DOI 10.1016/0024-3205(86)90289-4; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; GANONG WF, 1980, FED PROC, V39, P2923; GLAVIN GB, 1985, NEUROSCI BIOBEHAV R, V9, P233, DOI 10.1016/0149-7634(85)90048-X; Goenjian AK, 1996, AM J PSYCHIAT, V153, P929; HARFSTRAND A, 1986, P NATL ACAD SCI USA, V83, P9779, DOI 10.1073/pnas.83.24.9779; IRWIN J, 1986, BRAIN RES, V379, P98, DOI 10.1016/0006-8993(86)90260-X; JONES MT, 1976, J ENDOCRINOL, V69, P1, DOI 10.1677/joe.0.0690001; KOSTEN TR, 1987, PSYCHONEUROENDOCRINO, V12, P13, DOI 10.1016/0306-4530(87)90017-5; KVETNANSKY R, 1978, ENDOCRINOLOGY, V103, P1861; LEMIEUX AM, 1995, PSYCHOSOM MED, V57, P105, DOI 10.1097/00006842-199503000-00002; MASON JW, 1986, J NERV MENT DIS, V174, P145, DOI 10.1097/00005053-198603000-00003; MASON JW, 1988, J NERV MENT DIS, V176, P498, DOI 10.1097/00005053-198808000-00008; MCFALL ME, 1990, BIOL PSYCHIAT, V27, P1165, DOI 10.1016/0006-3223(90)90053-5; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; MEANEY MJ, 1985, BEHAV NEUROSCI, V99, P765, DOI 10.1037/0735-7044.99.4.765; MELLMAN TA, 1995, BIOL PSYCHIAT, V38, P174, DOI 10.1016/0006-3223(94)00238-X; MUNCK A, 1984, ENDOCR REV, V93, P9783; Murburg MM, 1995, BIOL PSYCHIAT, V38, P819, DOI 10.1016/0006-3223(95)00044-5; PITMAN RK, 1990, BIOL PSYCHIAT, V27, P245, DOI 10.1016/0006-3223(90)90654-K; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P645; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Saunders B. E., 1989, J INTERPERS VIOLENCE, V4, P267, DOI DOI 10.1177/088626089004003001; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; Spitzer R. L., 1990, STRUCTURED CLIN INTE; Stanford SC, 1993, STRESS SYNAPSE SYNDR, P281; TSUDA A, 1982, PHYSIOL BEHAV, V29, P337, DOI 10.1016/0031-9384(82)90023-3; WEINER RI, 1978, PHYSIOL REV, V58, P905, DOI 10.1152/physrev.1978.58.4.905; YANG RK, 1988, J LIQ CHROMATOGR, V11, P3223, DOI 10.1080/01483918808076791; Yatham LN, 1996, PSYCHIAT RES, V63, P1, DOI 10.1016/0165-1781(96)02896-X; YEHUDA R, 1990, J NERV MENT DIS, V178, P366, DOI 10.1097/00005053-199006000-00004; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; YEHUDA R, 1991, AM J PSYCHIAT, V148, P499; YEHUDA R, 1993, BIOL PSYCHIAT, V34, P18, DOI 10.1016/0006-3223(93)90252-9; Yehuda R, 1996, PSYCHONEUROENDOCRINO, V21, P1, DOI 10.1016/0306-4530(95)00055-0; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; Yehuda R, 1997, NATO ADV SCI I A-LIF, V291, P221; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; YEHUDA R, IN PRESS BIOL PSYCHI	45	55	56	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223			BIOL PSYCHIAT	Biol. Psychiatry	JUN 1	1998	43	11					855	859		10.1016/S0006-3223(97)00554-4			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	ZP304	WOS:000073738900012	9611677				2022-02-06	
J	Chen, Y; Shohami, E; Constantini, S; Weinstock, M				Chen, Y; Shohami, E; Constantini, S; Weinstock, M			Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; cholinergic activity; closed-head injury; mecamylamine; mice; scopolamine; spatial memory	CEREBRAL BLOOD-FLOW; ALZHEIMERS-DISEASE; RAT; IMPAIRMENT; PERFORMANCE; METABOLISM; ISCHEMIA; TRAUMA; ANTAGONIST; FOREBRAIN	The effects of Rivastigmine, a novel centrally-acting anticholinesterase agent, were evaluated on cerebral edema, neurological and motor deficits, and impairment of spatial memory induced in mice by closed-head injury (CHI), Severe injury was induced in the left hemisphere of mice under ether anesthesia. Rivastigmine (1 or 2 mg/kg) or saline (10 ml/kg) was injected SC 5 min later, Rivastigmine (2 mg/kg) reduced cerebral edema by at least 50% (p < 0.01), 24 h after CHI and accelerated the recovery of motor function 7 and 14 days after CHI. Control mice (n = 24), previously trained to find the goal platform in a Morris water maze failed to recall or relearn its position for at least 11 days post-injury, Those given a single injection of Rivastigmine (2 mg/kg) regained their pre-test latencies by the third day after CHI, The neuroprotective effects of Rivastigmine on brain edema, neurological and motor function, and performace in the Morris water maze were completely antagonized by simultaneous SC injection of either scopolamine (0.5 mg/kg) or mecamylamine (2.5 mg/kg). The antagonists alone had no significant effect on any of these parameters, These data show that the reduction by Rivastigmine of the immediate and long-term sequelae of brain injury are mediated by increased cholinergic activity at both muscarinic and nicotinic receptors.	Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; Sourasky Tel Aviv Med Ctr, Div Pediat Neurosurg, Tel Aviv, Israel		Weinstock, M (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.						ANAND R, 1996, J DRUG DEV CLIN PR, V8, P1; BROOKS D N, 1975, Cortex, V11, P329; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CHEN Y, 1998, IN PRESS BRAIN RES; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1996, J NEUROTRAUM, V13, P615; Dunnett S B, 1990, Neuroreport, V1, P61, DOI 10.1097/00001756-199009000-00017; ENZ A, 1989, KLIN PHARM, V2, P271; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN ED, 1987, BEHAV NEURAL BIOL, V48, P206, DOI 10.1016/S0163-1047(87)90752-7; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SADOSHIMA S, 1995, J CEREBR BLOOD F MET, V15, P845, DOI 10.1038/jcbfm.1995.105; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SCREMIN OU, 1989, STROKE, V20, P92, DOI 10.1161/01.STR.20.1.92; SCREMIN OU, 1993, J CEREBR BLOOD F MET, V13, P702, DOI 10.1038/jcbfm.1993.89; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1993, J ANESTH ANALG, V71, P141; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; TANAKA K, 1994, NEUROCHEM RES, V19, P117, DOI 10.1007/BF00966804; TANAKA K, 1995, NEUROCHEM RES, V20, P663, DOI 10.1007/BF01705533; TSUJIMOTO S, 1993, ACTA NEUROCHIR, V124, P127, DOI 10.1007/BF01401134; VOGELS OJM, 1990, NEUROBIOL AGING, V11, P3, DOI 10.1016/0197-4580(90)90056-6; WEINSTOCK M, 1994, J NEURAL TRANSM-SUPP, P219; Weinstock M., 1986, ALZHEIMERS PARKINSON, P539; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Yamaguchi T, 1996, NEUROPHARMACOLOGY, V35, P329, DOI 10.1016/0028-3908(95)00171-9; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	43	55	61	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1998	15	4					231	237		10.1089/neu.1998.15.231			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZF401	WOS:000072893800001	9555969				2022-02-06	
J	Seel, RT; Kreutzer, JS; Sander, AM				Seel, RT; Kreutzer, JS; Sander, AM			Concordance of patients' and family members' ratings of neurobehavioral functioning after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED HEAD-INJURY; FOLLOW-UP; SOCIAL-ADJUSTMENT; RELATIVES; RECOVERY; ADULTS	Objective: To examine differences in family and patient evaluation of neurobehavioral functioning in adults with traumatic brain injury (TBI). Design: Differences were examined by conducting 70 paired sample t tests on scale items and 6 paired sample t tests on scale scores from a neurobehavioral inventory. Setting: Medical center outpatient clinic. Participants: Three hundred one consecutive adult patients with TBI and 301 informants, primarily family members, completed the neurobehavioral inventory. Main Outcome Measure: Neurobehavioral Functioning Inventory (NFI) comprised of six scales with items describing symptoms and daily living problems. Results: Paired t test analyses of the six scales indicated that patients reported a significantly greater level of communication problems than did their matched family members. No differences were found for the other five scales. Paired t test analyses of the 70 scale items revealed significant differences in patient and family ratings for only 13 items. In all 13 instances, patients reported greater levels of dysfunction than were reported by their family members. Analysis of variance (ANOVA) indicated a main effect of injury severity for only the Communication and Memory/Attention scales. Conclusions: Findings indicate general agreement between family members and patients regarding patients' everyday problems. Results do not support contentions that patients tend to underestimate difficulties. Agreement levels appear related to injury severity, item specificity, and item content. More research is needed to identify other variables relating to agreement levels, including age, injury severity, and amount of contact between patients and family members. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHYS MED & REHABIL, RICHMOND, VA 23298 USA								Barco PP, 1991, COGNITIVE REHABILITA, P129; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; *COMM ACCR REH FAC, 1996, STAND MED REH; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; KAY T, 1988, ADM MANUAL NYU HEAD; KEPPEL G, 1991, DEISGN ANAL RES HDB; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Sherer M., 1995, J INT NEUROPSYCH SOC, V1, P163; SHERER M, 1996, J INT NEUROPSYCH SOC, V2, P17; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	24	55	56	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	1997	78	11					1254	1259		10.1016/S0003-9993(97)90340-3			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	YE945	WOS:A1997YE94500015	9365357				2022-02-06	
J	Tang, YP; Noda, Y; Hasegawa, T; Nabeshima, T				Tang, YP; Noda, Y; Hasegawa, T; Nabeshima, T			A concussive-like brain injury model in mice .1. Impairment in learning and memory	JOURNAL OF NEUROTRAUMA			English	Article						concussive-like brain injury (CLBI); learning and memory; mouse; traumatic brain injury (TBI); weight-drop impact	CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION MODEL; CLOSED-HEAD-INJURY; LONG-TERM; RAT; DEFICITS; TRAUMA; MILD; PATHOPHYSIOLOGY; CLASSIFICATION	The modeling of human concussive brain injury (CBI) in the laboratory has been challenging. In the present study, we developed an experimental CBI model in mice using a novel weight-drop device. Various injury levels were examined by adjusting the height of the falling weight (diameter 10 mm, length 20 cm, weight 21 g). At a height of 50 cm, the impact resulted in a mortality rate of 46.7% with a skull fracture rate of 28.6%. At a height of 25 cm, however, the impact produced a concussive-like brain injury (CLBI) to the mice without skull fracture. A series of pathophysiological and neurobehavioral responses was evaluated at this injury level. The CLBI mice lost muscle tone and righting reflex response immediately following the trauma and recovered from the latter within a short duration of 1.6 +/- 0.32 min (mean +/- SE). Brain edema formation started at 12 h, reached a maximum at 24 h and recovered 48 h. Typically edema was found in the neocortex, hippocampus, and cerebellum, but not in the brain stem. Deficits in the feeding behaviors lasted for 2 days, accompanied by lower body weight persisting for 5 days. The body weight growth rate for 24 h returned to the control levels by the third day postinjury. Learning and memory were evaluated at the end of 1-3 weeks after the trauma using a water-finding task. At 1 week, exploratory behaviors were slightly inhibited while learning and memory were profoundly impaired. Interestingly, the learning and memory deficits lasted for 2 weeks while recovering to the control levels by 3 weeks. No motor disability was found in the CLBI mice during the 3-week evaluations. These results indicate that the weight-drop impact produced graded injury to the brain, and at the injury level of 25 cm it produced a CLBI in the mice in which the characteristics of transient loss of neurobehavioral responses, short duration of brain edema, and long-lasting learning and memory deficits are similar to those of human CBI.	NAGOYA UNIV,SCH MED,DEPT NEUROPHARMACOL,SHOWA KU,NAGOYA,AICHI 466,JAPAN; NAGOYA UNIV,SCH MED,HOSP PHARM,SHOWA KU,NAGOYA,AICHI 466,JAPAN				Tang, Ya-Ping/A-1035-2011				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; BECKMAN DL, 1969, P SOC EXP BIOL MED, V130, P5; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LINDGREN S, 1966, BIOPHYSIK, V3, P74; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MANAKA S, 1978, NEUROSCI LETT, V8, P255, DOI 10.1016/0304-3940(78)90131-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miyazaki S, 1989, INTRACRANIAL PRESSUR, P651; NABESHIMA T, 1994, EUR J PHARMACOL, V255, P57, DOI 10.1016/0014-2999(94)90082-5; NABESHIMA T, 1993, METHODS NEUROSCIENCE, V14, P217; NELSON SR, 1996, HEAD INJURY C P, P444; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARKINSON D, 1978, J NEUROSURG, V3, P76; REEVES TM, 1995, EXP BRAIN RES, V106, P248; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P211; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; RUTHERFORD WH, 1977, LANCET, V1, P1; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEASDALE G, 1976, BRIT J ANAESTH, V48, P761, DOI 10.1093/bja/48.8.761; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261; WALKER AE, 1994, J NEUROSURG, V81, P493, DOI 10.3171/jns.1994.81.3.0493; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YAMAMOTO M, 1987, N-S ARCH PHARMACOL, V336, P511; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	51	55	59	0	4	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	1997	14	11					851	862		10.1089/neu.1997.14.851			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YK511	WOS:A1997YK51100004	9421456				2022-02-06	
J	Maxeiner, H				Maxeiner, H			Detection of ruptured cerebral bridging veins at autopsy	FORENSIC SCIENCE INTERNATIONAL			English	Article						subdural bleeding; head injury; bridging veins; postmortem X-ray	SUBDURAL-HEMATOMA	Subdural hematomas (SDH) are a frequent autopsy finding in victims of closed head injuries. About 2/3 of the cases in our own massive SDH series had brain contusions as a cause of bleeding. In about 1/3 of the cases, SDH resulted from ruptured vessels of the brain surface in the absence of contusions. Our experience has shown that such an ''isolated'' SDH may be expected in about 5% of fatal blunt head injuries. A technique is presented to detect bridging vein leakage before there is any risk of artificial damage. After sawing through the skull in the fronto-occipital plane and cutting through the upper half of the brain together with the calvarium, approximately 5-10 ml of barium sulfate are instilled into the superior sagittal sinus by a balloon catheter at low pressure, and X-rays are taken. If there is extravasation, the rupture is visible before further preparation. (C) 1997 Elsevier Science Ireland Ltd.			Maxeiner, H (corresponding author), FREE UNIV BERLIN,MED CTR BENJAMIN FRANKLIN,INST FORENS MED,HITTORFSSTR 18,D-14195 BERLIN,GERMANY.						AVIS SP, 1993, AM J FOREN MED PATH, V14, P130, DOI 10.1097/00000433-199306000-00005; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; KRAULAND W, 1982, VERLETZUNGEN INTRAKR; Leth P, 1997, FORENSIC SCI INT, V85, P65, DOI 10.1016/S0379-0738(96)02082-8; OLEARY PM, 1986, ANN EMERG MED, V15, P944, DOI 10.1016/S0196-0644(86)80682-5; Rothschild M A, 1990, Beitr Gerichtl Med, V48, P223; Voigt G E, 1968, Dtsch Z Gesamte Gerichtl Med, V64, P9, DOI 10.1007/BF00585127; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; [No title captured]	9	55	58	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	SEP 19	1997	89	1-2					103	110		10.1016/S0379-0738(97)00124-2			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	XV942	WOS:A1997XV94200012	9306669				2022-02-06	
J	Petras, JM; Bauman, RA; Elsayed, NM				Petras, JM; Bauman, RA; Elsayed, NM			Visual system degeneration induced by blast overpressure	TOXICOLOGY			English	Article; Proceedings Paper	Symposium on the Molecular Mechanism(s) of Blast Overpressure-Induced Injury	OCT   26, 1995	WALTER REED ARMY INST RES, WASHINGTON, DC		WALTER REED ARMY INST RES	brain injury; visual; axonopathy; blast overpressure; rats	SUPERIOR COLLICULUS; INJURIES; NUCLEUS; MAMMALS; EAR	The effect of blast overpressure on visual system pathology was studied in 14 male Sprague-Dawley rats weighing 360-432 g. Blast overpressure was simulated using a compressed-air driven shock tube, with the aim of studying a range of overpressures causing sublethal injury. Neither control (unexposed) rats nor rats exposed to 83 kiloPascals (kPa) overpressure showed evidence of visual system pathology. Neurological injury to brain visual pathways was observed in male rats surviving blast overpressure exposures of 104-110 kPa and 129-173 kPa. Optic nerve fiber degeneration was ipsilateral to the blast pressure wave. The optic chiasm contained small numbers of degenerated fibers. Optic tract fiber degeneration was present bilaterally, but was predominantly ipsilateral. Optic tract fiber degeneration was followed to nuclear groups at the level of the midbrain, midbrain-diencephalic junction, and the thalamus where degenerated fibers arborized among the neurons of: (i) the superior colliculus, (ii) pretectal region, and (iii) the lateral geniculate body. The superior colliculus contained fiber degeneration localized principally to two superficial layers (i) the stratum opticum (layer III) and (ii) stratum cinereum (layer II). The pretectal area contained degenerated fibers which were widespread in (i) the nucleus of the optic tract, (ii) olivary pretectal nucleus, (iii) anterior pretectal nucleus, and (iv) the posterior pretectal nucleus. Degenerated fibers in the lateral geniculate body were not universally distributed. They appeared to arborize among neurons of the dorsal and ventral nuclei: the ventral lateral geniculate nucleus (parvocellular and magnocellular parts); and the dorsal lateral geniculate nucleus. The axonopathy observed in the central visual pathways and nuclei of the rat brain are consistent with the presence of blast overpressure induced injury to the retina. The orbital cavities of the human skull contain frontally-directed eyeballs for binocular vision. Humans looking directly into an oncoming blast wave place both eyes at risk. With bilateral visual system injury, neurological deficits may include loss or impairments of ocular movements, and of the pupillary and accommodation reflexes, retinal hemorrhages, scotomas, and general blindness. These findings suggest that the retina should be investigated for the presence of traumatic or ischemic cellular injury, hemorrhages, scotomas, and retinal detachment. (C) 1997 Elsevier Science Ireland Ltd.	WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,DIV MED,DEPT RESP RES,WASHINGTON,DC 20307; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DEPT ENVIRONM & OCCUPAT HLTH SCI,LOS ANGELES,CA 90024		Petras, JM (corresponding author), WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,DIV NEUROSCI,DEPT NEUROBEHAV ASSESSMENT,WASHINGTON,DC 20307, USA.						Abbott WD, 1943, J AMER MED ASSOC, V121, P664, DOI 10.1001/jama.1943.02840090034010; ALBANO JE, 1982, J NEUROPHYSIOL, V48, P318, DOI 10.1152/jn.1982.48.2.318; ASCROFT PB, 1943, LANCET, V244, P234; Barrow DW, 1944, J AMER MED ASSOC, V125, P900, DOI 10.1001/jama.1944.02850310020006; BIZZI E, 1981, HDB PHYSL 1, V2, P1321; BRISMAR B, 1982, J TRAUMA, V22, P216, DOI 10.1097/00005373-198203000-00007; Buttner-Ennever J A, 1979, Prog Brain Res, V50, P619; BUTTNERENNEVER JA, 1982, BRAIN, V105, P125, DOI 10.1093/brain/105.1.125; CAMMERMEYER J, 1962, Ergeb Anat Entwicklungsgesch, V36, P1; CAMMERMEYER J, 1978, HISTOCHEMISTRY, V56, P97, DOI 10.1007/BF00508437; CAMMERMEYER J, 1960, EXP NEUROL, V2, P379, DOI 10.1016/0014-4886(60)90022-4; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; CAMPBELL CB, 1969, ANN NY ACAD SCI, V167, P388, DOI 10.1111/j.1749-6632.1969.tb20458.x; CELANDER H, 1955, ACTA PHYSL SCAND, V33, P5; CHAIT RH, 1989, ANN OTO RHINOL LARYN, V98, P9; CLEMEDSON C.-J., 1957, ACTA PATHOL ET MICROBIOL SCAND, V40, P89; COHEN B, 1968, ARCH NEUROL-CHICAGO, V18, P78, DOI 10.1001/archneur.1968.00470310092008; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; CUMMINGS JF, 1977, J COMP NEUROL, V173, P655, DOI 10.1002/cne.901730404; CUMMINGS JF, 1969, ANN NY ACAD SCI, V167, P293, DOI 10.1111/j.1749-6632.1969.tb20452.x; Drury RA, 1980, CARLETONS HISTOLOGIC; Ebbesson S.O.E., 1970, CONT RES METHODS NEU, P132; FINK ROBERT P., 1967, BRAIN RES, V4, P369, DOI 10.1016/0006-8993(67)90166-7; FRYBERG ER, 1988, ANN SURG, V208, P569; HAYHOW WR, 1959, J COMP NEUROL, V113, P281, DOI 10.1002/cne.901130205; HENN V, 1984, BRAIN, V107, P619, DOI 10.1093/brain/107.2.619; Henn V, 1982, Hum Neurobiol, V1, P77; Henn V, 1982, Hum Neurobiol, V1, P87; HIRSCH FG, 1968, ANN NY ACAD SCI, V152, P147, DOI 10.1111/j.1749-6632.1968.tb11972.x; KEREN A, 1981, BRIT HEART J, V46, P455; KERR AG, 1975, J LARYNGOL OTOL, V89, P131, DOI 10.1017/S002221510008018X; KERR AG, 1975, BRIT MED J, V1, P559, DOI 10.1136/bmj.1.5957.559; LEIGH RJ, 1983, NEUROLOGY EYE MOVEME; MASON WV, 1971, P SOC EXP BIOL MED, V136, P1253; MILLER JD, 1993, AM J PHYSIOL, V264, pR821, DOI 10.1152/ajpregu.1993.264.5.R821; MOE JB, 1986, NATO ASI SERIES A, V111, P473; MORIN LP, 1994, BRAIN RES REV, V67, P102; NAUTA WJH, 1951, STAIN TECHNOL, V26, P5, DOI 10.3109/10520295109113170; NAUTA WJH, 1954, STAIN TECHNOL, V29, P91, DOI 10.3109/10520295409115448; Nauta WJH, 1970, CONT RES METHODS NEU; Phillips Y., 1991, CONVENTIONAL WARFARE, V1, P271; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; PHILLIPS YY, 1989, ANN OTOL RHINOL S140, V98, P17; PHILLIPS YY, 1991, TXB MILITARY MED 1, V5, P221; Phillips YY, 1991, CONVENTIONAL WARFARE, P295; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; RICHMOND DR, 1968, NEW YORK ACAD SCI, V152, P103; ROBERTO M, 1989, ANN OTO RHINOL LARYN, V98, P23; ROBINSON DA, 1981, HDB PHYSL NERVOUS SY, V2, P1275; SCALIA F, 1972, J COMP NEUROL, V145, P223, DOI 10.1002/cne.901450208; WHITE CS, 1970, SPACE LIFE SCI, V2, P158, DOI 10.1007/BF01101282; WHITE CS, 1967, DASA2064, pR1; WHITE CS, 1960, CLINICAL CARDIOPULMO, P974; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; ZEE DS, 1986, DIS NERVOUS SYSTEM C, V1, P507; Zuckerman S, 1940, LANCET, V2, P219	56	55	57	1	5	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0300-483X			TOXICOLOGY	Toxicology	JUL 25	1997	121	1					41	49		10.1016/S0300-483X(97)03654-8			9	Pharmacology & Pharmacy; Toxicology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	XG756	WOS:A1997XG75600004	9217314				2022-02-06	
J	Lamb, RG; Harper, CC; McKinney, JS; Rzigalinski, BA; Ellis, EF				Lamb, RG; Harper, CC; McKinney, JS; Rzigalinski, BA; Ellis, EF			Alterations in phosphatidylcholine metabolism of stretch-injured cultured rat astrocytes	JOURNAL OF NEUROCHEMISTRY			English	Article						cultured astrocytes; stretch-induced cell injury; phosphatidylcholine biosynthesis; phospholipase activity; phosphocholine cytidylyltransferase activity; oxyradical scavengers; antioxidants	EXPERIMENTAL BRAIN INJURY; ARACHIDONIC-ACID; PHOSPHOLIPASE-C; HEAD-INJURY; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; LIPID-PEROXIDATION; LIVER; SUPEROXIDE; CTP; MECHANISMS	The primary objective of this study was to determine the influence of stretch-induced cell injury on the metabolism of cellular phosphatidylcholine (PC). Neonatal rat astrocytes were grown to confluency in Silastic-bottomed tissue culture wells in medium that was usually supplemented with 10 mu M unlabeled arachidonate. Cell injury was produced by stretching (5-10 mm) the Silastic membrane with a 50-ms pulse of compressed air. Stretch-induced cell injury increased the incorporation of [H-3]choline into PC in an incubation time- and stretch magnitude-dependent manner. PC biosynthesis was increased three- to fourfold between 1.5 and 4.5 h after injury and returned to control levels by 24 h postinjury. Stretch-induced cell injury also increased the activity of several enzymes involved in the hydrolysis [phospholipase A(2) (EC 3.1.1.4) and C (PLC; EC 3.1.4.3)] and biosynthesis [phosphocholine cytidylyltransferase (PCT; EC 2.7.7.15)] of PC, Stretch-induced increases in PC biosynthesis and PCT activity correlated well (r = 0.983) and were significantly reduced by pretreating (1 h) the cells with an iron chelator (deferoxamine) or scavengers of reactive oxygen species such as superoxide dismutase and catalase, The stretch-dependent increase in PC biosynthesis was also reduced by antioxidants (vitamin E, vitamin E succinate, vitamin E phosphate, melatonin, and n-acetylcysteine), Arachidonate-enriched cells were more susceptible to stretch-induced injury because lactate dehydrogenase release and PC biosynthesis were significantly less in non-arachidonate-enriched cells. In summary, the data suggest that stretch-induced cell injury is (a) a result of an increase in the cellular level of hydroxyl radicals produced by an iron-catalyzed Haber-Weiss reaction, (b) due in part to the interaction of oxyradicals with the polyunsaturated fatty acids of cellular phospholipids such as PC, and (c) reversible as long as the cell's membrane repair functions (PC hydrolysis and biosynthesis) are sufficient to repair injured membranes. These results suggest that stretch-induced cell injury in vitro may mimic in part experimental traumatic brain injury in vivo because alterations in cellular PC biosynthesis and PLC activity are similar in both models, Therefore, this in vitro model of stretch-induced injury may supplement or be a reasonable alternative to some in vivo models of brain injury for determining the mechanisms by which traumatic cell injury results in cell dysfunction.			Lamb, RG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,BOX 980613,MCV STN,RICHMOND,VA 23298, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R55AA008758, R01AA008758] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA 08758] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 27214] Funding Source: Medline		AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHAN PH, 1988, J NEUROCHEM, V50, P1185, DOI 10.1111/j.1471-4159.1988.tb10591.x; COLEMAN JB, 1988, TOXICOL APPL PHARM, V95, P200, DOI 10.1016/0041-008X(88)90156-1; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; GAMACHE DA, 1988, BIOCHIM BIOPHYS ACTA, V958, P116, DOI 10.1016/0005-2760(88)90252-4; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [DOI 10.1098/RSPA.1934.0221, 10.1098/rspa.1934.0221]; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; HUBAND S, 1995, FASEB J, V9, pA957; ISHIDATE K, 1980, BIOCHIM BIOPHYS ACTA, V620, P49; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; LAMB RG, 1982, TOXICOL APPL PHARM, V63, P216, DOI 10.1016/0041-008X(82)90044-8; LAMB RG, 1994, HEPATOLOGY, V19, P174, DOI 10.1002/hep.1840190127; LAMB RG, 1970, J BIOL CHEM, V245, P3075; LAMB RG, 1988, LIVER DRUGS EXPT PHA, P53; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCORD JM, 1978, FEBS LETT, V86, P139, DOI 10.1016/0014-5793(78)80116-1; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; REYNOLDS ES, 1980, TOXIC INJURY LIVER B, P541; RZIGALINSKI BA, 1994, BBA-MOL CELL RES, V1223, P219, DOI 10.1016/0167-4889(94)90229-1; SANGHERA JS, 1990, BIOCHIM BIOPHYS ACTA, V1042, P380, DOI 10.1016/0005-2760(90)90168-W; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SPECTOR AA, 1985, J LIPID RES, V26, P1015; TAVLIN SJ, 1995, J NEUROPHYSIOL, V74, P2767; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; WEY HE, 1993, TOXICOL APPL PHARM, V120, P72, DOI 10.1006/taap.1993.1088; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; YAO ZM, 1990, J BIOL CHEM, V265, P4326; YOUNES M, 1988, LIVER DRUGS EXPT PHA, P31	37	55	58	0	3	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	MAY	1997	68	5					1904	1910					7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WU248	WOS:A1997WU24800015	9109516				2022-02-06	
J	Yundt, KD; Grubb, RL; Diringer, MN; Powers, WJ				Yundt, KD; Grubb, RL; Diringer, MN; Powers, WJ			Cerebral hemodynamic and metabolic changes caused by brain retraction after aneurysmal subarachnoid hemorrhage	NEUROSURGERY			English	Article						brain retraction; cerebral aneurysm; cerebral blood flow; subarachnoid hemorrhage; vasospasm	POSITRON EMISSION TOMOGRAPHY; BLOOD-FLOW; INTRAVENTRICULAR PRESSURE; INTRAVENOUS (H2O)-O-15; OXYGEN UTILIZATION; PATHO-PHYSIOLOGY; ISCHEMIA; VASOSPASM; INJURY; RAT	OBJECTIVE: The cerebral hemodynamic and metabolic effects of aneurysmal subarachnoid hemorrhage are complex. To investigate the impact of surgical retraction, we analyzed positron emission tomography (PET) studies that measured the regional cerebral metabolic rate for oxygen, regional oxygen extraction fraction, and regional cerebral blood flow in four patients before and after right frontotemporal craniotomies for clipping of ruptured anterior circulation aneurysms. METHODS: Preoperative studies were conducted 1 day before surgery and postoperative studies 6 to 17 days after surgery. No patient had hydrocephalus or intracerebral hematoma. At the time of the second PET study, none of the patients had signs of clinical vasospasm. Regional measurements were obtained from the right ventrolateral frontal and anterior temporal regions corresponding to the area of retraction and compared to the same regions in the opposite hemisphere. To establish a quantitative means to differentiate between hemodynamic and metabolic changes related to arterial vasospasm and those caused by brain retraction, we studied a second group of preoperative patients, who had undergone PET during angiographic and clinical vasospasm. RESULTS: There was a 45% reduction in regional cerebral metabolic rate for oxygen (1.87 +/- 0.22 to 1.04 +/- 0.28 mi 100 g(-1) min(-1)) and 32% reduction in regional oxygen extraction fraction (0.41 +/- 0.04 to 0.28 +/- 0.03) in the region of retraction but no change in the opposite hemisphere (paired t test; P = 0.042 and 0.003, respectively). There was no change in regional cerebral blood flow in any region. Brain retraction produced a focal area of tissue injury at the site of retractor blade placement, as compared to more diffuse vascular territory changes produced by vasospasm. CONCLUSION: This reduction in the cerebral metabolic rate of oxygen and the oxygen extraction fraction indicates a primary reduction in metabolism and uncoupling of flow and metabolism (luxury perfusion). Similar findings of luxury perfusion have been reported after ischemic stroke and traumatic brain injury. Further studies will be necessary to fully understand the clinical and pathophysiological significance of these observations.	WASHINGTON UNIV, SCH MED, DEPT NEUROL & NEUROL SURG, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT RADIOL, ST LOUIS, MO 63110 USA; JEWISH HOSP ST LOUIS, LILLIAN STRAUSS INST NEUROSCI, ST LOUIS, MO 63110 USA				Diringer, Michael N/C-1165-2008	Diringer, Michael N/0000-0003-2337-5537	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-13851] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-06833] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL013851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS006833, P50NS006833] Funding Source: NIH RePORTER		AHN CS, 1994, J CEREBR BLOOD F MET, V14, P324, DOI 10.1038/jcbfm.1994.39; ALBIN MS, 1977, ACTA NEUROL SCAND, V56, P522; ANDREWS RJ, 1993, NEUROSURGERY, V33, P1052; BARON JC, 1985, NEURORADIOLOGY, V27, P509, DOI 10.1007/BF00340846; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CARPENTER DA, 1991, J CEREBR BLOOD F MET, V11, P837, DOI 10.1038/jcbfm.1991.143; FARRAR JK, 1981, J NEUROSURG, V55, P857; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; FRACKOWIAK RSJ, 1985, Q J MED, V57, P713; FUKAMACHI A, 1985, SURG NEUROL, V23, P575, DOI 10.1016/0090-3019(85)90006-0; GRUBB RL, 1977, J NEUROSURG, V46, P446, DOI 10.3171/jns.1977.46.4.0446; HAHN FJY, 1976, AM J ROENTGENOL, V126, P593, DOI 10.2214/ajr.126.3.593; HARADA S, 1994, ACTA NEUROCHIR, P449; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; HINO A, 1989, STROKE, V20, P1504, DOI 10.1161/01.STR.20.11.1504; Ishikawa M, 1989, Neurol Med Chir (Tokyo), V29, P382, DOI 10.2176/nmc.29.382; JAKOBSEN M, 1987, J CEREB BLOOD FLO S1, V7, pS650; JAKOBSEN M, 1987, J CEREB BLOOD FLO S1, V7, pS660; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; MARTIN WRW, 1987, J CEREBR BLOOD F MET, V7, P421, DOI 10.1038/jcbfm.1987.85; MINTUN MA, 1984, J NUCL MED, V25, P177; NAZZARO JM, 1992, J NEUROSURG, V76, P746, DOI 10.3171/jns.1992.76.5.0746; OBRIEN PC, 1988, MAYO CLIN PROC, V63, P1140, DOI 10.1016/S0025-6196(12)65511-6; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; POWERS WJ, 1992, NEUROL CLIN, V10, P31, DOI 10.1016/S0733-8619(18)30232-9; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; POWERS WJ, 1985, J NEUROSURG, V62, P539, DOI 10.3171/jns.1985.62.4.0539; RAICHLE ME, 1983, J NUCL MED, V24, P790; RICE BJ, 1990, J NEUROSURG, V73, P165, DOI 10.3171/jns.1990.73.2.0165; ROSEN JM, 1994, CLIN NUCL MED, V19, P595, DOI 10.1097/00003072-199407000-00006; ROSENORN J, 1985, J NEUROSURG, V63, P608, DOI 10.3171/jns.1985.63.4.0608; ROSENORN J, 1982, J NEUROSURG, V56, P826, DOI 10.3171/jns.1982.56.6.0826; ROSENORN J, 1987, ACTA NEUROCHIR, V87, P140, DOI 10.1007/BF01476065; ROUSSEAUX M, 1994, STROKE, V25, P135, DOI 10.1161/01.STR.25.1.135; TERPOGOSSIAN MM, 1982, J COMPUT ASSIST TOMO, V6, P125, DOI 10.1097/00004728-198202000-00021; UEMURA K, 1987, J CEREB BLOOD FLO S1, V7, pS32; VOLDBY B, 1985, J NEUROSURG, V62, P48, DOI 10.3171/jns.1985.62.1.0048; WELCH MJ, 1985, J LABELLED COMPD RAD, V22, P1193, DOI 10.1002/jlcr.2580221114; WISE RJS, 1983, BRAIN, V106, P197, DOI 10.1093/brain/106.1.197; YOKOH A, 1987, ACTA NEUROCHIR, V87, P134, DOI 10.1007/BF01476064; ZAR JH, 1984, BIOSTAT ANAL, V2, P185	45	55	56	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	1997	40	3					442	450		10.1097/00006123-199703000-00003			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WJ763	WOS:A1997WJ76300009	9055282				2022-02-06	
J	Strebel, S; Lam, AM; Matta, BF; Newell, DW				Strebel, S; Lam, AM; Matta, BF; Newell, DW			Impaired cerebral autoregulation after mild brain injury	SURGICAL NEUROLOGY			English	Article						brain; head injury; autoregulation; cerebral blood flow velocity; equipment; transcranial Doppler ultrasonography; sympathetic nervous system; pharmacology; phenylephrine	SEVERE HEAD-INJURY; BLOOD-FLOW; ANESTHESIA	BACKGROUND Severe head injury may impair cerebral autoregulation, which can increase the risk of secondary neuronal injury. The likelihood of impairment in autoregulation is assumed to be low with mild head injury. We report here the absence of cerebral autoregulation in a patient who suffered a concussion from an automobile accident 6 days earlier. METHODS The patient participated in a clinical study approved by the institutional human subjects review committee, investigating the dose-effect relationship of anesthetics on cerebral autoregulation. The patient was scheduled to undergo repair of a knee injury suffered during a motor vehicle accident, during which she had a concussion. The screening evaluation revealed no evidence of neurologic disease. The test was to be performed three times in each patient: baseline autoregulation measurements during stable fentanyl-nitrous oxide anesthesia, second and third measurements during low dose and high dose of the anesthetic to which the patient was assigned. Autoregulation was tested by increasing the mean systemic blood pressure from 80 mm Hg-100 mm Hg using a phenylephrine infusion while simultaneously recording flow velocity from a middle cerebral artery using transcranial Doppler ultrasonography. RESULTS Static autoregulation testing during baseline testing demonstrated complete absence of this homeostatic mechanism and the study was canceled. Repeated testing in the recovery unit after the patient awoke showed identical results. CONCLUSIONS Trivial mild head injury may result in loss of cerebral autoregulation. A clinical study of a larger series to document the incidence is warranted. (C) 1997 by Elsevier Science Inc.	UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT ANESTHESIOL,SCH MED,SEATTLE,WA 98104; UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT NEUROL SURG,SCH MED,SEATTLE,WA 98104								AGNOLI A, 1968, CIRCULATION, V38, P800, DOI 10.1161/01.CIR.38.4.800; ANDERSON DW, 1980, NEUROSURGERY, V53, P1; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GORDON E, 1973, ACTA ANAESTH SCAND, V17, P63, DOI 10.1111/j.1399-6576.1973.tb00799.x; KASOFF SS, 1972, J NEUROSURG, V36, P463, DOI 10.3171/jns.1972.36.4.0463; LANGFITT TW, 1982, CLIN NEUR, V29, P353; MCPHERSON RW, 1985, BRIT J ANAESTH, V57, P1232, DOI 10.1093/bja/57.12.1232; PAULSON OB, 1970, NEUROLOGY, V20, P63, DOI 10.1212/WNL.20.1.63; SMITH AL, 1970, J APPL PHYSIOL, V29, P665, DOI 10.1152/jappl.1970.29.5.665; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008	12	55	56	0	2	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	FEB	1997	47	2					128	131		10.1016/S0090-3019(96)00459-4			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WJ477	WOS:A1997WJ47700014	9040813				2022-02-06	
J	Haseler, LJ; Arcinue, E; Danielsen, ER; Bluml, S; Ross, BD				Haseler, LJ; Arcinue, E; Danielsen, ER; Bluml, S; Ross, BD			Evidence from proton magnetic resonance spectroscopy for a metabolic cascade of neuronal damage in shaken baby syndrome	PEDIATRICS			English	Article						shaken baby syndrome; traumatic brain injury; neuronal injury; magnetic resonance imaging; magnetic resonance spectroscopy	HUMAN BRAIN; INFANT; INJURY; CHILDREN; SHAKING; SYSTEM; WATER	Objective. The purpose of this study was to use proton magnetic resonance spectroscopy (MRS) as a metabolic assay to describe biochemical changes during the evolution of neuronal injury in infants after shaken baby syndrome (SBS), that explain the disparity between apparent physical injury and the neurological deficit after SBS. Methodology. Three infants [6 months (A), 5 weeks (B), 7 months (C)] with SBS were examined repeatedly using localized quantitative proton MRS. Examinations were performed on days 7 and 13 (A), on days 1, 3, 5,and 12 (B), and on days 7 and 19 (C) posttrauma. Long-term follow-up examinations were performed 5 months posttrauma (A) and 4.6 months posttrauma (B). Data were compared to control data from 52 neurologically normal infants presented in a previous study. Results. Spectra from parietal white matter obtained at approximately the same time after injury (5 to 7 days) showed markedly different patterns of abnormality. Infant A shows near normal levels of the neuronal marker N-acetyl aspartate, creatine, and phosphocreatine, although infant C shows absent N-acetyl aspartate, almost absent creatine and phosphocreatine, and a great excess of lactate/lipid and lipid. Analysis of the time course in infant B appears to connect these variations as markers of the severity of head injury suffered in the abuse, indicating a progression of biochemical abnormality. The principal cerebral metabolites detected by MRS that remain normal up to 24 hours fall precipitately to similar to 40% of normal within 5 to 12 days, with lactate/lipid and lipid levels more than doubling concentration between days 5 and 12. Conclusions. A strong impression is gained of MRS as a prognostic marker because infant A recovered although infants B and C remained in a state consistent with compromised neurological capacity. Loss of integrity of the proton MR spectrum appears to signal irreversible neurological damage and occurs at a time when clinical and neurological status gives no indication of long-term outcome. These results suggest the value of sequential MRS in the management of SBS.	HUNTINGTON MED RES INST, PASADENA, CA USA; CALTECH, DEPT CHEM, PASADENA, CA 91125 USA; HUNTINGTON MEM HOSP, PEDIAT INTENS CARE UNIT, PASADENA, CA USA; SCHULTE RES FDN, SANTA BARBARA, CA USA					Haseler, Luke/0000-0003-1607-4402; Bluml, Stefan/0000-0003-2124-797X			AULD KL, 1995, PEDIATR NEUROL, V12, P323, DOI 10.1016/0887-8994(95)00062-K; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; ERNST T, 1993, P SOC MAGNETIC RESON, P323; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; HASELER LJ, 1995, P 3 SOC MAGNETIC RES, V1, P381; Kreis R, 1996, J CLIN INVEST, V97, P1142, DOI 10.1172/JCI118528; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; LEADBEATTER S, 1995, BRIT MED J, V310, P1600, DOI 10.1136/bmj.310.6994.1600; LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704; NIXON RA, 1993, ANN NY ACAD SCI, V679, P87, DOI 10.1111/j.1749-6632.1993.tb18291.x; ROSS BD, 1996, IN PRESS MRI CENTRAL; VERITY MA, 1993, ANN NY ACAD SCI, V679, P110; 1995, J PEDIAT NEUROBIOL N, V26, P285	19	55	57	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JAN	1997	99	1					4	14		10.1542/peds.99.1.4			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	WB350	WOS:A1997WB35000002	8989330				2022-02-06	
J	Ingebrigtsen, T; Romner, B; Trumpy, JH				Ingebrigtsen, T; Romner, B; Trumpy, JH			Management of minor head injury: The value of early computed tomography and serum protein S-100 measurements	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						minor head injury; computed tomography; brain injury; protein S-100	NEURON-SPECIFIC ENOLASE; TRAUMATIC INTRACRANIAL HEMATOMA; CENTRAL NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; DAMAGE; MILD; ADMISSION	Computed tomography (CT) scan was performed within 6 h in 91 patients with minor head injury (MHI). Eight patients (9%) demonstrated intracranial lesions on CT scan (6 brain contusions, 1 brain edema and 1 extradural hematoma), No patient required craniotomy, In patients with normal CT scan, no complications to the head injury were observed, Patients with intracranial lesions were hospitalized significantly longer (mean 9.4 days) than patients without (mean 1.6 days), In a subgroup of 50 patients with normal CT scan, serum S-100 protein was measured on admission, Elevated S-100 levels were seen in 10 of 50 patients (0.5-2.4 mu g/L, mean 1.1), These patients were hospitalized significantly longer (mean 3.4 days) compared to patients with normal CT scan and normal S-100 levels (mean 1.1 days), MHI patients with GCS 14-15 without neurological deficits can safely be discharged when CT scan is normal, Serum protein S-100 measurements appear to provide information about diffuse brain injury after MHI. (C) Pearson Professional Ltd 1997			Ingebrigtsen, T (corresponding author), UNIV TROMSO HOSP,DEPT NEUROSURG,N-9038 TROMSO,NORWAY.			Ingebrigtsen, Tor/0000-0001-5966-9786			AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; Edna T H, 1987, J Oslo City Hosp, V37, P41; Eide Per Kristian, 1993, Tidsskrift for den Norske Laegeforening, V113, P1227; FAGNART OC, 1988, CLIN CHEM, V34, P1387; GALBRAIHT S, 1981, LANCET, V2, P791; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; JENKINS A, 1986, LANCET, V2, P445; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; KATO K, 1982, BIOMED RES-TOKYO, V3, P24; KELLY R, 1981, J ROY SOC MED, V74, P242; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KVARNES TL, 1978, ACTA NEUROCHIR, V41, P223, DOI 10.1007/BF01809151; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; MICHETTI F, 1980, J NEUROL SCI, V44, P259, DOI 10.1016/0022-510X(80)90133-1; MICHETTI F, 1979, NEUROSCI LETT, V11, P247; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MOKUNO K, 1983, J NEUROL SCI, V60, P443, DOI 10.1016/0022-510X(83)90155-7; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RABOW L, 1985, ACTA NEUROCHIR, V76, P137, DOI 10.1007/BF01418476; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SABERS A, 1988, Ugeskrift for Laeger, V150, P1161; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SINDIC CJM, 1982, J NEUROL NEUROSUR PS, V45, P1130, DOI 10.1136/jnnp.45.12.1130; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363	34	55	57	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	1997	4	1					29	33		10.1016/S0967-5868(97)90007-2			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE662	WOS:A1997WE66200007	18638920				2022-02-06	
J	Yundt, KD; Diringer, MN				Yundt, KD; Diringer, MN			The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury	CRITICAL CARE CLINICS			English	Article							SEVERE HEAD-INJURY; VENOUS OXYGEN-SATURATION; BLOOD-FLOW; CEREBROVASCULAR-DISEASE; COMATOSE PATIENTS; PROLONGED HYPERVENTILATION; INTRAVENTRICULAR PRESSURE; INTRACRANIAL-PRESSURE; POSITRON TOMOGRAPHY; PERFUSION-PRESSURE	Traumatic brain injury is a common occurrence in the United States, leading to approximately 190,000 deaths or long-term disabilities. Following the primary insult, secondary disturbances in cerebral blood now (CBF) and metabolism may have deleterious effects on potentially viable neurons. Recent studies evaluating CBF immediately following head injury have revealed flows low enough to produce cerebral ischemia. Hyperventilation is used routinely to lower suspected increased intracranial pressure (ICP). Aggressive hyperventilation produces a marked reduction in CBF, which may give rise to or exacerbate cerebral ischemia, thus enhancing rather than reducing secondary injury. This article reviews the role of hyperventilation in the treatment of increased ICP and its impact on cerebral ischemia following traumatic brain injury.			Yundt, KD (corresponding author), WASHINGTON UNIV, SCH MED, DEPT NEUROL SURG, 660 S EUCLID AVE, BOX 8057, ST LOUIS, MO 63110 USA.		Diringer, Michael N/C-1165-2008	Diringer, Michael N/0000-0003-2337-5537			ADAMS JH, 1972, SCI FDN NEUROLOGY, P488; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; ALTMAN DI, 1993, PEDIATRICS, V92, P99; ALTMAN DI, 1991, J NUCL MED, V32, P1738; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BARON JC, 1985, NEURORADIOLOGY, V27, P509, DOI 10.1007/BF00340846; BARON JC, 1989, J CEREBR BLOOD F MET, V9, P723, DOI 10.1038/jcbfm.1989.105; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; Bullock R, 1995, GUIDELINES MANAGEMEN; CARPENTER DA, 1991, J CEREBR BLOOD F MET, V11, P837, DOI 10.1038/jcbfm.1991.143; CARPENTER DA, 1990, NEUROLOGY, V40, P1587, DOI 10.1212/WNL.40.10.1587; Christensen MS, 1973, STROKE, V4, P568, DOI 10.1161/01.STR.4.4.568; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; CROCKARD HA, 1973, BMJ-BRIT MED J, V4, P634, DOI 10.1136/bmj.4.5893.634; CRUZ J, 1994, CRIT CARE MED, V22, P1465, DOI 10.1097/00003246-199409000-00018; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; CRUZ J, 1992, J NEUROSURG, V77, P162; CRUZ J, 1992, J NEUROSURG, V77, P975; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; FARRAR JK, 1991, J CEREB BLOOD FLOW M, V11, pS553; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; FINNERTY FA, 1954, J CLIN INVEST, V33, P1227, DOI 10.1172/JCI102997; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; FRACKOWIAK RSJ, 1985, Q J MED, V57, P713; FRACKOWIAK RSJ, 1985, BRAIN IMAGING BRAIN, P139; FREWEN TC, 1989, CRIT CARE MED, V17, P912, DOI 10.1097/00003246-198909000-00015; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gibbs EL, 1942, J BIOL CHEM, V144, P325; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GOTOH F, 1965, ARCH NEUROL-CHICAGO, V12, P410, DOI 10.1001/archneur.1965.00460280080008; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; HOFF JT, 1975, STROKE, V6, P28, DOI 10.1161/01.STR.6.1.28; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KEE DB, 1984, NEUROSURGERY, V15, P125, DOI 10.1227/00006123-198407000-00026; KETY SS, 1946, J CLIN INVEST, V25, P107, DOI 10.1172/JCI101680; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LASSEN NA, 1976, BRIT J ANAESTH, V48, P719, DOI 10.1093/bja/48.8.719; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; *NAT HEAD INJ FDN, 1995, FACTS TRAUM BRAIN IN; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PLUM F, 1967, AM J PHYSIOL, V212, P864, DOI 10.1152/ajplegacy.1967.212.4.864; POWERS WJ, 1992, NEUROL CLIN, V10, P31, DOI 10.1016/S0733-8619(18)30232-9; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; POWERS WJ, 1984, ANN NEUROL, V16, P546, DOI 10.1002/ana.410160504; POWERS WJ, 1987, ANN INTERN MED, V106, P27, DOI 10.7326/0003-4819-106-1-27; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; POWERS WJ, 1987, CEREBROVASC DIS, P273; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; RAICHLE ME, 1976, ARCH NEUROL-CHICAGO, V33, P523, DOI 10.1001/archneur.1976.00500080001001; REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; ROPPER AH, 1988, NEUROLOGICAL NEUROSU, P9; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHEINBERG P, 1949, J CLIN INVEST, V28, P1163, DOI 10.1172/JCI102150; SHARAN M, 1989, ANN BIOMED ENG, V17, P13, DOI 10.1007/BF02364271; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Siesj? BK., 1978, BRAIN ENERGY METABOL; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SUTTON LN, 1990, J NEUROSURG, V73, P927, DOI 10.3171/jns.1990.73.6.0927; VANRIJEN PC, 1989, MAGN RESON MED, V10, P182, DOI 10.1002/mrm.1910100204; WILSON DF, 1992, ADV EXP MED BIOL, V316, P341; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; YE GF, 1994, ADV EXP MED BIOL, V361, P7; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087; ZIVIN JA, 1988, ARCH NEUROL-CHICAGO, V45, P387, DOI 10.1001/archneur.1988.00520280033012	85	55	58	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	JAN	1997	13	1					163	+		10.1016/S0749-0704(05)70300-6			1	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WE065	WOS:A1997WE06500009	9012580				2022-02-06	
J	Krauss, JK; Trankle, R; Kopp, KH				Krauss, JK; Trankle, R; Kopp, KH			Post-traumatic movement disorders in survivors of severe head injury	NEUROLOGY			English	Article							POSTTRAUMATIC TREMOR; STEREOTAXIC SURGERY; BRAIN INJURY; DYSTONIA; PARKINSONISM; CHILDREN; MIDBRAIN	The present study investigates the occurrence of post-traumatic movement disorders in survivors of severe head injury. We studied a series of 398 consecutive patients who were admitted to the hospital with a Glasgow Coma Score of 8 or less after they sustained a head trauma. One hundred thirty-four out of 398 patients (34%) died after they were admitted to the hospital or in the further course. A recent follow-up was obtained in 221 of the 264 remaining patients (84%). Follow-up consisted of a three-level assessment, including questionnaires, telephone interviews, and personal examinations. Fifty out of 221 patients (22.6%) had developed movement disorders secondary to the head trauma, which were transient in 23 patients (10.4%) and persistent in 27 patients (12.2%). Forty-two patients (19%) had tremors, nine (4.1%) had dystonia, and seven (3.2%) had other movement disorders. Twelve patients (5.4%) had disabling tow-frequency kinetic tremors (2.5 to 4 Hz) or dystonia, or both. Low-frequency kinetic tremors developed with a latency from 2 weeks to 6 months after trauma, and dystonia with a latency from 2 months to 2 years. When compared with patients without movement disorders, this subgroup was characterized by a different distribution profile of Glasgow Coma Scores with a higher proportion of lower scores on admission (p < 0.05). When we compared the initial CT findings, there were highly significant associations between generalized brain edema and the occurrence of any movement disorders, between generalized brain edema and the occurrence of persistent movement disorders, and between generalized brain edema and the occurrence of kinetic tremors and dystonia. We detected similar associations for focal cerebral lesions, but not for subdural and epidural hematomas. In conclusion, transient or persistent movement disorders are common sequelae in survivors of severe head injury. Disabling movement disorders such as kinetic tremors and dystonia, however, occur only in a small group of patients.	UNIV FREIBURG,DEPT NEUROSURG,FREIBURG,GERMANY; UNIV FREIBURG,DEPT ANESTHESIOL & INTENS CARE MED,FREIBURG,GERMANY		Krauss, JK (corresponding author), BAYLOR COLL MED,DEPT NEUROSURG,6560 FANNIN,SUITE 944,HOUSTON,TX 77030, USA.						ANDREW J, 1982, J NEUROL NEUROSUR PS, V45, P815, DOI 10.1136/jnnp.45.9.815; BAIN P, 1993, J NEUROL NEUROSUR PS, V69, P839; BIARY N, 1989, NEUROLOGY, V39, P103, DOI 10.1212/WNL.39.1.103; BULLARD DE, 1984, J NEUROSURG, V61, P316, DOI 10.3171/jns.1984.61.2.0316; BURKE RE, 1980, J NEUROL NEUROSUR PS, V43, P789, DOI 10.1136/jnnp.43.9.789; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DE MORSIER G., 1960, PSYCHIAT ET NEUROL, V139, P60; FACTOR SA, 1991, MOV DISORD, V3, P30; FACTOR SA, 1993, PARKINSONIAN SYNDROM, P95; Fahn S, 1982, Adv Neurol, V35, P349; Fahn S., 1988, ADV NEUROL, P1; GOETZ CG, 1992, NEUROL CLIN, V10, P907, DOI 10.1016/S0733-8619(18)30187-7; GOETZ CG, 1991, ANN NEUROL, V29, P191, DOI 10.1002/ana.410290213; Grimberg L, 1934, J NERV MENT DIS, V79, P14, DOI 10.1097/00005053-193401000-00002; JANKOVIC J, 1980, ANN INTERN MED, V93, P460, DOI 10.7326/0003-4819-93-3-460; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JOHNSON SLJ, 1992, ARCH DIS CHILD, V67, P227, DOI 10.1136/adc.67.2.227; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; Kono M, 1993, P 10 INT C NEUR SURG; Krauss J K, 1996, Parkinsonism Relat Disord, V2, P35, DOI 10.1016/1353-8020(95)00018-6; KRAUSS JK, 1994, J NEUROSURG, V80, P810, DOI 10.3171/jns.1994.80.5.0810; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; KREMER M, 1947, J NEUROL NEUROSUR PS, V10, P49, DOI 10.1136/jnnp.10.2.49; LAKKE JPWF, 1981, J NEUROL SCI, V51, P311, DOI 10.1016/0022-510X(81)90109-X; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; MAKI Y, 1980, CHILD BRAIN, V7, P113; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1992, BRIT J SURG, V79, P60, DOI 10.1002/bjs.1800790122; MONCKTON S, 1863, BRIT MED J, P382; Munoz JE, 1996, MOVEMENT DISORD, V11, P96, DOI 10.1002/mds.870110119; Narayan RK, 1991, PRINCIPLES NEUROSURG, P235; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; REMY P, 1995, NEUROLOGY, V45, P472, DOI 10.1212/WNL.45.3.472; RONDOT P, 1994, J NEUROL NEUROSUR PS, V57, P658, DOI 10.1136/jnnp.57.5.658; SAMIE MR, 1990, NEUROLOGY, V40, P62, DOI 10.1212/WNL.40.1.62; Scott BL, 1996, NEUROLOGY, V46, P68, DOI 10.1212/WNL.46.1.68; STAROSTARUBINSTEIN S, 1983, SURG NEUROL, V20, P131, DOI 10.1016/0090-3019(83)90463-9; STEWART J, 1989, J NEUROL NEUROSUR PS, V52, P1200, DOI 10.1136/jnnp.52.10.1200; Szelozynska K, 1974, Neurol Neurochir Pol, V8, P167; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554	46	55	58	0	8	LITTLE BROWN CO	BOSTON	34 BEACON STREET, BOSTON, MA 02108-1493	0028-3878			NEUROLOGY	Neurology	DEC	1996	47	6					1488	1492		10.1212/WNL.47.6.1488			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VX507	WOS:A1996VX50700024	8960732				2022-02-06	
J	Wroblewski, BA; Joseph, AB; Cornblatt, RR				Wroblewski, BA; Joseph, AB; Cornblatt, RR			Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: A controlled, prospective study	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							CLOSED HEAD-INJURY; FLUOXETINE; POPULATION; SEIZURES; MOOD	Background: Untreated or poorly treated depression in patients who suffer from traumatic brain injury can result in greater functional disability and prolonged or ineffective hospital and rehabilitation stays. Literature available on the pharmacologic treatment of depression after traumatic brain injury is scarce. This study investigated in a controlled and prospective manner the use of desipramine, a tricyclic antidepressant, in a series of patients with severe traumatic brain injury. Method: Ten patients with severe traumatic brain injury and long-standing depression, as diagnosed by DSM-III-R criteria, were admitted to the study because of the intention to be treated with antidepressants. They were randomly assigned to blindly start on either desipramine treatment (N = 6) or placebo lead-in (N = 4), Patients starting with desipramine stayed on that drug; patients starting with placebo lead-in were blindly crossed over to desipramine after 1 month if there was no significant improvement demonstrated by DSM-III-R criteria, All rating clinicians, physicians, and patients were blind to actual treatment and any ratings data, DSM-III-R evaluations were done monthly. An affect/mood scale was done every 2 weeks. Results: Of all patients evaluable using the DSM-III-R, 6 (86%) of 7 demonstrated resolution of depression and depressed mood during desipramine treatment. (Three received desipramine throughout the study; 3 others started taking placebo and crossed over to desipramine.) One patient refused evaluation on DSM-III-R throughout; 2 patients, both on desipramine, dropped out because of adverse effects (seizure, mania). In addition, there was statistically significant (p = .001) improvement over time and different rates of improvement over time in the treated and untreated groups for the affect/mood scale data. Conclusion: Results from this small study, utilizing a blinded, placebo lead-in design appear to (1) demonstrate the clinically significant effectiveness of desipramine in treating long-standing depression in a series of patients with severe traumatic brain injury, as rated with DSM-III-R criteria; (2) show statistically significant improvement on the affect/mood scale data, favoring the treated versus untreated (placebo lead-in) group.	ASCO HEALTHCARE,WESTBOROUGH,MA; MIDDLESEX HOSP,CTR NEUROBEHAV REHABIL,WALTHAM,MA; HARVARD UNIV,SCH MED,BOSTON,MA; MCLEAN HOSP,BELMONT,MA 02178		Wroblewski, BA (corresponding author), MASSACHUSETTS COLL PHARM ALLIED HLTH SCI,GREENERY REHABIL CTR,99 CHESTNUT HILL AVE,BOSTON,MA 02135, USA.						BOYESON MG, 1994, AM J PHYS MED REHAB, V73, P76, DOI 10.1097/00002060-199404000-00002; BOYESON MG, 1991, NEUROREHABILITATION, V1, P33; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; DIVAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Gualtari CT, 1991, BRAIN INJURY, V5, P219; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; KETTER TA, 1991, J CLIN PSYCHOPHARM, V11, P198; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVINE R, 1994, J CLIN PSYCHOPHARM, V14, P145, DOI 10.1097/00004714-199404000-00011; LIPSEY JR, 1984, LANCET, V1, P297; MALKMUS D, 1980, REHABILITATION HEAD; PRESKORN SH, 1991, J CLIN PSYCHIAT, V52, P23; PRESKORN SH, 1991, J CLIN PSYCHIAT, V52, P353; QUITKIN FM, 1991, AM J PSYCHIAT, V148, P197; QUITKIN FM, 1991, AM J PSYCHIAT, V148, P193; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; WROBLEWSKI BA, 1992, AM J PSYCHIAT, V149, P273	25	55	56	0	1	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 240008, MEMPHIS, TN 38124	0160-6689			J CLIN PSYCHIAT	J. Clin. Psychiatry	DEC	1996	57	12					582	587		10.4088/JCP.v57n1206			8	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	WD707	WOS:A1996WD70700006	9010122				2022-02-06	
J	Cruz, J				Cruz, J			Adverse effects of pentobarbital on cerebral venous oxygenation of comatose patients with acute traumatic brain swelling: Relationship to outcome	JOURNAL OF NEUROSURGERY			English	Article						head injury; coma; intracranial pressure; jugular oxyhemoglobin saturation; barbiturate therapy; outcome	SEVERE HEAD-INJURY; BLOOD-FLOW; PERFUSION-PRESSURE; HYPERVENTILATION; CONSUMPTION; MANAGEMENT; TRIAL	Global cerebrovenous oxygenation was evaluated before and after intravenous administration of pentobarbital sodium for the management of refractory intracranial hypertension in 151 comatose patients who had acute traumatic brain swelling. Two groups of patients were identified: a group in which the jugular oxyhemoglobin saturation (SjO(2)) remained at or above 45% after pentobarbital bolus, and a group in which the SjO(2) dropped below 45%. The two groups were matched by predominant findings on computerized tomography scans of the head, as well as age, postresuscitation Glasgow Coma Scale scores, levels of total hemoglobin content, SjO(2), intracranial pressure (ICP), and cerebral perfusion pressure (CPP) prior to pentobarbital bolus. Outcomes were significantly worse (p < 0.0001) in patients who developed decreases in SjO(2) to levels below 45% than in those whose SjO(2) remained at or above 45%, despite the fact that there were no significant differences between the two groups with regard to ICP and CPP after an intravenous bolus of pentobarbital.			Cruz, J (corresponding author), ALLEGHENY UNIV HLTH SCI,DEPT NEUROSURG,MAIL STOP 455,PHILADELPHIA,PA 19102, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR303687] Funding Source: Medline		CRUZ J, 1993, CRIT CARE MED, V21, P1218, DOI 10.1097/00003246-199308000-00024; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; CRUZ J, 1995, J NEUROSURG, V82, P379, DOI 10.3171/jns.1995.82.3.0379; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; JENNETT B, 1975, LANCET, V1, P480; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; TEASDALE G, 1974, LANCET, V2, P81	16	55	58	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1996	85	5					758	761		10.3171/jns.1996.85.5.0758			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	VP489	WOS:A1996VP48900003	8893711				2022-02-06	
J	Mansfield, RT; Schiding, JK; Hamilton, RL; Kochanek, PM				Mansfield, RT; Schiding, JK; Hamilton, RL; Kochanek, PM			Effects of hypothermia on traumatic brain injury in immature rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						edema; head injury; hypothermia; immature rat; traumatic brain injury	METHYL-D-ASPARTATE; CEREBRAL BLOOD-FLOW; H-3 MK-801 BINDING; MODERATE HYPOTHERMIA; INTRACRANIAL HYPERTENSION; RECEPTOR COMPLEX; MILD HYPOTHERMIA; HEAD-INJURIES; CHILDREN; CORTEX	Hypothermia is beneficial in adult models of traumatic brain injury (TBI), but it has not been evaluated in an immature animal model. We hypothesized that brief hypothermia applied after TBI would reduce cerebral edema and lesion volume in immature rats. Male Wistar rats (3-4 weeks of age, 90-140 g) were anesthetized, intubated, mechanically ventilated, and subjected to TBI by a weight drop onto the exposed right parietal cortex. Hypothermic rats were then cooled to a brain temperature of 32.0 +/- 0.5 degrees C for 4 h, and control rats were maintained at a brain temperature of 37.0 +/- 0.5 degrees C. Cerebral edema(wet - dry weight method) was assessed at 4 and 24 h, and lesion volume was assessed at 5 days, At 4 h, a reduction of percent brain water in the traumatized hemisphere was observed in hypothermic versus normothermic rats (81.75 +/- 0.60 vs. 82.53 +/- 0.67%; p < 0.05), but by 24 h posttrauma, the groups were similar (p = 0.82). Total lesion volume (47.2 +/- 8.5 vs. 44.4 +/- 10.0 mm(3); p = 0.51) and necrotic volume (20.2 +/- 6.3 vs. 20.0 +/- 7.9 mm(3); p = 0.95) were similar in the hypothermic and normothermic groups. We conclude that in this model, a transient (4-h) application of moderate (32 degrees C) hypothermia reduces the cerebral edema characteristically seen in immature rats at 4 h, but this reduction is not sustained at 24 h. Attenuating or delaying the development of cerebral edema could have important therapeutic relevance after TBI. Transient hypothermia, however, did not reduce lesion volume at 5 days posttrauma.	UNIV PITTSBURGH, SAFAR CTR RESUSCITAT RES, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT ANESTHESIOL & CRIT CARE MED, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT PEDIAT, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT PATHOL, PITTSBURGH, PA 15260 USA				Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X			ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Biagas K. V., 1992, Society for Neuroscience Abstracts, V18, P1088; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CARSON F, 1980, THEORY PRACTICE HIST, P252; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; DSOUZA SW, 1992, LANCET, V339, P1240, DOI 10.1016/0140-6736(92)91188-E; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; LANGFITT TW, 1977, ANN SURG, V186, P411, DOI 10.1097/00000658-197710000-00002; LIN B, 1994, STROKE, V25, P254; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; MAGNUSSON KR, 1993, BRAIN RES, V604, P334, DOI 10.1016/0006-8993(93)90386-2; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MCDONALD JW, 1992, BRAIN RES, V583, P54, DOI 10.1016/S0006-8993(10)80009-5; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; PIGGOTT MA, 1992, BRAIN RES, V588, P277, DOI 10.1016/0006-8993(92)91586-4; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; REAM AK, 1982, ANESTHESIOLOGY, V56, P41, DOI 10.1097/00000542-198201000-00009; ROSOMOFF HL, 1959, J NEUROSURG, V16, P177, DOI 10.3171/jns.1959.16.2.0177; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19, DOI 10.1152/ajplegacy.1955.183.1.19; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SHULMAN K, 1959, AM J SURG, V98, P704, DOI 10.1016/0002-9610(59)90495-7; SLATER P, 1993, BRIT J PHARMACOL, V108, P1143, DOI 10.1111/j.1476-5381.1993.tb13518.x; STEEN PA, 1980, ANESTHESIOLOGY, V52, P224, DOI 10.1097/00000542-198003000-00007; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAMARU M, 1991, BRAIN RES, V542, P83, DOI 10.1016/0006-8993(91)91001-H; VERHEUL HB, 1993, BRAIN RES, V618, P203, DOI 10.1016/0006-8993(93)91267-V; YAGER J, 1993, PEDIATR RES, V34, P525, DOI 10.1203/00006450-199310000-00029; YOUNG RSK, 1983, STROKE, V14, P622, DOI 10.1161/01.STR.14.4.622; YOUNG RSK, 1980, JAMA-J AM MED ASSOC, V244, P1233, DOI 10.1001/jama.244.11.1233	37	55	56	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	1996	16	2					244	252		10.1097/00004647-199603000-00009			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	TW393	WOS:A1996TW39300009	8594056				2022-02-06	
J	Yoles, E; Belkin, M; Schwartz, M				Yoles, E; Belkin, M; Schwartz, M			HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy	JOURNAL OF NEUROTRAUMA			English	Article						tetrahydrocannabinol; crush injury; optic nerve; metabolism; electrophysiology	TRAUMATIC BRAIN INJURY; EXPERIMENTAL HEAD-INJURY; CNS WHITE MATTER; ANOXIC INJURY; CEREBRAL-CORTEX; GRADED CRUSH; RAT; METABOLISM; CAT; RECEPTOR	HU-211 is a novel synthetic analog of tetrahydrocannabinol that was recently shown in animal models to be nonpsychotropic. In this study we show that HU-211 can potentially be used as a neuroprotective compound in the CNS. Using a calibrated crush injury of adult rat optic nerve, we show that HU-211 can reduce injury-induced metabolic and electrophysiological deficits. Energy metabolism was monitored by measuring the intramitochondrial nicotine-amine adenine dinucleotide redox state hourly for 6 h after injury and treatment. Electrophysiological activity was assessed by compound action potential and visual evoked potential response. Beneficial effects were dose-dependent, being optimal at 7 mg/kg, administered intraperitoneally. The time window during which treatment was effective was found to be from the time of injury for at least 5 h, with treatment most effective at the time of injury. These results strongly suggest that HU-211, given immediately after CNS injury at the optimal dosage, may possess neuroprotective activities.	WEIZMANN INST SCI, DEPT NEUROBIOL, IL-76100 REHOVOT, ISRAEL; TEL AVIV UNIV, SHEBA MED CTR, SACKLER FAC MED, GOLDSCHLEGER EYE RES INST, TEL HASHOMER, ISRAEL				Belkin, Michael/AAK-4728-2020				ASSIA E, 1989, BRAIN RES, V476, P205, DOI 10.1016/0006-8993(89)91240-7; BRAY GM, 1991, ANN NY ACAD SCI, V633, P214; CHANCE B, 1965, NATURE, V206, P257, DOI 10.1038/206257a0; CHANCE B, 1966, 3 P INT C HYP MED, P15; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; DUBOC D, 1990, TRANSPLANTATION, V50, P751; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FARBER JL, 1990, ENVIRON HEALTH PERSP, V84, P107, DOI 10.2307/3430711; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; MAYEVSKY A, 1984, BRAIN RES REV, V7, P49, DOI 10.1016/0165-0173(84)90029-8; MAYEVSKY A, 1982, SCIENCE, V217, P527; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MECHOULAM R, 1988, EXPERIENTIA, V44, P762, DOI 10.1007/BF01959156; MINEZAKI K K, 1990, Heart and Vessels, V5, P193, DOI 10.1007/BF02058689; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; OSBAKKEN M, 1991, CARDIOVASC RES, V25, P749, DOI 10.1093/cvr/25.9.749; QUIGLEY HA, 1995, OPHTHAL VIS SCI, V36, P774; RANSOM BR, 1990, STROKE, V21, P52; RANSOM BR, 1990, NEUROLOGY, V40, P1399, DOI 10.1212/WNL.40.9.1399; SAUTTER J, 1991, BRAIN RES, V565, P23, DOI 10.1016/0006-8993(91)91732-G; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; STYS PK, 1993, P NATL ACAD SCI USA, V90, P6976, DOI 10.1073/pnas.90.15.6976; STYS PK, 1992, J NEUROSCI, V12, P430; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; WAGNER KR, 1985, J NEUROSURG, V63, P88, DOI 10.3171/jns.1985.63.1.0088; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Yoles E., 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P297; YOLES E, 1992, INVEST OPHTH VIS SCI, V33, P3586; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZALISH M, 1993, RETINA-J RET VIT DIS, V13, P145, DOI 10.1097/00006982-199313020-00010; ZIVIN JA, 1991, SCI AM, V265, P36	43	55	57	1	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1996	13	1					49	57		10.1089/neu.1996.13.49			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TW167	WOS:A1996TW16700007	8714863				2022-02-06	
J	WATSON, MR; FENTON, GW; MCCLELLAND, RJ; LUMSDEN, J; HEADLEY, M; RUTHERFORD, WH				WATSON, MR; FENTON, GW; MCCLELLAND, RJ; LUMSDEN, J; HEADLEY, M; RUTHERFORD, WH			THE POST-CONCUSSIONAL STATE - NEUROPHYSIOLOGICAL ASPECTS	BRITISH JOURNAL OF PSYCHIATRY			English	Article							MINOR HEAD-INJURY; SEQUELAE	Background. Twenty-six young men admitted to an Accident and Emergency Department for observation following a minor closed head injury (post-traumatic amnesia (PTA) less than 12 hours) were investigated within 24 hours of admission (day 0) and followed up at 10 days, 6 weeks and 1 year after the trauma. Method. Investigations at day 0 included physical examination, completion of post-concussional symptom and stress-arousal checklists, computerised EEG (CEEG) and auditory brainstem evoked potential (BAEP) recordings. These were repeated at ten days and six weeks. At 12 months follow-up. the Present State Examination (PSE) was carried out and a further post-concussional symptom checklist completed. Results. Post-concussional symptomatology declined progressively from day 0 but half had residual symptoms at 1 year. Seventy-two per cent ran an acute course with recovery by 6 weeks, 8% a chronic unremitting course and 20% initially improved but had an exacerbation of symptoms between 6 weeks and 12 months. The CEEG alpha-theta ratios decreased significantly between days 0 and 10, reaching a baseline thereafter. Measures of CEEG recovery from all channels correlated with symptom counts at six weeks; the slower the recovery the greater the symptoms. A relative delay in left temporal recovery was associated with residual psychiatric morbidity (PSE ID scores) at 12 months. Prolonged central brainstem conduction times occurred in 27% of patients at day 0. These correlated positively with PTA and degree of psychiatric morbidity (PSE ID scores) at 12 months. Conclusions. Symptom chronicity was accompanied by continuing brainstem dysfunction, while the degree of transient cortical dysfunction appeared to have a direct influence in the intensity of early organic symptom reaction to the trauma. Levels of perceived stress at the time of the injury, or afterwards, were not related to symptom formation.	HOLYWELL HOSP,BELFAST,ANTRIM,NORTH IRELAND; UNIV DUNDEE,DUNDEE,SCOTLAND; QUEENS UNIV BELFAST,BELFAST,ANTRIM,NORTH IRELAND; BROADMOOR HOSP,DEPT NEUROPHYSIOL,CROWTHORNE,BERKS,ENGLAND; ST LUKES HOSP,ARMAGH,NORTH IRELAND; CRAIGAVON AREA HOSP,ARMAGH,NORTH IRELAND; ROYAL VICTORIA HOSP,DEPT ACCID & EMERGENCY,BELFAST BT12 6BA,ANTRIM,NORTH IRELAND								Cartlidge N E, 1981, HEAD INJURY; COOPER R, 1965, ELECTROEN CLIN NEURO, V18, P217, DOI 10.1016/0013-4694(65)90088-X; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; GRONWALL D, 1974, LANCET, V2, P605; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MACKAY C, 1978, BRIT J SOC CLIN PSYC, V17, P283, DOI 10.1111/j.2044-8260.1978.tb00280.x; McAllister H G, 1983, Br J Audiol, V17, P275, DOI 10.3109/03005368309081489; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; RUTHERFORD WH, 1977, LANCET, V1, P1; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; Trimble M.R., 1981, POSTTRAUMATIC NEUROS; World Health Organization, 1978, MENT DIS GLOSS GUID	20	55	57	0	2	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON, ENGLAND SW1X 8PG	0007-1250			BRIT J PSYCHIAT	Br. J. Psychiatry	OCT	1995	167						514	521		10.1192/bjp.167.4.514			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	TA964	WOS:A1995TA96400017	8829722				2022-02-06	
J	MARMAROU, A				MARMAROU, A			TRAUMATIC BRAIN EDEMA - AN OVERVIEW	ACTA NEUROCHIRURGICA			English	Article						VASOGENIC EDEMA; TRAUMATIC EDEMA; MRI; RESOLUTION	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; PRIMARY ASTROCYTE CULTURES; COMPUTED-TOMOGRAPHY; EXTRACELLULAR POTASSIUM; INTRACRANIAL-PRESSURE; COMPRESSION; CLEARANCE; BARRIER; CIRCULATION	This article provides a brief summary of concepts describing the formation and resolution of traumatic brain edema. Recent laboratory and clinical data are reviewed targeted toward resolving the contribution of edema to the swelling process. These data, indicate that blood volume is reduced in areas of ischemia following traumatic injury and edema volume is increased. Thus, edema is the major contributor to the swelling process in diffuse injury. As clinical MRI studies have not revealed barrier compromise in the presence of swelling, it is considered that other forms of edema, primarily ischemic and neurotoxic, make a substantial contribution to the edema volume.			MARMAROU, A (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, BOX 508, MCV STN, RICHMOND, VA 23298 USA.						BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, INTRACRANIAL PRESSUR, V8; CLUBB RJ, 1980, J NEUROSURG, V52, P189, DOI 10.3171/jns.1980.52.2.0189; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; CSERR HF, 1977, EXP EYE RES, V25, P461, DOI 10.1016/S0014-4835(77)80041-9; CZERNICKI Z, 1977, ACTA NEUROCHIR, V36, P181, DOI 10.1007/BF01405390; EISENBERG H, 1988, APR ANN M AM ASS NEU; Flexner LB, 1933, Q REV BIOL, V8, P397, DOI 10.1086/394447; FODA M, 1993, IN PRESS J NEUROSURG; GO KG, 1991, CEREBRAL PATHOPHYSIO; His, 1865, Z WISS ZOOL, V15, P127; ISHII S, 1966, HEAD INJURY, P276; JAKOBSSON DE, 1990, NEUROL RES, V12, P153; JAKOBSSON KE, 1990, ACTA NEUROCHIR, V104, P126, DOI 10.1007/BF01842830; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; KIMELBERG HK, 1989, J NEUROSCI, V9, P1141; KIMELBERG HK, 1987, J PHYSIOL-PARIS, V82, P294; KLATZO I, 1960, J NEUROPATH EXP NEUR, V19, P475, DOI 10.1097/00005072-196010000-00001; Klatzo I, 1980, Adv Neurol, V28, P359; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KUHL DE, 1980, J NEUROSURG, V52, P309, DOI 10.3171/jns.1980.52.3.0309; LANGFITT TW, 1965, NEUROLOGY, V15, P761, DOI 10.1212/WNL.15.8.761; LOWELL HM, 1971, J NEUROSURG, V34, P760, DOI 10.3171/jns.1971.34.6.0760; MARMAROU A, 1988, 7TH INT S INT PRESS; MARMAROU A, 1991, IN PRESS ICP CRANIOS; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Milhorat T, 1983, NEUROBIOLOGY CEREBRO, P1; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1973, J NEUROSURG, V39, P186, DOI 10.3171/jns.1973.39.2.0186; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OHATA K, 1990, ACTA NEUROPATHOL, V81, P162, DOI 10.1007/BF00334505; OHATA K, 1992, J NEUROSURG, V77, P387, DOI 10.3171/jns.1992.77.3.0387; PENN RD, 1982, HEAD INJURY, P233; Ponten U, 1986, Acta Radiol Suppl, V369, P360; REULEN HJ, 1978, J NEUROSURG, V48, P754, DOI 10.3171/jns.1978.48.5.0754; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; SAKAMOTO H, 1986, INTRACRANIAL PRESSUR, V6, P166; SCHETTINI A, 1989, J NEUROSURG, V71, P578, DOI 10.3171/jns.1989.71.4.0578; SCHROEDER M, 1993, LOCAL CEREBRAL BLOOD; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; VORBRODT AW, 1985, ACTA NEUROPATHOL, V66, P265, DOI 10.1007/BF00690958; WOLMAN M, 1981, ACTA NEUROPATHOL, V54, P55, DOI 10.1007/BF00691332; Wood JH., 1980, NEUROBIOLOGY CEREBRO, V1, P1; YAMAGUCHI M, 1976, STROKE, V7, P77, DOI 10.1161/01.STR.7.1.77; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	51	55	60	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			421	424					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600114	7976607				2022-02-06	
J	CARPENTIERI, SC; MULHERN, RK; DOUGLAS, S; HANNA, S; FAIRCLOUGH, DL				CARPENTIERI, SC; MULHERN, RK; DOUGLAS, S; HANNA, S; FAIRCLOUGH, DL			BEHAVIORAL RESILIENCY AMONG CHILDREN SURVIVING BRAIN-TUMORS - A LONGITUDINAL-STUDY	JOURNAL OF CLINICAL CHILD PSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; VENTRICULAR ENLARGEMENT; CHRONIC ILLNESS; LEUKEMIA; QUALITY; ADJUSTMENT; CHECKLIST; SEQUELAE; AUTISM; CANCER	Compared the social and behavioral adjustment of 40 long-term survivors of childhood brain tumors to a matched control group of children surviving cancers that did not involve the central nervous system. Both groups exhibited significant elevations on the Behavior Problems scales of the Child Behavior Checklist (CBCL) relative to nonclinical norms, although approximately 50% of the children in both groups did not have significantly elevated scores on the CBCL. Contrary to expectations, the brain tumor group did not have significantly more signs of psychopathology than did the cancer control group and examination of serial evaluations suggested a significant decrease in symptoms of emotional disturbance since diagnosis in most children treated for brain tumors. Children in the brain tumor group did display more problems in the Social Competence scales than did children in the cancer control group, especially those related to inhibition of activities and school performance.	MEMPHIS STATE UNIV, MEMPHIS, TN 38152 USA; UNIV TENNESSEE, SCH MED, DEPT PEDIAT, KNOXVILLE, TN 37996 USA; ST JUDE CHILDRENS RES HOSP, DIV BIOSTAT, MEMPHIS, TN 38101 USA; ST JUDE CHILDRENS RES HOSP, DIV DIAGNOST IMAGING, MEMPHIS, TN 38101 USA		CARPENTIERI, SC (corresponding author), ST JUDE CHILDRENS RES HOSP, DIV PSYCHOL, POB 318, 332 N LAUDERDALE, MEMPHIS, TN 38101 USA.						ACHENBACH TM, 1983, CHILD BEHAVIOR CHECK; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BARON D, 1986, MANUAL APPLE 2E CBCL; CARPENTIERI SC, IN PRESS ARCH CLIN N; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; DANOFF BF, 1982, CANCER, V48, P1580, DOI 10.1002/1097-0142(19820415)49:8<1580::AID-CNCR2820490810>3.0.CO;2-7; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GORTMAKER SL, 1990, PEDIATRICS, V85, P267; GREENBERG HS, 1989, J PEDIATR-US, V114, P488, DOI 10.1016/S0022-3476(89)80581-5; HENDREN RL, 1991, J AM ACAD CHILD PSY, V30, P466, DOI 10.1097/00004583-199105000-00018; Hollingshead A. B., 1957, 2 FACTOR INDEX SOCIA; KORNHUBER HH, 1985, EUR ARCH PSY CLIN N, V235, P129, DOI 10.1007/BF00380981; KUN LE, 1983, J NEUROSURG, V58, P1, DOI 10.3171/jns.1983.58.1.0001; KUPST MJ, 1988, J PEDIATR PSYCHOL, V13, P7, DOI 10.1093/jpepsy/13.1.7; LANNERING B, 1990, MED PEDIATR ONCOL, V18, P304, DOI 10.1002/mpo.2950180410; LEBARON S, 1988, CANCER, V62, P1215, DOI 10.1002/1097-0142(19880915)62:6<1215::AID-CNCR2820620629>3.0.CO;2-C; MALEY JE, 1980, AM J PSYCHIAT, V137, P94; MEADOWS A T, 1986, Cancer, V58, P524, DOI 10.1002/1097-0142(19860715)58:2+<524::AID-CNCR2820581319>3.0.CO;2-C; MULHERN RK, 1992, MED PEDIATR ONCOL, V20, P181, DOI 10.1002/mpo.2950200302; MULHERN RK, 1988, J CHILD NEUROL, V3, P47, DOI 10.1177/088307388800300111; MULHERN RK, 1989, PEDIATRICS, V83, P18; MULHERN RK, IN PRESS J PEDIATRIC; MULHERN RK, 1990, CHILD ADOLESCENT DIS, P267; PERRIN EC, 1991, J PEDIATR PSYCHOL, V16, P411, DOI 10.1093/jpepsy/16.4.411; PLESS IB, 1991, J CHILD PSYCHOL PSYC, V32, P347, DOI 10.1111/j.1469-7610.1991.tb00312.x; PRIOR MR, 1984, ARCH NEUROL-CHICAGO, V41, P482, DOI 10.1001/archneur.1984.04050170028010; REISS D, 1983, AM J PSYCHIAT, V140, P453; RUTTER M, 1970, CLIN DEV MED, V0035; SANDBERG DE, 1991, J AM ACAD CHILD PSY, V30, P124, DOI 10.1097/00004583-199101000-00019; SAWYER M, 1986, AM J PEDIAT HEMATOL, V8, P200; SCHULZ SC, 1983, AM J PSYCHIAT, V140, P1592; SOLLEE ND, 1987, J ABNORM CHILD PSYCH, V15, P479, DOI 10.1007/BF00917235; TATUM WO, 1989, ANN NEUROL, V25, P196, DOI 10.1002/ana.410250216; TAYLOR HG, 1990, NEW ENGL J MED, V323, P1657, DOI 10.1056/NEJM199012133232403; Wechsler D., 1974, WECHSLER INTELLIGENC; WILLIAMS JM, 1986, CANCER TREAT REV, V13, P113	36	55	56	0	5	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0047-228X			J CLIN CHILD PSYCHOL	J. Clin. Child Psychol.	JUN	1993	22	2					236	246		10.1207/s15374424jccp2202_10			11	Psychology, Clinical; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	LT894	WOS:A1993LT89400010					2022-02-06	
J	GOODWIN, SR; FRIEDMAN, WA; BELLEFLEUR, M				GOODWIN, SR; FRIEDMAN, WA; BELLEFLEUR, M			IS IT TIME TO USE EVOKED-POTENTIALS TO PREDICT OUTCOME IN COMATOSE CHILDREN AND ADULTS	CRITICAL CARE MEDICINE			English	Article						ANOXIA; COMA; DROWNING; ENCEPHALITIS; TRAUMA; EVOKED POTENTIALS; HEAD INJURY; MORTALITY; VEGETATIVE; PATIENT OUTCOME ASSESSMENT; PEDIATRICS; NEUROLOGY	AUDITORY BRAIN-STEM; SEVERE HEAD-INJURY; PROGNOSTIC UTILITY; TRAUMATIC COMA; RESPONSES; DEATH; LATENCY; PRESSURE; DAMAGE; SEPS	Objective: To determine the value of multimodality-evoked potential recordings in predicting outcome in comatose children. Design: Prospective series and literature review. Setting: Pediatric ICU in a university hospital. Patients: Forty-one children with a Glasgow Coma Scale score of < 8, who were admitted to the pediatric ICU between 1984 and 1989. Interventions: Forty-one patients underwent brainstem auditory-evoked potential testing within 72 hrs of admission. Of these patients, 37 also had somatosensory-evoked potential testing at the same time. Four patients did not receive somatosensory-evoked potential testing for various nonmedical reasons. Measurements and Main Results: Multimodality-evoked potential recordings were used to predict outcome in these comatose children. Outcomes were categorized as bad (death or chronic vegetative state) or good (all other outcomes). Survivor outcomes were determined at discharge and on subsequent follow-up visits from 1 to 3 yrs later. There were no false pessimistic predictions, and two false optimistic predictions in this series. A comprehensive literature review of coma outcome prediction, using multimodality-evoked potential recordings, revealed 20 series with 982 additional patients in whom the predictive errors of false optimism and false pessimism could be determined. Five cases of false pessimism and 99 cases of false optimism were identified in the 982 additional patients. If neonates are excluded, the false pessimism number is reduced to three. Conclusions: A bad outcome can be reliably predicted using multimodality-evoked potential recordings with little chance of a false pessimistic prediction. The acceptable error of false optimism occurs frequently, since patients often die of progressive neurologic and nonneurologic problems that may or may not be present at the time of the evoked potential recordings. Thus, in comatose children, multimodality-evoked potential recordings are a useful adjunct to clinical examination and other diagnostic aids in predicting outcome and in making decisions regarding the degree of intervention to offer.	UNIV FLORIDA,COLL MED,DEPT PEDIAT,GAINESVILLE,FL 32611; UNIV FLORIDA,COLL MED,DEPT NEUROSURG,GAINESVILLE,FL 32611		GOODWIN, SR (corresponding author), UNIV FLORIDA,COLL MED,DEPT ANESTHESIOL,GAINESVILLE,FL 32611, USA.						AHMED I, 1988, CLIN ELECTROENCEPHAL, V19, P78, DOI 10.1177/155005948801900209; ALLMAN FD, 1986, AM J DIS CHILD, V40, P571; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; ASHWAL S, 1987, PEDIATR NEUROL, V3, P69, DOI 10.1016/0887-8994(87)90030-0; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; DEAR PRF, 1985, ARCH DIS CHILD, V60, P17, DOI 10.1136/adc.60.1.17; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; DEMEIRLEIR LJ, 1987, PEDIATR NEUROL, V3, P78, DOI 10.1016/0887-8994(87)90031-2; EDGREN E, 1983, CRIT CARE MED, V11, P4, DOI 10.1097/00003246-198301000-00002; ELWANY S, 1988, J LARYNGOL OTOL, V102, P755, DOI 10.1017/S0022215100106383; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; FRANK LM, 1985, NEUROLOGY, V35, P931, DOI 10.1212/WNL.35.6.931; Friedman W A, 1988, Clin Neurosurg, V34, P187; FRIEDMAN WA, 1985, J NEUROSURG, V62, P552, DOI 10.3171/jns.1985.62.4.0552; GOLDIE WD, 1981, NEUROLOGY, V31, P248, DOI 10.1212/WNL.31.3.248; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HANSOTIA P, 1981, NEUROLOGY, V31, P83, DOI 10.1212/WNL.31.1.83; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; JAIN S, 1984, ACTA NEUROL SCAND, V69, P163, DOI 10.1111/j.1600-0404.1984.tb07795.x; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JOHNSTON B, 1984, ACTA NEUROL SCAND, V69, P417, DOI 10.1111/j.1600-0404.1984.tb07825.x; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KAGA K, 1985, ANN NEUROL, V18, P360, DOI 10.1002/ana.410180318; KARNAZE DS, 1985, NEUROLOGY, V35, P1122, DOI 10.1212/WNL.35.8.1122; KASTE M, 1981, J NEUROSURG, V55, P511, DOI 10.3171/jns.1981.55.4.0511; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; MARSH RR, 1984, OTOLARYNG HEAD NECK, V92, P685, DOI 10.1177/019459988409200616; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARA T, 1988, AM J DIS CHILD, V142, P173, DOI 10.1001/archpedi.1988.02150020075032; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NATALONI S, 1988, RESUSCITATION, V16, P127, DOI 10.1016/0300-9572(88)90077-9; NEWLON PG, 1983, NEUROSURGERY, V12, P613, DOI 10.1227/00006123-198306000-00003; NOSEWORTHY TW, 1985, CRIT CARE MED, V13, P743, DOI 10.1097/00003246-198509000-00010; ROSENBERG C, 1984, ARCH NEUROL-CHICAGO, V41, P835, DOI 10.1001/archneur.1984.04050190041012; STARR A, 1976, BRAIN, V99, P543, DOI 10.1093/brain/99.3.543; STEINHART CM, 1985, CRIT CARE MED, V13, P560, DOI 10.1097/00003246-198507000-00010; STOCKARD JJ, 1978, ANN NEUROL, V3, P368, DOI 10.1002/ana.410030416; TAYLOR MJ, 1983, NEW ENGL J MED, V309, P1169, DOI 10.1056/NEJM198311103091908; TAYLOR MJ, 1989, PEDIATR NEUROL, V5, P145, DOI 10.1016/0887-8994(89)90063-5; TSUBOKAWA T, 1980, J NEUROL NEUROSUR PS, V43, P1005, DOI 10.1136/jnnp.43.11.1005; VAPALAHTI M, 1986, ANN CLIN RES, V18, P37; WAGSTYL J, 1987, J PEDIATR SURG, V22, P127, DOI 10.1016/S0022-3468(87)80427-X; WALSER H, 1986, J NEUROL, V233, P34, DOI 10.1007/BF00313989; ZUCCARELLO M, 1985, CHILD NERV SYST, V1, P158, DOI 10.1007/BF00735731	50	55	55	0	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0090-3493			CRIT CARE MED	Crit. Care Med.	APR	1991	19	4					518	524		10.1097/00003246-199104000-00011			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH611	WOS:A1991FH61100011	2019138				2022-02-06	
J	LEVIN, HS; WILLIAMS, DH; VALASTRO, M; EISENBERG, HM; CROFFORD, MJ; HANDEL, SF				LEVIN, HS; WILLIAMS, DH; VALASTRO, M; EISENBERG, HM; CROFFORD, MJ; HANDEL, SF			CORPUS CALLOSAL ATROPHY FOLLOWING CLOSED HEAD-INJURY - DETECTION WITH MAGNETIC-RESONANCE-IMAGING	JOURNAL OF NEUROSURGERY			English	Article									LA GUARDIA HOSP,DEPT RADIOL,FOREST HILLS,NY; NMR ASSOCIATES,HOUSTON,TX		LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALEXANDER MP, 1988, NEUROLOGY, V38, P802, DOI 10.1212/WNL.38.5.802; BYNE W, 1988, BEHAV NEUROSCI, V102, P222, DOI 10.1037/0735-7044.102.2.222; DELACOSTE MC, 1988, BRAIN BEHAV EVOLUT, V31, P318, DOI 10.1159/000116598; DELACOSTEUTAMSING C, 1982, SCIENCE, V216, P1431, DOI 10.1126/science.7089533; DIETEMANN JL, 1988, NEURORADIOLOGY, V30, P478, DOI 10.1007/BF00339686; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LHERMITTE J, 1929, REV NEUROL, V37, P703; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; REINARZ SJ, 1988, AM J ROENTGENOL, V151, P791, DOI 10.2214/ajr.151.4.791; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; SCHOTT B, 1969, REV NEUROL-FRANCE, V120, P359; SIMON JH, 1987, AM J NEURORADIOL, V8, P599; SIMON JH, 1986, RADIOLOGY, V160, P363, DOI 10.1148/radiology.160.2.3726114; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1970, PATHOLOGY TRAUMA, P166; TEASDALE G, 1974, LANCET, V2, P81	19	55	55	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	JUL	1990	73	1					77	81		10.3171/jns.1990.73.1.0077			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DL088	WOS:A1990DL08800012	2352026				2022-02-06	
J	SHUM, DHK; MCFARLAND, K; BAIN, JD; HUMPHREYS, MS				SHUM, DHK; MCFARLAND, K; BAIN, JD; HUMPHREYS, MS			EFFECTS OF CLOSED-HEAD INJURY ON ATTENTIONAL PROCESSES - AN INFORMATION-PROCESSING STAGE ANALYSIS	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article									UNIV QUEENSLAND,DEPT PSYCHOL,ST LUCIA,QLD 4067,AUSTRALIA				Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262			BENYISHAY Y, 1983, REHABILITATION HEAD, P167; BOND MR, 1983, REHABILITATION HEAD, P97; BROOKS N, 1984, CLOSED HEAD INJURY P; DODD DH, 1973, PSYCHOL BULL, V79, P391, DOI 10.1037/h0034347; Fidell L.S., 1983, USING MULTIVARIATE S; FROWEIN HW, 1981, ACTA PSYCHOL, V47, P105, DOI 10.1016/0001-6918(81)90002-0; Gronwall D, 1974, PSYCHOL EFFECTS CONC; KEPPEL G, 1982, DESIGN ANAL RES HDB; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Miller E, 1970, Cortex, V6, P121; MULDER G, 1983, J CHILD PSYCHOL PSYC, V24, P19, DOI 10.1111/j.1469-7610.1983.tb00100.x; NETTLEBECK T, 1981, INT REV RES MENT RET, P61; PARSONS OA, 1978, J CONSULT CLIN PSYCH, V46, P608, DOI 10.1037/0022-006X.46.4.608; Sanders A. F., 1980, TUTORIALS MOTOR BEHA, P331, DOI DOI 10.1016/S0166-4115(08)61955-X; SANDERS AF, 1982, ACTA PSYCHOL, V51, P41, DOI 10.1016/0001-6918(82)90018-X; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren A. H., 1981, REACTION TIME ATTENT; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; [No title captured]	25	55	55	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR	1990	12	2					247	264		10.1080/01688639008400971			18	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	DB328	WOS:A1990DB32800006	2341554				2022-02-06	
J	Yang, YX; Ye, YQ; Kong, CG; Su, XH; Zhang, X; Bai, W; He, XS				Yang, Yongxiang; Ye, Yuqin; Kong, Chuiguang; Su, Xinhong; Zhang, Xin; Bai, Wei; He, Xiaosheng			MiR-124 Enriched Exosomes Promoted the M2 Polarization of Microglia and Enhanced Hippocampus Neurogenesis After Traumatic Brain Injury by Inhibiting TLR4 Pathway	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Exosome; MiR-124; Microglia; Neurogenesis; TLR4	INTERLEUKIN-1 RECEPTOR ANTAGONIST; FUNCTIONAL RECOVERY; ADULT NEUROGENESIS; CONTRIBUTES; MACROPHAGES; ACTIVATION; PROTECTION; REGULATOR; ABLATION; DELIVERY	MicroRNA-124 (miR-124) is a brain specific miRNA that is highly expressed in microglia. The upregulation of miR-124 contributes to M2 polarization of microglia, which is beneficial to neurogenesis. Exosomes are lipid membrane vesicles that can deliver miR-124 into the brain. However, whether miR-124 enriched exosomes (Exo-miR-124) can regulate the polarization of microglia and affect hippocampus neurogenesis after traumatic brain injury (TBI) is unknown. To clarify this, the Exo-miR-124 was first constructed, and then was intravenously administrated into rats via tail vein with the dose of 3x10(9) particles/each rat at 24h post TBI. The polarization of microglia in hippocampus was evaluated through measuring the signature genes and cytokines of M1/M2 phenotype by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immune sorbent assay (ELISA) at 7/14/21/28 days after TBI. Hippocampus neurogenesis was evaluated through detecting the proliferation marker BrdU/SOX2 and differentiation marker BrdU/NeuN by immunofluorescence (IF) at 7 and 28days after TBI respectively. Neurological function was evaluated by neurological severity score (NSS) and morris water maze (MWM) at 7/14/21/28 and 24-28days after TBI respectively. To explore the underlying mechanisms, the mRNA expression of TLR4 pathway molecules in hippocampus were measured by RT-PCR, and the polarization of microglia and the activation of TLR4 pathway in BV2 cells were measured after exosome treatment as well. Results demonstrated that Exo-miR-124 treatment promoted the M2 polarization of microglia, enhanced neurogenesis in hippocampus, and improved function recovery after TBI. The M2 polarization effect of Exo-miR-124 was produced through inhibiting TLR4 pathway, which was verified in hippocampus and BV2 microglia. In conclusion, Exo-miR-124 treatment promoted M2 polarization of microglia and improved hippocampal neurogenesis and functional recovery after brain injury, which might be a strategy to improve the outcome of TBI.	[Yang, Yongxiang; Ye, Yuqin; Kong, Chuiguang; Su, Xinhong; Zhang, Xin; Bai, Wei; He, Xiaosheng] Fourth Mil Med Univ, Airforce Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Yang, Yongxiang] PLA 422nd Hosp, Dept Neurosurg, Zhanjiang 524005, Peoples R China; [Ye, Yuqin] Hunan Normal Univ, Affiliated Hosp 2, PLA 163rd Hosp, Dept Neurosurg, Changsha 410000, Hunan, Peoples R China		He, XS (corresponding author), Fourth Mil Med Univ, Airforce Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.	hexiaos@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471264]; Science and Technology Development Fund of Airforce Military Medical University (Fourth Military Medical University) [2016XC178, 2016XC210]	The present work was supported by Grants from National Natural Science Foundation of China (81471264 to XH), Science and Technology Development Fund of Airforce Military Medical University (Fourth Military Medical University) (2016XC178 and 2016XC210 to XH).	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amici SA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01520; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Braccioli L, 2014, MOL NEUROBIOL, V49, P113, DOI 10.1007/s12035-013-8504-9; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; de Miranda AS, 2017, J NEUROL SCI, V372, P482, DOI 10.1016/j.jns.2016.10.052; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Huang S, 2018, FASEB J, V32, P2315, DOI 10.1096/fj.201700673RERR; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kalani A, 2014, MOL NEUROBIOL, V49, P590, DOI 10.1007/s12035-013-8544-1; Keene CD, 2009, AM J PATHOL, V174, P2300, DOI 10.2353/ajpath.2009.081153; Kiyota T, 2012, GENE THER, V19, P724, DOI 10.1038/gt.2011.126; Lee ST, 2017, J MOV DISORD, V10, P45, DOI 10.14802/jmd.16054; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Mouihate A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00173; Ning RZ, 2017, ONCOTARGET, V8, P95481, DOI 10.18632/oncotarget.20751; Periyasamy P, 2018, MOL NEUROBIOL, V55, P3196, DOI 10.1007/s12035-017-0584-5; Pinto S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00273; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Seong KJ, 2016, KOREAN J PHYSIOL PHA, V20, P41, DOI 10.4196/kjpp.2016.20.1.41; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Sun Y, 2013, CELL RES, V23, P1270, DOI 10.1038/cr.2013.116; Svahn AJ, 2016, DEV NEUROBIOL, V76, P507, DOI 10.1002/dneu.22328; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, NEUROTOXICOL TERATOL, V45, P75, DOI 10.1016/j.ntt.2014.07.003; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Wu MD, 2012, BRAIN BEHAV IMMUN, V26, P292, DOI 10.1016/j.bbi.2011.09.012; Xin HQ, 2017, STROKE, V48, P747, DOI 10.1161/STROKEAHA.116.015204; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xue F, 2015, TUMORI, V101, P542, DOI 10.5301/tj.5000226; Yang JL, 2017, MOL THER-NUCL ACIDS, V7, P278, DOI 10.1016/j.omtn.2017.04.010; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; YE Y, 2017, STEM CELLS INT, V2017, DOI DOI 10.1155/2017/5841814; Ye Y, 2016, NEURAL PLAST, V2016, DOI DOI 10.1155/2016/8072156280186795153466; Yu AY, 2017, IMMUNOL LETT, V182, P1, DOI 10.1016/j.imlet.2016.12.003; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	52	54	59	4	42	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2019	44	4					811	828		10.1007/s11064-018-02714-z			18	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HR2TP	WOS:000462990500007	30628018				2022-02-06	
J	Ding, MG; Ning, J; Feng, N; Li, ZY; Liu, ZH; Wang, YB; Wang, YM; Li, X; Huo, C; Jia, X; Xu, R; Fu, F; Wang, XM; Pei, JM				Ding, Mingge; Ning, Jiao; Feng, Na; Li, Zeyang; Liu, Zhenhua; Wang, Yuanbo; Wang, Yueming; Li, Xing; Huo, Cong; Jia, Xin; Xu, Rong; Fu, Feng; Wang, Xiaoming; Pei, Jianming			Dynamin-related protein 1-mediated mitochondrial fission contributes to post-traumatic cardiac dysfunction in rats and the protective effect of melatonin	JOURNAL OF PINEAL RESEARCH			English	Article						cardiac dysfunction; Drp1; mechanical trauma; melatonin; mitochondrial dynamics	ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; APOPTOSIS; HEART; FUSION; HEALTH; INFLAMMATION	Mechanical trauma (MT) causes myocardial injury and cardiac dysfunction. However, the underlying mechanism remains largely unclear. This study investigated the role of mitochondrial dynamics in post-traumatic cardiac dysfunction and the protective effects of melatonin. Adult male Sprague Dawley rats were subjected to 5-minute rotations (200 revolutions at a rate of 40rpm) to induce MT model. Melatonin was administrated intraperitoneally 5minute after MT. Mitochondrial morphology, myocardial injury, and cardiac function were determined in vivo. There was smaller size of mitochondria and increased number of mitochondria per m(2) in the hearts after MT when the secondary myocardial injury was induced. Melatonin treatment at the dose of 30mg/kg reduced serine 616 phosphorylation of Drp1 and inhibited mitochondrial Drp1 translocation and mitochondrial fission in the hearts of rats subjected to MT, which contributed to the reduction of myocardial injury and the improvement of cardiac function. In vitro, H9c2 cells cultured in 20% traumatic plasma (TP) for 12hour showed enhanced mitochondrial fission, mitochondrial membrane potential (m) loss, mitochondrial cytochrome c release, and decreased mitochondrial complex I-IV activities. Pretreatment with melatonin (100mol/L) efficiently inhibited TP-induced mitochondrial fission, m loss, cytochrome c release, and improved mitochondrial function. Melatonin's protective effects were attributed to its role in suppressing plasma TNF- overproduction, which was responsible for Drp1-mediated mitochondrial fission. Taken together, our results demonstrate for the first time that abnormal mitochondrial dynamics is involved in post-traumatic cardiac dysfunction. Melatonin has significant pharmacological potential in protecting against MT-induced cardiac dysfunction by preventing excessive mitochondrial fission.	[Ding, Mingge] Xi An Jiao Tong Univ, Dept Geriatr, Xian Cent Hosp, Xian, Shaanxi, Peoples R China; [Ding, Mingge; Ning, Jiao; Feng, Na; Li, Zeyang; Liu, Zhenhua; Wang, Yuanbo; Wang, Yueming; Fu, Feng; Pei, Jianming] Fourth Mil Med Univ, Dept Physiol, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Ding, Mingge; Li, Xing; Huo, Cong; Jia, Xin; Xu, Rong; Wang, Xiaoming] Fourth Mil Med Univ, Dept Geriatr, Xijing Hosp, Xian, Shaanxi, Peoples R China		Wang, XM (corresponding author), Fourth Mil Med Univ, Dept Geriatr, Xijing Hosp, Xian, Shaanxi, Peoples R China.; Fu, F; Pei, JM (corresponding author), Fourth Mil Med Univ, Dept Physiol, Xian, Shaanxi, Peoples R China.	fufeng048@126.com; xmwang@fmmu.edu.cn; jmpei8@fmmu.edu.cn		Fu, Feng/0000-0003-3752-4628; Liu, Zhenhua/0000-0003-4228-2504; Ding, Mingge/0000-0002-6136-6394	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81600235, 81670354, 81770243, 81270169]; Natural Science Foundation of ShaanxiNatural Science Foundation of Shaanxi Province [2016KTCL03-11, 2016ZDJC-13]	National Natural Science Foundation of China, Grant/Award Number: 81600235, 81670354, 81770243 and 81270169; Key Project of Natural Science Foundation of Shaanxi, Grant/Award Number: 2016KTCL03-11, 2016ZDJC-13	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bock JS, 2012, CARDIOL CLIN, V30, P545, DOI 10.1016/j.ccl.2012.07.001; Chen JY, 2015, J PINEAL RES, V59, P469, DOI 10.1111/jpi.12278; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Chuang JI, 2016, J PINEAL RES, V61, P230, DOI 10.1111/jpi.12343; Ding MG, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0501-2; Ding MG, 2017, AM J CHINESE MED, V45, P53, DOI 10.1142/S0192415X17500057; Dong YS, 2016, J PINEAL RES, V60, P253, DOI 10.1111/jpi.12300; El-Menyaru A, 2012, ANN CARD ANAESTH, V15, P287, DOI 10.4103/0971-9784.101875; Fu F, 2014, AM J CHINESE MED, V42, P95, DOI 10.1142/S0192415X14500062; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garcia JJ, 2014, J PINEAL RES, V56, P225, DOI 10.1111/jpi.12128; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144; Hu JQ, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12368; Ismailov RM, 2005, INT J CARDIOL, V105, P141, DOI 10.1016/j.ijcard.2004.11.025; Jing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30812; Li SH, 2007, AM J PHYSIOL-HEART C, V293, pH1847, DOI 10.1152/ajpheart.00578.2007; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu Z, 2017, J PINEAL RES, V62; Ma S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44623; Marcolini EG, 2015, EMERG MED CLIN N AM, V33, P519, DOI 10.1016/j.emc.2015.04.003; Marin-Garcia J, 2016, HEART FAIL REV, V21, P123, DOI 10.1007/s10741-016-9530-2; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Meng G., 2017, BR J PHARM; Nan JL, 2017, BBA-MOL CELL RES, V1864, P1260, DOI 10.1016/j.bbamcr.2017.03.006; Ong SB, 2017, CARDIOVASC DRUG THER, V31, P87, DOI 10.1007/s10557-016-6710-1; Ong SB, 2013, ANTIOXID REDOX SIGN, V19, P400, DOI 10.1089/ars.2012.4777; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Pei HF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12371; Poyet R, 2015, J Emerg Trauma Shock, V8, P110, DOI 10.4103/0974-2700.155513; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Rogers MA, 2017, CIRC RES, V121, P220, DOI 10.1161/CIRCRESAHA.116.310293; Simko F, 2014, J PINEAL RES, V57, P177, DOI 10.1111/jpi.12154; Tan DX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122124; Tao L, 2005, AM J PHYSIOL-HEART C, V288, pH2811, DOI 10.1152/ajpheart.01252.2004; Vasquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301; Vasudevan AR, 2003, LANCET, V362, P370, DOI 10.1016/S0140-6736(03)14024-X; Wei TM, 2002, HEART VESSELS, V17, P77, DOI 10.1007/s003800200048; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xu SC, 2016, J PINEAL RES, V60, P291, DOI 10.1111/jpi.12310; Yang Y, 2014, J PINEAL RES, V57, P357, DOI 10.1111/jpi.12175; Yoon Young Won, 2007, J Trauma, V63, pE73, DOI 10.1097/01.ta.0000246896.89156.70; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu LM, 2014, J PINEAL RES, V57, P228, DOI 10.1111/jpi.12161; Zepeda R, 2014, J CARDIOVASC PHARM, V63, P477, DOI 10.1097/FJC.0000000000000071; Zhao L, 2015, J PINEAL RES, V59, P230, DOI 10.1111/jpi.12254; Zhao XM, 2016, J PINEAL RES, V60, P132, DOI 10.1111/jpi.12290; Zhao YC, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12378; Zhou H, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12413	51	54	55	1	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	JAN	2018	64	1							e12447	10.1111/jpi.12447			13	Endocrinology & Metabolism; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	FP8HZ	WOS:000417884900002	29024001				2022-02-06	
J	Giacoppo, S; Thangavelu, SR; Diomede, F; Bramanti, P; Conti, P; Trubiani, O; Mazzon, E				Giacoppo, Sabrina; Thangavelu, Soundara Rajan; Diomede, Francesca; Bramanti, Placido; Conti, Pio; Trubiani, Oriana; Mazzon, Emanuela			Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37	FASEB JOURNAL			English	Article						inflammation; EAE; hPDLSC secretome; eperimental autoimmune ensephalomyelitis	MESENCHYMAL STEM-CELL; TRAUMATIC BRAIN-INJURY; IN-VITRO; CORTICAL-NEURONS; OXIDATIVE STRESS; MOUSE MODEL; AUTOPHAGY; APOPTOSIS; FAMILY; INTERLEUKIN-37	Recent research has widely investigated the anti-inflammatory effects of mesenchymal stem cells and their secretory products, termed the secretome, in the treatment of multiple sclerosis (MS). The present study examined the capacity of the conditioned medium (CM) from human periodontal ligament stem cells (hPLSCs) under hypoxia (H-hPDLSCs-CM) to suppress experimental autoimmune encephalomyelitis (EAE), a murine model of MS. To induce EAE, female C57BL/6 mice were immunized with myelin oligodendroglial glycoprotein peptide35-55. At the onset of symptoms, H-hPDLSCs-CM was infused via the tail vein of mice. Our results demonstrate the efficacy of H-hPDLSCs-CM treatment in diminishing clinical and histologic disease score. A key finding from this study is the marked expression of anti-inflammatory cytokine IL-37, paralleledby the suppression of proinflammatory cytokines in mice with EAE that were treated with H-hPDLSCs-CM. In addition, a consequent modulation of oxidative stress, autophagic, and apoptotic markers was observed in mice with EAE after hPDLSCsCM administration. In addition, to provide additional evidence of the molecular mechanisms that underlie H-hPDLSCs-CM, we investigated its therapeutic action in scratch injury-exposed NSC-34 neurons, an in vitro model of injury. This model reproduces severe inflammation and oxidative stress conditions as observed after EAE damage. In vitro results corroborate the ability of hPDLSCs-CM to modulate inflammatory, oxidative stress, and apoptotic pathways. Taken together, our findings suggest H-hPDLSCs-CM as a new pharmacologic opportunity for the management of MS.	[Giacoppo, Sabrina; Thangavelu, Soundara Rajan; Bramanti, Placido; Mazzon, Emanuela] IRCCS, Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy; [Diomede, Francesca; Trubiani, Oriana] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Stem Cells & Regenerat Med Lab, Chieti, Italy; [Conti, Pio] Univ G dAnnunzio, Immunol Div, Postgrad Med Sch, Chieti, Italy		Mazzon, E (corresponding author), IRCCS, Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy.	emazzon.irccs@gmail.com	Bramanti, Placido/K-5117-2016; Diomede, Francesca/AAL-6840-2020; Gao, Jing/M-8264-2018; Rajan, Thangavelu Soundara/J-9840-2016; Mazzon, Emanuela/AAL-4334-2020	Diomede, Francesca/0000-0002-0384-6509; Rajan, Thangavelu Soundara/0000-0001-8728-6176; mazzon, emanuela/0000-0002-5073-717X			Ahmed NEB, 2016, SCI REP-UK, V6, DOI 10.1038/srep35476; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84; Carinci F, 2016, J BIOL REG HOMEOS AG, V30, P945; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; DINARELLO CA, 1986, YALE J BIOL MED, V59, P97; Dulamea A, 2015, J Med Life, V8, P24; Farrokhi M, 2015, ACTA NEUROL BELG, V115, P609, DOI 10.1007/s13760-015-0491-3; Feng XD, 2017, BOSNIAN J BASIC MED, V17, P95, DOI 10.17305/bjbms.2017.1696; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Giacoppo S, 2017, ARCH IMMUNOL THER EX, V65, P363, DOI 10.1007/s00005-017-0460-z; Giacoppo S, 2017, FITOTERAPIA, V116, P77, DOI 10.1016/j.fitote.2016.11.010; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Jarmalaviciute A, 2016, NEURAL REGEN RES, V11, P904, DOI 10.4103/1673-5374.184480; Khwanraj K, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/8716016; Kumar S, 2013, NEUROBIOL DIS, V56, P131, DOI 10.1016/j.nbd.2013.04.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JH, 2008, J ENDOCRINOL INVEST, V31, P103, DOI 10.1007/BF03345575; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Li TT, 2017, MOL IMMUNOL, V87, P132, DOI 10.1016/j.molimm.2017.04.010; Liu JJ, 2015, STEM CELLS, V33, P627, DOI 10.1002/stem.1909; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Madrigal M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0260-8; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Meamar Rokhsareh, 2016, Adv Biomed Res, V5, P46, DOI 10.4103/2277-9175.178791; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Merino-Gonzalez C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00024; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Paschalidis N, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-33; Payette DJ, 2008, INT J CLIN EXP PATHO, V1, P44; Rajan TS, 2017, J CELL BIOCHEM, V118, P1531, DOI 10.1002/jcb.25815; Rajan TS, 2017, J CELL BIOCHEM, V118, P819, DOI 10.1002/jcb.25757; Rajan TS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38743; Rajan TS, 2016, EXP CELL RES, V349, P152, DOI 10.1016/j.yexcr.2016.10.008; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sarvar DP, 2016, ADV PHARM BULL, V6, P293, DOI 10.15171/apb.2016.041; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Sharpe PT, 2016, DEVELOPMENT, V143, P2273, DOI 10.1242/dev.134189; Song LJ, 2013, J CLIN IMMUNOL, V33, P111, DOI 10.1007/s10875-012-9791-z; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Teng X, 2014, J IMMUNOL, V192, P1815, DOI 10.4049/jimmunol.1300047; Tete S, 2012, INT J IMMUNOPATH PH, V25, P31, DOI 10.1177/039463201202500105; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Vertelov G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt153; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; Weber MS, 2012, CURR PHARM DESIGN, V18, P209; Wu TT, 2016, INT J BIOL SCI, V12, P884, DOI 10.7150/ijbs.15194; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Yang LB, 2015, APMIS, V123, P1025, DOI 10.1111/apm.12467; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001; Yu J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt234; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhuang XY, 2017, IMMUN INFLAMM DIS, V5, P373, DOI 10.1002/iid3.159	64	54	55	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5592	5608		10.1096/fj.201700524R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	WOS:000416588300039	28842429	Green Published			2022-02-06	
J	Sun, B; Dalvi, P; Abadjian, L; Tang, N; Pulliam, L				Sun, Bing; Dalvi, Pranjali; Abadjian, Linda; Tang, Norina; Pulliam, Lynn			Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV	AIDS			English	Article						aging; biomarker; exosomes; HIV-associated neurocognitive disorder; HIV; neurological impairment	PRECLINICAL ALZHEIMERS-DISEASE; TRAUMATIC BRAIN-INJURY; AMYLOID-BETA; CEREBROSPINAL-FLUID; ACTIVATION; EXPRESSION; PROTEINS; CELLS; NEURODEGENERATION; ACCUMULATION	Objective: To investigate proteins associated with neuronal damage in plasma neuronderived exosomes (NDE) of HIV-infected study participants as a liquid biomarker for cognitive impairment. Methods: Plasma NDE were isolated using precipitation and immunoadsorption with antibody to a cell surface-specific neuronal marker. Total exosomes and NDE were enumerated, characterized, and proteins extracted and targets quantified by ELISA. Results: Plasma NDE from 23 HIV seropositive individuals of which 11 had mild cognitive impairment, and 12 HIV seronegative controls of which three had cognitive impairment were isolated. NDE were enriched for the neuronal markers neurofilament light (NF-L) and synaptophysin (SYP). Neuropsychologically impaired individuals had fewer NDE compared with neuropsychologically normal study participants. NDE from neuropsychologically impaired study participants had significantly higher levels of high-mobility group box 1 (HMGB1), NF-L, and amyloid b proteins compared with neuropsychologically normal individuals. NDE HMGB1 protein significantly decreased with age in HIV-infected individuals. Conclusion: Plasma NDE were altered in several ways in HIV infection. Elevated HMGB1, NF-L, and amyloid beta proteins could distinguish cognitive impairment. NDE contents reflect neuronal health in 'real time' and may be useful for following cognitive impairment and response to therapy in HIV infection. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Sun, Bing; Dalvi, Pranjali; Abadjian, Linda; Tang, Norina; Pulliam, Lynn] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA		Pulliam, L (corresponding author), Univ Calif San Francisco, Dept Lab Med, Vet Affairs Med Ctr, 4150 Clement St,113A, San Francisco, CA 94143 USA.	lynn.pulliam@ucsf.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH085538, R21MH112483]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085538, R21MH112483] Funding Source: NIH RePORTER	The authors thank all the blood donors for their participation. The authors also thank Edward J. Goetzl (UCSF) for providing NDE isolation protocols and helpful discussions and Archana Gupta (SBI) for exosome technical support. This study was supported by the National Institute of Health awards R01MH085538 and R21MH112483 (LP). L.P. and B.S. designed the study. B.S. performed the study and analyzed the data. N.T. setup NanoSight parameters and P.D. performed analysis. L. A. performed neuropsychological tests. B.S. and N.T. refined exosome isolation procedure. L.P. and B.S. wrote the manuscript and all authors revised.	Achim CL, 2009, J NEUROIMMUNE PHARM, V4, P190, DOI 10.1007/s11481-009-9152-8; Amigorena S., 2006, CURR PROTOC CELL BIO; Andras IE, 2017, MOL CELL NEUROSCI, V79, P12, DOI 10.1016/j.mcn.2016.12.006; Banigan MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048814; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; Brew BJ, 2009, J NEUROIMMUNE PHARM, V4, P163, DOI 10.1007/s11481-008-9143-1; Calcagno A, 2016, J NEUROVIROL, V22, P88, DOI 10.1007/s13365-015-0371-x; Carroll Antonia, 2017, F1000Res, V6, P312, DOI 10.12688/f1000research.10651.1; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Eitan E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01386-z; Enokido Y, 2008, BIOCHEM BIOPH RES CO, V376, P128, DOI 10.1016/j.bbrc.2008.08.108; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Gisslen M, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-63; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gougeon ML, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00245; Gray LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090620; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Hamlett ED, 2017, ALZHEIMERS DEMENT, V13, P541, DOI 10.1016/j.jalz.2016.08.012; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jeon AHW, 2013, J BIOL CHEM, V288, P15352, DOI 10.1074/jbc.M112.441840; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; McGuire JL, 2015, J NEUROVIROL, V21, P439, DOI 10.1007/s13365-015-0333-3; Mullins RJ, 2017, HUM BRAIN MAPP, V38, P1933, DOI 10.1002/hbm.23494; Peluso MJ, 2013, J INFECT DIS, V207, P1703, DOI 10.1093/infdis/jit088; Peterson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116081; Pulliam L, 2015, DNA CELL BIOL, V34, P459, DOI 10.1089/dna.2015.2884; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Seipold L, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00037; Seipold L, 2017, BBA-MOL CELL RES, V1864, P217, DOI 10.1016/j.bbamcr.2016.11.003; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Sun B, 2013, JAIDS-J ACQ IMM DEF, V62, P190, DOI 10.1097/QAI.0b013e31827b61f1; Takata K, 2003, BIOCHEM BIOPH RES CO, V301, P699, DOI 10.1016/S0006-291X(03)00024-X; Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR; Thali M, 2011, BIOCHEM SOC T, V39, P529, DOI 10.1042/BST0390529; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thierry S, 2007, AIDS, V21, P283, DOI 10.1097/QAD.0b013e3280115b50; Venegas C, 2017, J LEUKOCYTE BIOL, V101, P87, DOI 10.1189/jlb.3MR0416-204R; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001	52	54	55	2	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0269-9370	1473-5571		AIDS	Aids	SEP 10	2017	31	14					F9	F17		10.1097/QAD.0000000000001595			9	Immunology; Infectious Diseases; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Virology	FF2FU	WOS:000408714100001	28692534	Green Accepted			2022-02-06	
J	Semple, BD; O'Brien, TJ; Gimlin, K; Wright, DK; Kim, SE; Casillas-Espinosa, PM; Webster, KM; Petrou, S; Noble-Haeusslein, LJ				Semple, Bridgette D.; O'Brien, Terence J.; Gimlin, Kayleen; Wright, David K.; Kim, Shi Eun; Casillas-Espinosa, Pablo M.; Webster, Kyria M.; Petrou, Steven; Noble-Haeusslein, Linda J.			Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain	JOURNAL OF NEUROSCIENCE			English	Article						cytokine; interleukin; neurotrauma; pediatric; seizure; traumatic brain injury	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC EPILEPSY; IMMATURE BRAIN; DENTATE GYRUS; TEMPORAL-LOBE; ANIMAL-MODELS; MICE; ANTAGONIST; RATS; NEUTRALIZATION	Epilepsy after pediatric traumatic brain injury (TBI) is associated with poor quality of life. This study aimed to characterize post-traumatic epilepsy in a mouse model of pediatric brain injury, and to evaluate the role of interleukin-1 (IL-1) signaling as a target for pharmacological intervention. Male mice received a controlled cortical impact or sham surgery at postnatal day 21, approximating a toddler-aged child. Mice were treated acutely with an IL-1 receptor antagonist (IL-1Ra; 100 mg/kg, s.c.) or vehicle. Spontaneous and evoked seizures were evaluated from video-EEG recordings. Behavioral assays tested for functional outcomes, postmortem analyses assessed neuropathology, and brain atrophy was detected by ex vivo magnetic resonance imaging. At 2 weeks and 3 months post-injury, TBI mice showed an elevated seizure response to the convulsant pentylenetetrazol compared with sham mice, associated with abnormal hippocampal mossy fiber sprouting. A robust increase in IL-1 beta and IL-1 receptor were detected after TBI. IL-1Ra treatment reduced seizure susceptibility 2 weeks after TBI compared with vehicle, and a reduction in hippocampal astrogliosis. In a chronic study, IL-1Ra-TBI mice showed improved spatial memory at 4 months post-injury. At 5 months, most TBI mice exhibited spontaneous seizures during a 7 d video-EEG recording period. At 6 months, IL-1Ra-TBI mice had fewer evoked seizures compared with vehicle controls, coinciding with greater preservation of cortical tissue. Findings demonstrate this model's utility to delineate mechanisms underlying epileptogenesis after pediatric brain injury, and provide evidence of IL-1 signaling as a mediator of post-traumatic astrogliosis and seizure susceptibility.	[Semple, Bridgette D.; O'Brien, Terence J.; Kim, Shi Eun; Casillas-Espinosa, Pablo M.; Webster, Kyria M.] Univ Melbourne, Dept Med, Melbourne Brain Ctr, Royal Melbourne Hosp, Kenneth Myer Bldg, Parkville, Vic 3050, Australia; [Gimlin, Kayleen; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3050, Australia; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dell Med Sch, Dept Psychol, Austin, TX 78701 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78701 USA		Semple, BD (corresponding author), Univ Melbourne, Dept Med, Melbourne Brain Ctr, Royal Melbourne Hosp, Kenneth Myer Bldg, Parkville, Vic 3050, Australia.	Bridgette.Semple@unimelb.edu.au	Tercovich, Kayleen/I-8941-2018; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Tercovich, Kayleen/0000-0003-0450-8912; Wright, David/0000-0002-7535-8651; Petrou, Steven/0000-0002-4960-6375; O'Brien, Terence/0000-0002-7198-8621	NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia; UoM Early Career Grant; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS077767]; Rebecca L. Cooper Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077767, R01NS050159] Funding Source: NIH RePORTER	This work was supported by an NHMRC Early Career Fellowship, a UoM Early Career Grant, NIH/NINDS R01 NS077767, and funding from the Rebecca L. Cooper Medical Research Foundation. We thank Ann Turnley (UoM) for providing access to the controlled cortical impactor device, Leigh Johnson (UoM) for guidance and oversight of neuroimaging, and the scientific and technical assistance of the animal MRI facility at the Florey Institute of Neuroscience and Mental Health, a node of the National Imaging Facility.	ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Babb T L, 1997, Adv Neurol, V72, P45; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Blanco MM, 2009, EPILEPSIA, V50, P824, DOI 10.1111/j.1528-1167.2008.01797.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Greenhalgh AD, 2010, BRIT J PHARMACOL, V160, P153, DOI 10.1111/j.1476-5381.2010.00684.x; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jeub M, 1999, NEUROSCIENCE, V94, P465, DOI 10.1016/S0306-4522(99)00249-3; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; LOSCHER W, 1991, EPILEPSY RES, V9, P1, DOI 10.1016/0920-1211(91)90041-D; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; McCann SK, 2016, TRANSL STROKE RES, V7, P395, DOI 10.1007/s12975-016-0489-z; Nardou R, 2013, SEMIN FETAL NEONAT M, V18, P175, DOI 10.1016/j.siny.2013.02.003; Nehlig A, 1996, EPILEPSY RES, V26, P93, DOI 10.1016/S0920-1211(96)00045-9; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rattka M, 2011, NEUROPHARMACOLOGY, V60, P505, DOI 10.1016/j.neuropharm.2010.11.005; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Van Nieuwenhuyse B, 2015, BRAIN RES, V1627, P1, DOI 10.1016/j.brainres.2015.08.016; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Viviani B, 2003, J NEUROSCI, V23, P8692; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003	54	54	58	0	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	AUG 16	2017	37	33					7864	7877		10.1523/JNEUROSCI.0982-17.2017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD7KR	WOS:000407705500009	28724747	Green Published, Bronze			2022-02-06	
J	Cortes, N; Lincoln, AE; Myer, GD; Hepburn, L; Higgins, M; Putukian, M; Caswell, SV				Cortes, Nelson; Lincoln, Andrew E.; Myer, Gregory D.; Hepburn, Lisa; Higgins, Michael; Putukian, Margot; Caswell, Shane V.			Video Analysis Verification of Head Impact Events Measured by Wearable Sensors	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injury/concussion; wearable sensor; accelerometer; methodology	HIGH-SCHOOL FOOTBALL; ACCELERATION MEASUREMENT; LABORATORY EVALUATION; EXPOSURE; SYSTEM; BIOMECHANICS; KINEMATICS; LOCATION; PLAYERS; VALIDATION	Background: Wearable sensors are increasingly used to quantify the frequency and magnitude of head impact events in multiple sports. There is a paucity of evidence that verifies head impact events recorded by wearable sensors. Purpose: To utilize video analysis to verify head impact events recorded by wearable sensors and describe the respective frequency and magnitude. Study Design: Cohort study (diagnosis); Level of evidence, 2. Methods: Thirty male (mean age, 16.6 +/- 1.2 years; mean height, 1.77 +/- 0.06 m; mean weight, 73.4 +/- 12.2 kg) and 35 female (mean age, 16.2 +/- 1.3 years; mean height, 1.66 +/- 0.05 m; mean weight, 61.2 +/- 6.4 kg) players volunteered to participate in this study during the 2014 and 2015 lacrosse seasons. Participants were instrumented with GForceTracker (GFT; boys) and X-Patch sensors (girls). Simultaneous game video was recorded by a trained videographer using a single camera located at the highest midfield location. One-third of the field was framed and panned to follow the ball during games. Videographic and accelerometer data were time synchronized. Head impact counts were compared with video recordings and were deemed valid if (1) the linear acceleration was >= 20g, (2) the player was identified on the field, (3) the player was in camera view, and (4) the head impact mechanism could be clearly identified. Descriptive statistics of peak linear acceleration (PLA) and peak rotational velocity (PRV) for all verified head impacts >= 20g were calculated. Results: For the boys, a total recorded 1063 impacts (2014: n = 545; 2015: n = 518) were logged by the GFT between game start and end times (mean PLA, 46 +/- 31g; mean PRV, 1093 +/- 661 deg/s) during 368 player-games. Of these impacts, 690 were verified via video analysis (65%; mean PLA, 48 +/- 34g; mean PRV, 1242 +/- 617 deg/s). The X-Patch sensors, worn by the girls, recorded a total 180 impacts during the course of the games, and 58 (2014: n = 33; 2015: n = 25) were verified via video analysis (32%; mean PLA, 39 +/- 21g; mean PRV, 1664 +/- 619 rad/s). Conclusion: The current data indicate that existing wearable sensor technologies may substantially overestimate head impact events. Further, while the wearable sensors always estimated a head impact location, only 48% of the impacts were a result of direct contact to the head as characterized on video. Using wearable sensors and video to verify head impacts may decrease the inclusion of false-positive impacts during game activity in the analysis.	[Cortes, Nelson; Lincoln, Andrew E.; Myer, Gregory D.; Hepburn, Lisa; Higgins, Michael; Putukian, Margot; Caswell, Shane V.] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, 10890 George Mason Circle,Bull Run Hall 220, Manassas, VA 20110 USA; [Lincoln, Andrew E.; Hepburn, Lisa] MedStar Hlth Res Inst, Baltimore, MD USA; [Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Higgins, Michael] Univ Virginia, Charlottesville, VA USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA		Cortes, N (corresponding author), George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, 10890 George Mason Circle,Bull Run Hall 220, Manassas, VA 20110 USA.	ncortes@gmu.edu	; Myer, Gregory/H-6572-2016	Cortes, Nelson/0000-0001-8762-3144; Myer, Gregory/0000-0002-9983-8422	US Lacrosse Sports Science and Safety Committee grant	One or more of the authors has declared the following potential conflict of interest or source of funding: Financial support via US Lacrosse Sports Science and Safety Committee grant funding was received to conduct the study. Funding was primarily used to support equipment and personnel.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Miyashita T, 2016, ATHLETIC TRAINING SP, V8, P202, DOI DOI 10.3928/19425864-20160503-01; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Schmidt JD, 2015, CLIN J SPORT MED, V25, P494, DOI 10.1097/JSM.0000000000000143; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	52	54	54	0	26	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2017	45	10					2379	2387		10.1177/0363546517706703			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	FC4VS	WOS:000406839600022	28541813				2022-02-06	
J	Ellis, MJ; Cordingley, DM; Vis, S; Reimer, KM; Leiter, J; Russell, K				Ellis, Michael J.; Cordingley, Dean M.; Vis, Sara; Reimer, Karen M.; Leiter, Jeff; Russell, Kelly			Clinical predictors of vestibulo-ocular dysfunction in pediatric sports-related concussion	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						sports-related concussion; vestibulo-ocular dysfunction; postconcussion syndrome; predictor; trauma	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; PROLONGED RECOVERY; GENDER-DIFFERENCES; ADOLESCENTS; REHABILITATION; MANAGEMENT; DISORDERS; DIZZINESS	OBJECTIVE There were 2 objectives of this study. The first objective was to identify clinical variables associated with vestibulo-ocular dysfunction (VOD) detected at initial consultation among pediatric patients with acute sports-related concussion (SRC) and postconcussion syndrome (PCS). The second objective was to reexamine the prevalence of VOD in this clinical cohort and evaluate the effect of VOD on length of recovery and the development of PCS. METHODS A retrospective review was conducted for all patients with acute SRC and PCS who were evaluated at a pediatric multidisciplinary concussion program from September 2013 to May 2015. Acute SRS was defined as present; ing < 30 days postinjury, and PCS was defined according to the International Classification of Diseases, 10th Revision criteria and included being symptomatic 30 days or longer postinjury. The initial assessment included clinical history and physical examination performed by 1 neurosurgeon. Patients were assessed for VOD, defined as the presence of more than 1 subjective vestibular and oculomotor complaint (dizziness, diplopia, blurred vision, etc.) and more than 1 objective physical examination finding (abnormal near point of convergence, smooth pursuits, saccades, or vestibulo-ocular reflex testing). Poisson regression analysis was used to identify factors that increased the risk of VOD at initial presentation and the development of PCS. RESULTS Three hundred ninety-nine children, including 306 patients with acute SRC and 93 with PCS, were included. Of these patients, 30.1% of those with acute SRC (65.0% male, mean age 13.9 years) and 43.0% of those with PCS (41.9% male, mean age 15.4 years) met the criteria for VOD at initial consultation. Independent predictors of VOD at initial consultation included female sex, preinjury history of depression, posttraumatic amnesia, and presence of dizziness, blurred vision, or difficulty focusing at the time of injury. Independent predictors of PCS among patients with acute SRC included the presence of VOD at initial consultation, preinjury history of depression, and posttraumatic amnesia at the time of injury. CONCLUSIONS This study identified important potential risk factors for the development of VOD following pediatric SRC. These results provide confirmatory evidence that VOD at initial consultation is associated with prolonged recovery and is an independent predictor for the development of PCS. Future studies examining clinical prediction rules in pediatric concussion should include VOD. Additional research is needed to elucidate the natural history of VOD following SRC and establish evidence-based indications for targeted vestibular rehabilitation.	[Ellis, Michael J.; Leiter, Jeff] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Neurosurg Sect, Winnipeg, MB, Canada; [Ellis, Michael J.; Cordingley, Dean M.; Vis, Sara; Reimer, Karen M.; Leiter, Jeff] Pan Am Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada; [Ellis, Michael J.; Russell, Kelly] Childrens Hosp Res Inst Manitoba, Canada North Concuss Network, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Am Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		Russell, Kelly/0000-0002-9159-9201	Pan Am Clinic Foundation; Winnipeg Jets True North Foundation; Manitoba Health Research Council	All phases of this study were supported by a grant from the Pan Am Clinic Foundation, Winnipeg Jets True North Foundation, and the Manitoba Health Research Council.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bedgood A, 2015, CLIN J SPORT MED, V25, pE26, DOI 10.1097/JSM.0000000000000114; Bittencourt J, 2013, NEUROPSYCH DIS TREAT, V9, P1393, DOI 10.2147/NDT.S45931; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Winograd-Gurvich C, 2006, NEUROSCI RES, V56, P253, DOI 10.1016/j.neures.2006.07.003; Wu H, 2015, PEDIAT EMERG CARE; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	41	54	55	0	21	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2017	19	1					38	45		10.3171/2016.7.PEDS16310			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EG0LS	WOS:000390724900006	27689244	Bronze			2022-02-06	
J	Gabler, LF; Crandall, JR; Panzer, MB				Gabler, Lee F.; Crandall, Jeff R.; Panzer, Matthew B.			Assessment of Kinematic Brain Injury Metrics for Predicting Strain Responses in Diverse Automotive Impact Conditions	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Brain injury criteria; Head kinematics; Translational; Rotational; Finite element modeling	DIFFUSE AXONAL INJURY; HEAD; CONCUSSION; MODEL; SIMON	Numerous injury criteria have been developed to predict brain injury using the kinematic response of the head during impact. Each criterion utilizes a metric that is some mathematical combination of the velocity and/or acceleration components of translational and/or rotational head motion. Early metrics were based on linear acceleration of the head, but recent injury criteria have shifted towards rotational-based metrics. Currently, there is no universally accepted metric that is suitable for a diverse range of head impacts. In this study, we assessed the capability of fifteen existing kinematic-based metrics for predicting strain-based brain response using four different automotive impact conditions. Tissue-level strains were obtained through finite element model simulation of 660 head impacts including occupant and pedestrian crash tests, and pendulum head impacts. Correlations between head kinematic metrics and predicted brain strain-based metrics were evaluated. Correlations between brain strain and metrics based on angular velocity were highest among those evaluated, while metrics based on linear acceleration were least correlative. BrIC and RVCI were the kinematic metrics with the highest overall correlation; however, each metric had limitations in certain impact conditions. The results of this study suggest that rotational head kinematics are the most important parameters for brain injury criteria.	[Gabler, Lee F.; Crandall, Jeff R.; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomechan, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA		Panzer, MB (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomechan, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	mbp2q@virginia.edu			Partnership for Dummy Technology and Biomechanics (PDB)	The authors thank the Partnership for Dummy Technology and Biomechanics (PDB) for support and funding for this research. We also thank Dr. Erik Takhounts, Vikas Hasija, and Daniel Parent of NHTSA, and David Zuby, Becky Mueller, and Anna MacAlister of IIHS for their help in obtaining head kinematic data from the NHTSA and IIHS databases, respectively.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F, 2001, P INT TECHN C ENH SA, P7; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Crandall J., 2013, INJURY CRITERIA DEV; Crandall J., 2014, ATD THORACIC RESPONS; Forman Jason L, 2013, Stapp Car Crash J, V57, P343; Gadd C., 1966, SAE TECHNICAL PAPER; Gennarelli T, 1971, P 15 STAPP CAR CRASH; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1979, P 23 STAPP CAR CRASH, P563; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kerrigan J, 2012, INT J CRASHWORTHINES, V17, P243, DOI 10.1080/13588265.2011.648517; Kerrigan JR, 2008, STAPP CAR C, V52, P527; Kimpara H., 2011, INT J AUTOMOT ENG, V2, P13; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laituri K, 2015, SAE TECHNICAL PAPER; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Mueller B., 2015, P 24 INT TECHN C ENH; National Operating Committee on the Standards for Athletic Equipment (NOCSAE), 2012, STAND TEST METH EQ U; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J.A, 1986, P 1986 INT IRCOBI C; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1967, DTIC DOCUMENT; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Ono K., 1980, SAE TECHNICAL PAPER; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Patrick L. M., 1963, P AM ASS AUT MED ANN, V7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; SAE, 1995, TECHNICAL REPORT; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Subit D., 2008, P INT RES COUNC BIOM; Takahashi, 2015, SAE TECHNICAL PAPER; Takhounts E. G., 2011, P 22 ENH SAF VEH C; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault L. E., 1990, INT IRCOBI C BIOM IM; Versace J, 1971, REV SEVERITY INDEX; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	52	54	54	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2016	44	12					3705	3718		10.1007/s10439-016-1697-0			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	EC4MB	WOS:000388103900022	27436295				2022-02-06	
J	Dippel, G; Chmielewski, W; Muckschel, M; Beste, C				Dippel, Gabriel; Chmielewski, Witold; Mueckschel, Moritz; Beste, Christian			Response mode-dependent differences in neurofunctional networks during response inhibition: an EEG-beamforming study	BRAIN STRUCTURE & FUNCTION			English	Article						Beamforming; EEG; Temporo-parietal junction; Theta frequency; Response inhibition	EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; NEURAL MECHANISMS; HEALTHY CONTROLS; TASK; THETA; OSCILLATIONS; PERFORMANCE; CORTEX	Response inhibition processes are one of the most important executive control functions and have been subject to intense research in cognitive neuroscience. However, knowledge on the neurophysiology and functional neuroanatomy on response inhibition is biased because studies usually employ experimental paradigms (e.g., sustained attention to response task, SART) in which behavior is susceptible to impulsive errors. Here, we investigate whether there are differences in neurophysiological mechanisms and networks depending on the response mode that predominates behavior in a response inhibition task. We do so comparing a SART with a traditionally formatted task paradigm. We use EEG-beamforming in two tasks inducing opposite response modes during action selection. We focus on theta frequency modulations, since these are implicated in cognitive control processes. The results show that a response mode that is susceptible to impulsive errors (response mode used in the SART) is associated with stronger theta band activity in the left temporo-parietal junction. The results suggest that the response modes applied during response inhibition differ in the encoding of surprise signals, or related processes of attentional sampling. Response modes during response inhibition seem to differ in processes necessary to update task representations relevant to behavioral control.	[Dippel, Gabriel; Chmielewski, Witold; Mueckschel, Moritz; Beste, Christian] Tech Univ Dresden, Dept Child & Adolescent Psychiat, Cognit Neurophysiol, Fac Med, Schubertstr 42, D-01309 Dresden, Germany		Beste, C (corresponding author), Tech Univ Dresden, Dept Child & Adolescent Psychiat, Cognit Neurophysiol, Fac Med, Schubertstr 42, D-01309 Dresden, Germany.	christian.beste@uniklinikum-dresden.de			Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE4045/10-2]	This work was supported by a Grant from the Deutsche Forschungsgemeinschaft BE4045/10-2 to CB.	Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Band GPH, 1999, ACTA PSYCHOL, V101, P179, DOI 10.1016/S0001-6918(99)00005-0; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Beste C, 2012, NEUROIMAGE, V62, P137, DOI 10.1016/j.neuroimage.2012.05.019; Beste C, 2011, NEUROPSYCHOLOGIA, V49, P3484, DOI 10.1016/j.neuropsychologia.2011.08.024; Beste C, 2010, HUM BRAIN MAPP, V31, P621, DOI 10.1002/hbm.20892; Beste C, 2010, NEUROPSYCHOLOGIA, V48, P366, DOI 10.1016/j.neuropsychologia.2009.09.023; Bressler SL, 2015, CURR OPIN NEUROBIOL, V31, P62, DOI 10.1016/j.conb.2014.08.010; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Carter L, 2013, BRAIN COGNITION, V82, P35, DOI 10.1016/j.bandc.2013.02.002; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Chmielewski WX, 2016, BRAIN STRUCT FUNCT, V221, P3949, DOI 10.1007/s00429-015-1137-1; Cohen MX, 2014, TRENDS NEUROSCI, V37, P480, DOI 10.1016/j.tins.2014.06.004; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; De Blasio FM, 2013, INT J PSYCHOPHYSIOL, V87, P279, DOI 10.1016/j.ijpsycho.2012.09.016; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fallgatter AJ, 2001, J NEURAL TRANSM, V108, P679, DOI 10.1007/s007020170045; Fassbender C, 2009, EUR J NEUROSCI, V29, P181, DOI 10.1111/j.1460-9568.2008.06557.x; Fiebelkorn IC, 2013, NEUROIMAGE, V69, P126, DOI 10.1016/j.neuroimage.2012.11.021; Geng JJ, 2013, NEUROSCI BIOBEHAV R, V37, P2608, DOI 10.1016/j.neubiorev.2013.08.010; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Harper J, 2014, CLIN NEUROPHYSIOL, V125, P124, DOI 10.1016/j.clinph.2013.06.025; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Helton WS, 2005, BRIT J PSYCHOL, V96, P249, DOI 10.1348/000712605X38369; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Kenemans JL, 2005, INT J PSYCHOPHYSIOL, V58, P59, DOI 10.1016/j.ijpsycho.2005.03.009; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Muckschel M, 2016, NEUROIMAGE, V125, P342, DOI 10.1016/j.neuroimage.2015.09.075; Muckschel M, 2014, CEREB CORTEX, V24, P2120, DOI 10.1093/cercor/bht066; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; Oostenveld R, 2003, CLIN NEUROPHYSIOL, V114, P1194, DOI 10.1016/S1388-2457(03)00059-2; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Quetscher C, 2015, BRAIN STRUCT FUNCT, V220, P3555, DOI 10.1007/s00429-014-0873-y; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roche RAP, 2005, EXP BRAIN RES, V160, P60, DOI 10.1007/s00221-004-1985-z; Rondi-Reig L, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00205; Staub B, 2014, ACTA PSYCHOL, V146, P51, DOI 10.1016/j.actpsy.2013.12.003; Stevenson H, 2011, BRAIN COGNITION, V77, P215, DOI 10.1016/j.bandc.2011.08.007; TallonBaudry C, 1997, J NEUROSCI, V17, P722; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00203; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040	52	54	54	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	NOV	2016	221	8					4091	4101		10.1007/s00429-015-1148-y			11	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	EA1LA	WOS:000386352500015	26608829				2022-02-06	
J	Roux, A; Muller, L; Jackson, SN; Post, J; Baldwin, K; Hoffer, B; Balaban, CD; Barbacci, D; Schultz, A; Gouty, S; Cox, BM; Woods, AS				Roux, Aurelie; Muller, Ludovic; Jackson, Shelley N.; Post, Jeremy; Baldwin, Katherine; Hoffer, Barry; Balaban, Carey D.; Barbacci, Damon; Schultz, Albert; Gouty, Shawn; Cox, Brian M.; Woods, Amina S.			Mass spectrometry imaging of rat brain lipid profile changes over time following traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Controlled cortical impact; Mass spectrometry imaging; Silver nanoparticles implantation; Lipids	POSTTRAUMATIC EPILEPSY; CHOLESTEROL-METABOLISM; SILVER NANOPARTICLES; PHOSPHOLIPASE-C; CERAMIDE; DISEASE; MECHANISMS; SPHINGOMYELIN; APOPTOSIS; SECTIONS	Background: Mild traumatic brain injury (TBI) is a common public health issue that may contribute to chronic degenerative disorders. Membrane lipids play a key role in tissue responses to injury, both as cell signals and as components of membrane structure and cell signaling. This study demonstrates the ability of high resolution mass spectrometry imaging (MSI) to assess sequences of responses of lipid species in a rat controlled cortical impact model for concussion. New method: A matrix of implanted silver nanoparticles was implanted superficially in brain sections for matrix-assisted laser desorption (MALDI) imaging of 50 mu m diameter microdomains across unfixed cryostat sections of rat brain. Ion-mobility time-of-flight MS was used to analyze and map changes over time in brain lipid composition in a rats after Controlled Cortical Impact (CCI) TBI. Results: Brain MS images showed changes in sphingolipids near the CCI site, including increased ceramides and decreased sphingomyelins, accompanied by changes in glycerophospholipids and cholesterol derivatives. The kinetics differed for each lipid class; for example ceramides increased as early as 1 day after the injury whereas other lipids changes occurred between 3 and 7 days post injury. Comparison with existing method(s): Silver nanoparticles MALDI matrix is a sensitive new tool for revealing previously undetectable cellular injury response and remodeling in neural, glial and vascular structure of the brain. Conclusions: Lipid biochemical and structural changes after TBI could help highlighting molecules that can be used to determine the severity of such injuries as well as to evaluate the efficacy of potential treatments. (C) 2016 Published by Elsevier B.V.	[Roux, Aurelie; Muller, Ludovic; Jackson, Shelley N.; Post, Jeremy; Baldwin, Katherine; Woods, Amina S.] NIDA, Struct Biol Unit, Integrat Neurosci Branch, NIH,IRP, Baltimore, MD 21224 USA; [Gouty, Shawn; Cox, Brian M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Dept Pharmacol, Bethesda, MD 20814 USA; [Barbacci, Damon; Schultz, Albert] Ionwerks Inc, Houston, TX 77002 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15213 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; [Hoffer, Barry] Univ Hosp Cleveland, Cleveland, OH 44106 USA		Woods, AS (corresponding author), NIDA, Struct Biol Unit, Integrat Neurosci Branch, NIH,IRP, Baltimore, MD 21224 USA.	awoods@intra.nida.nih.gov	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844	U.S. Department of DefenseUnited States Department of Defense; Center for Neuroscience and Regenerative Medicine (CNRM), Rockville, MD; Intramural Research Program of the National Institute on Drug Abuse, NIH; NIH SBIR Phase IIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44DA030853-03 5R44DA036263-03]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000589, R44DA036263, R44DA030853] Funding Source: NIH RePORTER	The authors declare no competing financial interests. This work was supported in part by a grant from the U.S. Department of Defense and the Center for Neuroscience and Regenerative Medicine (CNRM), Rockville, MD and by the Intramural Research Program of the National Institute on Drug Abuse, NIH. Ionwerks gratefully acknowledges support of this work through NIH SBIR Phase II grants R44DA030853-03 5R44DA036263-03". The authors acknowledge Dr. Mari Prieto and Glen Gregory of the Thermo Fisher Corporation for technical and instrumentation advice. The authors also thank Gregory Bull for his technical support. The opinions and assertions contained herein are the personal opinions of the authors and are not to be construed as official or reflecting the views of the Uniformed Services University, the Department of Defense, NIDA or the NIH.	Adibhatla RM, 2006, AAPS J, V8, pE314; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Altura BM, 2002, BRAIN RES BULL, V58, P271, DOI 10.1016/S0361-9230(02)00772-4; Aureli M, 2014, GLYCOCONJUGATE J, V31, P449, DOI 10.1007/s10719-014-9541-y; Colsch B, 2010, GLYCOBIOLOGY, V20, P661, DOI 10.1093/glycob/cwq031; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Delvolve AM, 2011, ANAL METHODS-UK, V3, P1729, DOI 10.1039/c1ay05107e; Dhillon HS, 1999, NEUROCHEM RES, V24, P751, DOI 10.1023/A:1020779413122; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Faul M, 2010, TRAUMATIC BRAIN INJU; Fernandez JA, 2011, ANAL BIOANAL CHEM, V401, P29, DOI 10.1007/s00216-011-4696-x; Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5; Gorska M, 2002, HORM METAB RES, V34, P466, DOI 10.1055/s-2002-33597; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ichi I, 2007, NUTRITION, V23, P570, DOI 10.1016/j.nut.2007.04.014; Ionescu N, 2013, INDIAN J CLIN BIOCHE, V28, P361, DOI 10.1007/s12291-013-0327-y; Jackson SN, 2014, ANAL BIOANAL CHEM, V406, P1377, DOI 10.1007/s00216-013-7525-6; Jackson SN, 2005, ANAL CHEM, V77, P4523, DOI 10.1021/ac050276v; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kim JH, 2011, NEUROSCIENCE, V185, P125, DOI 10.1016/j.neuroscience.2011.04.018; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Muller L, 2015, KIDNEY INT, V88, P186, DOI 10.1038/ki.2015.3; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOPE; Novgorodov Sergei A, 2011, Int J Biochem Mol Biol, V2, P347; Olney J, 1978, KAINIC ACID TOOL NEU, P95; OLNEY JW, 1993, APMIS, V101, P103; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Piomelli D, 2005, PROSTAG OTH LIPID M, V77, P23, DOI 10.1016/j.prostaglandins.2004.09.006; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Roux A, 2015, ACS CHEM NEUROSCI, V6, P247, DOI 10.1021/cn500174c; Schull S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.62; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Waggie KS, 1999, LAB ANIM SCI, V49, P358; Wang HYJ, 2012, ANAL BIOANAL CHEM, V404, P113, DOI 10.1007/s00216-012-6077-5; Wang HYJ, 2010, RAPID COMMUN MASS SP, V24, P2057, DOI 10.1002/rcm.4620; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Woodcock J, 2006, IUBMB LIFE, V58, P462, DOI 10.1080/15216540600871118; Woods AS, 2006, AAPS J, V8, pE391, DOI 10.1007/BF02854910; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Woods AS, 2006, J PROTEOME RES, V5, P1017, DOI 10.1021/pr060016+; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85	55	54	54	3	49	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2016	272				SI		19	32		10.1016/j.jneumeth.2016.02.004			14	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA6LF	WOS:000386740000003	26872743	Bronze, Green Accepted			2022-02-06	
J	McKee, AC; Alosco, ML; Huber, BR				McKee, Ann C.; Alosco, Michael L.; Huber, Bertrand R.			Repetitive Head Impacts and Chronic Traumatic Encephalopathy	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Chronic traumatic encephalopathy; Repetitive head impacts; Traumatic brain injury; Neurodegenerative disease; Tau protein; Subconcussion; Concussion	FOOTBALL-LEAGUE PLAYER; PUNCH-DRUNK; INJURY; SPORT; NEUROPATHOLOGY; DEMENTIA	Chronic traumatic encephalopathy (CTE) is a distinctive neurodegenerative disease that occurs as a result of repetitive head impacts. CTE can only be diagnosed by postmortem neuropathologic examination of brain tissue. CTE is a unique disorder with a pathognomonic lesion that can be reliably distinguished from other neurodegenerative diseases. CTE is associated with violent behaviors, explosivity, loss of control, depression, suicide, memory loss and cognitive changes. There is increasing evidence that CTE affects amateur athletes as well as professional athletes and military veterans. CTE has become a major public health concern.	[McKee, Ann C.; Huber, Bertrand R.] VA Boston Healthcare Syst, Dept Pathol & Lab Med, 150 South Huntington Ave, Boston, MA 02130 USA; [McKee, Ann C.; Alosco, Michael L.; Huber, Bertrand R.] Boston Univ, Sch Med, Dept Neurol, 72 East Concord St, Boston, MA 02118 USA; [McKee, Ann C.; Alosco, Michael L.] Boston Univ, Sch Med, Alzheimers Dis Ctr, CTE Program, 72 East Concord St, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, 72 East Concord St, Boston, MA 02118 USA		McKee, AC (corresponding author), 72 East Concord St,Robinson 7800, Boston, MA 02118 USA.	amckee@bu.edu			Department of Veterans Affairs, the Veterans Affairs Biorepository [CSP 501]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086659-01]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064]; Department of Defense (CENC award) [WXWH-13-2-0095]; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Foundation; World Wrestling Entertainment; National Football League; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-AG06697, 1F32NS096803-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002170, I01RX000991] Funding Source: NIH RePORTER	The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, Massachusetts), the Boston VA Healthcare System, and the Boston University School of Medicine. They also gratefully acknowledge the help of all members of the Chronic Traumatic Encephalopathy Program at Boston University School of Medicine, the Boston VA, as well as the individuals and families whose participation and contributions made this work possible. This work was supported by the Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), National Institute of Neurological Disorders and Stroke (1U01NS086659-01), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), Department of Defense (W81XWH-13-2-0064, CENC award WXWH-13-2-0095), the National Operating Committee on Standards for Athletic Equipment and the Concussion Legacy Foundation. This work was also supported by unrestricted gifts from the Andlinger Foundation, the World Wrestling Entertainment and the National Football League. Michael Alosco is also supported by the T32-AG06697 post-doctoral fellowship and National Institutes of Health under grant (1F32NS096803-01).	Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Critchley M., 1949, HOMMAGE CLOVIS VINCE; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2015, NEUROLOGY, V85, P1008; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653	28	54	55	8	68	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					529	+		10.1016/j.nec.2016.05.009			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800014	27637402	Bronze, Green Accepted			2022-02-06	
J	Stahon, KE; Bastian, C; Griffith, S; Kidd, GJ; Brunet, S; Baltan, S				Stahon, Katharine E.; Bastian, Chinthasagar; Griffith, Shelby; Kidd, Grahame J.; Brunet, Sylvain; Baltan, Selva			Age-Related Changes in Axonal and Mitochondrial Ultrastructure and Function in White Matter	JOURNAL OF NEUROSCIENCE			English	Article						aging; axon; mitochondrial dynamic; myelin; neurodegeneration; three-dimensional electron microscopy	MYELINATED NERVE-FIBERS; RAT OPTIC-NERVE; ISCHEMIC-INJURY; SODIUM-CHANNELS; RHESUS-MONKEY; FUSION; CONDUCTION; APOPTOSIS; ATP; EXCITOTOXICITY	The impact of aging on CNS white matter (WM) is of general interest because the global effects of aging on myelinated nerve fibers are more complex and profound than those in cortical gray matter. It is important to distinguish between axonal changes created by normal aging and those caused by neurodegenerative diseases, including multiple sclerosis, stroke, glaucoma, Alzheimer's disease, and traumatic brain injury. Using three-dimensional electron microscopy, weshow that in mouse optic nerve, which is a pure and fully myelinated WMtract, aging axons are larger, have thicker myelin, and are characterized by longer and thicker mitochondria, which are associated with altered levels of mitochondrial shaping proteins. These structural alterations in aging mitochondria correlate with lower ATP levels and increased generation of nitric oxide, protein nitration, and lipid peroxidation. Moreover, mitochondria-smooth endoplasmic reticulum interactions are compromised due to decreased associations and decreased levels of calnexin and calreticulin, suggesting a disruption in Ca2+ homeostasis and defective unfolded protein responses in aging axons. Despite these age-related modifications, axon function is sustained in aging WM, which suggests that age-dependent changes do not lead to irreversible functional decline under normal conditions, as is observed in neurodegenerative diseases.	[Stahon, Katharine E.; Bastian, Chinthasagar; Griffith, Shelby; Kidd, Grahame J.; Brunet, Sylvain; Baltan, Selva] Cleveland Clin Fdn, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA		Baltan, S (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave NB30, Cleveland, OH 44195 USA.	baltans@ccf.org	Baltan, Selva/AAO-8237-2021	Bastian, Chinthasagar/0000-0001-5759-5496; Kidd, Grahame/0000-0003-3956-2206	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG033720]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56AG033720, R01AG033720] Funding Source: NIH RePORTER	This work was supported by NIA Grant AG033720 to S.B. We thank Dr. Chris Nelson for his help in editing this paper.	Baltan S, 2014, WHITE MATTER INJURY, P373; Baltan S, 2008, J NEUROSCI, V28, P1479, DOI 10.1523/JNEUROSCI.5137-07.2008; Baltan S, 2016, NEUROPHARMACOLOGY, V110, P626, DOI 10.1016/j.neuropharm.2015.09.015; Baltan S, 2012, J NEUROCHEM, V123, P108, DOI 10.1111/j.1471-4159.2012.07949.x; Baltan S, 2011, J NEUROSCI, V31, P3990, DOI 10.1523/JNEUROSCI.5379-10.2011; Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010; Baltan S, 2009, NEUROSCIENTIST, V15, P126, DOI 10.1177/1073858408324788; Bay V, 2012, GLIA, V60, P651, DOI 10.1002/glia.22299; Black JA, 2002, MOL BRAIN RES, V105, P19, DOI 10.1016/S0169-328X(02)00385-6; Blalock EM, 2003, J NEUROSCI, V23, P3807; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Bowley MP, 2010, J COMP NEUROL, V518, P3046, DOI 10.1002/cne.22379; Camacho P, 2003, CALNEXIN CALRETICULI, P126; Cavallotti C, 2003, ANAT HISTOL EMBRYOL, V32, P12, DOI 10.1046/j.1439-0264.2003.00431.x; Cavallotti C, 2002, CAN J OPHTHALMOL, V37, P389, DOI 10.1016/S0008-4182(02)80040-0; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; CUMMINS KL, 1979, ELECTROEN CLIN NEURO, V46, P634, DOI 10.1016/0013-4694(79)90101-9; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Feldman ML, 1998, J NEUROCYTOL, V27, P605, DOI 10.1023/A:1006926428699; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Guedes Guilherme, 2011, Curr Aging Sci, V4, P110; Heflin M, 2008, PATHOBIOLOGY OCULAR, P361; Hinman JD, 2006, J COMP NEUROL, V495, P351, DOI 10.1002/cne.20886; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kemper T. L., 1994, CLIN NEUROLOGY AGING, P3; Khan HA, 2003, J BIOSCIENCES, V28, P379, DOI 10.1007/BF02705114; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Murphy SP, 2014, J NEUROCHEM, V129, P509, DOI 10.1111/jnc.12498; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Parpura V, 2017, NEUROCHEM RES, V42, P19, DOI 10.1007/s11064-016-1848-6; Peters A, 2000, J COMP NEUROL, V419, P364, DOI 10.1002/(SICI)1096-9861(20000410)419:3<364::AID-CNE8>3.0.CO;2-R; Peters A, 1999, CEREB CORTEX, P49; Peters A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.011.2009; Ross MH, 2016, HISTOLOGY TEXT ATLAS, P356; Sandell JH, 2002, J COMP NEUROL, V445, P13, DOI 10.1002/cne.10162; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Uo T, 2009, J NEUROSCI, V29, P2824, DOI 10.1523/JNEUROSCI.6186-08.2009; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013	58	54	55	1	8	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 28	2016	36	39					9990	10001		10.1523/JNEUROSCI.1316-16.2016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC8BB	WOS:000388363800002	27683897	Green Published, Bronze			2022-02-06	
J	Rogers, JM; Johnstone, SJ; Aminov, A; Donnelly, J; Wilson, PH				Rogers, Jeffrey M.; Johnstone, Stuart J.; Aminov, Anna; Donnelly, James; Wilson, Peter H.			Test-retest reliability of a single-channel, wireless EEG system	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						EEG; Test-retest reliability; Portable; NeuroSky ThinkGear; Adults; Youth	TRAUMATIC BRAIN-INJURY; SPECTRAL PARAMETERS; POWER SPECTRA; LONG-TERM; CHILDREN; PERFORMANCE; DEPRESSION; STABILITY; ANXIETY; ADULTS	Recording systems to acquire electroencephalogram (EEG) data are traditionally lab-based. However, there are shortcomings to this method, and the ease of use and portability of emerging wireless EEG technologies offer a promising alternative. A previous validity study demonstrated data derived from a single-channel, wireless system (NeuroSky ThinkGear, San Jose, California) is comparable to EEG recorded from conventional lab-based equipment. The current study evaluated the reliability of this portable system using test-retest and reliable change analyses. Relative power (RP) of delta, theta, alpha, and beta frequency bands was derived from EEG data obtained from a single electrode over FP1 in 19 healthy youth (10-17 years old), 21 healthy adults (1828 years old), and 19 healthy older adults (55-79 years old), during eyes-open, eyes-closed, auditory oddball, and visual n-back conditions. Intra-class correlations (ICCs) and Coefficients of Repeatability (CRs) were calculated from RP data re-collected one-day, one-week, and one-month later. Participants' levels of mood and attention were consistent across sessions. Eyes-closed resting EEG measurements using the portable device were reproducible (ICCs 0.76-0.85) at short and longer retest intervals in all three participant age groups. While still of at least fair reliability (ICCs 0.57-0.85), EEG obtained during eyes-open paradigms was less stable, and any change observed over time during these testing conditions can be interpreted utilizing the CR values provided. Combined with existing validity data, these findings encourage application of the portable EEG system for the study of brain function. (C) 2016 Elsevier B.V. All rights reserved.	[Rogers, Jeffrey M.; Aminov, Anna; Wilson, Peter H.] Australian Catholic Univ, Sch Psychol, Sydney, NSW 2059, Australia; [Johnstone, Stuart J.] Univ Wollongong, Sch Psychol, Wollongong, NSW 2522, Australia; [Donnelly, James] Southern Cross Univ, Sch Hlth & Human Sci, Lismore, NSW, Australia		Rogers, JM (corresponding author), Univ Sydney, Brain & Mind Ctr, 94 Mallet St, Camperdown, NSW 2050, Australia.	jeffrey.rogers@sydney.edu.au; stuart_johnstone@uow.edu.au; anna.aminov@acu.edu.au; jim.donnelly@scu.edu.au; peterH.wilson@acu.edu.au	Wilson, Peter H./E-2881-2018; Donnelly, James F/P-5932-2015	Wilson, Peter H./0000-0003-3747-0287; Donnelly, James F/0000-0002-2052-7948; Rogers, Jeffrey M/0000-0002-0320-969X			Andreassi J.L., 2007, PSYCHOPHYSIOLOGY HUM, V5th; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Barry RJ, 2014, INT J PSYCHOPHYSIOL, V94, P236, DOI 10.1016/j.ijpsycho.2014.08.915; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; Cacioppo J. T., 2007, HDB PSYCHOPHYSIOLOGY; Cannon RL, 2012, NEUROSCI LETT, V518, P27, DOI 10.1016/j.neulet.2012.04.035; Catafau AM, 2008, SYNAPSE, V62, P62, DOI 10.1002/syn.20465; Chi Y. M., 2010, IEEE REV BIOMED ENG, V3, P106, DOI DOI 10.1109/RBME.2010.2084078; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; Collado-Mateo D, 2015, SOMATOSENS MOT RES, V32, P219, DOI 10.3109/08990220.2015.1074566; Corsi-Cabrera M, 2007, CLIN NEUROPHYSIOL, V118, P9, DOI 10.1016/j.clinph.2006.08.013; Egerton A, 2010, NEUROIMAGE, V50, P524, DOI 10.1016/j.neuroimage.2009.12.058; Ekandem JI, 2012, ERGONOMICS, V55, P592, DOI 10.1080/00140139.2012.662527; Enoch MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003620; FEIN G, 1983, ELECTROEN CLIN NEURO, V55, P399, DOI 10.1016/0013-4694(83)90127-X; Fernandez T, 1993, Int J Neurosci, V68, P255; Forn C, 2007, HUM BRAIN MAPP, V28, P424, DOI 10.1002/hbm.20284; Gargiulo G, 2010, CLIN NEUROPHYSIOL, V121, P686, DOI 10.1016/j.clinph.2009.12.025; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; Gevins A, 2012, CLIN NEUROPHYSIOL, V123, P1291, DOI 10.1016/j.clinph.2011.11.004; Gevins A, 2011, CLIN NEUROPHYSIOL, V122, P114, DOI 10.1016/j.clinph.2010.06.010; Gudmundsson S, 2007, CLIN NEUROPHYSIOL, V118, P2162, DOI 10.1016/j.clinph.2007.06.018; Guevara MA, 1996, INT J PSYCHOPHYSIOL, V23, P145, DOI 10.1016/S0167-8760(96)00038-4; Handy TC, 2005, EVENT RELATED POTENT; Hatz F, 2014, CLIN NEUROPHYSIOL; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jatoi MA, 2014, BIOMED SIGNAL PROCES, V11, P42, DOI 10.1016/j.bspc.2014.01.009; Johnstone SJ, 2012, CLIN EEG NEUROSCI, V43, P112, DOI 10.1177/1550059411435857; Kennett R, 2012, J NEUROL, V259, P783, DOI 10.1007/s00415-012-6425-6; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Lewis RS, 2007, BIOL PSYCHOL, V75, P239, DOI 10.1016/j.biopsycho.2007.03.004; Lopes da Silva, 2010, NIEDERMEYERS ELECTRO; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; LUND TR, 1995, PSYCHOPHYSIOLOGY, V32, P66, DOI 10.1111/j.1469-8986.1995.tb03407.x; Lyneham HJ, 2013, J ANXIETY DISORD, V27, P711, DOI 10.1016/j.janxdis.2013.09.008; Martin-Buro MC, 2016, HUM BRAIN MAPP, V37, P179, DOI 10.1002/hbm.23027; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McEvoy LK, 2000, CLIN NEUROPHYSIOL, V111, P457, DOI 10.1016/S1388-2457(99)00258-8; Messer SC, 1995, INT J METH PSYCH RES, V5, P251; Mollica CM, 2005, CHILD NEUROPSYCHOL, V11, P303, DOI 10.1080/092970490911306; Mostow J, 2011, LECT NOTES ARTIF INT, V6738, P230, DOI 10.1007/978-3-642-21869-9_31; Napflin M, 2007, CLIN NEUROPHYSIOL, V118, P2519, DOI 10.1016/j.clinph.2007.07.022; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Paasch Valerie, 2012, Neurodiagn J, V52, P333; Peat J., 2014, MED STAT GUIDE SPSS; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Rijsdijk M, 2008, NETH J CRIT CARE, V12, P157; Rogers JM, 2015, BRAIN INJURY, V29, P343, DOI 10.3109/02699052.2014.976273; Rogers JM, 2012, ADV COGN PSYCHOL, V8, P281, DOI [10.2478/v10053-008-0123-z, 10.5709/acp-0123-z]; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Seshia SS, 2008, CAN J NEUROL SCI, V35, P133; Shao SY, 2009, IEEE T BIO-MED ENG, V56, P336, DOI 10.1109/TBME.2008.2005969; Sheorajpanday RVA, 2009, CLIN NEUROPHYSIOL, V120, P845, DOI 10.1016/j.clinph.2009.02.171; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; The Psychological Corporation, 1998, PAC AUD SER ADD TEST; Tong S., 2009, QUANTITATIVE EEG ANA; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Vuga M, 2006, INT J PSYCHOPHYSIOL, V59, P107, DOI 10.1016/j.ijpsycho.2005.02.008; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009	66	54	59	0	44	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	AUG	2016	106						87	96		10.1016/j.ijpsycho.2016.06.006			10	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	DT7EG	WOS:000381649300009	27318008	Green Submitted			2022-02-06	
J	Schumacher, M; Denier, C; Oudinet, JP; Adams, D; Guennoun, R				Schumacher, Michael; Denier, Christian; Oudinet, Jean-Paul; Adams, David; Guennoun, Rachida			Progesterone neuroprotection: The background of clinical trial failure	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article; Proceedings Paper	8th International Meeting on Steroids and Nervous System	2015	Torino, ITALY			Progesterone; Traumatic brain injury; Stroke; Translational research; Biomarkers; Animal models; Clinical trials	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; SEX STEROID-HORMONES; SEVERE HEAD-INJURY; INTRAVENOUS T-PA; VITAMIN-D; ISCHEMIC-STROKE; NERVOUS-SYSTEM; ENDOVASCULAR TREATMENT; GENE-EXPRESSION	Since the first pioneering studies in the 1990s, a large number of experimental animal studies have demonstrated the neuroprotective efficacy of progesterone for brain disorders, including traumatic brain injury (TBI). In addition, this steroid has major assets: it easily crosses the blood-brain-barrier, rapidly diffuses throughout the brain and exerts multiple beneficial effects by acting on many molecular and cellular targets. Moreover, progesterone therapies are well tolerated. Notably, increased brain levels of progesterone are part of endogenous neuroprotective responses to injury. The hormone thus emerged as a particularly promising protective candidate for TBI and stroke patients. The positive outcomes of small Phase 2 trials aimed at testing the safety and potential protective efficacy of progesterone in TBI patients then provided support and guidance for two large, multicenter, randomized and placebo-controlled Phase 3 trials, with more than 2000 TBI patients enrolled. The negative outcomes of both trials, named ProTECT III and SyNAPSE, came as a big disappointment. If these trials were successful, progesterone would have become the first efficient neuroprotective drug for brain-injured patients. Thus, progesterone has joined the numerous neuroprotective candidates that have failed in clinical trials. The aim of this review is a reappraisal of the preclinical animal studies, which provided the proof of concept for the clinical trials, and we critically examine the design of the clinical studies. We made efforts to present a balanced view of the strengths and limitations of the translational studies and of some serious issues with the clinical trials. We place particular emphasis on the translational value of animal studies and the relevance of TBI biomarkers. The probability of failure of ProTECT III and SyNAPSE was very high, and we present them within the broader context of other unsuccessful trials. (C) 2015 Elsevier Ltd. All rights reserved.	[Schumacher, Michael; Denier, Christian; Oudinet, Jean-Paul; Adams, David; Guennoun, Rachida] INSERM, U1195, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France; [Schumacher, Michael; Denier, Christian; Oudinet, Jean-Paul; Adams, David; Guennoun, Rachida] Univ Paris 11, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France; [Schumacher, Michael; Denier, Christian; Oudinet, Jean-Paul; Adams, David; Guennoun, Rachida] Univ Paris Saclay, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France; [Denier, Christian; Adams, David] CHU Bicetre, Dept Neurol, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France		Schumacher, M (corresponding author), INSERM, U1195, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.; Schumacher, M (corresponding author), Univ Paris 11, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.; Schumacher, M (corresponding author), Univ Paris Saclay, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.	michael.schumacher@inserm.fr	Schumacher, Michael/G-3581-2013; Guennoun, Rachida/F-2420-2011	Schumacher, Michael/0000-0001-6117-5371; Guennoun, Rachida/0000-0002-9219-7300			Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Armstrong R. C., 2015, NEUROPHARMACOLOGY; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Banks WA, 2012, ENDOCRINOLOGY, V153, P4111, DOI 10.1210/en.2012-1435; Bansal Y, 2014, EUR J MED CHEM, V76, P31, DOI 10.1016/j.ejmech.2014.01.060; Barakat-Walter I, 2007, J NEUROTRAUM, V24, P567, DOI 10.1089/neu.2006.0104; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Brody David L, 2015, Handb Clin Neurol, V127, P267, DOI 10.1016/B978-0-444-52892-6.00017-9; Bruce ED, 2015, MOL CELL NEUROSCI, V66, P103, DOI 10.1016/j.mcn.2015.03.017; Buccafusco JJ, 2009, NEUROTHERAPEUTICS, V6, P4, DOI 10.1016/j.nurt.2008.10.031; Butler J, 2015, AM HEART J, V169, P305, DOI 10.1016/j.ahj.2014.12.001; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2015, INT J STROKE, V10, P153, DOI 10.1111/ijs.12186; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Cermenati G, 2010, J NEUROSCI, V30, P11896, DOI 10.1523/JNEUROSCI.1898-10.2010; Chase Alex, 2015, Nat Rev Neurol, V11, P65, DOI 10.1038/nrneurol.2014.258; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Dechartres A, 2009, J CLIN EPIDEMIOL, V62, P695, DOI 10.1016/j.jclinepi.2008.09.011; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Farooqi N, 2010, J NEUROCHEM, V115, P829, DOI 10.1111/j.1471-4159.2010.06982.x; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Finlay CJ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00095; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Furlan AJ, 2015, NEW ENGL J MED, V372, P2347, DOI 10.1056/NEJMe1503217; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Garay L, 2008, NEUROIMMUNOMODULAT, V15, P76, DOI 10.1159/000135627; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Genazzani AR, 1998, J CLIN ENDOCR METAB, V83, P2099, DOI 10.1210/jc.83.6.2099; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; GLOTH FM, 1995, J AM GERIATR SOC, V43, P822, DOI 10.1111/j.1532-5415.1995.tb07059.x; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Groves NJ, 2014, ANNU REV NUTR, V34, P117, DOI 10.1146/annurev-nutr-071813-105557; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; GUTAI JP, 1977, J CLIN ENDOCR METAB, V44, P116, DOI 10.1210/jcem-44-1-116; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Harsan LA, 2008, J NEUROSCI, V28, P14189, DOI 10.1523/JNEUROSCI.4453-08.2008; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hoyer C, 2014, NEUROPSYCHOBIOLOGY, V69, P187, DOI 10.1159/000360859; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Hueston CM, 2014, ENDOCRINOLOGY, V155, P3527, DOI 10.1210/en.2014-1060; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Irwin RW, 2011, ENDOCRINOLOGY, V152, P556, DOI 10.1210/en.2010-1061; Jalali R, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/289803; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jickling GC, 2015, METAB BRAIN DIS, V30, P461, DOI 10.1007/s11011-014-9499-2; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kahle MP, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/374098; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Kurki T, 2014, NEURORADIOLOGY, V56, P833, DOI 10.1007/s00234-014-1410-7; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; LeGrand SA, 2007, J NEUROTRAUM, V24, P1437, DOI 10.1089/neu.2007.0293; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liere P, 2009, J LIPID RES, V50, P2430, DOI 10.1194/jlr.M900162-JLR200; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lofgren M, 2006, HORM BEHAV, V50, P208, DOI 10.1016/j.yhbeh.2006.03.002; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MacDougall NJJ, 2011, J CEREBR BLOOD F MET, V31, P807, DOI 10.1038/jcbfm.2010.210; Makoukji J, 2012, P NATL ACAD SCI USA, V109, P3973, DOI 10.1073/pnas.1121367109; Marcucci M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003143; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; McGrath J, 2001, TRENDS NEUROSCI, V24, P570, DOI 10.1016/S0166-2236(00)01949-4; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Meffre D, 2015, P NATL ACAD SCI USA, V112, P7587, DOI 10.1073/pnas.1424951112; Melcangi RC, 2014, PROG NEUROBIOL, V113, P1, DOI 10.1016/j.pneurobio.2013.09.005; Mitro N, 2012, NEUROCHEM INT, V60, P616, DOI 10.1016/j.neuint.2012.02.025; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mumford SL, 2010, J CLIN ENDOCR METAB, V95, pE80, DOI 10.1210/jc.2010-0109; Namiki J, 2011, CLIN NEUROL NEUROSUR, V113, P393, DOI 10.1016/j.clineuro.2011.01.001; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Pankevich DE, 2014, NEURON, V84, P546, DOI 10.1016/j.neuron.2014.10.007; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Peper JS, 2011, PSYCHONEUROENDOCRINO, V36, P1101, DOI 10.1016/j.psyneuen.2011.05.004; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ringel M, 2013, NAT REV DRUG DISCOV, V12, P901, DOI 10.1038/nrd4164; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sakoglu U, 2011, BIOCHEM PHARMACOL, V81, P1374, DOI 10.1016/j.bcp.2010.12.029; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schoepp DD, 2011, NAT REV DRUG DISCOV, V10, P715, DOI 10.1038/nrd3559; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Schumacher M, 2015, STEROIDS, V103, P42, DOI 10.1016/j.steroids.2015.08.013; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Schumacher M, 2008, CURR OPIN PHARMACOL, V8, P740, DOI 10.1016/j.coph.2008.10.002; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin SS, 2014, PROG NEUROL SURG, V28, P86, DOI 10.1159/000358767; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Si DW, 2014, BEHAV BRAIN RES, V264, P135, DOI 10.1016/j.bbr.2014.01.049; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Sieber BA, 2014, ANN NEUROL, V76, P469, DOI 10.1002/ana.24261; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Strom JO, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-41; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P249, DOI 10.3233/PRM-2009-0099; Tang H., 2015, BRAIN INJURY, V29, P1259; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011; TEASDALE G, 1974, LANCET, V2, P81; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vukusic S, 2009, J NEUROL SCI, V286, P114, DOI 10.1016/j.jns.2009.08.056; Vukusic S, 2015, NAT REV NEUROL, V11, P280, DOI 10.1038/nrneurol.2015.53; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Washington P. M., 2015, EXP NEUROL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Yawno T, 2009, NEUROSCIENCE, V163, P838, DOI 10.1016/j.neuroscience.2009.07.009; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Yu CG, 2015, J NEUROSCI RES, V93, P199, DOI 10.1002/jnr.23503; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	218	54	56	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	JUN	2016	160				SI		53	66		10.1016/j.jsbmb.2015.11.010			14	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	DN1QM	WOS:000376840500008	26598278				2022-02-06	
J	Abaji, JP; Curnier, D; Moore, RD; Ellemberg, D				Abaji, Joseph Patrick; Curnier, Daniel; Moore, Robert Davis; Ellemberg, Dave			Persisting Effects of Concussion on Heart Rate Variability during Physical Exertion	JOURNAL OF NEUROTRAUMA			English	Article						cardiac autonomic modulation; concussion; physical activity	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE VARIABILITY; ISOMETRIC HANDGRIP TEST; RESPIRATORY RESISTANCE; APPROXIMATE ENTROPY; RECOVERY; DEFICITS; SYSTEMS	The purpose of this study was to evaluate cardiac autonomic modulation in university athletes during the post-acute to late phase (mean, 95 days +/- 63) of injury at rest and during physical exertion. We also sought to evaluate the effect of time since injury and number of injuries on heart rate variability (HRV). We hypothesized that physical exertion would reveal persisting modifications in HRV following a concussion. We included, in a cross-sectional design, athletes who sustained a concussion and matched controls. Concussions were identified by a medical doctor using established criteria. Twelve male concussed and 12 control athletes took part in the study. Control participants were teammates who were chosen to match the concussed athletes with regard to their height, weight, education, and age. The beat-to-beat electrocardiogram intervals of the participants were measured at rest and during physical exertion (isometric hand grip contraction; IHGC), which was sustained for 3 minutes at 30% of the participants' maximum. Linear and nonlinear parameters of HRV were calculated. The ratio between low and high frequency (LF/HF) bands was calculated to assess the sympathovagal balance. During the IHGC, but not at rest, concussed athletes presented significantly lower power in HF bands, leading to a significantly higher LF/HF ratio (p <= 0.05). Thus, asymptomatic athletes still may exhibit modifications in cardiac autonomic modulation weeks to months following injury. These modifications may only become apparent during physical exertion. Monitoring HRV may aid diagnosis and provide insight about safe return to play.	[Abaji, Joseph Patrick; Curnier, Daniel; Moore, Robert Davis; Ellemberg, Dave] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Curnier, Daniel; Ellemberg, Dave] Univ Montreal, Res Ctr, CHU St Justine, Montreal, PQ, Canada		Ellemberg, D (corresponding author), 2100 Eduard Montpetit, Montreal, PQ H3T 1J4, Canada.	dave.ellemberg@umontreal.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bartels MN, 2004, RESP PHYSIOL NEUROBI, V144, P91, DOI 10.1016/j.resp.2004.08.002; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Berntson GG, 1996, BIOL PSYCHOL, V44, P1, DOI 10.1016/S0301-0511(96)05197-6; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Camm AJ, 1996, EUR HEART J, V17, P354; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gianaros PJ, 2001, PSYCHOPHYSIOLOGY, V38, P540, DOI 10.1017/S004857720100004X; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kelly JP, 1997, NEUROLOGY, V48, P581; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Khurana RK, 1996, CLIN AUTON RES, V6, P211, DOI 10.1007/BF02291136; King ML, 1997, BRAIN INJURY, V11, P445; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; LEIPZIG TJ, 1986, NEUROSURGERY, V19, P356, DOI 10.1227/00006123-198609000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Marques AH, 2010, NEUROIMMUNOMODULAT, V17, P205, DOI 10.1159/000258725; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Petrofsky J, 2009, DIABETES TECHNOL THE, V11, P361, DOI 10.1089/dia.2008.0094; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ritz T, 2000, BIOL PSYCHOL, V52, P143, DOI 10.1016/S0301-0511(99)00026-5; Ritz T, 2002, PSYCHOPHYSIOLOGY, V39, P86, DOI 10.1017/S0048577201020066; Ritz T, 2000, BIOL PSYCHOL, V55, P119, DOI 10.1016/S0301-0511(00)00075-2; Rottenberg J, 2003, PSYCHOPHYSIOLOGY, V40, P1, DOI 10.1111/1469-8986.00001; Saboul D, 2014, EUR J SPORT SCI, V14, pS282, DOI 10.1080/17461391.2012.691116; Schipke J., 1999, J CLIN BASIC CARDIOL, V2, P92; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; de Araujo CGS, 2011, ARQ BRAS CARDIOL, V97, P413, DOI 10.1590/S0066-782X2011005000102; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74	47	54	55	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					811	817		10.1089/neu.2015.3989			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800002	26159461				2022-02-06	
J	Carr, W; Stone, JR; Walilko, T; Young, LA; Snook, TL; Paggi, ME; Tsao, JW; Jankosky, CJ; Parish, RV; Ahlers, ST				Carr, Walter; Stone, James R.; Walilko, Tim; Young, Lee Ann; Snook, Tianlu Li; Paggi, Michelle E.; Tsao, Jack W.; Jankosky, Christopher J.; Parish, Robert V.; Ahlers, Stephen T.			Repeated Low-Level Blast Exposure: A Descriptive Human Subjects Study	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium	AUG 17-21, 2014	Fort Lauderdale, FL				TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; FUNCTIONAL MRI; MILD; PERFORMANCE; CONCUSSION; SAMPLE	The relationship between repeated exposure to blast overpressure and neurological function was examined in the context of breacher training at the U.S. Marine Corps Weapons Training Battalion Dynamic Entry School. During this training, Students are taught to apply explosive charges to achieve rapid ingress into secured buildings. For this study, both Students and Instructors participated in neurobehavioral testing, blood toxin screening, vestibular/auditory testing, and neuroimaging. Volunteers wore instrumentation during training to allow correlation of human response measurements and blast overpressure exposure. The key findings of this study were from high-memory demand tasks and were limited to the Instructors. Specific tests showing blast-related mean differences were California Verbal Learning Test II, Automated Neuropsychological Assessment Metrics subtests (Match-to-Sample, Code Substitution Delayed), and Delayed Matching-to-Sample 10-second delay condition. Importantly, apparent deficits were paralleled with functional magnetic resonance imaging using the n-back task. The findings of this study are suggestive, but not conclusive, owing to small sample size and effect. The observed changes yield descriptive evidence for potential neurological alterations in the subset of individuals with occupational history of repetitive blast exposure. This is the first study to integrate subject instrumentation for measurement of individual blast pressure exposure, neurocognitive testing, and neuroimaging.	[Carr, Walter] Walter Reed Army Inst Res, Dept Behav Biol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Stone, James R.; Snook, Tianlu Li] Univ Virginia Hlth Syst, 480 Ray C Hunt Dr,Room 281,Box 801339, Charlottesville, VA 22903 USA; [Walilko, Tim] Appl Res Associates Inc, 7921 Shaffer Pkwy, Littleton, CO 80127 USA; [Young, Lee Ann] Appl Res Associates Inc, 950 Isom Rd, San Antonio, TX 78216 USA; [Paggi, Michelle E.] Weill Cornell Med Coll, 21 Bloomingdale Rd, White Plains, NY 10605 USA; [Tsao, Jack W.] US Navy, Bur Med & Surg, Traumat Brain Injury Programs, 2300 East St Northwest, Washington, DC 20372 USA; [Jankosky, Christopher J.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Parish, Robert V.] MEDCOM Irwin Army Community Hosp, 600 Caisson Hill Rd, Ft Riley, KS 66442 USA; [Ahlers, Stephen T.] US Navy, Med Res Ctr, Operat & Undersea Med, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Carr, W (corresponding author), Walter Reed Army Inst Res, Dept Behav Biol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.			Paggi, Michelle/0000-0002-6157-9787			AHLERS ST, 1994, FOOD COMPONENTS ENHA, P301; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dricot L, 2008, NEUROIMAGE, V40, P318, DOI 10.1016/j.neuroimage.2007.11.012; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Fine EM, 2008, J CLIN EXP NEUROPSYC, V30, P463, DOI 10.1080/13803390701531912; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS3, DOI 10.1016/j.acn.2006.10.001; Kelley A, 201016 US ARM AER RE; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Needham CE, 2010, SHOCK WAVE HIGH PRES, P37, DOI 10.1007/978-3-642-05288-0_5; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Ruff RM, 1999, BRAIN INJURY, V13, P943; St Onge Paul, 2011, US Army Med Dep J, P97; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; THOMAS JR, 1989, AVIAT SPACE ENVIR MD, V60, P1063; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836	20	54	54	0	7	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2016	181	5		S			28	39		10.7205/MILMED-D-15-00137			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	DW5LJ	WOS:000383686400007	27168550	Bronze			2022-02-06	
J	Hall, ED; Wang, JA; Bosken, JM; Singh, IN				Hall, Edward D.; Wang, Juan A.; Bosken, Jeffrey M.; Singh, Indrapal N.			Lipid peroxidation in brain or spinal cord mitochondria after injury	JOURNAL OF BIOENERGETICS AND BIOMEMBRANES			English	Article						Oxidative stress; Traumatic brain injury; Spinal cord injury; Mitochondria; Lipid peroxidation; Antioxidant	MEDIATED CYTOSKELETAL DEGRADATION; TRAUMATIC BRAIN; CYCLOSPORINE-A; ANTIOXIDANT THERAPIES; OXIDATIVE DAMAGE; IMPAIRED MITOCHONDRIAL; PEROXYNITRITE; DYSFUNCTION; RAT; PROTECTION	Extensive evidence has demonstrated an important role of oxygen radical formation (i.e., oxidative stress) as a mediator of the secondary injury process that occurs following primary mechanical injury to the brain or spinal cord. The predominant form of oxygen radical-induced oxidative damage that occurs in injured nervous tissue is lipid peroxidation (LP). Much of the oxidative stress in injured nerve cells initially begins in mitochondria via the generation of the reactive nitrogen species peroxynitrite (PN) which then can generate multiple highly reactive free radicals including nitrogen dioxide (aEuro cent NO2), hydroxyl radical (aEuro cent OH) and carbonate radical (aEuro cent CO3). Each can readily induce LP within the phospholipid membranes of the mitochondrion leading to respiratory dysfunction, calcium buffering impairment, mitochondrial permeability transition and cell death. Validation of the role of LP in central nervous system secondary injury has been provided by the mitochondrial and neuroprotective effects of multiple antioxidant agents which are briefly reviewed.	[Hall, Edward D.; Wang, Juan A.; Bosken, Jeffrey M.; Singh, Indrapal N.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Hall, Edward D.] Univ Kentucky, Med Ctr, Anat & Neurobiol Neurosurg Neurol & Phys Med & Re, Room B477,Biomed & Biol Sci Res Bldg, Lexington, KY 40536 USA		Hall, ED (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA.	edhall@uky.edu	Hall, Edward D/F-8930-2013		National Institute of Neurological Disorders Stroke (NINDS) [R01 NS046566, R01 NS083405, R01 NS084857, P01 NS058484, R21 NS077434, P30 NS051220]; Kentucky Spinal Cord & Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS051220, P01NS058484, R21NS077434, R01NS084857, R01NS046566, R01NS083405] Funding Source: NIH RePORTER	The research described in the authors' laboratory was partially funded by grants from the National Institute of Neurological Disorders & Stroke (NINDS) including R01 NS046566, R01 NS083405, R01 NS084857, P01 NS058484, R21 NS077434 and P30 NS051220 and grants from the Kentucky Spinal Cord & Head Injury Research Trust.	Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bao F, 2003, NEUROSCIENCE, V116, P59, DOI 10.1016/S0306-4522(02)00571-7; Bao F, 2002, NEUROSCIENCE, V115, P839, DOI 10.1016/S0306-4522(02)00506-7; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Hall ED, 1997, J PHARMACOL EXP THER, V281, P895; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hamann K, 2008, J NEUROCHEM, V107, P712, DOI 10.1111/j.1471-4159.2008.05622.x; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; Hamann K, 2009, J NEUROCHEM, V111, P1348, DOI 10.1111/j.1471-4159.2009.06395.x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lopez-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; MUIZELAAR JP, 1995, J NEUROSURG, V83, P942; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Vaishnav RA, 2010, J NEUROTRAUM, V27, P1311, DOI 10.1089/neu.2009.1172; Valdez LB, 2000, FREE RADICAL BIO MED, V29, P349, DOI 10.1016/S0891-5849(00)00301-4; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Zanella B, 2002, BIOCHEM BIOPH RES CO, V290, P1010, DOI 10.1006/bbrc.2001.6284	43	54	59	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0145-479X	1573-6881		J BIOENERG BIOMEMBR	J. Bioenerg. Biomembr.	APR	2016	48	2					169	174		10.1007/s10863-015-9600-5			6	Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Cell Biology	DJ7SX	WOS:000374413700007	25595872	Green Accepted			2022-02-06	
J	Sabirzhanov, B; Stoica, BA; Zhao, Z; Loane, DJ; Wu, J; Dorsey, SG; Faden, AI				Sabirzhanov, B.; Stoica, B. A.; Zhao, Z.; Loane, D. J.; Wu, J.; Dorsey, S. G.; Faden, A. I.			miR-711 upregulation induces neuronal cell death after traumatic brain injury	CELL DEATH AND DIFFERENTIATION			English	Article							SIGNALING PATHWAY; MIRNA PROMOTERS; GENE-EXPRESSION; SEX-DIFFERENCES; PROBE LEVEL; APOPTOSIS; AKT; PROTEINS; NEUROPROTECTION; ACTIVATION	Traumatic brain injury (TBI) is a leading cause of mortality and disability. MicroRNAs (miRs) are small noncoding RNAs that negatively regulate gene expression at post-transcriptional level and may be key modulators of neuronal apoptosis, yet their role in secondary injury after TBI remains largely unexplored. Changes in miRs after controlled cortical impact (CCI) in mice were examined during the first 72 h using miR arrays and qPCR. One selected miR (711) was examined with regard to its regulation and relation to cell death; effects of miR-711 modulation were evaluated after CCI and using in vitro cell death models of primary cortical neurons. Levels of miR-711 were increased in the cortex early after TBI and in vitro models through rapid upregulation of miR-711 transcription (pri-miR-711) rather than catabolism. Increases coincided with downregulation of the pro-survival protein Akt, a predicted target of miR-711, with sequential activation of forkhead box O3 (FoxO3)a/glycogen synthase kinase 3 (GSK3)alpha/beta, pro-apoptotic BH3-only molecules PUMA (Bcl2-binding component 3) and Bim (Bcl2-like 11 (apoptosis facilitator)), and mitochondrial release of cytochrome c and AIF. miR-711 and Akt (mRNA) co-immunoprecipitated with the RNA-induced silencing complex (RISC). A miR-711 hairpin inhibitor attenuated the apoptotic mechanisms and decreased neuronal death in an Akt-dependent manner. Conversely, a miR-711 mimic enhanced neuronal apoptosis. Central administration of the miR-711 hairpin inhibitor after TBI increased Akt expression and attenuated apoptotic pathways. Treatment reduced cortical lesion volume, neuronal cell loss in cortex and hippocampus, and long-term neurological dysfunction. miR-711 changes contribute to neuronal cell death after TBI, in part by inhibiting Akt, and may serve as a novel therapeutic target.	[Sabirzhanov, B.; Stoica, B. A.; Zhao, Z.; Loane, D. J.; Wu, J.; Faden, A. I.] Univ Maryland, Sch Med, Dept Anesthesiol, 655 West Baltimore St,Room 6-010,BRD,Room 6-015, Baltimore, MD 21201 USA; [Sabirzhanov, B.; Stoica, B. A.; Zhao, Z.; Loane, D. J.; Wu, J.; Faden, A. I.] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Dorsey, S. G.] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Dorsey, S. G.] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA		Sabirzhanov, B; Stoica, BA (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 655 West Baltimore St,Room 6-010,BRD,Room 6-015, Baltimore, MD 21201 USA.	bsabirzhanov@anes.umm.edu; bstoica@anes.umm.edu	Loane, David/ABD-5177-2021; STOICA, BOGDAN/H-9782-2013	Loane, David/0000-0003-0393-3503; STOICA, BOGDAN/0000-0002-2501-6434	 [RO1 NS061839];  [R01 NR012686]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061839, R01NS096002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR012686] Funding Source: NIH RePORTER	This work was supported by grants RO1 NS061839 to AIF and R01 NR012686 to SGD. We thank Taryn Aubrecht and Xiaoyi Lin for technical assistance.	Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Engel T, 2010, J NEUROCHEM, V115, P92, DOI 10.1111/j.1471-4159.2010.06909.x; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; He CJ, 2012, NUCLEIC ACIDS RES, V40, P4002, DOI 10.1093/nar/gkr1312; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jeong JK, 2012, BIOCHEM BIOPH RES CO, V429, P93, DOI 10.1016/j.bbrc.2012.10.086; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mohite A, 2011, BIOCHEMISTRY-US, V50, P1691, DOI 10.1021/bi101654w; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Stoica BA, 2003, MOL CELL NEUROSCI, V22, P365, DOI 10.1016/S1044-7431(02)00028-3; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zareen N, 2013, CELL DEATH DIFFER, V20, P1719, DOI 10.1038/cdd.2013.128; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	57	54	58	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	APR	2016	23	4					654	668		10.1038/cdd.2015.132			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3SP	WOS:000374126800011	26470728	Green Published, Bronze			2022-02-06	
S	Gardner, AJ; Zafonte, R		Rosano, C; Ikram, MA; Ganguli, M		Gardner, A. J.; Zafonte, R.			Neuroepidemiology of traumatic brain injury	NEUROEPIDEMIOLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							GLASGOW COMA SCALE; WESTMEAD PTA SCALE; SEVERE HEAD-INJURY; AXONAL INJURY; POSTTRAUMATIC AMNESIA; CORTICOSPINAL NEURONS; TRANSFORMING RESEARCH; COGNITIVE IMPAIRMENT; OUTCOME PREDICTION; CLINICAL KNOWLEDGE	Traumatic brain injury (TBI) is a significant public-health concern. TBI is defined as an acute brain injury resulting from mechanical energy to the head from external physical forces. Some of the leading causes of TBI include falls, assaults, motor vehicle or traffic accidents, and sport-related concussion. Two of the most common identified risk factors are sex (males are nearly three times more likely to suffer a TBI than females); and a bimodal age pattern (persons 65 years and older, and children under 14 years old). It is estimated that approximately 1.5-2 million Americans suffer from TBI annually. TBIs account for around 1.4 million emergency room visits, 275 000 hospital admissions, and 52 000 deaths in the USA each year. TBI contributes to approximately 30% of all deaths in the USA annually. In Australia, it is estimated that approximately 338 700 individuals (1.9% of the population) suffer from a disability related to TBI. Of these, 160 200 were severely or profoundly affected by acquired brain injury, requiring daily support. In the UK, TBI accounted for 3.4% of all emergency department attendances annually. An overall rate of 453 per 100 000 was found for all TBI severities, of which 40 per 100 000 (10.9%) were moderate to severe. TBI often results in residual symptoms that affect an individual's cognition, movement, sensation, and/or emotional functioning. Recovery and rehabilitation from TBI may require considerable resources and may take years. Some individuals never fully recover, and some require lifetime ongoing care and support. TBI has an enormous social and financial cost, with estimates of the annual financial burden associated with TBI ranging between 9 and 10 billion US dollars.	[Gardner, A. J.] Hunter New England Local Hlth Dist Sports Concuss, Callaghan, NSW, Australia; [Gardner, A. J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Zafonte, R.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, R.] Brigham & Womens Hosp, MassGen Hosp Children, Sport Concuss Program, Boston, MA USA; [Zafonte, R.] Brigham & Womens Hosp, Red Sox Fdn, 75 Francis St, Boston, MA 02115 USA; [Zafonte, R.] Brigham & Womens Hosp, Massachusetts Gen Hosp, Home Base Program, 75 Francis St, Boston, MA 02115 USA		Gardner, AJ (corresponding author), Calvary Mater Hosp, Ctr Translat Neurosci & Mental Hlth, Level 5,McCauley Bldg, Waratah, NSW 2298, Australia.	andrew.gardner@neurogard.com.au		Gardner, Andrew/0000-0001-5031-5586			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bonatz H, 2000, J NEUROSCI METH, V100, P105, DOI 10.1016/S0165-0270(00)00238-7; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Bowen A, 1999, BRAIN INJURY, V13, P547; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Briggs R, 2015, DEV MED CHILD NEUROL, V57, P618, DOI 10.1111/dmcn.12674; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Evans R., 2006, NEUROLOGY AND TRAUMA; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Faul M, 2010, TRAUMATIC BRAIN INJU; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giehl KM, 1997, EUR J NEUROSCI, V9, P2479, DOI 10.1111/j.1460-9568.1997.tb01665.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Graham DI, 1991, GREENFIELDS NEUROPAT, P823; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1975, LANCET, V1, P480; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Katz D.I., 2007, BRAIN INJURY MED PRI, P3; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lehmann C, 2009, BRAIN RES, V1297, P1, DOI 10.1016/j.brainres.2009.08.070; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan TM, 2015, INT ENCY SOCIAL BEHA, P636; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Novack T, 2000, THE ORIENTATION LOG; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ranaivo HR, 2011, J NEUROTRAUM, V28, P1757, DOI 10.1089/neu.2011.1799; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Ribot, 1881, MALADIES MEMOIRE; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schootman M, 2000, BRAIN INJURY, V14, P373; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 1999, J NEUROSCI, V19, P4263; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stein DG, 2015, HDB CLIN NEUROLOGY; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	106	54	57	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		9780-1-28-02990-9; 9780-1-28-02973-2	HAND CLINIC			2016	138						207	223		10.1016/B978-0-12-802973-2.00012-4			17	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI3EQ	WOS:000410828400014	27637960				2022-02-06	
J	Mishra, V; Shuai, B; Kodali, M; Shetty, GA; Hattiangady, B; Rao, XL; Shetty, AK				Mishra, Vikas; Shuai, Bing; Kodali, Maheedhar; Shetty, Geetha A.; Hattiangady, Bharathi; Rao, Xiaolan; Shetty, Ashok K.			Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation	SCIENTIFIC REPORTS			English	Article							TEMPORAL-LOBE EPILEPSY; NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELL; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; GRANULE CELLS; KAINIC ACID; RAT MODEL; THERAPEUTIC IMPLICATIONS	Antiepileptic drug therapy, though beneficial for restraining seizures, cannot thwart status epilepticus (SE) induced neurodegeneration or down-stream detrimental changes. We investigated the efficacy of resveratrol (RESV) for preventing SE-induced neurodegeneration, abnormal neurogenesis, oxidative stress and inflammation in the hippocampus. We induced SE in young rats and treated with either vehicle or RESV, commencing an hour after SE induction and continuing every hour for three-hours on SE day and twice daily thereafter for 3 days. Seizures were terminated in both groups two-hours after SE with a diazepam injection. In contrast to the vehicle-treated group, the hippocampus of animals receiving RESV during and after SE presented no loss of glutamatergic neurons in hippocampal cell layers, diminished loss of inhibitory interneurons expressing parvalbumin, somatostatin and neuropeptide Y in the dentate gyrus, reduced aberrant neurogenesis with preservation of reelin + interneurons, lowered concentration of oxidative stress byproduct malondialdehyde and pro-inflammatory cytokine tumor necrosis factor-alpha, normalized expression of oxidative stress responsive genes and diminished numbers of activated microglia. Thus, 4 days of RESV treatment after SE is efficacious for thwarting glutamatergic neuron degeneration, alleviating interneuron loss and abnormal neurogenesis, and suppressing oxidative stress and inflammation. These results have implications for restraining SE-induced chronic temporal lobe epilepsy.	[Mishra, Vikas; Shuai, Bing; Kodali, Maheedhar; Shetty, Geetha A.; Hattiangady, Bharathi; Rao, Xiaolan; Shetty, Ashok K.] Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX 76502 USA; [Mishra, Vikas; Shuai, Bing; Kodali, Maheedhar; Shetty, Geetha A.; Hattiangady, Bharathi; Rao, Xiaolan; Shetty, Ashok K.] Cent Texas Vet Hlth Care Syst, Olin E Teague Vet Affairs Med Ctr, Res Serv, Temple, TX USA; [Mishra, Vikas; Shuai, Bing; Kodali, Maheedhar; Shetty, Geetha A.; Hattiangady, Bharathi; Rao, Xiaolan; Shetty, Ashok K.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA		Shetty, AK (corresponding author), Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX 76502 USA.	Shetty@medicine.tamhsc.edu	Shetty, Ashok/AAT-7273-2020; Shetty, Ashok K/A-2428-2008	Shetty, Ashok/0000-0001-5049-6671; Shetty, Ashok K/0000-0001-5049-6671; Mishra, Vikas/0000-0001-7162-5882	State of Texas (Emerging Technology Funds); Department of Veterans Affairs (VA Merit Award) [I01 BX002351]; Veterans AffairsUS Department of Veterans Affairs [I01BX002351] Funding Source: NIH RePORTER	This study was supported by the State of Texas (Emerging Technology Funds to A.K.S.) and the Department of Veterans Affairs (VA Merit Award, I01 BX002351 to A.K.S.). Dr. Shetty is also Research Career Scientist at the Olin E. Teague Veterans' Medical Center, Central Texas Veterans Health Care System Temple, Texas. We thank MegaResveratrol (Candlewood Stars Inc., 60 Newtown Road, Danbury CT, USA) for supplying resveratrol to this study for no fee. The summary information on various genes discussed in this study was obtained from GeneCards (human gene database at: http://www.genecards.org), National Center for Biotechnology Information (NCBI at: http://www.ncbi.nlm.nih.gov/gene) and Online Mendelian Inheritance in Man (OMIM at: http://www.omim.org). The contents of this article suggest the views of authors and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Ben-Ari Y., 2012, JASPERS BASIC MECH E; Chen JWY, 2006, LANCET NEUROL, V5, P246, DOI 10.1016/S1474-4422(06)70374-X; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Chung JH, 2012, TRENDS CELL BIOL, V22, P546, DOI 10.1016/j.tcb.2012.07.004; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Detampel P, 2012, DRUG METAB REV, V44, P253, DOI 10.3109/03602532.2012.700715; Dichter MA, 2009, EPILEPSIA, V50, P41, DOI 10.1111/j.1528-1167.2008.02009.x; Fellin T, 2005, TRENDS MOL MED, V11, P530, DOI 10.1016/j.molmed.2005.10.007; Friedman LK, 2013, NEUROSCIENCE, V230, P39, DOI 10.1016/j.neuroscience.2012.10.063; Furukawa A, 2011, NEUROBIOL DIS, V43, P706, DOI 10.1016/j.nbd.2011.05.024; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Gupta YK, 2002, PHARMACOLOGY, V65, P170, DOI 10.1159/000058044; Gupta YK, 2002, PHARMACOL BIOCHEM BE, V71, P245, DOI 10.1016/S0091-3057(01)00663-3; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hattiangady B, 2008, EXP NEUROL, V212, P468, DOI 10.1016/j.expneurol.2008.04.040; Hattiangady B, 2011, AGING DIS, V2, P1; Hattiangady B, 2010, HIPPOCAMPUS, V20, P97, DOI 10.1002/hipo.20594; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hester MS, 2014, EPILEPSY BEHAV, V38, P105, DOI 10.1016/j.yebeh.2013.12.022; Houser CR, 2014, ADV EXP MED BIOL, V813, P151, DOI 10.1007/978-94-017-8914-1_12; Janigro D, 2013, EPILEPSIA, V54, P30, DOI 10.1111/epi.12271; Kim HJ, 2013, NEUROCHEM RES, V38, P117, DOI 10.1007/s11064-012-0897-8; Kleen JK, 2012, JASPERS BASIC MECH E; Kodali M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08075; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Kuruba R, 2009, EPILEPSY BEHAV, V14, P65, DOI 10.1016/j.yebeh.2008.08.020; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McCloskey DP, 2006, EUR J NEUROSCI, V24, P2203, DOI 10.1111/j.1460-9568.2006.05101.x; Menon B, 2012, SEIZURE-EUR J EPILEP, V21, P780, DOI 10.1016/j.seizure.2012.09.003; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2012, JASPERS BASIC MECH E, V4; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rao MS, 2007, NEUROBIOL DIS, V27, P117, DOI 10.1016/j.nbd.2007.03.016; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Rogawski, 2012, JASPERS BASIC MECH E; Sankar R., 2012, JASPERS BASIC MECH E; Scharfman HE, 2003, J NEUROPHYSIOL, V90, P2536, DOI 10.1152/jn.00251.2003; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman HE, 2002, NEUROSCIENCE, V111, P71, DOI 10.1016/S0306-4522(01)00599-1; Scharfman Helen E., 2002, Epilepsy Curr, V2, P63, DOI 10.1046/j.1535-7597.2002.00023.x; Scharfman HE, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03480.x; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Shetty AK, 2007, STEM CELLS, V25, P2396, DOI 10.1634/stemcells.2007-0313; Shetty AK, 2011, PHARMACOL THERAPEUT, V131, P269, DOI 10.1016/j.pharmthera.2011.04.008; Shetty GA, 2013, AGE, V35, P2165, DOI 10.1007/s11357-012-9507-6; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Sun AY, 1997, NEUROCHEM RES, V22, P1187, DOI 10.1023/A:1021968526696; Temkin N. R., 2004, EPILEPSY RES, V60, P80; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Waldau B, 2010, STEM CELLS, V28, P1153, DOI 10.1002/stem.446; Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020; Wang HM, 2013, PHARMACOL BIOCHEM BE, V105, P134, DOI 10.1016/j.pbb.2012.12.016; Wang Q, 2004, NEUROCHEM RES, V29, P2105, DOI 10.1007/s11064-004-6883-z; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wasterlain CG, 2013, EPILEPSIA, V54, P78, DOI 10.1111/epi.12285; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu Z, 2009, NEUROCHEM RES, V34, P1393, DOI 10.1007/s11064-009-9920-0; Zini R, 1999, DRUG EXP CLIN RES, V25, P87	73	54	56	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 7	2015	5								17807	10.1038/srep17807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7CQ	WOS:000365859100001	26639668	Green Submitted, Green Published, gold			2022-02-06	
J	Febinger, HY; Thomasy, HE; Pavlova, MN; Ringgold, KM; Barf, PR; George, AM; Grillo, JN; Bachstetter, AD; Garcia, JA; Cardona, AE; Opp, MR; Gemma, C				Febinger, Heidi Y.; Thomasy, Hannah E.; Pavlova, Maria N.; Ringgold, Kristyn M.; Barf, Paulien R.; George, Amrita M.; Grillo, Jenna N.; Bachstetter, Adam D.; Garcia, Jenny A.; Cardona, Astrid E.; Opp, Mark R.; Gemma, Carmelina			Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						CX3CR1; TBI; Microglia; Cognitive function; Cytokines	CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; FRACTALKINE-RECEPTOR; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; ALTERNATIVE ACTIVATION; CHEMOKINE FRACTALKINE; AMYLOID DEPOSITION; MACROPHAGE SUBSETS	Background: Neuroinflammation is an important secondary mechanism that is a key mediator of the long-term consequences of neuronal injury that occur in traumatic brain injury (TBI). Microglia are highly plastic cells with dual roles in neuronal injury and recovery. Recent studies suggest that the chemokine fractalkine (CX3CL1, FKN) mediates neural/microglial interactions via its sole receptor CX3CR1. CX3CL1/CX3CR1 signaling modulates microglia activation, and depending upon the type and time of injury, either protects or exacerbates neurological diseases. Methods: In this study, mice deficient in CX3CR1 were subjected to mild controlled cortical impact injury (CCI), a model of TBI. We evaluated the effects of genetic deletion of CX3CR1 on histopathology, cell death/survival, microglia activation, and cognitive function for 30 days post-injury. Results: During the acute post-injury period (24 h-15 days), motor deficits, cell death, and neuronal cell loss were more profound in injured wild-type than in CX3CR1(-/-) mice. In contrast, during the chronic period of 30 days post-TBI, injured CX3CR1(-/-) mice exhibited greater cognitive dysfunction and increased neuronal death than wild-type mice. The protective and deleterious effects of CX3CR1 were associated with changes in microglia phenotypes; during the acute phase CX3CR1(-/-) mice showed a predominant anti-inflammatory M2 microglial response, with increased expression of Ym1, CD206, and TGF beta. In contrast, increased M1 phenotypic microglia markers, Marco, and CD68 were predominant at 30 days post-TBI. Conclusion: Collectively, these novel data demonstrate a time-dependent role for CX3CL1/CX3CR1 signaling after TBI and suggest that the acute and chronic responses to mild TBI are modulated in part by distinct microglia phenotypes.	[Febinger, Heidi Y.; Thomasy, Hannah E.; Pavlova, Maria N.; Ringgold, Kristyn M.; Barf, Paulien R.; George, Amrita M.; Grillo, Jenna N.; Opp, Mark R.; Gemma, Carmelina] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98001 USA; [Thomasy, Hannah E.] Univ Washington, Neurosci Grad Program, Seattle, WA 98104 USA; [Grillo, Jenna N.] Univ Washington, Dept Biol, Seattle, WA 98104 USA; [Bachstetter, Adam D.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Garcia, Jenny A.; Cardona, Astrid E.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Garcia, Jenny A.; Cardona, Astrid E.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA		Gemma, C (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, BOX 359724, Seattle, WA 98001 USA.	cgemma@u.washington.edu	Cardona, Astrid E/K-4749-2013	Cardona, Astrid E/0000-0002-5093-8078; Bachstetter, Adam/0000-0003-4646-6757; Gemma, Carmelina/0000-0002-4480-0056; Opp, Mark/0000-0002-9831-9866	Department of Anesthesiology and Pain Medicine of the University of Washington; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [SC1GM095426]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [SC1GM095426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG044919] Funding Source: NIH RePORTER	This study was supported by the Department of Anesthesiology and Pain Medicine of the University of Washington and by NIH SC1GM095426.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Gaetani P, 2013, J NEUROSURG SCI, V57, P55; Garcia JA, 2013, J IMMUNOL, V191, P1063, DOI 10.4049/jimmunol.1300040; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kubova H, 2001, J NEUROSCI, V21, P3593, DOI 10.1523/JNEUROSCI.21-10-03593.2001; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Thawer SG, 2013, J NEUROIMMUNOL, V261, P7, DOI 10.1016/j.jneuroim.2013.04.008; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yoshida H, 2001, NEUROSCI LETT, V303, P132, DOI 10.1016/S0304-3940(01)01699-8; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y	58	54	55	1	22	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	SEP 2	2015	12								154	10.1186/s12974-015-0386-5			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CQ1CC	WOS:000360333900001	26329692	gold, Green Published			2022-02-06	
J	Maerlender, A; Rieman, W; Lichtenstein, J; Condiracci, C				Maerlender, Arthur; Rieman, Wanda; Lichtenstein, Jonathan; Condiracci, C.			Programmed Physical Exertion in Recovery From Sports-Related Concussion: A Randomized Pilot Study	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							EXERCISE	Although no data exist, general practice recommends only rest following concussion. This randomized clinical trial found that programmed physical exertion during recovery produced no significant differences in recovery time between groups of participants. However, high levels of exertion were deleterious. This study provides initial evidence that moderate physical activity is a safe replacement behavior during recovery.	[Maerlender, Arthur] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68558 USA; [Lichtenstein, Jonathan] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Condiracci, C.] Antioch New England Grad Sch, Keene, NH USA		Maerlender, A (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68558 USA.	amaerlender2@unl.edu			Hitchcock Foundation	Funding for this study was provided by the Hitchcock Foundation.	Borg G., 1998, BORGS PERCEIVED EXER; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Hinton-Bayre AD, 2012, CLIN J SPORT MED, V22, P105, DOI 10.1097/JSM.0b013e318248a526; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	13	54	55	0	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JUL 4	2015	40	5					273	278		10.1080/87565641.2015.1067706			6	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CP2MH	WOS:000359710700001	26230745	Green Published			2022-02-06	
J	Julio-Amilpas, A; Montiel, T; Soto-Tinoco, E; Geronimo-Olvera, C; Massieu, L				Julio-Amilpas, Alberto; Montiel, Teresa; Soto-Tinoco, Eva; Geronimo-Olvera, Cristian; Massieu, Lourdes			Protection of hypoglycemia-induced neuronal death by beta-hydroxybutyrate involves the preservation of energy levels and decreased production of reactive oxygen species	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						energy failure; hypoglycemia; ketone bodies; neuronal death; oxidative stress	FUNCTION IMPROVING AGENT; KETONE-BODY UTILIZATION; TRAUMATIC BRAIN-INJURY; KETOGENIC DIET; RAT-BRAIN; GLYCOLYSIS INHIBITION; COGNITIVE IMPAIRMENT; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; IN-VIVO	Glucose is the main energy substrate in brain but in certain circumstances such as prolonged fasting and the suckling period alternative substrates can be used such as the ketone bodies (KB), beta-hydroxybutyrate (BHB), and acetoacetate. It has been shown that KB prevent neuronal death induced during energy limiting conditions and excitotoxicity. The protective effect of KB has been mainly attributed to the improvement of mitochondrial function. In the present study, we have investigated the protective effect of D-BHB against neuronal death induced by severe noncoma hypoglycemia in the rat in vivo and by glucose deprivation (GD) in cortical cultures. Results show that systemic administration of D-BHB reduces reactive oxygen species (ROS) production in distinct cortical areas and subregions of the hippocampus and efficiently prevents neuronal death in the cortex of hypoglycemic animals. In vitro results show that D-BHB stimulates ATP production and reduces ROS levels, while the nonphysiologic isomer of BHB, L-BHB, has no effect on energy production but reduces ROS levels. Data suggest that protection by BHB, not only results from its metabolic action but is also related to its capability to reduce ROS, rendering this KB as a suitable candidate for the treatment of ischemic and traumatic injury.	[Julio-Amilpas, Alberto; Montiel, Teresa; Soto-Tinoco, Eva; Geronimo-Olvera, Cristian; Massieu, Lourdes] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neuropatol Mol, Div Neurociencias, Mexico City 04510, DF, Mexico		Massieu, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neuropatol Mol, Div Neurociencias, AP 70-253, Mexico City 04510, DF, Mexico.	lmassieu@ifc.unam.mx		Soto-Tinoco, Eva/0000-0001-8482-2076	CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [S112179]; PAPIIT (UNAM)Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IN204213]	This work was supported by CONACYT S112179 and PAPIIT (UNAM) IN204213 grants to LM.	Amador-Alvarado L, 2014, METAB BRAIN DIS, V29, P711, DOI 10.1007/s11011-014-9508-5; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Choi BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081523; Ennis K, 2008, BRAIN RES, V1224, P119, DOI 10.1016/j.brainres.2008.06.003; Gibson CL, 2012, J NEUROCHEM, V123, P52, DOI 10.1111/j.1471-4159.2012.07943.x; Haces ML, 2010, NEUROSCIENCE, V165, P28, DOI 10.1016/j.neuroscience.2009.10.003; Haces ML, 2008, EXP NEUROL, V211, P85, DOI 10.1016/j.expneurol.2007.12.029; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Massieu L, 2003, NEUROSCIENCE, V120, P365, DOI 10.1016/S0306-4522(03)00266-5; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; Mejia-Toiber J, 2006, NEUROCHEM RES, V31, P1399, DOI 10.1007/s11064-006-9189-5; Neal EG, 2009, EPILEPSIA, V50, P1109, DOI 10.1111/j.1528-1167.2008.01870.x; NEHLIG A, 1993, PROG NEUROBIOL, V40, P163, DOI 10.1016/0301-0082(93)90022-K; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; Nordli DR, 2001, PEDIATRICS, V108, P129, DOI 10.1542/peds.108.1.129; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; SANDBERG M, 1986, J NEUROCHEM, V47, P178; Schutz PW, 2011, EXP NEUROL, V227, P180, DOI 10.1016/j.expneurol.2010.10.013; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2003, J NEUROSCI, V23, P10681; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Tai KK, 2008, J NEURAL TRANSM, V115, P1011, DOI 10.1007/s00702-008-0050-7; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Tkacs NC, 2005, J CEREBR BLOOD F MET, V25, P1645, DOI 10.1038/sj.jcbfm.9600152; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Yamada KA, 2005, NEUROSCI LETT, V385, P210, DOI 10.1016/j.neulet.2005.05.038; Yudkoff M, 2001, J NEUROSCI RES, V66, P931, DOI 10.1002/jnr.10083; Zhang JY, 2013, BIOMATERIALS, V34, P7552, DOI 10.1016/j.biomaterials.2013.06.043; Zhang YF, 2013, J CEREBR BLOOD F MET, V33, P1307, DOI 10.1038/jcbfm.2013.87; Zhou D, 2012, EUR J PEDIATR, V171, P103, DOI 10.1007/s00431-011-1489-3	44	54	55	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2015	35	5					851	860		10.1038/jcbfm.2015.1			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CH1GK	WOS:000353769100020	25649993	Green Published, Bronze			2022-02-06	
J	Fuller, CW; Taylor, A; Raftery, M				Fuller, Colin W.; Taylor, Aileen; Raftery, Martin			Epidemiology of concussion in men's elite Rugby-7s (Sevens World Series) and Rugby-15s (Rugby World Cup, Junior World Championship and Rugby Trophy, Pacific Nations Cup and English Premiership)	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CONSENSUS STATEMENT; POSITION STATEMENT; INJURIES; UNION; SPORT	Objective To determine the incidence, nature and causes of concussions sustained during men's elite professional Rugby-7s and Rugby-15s. Design A prospective cohort study recording injuries classified as a time-loss concussion. Population Players competing in the following tournaments: Rugby 15s-English Premiership (2007/2008 to 2010/2011), Rugby World Cup (2007, 2011), Pacific Nations Cup (2012, 2013), Junior World Championship (2008, 2010-2013), Junior World Rugby Trophy (2008, 2010-2013); Rugby 7s-Sevens World Series (2008/2009, 2010/2011 to 2012/2013). Method The study was implemented according to the international consensus statement for epidemiological studies in rugby union; the main outcome measures included the number, incidence (number of concussions/1000 player-match-hours), mean and median severity (days absence) and cause of concussion. Results The incidence of concussion in Rugby-7s was significantly higher than that in Rugby-15s (risk ratio=1.84; p<0.001). The severity of concussions were significantly higher in Rugby-7s than Rugby-15s (mean-Rugby-7s: 19.2, Rugby-15s: 10.1; median-Rugby 7s: 20, Rugby-15s: 7; p<0.001). The main causes of concussion were tackling (44.1%) in Rugby-7s and collisions (43.6%) in Rugby-15s. Significantly more (risk ratio=1.49; p=0.004) concussed players were removed immediately from the game in Rugby-7s (69.7%) compared to Rugby-15s (46.7%). Conclusions Six actions were identified to improve the management of concussion in rugby: implement a pitch-side concussion assessment protocol; improve compliance with return-to-play protocols; work with referees to review the nature and consequences of collisions; improve players' tackle technique; investigate the forces involved in tackles and collisions; and evaluate reasons for the higher incidence of concussions in Rugby-7s.	[Fuller, Colin W.; Taylor, Aileen; Raftery, Martin] Int Rugby Board, Dublin 2, Ireland		Fuller, CW (corresponding author), Int Rugby Board, Huguenot House, Dublin 2, Ireland.	colin.fuller@f-marc.com			International Rugby Board; Rugby Football Union	The epidemiological studies were funded by the International Rugby Board (Rugby World Cup, Junior World Championship, Junior World Rugby Trophy, Pacific Nations Cup, Sevens World Series) and the Rugby Football Union (English Premiership). Data collection studies were funded by the International Rugby Board and the Rugby Football Union.	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], TITLE ERROR; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2010, CLIN J SPORT MED, V20, P179, DOI 10.1097/JSM.0b013e3181df1eea; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Higham DG, 2012, J SCI MED SPORT, V15, P277, DOI 10.1016/j.jsams.2011.11.256; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Kelly JP, 1997, NEUROLOGY, V48, P581; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kirkwood B. R., 2003, ESSENTIAL MEDICAL ST; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Orchard J., 1995, SPORT HLTH, V11, P39; Patricios JS, 2014, BRIT J SPORT MED, V48, P76, DOI 10.1136/bjsports-2013-093031; Raftery M, 2014, BRIT J SPORT MED, V48, P79, DOI 10.1136/bjsports-2013-093051; West TA, 2008, J NEUROTRAUM, V38, P975; White PE, 2014, BRIT J SPORT MED, V48, P130, DOI 10.1136/bjsports-2013-092720	25	54	54	4	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR	2015	49	7					478	483		10.1136/bjsports-2013-093381			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CD6ZA	WOS:000351238500012	24659504				2022-02-06	
J	Kostyun, RO; Milewski, MD; Hafeez, I				Kostyun, Regina O.; Milewski, Matthew D.; Hafeez, Imran			Sleep Disturbance and Neurocognitive Function During the Recovery From a Sport-Related Concussion in Adolescents	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sleep; ImPACT; athletes	4TH INTERNATIONAL-CONFERENCE; PREDICT PROTRACTED RECOVERY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; POSTCONCUSSION SYNDROME; ACADEMIC-PERFORMANCE; CONSENSUS STATEMENT; DAYTIME SLEEPINESS; SYMPTOMS; PATTERNS	Background: Sleep disturbances are a hallmark sign after a sport-related concussion (SRC). Poor sleep has been shown to adversely affect baseline neurocognitive test scores, but it is not comprehensively understood how neurocognitive function is affected by disrupted sleep during recovery from a concussion. Purpose: To identify the correlation between adolescent athletes' neurocognitive function and their self-reported sleep quantity and sleep disturbance symptoms during recovery from SRC. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Immediate Post-Concussion Assessment and Cognition Testing (ImPACT) data were retrospectively collected for 545 adolescent athletes treated for SRC at a sports medicine concussion clinic. Patients were stratified into groups based on 2 criteria: self-reported sleep duration and self-reported sleep disturbance symptoms during postinjury ImPACT testing. Sleep duration was classified as short (<7 hours), intermediate (7-9 hours), and long (>9 hours). Sleep disturbance symptoms were self-reported as part of the Post-Concussion Symptom Scale (PCSS) as either sleeping less than normal, sleeping more than normal, or having trouble falling asleep. One-way analyses of variance were conducted to examine the effects that sleep duration as well as self-reported sleep disturbance symptoms had on composite scores. A total of 1067 ImPACT tests were analyzed: test 1, 545; test 2, 380; and test 3, 142. Results: Sleeping fewer than 7 hours the night before testing correlated with higher PCSS scores (P < .001), whereas sleeping longer than 9 hours correlated with worse visual memory (P = .01), visual motor speed (P <.001), and reaction time (P = .04) composite scores. With regard to self-reported sleep disturbance symptoms, patients demonstrated worse composite scores during ImPACT testing when they self-reported sleeping more than normal (ImPACT test 1: verbal memory, P < .001; visual motor speed, P = .05; reaction time, P = .01; ImPACT test 2: verbal memory, P < .001; visual memory, P < .001; visual motor speed, P < .001; reaction time, P = .01). Adolescent patients recovering from SRC demonstrated higher (worse) PCSS scores (P < .001) when they sensed that their sleep had been disrupted. Conclusion: Adolescent patients who perceive that their sleep is somehow disrupted after SRC may report a greater number of concussion symptoms during their recovery. In addition, the study results suggest that sleeping more than normal may identify an individual who continues to be actively recovering from concussion, given the correlation between lower neurocognitive function and this self-reported symptom.	[Kostyun, Regina O.; Milewski, Matthew D.; Hafeez, Imran] Elite Sports Med, Farmington, CT USA		Kostyun, RO (corresponding author), Connecticut Childrens Med Ctr, Elite Sports Med, 399 Farmington Ave, Farmington, CT 06032 USA.	rkostyun@connecticutchildrens.org	Meijer, Anna/K-5118-2016				Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; CARSKADON M A, 1990, Pediatrician, V17, P5; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; CHALLAMEL MJ, 1994, SLEEP, V17, pS17, DOI 10.1093/sleep/17.suppl_8.S17; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Drake C, 2003, SLEEP, V26, P455; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eaton DK, 2010, J ADOLESCENT HEALTH, V46, P399, DOI 10.1016/j.jadohealth.2009.10.011; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galland BC, 2012, SLEEP MED REV, V16, P213, DOI 10.1016/j.smrv.2011.06.001; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kotagal S, 2009, CHILD ADOL PSYCH CL, V18, P967, DOI 10.1016/j.chc.2009.04.006; Krueger JM, 2003, FRONT BIOSCI-LANDMRK, V8, pD511, DOI 10.2741/1031; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Neveus T, 2001, ACTA PAEDIATR, V90, P1450; Ohayon MM, 2000, J AM ACAD CHILD PSY, V39, P1549, DOI 10.1097/00004583-200012000-00019; Perez-Chada D, 2007, SLEEP, V30, P1698, DOI 10.1093/sleep/30.12.1698; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Trockel MT, 2000, J AM COLL HEALTH, V49, P125, DOI 10.1080/07448480009596294; Wolfson AR, 2003, SLEEP MED REV, V7, P491, DOI 10.1016/S1087-0792(03)90003-7; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	54	54	54	0	35	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2015	43	3					633	640		10.1177/0363546514560727			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	CC6JP	WOS:000350471500016	25520301				2022-02-06	
J	Jalloh, I; Carpenter, KLH; Grice, P; Howe, DJ; Mason, A; Gallagher, CN; Helmy, A; Murphy, MP; Menon, DK; Carpenter, TA; Pickard, JD; Hutchinson, PJ				Jalloh, Ibrahim; Carpenter, Keri L. H.; Grice, Peter; Howe, Duncan J.; Mason, Andrew; Gallagher, Clare N.; Helmy, Adel; Murphy, Michael P.; Menon, David K.; Carpenter, T. Adrian; Pickard, John D.; Hutchinson, Peter J.			Glycolysis and the pentose phosphate pathway after human traumatic brain injury: microdialysis studies using 1,2-C-13(2) glucose	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						C-13-labeling; glycolysis; lactate; pentose phosphate pathway; traumatic brain injury (human)	POSITRON-EMISSION-TOMOGRAPHY; TRICARBOXYLIC-ACID CYCLE; C-13-LABELED MICRODIALYSIS; OXIDATIVE STRESS; LACTATE; METABOLISM; FLUX; C-13; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; GLUTATHIONE	Increased 'anaerobic' glucose metabolism is observed after traumatic brain injury (TBI) attributed to increased glycolysis. An alternative route is the pentose phosphate pathway (PPP), which generates putatively protective and reparative molecules. To compare pathways we employed microdialysis to perfuse 1,2-C-13(2) glucose into the brains of 15 TBI patients and macroscopically normal brain in six patients undergoing surgery for benign tumors, and to simultaneously collect products for nuclear magnetic resonance (NMR) analysis. C-13 enrichment for glycolytic 2,3-C-13(2) lactate was the median 5.4% (interquartile range (IQR) 4.6-7.5%) in TBI brain and 4.2% (2.4-4.4%) in 'normal' brain (P < 0.01). The ratio of PPP-derived 3-C-13 lactate to glycolytic 2,3-C-13(2) lactate was median 4.9% (3.6-8.2%) in TBI brain and 6.7% (6.3-8.9%) in 'normal' brain. An inverse relationship was seen for PPP-glycolytic lactate ratio versus PbtO2 (r = -0.5, P = 0.04) in TBI brain. Thus, glycolytic lactate production was significantly greater in TBI than 'normal' brain. Several TBI patients exhibited PPP-lactate elevation above the 'normal' range. There was proportionally greater PPP-derived lactate production with decreasing PbtO2. The study raises questions about the roles of the PPP and glycolysis after TBI, and whether they can be manipulated to achieve a better outcome. This study is the first direct comparison of glycolysis and PPP in human brain.	[Jalloh, Ibrahim; Carpenter, Keri L. H.; Gallagher, Clare N.; Helmy, Adel; Pickard, John D.; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Carpenter, Keri L. H.; Menon, David K.; Carpenter, T. Adrian; Pickard, John D.; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge CB2 0QQ, England; [Grice, Peter; Howe, Duncan J.; Mason, Andrew] Univ Cambridge, Dept Chem, Cambridge CB2 0QQ, England; [Gallagher, Clare N.] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB, Canada; [Murphy, Michael P.] MRC Mitochondrial Biol Unit, Cambridge, England; [Menon, David K.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England		Jalloh, I (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167 Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	ij232@cam.ac.uk	Helmy, Adel/AAS-3084-2020; Murphy, Michael/C-2120-2009	Helmy, Adel/0000-0002-0531-0556; Carpenter, Keri/0000-0001-8236-7727; Grice, Peter/0000-0003-4658-4534; Murphy, Michael/0000-0003-1115-9618; Hutchinson, Peter/0000-0002-2796-1835	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986 ID79068, G1002277 ID98489, G1002277 ID 98489]; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Medical Research Council/Royal College of Surgeons of EnglandUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; Raymond and Beverly Sackler Fellowship; National Institute for Health ResearchNational Institute for Health Research (NIHR); National Institute for Health Research, Academy of Medical Sciences/Health Foundation; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000183B, MC_U105663142, G1002277, G0001354, G0001354B, G9439390, G0600986, G0802251] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2006-14-004, NF-SI-0508-10327, NIHR-RP-R3-12-013, NF-SI-0512-10090] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0802251, MC_U105663142, G0600986, G1002277] Funding Source: UKRI	Medical Research Council (Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). I.J. was supported by the Medical Research Council ( Grant no. G1002277 ID 98489) and the National Institute for Health Research Biomedical Research Centre, Cambridge; K.L.H.C. was supported by the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); C.G. was supported by the the Canadian Institute of Health Research; A.H.-Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (Grant no. G0802251) and Raymond and Beverly Sackler Fellowship; D.K.M. and J.D.P. were supported by the National Institute for Health Research Senior Investigator Awards; P.J.H. was supported by the National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship.	Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; BenYoseph O, 1996, J NEUROCHEM, V66, P2329; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Brekke EMF, 2014, J CEREBR BLOOD F MET, V34, P724, DOI 10.1038/jcbfm.2014.8; Brekke EMF, 2012, J CEREBR BLOOD F MET, V32, P1788, DOI 10.1038/jcbfm.2012.85; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.3.CO;2-5; DOMANSKAJANIK K, 1988, RESUSCITATION, V16, P79, DOI 10.1016/0300-9572(88)90073-1; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Puskas F, 2000, FASEB J, V14, P1352, DOI 10.1096/fj.14.10.1352; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; ROSDAHL H, 1993, J PHYSIOL-LONDON, V471, P637, DOI 10.1113/jphysiol.1993.sp019920; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Talukdar I, 2005, J BIOL CHEM, V280, P40660, DOI 10.1074/jbc.M505531200; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tyson RL, 2000, NEUROREPORT, V11, P1845, DOI 10.1097/00001756-200006260-00009; Tyson RL, 2003, BRAIN RES, V992, P43, DOI 10.1016/j.brainres.2003.08.027; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Zuurbier CJ, 2004, CARDIOVASC RES, V62, P145, DOI 10.1016/j.cardiores.2004.01.010	34	54	54	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2015	35	1					111	120		10.1038/jcbfm.2014.177			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AY2AZ	WOS:000347392200014	25335801	Green Published, hybrid, Green Accepted			2022-02-06	
J	Shin, JC; Kim, KN; Yoo, J; Kim, IS; Yun, S; Lee, H; Jung, K; Hwang, K; Kim, M; Lee, IS; Shin, JE; Park, KI				Shin, Ji Cheol; Kim, Keung Nyun; Yoo, Jeehyun; Kim, Il-Sun; Yun, Seokhwan; Lee, Hyejin; Jung, Kwangsoo; Hwang, Kyujin; Kim, Miri; Lee, Il-Shin; Shin, Jeong Eun; Park, Kook In			Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury	NEURAL PLASTICITY			English	Article							QUALITY-OF-LIFE; STEM-CELLS; FUNCTIONAL RECOVERY; MOTOR RECOVERY; IMMUNE CELLS; ICCP PANEL; REPAIR; MODEL; DIFFERENTIATION; COMPLICATIONS	In a phase I/IIa open-label and nonrandomized controlled clinical trial, we sought to assess the safety and neurological effects of human neural stem/progenitor cells (hNSPCs) transplanted into the injured cord after traumatic cervical spinal cord injury (SCI). Of 19 treated subjects, 17 were sensorimotor complete and 2 were motor complete and sensory incomplete. hNSPCs derived from the fetal telencephalon were grown as neurospheres and transplanted into the cord. In the control group, who did not receive cell implantation but were otherwise closely matched with the transplantation group, 15 patients with traumatic cervical SCI were included. At 1 year after cell transplantation, there was no evidence of cord damage, syrinx or tumor formation, neurological deterioration, and exacerbating neuropathic pain or spasticity. The American Spinal Injury Association Impairment Scale (AIS) grade improved in 5 of 19 transplanted patients, 2 (A -> C), 1 (A -> B), and 2 (B -> D), whereas only one patient in the control group showed improvement (A -> B). Improvements included increased motor scores, recovery of motor levels, and responses to electrophysiological studies in the transplantation group. Therefore, the transplantation of hNSPCs into cervical SCI is safe and well-tolerated and is of modest neurological benefit up to 1 year after transplants. This trial is registered with Clinical Research Information Service (CRIS), Registration Number: KCT0000879.	[Shin, Ji Cheol; Yoo, Jeehyun] Yonsei Univ, Coll Med, Dept Rehabil Med, Seoul 120752, South Korea; [Shin, Ji Cheol; Yoo, Jeehyun] Yonsei Univ, Coll Med, Res Inst Rehabil Med, Seoul 120752, South Korea; [Kim, Keung Nyun] Yonsei Univ, Coll Med, Dept Neurosurg, Seoul 120752, South Korea; [Kim, Il-Sun; Lee, Il-Shin; Shin, Jeong Eun; Park, Kook In] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat, Seoul 120752, South Korea; [Yun, Seokhwan; Lee, Hyejin; Jung, Kwangsoo; Hwang, Kyujin; Kim, Miri; Park, Kook In] Yonsei Univ, Coll Med, Plus Project Med Sci BK21, Seoul 120752, South Korea		Park, KI (corresponding author), Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat, Seoul 120752, South Korea.	kipark@yuhs.ac		Jung, Kwangsoo/0000-0001-7365-7247; Kim, Il-Sun/0000-0003-4033-4323; Hwang, kyujin/0000-0001-5193-5154; Yun, Seokhwan/0000-0002-9504-5230; Yoo, Jeehyun/0000-0002-1555-8029; Shin, Ji Cheol/0000-0002-1133-1361; Shin, Jeong Eun/0000-0002-4376-8541	National Research Foundation [2013M3A9B4076545]; Korean Health Technology RD Project [A121943, HI14C1564]; Faculty Grant of Yonsei University College of Medicine [6-2006-0017]; Severance Hospital in Seoul, Korea	This work was supported by Grants from National Research Foundation (2013M3A9B4076545) and Korean Health Technology R&D Project (A121943, HI14C1564), Faculty Grant of Yonsei University College of Medicine (6-2006-0017), and the Severance Hospital in Seoul, Korea. The authors thank Professor Chang-il Park, Department of Rehabilitation Medicine, and Professor Chul Lee, Department of Pediatrics, Yonsei University College of Medicine, for supporting the clinical trial in the Severance Hospital.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Akesson E, 2007, PHYSIOL BEHAV, V92, P60, DOI 10.1016/j.physbeh.2007.05.056; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barrett H, 2003, ARCH PHYS MED REHAB, V84, P789, DOI 10.1016/S0003-9993(02)04944-4; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; Consortium for Spinal Cord Medicine, 2003, J SPINAL CORD MED, V23, P289; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Curt A, 1999, SPINAL CORD, V37, P157, DOI 10.1038/sj.sc.3100809; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Ditunno JF, 2000, ARCH PHYS MED REHAB, V81, P389, DOI 10.1053/mr.2000.3779; Ditunno Jr J. F., 2002, SPINAL CORD MED; Dumitru D., 2002, ELECTRODIAGNOSTIC ME; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Fisher CG, 2005, SPINE, V30, P2200, DOI 10.1097/01.brs.0000181058.06412.a9; Flanders AE, 1996, RADIOLOGY, V201, P649, DOI 10.1148/radiology.201.3.8939210; Globe Newswire Stem Cells Inc, STEM CELLS; Graves, 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323; Hitzig SL, 2008, AM J PHYS MED REHAB, V87, P545, DOI 10.1097/PHM.0b013e31817c16d6; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Jensen MP, 1992, HDB PAIN ASSESSMENT; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Lechner HE, 2006, ARCH PHYS MED REHAB, V87, P15, DOI 10.1016/j.apmr.2005.07.312; Lee H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104092; Lima C, 2010, NEUROREHAB NEURAL RE, V24, P10, DOI 10.1177/1545968309347685; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Macias MY, 2006, EXP NEUROL, V201, P335, DOI 10.1016/j.expneurol.2006.04.035; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; MARINO RJ, 1994, MUSCLE NERVE, V17, P1466, DOI 10.1002/mus.880171218; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Moviglia GA, 2006, CYTOTHERAPY, V8, P202, DOI 10.1080/14653240600736048; Noonan VK, 2008, ARCH PHYS MED REHAB, V89, P1074, DOI 10.1016/j.apmr.2007.10.041; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Potter K, 2003, BRIT J RADIOL, V76, P347, DOI 10.1259/bjr/11881183; Ramon S, 1997, SPINAL CORD, V35, P664, DOI 10.1038/sj.sc.3100490; Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Shinawi M, 2008, DRUG DISCOV TODAY, V13, P760, DOI 10.1016/j.drudis.2008.06.007; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Steeves JD, 2011, SPINAL CORD, V49, P257, DOI 10.1038/sc.2010.99; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; Xie J, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E11; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	65	54	58	0	9	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2015	2015								630932	10.1155/2015/630932			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU5KD	WOS:000363569900001	26568892	Green Published, gold, Green Submitted			2022-02-06	
J	Clausen, BH; Degn, M; Martin, NA; Couch, Y; Karimi, L; Ormhoj, M; Mortensen, MLB; Gredal, HB; Gardiner, C; Sargent, IIL; Szymkowski, DE; Petit, GH; Deierborg, T; Finsen, B; Anthony, DC; Lambertsen, KL				Clausen, Bettina Hjelm; Degn, Matilda; Martin, Nellie Anne; Couch, Yvonne; Karimi, Leena; Ormhoj, Maria; Mortensen, Maria-Louise Bergholdt; Gredal, Hanne Birgit; Gardiner, Chris; Sargent, Ian I. L.; Szymkowski, David E.; Petit, Geraldine H.; Deierborg, Tomas; Finsen, Bente; Anthony, Daniel Clive; Lambertsen, Kate Lykke			Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia	JOURNAL OF NEUROINFLAMMATION			English	Article						SolTNF and tmTNF; Granulocytes; Behavior; Acute phase response; Microvesicle; Inflammation	TUMOR-NECROSIS-FACTOR; MICROGLIAL-MACROPHAGE SYNTHESIS; TRAUMATIC BRAIN-INJURY; FACTOR-ALPHA; CHRONIC STROKE; ETANERCEPT; MODEL; MICE; EXPRESSION; PROTECTS	Background: The innate immune system contributes to the outcome after stroke, where neuroinflammation and post-stroke systemic immune depression are central features. Tumor necrosis factor (TNF), which exists in both a transmembrane (tm) and soluble (sol) form, is known to sustain complex inflammatory responses associated with stroke. We tested the effect of systemically blocking only solTNF versus blocking both tmTNF and solTNF on infarct volume, functional outcome and inflammation in focal cerebral ischemia. Methods: We used XPro1595 (a dominant-negative inhibitor of solTNF) and etanercept (which blocks both solTNF and tmTNF) to test the effect of systemic administration on infarct volume, functional recovery and inflammation after focal cerebral ischemia in mice. Functional recovery was evaluated after one, three and five days, and infarct volumes at six hours, 24 hours and five days after ischemia. Brain inflammation, liver acute phase response (APR), spleen and blood leukocyte profiles, along with plasma microvesicle analysis, were evaluated. Results: We found that both XPro1595 and etanercept significantly improved functional outcomes, altered microglial responses, and modified APR, spleen T cell and microvesicle numbers, but without affecting infarct volumes. Conclusions: Our data suggest that XPro1595 and etanercept improve functional outcome after focal cerebral ischemia by altering the peripheral immune response, changing blood and spleen cell populations and decreasing granulocyte infiltration into the brain. Blocking solTNF, using XPro1595, was just as efficient as blocking both solTNF and tmTNF using etanercept. Our findings may have implications for future treatments with anti-TNF drugs in TNF-dependent diseases.	[Clausen, Bettina Hjelm; Martin, Nellie Anne; Couch, Yvonne; Karimi, Leena; Ormhoj, Maria; Mortensen, Maria-Louise Bergholdt; Gredal, Hanne Birgit; Finsen, Bente; Anthony, Daniel Clive; Lambertsen, Kate Lykke] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, DK-5000 Odense, Denmark; [Degn, Matilda] Glostrup Cty Hosp, Dept Diagnost, Mol Sleep Lab, DK-2600 Glostrup, Denmark; [Couch, Yvonne; Anthony, Daniel Clive] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Gardiner, Chris; Sargent, Ian I. L.] Univ Oxford, Nuffield Dept Obstet & Gynecol, Oxford OX1 3QT, England; [Petit, Geraldine H.; Deierborg, Tomas] Lund Univ, Dept Clin Sci, Neuronal Survival Unit, Lab Expt Med Sci, S-22100 Lund, Sweden; [Szymkowski, David E.] Xencor Inc, Monrovia, CA 91016 USA; [Gredal, Hanne Birgit] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, DK-1870 Frederiksberg, Denmark		Lambertsen, KL (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, JB Winsloewsvej 21, DK-5000 Odense, Denmark.	klambertsen@health.sdu.dk	Anthony, Daniel C/F-7765-2010; Gardiner, Chris/F-1178-2011; Deierborg, Tomas/P-6345-2015; Lambertsen, Kate L./I-8676-2014	Anthony, Daniel C/0000-0003-1380-6655; Gardiner, Chris/0000-0002-2318-0062; Deierborg, Tomas/0000-0002-3651-3444; Degn, Matilda/0000-0003-3093-3525; Lambertsen, Kate L./0000-0001-9276-4902; Ormhoj, Maria/0000-0002-0997-8262; Clausen, Bettina Hjelm/0000-0003-3302-2022; Finsen, Bente/0000-0002-8323-9329; Szymkowski, David/0000-0002-8934-7902; Gredal, Hanne/0000-0001-5582-1816	Lundbeck Foundation, Copenhagen, DenmarkLundbeckfonden [R54-A5539, R67-A6383]; Novo Nordisk Foundation, Hellerup, DenmarkNovo Nordisk Foundation [R153-A-12550, R168-A14120]; Carlsberg Foundation, Copenhagen, DenmarkCarlsberg Foundation [2007_01_0176]; Fonden til Laegevidenskabens Fremme; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/J003360/1] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/J003360/1] Funding Source: UKRI	We acknowledge skilled technical help from technicians Louise Lykkemark, Dorte Lyholmer, Signe Marie Andersen and Sussanne Petersen. This work was supported by research grants from the Lundbeck Foundation, Copenhagen, Denmark (KLL (R54-A5539) and BHC (R67-A6383)), the Novo Nordisk Foundation, Hellerup, Denmark (R153-A-12550 and R168-A14120) and the Carlsberg Foundation, Copenhagen, Denmark (KLL, 2007_01_0176). Fonden til Laegevidenskabens Fremme is also acknowledged for their financial support.	Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Azevedo Luciano C P, 2007, Recent Pat Cardiovasc Drug Discov, V2, P41, DOI 10.2174/157489007779606121; Barnum CJ, 2014, J PARKINSON DIS, V4, P349, DOI 10.3233/JPD-140410; Bautista LE, 2005, J HUM HYPERTENS, V19, P149, DOI 10.1038/sj.jhh.1001785; Boettger MK, 2008, ARTHRITIS RHEUM-US, V58, P2368, DOI 10.1002/art.23608; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Couch Y, 2013, BRAIN BEHAV IMMUN, V29, P136, DOI 10.1016/j.bbi.2012.12.017; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Johansen Flemming Fryd, 2003, J Stroke Cerebrovasc Dis, V12, P97; King MD, 2013, NEUROSCI LETT, V542, P92, DOI 10.1016/j.neulet.2013.02.051; Lambertsen KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047744; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Lambertsen KL, 2005, J CEREBR BLOOD F MET, V25, P119, DOI 10.1038/sj.jcbfm.9600014; Lambertsen KL, 2002, J CEREBR BLOOD F MET, V22, P785, DOI 10.1097/00004647-200207000-00004; Li K, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/901420; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; Nielsen HH, 2011, AM J PATHOL, V179, P2028, DOI 10.1016/j.ajpath.2011.06.006; Novrup HG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0159-6; Olleros ML, 2009, J INFECT DIS, V199, P1053, DOI 10.1086/597204; Petit GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060691; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Scheinfeld N, 2004, J Dermatolog Treat, V15, P280; Shen C, 2005, CLIN IMMUNOL, V115, P250, DOI 10.1016/j.clim.2005.01.007; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Soriano SG, 1999, STROKE, V30, P134, DOI 10.1161/01.STR.30.1.134; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Sumbria RK, 2012, J CEREBR BLOOD F MET, V32, P1933, DOI 10.1038/jcbfm.2012.97; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; Verderio C, 2012, ANN NEUROL, V72, P610, DOI 10.1002/ana.23627; Yu NC, 1998, NEUROIMMUNOMODULAT, V5, P42, DOI 10.1159/000026325; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872	45	54	54	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 12	2014	11								203	10.1186/s12974-014-0203-6			17	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AY2NH	WOS:000347426400001	25498129	gold, Green Published			2022-02-06	
J	Zehtabchi, S; Baki, SGA; Falzon, L; Nishijima, DK				Zehtabchi, Shahriar; Baki, Samah G. Abdel; Falzon, Louise; Nishijima, Daniel K.			Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							COAGULOPATHY; COAGULATION	Objective: The antifibrinolytic agent tranexamic acid (TXA) has demonstrated clinical benefit in trauma patients with severe bleeding, but its effectiveness in patients with traumatic brain injury (TBI) is unclear. We conducted a systematic review to evaluate the following research question: In ED patients with or at risk of intracranial hemorrhage (ICH) secondary to TBI, does TXA compared to placebo improve patients' outcomes? Methods: MEDLINE, EMBASE, CINAHL, and other databases were searched for randomized controlled trial (RCT) or quasi-RCT studies that compared the effect of TXA to placebo on outcomes of TBI patients. The main outcomes of interest included mortality, neurologic function, hematoma expansion, and adverse effects. We used "Grading quality of evidence and strength of recommendations" to assess the quality of trials. Two authors independently abstracted data using a data collection form. Results from studies were pooled when appropriate. Results: Of 1030 references identified through the search, 2 high-quality RCTs met inclusion criteria. The effect of TXA on mortality had a pooled relative risk of 0.64 (95% confidence interval [CI], 0.41-1.02); on unfavorable functional status, a relative risk of 0.77 (95% CI, 0.59-1.02); and on ICH progression, a relative risk of 0.76 (95% CI, 0.58-0.98). No serious adverse effects (such as thromboembolic events) associated with TXA group were reported in the included trials. Conclusion: Pooled results from the 2 RCTs demonstrated statistically significant reduction in ICH progression with TXA and a nonstatistically significant improvement of clinical outcomes in ED patients with TBI. Further evidence is required to support its routine use in patients with TBI. (C) 2014 Elsevier Inc. All rights reserved.	[Zehtabchi, Shahriar; Baki, Samah G. Abdel] Suny Downstate Med Ctr, Dept Emergency Med, Brooklyn, NY 11203 USA; [Falzon, Louise] Columbia Univ, Dept Med, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY USA; [Nishijima, Daniel K.] Univ Calif Davis, Dept Emergency Med, Davis, CA 95616 USA		Zehtabchi, S (corresponding author), Suny Downstate Med Ctr, Dept Emergency Med, 450 Clarkson Ave,Box 1228, Brooklyn, NY 11203 USA.	Shahriar.zehtabchi@downstate.edu; samahabdulbaki@gmail.com; af2215@cumc.columbia.edu; daniel.nishijima@ucdmc.ucdavis.edu	Falzon, Louise/AAG-2404-2019	Falzon, Louise/0000-0002-9449-6056; zehtabchi, shahriar/0000-0002-6427-986X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R41HD072881-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R41HD072881] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002] Funding Source: NIH RePORTER	SZ, LF, and DKN have no conflict of interest to report. SGA owns stock options in Bio-Signal Group Corporation and is a coinventor on US patents pending 61/554, 743 and 13/284, and 886. He is also the principal investigator of a National Institutes of Health-funded trial 5R41HD072881-02.	Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; CRASH-2 CollaboratorsIntracranial Bleeding Study, 2011, BMJ-BRIT MED J, V343, P354; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; Faul M, 2010, TRAUMATIC BRAIN INJU; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Olin GL, 2006, 5 MOST COSTLY MED CO; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Roberts I, 2012, COCHRANE DB SYST REV; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	25	54	58	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2014	32	12					1503	1509		10.1016/j.ajem.2014.09.023			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AW6AX	WOS:000346353000013	25447601	Green Accepted			2022-02-06	
J	Flint, AC; Conell, C; Rao, VA; Klingman, JG; Sidney, S; Johnston, C; Hemphill, JC; Kamel, H; Davis, SM; Donnan, GA				Flint, Alexander C.; Conell, Carol; Rao, Vivek A.; Klingman, Jeff G.; Sidney, Stephen; Johnston, Claiborne; Hemphill, J. Claude; Kamel, Hooman; Davis, Stephen M.; Donnan, Geoffrey A.			Effect of Statin Use During Hospitalization for Intracerebral Hemorrhage on Mortality and Discharge Disposition	JAMA NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; INSTRUMENTAL VARIABLES; METAANALYSIS; THERAPY; IMPROVE; RISK; ATORVASTATIN; ASSOCIATION	IMPORTANCE Statin use during hospitalization is associated with improved survival and a better discharge disposition among patients with ischemic stroke. It is unclear whether inpatient statin use has a similar effect among patients with intracerebral hemorrhage (ICH). OBJECTIVE To determine whether inpatient statin use in ICH is associated with improved outcomes and whether the cessation of statin use is associated with worsened outcomes. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of 3481 patients with ICH admitted to any of 20 hospitals in a large integrated health care delivery system over a 10-year period. Detailed electronic medical and pharmacy records were analyzed to explore the association between inpatient statin use and outcomes. MAIN OUTCOMES AND MEASURES The primary outcome measureswere survival to 30 days after ICH and discharge to home or inpatient rehabilitation facility. We used multivariable logistic regression, controlling for demographics, comorbidities, initial severity, and code status. In addition, we used instrumental variable modeling to control for confounding by unmeasured covariates at the individual patient level. RESULTS Among patients hospitalized for ICH, inpatient statin users were more likely than nonusers to be alive 30 days after ICH (odds ratio [OR], 4.25 [95% CI, 3.46-5.23]; P < .001) and were more likely than nonusers to be discharged to their home or an acute rehabilitation facility (OR, 2.57 [95% CI, 2.16-3.06]; P < .001). Patients whose statin therapy was discontinued were less likely than statin users to survive to 30 days (OR, 0.16 [95% CI, 0.12-0.21]; P < .001) and were less likely than statin users to be discharged to their home or an acute rehabilitation facility (OR, 0.26 [95% CI, 0.20-0.35]; P < .001). Instrumental variable models of local treatment environment (to control for confounding by unmeasured covariates) confirmed that a higher probability of statin therapy was associated with a higher probability of 30-day survival (with an increase in probability of 0.15 [95% CI, 0.04-0.25]; P = .01) and a better chance of being discharged to home or an acute rehabilitation facility (with an increase in probability of 0.13 [95% CI, 0.02-0.24]; P = .02). CONCLUSIONS AND RELEVANCE Inpatient statin use is associated with improved outcomes after ICH, and the cessation of statin use is associated with worsened outcomes after ICH. Given the association between statin cessation and substantially worsened outcomes, the risk-benefit balance of discontinuing statin therapy in the acute setting of ICH should be carefully considered.	[Flint, Alexander C.; Rao, Vivek A.] Kaiser Permanente No Calif, Dept Neurosci, Redwood City, CA 94025 USA; [Conell, Carol; Sidney, Stephen] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Klingman, Jeff G.] Kaiser Permanente, Dept Neurol, Walnut Creek, CA USA; [Johnston, Claiborne] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Hemphill, J. Claude] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kamel, Hooman] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Kamel, Hooman] Weill Cornell Med Coll, Dept Neurosci, New York, NY USA; [Davis, Stephen M.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [Donnan, Geoffrey A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3050, Australia		Flint, AC (corresponding author), Kaiser Permanente No Calif, Dept Neurosci, 1150 Vet Blvd, Redwood City, CA 94025 USA.	alexander.c.flint@kp.org	Hemphill, Claude/AAY-5630-2021; Demchuk, Andrew M/E-1103-2012	Hemphill, Claude/0000-0003-4019-7525; Demchuk, Andrew M/0000-0002-4930-7789; Donnan, Geoffrey/0000-0001-6324-3403; Flint, Alexander/0000-0002-3721-2694	Kaiser Foundation Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK092317] Funding Source: NIH RePORTER	The present study was supported by a Community Benefit grant from the Kaiser Foundation Research Institute.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Biffi A, 2011, NEUROLOGY, V76, P1581, DOI 10.1212/WNL.0b013e3182194be9; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Brookhart MA, 2007, MED CARE, V45, pS116, DOI 10.1097/MLR.0b013e318070c057; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Bustamante A, 2013, STROKE, V44, P2060, DOI 10.1161/STROKEAHA.113.000916; de Oliveira CV, 2013, PHARMACOL RES, V71, P1, DOI 10.1016/j.phrs.2013.02.003; Flint AC, 2012, NEUROLOGY, V78, P1678, DOI 10.1212/WNL.0b013e3182575142; Flint AC, 2012, STROKE, V43, P147, DOI 10.1161/STROKEAHA.111.627729; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldstein LB, 2008, NEUROLOGY, V70, P2364, DOI 10.1212/01.wnl.0000296277.63350.77; Goldstein LB, 2013, STROKE, V44, P2058, DOI 10.1161/STROKEAHA.113.000915; Hackam DG, 2011, CIRCULATION, V124, P2233, DOI 10.1161/CIRCULATIONAHA.111.055269; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Karki K, 2009, STROKE, V40, P3384, DOI 10.1161/STROKEAHA.108.544395; Lee JG, 2012, KOREAN J INTERN MED, V27, P317, DOI 10.3904/kjim.2012.27.3.317; Lei C, 2014, EUR J NEUROL, V21, P192, DOI 10.1111/ene.12273; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Nardi K, 2012, NEUROLOGY, V79, P1101, DOI 10.1212/WNL.0b013e3182608c82; Naval NS, 2008, NEUROCRIT CARE, V8, P6, DOI 10.1007/s12028-007-0080-2; Naval NS, 2008, NEUROCRIT CARE, V8, P13, DOI 10.1007/s12028-007-0081-1; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Rassen JA, 2010, EUR HEART J, V31, P561, DOI 10.1093/eurheartj/ehp437; Rocco A, 2012, CEREBROVASC DIS, V33, P362, DOI 10.1159/000335840; Scheitz JF, 2014, STROKE, V45, P509, DOI 10.1161/STROKEAHA.113.002751; Scheitz JF, 2013, STROKE, V44, P1472, DOI 10.1161/STROKEAHA.111.000001; Spence JD, 2012, NEUROLOGY, V79, P1076, DOI 10.1212/WNL.0b013e3182608caf; Tapia-Perez JH, 2013, NEUROSURG REV, V36, P279, DOI 10.1007/s10143-012-0431-0; Tapia-Perez JH, 2013, NEUROSURG REV, V36, P287; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0	36	54	57	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	NOV	2014	71	11					1364	1371		10.1001/jamaneurol.2014.2124			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AT7WN	WOS:000345145300005	25244578	Bronze			2022-02-06	
J	Baugh, CM; Kroshus, E; Daneshvar, DH; Stern, RA				Baugh, Christine M.; Kroshus, Emily; Daneshvar, Daniel H.; Stern, Robert A.			Perceived Coach Support and Concussion Symptom-Reporting: Differences between Freshmen and Non-Freshmen College Football Players	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							TRAUMATIC BRAIN-INJURY; SCHOOL; EDUCATION; DISEASE; EPIDEMIOLOGY; SPORTS; IMPACT	This paper examines college athletes' perceived support for concussion reporting from coaches and teammates and its variation by year-in-school, finding significant differences in perceived coach support. It also examines the effects of perceived coach support on concussion reporting behaviors, finding that greater perceived coach support is associated with fewer undiagnosed concussions and returning to play while symptomatic less frequently in the two weeks preceding the survey. Coaches play a critical role in athlete concussion reporting.	[Baugh, Christine M.] Boston Univ, Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA; [Baugh, Christine M.; Daneshvar, Daniel H.; Stern, Robert A.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Baugh, Christine M.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Daneshvar, Daniel H.] Sports Legacy Inst Community Educ SLICE Program, Waltham, MA USA; [Stern, Robert A.] Boston Univ, Clin Core, Alzheimers Dis Ctr, Boston, MA 02215 USA; [Stern, Robert A.] Boston Univ, Ctr Study Traumat Encephalopathy, Boston, MA 02215 USA		Baugh, CM (corresponding author), Boston Univ, Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA.		, Bob/ABA-8507-2020; Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513; Stern, Robert/0000-0002-5008-077X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56 NS078337] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS078337] Funding Source: NIH RePORTER		ADLER PA, 1988, ADMIN SCI QUART, V33, P401, DOI 10.2307/2392716; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 2013, US TODAY; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bazarian J. J., 2013, MAGNETIC RESONANCE I, V30, P171; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio S. P., 2014, CONCUSSIONS ATHLETIC, P313; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2010, J SPORT SCI MED, V9, P418; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Faure C., 2011, SPORT J, V14, P34; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Holmes P, 2011, J SPORT ECON, V12, P157, DOI 10.1177/1527002510378820; Hudd S, 2000, COLL STUD J, V34, P217; Institute of Medicine, 2013, SPORTS REL CONC YOUT; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr Z. Y., 2014, BRAIN INJUR IN PRESS; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kroshus E., 2014, ANN BEHAV M IN PRESS; Kroshus E., 2014, J ADOLESCENT HEALTH, V54, pe2; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; OPPENHEIMER BT, 1984, J COUNS PSYCHOL, V31, P45, DOI 10.1037/0022-0167.31.1.45; Papanikolaou Z., 2003, ATHL INSIGHT, V5; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Pritchard M, 2005, ATHLETIC INSIGHT ONL, V5, P1; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sarris CE, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12224; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; United States Bureau of Labor Statistics, 2013, OCC EMPL WAG; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	52	54	54	0	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	FAL	2014	42	3			SI		314	322		10.1111/jlme.12148			9	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	AQ4ED	WOS:000342745000006	25264089				2022-02-06	
J	Cournoyer, J; Tripp, BL				Cournoyer, Janie; Tripp, Brady L.			Concussion Knowledge in High School Football Players	JOURNAL OF ATHLETIC TRAINING			English	Article						head injuries; education; symptoms; consequences; adolescent	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SPORTS; EPIDEMIOLOGY; MANAGEMENT; STATEMENT; CHILDREN	Context: Participating in sports while experiencing symptoms of a concussion can be dangerous. An athlete's lack of knowledge may be one factor influencing his or her decision to report symptoms. In an effort to enhance concussion education among high school athletes, legislation in Florida has attempted to address the issue through parental consent forms. Objective: To survey high school varsity football players to determine their level of knowledge about concussions after the initiation of new concussion-education legislation. Design: Cross-sectional study. Setting: Descriptive survey administered in person during a team meeting. Patients or Other Participants: A total of 334 varsity football players from 11 high schools in Florida. Main Outcome Measure(s): Participants completed a survey and identified the symptoms and consequences of a concussion among distractors. They also indicated whether they had received education about concussions from a parent, formal education, neither, or both. Results: The most correctly identified symptoms were headache (97%), dizziness (93%), and confusion (90%), and the most correctly identified consequence was persistent headache (93%). Participants reported receiving education from their parents (54%) or from a formal source (60%). Twenty-five percent reported never receiving any education regarding concussions. No correlations were found between the method of education and the knowledge of symptoms or consequences of concussion. Conclusions: The high school football players we surveyed did not have appropriate knowledge of the symptoms and consequences of concussions. Nausea or vomiting, neck pain, grogginess, difficulty concentrating, and personality or behavioral changes were often missed by participants, and only a small proportion correctly identified brain hemorrhage, coma, and death as possible consequences of inappropriate care after a concussion. Even with parents or guardians signing a consent form indicating they discussed concussion awareness with their child, 46% of athletes suggested they had not.	[Cournoyer, Janie; Tripp, Brady L.] Univ Florida, Gainesville, FL USA		Cournoyer, J (corresponding author), Univ Ottawa, A106,200 Lees Ave, Ottawa, ON K1S 5S9, Canada.	jcournoyer@ufl.edu		Cournoyer, Janie/0000-0001-9043-7756; Tripp, Brady/0000-0002-9090-1851			[Anonymous], 2007, HEADS CONC YOUTH SPO; [Anonymous], 1999, JAMA-J AM MED ASSOC, V282, P964; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cook Rebecca S, 2006, J Trauma Nurs, V13, P58; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 2000, SEMIN NEUROL, V20, P165, DOI 10.1055/s-2000-9835; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	25	54	54	0	30	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2014	49	5					654	658		10.4085/1062-6050-49.3.34			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	AY4NN	WOS:000347555600012	25162779	Green Published			2022-02-06	
J	Schmidt, JD; Guskiewicz, KM; Blackburn, JT; Mihalik, JP; Siegmund, GP; Marshall, SW				Schmidt, Julianne D.; Guskiewicz, Kevin M.; Blackburn, J. Troy; Mihalik, Jason P.; Siegmund, Gunter P.; Marshall, Stephen W.			The Influence of Cervical Muscle Characteristics on Head Impact Biomechanics in Football	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; mild traumatic brain injury; neck musculature; neck strength; neck stiffness	SEGMENT DYNAMIC STABILIZATION; NECK SEGMENT; FUNCTIONAL-ANATOMY; GENDER-DIFFERENCES; STRENGTH; STIFFNESS; COLLEGIATE; INJURY; SPINE; PLAYERS	Background: An athlete is thought to reduce head acceleration after impact by contracting the cervical musculature, which increases the effective mass of the head. Purpose: To compare the odds of sustaining higher magnitude in-season head impacts between athletes with higher and lower preseason performance on cervical muscle characteristics. Study Design: Cohort study; Level of evidence, 2. Methods: Forty-nine high school and collegiate American football players completed a preseason cervical testing protocol that included measures of cervical isometric strength, muscle size, and response to cervical perturbation. Head impact biomechanics were captured for each player using the Head Impact Telemetry System. A median split was used to categorize players as either high or low performers for each of the following outcome measures: isometric strength (peak torque, rate of torque development), muscle size (cross-sectional area), and response to cervical perturbation (stiffness, angular displacement, muscle onset latency). The odds of sustaining moderate and severe head impacts were computed against the reference odds of sustaining mild head impacts across cervical characteristic categorizations. Results: Linemen with stronger lateral flexors and composite cervical strength had about 1.75 times' increased odds of sustaining moderate linear head impacts rather than mild impacts compared with weaker linemen. Players who developed extensor torque more quickly had 2 times the increased odds of sustaining severe linear head impacts (odds ratio [OR], 2.10; 95% CI, 1.08-4.05) rather than mild head impacts. However, players with greater cervical stiffness had reduced odds of sustaining both moderate (OR, 0.77; 95% CI, 0.61-0.96) and severe (OR, 0.64; 95% CI, 0.46-0.89) head impacts compared with players with less cervical stiffness. Conclusion: The study findings showed that greater cervical stiffness and less angular displacement after perturbation reduced the odds of sustaining higher magnitude head impacts; however, the findings did not show that players with stronger and larger neck muscles mitigate head impact severity.	[Schmidt, Julianne D.; Guskiewicz, Kevin M.; Blackburn, J. Troy; Mihalik, Jason P.; Siegmund, Gunter P.; Marshall, Stephen W.] Univ N Carolina, Chapel Hill, NC 27514 USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Siegmund, Gunter P/B-7003-2013	Siegmund, Gunter/0000-0003-2387-941X; Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130; Mihalik, Jason/0000-0001-6085-8322			Almosnino S, 2010, J ATHL TRAINING, V45, P453, DOI 10.4085/1062-6050-45.5.453; Almosnino S, 2009, BMC SPORTS SCI MED R, V1, DOI 10.1186/1758-2555-1-22; Alricsson M, 2004, AVIAT SPACE ENVIR MD, V75, P23; Andersen LL, 2008, J BIOMECH, V41, P2029, DOI 10.1016/j.jbiomech.2008.03.016; Anthropology Research Project, 1978, ANTHR SOURC BOOK; Arts IMP, 2010, MUSCLE NERVE, V41, P32, DOI 10.1002/mus.21458; Banerjee R, 2004, AM J SPORT MED, V32, P1077, DOI 10.1177/0363546504265605; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Blackburn JT, 2011, CLIN BIOMECH, V26, P278, DOI 10.1016/j.clinbiomech.2010.10.002; Boden BP, 2000, ORTHOPEDICS, V23, P573, DOI 10.3928/0147-7447-20000601-15; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Burnett A, 2007, J ELECTROMYOGR KINES, V17, P635, DOI 10.1016/j.jelekin.2006.06.003; Burnett Angus F, 2005, Work, V25, P205; Cheng CH, 2008, EUR J APPL PHYSIOL, V103, P647, DOI 10.1007/s00421-008-0760-4; de Koning CHP, 2008, EUR SPINE J, V17, P905, DOI 10.1007/s00586-008-0656-3; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Falla D, 2002, EUR J APPL PHYSIOL, V87, P542, DOI 10.1007/s00421-002-0661-x; Falla D, 2002, CLIN NEUROPHYSIOL, V113, P57, DOI 10.1016/S1388-2457(01)00708-8; Falla D, 2012, CLIN J PAIN, V28, P628, DOI 10.1097/AJP.0b013e31823e9378; Granata KP, 2002, J ELECTROMYOGR KINES, V12, P119, DOI 10.1016/S1050-6411(02)00002-0; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hedlund J, 2000, Inj Prev, V6, P82, DOI 10.1136/ip.6.2.82; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hurd WJ, 2006, KNEE SURG SPORT TR A, V14, P60, DOI 10.1007/s00167-005-0624-y; Kubo K, 2007, MED SCI SPORT EXER, V39, P1801, DOI 10.1249/mss.0b013e31813e630a; Mansell J, 2005, J ATHL TRAINING, V40, P310; MAYOUXBENHAMOU MA, 1989, ERGONOMICS, V32, P513, DOI 10.1080/00140138908966121; MCGILL S, 1994, SPINE, V19, P696, DOI 10.1097/00007632-199403001-00009; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; MORGAN DL, 1977, AM J PHYSIOL, V232, pC45, DOI 10.1152/ajpcell.1977.232.1.C45; O'Sullivan C, 2009, MANUAL THER, V14, P572, DOI 10.1016/j.math.2008.12.005; Panjabi MM, 1998, CLIN BIOMECH, V13, P11, DOI 10.1016/S0268-0033(97)00057-0; Portero R, 2013, J BIOMECH, V46, P925, DOI 10.1016/j.jbiomech.2012.12.009; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; REID SE, 1981, AVIAT SPACE ENVIR MD, V52, P78; Rezasoltani A, 2002, J REHABIL RES DEV, V39, P423; Rezasoltani A, 1999, SCAND J MED SCI SPOR, V9, P214; Rezasoltani A, 1998, CLIN REHABIL, V12, P36, DOI 10.1191/026921598673972662; Seng KY, 2002, CLIN BIOMECH, V17, P545, DOI 10.1016/S0268-0033(02)00067-0; Siegmund GP, 2008, EXERC SPORT SCI REV, V36, P76, DOI 10.1097/JES.0b013e318168f1ce; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; Strimpakos N, 2004, ARCH PHYS MED REHAB, V85, P1309, DOI 10.1016/j.apmr.2003.08.104; Swartz EE, 2005, J ATHL TRAINING, V40, P155; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Uemura Naoya, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P494; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; WILSON GJ, 1991, INT J SPORTS MED, V12, P403, DOI 10.1055/s-2007-1024702; Ylinen JJ, 1999, CLIN BIOMECH, V14, P217, DOI 10.1016/S0268-0033(98)00063-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	57	54	54	0	65	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2014	42	9					2056	2066		10.1177/0363546514536685			11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	AP9GQ	WOS:000342387400003	24928761				2022-02-06	
J	Croall, ID; Cowie, CJA; He, JB; Peel, A; Wood, J; Aribisala, BS; Mitchell, P; Mendelow, AD; Smith, FE; Millar, D; Kelly, T; Blamire, AM				Croall, Iain D.; Cowie, Christopher J. A.; He, Jiabao; Peel, Anna; Wood, Joshua; Aribisala, Benjamin S.; Mitchell, Patrick; Mendelow, A. David; Smith, Fiona E.; Millar, David; Kelly, Tom; Blamire, Andrew M.			White matter correlates of cognitive dysfunction after mild traumatic brain injury	NEUROLOGY			English	Article							NONDISRUPTIVE AXONAL INJURY; CORPUS-CALLOSUM; CELLULAR EDEMA; VERBAL FLUENCY; DIFFUSION; IMPAIRMENT; ACTIVATION; ANISOTROPY; GLIOSIS; ADULTS	Objective: To relate neurophysiologic changes after mild/moderate traumatic brain injury to cognitive deficit in a longitudinal diffusion tensor imaging investigation. Methods: Fifty-three patients were scanned an average of 6 days postinjury (range = 1-14 days). Twenty-three patients were rescanned 1 year later. Thirty-three matched control subjects were recruited. At the time of scanning, participants completed cognitive testing. Tract-Based Spatial Statistics was used to conduct voxel-wise analysis on diffusion changes and to explore regressions between diffusion metrics and cognitive performance. Results: Acutely, increased axial diffusivity drove a fractional anisotropy (FA) increase, while decreased radial diffusivity drove a negative regression between FA and Verbal Letter Fluency across widespread white matter regions, but particularly in the ascending fibers of the corpus callosum. Raised FA is hypothesized to be caused by astrogliosis and compaction of axonal neurofilament, which would also affect cognitive functioning. Chronically, FA was decreased, suggesting myelin sheath disintegration, but still regressed negatively with Verbal Letter Fluency in the anterior forceps. Conclusions: Acute mild/moderate traumatic brain injury is characterized by increased tissue FA, which represents a clear neurobiological link between cognitive dysfunction and white matter injury after mild/moderate injury.	[Croall, Iain D.; Cowie, Christopher J. A.; Wood, Joshua; Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Croall, Iain D.; Cowie, Christopher J. A.; Wood, Joshua; Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Newcastle MR Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cowie, Christopher J. A.; Mitchell, Patrick; Mendelow, A. David] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Kelly, Tom] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Neuropsychol, Newcastle Upon Tyne, Tyne & Wear, England; [He, Jiabao] Univ Aberdeen, Sch Med & Dent, Aberdeen Biomed Imaging Ctr, Aberdeen AB9 1FX, Scotland; [Peel, Anna] Univ Durham, Dept Psychol, Durham DH1 3HP, England; [Aribisala, Benjamin S.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh EH8 9YL, Midlothian, Scotland; [Millar, David] NeuroCog, Newcastle Upon Tyne, Tyne & Wear, England		Croall, ID (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	i.d.croall@newcastle.ac.uk	Mendelow, Alexander/AAW-2878-2021; Blamire, Andrew/AAU-6100-2021	He, Jiabao/0000-0001-7794-7188; Cowie, Christopher/0000-0003-0439-2278; Blamire, Andrew/0000-0002-8749-1257	Sir Jules Thorn Charitable Trust Biomedical Research Award; The Sir Jules Thorn Charitable Trust [05JTA] Funding Source: researchfish	Funding for the study and a studentship to I.D.C. has been provided by Sir Jules Thorn Charitable Trust Biomedical Research Award.	Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Gaillard WD, 2000, NEUROLOGY, V54, P180, DOI 10.1212/WNL.54.1.180; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Matsukawa H, 2011, J NEUROSURG, V115, P1019, DOI 10.3171/2011.6.JNS11513; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pihlajamaki M, 2000, ANN NEUROL, V47, P470, DOI 10.1002/1531-8249(200004)47:4<470::AID-ANA10>3.0.CO;2-M; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Voets NL, 2006, BRAIN, V129, P754, DOI 10.1093/brain/awh679; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	38	54	54	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	AUG 5	2014	83	6					494	501		10.1212/WNL.0000000000000666			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN1XV	WOS:000340378200009	25031282	Green Published			2022-02-06	
J	Stocchetti, N; Picetti, E; Berardino, M; Buki, A; Chesnut, RM; Fountas, KN; Horn, P; Hutchinson, PJ; Iaccarino, C; Kolias, AG; Koskinen, LO; Latronico, N; Maas, AIR; Payen, JF; Rosenthal, G; Sahuquillo, J; Signoretti, S; Soustiel, JF; Servadei, F				Stocchetti, Nino; Picetti, Edoardo; Berardino, Maurizio; Buki, Andras; Chesnut, Randall M.; Fountas, Kostas N.; Horn, Peter; Hutchinson, Peter J.; Iaccarino, Corrado; Kolias, Angelos G.; Koskinen, Lars-Owe; Latronico, Nicola; Maas, Andrews I. R.; Payen, Jean-Francois; Rosenthal, Guy; Sahuquillo, Juan; Signoretti, Stefano; Soustiel, Jean F.; Servadei, Franco			Clinical applications of intracranial pressure monitoring in traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Intracranial pressure; Monitoring; Management	SEVERE HEAD-INJURY; INITIAL COMPUTERIZED-TOMOGRAPHY; CEREBRAL PERFUSION-PRESSURE; WAKE-UP TEST; DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; SCAN; HYPERTENSION; MORTALITY; PREDICTORS	Intracranial pressure (ICP) monitoring has been for decades a cornerstone of traumatic brain injury (TBI) management. Nevertheless, in recent years, its usefulness has been questioned in several reports. A group of neurosurgeons and neurointensivists met to openly discuss, and provide consensus on, practical applications of ICP in severe adult TBI. A consensus conference was held in Milan on October 5, 2013, putting together neurosurgeons and intensivists with recognized expertise in treatment of TBI. Four topics have been selected and addressed in pro-con presentations: 1) ICP indications in diffuse brain injury, 2) cerebral contusions, 3) secondary decompressive craniectomy (DC), and 4) after evacuation of intracranial traumatic hematomas. The participants were asked to elaborate on the existing published evidence (without a systematic review) and their personal clinical experience. Based on the presentations and discussions of the conference, some drafts were circulated among the attendants. After remarks and further contributions were collected, a final document was approved by the participants. The group made the following recommendations: 1) in comatose TBI patients, in case of normal computed tomography (CT) scan, there is no indication for ICP monitoring; 2) ICP monitoring is indicated in comatose TBI patients with cerebral contusions in whom the interruption of sedation to check neurological status is dangerous and when the clinical examination is not completely reliable. The probe should be positioned on the side of the larger contusion; 3) ICP monitoring is generally recommended following a secondary DC in order to assess the effectiveness of DC in terms of ICP control and guide further therapy; 4) ICP monitoring after evacuation of an acute supratentorial intracranial hematoma should be considered for salvageable patients at increased risk of intracranial hypertension with particular perioperative features.	[Stocchetti, Nino] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Physiopathol & Transplant, Neuro ICU, Milan, Italy; [Picetti, Edoardo] Azienda Osped Univ Parma, Div Anesthesia & Intens Care, I-43100 Parma, Italy; [Berardino, Maurizio] AOU Citta Salute & Sci, Orthoped & Trauma Hosp, Anesthesia & ICU, Turin, Italy; [Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras] Clin Neurosci Image Ctr Hungarian Acad Sci HAS, Pecs, Hungary; [Chesnut, Randall M.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Chesnut, Randall M.] Univ Washington, Dept Orthopaed Surg, Sch Med, Seattle, WA 98195 USA; [Chesnut, Randall M.] Univ Washington, Sch Global Hlth, Seattle, WA 98195 USA; [Fountas, Kostas N.] Univ Thessaly, Sch Med, Dept Neurosurg, Larisa, Greece; [Horn, Peter] Dr Horst Schmidt Klin HSK, Dept Neurosurg, Wiesbaden, Germany; [Hutchinson, Peter J.; Kolias, Angelos G.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Hutchinson, Peter J.; Kolias, Angelos G.] Univ Cambridge, Cambridge, England; [Iaccarino, Corrado; Servadei, Franco] Azienda Osped Univ Parma, ASMN IRCCS Reggio Emilia, Div Neurotraumatol Neurosurg, Reggio Emilia, Italy; [Koskinen, Lars-Owe] Umea Univ Hosp, Dept Neurosurg, S-90185 Umea, Sweden; [Latronico, Nicola] Spedali Civil Brescia, Dept Anesthesia & Crit Care Med, Univ Brescia, I-25125 Brescia, Italy; [Maas, Andrews I. R.] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Payen, Jean-Francois] CHU Grenoble, Pole Anesthesie Reanimat, F-38043 Grenoble 9, France; [Rosenthal, Guy] Hadassah Hebrew Univ, Dept Neurosurg, Med Ctr, Jerusalem, Israel; [Sahuquillo, Juan] Univ Autonoma Barcelona, Dept Neurosurg, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain; [Signoretti, Stefano] Azienda Osped S Camillo Forlanini, Dept Head & Neck Surg, Div Neurosurg, Rome, Italy; [Soustiel, Jean F.] Bar Ilan Univ, Dept Neurosurg, Galilee Med Ctr, Fac Med, Nahariyya, Israel		Picetti, E (corresponding author), Azienda Osped Univ Parma, Div Anesthesia & Intens Care, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Stocchetti, Nino/O-7444-2017; Payen, Jean-Francois/L-6667-2014; Koskinen, Lars-Owe/AAQ-8957-2020; Iaccarino, Corrado/L-3190-2013; Sahuquillo, Juan/B-3577-2008; Signoretti, stefano/AAL-5631-2020; LATRONICO, Nicola/F-1557-2010	Stocchetti, Nino/0000-0003-3250-6834; Iaccarino, Corrado/0000-0002-5133-6327; Sahuquillo, Juan/0000-0003-0713-5875; Signoretti, stefano/0000-0002-8086-1622; Hutchinson, Peter/0000-0002-2796-1835; Kolias, Angelos/0000-0003-3992-0587; LATRONICO, Nicola/0000-0002-2521-5871; Koskinen, Lars-Owe/0000-0003-3528-8502; Chesnut, Randall/0000-0001-6377-3666; Servadei, Franco/0000-0002-3595-3464	Codman (a division of Ethicon Ltd.); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025, G1002277] Funding Source: UKRI	We gratefully acknowledge the financial support by Codman (a division of Ethicon Ltd.)	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bratton SL, 2007, J NEUROTRAUM, V24, pS37; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cortnum S, 2010, NEUROSURGERY, V66, P900, DOI [10.1227/01.NEU.0000367722.66098.21, 10.1227/01. NEU.0000367722.66098.21]; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Hutchinson PJ, 2011, CRIT CARE S1, V15, P312; Iaccarino C, 2008, TELERADIOLOGY, P181; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Marion DW, 2006, NEUROSURGERY, V58, P655; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Zweckberger K, 2011, NEUROL RES, V33, P875, DOI 10.1179/1743132811Y.0000000017	46	54	58	0	17	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	AUG	2014	156	8					1615	1622		10.1007/s00701-014-2127-4			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AM3BA	WOS:000339724900029	24849391				2022-02-06	
J	Yang, T; Kong, B; Gu, JW; Kuang, YQ; Cheng, L; Yang, WT; Xia, X; Shu, HF				Yang, Tao; Kong, Bin; Gu, Jian-Wen; Kuang, Yong-Qin; Cheng, Lin; Yang, Wen-Tao; Xia, Xun; Shu, Hai-Feng			Anti-apoptotic and Anti-oxidative Roles of Quercetin After Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Quercetin; Oxidative stress; Inflammation; Apoptosis	SPINAL-CORD-INJURY; INFLAMMATORY RESPONSE; LIPID-PEROXIDATION; HYPERBARIC-OXYGEN; CEREBRAL-ISCHEMIA; SIGNALING PATHWAY; RATS; PATHOPHYSIOLOGY; PEROXYNITRITE; STROKE	Experimental studies have demonstrated significant secondary damage (including cell apoptosis, blood-brain barrier disruption, inflammatory responses, excitotoxic damage, and free radical production) after traumatic brain injury (TBI). Quercetin is a natural flavonoid found in high quantities in fruits and vegetables, and may be a potential antioxidant and free radical scavenger. The purpose of this study was to determine the effects of quercetin on TBI-induced upregulation of oxidative stress, inflammation, and apoptosis in adult Sprague-Dawley rats. Animals were subjected to Feeney's weight-drop injury, thus inducing the parietal contusion brain injury model. Quercetin was administered (30 mg/kg intraperitoneal injection) 0, 24, 48, and 72 h after TBI. Quercetin reduced cognitive deficits, the number of TUNEL- and ED-1-positive cells, the protein expressions of Bax and cleaved-caspase-3 proteins, and the levels of TBARS and proinflammatory cytokines, and increased the activity of antioxidant enzymes (GSH-Px, SOD, and CAT) at 1 week after TBI. Our results suggest that in TBI rats, quercetin improves cognitive function owing to its neuroprotective action via the inhibition of oxidative stress, leading to a reduced inflammatory response, thereby reducing neuronal death.	[Yang, Tao; Kong, Bin; Gu, Jian-Wen; Kuang, Yong-Qin; Cheng, Lin; Yang, Wen-Tao; Xia, Xun; Shu, Hai-Feng] Chengdu Mil Gen Hosp, Dept Neurosurg, Chengdu 610083, Sichuan, Peoples R China; [Yang, Tao; Kong, Bin; Xia, Xun] Third Mil Med Univ, Chongqing 400038, Peoples R China		Gu, JW (corresponding author), Chengdu Mil Gen Hosp, Dept Neurosurg, 270 Rong Du Rd, Chengdu 610083, Sichuan, Peoples R China.	zht0723@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071037, 81271395]	This work was supported by a grant from the National Natural Science Foundation of China (Nos. 81071037 and 81271395).	Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Cho JY, 2006, NEUROSCI LETT, V404, P330, DOI 10.1016/j.neulet.2006.06.010; Dok-Go H, 2003, BRAIN RES, V965, P130, DOI 10.1016/S0006-8993(02)04150-1; Fujimoto T, 2000, SPINE, V25, P24, DOI 10.1097/00007632-200001010-00006; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Imam SZ, 2000, BRAIN RES, V855, P186, DOI 10.1016/S0006-8993(99)02249-0; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Kahraman S, 2007, NEUROCHEM RES, V32, P1547, DOI 10.1007/s11064-007-9354-5; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kinaci MK, 2012, EXP THER MED, V3, P249, DOI 10.3892/etm.2011.382; Lee JK, 2011, ACTA NEUROCHIR, V153, P1321, DOI 10.1007/s00701-010-0889-x; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pearse D, 2010, CURR OPIN INVEST DR, V11, P1207; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SCHMIDLEY JW, 1990, STROKE, V21, P1086, DOI 10.1161/01.STR.21.7.1086; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; Schultke E, 2003, J NEUROTRAUM, V20, P583, DOI 10.1089/089771503767168500; Serarslan Y, 2010, J CLIN NEUROSCI, V17, P349, DOI 10.1016/j.jocn.2009.03.036; Song YX, 2013, LIFE SCI, V92, P1215, DOI 10.1016/j.lfs.2013.05.007; Talmadge RJ, 2002, J APPL PHYSIOL, V93, P1487, DOI 10.1152/japplphysiol.00053.2002; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	29	54	56	2	21	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2014	34	6					797	804		10.1007/s10571-014-0070-9			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AL8IT	WOS:000339382500003	24846663				2022-02-06	
J	Tremblay, S; Beaule, V; Proulx, S; Tremblay, S; Marjanska, M; Doyon, J; Lassonde, M; Theoret, H				Tremblay, Sara; Beaule, Vincent; Proulx, Sebastien; Tremblay, Sebastien; Marjanska, Malgorzata; Doyon, Julien; Lassonde, Maryse; Theoret, Hugo			Multimodal assessment of primary motor cortex integrity following sport concussion in asymptomatic athletes	CLINICAL NEUROPHYSIOLOGY			English	Article						Sport concussion; Traumatic brain injury; Magnetic resonance spectroscopy; Transcranial magnetic stimulation; GABA; Glutamate	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; COLLEGIATE FOOTBALL PLAYERS; RECURRENT CONCUSSION; CORTICAL THICKNESS; MR SPECTROSCOPY; LONG-TERM; INHIBITION; RECOVERY; MODERATE	Objective: Recent studies have shown, in asymptomatic concussed athletes, metabolic disruption in the primary motor cortex (M1) and abnormal intracortical inhibition lasting for more than six months. The present study aims to assess if these neurochemical and neurophysiological alterations are persistent and linked to M1 cortical thickness. Methods: Sixteen active football players who sustained their last concussion, on average, three years prior to testing and 14 active football players who never sustained a concussion were recruited for a single session of proton magnetic resonance spectroscopy (H-1-MRS) and transcranial magnetic stimulation (TMS). Measures of M1 and whole brain cortical thickness were acquired, and H-1-MRS data were acquired from left M1 using a MEGA-PRESS sequence. Cortical silent period (CSP) and long-interval intracortical inhibition (LICI) were measured with TMS applied over left M1. Results: No significant group differences were observed for metabolic concentrations, TMS measures, and cortical thickness. However, whereas GABA and glutamate levels were positively correlated in control athletes, this relationship was absent in concussed athletes. Conclusion: These data suggest the general absence of neurophysiologic, neurometabolic and neuroanatomical disruptions in M1 three years following the last concussive event. However, correlational analyses suggest the presence of a slight metabolic imbalance between GABA and glutamate concentrations in the primary motor cortex of concussed athletes. Significance: The present study highlights the importance of multimodal assesments of the impacts of sport concussions. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Tremblay, Sara; Beaule, Vincent; Lassonde, Maryse; Theoret, Hugo] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ H3C 3J7, Canada; [Tremblay, Sara; Beaule, Vincent; Lassonde, Maryse; Theoret, Hugo] Ctr Hosp Univ Hop St Justine, Ctr Rech, Montreal, PQ, Canada; [Proulx, Sebastien; Tremblay, Sebastien; Doyon, Julien] Inst Univ Geriatrie Montreal, Ctr Rech, Unite Neuroimagerie Fonct, Montreal, PQ, Canada; [Proulx, Sebastien] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2T5, Canada; [Marjanska, Malgorzata] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Marjanska, Malgorzata] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA		Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca	Meijer, Anna/K-5118-2016; Tremblay, Sara/X-5471-2019; Proulx, Sebastien/AAX-5694-2021	Proulx, Sebastien/0000-0003-1709-3277; Theoret, Hugo/0000-0002-7458-8797; Tremblay, Sebastien/0000-0001-6251-9797; Marjanska, Malgorzata/0000-0002-4727-2447	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de Recheche du Quebec - Sante; Biotechnology Research Center (BTRC) [P41 RR008079, P41 EB015894 (NIBIB)]; NCC [P30 NS076408]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS076408] Funding Source: NIH RePORTER	This work was supported by grants from the Canadian Institutes of Health Research and the Fonds de Recheche du Quebec - Sante to H.T. and M.L. M.M. acknowledges the support from Biotechnology Research Center (BTRC) grant P41 RR008079 and P41 EB015894 (NIBIB), and NCC P30 NS076408. The authors would like to thank Edward J. Auerbach, Ph.D. (Center for Magnetic Resonance Research, University of Minnesota) for implementing MEGA-PRESS sequence on Siemens, and Romain Valabregue, Ph.D. (Centre de NeuroImagerie de Recherche, Paris, France) and Brice Tiret, Ing (Unite de neuroimagerie fonctionnelle, Montreal) for developing processing tools.	Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Chin LS, 2013, CURR SPORT MED REP, V47, P15; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Giza CC, 2001, J ATHL TRAINING, V36, P228; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Henry PG, 2006, MAGN RESON MED, V55, P250, DOI 10.1002/mrm.20764; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Kelly JP, 1997, NEUROLOGY, V48, P581; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDonnell MN, 2007, EXP BRAIN RES, V180, P181, DOI 10.1007/s00221-006-0849-0; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Prescot AP, 2013, DRUG ALCOHOL DEPEN, V129, P232, DOI 10.1016/j.drugalcdep.2013.02.028; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	67	54	55	2	25	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	JUL	2014	125	7					1371	1379		10.1016/j.clinph.2013.11.040			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI0AC	WOS:000336507100012	24462505	Green Accepted			2022-02-06	
J	Walko, TD; Bola, RA; Hong, JD; Au, AK; Bell, MJ; Kochanek, PM; Clark, RSB; Aneja, RK				Walko, Thomas D., III; Bola, R. Aaron; Hong, John D.; Au, Alicia K.; Bell, Michael J.; Kochanek, Patrick M.; Clark, Robert S. B.; Aneja, Rajesh K.			CEREBROSPINAL FLUID MITOCHONDRIAL DNA: A NOVEL DAMP IN PEDIATRIC TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Mitochondrial DNA; cerebrospinal fluid; traumatic brain injury	GROUP BOX-1 PROTEIN; UNITED-STATES; CYTOCHROME-C; HMGB1; INFLAMMATION; RESPONSES; CHILDREN; DANGER; PLASMA	Danger-associated molecular patterns (DAMPs) are nuclear or cytoplasmic proteins that are released from the injured tissues and activate the innate immune system. Mitochondrial DNA (mtDNA) is a novel DAMP that is released into the extracellular milieu subsequent to cell death and injury. We hypothesized that cell death within the central nervous system in children with traumatic brain injury (TBI) would lead to the release of mtDNA into the cerebrospinal fluid (CSF) and has the potential to predict the outcome after trauma. Cerebrospinal fluid was collected from children with severe TBI who required intracranial pressure monitoring with Glasgow Coma Scale (GCS) scores of 8 or less via an externalized ventricular drain. Control CSF was obtained in children without TBI or meningoencephalitis who demonstrated no leukocytes in the diagnostic lumbar puncture. The median age for patients with TBI was 6.3 years, and 62% were male. The common mechanisms of injury included motor vehicle collision (35.8%), followed by falls (21.5%) and inflicted TBI (19%); six children (14.2%) died during their intensive care unit course. The mean CSF mtDNA concentration was 1.10E+05 +/- 2.07E+05 and 1.63E+03 +/- 1.80E+03 copies/L in the pediatric TBI and control populations, respectively. Furthermore, the mean CSF mtDNA concentration in pediatric patients who later died or had severe disability was significantly higher than that of the survivors (1.63E+05 +/- 2.77E+05 vs. 5.05E+04 +/- 6.21E+04 copies/L) (P < 0.0001). We found a significant correlation between CSF mtDNA and high mobility group box 1, another prototypical DAMP, concentrations ( = 0.574, P < 0.05), supporting the notion that both DAMPs are increased in the CSF after TBI. Our data suggest that CSF mtDNA is a novel DAMP in TBI and appears to be a useful biomarker that correlates with neurological outcome after TBI. Further inquiry into the components of mtDNA that modulate the innate immune response will be helpful in understanding the mechanism of local and systemic inflammation after TBI.	[Walko, Thomas D., III] SUNY Buffalo, Dept Crit Care Med, Buffalo, NY 14260 USA; [Bola, R. Aaron] SUNY Buffalo, Buffalo, NY 14260 USA; [Hong, John D.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Au, Alicia K.; Kochanek, Patrick M.; Clark, Robert S. B.; Aneja, Rajesh K.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Au, Alicia K.; Bell, Michael J.; Kochanek, Patrick M.; Clark, Robert S. B.; Aneja, Rajesh K.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Bell, Michael J.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA		Aneja, RK (corresponding author), Childrens Hosp Pittsburgh, Dept Crit Care Med, 4401 Penn Ave,Fac Pavil Bldg,Suite 2000, Pittsburgh, PA 15224 USA.	anejar@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Hong, John/0000-0002-5563-417X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM098474] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM098474] Funding Source: NIH RePORTER		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; Faul M, 2010, TRAUMATIC BRAIN INJU; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manganelli V, 2010, CRIT CARE, V14, DOI 10.1186/cc9316; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	34	54	56	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2014	41	6					499	503		10.1097/SHK.0000000000000160			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	AH6CI	WOS:000336217900005	24667615	Green Accepted			2022-02-06	
J	Yeh, PH; Wang, BQ; Oakes, TR; French, LM; Pan, H; Graner, J; Liu, W; Riedy, G				Yeh, Ping-Hong; Wang, Binquan; Oakes, Terrence R.; French, Louis M.; Pan, Hai; Graner, John; Liu, Wei; Riedy, Gerard			Postconcussional Disorder and PTSD Symptoms of Military-Related Traumatic Brain Injury Associated With Compromised Neurocircuitry	HUMAN BRAIN MAPPING			English	Article						traumatic brain injury; diffusion tensor imaging; blast injury; concussion; post-traumatic stress disorder; neurocircuitry	DIFFUSE AXONAL INJURY; TENSOR IMAGING FINDINGS; WHITE-MATTER PATHWAYS; REACTION-TIME; HEAD-INJURY; WALLERIAN DEGENERATION; FIBER TRACTOGRAPHY; WATER DIFFUSION; WORKING-MEMORY; BLAST INJURY	Traumatic brain injury (TBI) is a common combat injury, often through explosive blast, and produces heterogeneous brain changes due to various mechanisms of injury. It is unclear whether the vulnerability of white matter differs between blast and impact injury, and the consequences of microstructural changes on neuropsychological function are poorly understood in military TBI patients. Diffusion tensor imaging (DTI) techniques were used to assess the neurocircuitry in 37 US service members (29 mild, 7 moderate, 1 severe; 17 blast and 20 nonblast), who sustained a TBI while deployed, compared to 14 nondeployed, military controls. High-dimensional deformable registration of MRI diffusion tensor data was followed by fiber tracking and tract-specific analysis along with region-of-interest analysis. DTI results were examined in relation to post-concussion and post-traumatic stress disorder (PTSD) symptoms. The most prominent white matter microstructural injury for both blast and nonblast patients was in the frontal fibers within the fronto-striatal (corona radiata, internal capsule) and fronto-limbic circuits (fornix, cingulum), the fronto-parieto-occipital association fibers, in brainstem fibers, and in callosal fibers. Subcortical superior-inferiorly oriented tracts were more vulnerable to blast injury than nonblast injury, while direct impact force had more detrimental effects on anterior-posteriorly oriented tracts, which tended to cause heterogeneous left and right hemispheric asymmetries of white matter connectivity. The tractography using diffusion anisotropy deficits revealed the cortico-striatal-thalamic-cerebellar-cortical (CSTCC) networks, where increased post-concussion and PTSD symptoms were associated with low fractional anisotropy in the major nodes of compromised CSTCC neurocircuitry, and the consequences on cognitive function were explored as well. Hum Brain Mapp 35:2652-2673, 2014. (c) 2013 Wiley Periodicals, Inc.	[Yeh, Ping-Hong; Wang, Binquan; Pan, Hai; Liu, Wei; Riedy, Gerard] Henry Jackson Fdn Adv Mil Med, Traumat Brain Injury Image Anal Lab, Dept Radiol, Rockville, MD USA; [Oakes, Terrence R.; Graner, John; Riedy, Gerard] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [French, Louis M.; Riedy, Gerard] Uniformed Serv Univ Hlth Sci, CNRM, Bethesda, MD 20814 USA; [Riedy, Gerard] Walter Reed Natl Mil Med Ctr, Natl Capital Neuroimaging Consortium, Bethesda, MD USA		Yeh, PH (corresponding author), 12725 Twinbrook Pkwy,Room 269, Rockville, MD 20852 USA.	pinghongyeh@gmail.com	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	CDMRPUnited States Department of Defense [PT074437]; NARSAD, Brain Behavior Research Fund Grant [18317]	This research was partly supported by CDMRP to USUHS (CNRM) Grant PT074437 (G.R.) and NARSAD, Brain Behavior Research Fund Grant 18317 (P-H. Y.).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, DIAGN STAT MAN MENT, V4a; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; BARKLEY RA, 1990, J CONSULT CLIN PSYCH, V58, P775, DOI 10.1037/0022-006X.58.6.775; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belanger HG, 2009, J INT NEUROPSYCH SOC, P1; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blumberg HP, 2007, BIOL PSYCHIAT, V62, P104, DOI 10.1016/j.biopsych.2007.04.035; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cader S, 2007, NEUROIMAGE, V36, P19, DOI 10.1016/j.neuroimage.2007.02.036; Camara E, 2009, FRONT NEUROSCI-SWITZ, V3, P350, DOI 10.3389/neuro.01.034.2009; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; Conners K., 2002, CONNERS CONTINUOUS P; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Haatveit BC, 2010, J CLIN EXP NEUROPSYC, V32, P871, DOI 10.1080/13803391003596421; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; IIZUKA H, 1989, STROKE, V20, P1396, DOI 10.1161/01.STR.20.10.1396; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jack J. J. B., 1983, ELECT CURRENT FLOW E; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; Oishi K, 2005, NEUROSCI RES, V52, P37, DOI 10.1016/j.neures.2005.01.008; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Palmer HS, 2010, J NEUROTRAUM, V27, P853, DOI 10.1089/neu.2009.1225; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Peng HL, 2009, NEUROIMAGE, V46, P967, DOI 10.1016/j.neuroimage.2009.03.046; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Ruff Robert L, 2010, F1000 Med Rep, V2, P64, DOI 10.3410/M2-64; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P301, DOI 10.1097/01.ALC.0000052584.05305.98; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tang CY, 2010, INTELLIGENCE, V38, P293, DOI 10.1016/j.intell.2010.03.003; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Writer BW, 2010, J REHABIL RES DEV, V47, P841, DOI 10.1682/JRRD.2009.10.0162; Yeh P.-H., 2012, OPEN J MED IMAGING, V2, P137, DOI [10.4236/ojmi.2012.24025, DOI 10.4236/OJMI.2012.24025]; Yeh PH, 2010, PSYCHIAT RES-NEUROIM, V184, P177, DOI 10.1016/j.pscychresns.2010.07.007; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013; Zhang H, 2005, LECT NOTES COMPUT SC, V3749, P172; Zhang SW, 2011, NEUROIMAGE, V54, P974, DOI 10.1016/j.neuroimage.2010.09.008	135	54	54	1	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUN	2014	35	6					2652	2673		10.1002/hbm.22358			22	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AF2PX	WOS:000334555100014	24038816	Green Published			2022-02-06	
J	Zhou, YX; Lui, YW; Zuo, XN; Milham, MP; Reaume, J; Grossman, RI; Ge, YL				Zhou, Yongxia; Lui, Yvonne W.; Zuo, Xi-Nian; Milham, Michael P.; Reaume, Joseph; Grossman, Robert I.; Ge, Yulin			Characterization of Thalamo-cortical Association Using Amplitude and Connectivity of Functional MRI in Mild Traumatic Brain Injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						fractional amplitude of low frequency fluctuation; functional connectivity (fcMRI); coherence; mild traumatic brain injury; thalamus; resting-state fMRI	RESTING-STATE FMRI; GAMMA OSCILLATIONS; ALPHA-RHYTHM; BOLD SIGNAL; THALAMUS; FREQUENCY; HUMANS; STIMULATION; COHERENCE; SCHIZOPHRENIA	PurposeTo examine thalamic and cortical injuries using fractional amplitude of low-frequency fluctuations (fALFFs) and functional connectivity MRI (fcMRI) based on resting state (RS) and task-related fMRI in patients with mild traumatic brain injury (MTBI). Materials and MethodsTwenty-seven patients and 27 age-matched controls were recruited. The 3 Tesla fMRI at RS and finger tapping task were used to assess fALFF and fcMRI patterns. fALFFs were computed with filtering (0.01-0.08 Hz) and scaling after preprocessing. fcMRI was performed using a standard seed-based correlation method, and delayed fcMRI (coherence) in frequency domain were also performed between thalamus and cortex. ResultsIn comparison with controls, MTBI patients exhibited significantly decreased fALFFs in the thalamus (and frontal/temporal subsegments) and cortical frontal and temporal lobes; as well as decreased thalamo-thalamo and thalamo-frontal/ thalamo-temporal fcMRI at rest based on RS-fMRI (corrected P < 0.05). This thalamic and cortical disruption also existed at task-related condition in patients. ConclusionThe decreased fALFFs (i.e., lower neuronal activity) in the thalamus and its segments provide additional evidence of thalamic injury in patients with MTBI. Our findings of fALFFs and fcMRI changes during motor task and resting state may offer insights into the underlying cause and primary location of disrupted thalamo-cortical networks after MTBI. J. Magn. Reson. Imaging 2014;39:1558-1568. (c) 2013 Wiley Periodicals, Inc.	[Zhou, Yongxia; Lui, Yvonne W.; Reaume, Joseph; Grossman, Robert I.; Ge, Yulin] NYU, Langone Med Ctr, Dept Radiol, Ctr Biomed Imaging, New York, NY 10016 USA; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Key Lab Behav Sci,Magnet Resonance Imaging Res Ct, Beijing 100101, Peoples R China; [Milham, Michael P.] Child Mind Inst, New York, NY USA		Ge, YL (corresponding author), NYU, Sch Med, Dept Radiol, Ctr Biomed Imaging, 660 First Ave,4th Floor, New York, NY 10016 USA.	yulin.ge@nyumc.org	Milham, Michael P/K-9501-2014; Zuo, Xi-Nian/A-7273-2009; Ge, Yulin/D-9060-2019; Milham, Michael P./Y-3160-2019; Ge, Yulin/L-7052-2019	Zuo, Xi-Nian/0000-0001-9110-585X; Ge, Yulin/0000-0002-2320-6031; Zhou, Yongxia (Sharon)/0000-0002-4931-2318	NIH-RO1United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS039135-10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135, R01NS029029] Funding Source: NIH RePORTER	Contract grant sponsor: NIH-RO1; Contract grant number: NS039135-10.	Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Bajo R, 2010, J ALZHEIMERS DIS, V22, P183, DOI 10.3233/JAD-2010-100177; Ben-Simon E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003984; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; CHATILA M, 1993, CR ACAD SCI III-VIE, V316, P51; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Jones EG, 2007, THALAMUS; Kalcher K, 2013, NEUROIMAGE, V70, P80, DOI 10.1016/j.neuroimage.2012.12.019; Kempf F, 2009, EUR J NEUROSCI, V29, P943, DOI 10.1111/j.1460-9568.2009.06655.x; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Lopes da Silva F. H., 1973, KYBERNETIK, V15, P27, DOI DOI 10.1007/BF00270757; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Muller K, 2004, J MAGN RESON IMAGING, V20, P145, DOI 10.1002/jmri.20064; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Pollack Robert, 1999, MISSING MOMENT UNCON; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; Salomon RM, 2012, DRUG ALCOHOL DEPEN, V120, P41, DOI 10.1016/j.drugalcdep.2011.06.022; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Shim WH, 2013, J NEUROPHYSIOL, V109, P238, DOI 10.1152/jn.00332.2012; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Sparing R, 2007, EUR J NEUROSCI, V25, P319, DOI 10.1111/j.1460-9568.2006.05252.x; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Sun YM, 2011, BRAIN RES, V1413, P98, DOI 10.1016/j.brainres.2011.06.065; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang G, 2012, J ALTERN COMPLEM MED, V18, P387, DOI 10.1089/acm.2010.0205; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	40	54	57	0	17	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUN	2014	39	6					1558	1568		10.1002/jmri.24310			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AG5LM	WOS:000335460500028	24014176	Green Accepted			2022-02-06	
J	Dada, T; Rosenzweig, JM; Al Shammary, M; Firdaus, W; Al Rebh, S; Borbiev, T; Tekes, A; Zhang, JY; Alqahtani, E; Mori, S; Pletnikov, MV; Johnston, MV; Burd, I				Dada, Tahani; Rosenzweig, Jason M.; Al Shammary, Mofeedah; Firdaus, Wance; Al Rebh, Shorouq; Borbiev, Talaibek; Tekes, Aylin; Zhang, Jiangyang; Alqahtani, Eman; Mori, Susumu; Pletnikov, Mikhail V.; Johnston, Michael V.; Burd, Irina			Mouse model of intrauterine inflammation: Sex-specific differences in long-term neurologic and immune sequelae	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Intrauterine inflammation; Preterm birth; Mouse model; Lipopolysaccharide; Brain damage; MRI; Behavior	TRAUMATIC BRAIN-INJURY; INDUCED PRETERM BIRTH; GESTATIONAL-AGE; CEREBRAL-PALSY; RISK-FACTOR; FETAL; CHORIOAMNIONITIS; MICROGLIA; LIPOPOLYSACCHARIDE; INFECTION	Preterm infants, especially those that are exposed to prenatal intrauterine infection or inflammation, are at a major risk for adverse neurological outcomes, including cognitive, motor and behavioral disabilities. We have previously shown in a mouse model that there is an acute fetal brain insult associated with intrauterine inflammation. The objectives of this study were: (1) to elucidate long-term (into adolescence and adulthood) neurological outcomes by assessing neurobehavioral development, MRI, immunohistochemistry and flow cytometry of cells of immune origin and (2) to determine whether there are any sex-specific differences in brain development associated with intrauterine inflammation. Our results have shown that prenatal exposure appeared to lead to changes in MRI and behavior patterns throughout the neonatal period and during adulthood. Furthermore, we observed chronic brain inflammation in the offspring, with persistence of microglial activation and increased numbers of macrophages in the brain, ultimately resulting in neuronal loss. Moreover, our study highlights the sex-specific differences in long-term sequelae. This study, while extending the growing literature of adverse neurologic outcomes following exposure to inflammation during early development, presents novel findings in the context of intrauterine inflammation. (C) 2014 Elsevier Inc. All rights reserved.	[Dada, Tahani; Rosenzweig, Jason M.; Al Shammary, Mofeedah; Firdaus, Wance; Al Rebh, Shorouq; Borbiev, Talaibek; Burd, Irina] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Integrated Res Ctr Fetal Med, Baltimore, MD 21205 USA; [Tekes, Aylin; Zhang, Jiangyang; Alqahtani, Eman; Mori, Susumu] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD USA; [Pletnikov, Mikhail V.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Johnston, Michael V.; Burd, Irina] Kennedy Krieger Inst, Dept Neurosci, Baltimore, MD USA; [Burd, Irina] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Burd, I (corresponding author), Johns Hopkins Univ Hosp, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Phipps 228,600 North Wolfe St, Baltimore, MD 21287 USA.	iburd@jhmi.edu	Pletnikov, Mikhail V/G-8709-2012	Pletnikov, Mikhail V/0000-0002-8819-6559; Burd, Irina/0000-0001-7256-7784; Zhang, Jiangyang/0000-0003-4146-8163; Zhang, Jiangyang/0000-0003-0740-2662	Aramco Services Company Fellowship Fund; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073315]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS28208]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 EB003543]; Brain Science Institute, Johns Hopkins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD074593, K08HD073315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB003543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH083728, P50MH094268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS028208] Funding Source: NIH RePORTER	This work was supported by Aramco Services Company Fellowship Fund (W.F., J.M.R.), NICHD K08HD073315 (I.B.), NINDS NS28208 (M.J.), NIH RO1 EB003543 (S.M.), and a grant support from Brain Science Institute, Johns Hopkins (SM).	Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; Balakrishnan B, 2013, DEV NEUROSCI-BASEL, V35, P396, DOI 10.1159/000353156; Beloosesky R, 2006, AM J OBSTET GYNECOL, V194, P268, DOI 10.1016/j.ajog.2005.06.082; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Burd I., 2010, AM J OBSTET GYNECOL, V202, pe1; Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x; Burd I, 2011, REPROD SCI, V18, P900, DOI 10.1177/1933719111398498; Burd I, 2009, AM J OBSTET GYNECOL, V201, pS3, DOI 10.1016/j.ajog.2009.10.018; Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Cheng Y, 2011, NEUROIMAGE, V56, P1027, DOI 10.1016/j.neuroimage.2011.02.022; Dammann O, 2008, CLIN PERINATOL, V35, P643, DOI 10.1016/j.clp.2008.07.011; de Vries LS, 2009, ANN NEUROL, V66, P127, DOI 10.1002/ana.21761; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Glass H.C., 2009, J PEDIAT, V154, pe1; Hagberg H, 2005, CURR OPIN NEUROL, V18, P117, DOI 10.1097/01.wco.0000162851.44897.8f; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Hill Joanna M., 2008, V39, P131, DOI 10.1007/978-1-60327-099-1_10; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002; Johnson S, 2010, J PEDIATR-US, V156, P525, DOI 10.1016/j.jpeds.2009.10.041; Johnston MV, 2007, DEV MED CHILD NEUROL, V49, P74, DOI 10.1017/S0012162207000199; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Lieblein-Boff JC, 2013, J NEUROSCI, V33, P16334, DOI 10.1523/JNEUROSCI.0708-13.2013; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Saadani-Makki F, 2009, J CHILD NEUROL, V24, P1179, DOI 10.1177/0883073809338213; Schendel D, 2008, PEDIATRICS, V121, P1155, DOI 10.1542/peds.2007-1049; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Sharma J, 2011, ASN NEURO, V3, DOI 10.1042/AN20100032; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207	45	54	54	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAY	2014	38						142	150		10.1016/j.bbi.2014.01.014			9	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	AF8RU	WOS:000334984100016	24486323	Green Accepted			2022-02-06	
J	Crack, PJ; Zhang, M; Morganti-Kossmann, MC; Morris, AJ; Wojciak, JM; Fleming, JK; Karve, I; Wright, D; Sashindranath, M; Goldshmit, Y; Conquest, A; Daglas, M; Johnston, LA; Medcalf, RL; Sabbadini, RA; Pebay, A				Crack, Peter J.; Zhang, Moses; Morganti-Kossmann, Maria Cristina; Morris, Andrew J.; Wojciak, Jonathan M.; Fleming, Jonathan K.; Karve, Ila; Wright, David; Sashindranath, Maithili; Goldshmit, Yona; Conquest, Alison; Daglas, Maria; Johnston, Leigh A.; Medcalf, Robert L.; Sabbadini, Roger A.; Pebay, Alice			Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes	JOURNAL OF NEUROINFLAMMATION			English	Article						Lysophosphatidic acid; Traumatic brain injury; Human cerebrospinal fluid; Control cortical impact; Magnetic resonance imaging; Anti-LPA antibody; IL-6	CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; AUTOTAXIN; MICE; IDENTIFICATION; RECEPTOR; HYPOXIA	Background: Lysophosphatidic acid (LPA) is a bioactive phospholipid with a potentially causative role in neurotrauma. Blocking LPA signaling with the LPA-directed monoclonal antibody B3/Lpathomab is neuroprotective in the mouse spinal cord following injury. Findings: Here we investigated the use of this agent in treatment of secondary brain damage consequent to traumatic brain injury (TBI). LPA was elevated in cerebrospinal fluid (CSF) of patients with TBI compared to controls. LPA levels were also elevated in a mouse controlled cortical impact (CCI) model of TBI and B3 significantly reduced lesion volume by both histological and MRI assessments. Diminished tissue damage coincided with lower brain IL-6 levels and improvement in functional outcomes. Conclusions: This study presents a novel therapeutic approach for the treatment of TBI by blocking extracellular LPA signaling to minimize secondary brain damage and neurological dysfunction.	[Crack, Peter J.; Zhang, Moses; Karve, Ila] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Morganti-Kossmann, Maria Cristina] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Morganti-Kossmann, Maria Cristina] Univ Arizona, Phoenix Childrens Hosp, Dept Child Hlth, Barrow Neurol Inst, Phoenix, AZ USA; [Morris, Andrew J.] Univ Kentucky, Coll Med, Div Cardiovasc Med, Lexington, KY USA; [Wojciak, Jonathan M.; Fleming, Jonathan K.; Sabbadini, Roger A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Wojciak, Jonathan M.; Fleming, Jonathan K.; Sabbadini, Roger A.] Lpath Inc, San Diego, CA USA; [Wright, David; Johnston, Leigh A.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Wright, David] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Sashindranath, Maithili; Daglas, Maria; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Goldshmit, Yona; Conquest, Alison; Pebay, Alice] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Australia; [Goldshmit, Yona; Conquest, Alison; Pebay, Alice] Univ Melbourne, Dept Ophthalmol, East Melbourne, Australia; [Goldshmit, Yona] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Conquest, Alison] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Conquest, Alison] Monash Univ, Melbourne, Vic 3004, Australia; [Johnston, Leigh A.] Univ Melbourne, Dept Elect & Elect Engn, Neuroengn Lab, Parkville, Vic 3052, Australia		Crack, PJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	pcrack@unimelb.edu.au; apebay@unimelb.edu.au	Medcalf, Robert L/E-9632-2011; Johnston, Leigh A/D-7102-2014; Sashindranath, Maithili/AAI-7408-2021; Crack, Peter/ABE-2065-2020	Johnston, Leigh A/0000-0002-5032-4674; Sashindranath, Maithili/0000-0002-9712-4784; Crack, Peter/0000-0002-5030-0330; Morganti-Kossmann, Cristina/0000-0002-0807-2063; Wright, David/0000-0002-7535-8651; Daglas, Maria/0000-0002-9356-4061; Pebay, Alice/0000-0002-7408-9453	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [628391]; NHMRCNational Health and Medical Research Council of Australia; Transport Accident Commission project grant; ANZ Trustees Program - Medical Research & Technology in Victoria - William Buckland Foundation; United States National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R43CA132395-01A2]; Australian Research Council Future FellowshipAustralian Research Council; University of Melbourne Collaboration Grant; Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R43CA132395] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR024598, S10RR026884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103527] Funding Source: NIH RePORTER	The authors thank Mr Duncan Crombie (Centre for Eye Research Australia and University of Melbourne) for his technical assistance. This work was supported by a National Health and Medical Research Council of Australia Project Grant 628391 (PJC), a NHMRC Career Development Award Fellowship (AP), a Transport Accident Commission project grant (AP), the ANZ Trustees Program - Medical Research & Technology in Victoria - William Buckland Foundation (AP), the United States National Institutes of Health (1R43CA132395-01A2 to RM), an Australian Research Council Future Fellowship (PJC), a University of Melbourne Collaboration Grant and the Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Frisca F, 2012, INT REV CEL MOL BIO, V296, P273, DOI 10.1016/B978-0-12-394307-1.00005-9; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Goldshmit Y, 2010, CELL TISSUE RES, V341, P23, DOI 10.1007/s00441-010-0977-5; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Nakamura K, 2007, ANAL BIOCHEM, V367, P20, DOI 10.1016/j.ab.2007.05.004; On NH, 2013, J CEREBR BLOOD F MET, V33, P1944, DOI 10.1038/jcbfm.2013.154; Rasouli J, 2012, NEUROSCI LETT, V519, P4, DOI 10.1016/j.neulet.2012.03.089; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037	26	54	54	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	FEB 27	2014	11								37	10.1186/1742-2094-11-37			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AF8CX	WOS:000334944100001	24576351	Green Published, gold			2022-02-06	
J	Apetz, N; Munch, G; Govindaraghavan, S; Gyengesi, E				Apetz, Nadine; Muench, Gerald; Govindaraghavan, Suresh; Gyengesi, Erika			Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer's Disease - A Translational Perspective	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Alzheimer's disease; inflammation; non-steroidal anti-inflammatory drugs; plant secondary metabolites; reactive oxygen species; treatment	GINKGO-BILOBA EXTRACT; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; POLYUNSATURATED FATTY-ACIDS; ACTIVATED RECEPTOR-GAMMA; NF-KAPPA-B; OMEGA-3-FATTY-ACID DOCOSAHEXAENOIC ACID; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE	Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by deposition of amyloid beta, neurofibrillary tangles, astrogliosis and microgliosis, leading to neuronal dysfunction and loss in the brain. Bio- and histochemical evidence suggests a pivotal role of central and peripheral inflammation in its aetiopathology, linked to the production of free radicals. Numerous epidemiological studies support that the long-term use of non-steroidal anti-inflammatory drugs is preventive against AD, but these medications do not slow down the progression of the disease in already diagnosed patients. There are a number of studies focusing on traditional herbal medicines and small molecules (usually plant secondary metabolites) as potential anti-inflammatory drugs, particulary in respect to cytokine suppression. For instance, omega-3 polyunsaturated fatty acids and a number of polyphenolic phytochemicals have been shown to be effective against inflammation in animal and cell models. Some of these plant secondary metabolites have also been shown to possess antioxidant, anti-inflammatory, anti-amyloidogenic, neuroprotective, and cognition-enhancing effects. This review will provide an overview the effects of catechins/proanthocyanidins from green tea, curcumin from turmeric, extracts enriched in bacosides from Brahmi (Bacopa monnieri), flavone glycosides from Ginkgo biloba, and omega-3 polyunsaturated fatty acids. They do not only counteract one pathophysiological aspect of AD in numerous in vitro and in vivo studies of models of AD, but also ameliorate several of the above mentioned pathologies. The evidence suggests that increased consumption of these compounds might lead to a safe strategy to delay the onset of AD. The continuing investigation of the potential of these substances is necessary as they are promising to yield a possible remedy for this pervasive disease.	[Apetz, Nadine; Muench, Gerald; Gyengesi, Erika] Univ Western Sydney, Sch Med, Dept Pharmacol, Campbelltown, NSW, Australia; [Muench, Gerald] Univ Western Sydney, Ctr Complementary Med Res, Penrith, NSW 2751, Australia; [Muench, Gerald; Gyengesi, Erika] Univ Western Sydney, Mol Med Res Grp, Penrith, NSW 2751, Australia; [Govindaraghavan, Suresh] IMCD Australia Ltd, Network Nutr Capitol Ingredients, Bella Vista, NSW, Australia		Munch, G (corresponding author), Univ Western Sydney, Sch Med, Locked Bag 1797, Penrith, NSW 2751, Australia.	g.muench@uws.edu.au	Gyengesi, Erika/S-1251-2019	Gyengesi, Erika/0000-0001-7371-7385	Commonwealth Government; University of Western Sydney	The authors would like to thank the Commonwealth Government and the University of Western Sydney for granting an Australian Postgraduate Award and scholarship to Nadine Apetz. The authors thank Mrs. Margaret Clarke for the final editing of the manuscript.	Ahmed S, 2002, FREE RADICAL BIO MED, V33, P1097, DOI 10.1016/S0891-5849(02)01004-3; Aisen PS, 2008, CURR ALZHEIMER RES, V5, P73, DOI 10.2174/156720508783884602; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; ANDERSEN K, 1995, NEUROLOGY, V45, P1441, DOI 10.1212/WNL.45.8.1441; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Augustin S, 2009, ARCH BIOCHEM BIOPHYS, V481, P177, DOI 10.1016/j.abb.2008.10.032; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bastianetto S, 2000, EUR J NEUROSCI, V12, P1882, DOI 10.1046/j.1460-9568.2000.00069.x; BAUER J, 1991, FEBS LETT, V285, P111, DOI 10.1016/0014-5793(91)80737-N; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Beard CM, 1998, MAYO CLIN PROC, V73, P951, DOI 10.4065/73.10.951; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; BENZI G, 1995, NEUROBIOL AGING, V16, P661, DOI 10.1016/0197-4580(95)00066-N; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; CACABELOS R, 1994, METHOD FIND EXP CLIN, V16, P141; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Calabrese C, 2008, J ALTERN COMPLEM MED, V14, P707, DOI 10.1089/acm.2008.0018; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004; Channa S, 2006, J ETHNOPHARMACOL, V104, P286, DOI 10.1016/j.jep.2005.10.009; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Cho JW, 2007, INT J MOL MED, V19, P469; Choi YT, 2001, LIFE SCI, V70, P603, DOI 10.1016/S0024-3205(01)01438-2; Clostre F, 1999, ANN PHARM FR, V57, P8; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Das UN, 2007, MED SCI MONITOR, V13, pRA214; Deepak M, 2005, PHYTOCHEM ANALYSIS, V16, P24, DOI 10.1002/pca.805; Di Virgilio F, 2004, CURR PHARM DESIGN, V10, P1647; Dreiseitel A, 2009, BRIT J PHARMACOL, V158, P1942, DOI 10.1111/j.1476-5381.2009.00495.x; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Dzenko KA, 1997, J NEUROIMMUNOL, V80, P6, DOI 10.1016/S0165-5728(97)00128-8; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fang L, 2013, MINI-REV MED CHEM, V13, P870, DOI 10.2174/1389557511313060009; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Freund-Levi Y, 2008, INT J GERIATR PSYCH, V23, P161, DOI 10.1002/gps.1857; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Garai S, 1996, PHYTOCHEMISTRY, V42, P815, DOI 10.1016/0031-9422(95)00936-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gella A, 2009, CELL ADHES MIGR, V3, P88, DOI 10.4161/cam.3.1.7402; GENTLEMAN S, 1992, BRIT MED J, V304, P118, DOI 10.1136/bmj.304.6819.118-d; Giacalone M, 2011, NUTR NEUROSCI, V14, P119, DOI 10.1179/1476830511Y.0000000007; Good PF, 1996, AM J PATHOL, V149, P21; Goyarzu F, 2004, NUTR NEUROSCI, V7, P75, DOI 10.1080/10284150410001710410; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84; Gustaw-Rothenberg K, 2009, INT J ENV RES PUB HE, V6, P1335, DOI 10.3390/ijerph6041335; Han Guang-Liang, 2005, Wei Sheng Yan Jiu, V34, P581; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haque AM, 2006, J NUTR, V136, P1043, DOI 10.1093/jn/136.4.1043; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Holcomb LA, 2006, J ALZHEIMERS DIS, V9, P243; Ilieva I, 2004, EXP EYE RES, V79, P181, DOI 10.1016/j.exer.2004.03.009; In 't Veld BA, 2000, NEUROBIOL AGING S1, V21, P204; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Jain P., 1994, Indian Journal of Experimental Biology, V32, P633; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jurenka JS, 2009, ALTERN MED REV, V14, P141; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; Kamphuis PJGH, 2010, J ALZHEIMERS DIS, V20, P765, DOI 10.3233/JAD-2010-091558; Kanowski S, 1997, PHYTOMEDICINE, V4, P3, DOI 10.1016/S0944-7113(97)80021-9; Katiyar SK, 1999, PHOTOCHEM PHOTOBIOL, V69, P148, DOI 10.1111/j.1751-1097.1999.tb03267.x; Khairallah Mervat Ibrahim, 2011, Pak J Biol Sci, V14, P257, DOI 10.3923/pjbs.2011.257.272; Kim J, 2010, J NEUROCHEM, V112, P1415, DOI 10.1111/j.1471-4159.2009.06562.x; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332; Kuka S., 2012, ACTA MED MART, V12, P5; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukull WA, 2002, MED CLIN N AM, V86, P573, DOI 10.1016/S0025-7125(02)00010-X; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Kwak WJ, 2002, PLANTA MED, V68, P316, DOI 10.1055/s-2002-26742; Lau FC, 2005, NEUROBIOL AGING, V26, pS128, DOI 10.1016/j.neurobiolaging.2005.08.007; Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205; Lau FC, 2009, J FUNCT FOODS, V1, P274, DOI 10.1016/j.jff.2009.05.001; Laurin D, 2003, J ALZHEIMERS DIS, V5, P315, DOI 10.3233/JAD-2003-5407; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; Lee HS, 2007, PHARMAZIE, V62, P937, DOI 10.1691/ph.2007.12.7563; Lee JW, 2009, J NUTR, V139, P1987, DOI 10.3945/jn.109.109785; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lee SY, 2005, MOL BRAIN RES, V140, P45, DOI 10.1016/j.molbrainres.2005.07.009; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Lev-Ari Shahar, 2006, J Soc Integr Oncol, V4, P21; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Limpeanchob N, 2008, J ETHNOPHARMACOL, V120, P112, DOI 10.1016/j.jep.2008.07.039; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Lu CH, 2012, INDIAN J PHARMACOL, V44, P118, DOI 10.4103/0253-7613.91881; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Mandel SA, 2008, CNS NEUROSCI THER, V14, P352, DOI 10.1111/j.1755-5949.2008.00060.x; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Martorana Adriana, 2012, Longev Healthspan, V1, P8, DOI 10.1186/2046-2395-1-8; Massoud F, 2010, CURR NEUROPHARMACOL, V8, P69, DOI 10.2174/157015910790909520; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; Maurer K, 1997, J PSYCHIATR RES, V31, P645, DOI 10.1016/S0022-3956(97)00022-8; McCusker SM, 2001, LANCET, V357, P436, DOI 10.1016/S0140-6736(00)04008-3; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; McGeer PL, 2002, J NEUROVIROL, V8, P529, DOI 10.1080/13550280290100969; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; MEYDANI SN, 1991, J NUTR, V121, P547, DOI 10.1093/jn/121.4.547; Migliore L, 2005, NEUROBIOL AGING, V26, P587, DOI 10.1016/j.neurobiolaging.2004.10.002; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Moreira PI, 2010, METHODS MOL BIOL, V610, P419, DOI 10.1007/978-1-60327-029-8_25; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Munch G, 1998, J NEURAL TRANSM, V105, P439, DOI 10.1007/s007020050069; Munoz DG, 2000, CAN MED ASSOC J, V162, P65; Narala VR, 2009, GENE THER MOL BIOL, V13, P20; Narayanan BA, 2003, CANCER RES, V63, P972; Netland EE, 1998, NEUROBIOL AGING, V19, P201, DOI 10.1016/S0197-4580(98)00047-5; NETTLETON JA, 1991, J AM DIET ASSOC, V91, P331; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.3.CO;2-7; Nunomura A, 2005, ANTIOXIDANT THERAPIE, P131; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Papassotiropoulos A, 1999, ANN NEUROL, V45, P666, DOI 10.1002/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO;2-3; PAPPOLLA MA, 1992, AM J PATHOL, V140, P621; Perry RT, 2001, AM J MED GENET, V105, P332, DOI 10.1002/ajmg.1371; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Prosperi C, 2004, INT J IMMUNOPATH PH, V17, P317, DOI 10.1177/039463200401700312; Reid AT, 2013, EUR NEUROPSYCHOPHARM, V23, P63, DOI 10.1016/j.euroneuro.2012.11.010; Retz W, 1998, J NEURAL TRANSM-SUPP, P221; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; RICH JB, 1995, NEUROLOGY, V45, P51, DOI 10.1212/WNL.45.1.51; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Ringman JM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt146; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Routray W, 2011, COMPR REV FOOD SCI F, V10, P303, DOI 10.1111/j.1541-4337.2011.00164.x; Russo A, 2003, LIFE SCI, V73, P1517, DOI 10.1016/S0024-3205(03)00476-4; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI [10.1111/j.1365-277X.2004.00552.x, 10.1111/j.1365-277X.2007.00770.x]; Saini N, 2012, NEUROCHEM RES, V37, P1928, DOI 10.1007/s11064-012-0811-4; Sanchez-Ferro A, 2013, NEUROPSYCH DIS TREAT, V9, P55, DOI [10.2147/NDT.529105, 10.2147/NDT.S29105]; Sastre M, 2003, J NEUROSCI, V23, P9796; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Schneider Lon S., 2005, Current Alzheimer Research, V2, P541, DOI 10.2174/156720505774932287; Shi J, 2000, NEUROBIOL AGING, V21, P357, DOI 10.1016/S0197-4580(00)00119-6; Siddiqui R, 2012, VIRULENCE, V3, P159, DOI 10.4161/viru.17631; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Singh VK, 1997, J PSYCHIAT RES, V31, P657, DOI 10.1016/S0022-3956(97)00023-X; Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stackman RW, 2003, EXP NEUROL, V184, P510, DOI 10.1016/S0014-4886(03)00399-6; Stevenson DE, 2007, CELL MOL LIFE SCI, V64, P2900, DOI 10.1007/s00018-007-7237-1; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Stough C, 2001, PSYCHOPHARMACOLOGY, V156, P481, DOI 10.1007/s002130100815; Stough C, 2008, PHYTOTHER RES, V22, P1629, DOI 10.1002/ptr.2537; Strohmeyer R, 2001, J ALZHEIMERS DIS, V3, P131, DOI 10.3233/JAD-2001-3118; Sun XT, 2012, DRUG DISCOV THER, V6, P285, DOI 10.5582/ddt.2012.v6.6.285; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Szekely CA, 2008, NEUROLOGY, V70, P2291, DOI 10.1212/01.wnl.0000313933.17796.f6; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; TIMELL TE, 1978, WOOD SCI TECHNOL, V12, P89; Torri E, 2007, J PHARM PHARMACOL, V59, P591, DOI 10.1211/jpp.59.4.0015; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Uabundit N, 2010, J ETHNOPHARMACOL, V127, P26, DOI 10.1016/j.jep.2009.09.056; VANE J, 1987, FASEB J, V1, P89, DOI 10.1096/fasebj.1.2.3111928; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; Vane J. R., 1998, AM J MED, V104, p2S, DOI [10.1016/S0002-9343(97)00203-9, DOI 10.1016/S0002-9343(97)00203-9]; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7; Viji V, 2008, J ETHNOPHARMACOL, V118, P305, DOI 10.1016/j.jep.2008.04.017; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Wadsworth TL, 2001, CHEM-BIOL INTERACT, V137, P43, DOI 10.1016/S0009-2797(01)00208-3; Watkins BA, 2001, EXP BIOL MED, V226, P485, DOI 10.1177/153537020122600601; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weih M, 2007, J NEURAL TRANSM, V114, P1187, DOI 10.1007/s00702-007-0704-x; Weinreb O, 2004, J NUTR BIOCHEM, V15, P506, DOI 10.1016/j.jnutbio.2004.05.002; WHEELAN L, 1959, ANN HUM GENET, V23, P300, DOI 10.1111/j.1469-1809.1959.tb01473.x; Williams R, 2014, FOOD FUNCT, V5, P517, DOI 10.1039/c3fo60467e; Willis LM, 2010, GLIA, V58, P679, DOI 10.1002/glia.20954; Wong A, 2001, EUR J NEUROSCI, V14, P1961, DOI 10.1046/j.0953-816x.2001.01820.x; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Xie CH, 2011, MOL NUTR FOOD RES, V55, P1587, DOI 10.1002/mnfr.201100344; Yan Q, 2003, J NEUROSCI, V23, P7504; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yoshikawa T, 1999, ANTIOXID REDOX SIGN, V1, P469, DOI 10.1089/ars.1999.1.4-469; Yves C., 2005, GINKGO BILOBA EXTRAC, P43; Zhang LL, 2013, NEUROPHARMACOLOGY, V70, P200, DOI 10.1016/j.neuropharm.2012.10.023; Zhu YY, 2008, REJUV RES, V11, P891, DOI 10.1089/rej.2008.0757	208	54	57	3	63	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	7					1175	1191		10.2174/1871527313666140917110635			17	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AS0UG	WOS:000343993400008	25230232				2022-02-06	
J	Depue, BE; Olson-Madden, JH; Smolker, HR; Rajamani, M; Brenner, LA; Banich, MT				Depue, B. E.; Olson-Madden, J. H.; Smolker, H. R.; Rajamani, M.; Brenner, L. A.; Banich, M. T.			Reduced Amygdala Volume Is Associated with Deficits in Inhibitory Control: A Voxel- and Surface-Based Morphometric Analysis of Comorbid PTSD/Mild TBI	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; HIPPOCAMPAL VOLUME; NEUROCIRCUITRY MODELS; BASOLATERAL AMYGDALA; FUNCTIONAL MRI; METAANALYSIS; SYMPTOMS; VETERANS	A significant portion of previously deployed combat Veterans from Operation Enduring Freedom and Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) are affected by comorbid posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). Despite this fact, neuroimaging studies investigating the neural correlates of cognitive dysfunction within this population are almost nonexistent, with the exception of research examining the neural correlates of diagnostic PTSD or TBI. The current study used both voxel-based and surface-based morphometry to determine whether comorbid PTSD/mTBI is characterized by altered brain structure in the same regions as observed in singular diagnostic PTSD or TBI. Furthermore, we assessed whether alterations in brain structures in these regions were associated with behavioral measures related to inhibitory control, as assessed by the Go/No-go task, self-reports of impulsivity, and/or PTSD or mTBI symptoms. Results indicate volumetric reductions in the bilateral anterior amygdala in our comorbid PTSD/mTBI sample as compared to a control sample of OEF/OIF Veterans with no history of mTBI and/or PTSD. Moreover, increased volume reduction in the amygdala predicted poorer inhibitory control as measured by performance on the Go/No-go task, increased self-reported impulsivity, and greater symptoms associated with PTSD. These findings suggest that alterations in brain anatomy in OEF/OIF/OND Veterans with comorbid PTSD/mTBI are associated with both cognitive deficits and trauma symptoms related to PTSD.	[Depue, B. E.; Smolker, H. R.; Banich, M. T.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Depue, B. E.; Banich, M. T.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Olson-Madden, J. H.; Rajamani, M.; Brenner, L. A.] VISN, Mental Illness Res Educ & Clin Ctr 19, Denver, CO 80220 USA; [Olson-Madden, J. H.; Brenner, L. A.] Univ Colorado Denver, Aurora, CO 80045 USA		Depue, BE (corresponding author), Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA.	depue@colorado.edu	Brenner, Lisa A./AAG-2442-2019	BANICH, MARIE/0000-0001-9373-9194	Colorado Traumatic Brain Injury Trust Fund Program	Support for this project was provided by the Colorado Traumatic Brain Injury Trust Fund Program.	Allen L., 1997, CARB 97 MANUAL COMPU; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Briere J., 1996, TRAUMA SYMPTOM INVEN; Bryant RA, 2011, J CLIN PSYCHIAT, V72, P233, DOI 10.4088/JCP.09r05072blu; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; De Bellis MD, 2001, BIOL PSYCHIAT, V50, P305, DOI 10.1016/S0006-3223(01)01105-2; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Epstein JN, 2007, J CHILD PSYCHOL PSYC, V48, P899, DOI 10.1111/j.1469-7610.2007.01761.x; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Falconer E., 2008, J PSYCHIATR NEUROSCI, V33, P413; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gopal A, 2013, PSYCHIAT RES-NEUROIM, V211, P24, DOI 10.1016/j.pscychresns.2012.10.010; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Hastie T., 2009, LINEAR METHODS REGRE; Hedges DW, 2010, COGN BEHAV NEUROL, V23, P124, DOI 10.1097/WNN.0b013e3181e1cbe1; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hoge C. W., 2008, US ARMY MED DEP J; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Imielinska C., 2006, INFORM VISUAL, V5, P279, DOI DOI 10.1057/PALGRAVE.IVS.9500137; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lui S., 2013, J PSYCHIATR NEUROSCI, V38; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Royer S, 1999, J NEUROSCI, V19, P10575; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Spitzer R, 1995, STRUCTURED CLIN INTE; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zachary R. A., 1986, SHIPLEY I LIVING SCA	75	54	54	3	15	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								691505	10.1155/2014/691505			11	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AD0MY	WOS:000332929700001	24724093	Green Submitted, Green Published, gold			2022-02-06	
J	Luo, T; Wu, JF; Kabadi, SV; Sabirzhanov, B; Guanciale, K; Hanscom, M; Faden, J; Cardiff, K; Bengson, CJ; Faden, AI				Luo, Tao; Wu, Junfang; Kabadi, Shruti V.; Sabirzhanov, Boris; Guanciale, Kelsey; Hanscom, Marie; Faden, Juliane; Cardiff, Katherine; Bengson, Charles Jeremy; Faden, Alan I.			Propofol Limits Microglial Activation after Experimental Brain Trauma through Inhibition of Nicotinamide Adenine Dinucleotide Phosphate Oxidase	ANESTHESIOLOGY			English	Article							NADPH OXIDASE; CELL-DEATH; NITRIC-OXIDE; PROVIDES NEUROPROTECTION; INFLAMMATORY RESPONSES; COGNITIVE DEFICITS; PREFRONTAL CORTEX; SPATIAL MEMORY; CDK INHIBITOR; MOUSE MODEL	Background: Microglial activation is implicated in delayed tissue damage after traumatic brain injury (TBI). Activation of microglia causes up-regulation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, with the release of reactive oxygen species and cytotoxicity. Propofol appears to have antiinflammatory actions. The authors evaluated the neuroprotective effects of propofol after TBI and examined in vivo and in vitro whether such actions reflected modulation of NADPH oxidase. Methods: Adult male rats were subjected to moderate lateral fluid percussion TBI. Effect of propofol on brain microglial activation and functional recovery was assessed up to 28 days postinjury. By using primary microglial and BV2 cell cultures, the authors examined propofol modulation of lipopolysaccharide and interferon-gamma-induced microglial reactivity and neurotoxicity. Results: Propofol improved cognitive recovery after TBI in novel object recognition test (48 +/- 6% for propofol [n = 15] vs. 30 +/- 4% for isoflurane [n = 14]; P = 0.005). The functional improvement with propofol was associated with limited microglial activation and decreased cortical lesion volume and neuronal loss. Propofol also attenuated lipopolysaccharide- and interferon-gamma-induced microglial activation in vitro, with reduced expression of inducible nitric oxide synthase, nitric oxide, tumor necrosis factor-alpha, interlukin-1 beta, reactive oxygen species, and NADPH oxidase. Microglial-induced neurotoxicity in vitro was also markedly reduced by propofol. The protective effect of propofol was attenuated when the NADPH oxidase subunit p22(phox) was knocked down by small interfering RNA. Moreover, propofol reduced the expression of p22(phox) and gp91(phox), two key components of NADPH oxidase, after TBI. Conclusion: The neuroprotective effects of propofol after TBI appear to be mediated, in part, through the inhibition of NADPH oxidase.	[Luo, Tao; Wu, Junfang; Kabadi, Shruti V.; Sabirzhanov, Boris; Guanciale, Kelsey; Hanscom, Marie; Faden, Juliane; Cardiff, Katherine; Bengson, Charles Jeremy; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, HSF 2,Room S247,20 Penn St, Baltimore, MD 21201 USA; [Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Faden, Alan I.] Univ Maryland, Sch Med, Ctr STAR, Baltimore, MD 21201 USA		Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, HSF 2,Room S247,20 Penn St, Baltimore, MD 21201 USA.	afaden@anes.umm.edu		Faden, Alan I./0000-0003-0128-2348; Hanscom, Marie/0000-0001-8308-135X	National Institutes of Health, Bethesda, MarylandUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS061839, NS037313]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061839, R01NS037313] Funding Source: NIH RePORTER	This work was supported by grants R01 NS061839 and NS037313 from National Institutes of Health, Bethesda, Maryland (to Dr. Faden). Dr. Luo received departmental salary support. The authors declare no competing interests. The first two authors contributed equally to this article.	Adachi YU, 2005, ACTA ANAESTH SCAND, V49, P331, DOI 10.1111/j.1399-6576.2005.00564.x; Adembri C, 2007, CNS DRUG REV, V13, P333, DOI 10.1111/j.1527-3458.2007.00015.x; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Barger SW, 2007, J NEUROCHEM, V101, P1205, DOI 10.1111/j.1471-4159.2007.04487.x; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Block ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S8; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Cross L, 2013, LEARN MEMORY, V20, P41, DOI 10.1101/lm.028266.112; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Gui B, 2012, INFLAMMATION, V35, P1632, DOI 10.1007/s10753-012-9478-x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HARA M, 1994, ANESTHESIOLOGY, V81, P988, DOI 10.1097/00000542-199410000-00026; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; Hsing CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017598; Hsu BG, 2005, CLIN EXP PHARMACOL P, V32, P24, DOI 10.1111/j.1440-1681.2005.04155.x; Iijima T, 2006, BRAIN RES, V1099, P25, DOI 10.1016/j.brainres.2006.04.117; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Ito H, 1999, ACTA ANAESTH SCAND, V43, P153, DOI 10.1034/j.1399-6576.1999.430206.x; Jeohn GH, 2000, BRAIN RES, V880, P173, DOI 10.1016/S0006-8993(00)02737-2; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JA, 2009, ANESTHESIOLOGY, V111, P566, DOI 10.1097/ALN.0b013e3181af5b3d; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee IH, 2008, ANESTH ANALG, V107, P1211, DOI 10.1213/ane.0b013e31817ee879; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Mander PK, 2006, J IMMUNOL, V176, P1046, DOI 10.4049/jimmunol.176.2.1046; Munch G, 2003, EXP BRAIN RES, V150, P1, DOI 10.1007/s00221-003-1389-5; Murasaki O, 2003, J PHARMACOL EXP THER, V307, P995, DOI 10.1124/jpet.103.055772; Murphy PG, 1996, BRIT J ANAESTH, V76, P536, DOI 10.1093/bja/76.4.536; Nguyen HT, 2009, ANESTHESIOLOGY, V110, P326, DOI 10.1097/ALN.0b013e3181942b5b; ORSER BA, 1994, J NEUROSCI, V14, P7747; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Richardson JE, 2007, ANESTHESIOLOGY, V107, P412, DOI 10.1097/01.anes.0000278875.36639.2c; Sanders RD, 2013, CRIT CARE MED, V41, P1627, DOI 10.1097/CCM.0b013e31827c0c8d; Shibakawa YS, 2005, BRIT J ANAESTH, V95, P803, DOI 10.1093/bja/aei256; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Someya A, 1999, J LEUKOCYTE BIOL, V66, P851, DOI 10.1002/jlb.66.5.851; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027890; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Thiry JC, 2004, EUR J PHARMACOL, V499, P29, DOI 10.1016/j.ejphar.2004.05.043; Todd MM, 1996, J NEUROSURG ANESTH, V8, P296, DOI 10.1097/00008506-199610000-00007; Tsao CM, 2008, CRIT CARE MED, V36, P887, DOI 10.1097/CCM.0B013E318165395E; Vanlersberghe C., 2008, V182, P227, DOI 10.1007/978-3-540-74806-9_11; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; Wu JF, 2010, GLIA, V58, P315, DOI 10.1002/glia.20925; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044027, 10.1371/journal.pone.0046393]; Xu X, 2008, NEUROSCIENCE, V154, P1002, DOI 10.1016/j.neuroscience.2008.04.013; Ye XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052887; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	83	54	58	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	DEC	2013	119	6					1370	1388		10.1097/ALN.0000000000000020			19	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	301JJ	WOS:000330528300018	24121215	Bronze			2022-02-06	
J	Tompkins, P; Tesiram, Y; Lerner, M; Gonzalez, LP; Lightfoot, S; Rabb, CH; Brackett, DJ				Tompkins, Paul; Tesiram, Yasvir; Lerner, Megan; Gonzalez, Larry P.; Lightfoot, Stan; Rabb, Craig H.; Brackett, Daniel J.			Brain Injury: Neuro-Inflammation, Cognitive Deficit, and Magnetic Resonance Imaging in a Model of Blast Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast injury; cognitive deficit; inflammatory response; traumatic brain injury	MORRIS WATER MAZE; INDUCED NEUROTRAUMA; RATS; MEMORY; PERSEVERATION; INVOLVEMENT; NAVIGATION; EXPOSURE; SHOCK; PTSD	Blast wave-induced traumatic injury from terrorist explosive devices can occur at any time in either military or civilian environments. To date, little work has focused on the central nervous system response to a non-penetrating blast injury. We have evaluated the effect of a single 80-psi blast-overpressure wave in a rat model. Histological and immunochemical studies showed an early inflammatory response, tissue damage and the initiation of apoptosis. With regard to inflammation, polymorphonuclear leukocytes and lymphocytes infiltrated brain parenchyma within 1h post-blast. Glial-fibrillary protein, cyclo-oxygenase-2ir, interleukin-1 and tumor necrosis factor were present by 1h and remained detectable at three weeks post-injury. High mobility group box-1 protein was detectable at three weeks. With regard to tissue damage, S100 and 4-hydroxynonenal were present at 1h and remained detectable at three weeks. Amyloid precursor protein was detectable at three weeks. As for apoptosis, Cleaved Caspase-3 was detectable at three weeks. Morris water maze assessment of cognitive function showed that blast injured animals required significantly more time to reach the platform on day 1 of training and traveled a greater distance to get to the platform on days 1 and 2. Blast-injured animals showed a significant increase in swimming speed (p<0.001), increased total distance traveled (p<0.001) and increased number of entries into the previous quadrant that had contained the escape platform (p<0.05). Magnetic resonance imaging showed hyperintense regions in the somatosensory area within 1h. T2 relaxation times and apparent diffusion coefficients show increasing trends in both somatosensory and cortical regions. These data indicate an early and lasting response of brain tissue to non-penetrating blast over-pressure injury. This early inflammatory response is indicative of a mild traumatic brain injury. There is evidence of early hippocampal dysfunction.	[Tompkins, Paul; Rabb, Craig H.] Univ Oklahoma, HSC, Dept Neurosurg, Oklahoma City, OK 73104 USA; [Gonzalez, Larry P.] Univ Oklahoma, HSC, Dept Psychiat & Behav Sci, Oklahoma City, OK 73104 USA; [Tesiram, Yasvir] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; [Lerner, Megan; Brackett, Daniel J.] Univ Oklahoma, HSC, Dept Surg, Oklahoma City, OK 73104 USA; [Lightfoot, Stan] Univ Oklahoma, HSC, Dept Pathol, Oklahoma City, OK 73104 USA; [Lightfoot, Stan] Vet Adm Med Ctr, Oklahoma City, OK 73104 USA		Tompkins, P (corresponding author), Univ Oklahoma, HSC, Dept Neurosurg, 1122 NE 13th St,Room 340, Oklahoma City, OK 73104 USA.	Paul-Tompkins@ouhsc.edu	Gonzalez, Larry P/A-4362-2008; Tesiram, Yasvir A/B-7332-2016	Tesiram, Yasvir A/0000-0003-3008-2927			Arkhipov V, 2008, PHARMACOL BIOCHEM BE, V88, P299, DOI 10.1016/j.pbb.2007.08.012; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Irwin R J, 1998, J Okla State Med Assoc, V91, P387; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Kaufmann W, 2012, TOXICOL PATHOL, V40, P87, DOI 10.1177/0192623312439125; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kaur C, 1996, ARCH HISTOL CYTOL, V59, P239, DOI 10.1679/aohc.59.239; Kita T, 2000, INT J LEGAL MED, V113, P221, DOI 10.1007/s004149900095; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Mann PC, 2012, TOXICOL PATHOL, V40, P7, DOI 10.1177/0192623312438738; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Regitnig P, 2002, VIRCHOWS ARCH, V441, P328, DOI 10.1007/s00428-002-0646-5; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Whishaw IQ, 1997, HIPPOCAMPUS, V7, P361, DOI 10.1002/(SICI)1098-1063(1997)7:4<361::AID-HIPO2>3.0.CO;2-M	42	54	55	0	26	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2013	30	22					1888	1897		10.1089/neu.2012.2674			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	243PH	WOS:000326328400007	23777197				2022-02-06	
J	Schwulst, SJ; Trahanas, DM; Saber, R; Perlman, H				Schwulst, Steven J.; Trahanas, Diane M.; Saber, Rana; Perlman, Harris			Traumatic brain injury-induced alterations in peripheral immunity	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	72nd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 18-23, 2013	San Francisco, CA	Amer Assoc Surg Trauma		Traumatic brain injury; immunosuppression; peripheral immunity; innate immunity; mice	SPINAL-CORD-INJURY; BETA-BLOCKER EXPOSURE; HEAD-INJURY; IMPROVED SURVIVAL; ACTIVATION; STROKE; DISEASE; CELLS; MODEL	BACKGROUND: The complex alterations that occur in peripheral immunity after traumatic brain injury (TBI) have been poorly characterized to date. The purpose of this study was to determine the temporal changes in the peripheral immune response after TBI in a murine model of closed head injury. METHODS: C57Bl/6 mice underwent closed head injury via a weight drop technique (n = 5) versus sham injury (n = 3) per time point. Blood, spleen, and thymus were collected, and immune phenotype, cytokine expression, and antibody production were determined via flow cytometry and multiplex immunoassays at 1, 3, 7, 14, 30, and 60 days after injury. RESULTS: TBI results in acute and chronic changes in both the innate and adaptive immune response. TBI resulted in a striking loss of thymocytes as early as 3 days after injury (2.1 x 10(7) TBI vs. 5.6 x 10(7) sham, p = 0.001). Similarly, blood monocyte counts were markedly diminished as early as 24 hours after TBI (372 per deciliter TBI vs. 1359 per deciliter sham, p = 0.002) and remained suppressed throughout the first month after injury. At 60 days after injury, monocytes were polarized toward an anti-inflammatory (M2) phenotype. TBI also resulted in diminished interleukin 12 expression from Day 14 after injury throughout the remainder of the observation period. CONCLUSION: TBI results in temporal changes in both the peripheral and the central immune systems culminating in an overall immune suppressed phenotype and anti-inflammatory milieu. (J Trauma Acute Care Surg. 2013;75:780-788. Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Schwulst, Steven J.; Trahanas, Diane M.] Northwestern Univ, Dept Surg, Div Trauma, Chicago, IL 60611 USA; [Schwulst, Steven J.; Trahanas, Diane M.] Northwestern Univ, Dept Surg, Div Crit Care, Chicago, IL 60611 USA; [Saber, Rana; Perlman, Harris] Northwestern Univ, Dept Med, Div Rheumatol, Chicago, IL 60611 USA		Schwulst, SJ (corresponding author), Northwestern Univ, Dept Surg, 676 N St Clair St Suite 650, Chicago, IL 60611 USA.	sschwuls@nmh.org			NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL108795, P01 HL108795] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI092490, R21 AI092490] Funding Source: Medline; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01 AR050250, R01 AR054796, AR050250, AR054796] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL108795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R21AI092490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR054796, R01AR050250] Funding Source: NIH RePORTER		Barker RN, 1999, PATHOBIOLOGY, V67, P302, DOI 10.1159/000028085; Becher B, 2000, GLIA, V29, P293; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Campagnolo DI, 1997, AM J PHYS MED REHAB, V76, P276, DOI 10.1097/00002060-199707000-00005; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; CZLONKOWSKA A, 1979, J NEUROL SCI, V43, P455, DOI 10.1016/0022-510X(79)90024-8; Enderson BL, 2007, J TRAUMA, V62, P33; Faul M, 2010, TRAUMATIC BRAIN INJU; FELTEN DL, 1987, IMMUNOL REV, V100, P225, DOI 10.1111/j.1600-065X.1987.tb00534.x; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gui T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/693083; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; Huschak G, 2003, CLIN EXP IMMUNOL, V134, P491, DOI 10.1111/j.1365-2249.2003.02302.x; Imhoff M, 1990, Ann Ital Chir, V61, P525; Imhoff M, 1990, ANN ITAL CHIR, V61, P529; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Lech M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/951390; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; MEERT KL, 1995, CRIT CARE MED, V23, P822, DOI 10.1097/00003246-199505000-00008; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; Rehm KE, 2012, NEUROIMMUNOMODULAT, V19, P220, DOI 10.1159/000334711; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Vega JL, 2003, J NEUROPATH EXP NEUR, V62, P848, DOI 10.1093/jnen/62.8.848; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	41	54	54	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2013	75	5					780	788		10.1097/TA.0b013e318299616a			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	300IP	WOS:000330457900005	24158195	Green Accepted			2022-02-06	
J	Hampshire, A; MacDonald, A; Owen, AM				Hampshire, Adam; MacDonald, Alex; Owen, Adrian M.			Hypoconnectivity and Hyperfrontality in Retired American Football Players	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; FUNCTIONAL ABNORMALITIES; IMPACT; ENCEPHALOPATHY; CONCUSSION; PERMUTATION; EXPOSURE; DISEASE; TESTS	Recent research has raised concerns about the long-term neurological consequences of repetitive concussive and sub-concussive injuries in professional players of American Football. Despite this interest, the neural and psychological status of retired players remains unknown. Here, we evaluated the performances and brain activation patterns of retired National Football League players (NFL alumni) relative to controls using an fMRI-optimised neuropsychological test of executive function. Behaviourally, the NFL alumni showed only modest performance deficits on the executive task. By contrast, they showed pronounced hyperactivation and hypoconnectivity of the dorsolateral frontal and frontopolar cortices. Critically, abnormal frontal-lobe function was correlated with the number of times that NFL alumni reported having been removed from play after head injury and was evident in individual players. These results support the hypothesis that NFL alumni have a heightened probability of developing executive dysfunction and suggest that fMRI provides the most sensitive biomarker of the underlying neural abnormality.	[Hampshire, Adam] Imperial Coll London, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Hampshire, Adam; MacDonald, Alex; Owen, Adrian M.] Univ Western Ontario, Ctr Nat Sci, Brain & Mind Inst, London, ON N6A 5B7, Canada		Hampshire, A (corresponding author), Imperial Coll London, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England.	adamdghampshire@gmail.com	Williams, Jackie/B-3495-2015; Owen, Adrian M/B-4997-2015		Hubbard Foundation; Canada Excellence Research Chair Program	Funding was provided by the Hubbard Foundation and the Canada Excellence Research Chair Program. Participants were enrolled and scanned by David Hubbard MD at the Applied fMRI Institute.	Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brett M., 8 INT C FUNCT MAPP H; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Grant JE, 2013, EUROPEAN NEUROPSYCHO; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Russo Michael B, 2010, Continuum (Minneap Minn), V16, P161, DOI 10.1212/01.CON.0000391462.98911.26; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Weir DR., 2009, NATL FOOTBALL LEAGUE; Williams-Gray CH, 2007, J NEUROSCI, V27, P4832, DOI 10.1523/JNEUROSCI.0774-07.2007; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014	32	54	55	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 17	2013	3								2972	10.1038/srep02972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237IJ	WOS:000325862500001	24135857	Green Published, gold			2022-02-06	
J	Corrigan, JD; Bogner, J; Mellick, D; Bushnik, T; Dams-O'Connor, K; Hammond, FM; Hart, T; Kolakowsky-Hayner, S				Corrigan, John D.; Bogner, Jennifer; Mellick, Dave; Bushnik, Tamara; Dams-O'Connor, Kristen; Hammond, Flora M.; Hart, Tessa; Kolakowsky-Hayner, Stephanie			Prior History of Traumatic Brain Injury Among Persons in the Traumatic Brain Injury Model Systems National Database	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anxiety; Brain injuries; Craniocerebral trauma; Depression; Rehabilitation	VALIDITY; IDENTIFICATION; RELIABILITY; TBI; REPRESENTATIVENESS; PREDICTORS; OUTCOMES; SCALE	Objective: To determine the association between demographic, psychosocial, and injury-related characteristics and traumatic brain injury (TBI) occurring prior to a moderate or severe TBI requiring rehabilitation. Design: Secondary data analysis. Setting: TBI Model System inpatient rehabilitation facilities. Participants: Persons (N=4464) 1, 2, 5, 10, 15, or 20 years after TBI resulting in participation in the TBI Model System National Database. Interventions: Not applicable. Main Outcome Measures: History of TBI prior to the TBI Model System Index injury, pre-Index injury demographic and behavioral characteristics, Index injury characteristics, post-Index injury behavioral health and global outcome. Results: Twenty percent of the cohort experienced TBIs preceding the TBI Model System Index injury-80% of these were mild and 40% occurred before age 16. Pre- and post-Index injury behavioral issues, especially substance abuse, were highly associated with having had a prior TBI. Greater severity of the pre-Index injury as well as occurrence before age 6 often showed stronger associations. Unexpectedly, pre-Index TBI was associated with less severe Index injuries and better functioning on admission and discharge from rehabilitation. Conclusions: Findings suggest that earlier life TBI may have important implications for rehabilitation after subsequent TBI, especially for anticipating behavioral health issues in the chronic stage of recovery. Results provide additional evidence for the potential consequences of early life TBI, even if mild. (c) 2013 by the American Congress of Rehabilitation Medicine	[Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Mellick, Dave] Craig Hosp, Res Dept, Englewood, CO USA; [Bushnik, Tamara] NYU, Langone Sch Med, New York, NY USA; [Bushnik, Tamara; Kolakowsky-Hayner, Stephanie] Rehabil Res Ctr, Santa Clara Valley Med Ctr, San Jose, CA USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Bogner, Jennifer/E-2773-2011; Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, Traumatic Brain Injury Model System Centers [H133A070029, H133A070022, H133A070033, H113A070040, H133A070038, H113A070074, HI33A0120085]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, Traumatic Brain Injury Model System Centers (grant nos. H133A070029, H133A070022, H133A070033, H113A070040, H133A070038, H113A070074, HI33A0120085).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bernard, 2006, CONT ISSUES COMMUN S, V33, P42, DOI [10.1044/cicsd_33_S_42, DOI 10.1044/cicsd_33_S_42]; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSSI JS, 1985, EDUC PSYCHOL MEAS, V45, P737, DOI 10.1177/0013164485454004; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; *TRAUM BRAIN INJ M, 2013, SYLL; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Warner M, 2000, Vital Health Stat 10, P1; Whiteneck G, 2001, COLORADO TRAUMATIC B; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	32	54	54	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1940	1950		10.1016/j.apmr.2013.05.018			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	231TU	WOS:000325442100012	23770276	Green Submitted, Green Accepted			2022-02-06	
J	Buckley, TA; Munkasy, BA; Tapia-Lovler, TG; Wikstrom, EA				Buckley, Thomas A.; Munkasy, Barry A.; Tapia-Lovler, Tiffen G.; Wikstrom, Erik A.			Altered gait termination strategies following a concussion	GAIT & POSTURE			English	Article						Concussion; Gait termination; Postural control	ANKLE INSTABILITY; DEFICITS	The purpose was to determine if planned gait termination can identify acute and lingering motor control strategy alterations in post-concussion individuals. Controls completed two standard gait and five planned gait termination trials once while concussed individuals were tested on Day-1 and Day-10 post-concussion. Dependent variables included gait velocity and normalized, relative to standard gait, peak propulsive and braking forces. Control and only Day-1 post-concussion gait velocity differed. Normalized peak propulsive and braking forces were altered on both Day-1 and Day-10. Altered propulsive and braking forces persisted despite all concussion participants achieving their baseline values on standard concussion clinical tests. Thus gait termination can detect both acute and lingering motor control strategy alterations following concussion. (C) 2013 Elsevier B.V. All rights reserved.	[Buckley, Thomas A.; Munkasy, Barry A.; Tapia-Lovler, Tiffen G.] Georgia So Univ, Dept Hlth & Kinesiol, Statesboro, GA 30460 USA; [Wikstrom, Erik A.] Univ N Carolina, Dept Kinesiol, Charlotte, NC 28223 USA		Buckley, TA (corresponding author), Georgia So Univ, Dept Hlth & Kinesiol, Box 8076, Statesboro, GA 30460 USA.	TBuckley@Georgiasouthern.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Wikstrom, Erik/0000-0002-7260-0502	National Institute of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS135 070744-01A1]; Georgia Southern University Faculty Research Committee; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS070744] Funding Source: NIH RePORTER	This project was funded by the National Institute of Health/National Institute of Neurological Disorders and Stroke (1R15NS135 070744-01A1) and the Georgia Southern University Faculty Research Committee. The funding source had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Bishop M, 2006, NEUROSCI LETT, V397, P240, DOI 10.1016/j.neulet.2005.12.031; Bishop M, 2004, GAIT POSTURE, V20, P134, DOI 10.1016/j.gaitpost.2003.07.004; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; O'Kane FW, 2003, GAIT POSTURE, V17, P170, DOI 10.1016/S0966-6362(02)00104-2; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Perry SD, 2001, BRAIN RES, V913, P27, DOI 10.1016/S0006-8993(01)02748-2; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Wang JJ, 2009, J NEURAL TRANSM, V116, P1087, DOI 10.1007/s00702-009-0269-y; Wikstrom EA, 2012, CLIN BIOMECH, V27, P619, DOI 10.1016/j.clinbiomech.2012.01.001; Wikstrom EA, 2010, MED SCI SPORT EXER, V42, P197, DOI 10.1249/MSS.0b013e3181ad1e2f	15	54	55	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JUL	2013	38	3					549	551		10.1016/j.gaitpost.2013.02.008			3	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	216KZ	WOS:000324283600034	23489951	Green Accepted			2022-02-06	
J	Reddy, CC; Collins, M; Lovell, M; Kontos, AP				Reddy, Cara Camiolo; Collins, Michael; Lovell, Mark; Kontos, Anthony P.			Efficacy of Amantadine Treatment on Symptoms and Neurocognitive Performance Among Adolescents Following Sports-Related Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amantadine; concussion; postconcussion symptoms	TRAUMATIC BRAIN-INJURY; RECOVERY; IMPACT; SPECIFICITY; SENSITIVITY	Objective: To evaluate the efficacy of amantadine in the treatment of symptoms and neurocognitive performance in adolescents following sports-related concussion. Participants: A clinical sample of 25 male (n = 11) and female (n = 14) adolescent subjects with an age-, sex-, and concussion history-matched group of 25 male (n = 11) and female (n = 14) control subjects. Setting: Outpatient concussion clinic. Intervention: Retrospective, case-control design. Treatment group consisted of patients treated with 100 mg of amantadine twice daily (200 mg total per day) following a period of rest. Matched controls were evaluated and treated conservatively without medication at the same concussion program prior to the start of the current amantadine protocol. Main Outcome Measures: Immediate Postconcussion Assessment and Cognitive Test computerized neurocognitive test battery and symptom report. Results: Results support significantly greater improvements from pre-to posttest in reported symptoms, verbal memory, and reaction time performance for the amantadine group than the matched controls. There were no significant differences for visual memory or visual motor processing speed. Conclusion: This study provides empirical support for amantadine as an effective pharmacologic treatment of certain concussion-related cognitive deficits and symptoms in athletes with protracted recovery of more than 3 weeks.	[Reddy, Cara Camiolo] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Pittsburgh, PA 15219 USA; [Reddy, Cara Camiolo; Collins, Michael; Lovell, Mark; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthoped Surg, Pittsburgh, PA 15219 USA		Reddy, CC (corresponding author), Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, 1400 Locust St D-G103, Pittsburgh, PA 15219 USA.	camice@upmc.edu	Meijer, Anna/K-5118-2016	Kontos, Anthony/0000-0002-3749-4310			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Centers for Disease Control and Prevention, WHAT AR SIGNS SYMPT; Chandler M, 1998, BRAIN INJURY, V2, P309; Chen JJ, 2007, PHARMACOTHERAPY, V27, p161S, DOI 10.1592/phco.27.12part2.161S; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Giza CC, 2001, J ATHL TRAINING, V36, P228; Green LB, 2004, AM J PHYS MED REHAB, V83, P893, DOI 10.1097/01.PHM.0000143400.15346.C8; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider WN, 1999, BRAIN INJURY, V13, P863; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	29	54	54	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2013	28	4					260	265		10.1097/HTR.0b013e318257fbc6			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZO	WOS:000330363900003	22613947				2022-02-06	
J	Anderson, V; Beauchamp, MH; Yeates, KO; Crossley, L; Hearps, SJC; Catroppa, C				Anderson, Vicki; Beauchamp, Miriam H.; Yeates, Keith Owen; Crossley, Louise; Hearps, Stephen J. C.; Catroppa, Cathy			Social Competence at 6 Months Following Childhood Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Children; Recovery; Social skills; Behavior; Environment	PROBLEM-SOLVING SKILLS; CLOSED-HEAD-INJURY; SELF-REGULATION; CHILDREN; ADJUSTMENT; OUTCOMES; RECOVERY; ADOLESCENTS; FRIENDSHIP; TERM	Children with traumatic brain injury (TBI) are at risk for social impairment. This study aimed to examine social function at 6 months post-TBI and to explore the contribution of injury, cognitive, and environmental influences. The sample included 136 children, 93 survivors of TBI, and 43 healthy controls. TBI participants were recruited on admission and underwent magnetic resonance imaging scan within 8 weeks of injury and behavioral assessment at 6 months post-injury. Healthy controls underwent magnetic resonance imaging scans and behavioral assessment on recruitment. Assessment included parent and child questionnaires tapping social outcome and child-direct testing of cognitive abilities important for social competence (communication, attention/executive function, social cognition). Injury characteristics and environmental measures were collected. At 6-months post-injury, social problems were evident, but not global. Social participation appeared most vulnerable, with more severe injuries leading to greater problems. Greater injury severity and poorer communication skills were associated with poorer social adjustment and social participation, with the impact of family function also significant. Processing speed, younger age, and male gender also contributed to social outcomes. Further follow-up is required to track the recovery of social skills and the changing influences of cognition, brain, and environment over time.	[Anderson, Vicki; Beauchamp, Miriam H.; Crossley, Louise; Hearps, Stephen J. C.; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic 3010, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen] Nationwides Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA		Anderson, V (corresponding author), Murdoch Childrens Res Inst, 4 West,Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Yeates, Keith/AAJ-4223-2020; Hearps, Stephen/L-6853-2016; Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Hearps, Stephen/0000-0003-2984-1172; Yeates, Keith/0000-0001-7680-2892	Victorian Government Operational Infrastructure Scheme; Victorian Neurotrauma Initiative	The Victorian Neurotrauma Initiative funded this research, and it was also supported by the Victorian Government Operational Infrastructure Scheme. The authors declare no conflicts of interest.	Ackerman BP, 2006, ADV CHILD DEV BEHAV, V34, P91, DOI 10.1016/S0065-2407(06)80005-4; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P341, DOI 10.1097/01.HTR.0000336850.29574.7a; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bos KJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.016.2009; Bowker JC, 2010, J APPL DEV PSYCHOL, V31, P231, DOI 10.1016/j.appdev.2010.01.001; Bowker JC, 2007, EUR J DEV PSYCHOL, V4, P1, DOI 10.1080/17405620701632069; Bowlby J, 1962, DEPRIVATION MATERNAL; Bulotsky-Shearer RJ, 2008, DEV PSYCHOL, V44, P139, DOI 10.1037/0012-1649.44.1.139; Burgess KB, 2006, CHILD DEV, V77, P371, DOI 10.1111/j.1467-8624.2006.00876.x; Burnett S., 2012, DEV SOCIAL NEUROSCIE, P45; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; CAVELL TA, 1990, J CLIN CHILD PSYCHOL, V19, P111, DOI 10.1207/s15374424jccp1902_2; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; COFFEY CE, 1991, PSYCHOPATHOLOGY BRAI; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M., 2000, AUTISM INT J RES PRA, V4, P370, DOI DOI 10.1177/1362361300004004003; DENNIS M, 2012, J INT NEUROPSYCH SOC, V19, P1; Dennis M., 2012, J INT NEUROPSYCH SOC, V18, P1; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Dwyer KM, 2010, J SOC PERS RELAT, V27, P91, DOI 10.1177/0265407509346420; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fidell L.S., 2000, USING MULTIVARIATE S; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Hanten G., 2008, NEUROIMAGE, V31, P429; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Manly T, 1999, TEA CH TEST EVERYDAY; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Parker J. G., 1989, FRIENDSHIP QUALITY Q; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Sullivan MC, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/657923; TEASDALE G, 1974, LANCET, V2, P81; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; UCLA: Academic Technology Services, 2012, STAT DAT AN EX TOB A; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1999, WASI WECHSLER ABBREV; Wigg E. H., 1989, TEST LANGUAGE COMPET; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	74	54	55	0	30	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2013	19	5					539	550		10.1017/S1355617712001543			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	136OB	WOS:000318370100006	23552444				2022-02-06	
J	Caicco, MJ; Zahir, T; Mothe, AJ; Ballios, BG; Kihm, AJ; Tator, CH; Shoichet, MS				Caicco, Matthew J.; Zahir, Tasneem; Mothe, Andrea J.; Ballios, Brian G.; Kihm, Anthony J.; Tator, Charles H.; Shoichet, Molly S.			Characterization of hyaluronan-methylcellulose hydrogels for cell delivery to the injured spinal cord	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						hydrogel; cell therapy; spinal cord injury; hyaluronan; cell scaffold	TRANSPLANTATION; TISSUE; STIMULATION; THERAPY; REPAIR; SYSTEM; BRAIN	No effective clinical treatment currently exists for traumatic spinal cord injury. Cell replacement therapy holds promise for attaining functional repair. Cells may be delivered directly or near the injury site; however, this strategy requires a delivery vehicle to maintain cell viability. We have identified an injectable, biocompatible, and biodegradable hydrogel scaffold composed of hyaluronan (HA) and methylcellulose (MC) that may be an effective scaffold for therapeutic cell delivery. The purpose of the present study was to determine the effects of polymer concentration on HAMC mechanical strength, gelation time, and cell viability. The yield stress of HAMC, a measure of mechanical stiffness, was tunable via manipulation of MC and HA content. Measurement of the elastic and storage moduli as functions of time revealed that HAMC gels in less than 5 min at physiological temperatures. Human umbilical tissue-derived cells encapsulated in HAMC were homogenously and stably distributed over 3 days in culture and extended processes into the scaffold. Cell viability was stable over this period in all but the most concentrated HAMC formulation. Because of its strength-tunability, rapid gelation, and ability to maintain cell viability, HAMC is a promising vehicle for cell delivery and is being tested in ongoing in vivo studies. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.	[Caicco, Matthew J.; Zahir, Tasneem; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Caicco, Matthew J.; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Mothe, Andrea J.; Tator, Charles H.] Toronto Western Hosp, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON M5T 2S8, Canada; [Mothe, Andrea J.; Tator, Charles H.] Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada; [Ballios, Brian G.; Shoichet, Molly S.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Kihm, Anthony J.] Ethicon Inc, Adv Technol & Regenerat Med LLC, Somerville, NJ 08876 USA		Shoichet, MS (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	molly.shoichet@utoronto.ca			Johnson & Johnson Corporate Office of Science and Technology and Advanced Technologies and Regenerative Medicine, LLC (ATRM); CIHR TPRM Graduate FellowshipCanadian Institutes of Health Research (CIHR); Ontario Graduate ScholarshipOntario Graduate Scholarship; CIHR CGSD Graduate FellowshipCanadian Institutes of Health Research (CIHR)	Contract grant sponsors: Johnson & Johnson Corporate Office of Science and Technology and Advanced Technologies and Regenerative Medicine, LLC (ATRM); CIHR TPRM Graduate Fellowship; The Ontario Graduate Scholarship; CIHR CGSD Graduate Fellowship	Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131; Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004; Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009; CHANG GL, 1988, J BIOMECH ENG-T ASME, V110, P115, DOI 10.1115/1.3108415; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001; Enzmann GU, 2006, J NEUROTRAUM, V23, P479, DOI 10.1089/neu.2006.23.479; FRISCH SM, 1994, J CELL BIOL, V127, P1085, DOI 10.1083/jcb.127.4.1085; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Harris IR, 2005, US Pat, Patent No. [2006/022,317,7A1, 20060223177]; Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f; Joh T, 2001, GELS HDB, P51; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Reir PJ, 2004, NEURORX, V1, P424; SARKAR N, 1979, J APPL POLYM SCI, V24, P1073, DOI 10.1002/app.1979.070240420; Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r; Shoichet MS, 2000, ADV DRUG DELIVER REV, V42, P81, DOI 10.1016/S0169-409X(00)00055-7; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001; Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031	22	54	56	3	85	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	MAY	2013	101	5					1472	1477		10.1002/jbm.a.34454			6	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	115MG	WOS:000316815700027	23129254				2022-02-06	
J	Dehghan, F; Hadad, MK; Asadikram, G; Najafipour, H; Shahrokhi, N				Dehghan, Fatemeh; Hadad, Mohammad Khaksari; Asadikram, Gholamreza; Najafipour, Hamid; Shahrokhi, Nader			Effect of Melatonin on Intracranial Pressure and Brain Edema Following Traumatic Brain Injury: Role of Oxidative Stresses	ARCHIVES OF MEDICAL RESEARCH			English	Article						Brain edema; Melatonin; Intracranial pressure; Neurological outcomes	FOCAL CEREBRAL-ISCHEMIA; SEX STEROID-HORMONES; CLOSED-HEAD INJURY; BARRIER PERMEABILITY; CEREBROSPINAL-FLUID; BLOOD-FLOW; ANTIOXIDANT THERAPIES; RADICAL SCAVENGER; DAMAGE; RATS	Background and Aims. Traumatic brain injury (TBI) is one of the main causes of brain edema and increased intracranial pressure (ICP). In the clinic it is essential to limit the development of ICP after TBI. In the present study, the effects of melatonin on these parameters at different time points and alterations of oxidant factors as one of the probable involved mechanisms have been evaluated. Methods. Albino N-Mary rats were divided into five groups of sham, TBI, TBI + vehicle, TBI + Mel5 and TBI + Mel20. Brain injury was induced by Marmarou method. Melatonin was injected i.p. at 1, 24, 48 and 72 h after brain trauma. Brain water and Evans blue dye contents as well as oxidant/antioxidant factors were measured 72 h after TBI. ICP and neurological scores were determined at -1, 1, 24, 48 and 72 h post-TBI. Results. Brain water and Evans blue dye contents in melatonin-treated groups decreased as compared to the TBI + vehicle group (p <0.001). Veterinary coma scale (VCS) at 24, 48 and 72 h after TBI showed a significant increase in melatonin groups (TBI + Mel5: p <0.01and TBI + Mel20: p <0.001) in comparison to the TBI + vehicle group. ICP at 24, 48 and 72 h after TBI decreased in melatonin groups as compared to the TBI + vehicle group (p <0.001). Superoxide dismutase and glutathione peroxidase activities showed a significant increase, whereas malondialdehyde level in these groups was significantly lower in melatonin groups in comparison to the TBI + vehicle group (p <0.001). Conclusion. Melatonin decreases brain edema, BBB permeability and ICP, but increases VCS after TBI. These effects are probably due to inhibition of oxidative stress. 2013 IMSS. Published by Elsevier Inc.	[Dehghan, Fatemeh; Shahrokhi, Nader] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran; [Hadad, Mohammad Khaksari; Asadikram, Gholamreza; Najafipour, Hamid] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran		Shahrokhi, N (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran.	nshahrokhisa@yahoo.com	Shahrokhi, Nader/AAV-3747-2020; Najafipour, Hamid/U-7922-2017; Asadikaram, Gholamreza/AAG-4437-2021	Shahrokhi, Nader/0000-0002-0149-7819; Najafipour, Hamid/0000-0002-8030-8704; Asadikaram, Gholamreza/0000-0002-9100-0756; Asadi karam, Gholamreza/0000-0002-6417-5200; Khaksari, Mohammad/0000-0003-0770-4281	Neuroscience Research Centre of Kerman University of Medical sciences	The present study was financially supported by the Neuroscience Research Centre of Kerman University of Medical sciences. Data reported are part of the Master of Science thesis presented by Fatemeh Dehghan.	Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Aygun D, 2012, HISTOL HISTOPATHOL, V27, P417, DOI 10.14670/HH-27.417; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Chen HY, 2006, J PINEAL RES, V41, P175, DOI 10.1111/j.1600-079X.2006.00351.x; Chen TY, 2006, J PINEAL RES, V40, P242, DOI 10.1111/j.1600-079X.2005.00307.x; Chern CM, 2012, FREE RADICAL BIO MED, V52, P1634, DOI 10.1016/j.freeradbiomed.2012.01.030; Chieregato A, 2007, NEUROSURGERY, V60, P115, DOI 10.1227/01.NEU.0000249194.76527.28; Cirak B, 1999, PEDIATR NEUROSURG, V31, P298, DOI 10.1159/000028879; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Erol FS, 2008, J CLIN NEUROSCI, V15, P784, DOI 10.1016/j.jocn.2007.06.009; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fujimoto T, 2000, SPINE, V25, P769, DOI 10.1097/00007632-200004010-00003; Ganguly K, 2009, J PINEAL RES, V47, P43, DOI 10.1111/j.1600-079X.2009.00687.x; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gnezdilova A. V., 2010, Eksperimental'naya i Klinicheskaya Farmakologiya, V73, P11; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; Gorgulu AK, 2001, NEUROSURGERY, V49, P1434; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Gutierrez-Cuesta J, 2007, J PINEAL RES, V42, P394, DOI 10.1111/j.1600-079X.2007.00433.x; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hung YC, 2008, J PINEAL RES, V45, P459, DOI 10.1111/j.1600-079X.2008.00617.x; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jamali S, 1998, BRAIN INJURY, V12, P525, DOI 10.1080/026990598122485; Kabadi SV, 2010, ANN NY ACAD SCI, V1199, P105, DOI 10.1111/j.1749-6632.2009.05352.x; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Klussmann S, 2005, J MOL MED, V83, P657, DOI 10.1007/s00109-005-0663-3; Kondoh T, 2002, LIFE SCI, V72, P583, DOI 10.1016/S0024-3205(02)02256-7; Leon J, 2004, LIFE SCI, V75, P765, DOI 10.1016/j.lfs.2004.03.003; Li ZQ, 2009, BRAIN RES, V1264, P98, DOI 10.1016/j.brainres.2009.01.055; Lisa Hill CG, 2007, ANAESTHESIA, P30; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Maslennikov D, 2011, EUR NEUROPSYCHOPHARM, V21, pS127, DOI 10.1016/S0924-977X(11)70143-2; Meki ARMA, 2001, COMP BIOCHEM PHYS C, V130, P305, DOI 10.1016/S1532-0456(01)00248-4; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Niles LP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-41; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Ozdemir D, 2005, PHYSIOL RES, V54, P631; PIERI C, 1994, LIFE SCI, V55, pPL271, DOI 10.1016/0024-3205(94)00666-0; Pugliese F, 2007, TRANSPL P, V39, P1883, DOI 10.1016/j.transproceed.2007.05.062; RAO BR, 1980, AUSTRALAS RADIOL, V24, P24, DOI 10.1111/j.1440-1673.1980.tb02150.x; Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237; Reiter RJ, 2000, ANN NY ACAD SCI, V917, P376; Reiter RJ, 2010, MARMARA PHARM J, V14, P1, DOI 10.12991/201014457; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Rowlands HE, 2007, PAEDIAT CHILD HLTH, V17, P82, DOI DOI 10.1016/J.PAED.2007.01.011; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; Savaskan E, 2001, NEUROBIOL AGING, V22, P541, DOI 10.1016/S0197-4580(00)00259-1; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Soustiel JF, 2010, NEUROTHERAPEUTICS, V7, P13, DOI 10.1016/j.nurt.2009.11.001; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Swarnakar S, 2011, J PINEAL RES, V50, P8, DOI 10.1111/j.1600-079X.2010.00812.x; Takasugi Y, 2005, EXP ANIM TOKYO, V54, P193, DOI 10.1538/expanim.54.193; Toklu H, 2009, MARMARA MED J, V22, P34; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Turgut M, 2007, BRAIN RES, V1175, P117, DOI 10.1016/j.brainres.2007.07.056; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wakatsuki A, 2001, J PINEAL RES, V31, P167, DOI 10.1034/j.1600-079x.2001.310211.x; Xiao F, 2002, ACAD EMERG MED, V9, P933, DOI 10.1111/j.1553-2712.2002.tb02196.x	81	54	56	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0188-4409	1873-5487		ARCH MED RES	Arch. Med. Res.	MAY	2013	44	4					251	258		10.1016/j.arcmed.2013.04.002			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	185TV	WOS:000321994100001	23608674				2022-02-06	
J	Hylin, MJ; Orsi, SA; Zhao, J; Bockhorst, K; Perez, A; Moore, AN; Dash, PK				Hylin, Michael J.; Orsi, Sara A.; Zhao, Jing; Bockhorst, Kurt; Perez, Alec; Moore, Anthony N.; Dash, Pramod K.			Behavioral and Histopathological Alterations Resulting from Mild Fluid Percussion Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; concussion; DTI; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; DIFFUSE AXONAL INJURY; UNMYELINATED AXONS; CORPUS-CALLOSUM; CORTICAL IMPACT; RATS; CONCUSSION; DEFICITS; MEMORY	The majority of people who sustain a traumatic brain injury (TBI) have an injury that can be classified as mild (often referred to as concussion). Although head CT scans for most subjects who have sustained a mild TBI (mTBI) are negative, these persons may still suffer from neurocognitive and neurobehavioral deficits. In order to expedite pre-clinical research and develop therapies, there is a need for well-characterized animal models of mTBI that reflect the neurological, neurocognitive, and pathological changes seen in human patients. In the present study, we examined the motor, cognitive, and histopathological changes resulting from 1.0 and 1.5 atmosphere (atm) overpressure fluid percussion injury (FPI). Both 1.0 and 1.5 atm FPI injury caused transient suppression of acute neurological functions, but did not result in visible brain contusion. Animals injured with 1.0 atm FPI did not show significant motor, vestibulomotor, or learning and memory deficits. In contrast, 1.5 atm injury caused transient motor disturbances, and resulted in a significant impairment of spatial learning and short-term memory. In addition, 1.5 atm FPI caused a marked reduction in cerebral perfusion at the site of injury that lasted for several hours. Consistent with previous studies, 1.5 atm FPI did not cause visible neuronal loss in the hippocampus or in the neocortex. However, a robust inflammatory response (as indicated by enhanced GFAP and Iba1 immunoreactivity) in the corpus callosum and the thalamus was observed. Examination of fractional anisotropy color maps after diffusion tensor imaging (DTI) revealed a significant decrease of FA values in the cingulum, an area found to have increased silver impregnation, suggesting axonal injury. Increased silver impregnation was also observed in the corpus callosum, and internal and external capsules. These findings are consistent with the deficits and pathologies associated with mild TBI in humans, and support the use of mild FPI as a model to evaluate putative therapeutic options.	[Hylin, Michael J.; Orsi, Sara A.; Zhao, Jing; Perez, Alec; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Bockhorst, Kurt] Univ Texas Hlth Sci Ctr Houston, Dept Radiol, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, POB 20036, Houston, TX 77225 USA.	p.dash@uth.tmc.edu	Hylin, Michael/U-2878-2019	Dash, Pramod/0000-0001-6746-1002	DODUnited States Department of Defense [W81XWH-08-2-0134]; TIRR Foundation	The authors would like to thank Dr. Bruce Lyeth of the University of California, Davis for kindly providing the hubs used to mount the rats to the FPI device. We also thank the Imaging Core of the Mission Connect Mild TBI Translational Consortium under the direction of Dr. Ponada Narayana for their assistance with the MRI. The work performed in the authors' laboratories were made possible by grants from DOD (W81XWH-08-2-0134) and TIRR Foundation.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bedell EA, 1998, J NEUROTRAUM, V15, P985, DOI 10.1089/neu.1998.15.985; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Blum S, 1999, J NEUROSCI, V19, P3535; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	52	54	54	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	9			SI		702	715		10.1089/neu.2012.2630			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	145BJ	WOS:000318987600003	23301501	Green Published			2022-02-06	
J	Schmidt, J; Fleming, J; Ownsworth, T; Lannin, NA				Schmidt, Julia; Fleming, Jennifer; Ownsworth, Tamara; Lannin, Natasha A.			Video Feedback on Functional Task Performance Improves Self-awareness After Traumatic Brain Injury: A Randomized Controlled Trial	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						cognition; rehabilitation; occupational therapy; neuropsychology	INTERVENTIONS; DEFICITS; REHABILITATION; SAMPLE; ADULTS; SKILLS	Background. Feedback is used in rehabilitation to improve self-awareness in people with traumatic brain injury (TBI), but there have been no comparisons of the different methods of providing feedback. Objective. To compare the effect of different methods of feedback on impaired self-awareness after TBI. Method. This was a randomized, assessor-blinded trial with concealed allocation. A total of 54 participants with TBI and impaired self-awareness (85% male) were recruited from inpatient and community rehabilitation settings. Participants performed a meal preparation task on 4 occasions and were randomly assigned to 1 of 3 feedback intervention groups: video plus verbal feedback, verbal feedback, or experiential feedback. The primary outcome was improvement in online awareness measured by the number of errors made during task completion. Secondary outcomes included level of intellectual awareness, self-perception of rehabilitation, and emotional status. Results. Receiving video plus verbal feedback reduced the number of errors more than verbal feedback alone (mean difference = 19.7 errors; 95% confidence interval [CI] = 9.2-30.1) and experiential feedback alone (mean difference = 12.4 errors; 95% CI = 1.8-23.0). Conclusion. The results suggest that the video plus verbal feedback approach used in this study was effective in improving self-awareness in people with TBI. The results also provide evidence that improvement in self-awareness was not accompanied by deterioration in emotional status.	[Schmidt, Julia] Royal Rehabil Ctr, Sydney, NSW, Australia; [Schmidt, Julia; Fleming, Jennifer] Univ Queensland, Brisbane, Qld 4072, Australia; [Schmidt, Julia; Fleming, Jennifer] Metro South Hlth Serv Dist, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Ownsworth, Tamara] Griffith Univ, Brisbane, Qld 4111, Australia; [Lannin, Natasha A.] Alfred Hlth, Melbourne, Vic, Australia; [Lannin, Natasha A.] La Trobe Univ, Melbourne, Vic, Australia; [Lannin, Natasha A.] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	j.fleming@uq.edu.au	Lannin, Natasha A/A-4195-2013; Ownsworth, Tamara/ABB-6961-2021	Lannin, Natasha A/0000-0002-2066-8345; Ownsworth, Tamara/0000-0003-1835-7094; Schmidt, Julia/0000-0003-2004-4871	Occupational Therapists Board of Queensland; Wenkart Foundation, Australia; Cerebral Palsy Alliance, Australia	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This trial has been partially funded through a grant awarded by the Occupational Therapists Board of Queensland. At the time of this study, JS was supported by a fellowship provided by the Wenkart Foundation, Australia, and NAL was supported by the Balnaves Fellowship provided by the Cerebral Palsy Alliance, Australia. There are no industrial links or affiliations of authors involved in this study, and there are no conflicts of interest.	Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Alexy WD, 1983, COGNITIVE REHABILITA, V1, P8; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Burgess P, 1996, BEHAV ASSESSMENT DYS; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming J, 2009, INTERNATIONAL HANDBOOK OF OCCUPATIONAL THERAPY INTERVENTIONS, P225, DOI 10.1007/978-0-387-75424-6_20; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; McNaughton S., 1987, PAUSE PROMPT PRAISE; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Pocock, 1983, CLIN TRIALS PRACTICA; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmidt J, 2012, AUST OCCUP THER J, V59, P138, DOI 10.1111/j.1440-1630.2012.00998.x; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Tabachnick B.G., 2001, USING MULTIVARIATE S; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wechsler D., 2002, WAIS 3 WMS 3 TECHNIC; [No title captured]; [No title captured]	30	54	54	1	33	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2013	27	4					316	324		10.1177/1545968312469838			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	136JX	WOS:000318359300004	23270921				2022-02-06	
J	Sword, J; Masuda, T; Croom, D; Kirov, SA				Sword, Jeremy; Masuda, Tadashi; Croom, Deborah; Kirov, Sergei A.			Evolution of neuronal and astroglial disruption in the peri-contusional cortex of mice revealed by in vivo two-photon imaging	BRAIN			English	Article						acute brain injury; dendritic beading; astroglial swelling; cortical spreading depolarization; in vivo; two-photon microscopy	TRAUMATIC BRAIN-INJURY; CORTICAL SPREADING DEPRESSION; CEREBRAL-ARTERY OCCLUSION; HEMODYNAMIC DEPRESSION; DENDRITIC STRUCTURE; ISCHEMIA; IMPACT; GLUTAMATE; RAT; NEURODEGENERATION	In traumatic brain injury mechanical forces applied to the cranium and brain cause irreversible primary neuronal and astroglial damage associated with terminal dendritic beading and spine loss representing acute damage to synaptic circuitry. Oedema develops quickly after trauma, raising intracranial pressure that results in a decrease of blood flow and consequently in cerebral ischaemia, which can cause secondary injury in the peri-contusional cortex. Spreading depolarizations have also been shown to occur after traumatic brain injury in humans and in animal models and are thought to accelerate and exacerbate secondary tissue injury in at-risk cortical territory. Yet, the mechanisms of acute secondary injury to fine synaptic circuitry within the peri-contusional cortex after mild traumatic brain injury remain unknown. A mild focal cortical contusion model in adult mouse sensory-motor cortex was implemented by the controlled cortical impact injury device. In vivo two-photon microscopy in the peri-contusional cortex was used to monitor via optical window yellow fluorescent protein expressing neurons, enhanced green fluorescent protein expressing astrocytes and capillary blood flow. Dendritic beading in the peri-contusional cortex developed slowly and the loss of capillary blood flow preceded terminal dendritic injury. Astrocytes were swollen indicating oedema and remained swollen during the next 24 h throughout the imaging session. There were no recurrent spontaneous spreading depolarizations in this mild traumatic brain injury model; however, when spreading depolarizations were repeatedly induced outside the peri-contusional cortex by pressure-injecting KCl, dendrites undergo rapid beading and recovery coinciding with passage of spreading depolarizations, as was confirmed with electrophysiological recordings in the vicinity of imaged dendrites. Yet, accumulating metabolic stress resulting from as few as four rounds of spreading depolarization significantly added to the fraction of beaded dendrites that were incapable to recover during repolarization, thus facilitating terminal injury. In contrast, similarly induced four rounds of spreading depolarization in another set of control healthy mice caused no accumulating dendritic injury as dendrites fully recovered from beading during repolarization. Taken together, our data suggest that in the mild traumatic brain injury the acute dendritic injury in the peri-contusional cortex is gated by the decline in the local blood flow, most probably as a result of developing oedema. Furthermore, spreading depolarization is a specific mechanism that could accelerate injury to synaptic circuitry in the metabolically compromised peri-contusional cortex, worsening secondary damage following traumatic brain injury.	[Sword, Jeremy] Georgia Hlth Sci Univ, Grad Program Neurosci, Augusta, GA 30912 USA; [Masuda, Tadashi; Kirov, Sergei A.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Croom, Deborah; Kirov, Sergei A.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA 30912 USA		Kirov, SA (corresponding author), Georgia Hlth Sci Univ, Dept Neurosurg, Brain & Behav Discovery Inst, 1120 15th St,CB-3706, Augusta, GA 30912 USA.	skirov13@gmail.com			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS057113]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057113] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NS057113 (S.A.K.).	Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BINDOKAS VP, 1995, J NEUROSCI, V15, P6999; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon C. Edward, 2009, P385, DOI 10.1007/978-1-60327-185-1_33; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Jagt TAV, 2008, J NEUROSCI, V28, P5029, DOI 10.1523/JNEUROSCI.5069-07.2008; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Maeda T, 1997, ACT NEUR S, V70, P102; Masuda T, 2010, BRAIN RES, V1355, P228, DOI 10.1016/j.brainres.2010.07.101; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mongin AA, 2002, AM J PHYSIOL-CELL PH, V283, pC569, DOI 10.1152/ajpcell.00438.2001; MONGIN AA, 2005, NEUROGLIA, P550; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Risher WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022351; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rosidi NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026612; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shuttleworth CWR, 2001, J NEUROSCI, V21, P4225, DOI 10.1523/JNEUROSCI.21-12-04225.2001; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Tom WJ, 2008, IEEE T MED IMAGING, V27, P1728, DOI 10.1109/TMI.2008.925081; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yuzawa I, 2012, J CEREBR BLOOD F MET, V32, P376, DOI 10.1038/jcbfm.2011.148; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	76	54	54	1	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAY	2013	136		5				1446	1461		10.1093/brain/awt026			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140DN	WOS:000318634600010	23466395	Green Published, Bronze			2022-02-06	
J	Martini, D; Eckner, J; Kutcher, J; Broglio, SP				Martini, Douglas; Eckner, James; Kutcher, Jeffery; Broglio, Steven P.			Subconcussive Head Impact Biomechanics: Comparing Differing Offensive Schemes	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						ACCELERATION; HELMET; MAGNITUDE; HEAD IMPACT TELEMETRY SYSTEM; FOOTBALL	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL; BRAIN-INJURY; CONCUSSION; ASSOCIATION; IMPAIRMENT; SEVERITY	MARTINI, D., J. ECKNER, J. KUTCHER, and S. P. BROGLIO. Subconcussive Head Impact Biomechanics: Comparing Differing Offensive Schemes. Med. Sci. Sports Exerc., Vol. 45, No. 4, pp. 755-761, 2013. Purpose: Recent literature suggests that subconcussive impacts may influence cognitive functioning across the life span. These effects are suggested to manifest as functional and possibly structural changes. Head impact biomechanics during American football have been characterized from the high school to professional level, but style of play has not been considered. The aim of this investigation was to quantify and compare head impact frequencies and magnitudes between two different offensive schemes. Methods: We investigated the frequencies and magnitudes (linear acceleration [g], rotational acceleration [rad.s(-2)], and HITsp) of head impacts sustained by 83 high school football athletes, playing for schools using two different offensive schemes. The two schemes comprised a run-first offense (42 athletes) and a pass-first offense (41 athletes). The Head Impact Telemetry System was used to record head impact measures. Results: A total of 35,620 impacts were recorded across two seasons. Athletes in the run-first offense sustained an average of 456 head impacts per season (41 practices and 9 games), whereas the pass-first offense athletes sustained an average of 304 head impacts per season (44 practices and 9 games). The pass-first offense, however, sustained significantly higher impact magnitudes (P values < 0.05; 28.56g, 1777.58 rad.s(-2), and 16.24) than the run-first offense (25.67g, 1675.36 rad.s(-2), and 15.48) across a season. Conclusions: These data provide a first look at how different offensive strategies may influence head impact exposure in football athletes. In the study population, a run-first offense was associated with more frequent head impacts, of smaller magnitude, than a pass-first offense.	[Martini, Douglas; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Neurotrauma Res Lab, Ann Arbor, MI 48109 USA; [Eckner, James] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Eckner, James; Kutcher, Jeffery; Broglio, Steven P.] Michigan NeuroSport, Ann Arbor, MI USA; [Kutcher, Jeffery] Univ Michigan, Dept Neurol, Ann Arbor, MI USA		Broglio, SP (corresponding author), Univ Michigan, Sch Kinesiol, 1402 Washington Hts, Ann Arbor, MI 48109 USA.	broglio@umich.edu	Meijer, Anna/K-5118-2016		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD001097] Funding Source: Medline		Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Talavage TM, 2010, J NEUROTRAUMA; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0	27	54	54	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	APR	2013	45	4					755	761		10.1249/MSS.0b013e3182798758			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	109ZK	WOS:000316410600019	23135370	Green Accepted			2022-02-06	
J	Tian, CL; Wang, XW; Wang, XD; Wang, L; Wang, XG; Wu, SM; Wan, ZX				Tian, Chunlei; Wang, Xiongwei; Wang, Xiaodan; Wang, Lei; Wang, Xuguang; Wu, Shengmei; Wan, Zhixian			Autologous Bone Marrow Mesenchymal Stem Cell Therapy in the Subacute Stage of Traumatic Brain Injury by Lumbar Puncture	EXPERIMENTAL AND CLINICAL TRANSPLANTATION			English	Article						Cerebral lesion; Regenerative therapy; Transplant; Vegetative state; Motor	SPINAL-CORD-INJURY; TRANSPLANTATION; PROLIFERATION; DELIVERY; STROKE; EPIDEMIOLOGY; RECOVERY; SURVIVAL	Objectives: To explore the clinical therapeutic effects and safety of autologous bone marrow mesenchymal stem cell therapy for traumatic brain injury by lumbar puncture. Materials and Methods: A total of 97 patients (24 with persistent vegetative state and 73 with disturbance motor activity) who developed a complex cerebral lesion after traumatic brain injury received autologous bone marrow mesenchymal stem cell therapy voluntarily. The stem cells were isolated from the bone marrow of the patients and transplanted into the subarachnoid space by lumbar puncture. Results: Fourteen days after cell therapy, no serious complications or adverse events were reported. To a certain extent, 38 of 97 patients (39.2%) improved in the function of brain after transplant (P = .007). Eleven of 24 patients (45.8%) with persistent vegetative state showed posttherapeutic improvements in consciousness (P = .024). Twenty-seven of 73 patients (37.0%) with a motor disorder began to show improvements in motor functions (P = .025). The age of patients and the time elapsed between injury and therapy had effects on the outcomes of the cellular therapy (P < .05). No correlation was found between the number of cell injections and improvements (P>.05). Conclusions: This study suggests that the bone marrow stem cell therapy is safe and effective on patients with traumatic brain injury complications, such as persistent vegetative state and motor disorder, through lumbar puncture. Young patients improve more easily than older ones. The earlier the cellular therapy begins in the subacute stage of traumatic brain injury, the better the results.	[Tian, Chunlei; Wang, Xiongwei; Wang, Xiaodan; Wang, Lei; Wang, Xuguang; Wu, Shengmei; Wan, Zhixian] China Three Gorges Univ, Inst Neurol, Coll Clin Med Sci 1, Yichang 443003, Hubei, Peoples R China; [Tian, Chunlei; Wang, Xiongwei; Wang, Lei; Wang, Xuguang; Wu, Shengmei; Wan, Zhixian] Yichang Ctr Peoples Hosp, Dept Neurosurg, Yichang 443003, Hubei, Peoples R China		Wang, XW (corresponding author), China Three Gorges Univ, Inst Neurol, Coll Clin Med Sci 1, Yi Ling Da Dao 183, Yichang 443003, Hubei, Peoples R China.	xwwyc@yahoo.cn					Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Arango MF, 2007, EVIDENCE BASED NEURO, P142; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hilfiker A, 2011, LANGENBECK ARCH SURG, V396, P489, DOI 10.1007/s00423-011-0762-2; Jang DK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/238409; Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kumar AA, 2009, EXP CLIN TRANSPLANT, V7, P241; Lerner AJ, 2006, DIAGNOSTIC CRITERIA, P69; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Sykova E, 2007, CELL DEATH DIFFER, V14, P1336, DOI 10.1038/sj.cdd.4402140; Tolar J, 2006, BLOOD, V107, P4182, DOI 10.1182/blood-2005-08-3289; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Weiner Leslie P., 2008, V438, P3, DOI 10.1007/978-1-59745-133-8_1; Wilkinson L, 2005, ESSENTIAL NEUROLOGY, P55; Wislet-Gendebien S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601560; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	34	54	55	1	7	BASKENT UNIV	ANKARA	TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY	1304-0855			EXP CLIN TRANSPLANT	Exp. Clin. Transplant.	APR	2013	11	2					176	181		10.6002/ect.2012.0053			6	Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Transplantation	137SQ	WOS:000318458100015	22891928				2022-02-06	
J	Hopkins, RO; Suchyta, MR; Farrer, TJ; Needham, D				Hopkins, Ramona O.; Suchyta, Mary R.; Farrer, Thomas J.; Needham, Dale			Improving Post-Intensive Care Unit Neuropsychiatric Outcomes Understanding Cognitive Effects of Physical Activity	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article						cognitive outcome; critical illness; early mobility; physical rehabilitation; depression	QUALITY-OF-LIFE; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; GROWTH-FACTOR-I; NEUROTROPHIC FACTOR; AEROBIC EXERCISE; CRITICAL ILLNESS; CARDIOPULMONARY FITNESS; PSYCHOLOGICAL OUTCOMES	Critical illness and its treatment often result in long-term neuropsychiatric morbidities. Consequently, there is a need to focus on means to prevent or ameliorate these morbidities. Animal models provide important data regarding the neurobiological effects of physical activity, including angiogenesis, neurogenesis, and release of neurotrophic factors that enhance plasticity. Studies in noncritically ill patients demonstrate that exercise is associated with increased cerebral blood flow, neurogenesis, and brain volume, which are associated with improved cognition. Clinically, research in both healthy and diseased human subjects suggests that exercise improves neuropsychiatric outcomes. In the critical care setting, early physical rehabilitation and mobilization are safe and feasible, with demonstrated improvements in physical functional outcomes. Such activity may also reduce the duration of delirium in the intensive care unit (ICU) and improve neuropsychiatric outcomes, although data are limited. Barriers exist regarding implementing ICU rehabilitation in routine care, including use of sedatives and lack of awareness of post-ICU cognitive impairments. Further research is necessary to determine whether prior animal and human research, in conjunction with preliminary results from existing ICU studies, can translate into improvements for neuropsychiatric outcomes in critically ill patients. Studies are needed to evaluate biological mechanisms, risk factors, the role of pre-ICU functional level, and the timing, duration, and type of physical activity for optimal patient outcomes.	[Hopkins, Ramona O.; Suchyta, Mary R.] Intermt Med Ctr, Dept Med, Pulm & Crit Care Med Div, Murray, UT 84107 USA; [Hopkins, Ramona O.; Farrer, Thomas J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Suchyta, Mary R.] Univ Utah, ARUP Labs Informat Dept, Salt Lake City, UT USA; [Needham, Dale] Johns Hopkins Univ, Sch Med, Outcomes Crit Illness & Surg OACIS Grp, Div Pulm & Crit Care Med, Baltimore, MD USA; [Needham, Dale] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA		Hopkins, RO (corresponding author), Intermt Med Ctr, Dept Med, Pulm & Crit Care Div, Murray, UT 84107 USA.	mona.hopkins@imail.org		Farrer, Thomas J./0000-0001-8092-6214			Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Barnes DE, 2008, J AM GERIATR SOC, V56, P1658, DOI 10.1111/j.1532-5415.2008.01841.x; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Brummel NE, PHYS THER IN PRESS; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Bullitt E, 2009, AM J NEURORADIOL, V30, P1857, DOI 10.3174/ajnr.A1695; Bullitt E, 2010, NEUROBIOL AGING, V31, P290, DOI 10.1016/j.neurobiolaging.2008.03.022; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Chen SY, 2011, J FORMOS MED ASSOC, V110, P572, DOI 10.1016/j.jfma.2011.07.008; Chiang LL, 2006, PHYS THER, V86, P1271, DOI 10.2522/ptj.20050036; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Connolly B, 2012, CRIT CARE, V16, DOI [10.1186/cc11219, 10.1186/CC11219]; Cumming TB, INT PSYCHOG IN PRESS; Davis JC, 2010, ARCH INTERN MED, V170, P2036, DOI 10.1001/archinternmed.2010.462; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Ding YH, 2004, CURR NEUROVASC RES, V1, P411, DOI 10.2174/1567202043361875; Duning T, 2010, DIABETES CARE, V33, P639, DOI 10.2337/dc09-1740; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Emery CF, 2003, HEALTH PSYCHOL, V22, P598, DOI 10.1037/0278-6133.22.6.598; Emery CF, 1998, HEALTH PSYCHOL, V17, P232, DOI 10.1037/0278-6133.17.3.232; EMERY CF, 1991, CHEST, V100, P613, DOI 10.1378/chest.100.3.613; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Etnier JL, 2001, MED SCI SPORT EXER, V33, P1620, DOI 10.1097/00005768-200110000-00002; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gustafsson T, 2001, FRONT BIOSCI-LANDMRK, V6, pD75, DOI 10.2741/gustafss; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hollman W, 2005, EUR REV AGING PHYS A, V2, P35; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hopkins RO, 2012, SEMIN RESP CRIT CARE, V33, P348, DOI 10.1055/s-0032-1321984; Hopkins RO, 2010, BRAIN INJURY, V24, P1478, DOI 10.3109/02699052.2010.506861; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, PHYS THER IN PRESS; Hopkins RO, LEGACY CRIT IN PRESS; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Jackson James C, 2011, Anesthesiol Clin, V29, P751, DOI 10.1016/j.anclin.2011.09.012; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Jackson JC, 2004, INTENS CARE MED, V30, P2009, DOI 10.1007/s00134-004-2422-2; Jones C, 2007, INTENS CARE MED, V33, P978, DOI 10.1007/s00134-007-0600-8; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Leditschke I Anne, 2012, Cardiopulm Phys Ther J, V23, P26; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; Marks BL, 2011, BRIT J SPORT MED, V45, P1208, DOI 10.1136/bjsm.2009.068114; Marks BL, 2007, ANN NY ACAD SCI, V1097, P171, DOI 10.1196/annals.1379.022; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Morandi A, 2012, CRIT CARE MED, V40, P2182, DOI 10.1097/CCM.0b013e318250acdc; Morandi A, 2011, CURR OPIN CRIT CARE, V17, P43, DOI 10.1097/MCC.0b013e3283427243; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Morris PE, 2011, AM J MED SCI, V341, P373, DOI 10.1097/MAJ.0b013e31820ab4f6; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; Needham DM, 2007, J CRIT CARE, V22, P275, DOI 10.1016/j.jcrc.2007.02.001; Needham DM, 2012, CRIT CARE MED, V40, P1340, DOI 10.1097/CCM.0b013e31823b8df7; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Needham DM, 2011, AM J RESP CRIT CARE, V183, P962, DOI 10.1164/rccm.201012-2042ED; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Ozdemir F, 2001, ARCH PHYS MED REHAB, V82, P1375, DOI 10.1053/apmr.2001.25973; Palleschi L, 1996, ARCH GERONTOL GERIAT, P47; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Pyoria O, 2007, DISABIL REHABIL, V29, P503, DOI 10.1080/09638280600902497; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Rand D, 2010, NEUROREHAB NEURAL RE, V24, P722, DOI 10.1177/1545968310368684; Rhyu IJ, 2010, NEUROSCIENCE, V167, P1239, DOI 10.1016/j.neuroscience.2010.03.003; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Swardfager W, 2011, BRAIN BEHAV IMMUN, V25, P1264, DOI 10.1016/j.bbi.2011.04.017; Swardfager W, 2010, J AM GERIATR SOC, V58, P1519, DOI 10.1111/j.1532-5415.2010.02966.x; Thomsen GE, 2008, CRIT CARE MED, V36, P1119, DOI 10.1097/CCM.0b013e318168f986; van den Boogaard M, 2012, CRIT CARE MED, V40, P112, DOI 10.1097/CCM.0b013e31822e9fc9; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vasilevskis EE, 2010, CRIT CARE MED, V38, pS683, DOI 10.1097/CCM.0b013e3181f245d3; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vreugdenhil A, 2012, SCAND J CARING SCI, V26, P12, DOI 10.1111/j.1471-6712.2011.00895.x; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Yaguez L, 2011, INT J GERIATR PSYCH, V26, P173, DOI 10.1002/gps.2510; Zanni JM, 2010, J CRIT CARE, V25, P254, DOI 10.1016/j.jcrc.2009.10.010	96	54	56	0	32	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	DEC 15	2012	186	12					1220	1228		10.1164/rccm.201206-1022CP			9	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Respiratory System	057OZ	WOS:000312574200008	23065013				2022-02-06	
J	Aries, MJH; Czosnyka, M; Budohoski, KP; Kolias, AG; Radolovich, DK; Lavinio, A; Pickard, JD; Smielewski, P				Aries, Marcel J. H.; Czosnyka, Marek; Budohoski, Karol P.; Kolias, Angelos G.; Radolovich, Danila K.; Lavinio, Andrea; Pickard, John D.; Smielewski, Peter			Continuous Monitoring of Cerebrovascular Reactivity Using Pulse Waveform of Intracranial Pressure	NEUROCRITICAL CARE			English	Article						Brain injuries; Intracranial pressure; Physiological adaptation; Outcome assessment; Wavelet analysis	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; AUTOREGULATION; DYNAMICS	Guidelines for the management of traumatic brain injury (TBI) call for the development of accurate methods for assessment of the relationship between cerebral perfusion pressure (CPP) and cerebral autoregulation and to determine the influence of quantitative indices of pressure autoregulation on outcome. We investigated the relationship between slow fluctuations of arterial blood pressure (ABP) and intracranial pressure (ICP) pulse amplitude (an index called PAx) using a moving correlation technique to reflect the state of cerebral vasoreactivity and compared it to the index of pressure reactivity (PRx) as a moving correlation coefficient between averaged values of ABP and ICP. A retrospective analysis of prospective 327 TBI patients (admitted on neurocritical care unit of a university hospital in the period 2003-2009) with continuous ABP and ICP monitoring. PAx was worse in patients who died compared to those who survived (-0.04 +/- A 0.15 vs. -0.16 +/- A 0.15, chi(2) = 28, p < 0.001). In contrast to PRx, PAx was able to differentiate between fatal and non-fatal outcome in a group of 120 patients with ICP levels below 15 mmHg (-0.04 +/- A 0.16 vs. -0.14 +/- A 0.16, chi(2) = 6, p = 0.01). PAx is a new modified index of cerebrovascular reactivity which performs equally well as established PRx in long-term monitoring in severe TBI patients, but importantly is potentially more robust at lower values of ICP. In view of establishing an autoregulation-oriented CPP therapy, continuous determination of PAx is feasible but its value has to be evaluated in a prospective controlled trail.	[Aries, Marcel J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands; [Aries, Marcel J. H.; Czosnyka, Marek; Budohoski, Karol P.; Kolias, Angelos G.; Pickard, John D.; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Acad Neurosurg Unit, Cambridge, England; [Radolovich, Danila K.] Univ Hosp Pavia, Dept Intens Care, Pavia, Italy; [Lavinio, Andrea] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England		Aries, MJH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	m.j.h.aries@umcg.nl	Lavinio, Andrea/M-1778-2016	Kolias, Angelos/0000-0003-3992-0587; Smielewski, Peter/0000-0001-5096-3938	Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development; European Federation of Neurological Societies (EFNS); Royal College of Surgeons of England; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Raymond and Beverly Sackler Studentship; Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G0001237] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B, G0001237, G1000183B, G0600986, G0001354, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	Marcel JH Aries is supported by the Netherlands Organisation for Health Research and Development and a fellowship of the European Federation of Neurological Societies (EFNS). Angelos G. Kolias is supported by a Royal College of Surgeons of England Research Fellowship, a National Institute for Health Research (NIHR) Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. John D. Pickard is a NIHR senior investigator and is a principal investigator (PI) within the NIHR Biomedical Research Centre (Cambridge University Hospital Foundation Trust) and lead PI for the Medical Research Council (MRC) 'Acute Brain Injury Programme' grant.	AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Bentsen G, 2008, CRIT CARE MED, V36, P2414, DOI 10.1097/CCM.0b013e318180fe04; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eide PK, 2006, ACTA NEUROCHIR, V148, P1267, DOI 10.1007/s00701-006-0908-0; Holm S, 2008, MED ENG PHYS, V30, P164, DOI 10.1016/j.medengphy.2007.03.003; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; Mahfoud F, 2010, ACTA NEUROCHIR, V152, P443, DOI 10.1007/s00701-009-0520-1; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Rosner M., 1986, INTRACRANIAL PRESSUR, P137, DOI [10.1007/978-3-642-70971-5_25, DOI 10.1007/978-3-642-70971-5_25]; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	24	54	54	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2012	17	1					67	76		10.1007/s12028-012-9687-z			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	976NG	WOS:000306591000009	22477613				2022-02-06	
J	Bennett, TD; Riva-Cambrin, J; Keenan, HT; Korgenski, EK; Bratton, SL				Bennett, Tellen D.; Riva-Cambrin, Jay; Keenan, Heather T.; Korgenski, E. Kent; Bratton, Susan L.			Variation in Intracranial Pressure Monitoring and Outcomes in Pediatric Traumatic Brain Injury	ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE			English	Article							CRITICALLY-ILL CHILDREN; GLASGOW COMA SCALE; SEVERITY SCORE; YOUNG-CHILDREN; UNITED-STATES; CARE; THERAPY; VOLUME; MORTALITY; HOSPITALIZATIONS	Objectives: To describe between-hospital and patient-level variation in intracranial pressure (ICP) monitoring and to evaluate ICP monitoring in association with hospital features and outcome in children with traumatic brain injury (TBI). Design: Retrospective cohort study. Setting: Children's hospitals participating in the Pediatric Health Information System database (January 2001 to June 2011). Participants: Children (aged <18 years) with TBI and head Abbreviated Injury Scale scores of at least 3 who were ventilated for at least 96 consecutive hours or who died in the first 4 days after hospital admission. Main Outcome Measures: Monitoring of ICP. Results: A total of 4667 children met the study criteria. Hospital mortality was 41% (n=1919). Overall, 55% of patients (n=2586) received ICP monitoring. Expected hospital ICP monitoring rates after adjustment for patient age, cardiac arrest, inflicted injury, craniotomy or craniectomy, head Abbreviated Injury Scale score, and Injury Severity Score were 47% to 60%. Observed hospital ICP monitoring rates were 14% to 83%. Hospitals with more observed ICP monitoring, relative to expected, and hospitals with higher patient volumes had lower rates of mortality or severe disability. After adjustment for between-hospital variation and patient severity of injury, ICP monitoring was independently associated with age 1 year and older (odds ratio, 3.1; 95% CI, 2.5-3.8) vs age younger than 1 year. Conclusions: There was significant between-hospital variation in ICP monitoring that cannot be attributed solely to differences in case mix. Hospitals that monitor ICP more frequently and hospitals with higher patient volumes had better patient outcomes. Infants with TBI are less likely to receive ICP monitoring than are older children.	[Bennett, Tellen D.; Korgenski, E. Kent] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84158 USA		Bennett, TD (corresponding author), Univ Utah, Sch Med, Dept Pediat, POB 581289, Salt Lake City, UT 84158 USA.	tell.bennett@hsc.utah.edu	Bratton, Susan L./O-2353-2013	Bratton, Susan L./0000-0002-4605-8078; Bennett, Tellen/0000-0003-1483-4236	National Cancer Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1KM1CA156723]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [KM1CA156723] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001067] Funding Source: NIH RePORTER	Dr Bennett is partially supported by the Mentored Scholars Program for Translational Comparative Effectiveness Research grant 1KM1CA156723 from the National Cancer Institute, National Institutes of Health.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; American College of Surgeons Committee on Traum, VER TRAUM CTR; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; BERWICK DM, 1991, MED CARE, V29, P1212, DOI 10.1097/00005650-199112000-00004; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; *EXP GROUP INJ SEV, DISC DOC INJ SEV MEA; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Goldin AB, 2007, PEDIATRICS, V119, P905, DOI 10.1542/peds.2006-2040; Goodman DC, 2009, PEDIATR CLIN N AM, V56, P745, DOI 10.1016/j.pcl.2009.05.007; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2006, PEDIAT CRITICAL CARE, P1596; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McLeod L, 2011, ARCH PEDIAT ADOL MED, V165, P857, DOI 10.1001/archpediatrics.2011.132; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Odetola FO, 2006, PEDIATRICS, V117, P1893, DOI 10.1542/peds.2005-2179; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Tepas JJ, 2009, J TRAUMA, V67, P185, DOI 10.1097/TA.0b013e3181a5f03c; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Tri-Analytics Inc. and The Johns Hopkins University, 1997, ICDMAP 90 SOFTW US G; US Health Care Financing Administration, 2007, INT CLASS DIS; Weiss PF, 2009, J PEDIAT, V155, P812; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	44	54	56	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	1072-4710	1538-3628		ARCH PEDIAT ADOL MED	Arch. Pediatr. Adolesc. Med.	JUL	2012	166	7					641	647					7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	967HJ	WOS:000305897200011	22751878	Green Accepted, Bronze			2022-02-06	
J	Holt, RF; Beer, J; Kronenberger, WG; Pisoni, DB; Lalonde, K				Holt, Rachael Frush; Beer, Jessica; Kronenberger, William G.; Pisoni, David B.; Lalonde, Kaylah			Contribution of Family Environment to Pediatric Cochlear Implant Users' Speech and Language Outcomes: Some Preliminary Findings	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						cochlear implant; children; executive function; language; family environment	DEFICIT HYPERACTIVITY DISORDER; EARLY VOCABULARY DEVELOPMENT; TRAUMATIC BRAIN-INJURY; HARD-OF-HEARING; EXECUTIVE FUNCTION; DEAF-CHILDREN; YOUNG-CHILDREN; EARLY INTERVENTION; SOCIOECONOMIC-STATUS; TEACHING PARENTS	Purpose: To evaluate the family environments of children with cochlear implants and to examine relationships between family environment and postimplant language development and executive function. Method: Forty-five families of children with cochlear implants completed a self-report family environment questionnaire (Family Environment Scale-Fourth Edition; Moos & Moos, 2009) and an inventory of executive function (Behavior Rating Inventory of Executive Function [Gioia, Isquith, Guy, & Kenworthy, 2000] or Behavior Rating Inventory of Executive Function-Preschool Version [Gioia, Espy, & Isquith, 2003]). The authors also evaluated children's receptive vocabulary (Peabody Picture Vocabulary Test-Fourth Edition; Dunn & Dunn, 2007) and global language skills (Preschool Language Scale-Fourth Edition [Zimmerman, Steiner, & Pond, 2002] and Clinical Evaluation of Language Fundamentals-Fourth Edition [Semel, Wiig, & Secord, 2003]). Results: The family environments of children with cochlear implants differed from those of normal-hearing children but not in clinically significant ways. Language development and executive function were found to be atypical but not uncharacteristic of this clinical population. Families with higher levels of self-reported control had children with smaller vocabularies. Families reporting a higher emphasis on achievement had children with fewer executive function and working memory problems. Finally, families reporting a higher emphasis on organization had children with fewer problems related to inhibition. Conclusion: Some of the variability in cochlear implantation outcomes that have protracted periods of development is related to family environment. Because family environment can be modified and enhanced by therapy or education, these preliminary findings hold promise for future work in helping families to create robust language-learning environments that can maximize their child's potential with a cochlear implant.	[Holt, Rachael Frush; Lalonde, Kaylah] Indiana Univ, Bloomington, IN 47405 USA; [Beer, Jessica; Kronenberger, William G.; Pisoni, David B.] Indiana Univ Sch Med, Indianapolis, IN USA		Holt, RF (corresponding author), Indiana Univ, Bloomington, IN 47405 USA.	raholt@indiana.edu			National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [T32 DC00011, DC009581]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC009581, T32DC000012, T32DC000011, R55DC009581] Funding Source: NIH RePORTER	This work was supported by National Institute on Deafness and Other Communication Disorders Grants T32 DC00011 and DC009581. Portions of this work were presented at the 13th Symposium of Cochlear Implants in Children, Chicago, IL (July 2011). We are grateful to Shirley Henning and Bethany Colson for their contributions to data collection.	AKHTAR N, 1991, J CHILD LANG, V18, P41, DOI 10.1017/S0305000900013283; Allhusen V, 2005, DEV PSYCHOL, V41, P99, DOI 10.1037/0012-1649.41.1.99; American National Standards Institute, 2004, S362004 ANSI; Bailey Jr. D., 1988, EXCEPT CHILDREN, V64, P313; Bates E., 1982, ADV CHILD DEV BEHAV, V16, P8; Beer Jessica, 2011, Cochlear Implants Int, V12 Suppl 1, pS89, DOI 10.1179/146701011X13001035752570; BELSKY J, 1981, DEV PSYCHOL, V17, P3, DOI 10.1037/0012-1649.17.1.3; Bernier A, 2010, CHILD DEV, V81, P326, DOI 10.1111/j.1467-8624.2009.01397.x; Bertram B, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P97; Bibcok M. B., 2009, SOCIAL INTERACTION D, V123, P17; BIEDERMAN J, 1995, ARCH GEN PSYCHIAT, V52, P464; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; BRINICH PM, 1980, J COMMUN DISORD, V13, P75, DOI 10.1016/0021-9924(80)90024-6; BRUCE C, 1992, J COMMUNITY PSYCHOL, P10; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Burger T, 2005, AM ANN DEAF, V150, P5, DOI 10.1353/aad.2005.0017; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Carlson SM, 2009, NEW DIR CHILD ADOLES, V123, P87, DOI 10.1002/cd.237; Ciccia AH, 2009, TOP LANG DISORD, V29, P249, DOI 10.1097/TLD.0b013e3181b53211; Clark CAC, 2010, DEV PSYCHOL, V46, P1176, DOI 10.1037/a0019672; Coldwell J, 2006, J CHILD PSYCHOL PSYC, V47, P1116, DOI 10.1111/j.1469-7610.2006.01655.x; Conway CM, 2011, DEV NEUROPSYCHOL, V36, P237, DOI 10.1080/87565641.2010.549869; Conway CM, 2011, DEVELOPMENTAL SCI, V14, P69, DOI 10.1111/j.1467-7687.2010.00960.x; Conway CM, 2009, CURR DIR PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-8721.2009.01651.x; Cross T. G., 1980, 1ST LANGUAGE, V1, P163; DesJardin JL, 2007, EAR HEARING, V28, P456, DOI 10.1097/AUD.0b013e31806dc1ab; DesJardin JL, 2009, J DEAF STUD DEAF EDU, V14, P22, DOI 10.1093/deafed/enn011; Desjardin JL, 2005, J EARLY INTERVENTION, V27, P193, DOI 10.1177/105381510502700306; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Dunn, 2007, PPVT 4 PEABODY PICTU; Edwards L, 2009, INT J AUDIOL, V48, P554, DOI 10.1080/14992020902894533; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P379, DOI 10.1207/s15326942dn2601_1; Figueras B, 2008, J DEAF STUD DEAF EDU, V13, P362, DOI 10.1093/deafed/enm067; Geers A, 2003, EAR HEARING, V24, p24S, DOI 10.1097/01.AUD.0000051687.99218.0F; Geers Ann E, 2011, Ear Hear, V32, p2S, DOI 10.1097/AUD.0b013e3181ffd5b5; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Gioia G. A., 2003, BEHAV RATING INVENTO; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hart B., 1995, MEANINGFUL DIFFERENC; HELLMAN SA, 1991, AM ANN DEAF, V136, P77, DOI 10.1353/aad.2012.1077; HENGGELER S W, 1983, Journal of Pediatric Psychology, V8, P83, DOI 10.1093/jpepsy/8.1.83; Hill D., 1987, PSYCHOSOC REHABIL J, V10, P25, DOI [10.1037/h0099597, DOI 10.1037/H0099597]; Hintermair M, 2006, J DEAF STUD DEAF EDU, V11, P493, DOI 10.1093/deafed/enl005; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Holt RF, 2008, EAR HEARING, V29, P492, DOI 10.1097/AUD.0b013e31816c409f; Hughes C, 2007, DEV PSYCHOL, V43, P1447, DOI 10.1037/0012-1649.43.6.1447; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P663, DOI 10.1016/j.jecp.2010.06.005; Hughes CH, 2009, NEW DIR CHILD ADOLES, V123, P35, DOI 10.1002/cd.234; Jarratt KP, 2005, APPL NEUROPSYCHOL, V12, P83, DOI 10.1207/s15324826an1202_4; Kaiser AP, 2003, INFANT YOUNG CHILD, V16, P9, DOI 10.1097/00001163-200301000-00003; Kaiser AP, 1996, TOP EARLY CHILD SPEC, V16, P375, DOI 10.1177/027112149601600307; Kirk KI, 2002, ANN OTO RHINOL LARYN, V111, P69, DOI 10.1177/00034894021110S515; KRONENBERGER WG, 1990, J CLIN CHILD PSYCHOL, V19, P380, DOI 10.1207/s15374424jccp1904_10; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; LEDERBERG AR, 1990, CHILD DEV, V61, P1596; Loomis JW, 1997, DEV MED CHILD NEUROL, V39, P620; MACTURK RH, 1993, AM ANN DEAF, V138, P19, DOI 10.1353/aad.2012.0575; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McClelland MM, 2007, DEV PSYCHOL, V43, P947, DOI 10.1037/0012-1649.43.4.947; McWilliam RA, 2001, INFANT YOUNG CHILD, V13, P55, DOI 10.1097/00001163-200113040-00011; Meadow-Orlans K. P., 1993, J APPLIED DEV PSYCHO, V14, P407, DOI DOI 10.1016/0193-3973(93)90017-P; MILLS PD, 1991, HOSP COMMUNITY PSYCH, V42, P1144; Mitchell R. E., 2004, SIGN LANG STUD, V4, P138, DOI DOI 10.1353/SLS.2004.0005; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; Moos R., 2009, FAMILY ENV SCALE MAN, V4th; NIENHUYS TG, 1985, APPL PSYCHOLINGUIST, V6, P121, DOI 10.1017/S014271640000607X; Nikolopoulos TP, 2004, INT J PEDIATR OTORHI, V68, P137, DOI 10.1016/j.ijporl.2003.09.020; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Pisoni David B, 2011, Ear Hear, V32, p60S, DOI 10.1097/AUD.0b013e3181ffd58e; Pisoni DB, 2010, OXFORD HDB DEAF STUD, V1, P439; PRATT SR, 1991, EAR HEARING, V12, P328, DOI 10.1097/00003446-199110000-00005; Pressman L., 1999, J DEAF STUDIES, V2, P27; Rice F, 2006, J AM ACAD CHILD PSY, V45, P841, DOI 10.1097/01.chi.0000219834.08602.44; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Rousey AM, 2002, RES DEV DISABIL, V23, P17, DOI 10.1016/S0891-4222(01)00089-0; Schroeder VM, 2010, EARLY CHILD DEV CARE, V180, P1285, DOI 10.1080/03004430902981512; Semel E., 2003, CLIN EVALUATION LANG; Spencer P. E., 1990, ED DEV ASPECTS DEAFN, P350; TOMASELLO M, 1986, CHILD DEV, V57, P1454, DOI 10.2307/1130423; Vaccari C, 1997, J CHILD PSYCHOL PSYC, V38, P793, DOI 10.1111/j.1469-7610.1997.tb01597.x; Varni JW, 1996, J CHILD PSYCHOL PSYC, V37, P321, DOI 10.1111/j.1469-7610.1996.tb01409.x; WEDELLMONNIG J, 1980, CHILD DEV, V51, P766, DOI 10.2307/1129463; Welsh JA, 2010, J EDUC PSYCHOL, V102, P43, DOI 10.1037/a0016738; YODER PJ, 2001, COMMUN DISORD Q, V22, P135, DOI DOI 10.1177/152574010102200303; Zimmerman I. L., 2002, PRESCHOOL LANGUAGE S	85	54	57	1	48	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1092-4388			J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	JUN 1	2012	55	3					848	864		10.1044/1092-4388(2011/11-0143)			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	084FO	WOS:000314523500015	22232387	Green Accepted			2022-02-06	
J	Ferguson, PL; Pickelsimer, EE; Corrigan, JD; Bogner, JA; Wald, M				Ferguson, Pamela L.; Pickelsimer, Emily Elisabeth; Corrigan, John D.; Bogner, Jennifer A.; Wald, Marlena			Prevalence of Traumatic Brain Injury Among Prisoners in South Carolina	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; craniocerebral trauma; epidemiology; postconcussion syndrome; prevalence; prisoners	VIOLENT CRIMINAL BEHAVIOR; TBI IDENTIFICATION METHOD; HEAD-INJURY; SUBSTANCE-ABUSE; PSYCHIATRIC-DISORDERS; SEXUAL OFFENSES; BIRTH COHORT; FOLLOW-UP; POPULATION; VALIDITY	Objective: To determine lifetime prevalence of traumatic brain injury (TBI) in a statewide sample of prisoners. Design: Retrospective and cross-sectional cohort study. Participants: Stratified random sample of prisoners scheduled to be released by release type for each gender (275 men and 267 women with completed sentences and 19 men and 15 women granted parole) and a random sample of prisoners by gender with lifetime or death sentences (26 men and 34 women). Primary Measure: Weighted prevalence of TBI. In-person interviews ascertained history of TBI using a customized version of the Ohio State University TBI Identification Method. Results: Sixty-five percent of male releases and nonreleases, and 72% and 73% of female releases and nonreleases, reported at least 1 TBI with an alteration of consciousness. Forty-two percent of male releases and 50% of nonreleases, and 50% of female releases and 33% of nonreleases, reported at least 1 TBI with loss of consciousness. Thirty-five percent of male releases and 42% of nonreleases, and 55% of female releases and 58% of nonreleases, reported ongoing symptoms from TBI. Conclusions: A substantial proportion of prisoners reported having experienced a TBI during their lifetime. The ongoing TBI symptoms reported by prisoners may impact their success on release.	[Ferguson, Pamela L.; Pickelsimer, Emily Elisabeth] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Corrigan, John D.; Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Wald, Marlena] Ctr Dis Control & Prevent, Natl Ctr Injury Control & Prevent, Atlanta, GA USA		Ferguson, PL (corresponding author), Med Univ S Carolina, Dept Med, 135 Cannon St,Ste 303,MSC 835, Charleston, SC 29425 USA.	ferguspl@musc.edu	Bogner, Jennifer/E-2773-2011; Corrigan, John D./E-2921-2011		NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U49CE001318] Funding Source: NIH RePORTER; NCIPC CDC HHS [U49CE001318] Funding Source: Medline		Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; [Anonymous], 2001, POL TRAIN SER MAR PO; [Anonymous], 2002, STAT 30 TRAIN CORR P; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brain Injury Association of Wyoming, 2008, STUD UND BRAIN INJ W; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Browne A, 1999, INT J LAW PSYCHIAT, V22, P301, DOI 10.1016/S0160-2527(99)00011-4; CARLSSON GS, 1983, J NEUROL NEUROSUR PS, V46, P818, DOI 10.1136/jnnp.46.9.818; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Center for Substance Abuse Treatment, 1998, TREATM IMPR PROT TIP; Cohen R A, 1999, Violence Vict, V14, P397; Coid J., 2005, TXB PERSONALITY DISO, P579; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, BRAIN INJURY, V21, P343, DOI 10.1080/02699050701253103; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Souza Carlos Alberto Crespo de, 2003, Rev. Bras. Psiquiatr., V25, P206, DOI 10.1590/S1516-44462003000400005; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Epilepsy Foundation of Texas, OFF REC TEX SIZ TRAI; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Greve KW, 2001, BRAIN INJURY, V15, P255; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Halldorsson Jonas G, 2008, Neuropsychiatr Dis Treat, V4, P405; Harlow C. W., 1999, 172879 NCJ US DEP JU; Hawley CA, 2003, BRAIN INJURY, V17, P743, DOI 10.1080/0269905031000089341; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jackson M., 2011, CORRECTIONS RES PAPE; Johnson H, 2004, RES PUBLIC POLICY SE; Kaufman CW, 2001, CARLOS ALBIZU U PUBL; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Kushel MB, 2005, AM J PUBLIC HEALTH, V95, P1747, DOI 10.2105/AJPH.2005.065094; Langevin R, 2006, BRAIN COGNITION, V60, P206; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Luiselli JK, 2000, INT J OFFENDER THER, V44, P647, DOI 10.1177/0306624X00446002; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merbitz C., 1995, J OFFENDER REHABILIT, V22, P11, DOI DOI 10.1300/J076V22N03_02; Miller E, 1999, PSYCHOL CRIME LAW, V5, P297, DOI 10.1080/10683169908401774; Minnesota Department of Corrections, 2008, ANN C BRAIN INJ ASS; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; O'Shanick GJ, 2011, TXB TRAUMATIC BRAIN, P211; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Sherman RK, 2001, COLORADO MENTAL HLTH; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Yeager CA, 2000, CHILD ADOL PSYCH CL, V9, P793; Young MH, 2004, J FORENSIC SCI, V49, P141	74	54	54	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2012	27	3					E11	E20		10.1097/HTR.0b013e31824e5f47			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941CV	WOS:000303941500002	22573044				2022-02-06	
J	Lange, RT; Iverson, GL; Brubacher, JR; Madler, B; Heran, MK				Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.; Maedler, Burkhard; Heran, Manraj K.			Diffusion Tensor Imaging Findings Are Not Strongly Associated With Postconcussional Disorder 2 Months Following Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						corpus callosum; diffusion tensor imaging; mild traumatic brain injury; postconcussion symptoms	GOOD OLD DAYS; CORPUS-CALLOSUM; AXONAL INJURY; BASE RATES; MODERATE; ABNORMALITIES; SYMPTOMS; PERFORMANCE; ETIOLOGY	Objective: To examine the relation between diffusion tensor imaging (DTI) of the corpus callosum and postconcussion symptom reporting following mild traumatic brain injury (MTBI). Participants: Sixty patients with MTBI and 34 patients with orthopedic/soft-tissue injuries (Trauma Controls) prospectively enrolled from consecutive admissions to a level 1 trauma center. Procedure: Diffusion tensor imaging of the corpus callosum was undertaken using a Phillips 3T scanner at 6 to 8 weeks postinjury. Participants also completed a postconcussion symptom checklist. The MTBI group was divided into 2 subgroups based on the International Classification of Diseases, Tenth Revision symptom criteria for postconcussion disorder (PCD): PCD Present (n = 21), PCD Absent (n = 39). Main Outcome Measures: Measures of fractional anisotropy and mean diffusivity for the genu, body, and splenium of the corpus callosum. Participants also completed the British Columbia Post-Concussion Symptom Inventory. Results: The MTBI group reported more postconcussion symptoms than the trauma controls. There were no significant differences between MTBI and trauma control groups on all DTI measures. In the MTBI sample, there were no significant differences on all DTI measures between those who did and did not meet the International Classification of Diseases, Tenth Revision research criteria for postconcussion disorder. Conclusions: These data do not support an association between white matter integrity in the corpus callosum and self-reported postconcussion syndrome 6 to 8 weeks post-MTBI.	[Lange, Rael T.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.; Maedler, Burkhard; Heran, Manraj K.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Brubacher, Jeffrey R.; Heran, Manraj K.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada		Lange, RT (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Bldg 1,Room B207,6900 Georgia Ave NW, Washington, DC 20307 USA.	rlange@dvbic.org		Iverson, Grant/0000-0001-7348-9570; Brubacher, Jeffrey/0000-0002-4866-4231	Alcohol Beverage Medical Research Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-89374]	This study was supported, in part, by a research grant from the Alcohol Beverage Medical Research Foundation and the Canadian Institutes of Health Research (MOP-89374).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sosin DM, 1996, BRAIN INJURY, V10, P47; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan Michael J L, 2002, Pain Res Manag, V7, P120; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	47	54	54	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2012	27	3					188	198		10.1097/HTR.0b013e318217f0ad			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941CV	WOS:000303941500007	21642855				2022-02-06	
J	Register-Mihalik, JK; Kontos, DL; Guskiewicz, KM; Mihalik, JP; Conder, R; Shields, EW				Register-Mihalik, Johna K.; Kontos, Daniel L.; Guskiewicz, Kevin M.; Mihalik, Jason P.; Conder, Robert; Shields, Edgar W.			Age-Related Differences and Reliability on Computerized and Paper-and-Pencil Neurocognitive Assessment Batteries	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; traumatic brain injuries; serial testing	TEST-RETEST RELIABILITY; RELIABLE CHANGE INDEXES; VERBAL-LEARNING TEST; HIGH-SCHOOL; NEUROPSYCHOLOGICAL DEFICITS; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; CONCUSSION; RECOVERY	Context: Neurocognitive testing is a recommended component in a concussion assessment. Clinicians should be aware of age and practice effects on these measures to ensure appropriate understanding of results. Objective: To assess age and practice effects on computerized and paper-and-pencil neurocognitive testing batteries in collegiate and high school athletes. Design: Cohort study. Setting: Classroom and laboratory. Patients or Other Participants: Participants consisted of 20 collegiate student-athletes (age 20.00 +/- 0.79 years) and 20 high school student-athletes (age = 16.00 +/- 0.86 years). Main Outcome Measure(s): Hopkins Verbal Learning Test scores, Brief Visual-Spatial Memory Test scores, Trail Making Test B total time, Symbol Digit Modalities Test score, Stroop Test total score, and 5 composite scores from the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) served as outcome measures. Mixed-model analyses of variance were used to examine each measure. Results: Collegiate student-athletes performed better than high school student-athletes on ImPACT processing speed composite score (F-1,F-38 = 5.03, P = .031) at all time points. No other age effects were observed. The Trail Making Test B total time (F-2,F-66 = 73.432, P < .001), Stroop Test total score (F-2,F-76 = 96.85, P = < .001) and ImPACT processing speed composite score (F-2,F-76 = 5.81, P = .005) improved in test sessions 2 and 3 compared with test session 1. Intraclass correlation coefficient calculations demonstrated values ranging from 0.12 to 0.72. Conclusions: An athlete's neurocognitive performance may vary across sessions. It is important for clinicians to know the reliability and precision of these tests in order to properly interpret test scores.	[Register-Mihalik, Johna K.] WakeMed Hlth & Hosp, Emergency Serv Inst, Clin Res Unit, Raleigh, NC 27610 USA; [Register-Mihalik, Johna K.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Matthew Gfeller Sport Related Traumat Brain Inju, Raleigh, NC USA; [Kontos, Daniel L.; Shields, Edgar W.] Univ N Carolina, Dept Exercise Sci, Chapel Hill, NC 27515 USA; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC 27515 USA; [Conder, Robert] Carolina Neuropsychol Serv, Raleigh, NC USA		Register-Mihalik, JK (corresponding author), WakeMed Hlth & Hosp, Emergency Serv Inst, Clin Res Unit, 3024 New Bern Ave, Raleigh, NC 27610 USA.	jmihalik@wakemed.org		Guskiewicz, Kevin/0000-0002-8682-2130; Mihalik, Jason/0000-0001-6085-8322			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Duff K, 2007, ARCH CLIN NEUROPSYCH, V22, P15, DOI 10.1016/j.acn.2006.08.013; Elwell MD, 1989, RELIABILITY VALIDITY; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Franzen M D, 1987, Arch Clin Neuropsychol, V2, P265, DOI 10.1016/0887-6177(87)90014-X; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M.R.C.M., 2003, IMMEDIATE POSTCONCUS; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MCCAFFREY RJ, 1992, CLIN NEUROPSYCHOL, V0006, P00032, DOI [DOI 10.1080/138540492084041_15, DOI 10.1080/13854049208404115]; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876; Reitan RM, 1992, TRAIL MAKING TEST MA; Rosenbaum AM, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P137, DOI 10.1007/0-387-32565-4_7; Salthouse TA, 2009, J INT NEUROPSYCH SOC, V15, P650, DOI 10.1017/S1355617709990385; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Smith A, 1972, SYMBOL DIGIT MODALIT; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Woods SP, 2005, ASSESSMENT, V12, P96, DOI 10.1177/1073191104270342	47	54	54	0	23	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2012	47	3					297	305		10.4085/1062-6050-47.3.13			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	953AJ	WOS:000304839000007	22892411	Green Published, Green Submitted			2022-02-06	
J	Ranaivo, HR; Hodge, JN; Choi, N; Wainwright, MS				Ranaivo, Hantamalala Ralay; Hodge, Jessica N.; Choi, Nicole; Wainwright, Mark S.			Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways	JOURNAL OF NEUROINFLAMMATION			English	Article						Matrix metalloproteinase; Astrocyte; Blood brain barrier; Mitogen-activated protein kinases	BLOOD-BRAIN-BARRIER; FOCAL CEREBRAL-ISCHEMIA; RAT CORTICAL ASTROCYTES; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; INTRACEREBRAL HEMORRHAGE; TISSUE INHIBITOR; KAPPA-B; NEUROLOGICAL DEFICIT; EFFICACY ANALYSIS	Background: Astrocytes are an integral component of the blood-brain barrier (BBB) which may be compromised by ischemic or traumatic brain injury. In response to trauma, astrocytes increase expression of the endopeptidase matrix metalloproteinase (MMP)-9. Compromise of the BBB leads to the infiltration of fluid and blood-derived proteins including albumin into the brain parenchyma. Albumin has been previously shown to activate astrocytes and induce the production of inflammatory mediators. The effect of albumin on MMP-9 activation in astrocytes is not known. We investigated the molecular mechanisms underlying the production of MMP-9 by albumin in astrocytes. Methods: Primary enriched astrocyte cultures were used to investigate the effects of exposure to albumin on the release of MMP-9. MMP-9 expression was analyzed by zymography. The involvement of mitogen-activated protein kinase (MAPK), reactive oxygen species (ROS) and the TGF-beta receptor-dependent pathways were investigated using pharmacological inhibitors. The production of ROS was observed by dichlorodihydrofluorescein diacetate fluorescence. The level of the MMP-9 inhibitor tissue inhibitor of metalloproteinase (TIMP)-1 produced by astrocytes was measured by ELISA. Results: We found that albumin induces a time-dependent release of MMP-9 via the activation of p38 MAPK and extracellular signal regulated kinase, but not Jun kinase. Albumin-induced MMP-9 production also involves ROS production upstream of the MAPK pathways. However, albumin-induced increase in MMP-9 is independent of the TGF-beta receptor, previously described as a receptor for albumin. Albumin also induces an increase in TIMP-1 via an undetermined mechanism. Conclusions: These results link albumin (acting through ROS and the p38 MAPK) to the activation of MMP-9 in astrocytes. Numerous studies identify a role for MMP-9 in the mechanisms of compromise of the BBB, epileptogenesis, or synaptic remodeling after ischemia or traumatic brain injury. The increase in MMP-9 produced by albumin further implicates both astrocytes and albumin in the acute and long-term complications of acute CNS insults, including cerebral edema and epilepsy.	[Ranaivo, Hantamalala Ralay; Hodge, Jessica N.; Choi, Nicole; Wainwright, Mark S.] Childrens Mem Hosp, Dept Pediat, Div Neurol, Chicago, IL 60614 USA; [Wainwright, Mark S.] Childrens Mem Hosp, Dept Pediat, Div Crit Care, Chicago, IL 60614 USA; [Ranaivo, Hantamalala Ralay; Hodge, Jessica N.; Choi, Nicole; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Ctr Interdisciplinary Res Pediat Crit Illness & I, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Childrens Mem Hosp, Dept Pediat, Div Neurol, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu	Ritter, Stefanie L/D-9312-2012		Medical Research Junior Board Foundation; Lyndsey Whittingham Foundation	We thank MaryAnn Chrzaszcz and Kevin McDonough for technical assistance. Dr Wainwright is supported by the Medical Research Junior Board Foundation, and by the Lyndsey Whittingham Foundation.	Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Barr TL, 2010, STROKE, V41, pE123, DOI 10.1161/STROKEAHA.109.570515; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Bento-Abreu A, 2008, J NEUROCHEM, V106, P1149, DOI 10.1111/j.1471-4159.2008.05462.x; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Calvo CF, 2005, J NEUROSCI RES, V80, P707, DOI 10.1002/jnr.20511; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Choi MS, 2008, BRAIN RES BULL, V76, P368, DOI 10.1016/j.brainresbull.2008.02.031; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Guo M, 2008, NEUROSCIENCE, V151, P340, DOI 10.1016/j.neuroscience.2007.10.006; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hill MD, 2007, INT J STROKE, V2, P214, DOI 10.1111/j.1747-4949.2007.00143.x; Hill MD, 2011, STROKE, V42, P1621, DOI 10.1161/STROKEAHA.110.610980; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Kim GW, 2009, NEUROBIOL DIS, V36, P169, DOI 10.1016/j.nbd.2009.07.008; Kochanek PM, 2010, DEV NEUROSCI-BASEL, V32, P335, DOI 10.1159/000323016; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee SR, 2007, NEUROSCI LETT, V417, P1, DOI 10.1016/j.neulet.2007.01.017; Maddahi A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-56; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nadal A, 2001, Prog Brain Res, V132, P367; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; Ralay-Ranaivo H, 2011, J NEUROTRAUM, V28, P1757; Ranaivo HR, 2010, EXP NEUROL, V226, P310, DOI 10.1016/j.expneurol.2010.09.005; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siddiqui SS, 2004, AM J PHYSIOL-LUNG C, V286, pL1016, DOI 10.1152/ajplung.00356.2003; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Takacs E, 2010, NEUROCHEM INT, V56, P799, DOI 10.1016/j.neuint.2010.03.003; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Tung WH, 2010, BRIT J PHARMACOL, V161, P1566, DOI 10.1111/j.1476-5381.2010.00982.x; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Xue MZ, 2006, J NEUROSCI, V26, P10281, DOI 10.1523/JNEUROSCI.2806-06.2006; Xue MZ, 2009, BRAIN, V132, P26, DOI 10.1093/brain/awn215; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	64	54	54	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	APR 16	2012	9								68	10.1186/1742-2094-9-68			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	993JK	WOS:000307854500001	22507553	Green Published, gold			2022-02-06	
J	Wang, XL; Vaccari, JPD; Wang, HD; Diaz, P; German, R; Marcillo, AE; Keane, RW				Wang, Xiaoliang; Vaccari, Juan Pablo de Rivero; Wang, Handong; Diaz, Paulo; German, Ramon; Marcillo, Alex E.; Keane, Robert W.			Activation of the Nuclear Factor E2-Related Factor 2/Antioxidant Response Element Pathway Is Neuroprotective after Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						antioxidant response element; inflammation; neuroprotection; nuclear factor E2-related factor 2; oxidative stress; SCI	TRANSCRIPTION FACTOR NRF2; TRAUMATIC BRAIN-INJURY; KAPPA-B; INTRACEREBRAL HEMORRHAGE; HEME OXYGENASE-1; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; PROTECTS; MICE; GLUTATHIONE	The activation of oxidative damage, neuroinflammation, and mitochondrial dysfunction has been implicated in secondary pathomechanisms following spinal cord injury (SCI). These pathophysiological processes lead to cell death and are tightly regulated by nuclear factor E2-related factor 2/antioxidant response element (Nrf2/ARE) signaling. Here, we investigated whether activation of Nrf2/ARE is neuroprotective following SCI. Female Fischer rats were subjected to mild thoracic SCI (T8) using the New York University injury device. As early as 30 min after SCI, levels of Nrf2 transcription factor were increased in both nuclear and cytoplasmic fractions of neurons and astrocytes at the lesion site and remained elevated for 3 days. Treatment of injured rats with sulforaphane, an activator of Nrf2/ARE signaling, significantly increased levels of Nrf2 and glutamate-cysteine ligase (GCL), a rate-limiting enzyme for synthesis of glutathione, and decreased levels of inflammatory cytokines, interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) thus leading to a reduction in contusion volume and improvement in coordination. These results show that activation of the Nrf2/ARE pathway following SCI is neuroprotective and that sulforaphane is a viable compound for neurotherapeutic intervention in blocking pathomechanisms following SCI.	[Wang, Xiaoliang; Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Wang, Xiaoliang; Wang, Handong] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Vaccari, Juan Pablo de Rivero; Diaz, Paulo; German, Ramon; Marcillo, Alex E.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA		Keane, RW (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave,R-430, Miami, FL 33136 USA.	rkeane@miami.edu	de Rivero Vaccari, Juan Pablo/H-5718-2019; de Rivero Vaccari, Juan Pablo/ABE-3248-2020	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS059836]; Craig Neilsen Foundation [124671]; Jinling Hospital of China [2009M014]; China Scholarship CouncilChina Scholarship Council [2009619088]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS059836] Funding Source: NIH RePORTER	These studies were supported by National Institutes of Health grant NS059836 and Craig Neilsen Foundation 124671 to R. W. K., grant from Jinling Hospital of China (2009M014), and grant from China Scholarship Council (2009619088). We thank Frank Brand III, Geoffrey Yurcisin, Denise Koivisto, and Ileana Oropesa for technical assistance.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Bains M., 2011, BIOCH BIOPHYSICA ACT; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jin W., 2008, MEDIAT INFLAMM, V725, P174; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Khodagholi F, 2010, MOL CELL BIOCHEM, V337, P39, DOI 10.1007/s11010-009-0284-1; Kotlo KU, 2003, ONCOGENE, V22, P797, DOI 10.1038/sj.onc.1206077; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Liu XY, 2008, CELL MOL NEUROBIOL, V28, P769, DOI 10.1007/s10571-007-9219-0; Liu Y, 2002, J NEUROTRAUM, V19, P479, DOI 10.1089/08977150252932424; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mao L., 2010, MEDIAT INFLAMM, V238, P321; Peng ZM, 2010, MOL PHARMACOL, V77, P784, DOI 10.1124/mol.109.061424; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Reddy PVB, 2010, NEUROCHEM INT, V56, P780, DOI 10.1016/j.neuint.2010.02.017; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Soane L, 2010, J NEUROSCI RES, V88, P1355, DOI 10.1002/jnr.22307; Tsvetkov P, 2011, J BIOL CHEM, V286, P8839, DOI 10.1074/jbc.M110.193276; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2009, NEUROSCI LETT, V465, P226, DOI 10.1016/j.neulet.2009.09.013; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009	44	54	59	0	20	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					936	+		10.1089/neu.2011.1922			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900021	21806470	Green Published			2022-02-06	
J	Tian, LL; Guo, RB; Yue, XY; Lv, QS; Ye, XC; Wang, ZZ; Chen, ZY; Wu, B; Xu, GL; Liu, XF				Tian, Lili; Guo, Ruibing; Yue, Xuanye; Lv, Qiushi; Ye, Xinchun; Wang, Zhenzhen; Chen, Zhaoyao; Wu, Bo; Xu, Gelin; Liu, Xinfeng			Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Alzheimer's disease; Amyloid-beta peptide; Intranasal delivery; Nerve growth factor; Traumatic brain injury	P75 NEUROTROPHIN RECEPTOR; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TRANSGENIC MICE; FACTOR-I; NGF; DELIVERY; MEMORY; SURVIVAL; THERAPY	The marked increase of amyloid-beta (A beta) peptide after traumatic brain injury (TBI), confers a risk factor for Alzheimer's disease (AD) in patients' later life. Nerve growth factor (NGF) is great potential to repair brain injury. But its clinical application is limited because of lacking feasible methods for delivering NGF into brain. This study investigated the effects of NGF, delivered intranasally, on the A beta burden in the injured ipsilateral cortex and hippocampus of rats with TBI. Adult male Sprague-Dawley rats were subjected to the modified Feeney's weight-drop model and treated without or with NGF by intranasal route. Motor and cognitive functional outcome, immunostaining, ELISA assay and western blot were performed. Compared to sham operated rats, TBI rats exhibited significantly increased APP and A beta(42) expression as well as decreased functional outcome after TBI. Intranasal administration of NGF significantly attenuated A beta(42) deposits, and improved functional outcome after TBI. Thus, intranasal delivery of NGF provides a potential strategy for reducing the risk of developing AD in the later life of TBI patients. (C) 2012 Elsevier B.V. All rights reserved.	[Tian, Lili; Guo, Ruibing; Yue, Xuanye; Lv, Qiushi; Ye, Xinchun; Chen, Zhaoyao; Xu, Gelin; Liu, Xinfeng] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing 210002, Jiangsu, Peoples R China; [Yue, Xuanye; Ye, Xinchun] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou 221002, Jiangsu, Peoples R China; [Wang, Zhenzhen] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Geriatr, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Zhaoyao] Jiangsu Prov Hosp Tradit Chinese Med, Dept Neurol, Nanjing 210029, Jiangsu, Peoples R China; [Wu, Bo] Nanjing Univ, Sch Med, Jinling Hosp, Dept Pathol, Nanjing 210002, Jiangsu, Peoples R China		Xu, GL (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	xfliu2@yahoo.com.cn		Tian, Lili/0000-0001-9421-1535; Chen, Zhaoyao/0000-0002-8441-5355; Xu, Gelin/0000-0002-6194-0341	Nature Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30870848]	This work was supported by the grant from Nature Science Foundation of China to GX (NSFC 30870848). We are thankful for the excellent technical assistance of Genbao Feng, Henghui Ma and Bo Yu.	Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; BARONE S, 1991, EXP NEUROL, V114, P351, DOI 10.1016/0014-4886(91)90161-5; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bulbarelli A, 2009, MOL CELL NEUROSCI, V40, P365, DOI 10.1016/j.mcn.2008.12.006; Cai Zhi-You, 2008, Neurosci Bull, V24, P305, DOI 10.1007/s12264-008-0324-y; Calissano P, 2010, DEV NEUROBIOL, V70, P372, DOI 10.1002/dneu.20759; Capsoni S, 2002, P NATL ACAD SCI USA, V99, P12432, DOI 10.1073/pnas.192442999; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; Cheng SM, 2009, NEUROL RES, V31, P753, DOI 10.1179/174313209X382557; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Ding J, 2011, J NEUROSCI RES, V89, P222, DOI 10.1002/jnr.22535; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Djupesland PG, 2008, NEUROLOGY, V71, P864, DOI 10.1212/01.wnl.0000327291.47162.ed; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Frey WH, 1997, DRUG DELIV, V4, P87, DOI 10.3109/10717549709051878; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hock C, 1998, EUR NEUROL, V39, P111, DOI 10.1159/000007917; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Lawrence D, 2002, LANCET, V359, P1674, DOI 10.1016/S0140-6736(02)08601-4; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; Matrone C, 2009, P NATL ACAD SCI USA, V106, P11358, DOI 10.1073/pnas.0904998106; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Neugroschl J, 2010, MT SINAI J MED, V77, P3, DOI 10.1002/msj.20165; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; PRADIER P, 1994, J PHYSIOLOGY-PARIS, V88, P273, DOI 10.1016/0928-4257(94)90008-6; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shi CG, 2010, NEUROCHEM RES, V35, P1302, DOI 10.1007/s11064-010-0183-6; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Vaka SRK, 2009, J PHARM SCI-US, V98, P3640, DOI 10.1002/jps.21674; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Wang CS, 2000, BRAIN RES, V865, P157, DOI 10.1016/S0006-8993(00)02183-1; Wang YJ, 2010, NEUROTOX RES, V17, P257, DOI 10.1007/s12640-009-9098-x; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	56	54	61	1	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 27	2012	1440						47	55		10.1016/j.brainres.2011.12.059			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915RW	WOS:000302046100005	22284619				2022-02-06	
J	Barnes, SM; Walter, KH; Chard, KM				Barnes, Sean M.; Walter, Kristen H.; Chard, Kathleen M.			Does a History of Mild Traumatic Brain Injury Increase Suicide Risk in Veterans With PTSD?	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; posttraumatic stress disorder; PTSD; suicide; veteran	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PERSONALITY-DISORDERS; MAJOR DEPRESSION; US VETERANS; IRAQ; ASSOCIATION; AFGHANISTAN; BEHAVIOR; SYMPTOMS	Objective: Research shows that posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) independently increase suicide risk; however, scant research has investigated whether mTBI increases suicide risk above and beyond the risk associated with PTSD alone. Design: The current research compared suicide risk factors among a matched sample of Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) military personnel and veterans with PTSD alone or PTSD and a history of an mTBI. Results: Differences in the assessed risk factors were small and suggest that if PTSD and mTBI are associated with elevations in suicide risk relative to PTSD alone, the added risk is likely mediated or confounded by PTSD symptom severity. Conclusion: This finding highlights the importance of screening and treating military personnel and veterans for PTSD. Future explication of the impact of TBI-related impairments on suicide risk will be critical as we strive to ensure safety and optimize care for our military personnel and veterans.	[Barnes, Sean M.; Walter, Kristen H.; Chard, Kathleen M.] Cincinnati VA Med Ctr, PTSD, Cincinnati, OH 45220 USA; [Barnes, Sean M.; Walter, Kristen H.; Chard, Kathleen M.] Cincinnati VA Med Ctr, Anxiety Disorders Clin, Cincinnati, OH 45220 USA; [Barnes, Sean M.] VA VISN 19 Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Chard, Kathleen M.] Univ Cincinnati, Sch Med, Cincinnati, OH 45221 USA		Chard, KM (corresponding author), Cincinnati VA Med Ctr, PTSD, 3200 Vine St, Cincinnati, OH 45220 USA.	Kathleen.Chard@va.gov	Walter, Kristen H/S-1827-2019				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; BECK AT, 1990, AM J PSYCHIAT, V147, P190; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bernal M, 2007, J AFFECT DISORDERS, V101, P27, DOI 10.1016/j.jad.2006.09.018; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Borges G, 2010, CURR OPIN PSYCHIATR, V23, P195, DOI 10.1097/YCO.0b013e3283386322; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Defense and Veterans Brain Injury Center, 2010, DEP DEF NUMB TRAUM B; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Duerden M., 2009, WHAT ARE HAZARD RATI; Ferraro KF, 2003, AM SOCIOL REV, V68, P707, DOI 10.2307/1519759; Field T, 2001, ADOLESCENCE, V36, P241; First M.B., 1996, STRUCTURED CLIN INTE; Freeman TW, 2000, J NERV MENT DIS, V188, P460, DOI 10.1097/00005053-200007000-00011; Gradus JL, 2010, AM J EPIDEMIOL, V171, P721, DOI 10.1093/aje/kwp456; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; Ilgen MA, 2010, SUICIDE LIFE-THREAT, V40, P597, DOI 10.1521/suli.2010.40.6.597; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jaycox, 2008, INVISIBLE WOUNDS WAR; Joiner TE, 2005, J ABNORM PSYCHOL, V114, P291, DOI 10.1037/0021-843X.114.2.291; Jurisic B, 2009, CRISIS, V30, P34, DOI 10.1027/0227-5910.30.1.34; Kalivas PW, 2003, AM J PSYCHIAT, V160, P1, DOI 10.1176/appi.ajp.160.1.1; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kposowa AJ, 2000, J EPIDEMIOL COMMUN H, V54, P254, DOI 10.1136/jech.54.4.254; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Maffei C, 1997, J PERS DISORD, V11, P279, DOI 10.1521/pedi.1997.11.3.279; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Morgan C, 2008, PSYCHOL MED, V38, P1701, DOI 10.1017/S0033291708004534; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; NORSTROM T, 1995, SOC FORCES, V74, P293, DOI 10.2307/2580633; Nye EC, 2007, MIL MED, V172, P1144; Oquendo M, 2005, AM J PSYCHIAT, V162, P560, DOI 10.1176/appi.ajp.162.3.560; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Oquendo MA, 2003, AM J PSYCHIAT, V160, P580, DOI 10.1176/appi.ajp.160.3.580; Pfeiffer PN, 2009, DEPRESS ANXIETY, V26, P752, DOI 10.1002/da.20583; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rudd MD, 1996, J ABNORM PSYCHOL, V105, P541, DOI 10.1037/0021-843X.105.4.541; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seguin M, 2007, PSYCHOL MED, V37, P1575, DOI 10.1017/S0033291707000955; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; United States Department of Defense Defense Manpower Data Center Data Analysis & Programs Division, 2011, US ACT DUT MIL DEATH; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weathers F. W., 1991, PCL S DSM 4; Wingate LR, 2004, BEHAV SCI LAW, V22, P651, DOI 10.1002/bsl.612; Zanarini MC, 2000, J PERS DISORD, V14, P291, DOI 10.1521/pedi.2000.14.4.291; Zivin K, 2007, AM J PUBLIC HEALTH, V97, P2193, DOI 10.2105/AJPH.2007.115477	70	54	54	1	20	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2012	57	1					18	26		10.1037/a0027007			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	901JX	WOS:000300964300004	22369114				2022-02-06	
J	Fried-Oken, M; Beukelman, DR; Hux, K				Fried-Oken, Melanie; Beukelman, David R.; Hux, Karen			Current and Future AAC Research Considerations for Adults with Acquired Cognitive and Communication Impairments	ASSISTIVE TECHNOLOGY			English	Article						acquired disabilities; aphasia; augmentative and alternative communication (AAC); cognition; dementia; primary progressive aphasia; traumatic brain injury	PROGRESSIVE APHASIA; 3 VARIANTS; INTERFACE; PEOPLE; ACCESS; IMPACT; ICF	Adults with acquired language impairments secondary to stroke, traumatic brain injury, and neurodegenerative diseases are candidates for communication supports outside of the traditional restoration-based approaches to intervention. Recent research proves repeatedly that augmentative and alternative communication (AAC) provides a means for participation, engagement, conversation, and message transfer when individuals can no longer expect full return of pre-morbid communication skills and that inclusion of communication supports should begin early. We discuss current research and future directions for integrated systems of technical supports that include low-technology, high tech, and partner-dependent strategies for adults with severe and chronic aphasia, cognitive-communication problems resulting from traumatic brain injuries, and primary progressive aphasia.	[Fried-Oken, Melanie] Oregon Hlth & Sci Univ, CDRC, Portland, OR 97239 USA; [Beukelman, David R.; Hux, Karen] Univ Nebraska, Lincoln, NE USA		Fried-Oken, M (corresponding author), Oregon Hlth & Sci Univ, CDRC, POB 574, Portland, OR 97239 USA.	friedm@ohsu.edu	Hux, Karen/AAQ-2078-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD047754] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD047754] Funding Source: Medline		American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; Beukelman D, 1985, COMMUNICATION AUGMEN; Beukelman DR, 2007, AUGMENT ALTERN COMM, V23, P230, DOI 10.1080/07434610701553668; Burke R, 2008, AUGMENT ALTERN COMM, V24, P56, DOI 10.1080/07434610701421015; Chapey R., 2001, LANGUAGE INTERVENTIO, P246; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cress C., 1999, AUGMENT ALTERN COMM, V15, P248, DOI [10.1080/07434619912331278785, DOI 10.1080/07434619912331278785]; DeRuyter F, 1995, Assist Technol, V7, P3; DeRuyter F., 1987, AUGMENTATIVE ALTERNA, V3, P18, DOI DOI 10.1080/07434618712331274209; DERUYTER F, 1989, AUGMENTATIVE ALTERNA, V5, P49, DOI DOI 10.1080/07434618912331274966; Dietz A, 2009, APHASIOLOGY, V23, P1053, DOI 10.1080/02687030802635832; Doyle M, 2000, AUG ALTER COMMUN SER, P271; Duffy, 2005, MOTOR SPEECH DISORDE; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Fager S., 2007, AUGMENTATIVE COMMUNI, P59; Fager S., 2011, ASSISTING SURVIVORS, P227; Fager S, 2012, ASSIST TECHNOL, V24, P25, DOI 10.1080/10400435.2011.648712; Fox L., 2000, AUGMENTATIVE ALTERNA, P3; Fox LE, 2001, APHASIOLOGY, V15, P171, DOI 10.1080/02687040042000133; Fried-Oken M, 1995, ASHA AAC SPECIAL INT, V4, P3; Fried-Oken M., 2010, PERSPECT NEUROPHYSIO, V20, P21, DOI [10.1044/nnsld20.1.21, DOI 10.1044/NNSLD20.1.21]; Fried-Oken M., 2008, PERSPECTIVES AUGMENT, V17, P99; Fried-Oken M., 1992, J HEAD TRAUMA REHAB, V9, DOI [DOI 10.1097/00001199-199209000-00008, 10.1097/00001199-199209000-00008]; Garrett K. L., 1989, AUGMENT ALTERN COMM, V5, P55, DOI [10.1080/07434618912331274976, DOI 10.1080/07434618912331274976]; Garrett KL, 2002, APHASIOLOGY, V16, P523, DOI 10.1080/02687030244000149; Garrett KL, 1995, CLIN APHASIOL, V23, P237; Garrett KL., 2005, AUGMENTATIVE ALTERNA, P467; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; HELMESTABROOKS N, 2001, CLQT COGNITIVE LINGU; Higginbotham DJ, 2012, ASSIST TECHNOL, V24, P14, DOI 10.1080/10400435.2011.648714; Hodges J R, 1996, J Int Neuropsychol Soc, V2, P511; Hux K., 2011, ASSISTING SURVIVORS, P121; Hux K, 2008, LANGUAGE INTERVENTIO, V5th, P814; Hux K, 2010, APHASIOLOGY, V24, P643, DOI 10.1080/02687030902869299; Johnson RK, 2008, AUGMENT ALTERN COMM, V24, P269, DOI 10.1080/07434610802463957; Kagan A, 2008, APHASIOLOGY, V22, P258, DOI 10.1080/02687030701282595; Keenan J, 1993, AUGMENTATIVE ALTERNA, V9, P184, DOI DOI 10.1080/07434619312331276591; Kimberly MHA, 2005, AUGMENT ALTERN COMM, V21, P218, DOI 10.1080/07434610400016694; King J. M., 1995, AUGMENTATIVE ALTERNA, V11, P187, DOI DOI 10.1080/07434619512331277309; LaPointe L., 2005, APHASIA RELATED NEUR, P1; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Lasker J., 1997, AUGMENT ALTERN COMM, V13, P108, DOI [10.1080/07434619712331277908, DOI 10.1080/07434619712331277908]; Lasker J., 2007, AUGMENTATIVE COMMUNI, P163; Lasker JP, 2005, APHASIOLOGY, V19, P399, DOI 10.1080/02687030444000840; Light J., 1988, AUGMENTATIVE ALTERNA, V4, P2, DOI DOI 10.1080/07434618812331274557; LYON JG, 1995, APHASIOLOGY, V9, P84, DOI 10.1080/02687039508248694; LYON JG, 1995, APHASIOLOGY, V9, P33, DOI 10.1080/02687039508248687; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); McNeil MR, 2001, APHASIOLOGY, V15, P901, DOI 10.1080/02687040143000276; Mesulam MM, 2001, ANN NEUROL, V49, P425, DOI 10.1002/ana.91; MESULAM MM, 1982, ANN NEUROL, V11, P592, DOI 10.1002/ana.410110607; Murray LL, 1998, APHASIOLOGY, V12, P651, DOI 10.1080/02687039808249564; National Aphasia Association, 2009, APH FREQ ASK QUEST; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Raghavendra P, 2007, AUGMENT ALTERN COMM, V23, P349, DOI 10.1080/07434610701650928; Rogers MA, 2000, AUG ALTER COMMUN SER, P305; Rogers MA, 1998, APHASIOLOGY, V12, P635, DOI 10.1080/02687039808249563; Rowland C, 2012, AUGMENT ALTERN COMM, V28, P21, DOI 10.3109/07434618.2012.654510; Shane HC, 2012, ASSIST TECHNOL, V24, P3, DOI 10.1080/10400435.2011.648716; Simmons-Mackie Nina, 2007, Seminars in Speech and Language, V28, P244, DOI 10.1055/s-2007-986521; Simms NJ, 2001, EUR FED CORR PUBL, P246; Trautman J., 2002, PATIENTS CLIN PATHWA; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; World Health Organization, 2007, INT CLASS FUNCT DIS; Yorkston KM, 2000, AUG ALTER COMMUN SER, P55	66	54	54	1	88	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.		2012	24	1			SI		56	66		10.1080/10400435.2011.648713			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	957QD	WOS:000305176800007	22590800	Green Accepted, Green Published			2022-02-06	
J	Hsieh, MY; Ponsford, J; Wong, D; Schonberger, M; Taffe, J; Mckay, A				Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; Schoenberger, Michael; Taffe, John; Mckay, Adam			Motivational interviewing and cognitive behaviour therapy for anxiety following traumatic brain injury: A pilot randomised controlled trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Anxiety; Motivational interviewing; Cognitive behaviour therapy; Traumatic brain injury	SCHEDULED TELEPHONE INTERVENTION; CASE EXPERIMENTAL-DESIGN; PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; STRESS-DISORDER; 1ST YEAR; PROGRAM; PSYCHOTHERAPY; RECOVERY	Although cognitive-behavioural therapy (CBT) is the treatment of choice for anxiety, its delivery needs to be adapted for individuals with traumatic brain injury (TBI). It also requires clients' active engagement for maximum benefit. This study was a pilot randomised controlled trial involving an anxiety treatment programme adapted for people with TBI, based on CBT and motivational interviewing (MI). Twenty-seven participants with moderate/severe TBI (aged 21-73 years, 78% males) recruited from a brain injury rehabilitation hospital were randomly allocated to receive MI + CBT (n = 9), non-directive counselling (NDC) + CBT (n = 10) and treatment-as-usual (TAU) (n = 8). CBT and MI were manualised and delivered in 12 weekly individual sessions. Primary outcome was self-reported anxiety symptoms assessed at baseline, at the end of NDC/MI and immediately following CBT. Assessment was conducted by assessors blinded to group assignment. Intention-to-treat analyses showed that the two active treatment groups demonstrated significantly greater anxiety reduction than TAU. Participants receiving MI showed greater response to CBT, in terms of reduction in anxiety, stress and non-productive coping, compared to participants who received NDC. The results provided preliminary support for the adapted CBT programme, and the potential utility of MI as treatment prelude. Longer follow-up data are required to evaluate the maintenance of treatment effects.	[Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; Taffe, John; Mckay, Adam] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Hsieh, Ming-Yun; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Mckay, Adam] Epworth Med Fdn, Melbourne, Vic, Australia; [Hsieh, Ming-Yun] Arbias, Melbourne, Vic, Australia; [Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	McKay, Adam JD/M-6003-2017; Wong, Dana/AAD-3410-2020	McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Monash UniversityMonash University; Victorian Brain Injury Recovery Association (Australia)	This study was supported in part by grants from the National Health and Medical Research Council and Monash University, and a scholarship from the Victorian Brain Injury Recovery Association (Australia). The funding sources had no role in study design and analysis of data. The authors alone were responsible for the content and writing of the paper. A portion of the preliminary findings of this paper was presented at the International Congress of Applied Psychology conference in Melbourne, 2010.	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Buckner JD, 2009, BEHAV RES THER, V47, P710, DOI 10.1016/j.brat.2009.04.009; Burgess P.W., 1997, HAYLING BRIXTON TEST; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Coughlin A, 2007, MEMORY INFORM PROCES; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dahm J, 2009, APS ANN C PERTH AUST; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Devilly G. J., 2005, CLINTOOLS SOFTWARE W; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; First M, 2007, STRUCTURED CLIN INTE; Fleming JM, 1996, BRAIN INJURY, V10, P1; Friedli K, 1997, LANCET, V350, P1662, DOI 10.1016/S0140-6736(97)05298-7; Frydenberg E., 1996, COPING SCALE ADULTS; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hox J.J., 2010, QUANTITATIVE METHODO, V2; Hsieh M.-Y., NEUROPSYCHO IN PRESS, DOI [10.1080/09602011.2012.676284, DOI 10.1080/09602011.2012.676284]; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Madson MB, 2005, PSYCHOL ADDICT BEHAV, V19, P303, DOI 10.1037/0893-164X.19.3.303; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Merlo Lisa J., 2010, Cognitive Behaviour Therapy, V39, P24, DOI 10.1080/16506070902831773; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Moyers TB., 2007, REVISED GLOBAL SCALE; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Perna R, 2006, J HEAD TRAUMA REHAB, V21, P82, DOI 10.1097/00001199-200601000-00009; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; StataCorp, 2013, STATA STAT SOFTWARE; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Westra HA, 2006, COGNITIVE THER RES, V30, P481, DOI 10.1007/s10608-006-9016-y; Westra HA, 2010, TREATMENT RESISTANT ANXIETY DISORDERS: RESOLVING IMPASSES TO SYMPTOM REMISSION, P199; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wood Angela M, 2004, Clin Trials, V1, P368; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390; [No title captured]	65	54	54	2	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	4					585	608		10.1080/09602011.2012.678860			24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	995SC	WOS:000308031600007	22632385				2022-02-06	
J	Kasahara, M; Menon, DK; Salmond, CH; Outtrim, JG; Tavares, JVT; Carpenter, TA; Pickard, JD; Sahakian, BJ; Stamatakis, EA				Kasahara, Maki; Menon, David K.; Salmond, Claire H.; Outtrim, Joanne G.; Tavares, Joana V. Taylor; Carpenter, T. Adrian; Pickard, John D.; Sahakian, Barbara J.; Stamatakis, Emmanuel A.			Traumatic brain injury alters the functional brain network mediating working memory	BRAIN INJURY			English	Article						fMRI; plasticity; right inferior frontal gyrus; working memory	INHIBITORY CONTROL; MILD; ACTIVATION; FMRI; METHYLPHENIDATE; CONNECTIVITY; IMPAIRMENT; COMPONENTS; COMMON; LOAD	Primary objective: Investigation of the impact of traumatic brain injury (TBI) on the functional brain network that mediates working memory function. Research design: Functional magnetic resonance imaging (fMRI) during an n-back working memory task in nine chronic-stage patients with TBI and nine age-matched healthy controls. In addition to classical analyses investigating regional activity, the authors examined functional connectivity of the brain regions critical to working memory performance using psychophysiological interaction (PPI) analyses. Main outcomes and results: Patients with TBI made a greater percentage of errors than controls at high working memory load conditions. The fMRI data showed that the activation of the left inferior parietal gyrus (LIPG) was significantly reduced, whereas the activation of the right inferior frontal gyrus (RIFG) was significantly increased in patients compared with controls. Task performance accuracy was significantly associated with the activation of the LIPG in controls and the activation of the RIFG in patients. PPI analyses on fMRI data further suggested that the functional connectivity between the RIFG and LIPG was compromised in patients. Conclusion: The abnormal functional connectivity between LIPG and RIFG may underlie the observed working memory deficits and abnormal brain activation pattern in patients.	[Kasahara, Maki; Menon, David K.; Outtrim, Joanne G.; Stamatakis, Emmanuel A.] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Salmond, Claire H.; Tavares, Joana V. Taylor; Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Carpenter, T. Adrian] Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge, England; [Pickard, John D.] Addenbrookes Hosp, Neurosurg Unit, Dept Clin Neurosci, Cambridge, England; [Sahakian, Barbara J.] Addenbrookes Hosp, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England		Stamatakis, EA (corresponding author), Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Box 93,Hills Rd, Cambridge CB2 0QQ, England.	eas46@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Outtrim, Joanne/0000-0001-8118-6430; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Evelyn Trust [RUAG/018]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390]; National Institute for Health ResearchNational Institute for Health Research (NIHR); Addenbrooke's Charitable Trust (Cambridge, UK); NHS National Institute for Health ResearchNational Institute for Health Research (NIHR); Glaxo SmithKlineGlaxoSmithKline; SolvaySolvay SA; Linde; Medical Research Council grant (Wolfson Brain Imaging Centre)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986]; McDonnell Foundation; Queens' College, Cambridge; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B, G0001354, G1000183B, G0600986, G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986, G0001237] Funding Source: UKRI	This study was supported by the Evelyn Trust (grant number RUAG/018 to D. K. M. (principal investigator), J.D.P., and B.J.S.); Medical Research Council program grant (grant number G9439390 to D. K. M., J.D.P., T. A. C., and B.J.S.); and funds given to the neuroscience theme of the Cambridge Biomedical Research Centre by the National Institute for Health Research (to D. K. M. and J.D.P.).; M.K. was funded by Addenbrooke's Charitable Trust (Cambridge, UK) during the analysis of the data.; D.K.M. is supported by a senior investigator grant from the NHS National Institute for Health Research. He has received lecture fees, consultancy fees and support for research from Glaxo SmithKline, Solvay and Linde. He is on the editorial boards of PloS Medicine, Critical Care, and Neurocritical Care.; J.D.P. is supported by NHS National Institute for Health Research senior investigator award. He is also a lead principal investigator for Medical Research Council grant G0600986 (Wolfson Brain Imaging Centre Acute Brain Injury Collaborative Grant), together with being co-applicant on grants from the Medical Research Council and McDonnell Foundation on vegetative state. He is a director of Medicam/Technicam, Ltd., and is on the scientific advisory board for Codman (Johnson & Johnson). He is an honorary civilian consultant (neurosurgery) for the UK Army.; E.A.S. is supported by the Stephen Erskine Fellowship, Queens' College, Cambridge. He is on the editorial board of Neuroscience Imaging.	Backman L, 2009, NEUROBIOLOGY AGING; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Ciaramelli E, 2006, BRAIN COGNITION, V60, P198; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; D'Arcy RCN, 2005, COGNITIVE BRAIN RES, V22, P177, DOI 10.1016/j.cogbrainres.2004.08.007; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim J, 2010, J NEUROTRAUMA; Kim JJ, 2003, AM J PSYCHIAT, V160, P919, DOI 10.1176/appi.ajp.160.5.919; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Maruishi M, 2009, J NEUROL NEUROSUR PS, V78, P168; Marvel CL, 2009, CORTEX; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McHugh T, 2006, BRAIN COGNITION, V60, P209; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Mehta MA, 2000, J NEUROSCI, V20; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Raboyeau G, 2008, NEUROLOGY, V70, P290, DOI 10.1212/01.wnl.0000287115.85956.87; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; Stricker JL, 2006, J INT NEUROPSYCH SOC, V12, P591, DOI 10.1017/S1355617706060851; Tsukiura T, 2001, COGNITIVE BRAIN RES, V11, P13, DOI 10.1016/S0926-6410(00)00059-8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Weissman DH, 2002, NEUROIMAGE, V17, P1266, DOI 10.1006/nimg.2002.1284	42	54	54	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1170	1187		10.3109/02699052.2011.608210			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200004	21932994				2022-02-06	
J	Huang, MI; O'Riordan, MA; Fitzenrider, E; McDavid, L; Cohen, AR; Robinson, S				Huang, Mary I.; O'Riordan, Mary Ann; Fitzenrider, Ellen; McDavid, Lolita; Cohen, Alan R.; Robinson, Shenandoah			Increased incidence of nonaccidental head trauma in infants associated with the economic recession Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						nonaccidental head trauma; economic recession; trauma; unemployment; Glasgow Coma Scale	INJURY; CHILDREN	Object. Nonaccidental head trauma (NAHT) is a major cause of death in infants. During the current economic recession, the authors noticed an anecdotal increase in infants with NAHT without an increase in the overall number of infants admitted with traumatic injuries. An analysis was performed to determine whether there was an association between economic recession and NAHT. Methods. With Institutional Review Board approval, the trauma database was searched for NAHT in infants 0-2 years old during nonrecession (December 2001 to November 2007) and recession (December 2007 to June 2010) periods. Incidence is reported as infants with NAHT per month summarized over time periods. Continuous variables were compared using Mann-Whitney U-tests, and proportions were compared using the Fisher exact test. Results. Six hundred thirty-nine infant traumas were observed during the study time period. From the nonrecession to the recession period, there was an 8.2% reduction in all traumas (458 in 72 months [6.4 /month] vs 181 in 31 months [5.8/month]) and a 3.5% reduction in accidental head traumas (142 in 72 months [2.0/month] vs 59 in 31 months [1.9/month]). Nonaccidental head trauma accounted for 14.6% of all traumas (93/639). The median patient age was 4.0 months and 52% were boys. There were no significant differences in the representative counties of referral or demographics between nonrecession and recession populations (all p > 0.05). The monthly incidence rates of NAHT doubled from nonrecession to recession periods (50 in 72 months [0.7/month] vs 43 in 31 months [1.4/month]; p = 0.01). During this recession, at least 1 NAHT was reported in 68% of the months compared with 44% of the months during the nonrecession period (p = 0.03). The severity of NAHTs also increased, with a greater proportion of deaths (11.6% vs 4%, respectively; p = 0.16) and severe brain injury (Glasgow Coma Scale score <= 8: 19.5% vs 4%, respectively; p = 0.06) during the recession. Conclusions. In the context of an overall reduction in head trauma, the significant increase in the incidence of NAHT appears coincident with economic recession. Although the cause is likely multifactorial, a full analysis of the basis of this increase is beyond the scope of this study. This study highlights the need to protect vulnerable infants during challenging economic times. (DOI: 10.3171/2011.5.PEDS1139)	[Huang, Mary I.; Cohen, Alan R.; Robinson, Shenandoah] Case Western Reserve Univ, Univ Hosp Rainbow Babies & Childrens Hosp, Div Pediat Neurol Surg, Neurol Inst,Sch Med, Cleveland, OH USA; [O'Riordan, Mary Ann; McDavid, Lolita] Case Western Reserve Univ, Dept Pediat, Univ Hosp Rainbow Babies & Childrens Hosp, Neurol Inst,Sch Med, Cleveland, OH 44106 USA; [Fitzenrider, Ellen; Cohen, Alan R.; Robinson, Shenandoah] Case Western Reserve Univ, Univ Hosp Rainbow Babies & Childrens Hosp, Pediat Trauma Ctr, Neurol Inst,Sch Med, Cleveland, OH USA		Huang, MI (corresponding author), Univ Hosp Case Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.	maryihuang@gmail.com					Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; Johnson N, UPDATE STATE BUDGET; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Mok JYQ, 2010, J EPIDEMIOL COMMUN H, V64, P1049, DOI 10.1136/jech.2009.090217; Stoodley N, 2002, LANCET, V360, P271, DOI 10.1016/S0140-6736(02)09563-6; The National Bureau of Economic Research, US BUS CYCL EXP CONT; Tucker IB, 2008, SURVEY EC, P243; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130	10	54	55	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2011	8	2					171	176		10.3171/2011.5.PEDS1139			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	797RI	WOS:000293144900011	21806359				2022-02-06	
J	Spinella, PC; Wade, CE; Blackbourne, LH; Borgman, MA; Zarzabal, LA; Du, F; Perkins, JG; Maegele, M; Schreiber, M; Hess, JR; Jastrow, KM; Gonzalez, EA; Holcomb, JB; Kozar, R				Spinella, Philip C.; Wade, Charles E.; Blackbourne, Lorne H.; Borgman, Matthew A.; Zarzabal, Lee A.; Du, Fei; Perkins, Jeremy G.; Maegele, Marc; Schreiber, Martin; Hess, John R.; Jastrow, Kenneth M., III; Gonzalez, Ernest A.; Holcomb, John B.; Kozar, Rosemary		Trauma Outcomes Grp	The Association of Blood Component Use Ratios With the Survival of Massively Transfused Trauma Patients With and Without Severe Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Transfusion; Mortality; Red Blood Cell; Plasma; Platelets	DAMAGE CONTROL RESUSCITATION; FRESH-FROZEN PLASMA; EARLY COAGULOPATHY; MORTALITY; PLATELETS; IMPACT; CELLS; TIME; EPIDEMIOLOGY; COAGULATION	Background: The effect of blood component ratios on the survival of patients with traumatic brain injury (TBI) has not been studied. Methods: A database of patients transfused in the first 24 hours after admission for injury from 22 Level I trauma centers over an 18-month period was queried to find patients who (1) met different definitions of massive transfusion (5 units red blood cell [RBC] in 6 hours vs. 10 units RBC in 24 hours), (2) received high or low ratios of platelets or plasma to RBC units (<1:2 vs. >= 1:2), and (3) had severe TBI (head abbreviated injury score >= 3) (TBI+). Results: Of 2,312 total patients, 850 patients were transfused with >= 5 RBC units in 6 hours and 807 could be classified into TBI+ (n = 281) or TBI- (n = 526). Six hundred forty-three patients were transfused with >= 10 RBC units in 24 hours with 622 classified into TBI+ (n = 220) and TBI- (n = 402). For both high-risk populations, a high ratio of platelets:RBCs (not plasma) was independently associated with improved 30-day survival for patients with TBI+ and a high ratio of plasma:RBCs (not platelets) was independently associated with improved 30-day survival in TBI- patients. Conclusions: High platelet ratio was associated with improved survival in TBI+ patients while a high plasma ratio was associated with improved survival in TBI- patients. Prospective studies of blood product ratios should include TBI in the analysis for determination of optimal use of ratios on outcome in injured patients.	[Spinella, Philip C.] St Louis Childrens Hosp, Div Crit Care Med, Dept Pediat, St Louis, MO 63110 USA; [Spinella, Philip C.; Wade, Charles E.; Blackbourne, Lorne H.] USA, Inst Surg Res, San Antonio, TX USA; [Borgman, Matthew A.] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Zarzabal, Lee A.; Du, Fei] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Perkins, Jeremy G.] Walter Reed Army Med Ctr, Dept Med, Washington, DC 20307 USA; [Maegele, Marc] Merheim Med Ctr, Dept Surg, Cologne, Germany; [Schreiber, Martin] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Hess, John R.] R Adams Cowley Shock Trauma Ctr, Dept Pathol, Baltimore, MD USA; [Jastrow, Kenneth M., III; Gonzalez, Ernest A.; Holcomb, John B.; Kozar, Rosemary] Univ Texas Hlth Sci Ctr, Div Acute Care Surg, Ctr Translat Injury Res, Houston, TX USA		Spinella, PC (corresponding author), St Louis Childrens Hosp, Div Crit Care Med, Dept Pediat, 1 Childrens Pl,Campus Box 8116, St Louis, MO 63110 USA.	spinella_p@wustl.kids.edu	Borgman, Matthew A/L-9477-2015; Hess, John R./K-4001-2013	Borgman, Matthew A/0000-0002-2008-7380; Hess, John R./0000-0001-8596-4420; Macleod, Jana/0000-0003-3401-7575; holcomb, john/0000-0001-8312-9157	US ArmyUnited States Department of Defense [W81XWH-07-1-0717]	We thank Joel Michalek, PhD, for his contributions to the statistical analysis and preparation of the manuscript. The authors wish to acknowledge the support of the numerous research coordinators at the various centers. This work was funded in part by a grant from the US Army to the University of Texas Health Science Center San Antonio, W81XWH-07-1-0717.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Duchesne JC, 2009, J TRAUMA, V67, P228; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2006, TRANSFUSION, V46, P685, DOI 10.1111/j.1537-2995.2006.00816.x; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; Kashuk JL, 2008, J TRAUMA, V65, P261, DOI 10.1097/TA.0b013e31817de3e1; KOZAR RA, 2009, SHOCK, V31, pS89; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; McMullin NR, 2006, INTENSIVE CARE MEDICINE: ANNUAL UPDATE 2006, P265, DOI 10.1007/0-387-35096-9_25; Moore FA, 2008, J TRAUMA, V64, P1010, DOI 10.1097/TA.0b013e31816a2417; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peng R, 1998, AM SURGEON, V64, P950; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; Sambasivan CN, 2009, AM J SURG, V197, P576, DOI 10.1016/j.amjsurg.2008.12.011; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Spinella PC, 2007, CRIT CARE MED, V35, pA152; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Teixeira PGR, 2009, J TRAUMA, V66, P693, DOI 10.1097/TA.0b013e31817e5c77; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	36	54	55	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2011	71			3			S343	S352		10.1097/TA.0b013e318227ef2d			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	806XE	WOS:000293849700005	21814102				2022-02-06	
J	Zumstein, MA; Moser, M; Mottini, M; Ott, SR; Sadowski-Cron, C; Radanov, BP; Zimmermann, H; Exadaktylos, A				Zumstein, Matthias A.; Moser, Mario; Mottini, Matthias; Ott, Sebastian R.; Sadowski-Cron, Charlotte; Radanov, Bogdan P.; Zimmermann, Heinz; Exadaktylos, Aristomenis			Long-Term Outcome in Patients With Mild Traumatic Brain Injury: A Prospective Observational Study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Mild traumatic brain injury; Beltz score; Long-term outcome; Intracranial injury	HEAD-INJURY; COMPUTED-TOMOGRAPHY; CHRONIC PAIN; SEQUELAE; PREVALENCE; VALIDATION; PREDICTION; SYMPTOMS; ADULTS	Background: Mild traumatic brain injury (MTBI) is common; up to 37% of adult men have a history of MTBI. Complaints after MTBI are persistent headaches, memory impairment, depressive mood disorders, and disability. The reported short- and long-term outcomes of patients with MTBI have been inconsistent. We have now investigated long-term clinical and neurocognitive outcomes in patients with MTBI (at admission, and after 1 and 10 years). Methods: Patients of a previous study investigating MTBI short-term outcome were prospectively reassessed after +/-10 year using the same standardized data entry form and validated questionnaire (Beltztest with Beltz Score [BeSc]) for evaluation of Quality of life (QoL) and neurocognitive outcome (higher scores indicate lower QoL). Results: Eighty-six of 176 patients (49%) could be reassessed (n = 75 lost to follow-up; n = 8 second brain trauma; n = 7 death), 10.4 +/- 2 years after initial evaluation. Over time, overall BeSc was significantly increased (5.92 +/- 10.3 [admission] vs. 10.7 +/- 12.8 [1 year] vs. 20.86 +/- 17.1 [10 year]; p < 0.0001); only 54 of 86 patients (62.8%) presented with a normal BeSc. Long-term complaints were fatigue, insomnia, and exhaustion. Ten of eighty-six patients (11.6%) had intracranial injury (ICI) and initial BeSc was almost twofold higher in patients with ICI than in patients without ICI (10.0 +/- 8.4 vs. 5.3 +/- 9.6; p = 0.007). This difference was not seen after 1 year or after 10 years (10.3 +/- 11.6 vs. 10.3 +/- 10.1 and 21.4 +/- 17.3 vs. 16.1 +/- 16.4, respectively). Eight of eighty-six patients (9.3%) lost their jobs because of persistent complaints after MTBI. Conclusion: BeSc deteriorates over time; our data suggest a decline in general health and QoL in a substantial proportion of patients (37.2%) 10 years after MTBI. Patients without ICI appear to have a better long-term outcome with regard to subjective complaints and QoL.	[Ott, Sebastian R.] Univ Hosp Bern, Dept Emergency Med, Inselspital, CH-3010 Bern, Switzerland; Univ Bern, CH-3010 Bern, Switzerland		Ott, SR (corresponding author), Univ Hosp Bern, Dept Emergency Med, Inselspital, CH-3010 Bern, Switzerland.	sebastian.ott@insel.ch	Zumstein, Matthias/AAV-3268-2020	Zumstein, Matthias/0000-0001-5480-6008			Angst J, 2002, BIPOLAR DISORD, V4, P11, DOI 10.1034/j.1399-5618.4.s1.1.x; *BUND STAT, 1997, SCHWEIZ GES; Coles R R, 1984, J Laryngol Otol Suppl, V9, P7; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Dunning J, 2004, J NEUROTRAUM, V21, P877, DOI 10.1089/0897715041526122; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobs A, 1996, J NUCL MED, V37, P1605; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; LEZAK M, 1995, NEUROPHYSIOLOGICAL A; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pilgramm M, 2004, HNO, V52, P844; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VONZERSSEN D, 1971, THERAPIEWOCHE, V21, P1908; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; ZERSSEN D, 1976, BESCHWERDELISTE MANU; ZERSSEN DV, 1973, ARCH PSYCHIAT NERVEN, V217, P299, DOI 10.1007/BF02552842	40	54	54	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					120	127		10.1097/TA.0b013e3181f2d670			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	790RR	WOS:000292607400031	21045743				2022-02-06	
J	Kharlamov, EA; Lepsveridze, E; Meparishvili, M; Solomonia, RO; Lu, B; Miller, ER; Kelly, KM; Mtchedlishvili, Z				Kharlamov, Elena A.; Lepsveridze, Eka; Meparishvili, Maia; Solomonia, Revaz O.; Lu, Bo; Miller, Eric R.; Kelly, Kevin M.; Mtchedlishvili, Zakaria			Alterations of GABA(A) and glutamate receptor subunits and heat shock protein in rat hippocampus following traumatic brain injury and in posttraumatic epilepsy	EPILEPSY RESEARCH			English	Article						Controlled cortical impact; Epileptogenesis; Hippocampus; Traumatic brain injury; Posttraumatic epilepsy; Western blot	CONTROLLED CORTICAL IMPACT; D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; NR2B-CONTAINING NMDA RECEPTORS; SUBCELLULAR STRESS-RESPONSE; TRANSIENT GLOBAL-ISCHEMIA; FLUID-PERCUSSION INJURY; DENTATE GYRUS; KINASE-II; SYNAPTIC PLASTICITY	Traumatic brain injury (TBI) can result in the development of posttraumatic epilepsy (PTE). Recently, we reported differential alterations in tonic and phasic GABA(A) receptor (GABA(A)R) currents in hippocampal dentate granule cells 90 days after controlled cortical impact (CCI) (Mtchedlishvili et al., 2010). In the present study, we investigated long-term changes in the protein expression of GABA(A)R alpha 1, alpha 4, gamma 2, and delta subunits, NMDA (NR2B) and AMPA (GluR1) receptor subunits, and heat shock proteins (HSP70 and HSP90) in the hippocampus of Sprague-Dawley rats evaluated by Western blotting in controls, CC-injured animals without PTE (CCI group), and CCI-injured animals with PTE (PTE group). No differences were found among all three groups for alpha 1 and alpha 4 subunits. Significant reduction of gamma 2 protein was observed in the PTE group compared to control. CCI caused a 194% and 127% increase of delta protein in the CCI group compared to control (p < 0.0001), and PTE (p < 0.0001) groups, respectively. NR2B protein was increased in CCI and PTE groups compared to control (p = 0.0001, and p = 0.011, respectively). GluR1 protein was significantly decreased in CCI and PTE groups compared to control (p = 0.003, and p = 0.001, respectively), and in the PTE group compared to the CCI group (p = 0.036). HSP70 was increased in CCI and PTE groups compared to control (p = 0.014, and p = 0.005, respectively); no changes were found in HSP90 expression. These results provide for the first time evidence of long-term alterations of GABA(A) and glutamate receptor subunits and a HSP following CCI. (c) 2011 Elsevier B.V. All rights reserved.	[Kharlamov, Elena A.; Lepsveridze, Eka; Lu, Bo; Miller, Eric R.; Kelly, Kevin M.; Mtchedlishvili, Zakaria] Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Neurosci Res, Pittsburgh, PA 15212 USA; [Kharlamov, Elena A.; Kelly, Kevin M.; Mtchedlishvili, Zakaria] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA; [Kelly, Kevin M.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Lepsveridze, Eka; Meparishvili, Maia; Solomonia, Revaz O.] Ilia State Univ, Inst Biol Chem, Tbilisi, Georgia; [Lepsveridze, Eka; Meparishvili, Maia; Solomonia, Revaz O.] I Beritashvili Inst Physiol, Tbilisi, Georgia		Kharlamov, EA (corresponding author), Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Neurosci Res, 320 East North Ave,9J1 S Tower, Pittsburgh, PA 15212 USA.	ekharlam@wpahs.org	Lepsveridze, Eka/ABC-5582-2021		Health Research Formula Fund [RFA 01-07-26]; Pennsylvania Department of Health; Epilepsy Foundation; Georgian National Science Scholars Program	The study was supported by Health Research Formula Fund RFA 01-07-26, Pennsylvania Department of Health, and a Research Grant from the Epilepsy Foundation to ZM and a grant from the Georgian National Science Scholars Program (EL). We thank Teresa M. Hentosz for assistance in the preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; ARAKI T, 1993, MOL BRAIN RES, V20, P263, DOI 10.1016/0169-328X(93)90050-Y; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Bush PC, 1999, J NEUROPHYSIOL, V82, P1748, DOI 10.1152/jn.1999.82.4.1748; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Cendes F, 2005, CURR OPIN NEUROL, V18, P173, DOI 10.1097/01.wco.0000162860.49842.90; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; Clayton DA, 2002, J NEUROSCI, V22, P3628; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; D'Souza SM, 1998, CELL STRESS CHAPERON, V3, P188, DOI 10.1379/1466-1268(1998)003<0188:CEOHSP>2.3.CO;2; DeBlas AL, 1996, MOL NEUROBIOL, V12, P55, DOI 10.1007/BF02740747; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Dingledine R, 1999, PHARMACOL REV, V51, P7; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Ekimova IV, 2010, J NEUROCHEM, V115, P1035, DOI 10.1111/j.1471-4159.2010.06989.x; Emond MR, 2010, J PHYSIOL-LONDON, V588, P1929, DOI 10.1113/jphysiol.2010.187229; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Eugene E, 2007, J NEUROSCI, V27, P14108, DOI 10.1523/JNEUROSCI.2618-07.2007; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Fritschy JM, 1999, NEUROCHEM INT, V34, P435, DOI 10.1016/S0197-0186(99)00040-6; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; GALLAGHER S, 2008, CURR PROTOC IMMUNOL, pCH8; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; GASS P, 1995, NEUROSCIENCE, V65, P27, DOI 10.1016/0306-4522(95)92049-P; GASS P, 1994, NEUROSCI LETT, V182, P188, DOI 10.1016/0304-3940(94)90794-3; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Goebel SM, 2005, MOL BRAIN RES, V142, P65, DOI 10.1016/j.molbrainres.2005.09.012; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Gutierrez A, 1996, MOL BRAIN RES, V35, P91, DOI 10.1016/0169-328X(95)00187-W; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hellier JL, 2009, NEUROPHARMACOLOGY, V56, P414, DOI 10.1016/j.neuropharm.2008.09.009; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hota SK, 2010, FREE RADICAL BIO MED, V49, P178, DOI 10.1016/j.freeradbiomed.2010.03.027; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; IZUMOTO S, 1993, J NEUROSCI RES, V35, P20, DOI 10.1002/jnr.490350104; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Joshi S, 2009, NEUROSCIENCE, V164, P507, DOI 10.1016/j.neuroscience.2009.08.008; KAPUR J, 1989, J NEUROPHYSIOL, V61, P427, DOI 10.1152/jn.1989.61.2.427; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kharlamov EA, 2007, BRAIN RES, V1127, P151, DOI 10.1016/j.brainres.2006.09.107; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Korpi ER, 2002, NEUROSCIENCE, V109, P733, DOI 10.1016/S0306-4522(01)00527-9; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lagrange Andre, 2005, Epilepsy Curr, V5, P91, DOI 10.1111/j.1535-7511.2005.05304.x; Lagrange AH, 2007, J PHYSIOL-LONDON, V578, P655, DOI 10.1113/jphysiol.2006.122135; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Liu FY, 2007, BIOCHEM BIOPH RES CO, V358, P825, DOI 10.1016/j.bbrc.2007.05.010; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lively S, 2008, J NEUROCHEM, V107, P1335, DOI 10.1111/j.1471-4159.2008.05696.x; Loftis JM, 2003, PHARMACOL THERAPEUT, V97, P55, DOI 10.1016/S0163-7258(02)00302-9; Loup F, 2009, BRAIN, V132, P2449, DOI 10.1093/brain/awp178; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mallouk Y, 1999, INT J MOL MED, V4, P463; Mangan PS, 2005, MOL PHARMACOL, V67, P775, DOI 10.1124/mol.104.007385; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Meng FJ, 2003, BRAIN RES, V967, P161, DOI 10.1016/S0006-8993(02)04267-1; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Miranda JD, 1997, J BIOL CHEM, V272, P16288, DOI 10.1074/jbc.272.26.16288; Moddel G, 2005, BRAIN RES, V1046, P10, DOI 10.1016/j.brainres.2005.03.042; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Pal S, 2000, CELL CALCIUM, V28, P181, DOI 10.1054/ceca.2000.0146; Park CS, 2008, NEUROSCIENCE, V151, P43, DOI 10.1016/j.neuroscience.2007.09.075; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Ratzliff ADH, 2004, J NEUROSCI, V24, P2259, DOI 10.1523/JNEUROSCI.5191-03.2004; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Raza M, 2004, P NATL ACAD SCI USA, V101, P17522, DOI 10.1073/pnas.0408155101; Rebola N, 2010, J PHYSIOL-LONDON, V588, P93, DOI 10.1113/jphysiol.2009.179382; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; ROGERS SW, 1991, J NEUROSCI, V11, P2713; RUANO D, 1991, J PHARMACOL EXP THER, V256, P902; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Schwarzer C, 1997, NEUROSCIENCE, V80, P1001, DOI 10.1016/S0306-4522(97)00145-0; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; SHARP FR, 1993, STROKE, V24, pI72; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Solomonia R, 2010, NEUROSCI LETT, V468, P277, DOI 10.1016/j.neulet.2009.11.012; Solomonia RO, 2005, J PHYSIOL-LONDON, V569, P643, DOI 10.1113/jphysiol.2005.098012; Spigelman I, 2003, J NEUROPHYSIOL, V90, P903, DOI 10.1152/jn.01022.2002; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056; Toth Z, 1997, J NEUROSCI, V17, P8106; Tretter V, 1997, J NEUROSCI, V17, P2728; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Truettner JS, 2009, BRAIN RES, V1249, P9, DOI 10.1016/j.brainres.2008.10.032; VASS K, 1988, ACTA NEUROPATHOL, V77, P128; Waheed AA, 2002, J BIOL CHEM, V277, P32409, DOI 10.1074/jbc.C200383200; Wei WZ, 2003, J NEUROSCI, V23, P10650; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yang TT, 2008, ACTA NEUROPATHOL, V115, P219, DOI 10.1007/s00401-007-0297-3; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zara V, 2009, BIOCHEM J, V419, P369, DOI 10.1042/BJ20082270; Zhan XH, 2008, BRAIN RES, V1234, P183, DOI 10.1016/j.brainres.2008.07.094; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	168	54	58	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	JUN	2011	95	1-2					20	34		10.1016/j.eplepsyres.2011.02.008			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	788GV	WOS:000292434300003	21439793				2022-02-06	
J	Thal, SC; Heinemann, M; Luh, C; Pieter, D; Werner, C; Engelhard, K				Thal, Serge C.; Heinemann, Marius; Luh, Clara; Pieter, Dana; Werner, Christian; Engelhard, Kristin			Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-gamma-Independent Mechanisms	JOURNAL OF NEUROTRAUMA			English	Article						inflammation; pioglitazone; peroxisome proliferator-activated receptor-gamma; rosiglitazone; traumatic brain injury	ACTIVATED-RECEPTOR-GAMMA; TRANSIENT FOCAL ISCHEMIA; CONTROLLED CORTICAL IMPACT; GENE-EXPRESSION; INFLAMMATORY CYTOKINES; AGONIST ROSIGLITAZONE; NITRIC-OXIDE; IN-VITRO; INJURY; NEUROPROTECTION	Inflammatory and ischemic processes contribute to the development of secondary brain damage after mechanical brain injury. Recent data suggest that thiazolidinediones (TZDs), a class of drugs approved for the treatment of non-insulin-dependent diabetes mellitus, effectively reduces inflammation and brain lesion by stimulation of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma). The present study investigates the influence of the TZD pioglitazone and rosiglitazone on inflammation and secondary brain damage after experimental traumatic brain injury (TBI). A controlled cortical impact (CCI) injury was induced in male C57BL/6 mice to investigate following endpoints: (1) mRNA expression of PPAR-gamma and PPAR-gamma target genes (LPL, GLT1, and IRAP/Lnpep), and inflammatory markers (TNF-alpha, IL-1 beta, IL-6, and iNOS), at 15 min, 3 h, 6 h, 12 h, and 24 h post-trauma; (2) contusion volume, neurological function, and gene expression after 24 h in mice treated with pioglitazone (0.5 and 1 mg/kg) or rosiglitazone (5 and 10 mg/kg IP at 30 min post-trauma); and (3) the role of PPAR-gamma to mediate protection was determined in animals treated with pioglitazone, the PPAR-gamma inhibitor T0070907, and a combination of both. Inflammatory marker genes, but not PPAR-gamma gene expression, was up-regulated after trauma. Pioglitazone reduced the histological damage and inflammation in a dose-dependent fashion. In contrast, rosiglitazone failed to suppress inflammation and histological damage. PPAR-gamma and PPAR-gamma target gene expression was not induced by pioglitazone and rosiglitazone. In line with these results, pioglitazone-mediated protection was not reversed by T0070907. The results indicate that the neuroprotective effects of pioglitazone are not solely related to PPAR-gamma-dependent mechanisms.	[Thal, Serge C.; Heinemann, Marius; Luh, Clara; Pieter, Dana; Werner, Christian; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	Takeda Pharma, Germany	Takeda Pharma, Germany, supported this project with an unrestricted grant. The authors want to thank Dr. Joachim Fuchs, M. D., Ph.D. (Takeda Pharma) and Dr. Kristian Lobner, Ph.D. (GlaxoSmithKline) for providing pioglitazone and rosiglitazone.	Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046/j.1460-9568.2000.00110.x; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8; Ferger B, 2004, J NEUROCHEM, V89, P822, DOI 10.1111/j.1471-4159.2004.02399.x; Gemma C, 2004, NEUROREPORT, V15, P2255, DOI 10.1097/00001756-200410050-00023; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Heneka MT, 2000, J NEUROSCI, V20, P6862, DOI 10.1523/JNEUROSCI.20-18-06862.2000; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Katayama Y, 1998, ACT NEUR S, V71, P289; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; McTigue DM, 2007, EXP NEUROL, V205, P396, DOI 10.1016/j.expneurol.2007.02.009; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Orasanu G, 2008, J AM COLL CARDIOL, V52, P869, DOI 10.1016/j.jacc.2008.04.055; Overbergh L, 2003, J Biomol Tech, V14, P33; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Shimazu T, 2005, STROKE, V36, P353, DOI 10.1161/01.STR.0000152271.21943.a2; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Takeuchi Y, 2007, CARCINOGENESIS, V28, P1692, DOI 10.1093/carcin/bgm095; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x; Uryu S, 2002, BRAIN RES, V924, P229, DOI 10.1016/S0006-8993(01)03242-5; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhao Y, 2005, EUR J NEUROSCI, V22, P278, DOI 10.1111/j.1460-9568.2005.04200.x; ZIMMERMAN RA, 1978, NEURORADIOLOGY, V16, P320, DOI 10.1007/BF00395288; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	51	54	58	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2011	28	6					983	993		10.1089/neu.2010.1685			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	788PT	WOS:000292457600012	21501066				2022-02-06	
J	Wilson, KR; Donders, J; Nguyen, L				Wilson, Kathryn R.; Donders, Jacobus; Nguyen, Loan			Self and Parent Ratings of Executive Functioning After Adolescent Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; executive functioning; deficit awareness	QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL ASSESSMENT; CHILDREN; AWARENESS; INVENTORY; VALIDITY; DEFICITS; MODERATE; IMPACT	Objective: To examine the level of agreement between adolescents with traumatic brain injury (TB!) and their parents in standardized ratings of executive functioning, and to determine correlates of discrepancies between those ratings. Participants: Ninety-eight 11- to 16-year-old adolescents with TBI and their parents, and 97 neuropsychologically healthy controls. Method: Five-year consecutive series of rehabilitation referrals for TBI. Measures: Behavior Rating Inventory of Executive Function Self Report (BRIEF-SR) and Behavior Rating Inventory of Executive Function (BRIEF) parent report versions. Results: Self and parent ratings were moderately positively correlated in both the TBI group and the control group, but parents generally identified more executive dysfunction than did the adolescents. Parent-adolescent discrepancies were statistically significantly greater in the TBI group than in the control group on the Metacognitive index but not the Behavioral Regulation index. The degree of the former discrepancy was predicted by duration of coma in the TBI group. Conclusions: Adolescents with more severe TBI may underestimate their own degree of executive dysfunction in daily life, particularly aspects of metacognitive abilities, possibly, in part, because of an organic-based lack of deficit awareness.	[Wilson, Kathryn R.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; [Nguyen, Loan] Hope Coll, Dept Psychol, Holland, MI USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Gioia, 2004, BRIEF SR BEHAV RATIN; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Heaton R.K., 1981, WISCONSIN CARD SORTI; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; HUGHES DM, 2008, INT J LANG COMM DIS, V1, P1; Kizilbash A, 1999, CHILD NEUROPSYCHOL, V5, P224, DOI 10.1076/0929-7049(199912)05:04;1-R;FT224; LeJeune B, 2010, CHILD NEUROPSYCHOL, V16, P182, DOI 10.1080/09297040903352556; MacAllister WS, 2009, MULT SCLER J, V15, P1502, DOI 10.1177/1352458509345902; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; MCAULEY T, 2010, J INT NEUROPSYCH SOC, V16, P1; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; SESMA HW, 2010, PEDIATRICS, V121, P1686; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077	30	54	54	0	13	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2011	56	2					100	106		10.1037/a0023446			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	769KL	WOS:000291011800003	21574728				2022-02-06	
J	Whiteneck, G; Gassaway, J; Dijkers, M; Backus, D; Charlifue, S; Chen, D; Hammond, F; Hsieh, CH; Smout, RJ				Whiteneck, Gale; Gassaway, Julie; Dijkers, Marcel; Backus, Deborah; Charlifue, Susan; Chen, David; Hammond, Flora; Hsieh, Ching-Hui; Smout, Randall J.			Inpatient treatment time across disciplines in spinal cord injury rehabilitation	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; Rehabilitation; Health services research; Occupational therapy; Physical therapy; Rehabilitation nursing; Psychology; Speech-language pathology; Social work; Case management; Recreation therapy; Practice-based evidence; Paraplegia; Tetraplegia	LENGTH-OF-STAY; SCIREHAB PROJECT SERIES; MEDICAL REHABILITATION; STROKE REHABILITATION; FUNCTIONAL STATUS; TRAUMATIC BRAIN; OUTCOMES; IMPROVEMENT; SEVERITY; INTENSITY	Background/objective: Length of stay (LOS) for rehabilitation treatment after spinal cord injury (SCI) has been documented extensively. However, there is almost no published research on the nature, extent, or intensity of the various treatments patients receive during their stay. This study aims at providing such information on a large sample of patients treated by specialty rehabilitation inpatient programs. Methods: Six hundred patients with traumatic SCI admitted to six rehabilitation centers were enrolled. Time spent on various therapeutic activities was documented by each rehabilitation clinician after each patient encounter. Patients were grouped by neurologic level and completeness of injury. Total time spent by each rehabilitation discipline over a patient's stay and total minutes of treatment per week were calculated. Ordinary least squares stepwise regression models were used to identify patient and injury characteristics associated with time spent in rehabilitation treatment overall and within each discipline. Results: Average LOS was 55 days (standard deviation 37), during which 180 (106) hours of treatment were received, or 24 (5) hours per week. Extensive variation was found in the amount of treatment received, between and within neurologic groups. Total hours of treatment provided throughout a patient's stay were primarily determined by LOS, which in turn was primarily predicted by medical acuity. Variation in minutes per week of treatment delivered by individual disciplines was predicted poorly by patient and injury characteristics. Conclusions: Variations between and within SCI rehabilitation patient groups in LOS, minutes of treatment per week overall, and for each rehabilitation discipline are large. Variation in treatment intensity was not well explained by patient and injury characteristics. In accordance with practice-based evidence methodology, the next step in the SCIRehab study will be to determine which treatment interventions are related with positive outcomes (at 1 year post injury), after controlling for patient and injury differences.	[Gassaway, Julie; Smout, Randall J.] Inst Clin Outcomes Res, Salt Lake City, UT 84102 USA; [Whiteneck, Gale; Charlifue, Susan] Craig Hosp, Englewood, CO USA; [Dijkers, Marcel] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Backus, Deborah] Shepherd Ctr, Atlanta, GA USA; [Backus, Deborah] Emory Univ, Sch Med, Atlanta, GA USA; [Chen, David] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Hammond, Flora] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora] Indiana Univ, Indianapolis, IN 46204 USA; [Hsieh, Ching-Hui] Natl Rehabil Hosp, Ctr Postacute Studies, Washington, DC USA		Gassaway, J (corresponding author), Inst Clin Outcomes Res, 699 E South Temple, Salt Lake City, UT 84102 USA.	jgassaway@isiscor.com	Heinemann, Allen W/K-6283-2012	Heinemann, Allen W/0000-0003-2782-7326; Dijkers, Marcel/0000-0002-8362-5596	National Institute on Disability and Rehabilitation Research, Office of Rehabilitative Services, US Department of EducationUS Department of Education [H133A060103, H133N060005]; Carolinas Rehabilitation, Mount Sinai School of Medicine [H133N060027]; National Rehabilitation Hospital [H133N060028]; Rehabilitation Institute of Chicago [H133N060014]; Shepherd Center [H133N060009]	The contents of this paper were developed under grants from the National Institute on Disability and Rehabilitation Research, Office of Rehabilitative Services, US Department of Education, to Craig Hospital (grant # H133A060103 and # H133N060005), Carolinas Rehabilitation, Mount Sinai School of Medicine (grant # H133N060027), National Rehabilitation Hospital (grant # H133N060028), Rehabilitation Institute of Chicago (grant # H133N060014), and Shepherd Center (grant # H133N060009). The opinions contained in this publication are those of the grantees and do not necessarily reflect those of the US Department of Education.	Abeyta N, 2009, J SPINAL CORD MED, V32, P336, DOI 10.1080/10790268.2009.11760787; AVERILL RF, 1992, HEALTH SERV RES, V27, P587; Berns S, 1957, REHABILITATION MONOG; Brougham R, 2011, J SPINAL CORD MED, V34, P186, DOI 10.1179/107902611X12971826988174; Cahow C, 2009, J SPINAL CORD MED, V32, P298, DOI 10.1080/10790268.2009.11760783; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; DEJONG G, 2007, ANN C AM C REH MED W; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1284, DOI 10.1016/j.apmr.2009.02.009; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Fiedler R., 1996, FUNCTIONAL ELEVATION, P75; Fiedler RC, 2000, AM J PHYS MED REHAB, V79, P184, DOI 10.1097/00002060-200003000-00012; Foy T, 2011, J SPINAL CORD MED, V34, P162, DOI 10.1179/107902611X12971826988093; Fromovich-Amit Y, 2009, SPINAL CORD, V47, P597, DOI 10.1038/sc.2008.178; Garcia RA, 2002, AM J PHYS MED REHAB, V81, P458, DOI 10.1097/00002060-200206000-00011; Gassaway J, 2005, ARCH PHYS MED REHAB, V86, pS16, DOI 10.1016/j.apmr.2005.08.114; Gassaway J, 2011, J SPINAL CORD MED, V34, P176, DOI 10.1179/107902611X12971826988138; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; HAMMOND F, 2010, J SPINAL CORD MED, V33; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2002, J PEDIATR-US, V141, P496, DOI 10.1067/mpd.2002.126925; HORN SD, 1991, MED CARE, V29, P305, DOI 10.1097/00005650-199104000-00001; HORN SD, 1997, CLIN PRACTICE IMPROV; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Huston T, 2011, J SPINAL CORD MED, V34, P196, DOI 10.1179/107902611X12971826988219; Jakob W, 2009, J NEUROTRAUM, V26, P2037, DOI 10.1089/neu.2008.0824; Johnson K, 2009, J SPINAL CORD MED, V32, P329, DOI 10.1080/10790268.2009.11760786; Johnston MV, 2004, J SPINAL CORD MED, V27, P241, DOI 10.1080/10790268.2004.11753755; Marino R., 2003, REFERENCE MANUAL INT; McKinley W, 2007, J SPINAL CORD MED, V30, P215, DOI 10.1080/10790268.2007.11753929; MEINERS T, 2004, E REHABILITATION STU, V43, P129; Natale A, 2009, J SPINAL CORD MED, V32, P270, DOI 10.1080/10790268.2009.11760781; National Spinal Cord Injury Statistical Center, 2009, ANN REP SPIN CORD IN; Osterthun R, 2009, SPINAL CORD, V47, P339, DOI 10.1038/sc.2008.127; Ozelie R, 2009, J SPINAL CORD MED, V32, P283, DOI 10.1080/10790268.2009.11760782; Pagliacci MC, 2003, ARCH PHYS MED REHAB, V84, P1266, DOI 10.1016/S0003-9993(03)00234-X; Pagliacci MC, 2003, SPINAL CORD, V41, P620, DOI 10.1038/sj.sc.3101521; Post MWM, 2005, J REHABIL RES DEV, V42, P75, DOI 10.1682/JRRD.2004.10.0133; Rundquist J, 2011, J SPINAL CORD MED, V34, P205, DOI 10.1179/107902611X12971826988255; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Seel R T, 2001, J Spinal Cord Med, V24, P241; Stevens J, 1999, INTERMEDIATE STAT MO; Stevens J., 2003, PARTIAL SEMIPARTIAL; Taylor S, 2011, J SPINAL CORD MED, V34, P151, DOI 10.1179/10 7902611X12971826988057; Tooth L, 2003, SPINAL CORD, V41, P220, DOI 10.1038/sj.sc.3101433; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Willson D F, 2000, Pediatr Crit Care Med, V1, P127, DOI 10.1097/00130478-200010000-00007; Wilson C, 2009, J SPINAL CORD MED, V32, P319, DOI 10.1080/10790268.2009.11760785; Yokoyama O, 2006, ARCH PHYS MED REHAB, V87, P1189, DOI 10.1016/j.apmr.2006.05.017	53	54	55	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	MAR	2011	34	2					133	148		10.1179/107902611X12971826988011			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744FR	WOS:000289080800003	21675353	Green Published			2022-02-06	
J	Courtney, MW; Courtney, AC				Courtney, Michael W.; Courtney, Amy C.			Working toward exposure thresholds for blast-induced traumatic brain injury: Thoracic and acceleration mechanisms	NEUROIMAGE			English	Article						Blast injury; Traumatic brain injury; TBI; Behind armor blunt trauma; Blast wave; Ballistic pressure wave	PRESSURE WAVE INJURIES; CENTRAL-NERVOUS-SYSTEM; MISSILE EXTREMITY IMPACT; ARMOR BLUNT TRAUMA; INDUCED NEUROTRAUMA; HUMAN TORSO; VELOCITY; SHOCK; INVOLVEMENT; LIGHT	Research in blast-induced lung injury resulted in exposure thresholds that are useful in understanding and protecting humans from such injury. Because traumatic brain injury (TBI) due to blast exposure has become a prominent medical and military problem, similar thresholds should be identified that can put available research results in context and guide future research toward protecting war fighters as well as diagnosis and treatment. At least three mechanical mechanisms by which the blast wave may result in brain injury have been proposed-a thoracic mechanism, head acceleration, and direct cranial transmission. These mechanisms need not be mutually exclusive. In this study, likely regions of interest for the first two mechanisms based on blast characteristics (positive pulse duration and peak effective overpressure) are developed using available data from blast experiments and related studies, including behind-armor blunt trauma and ballistic pressure wave studies. These related studies are appropriate to include because blast-like pressure waves are produced that result in neurological effects like those caused by blast. Results suggest that injury thresholds for each mechanism are dependent on blast conditions, and that under some conditions, more than one mechanismmay contribute. There is a subset of blast conditions likely to result in TBI due to head acceleration and/or a thoracic mechanism without concomitant lung injury. These results can be used to guide experimental designs and compare additional data as they become available. Additional data are needed before actual probabilities or severity of TBI for a given exposure can be described. (C) 2010 Elsevier Inc. All rights reserved.	[Courtney, Michael W.] USAF Acad, Colorado Springs, CO 80840 USA; [Courtney, Amy C.] Force Protect Ind Inc, Ladson, SC 29456 USA		Courtney, MW (corresponding author), BTG Res, POB 62541, Colorado Springs, CO 80962 USA.	Michael.Courtney@usafa.edua; amy_courtney@post.harvard.edu		Courtney, Amy/0000-0002-1925-8736			Alley M., 2009, THESIS PURDUE U W LA; Axelsson H, 1996, J TRAUMA, V40, pS31, DOI 10.1097/00005373-199603001-00006; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; Bowen LG, 1968, 2113 DEF AT SUPP AG; Cannon L, 2001, J R Army Med Corps, V147, P87; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1999, WORLD J SURG, V23, P44, DOI 10.1007/s002689900563; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; CERNAK I, 2005, RESTORATIVE NEUROLOG, V23, P139; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cooper GJ, 1996, J TRAUMA, V40, pS105, DOI 10.1097/00005373-199603001-00024; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney A, 2007, BRAIN INJURY, V21, P657, DOI 10.1080/02699050701481571; Cripps NPJ, 1996, J TRAUMA, V40, pS206, DOI 10.1097/00005373-199603001-00045; Drobin D, 2007, J TRAUMA, V63, P405, DOI 10.1097/01.ta.0000236015.68105.48; Dubos Rene, 1950, **DROPPED REF**; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; GORANSSON AM, 1988, J TRAUMA, V28, pS204; GRYTH D, 2007, THESIS KAROLINSKA I; Gryth D, 2008, J TRAUMA, V64, P1420, DOI 10.1097/TA.0b013e318054e247; Gryth D, 2007, MIL MED, V172, P1110, DOI 10.7205/MILMED.172.10.1110; HARVEY EN, 1947, J EXP MED, V85, P321, DOI 10.1084/jem.85.3.321; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; JOHNSON DL, 1994, 942 US ARM AER RES L; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; KRAJSA J, 2009, THESIS MASARYK U BRN; Krave U, 2005, EUR J NEUROSCI, V21, P2876, DOI 10.1111/j.1460-9568.2005.04115.x; Lee M, 1997, J FLUID STRUCT, V11, P819, DOI 10.1006/jfls.1997.0103; Liu G, 2008, COMBUST EXPLO SHOCK+, V44, P213, DOI 10.1007/s10573-008-0028-7; Merkle AC, 2008, J TRAUMA, V64, P1555, DOI 10.1097/TA.0b013e318160ff3a; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Moss W.C., 2009, J ACOUST SOC AM, V125, P2650; NYEIN M, 2008, P 26 ARM SCI C DEC 1; ONO K, 1980, SAE PUBLICATION; PARVIN SJ, 2007, LETHAL PHYS INJURY M; PRICE GR, 2005, CURRENT STATUS RATIN; Roberts JC, 2007, J BIOMECH, V40, P125, DOI 10.1016/j.jbiomech.2005.11.003; Saljo A, 2003, J NEUROTRAUM, V20, P787, DOI 10.1089/089771503767870014; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott SG, 2005, FEDERAL PRACTITIONER, V22, P67; Singerm E, 2008, TECHNOL REV, V111, P52; STUHMILLER JH, 1994, HLTH HAZARDS ASSESSM; STUHMILLER JH, 1998, RTO HFM SPEC M MOD A; SUNESON A, 1988, J TRAUMA, V28, pS197, DOI 10.1097/00005373-198801001-00041; SUNESON A, 1987, J TRAUMA, V27, P782, DOI 10.1097/00005373-198707000-00016; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; SUNESON A, 1990, J TRAUMA, V30, P281, DOI 10.1097/00005373-199003000-00006; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Wang Q, 2004, J TRAUMA, V56, P604, DOI 10.1097/01.TA.0000058122.57737.0E; WRIGHT HC, 1950, 50639 ROYAL NAV; Yang ZH, 1996, J TRAUMA, V40, pS81, DOI 10.1097/00005373-199603001-00019; YELVERTON JT, 1973, DNA3114T; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	65	54	56	0	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN	2011	54			1			S55	S61		10.1016/j.neuroimage.2010.05.025			7	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	813ZF	WOS:000294408600008	20483376	Green Submitted			2022-02-06	
J	Hajek, CA; Yeates, KO; Taylor, HG; Bangert, B; Dietrich, A; Nuss, KE; Rusin, J; Wright, M				Hajek, Christine A.; Yeates, Keith Owen; Taylor, H. Gerry; Bangert, Barbara; Dietrich, Ann; Nuss, Kathryn E.; Rusin, Jerome; Wright, Martha			Agreement between Parents and Children on Ratings of Post-Concussive Symptoms Following Mild Traumatic Brain Injury	CHILD NEUROPSYCHOLOGY			English	Article						Head injury; Post-concussion syndrome; Interrater agreement; Correlational agreement; Outcome	POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; SCALE; INTERVIEW; BEHAVIOR; CRITERIA	The level of parent-child agreement on post-concussive symptoms (PCS) was examined in children following mild traumatic brain injuries (TBI). As part of a larger longitudinal study, 186 children with mild TBI and 99 with orthopedic injuries (OI), from 8 to 15 years of age, were recruited prospectively. Parents and children completed the PCS Interview (PCS-I) and the Health and Behavior Inventory (HBI) at 2 weeks, 1 month, 3 months, and 12 months postinjury. Item-level correlations between child and parent ratings on both measures of PCS were significant but modest in both groups. Parent-child correlations for composite scales on the HBI and the total score on the PCS-I were significant in both groups, but somewhat higher in the OI group than in the mild TBI group. Mean symptom ratings tended to be significantly higher for children as compared to parents, especially for somatic symptoms. Parents and children display modest agreement when reporting PCS; their ratings correlate significantly, but children report higher mean levels of symptoms than parents.	[Yeates, Keith Owen] Nationwide Childrens Hosp, Dept Psychol, Res Inst, Columbus, OH 43205 USA; [Hajek, Christine A.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Hajek, Christine A.; Yeates, Keith Owen; Dietrich, Ann; Nuss, Kathryn E.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Taylor, H. Gerry; Wright, Martha] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Radiol, Cleveland, OH USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Neurosurg, Cleveland, OH USA; [Dietrich, Ann; Nuss, Kathryn E.] Nationwide Childrens Hosp, Dept Emergency Med, Columbus, OH 43205 USA; [Rusin, Jerome] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH 43205 USA		Yeates, KO (corresponding author), Nationwide Childrens Hosp, Dept Psychol, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	keith.yeates@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Koterba, Christine/AAS-9518-2021	Yeates, Keith/0000-0001-7680-2892; Nuss, Kathryn/0000-0003-2185-7364	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD39834, K02 HD44099]; National Center for Medical Rehabilitation Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02HD044099, R01HD039834] Funding Source: NIH RePORTER	The larger study on which the research was based was supported by grants R01 HD39834 and K02 HD44099 from the National Institute of Child Health and Human Development and the National Center for Medical Rehabilitation Research to Keith Owen Yeates. The authors wish to acknowledge the contributions of Lauren Ayr, Anne Birnbaum, Amy Clemens, Taryn Fay, Kalaichelvi Ganesalingham, Amanda Lininger, Melissa Ginn, Katie Pestro, Elizabeth Roth, Elizabeth Shaver, and Heidi Walker in conducting the study. Portions of the research were presented at the annual meeting of the International Neuropsychological Society in Atlanta, GA, February 2009.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; *AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Chambers CT, 1998, CLIN J PAIN, V14, P336, DOI 10.1097/00002508-199812000-00011; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Choudhury MS, 2003, J AM ACAD CHILD PSY, V42, P957, DOI 10.1097/01.CHI.0000046898.27264.A2; Comer JS, 2004, J AM ACAD CHILD PSY, V43, P878, DOI 10.1097/01.chi.0000125092.35109.c5; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; EDELBROCK C, 1986, J CHILD PSYCHOL PSYC, V27, P181, DOI 10.1111/j.1469-7610.1986.tb02329.x; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; HODGES K, 1990, J CHILD PSYCHOL PSYC, V31, P427, DOI 10.1111/j.1469-7610.1990.tb01579.x; Karver MS, 2006, J ABNORM CHILD PSYCH, V34, P251, DOI 10.1007/s10802-005-9015-6; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Martin JL, 2004, J DEV BEHAV PEDIATR, V25, P150, DOI 10.1097/00004703-200406000-00002; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Munoz SR, 1997, J APPL STAT, V24, P105, DOI 10.1080/02664769723918; Raghunathan TE, 1996, PSYCHOL METHODS, V1, P178, DOI 10.1037/1082-989X.1.2.178; REY JM, 1992, J ADOLESCENCE, V15, P219, DOI 10.1016/0140-1971(92)90026-2; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	37	54	54	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2011	17	1					17	33	PII 925012785	10.1080/09297049.2010.495058			17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	716BK	WOS:000286939700002	20680882	Green Accepted			2022-02-06	
J	Reeves, TM; Greer, JE; Vanderveer, AS; Phillips, LL				Reeves, Thomas M.; Greer, John E.; Vanderveer, Andrew S.; Phillips, Linda L.			Proteolysis of Submembrane Cytoskeletal Proteins Ankyrin-G and alpha II-Spectrin Following Diffuse Brain Injury: A Role in White Matter Vulnerability at Nodes of Ranvier	BRAIN PATHOLOGY			English	Article						corpus callosum; membrane cytoskeleton; proteolysis; rat; traumatic axonal injury; traumatic brain injury	TRAUMATIC AXONAL INJURY; CONTROLLED CORTICAL IMPACT; INTRAAXONAL NEUROFILAMENT COMPACTION; HUMAN ERYTHROCYTE ANKYRIN; GATED SODIUM-CHANNELS; RAT-BRAIN; UNMYELINATED AXONS; FLUID PERCUSSION; AXOLEMMAL PERMEABILITY; NEURONAL DEGENERATION	A high membrane-to-cytoplasm ratio makes axons particularly vulnerable to traumatic injury. Posttraumatic shifts in ionic homeostasis promote spectrin cleavage, disrupt ankyrin linkages and destabilize axolemmal proteins. This study contrasted ankyrin-G and alpha II-spectrin degradation in cortex and corpus callosum following diffuse axonal injury produced by fluid percussion insult. Ankyrin-G lysis occurred preferentially in white matter, with acute elevation of all fragments and long-term reduction of a low kD form. Calpain-generated alpha II-spectrin fragments increased in both regions. Caspase-3 lysis of alpha II-spectrin showed a small, acute rise in cortex but was absent in callosum. White matter displayed nodal damage, with horseradish peroxidase permeability into the submyelin space. Ankyrin-G-binding protein neurofascin and spectrin-binding protein ankyrin-B showed acute alterations in expression. These results support ankyrin-G vulnerability in white matter following trauma and suggest that ankyrin-G and alpha II-spectrin proteolysis disrupts Node of Ranvier integrity. The time course of such changes were comparable to previously observed functional deficits in callosal fibers.	[Reeves, Thomas M.; Greer, John E.; Vanderveer, Andrew S.; Phillips, Linda L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Med Ctr, Richmond, VA 23298 USA		Reeves, TM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Med Ctr, POB 980709, Richmond, VA 23298 USA.	tmreeves@vcu.edu	Greer, John/K-1008-2012		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS057758, NS056247]; Virginia Commonwealth Neurotrauma Initiative [07-302F]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057758, P30NS047463, R01NS056247] Funding Source: NIH RePORTER	The authors wish to thank Lesley Harris, Raiford Black, Nancy Lee and Judy Williamson for their excellent technical assistance in this study. We also acknowledge Dr. Jiepei Zhu for his important contribution to the HRP permeability experiments. These studies were supported by funding from NIH grants NS057758 and NS056247 and from Virginia Commonwealth Neurotrauma Initiative 07-302F. Microscopy was performed at VCU, Department of Anatomy and Neurobiology Microscopy Facility which is supported, in part, with funding from NIH-NINDS Center Core Grant NS047463.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CHAN W, 1993, J CELL BIOL, V123, P1463, DOI 10.1083/jcb.123.6.1463; Cohen J., 2013, STAT POWER ANAL BEHA; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DAVIS JQ, 1990, J BIOL CHEM, V265, P17252; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dubreuil RR, 1996, J CELL BIOL, V133, P647, DOI 10.1083/jcb.133.3.647; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; GRAHAM DI, 1988, PROG CLIN BIOL RES, V234, P159; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HALL TG, 1987, J BIOL CHEM, V262, P10537; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Harada K, 1997, J NEUROCHEM, V69, P371; HARRIS AS, 1988, J NEUROSCI, V8, P2640; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hryniewicz-Jankowska A, 2002, FOLIA HISTOCHEM CYTO, V40, P239; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; Inserte J, 2005, CIRC RES, V97, P465, DOI 10.1161/01.RES.0000181170.87738.f3; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Keppel G., 1991, DESIGN ANAL RES HDB; KORDELI E, 1991, J CELL BIOL, V114, P1243, DOI 10.1083/jcb.114.6.1243; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kunimoto M, 1995, NEUROREPORT, V6, P2545, DOI 10.1097/00001756-199512150-00023; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; LI ZP, 1993, J BIOL CHEM, V268, P11489; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Maier O, 2006, EXP CELL RES, V312, P500, DOI 10.1016/j.yexcr.2005.11.014; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; PERLMUTTER LS, 1990, J COMP NEUROL, V296, P269, DOI 10.1002/cne.902960207; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rubtsov AM, 2000, FEBS LETT, V482, P1, DOI 10.1016/S0014-5793(00)01924-4; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Sakaue M, 2003, J NEUROSCI RES, V73, P831, DOI 10.1002/jnr.10715; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Susuki K, 2008, EXP BIOL MED, V233, P394, DOI 10.3181/0709-MR-243; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wood SJ, 1998, J CELL BIOL, V140, P675, DOI 10.1083/jcb.140.3.675; YOSHIDA K, 1995, CIRC RES, V77, P603, DOI 10.1161/01.RES.77.3.603; Yoshida K, 2000, METH MOL B, V144, P267; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	89	54	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	NOV	2010	20	6					1055	1068		10.1111/j.1750-3639.2010.00412.x			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	660KS	WOS:000282642100006	20557305	Green Published, Green Accepted			2022-02-06	
J	Omoto, S; Ueno, M; Mochio, S; Takai, T; Yamashita, T				Omoto, Shusaku; Ueno, Masaki; Mochio, Soichiro; Takai, Toshiyuki; Yamashita, Toshihide			Genetic Deletion of Paired Immunoglobulin-Like Receptor B Does Not Promote Axonal Plasticity or Functional Recovery after Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD-INJURY; NOGO-66 RECEPTOR; CORTICOSPINAL TRACT; NEURITE OUTGROWTH; SENSORIMOTOR DYSFUNCTION; STROKE RECOVERY; STAIRCASE TEST; REGENERATION; INHIBITION	The rewiring of neural networks is a fundamental step in recovering behavioral functions after brain injury. However, there is limited potential for axonal plasticity in the adult CNS. The myelin-associated proteins Nogo, myelin-associated glycoprotein (MAG), and oligodendrocyte myelin glycoprotein (OMgp) are known to inhibit axonal plasticity, and thus targeting the inhibitory pathways they participate in is a potential means of promoting plasticity and functional recovery. Each of Nogo, MAG, and OMgp interacts with both the Nogo receptor (NgR) and paired immunoglobulin-like receptor B (PirB). Here, we determined whether blocking PirB activity enhances axonal reorganization and functional recovery after cortical injury. We found that axons of the contralesional corticospinal tract sprouted into the denervated side of the cervical spinal cord after unilateral injury of the motor cortex. The extent to which this axonal reorganization occurred was far greater in mice lesioned during early postnatal days than in mice lesioned at an age when myelin had begun to form. This suggests that myelin-associated proteins might limit axonal remodeling in vivo. However, the number of sprouting fibers within either the corticospinal or corticorubral tract was not enhanced in PirB(-/-) mice. Blocking PirB signaling also failed to enhance functional recovery with three motor tests. Our results suggest that blocking the function of PirB is not sufficient to promote axonal reorganization or functional recovery after cortical injury.	[Omoto, Shusaku; Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan; [Omoto, Shusaku; Mochio, Soichiro] Jikei Univ, Sch Med, Dept Neurol, Minato Ku, Tokyo 1058461, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Sendai, Miyagi 9808575, Japan; [Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan		Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid for Young Scientists (S) from Japan Society for the Promotion of Science. We thank Yuka Nakamura, Yuki Fujita, and Sachiko Lee for the helpful advice and technical support they provided during the course of this study.	AKINTUNDE A, 1992, BRAIN RES, V586, P208, DOI 10.1016/0006-8993(92)91629-S; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baird AL, 2001, BRAIN RES BULL, V54, P243, DOI 10.1016/S0361-9230(00)00457-3; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fujita N, 1998, J NEUROSCI, V18, P1970; Giger RJ, 2008, RESTOR NEUROL NEUROS, V26, P97; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; JORDAN C, 1989, J NEUROSCI, V9, P248; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; KUANG RZ, 1990, J COMP NEUROL, V302, P461, DOI 10.1002/cne.903020304; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li SX, 2003, J NEUROSCI, V23, P4219; Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Low K, 2008, J NEUROSCI, V28, P1099, DOI 10.1523/JNEUROSCI.4906-07.2008; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; ONO K, 1990, BRAIN DEV-JPN, V12, P226, DOI 10.1016/S0387-7604(12)80330-5; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Pronichev I V, 1998, Neurosci Behav Physiol, V28, P80, DOI 10.1007/BF02461916; REINOSO BS, 1989, EXP BRAIN RES, V74, P387; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takahashi M, 2009, EUR J NEUROSCI, V30, P1878, DOI 10.1111/j.1460-9568.2009.06989.x; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Vanek P, 1998, EUR J NEUROSCI, V10, P45, DOI 10.1046/j.1460-9568.1998.00018.x; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wu CY, 2006, J HISTOCHEM CYTOCHEM, V54, P997, DOI 10.1369/jhc.5A6901.2006; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	57	54	61	0	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 29	2010	30	39					13045	13052		10.1523/JNEUROSCI.3228-10.2010			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	659MY	WOS:000282571800015	20881122	Bronze, Green Published			2022-02-06	
J	Gracies, JM; Bayle, N; Vinti, M; Alkandari, S; Vu, P; Loche, CM; Colas, C				Gracies, J. -M.; Bayle, N.; Vinti, M.; Alkandari, S.; Vu, P.; Loche, C. M.; Colas, C.			Five-step clinical assessment in spastic paresis	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Muscle contraction; Spastic paresis; Motor skills disorders	TRAUMATIC BRAIN-INJURY; INDUCED MOVEMENT THERAPY; SPINAL-CORD-INJURY; WALKING SPEED; UPPER-LIMB; INTERRATER RELIABILITY; HEMIPLEGIC PATIENTS; MULTIPLE-SCLEROSIS; BOTULINUM TOXIN; ASHWORTH SCALE	Among the three main factors of motor impairment that emerge in chronological order following a lesion to central motor pathways, the last two antagonize movement: 1) stretch-sensitive paresis, a reduction of agonist motor unit recruitment upon voluntary command, worsened by antagonist stretch; 2) soft tissue contracture, and 3) muscle overactivity. Types of muscle overactivity include 1) spasticity, an increase in the velocity-dependent response to muscle stretch, measured at rest; 2) spastic dystonia, i.e., chronic tonic muscle activity at rest, sensitive to stretch of the dystonic muscle and 3) spastic co-contraction, an inappropriate degree of antagonistic contraction during voluntary agonist command, sensitive to stretch of the co-contracting muscle. A five-step clinical assessment may closely parallel this phenomenology, in which the first four steps aim at quantifying the antagonistic potential of each muscle group. Step-1 measures passive range of motion, i.e., the angle of arrest upon slow stretch of the muscle group assessed (minimizing spastic dystonia), which provides insight on soft tissue length and extensibility. Step-2 measures the angle of catch or clonus upon fast passive stretch of the muscle group assessed, which provides insight on stretch reflex excitability. Step-3 measures the range of active motion against the muscle group assessed, a net result of agonist recruitment minus the combined resistance from passive soft tissue stiffness and spastic co-contraction in the muscle group assessed. Step-4 measures the maximal frequency of rapid alternating movements along the maximal active range of motion, evaluating Step-3 performance repeatability. Step-5 evaluates active function, using for example a walking test (10 m or 2 min) for lower limb and the Modified Frenchay Scale for upper limb assessment, and perceived function through patient global subjective assessment.	[Gracies, J. -M.] Univ Paris Est Creteil, Grp Hosp Henri Mondor, AP HP, Unite Neuroreeduc,Serv Med Phys & Readapt, F-94010 Creteil, France; [Gracies, J. -M.; Bayle, N.; Vinti, M.; Alkandari, S.; Vu, P.; Loche, C. M.; Colas, C.] Henri Mondor Univ Hosp, Phys & Rehabil Med Serv, Unit Neuroreeduc, Creteil, France; [Gracies, J. -M.; Bayle, N.; Vinti, M.] Arts & Metiers ParisTech, LBM, F-75013 Paris, France		Gracies, JM (corresponding author), Univ Paris Est Creteil, Grp Hosp Henri Mondor, AP HP, Unite Neuroreeduc,Serv Med Phys & Readapt, 50 Av Marechal de Lattre de Tassigny, F-94010 Creteil, France.	jean-michel.gracies@hmn.aphp.fr					Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Blanton S, 1999, PHYS THER, V79, P847, DOI 10.1093/ptj/79.9.847; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; BUTLER P, 1984, DEV MED CHILD NEUROL, V26, P607; Clark M S, 1983, Int Rehabil Med, V5, P41; Collen F M, 1990, Int Disabil Stud, V12, P6; Collin C, 1988, Int Disabil Stud, V10, P61; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Dean CM, 2001, CLIN REHABIL, V15, P415, DOI 10.1191/026921501678310216; Denny-Brown D., 1966, CEREBRAL CONTROL MOV, P124; Desrosiers J, 1993, CAN J OCCUP THER, V60, P9, DOI DOI 10.1177/000841749306000104; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Giger JM, 2009, J APPL PHYSIOL, V107, P1204, DOI 10.1152/japplphysiol.00344.2009; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Gracies J, 2006, MOVEMENT DISORD, V21, pS423; Gracies JM, 2010, ARCH PHYS MED REHAB, V91, P421, DOI 10.1016/j.apmr.2009.11.017; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, P9, DOI 10.1016/j.apmr.2008.04.030; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Gracies JM, 1997, ANN NEUROL, V42, pT183; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Gracies JM, 2002, HDB BOTULINUM TOXIN, P221; Granat MH, 1996, ARCH PHYS MED REHAB, V77, P19, DOI 10.1016/S0003-9993(96)90214-2; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; JOHN J, 1984, INT J REHABIL RES, V7, P173, DOI 10.1097/00004356-198406000-00005; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lance J.W., 1980, SPASTICITY DISORDERE, P485; LEMETAYER M, 1981, NEUROPSYCHIAT ENFAN, V29, P587; Lincoln N, 1979, Physiotherapy, V65, P48; LINDMARK B, 1988, SCAND J REHABIL MED, V20, P111; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Nielsen J F, 1996, Mult Scler, V1, P296; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Post MWM, 1996, ARCH PHYS MED REHAB, V77, P440, DOI 10.1016/S0003-9993(96)90031-3; PRIMERANO A, 2010, ANN MED PHY IN PRESS; Raineteau O, 2002, EUR J NEUROSCI, V16, P1761, DOI 10.1046/j.1460-9568.2002.02243.x; RAPIN I, 1966, DEV MED CHILD NEUROL, V8, P45; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Roth EJ, 1997, AM J PHYS MED REHAB, V76, P128, DOI 10.1097/00002060-199703000-00008; Simpson DM, 2009, J NEUROL NEUROSUR PS, V80, P380, DOI 10.1136/jnnp.2008.159657; TARDIEU G, 1954, REV NEUROL, V91, P143; TARDIEU G, 1977, NEUROLOGIE; Tardieu G, 1966, EVALUATION CARACTERE, P1; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521	57	54	56	1	15	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	SEP	2010	46	3					411	421					11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	675LP	WOS:000283832500011	20927007				2022-02-06	
J	Wang, GH; Zhang, XG; Jiang, ZL; Li, X; Peng, LL; Li, YC; Wang, Y				Wang, Guo-Hua; Zhang, Xiang-Gen; Jiang, Zheng-Lin; Li, Xia; Peng, Liang-Liang; Li, Yong-Cai; Wang, Yong			Neuroprotective Effects of Hyperbaric Oxygen Treatment on Traumatic Brain Injury in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; hyperbaric oxygen; neuroprotective effect; secondary brain damage; time window; traumatic brain injury	SEVERE HEAD-INJURY; EXPERIMENTAL ANIMAL-MODELS; INTRACRANIAL-PRESSURE; CEREBRAL OXYGENATION; MITOCHONDRIAL-FUNCTION; THERAPY; APOPTOSIS; METABOLISM; CONTUSIONS; HYPEROXIA	This study was designed to evaluate the potential benefits of hyperbaric oxygen (HBO) in the treatment of traumatic brain injury (TBI). The right cerebral cortex of rats was injured by the impact of a 20-g object dropped from a predetermined height. The rats received HBO treatment at 3 ATA for 60 min after TBI. Neurological behavior score, brain water content, neuronal loss in the hippocampus, and cell apoptosis in brain tissue surrounding the primary injury site were examined to determine brain damage severity. Three and six hours after TBI, HBO-treated rats displayed a significant reduction in brain damage. However, by 12 h after TBI, the efficacy of HBO treatment was considerably attenuated. Furthermore, at 24, 48, and 72 h after TBI, the HBO treatment did not show any notable effects. In contrast, multiple HBO treatments (three or five times in all), even when started 48 h after TBI, remarkably reduced neurology deficit scores and the loss of neuronal numbers in the hippocampus. Although multiple treatments started at 48 h significantly improved neurological behaviors and reduced brain injury, the overall beneficial effects were substantially weaker than those seen after a single treatment at 6 h. These results suggest that: (1) HBO treatment could alleviate brain damage after TBI; (2) a single treatment with HBO has a time limitation of 12 h post-TBI; and (3) multiple HBO treatments have the possibility to extend the post-TBI delivery time window. Therefore, our results clearly suggest the validity of HBO therapy for the treatment of TBI.	[Wang, Guo-Hua; Zhang, Xiang-Gen; Jiang, Zheng-Lin; Li, Xia; Peng, Liang-Liang] Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong 226001, Jiangsu, Peoples R China; [Li, Yong-Cai; Wang, Yong] First Hosp Nantong, Dept Neurosurg, Nantong, Jiangsu, Peoples R China; [Zhang, Xiang-Gen] Shanghai Salvage Corp, Shanghai, Peoples R China		Jiang, ZL (corresponding author), Nantong Univ, Inst Naut Med, Dept Neuropharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn		Wang, Guohua/0000-0002-4810-8534	Administration of Science and Technology of Nantong, Jiangsu Province, China [S5031]	The authors wish to thank Dr. Temugin Berta for help revising the manuscript, and Dr. Yong-Jing Gao for constructive suggestions about the writing of the manuscript. This study was supported by a grant from the Administration of Science and Technology of Nantong (project no. S5031), Jiangsu Province, China.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; BLENKARN GD, 1969, J PHARMACOL EXP THER, V166, P346; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Calvert JW, 2003, J APPL PHYSIOL, V95, P2072, DOI 10.1152/japplphysiol.00630.2003; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Conti AC, 1998, J NEUROSCI, V18, P5663; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; Cormio M, 1997, J CLIN NEUROSCI, V4, P132, DOI 10.1016/S0967-5868(97)90062-X; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Goldman RJ, 2009, PM&R, V1, P471, DOI 10.1016/j.pmrj.2009.03.012; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; Hampson N, 2003, UNDERSEA HYPERBAR M, V30, P147; Kleen M, 1999, Minerva Anestesiol, V65, P393; KOHSHI K, 1991, Neurologia Medico-Chirurgica, V31, P575, DOI 10.2176/nmc.31.575; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liu Zhan, 2006, Chin J Traumatol, V9, P168; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Nemoto EM, 2007, NEUROL RES, V29, P116, DOI 10.1179/016164107X174138; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Oppel L, 2003, BRAIN INJURY, V17, P225, DOI 10.1080/0269905021000030814; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V105, P113; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Rogatsky GG, 2003, NEUROL RES, V25, P95, DOI 10.1179/016164103101201003; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; SHEFFIELD PJ, 1976, AVIAT SPACE ENVIR MD, V47, P759; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Sukoff MH, 2001, J NEUROSURG, V95, P544; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; WEISEND MP, 1994, J NEUROSURG, V80, P120, DOI 10.3171/jns.1994.80.1.0120; Yin DL, 2005, NEUROCRIT CARE, V2, P206, DOI 10.1385/NCC:2:2:206; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	55	54	68	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1733	1743		10.1089/neu.2009.1175			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500018	20568957				2022-02-06	
J	Klose, M; Brennum, J; Poulsgaard, L; Kosteljanetz, M; Wagner, A; Feldt-Rasmussen, U				Klose, Marianne; Brennum, Jannick; Poulsgaard, Lars; Kosteljanetz, Michael; Wagner, Aase; Feldt-Rasmussen, Ulla			Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage	CLINICAL ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY FUNCTION; LONG-TERM; NEUROENDOCRINE DYSFUNCTION; GROWTH-HORMONE; ACUTE-PHASE; THYROID-FUNCTION; GH DEFICIENCY; FREE CORTISOL; SEPTIC SHOCK	Objective Aneurysmal subarachnoid haemorrhage (SAH) has recently been reported as a common cause of chronic hypopituitarism, and introduction of routine neuroendocrine screening has been advocated. We aimed at estimating the risk of hypopituitarism after SAH using strict criteria including confirmatory testing in case of suggested insufficiency. Design Cross-sectional evaluation with a nested prospective subgroup. Patients and measurements Endocrine evaluation was performed at a median of 14 months (range 11-26) post-SAH in 62 patients with SAH and 30 healthy controls. Twenty-six patients were followed prospectively (median 7 days, and 12 months post-SAH). Endocrine evaluation included baseline evaluation, which was combined with an insulin tolerance test (ITT) or, if contraindicated, GHRH + arginine tests and a standard ACTH test at evaluation 1-2 years post-SAH. Pituitary insufficiencies were confirmed by re-evaluation. Results Early post-SAH hormone alterations mimicking central hypogonadism were present in 58% of the patients and associated with a worse clinical state (P < 0.05). One to 2 years post-SAH, initial neuroendocrine evaluation identified seven patients (11%) with abnormal results; three had free T4 and TSH suggestive of central hypothyroidism, three men had testosterone below 10 nm, and one had an insufficient GH and cortisol response to the ITT. None of these abnormalities was confirmed upon confirmatory testing. Conclusion In the largest reported cohort of patients with SAH to date, with early and late endocrine evaluation, none of the patients had chronic hypopituitarism. Based on these findings, the introduction of routine neuroendocrine screening is not justified, and the data suggest the importance of using strict diagnostic criteria in patients with a low pretest probability of hypopituitarism.	[Klose, Marianne; Feldt-Rasmussen, Ulla] Copenhagen Univ Hosp, Dept Med Endocrinol, Rigshosp, DK-2100 Copenhagen, Denmark; [Brennum, Jannick; Poulsgaard, Lars; Kosteljanetz, Michael] Copenhagen Univ Hosp, Dept Neurosurg, Rigshosp, DK-2100 Copenhagen, Denmark; [Wagner, Aase] Copenhagen Univ Hosp, Dept Radiol, Rigshosp, DK-2100 Copenhagen, Denmark		Klose, M (corresponding author), Copenhagen Univ Hosp, Dept Med Endocrinol, Rigshosp, PE2131,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	klose@rh.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Brennum, Jannick/0000-0002-7961-0156	Novo NordiskNovo Nordisk; A.P. Moller Foundation for the Advancement of Medical Science,; King Christian the 10th Foundation; Copenhagen University, Denmark; PfizerPfizer	The study was supported by an unrestricted grant from Novo Nordisk, A.P. Moller Foundation for the Advancement of Medical Science, and King Christian the 10th Foundation. M Klose was supported by a fellowship from Copenhagen University, Denmark.; MK has received lecture fees from Novo Nordisk and Pfizer, LP, MKo, AW and JB have nothing to declare. UFR has received lecture fees from Novo Nordisk and Pfizer, and an unrestricted grant from Novo Nordisk for the present study.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Andersen S, 2003, THYROID, V13, P1069, DOI 10.1089/105072503770867237; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cansu A, 2006, EPILEPSIA, V47, P1855, DOI 10.1111/j.1528-1167.2006.00821.x; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; HARRIS EK, 1970, CLIN CHEM, V16, P1022; Herzog AG, 2005, CURR OPIN NEUROL, V18, P167, DOI 10.1097/01.wco.0000162859.42218.fd; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Isojarvi JIT, 2001, EPILEPSIA, V42, P930, DOI 10.1046/j.1528-1157.2001.042007930.x; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2007, J CLIN ENDOCR METAB, V92, P1326, DOI 10.1210/jc.2006-1791; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; OSTERMAN PO, 1975, ACTA NEUROL SCAND, V52, P56, DOI 10.1111/j.1600-0404.1975.tb02827.x; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Vestergaard P, 1997, HORM METAB RES, V29, P106, DOI 10.1055/s-2007-979000	33	54	56	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	JUL	2010	73	1					95	101		10.1111/j.1365-2265.2010.03791.x			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	612QR	WOS:000278917100015	20105184				2022-02-06	
J	Gottshall, KR; Hoffer, ME				Gottshall, Kim R.; Hoffer, Michael E.			Tracking Recovery of Vestibular Function in Individuals With Blast-Induced Head Trauma Using Vestibular-Visual-Cognitive Interaction Tests	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						concussion; traumatic brain injury; balance	GAZE STABILIZATION; DYNAMIC POSTUROGRAPHY; DIZZINESS	Background and Purpose: Traumatic brain injury secondary to blast exposure is a significant international concern and a growing rehabilitation issue. Our objective was to determine whether a novel battery of vestibular-visual-cognitive interaction tests provides objective data to document functioning, and the changes in functioning associated with vestibular physical therapy (VPT) treatment, in individuals with blast-induced balance disorder. Methods: Eighty-two individuals with blast-induced mild traumatic brain injury were evaluated at baseline using a set of vestibular-visual-cognitive tests. Testing was repeated at 4-week intervals after beginning VPT. The tests included static visual acuity, perception time, target acquisition, target following (TF), dynamic visual acuity (DVA), and gaze stabilization tests. The VPT program consisted of exercise procedures that targeted the vestibulo-ocular reflex, cervico-ocular reflex, and depth perception. Somatosensory balance exercises, dynamic gait, and aerobic function exercises were also included. Participants attended VPT twice weekly for 1-hour appointments and were instructed to perform the exercises at home on other days. Mean test values were determined and compared with normative values previously collected in our laboratory from individuals without vestibular dysfunction. Results: Mean participant pre-VPT measures for perception time and target acquisition were similar to normative values, and there was no significant change in these measures. Initially, TF and DVA scores were below normative levels but returned to normative levels after 8 weeks of VPT. Gaze stabilization scores were below normative levels pre-VPT but improved by the time of the week 8 evaluation. Conclusions: This battery of vestibular-visual-cognitive tests seems to be reasonable to establish initial status and to evaluate participant progress associated with participation in VPT. Our data suggest meaningful improvement in TF and DVA after 8 weeks of treatment. A treatment period of 12 weeks or longer may be required for gaze stabilization scores to return to normative values.	[Gottshall, Kim R.; Hoffer, Michael E.] USN, Med Ctr, San Diego, CA 92152 USA		Gottshall, KR (corresponding author), USN, Med Ctr, San Diego, CA 92152 USA.	Kim.gottshall@med.navy.mil					Badaracco C, 2007, OTOL NEUROTOL, V28, P809, DOI 10.1097/MAO.0b013e3180cab73f; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Gottshall Kim, 2005, Work, V24, P381; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; Gottshall KR, 2006, J VESTIBUL RES-EQUIL, V16, P29; Gottshall KR, 2003, LARYGNOSCOPE, V113, P1736; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Mishra A, 2009, AM J AUDIOL, V18, P53, DOI 10.1044/1059-0889(2009/06-0024); NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; PAIGE GD, 1989, ACTA OTO-LARYNGOL, V108, P1, DOI 10.3109/00016488909107385; Pritcher MR, 2008, OTOL NEUROTOL, V29, P982, DOI 10.1097/MAO.0b013e31818457fb; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Whitney SL, 2009, GAIT POSTURE, V29, P194, DOI 10.1016/j.gaitpost.2008.08.002	17	54	55	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUN	2010	34	2					94	97		10.1097/NPT.0b013e3181dead12			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	V21PD	WOS:000208218600008	20588095				2022-02-06	
J	Wang, JP; Jiang, C; Liu, CL; Li, X; Chen, NN; Hao, YJ				Wang, Jianping; Jiang, Chao; Liu, Chunling; Li, Xin; Chen, Ningning; Hao, Yujin			Neuroprotective effects of progesterone following stroke in aged rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Progesterone; Infarct volume; Brain water content; Functional deficits; Aged rats	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; INFARCT VOLUME; ISCHEMIA; OCCLUSION; EDEMA; EXPRESSION; RECOVERY	Recent studies indicate that progesterone (PROG) protects against animal brain injury, including ischemic stroke, in various animal models. However, there are insufficient studies about PROG in other various groups such as ovariectomized females and aged animals. This study was designed to examine the efficacy of PROG on infarct volume, brain water content and functional outcome after cerebral ischemia in aged rats. Thirty-six male aged Sprague-Dawley rats underwent permanent middle cerebral artery occlusion (pMCAO) with the intraluminal filament technique and sham operation. After induction of pMCAO, the rats received an initial intraperitoneal injection of PROG (8 mg/kg) or vehicle at 1 h post-occlusion followed by subcutaneous injections at 6, 24 and 48 h. Functional deficits were tested with Zea Longa and Rotarod test at 24, 48 and 72 h after pMCAO. The rats were killed 72 h after surgery and infarct volume were determined with 2,3,5-triphenyltetrazolium chloride (TTC) staining and digital image analysis. Brain water content was determined by the dry-wet weight method. PROG-treated rats showed a substantial reduction in the volume of the infarction (% contralateral hemisphere) and brain water content compared to vehicle-treated rats. In addition, there was a significant improvement in ability to remain on an accelerating rotarod and increased Zea Longa scores observed in the pMCAO rats treated with PROG compared to vehicle. These findings point to the response of aged adult rats to PROG in cerebral ischemia, and suggest that such response need to be considered in the development of neuroprotective agents for stroke. (C) 2010 Elsevier B.V. All rights reserved.	[Wang, Jianping; Jiang, Chao] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China; [Liu, Chunling; Li, Xin; Chen, Ningning; Hao, Yujin] Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou 450014, Henan, Peoples R China		Wang, JP (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Kangfu Rd, Zhengzhou 450052, Henan, Peoples R China.	jcmd666@126.com			Medical Science and Technology Research Programs of Henan Province [WKJ2007-2-031]	This work was supported by grants from Medical Science and Technology Research Programs of Henan Province (WKJ2007-2-031).	ARNOLD KG, 1981, AGE AGEING, V10, P5, DOI 10.1093/ageing/10.1.5; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Buga AM, 2009, ROM J MORPHOL EMBRYO, V50, P559; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; GINSBERG MD, 1988, NEUROCHEM PATHOL, V9, P171; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; HOYER S, 1987, GERONTOLOGY, V33, P203, DOI 10.1159/000212877; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MIZOI K, 1986, Neurological Research, V8, P75; Pitkanen A, 2003, IDRUGS, V6, P200; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Takaba H, 2004, CELL MOL NEUROBIOL, V24, P589, DOI 10.1023/B:CEMN.0000036400.55503.5e; Tatlisumak T, 2000, J NEUROL SCI, V178, P107, DOI 10.1016/S0022-510X(00)00380-4; Vandromme M, 2008, CRIT CARE, V12, DOI 10.1186/cc6899; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; YAO H, 1991, STROKE, V22, P1414, DOI 10.1161/01.STR.22.11.1414	28	54	58	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2010	209	1					119	122		10.1016/j.bbr.2010.01.026			4	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	582FW	WOS:000276582900017	20109497				2022-02-06	
J	Campbell, JD; Yoon, DP; Johnstone, B				Campbell, James D.; Yoon, Dong Phil; Johnstone, Brick			Determining Relationships Between Physical Health and Spiritual Experience, Religious Practices, and Congregational Support in a Heterogeneous Medical Sample	JOURNAL OF RELIGION & HEALTH			English	Article						Health; Spiritual belief; Religious practices; Congregational support; Psychoneuroimmunological models	QUALITY-OF-LIFE; CONSTRUCT-VALIDITY; STYLE DISRUPTIONS; CANCER-PATIENTS; MENTAL-HEALTH; OUTCOMES; STROKE; REHABILITATION; INTERVENTION; DISABILITIES	Previous research indicates that increased religiosity/spirituality is related to better health, but the specific nature of these relationships is unclear. The purpose of this study was to determine the relationships between physical health and spiritual belief, religious practices, and congregational support using the Brief Multidimensional Measure of Religiousness/Spirituality and the Medical Outcomes Scale Shortform-36. A total of 168 participants were surveyed with the following medical disorders: Cancer, Spinal Cord Injury, Traumatic Brain Injury, and Stroke, plus a healthy sample from a primary care setting. The results show that individuals with chronic medical conditions do not automatically turn to religious and spiritual resources following onset of their disorder. Physical health is positively related to frequency of attendance at religious services, which may be related to better health leading to increased ability to attend services. In addition, spiritual belief in a loving, higher power, and a positive worldview are associated with better health, consistent with psychoneuroimmunological models of health. Practical implications for health care providers are discussed.	[Campbell, James D.; Yoon, Dong Phil; Johnstone, Brick] Univ Missouri, Dept Family & Community Med, Columbia, MO 65212 USA		Campbell, JD (corresponding author), Univ Missouri, Dept Family & Community Med, MA306 Med Sci Bldg, Columbia, MO 65212 USA.	campbellj@health.missouri.edu; yond@missouri.edu; johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			Astin John A, 2004, Adv Mind Body Med, V20, P14; Baskin TW, 2004, J COUNS DEV, V82, P79, DOI 10.1002/j.1556-6678.2004.tb00288.x; Berges IM, 2007, EXP AGING RES, V33, P1, DOI 10.1080/03610730601005893; Brillhart Barbara, 2005, Rehabil Nurs, V30, P31; Cohen L, 2001, PSYCHOSOM MED, V63, P951, DOI 10.1097/00006842-200111000-00014; COLANTONIO A, 1993, J GERONTOL, V48, pS261, DOI 10.1093/geronj/48.5.S261; Devins GM, 2006, PSYCHO-ONCOLOGY, V15, P221, DOI 10.1002/pon.940; Devins GM, 2001, MED CARE, V39, P1097, DOI 10.1097/00005650-200110000-00007; Ellis MR, 2002, J FAM PRACTICE, V51, P249; Faull K, 2006, DISABIL REHABIL, V28, P729, DOI 10.1080/09638280500265946; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; George LK, 2000, J SOC CLIN PSYCHOL, V19, P102, DOI 10.1521/jscp.2000.19.1.102; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Giaquinto S, 2007, STROKE, V38, P993, DOI 10.1161/01.STR.0000257996.26950.59; GOLDMAN N, 1995, SOC SCI MED, V40, P1717, DOI 10.1016/0277-9536(94)00281-W; Haley KC, 2001, J RELIG HEALTH, V40, P305, DOI 10.1023/A:1012561909054; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Idler EL, 1997, J GERONTOL B-PSYCHOL, V52, pS306, DOI 10.1093/geronb/52B.6.S306; JOHNSTONE B, J RELIG HLT IN PRESS; Kabat-Zinn J, 1998, PSYCHOSOM MED, V60, P625, DOI 10.1097/00006842-199809000-00020; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kendler KS, 2003, AM J PSYCHIAT, V160, P496, DOI 10.1176/appi.ajp.160.3.496; Kim J, 2000, REHABIL PSYCHOL, V45, P365, DOI 10.1037/0090-5550.45.4.365; Koenig HaroldG., 2001, HDB RELIG HLTH; Koenig T, 2002, GERONTOLOGIST, V42, P92, DOI 10.1093/geront/42.suppl_3.20; Lee BY, 2005, ZYGON, V40, P443, DOI 10.1111/j.1467-9744.2005.00674.x; MAGYARRUSSELL GM, 2005, THESIS B GREEN STATE; McCullough ME, 2000, HEALTH PSYCHOL, V19, P211, DOI 10.1037//0278-6133.19.3.211; Mokuau N, 2001, Pac Health Dialog, V8, P407; Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006000300018; Moreira-Almeida A, 2006, SOC SCI MED, V63, P843, DOI 10.1016/j.socscimed.2006.03.001; Mulligan Thomas, 2005, Consult Pharm, V20, P1025, DOI 10.4140/TCP.n.2005.1025; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; NISSIM EN, 2003, THESIS F DICKINSON U; NOREAU L, 1996, CANADIAN J REHABILIT, V10, P81; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.3.CO;2-T; Pargament KI, 1998, LAWS LIF SYMP SER, V1, P59; Pargament KI., 1999, MULTIDIMENSIONAL MEA, P43; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Ray O, 2004, AM PSYCHOL, V59, P29, DOI 10.1037/0003-066X.59.1.29; Rippentrop AE, 2005, PAIN, V116, P311, DOI 10.1016/j.pain.2005.05.008; *SF 36, 2006, SF 36 HLTH SURV; Sherman AC, 2001, PSYCHO-ONCOLOGY, V10, P436, DOI 10.1002/pon.523; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Thoresen C E, 1999, J Health Psychol, V4, P291, DOI 10.1177/135910539900400314; Thoresen CE, 2002, ANN BEHAV MED, V24, P3, DOI 10.1207/S15324796ABM2401_02; Treloar LL, 2002, J ADV NURS, V40, P594, DOI 10.1046/j.1365-2648.2002.02417.x; Underwood LG, 2002, ANN BEHAV MED, V24, P22, DOI 10.1207/S15324796ABM2401_04; Van Ness PH, 2003, J GERONTOL B-PSYCHOL, V58, pS21, DOI 10.1093/geronb/58.1.S21; Williams J.E., 2006, RES SOCIAL SCI STUDY, V17, P177; Yoon DP, 2005, J HUM BEHAV SOC ENVI, V10, P191, DOI 10.1300/J137v10n01_05	53	54	54	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4197	1573-6571		J RELIG HEALTH	J. Relig. Health	MAR	2010	49	1					3	17		10.1007/s10943-008-9227-5			15	Public, Environmental & Occupational Health; Religion	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Public, Environmental & Occupational Health; Religion	556YP	WOS:000274631200002	20162451				2022-02-06	
J	Itoh, T; Satou, T; Nishida, S; Tsubaki, M; Imano, M; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Tsubaki, Masahiro; Imano, Motohiro; Hashimoto, Shigeo; Ito, Hiroyuki			Edaravone Protects Against Apoptotic Neuronal Cell Death and Improves Cerebral Function After Traumatic Brain Injury in Rats	NEUROCHEMICAL RESEARCH			English	Article						Edaravone; Traumatic brain injury; Neuroprotection; Apoptosis; Oxidative stress	CENTRAL-NERVOUS-SYSTEM; RADICAL SCAVENGER; OXYGEN RADICALS; ISCHEMIA; ACTIVATION; MCI-186; PATHWAY; DAMAGE; PROLIFERATION; ACCUMULATION	Edaravone is a novel free radical scavenger used clinically in patients with acute cerebral infarction; however, it has not been assessed in traumatic brain injury (TBI). We investigated the effects of edaravone on cerebral function and morphology following TBI. Rats received TBI with a pneumatic controlled injury device. Edaravone (3 mg/kg) or physiological saline was administered intravenously following TBI. Numbers of 8-OHdG-, 4-HNE-, and ssDNA-positive cells around the damaged area after TBI were significantly decreased in the edaravone group compared with the saline group (P < 0.01). There was a significant increase in neuronal cell number and improvement in cerebral dysfunction after TBI in the edaravone group compared with the saline group (P < 0.01). Edaravone administration following TBI inhibited free radical-induced neuronal degeneration and apoptotic cell death around the damaged area. In summary, edaravone treatment improved cerebral dysfunction following TBI, suggesting its potential as an effective clinical therapy.	[Itoh, Tatsuki; Satou, Takao; Ito, Hiroyuki] Kinki Univ, Sch Med, Dept Pathol, Osaka 5898511, Japan; [Satou, Takao] Kinki Univ Hosp, Div Hosp Pathol, Sch Med, Osaka, Japan; [Satou, Takao] Kinki Univ, Div Sports Med, Inst Life Sci, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Sch Pharmaceut Sci, Osaka 5898511, Japan; [Imano, Motohiro] Kinki Univ, Sch Med, Dept Surg, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp					Arai T, 2008, J PHARMACOL EXP THER, V324, P529, DOI 10.1124/jpet.107.131391; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; CHAN PH, 1985, PROG BRAIN RES, V63, P227; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Elvander E, 2004, NEUROSCIENCE, V126, P541, DOI 10.1016/j.neuroscience.2004.03.058; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Han Ning, 2008, Neurosci Bull, V24, P351, DOI 10.1007/s12264-008-0711-4; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Lee EJ, 2005, J PINEAL RES, V38, P42, DOI 10.1111/j.1600-079X.2004.00173.x; Mizuno A, 1998, GEN PHARMACOL-VASC S, V30, P575, DOI 10.1016/S0306-3623(97)00311-X; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Niyaz M, 2007, J NEUROSCI RES, V85, P2933, DOI 10.1002/jnr.21412; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Takizawa Y, 2009, PEDIATR RES, V65, P636, DOI 10.1203/PDR.0b013e3181a16a9f; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Walton KM, 1998, J NEUROCHEM, V70, P1764; Wang XY, 2001, BIOL NEONATE, V79, P172; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Wen J, 2006, BIOL PHARM BULL, V29, P713, DOI 10.1248/bpb.29.713; Wu T, 2006, BIOL PHARM BULL, V29, P1613, DOI 10.1248/bpb.29.1613; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3; Yasuoka N, 2004, DEV BRAIN RES, V151, P129, DOI 10.1016/j.devbrainres.2004.04.006; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06	34	54	59	0	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	FEB	2010	35	2					348	355		10.1007/s11064-009-0061-2			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	544UP	WOS:000273685100018	19768539				2022-02-06	
J	Arango-Lasprilla, JC; Quijano, MC; Aponte, M; Cuervo, MT; Nicholls, E; Rogers, HL; Kreutzer, J				Arango-Lasprilla, Juan Carlos; Cristina Quijano, Maria; Aponte, Monica; Teresa Cuervo, Maria; Nicholls, Elizabeth; Lynn Rogers, Heather; Kreutzer, Jeffrey			Family needs in caregivers of individuals with traumatic brain injury from Colombia, South America	BRAIN INJURY			English	Article						Caregivers; family; traumatic brain injury	NEUROSURGICAL TRAUMA; SOCIAL SUPPORT; IMPACT; DEPRESSION; MEMBERS; TBI; INTEGRATION; PREVALENCE; EMPLOYMENT; ATTENTION	Objective: The aim of the present study was to determine the most and least important family needs in a group of family caregivers of individuals with TBI from Cali, Colombia, and to examine which of those needs were more likely to be met and unmet. Design: Cross-sectional descriptive study. Setting: Valle University Hospital in Cali, Colombia. Participants: Twenty-nine family caregivers of individuals with traumatic brain injury. Outcome measure: The Family Needs Questionnaire, a 40-item questionnaire divided into six sub-scales. Results: Health Information, Community Support Network and Professional Support Network sub-scales were the most important needs reported by this group of Colombian TBI family caregivers. The most frequently met needs in the present study fell within Health Information, Involvement with Care and Instrumental Support sub-scales and the most frequently unmet needs fell within the Emotional Support, Instrumental Support and Professional Support sub-scales. Conclusions: Family needs in caregivers of individuals with TBI from Colombia are similar, but more likely to be unmet, than those reported in previous studies. Interventions designed to meet family caregivers' needs in these areas should be implemented in Colombia.	[Arango-Lasprilla, Juan Carlos; Nicholls, Elizabeth; Kreutzer, Jeffrey] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Cristina Quijano, Maria; Aponte, Monica; Teresa Cuervo, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia; [Lynn Rogers, Heather] Univ Antioquia, Grp Rehabil Salud, Medellin, Colombia		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, West Hosp, MCV Campus,3rd Floor,Room 3-102,1200 E Broad St, Richmond, VA 23298 USA.	jcarangolasp@vcu.edu	Rogers, Heather L./AAB-8486-2022	Rogers, Heather L./0000-0002-7562-4542; Quijano Martinez, Maria Cristina/0000-0003-3548-1628; Cuervo Cuesta, Maria teresa/0000-0002-4907-4604	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of EducationUS Department of Education [H133A070036]	Supported in part by the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education (grant no. H133A070036). The authors report no further conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; CAMPBELL CH, 1988, REHABILITATION NURSI, V13, P325; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Engli M, 1993, J Neurosci Nurs, V25, P78; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Firsching R, 2001, WORLD J SURG, V25, P1221; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Izaute M, 2008, BRAIN INJURY, V22, P758, DOI 10.1080/02699050802366002; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mathis M, 1984, J Neurosurg Nurs, V16, P36; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Moules S, 1999, BRAIN INJURY, V13, P983; Murray C. J., 1996, GLOBAL HLTH STAT COM; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Raja IA, 2001, WORLD J SURG, V25, P1230; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; STEBBINS P, 1999, J REHABIL, V64, P15; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Zhao YD, 2001, WORLD J SURG, V25, P1202	49	54	57	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	7-8					1017	1026		10.3109/02699052.2010.490516			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000012	20545455				2022-02-06	
J	Berger, RP; Bazaco, MC; Wagner, AK; Kochanek, PM; Fabio, A				Berger, Rachel Pardes; Bazaco, Michael C.; Wagner, Amy K.; Kochanek, Patrick M.; Fabio, Anthony			Trajectory Analysis of Serum Biomarker Concentrations Facilitates Outcome Prediction after Pediatric Traumatic and Hypoxemic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury, pediatric; Hypoxic ischemic encephalopathy; Outcome; Trajectory analysis; Neuron-specific enolase; S100B; Myelin basic protein	NEURON-SPECIFIC ENOLASE; SEVERE HEAD-INJURY; GLASGOW COMA SCALE; MAGNETIC-RESONANCE SPECTROSCOPY; CEREBROSPINAL-FLUID; PERIPHERAL MARKERS; CHILDREN; S100B; PROTEIN; DAMAGE	Traumatic brain injury (TBI) and hypoxic ischemic encephalopathy (HIE) are leading causes of morbidity and mortality in children. Several studies over the past several years have evaluated the use of serum biomarkers to predict outcome after pediatric brain injury. These studies have all used simple point estimates such as initial and peak biomarker concentrations to predict outcome. However, this approach does not recognize patterns of change over time. Trajectory analysis is a type of analysis which can capture variance in biomarker concentrations over time and has been used with success in the social sciences. We used trajectory analysis to evaluate the ability of the serum concentrations of 3 brain-specific biomarkers - S100B, neuron-specific enolase (NSE) and myelin basic protein (MBP) - to predict poor outcome (Glasgow Outcome Scale scores 3-5) after pediatric TBI and HIE. Clinical and biomarker data from 100 children with TBI or HIE were evaluated. For each biomarker, we validated 2-, 3- and 4-group models for outcome prediction, using sensitivity and specificity. For S100B, the 3-group model predicted poor outcome with a sensitivity of 59% and specificity of 100%. For NSE, the 3-group model predicted poor outcome with a sensitivity of 48% and specificity of 98%. For MBP, the 3-group model predicted poor outcome with a sensitivity of 73% and specificity of 61%. Thus, when the models predicted a poor outcome, there was a very high probability of a poor outcome. In contrast, 17% of subjects with a poor outcome were predicted to have a good outcome by all 3 biomarker trajectories. These data suggest that trajectory analysis of biomarker data may provide a useful approach for predicting outcome after pediatric brain injury. Copyright (C) 2010 S. Karger AG, Basel	[Berger, Rachel Pardes] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Safar Ctr Resuscitat Res, Pittsburgh, PA 15227 USA; [Wagner, Amy K.] Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Fabio, Anthony] Univ Pittsburgh, Dept Neurosurg, Ctr Injury Res & Control, Pittsburgh, PA USA; [Bazaco, Michael C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA		Berger, RP (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15227 USA.	Rachel.p.berger@gmail.com	Bazaco, Michael/I-9026-2012; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Fabio, Anthony/0000-0002-6808-4939	University of Pittsburgh Center for Injury Control and Research/CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA;  [R01HD055986]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE323155] Funding Source: NIH RePORTER	The authors would like to thank Keri Feldman for her technical expertise in generating the biomarker measurements. This study was supported by the University of Pittsburgh Center for Injury Control and Research/CDC (P.M.K., R.P.B., A.F., A.W.) and R01HD055986 (R.P.B.).	Abatemarco DJ, 2008, JT COMM J QUAL PATIE, V34, P106, DOI 10.1016/S1553-7250(08)34013-6; Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Amin K, 2009, J NEUROTRAUM, V26, pA71; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Brophy G, 2008, J NEUROTRAUM, V25, P902; Carter BG, 2005, INTENS CARE MED, V31, P840, DOI 10.1007/s00134-005-2634-0; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GREWAL M, 1991, J PEDIATR SURG, V26, P1161, DOI 10.1016/0022-3468(91)90323-L; Guan Wei, 2003, Chin J Traumatol, V6, P218; Haviland AM, 2005, PSYCHOMETRIKA, V70, P557, DOI 10.1007/s11336-004-1261-y; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Lo T, 2009, J NEUROTRAUM, V26, pA46; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Meynaar IA, 2003, INTENS CARE MED, V29, P189, DOI 10.1007/s00134-002-1573-2; Nagin D.S., 2005, GROUP BASED MODELING; Niyonkuru C, 2009, J NEUROTRAUM, V26, pA16; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ozawa H, 2009, J NEUROTRAUM, V26, pA71; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Sandroni C, 1995, Eur J Emerg Med, V2, P33, DOI 10.1097/00063110-199503000-00008; Schindler MB, 1996, NEW ENGL J MED, V335, P1473, DOI 10.1056/NEJM199611143352001; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Topjian AA, 2009, PEDIATR CRIT CARE ME, V10, P479, DOI 10.1097/PCC.0b013e318198bdb5; Unden J, 2004, BRIT J NEUROSURG, V18, P277, DOI 10.1080/02688690410001732742; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412	50	54	62	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					396	405		10.1159/000316803			10	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900007	20847541	Green Published, Bronze			2022-02-06	
J	Chevignard, M; Toure, H; Brugel, DG; Poirier, J; Laurent-Vannier, A				Chevignard, M.; Toure, H.; Brugel, D. G.; Poirier, J.; Laurent-Vannier, A.			A comprehensive model of care for rehabilitation of children with acquired brain injuries	CHILD CARE HEALTH AND DEVELOPMENT			English	Article						assessment of outcome; childhood disability; model of care; multidisciplinary; rehabilitation; traumatic brain injury	OF-THE-SCIENCE; EXECUTIVE FUNCTION; PEDIATRIC TRAUMA; YOUNG-CHILDREN; HEAD-INJURY; OUTCOMES; TBI; SERVICES; PROGRAM; STROKE	Background Acquired brain injury (ABI) is a leading cause of death and lifelong acquired disability in children and remains a significant public health issue. Deficits may only become fully apparent when developmental demands increase and once cognitive processes are expected to be fully developed. It is therefore necessary to provide organized long-term follow-up for children post ABI. Despite these recommendations, it has been shown that only a small proportion of children received specialized rehabilitation and adequate follow-up after ABI. Aims The aims are: (i) to describe a comprehensive model of care devoted to children with acquired brain injuries; and (ii) to provide descriptive data analysing the characteristics of children followed up, the type/amount of services provided and general outcomes. Programme description The programme features an in- and outpatient rehabilitation facility, where multidisciplinary rehabilitation and specialized schooling are provided. The ultimate goal of the programme is to promote each child's successful reintegration in school and in the community. Adequate preparation of discharge is essential, long-term follow-up is organized, and an outreach programme has been developed to deal with the complex delayed psychosocial issues. Results Overall outcome, as measured by the Glasgow Outcome Scale, improved dramatically between admission (3.3; SD = 0.45) and discharge (2.15; SD = 0.74). Most of the children were discharged home with an adequate personalized plan for ongoing rehabilitation and school adaptations. Analysis of the outreach programme underlines the more challenging issues arising in late adolescence-early adulthood. Conclusion Given the specificities of childhood ABI, long-term specific care must be organized and co-ordinated, regardless of injury severity.	[Chevignard, M.; Toure, H.; Brugel, D. G.; Laurent-Vannier, A.] Hop Natl St Maurice, Phys Med & Rehabil Dept Children Acquired Neurol, St Maurice, France; [Chevignard, M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Chevignard, M.] Univ Paris 06, UMR S 731, Paris, France; [Toure, H.; Brugel, D. G.; Poirier, J.; Laurent-Vannier, A.] Hop Natl St Maurice, Ctr Suivi & Insert, Outreach Program, St Maurice, France		Chevignard, M (corresponding author), INR A Hop Natl St Maurice, 14 Rue Val Osne, F-94415 St Maurice, France.	m.chevignard@hopital-saint-maurice.fr			Hopital National de Saint Maurice' (France); France-Traumatisme Crnien-SOFMER; SFERHE	This work was conducted in a clinical setting, and was therefore supported by the 'Hopital National de Saint Maurice' (France), where the study was performed. It was also supported by a grant of 'France-Traumatisme Crnien-SOFMER' and a grant from SFERHE. We thank Dr Pascale Pradat-Diehl, Dr Cheryl Soo and Associate Professor Cathy Catroppa for their helpful advice about the article and for the English corrections. We wish to acknowledge the whole team for their active work in this network of care.	Aitken ME, 2005, ARCH PHYS MED REHAB, V86, P175, DOI 10.1016/j.apmr.2004.02.026; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; AUBERT S, 2007, DEV NEUROREHABIL, V10, P275; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Callu D, 2008, DEV NEUROREHABIL, V11, P16, DOI 10.1080/17518420701419227; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chung B, 2004, PEDIATRICS, V114, P206; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Emanuelson I, 2003, INT J REHABIL RES, V26, P257, DOI 10.1097/00004356-200312000-00002; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Gillett J, 2004, NEUROREHABILITATION, V19, P207; GIROUD M, 1995, J CLIN EPIDEMIOL, V48, P1343, DOI 10.1016/0895-4356(95)00039-9; Glang A, 2004, NEUROREHABILITATION, V19, P219; Gordon AL, 2002, J CHILD NEUROL, V17, P429, DOI 10.1177/088307380201700606; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Gregg J, 1999, LANCET, V354, pS28; Grill J, 2004, J NEUROSURG, V101, P152, DOI 10.3171/ped.2004.101.2.0152; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hartel C, 2004, EUR J NEUROL, V11, P431, DOI 10.1111/j.1468-1331.2004.00861.x; Heinemann AW, 2007, AM J PHYS MED REHAB, V86, P869, DOI 10.1097/PHM.0b013e31815840b3; Hoofien D, 2001, BRAIN INJURY, V15, P189; *INSEE, 2004, INSEE DIV ENQ ET DEM, P2004; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; JENNETT B, 1975, LANCET, V1, P480; Kieffer V, 2007, ARCH PEDIATRIE, V14, P1282, DOI 10.1016/j.arcped.2007.08.009; Kieffer-Renaux V, 2005, PEDIATR BLOOD CANCER, V45, P814, DOI 10.1002/pbc.20329; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; LAURENTVANNIER A, 2008, BRAIN INJURY S1, V22, P206; LAURENTVANNIER A, 2005, ANN READAPTATION MED, V48, P481; LAURENTVANNIER A, 1998, ANN READAPTATION MED, V41, P93; Lexell J, 2007, J HEAD TRAUMA REHAB, V22, P229, DOI 10.1097/01.HTR.0000281838.00344.03; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; McDougall J, 2006, BRAIN INJURY, V20, P1189, DOI 10.1080/02699050600975541; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Nybo T, 1999, BRAIN INJURY, V13, P759; Nyein K, 2007, J HEAD TRAUMA REHAB, V22, P239, DOI 10.1097/01.HTR.0000281840.85096.1f; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Packer RJ, 2003, J CLIN ONCOL, V21, P3255, DOI 10.1200/JCO.2003.01.202; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Rickert CH, 1997, CHILD NERV SYST, V13, P507, DOI 10.1007/s003810050127; Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Tomlin P, 2002, DEV MED CHILD NEUROL, V44, P828; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; *VICT PAED REH SER, 2007, VICT PAED REH SERV M; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	74	54	54	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1862	1365-2214		CHILD CARE HLTH DEV	Child Care Health Dev.	JAN	2010	36	1					31	43		10.1111/j.1365-2214.2009.00949.x			13	Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics	536BF	WOS:000273016400004	19438875				2022-02-06	
J	Xiong, Y; Mahmood, A; Qu, CS; Kazmi, H; Zhang, ZG; Noguchi, CT; Schallert, T; Chopp, M				Xiong, Ye; Mahmood, Asim; Qu, Changsheng; Kazmi, Humaira; Zhang, Zheng Gang; Noguchi, Constance T.; Schallert, Timothy; Chopp, Michael			Erythropoietin Improves Histological and Functional Outcomes after Traumatic Brain Injury in Mice in the Absence of the Neural Erythropoietin Receptor	JOURNAL OF NEUROTRAUMA			English	Article						erythropoietin receptor null; mouse; sensorimotor; spatial learning; traumatic brain injury	RECOMBINANT-HUMAN-ERYTHROPOIETIN; FOCAL CEREBRAL-ISCHEMIA; IN-VITRO; ENHANCES NEUROGENESIS; NEONATAL STROKE; SPATIAL MEMORY; UP-REGULATION; HEAD-INJURY; RATS; PROTECTS	Erythropoietin (EPO), essential for erythropoiesis, provides neuroprotection. The EPO receptor (EPOR) is expressed in both neural and non-neural cells in the brain. This study was designed to test the hypothesis that EPO provides beneficial therapeutic effects, even in the absence of the neural EPOR. In this study, EPOR-null mice were rescued with selective EpoR expression driven by the endogenous EpoR promoter in hematopoietic tissue, but not in the neural cells. Anesthetized young adult female EPOR-null and wild-type mice were subjected to traumatic brain injury (TBI) induced by controlled cortical impact. EPO (5000 U/kg) or saline was intraperitoneally administered at 6 h and 3 and 7 days post-injury. Sensorimotor and spatial learning functions were assessed. Expression of EPOR and its downstream signal proteins were evaluated by Western blot analysis. Our data demonstrated that EPO treatment significantly reduced cortical tissue damage and hippocampal cell loss, and improved spatial learning following TBI in both the wild-type and EPOR-null mice. EPO treatment significantly improved sensorimotor functional recovery, with better outcomes in the wild-type mice. EPO treatment upregulated anti-apoptotic proteins (p-Akt and Bcl-XL) in the ipsilateral hippocampus and cortex of the injured wild-type and EPOR-null mice. These data demonstrate that EPO significantly provides neuroprotection following TBI, even in the absence of EPOR in the neural cells, suggesting that its therapeutic benefits may be mediated through vascular protection.	[Zhang, Zheng Gang; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Xiong, Ye; Mahmood, Asim; Qu, Changsheng; Kazmi, Humaira] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Noguchi, Constance T.] NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Schallert, Timothy] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Schallert, Timothy] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Chopp, M (corresponding author), Henry Ford Hlth Syst, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu		Xiong, Ye/0000-0001-9770-6031	National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [RO1 NS62002, PO1 NS42345]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [ZIADK025061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345, R01NS062002] Funding Source: NIH RePORTER	This work was supported by National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) Health grants RO1 NS62002 and PO1 NS42345, and NIDDK Intramural Research.	Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bianca RDD, 2009, SHOCK, V31, P529, DOI 10.1097/SHK.0b013e31818909c0; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Chi OZ, 2008, PHARMACOLOGY, V82, P38, DOI 10.1159/000127839; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Jelkmann W., 2000, Current Pharmaceutical Biotechnology, V1, P11, DOI 10.2174/1389201003379068; Keogh CL, 2007, J PHARMACOL EXP THER, V322, P521, DOI 10.1124/jpet.107.121392; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Mogensen J, 2008, BEHAV BRAIN RES, V186, P215, DOI 10.1016/j.bbr.2007.08.009; Naranda T, 2002, ENDOCRINOLOGY, V143, P2293, DOI 10.1210/en.143.6.2293; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Noguchi Constance Tom, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000860; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Shafi NI, 2008, J NEUROTRAUM, V25, P257, DOI 10.1089/neu.2007.0347; Spandou E, 2005, BRAIN RES, V1045, P22, DOI 10.1016/j.brainres.2005.03.013; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; van der Kooij MA, 2008, BRAIN RES REV, V59, P22, DOI 10.1016/j.brainresrev.2008.04.007; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wojchowski DM, 1999, EXP CELL RES, V253, P143, DOI 10.1006/excr.1999.4673; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Zhande R, 2007, AM J PHYSIOL-HEART C, V292, pH2467, DOI 10.1152/ajpheart.00649.2006; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59	51	54	59	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					205	215		10.1089/neu.2009.1001			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200018	19715391	Green Published			2022-02-06	
J	Gary, KW; Arango-Lasprilla, JC; Ketchum, JM; Kreutzer, JS; Copolillo, A; Novack, TA; Jha, A				Gary, Kelli W.; Arango-Lasprilla, Juan C.; Ketchum, Jessica M.; Kreutzer, Jeffrey S.; Copolillo, Al; Novack, Thomas A.; Jha, Amitabh			Racial Differences in Employment Outcome After Traumatic Brain Injury at 1, 2, and 5 Years Postinjury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Employment; Rehabilitation	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; ACUTE PREDICTORS; MODEL SYSTEMS; FOLLOW-UP; RETURN; WORK; COMA; RELIABILITY; POPULATION	Objectives: To examine racial differences in competitive employment outcomes at 1, 2, and 5 years after traumatic brain injury (TBI) and to determine whether changes in not competitive employment rates over time differ between blacks and whites with TBI after adjusting for demographic and injury characteristics. Design: Retrospective cohort study. Setting: Sixteen TBI Model System Centers. Participants: Blacks (n=615) and whites (n=1407) with moderate to severe TBI. Interventions: Not applicable. Main Outcome Measure: Employment status dichotomized as competitively employed versus not competitively employed. Results: After adjusting for demographic and injury characteristics. repeated-measures logistic regression indicated that (1) the odds of not being competitively employed were significantly greater for blacks than whites regardless of the follow-up year (all P<.001); (2) the odds of not being competitively employed declined significantly over time for each race (P <=.004); and (3) changes over time in the odds of not being competitively employed versus being competitively employed were not different between blacks and whites (P=.070). In addition, age, discharge FIM and Disability Rating Scale, length of stay in acute and rehabilitation, preinjury employment, sex, education, marital status, and cause of injury were significant predictors of employment status postinjury. Conclusions: Short- and long-term employment is not favorable for people with TBI regardless of race; however, blacks fare worse in employment outcomes compared with whites. Rehabilitation professionals should work to improve return to work for all persons with TBI, with special emphasis on addressing specific needs of blacks.	[Gary, Kelli W.; Arango-Lasprilla, Juan C.; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23219 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23219 USA; [Copolillo, Al] Virginia Commonwealth Univ, Dept Occupat Therapy, Richmond, VA 23219 USA; [Novack, Thomas A.] Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA; [Novack, Thomas A.] Univ Alabama, Dept Psychol, Birmingham, AL 35294 USA; [Jha, Amitabh] Univ Colorado, Sch Med, Craig Hosp, Dept Phys Med & Rehabil, Englewood, CO USA		Gary, KW (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 730 E Broad St,POB 843038, Richmond, VA 23219 USA.	williamsjonk@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691	National Institute on Disability and Rehabilitation Research; U.S. Department of EducationUS Department of Education [H133A070036, H133P040006, H133A070039, H133A060038]	Supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grant nos. H133A070036, H133P040006, H133A070039, H133A060038).	[Anonymous], 1997, GUID UN DAT SET MED; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lemeshow S, 2000, APPL LOGISTIC REGRES; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenthal M., 1996, J HEAD TRAUMA REHAB, V11, P69; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; TEASDALE G, 1974, LANCET, V2, P81; *US BUR LAB STAT, 2009, EMPL SIT SUMM; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Verbeke G., 2006, MODELS DISCRETE LONG; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; [No title captured]	41	54	54	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2009	90	10					1699	1707		10.1016/j.apmr.2009.04.014			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	507UA	WOS:000270879400009	19801059				2022-02-06	
J	Riordan, WP; Norris, PR; Jenkins, JM; Morris, JA				Riordan, William P., Jr.; Norris, Patrick R.; Jenkins, Judith M.; Morris, John A., Jr.			Early Loss of Heart Rate Complexity Predicts Mortality Regardless of Mechanism, Anatomic Location, or Severity of Injury in 2178 Trauma Patients	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	70th Annual Meeting of the Society-of-University-Surgeons/4th Annual Academic Surgical Congress	FEB 03-06, 2009	Ft Myers, FL	Soc Univ Surg, Assoc Acad Surg		heart rate variability; physiologic complexity; trauma; injury etiology; monitoring; intensive care unit; critical care	RATE-VARIABILITY; SPECTRAL-ANALYSIS; BRAIN-INJURY; DEATH; CARE; ICU	Background. Reduced heart rate (HR) complexity (e.g., a lack of randomness or unpatterned variability) is an established predictor of trauma patient mortality. However, this finding has not been validated across the diverse spectrum of traumatic injury, and underlying mechanisms of this relationship are poorly understood. Materials and Methods. Two thousand one hundred seventy-eight trauma patients were admitted directly to the intensive care unit (ICU), and had sufficient (> 6 h) continuous integer heart rate data within the first d. Patients were stratified by location of isolated severe injury (head, torso, both, or neither), primary mechanism (blunt or penetrating), and probability of survival, an accepted scoring system based on age, admission vital signs, and injury type and severity. HR multiscale entropy (MSE) was calculated (sum of scales, Costa's algorithm, physionet.org, m = 2, r = 0.15) to estimate complexity. Univariate analysis was performed by comparing MSE between survivors and nonsurvivors in each subgroup. Multivariate analysis incorporated logistic regression to characterize the relationship between MSE and risk of death, controlling for probability of survival. The MSE odds ratios (OR) and area under the receiver operator curve (AUC) were calculated. Results. Reduced MSE was significantly associated with increasing mortality, and was independent of probability of survival in all multivariate analyses (OR 0.87-0.94). This range of odds ratios implies that a patient with an MSE of 15 has roughly a 2- to 6-fold increase in odds of death versus a patient with an MSE of 25. The relationship between MSE and death was moderately stronger in patients with isolated severe head injury versus torso injury, and significantly stronger in patients with penetrating versus blunt mechanism of injury. MSE measured early in the hospital stay remained a robust predictor of mortality in all subgroups, even stratified by narrow ranges of probability of survival. Conclusions. Early reduction of heart rate complexity is an important risk factor across diverse injury etiology. This suggests common underlying physiologic mechanisms linking the loss of biologic complexity to death. (C) 2009 Elsevier Inc. All rights reserved.	[Riordan, William P., Jr.] Vanderbilt Univ, Med Ctr, Dept Surg, VUMC Trauma, Nashville, TN 37212 USA; [Norris, Patrick R.] Vanderbilt Univ, Dept Biomed Engn, Med Ctr, Nashville, TN 37235 USA		Riordan, WP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, VUMC Trauma, 1211 21st Ave S,404 Med Arts Bldg, Nashville, TN 37212 USA.	william.riordan@vanderbilt.edu					Baillard C, 2002, CRIT CARE MED, V30, P306, DOI 10.1097/00003246-200202000-00007; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Conci F, 2001, J NEUROL NEUROSUR PS, V71, P621, DOI 10.1136/jnnp.71.5.621; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Gang Yi, 2002, Curr Opin Crit Care, V8, P371, DOI 10.1097/00075198-200210000-00002; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; LOWENSOHN RI, 1977, LANCET, V1, P626; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Papaioannou VE, 2006, J CRIT CARE, V21, P95, DOI 10.1016/j.jcrc.2005.12.007; Proctor KG, 2007, J TRAUMA, V63, P33, DOI 10.1097/01.ta.0000251593.32396.df; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010; Winchell RJ, 1996, J SURG RES, V63, P11, DOI 10.1006/jsre.1996.0214	23	54	56	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2009	156	2					283	289		10.1016/j.jss.2009.03.086			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	503TW	WOS:000270564300018	19592027				2022-02-06	
J	Wang, JA; Lin, W; Morris, T; Banderali, U; Juranka, PF; Morris, CE				Wang, Jun A.; Lin, Wei; Morris, Terence; Banderali, Umberto; Juranka, Peter F.; Morris, Catherine E.			Membrane trauma and Na+ leak from Nav1.6 channels	AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY			English	Article						sodium dye; stretch; shear; bleb	INJURY IN-VITRO; SODIUM-CHANNEL; SKELETAL-MUSCLE; FUNCTIONAL-ANALYSIS; SLOW INACTIVATION; MOLECULAR-CLONING; LIPID RAFTS; HUMAN HEART; VOLTAGE; TETRODOTOXIN	Wang JA, Lin W, Morris T, Banderali U, Juranka PF, Morris CE. Membrane trauma and Na+ leak from Nav1.6 channels. Am J Physiol Cell Physiol 297: C823-C834, 2009. First published August 5, 2009; doi: 10.1152/ajpcell.00505.2008.-During brain trauma, white matter experiences shear and stretch forces that, without severing axons, nevertheless trigger their secondary degeneration. In central nervous system (CNS) trauma models, voltage-gated sodium channel (Nav) blockers are neuroprotective. This, plus the rapid tetrodotoxin-sensitive Ca2+ overload of stretch-traumatized axons, points to "leaky" Nav channels as a pivotal early lesion in brain trauma. Direct effects of mechanical trauma on neuronal Nav channels have not, however, been tested. Here, we monitor immediate responses of recombinant neuronal Nav channels to stretch, using patch-clamp and Na+-dye approaches. Trauma constituted either bleb-inducing aspiration of cell-attached oocyte patches or abrupt uniaxial stretch of cells on an extensible substrate. Nav1.6 channel transient current displayed irreversible hyperpolarizing shifts of steady-state inactivation [availability(V)] and of activation [g(V)] and, thus, of window current. Left shift increased progressively with trauma intensity. For moderately intense patch trauma, a similar to 20-mV hyperpolarizing shift was registered. Nav1.6 voltage sensors evidently see lower energy barriers posttrauma, probably because of the different bilayer mechanics of blebbed versus intact membrane. Na+ dye-loaded human embryonic kidney (HEK) cells stably transfected with alpha Nav1.6 were subjected to traumatic brain injury-like stretch. Cytoplasmic Na+ levels abruptly increased and the trauma-induced influx had a significant tetrodotoxin-sensitive component. Nav1.6 channel responses to cell and membrane trauma are therefore consistent with the hypothesis that mechanically induced Nav channel leak is a primary lesion in traumatic brain injury. Nav1.6 is the CNS node of Ranvier Nav isoform. When, during head trauma, nodes experienced bleb-inducing membrane damage of varying intensities, nodal Nav1.6 channels should immediately "leak" over a broadly left-smeared window current range.	[Wang, Jun A.; Lin, Wei; Morris, Terence; Banderali, Umberto; Juranka, Peter F.; Morris, Catherine E.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8M5, Canada		Morris, CE (corresponding author), Ottawa Hosp, Res Inst, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	cmorris@uottawa.ca	Banderali, Umberto/AAW-2463-2021	Morris, Catherine/0000-0002-7401-6545	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada	This work was supported by a grant to C.E. Morris from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada.	Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Baptiste DC, 2008, EXPERT OPIN EMERG DR, V13, P63, DOI [10.1517/14728214.13.1.63, 10.1517/14728214.13.1.63 ]; Bement WM, 2007, CURR OPIN CELL BIOL, V19, P95, DOI 10.1016/j.ceb.2006.12.001; BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603, DOI 10.1007/BF00370302; BLANCHARD CE, 1985, J NEUROCYTOL, V14, P1053, DOI 10.1007/BF01224812; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; Duprat F, 2000, MOL PHARMACOL, V57, P906; Fayaz I, 2000, J NEUROSCI METH, V102, P69, DOI 10.1016/S0165-0270(00)00282-X; FIELDS RD, 1988, BRAIN RES, V443, P231, DOI 10.1016/0006-8993(88)91617-4; FLEIG A, 1994, PFLUG ARCH EUR J PHY, V427, P399, DOI 10.1007/BF00374253; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Laitko U, 2004, J GEN PHYSIOL, V123, P135, DOI 10.1085/jgp.200308965; Laitko U, 2006, J GEN PHYSIOL, V127, P687, DOI 10.1085/jgp.200509394; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; MAKITA N, 1994, J BIOL CHEM, V269, P7571; Makita N, 1996, CIRC RES, V78, P244, DOI 10.1161/01.RES.78.2.244; Mantegazza M, 2005, J NEUROSCI, V25, P3341, DOI 10.1523/JNEUROSCI.0104-05.2005; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Moran O, 2003, NEUROSCI LETT, V336, P175, DOI 10.1016/S0304-3940(02)01284-3; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Morris CE, 2007, CURR TOP MEMBR, V59, P297, DOI 10.1016/S1063-5823(06)59011-8; Morris Catherine E., 2006, V322, P315; Patra M, 2005, EUR BIOPHYS J BIOPHY, V35, P79, DOI 10.1007/s00249-005-0011-0; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Qin N, 2003, EUR J BIOCHEM, V270, P4762, DOI 10.1046/j.1432-1033.2003.03878.x; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rosenberg LJ, 2005, GLIA, V49, P107, DOI 10.1002/glia.20096; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Shcherbatko A, 1999, BIOPHYS J, V77, P1945, DOI 10.1016/S0006-3495(99)77036-0; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shirahata E, 2006, J NEUROPHYSIOL, V96, P1347, DOI 10.1152/jn.01264.2005; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; Smith MR, 1998, J NEUROSCI, V18, P6093; Stadnicka A, 1999, ANESTHESIOLOGY, V90, P1671, DOI 10.1097/00000542-199906000-00024; STYS PK, 1993, P NATL ACAD SCI USA, V90, P6976, DOI 10.1073/pnas.90.15.6976; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tabarean IV, 1999, BIOPHYS J, V77, P758, DOI 10.1016/S0006-3495(99)76930-4; Teng YD, 1997, J NEUROSCI, V17, P4359; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; WAN X, 1995, J MEMBRANE BIOL, V145, P21; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Welch NC, 2008, NEUROPHARMACOLOGY, V55, P1165, DOI 10.1016/j.neuropharm.2008.07.015; Wiggins P, 2005, BIOPHYS J, V88, P880, DOI 10.1529/biophysj.104.047431; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xiao YF, 2006, AM J PHYSIOL-CELL PH, V290, pC362, DOI 10.1152/ajpcell.00296.2005; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P117, DOI 10.1111/j.1469-7793.2000.t01-1-00117.x	65	54	54	0	4	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6143	1522-1563		AM J PHYSIOL-CELL PH	Am. J. Physiol.-Cell Physiol.	OCT	2009	297	4					C823	C834		10.1152/ajpcell.00505.2008			12	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	501KY	WOS:000270381900005	19657055	Green Published			2022-02-06	
J	Huska, D; Hubalek, J; Adam, V; Vajtr, D; Horna, A; Trnkova, L; Havel, L; Kizek, R				Huska, Dalibor; Hubalek, Jaromir; Adam, Vojtech; Vajtr, David; Horna, Ales; Trnkova, Libuse; Havel, Ladislav; Kizek, Rene			Automated nucleic acids isolation using paramagnetic microparticles coupled with electrochemical detection	TALANTA			English	Article						mRNA; Isolation; Magnetic particle and bead; Cyclic voltammetry; Square wave voltammetry; Brain tissue; Maize plants; Cadmium	TRAUMATIC BRAIN-INJURY; ELIMINATION VOLTAMMETRY; MAGNETIC PARTICLES; DNA HYBRIDIZATION; OSZILLOGRAPHISCHE POLAROGRAPHIE; CARBON ELECTRODES; GENOMIC DNA; NANOPARTICLES; EXTRACTION; OLIGONUCLEOTIDES	Easy, efficient and low demanding separation of mRNA from biological material is needed to study gene expression and to use in chip technologies. It is common knowledge that each mRNA molecule contains sequence of 25 adenines. This feature can be used for binding mRNA on the surface of the particles coated by thymine chains. The present work reports on suggesting and optimizing of mRNA separation and detection from biological material via paramagnetic microparticles coupled with electrochemical detection. Primarily we optimized cyclic and square wave voltammetric conditions to detect poly(A),which was used as standard to mimic behaviour of mRNA. Under the optimized square wave voltammetric conditions (frequency 280 Hz, accumulation time 200 s, supporting electrolyte and its temperature: acetate buffer 4.6 and 35 degrees C) we estimated detection limit down to 1 ng of poly(A) per ml. To enhance effectiveness and repeatability of isolation of nucleic acid automated approach for rinsing and hybridizing was proposed. We optimized the whole procedure and experimental conditions. Using automated way of isolation and under optimized conditions the yield of poly(A) (isolated concentration of poly(A)/given concentration of poly(A)*100) was approximately 75%. The suggested and optimized method for poly(A) isolation and detection was utilized for the analysis of brain tissues of patients with traumatic brain injury. The total amount of isolated mRNA varied from 40 to 760 g of mRNA per g of brain tissue. The isolation of mRNA from six samples per run was not longer than 2.5 h. Moreover, we applied the optimized procedure on fully automated pipetting instrument to isolate mRNA. The instrument was successfully tested on the analysis of extracts from roots of maize plants treated with cadmium(II) ions. (C) 2009 Elsevier B.V. All rights reserved.	[Huska, Dalibor; Adam, Vojtech; Kizek, Rene] Mendel Univ Agr & Forestry Brno, Dept Chem & Biochem, CZ-61300 Brno, Czech Republic; [Huska, Dalibor; Havel, Ladislav] Mendel Univ Agr & Forestry Brno, Dept Plant Biol, CZ-61300 Brno, Czech Republic; [Hubalek, Jaromir] Brno Univ Technol, Fac Elect Engn & Commun, Dept Microelect, CZ-60200 Brno, Czech Republic; [Adam, Vojtech] Mendel Univ Agr & Forestry Brno, Fac Agron, Dept Anim Nutr & Forage Prod, CZ-61300 Brno, Czech Republic; [Vajtr, David] Charles Univ Prague, Fac Med 2, Dept Clin Biochem & Pathobiochem, CZ-15006 Prague 5, Czech Republic; [Horna, Ales] Tomas Bata Univ, Fac Technol, CZ-76272 Zlin, Czech Republic; [Trnkova, Libuse] Masaryk Univ, Fac Sci, Dept Chem, CZ-61137 Brno, Czech Republic		Kizek, R (corresponding author), Mendel Univ Agr & Forestry Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.	kizek@sci.muni.cz	Kizek, Rene/D-7748-2012; Horna, Ales/H-6388-2012; Hubalek, Jaromir/D-7753-2012; Adam, Vojtech/D-7686-2012; Huska, Dalibor/M-8285-2019; Huska, Dalibor/J-9493-2018; Havel, Ladislav/C-8954-2012	Hubalek, Jaromir/0000-0002-7496-2558; Adam, Vojtech/0000-0002-8527-286X; Huska, Dalibor/0000-0003-3852-8751; Havel, Ladislav/0000-0003-3378-2785; Kizek, Rene/0000-0002-0467-6169	GACRGrant Agency of the Czech Republic [102/08/1546, KAN208130801]	Financial support from the grant GACR 102/08/1546 and KAN208130801 is highly acknowledged.	Abreu FC, 2002, BIOSENS BIOELECTRON, V17, P913, DOI 10.1016/S0956-5663(02)00082-9; Archer MJ, 2006, ANAL BIOCHEM, V355, P285, DOI 10.1016/j.ab.2006.05.005; Becker C, 2007, J MAGN MAGN MATER, V311, P234, DOI 10.1016/j.jmmm.2006.11.203; Brett AMO, 2003, ELECTROCHEM COMMUN, V5, P178, DOI 10.1016/S1388-2481(03)00014-6; Cao ZJ, 2006, ANAL CHIM ACTA, V557, P152, DOI 10.1016/j.aca.2005.10.048; Cler L, 2006, MOL CELL PROBE, V20, P191, DOI 10.1016/j.mcp.2005.12.003; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Diculescu VC, 2005, SENSORS-BASEL, V5, P377, DOI 10.3390/s5060377; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Fojta M, 2003, ELECTROANAL, V15, P431, DOI 10.1002/elan.200390050; Fojta M, 2002, TALANTA, V56, P867, DOI 10.1016/S0039-9140(01)00660-9; Gijs MAM, 2004, MICROFLUID NANOFLUID, V1, P22, DOI 10.1007/s10404-004-0010-y; Heer R, 2007, J MAGN MAGN MATER, V311, P244, DOI 10.1016/j.jmmm.2006.10.1154; Hsing IM, 2007, ELECTROANAL, V19, P755, DOI 10.1002/elan.200603785; Jaffrezic-Renault N, 2007, SENSORS-BASEL, V7, P589, DOI 10.3390/s7040589; Ki JS, 2007, J BIOSCI BIOENG, V103, P242, DOI 10.1263/jbb.103.242; Kinoshita T, 2007, J MAGN MAGN MATER, V311, P255, DOI 10.1016/j.jmmm.2006.10.1161; Kizek R, 2002, BIOELECTROCHEMISTRY, V55, P119, DOI 10.1016/S1567-5394(01)00139-6; Korbut O, 2003, SENSORS-BASEL, V3, P1, DOI 10.3390/s30100001; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Lagae L, 2005, IEE P-CIRC DEV SYST, V152, P393, DOI 10.1049/ip-cds:20050022; LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001; Lund-Olesen T, 2007, J MAGN MAGN MATER, V311, P396, DOI 10.1016/j.jmmm.2006.10.1171; Lunov O, 2007, J MAGN MAGN MATER, V311, P162, DOI 10.1016/j.jmmm.2006.10.1172; Matsunaga T, 1996, ANAL CHEM, V68, P3551, DOI 10.1021/ac9603690; Mikelova R, 2007, ELECTROANAL, V19, P348, DOI 10.1002/elan.200603739; Minc N, 2004, ANAL CHEM, V76, P3770, DOI 10.1021/ac035246b; Mykhaylyk O, 2007, J MAGN MAGN MATER, V311, P275, DOI 10.1016/j.jmmm.2006.10.1178; Ngomsik AF, 2005, CR CHIM, V8, P963, DOI 10.1016/j.crci.2005.01.001; Nikitin PI, 2007, J MAGN MAGN MATER, V311, P445, DOI 10.1016/j.jmmm.2006.10.1180; PALECEK E, 1958, NATURWISSENSCHAFTEN, V45, P186, DOI 10.1007/BF00621332; Palecek E, 2002, TALANTA, V56, P919, DOI 10.1016/S0039-9140(01)00666-X; Palecek E, 2002, ANAL CHIM ACTA, V469, P73, DOI 10.1016/S0003-2670(01)01605-1; PALECEK E, 1960, BIOCHEMISTRY-MOSCOW+, V25, P619; PALECEK E, 1960, COLLECT CZECH CHEM C, V25, P2283; Palecek E, 2007, TALANTA, V74, P276, DOI 10.1016/j.talanta.2007.08.020; Pichl L, 2005, TRANSFUSION, V45, P1106, DOI 10.1111/j.1537-2995.2005.04356.x; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Revyakin A, 2005, NAT METHODS, V2, P127, DOI 10.1038/nmeth0205-127; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Tomschik M, 1999, J ELECTROANAL CHEM, V476, P71, DOI 10.1016/S0022-0728(99)00369-1; Trnkova L, 2006, ELECTROANAL, V18, P662, DOI 10.1002/elan.200503447; Trnkova L, 2005, SENSORS-BASEL, V5, P448, DOI 10.3390/s5060448; Trnkova L, 2004, BIOELECTROCHEMISTRY, V63, P25, DOI 10.1016/j.bioelechem.2003.09.012; Trnkova L, 2000, ELECTROANAL, V12, P905, DOI 10.1002/1521-4109(200008)12:12<905::AID-ELAN905>3.0.CO;2-R; Trnkova L, 2002, BIOELECTROCHEMISTRY, V55, P131, DOI 10.1016/S1567-5394(01)00145-1; Vajtr D, 2007, CESK SLOV NEUROL N, V70, P515; Wang J, 2001, ANALYST, V126, P2020, DOI 10.1039/b106343j; Xu CJ, 2007, POLYM INT, V56, P821, DOI 10.1002/pi.2251; Yeung SW, 2006, BIOSENS BIOELECTRON, V21, P989, DOI 10.1016/j.bios.2005.03.008; Yu CH, 2007, J PHYS CHEM C, V111, P7879, DOI 10.1021/jp071289a	51	54	56	0	42	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	JUL 15	2009	79	2					402	411		10.1016/j.talanta.2009.04.007			10	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	473OK	WOS:000268216900046	19559897				2022-02-06	
J	Hayashi, T; Kaneko, Y; Yu, S; Bae, E; Stahl, CE; Kawase, T; van Loveren, H; Sanberg, PR; Borlongan, CV				Hayashi, Takuro; Kaneko, Yuji; Yu, SeongJin; Bae, EunKyung; Stahl, Christine E.; Kawase, Takeshi; van Loveren, Harry; Sanberg, Paul R.; Borlongan, Cesar V.			Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats	BRAIN RESEARCH			English	Article						Head injury; MMP-9; Cortex; Immunohistochemistry; Quantitative real-time PCR	CONTROLLED CORTICAL IMPACT; EXPRESSION; MATRIX-METALLOPROTEINASE-9; SYNAPTOGENESIS; THERAPY; DEATH; MICE	Recent laboratory evidence implicates matrix metalloproteinases (MMPs) as playing a pivotal role in ischemic and traumatic brain injuries (TBI). Here, quantitative real-time PCR analyses revealed that brains from TBI rats displayed significantly elevated MMP-9 expression at 24 h post-TBI, which remained upregulated at least until 48 h after injury. Immunohistochemical analyses similarly revealed significantly increased MMP-9 immunoreactivity at 24 and 48 h post-TBI. These results demonstrate that alterations in MMPs (i.e., MMP-9) commenced immediately after TBI, suggesting that treatment strategies designed to maintain MMP integrity should be initiated in the acute phase of injury. (C) 2009 Elsevier B.V. All rights reserved.	[Hayashi, Takuro; Kaneko, Yuji; Yu, SeongJin; Bae, EunKyung; van Loveren, Harry; Sanberg, Paul R.; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg, 12906 Bruce B Downs Blvd MDC78, Tampa, FL 33612 USA; [Stahl, Christine E.] Dwight D Eisenhower Army Med Ctr, Dept Internal Med, Ft Gordon, GA 30905 USA; [Kawase, Takeshi] Keio Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1608582, Japan		Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg, 12906 Bruce B Downs Blvd MDC78, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782			Chuck Y, 2008, MILD TRAUMATIC BRAIN; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LEE H, 2009, NEUROBIOL DIS   0106; MAMMIS A, 2008, SURG NEUROL     0910; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44	25	54	57	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 14	2009	1280						172	177		10.1016/j.brainres.2009.05.040			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	469OS	WOS:000267909800020	19464272				2022-02-06	
J	Yu, Z; Graudejus, O; Tsay, C; Lacour, SP; Wagner, S; Morrison, B				Yu, Zhe; Graudejus, Oliver; Tsay, Candice; Lacour, Stephanie P.; Wagner, Sigurd; Morrison, Barclay, III			Monitoring Hippocampus Electrical Activity In Vitro on an Elastically Deformable Microelectrode Array	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; in vitro studies; outcome measures; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SOURCE DENSITY ANALYSIS; STRETCH-INDUCED INJURY; SLICE CULTURES; MULTIELECTRODE ARRAY; INTEGRATED-CIRCUITS; RECORDINGS; STIMULATION; ELASTOMER; POLYIMIDE	Interfacing electronics and recording electrophysiological activity in mechanically active biological tissues is challenging. This challenge extends to recording neural function of brain tissue in the setting of traumatic brain injury (TBI), which is caused by rapid (within hundreds of milliseconds) and large (greater than 5% strain) brain deformation. Interfacing electrodes must be biocompatible on multiple levels and should deform with the tissue to prevent additional mechanical damage. We describe an elastically stretchable microelectrode array (SMEA) that is capable of undergoing large, biaxial, 2-D stretch while remaining functional. The new SMEA consists of elastically stretchable thin metal films on a silicone membrane. It can stimulate and detect electrical activity from cultured brain tissue (hippocampal slices), before, during, and after large biaxial deformation. We have incorporated the SMEA into a well-characterized in vitro TBI research platform, which reproduces the biomechanics of TBI by stretching the SMEA and the adherent brain slice culture. Mechanical injury parameters, such as strain and strain rate, can be precisely controlled to generate specific levels of damage. The SMEA allowed for quantification of neuronal function both before and after injury, without breaking culture sterility or repositioning the electrodes for the injury event, thus enabling serial and long-term measurements. We report tests of the SMEA and an initial application to study the effect of mechanical stimuli on neuron function, which could be employed as a high-content, drug-screening platform for TBI.	[Yu, Zhe; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Graudejus, Oliver; Tsay, Candice; Wagner, Sigurd] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Lacour, Stephanie P.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Lacour, Stephanie P./E-6375-2010; Morrison, Barclay/B-7132-2008; Lacour, Stephanie/AAR-2213-2020; Yu, Zhe/K-6180-2013	Morrison, Barclay/0000-0001-7676-0864; Lacour, Stephanie/0000-0001-9075-4022; Yu, Zhe/0000-0002-1401-2294	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R21 052794]; New Jersey Commission on Science and Technology; University Research Fellowship	The authors would like to acknowledge the assistance of J. Jones. This work was supported by NIH (NINDS R21 052794), the New Jersey Commission on Science and Technology, and a University Research Fellowship from the Royal Society (S.P.L.).	Beggs JM, 2003, J NEUROSCI, V23, P11167; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cheung KC, 2007, BIOSENS BIOELECTRON, V22, P1783, DOI 10.1016/j.bios.2006.08.035; CHIU SL, 1994, J APPL PHYS, V76, P5136, DOI 10.1063/1.357227; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; DEADWYLER SA, 1995, SCIENCE, V270, P1316, DOI 10.1126/science.270.5240.1316; Diogo ACM, 2003, J NEUROSCI, V23, P3881; Doetsch GS, 2000, PHYSIOL BEHAV, V69, P187, DOI 10.1016/S0031-9384(00)00201-8; Egert U, 1998, BRAIN RES PROTOC, V2, P229, DOI 10.1016/S1385-299X(98)00013-0; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Lacour SP, 2004, IEEE ELECTR DEVICE L, V25, P179, DOI 10.1109/LED.2004.825190; Li T, 2004, APPL PHYS LETT, V85, P3435, DOI 10.1063/1.1806275; Liu WF, 2001, IEEE T COMPON PACK T, V24, P520, DOI 10.1109/6144.946501; Madou MJ, 2002, FUNDAMENTALS MICROFA; Meacham KW, 2008, BIOMED MICRODEVICES, V10, P259, DOI 10.1007/s10544-007-9132-9; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; NISCH W, 1994, BIOSENS BIOELECTRON, V9, P737, DOI 10.1016/0956-5663(94)80072-3; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PASHLEY DW, 1960, PROC R SOC LON SER-A, V255, P218, DOI 10.1098/rspa.1960.0064; Ray AM, 2003, J NEUROSCI, V23, P10146; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Sanchez JC, 2006, EXP NEUROL, V198, P31, DOI 10.1016/j.expneurol.2005.10.031; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shimono K, 2002, J NEUROSCI METH, V120, P193, DOI 10.1016/S0165-0270(02)00202-9; Spaepen F, 2000, ACTA MATER, V48, P31, DOI 10.1016/S1359-6454(99)00286-4; Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131; TAMAI T, 1982, IEEE T COMPON HYBR, V5, P56, DOI 10.1109/TCHMT.1982.1135954; TAUBE JS, 1988, J NEUROSCI, V8, P1645; Thiebaud P, 1999, BIOSENS BIOELECTRON, V14, P61, DOI 10.1016/S0956-5663(98)00098-0; van Bergen A, 2003, BRAIN RES PROTOC, V11, P123, DOI 10.1016/S1385-299X(03)00024-2; Warren DJ, 2001, NEUROSCIENCE, V105, P19, DOI 10.1016/S0306-4522(01)00174-9; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3; Yu Z, 2007, NANO LETT, V7, P2188, DOI 10.1021/nl070291a; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	57	54	54	1	35	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2009	26	7					1135	1145		10.1089/neu.2008.0810			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	470HJ	WOS:000267965500018	19594385	Green Published			2022-02-06	
J	Itoh, T; Satou, T; Nishida, S; Tsubaki, M; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Tsubaki, Masahiro; Hashimoto, Shigeo; Ito, Hiroyuki			Expression of amyloid precursor protein after rat traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Amyloid precursor protein; traumatic brain injury; Alzheimer's disease; dystrophic neurites; APP overexpression	ALZHEIMERS-DISEASE; HEAD-INJURY; NEUROFIBRILLARY TANGLES; LEVELS DECREASE; HIPPOCAMPUS; DEPOSITION; IMMUNOREACTIVITY; PROLIFERATION; NEURONS; CELLS	Objective: Previous reports have demonstrated that some focal brain injuries increase amyloid precursor protein (APP) immunoreactivity in the region surrounding the injury in the cerebral cortex. However, the chronologic changes in APP expression have not been evaluated after traumatic brain injury (TBI). Methods: In this study, we immunohistochemically and biologically investigated chronologic changes in cellular sources and levels of APP production after rat TBI. Results: In the present report, we show that traumatic brain injury increased the expression of APP in the neuronal perikarya and in damaged dystrophic neurites from 1 to 90 days after injury. Moreover, 7 days after injury, some macrophages/microglia also were co-localized with APP, which was overproduced by the neuronal perikarya and APP-positive dystrophic neurites after injury and then APP were phagocytosed by macrophages/microglia during this phase. However, astroglia did not express APP immunopositivity after brain injury. Discussion: These results suggested that long-term overexpression of APP was confirmed by immunohistochemical and biologic technique after TBI. This may be related to the induction of Alzheimer type dementia and it is a very important risk factor for this disease. [Neurol Res 2009; 31: 103-109]	[Itoh, Tatsuki; Satou, Takao; Ito, Hiroyuki] Kinki Univ, Dept Pathol, Sch Med, Osakasayama City, Osaka 5898511, Japan; [Satou, Takao] Kinki Univ Hosp, Sch Med, Div Hosp Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ, Inst Life Sci, Div Sports Med, Osakasayama City, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Sch Pharmaceut Sci, Osakasayama City, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Dept Pathol, Sch Med, 377-2 Ohnohigashi, Osakasayama City, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp					Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Itoh T, 2005, NEUROL RES, V27, P429, DOI 10.1179/016164105X18476; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1988, LANCET, V2, P1456; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Xie YY, 2003, J NEUROSCI RES, V73, P557, DOI 10.1002/jnr.10667; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	30	54	56	0	4	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	FEB	2009	31	1					103	109		10.1179/016164108X323771			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	415BA	WOS:000263908100014	19228461				2022-02-06	
J	Bergquist, T; Gehl, C; Mandrekar, J; Lepore, S; Hanna, S; Osten, A; Beaulieu, W				Bergquist, Thomas; Gehl, Carissa; Mandrekar, Jay; Lepore, Susan; Hanna, Sherrie; Osten, Angela; Beaulieu, William			The effect of internet-based cognitive rehabilitation in persons with memory impairments after severe traumatic brain injury	BRAIN INJURY			English	Article						Cognitive rehabilitation; telemedicine	SELF-AWARENESS; TELEREHABILITATION; TELETHERAPY; OUTCOMES	Primary objective: The current study examined whether cognitive rehabilitation delivered over the Internet was associated with improvements in functioning. Research design: A total of 14 individuals with medically documented traumatic brain injury completed this study. Participants completed 30 sessions of an active calendar acquisition intervention and 30 sessions of a control diary intervention in a cross-over study design for a total of 60 online sessions. All sessions were completed using an instant messaging system via the Internet. Measures of cognitive functioning, ratings of memory and mood and frequency of use of common memory and cognitive compensation techniques were gathered from participants and family members. Main outcomes and results: There were no significant differences between the active and control conditions on the primary outcome measure of memory functioning. However, significant improvements in use of compensatory strategies as well as family reports of improved memory and mood were observed following completion of all sessions. Individuals with less use of compensatory strategies at baseline were significantly less likely to complete the study. Conclusions: These results suggest that the Internet may be an effective delivering mechanism for compensatory cognitive rehabilitation, particularly among individuals who are already utilizing some basic compensatory strategies.	[Bergquist, Thomas; Gehl, Carissa; Mandrekar, Jay; Lepore, Susan; Hanna, Sherrie; Osten, Angela; Beaulieu, William] Mayo Clin, Coll Med, Rochester, MN 55905 USA		Bergquist, T (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	bergquist.thomas@mayo.edu		Gehl, Carissa/0000-0003-4370-0624	National Institute for Disability and Rehabilitation Research (NIDRR)	This research was supported by a TBI Model System grant from the National Institute for Disability and Rehabilitation Research (NIDRR).	Bergquist T, 2008, BRAIN INJURY, V22, P891, DOI 10.1080/02699050802405487; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Day J. C., 2005, COMPUTER INTERNET US; Diamond BJ, 2003, NEUROREHABILITATION, V18, P171; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kupachi A., 2002, LONG TERM USE COMPEN; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Randolph C., 1998, RBANS MANUAL REPEATA; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Wade SL, 2005, REHABIL PSYCHOL, V50, P323, DOI 10.1037/0090-5550.50.4.323; WILKINSON RT, 1993, WIDE RANGE ACHIEVEME; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	22	54	54	1	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	10					790	799	PII 914076410	10.1080/02699050903196688			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	485SP	WOS:000269144600002	19697167				2022-02-06	
J	Nakase-Richardson, R; Sepehri, A; Sherer, M; Yablon, SA; Evans, C; Mani, T				Nakase-Richardson, Risa; Sepehri, Arash; Sherer, Mark; Yablon, Stuart A.; Evans, Clea; Mani, Tanja			Classification Schema of Posttraumatic Amnesia Duration-Based Injury Severity Relative to 1-Year Outcome: Analysis of Individuals with Moderate and Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Classification; Rehabilitation	HEAD-INJURY; BATTERY	Objective: Early investigations classified traumatic brain injury (TBI) severity according to posttraumatic amnesia (PTA) duration, designating "greater than 7 days" as the most severe. PTA durations of more than 7 days are common in neurorehabilitation populations. Moreover, no study has derived a PTA severity schema anchored to late outcome. The purpose of this study was to develop a PTA severity classification schema. Design: Prospective observational study. Setting: Rehabilitation hospital. Participants: Sample included TBI Model System participants (N=280) with known or imputed PTA duration during acute hospitalization and 1-year productivity status. Participants were primarily male (70%), median age of 27 years; and the most common mechanism of injury was motor vehicle collisions (79%). For study purposes, 4 injury severity groups were identified by observing differences in productivity associated with different PTA durations. Interventions: None. Main Outcome Measure: Productivity status at 1 year postinjury. Results: Fisher exact test comparisons revealed significant differences among 3 of the groups. Most individuals with PTA fewer than 14 days had favorable 1-year outcome (68% productive), whereas worse outcomes were associated with PTA more than 28 days (18% productive). Conclusions: If validated by other investigators, the proposed schema will be useful in determining prognosis for late functional status based on PTA duration.	[Nakase-Richardson, Risa] James A Haley Vet Hosp, Psychol Serv, James A Haley Vet Affairs Med Ctr, Tampa, FL 33612 USA; [Sepehri, Arash; Yablon, Stuart A.; Evans, Clea; Mani, Tanja] Methodist Rehabil Ctr, Jackson, MS USA; [Sepehri, Arash; Yablon, Stuart A.; Evans, Clea; Mani, Tanja] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Houston, TX 77030 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Psychol Serv, James A Haley Vet Affairs Med Ctr, 116B,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov			National Institute on Disability Rehabilitation and Research [H133A020514]	Supported by the National Institute on Disability Rehabilitation and Research (grant no. H133A020514).	BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Jennett B, 1981, MANAGEMENT HEAD INJU; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1954, BRIT MED BULL, V10, P65, DOI 10.1093/oxfordjournals.bmb.a069376; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Symonds CP, 1943, LANCET, V1, P7; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	25	54	54	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2009	90	1					17	19		10.1016/j.apmr.2008.06.030			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	397IY	WOS:000262657600003	19154824				2022-02-06	
J	Sorond, FA; Serrador, JM; Jones, RN; Shaffer, ML; Lipsitz, LA				Sorond, Farzaneh A.; Serrador, Jorge M.; Jones, Richard N.; Shaffer, Michele L.; Lipsitz, Lewis A.			THE SIT-TO-STAND TECHNIQUE FOR THE MEASUREMENT OF DYNAMIC CEREBRAL AUTOREGULATION	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Dynamic cerebral autoregulation; Sit-to-stand procedure; Transcranial Doppler ultrasound	BLOOD-FLOW-VELOCITY; TRANSCRANIAL DOPPLER ULTRASOUND; CRITICAL CLOSING PRESSURE; VALSALVA MANEUVER; HEAD-INJURY; HUMANS; HEMODYNAMICS; CIRCULATION; SONOGRAPHY; STRESS	Measurement of cerebral autoregulation is important for the evaluation and management of a number of clinical disorders that affect cerebral blood flow. We currently lack simple bedside measures that mimic common physiologic stresses. Therefore, we evaluated a new sit-to-stand technique as an alternative method to the frequently-used thigh-cuff technique in health, volunteers. Continuous middle cerebral artery (MCA) blood flow velocities (BFV) and arterial blood pressure (ABP) were measured in response to standing from a sitting position, or rapid thigh-cuff deflation in 24 healthy subjects (50 +/- 22). Autoregulatory index (ARI) was calculated as the BFNI response for step changes in 6P using a second-order differential equation with a set of parameters that can be used to grade the performance of autoregulation. Of these 24 subjects, 30% could tolerate only two thigh-cuffs and refused to proceed with the third cuff, whereas none of our subjects had any difficulty with performing the three sit-to-stand trials. The two techniques produced similar changes in mean ABP, but the times to nadir of the blood pressure and BFV were significantly faster for the thigh-cuff. The mean group ARIs were similar between the two techniques. Although between-subjects variability was higher for sit-to-stand ARIs, the within-subject sit-to-stand ART variability was small. Thus, for the assessment of cerebral autoregulation, the sit-to-stand procedure is well tolerated and produces ART values that have low, within-subject variability. The sit-to-stand technique appears to be a suitable measure of individual ART values for inferring dynamic cerebral autoregulation.	[Sorond, Farzaneh A.] Brigham & Womens Hosp, Dept Neurol, Stroke Div, Boston, MA 02115 USA; [Sorond, Farzaneh A.; Jones, Richard N.; Shaffer, Michele L.; Lipsitz, Lewis A.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Sorond, Farzaneh A.; Serrador, Jorge M.; Jones, Richard N.; Lipsitz, Lewis A.] Harvard Univ, Sch Med, Boston, MA USA; [Lipsitz, Lewis A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gerontol, Boston, MA 02215 USA; [Serrador, Jorge M.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Shaffer, Michele L.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA		Sorond, FA (corresponding author), Brigham & Womens Hosp, Dept Neurol, Stroke Div, 45 Francis St, Boston, MA 02115 USA.	fsorond@partners.org	Serrador, Jorge/A-9172-2009; Jones, Richard Norman/J-3488-2013	Jones, Richard Norman/0000-0002-1049-218X; Serrador, Jorge Manuel/0000-0003-1830-4398	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z01 AG000294] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005134, K12 AG000294, P01 AG004390-20, K12 AG000294-18, P50 AG005134-259004, P60 AG008812, P60 AG008812-15, K23 AG030967-01A1, P01 AG004390, K23 AG030967] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P60AG008812, P01AG004390, P50AG005134, K12AG000294, K23AG030967, Z01AG000294] Funding Source: NIH RePORTER		Aaslid R, 1999, ACT NEUR S, V72, P47; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Bakker SLM, 2004, NEUROEPIDEMIOLOGY, V23, P178, DOI 10.1159/000078503; BIRCH AA, 1995, STROKE, V26, P834, DOI 10.1161/01.STR.26.5.834; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; Clark JM, 1996, J CEREBR BLOOD F MET, V16, P1255, DOI 10.1097/00004647-199611000-00021; DAHL A, 1992, J CEREBR BLOOD F MET, V12, P1049, DOI 10.1038/jcbfm.1992.142; Dawson SL, 1999, J APPL PHYSIOL, V86, P675, DOI 10.1152/jappl.1999.86.2.675; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Folino AF, 2006, HEART, V92, P724, DOI 10.1136/hrt.2005.069179; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; GREENFIELD JC, 1984, STROKE, V15, P76, DOI 10.1161/01.STR.15.1.76; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; LARSEN FS, 1995, HEPATOLOGY, V22, P730, DOI 10.1016/0270-9139(95)90290-2; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lipsitz LA, 2000, STROKE, V31, P1897, DOI 10.1161/01.STR.31.8.1897; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Matz P G, 1997, Clin Neurosurg, V44, P267; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Novak V, 2006, DIABETES CARE, V29, P1529, DOI 10.2337/dc06-0261; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Oehm E, 2003, ULTRASOUND OBST GYN, V22, P395, DOI 10.1002/uog.183; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; Ratsep T, 2001, J NEUROSURG, V95, P393, DOI 10.3171/jns.2001.95.3.0393; Schroeter ML, 2005, J CEREBR BLOOD F MET, V25, P1675, DOI 10.1038/sj.jcbfm.9600159; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Serrador JM, 2005, J APPL PHYSIOL, V98, P151, DOI 10.1152/japplphysiol.00471.2004; Shrout Patrick E., 1995, P213; Sorond FA, 2005, J GERONTOL A-BIOL, V60, P1484, DOI 10.1093/gerona/60.11.1484; SORTEBERG W, 1989, ACTA NEUROCHIR, V97, P47, DOI 10.1007/BF01577739; SUGIMORI H, 1995, STROKE, V26, P2053, DOI 10.1161/01.STR.26.11.2053; TIECKS FP, 1995, STROKE, V26, P1386, DOI 10.1161/01.STR.26.8.1386; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; ULRICH PT, 1995, J NEUROL SCI, V129, P120, DOI 10.1016/0022-510X(94)00252-J; VORSTRUP S, 1992, Neurological Research, V14, P31; White RP, 1997, STROKE, V28, P1340, DOI 10.1161/01.STR.28.7.1340; Wieling W, 2007, CLIN SCI, V112, P157, DOI 10.1042/CS20060091	44	54	55	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-5629			ULTRASOUND MED BIOL	Ultrasound Med. Biol.	JAN	2009	35	1					21	29		10.1016/j.ultrasmedbio.2008.08.001			9	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	390DN	WOS:000262144600004	18834658	Green Accepted			2022-02-06	
J	Greenberg, G; Mikulis, DJ; Ng, K; DeSouza, D; Green, RE				Greenberg, Gahl; Mikulis, David J.; Ng, Kevin; DeSouza, Danielle; Green, Robin E.			Use of Diffusion Tensor Imaging to Examine Subacute White Matter Injury Progression in Moderate to Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Follow-up studies; Magnetic resonance imaging; Rehabilitation	AXONAL INJURY; HEAD-INJURY; FIBER TRACKING; MR; RECOVERY; EXPERIENCE; CONTUSIONS; APOPTOSIS; FEATURES; ATROPHY	Objective: To demonstrate subacute progression of white matter (WM) injury (4.5mo-2.5y postinjury) in patients with traumatic brain injury using diffusion-tensor imaging. Design: Prospective, repeated-measures, within-subjects design. Setting: Inpatient neurorehabilitation program and teaching hospital MRI department. Participants: Brain-injured adults (N=13) with a mean Glasgow Coma Scale score of 7.67 +/- 4.16. Interventions: Not applicable. Main Outcome Measures: :Fractional anisotropy (FA) values were measured at 4.5 and 29 months postinjury in right and left frontal and temporal deep WM tracts and the anterior and posterior corpus callosum. Results: FA significantly decreased in frontal and temporal tracts: right frontal (.38 +/-.06 to.30 +/-.06; P<.005), left frontal (.37 +/-.06 to.32 +/-.06; P<.05), right temporal (.28 +/-.05 to .22 +/-.018; P<.005), and left temporal (.28 +/-.05 to .24 +/-.02; P<.05). No significant changes were in the corpus callosum. Conclusions: Preliminary results demonstrate progression of WM damage as evidenced by interval changes in diffusion anisotropy. Future research should examine the relationship between decreased FA and long-term clinical outcome.	[DeSouza, Danielle; Green, Robin E.] Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Mikulis, David J.] Univ Hlth Network, Res Inst, Div Brain Imaging & Behav Syst, Toronto Western Div, Toronto, ON, Canada; [Greenberg, Gahl; Mikulis, David J.; Ng, Kevin] Univ Hlth Network, Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada; [DeSouza, Danielle; Green, Robin E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada		Green, RE (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	green.robin@torontorehah.on.ca	Mikulis, David J/H-5167-2019; DeSouza, Danielle/J-9821-2019	DeSouza, Danielle/0000-0001-6861-5691; Mikulis, David/0000-0003-3956-0892; Green, Robin/0000-0001-9451-3963	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Physicians' Services Incorporated; Ontario Mental Health Foundation [MOP-67072, 05-50, 2005-ABI-392]	Supported by the Canadian Institutes of Health Research, the Physicians' Services Incorporated, and the Ontario Mental Health Foundation (grant nos. MOP-67072, 05-50, 2005-ABI-392).	ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gean AD, 1994, IMAGING HEAD TRAUMA; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Hollingshead AB, 1958, SOCIAL CLASS MENTAL; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MACKENZIE JD, 2002, AM J NEURORADIOL, V23, P1442; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Watts R, 2003, MENT RETARD DEV D R, V9, P168, DOI 10.1002/mrdd.10077; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zhang XP, 2006, J NEUROTRAUM, V23, P1583, DOI 10.1089/neu.2006.23.1583	48	54	55	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2008	89	12		2			S45	S50		10.1016/j.apmr.2008.08.211			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	388DB	WOS:000261999400006	19081441				2022-02-06	
J	Mauritz, W; Wilbacher, I; Majdan, M; Leitgeb, J; Janciak, I; Brazinova, A; Rusnak, M				Mauritz, Walter; Wilbacher, Ingrid; Majdan, Marek; Leitgeb, Johannes; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin			Epidemiology, treatment and outcome of patients after severe traumatic brain injury in European regions with different economic status	EUROPEAN JOURNAL OF PUBLIC HEALTH			English	Article							HEAD-INJURY; MANAGEMENT; TRIAL; CARE; ADMISSIONS; EFFICACY	Background: We hypothesized that the economic status of a region might influence quality of care and outcome of patients with severe brain trauma. Methods: Between January 2001 and December 2005, 13 centres enrolled patients with severe brain trauma. Data on accident, treatment and outcomes were collected prospectively. The regions were classified as high income (Austria, five centres), upper middle income (UMI) (Croatia, Slovakia, six centres) or lower middle income (LMI) (Bosnia, Macedonia, two centres). Data on epidemiology, treatment and outcomes were compared according to this classification. Quality of care was assessed using a new scoring system. Results: A total of 1172 data sets were analysed. Patients from the wealthier regions were significantly older. Low-level falls and traffic accidents contributed to more than two-third of all cases. Violence-related trauma was significantly more frequent in middle income regions. Treatment quality was significantly different; treatment according to guidelines for brain trauma management was provided most frequently for patients from high-income regions. Compared with expected mortality rates, mortality was 6.5 lower in the high-income centres, 2.4 lower in the UMI centres and 13 higher in the LMI centres. Advanced age, poor neurological status, high trauma severity and poor quality of care were associated with significantly lower odds for survival. Conclusions: The association between the economic status and outcome of brain trauma patients was due to the quality of care. Successful implementation of guidelines for brain trauma management requires a well-funded health care system.	[Mauritz, Walter; Wilbacher, Ingrid; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin] INRO, A-1080 Vienna, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Leitgeb, Johannes] Univ Hosp Vienna, Dept Trauma Surg, Vienna, Austria; [Majdan, Marek; Brazinova, Alexandra; Rusnak, Martin] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia		Mauritz, W (corresponding author), INRO, Molkergasse 4-3, A-1080 Vienna, Austria.	walter.mauritz@igeh.org	Brazinova, Alexandra/C-4265-2016; Rusnak, Martin/K-9349-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Rusnak, Martin/0000-0003-3321-1042; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712			BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BULLOCK R, 1996, GUIDELINES MANAGEMEN; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Firsching R, 2001, WORLD J SURG, V25, P1221; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2003, CLIN RES REGUL AFF, V20, P81, DOI 10.1081/CRP-120018744; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	24	54	60	0	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1101-1262			EUR J PUBLIC HEALTH	Eur. J. Public Health	DEC	2008	18	6					575	580		10.1093/eurpub/ckn079			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	376FF	WOS:000261168800008	18794186	Bronze			2022-02-06	
J	Ma, M; Lindsell, CJ; Rosenberry, CM; Shaw, GJ; Zemlan, FP				Ma, Marek; Lindsell, Christopher J.; Rosenberry, Clark M.; Shaw, George J.; Zemlan, Frank P.			Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							HEAD-INJURY; PROTEIN; S-100B; QUESTIONNAIRE; RELIABILITY; SF-36	Objectives: Our objective was to determine if the biomarker for axonal injury, serum cleaved tau (C-tau), predicts postconcussion syndrome (PCS) in adults after mild traumatic brain injury (mTBI). Methods: C-tau was measured from blood obtained in the emergency department. Outcome was assessed at 3 months post injury using the Rivermead Postconcussion Symptoms Questionnaire and Acute Medical Outcomes SF-36v2 Health Survey (SF-36). Results: Of 50 patients, there were 15 patients with detectable levels of C-tau, 10 patients with abnormal findings on initial head computed tomography (CT) and 22 patients with PCS. One-third of patients with detectable C-tau and 14.3% of patients without detectable C-tau had abnormal findings on head CT (P = .143). Serum C-tau was not detected more frequently in patients with PCS than those without, neither for all patients (P = .115) nor the subgroup with negative head CT (P = .253). Conclusions: C-tau is a poor predictor of PCS after mTBI regardless of head CT result. (C) 2008 Elsevier Inc. All rights reserved.	[Ma, Marek] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Lindsell, Christopher J.; Rosenberry, Clark M.; Shaw, George J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Zemlan, Frank P.] Univ Cincinnati, Dept Psychiat, Cincinnati, OH USA		Ma, M (corresponding author), Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA.	mamarek@uphs.upenn.edu		Lindsell, Christopher/0000-0002-3297-2811	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R43-NS46822]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R43NS046822] Funding Source: NIH RePORTER	Research supported by National Institutes of Health grant R43-NS46822 (FPZ).	Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177	16	54	55	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	SEP	2008	26	7					763	768		10.1016/j.ajem.2007.10.029			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	352UF	WOS:000259522200005	18774039	Green Accepted			2022-02-06	
J	Ganesalingam, K; Yeates, KO; Ginn, MS; Taylor, HG; Dietrich, A; Nuss, K; Wright, M				Ganesalingam, Kalaichelvi; Yeates, Keith Owen; Ginn, Melissa Susan; Taylor, H. Gerry; Dietrich, Ann; Nuss, Kathy; Wright, Martha			Family burden and parental distress following mild traumatic brain injury in children and its relationship to post-concussive symptoms	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article; Proceedings Paper	35th Annual Meeting of the International-Neuropsychological-Society	FEB 07-10, 2007	Portland, OR	Int Neuropsychol Soc		children; family burden; mild traumatic brain injury; parental distress; post-concussive symptoms	MINOR HEAD TRAUMA; POSTCONCUSSION SYNDROME; NEUROBEHAVIORAL SYMPTOMS; ACADEMIC-PERFORMANCE; BEHAVIOR PROBLEMS; RELIABILITY; PREDICTORS; OUTCOMES	Objective To examine the relationship of mild traumatic brain injuries (TBI) and post-concussive symptoms (PCS) to post injury family burden and parental distress, using data from a prospective, longitudinal study. Methods Participants included 71 children with mild TBI with loss of consciousness (LOC), 110 with mild TBI without LOC, and 97 controls with orthopedic injuries not involving the head (OI), and their parents. Shortly after injury, parents and children completed a PCS interview and questionnaire, and parents rated premorbid family functioning. Parents also rated family burden and parental distress shortly after injury and at 3 months post injury. Results Mild TBI with LOC was associated with greater family burden at 3 months than OI, independent of socioeconomic status and premorbid family functioning. Higher PCS shortly after injury was related to higher ratings of family burden and distress at 3 months. Conclusions Mild TBI are associated with family burden and distress more than mild injuries not involving the head, although PCS may influence post injury family burden and distress more than the injury per se. Clinical implications of the current findings are noted in the Discussion section.	[Ganesalingam, Kalaichelvi; Yeates, Keith Owen; Ginn, Melissa Susan] Nationwide Childrens Hosp, Inst Res, Columbus, OH 43205 USA; [Ganesalingam, Kalaichelvi; Yeates, Keith Owen; Dietrich, Ann; Nuss, Kathy] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Ganesalingam, Kalaichelvi; Yeates, Keith Owen; Dietrich, Ann; Nuss, Kathy] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Ganesalingam, Kalaichelvi; Yeates, Keith Owen; Dietrich, Ann; Nuss, Kathy] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Dietrich, Ann; Nuss, Kathy] Nationwide Childrens Hosp, Dept Emergency Med, Columbus, OH USA		Ganesalingam, K (corresponding author), Nationwide Childrens Hosp, Inst Res, 700 Childrens Dr, Columbus, OH 43205 USA.	Kalaichelvi.Ganesalingam@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Nuss, Kathryn/0000-0003-2185-7364; Yeates, Keith/0000-0001-7680-2892	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD39834, R01 HD039834-05, HD44099, K02 HD044099, R01 HD039834] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039834, K02HD044099] Funding Source: NIH RePORTER		*AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; AYR LK, 2005, INT NEUR SOC 34 ANN, P202; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; CASEY R, 1986, PEDIATRICS, V78, P497; CASEY R, 1987, PEDIATRICS, V80, P159; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Kelly JP, 1997, NEUROLOGY, V48, P581; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W., 1997, CLIN NEUROPSYCHOL, V11, P305; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; *WHO, ICS 10 CLASS MENT BE; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	35	54	54	0	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUL	2008	33	6					621	629		10.1093/jpepsy/jsm133			9	Psychology, Developmental	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	306XT	WOS:000256282400005	18227110	Green Published, Green Accepted			2022-02-06	
J	Sanchez-Carrion, R; Gomez, PV; Junque, C; Fernandez-Espejo, D; Falcon, C; Bargallo, N; Roig-Rovira, T; Ensenat-Cantallops, A; Bernabeu, M				Sanchez-Carrion, Rocio; Gomez, Pere Vendrell; Junque, Carme; Fernandez-Espejo, Davinia; Falcon, Carles; Bargallo, Nuria; Roig-Rovira, Teresa; Ensenat-Cantallops, Antonia; Bernabeu, Montserrat			Frontal hypoactivation on functional magnetic resonance imaging in working memory after severe diffuse traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; functional MRI; traumatic brain injury; working memory	LANGUAGE-SPECIFIC CORTEX; DUAL-TASK PERFORMANCE; HEAD-INJURY; MS PATIENTS; ACTIVATION; REORGANIZATION; ATTENTION; FMRI; DEFICITS; COMA	Working memory is frequently impaired after traumatic brain injury (TBI). The present study aimed to investigate working memory deficits in patients with diffuse axonal injury and to determine the contribution of cerebral activation dysfunctions to them. Eighteen patients with severe TBI and 14 healthy controls matched for age and gender were included in the study. TBI patients were selected according to signs of diffuse axonal injury on computed tomography (CT) and without any evidence of focal lesions on MRI clinical examination. Functional magnetic resonance (fMRI) was used to assess brain activation during n-back tasks (0-, 2-, and 3-back). Compared to controls, the TBI group showed significant working memory impairment on the Digits Backwards (p = 0.022) and Letter-Number Sequencing subtests from the WAIS-III (p < 0.001) under the 2-back (p = 0.008) and 3-back (p = 0.017) conditions. Both groups engaged bilateral fronto-parietal regions known to be involved in working memory, although patients showed less cerebral activation than did controls. Decreased activation in TBI patients compared to controls was observed mainly in the right superior and middle frontal cortex. The correlation patterns differed between patients and controls: while the control group showed a negative correlation between performance and activation in prefrontal cortex (PFC), TBI patients presented a positive correlation in right parietal and left parahippocampus for the low and high working memory load, respectively. In conclusion, severe TBI patients with diffuse brain damage show a pattern of cerebral hypoactivation in the right middle and superior frontal regions during working memory tasks, and also present an impaired pattern of performance correlations.	[Gomez, Pere Vendrell; Junque, Carme; Fernandez-Espejo, Davinia] Univ Barcelona, Dept Psychiat & Clin Psychobiol, IDIBAPS, E-08036 Barcelona, Spain; [Gomez, Pere Vendrell; Junque, Carme; Fernandez-Espejo, Davinia] Inst Univ Neurorehabiltacio Guttmann, Dept Neuropsychol, Badalona, Spain; [Gomez, Pere Vendrell; Junque, Carme; Falcon, Carles; Bargallo, Nuria] IDIBAPS, Biomed Res Inst August Pi & Sunyer, Barcelona, Spain; [Falcon, Carles; Bargallo, Nuria] Hosp Clin Barcelona, CDI, Dept Radiol, Neuroradiol Sect, Barcelona, Spain; [Bernabeu, Montserrat] Inst Univ Neurorehabiltacio Guttmann, Head Injury Unit, Badalona, Spain		Junque, C (corresponding author), Univ Barcelona, Dept Psychiat & Clin Psychobiol, IDIBAPS, Casanova 143, E-08036 Barcelona, Spain.	cjunque@ub.edu	Fernandez-Espejo, Davinia/AAT-5481-2021; Vendrell, Pere/B-4392-2011; Bargallo, Nuria/G-6854-2016; Junque, Carme/B-4400-2011	Fernandez-Espejo, Davinia/0000-0001-5941-7546; Vendrell, Pere/0000-0001-8918-5440; Bargallo, Nuria/0000-0001-6284-5402; Junque, Carme/0000-0002-6381-3063; falcon, carles/0000-0001-5564-2025			ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 1999, BRAIN COGNITION, V41, P87, DOI 10.1006/brcg.1999.1097; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; Desmond JE, 2003, NEUROIMAGE, V19, P1510, DOI 10.1016/S1053-8119(03)00102-2; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Forn C, 2006, NEUROIMAGE, V31, P686, DOI 10.1016/j.neuroimage.2005.12.030; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Germano C, 2005, NEUROPSYCHOL REV, V15, P1, DOI 10.1007/s11065-005-3583-7; Gilbert B, 2005, NEUROPSYCHOLOGY, V19, P106, DOI 10.1037/0894-4105.19.1.106; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Higginson CI, 2003, BRAIN COGNITION, V52, P343, DOI 10.1016/S0278-2626(03)00180-5; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P965, DOI 10.1076/jcen.25.7.965.16490; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Jones JA, 2003, NEUROREPORT, V14, P1129, DOI 10.1097/00001756-200306110-00006; Jonides J, 1998, J NEUROSCI, V18, P5026; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mehta MA, 2000, J NEUROSCI, V20; Na D G, 2000, Korean J Radiol, V1, P19; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Pataraia E, 2005, NEUROLOGY, V64, P481, DOI 10.1212/01.WNL.0000150900.71773.E6; Pataraia E, 2004, NEUROLOGY, V63, P1825, DOI 10.1212/01.WNL.0000144180.85779.9A; Penner IK, 2006, J PHYSIOL-PARIS, V99, P455, DOI 10.1016/j.jphysparis.2006.03.008; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Pfefferbaum A, 2001, NEUROIMAGE, V14, P7, DOI 10.1006/nimg.2001.0785; Poldrack Russell A, 2002, Top Magn Reson Imaging, V13, P61, DOI 10.1097/00002142-200202000-00005; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Price CJ, 2001, J COGNITIVE NEUROSCI, V13, P419, DOI 10.1162/08989290152001853; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Riecker A, 2002, NEUROCASE, V8, P417, DOI 10.1076/neur.8.5.417.16181; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Rossini P M, 2007, Eura Medicophys, V43, P241; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; TEASDALE G, 1974, LANCET, V2, P81; WECHSLER D, 1999, ESCALA INTENTELIGENC; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694; Wishart HA, 2004, NEUROLOGY, V62, P234, DOI 10.1212/01.WNL.0000103238.91536.5F; [No title captured]	85	54	54	1	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2008	25	5					479	494		10.1089/neu.2007.0417			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	303PY	WOS:000256054100005	18363509				2022-02-06	
J	Collins, CL; Micheli, LJ; Yard, EE; Comstock, RD				Collins, Christy L.; Micheli, Lyle J.; Yard, Ellen E.; Comstock, R. Dawn			Injuries sustained by high school rugby players in the United States, 2005-2006	ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE			English	Article							PERFORMANCE PROJECT; FOOTBALL INJURIES; RISK-FACTORS; ICE HOCKEY; EPIDEMIOLOGY; SPORTS; SOCCER; COHORT; SEASON; UNION	Objectives: To describe the incidence and characteristics of injuries among US high school rugby players and to identify possible injury risk factors. Design: Descriptive epidemiological study. Setting: The 2005 and 2006 US high school rugby seasons. Participants: A convenience sample of 121 boys' and girls' US high school rugby clubs. Main Exposures: Exposure to playing rugby. Main Outcome Measures: Incidence, characteristics, and risk factors of rugby injuries. Results: Enrolled clubs reported 594 injuries during 113 641 total high school rugby athletic exposures (81 627 practice exposures and 32 014 match exposures). Rugby injury rates were 5.2 injuries per 1000 total athletic exposures, 1.3 injuries per 1000 practice exposures, and 15.2 injuries per 1000 match exposures. The mean age of the injured athletes was 16.5 years (SD, 1.2 years; range, 13-19 years) and 87.0% were male. The most commonly injured body sites were the head (21.7%), ankle (13.3%), and shoulder (12.8%). Fractures (16.0%), concussions (15.8%), and ligament sprains ( incomplete tears) (15.7%) were the most common diagnoses. Practice and competition injuries were similar with respect to the proportion of concussions and head, shoulder, ankle, and knee injuries. More than half of all injuries resulted from being tackled (30.8%) and tackling (28.8%). Conclusions: As the popularity of youth rugby continues to grow in the United States, increasing numbers of physicians and certified athletic trainers will find themselves treating rugby-related injuries and answering questions from parents about the comparative safety of rugby. To our knowledge, this is the first large-scale study to describe injury rates and identify possible injury risk among US high school rugby players.	[Collins, Christy L.; Yard, Ellen E.; Comstock, R. Dawn] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Micheli, Lyle J.] Harvard Univ, Childrens Hosp, Sch Med, Div Sports Med, Boston, MA 02115 USA		Collins, CL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	christy.collins@nationwidechildrens.org					Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119, DOI 10.5694/j.1326-5377.1987.tb133299.x; DURIE RM, 2000, NZ J SPORTS MED, V28, P84; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; GARRAWAY M, 1995, LANCET, V345, P1485; GERRARD DF, 1994, BRIT J SPORT MED, V28, P229, DOI 10.1136/bjsm.28.4.229; *INT RUGB BOARD, 2007, LAWS GAM RUGB UN 200; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kucera KL, 2005, BRIT J SPORT MED, V39, P462, DOI 10.1136/bjsm.2004.013672; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; MAFFULI N, 2005, EPIDEMIOLOGY PEDIAT, P49; McIntosh Andrew S, 2005, Med Sport Sci, V49, P120, DOI 10.1159/000085394; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McManus A, 2004, J SCI MED SPORT, V7, P438, DOI 10.1016/S1440-2440(04)80261-5; Michael M, 2002, Clin Colorectal Cancer, V2, P93, DOI 10.3816/CCC.2002.n.015; MUELLER FO, FINAL REPORT N CARLO; *NAT COLL ATHL ASS, PAST ISS APPL; *NAT CTR CAT SPORT, 23 ANN REP FALL 1982; NATHAN M, 1983, S AFR MED J, V64, P132; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Pasque CB, 2000, AM J SPORT MED, V28, P509, DOI 10.1177/03635465000280041101; Powell JW, 1999, J ATHL TRAINING, V34, P277; Quarrie KL, 1996, BRIT J SPORT MED, V30, P53, DOI 10.1136/bjsm.30.1.53; Quarrie KL, 1995, BRIT J SPORT MED, V29, P263, DOI 10.1136/bjsm.29.4.263; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; ROUX CE, 1987, S AFR MED J, V71, P307; *RUGBYSMART, NZ RUGBYSMART PROGR; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Smith AM, 1997, AM J SPORT MED, V25, P500, DOI 10.1177/036354659702500413; Sparks J P, 1985, Br J Sports Med, V19, P71; Sparks J P, 1981, Br J Sports Med, V15, P30; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; *US RUGB REF ASS, US RUGB GUID APPL LA; WALLER AE, 1994, BRIT J SPORT MED, V28, P223, DOI 10.1136/bjsm.28.4.223; Weir MA, 1996, IRISH J MED SCI, V165, P165, DOI 10.1007/BF02940243; Yard EE, 2006, PEDIATRICS, V118, pE1342, DOI 10.1542/peds.2006-0834; 2004, RUGBY MAGAZINE	40	54	55	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	1072-4710			ARCH PEDIAT ADOL MED	Arch. Pediatr. Adolesc. Med.	JAN	2008	162	1					49	54		10.1001/archpediatrics.2007.1			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	248SQ	WOS:000252176100008	18180412	Bronze			2022-02-06	
J	Vanhaudenhuyse, A; Laureys, S; Perrin, F				Vanhaudenhuyse, Audrey; Laureys, Steven; Perrin, Fabien			Cognitive event-related potentials in comatose and post-comatose states	NEUROCRITICAL CARE			English	Article						coma; vegetative state; minimally conscious state; ERPs; N100; MMN; P300; N400	AUDITORY-EVOKED-POTENTIALS; MINIMALLY CONSCIOUS STATE; TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; MEDIAL TEMPORAL-LOBE; SUBJECTS OWN NAME; MISMATCH NEGATIVITY; INTRACEREBRAL POTENTIALS; PROGNOSTIC VALUE; PREDICTIVE-VALUE	We review the interest of cognitive event-related potentials (ERPs) in comatose, vegetative, or minimally conscious patients. Auditory cognitive ERPs are useful to investigate residual cognitive functions, such as echoic memory (MMN), acoustical and semantic discrimination (P300), and incongruent language detection (N400). While early ERPs (such as the absence of cortical responses on somatosensory-evoked potentials) predict bad outcome, cognitive ERPs (MMN and P300) are indicative of recovery of consciousness. In coma-survivors, cognitive potentials are more frequently obtained when using stimuli that are more ecologic or have an emotional content (such as the patient's own name) than when using classical sine tones.	[Perrin, Fabien] Univ Lyon 1, CNRS, UMR Neurosci Sensorielles Comportement Cognit 502, Lyon 07, France; [Vanhaudenhuyse, Audrey; Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Vanhaudenhuyse, Audrey; Laureys, Steven] Univ Liege, Dept Neurol, Liege, Belgium		Perrin, F (corresponding author), Univ Lyon 1, CNRS, UMR Neurosci Sensorielles Comportement Cognit 502, 50 Ave Tony Garnier, Lyon 07, France.	Fabien.Perrin@univ-lyonl.fr	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Vanhaudenhuyse, Audrey/AAP-2455-2020	Laureys, Steven/0000-0002-3096-3807; 			ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Carter BG, 2005, INTENS CARE MED, V31, P840, DOI 10.1007/s00134-005-2634-0; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; CONNOLLY JF, 1990, BRAIN LANG, V39, P302, DOI 10.1016/0093-934X(90)90016-A; DEGIORGIO CM, 1993, ACTA NEUROL SCAND, V87, P423; Dehaene S, 2004, COGNITIVE NEUROSCIEN; Fischer C, 1988, Agressologie, V29, P359; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Fischer C., 2001, EVALUATION NEUROPHYS, P169; GARCIALARREA L, 1992, J NEUROL NEUROSUR PS, V55, P792, DOI 10.1136/jnnp.55.9.792; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Glass I, 1998, CLIN ELECTROENCEPHAL, V29, P19, DOI 10.1177/155005949802900109; GOODIN DS, 1984, BRAIN, V107, P241, DOI 10.1093/brain/107.1.241; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Hagoort P, 1996, BRAIN, V119, P627, DOI 10.1093/brain/119.2.627; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; HARRIS DP, 1990, EAR HEARING, V11, P340, DOI 10.1097/00003446-199010000-00004; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Kotchoubey B, 2002, NEWS PHYSIOL SCI, V17, P38; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2003, NEUROSCI LETT, V352, P129, DOI 10.1016/j.neulet.2003.08.045; Kotchoubey B, 2001, NEUROSCI LETT, V310, P93, DOI 10.1016/S0304-3940(01)02057-2; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 1989, J Cogn Neurosci, V1, P38, DOI 10.1162/jocn.1989.1.1.38; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Lew HL, 1999, AM J PHYS MED REHAB, V78, P367, DOI 10.1097/00002060-199907000-00014; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; LITSCHER G, 1995, EVOKED POTENTIAL, V96, P413, DOI 10.1016/0168-5597(95)00045-T; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; MAROSI M, 1993, LANCET, V341, P1473, DOI 10.1016/0140-6736(93)90914-3; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Mutschler V, 1996, NEUROPHYSIOL CLIN, V26, P158, DOI 10.1016/0987-7053(96)89626-2; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 1992, ATTENTION BRAIN FUNC; Naccache L, 2005, CLIN NEUROPHYSIOL, V116, P988, DOI 10.1016/j.clinph.2004.10.009; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Perrin F, 2003, COGNITIVE BRAIN RES, V17, P36, DOI 10.1016/S0926-6410(03)00078-8; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Plum F., 1983, DIAGNOSIS STUPOR COM; POLICH J, 1989, J CLIN NEUROPHYSIOL, V6, P277, DOI 10.1097/00004691-198907000-00003; Prevec T., 1993, ELECTROENCEPHALOGR C, V87, pS130; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; Rees G, 2002, NEUROCASE, V8, P387, DOI 10.1093/neucas/8.5.387; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; Schoenle PW, 2004, NEUROREHABILITATION, V19, P329; SIGNORINO M, 1995, LANCET, V345, P255, DOI 10.1016/S0140-6736(95)90252-X; Signorino M, 1997, J PSYCHOPHYSIOL, V11, P59; SMITH ME, 1986, ELECTROEN CLIN NEURO, V63, P145, DOI 10.1016/0013-4694(86)90008-8; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; VERLEGER R, 1988, BIOL PSYCHOL, V27, P45, DOI 10.1016/0301-0511(88)90004-X; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O; [No title captured]	78	54	62	0	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care		2008	8	2					262	270		10.1007/s12028-007-9016-0			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	270KE	WOS:000253718900007	17990124				2022-02-06	
J	Carlsson, E; Paterson, BL; Scott-Findlay, S; Ehnfors, M; Ehrenberg, A				Carlsson, Eva; Paterson, Barbara L.; Scott-Findlay, Shannon; Ehnfors, Margareta; Ehrenberg, Anna			Methodological issues in interviews involving people with communication impairments after acquired brain damage	QUALITATIVE HEALTH RESEARCH			English	Article						communication impairment; qualitative research; interviewing; informed consent; fatigue	INFORMED-CONSENT; APHASIA; STROKE; PARTICIPANTS; EXPERIENCES; SELF; CONVERSATIONS; CHILDREN; VOICE	Qualitative research has made a significant contribution to the body of knowledge related to how people experience living with various chronic diseases and disabilities; however, the voices of certain vulnerable populations, particularly those with impairments that affect their ability to communicate, are commonly absent. In recent years, a few researchers have attempted to explore the most effective ways to ensure that the voices of people with communication impairments from acquired brain damages can be captured in qualitative research interviews; yet several methodological issues related to including this population in qualitative research remained unexamined. In this article, the authors draw on insights derived from their research on the experiences of adult survivors of stroke and traumatic brain injury to describe methodological issues related to sampling, informed consent, and fatigue in participant and researcher while also making some recommendations for conducting qualitative interviews with these populations.	Univ Orebro, Dept Hlth Sci, Orebro, Sweden; Univ New Brunswick, Tier 1 Canada Res Chair, Fredericton, NB, Canada; Univ Alberta, Dept Pediat, Edmonton, AB, Canada		Carlsson, E (corresponding author), Univ Orebro, Dept Hlth Sci, Orebro, Sweden.			Carlsson, Eva/0000-0002-0714-0167			Adams J, 2005, QUAL HEALTH RES, V15, P1293, DOI 10.1177/1049732305281761; Albrecht TL, 2005, CURR OPIN ONCOL, V17, P336, DOI 10.1097/01.cco.0000166654.23169.a2; Arscott K, 1999, PSYCHOL MED, V29, P1367, DOI 10.1017/S0033291799008715; Bargh JA, 2002, J SOC ISSUES, V58, P33, DOI 10.1111/1540-4560.00247; Beukelman D R, 1998, AUGMENTATIVE ALTERNA; BEUKELMAN DR, 1985, ARCH PHYS MED REHAB, V66, P675; BLOCH S, 1999, UNDERSTANDING TROUBL; Burton CR, 2000, J ADV NURS, V32, P301, DOI 10.1046/j.1365-2648.2000.01477.x; Camp DL, 2002, SOC SCI MED, V55, P823, DOI 10.1016/S0277-9536(01)00205-2; Carlsson E, 2004, J CLIN NURS, V13, P825, DOI 10.1111/j.1365-2702.2004.01023.x; Chesson, 2006, BR J LEARN DISABIL, V34, P11; DIKEMAN K, 1998, STROKE ENHANCING QUA, P103; Dockrell E., 2004, BILD PUBLICATIONS BR, V32, P161, DOI [10.1111/j.1468-3156.2004.00315.x, DOI 10.1111/J.1468-3156.2004.00315.X]; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Goldsmith M., 1996, HEARING VOICE PEOPLE; Goodson I. F., 2001, LIFE HIST RES ED SET; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P149, DOI 10.1007/BF01499323; HAMILTON I, 2000, THESIS LARAHOGSKOLAN; Hamilton RJ, 2006, QUAL HEALTH RES, V16, P821, DOI 10.1177/1049732306287599; Jimison HB, 1998, J AM MED INFORM ASSN, V5, P245, DOI 10.1136/jamia.1998.0050245; JOHNSTON JR, 1993, J SPEECH HEAR RES, V36, P973, DOI 10.1044/jshr.3605.973; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Killick J., 2001, COMMUNICATION CARE P; Kralik D, 2006, J ADV NURS, V53, P213, DOI 10.1111/j.1365-2648.2006.03717.x; Kvale S., 1996, INTERVIEWS INTRO QUA, V1st ed.; Lemieux L, 2001, SEX DISABIL, V19, P253, DOI 10.1023/A:1017953308761; LEWIS A, 2004, BRIT J LEARN DISABIL, V32, P191, DOI DOI 10.1111/J.1468-3156.2004.00313.X; Lyketsos CG, 2004, ALZ DIS ASSOC DIS, V18, P171; MCCOLL MA, 2002, DISABILITY REHABILIT, V22, P555; MCDOUGALL G, 2000, GERIATRIC NURSING RE, P322; Mead G.H., 1972, MIND SELF SOC; Mishler ElliotGeorge., 1986, RES INTERVIEWING CON; Montgomery JW, 2000, J SPEECH LANG HEAR R, V43, P293, DOI 10.1044/jslhr.4302.293; Moore TF, 2003, NURS SCI QUART, V16, P163, DOI 10.1177/0894318403251793251793; Moyle W, 2002, J ADV NURS, V39, P266, DOI 10.1046/j.1365-2648.2002.02273.x; Murphy J, 2005, HEALTH SOC CARE COMM, V13, P95, DOI 10.1111/j.1365-2524.2005.00528.x; Murphy J., 2000, BRIT J THERAPY REHAB, V7, P454; *NAT LIB MED, 2006, MED SUBJ HEAD; NEWBORN B, 1998, STROKE ENHANCING QUA, P189; Nilsson I, 1997, J ADV NURS, V25, P953, DOI 10.1046/j.1365-2648.1997.1997025953.x; Palmer BW, 2005, ARCH GEN PSYCHIAT, V62, P726, DOI 10.1001/archpsyc.62.7.726; Parr S, 2001, FOLIA PHONIATR LOGO, V53, P266, DOI 10.1159/000052681; Parr S., 1997, TALKING APHASIA LIVI; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; PATERSON B, 2001, REHABILITATION NURSI, V2, P48; Paterson B. L., 2001, META STUDY QUALITATI; Perry L, 2003, INT J NURS STUD, V40, P185, DOI 10.1016/S0020-7489(02)00060-3; Philpin SM, 2005, J ADV NURS, V50, P299, DOI 10.1111/j.1365-2648.2005.03393.x; Piamjariyakul U, 2006, WESTERN J NURS RES, V28, P602, DOI 10.1177/0193945906288582; SAMO MT, 1998, STROKE ENHANCING QUA, P189; SARNO MT, 1993, APHASIOLOGY, V7, P321, DOI 10.1080/02687039308249514; Simmons-Mackie NN, 2003, AM J SPEECH-LANG PAT, V12, P144, DOI 10.1044/1058-0360(2003/061); *SUBC BRAIN BEH SC, 1991, NTIS PUBL; Thorne S, 1997, RES NURS HEALTH, V20, P169; Thorne S, 2002, QUAL HEALTH RES, V12, P437, DOI 10.1177/104973202129120007; Yorkston KM, 2001, AM J SPEECH-LANG PAT, V10, P126, DOI 10.1044/1058-0360(2001/013)	56	54	54	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	DEC	2007	17	10					1361	1371		10.1177/1049732307306926			11	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	234BD	WOS:000251134800007	18000075				2022-02-06	
J	Hill-Briggs, F; Dial, JG; Morere, DA; Joyce, A				Hill-Briggs, Felicia; Dial, Jack G.; Morere, Donna A.; Joyce, Arthur			Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						accommodation; functional status; testing	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; SIGN-LANGUAGE; LATERALIZATION; REHABILITATION; PERFORMANCE; VALIDATION; ATTENTION; VALIDITY; DEFICITS	Conducting assessment with individuals with physical disability, visual impairment or blindness, and hearing impairment or deafness poses significant challenges for the neuropsychologist. Although standards for psychological testing have been devised to address assessment of persons with disabilities, little research has been conducted to validate neuropsychological test accommodation and modification practices that deviate from standard test administration or to develop test parameters and interpretive guidelines specifically for persons with different physical or sensory disabilities. This paper reviews issues pertaining to neuropsychological test selection and administration, common accommodation and modification practices, test development and validation, and disabilityrelated factors that influence interpretation of test results. Systematic research is needed to develop methodological parameters for testing and to ensure reliable and valid neuropsychological assessment practices for individuals with physical or sensory disabilities. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Johns Hopkins Sch Med, Baltimore, MD USA; Clin & Consulting Neuropsychol, Irving, TX USA; Gallaudet Univ, Washington, DC 20002 USA; N Texas State Univ, Vernon, TX USA		Hill-Briggs, F (corresponding author), Dept Med, 2024 E Monument St, Baltimore, MD 21205 USA.	fbriggsh@jhmi.edu		Hill-Briggs, Felicia/0000-0002-2804-3278			ALLEN DV, 1971, PSYCHON SCI, V24, P295; ALTENBACH JF, 1992, THESIS LOYOLA U CHIC; American Educational Research Association American Psychological Association National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; BIGLER ED, 1981, J CLIN PSYCHOL, V37, P849, DOI 10.1002/1097-4679(198110)37:4<849::AID-JCLP2270370430>3.0.CO;2-3; Bosworth RG, 1999, PSYCHOL SCI, V10, P256, DOI 10.1111/1467-9280.00146; BRADEN JP, 1994, DEAFNESS DEPRIVATION; BRIGGS PF, 1963, J CLIN PSYCHOL, V19, P427, DOI 10.1002/1097-4679(196310)19:4<427::AID-JCLP2270190417>3.0.CO;2-0; BRIGGS PF, 1960, J CLIN PSYCHOL, V16, P318, DOI 10.1002/1097-4679(196007)16:3<318::AID-JCLP2270160327>3.0.CO;2-N; Cattani A, 2005, BRAIN COGNITION, V58, P226, DOI 10.1016/j.bandc.2004.12.001; CHAN F, 1993, VOCATIONAL EVALUATIO, V26, P57; Charlier BL, 2000, Q J EXP PSYCHOL-A, V53, P349, DOI 10.1080/027249800390529; CLARK MD, 1985, THESIS U N CAROLINA; Corina DP, 2003, J COGNITIVE NEUROSCI, V15, P718, DOI 10.1162/089892903322307438; CORINA DP, 1992, SCIENCE, V255, P1258, DOI 10.1126/science.1546327; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DEE HL, 1969, CONFIN NEUROL, V31, P273; DEE HL, 1970, NEUROPSYCHOLOGIA, V8, P305, DOI 10.1016/0028-3932(70)90076-X; DEFILIPPO CL, 1981, THESIS WASHINGTON U; Dial J, 1990, MANUAL COMPREHENSIVE; DIAL JG, 1991, J VISUAL IMPAIR BLIN, V85, P153; DIAL JG, 1991, WORK WORTH DOING ADV, P47; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; EMMOREY K, 1993, COGNITION, V46, P139, DOI 10.1016/0010-0277(93)90017-P; Gannon J. R., 1981, DEAF HERITAGE NARRAT; GARAHAN MB, 1992, J AM GERIATR SOC, V40, P130, DOI 10.1111/j.1532-5415.1992.tb01932.x; GUTTERMAN J, 1985, J VISUAL IMPAIRM FEB, P55; HAMMILL DD, 1997, EXAMINER MANUAL COMP; HANSON VL, 1982, J EXP PSYCHOL LEARN, V8, P572, DOI 10.1037/0278-7393.8.6.572; HAUSER PC, 2000, THESIS GALLAUDET U; HAYES SP, 1942, OUTLOOK BLIND, V36, P225; HAYES SP, 1943, OUTLOOK BLIND, V37, P37; HOLM MB, 1998, HUMAN BRAIN FUNCT, P9; Iezzoni LI, 2001, J GEN INTERN MED, V16, P235, DOI 10.1046/j.1525-1497.2001.016004235.x; JOYCE A, 2004, J APPL REHABILITATIO, V35, P3; KASKEL LM, 1991, ISSUES PAPERS 5 NATL, P167; KASKEL LM, 1994, DIRECTIONS REHABILIT, V5; KOO DS, 2003, THESIS U ROCHESTER; Kuo HK, 2005, J AM GERIATR SOC, V53, P1154, DOI 10.1111/j.1532-5415.2005.53368.x; LaSasso Carol, 2003, J Deaf Stud Deaf Educ, V8, P250, DOI 10.1093/deafed/eng014; LEYBAERT J, 1983, CAHIERS PSYCHOL COGN, V3, P255; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; MacCluskie KC, 1998, J VISUAL IMPAIR BLIN, V92, P189, DOI 10.1177/0145482X9809200306; Maller S.J., 2003, OXFORD HDB DEAF STUD, P451; Mangiameli LJ, 1999, ARCH CLIN NEUROPSYCH, V14, P701; Mangiameli LJ, 1998, ARCH CLIN NEUROPSYCH, V13, P89; MARCOTTE AC, 1987, BRAIN LANG, V31, P276, DOI 10.1016/0093-934X(87)90075-7; Marschark M., 1997, RAISING ED DEAF CHIL; McCay V, 2005, J DEAF STUD DEAF EDU, V10, P225, DOI 10.1093/deafed/eni024; McCay V, 2001, AM ANN DEAF, V146, P429, DOI 10.1353/aad.2012.0200; MCGEE JM, 1994, THESIS U N TEXAS DEN; MCKEE DE, 1988, THESIS U PITTSBURGH; MEADOW KP, 1980, DEAFNESS CHILD DEV; Miller J.C., 2003, J VISUAL IMPAIRMENT, V97, P769; Miller K R, 2001, J Deaf Stud Deaf Educ, V6, P226, DOI 10.1093/deafed/6.3.226; Mooradian AD, 1997, CLIN NEUROSCI, V4, P322; Nelson PA, 2002, REHABIL PSYCHOL, V47, P184, DOI 10.1037//0090-5550.47.2.184; Nelson PA, 2001, ARCH CLIN NEUROPSYCH, V16, P766; NEVILLE HJ, 1987, BRAIN RES, V405, P284, DOI 10.1016/0006-8993(87)90297-6; O'Keeffe J., 1994, IMPLICATIONS AM DISA, P1; Park WL, 2005, ARCH PHYS MED REHAB, V86, P79, DOI 10.1016/j.apmr.2004.01.021; POIZNER H, 1981, J EXP PSYCHOL HUMAN, V7, P1146, DOI 10.1037/0096-1523.7.5.1146; Pollard RQ, 2005, REHABIL PSYCHOL, V50, P258, DOI 10.1037/0090-5550.50.3.258; PRATT SI, 1998, TEST IMTERPRETATION, P349; PRICE JR, 1987, J VISUAL IMPAIR BLIN, V81, P28; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; RABECK DD, 1994, THESIS U N TEXAS DEN; Reid JMV, 1997, J VISUAL IMPAIR BLIN, V91, P546; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Rettenbach R, 1999, J COGNITIVE NEUROSCI, V11, P560, DOI 10.1162/089892999563616; RICH CC, 1965, PERS GUID J, V43, P912, DOI 10.1002/j.2164-4918.1965.tb02848.x; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; RODA M, 1987, LANGUAGE COGNITION D; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; SANTISTEVAN EF, 1998, THESIS GALLAUDET U; SCHILDROTH A, 1994, AM J AUDIOLOGY   JUL, P27; Shapiro BK, 2004, J PEDIATR-US, V145, pS3, DOI 10.1016/j.jpeds.2004.05.014; Smith D. K., 2002, ASSESSING INDIVIDUAL, P147; SPREEN O, 1995, DEV NEUROPSYCHOLOGY; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Tekin M, 2001, LANCET, V358, P1082, DOI 10.1016/S0140-6736(01)06186-4; *US CENS BUR, 2000, DIS STAT 2000; Vernon M., 1990, PSYCHOL DEAFNESS; WAINAPEL SF, 1989, ARCH PHYS MED REHAB, V70, P439, DOI 10.1016/0003-9993(89)90002-6; Wechsler D., 1997, WAIS 3 MANUAL; WESHSLER D, 1997, WECHSLER MEMORY SCAL; Wilson M, 1997, J Deaf Stud Deaf Educ, V2, P121; Wilson M, 1997, J Deaf Stud Deaf Educ, V2, P150; Wolfson, 1993, HALSTEAD REITAN NEUR; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; [No title captured]	92	54	54	2	22	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2007	22	3					389	404		10.1016/j.acn.2007.01.013			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	196IO	WOS:000248475100013	17303374	Bronze			2022-02-06	
J	Fins, JJ; Schiff, ND; Foley, KM				Fins, Joseph J.; Schiff, Nicholas D.; Foley, Kathleen M.			Late recovery from the minimally conscious state - Ethical and policy implications	NEUROLOGY			English	Article							PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; SCHIAVO,TERRI; REHABILITATION; DISORDERS; SCHIAVO,THERESA; REIMBURSEMENT; DIAGNOSIS	We consider the ethical and public policy implications of late recovery from the minimally conscious state in light of an Institute of Medicine exploratory meeting convened to discuss current knowledge about disorders of consciousness as well as a recently published study demonstrating axonal regrowth in a patient two decades after traumatic injury. Participants at the meeting (which included the authors) described a lack of research initiatives for basic investigations of patients in these states, the frequent warehousing of patients following a diagnosis of persistent vegetative state that limits their access to appropriate neurologic and diagnostic tests, and the breadth of public confusion about disorders of consciousness. Meeting participants encouraged the Institute to pursue a more formal study to outline both the need for research and the unique opportunities to study consciousness, now available through the use of neuroimaging and related technologies. Areas of initial focus would be to define the epidemiology of the minimally conscious state, elucidate mechanisms of recovery, and identify clinically useful diagnostic and prognostic markers that will aid decision making at the bedside.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Div Med Eth, Ithaca, NY 14853 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA		Fins, JJ (corresponding author), New York Presbyterian Weill Cornell Med Ctr, Div Med Eth, 435 E 70 St,Suite 4-J, New York, NY 10021 USA.	jjfins@med.cornell.edu		Fins, Joseph/0000-0002-7221-0053			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Banja J, 1999, BRAIN INJURY, V13, P745, DOI 10.1080/026990599121142; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Didion J, 2005, NEW YORK REV BOOKS, V52, P60; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; Fins JJ, 2005, HASTINGS CENT REP, V35, P8, DOI 10.1353/hcr.2005.0038; Fins JJ, 2005, NEW YORK REV BOOKS, V52, P63; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.2307/3527759; FINS JJ, 2003, NY TIMES MAGAZI 1019, P12; FINS JJ, 2006, PALLIATIVE ETHIC CAR, P48; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; JENNETT B, 1972, LANCET, V1, P734; Jennett B., 2002, VEGETATIVE STATE; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; OCONNOR A, 2005, NY TIMES        0404, pB1; Quill TE, 2005, NEW ENGL J MED, V352, P1630, DOI 10.1056/NEJMp058062; SCHIFF ND, 2003, CEREBRUM, V5, P7; SMOTHERS R, 1996, NY TIMES        0216; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wilson FC, 2002, NEUROREHABILITATION, V17, P231; Wolfson J, 2006, DEATH STUD, V30, P113, DOI 10.1080/07481180500455590; Wolfson J, 2005, HASTINGS CENT REP, V35, P16, DOI 10.1353/hcr.2005.0071; ZIMMER C, 2004, NY TIMES MAGAZI 0928, P52; [No title captured]	31	54	56	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	JAN 23	2007	68	4					304	307		10.1212/01.wnl.0000252376.43779.96			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	128EA	WOS:000243639800017	17242341				2022-02-06	
J	Newsome, MR; Scheibel, RS; Steinberg, JL; Troyanskaya, M; Sharma, RG; Rauch, RA; Li, XQ; Levin, HS				Newsome, Mary R.; Scheibel, Randall S.; Steinberg, Joel L.; Troyanskaya, Maya; Sharma, Rajkumar G.; Rauch, Ronald A.; Li, Xioaqi; Levin, Harvey S.			Working memory brain activation following severe traumatic brain injury	CORTEX			English	Article; Proceedings Paper	2nd International Conference on Working Memory	AUG 17-20, 2004	Kyoto, JAPAN			traumatic brain injury; working memory; fMRI	PREFRONTAL CORTEX; PARAMETRIC MANIPULATION; FUNCTIONAL MRI; TASK; FMRI; MECHANISMS	Functional magnetic resonance imaging (fMRI) has shown that brain activation during performance of working memory (WM) tasks under high memory loads is altered in adults with severe traumatic brain injury (TBI) relative to uninjured subjects (Perlstein et a]., 2004; Scheibel et al., 2003). Our study attempted to equate TBI patients and orthopedically injured (OI) subjects on performance of an N-Back task that used faces as stimuli. To minimize confusion in TBI patients that was revealed in pilot work, we presented the memory conditions in two separate tasks, 0-versus 1-back and 0- versus 2-back. In the 0- versus 1-back task, OI subjects activated bilateral frontal areas more extensively than TBI patients, and TBI patients activated posterior regions more extensively than OI subjects. In the 0- versus 2-back task, there were no significant differences between the groups. Analysis of changes in activation over time on I-back disclosed that OI subjects had decreases in bilateral anterior and posterior regions, while TBI patients showed activation increases in those and other areas over time. In the 2-back condition, both groups showed decreases over time in fusiform and parahippocampal gyri, although the OI group also showed increases over time in frontal, parietal, and temporal areas not seen in the TBI patients. The greatest group differences were found in the 1-back condition, which places low demand on WM. Although the extent of activation in the 2-back condition did not differ between the two groups, deactivation in the 2-back condition was seen in the OI patients only, and both groups' patterns of activation over time varied, suggesting a dissociation between the TBI and OI patients in recruitment of neural areas mediating WM.	Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA		Newsome, MR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 725, Houston, TX 77030 USA.	mnewsome@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889, NS-42772] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042772, R01NS021889] Funding Source: NIH RePORTER		Baddeley A.D., 1986, WORKING MEMORY; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brett M, 2002, 8 INT CONFERANCE FUN REGION INTEREST ANAL, V16; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen J, 2000, NEUROIMAGE, V11, P378, DOI 10.1006/nimg.2000.0573; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; DONALDSON W, 1992, J EXP PSYCHOL GEN, V121, P275, DOI 10.1037/0096-3445.121.3.275; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; Graham D.I., 2002, GREENFIELDS NEUROPAT; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mehta MA, 2000, J NEUROSCI, V20; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Proctor A, 2000, BRAIN INJURY, V14, P633; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Swanson HL, 1999, DEV PSYCHOL, V35, P986, DOI 10.1037/0012-1649.35.4.986; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Zhang JX, 2003, NEUROIMAGE, V20, P1531, DOI 10.1016/j.neuroimage.2003.07.016	39	54	56	2	11	MASSON DIVISIONE PERIODICI	MILANO	VIA MUZIO ATTENDOLO DETTO SFORZA 7-9, 20141 MILANO, ITALY	0010-9452			CORTEX	Cortex	JAN	2007	43	1					95	111		10.1016/S0010-9452(08)70448-9			17	Behavioral Sciences; Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	140MI	WOS:000244509000008	17334210				2022-02-06	
J	Niemeier, JP; Marwitz, JH; Lesher, K; Walker, WC; Bushnik, T				Niemeier, Janet P.; Marwitz, Jennifer H.; Lesher, Katrina; Walker, William C.; Bushnik, Tamara			Gender differences in executive functions following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							CARD SORTING TEST; DISABILITY RATING-SCALE; CEREBRAL-BLOOD-FLOW; HEAD-INJURY; TEST-PERFORMANCE; PREFRONTAL CORTEX; CONTUSION INJURY; SEX-DIFFERENCES; SCHIZOPHRENIA; RECOVERY	The present study used the National Institute on Disability Rehabilitation and Research (NIDRR) funded Traumatic Brain Injury Model Systems (TBIMS) database to examine the effect of gender on presentation of executive dysfunction following traumatic brain injury (TBI) and variables that might impact the course and degree of recovery. The Wisconsin Card Sort Test (WCST) was chosen as a measure of executive function which has good credentials without reports of gender effects. Female subjects performed significantly better on the WCST than male subjects as shown by analyses of variance on scores of 1,331 patients for Categories Achieved (means for females = 4.09, males = 3.67, p =.003) and Perseverative Responses (means for females = 32.17, males = 36.42, p =.003). Outperformance by females was also noted in additional ANOVAs examining the interaction of education and gender, and ethnicity and gender in relation to Categories Achieved (p < .01), and for ethnicity and gender in relation to Perseverative Responses (p < .01). A multiple logistic regression revealed that gender, minority status, education level, history of illicit drug use, cause of injury, and length of coma each contributed uniquely to predicting Categories Achieved on the WCST. Simple logistic regression analyses showed that, of these variables, gender and cause of injury ( violent vs. non-violent) were the strongest predictors. In contrast, when examining Perseverative Responses, regression analyses found gender, minority status and length of coma predicted impairment. Simple logistic regression analyses showed that, of these three variables, gender and minority status were most robust in predicting impaired Perseverative Responses scores. Implications of these findings are discussed and recommendations for further research are offered.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Santa Clara Valley Med Ctr, Rehabil Res Ctr Traumat Brain Injury & Spinal Cor, San Jose, CA 95128 USA		Niemeier, JP (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980661, Richmond, VA 23298 USA.	jniemeir@mail2.vcu.edu		Bushnik, Tamara/0000-0003-3328-257X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A020516, H133A011403] Funding Source: Medline		Alexander M, 2006, J INT NEUROPSYCH SOC, V12, P192, DOI 10.1017/S1355617706060292; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Barcelo F, 2000, REV NEUROLOGIA, V30, P855, DOI 10.33588/rn.3009.99451; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bartok E, 2005, PROG NEURO-PSYCHOPH, V29, P621, DOI 10.1016/j.pnpbp.2005.01.008; BASSO A, 1982, CORTEX, V18, P469, DOI 10.1016/S0010-9452(82)80044-0; Bengtson M, 2000, EPILEPSY BEHAV, V1, P112, DOI 10.1006/ebeh.2000.0051; Blume AW, 2005, ADDICT BEHAV, V30, P301, DOI 10.1016/j.addbeh.2004.05.019; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brodsky MB, 2003, J SPEECH LANG HEAR R, V46, P1124, DOI 10.1044/1092-4388(2003/088); CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; CROCKETT D, 1986, INT J NEUROSCI, V30, P241, DOI 10.3109/00207458608985674; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Denckla M B, 1994, FRAMES REFERENCE ASS, P117; Dolan M, 2002, MED SCI LAW, V42, P34, DOI 10.1177/002580240204200107; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Drake RJ, 2003, SCHIZOPHR RES, V62, P165, DOI 10.1016/S0920-9964(02)00382-1; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; FEY ET, 1951, J CONSULT PSYCHOL, V15, P311; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.7.1120-1122; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Granger CV., 1997, GUIDE UNIFORM DATA S; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; HAALAND KY, 1987, J GERONTOL, V42, P345, DOI 10.1093/geronj/42.3.345; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; HALLAHAN DP, 1997, ADV LEARN BEHAV DISA, V11, P27; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1981, MANUAL WISCONSIN CAR; HECK ET, 1986, J CLIN EXP NEUROPSYC, V8, P313, DOI 10.1080/01688638608401321; Heyer EJ, 2000, J CLIN EXP NEUROPSYC, V22, P633; Jensen O K, 2001, Ugeskr Laeger, V163, P5029; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; KIMURA D, 1983, CAN J PSYCHOL, V37, P19, DOI 10.1037/h0080696; Konishi S, 1999, CEREB CORTEX, V9, P745, DOI 10.1093/cercor/9.7.745; Lacerda ALT, 2003, PROG NEURO-PSYCHOPH, V27, P657, DOI 10.1016/S0278-5846(03)00076-9; Lacreuse A, 2004, BEHAV PROCESS, V67, P313, DOI 10.1016/j.beproc.2004.05.004; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LYON GR, 1994, FRAMES REFERENCE ASS; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Perecman E., 1987, FRONTAL LOBES REVISI; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Schwartz JRL, 2004, CLIN NEUROPHARMACOL, V27, P74, DOI 10.1097/00002826-200403000-00005; Shad MU, 2004, NEUROIMAGE, V22, P1315, DOI 10.1016/j.neuroimage.2004.03.016; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; STEIN DG, 1999, COGNITIVE NEUROREHAB, P73; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; SUMMERFELT AT, 1991, J ABNORM PSYCHOL, V100, P613, DOI 10.1037/0021-843X.100.4.613; Taras HL, 2003, PEDIATRICS, V112, P1206, DOI 10.1542/peds.2012-3932; van der Naalt J, 2000, BRAIN INJURY, V14, P781; WAGNER AK, 2004, 65 ANN AM AC PHYS ME; Weigl E, 1941, J ABNORM SOC PSYCH, V36, P3, DOI 10.1037/h0055544; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483	73	54	58	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2007	17	3					293	313		10.1080/09602010600814729			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	165IQ	WOS:000246298500002	17474058				2022-02-06	
J	Otani, N; Nawashiro, H; Fukui, S; Ooigawa, H; Ohsumi, A; Toyooka, T; Shima, K; Gomi, H; Brenner, M				Otani, Naoki; Nawashiro, Hiroshi; Fukui, Shinji; Ooigawa, Hidetoshi; Ohsumi, Atsushi; Toyooka, Terushige; Shima, Katsuji; Gomi, Hiroshi; Brenner, Michael			Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						astrocytes; glial fibrillary acidic protein; hippocampus; excitotoxicity; kainate; seizures; traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; PERCUSSION BRAIN-INJURY; LONG-TERM POTENTIATION; REACTIVE ASTROCYTES; TEMPORAL PROFILES; INDUCED LESIONS; EXPRESSION; JUVENILE	Astrocytes perform a variety of functions in the adult central nervous system. Recent evidence suggests that the upregulation of glial fibrillary acidic protein (GFAP), an astrocyte-specific intermediate filament component, is a biological marker of neurotoxicity after cerebral injury. We herein compared the response to traumatic brain injury or kainic acid (KA)-induced neurotoxicity in GFAP knockout (GFAP-KO) and wild-type (WT) mice. Seventy-two hours after injury, all GFAP-KO mice showed hippocampal CA3 neurodegeneration, whereas WT mice did not show neurodegeneration. Seventy-two hours after KA administration, GFAP-KO mice were more susceptible to KA-induced seizures and had an increased number of pyknotic damaged CA3 neurons than did WT mice. These results indicate that GFAP plays a crucial role in pyramidal neuronal survival after injury or KA-induced neurotoxicity. (C) 2006 Elsevier Ltd. All rights reserved.	Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan; Gunma Univ, Lab Gene Engn, Inst Mol & Cellular Regulat, Gunma, Japan; Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Otani, N (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	gra006@ad.ndmc.ac.jp					Bolton SJ, 1998, EXP NEUROL, V154, P231, DOI 10.1006/exnr.1998.6927; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; FITZPATRICK JS, 1992, INT J DEV NEUROSCI, V10, P313, DOI 10.1016/0736-5748(92)90020-Z; GORNI H, 1995, NEURON, V14, P29; GRAMSBERGEN JBP, 1994, BRAIN RES, V667, P216, DOI 10.1016/0006-8993(94)91499-0; Hu RQ, 1998, BRAIN RES, V810, P229, DOI 10.1016/S0006-8993(98)00863-4; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Lenz G, 1997, BRAIN RES, V764, P188, DOI 10.1016/S0006-8993(97)00456-3; LIEBERMAN AP, 1992, J BIOL CHEM, V267, P2123; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McKeon RJ, 1997, EXP NEUROL, V148, P558, DOI 10.1006/exnr.1997.6698; NADLER JV, 1980, BRAIN RES, V195, P47; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Nawashiro H, 2000, J CEREBR BLOOD F MET, V20, P1040, DOI 10.1097/00004647-200007000-00003; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Sporbert A, 1999, MOL BRAIN RES, V67, P258, DOI 10.1016/S0169-328X(99)00067-4; WENZEL J, 1991, BRAIN RES, V560, P122, DOI 10.1016/0006-8993(91)91222-M; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0	24	54	56	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2006	13	9					934	938		10.1016/j.jocn.2005.10.018			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	116ZK	WOS:000242842100010	17085299				2022-02-06	
J	Da Dalt, L; Marchi, AG; Laudizi, L; Crichiutti, G; Messi, G; Pavanello, L; Valent, F; Barbone, F				Da Dalt, L; Marchi, AG; Laudizi, L; Crichiutti, G; Messi, G; Pavanello, L; Valent, F; Barbone, F			Predictors of intracranial injuries in children after blunt head trauma	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						closed head trauma; childhood; intracranial injury; clinical assessment	PEDIATRIC-PATIENTS; BRAIN-INJURIES; CONSCIOUSNESS; MANAGEMENT; CT; HOSPITALIZATION; YOUNGER; CANCER; RISKS	This study was conducted to determine if clinical features can predict the risk of intracranial injury (ICI) in pediatric closed head trauma. We enrolled 3,806 children under 16 years consecutively referred for acute closed head trauma to the paediatric emergency room of five Italian children's hospitals. Relevant outcomes were death and diagnosis of ICI. Clinical symptoms and signs were evaluated as possible outcome predictors. Children were also classified into five groups according to their clinical presentation. The association of ICI with signs and symptoms and the appropriateness of the five-group classification in predicting the likelihood of ICI were evaluated by logistic regression analyses. ICI was diagnosed in 22 children; 2 of them died. The risk of fatal and nonfatal ICI was 0.5 and 5.2 per 1,000 children with closed head trauma respectively. Significant associations were found between ICI and loss ofThis study was conducted to determine if clinical features can predict the risk of intracranial injury (ICI) in pediatric closed head trauma. We enrolled 3,806 children under 16 years consecutively referred for acute closed head trauma to the paediatric emergency room of five Italian children's hospitals. Relevant outcomes were death and diagnosis of ICI. Clinical symptoms and signs were evaluated as possible outcome predictors. Children were also classified into five groups according to their clinical presentation. The association of ICI with signs and symptoms and the appropriateness of the five-group classification in predicting the likelihood of ICI were evaluated by logistic regression analyses. ICI was diagnosed in 22 children; 2 of them died. The risk of fatal and nonfatal ICI was 0.5 and 5.2 per 1,000 children with closed head trauma respectively. Significant associations were found between ICI and loss of consciousness, prolonged headache, persistent drowsiness, abnormal mental status, focal neurological signs, signs of skull fracture in non-frontal areas and signs of basal skull fracture. The five-group classification of children allowed an excellent prediction in terms of likelihood of ICI (ROC area 0.972). Conclusions: Selection of children with closed head trauma based on different combinations of signs and symptoms allows for early identification of subjects at different risk for ICI. In patients with minor head injuries, the absence of loss of consciousness, drowsiness, amnesia, prolonged headache, clinical evidence of basal or non-frontal skull fracture identified 100% of children without lesions. Validation of our results with a larger sample of patients with ICI would be highly desirable.	Univ Padua, Dipartimento Pediat, I-35128 Padua, Italy; IRCCS, Burlo Garofolo Trieste, Trieste, Italy; Univ Modena, Pediat Clin, I-41100 Modena, Italy; Univ Udine, Pediat Clin, I-33100 Udine, Italy; Univ Udine, Cattedra Igiene & Epidemiol, I-33100 Udine, Italy		Da Dalt, L (corresponding author), Univ Padua, Dipartimento Pediat, Via Giustiniani 3, I-35128 Padua, Italy.	dadalt@pediatria.unipd.it	Valent, Francesca/J-4759-2016	Valent, Francesca/0000-0002-4071-0897; Barbone, Fabio/0000-0003-1337-5111			Batchelor J, 2002, EMERG MED J, V19, P515, DOI 10.1136/emj.19.6.515; BEGG CB, 1991, STAT MED, V10, P1887, DOI 10.1002/sim.4780101205; Bergman DA, 1999, PEDIATRICS, V104, P1407; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown FD, 2000, J ACCID EMERG MED, V17, P268; DAVIES RL, 1995, PEDIATRICS, V95, P345; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; FERNANDEZ JB, 1998, ESP PEDIAT, V48, P122; Glasgow JFT, 2000, ARCH DIS CHILD, V82, P333, DOI 10.1136/adc.82.4.333; Greenes DS, 2003, ANN EMERG MED, V42, P515, DOI 10.1067/S0196-0644(03)00631-0; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; *ISTAT, 2000, CAUS MORT; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Jan MMS, 1997, J PEDIATR-US, V130, P134, DOI 10.1016/S0022-3476(97)70322-6; Kuppermann N, 2004, ARCH DIS CHILD, V89, P593, DOI 10.1136/adc.2003.046821; Langlois J., 2001, TRAUMATIC BRAIN INJU, P1; Le Hors-Albouze H, 2003, ARCH PEDIATRIE, V10, P82, DOI 10.1016/S0929-693X(03)00232-X; Murgio A, 2001, CHILD NERV SYST, V17, P257, DOI 10.1007/s003810000403; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014	35	54	54	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	MAR	2006	165	3					142	148		10.1007/s00431-005-0019-6			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	009RC	WOS:000235129000002	16311740				2022-02-06	
J	Ucar, T; Tanriover, G; Gurer, I; Onal, MZ; Kazan, S				Ucar, T; Tanriover, G; Gurer, I; Onal, MZ; Kazan, S			Modified experimental mild traumatic brain injury model	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						mild head injury; experimental; model	LATERAL FLUID-PERCUSSION; CEREBRAL-BLOOD-FLOW; HEAD-INJURY; AXONAL INJURY; RATS; PATHOPHYSIOLOGY; PATTERNS	Background: Experimental models of traumatic brain injury (TBI), using a variety of techniques and species, have been devised with the aim of producing repeatable lesions resembling those found in head injuries. There are various TBI models mentioned in the literature. In experimental head trauma models, emphasis has been placed on the severe head injuries. There are only a few models developed to study mild traumatic brain injury (MTBI). In fact, MTBI is as an important a problem as severe head injuries for neurosurgeons. Methods: Fifty-six male Sprague-Dawley rats were subjected to MTBI with a weight-drop device, which was described by Marmarou et al. The said model was used in its original form as well as in modified forms by employing different weights dropped from the same height. Animals were divided into four groups of 14 rats as follows: Group I (n = 14), head injury was induced using 450 g-1 m weight-height impact; Group II (n = 14), head injury was induced using 350 g-1 m weight-height impact; Group III (n = 14), head injury was induced using 300 g-1 m weight-height impact; Group IV (n = 14), control group, no injury was applied. Animals were evaluated neurologically, physiologically, electrophysiologically, and histopathologically. Results: Group I and II animals (450 and 350 g-1 m weight-height impact, respectively) showed the symptoms of severe head injury, whereas Group III animals (300 g-1 m) showed more MTBI symptoms. Conclusions: We recommend the application of the modified MTBI model used for group III (300 g-1 m weightheight impact) as the most appropriate and the simplest model for future MTBI studies.	Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Histol, TR-07070 Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Pathol, TR-07070 Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Neurol, TR-07070 Antalya, Turkey		Ucar, T (corresponding author), Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey.	tucar@akdeniz.edu.tr	Gurer, Inanc Elif/C-3042-2016; Kazan, Saim/G-1782-2016; Tanriover, Gamze/A-3196-2012	Tanriover, Gamze/0000-0002-8002-5544			Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1982, HEAD INJURY BASIC CL; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANDREWS R J, 1992, Neurological Research, V14, P12; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; KRUIKJ JR, 2001, BRAIN INJURY, V15, P99; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1966, NEUROTRAUMA; Marmarou A, 1990, Adv Neurol, V52, P233; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1974, NEURAL TRAUMA; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PARK HK, 1992, CRIT REV NEUROSURG, V26, P44; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Ricker JH, 2000, J HEAD TRAUMA REHAB, V15, P859, DOI 10.1097/00001199-200004000-00007; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613	39	54	54	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2006	60	3					558	565		10.1097/01.ta.0000209172.75637.db			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	026WX	WOS:000236374900020	16531854				2022-02-06	
J	Coats, B; Margulies, SS				Coats, Brittany; Margulies, Susan S.			Material properties of porcine parietal cortex	JOURNAL OF BIOMECHANICS			English	Article						gray matter; material properties; porcine; brain	BRAIN	Computational models of the head can be used to simulate events associated with traumatic brain injury and to design protective equipment and environments. Accurate material property descriptions of biological tissues are crucial to the development of computational models that mimic human responses. Recent finite element models of adult head injury assign distinct homogeneous properties to white and gray matter regions within the brain, based on limited regional data. However, white matter is usually considered homogeneous, despite recent reports of significant mechanical property differences between corpus callosum and corona radiata. In this study, we extend our investigation of homogeneity to gray matter by measuring stiffness of cerebral cortex and comparing it to thalamus from our previous work. Using a parallel plate shear-testing device, we performed a sequence of stress relaxation tests at 2.5%, 5%, 10%, 20%, 30%, 40%, and then 50% strain. Force and displacement were measured and used to determine the stiffness in two different porcine cortical gray matter regions. While no significant difference was found between the two cortical regions, cortical gray matter was significantly less stiff than previously reported values of porcine thalamic gray matter (p < 0.01) and human cortical gray matter (p < 0.001). These data indicate that while intraregional gray matter may be considered homogenous, there exists heterogeneity between differing regions of the brain. The assumption of gray matter homogeneity should be carefully considered in future finite element models of the head. (c) 2005 Elsevier Ltd. All rights reserved.	Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu	Coats, Brittany/A-4523-2009		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39679] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER		Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Bonovas PM, 2001, PHYSIOL MEAS, V22, P65, DOI 10.1088/0967-3334/22/1/309; King A. I., 2003, IRCOBI C LISB PORT; Miller RT, 1998, P 42 STAPP CAR CRASH; *NCIPC, 2001, INJ FACT BOOK 2001 2; OGDEN RW, 1984, NONLINEAR ELASTIC DE; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; SHUCK L, 1972, J BASIC ENG, P905; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P 39 STAPP CAR CRASH	10	54	54	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.		2006	39	13					2521	2525		10.1016/j.jbiomech.2005.07.020			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	094MG	WOS:000241242900020	16153652				2022-02-06	
J	Skold, MK; Risling, M; Holmin, S				Skold, MK; Risling, M; Holmin, S			Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						glial fibrillary acidic protein; microtubuli-associated protein 2; neuron-specific enolase; rat; S100 beta	FOCAL CEREBRAL-ISCHEMIA; INTRACEREBRAL INFLAMMATORY RESPONSE; STIMULATES AXONAL OUTGROWTH; VEGF MESSENGER-RNA; RAT-BRAIN; FACTOR EXPRESSION; SPINAL-CORD; PERMEABILITY FACTOR; IN-VITRO; NEUROBIOCHEMICAL MARKERS	Angiogenesis following traumatic brain injuries (TBIs) may be of importance for post-traumatic reparative processes and the development of secondary injuries. We have previously shown expression of vascular endothelial growth factor (VEGF), a major regulator of endothelial cell proliferation, angiogenesis and vascular permeability, and VEGF receptors (VEGFR1 and 2) after TBI in rat. In the present work we tried to further elucidate the role of VEGF after TBI by performing specific VEGFR2 activity inhibition. In rats subjected to VEGFR2 blockage we report an increased haemorrhagic area (P < 0.05), early increase in serum levels of neural injury marker neuron-specific enolase (P < 0.05) and glial injury marker S100 beta (P < 0.05), and increased numbers of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labelling- (TUNEL-) and FluoroJade B- (P < 0.05) positive cells, all increases preceding the known VEGF/VEGFR vascular response in brain trauma. An increase in lesion area, as measured by decreased microtubuli-associated protein 2 expression (P < 0.05) and increased glial fibrillary acidic protein reactivity (P < 0.05), could also be demonstrated. In addition, vascular density, as measured by von Willebrandt factor-positive cells, was decreased (P < 0.05). No differences in post-traumatic inflammatory response, as measured by stainings for macrophages, granulocytes and intracellular adhesion molecules, were shown between the groups. Taken together, our findings point towards VEGF/VEGFR2 up-regulation after TBI as being an important endogenous cytoprotective mechanism in TBI. The possible importance of VEGF on the vascular, neuronal and glial compartments of the neurovascular unit after TBI is discussed.	Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Def Med, FOI, S-17177 Stockholm, Sweden; Karolinska Inst, Ctr Trauma Res, S-17177 Stockholm, Sweden; Karolinska Univ Hosp, Dept Clin Neurosci, Sect Clin CNS Res, Stockholm, Sweden		Skold, MK (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8,B1-5, S-17177 Stockholm, Sweden.	Mattias.Skold@neuro.ki.se	SkAld, Mattias/AAJ-8253-2020	Holmin, Staffan/0000-0002-1628-1615			Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; BREIER G, 1992, DEVELOPMENT, V114, P521; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; COFFIN JD, 1991, DEV BIOL, V148, P51, DOI 10.1016/0012-1606(91)90316-U; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; DelZoppo GJ, 1997, ANN NY ACAD SCI, V823, P132; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Fong TAT, 1999, CANCER RES, V59, P99; Gelaw B, 2001, SURGERY, V130, P497, DOI 10.1067/msy.2001.115833; Gerber HP, 1999, DEVELOPMENT, V126, P1149; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; Goldman CK, 1997, NEUROSURGERY, V40, P1269, DOI 10.1097/00006123-199706000-00029; Guan Wei, 2003, Chin J Traumatol, V6, P218; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Heil M, 2000, EUR J CELL BIOL, V79, P850, DOI 10.1078/0171-9335-00113; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; HOLMIN S, 1997, INFLAMMATION BRAIN C; ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2000, NEUROSCIENCE, V100, P713, DOI 10.1016/S0306-4522(00)00331-6; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Kish PE, 2001, J NEURO-ONCOL, V53, P243, DOI 10.1023/A:1012222522359; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Krum JM, 2002, NEUROSCIENCE, V110, P589, DOI 10.1016/S0306-4522(01)00615-7; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO;2-7; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Provias J, 1997, NEUROSURGERY, V40, P1016, DOI 10.1097/00006123-199705000-00027; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Risau W, 1998, PATHOL BIOL, V46, P171; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Selheim F, 2002, FEBS LETT, V512, P107, DOI 10.1016/S0014-5793(02)02232-9; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Skold MK, 2004, EXP NEUROL, V188, P20, DOI 10.1016/j.expneurol.2004.03.024; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Sorci G, 1998, BBA-MOL CELL RES, V1448, P277, DOI 10.1016/S0167-4889(98)00134-7; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Takamoto Takeshi, 2001, Kobe Journal of Medical Sciences, V47, P181; Ulger H, 2002, ANAT HISTOL EMBRYOL, V31, P31, DOI 10.1046/j.1439-0264.2002.00357.x; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, TRENDS CARDIOVAS MED, V12, P62, DOI 10.1016/S1050-1738(01)00149-9	97	54	58	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JAN	2006	23	1					21	34		10.1111/j.1460-9568.2005.04527.x			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	008PG	WOS:000235052400003	16420412				2022-02-06	
J	Schmitt, A; Bertsch, T; Henning, U; Tost, H; Klimke, A; Henn, FA; Falkai, P				Schmitt, A; Bertsch, T; Henning, U; Tost, H; Klimke, A; Henn, FA; Falkai, P			Increased serum S100B in elderly, chronic schizophrenic patients: Negative correlation with deficit symptoms	SCHIZOPHRENIA RESEARCH			English	Article						.S100B; schizophrenia; negative symptoms; clozapine; haloperidol	CALCIUM-BINDING PROTEINS; TRAUMATIC BRAIN INJURY; NEUROTROPHIC ACTIVITY; ANTIPSYCHOTIC-DRUGS; ALZHEIMERS-DISEASE; S100-BETA PROTEIN; PREFRONTAL CORTEX; 5-HT1A RECEPTORS; S-100B PROTEIN; VERBAL FLUENCY	In schizophrenia, elevations of serum and CSF S100B levels have been reported and related to state of the disease and negative symptoms. In elderly chronic schizophrenic inpatients with stable medication, S100B may be increased and correlated to psychopathology and neuropsychological deficits. We have measured serum levels of S100B in 41 elderly, chronic schizophrenic patients and 23 age- and gender-matched controls using an immunoluminometric assay. In patients, we assessed detailed psychopathology and neuropsychological performance and determined serum levels of haloperidol, clozapine and its two main metabolites desmethylclozapine and clozapine metabolite N-oxid by HPLC. S100B levels were increased in elderly chronic schizophrenic patients compared to healthy controls. In patients, levels were negatively correlated with deficit symptoms and positively with age. There were no significant differences of S100B between medication groups and no correlation with serum levels of antipsychotics or neuropsychological scores. Elevations of S100B in elderly chronic schizophrenic patients may be related to an active disease process lasting until old-age. Correlations point to the impact of S100B in neuroplasticity and ageing. Post-mortem studies should clarify the presence of altered S100B function in the brain and its relationship to neuroplastic or neurodegenerative processes. (c) 2005 Elsevier B.V. All rights reserved.	Cent Inst Mental Hlth, D-68070 Mannheim, Germany; Clin Nuremberg, Inst Clin Chem & Lab Med, D-90419 Nurnberg, Germany; Univ Dusseldorf, Dept Psychiat, Neurobiochem Res Unit, D-40629 Dusseldorf, Germany; Univ Saarland, Dept Psychiat, D-66421 Homburg, Germany		Schmitt, A (corresponding author), Cent Inst Mental Hlth, POB 12 21 20, D-68070 Mannheim, Germany.	schmitt@zi-mannheim.de	Falkai, Peter/E-3273-2017; Tost, med. Dr. phil. Heike/AAX-8305-2020; Schmitt, Andrea/V-3003-2018	Falkai, Peter/0000-0003-2873-8667; Schmitt, Andrea/0000-0002-5426-4023; Klimke, Ansgar/0000-0002-1160-5270			Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Andreasen N., 1983, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; *ASS AM PSYCH, 1994, DSM 4 DIAGN STAT MAN; Azmitia EC, 2002, PROG BRAIN RES, V136, P87; AZMITIA EC, 1990, BRAIN RES, V516, P354, DOI 10.1016/0006-8993(90)90942-5; BENES FM, 1991, SCHIZOPHR RES, V5, P187, DOI 10.1016/0920-9964(91)90063-W; BHATTACHARYYA A, 1992, J NEUROBIOL, V23, P451, DOI 10.1002/neu.480230410; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRITH CD, 1995, BRIT J PSYCHIAT, V167, P343, DOI 10.1192/bjp.167.3.343; Gattaz WF, 2000, SCHIZOPHR RES, V43, P91, DOI 10.1016/S0920-9964(99)00146-2; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Griffin WST, 1998, NEUROBIOL AGING, V19, P401, DOI 10.1016/S0197-4580(98)00074-8; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu JR, 1997, J NEUROCHEM, V69, P2294; Ichikawa J, 1998, EUR J PHARMACOL, V351, P163, DOI 10.1016/S0014-2999(98)00308-2; Jahn T., 1989, Z KLIN PSYCHOL, V18, P257; Joyce EM, 1996, PSYCHOL MED, V26, P39, DOI 10.1017/S0033291700033705; KIRCH DG, 1992, J NEURAL TRANSM-GEN, V89, P219, DOI 10.1007/BF01250674; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Lewis DA, 2001, AM J PSYCHIAT, V158, P1411, DOI 10.1176/appi.ajp.158.9.1411; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Li YK, 1998, J NEUROCHEM, V71, P1421; MARSHAK DR, 1992, NEUROBIOL AGING, V13, P1, DOI 10.1016/0197-4580(92)90002-F; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; McKeating EG, 1998, ACT NEUR S, V71, P117; MELTZER HY, 1991, PHARMACOL REV, V43, P587; MELTZER HY, 1998, AM PSYCHIAT PRESS TX, P747; Newman-Tancredi A, 1998, EUR J PHARMACOL, V355, P245, DOI 10.1016/S0014-2999(98)00483-X; OKADO N, 1993, J NEUROBIOL, V24, P687, DOI 10.1002/neu.480240512; Oswald W. D., 1986, NURNBERGER ALTERS IN; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PENA LA, 1995, MOL BRAIN RES, V34, P118, DOI 10.1016/0169-328X(95)00145-I; Portela LVC, 2002, CLIN CHEM, V48, P950; Poyurovsky M, 1997, INT CLIN PSYCHOPHARM, V12, P263, DOI 10.1097/00004850-199709000-00003; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Reitan RM, 1992, TRAIL MAKING TEST; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Rothermundt M, 2004, INT REV NEUROBIOL, V59, P445; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Schroeter ML, 1999, FEBS LETT, V449, P241, DOI 10.1016/S0014-5793(99)00451-2; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SHENG JG, 1994, J NEUROSCI RES, V39, P398, DOI 10.1002/jnr.490390406; Thune JJ, 2000, BRAIN RES REV, V31, P200, DOI 10.1016/S0165-0173(99)00038-7; UEDA S, 1995, MOL BRAIN RES, V29, P365, DOI 10.1016/0169-328X(94)00269-K; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; VANELDIK LJ, 1991, BRAIN RES, V542, P280, DOI 10.1016/0006-8993(91)91579-P; WHITAKERAZMITIA PM, 1994, PERSPECT DEV NEUROBI, V2, P233; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	60	54	60	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964			SCHIZOPHR RES	Schizophr. Res.	DEC 15	2005	80	2-3					305	313		10.1016/j.schres.2005.04.013			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	004MT	WOS:000234757600017	15964742				2022-02-06	
J	Levenson, CW				Levenson, CW			Trace metal regulation of neuronal apoptosis: From genes to behavior	PHYSIOLOGY & BEHAVIOR			English	Article						zinc; copper; iron; Parkinson's disease; Wilson's disease; motor behavior; trauma; anorexia	SUPPRESSOR PROTEIN P53; CULTURED HUMAN NEURONS; ZINC-DEFICIENCY; PARKINSONS-DISEASE; BRAIN-INJURY; CELL-DEATH; SUBSTANTIA-NIGRA; NEURODEGENERATIVE DISORDERS; INDUCED NEUROTOXICITY; ALZHEIMERS-DISEASE	The genetically programmed form of neuronal death known as apoptosis plays a role in many neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and Huntington's disease. Apoptosis is also responsible for neuronal death after traumatic brain and spinal cord injury, stroke, and seizures. The cognitive and behavioral consequences of all of these disorders can be devastating. Unfortunately the mechanisms that regulate neuronal apoptosis are complex. However, it is this very complexity that provides us with a wide array of potential targets for the development of anti-apoptotic strategies. Thus, our lab is currently exploring the molecular and cellular mechanisms responsible for neuronal apoptosis, with a particular focus on the role of the metals copper, zinc, and iron. Each of these metals is essential for normal central nervous system (CNS) development and function. However, imbalances, either excess or deficiency. can result in neuronal apoptosis. In this review, we show the relationship between these metals in neurodegenerative disorders and CNS injury, and the mechanisms that govern neuronal survival and apoptosis. (c) 2005 Elsevier Inc. All rights reserved.	Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA		Levenson, CW (corresponding author), 237 Biomed Res Facil, Tallahassee, FL 32306 USA.	levenson@neuro.fsu.edu		Levenson, Cathy W/0000-0003-4463-3136			Ahn YH, 1998, EXP NEUROL, V154, P47, DOI 10.1006/exnr.1998.6931; Aldskogius H, 2001, MICROSC RES TECHNIQ, V54, P40, DOI 10.1002/jemt.1119; ANDREWS RCR, 1992, MED HYPOTHESES, V38, P284; Bartzokis G, 1999, ARCH NEUROL-CHICAGO, V56, P569, DOI 10.1001/archneur.56.5.569; Beard J, 2003, J NUTR, V133, P1174, DOI 10.1093/jn/133.4.1174; Beard JL, 2002, BEHAV BRAIN RES, V134, P517, DOI 10.1016/S0166-4328(02)00092-X; Berg D, 1999, ULTRASOUND MED BIOL, V25, P901, DOI 10.1016/S0301-5629(99)00046-0; Black MM, 2003, J NUTR, V133, p1473S, DOI 10.1093/jn/133.5.1473S; Blakemore LJ, 2004, NEUROREPORT, V15, P919, DOI 10.1097/00001756-200404090-00037; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Chakravarty I, 2002, NUTR REV, V60, pS53, DOI 10.1301/00296640260130740; Charriaut-Marlangue C, 2004, THERAPIE, V59, P185, DOI 10.2515/therapie:2004035; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Conti AC, 1998, J NEUROSCI, V18, P5663; Costello DJ, 2004, J NEUROL NEUROSUR PS, V75, P631, DOI 10.1136/jnnp.2003.027441; Cruz JAA, 2000, EUR J CLIN NUTR, V54, pS29, DOI 10.1038/sj.ejcn.1600981; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; DEXTER DT, 1987, LANCET, V2, P1219; Evans SA, 2004, METABOLISM, V53, P727, DOI 10.1016/j.metabol.2004.01.009; FREEDMAN LP, 1993, J CELL BIOCHEM, V51, P140, DOI 10.1002/jcb.240510205; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Grossberg GT, 2003, J CLIN PSYCHIAT, V64, P3; He Y, 2003, FREE RADICAL BIO MED, V35, P540, DOI 10.1016/S0891-5849(03)00385-X; HENKIN RI, 1975, ARCH NEUROL-CHICAGO, V32, P745, DOI 10.1001/archneur.1975.00490530067006; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Hotz C, 2001, NUTR REV, V59, P80; HUNT DM, 1972, J NEUROCHEM, V19, P2811, DOI 10.1111/j.1471-4159.1972.tb03818.x; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Koeppen AH, 2001, PEDIATR NEUROL, V25, P148, DOI 10.1016/S0887-8994(01)00269-7; Kreuter M, 2004, ARCH IMMUNOL THER EX, V52, P141; Levenson CW, 2004, EXP NEUROL, V190, P506, DOI 10.1016/j.expneurol.2004.08.014; Levenson CW, 2003, NUTR REV, V61, P311, DOI 10.1301/nr.2003.sept.311-313; Levenson CW, 2000, DEV BRAIN RES, V119, P105, DOI 10.1016/S0165-3806(99)00163-7; Libonati JP, 2000, NUTR NEUROSCI, V3, P425, DOI 10.1080/1028415X.2000.11747342; Lind T, 2003, AM J CLIN NUTR, V77, P883, DOI 10.1093/ajcn/77.4.883; Logroscino G, 1997, NEUROLOGY, V49, P714, DOI 10.1212/WNL.49.3.714; LOGROSCINO G, 1998, MOVEMENT DISORD, V13, pS13; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; MAES M, 1994, J AFFECT DISORDERS, V31, P135, DOI 10.1016/0165-0327(94)90117-1; Maes M, 1999, J AFFECT DISORDERS, V56, P189, DOI 10.1016/S0165-0327(99)00011-7; Mahmoodi MR, 2001, BIOL TRACE ELEM RES, V81, P93, DOI 10.1385/BTER:81:2:093; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Micheletti A, 2001, SPORTS MED, V31, P577, DOI 10.2165/00007256-200131080-00002; Montine KS, 2002, NEUROTOX RES, V4, P663, DOI 10.1080/1029842021000045435; Narayanan VS, 2001, J NUTR, V131, P1427, DOI 10.1093/jn/131.5.1427; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; Popescu BO, 2004, J ALZHEIMERS DIS, V6, P123; Prasad AS, 2001, NUTRITION, V17, P67, DOI 10.1016/S0899-9007(00)00469-X; Prasad AS, 2001, NUTRITION, V17, P685, DOI 10.1016/S0899-9007(01)00598-6; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Przedborski S, 2004, NEUROLOGIST, V10, P1, DOI 10.1097/01.nrl.0000106920.84668.37; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Schwartz D, 1998, SEMIN CANCER BIOL, V8, P325, DOI 10.1006/scbi.1998.0095; Shabanzadeh AP, 2004, NEUROSCI LETT, V356, P69, DOI 10.1016/j.neulet.2003.10.073; Sheline CT, 2002, ANN NEUROL, V52, P195, DOI 10.1002/ana.10276; Skinner JD, 1999, J AM DIET ASSOC, V99, P1514, DOI 10.1016/S0002-8223(99)00371-5; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Steveson TC, 2003, ENDOCRINOLOGY, V144, P188, DOI 10.1210/en.2002-220716; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Tsuchiya D, 2003, NEUROSURGERY, V53, P1179, DOI 10.1227/01.NEU.0000090341.38659.CF; TUCKER DM, 1984, NEUROBIOLOGY ZINC B, V11, P139; Vanlandingham JW, 2003, NUTR NEUROSCI, V6, P39, DOI 10.1080/1028415021000056041; VanLandingham JW, 2002, NEUROMOL MED, V1, P171; Vaquero M P, 2002, J Nutr Health Aging, V6, P147; WEIGAND E, 1978, NUTR METAB, V22, P101; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WIGGLESWORTH JM, 1988, BRAIN IRON NEUROCHEM, P25; Yeiser EC, 2002, NUTR NEUROSCI, V5, P345, DOI 10.1080/1028415021000033811; Yeiser EC, 1999, NEUROSCI LETT, V277, P75, DOI 10.1016/S0304-3940(99)00825-3; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25	82	54	59	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	OCT 15	2005	86	3					399	406		10.1016/j.physbeh.2005.08.010			8	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	982FP	WOS:000233143700018	16125208				2022-02-06	
J	Lu, KT; Wang, YW; Wo, YY; Yang, YL				Lu, KT; Wang, YW; Wo, YY; Yang, YL			Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						traumatic brain injuries; IL-1; mitogen-activated protein kinase	I-KAPPA-B; TRANSDUCTION PATHWAYS; PROTEIN-KINASES; INTERLEUKIN-1; RECEPTOR; VIVO; HIPPOCAMPUS; EXPRESSION; ISCHEMIA; TARGETS	Traumatic brain injury (TBI) is one of the most prevalent causes of morbidity and mortality in youth. Interleukin-1 (IL-1) has many roles in the brain in addition to mediating glial inflammatory response; it has also been implicated in neurodegenerative diseases. We demonstrated the signal transduction pathway of IL-1 overproduction-induced cortical neuron loss during TBI. A calibrated weight-drop device (450 g weight and 2 m height) was used to induce TBI in adult male Sprague-Dawley rats under general anesthesia (sodium pentobarbital: 40 mg/kg, i.p.). Expression of interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta), extracellular signal-regulated kinase (ERK), Jun, and p-38 were determined by Western blotting and RT-PCR. Neuronal damage was evaluated by microscopic examination. We found both mRNA and proteins of cortical IIL-1 alpha and IL-1 beta increased three hours after TBI. Phosphorylation of ERK significantly increased but there were no significant effects on cortical expression of ERK, Jun and p-38. Administration of ERK inhibitor, PD98059, IL-1 alpha antibody and IL-1 beta antibody protected animals from TBI-induced neuronal damage. Our results suggest that TBI-induced cortical neuron death was mediated by the IL-1 receptor through ERK phosphorylation. (C) 2005 Elsevier Ireland Ltd. All rights reserved.	Natl Chia Yi univ, Inst Biotechnol, Dept Mol Biol & Biochem, Chiayi, Taiwan; Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan		Yang, YL (corresponding author), Natl Chia Yi univ, Inst Biotechnol, Dept Mol Biol & Biochem, 300 Univ Rd, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw					Arbabi S, 2002, CRIT CARE MED, V30, pS74, DOI 10.1097/00003246-200201001-00010; BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; CALDWELL J, 1995, BLOOD, V86, P3364, DOI 10.1182/blood.V86.9.3364.bloodjournal8693364; Daun JM, 2000, J INTERF CYTOK RES, V20, P843, DOI 10.1089/10799900050163217; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FARRAR WL, 1987, J IMMUNOL, V139, P459; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Hallegua DS, 2002, ANN RHEUM DIS, V61, P960, DOI 10.1136/ard.61.11.960; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LaPointe MC, 1999, HYPERTENSION, V33, P276, DOI 10.1161/01.HYP.33.1.276; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Molina-Holgado F, 2000, J NEUROIMMUNOL, V111, P1, DOI 10.1016/S0165-5728(00)00344-1; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Paxino G, 1997, RAT BRAIN STEREOTAXI; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009	28	54	59	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP	2005	386	1					40	45		10.1016/j.neulet.2005.05.057			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	955GR	WOS:000231214300009	16024175				2022-02-06	
J	Shewchenko, N; Withnall, C; Keown, M; Gittens, R; Dvorak, J				Shewchenko, N; Withnall, C; Keown, M; Gittens, R; Dvorak, J			Heading in football. Part 1: Development of biomechanical methods to investigate head response	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PROFESSIONAL SOCCER PLAYERS; BRAIN-INJURY; INTRACRANIAL PRESSURE; BALL PROPERTIES; CONCUSSION; IMPACT; ACCELERATION; IMPAIRMENT; SKILL	Objectives: There has been growing controversy regarding long term effects of repeated low severity head impacts such as when heading a football. However, there are few scientific data substantiating these concerns in terms of the biomechanical head response to impact. The present study aimed to develop a research me thodology to investigate the biomechanical response of human subjects during intentional heading and identify strategies for reducing head impact severity. Methods: A controlled laboratory study was carried. but with seven active football players, aged. 20-23 and of average stature and weight. The subjects were fitted with photographic targets for kinematic analysis and instrumented to measure head linear/angular accelerations and neck muscle activity. Balls were delivered at two speeds (6 m/s 8 m/s) as the subjects executed several specific forward heading manoeuvres in the standing position." Heading "speeds up to 11 m/s were seen when the head closing. speed was considered. One subject demonstrating averaged flexion extension muscle activity phased with head acceleration data and upper torso kinematics was used to validate a biofidelic 50th percentile human model with a detailed head and neck. The model was exercised under ball incoming speeds of 6-7 m/s with parameter variations including torso/head alignment, neck muscle tensing, and follow through. The model output was subsequently compared with additional laboratory tests with football players (n = 3). Additional heading scenarios were investigated including follow through, non-active ball impact, and non-contact events. Subject and model head responses were evaluated with peak linear and rotational accelerations and maximum incremental head impact power. Results: Modelling of neck muscle tensing predicted lower head accelerations and higher neck loads whereas volunteer head acceleration reductions were not consistent. Modelling of head-torso alignment predicted a modest reduction in volunteer head accelerations. Exaggerated follow through while heading reduced volunteer head accelerations modestly. Conclusion: Biomechanical methods were developed to measure head impact response. Changing the h biomechanics of currently accepted heading techniques will have inconsistent benefits towards the reduction of head loading. Furthermore, mathematical modelling suggested an increased risk of neck loads with one alternative technique. No consistent recommendations can be made on the basis of the current study for altering heading techniques to reduce impact severity.	FIFA Med Assessment & Res Ctr, Zurich, Switzerland			shewchenko@biokinetics.com					Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; BABBS CF, 2001, BIOMECHANICS HEADING; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Bayly PV, 2002, P ANN INT IEEE EMBS, P2577, DOI 10.1109/IEMBS.2002.1053434; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BURSLEM I, 1988, SCI FOOTBALL, P243; Dvorak J, 2000, AM J SPORT MED, V28, pS3; GLAISTER D, 1997, ACCLERATION INJURY S, P314; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; HARDY W, 2002, ACCIDENTAL INJURY BI, P27; Hirsch AE, 1970, 14 STAPP CAR CRASH C; Holbourn A. H. S., 1943, LANCET, V245, P438; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Klein GN, 2001, EUR SPINE J, V10, P141, DOI 10.1007/s005860100248; KRAMER F, 1990, IRCOBI C BIOM IMP; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; LUDWIG KM, 1998, BIOMECHANICAL ANAL S; Lynch JM, 1996, US SOCCER SPORTS MED, P81; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; MAWDSLEY HY, 1978, MOMENTUM, V3, P30; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; Moss S., 2000, ANTHROPOMETRY WORLDS; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Newman, 1986, GEN ACCELERATION MOD; NEWMAN J, 2005, IN PRESS J BIOMECH; Newman J, 2000, 44 STAPP CAR CRASH C; OMMAYA AK, 1984, HEAD INJURY BIOMECHA; Ono I., 1980, 24 STAPP CAR CRASH C; Peterson L, 2000, AM J SPORT MED, V28, pS51; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; SCHNEIDER K, 1988, INT J SPORT BIOMECH, V4, P258; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Sortland O, 1982, Br J Sports Med, V16, P80; SZABO TJ, 1996, 40 STAPP CAR CRASH C; THIBAULT LE, 1990, 34 ANN C ASS ADV AUT; TORTORA GJ, 1984, PRINCIPLES ANATOMY P; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; ZIEJEWSKI M, 2003, BRAIN INJ ASS 20 ANN	55	54	55	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	AUG	2005	39			1			I10	I25		10.1136/bjsm.2005.019034			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	954KI	WOS:000231153600003	16046351	Green Published, Bronze			2022-02-06	
J	Jones, NC; Prior, MJW; Burden-Teh, E; Marsden, CA; Morris, PG; Murphy, S				Jones, NC; Prior, MJW; Burden-Teh, E; Marsden, CA; Morris, PG; Murphy, S			Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						behaviour; interleukin-1 receptor antagonist; magnetic resonance imaging; nitric oxide synthase-2; trauma	CONVERTING-ENZYME; NEURONAL INJURY; FLUORO-JADE; HEAD-INJURY; EXPRESSION; MICE; SYNTHASE; RAT; OVEREXPRESSION; LOCALIZATION	Interleukin (IL)-1 beta plays an important role in the inflammatory response that results from traumatic brain injury and antagonism of the actions of this cytokine can affect outcome. We subjected male mice to aseptic cryogenic injury and assessed recovery through anatomical, histological and functional measures following treatment with recombinant mouse IL-1 receptor antagonist (IL-1ra). A single dose (1 mu g, i.c.v.) at the time of injury reduced lesion volume 3 days later, as assessed by Nissl staining, and also the number (30%) of FluoroJade-positive degenerating neurones. Mice treated with IL-1ra performed better on the beam balance and in the grid test as compared with vehicle-treated animals. Furthermore, IL-1ra-treated animals showed fewer (40%) nitric oxide synthase-2-positive cells in and around the lesion. These data suggest that activation of the IL-1 receptor following trauma contributes to the pathology and that antagonism can reduce both anatomical and functional consequences of neuroinflammation.	Univ Nottingham, Inst Cell Signalling, Nottingham NG7 2UH, England; Univ Nottingham, Inst Neurosci, Nottingham NG7 2UH, England; Univ Nottingham, Sir Peter Mansfield MR Ctr, Nottingham NG7 2UH, England		Murphy, S (corresponding author), Univ Nottingham, Inst Cell Signalling, Clifton Blvd, Nottingham NG7 2UH, England.	sean.murphy@nottingham.ac.uk	Jones, Nigel C/K-7773-2012	Burden-Teh, Esther/0000-0002-0033-2836; Jones, Nigel/0000-0002-1080-8439	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Colombo JA, 2002, J HISTOCHEM CYTOCHEM, V50, P1135, DOI 10.1177/002215540205000815; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; GARCIA JH, 1995, AM J PATHOL, V147, P1477; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; HONG XY, 1993, PAINT COATINGS IND, V1, P1; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; Lopez-Figueroa MO, 2000, BRAIN RES, V852, P239, DOI 10.1016/S0006-8993(99)02241-6; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Oprica M, 2004, ACTA NEUROPATHOL, V108, P69, DOI 10.1007/s00401-004-0868-5; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schuhmann MU, 2002, ACTA NEUROCHIR SUPPL, V81, P213; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Touzani O, 2002, J NEUROSCI, V22, P38, DOI 10.1523/JNEUROSCI.22-01-00038.2002	27	54	54	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2005	22	1					72	78		10.1111/j.1460-9568.2005.04221.x			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	946MW	WOS:000230577400008	16029197				2022-02-06	
J	Catroppa, C; Anderson, V				Catroppa, C; Anderson, V			A prospective study of the recovery of attention from acute to 2 years following pediatric traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						head injury; children; attention recovery	CLOSED-HEAD-INJURY; SUSTAINED ATTENTION; CHILDREN; CHILDHOOD; PERFORMANCE; SEQUELAE; DEFICITS; COHORT; SKILLS; SEVERITY	Limited research has investigated specific attentional sequelae following pediatric traumatic brain injury (TBI), such as sustained, selective, and shifting attention, as well as speed of processing. Little is known about the pattern of recovery of these skills or their interaction with ongoing development. The present study examined attentional abilities at acute, 6-, 12-, and 24-month time points postinjury in a group of 71 children who had sustained a mild, moderate, or severe TBI Results indicated that children who sustained a severe TBI generally performed poorest, but showed most recovery over time. The pattern of recovery was dependent on the attentional component being measured. Specifically, deficits were most evident on more complex and timed tasks. While a number of areas showed recovery over time, for some attentional components, difficulties persisted to 24 months postinjury.	Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Psychol, Parkville, Vic 3052, Australia; Univ Melbourne, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; BETTS J, IN PRESS DEV PSYCHOL; BROUWER WH, 1988, ROAD USER BEHAV THEO, P296; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; Daniel A., 1983, POWER PRIVILEGE PRES; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P85; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KAIL R, 1986, CHILD DEV, V57, P969, DOI 10.1111/j.1467-8624.1986.tb00259.x; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; Laurence S., 1978, RECOVERY BRAIN DAMAG, P369; Lennenberg E. H., 1967, BIOL FDN LANGUAGE; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Manly T., 1999, TEST EVERYDAY ATTENT; Maule AJ, 2000, ACTA PSYCHOL, V104, P283, DOI 10.1016/S0001-6918(00)00033-0; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner M, 1990, ANNU REV NEUROSCI, V15, P25; Rebok GW, 1997, CHILD NEUROPSYCHOL, V3, P28, DOI 10.1080/09297049708401366; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Robin DA, 1999, APHASIOLOGY, V13, P701, DOI 10.1080/026870399401812; ROTHI L, 1983, J CLIN NEUROPSYCHOLO, V3, P73; ROWE JK, 1995, ROWE BEHAV RATING IN; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tabachnick B. G., 1989, USING MULTIVARIATE S; Talland G.A., 1965, DERANGED MEMORY; TEASDALE G, 1974, LANCET, V2, P81; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; WOOD RL, 1988, J LEARN DISABIL, V21, P327, DOI 10.1177/002221948802100603; [No title captured]; [No title captured]	53	54	54	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2005	11	1					84	98		10.1017/S1355617705050101			15	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	906CA	WOS:000227616900009	15686611				2022-02-06	
J	Dimopoulou, I; Tsagarakis, S; Theodorakopoulou, M; Douka, E; Zervou, M; Kouyialis, AT; Thalassinos, N; Roussos, C				Dimopoulou, I; Tsagarakis, S; Theodorakopoulou, M; Douka, E; Zervou, M; Kouyialis, AT; Thalassinos, N; Roussos, C			Endocrine abnormalities in critical care patients with moderate-to-severe head trauma: incidence, pattern and predisposing factors	INTENSIVE CARE MEDICINE			English	Article						head trauma; cortisol hyporesponsiveness; hypogonadism; partial growth hormone deficiency; hypothyroidism; Marshall Computerized Tomographic Classification	BRAIN-INJURY; HYPOPITUITARISM; DYSFUNCTION; AXIS	Objective. To investigate the incidence and type of endocrine abnormalities in critical care patients with traumatic brain injury (TBI) and to examine their relationships to possible predisposing factors. Design. Prospective study. Setting. General intensive care unit in a university hospital. Patients and participants. Thirty-four TBI patients (27 men, 7 women), having a mean age of 37+/-16 years, were studied after weaning from mechanical ventilation. Interventions. Baseline endocrine assessment was carried out by measuring cortisol, corticotropin, dehydroepiandrosterone sulfate, free thyroxine, thyrotropin (TSH), testosterone, oestradiol, follicle stimulating hormone (FSH), luteinizing hormone, prolactin, growth hormone and insulin-like growth factor I. Dynamic evaluation was performed by human corticotropin releasing hormone and growth hormone releasing hormone in all patients. Male patients underwent additional investigation with gonadotropin-releasing hormone. Severity of neurological derangement was graded according to Glasgow Coma Scale (GCS), Marshall Computerized Tomographic Classification and intracranial pressure (ICP) levels. Measurements and results. Eighteen of the 34 patients (53%) had an abnormal result in at least one hormonal axis tested, with cortisol hyporesponsiveness and gonadal dysfunction being equally common, affecting 24% of patients. Endocrine abnormalities were associated with a higher brain CT-scan classification score (p=0.02). The GCS on admission correlated positively with baseline FSH (r=0.37, p=0.03), peak FSH (r=0.41, p=0.03), testosterone (r=0.44, p=0.02) and TSH (r=0.39, p=0.03). There were no relations between ICPmax and any baseline or dynamic hormone measurements. Conclusions. Patients with TBI receiving critical care show changes in their neuroendocrine responses, which depend upon clinical and radiological measures of head injury severity. Most common abnormalities include cortisol hyporesponsiveness and hypogonadism.	Natl & Kapodistrian Univ Athens, Sch Med, Evangelismos Hosp, Dept Crit Care Med, Athens, Greece; Natl & Kapodistrian Univ Athens, Sch Med, Evangelismos Hosp, Dept Diabet Endocrinol & Metab, Athens, Greece		Dimopoulou, I (corresponding author), 2 Pesmazoglou St, Athens 14561, Greece.	idimo@otenet.gr					BARRECA T, 1980, J CLIN ENDOCR METAB, V51, P1279, DOI 10.1210/jcem-51-6-1279; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, INTENS CARE MED, V30, P298, DOI 10.1007/s00134-003-2058-7; EDWARDS OM, 1986, MEDICINE, V65, P281; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; GOTTARDIS M, 1990, INTENS CARE MED, V16, P163, DOI 10.1007/BF01724795; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lamberts SWJ, 1998, LANCET, V352, P127; LEE SC, 1994, BRAIN INJURY, V8, P571; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MATSUURA H, 1985, NEUROSURGERY, V16, P791, DOI 10.1227/00006123-198506000-00009; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; Sassolas G, 1999, EUR J ENDOCRINOL, V141, P595, DOI 10.1530/eje.0.1410595; SCHLAGHECKE R, 1992, NEW ENGL J MED, V326, P226, DOI 10.1056/NEJM199201233260403; Segal-Lieberman G, 2000, Pituitary, V3, P181, DOI 10.1023/A:1011407910913; TEASDALE G, 1974, LANCET, V2, P81; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; Webb SM, 1999, J CLIN ENDOCR METAB, V84, P3696, DOI 10.1210/jc.84.10.3696; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	27	54	57	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUN	2004	30	6					1051	1057		10.1007/s00134-004-2257-x			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825BF	WOS:000221730300009	15069597				2022-02-06	
J	Ponsford, J; Facem, PC; Willmott, C; Rothwell, A; Kelly, AM; Nelms, R; Ng, KT				Ponsford, J; Facem, PC; Willmott, C; Rothwell, A; Kelly, AM; Nelms, R; Ng, KT			Use of the Westmead PTA scale to monitor recovery of memory after mild head injury	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC AMNESIA; COGNITIVE ORIENTATION; GALVESTON ORIENTATION; CONCUSSION; REHABILITATION; PREDICTORS; DURATION; LOG	Study objective: Duration of post-traumatic amnesia (PTA) is an important index of severity of head injury. Retrospective assessment of PTA duration is arguably unreliable. Existing objective measures of PTA duration are designed for use over a 24-hour timeframe and, therefore, are not useful for assessing PTA following mild head injury (MHI). A revised version of the Westmead PTA scale was developed for assessing patients with MHI in the Emergency Department (ED) at hourly intervals. The objective of this study was the field testing of this scale in EDs and assessment of validity and reliability of test items. Methods: The scale contained 12 items, assessing orientation, memory for a face and name in a photograph and three pictures of objects. This revised scale, administered by nursing staff, was completed at least four times at hourly intervals by 147 adults with MHI in the ED and again at follow-up 1 week later. It was also completed by 109 demographically similar controls. Results were compared with Glasgow Coma scores and retrospective estimates of PTA duration based on patient report and medical records. Results: Thirty-six per cent of MHI participants made errors on the scale in the ED, a significantly greater proportion than in MHI or controls at follow-up. Removal of the items 5 (day of week) and 9 (recall of name of face in photograph) improved the validity of the measure significantly. Scores correlated significantly with Glasgow Coma Scale scores and estimated duration of PTA. Conclusion: The Westmead Scale (minus items 5 and 9) is a valid measure of PTA duration in adult patients with MHI in ED. Its use will allow for more appropriate timing of discharge and accurate prognostic information.	Monash Univ, Clayton, Vic 3168, Australia; Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; Alfred Hosp, Melbourne, Vic, Australia; Univ Melbourne, Melbourne, Vic, Australia; Julia Farr Serv S Australia, Adelaide, SA, Australia; Western Hosp, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Epworth Med Fdn, Epworth Rehabil Ctr, Dept Psychol, 30 Erin St, Richmond, Vic 3121, Australia.	jennie.ponsford@med.monash.edu.au	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035			Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; [Anonymous], 1942, Proc R Soc Med, V35, P601; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BERROL S, 1992, REHABILITATION POST, P1; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Brooks D N, 1979, Int Rehabil Med, V1, P160; de Kruijk JR, 2001, BRAIN INJURY, V15, P117, DOI 10.1080/026990501458353; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; GRONWALL D, 1974, LANCET, V2, P605; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; KAY T, 1992, REHABILITATION POST, P109; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kraus J. F., 1999, REHABILITATION ADULT, P3; LEININGER B, 1992, REHABILITATION POST; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; NELSON HE, 1991, NATL ADULT READINT T; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PONSFORD J, 2002, 1 JOINT S NAT INT NE; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rey A., 1964, EXAMEN CLIN PSYCHOL; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Symonds C.P., 1940, INJURIES SKULL BRAIN, P69; Symonds CP, 1943, LANCET, V1, P7; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	52	54	55	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2004	18	6					603	614		10.1080/02699050310001646152			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	811DX	WOS:000220753700007	15204340				2022-02-06	
J	Kalpakjian, CZ; Lam, CS; Toussaint, LL; Merbitz, NKH				Kalpakjian, CZ; Lam, CS; Toussaint, LL; Merbitz, NKH			Describing quality of life and psychosocial outcomes after traumatic brain injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						quality of life; psychosocial outcomes; tramatic brain injury; assessment instruments	COMMUNITY INTEGRATION QUESTIONNAIRE; SPINAL-CORD; SATISFACTION; REHABILITATION; IMPAIRMENT; DISABILITY	Objective: To describe the quality of life (QOL) and psychosocial outcomes of a sample of adults with traumatic brain injury in 50 community dwelling adults with traumatic brain injury and examine the associations among these variables. Design: Cross-sectional. Results: Mean QOL rating was low average. Standardized measures had acceptable internal reliability and normal distributions in this sample. Subjects had significantly lower QOL and social support, higher negative affect, and similar positive affect and spirituality compared with standardization and other nondisabled samples. They also had a significantly higher level of community integration than other traumatic brain injury samples. Regression analyses suggested that social support, community integration, and positive affect make a unique and significant contribution to the QOL variance with R-2 of 0.492. The addition of spirituality reduced their respective unique variance, reducing positive affect to nonsignificant levels due to their high intercorrelation. Conclusions: Findings suggest that this sample experiences a wide range of QOL. Factors significantly associated with good QOL include community integration, positive affect, and social support; demographic variables had virtually no association with QOL. Evaluation of the sample's response to standardized scales not designed for a traumatic brain injury population support their use in similar QOL investigations.	Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; IIT, Inst Psychol, Chicago, IL 60616 USA; Idaho State Univ, Dept Psychol, Pocatello, ID 83209 USA		Kalpakjian, CZ (corresponding author), Univ Michigan Hosp, Dept Phys Med & Rehabil, Box 0491,300 N Ingalls, Ann Arbor, MI 48109 USA.			Kalpakjian, Claire/0000-0001-6652-1245			Ashley MJ, 1997, BRAIN INJURY, V11, P677; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brown M, 1999, MT SINAI J MED, V66, P160; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; Dawson DR, 2000, BRAIN COGNITION, V44, P35; ELLIOTT TR, 1992, PSYCHOL HEALTH, V7, P55, DOI 10.1080/08870449208404295; Frisch M.B., 1994, QUALITY LIFE INVENTO; Fuhrer MJ, 2000, DISABIL REHABIL, V22, P481, DOI 10.1080/096382800413961; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Hatch RL, 1998, J FAM PRACTICE, V46, P476; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Kim J, 2000, REHABIL PSYCHOL, V45, P365, DOI 10.1037/0090-5550.45.4.365; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; MANCINI JA, 1992, J GERONTOL, V47, pP14, DOI 10.1093/geronj/47.1.P14; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Pargament KI., 1997, PSYCHOL RELIG; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Smith J, 1998, CANADIAN J REHABILIT, V11, P131; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1994, BRAIN INJURY REHABIL, P355; [No title captured]	31	54	55	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	APR	2004	83	4					255	265		10.1097/01.PHM.0000118033.07952.8C			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	804VJ	WOS:000220325900001	15024324				2022-02-06	
J	Slewa-Younan, S; Green, AM; Baguley, IJ; Gurka, JA; Marosszeky, JE				Slewa-Younan, S; Green, AM; Baguley, IJ; Gurka, JA; Marosszeky, JE			Sex differences in injury severity and outcome measures after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; rehabilitation; sex differences; treatment outcome	HUMAN CORPUS-CALLOSUM; GENDER-DIFFERENCES; HEAD-INJURY; BLOOD-FLOW; ABILITY; WOMEN; PROGESTERONE; PERFORMANCE; DIMORPHISM; ESTROGEN	Objective: To investigate the effect of a patient's sex on various measures of injury severity and outcome after rehabilitation in a matched sample of patients with traumatic brain injury (TBI). Design: Retrospective data were retrieved from a database that contains information routinely collected on all patients admitted for inpatient rehabilitation. Setting: Inpatient rehabilitation unit of major teaching hospital in Australia. Participants: Fifty-four. women with TBI after a motor vehicle crash (MVC) were identified from the Brain Injury Rehabilitation Database. An equal number of men were then matched for age and years of education. All subjects met the study admission criteria of having being involved in a highspeed MVC. Exclusion criteria included history of a previous head injury, chronic amnesia, psychiatric disturbance, and significant alcohol and/or substance abuse. Interventions: Not applicable. Main Outcome Measures: Differences, by sex, in patient scores on measures of injury severity and outcome after TBI. Results: Men had significantly greater levels of injury severity as indicated by the Glasgow Coma Scale scores (U=994.0, P=.002) and length of posttraumatic amnesia (U=880.0, P=.016) when compared with women. No significant sex differences existed in the outcome measures or in injuries not associated with the central nervous system. Conclusions: Few investigations exist on the effect of patient sex on measures of injury severity and outcome after a TBI. In the present study, men's levels of injury severity were greater than women's despite the same admission criteria (high-speed MVC) being applied to both sexes.	Westmead Hosp, Brain Injury Unit, Wentworthville, NSW 2145, Australia; Univ Sydney, Dept Psychol Med, Sydney, NSW 2006, Australia; Univ Sydney, Dept Rehabil Med, Sydney, NSW 2006, Australia; Cumberland Hosp, NSW Inst Psychiat, Parramatta, NSW, Australia		Slewa-Younan, S (corresponding author), Westmead Hosp, Brain Injury Unit, POB 533, Wentworthville, NSW 2145, Australia.	shameran@biru.wsahs.nsw.gov.au	Baguley, Ian J/K-6878-2013; Baguley, Ian/AAM-5828-2021	Baguley, Ian J/0000-0001-5650-3705; 			ALLEN LS, 1991, J NEUROSCI, V11, P933; BENBOW CP, 1988, BEHAV BRAIN SCI, V11, P169, DOI 10.1017/S0140525X00049244; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Delgado AR, 1996, MEM COGNITION, V24, P504, DOI 10.3758/BF03200938; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; GUR RE, 1990, SCHIZOPHRENIA BULL, V16, P247, DOI 10.1093/schbul/16.2.247; HOLLOWAY RL, 1993, AM J PHYS ANTHROPOL, V92, P481, DOI 10.1002/ajpa.1330920407; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; JENNETT B, 1977, LANCET, V1, P878; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; KAUFMAN AS, 1991, J CLIN PSYCHOL, V47, P801, DOI 10.1002/1097-4679(199111)47:6<801::AID-JCLP2270470611>3.0.CO;2-C; KRAUS JF, 2000, NEUROSURG FOCUS, V8; KULYNYCH JJ, 1994, CEREB CORTEX, V4, P107, DOI 10.1093/cercor/4.2.107; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Rabinowicz T, 1999, J CHILD NEUROL, V14, P98, DOI 10.1177/088307389901400207; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1999, J NEUROTRAUM, V16, P988; SHAYWITZ BA, 1995, NATURE, V373, P561; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; WITELSON SF, 1992, J COMP NEUROL, V323, P326, DOI 10.1002/cne.903230303	26	54	57	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2004	85	3					376	379		10.1016/j.apmr.2003.05.007			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	801AC	WOS:000220067800004	15031820				2022-02-06	
J	Chapman, SB; Sparks, G; Levin, HS; Dennis, M; Roncadin, C; Zhang, LF; Song, J				Chapman, SB; Sparks, G; Levin, HS; Dennis, M; Roncadin, C; Zhang, LF; Song, J			Discourse macrolevel processing after severe pediatric traumatic brain injury	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; WRITTEN LANGUAGE PRODUCTION; DEVELOPMENTAL PLASTICITY; LEARNING-DISABILITIES; TEXT COMPREHENSION; SUMMARIZING TEXTS; PRACTICAL SCALE; CHILDREN; INSTRUCTION; ADOLESCENTS	The purpose of this study was to determine if discourse macrolevel processing abilities differed between children with severe traumatic brain injury (TBI) at least 2 years postinjury and typically developing children. Twenty-three children had sustained a severe TBI either before the age of 8 (n = 10) or after the age of 8 (n = 13). The remaining 32 children composed a control group of typically developing peers. The groups' summaries and interpretive lesson statements were analyzed according to reduction and transformation of narrative text information. Compared to the control group, the TBI group condensed the original text information to a similar extent. However, the TBI group produced significantly less transformed information during their summaries, especially those children who sustained early injuries. The TBI and control groups did not significantly differ in their production of interpretive lesson statements. In terms of related skills, discourse macrolevel summarization ability was significantly related to problem solving but not to lexical or sentence level language skills or memory. Children who sustain a severe TBI early in childhood are at an increased risk for persisting deficits in higher level discourse abilities, results that have implications for academic success and therapeutic practices.	Univ Texas, Ctr BrainHlth, Dallas, TX 75235 USA; Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Cognit Neurosci Lab, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Cognit Neurosci Lab, Houston, TX 77030 USA; Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; Bayer Pharmaceut, Dept Biometry, West Haven, CT USA		Chapman, SB (corresponding author), Univ Texas, Ctr BrainHlth, 1966 Inwood Rd, Dallas, TX 75235 USA.	schapman@utdallas.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2R01 NS 21889-16] Funding Source: Medline		Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; BROWN AL, 1983, CHILD DEV, V54, P968, DOI 10.1111/j.1467-8624.1983.tb00518.x; BROWN AL, 1983, J VERB LEARN VERB BE, V22, P1, DOI 10.1016/S0022-5371(83)80002-4; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAPMAN S, 2001, J HEAD TRAUMA REHAB, V16, P1; CHAPMAN S, IN PRESS J ALZHEIMER; Chapman S. B., 1995, AM J SPEECH-LANG PAT, V4, P124, DOI DOI 10.1044/1058-0360.0404.124; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chapman SB, 1997, APHASIOLOGY, V11, P337, DOI 10.1080/02687039708248475; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1999, BRAIN DAMAGE BEHAV C; CULHANE KA, 1993, INT NEUR SOC M SAN A; DELIS DC, 1984, UNPUB CALIFORNIA PRO; DELIS DC, 1986, CALIFORNIA VERBAL LE; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; DENNIS M, 1990, DISCOURSE ABILITY BR; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; HIDI S, 1986, REV EDUC RES, V56, P473, DOI 10.3102/00346543056004473; Hunt K. W., 1965, 3 NAT COUNC TEACH EN; JENNETT B, 1975, LANCET, V1, P480; JOHNSON NS, 1983, CHILDRENS LANGUAGE, P315; JOHNSON NS, 1978, THESIS U CALIFORNIA; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; KIRBY JR, 1985, HUM LEARN, V4, P159; KIRBY JR, 1988, INT C PSYCH SYND AUS; KIRBY JR, 1988, LEARNING STRATEGIES, P229, DOI DOI 10.1007/978-1-4899-2118-5_9; KIRBY JR, 1991, EDUC PSYCHOL, V11, P297, DOI DOI 10.1080/0144341910110306; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MALONE LD, 1992, EXCEPT CHILDREN, V58, P270, DOI 10.1177/001440299105800309; Nichelli P, 1995, NEUROREPORT, V6, P2309, DOI 10.1097/00001756-199511270-00010; REVELLE GL, 1985, CHILD DEV, V56, P654; Reyna VF, 1998, J EXP CHILD PSYCHOL, V71, P194, DOI 10.1006/jecp.1998.2472; Semel E., 1995, CLIN EVALUATION LANG, VThird; STEIN BL, 1992, J READING BEHAV, V24, P217, DOI 10.1080/10862969209547773; TEASDALE G, 1974, LANCET, V2, P81; Ulatowska H. K., 1994, DISCOURSE ANAL APPL, P29; VANDIJK TA, 1995, DISCOURSE COMPREHENSION, P383; Vauras, 1995, LEARN INSTR, V5, P143, DOI [10.1016/0959-4752(95)00009-R, DOI 10.1016/0959-4752(95)00009-R]; VAURAS M, 1994, J READING BEHAV, V26, P361, DOI 10.1080/10862969409547859; Wechsler D., 2011, WECHSLER ABBREVIATED; Worling DE, 1999, BRAIN LANG, V70, P220, DOI 10.1006/brln.1999.2156; Yorkston KM, 1997, ARCH PHYS MED REHAB, V78, P1096, DOI 10.1016/S0003-9993(97)90134-9; Yorkston KM, 1999, APHASIOLOGY, V13, P691, DOI 10.1080/026870399401803	53	54	54	0	4	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		2004	25	1-2					37	60		10.1207/s15326942dn2501&2_4			24	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	774CG	WOS:000188961700004	14984328				2022-02-06	
J	Gan, BK; Lim, JHG; Ng, IHB				Gan, BK; Lim, JHG; Ng, IHB			Outcome of moderate and severe traumatic brain injury amongst the elderly in Singapore	ANNALS ACADEMY OF MEDICINE SINGAPORE			English	Article						geriatric; Glasgow Outcome Score; Glasgow Coma Score; moderate and severe traumatic brain injury	SEVERE HEAD-INJURY; COMA-DATA-BANK; SUBARACHNOID HEMORRHAGE; CLINICAL COURSE; MORTALITY; AGE; CLASSIFICATION; TOMOGRAPHY; PROGNOSIS; VARIABLES	Introduction: In line with other established protocols, our unit has instituted a standardised protocol for the management of moderate and severe traumatic brain injury since 1996 in our neurointensive care unit. Materials and Methods: We reviewed the outcomes, at 6 months' postinjury, in an elderly group aged greater than or equal to64 years (73.86 +/- 8.0 years) and compared them to a younger group aged 20 to 40 years (29.2 +/- 5.7 years) in a cohort of 324 patients. Outcome was dichotomised as favourable (mild and moderate disability but independent; Glasgow Outcome Score [GOS] 4 and 5), unfavourable (severe disability and persistent vegetative state; GOS 2 and 3) and death (GOS 1). Results: In the elderly group, the mortality (55.4%) was slightly more than double that of the younger group (20.9%); 21.5% had an unfavourable outcome (14.2% in the younger group) and only 23% had a favourable outcome (compared to 64.9% in the younger group). The final outcomes were significantly worse in all levels in the elderly group. This was in spite of data showing that the mechanism of injury was of a higher impact in the younger group, with a higher incidence of polytrauma and cervical spine injury. On admission, the mean Glasgow Coma Score (GCS) was 8.3 +/- 3.91 for the elderly group and 8.59 +/- 4.05 for the younger group (P = 0.763). Computed tomography scan showed that the elderly had a higher incidence of mass lesions (extradural haematoma and subdural haematoma) and traumatic subarachnoid haemorrhage. A subgroup (29.2%) of elderly patients had no surgical intervention based on poor clinical/ neurological status, premorbid functional status and pre-existing medical conditions, with their family's consent. The GCS of less than or equal to8, on admission, was significant (P <0.001) in predicting mortality in the elderly. In the elderly group, the female gender had a higher mortality rate (70.4%) than the males (44.7%) (P = 0.19). Conclusion: Age must be considered an independent factor in outcome prediction in the elderly with moderate and severe traumatic brain injury. A more conservative approach in the management of an elderly patient with severe head injury may be reasonable given its dismal outcomes after careful dialogue with the relatives.	Natl Inst Neurosci, Dept Neurosurg, Sect Neurotrauma, Singapore 308433, Singapore		Ng, IHB (corresponding author), Natl Inst Neurosci, Dept Neurosurg, Sect Neurotrauma, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	Ivan_Ng@ttsh.com.sg					AMACHER AL, 1987, NEUROSURGERY, V20, P954; Baltas I, 1998, J Neurosurg Sci, V42, P85; BAXT WG, 1987, J TRAUMA, V27, P602, DOI 10.1097/00005373-198706000-00003; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; *BRAUN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; EDNA TH, 1983, ACTA NEUROCHIR, V69, P15, DOI 10.1007/BF02055848; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; JENNETT B, 1975, LANCET, V1, P480; Jennett B., 1982, NEUROLOGICAL DISORDE, P202; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V1, pS287; *MIN HLTH, 2002, HLTH FACTS SING 2002; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P789; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; ZWIMPFER TJ, 1993, CRIT CARE CLIN, V9, P727, DOI 10.1016/S0749-0704(18)30166-0	38	54	58	0	5	ACAD MEDICINE SINGAPORE	REPUBLIC SINGAPORE	142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE	0304-4602			ANN ACAD MED SINGAP	Ann. Acad. Med. Singap.	JAN	2004	33	1					63	67					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	776DD	WOS:000189100700013	15008565				2022-02-06	
J	Yan, P; Liu, NK; Kim, GM; Xu, JM; Xu, J; Li, Q; Hsu, CY; Xu, XM				Yan, P; Liu, NK; Kim, GM; Xu, JM; Xu, J; Li, Q; Hsu, CY; Xu, XM			Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats	EXPERIMENTAL NEUROLOGY			English	Article						glucocorticoids; inflammation; rat; spinal cord injury; TNF-alpha; TNF receptor	KAPPA-B ACTIVATION; CENTRAL-NERVOUS-SYSTEM; FACTOR-ALPHA; BRAIN-INJURY; TNF RECEPTOR; CELL-DEATH; MESSENGER-RNA; FUNCTIONAL RECOVERY; MOLECULAR-CLONING; CYTOKINES	Posttraumatic inflammation has been implicated in secondary tissue damage after spinal cord injury (SCI). Tumor necrosis factor-alpha (TNF-alpha) is a key inflammatory mediator that is increasingly expressed after SCI. The effect of TNF-alpha is mediated through its receptors TNFR1 (p55) and TNFR2 (p75). However, whether these two receptors are expressed after SCI has not been demonstrated. In the present study, the temporo-spatial expression of TNFR1 and TNFR2 was examined in rats that had received a 10 g impact injury dropped at a height of 12.5 mm using the New York University impact device. In sham operates, no detectable TNFR1 or TNFR2 immunoreactivity (IR) was observed. In contused spinal cord, TNFR1 protein expression and immunoreactivity (IR) were detected as early as 15 min postinjury, reached its peak at 8 h, and declined markedly after 1 and 3 days postinjury. The temporal pattern of TNFR2 expression was similar to that of TNFR1 but its expression peaked at 4 h postinjury. During peak expression, TNFR1- and TNFR2-IR were most intense at the site of injury and decreased gradually from the injury epicenter. TNFR1- and TNFR2-positive cells included neurons, astrocytes, and oligodendrocytes. Methylprednisolone (NIP), a synthetic glucocorticoid, partially inhibited the injury-induced expression of TNFR1 and TNFR2, an effect which could be reversed by RU486, an antagonist of glucocorticoid receptors. We suggest that the expression of TNFR1 and TNFR2 after SCI may contribute to posttraumatic inflammatory responses of TNF-alpha. (C) 2003 Elsevier Science (USA). All rights reserved.	Univ Louisville, Sch Med, Dept Neurol Surg, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; St Louis Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63104 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA		Xu, XM (corresponding author), Univ Louisville, Sch Med, Dept Neurol Surg, Kentucky Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR Rm 616, Louisville, KY 40292 USA.			Xu, Xiao-ming/0000-0002-7229-0081; Hsu, Chung Y./0000-0002-5632-2733	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37230, NS36350] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037230, R01NS036350] Funding Source: NIH RePORTER		ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; ARZT E, 1994, ENDOCRINOLOGY, V134, P672, DOI 10.1210/en.134.2.672; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 1998, J NEUROSCI, V18, P3251; BEUTLER B, 1994, ANN NY ACAD SCI, V730, P118, DOI 10.1111/j.1749-6632.1994.tb44244.x; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BRENNER T, 1994, BRAIN RES, V641, P51, DOI 10.1016/0006-8993(94)91814-7; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; ELDRED WD, 1983, J HISTOCHEM CYTOCHEM, V31, P285, DOI 10.1177/31.2.6339606; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Goodman J. W., 1991, Optics & Photonics News, V2, P11; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Haridas V, 1998, J IMMUNOL, V160, P3152; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; HEYDERMAN RS, 1995, INFLAMM RES, V44, P275, DOI 10.1007/BF02032568; HOLETS VR, 1987, BRAIN RES, V408, P141, DOI 10.1016/0006-8993(87)90366-0; HSU C Y, 1990, Journal of Neurotrauma, V7, P115, DOI 10.1089/neu.1990.7.115; HSU CY, 2001, TRAUMATIC CNS INJURY, P118; Kahn MA, 1999, J NEUROIMMUNOL, V95, P19, DOI 10.1016/S0165-5728(98)00258-6; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; Lin RH, 1997, J IMMUNOL, V158, P598; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Liu XZ, 1997, J NEUROSCI, V17, P5395; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLERGRAZIANO CL, 1994, SHOCK, V1, P317, DOI 10.1097/00024382-199405000-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nawashiro H, 1997, BRAIN RES, V778, P265, DOI 10.1016/S0006-8993(97)00981-5; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013; Okuyama M, 2000, ARTERIOSCL THROM VAS, V20, P1506, DOI 10.1161/01.ATV.20.6.1506; PERRETTI M, 1994, PHARMACOL RES, V30, P53, DOI 10.1016/1043-6618(94)80087-1; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; Steer JH, 1998, ANN RHEUM DIS, V57, P732, DOI 10.1136/ard.57.12.732; Sullivan PG, 1999, J NEUROSCI, V19, P6248; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; VANDENABEELE P, 1995, J IMMUNOL, V154, P2904; VANFURTH AM, 1995, CLIN DIAGN LAB IMMUN, V2, P689, DOI 10.1128/CDLI.2.6.689-692.1995; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.ge.19.120185.001233; Yan P, 2001, J NEUROTRAUM, V18, P563, DOI 10.1089/089771501300227369; Yan P, 1999, J NEUROSCI, V19, P9355; Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041	62	54	57	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	OCT	2003	183	2					286	297		10.1016/S0014-4886(03)00135-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	728PB	WOS:000185724600006	14552870				2022-02-06	
J	Green, P; Rohling, ML; Iverson, GL; Gervais, RO				Green, P; Rohling, ML; Iverson, GL; Gervais, RO			Relationships between olfactory discrimination and head injury severity	BRAIN INJURY			English	Article							WORD MEMORY TEST; POSTTRAUMATIC ANOSMIA; EXAGGERATION	The goal of this study was to examine the relationship between brain injury severity and scores on both an olfactory identification test and on many widely used neuropsychological tests in 367 patients with head injuries of varying levels of severity. It was hypothesized that valid olfactory test scores would correlate highly with injury severity because both the olfactory nerves and the primary olfactory cortices are especially vulnerable to damage in closed head injury. After removing data of doubtful validity from cases failing effort tests, olfactory test scores were related to Glasgow Coma Scale scores (GCS), post-traumatic amnesia and radiological abnormalities more strongly than any of the neuropsychological test scores. Based on the assumption that post-traumatic amnesia is caused by a different mechanism than loss of core consciousness, it was also predicted that there would be no cases with a GCS less than 13 and with no post-traumatic amnesia. As predicted, there were no cases in this group. The results support previous studies showing greater olfactory impairment with increased severity of head injury.	Neurobehav Associates, Edmonton, AB, Canada; Univ S Alabama, Mobile, AL 36688 USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Riverview Hosp, Vancouver, BC, Canada		Green, P (corresponding author), 201-17107-107 Ave, Edmonton, AB T5S 1G3, Canada.			Iverson, Grant/0000-0001-7348-9570			Allen L., 1997, CARB 97 MANUAL COMPU; ALLEN LM, 1999, CARB WMT MANUALS S; Berkow Robert, 1999, MERCK MANUAL DIAGNOS; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; COURVILLE CB, 1945, PATHOLOGY NERVOUS SY, P292; Damasio A., 1999, FEELING WHAT HAPPENS; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Green P, 2001, NEUROREHABILITATION, V16, P237; Green P, 1998, ARCH CLIN NEUROPSYCH, V13, P138; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; GREEN P, 1999, CARB WMT MANUALS S; Green P., 1996, WORD MEMORY TEST USE; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; Moore KL., 1999, CLIN ORIENTATED ANAT; Ogawa S, 1999, HETEROCYCLES, V50, P57, DOI 10.3987/COM-98-S(H)42; Rohling ML, 2000, ARCH CLIN NEUROPSYCH, V15, P839; SMITH CG, 1961, BASIC NEUROANATOMY; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63	23	54	56	2	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2003	17	6					479	496		10.1080/0269905031000070242			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	672GG	WOS:000182512400003	12745704				2022-02-06	
J	Burnett, DM; Kolakowsky-Hayner, SA; Slater, D; Stringer, A; Bushnik, T; Zafonte, R; Cifu, DX				Burnett, DM; Kolakowsky-Hayner, SA; Slater, D; Stringer, A; Bushnik, T; Zafonte, R; Cifu, DX			Ethnographic analysis of traumatic brain injury patients in the national model systems database	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						accidents; traffic; automobiles; brain injuries; demography; rehabilitation	SPINAL-CORD INJURY; HISPANICS; ETHNICITY; IMPACT	Objective: To compare demographics, injury characteristics, therapy service and intensity, and outcome in minority versus nonminority patients with traumatic brain injury (TBI). Design: Retrospective analysis. Setting: Twenty medical centers. Participants: Two thousand twenty patients (men, n=1518; women, n=502; nonminority, n=1168; minority, n=852) with TBI enrolled in the Traumatic Brain Injury Model Systems database. Interventions: Not applicable. Main Outcome Measures: Age, gender, marital status, education, employment status, injury severity (based on Glasgow Coma Scale [GCS] admission score, length of posttraumatic amnesia, duration of unconsciousness), intensity (hours) of therapy rendered, rehabilitation length of stay (LOS), rehabilitation charges, discharge disposition, postinjury employment status, FIMTM instrument change scores, and FIM efficiency scores. Independent sample t tests were used to analyze continuous variables; chi-square analyses were used to evaluate categorical data. Results: Demographics: overall, minorities were found to be mostly young men who were single, unemployed, and less well educated, with a longer work week if employed when injured. Etiology: motor vehicle crashes (MVCs) predominated as the cause of injury for both groups; however, minorities were more likely to sustain injury from acts of violence and auto-versuspedestrian crashes. Minorities also had higher GCS scores on admission and shorter LOS. Rehabilitation services: significant differences were found in the types and intensity of rehabilitation services provided; these included physical therapy, occupational therapy, and speech-language pathology, but not psychology. Conclusions: Minority patients who sustain TBI generally tend to be young men with less social responsibility. Although MVCs predominate as the primary etiology, acts of violence and auto-versus-pedestrian incidents are more common in the minority population. Minorities tend to have higher GCS scores at admission. Also, the type and intensity of rehabilitation services provided differed significantly for the various interdisciplinary subspecialties. Rehabilitation charges, discharge disposition, and postinjury employment status were similar for the 2 groups, even though LOS is typically 3 to 4 days shorter for the minority group. A more detailed investigation is warranted to explain these findings.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Emory Univ, Dept Rehabil Med, Atlanta, GA USA; Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA; Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA		Burnett, DM (corresponding author), Lester Schneider Hosp, 9048 Sugar Estates Rd, St Thomas, VI 00802 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Cifu, David/0000-0003-1600-9387; Bushnik, Tamara/0000-0003-3328-257X			Burnett DM, 2000, BRAIN INJURY, V14, P713; FAIR GW, 1980, J SCHOOL HEALTH, V50, P275, DOI 10.1111/j.1746-1561.1980.tb07769.x; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HOWARD G, 1994, STROKE, V25, P120; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; RINTALA R, 1998, TOP SPINAL CORD INJ, V4, P2; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; SACCO RL, 1991, STROKE, V22, P305, DOI 10.1161/01.STR.22.3.305; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226; ZWEIFLER RM, 1995, STROKE, V26, P245, DOI 10.1161/01.STR.26.2.245; 1983, WEBSTERS 9 NEW COLLE, P757	12	54	54	0	10	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					263	267		10.1053/apmr.2003.50091			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700017	12601659				2022-02-06	
J	Echemendia, RJ; Cantu, RC				Echemendia, RJ; Cantu, RC			Return to play following sports-related mild traumatic brain injury: The role for neuropsychology	APPLIED NEUROPSYCHOLOGY			English	Article						cerebral concussions; return to play; risk-benefit analysis; neuropsychology	HEAD-INJURY; FOOTBALL PLAYERS; CONCUSSION; PERFORMANCE; GUIDELINES	Cerebral concussions frequently occur at all levels of athletic competition. The effects from these concussions can be transient or may lead to chronic, debilitating symptoms. A growing literature has established that neuropsychological tests are useful in detecting the subtle neurocognitive changes that occur following concussions. The identification of these deficits and subsequent recovery of function can be important components in making return-to-play (RTP) decisions. This article describes the emergence of neuropsychology in sports medicine, discusses the context in which RTP decisions are made, outlines factors that are important to RTP decisions, and presents a model that views the RTP decision as a dynamic risk-benefit analysis that involves complex interactions among variables. It is argued that neuropsychology has a unique, but not exclusive, role in the decision making process. Implications for future research are discussed.	Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; Emerson Hosp, Div Neurosurg, Concord, MA USA		Echemendia, RJ (corresponding author), 119 S Burrowes St,Suite 602, State Coll, PA 16801 USA.	RJE2@psu.edu	Echemendia, Ruben/R-6939-2019	Echemendia, Ruben/0000-0001-6116-8462			BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; *COL MED SOC, 1991, GUID MAN CONC SPORTS; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; ECHEMENDIA RJ, IN PRESS SPORTS NEUR; Erlanger D, 2001, ARCH CLIN NEUROPSYCH, V16, P740; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; *I MED, 2002, 1OM WORKSH NEUR CONS; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; LEE SM, 1955, J CEREBRAL BLOOD FLO, V15, pS722; LIFSHITZ J, 1955, J NEUROTRAUM, V12, P129; LOVELL M, SPORTS NEUROPSYCHOLO; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SUTTON RL, 1994, ACTA NEUROCHRURGICA, V6, P466; [No title captured]	25	54	55	0	4	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	1					48	55		10.1207/S15324826AN1001_7			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	780NF	WOS:000189386900007	12734075				2022-02-06	
J	Turkstra, L; Jones, D; Toler, HL				Turkstra, L; Jones, D; Toler, HL			Brain injury and violent crime	BRAIN INJURY			English	Article							HEAD-INJURY; AGGRESSION; BEHAVIOR	Primary objective : To test the hypothesis that TBI is associated with violent crime, the prevalence and characteristics of traumatic brain injury (TBI) were compared between men convicted of domestic violence and a matched comparison group. Methods and procedures : Participants were 20 African American men convicted of domestic violence and 20 African American men without criminal convictions matched for age and socioeconomic status. Participants completed a questionnaire regarding health and behaviour history. Main outcomes and results : More than half of the participants in both groups had sustained a TBI, although injuries in the offender group were significantly more severe. There were significantly more reports of problems with anger management in the offender group. Conclusions : Published epidemiological data regarding TBI may underestimate the prevalence in urban populations, which may have confounded earlier studies of TBI and domestic violence. The reported prevalence in this sample of defendants suggests implications for the justice system.	Case Western Reserve Univ, Dept Commun Sci, Cleveland, OH 44106 USA; City Cleveland Hts Municipal Court, Cleveland, OH USA		Turkstra, L (corresponding author), Case Western Reserve Univ, Dept Commun Sci, 11206 Euclid Ave, Cleveland, OH 44106 USA.		Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921			*CDCP, 2000, EP TRAUM BRAIN INJ U; Cohen R A, 1999, Violence Vict, V14, P397; Damasio AR, 1995, ANN NY ACAD SCI, V769, P241, DOI 10.1111/j.1749-6632.1995.tb38142.x; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Eisenberg-Berg N., 1977, ROOTS CARING SHARING; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Greve KW, 2001, BRAIN INJURY, V15, P255; Hartley L. L, 1995, COGNITIVE COMMUNICAT; MUSCAT JE, 1988, AM J PUBLIC HEALTH, V78, P822, DOI 10.2105/AJPH.78.7.822; Raine A, 2001, AGGRESSIVE BEHAV, V27, P111, DOI 10.1002/ab.4; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 1989, MILD MODERATE HEAD I, P203	17	54	55	1	15	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	1					39	47		10.1080/0269905021000010122			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	633LK	WOS:000180284600003	12519646				2022-02-06	
J	Randolph, LC; Takacs, M; Davis, KA				Randolph, LC; Takacs, M; Davis, KA			Resuscitation in the pediatric trauma population: Admission base deficit remains an important prognostic indicator	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	32nd Annual Meeting of the Western-Trauma-Association	FEB 24-MAR 01, 2002	WHISTLER-BLACKCOMBE, CANADA	Western Trauma Assoc		post-traumatic shock; outcome	OXYGEN DEBT; RISK; PREDICTORS; CLEARANCE; MORTALITY; SHOCK	Background: Base deficit (BD), as an endpoint for trauma resuscitation, has been extensively studied in the adult trauma patient but not in the pediatric population. We proposed that admission BD would correlate with outcomes after trauma in a pediatric population. Methods: This study was a retrospective review of all patients admitted to the pediatric intensive care unit in an adult trauma center with pediatric commitment in whom an admission BD was available, over the 5-year period ending June 2001. Results: A total of 65 patients formed the study population. Overall mortality was 20%. Patients who died were younger (6 +/- 5 vs. 9 +/- 5 years; p = 0.009), had lower Glasgow Coma Scale scores at admission (7 +/- 5 vs. 10 +/- 5; p < 0.0001), had higher Injury Severity Scores (24 +/- 14 vs. 14 +/- 9; p < 0.0001), and had lower Pediatric Trauma Scores (7 +/- 4 vs. 10 +/- 2; p < 0.0001). No patient with a BD less negative than -5 died, whereas 13 of 37 patients with a BD of -5 or higher died (37%) (p < 0.0001). Of the 13 patients who died, 8 never cleared their BD and died within 33 +/- 18 hours of admission. Failure to clear BD was associated with 100% mortality. Five patients who normalized their BD died of isolated closed head injuries (time to death, 37 +/- 18 hours; p = not significant). All surviving patients normalized their BD within 43 +/- 41 hours of admission. Seventy-five percent of patients who survived (39 of 52) had a normal BD within 48 hours of admission. Conclusion: Admission BD in the pediatric trauma patient is a strong indicator of posttraumatic shock. An admission BD of less than or equal to -5 is predictive of severe injury and of poor outcome, with a 37% mortality in this series. Failure to clear BD is an extremely poor prognostic indicator.	Loyola Univ, Med Ctr, Div Trauma Surg Crit Care & Burns, Dept Surg, Maywood, IL 60153 USA		Davis, KA (corresponding author), Loyola Univ, Med Ctr, Div Trauma Surg Crit Care & Burns, Dept Surg, 2160 S 1st Ave,Bldg 110,Room 3272, Maywood, IL 60153 USA.	kdavis3@lumc.edu		Takacs, Michael/0000-0001-6783-2192			ABOUKHALIL B, 1994, CRIT CARE MED, V22, P633, DOI 10.1097/00003246-199404000-00020; ABRAMSON D, 1993, J TRAUMA, V35, P584, DOI 10.1097/00005373-199310000-00014; Chang MC, 1997, J TRAUMA, V42, P577, DOI 10.1097/00005373-199704000-00001; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Davis JW, 1998, J TRAUMA, V44, P114, DOI 10.1097/00005373-199801000-00014; DAVIS JW, 1991, SURG GYNECOL OBSTET, V173, P473; Davis JW, 1998, J TRAUMA, V45, P873, DOI 10.1097/00005373-199811000-00005; DUNHAM CM, 1991, CRIT CARE MED, V19, P231, DOI 10.1097/00003246-199102000-00020; Eichelberger M, 1993, PEDIAT TRAUMA PREVEN; Foreman John, 1997, P127; GOODWIN CW, 1997, COMPLICATONS SURG TR, P126; Kincaid EH, 2001, J TRAUMA, V51, P332, DOI 10.1097/00005373-200108000-00018; Porter JM, 1998, J TRAUMA, V44, P908, DOI 10.1097/00005373-199805000-00028; ROGERS MC, 1996, PEDIAT INTENSIVE CAR; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; SHOEMAKER WC, 1992, CHEST, V102, P208, DOI 10.1378/chest.102.1.208; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SHOEMAKER WC, 1971, SURG GYNECOL OBSTETR, V132, P1033; Siegel JH, 1997, J TRAUMA, V42, P199, DOI 10.1097/00005373-199702000-00005	20	54	61	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2002	53	5					838	842		10.1097/00005373-200211000-00006			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	618DV	WOS:000179403900006	12435932				2022-02-06	
J	Ruchhjoltz, S; Waydhas, C; Schroeder, T; Piepenbrink, K; Kuhl, H; Nast-Kolb, D				Ruchhjoltz, S; Waydhas, C; Schroeder, T; Piepenbrink, K; Kuhl, H; Nast-Kolb, D			The value of computed tomography in the early treatment of seriously injured patients	CHIRURG			German	Article						computed tomography; multiple severe trauma; clinical management; emergency room diagnostic; missed injuries	CHEST TRAUMA; MANAGEMENT	Background. The availability of newer,faster computed tomography (CT) technology has engendered discussion about whole-body CT-scanning for primary radiological diagnostics of seriously injured patients. Method. Within a quality management system,the scaled, priority-oriented scheme of conventional radiological and CT-diagnostics used in each institution was analysed and compared with the possible benefit of whole-body CT-scanning. Every patient with severe trauma admitted directly from the scene of an accident, underwent basic radiological and sonographic diagnostics in the emergency room (ER). According to the findings, patients in a stable vital condition had CT-scans when indicated by the guidelines of the particular institution. Results. From 5/1998 until 12/2000, a total of 832 patients were treated in the ER. Of those, 480 patients (average ISS 20) were admitted directly from the scene of the accident. Basic radiological - sonographic diagnostics (radiographs of cervical spine, chest, and abdomen, as well as abdominal sonography) took 15+/-8 min. Twenty-two (5%) of the patients in hemorrhagic shock needed emergency operations after 57+/-43 min. The remaining patients underwent further radiological diagnostics (spine, extremities etc.) after 44+/-27 min. In 79% (379) of patients, CT was indicated. Cranial CT for traumatic brain injury prevailed clearly with 74% of cases. Spine (24%), chest (18%),abdomen (5%) and pelvis (5%) were indicated comparatively less frequently. The incidence of delayed diagnoses (after ICU-admission) was 4% (22). In 2% (nine) of patients the lesions possibly could have been detected by a primary CT-scan. In the three cases with thoracic lesions, there was a deviation from the indication guidelines for thoracic CT as normally used in the institution. There were three cases of delayed diagnoses in both the cerebral (small contusion haematomas) region and the abdominal region. The abdominal lesions were detected by sonographic control examinations. No patient died because of a delayed diagnosis. The average X-ray dose was five times lower with the scaled diagnostic management comprising indicated CT when compared to the doses calculated for routine whole-body CT. Conclusion. While 74% of patients had cranial CT, only 25% needed CT for the trunk regions. Delayed diagnoses were rare and without severe consequences for the patient. Considering the five times higher X-ray doses combined with the possible time loss in patients with unstable conditions, primary whole-body CT-scanning should not be performed routinely when serious injury is suspected.	Univ Essen Gesamthsch Klinikum, Klin & Poliklin Unfallchirurg, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Zent Inst Rontgendiagnost, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Abt Anasthesiol & Intens Med, D-45122 Essen, Germany		Ruchhjoltz, S (corresponding author), Univ Essen Gesamthsch Klinikum, Klin & Poliklin Unfallchirurg, Hufelandstr 55, D-45122 Essen, Germany.						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blostein PA, 1997, J TRAUMA, V43, P13, DOI 10.1097/00005373-199707000-00006; Fosse JP, 1997, PRESSE MED, V26, P1232; Healey MA, 1996, J TRAUMA, V40, P875, DOI 10.1097/00005373-199606000-00004; Nast-Kolb D, 1998, UNFALLCHIRURG, V101, P82, DOI 10.1007/s001130050239; NASTKOLB D, 1994, UNFALLCHIRURG, V97, P292; Ruchholtz S, 2001, UNFALLCHIRURG, V104, P927, DOI 10.1007/s001130170033; Shanmuganathan K, 1999, RADIOLOGY, V212, P423, DOI 10.1148/radiology.212.2.r99au18423; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003	9	54	55	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0009-4722			CHIRURG	Chirurg	OCT	2002	73	10					1005	1012		10.1007/s00104-002-0429-1			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	616XY	WOS:000179329800006	12395159				2022-02-06	
J	Cruz, J; Minoja, G; Okuchi, K				Cruz, J; Minoja, G; Okuchi, K			Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: A randomized trial	NEUROSURGERY			English	Article						cerebral extraction of oxygen; clinical outcome; head injury; herniation syndrome; intracranial pressure; mannitol	CEREBRAL-BLOOD-FLOW; ACUTE BRAIN-INJURY; OXYGEN-CONSUMPTION; COMATOSE PATIENTS; METABOLIC-RATE; ACUTE ANEMIA; HEAD-INJURY; TRAUMA; HYPERVENTILATION; EXTRACTION	OBJECTIVE: We evaluated long-term clinical outcomes and postoperative physiological findings in acutely comatose patients with nonmissile surgical intraparenchymal temporal lobe hemorrhages and abnormal pupillary widening who received early preoperative high-dose mannitol (HDM) versus conventional dose mannitol treatment in the emergency room. METHODS: One hundred forty-one adult patients with traumatic, nonmissile, acute, intraparenchymal temporal lobe hemorrhages associated with early abnormal pupillary widening were prospectively and randomly assigned to receive emergency preoperative intravenous HDM treatment (approximately 1.4 g/kg; 72 patients) and were compared with a control group that was treated with a lower preoperative mannitol dose (approximately 0.7 g/kg; 69 patients). RESULTS: Early preoperative improvement of abnormal bilateral pupillary widening was significantly more frequent in the study group than in the control group (P < 0.03). The same was true for abnormal unilateral pupillary widening (P< 0.01). Early HDM treatment in the emergency room was also associated with significantly better 6-month clinical outcomes (P < 0.005). The two groups of patients were well matched with respect to diameter of the temporal lobe hemorrhages (approximately 4 cm) as well as timing of clot removal (approximately 2.5 hours after injury). Postoperative physiological findings revealed statistically significant between-group differences, with higher intracranial pressure and lower cerebral extraction of oxygen (global relative cerebral hyperperfusion) in the control group than in the HDM group. Postoperative global brain ischemia (abnormally low arteriojugular lactate difference values) was rare and was found for less than 3% of the patients in both groups. CONCLUSION: Early preoperative HDM administration in the emergency room was associated with improved clinical outcomes for adult comatose patients with acute, nonmissile, intraparenchymal temporal lobe hemorrhages and associated abnormal pupillary widening. Early improvement of bilateral or unilateral pupillary abnormalities and better postoperative control of intracranial hypertension and associated global relative cerebral hyperperfusion seemed to be relevant factors that were related to improved outcomes.	Comprehens Int Ctr Neuroemergencies, BR-04093970 Sao Paulo, Brazil; Univ Fed Sao Paulo, Sao Paulo, Brazil; Univ Insubria, Dept Anesthesiol & Crit Care Med, Varese, Italy; Nara Med Univ, Dept Emergency & Crit Care Med, Nara, Japan		Cruz, J (corresponding author), Comprehens Int Ctr Neuroemergencies, POB Cx Postal 57011, BR-04093970 Sao Paulo, Brazil.						BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; CRUZ J, 1994, CRIT CARE MED, V22, P1465, DOI 10.1097/00003246-199409000-00018; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; CRUZ J, 1993, CRIT CARE MED, V21, P1218, DOI 10.1097/00003246-199308000-00024; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Cruz J, 1996, CRIT CARE MED, V24, P953, DOI 10.1097/00003246-199606000-00013; CRUZ J, 1995, J NEUROSURG, V82, P379, DOI 10.3171/jns.1995.82.3.0379; CRUZ J, 1994, J NEUROSURG, V80, P143, DOI 10.3171/jns.1994.80.1.0143; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; Cruz J, 2001, NEUROSURGERY, V49, P864; CRUZ J, 1998, NEUROLOGIC NEUROSURG, P405; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gibbs EL, 1942, J BIOL CHEM, V144, P325; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; LANGFITT TW, 1968, JOHNS HOPKINS MED J, V122, P261; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; SHALIT MN, 1972, NEUROLOGY, V22, P155, DOI 10.1212/WNL.22.2.155; TABADDOR K, 1972, J TRAUMA, V12, P1053, DOI 10.1097/00005373-197212000-00006; TEASDALE G, 1974, LANCET, V2, P81	30	54	56	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2002	51	3					628	637		10.1097/00006123-200209000-00006			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	592FH	WOS:000177925700007	12188940				2022-02-06	
J	Rhoney, DH; Parker, D; Formea, CM; Yap, C; Coplin, WM				Rhoney, DH; Parker, D; Formea, CM; Yap, C; Coplin, WM			Tolerability of bolus versus continuous gastric feeding in brain-injured patients	NEUROLOGICAL RESEARCH			English	Article						brain injury; nutrition; mechanical ventilation; critical care; enteral nutrition; gastric feeding	CRITICALLY ILL PATIENTS; MECHANICALLY VENTILATED PATIENTS; CLOSED-HEAD-INJURY; CARE-UNIT PATIENTS; ENTERAL NUTRITION; RISK-FACTORS; PATIENTS INTOLERANT; CONTROLLED TRIAL; PNEUMONIA; ASPIRATION	Brain injured patients may exhibit altered gastric emptying; thus, some believe post-pyloric feeding to be tolerated better than gastric feeding. Reliable post-pylorus access can be difficult to obtain, so gastric feeding remains the preferred route for administering nutrition. Feeding intolerance may be associated with increased complications and costs. We sought to compare bolus (B) versus continuous (C) gastric feeding in brain injured patients. This retrospective cohort study was carried out at a neurological/neurosurgical intensive care unit at a Level I trauma and tertiary referral center. Our subjects were 152 consecutive patients over two years. Use of B or C feedings was based on clinicians' preferences. Abdominal examination and gastric residuals (>75 mL over four hours) defined feeding intolerance (FI). Putative risks for FI were compared between the groups. Demographic characteristics were similar between groups B (n=86) and C (n=66). Feeding intolerance occurred more often in group B than in group C (60.5% vs. 37.9%, p=0.009). Group C patients achieved 75% of nutritional goals faster than group B patients (median 3.3 vs. 4.6 days; p=0.03). Prokinetic agent use was similar between the groups and did not reduce the time to achieve nutritional goals. There was a trend towards a reduction in the incidence of infections in group C (p=0.05). Independent predictors of FI included: sucralfate (OR 2.3), propofol (OR 2.1), pentobarbital (OR 3.9) or paralytic (OR 3) use; older age (OR 5), days receiving mechanical ventilation (OR 1.2); and admission diagnosis of either intracerebral hemorrhage (OR 2.2) or ischemic stroke (OR 1.9). Continuous gastric feeding is better tolerated than B feedings in patients with acute brain injuries. Use of prokinetic agents did not affect time to achievement of nutritional goals. Use of common medications including sucralfate and propofol were associated with FI.	Wayne State Univ, Coll Pharm, Dept Pharm Practice, Detroit, MI USA; Allied Hlth Profess, Detroit, MI USA; Univ Detroit, Ctr Hlth, Detroit Receiving Hosp, Dept Pharm Serv, Detroit, MI 48221 USA; Univ Detroit, Ctr Hlth, Detroit Receiving Hosp, Dept Dietary Serv, Detroit, MI 48221 USA; Wayne State Univ, Sch Med, Detroit Med Ctr, Dept Neurol, Detroit, MI USA; Wayne State Univ, Sch Med, Detroit Med Ctr, Dept Neurol Surg, Detroit, MI USA		Rhoney, DH (corresponding author), Wayne State Univ, Dept Pharm, 4201 St Antoine, Detroit, MI 48201 USA.			Yap, Christina/0000-0002-6715-2514	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038905] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38905] Funding Source: Medline		Artigas AT, 2001, CRIT CARE MED, V29, P304, DOI 10.1097/00003246-200102000-00015; Bonten MJM, 1996, AM J RESP CRIT CARE, V154, P394, DOI 10.1164/ajrccm.154.2.8756812; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Cerra FB, 1997, CHEST, V111, P769, DOI 10.1378/chest.111.3.769; Chapman MJ, 2000, CRIT CARE MED, V28, P2334, DOI 10.1097/00003246-200007000-00026; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Davies AR, 2002, CRIT CARE MED, V30, P586, DOI 10.1097/00003246-200203000-00016; Day L, 2001, J Neurosci Nurs, V33, P148; Day L, 2001, J NEUROSCI NURS, V33, P155, DOI [10.1097/ 01376517- 200106000- 00007, DOI 10.1097/01376517-200106000-00007]]; Esparza J, 2001, INTENS CARE MED, V27, P660, DOI 10.1007/s001340100880; FOUNDATION BT, 2000, J NEUROTRAUM, V17, P539; FOX KA, 1995, AM J SURG, V170, P564, DOI 10.1016/S0002-9610(99)80016-6; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; JACOBS S, 1990, JPEN-PARENTER ENTER, V14, P353, DOI 10.1177/0148607190014004353; JENNETT B, 1975, LANCET, V1, P480; Jolliet P, 1999, CLIN NUTR, V18, P47, DOI 10.1016/S0261-5614(99)80049-1; Klodell CT, 2000, AM J SURG, V179, P168, DOI 10.1016/S0002-9610(00)00297-X; Kocan M J, 1986, J Neurosci Nurs, V18, P333; KUDSK KA, 1996, J CLIN NUTR, V3, P3; LAZARUS BA, 1990, ARCH PHYS MED REHAB, V71, P46; MacLaren R, 2000, CRIT CARE MED, V28, P438, DOI 10.1097/00003246-200002000-00025; MARIAN M, 1993, SURG GYNECOL OBSTET, V176, P475; MCCLAVE SA, 1992, JPEN-PARENTER ENTER, V16, P99, DOI 10.1177/014860719201600299; Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018; OLIVARES L, 1974, STROKE, V5, P654, DOI 10.1161/01.STR.5.5.654; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; SOCIETY AT, 1995, AM J RESP CRIT CARE, V153, P1711; Spain DA, 1995, J TRAUMA, V39, P1100, DOI 10.1097/00005373-199512000-00015; Spain DA, 1999, JPEN-PARENTER ENTER, V23, P288, DOI 10.1177/0148607199023005288; Spilker CA, 1996, CHEST, V110, P243, DOI 10.1378/chest.110.1.243; STRONG RM, 1992, JPEN-PARENTER ENTER, V16, P59, DOI 10.1177/014860719201600159; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TEASDALE G, 1974, LANCET, V2, P81; Yap CW, 2000, NEUROLOGY, V54, pA411; Yavagal DR, 2000, CRIT CARE MED, V28, P1408, DOI 10.1097/00003246-200005000-00025; YOUNG B, 1992, J NEUROTRAUMA S, V9, P375; Zaloga GP, 1999, CRIT CARE MED, V27, P259, DOI 10.1097/00003246-199902000-00024	40	54	55	1	4	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	SEP	2002	24	6					613	620		10.1179/016164102101200456			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	606WD	WOS:000178756900017	12238631				2022-02-06	
J	Muessel, MJ; Klein, RM; Wilson, AM; Berman, NEJ				Muessel, MJ; Klein, RM; Wilson, AM; Berman, NEJ			Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules	MOLECULAR BRAIN RESEARCH			English	Article						chemokine; monocyte-chemoattractant protein-1 (MCP-1); microglia; lesion; thalamus; retrograde degeneration; apoptosis	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LATERAL GENICULATE-NUCLEUS; IFN-GAMMA; INDUCED APOPTOSIS; BCL-2 EXPRESSION; INTERFERON-GAMMA; MESSENGER-RNA; FAS LIGAND	The mechanisms regulating retrograde neuronal degeneration and subsequent death of thalamic neurons following cortical injury are not well understood. However, the delay in the onset of retrograde cell death and observed morphological changes are consistent with apoptosis. Our previous studies demonstrated that monocyte chemoattractant protein-1 (MCP-1), a beta-chemokine that attracts cells of monocytic origin to sites of injury, is rapidly and specifically expressed in the lateral geniculate nucleus following visual cortical lesions. To determine the potential role of MCP-1 in retrograde degeneration, the present study examined the effect of genetic deletion of MCP-1 (MCP-1 KO or -/-) or its high affinity receptor CCR2 (CCR2 KO or -/-) on thalamic microglial activation and neuronal cell death following aspiration lesions of the visual cortex in adult mice. Deletion of the MCP-1 gene delayed microglial activation and transiently improved the survival of thalamic neurons. Deletion of the CCR2 receptor resulted in a significant increase in apoptosis as measured by nucleosomal fragmentation after injury compared to wild-type mice, but did not alter neuron survival, suggesting that glial apoptosis is increased in the receptor knockout mice. Investigation of Bcl-2, Bax, Fas, Fas ligand (FasL) and activated caspase-3, key regulators of apoptosis that can be modulated by cytokines, revealed complex alterations of mRNA and protein levels in MCP-/- and CCR2(-/-) mice. As examples, Bcl-2 protein was detected in wild-type, but not in MCP-/- mice. Caspase-3 activity was higher in MCP-/- mice compared to wild-type and CCR2(-/-) mice at 5 days after injury. High levels of activated caspase-3 correlate with the beginning of a period of delayed, but rapid cell death in the thalami of MCP-/- mice. In summary, our data strongly suggest that MCP-1 is involved in early microglial response to axotomy and that modulation of this chemokine could provide a novel strategy for improved neuronal survival following injury to the central nervous system. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA		Berman, NEJ (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038282] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD02528] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38282] Funding Source: Medline		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; Aoki T, 1999, CLIN NEUROPATHOL, V18, P51; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berman JW, 1996, J IMMUNOL, V156, P3017; Bernassola F, 1999, CELL DEATH DIFFER, V6, P652, DOI 10.1038/sj.cdd.4400537; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BURNS TM, 1993, GROWTH FACTORS, V9, P253, DOI 10.3109/08977199308991585; Casaccia-Bonnefil P, 2000, GLIA, V29, P124, DOI 10.1002/(SICI)1098-1136(20000115)29:2<124::AID-GLIA5>3.0.CO;2-O; CHAO CC, 1992, J IMMUNOL, V149, P2736; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Combs CK, 1999, J NEUROSCI, V19, P928; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; CUNNINGHAM TJ, 1987, ANN NY ACAD SCI, V495, P153, DOI 10.1111/j.1749-6632.1987.tb23673.x; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Della Bianca V, 1999, J BIOL CHEM, V274, P15493, DOI 10.1074/jbc.274.22.15493; Dorrie J, 1999, LEUKEMIA, V13, P1539, DOI 10.1038/sj.leu.2401479; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Elkabes S, 1996, J NEUROSCI, V16, P2508; Fadeel B, 1999, FASEB J, V13, P1647, DOI 10.1096/fasebj.13.13.1647; Felzien LK, 2001, BRAIN RES, V890, P137, DOI 10.1016/S0006-8993(00)03090-0; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; FUENTES ME, 1995, J IMMUNOL, V15, P55769; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Ghirnikar RS, 2001, J NEUROSCI RES, V64, P582, DOI 10.1002/jnr.1110; Giese A, 1998, BRAIN PATHOL, V8, P449; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Gu L, 1999, Chem Immunol, V72, P7, DOI 10.1159/000058723; Guthrie KM, 1997, J COMP NEUROL, V386, P137; Hadida F, 1999, J IMMUNOL, V163, P1105; Hermann DM, 2000, ACTA NEUROPATHOL, V99, P147, DOI 10.1007/PL00007418; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hogaboam CM, 2000, AM J PATHOL, V156, P1245, DOI 10.1016/S0002-9440(10)64995-4; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; Ishizuka K, 1997, PSYCHIAT CLIN NEUROS, V51, P135, DOI 10.1111/j.1440-1819.1997.tb02375.x; Ivacko J, 1997, J CEREBR BLOOD F MET, V17, P759; Jellinger K. A., 2000, Journal of Neural Transmission Supplement, V60, P21; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Koczyk D, 2000, INT J DEV NEUROSCI, V18, P591, DOI 10.1016/S0736-5748(99)00111-2; Koshiji M, 1998, CLIN EXP IMMUNOL, V111, P211; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lawrence DA, 2000, TOXICOLOGY, V142, P189, DOI 10.1016/S0300-483X(99)00144-4; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.00216.x; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MartinezPomares L, 1996, IMMUNOBIOLOGY, V195, P407, DOI 10.1016/S0171-2985(96)80012-X; MATSUYAMA T, 1994, BRAIN RES, V657, P342, DOI 10.1016/0006-8993(94)90989-X; McMahon EJ, 2001, J IMMUNOL, V167, P2964, DOI 10.4049/jimmunol.167.5.2964; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; Muessel M. J., 2001, Society for Neuroscience Abstracts, V27, P1751; Muessel MJ, 2000, BRAIN RES, V870, P211, DOI 10.1016/S0006-8993(00)02450-1; OTANI H, 1993, J BIOL CHEM, V268, P22733; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Peterson PK, 1997, J INFECT DIS, V175, P478, DOI 10.1093/infdis/175.2.478; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; ROSE JE, 1949, ELECTROEN CLIN NEURO, V1, P391, DOI 10.1016/0013-4694(49)90059-0; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Rudge J. S., 1993, ASTROCYTES PHARM FUN, P267; Saas P, 1999, J IMMUNOL, V162, P2326; Schultz MJ, 2001, J IMMUNOL, V166, P4059, DOI 10.4049/jimmunol.166.6.4059; Schweickart VL, 2000, J BIOL CHEM, V275, P9550, DOI 10.1074/jbc.275.13.9550; Smith C, 2001, EUR J NEUROSCI, V13, P443, DOI 10.1046/j.1460-9568.2001.01400.x; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.3.CO;2-P; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; TAKAMIYA Y, 1986, BRAIN RES, V383, P305, DOI 10.1016/0006-8993(86)90029-6; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tanabe K, 1999, J BIOL CHEM, V274, P15725, DOI 10.1074/jbc.274.22.15725; Toyoshima F, 1997, J CELL BIOL, V139, P1005, DOI 10.1083/jcb.139.4.1005; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Wang J, 2000, J CELL SCI, V113, P753; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; White CA, 1998, INT IMMUNOL, V10, P935, DOI 10.1093/intimm/10.7.935; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; WONG GHW, 1994, J IMMUNOL, V152, P1751; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zeuner A, 1999, CELL DEATH DIFFER, V6, P1075, DOI 10.1038/sj.cdd.4400596	97	54	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	JUN 30	2002	103	1-2					12	27	PII S0169-328X(02)00158-4	10.1016/S0169-328X(02)00158-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	583YV	WOS:000177440400002	12106688				2022-02-06	
J	Adibhatla, RM; Hatcher, JF; Sailor, K; Dempsey, RJ				Adibhatla, RM; Hatcher, JF; Sailor, K; Dempsey, RJ			Polyamines and central nervous system injury: spermine and spermidine decrease following transient focal cerebral ischemia in spontaneously hypertensive rats	BRAIN RESEARCH			English	Article						antioxidant; Fe2+ chelation; hydroxyl radical; putrescine; radical scavenger; spermidine/spermine-N-1-acetyltransferase; transient forebrain ischemia; traumatic brain injury	ORNITHINE-DECARBOXYLASE ACTIVITY; EDEMA FORMATION; LIPID-PEROXIDATION; BRAIN EDEMA; METABOLISM; CITICOLINE; OXIDASE; GERBIL; VOLUME; DAMAGE	Polyamines (putrescine, spermidine and spermine) are ubiquitous cellular components, but their specific role in central nervous system (CNS) injury has yet to be characterized. CNS injury results in increased activities of ornithine decarboxylase and spermidine/spermine-N-1-acetyltransferase, and accumulation of putrescine. The present study determined the polyamine profile in three models of CNS injury, in two different species (gerbil and rat) and two strains of rats (Sprague-Dawley and spontaneously hypertensive): ( 1) transient focal cerebral ischemia in spontaneously hypertensive rats (SHR); (2) traumatic brain injury in Sprague-Dawley rats; and (3) transient forebrain ischemia in gerbils. While there was a significant increase in putrescine in all three models, spermine and spermidine levels were unaltered in forebrain ischemia and traumatic brain injury. However, transient focal cerebral ischemia shows depletion of spermine and spermidine levels in injured hemisphere compared to contralateral region. Exogenous spermine significantly restored the spermine as well as spermidine levels in the ipsilateral hemisphere after transient focal cerebral ischemia, but did not alter putrescine levels or the ratio of spermidine to spermine. The loss of spermine in particular, may have several consequences that contribute to ischemic injury, including destabilization of chromatin, decreased mitochondrial Ca2+ buffering capacity, and increased susceptibility to oxidative stress. Based on our and other studies, we propose a tentative antioxidant mechanism of spermine neuroprotection. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Wisconsin, Ctr Clin Canc, Dept Neurol Surg, Madison, WI 53792 USA; Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI 53792 USA; Vet Adm Hosp, Madison, WI USA		Adibhatla, RM (corresponding author), Univ Wisconsin, Ctr Clin Canc, Dept Neurol Surg, H4-330,600 Highland Ave, Madison, WI 53792 USA.	adibhatl@neurosurg.wisc.edu		Sailor, Kurt/0000-0002-9574-6838	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS028000, P01NS031220] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS31220, R01 NS 28000] Funding Source: Medline		Adibhatla RM, 2002, J NEUROCHEM, V80, P12; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; Babu GN, 2001, NEUROSCI LETT, V300, P17, DOI 10.1016/S0304-3940(01)01538-5; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; BASU HS, 1995, POLYAMINES REGULATIO, V1, P101; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Coert BA, 2000, NEUROSCI LETT, V282, P5, DOI 10.1016/S0304-3940(00)00856-9; Cohen S A, 1998, Guttmacher Rep Public Policy, V1, P1; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; Dogan A, 1999, J NEUROCHEM, V72, P765, DOI 10.1046/j.1471-4159.1999.0720765.x; Els T, 2001, STROKE, V32, P43, DOI 10.1161/01.STR.32.1.43; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; GILAD GM, 1991, EXP NEUROL, V111, P349, DOI 10.1016/0014-4886(91)90102-I; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; HALL ED, 1997, PRIMER CEREBROVASCUL, P200; Henley CM, 1997, J NEUROCHEM, V69, P259; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; Kauppinen RA, 1995, PROG NEUROBIOL, V47, P545, DOI 10.1016/0301-0082(95)00037-2; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11426, DOI 10.1073/pnas.89.23.11426; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11428, DOI 10.1073/pnas.89.23.11428; KITADA M, 1981, RES COMMUN CHEM PATH, V33, P487; Lee Y, 1998, J BIOL CHEM, V273, P19490, DOI 10.1074/jbc.273.31.19490; LOVAAS E, 1991, FREE RADICAL BIO MED, V11, P455, DOI 10.1016/0891-5849(91)90061-7; LOVAAS E, 1995, MED HYPOTHESES, V45, P59, DOI 10.1016/0306-9877(95)90204-X; Lovaas E, 1997, Adv Pharmacol, V38, P119; Marzabadi MR, 1996, FREE RADICAL BIO MED, V21, P375, DOI 10.1016/0891-5849(96)00038-X; Morgan DML, 1998, BIOCHEM SOC T, V26, P586, DOI 10.1042/bst0260586; PASCHEN W, 1990, NEUROSCI LETT, V110, P232, DOI 10.1016/0304-3940(90)90817-S; PASCHEN W, 1987, NEUROCHEM PATHOL, V7, P143, DOI 10.1007/BF02834214; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PASCHEN W, 1992, CEREBROVAS BRAIN MET, V4, P59; PASCHEN W, 1987, J NEUROCHEM, V49, P35, DOI 10.1111/j.1471-4159.1987.tb03390.x; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Rao AM, 1998, NEUROSCI LETT, V256, P65, DOI 10.1016/S0304-3940(98)00780-0; Rao AM, 2000, J NEUROCHEM, V74, P1106; RAO AM, 1995, J NEUROCHEM, V65, P2639; RAO AM, 1999, RRD NEUROCHEMISTRY 2, V2, P517; SAUER D, 1992, NEUROSCI LETT, V141, P131, DOI 10.1016/0304-3940(92)90878-B; Schipper RG, 2000, SEMIN CANCER BIOL, V10, P55, DOI 10.1006/scbi.2000.0308; Seiler N, 2000, NEUROCHEM RES, V25, P471, DOI 10.1023/A:1007508008731; SHIN WW, 1985, J NEUROCHEM, V44, P1056, DOI 10.1111/j.1471-4159.1985.tb08724.x; SHOCKLEY RP, 1988, BRAIN RES, V454, P170, DOI 10.1016/0006-8993(88)90816-5; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TADOLINI B, 1988, BIOCHEM J, V249, P33, DOI 10.1042/bj2490033; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x	50	54	61	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 31	2002	938	1-2					81	86	PII S0006-8993(02)02447-2	10.1016/S0006-8993(02)02447-2			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563RV	WOS:000176270100011	12031538				2022-02-06	
J	Aksenova, M; Butterfield, DA; Zhang, SX; Underwood, M; Geddes, JW				Aksenova, M; Butterfield, DA; Zhang, SX; Underwood, M; Geddes, JW			Increased protein oxidation and decreased creatine kinase BB expression and activity after spinal cord contusion injury	JOURNAL OF NEUROTRAUMA			English	Article						creatine kinase; oxidative stress; protein oxidation; spinal cord injury	LIPID-PEROXIDATION PRODUCT; TRAUMATIC BRAIN INJURY; ENERGY-METABOLISM; VITAMIN-E; ALZHEIMERS-DISEASE; COMPRESSION TRAUMA; METHYLPREDNISOLONE; RATS; INACTIVATION; INHIBITION	Traumatic injury to the spinal cord triggers several secondary effects, including oxidative stress and compromised energy metabolism, which play a major role in biochemical and pathological changes in spinal cord tissue. Free radical generation and lipid peroxidation have been shown to be early events subsequent to spinal cord injury. In the present study, we demonstrated that protein oxidation increases in rat spinal cord tissue after experimental injury. As early as 1 h after injury, the level of protein carbonyls at the injury epicenter was significantly higher than in control (169%, p < 0.05) and increased gradually over the next 4 weeks to 1260% of control level. Both caudal and rostral parts of the injured spinal cord demonstrated a mild increase of protein carbonyls by 4 weeks postinjury (135-138%, p < 0.05). Immunocytochemical analysis of protein carbonyls in the spinal cord cross-sections showed increased protein carbonyl immunoreactivity in the epicenter section compared to rostral and caudal sections of the same animal or control laminectomy animals. Increased protein carbonyl formation in damaged spinal cord tissue was associated with changes in activity and expression of an oxidative sensitive enzyme, creatine kinase BB, which plays an important role in the maintenance of ATP level in the CNS tissue. Damage to CK function in the CNS may severely aggravate the impairment of energy metabolism. The results of our study indicate that events associated with oxidative damage are triggered immediately after spinal cord trauma but continue to occur over the subsequent 4 weeks. These results suggest that antioxidant therapeutic strategies may be beneficial to lessen the consequences of the injury and potentially improve the restoration of neurological function.	Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Dept Pharmacol, Lexington, KY 40506 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; Univ Kentucky, Ctr Membrane Sci, Lexington, KY 40506 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA		Butterfield, DA (corresponding author), Univ Kentucky, Dept Chem, 121 Chem Phys Bldg, Lexington, KY 40506 USA.	dabcns@uky.edu; jgeddes@uky.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-05119, AG-10836] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG010836] Funding Source: NIH RePORTER		Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Aksenova MV, 1999, DEMENT GERIATR COGN, V10, P158, DOI 10.1159/000017098; ANDERSON DK, 1980, J NEUROSURG, V52, P387, DOI 10.3171/jns.1980.52.3.0387; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; ANDERSON DK, 1994, NEUROBIOLOGY CENTRAL, P131; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BANERJEE A, 1991, AM J PHYSIOL, V261, pH590, DOI 10.1152/ajpheart.1991.261.2.H590; BARUT S, 1993, NEUROSURG REV, V16, P53, DOI 10.1007/BF00308614; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.biochem.54.1.831; Braughler J M, 1985, Cent Nerv Syst Trauma, V2, P269; BURBAEVA GS, 1992, DEMENTIA, V3, P91, DOI 10.1159/000107000; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Chung I, 1998, NEUROSCIENCE, V86, P1101, DOI 10.1016/S0306-4522(98)00103-1; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Goldberg AL, 1997, MOL BIOL REP, V24, P69, DOI 10.1023/A:1006860828265; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HALL ED, 1989, CRIT CARE CLIN, V5, P793; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALL NC, 1995, NEUROSCIENCE, V69, P591, DOI 10.1016/0306-4522(95)00289-U; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; HEMMER W, 1993, DEV NEUROSCI-BASEL, V15, P249, DOI 10.1159/000111342; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; IWASA K, 1989, FREE RADICAL BIO MED, V6, P599, DOI 10.1016/0891-5849(89)90067-1; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; KARKELA J, 1993, J NEUROL SCI, V116, P100, DOI 10.1016/0022-510X(93)90095-G; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Koc RK, 1999, SPINAL CORD, V37, P29, DOI 10.1038/sj.sc.3100732; Konorev EA, 1998, FEBS LETT, V427, P171, DOI 10.1016/S0014-5793(98)00413-X; Koufen P, 2000, BBA-MOL BASIS DIS, V1501, P44, DOI 10.1016/S0925-4439(00)00005-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leski ML, 2001, FREE RADICAL BIO MED, V30, P613, DOI 10.1016/S0891-5849(00)00500-1; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; MILLER K, 1993, AM J PHYSIOL, V265, pC1544, DOI 10.1152/ajpcell.1993.265.6.C1544; MORIYA T, 1994, J NEUROTRAUM, V11, P255, DOI 10.1089/neu.1994.11.255; Mu XJ, 2000, BRAIN RES, V870, P66, DOI 10.1016/S0006-8993(00)02402-1; NORBY HK, 1982, ACTANEUROCHIR WIEN, V65, P93; Pocernich CB, 2001, NEUROCHEM INT, V39, P141, DOI 10.1016/S0197-0186(01)00012-2; PREHN JHM, 1992, J CEREB BLOOD FLOW M, V12, P378; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Smith MA, 1998, J HISTOCHEM CYTOCHEM, V46, P731, DOI 10.1177/002215549804600605; Springer JE, 1997, J NEUROCHEM, V68, P2469; Stadtman E.R., 1997, ADV CELL AGING GERON, V2, P161; Subramaniam R, 1997, J NEUROCHEM, V69, P1161; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; THOMAS C, 1994, FREE RADICAL RES, V21, P387, DOI 10.3109/10715769409056591; TOMIMOTO H, 1993, ACTA NEUROPATHOL, V86, P447; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310; WANG WP, 1994, CHINESE MED J-PEKING, V107, P205; Yatin SM, 1999, NEUROCHEM RES, V24, P427, DOI 10.1023/A:1020997903147; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; ZHANG Y, 1993, SURG NEUROL, V39, P297, DOI 10.1016/0090-3019(93)90009-P; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V152, P349, DOI 10.1111/j.1748-1716.1994.tb09816.x	66	54	55	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2002	19	4					491	502		10.1089/08977150252932433			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	542XP	WOS:000175071200009	11990354				2022-02-06	
J	Magee, WL; Davidson, JW				Magee, WL; Davidson, JW			The effect of music therapy on mood states in neurological patients: A pilot study	JOURNAL OF MUSIC THERAPY			English	Article							RHYTHMIC AUDITORY-STIMULATION; TRAUMATIC BRAIN INJURY; PARKINSONS-DISEASE; GAIT; STROKE; INSTRUCTION; SPEECH	Music therapy as a clinical intervention has been demonstrated to improve mood states with a variety of populations, however this has not yet been shown empirically with participants with neurological impairments. This report presents the results of a pilot study examining the effect of music therapy on moods states in patients with acquired and complex neuro-disabilities. Using a single subject design, pre and postsession mood states were measured using the Profile of Mood States (Bipolar form). Analyses examined the main effects of pre/post measures as well as interactions between the specific musical therapeutic intervention, mood state, and diagnosis. Results showed that, in terms of composed-anxious, energetic-tired, and agreeable-hostile mood states, there was a significant difference between pre and post music therapy intervention in a positive direction. Although the study displayed that the benefits of music therapy in treating mood states in this patient group are limited, some of the results were affected by the difficulty of the POMS-BI questionnaire for the subject group. The results are discussed considering methodological improvements and arguing for the inclusion of music therapy as an effective intervention to address negative mood states in neuro-rehabilitation populations.	Royal Hosp Neurodisabil, Mus Therapy Dept, London SW15 3SW, England; Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England		Magee, WL (corresponding author), Royal Hosp Neurodisabil, Mus Therapy Dept, West Hill, London SW15 3SW, England.		Magee, Wendy L./AAP-6839-2020	Magee, Wendy L./0000-0003-4350-1289			Bailey L.M., 1984, MUSIC THER J AAMT, V4, P5, DOI [DOI 10.1093/MT/4.1.5, 10.1093/mt/4.1.5]; Bruscia K. E., 1987, IMPROVISATIONAL MODE; COHEN NS, 1995, J MUSIC THER, V32, P46, DOI 10.1093/jmt/32.1.46; COHEN NS, 1988, J MUSIC THER, V25, P85, DOI 10.1093/jmt/25.2.85; COHEN NS, 1992, J MUSIC THER, V29, P87, DOI 10.1093/jmt/29.2.102; COHEN NS, 1993, J MUSIC THER, V30, P81, DOI 10.1093/jmt/30.2.81; GERVIN AP, 1991, MUSIC THERAPY PERSPE, V9, P87, DOI DOI 10.1093/MTP/9.1.87; Hanser SB, 1998, J GERONTOL, V49, P265, DOI 10.1093/geronj/49.6.P265; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; LORR M, 1988, MANUAL PROFILE MOOD; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miller RA, 1996, ELECTROMYOGR MOTOR C, V101, P1, DOI 10.1016/0013-4694(95)00209-X; Nayak S, 2000, REHABIL PSYCHOL, V45, P274, DOI 10.1037/0090-5550.45.3.274; Prassas S, 1997, GAIT POSTURE, V6, P218, DOI 10.1016/S0966-6362(97)00010-6; Purdie H, 1997, INT J REHABIL RES, V20, P325, DOI 10.1097/00004356-199709000-00009; THAUT MH, 1989, J MUSIC THER, V26, P155, DOI 10.1093/jmt/26.3.155; Thaut MH, 1999, MOVEMENT DISORD, V14, P808, DOI 10.1002/1531-8257(199909)14:5<808::AID-MDS1014>3.0.CO;2-J; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Thaut MH, 1993, J NEUROL REHABIL, V7, P9, DOI DOI 10.1177/136140969300700103	19	54	56	2	34	NATL ASSOC MUSIC THERAPY INC	SILVER SPRING	8455 COLESVILLE RD, STE 1000, SILVER SPRING, MD 20910 USA	0022-2917			J MUSIC THER	J. Music Ther.	SPR	2002	39	1					20	29		10.1093/jmt/39.1.20			10	Music; Rehabilitation	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Music; Rehabilitation	553QJ	WOS:000175686700002	12015809				2022-02-06	
J	Dunham, CM; Sosnowski, C; Porter, JM; Siegal, J; Kohli, C				Dunham, CM; Sosnowski, C; Porter, JM; Siegal, J; Kohli, C			Correlation of noninvasive cerebral oximetry with cerebral perfusion in the severe head injured patient: A pilot study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	14th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 10-13, 2001	TARPON SPRINGS, FL	Eastern Assoc Surg Trauma			BRAIN-TISSUE PO2; VENOUS OXYGEN-SATURATION; JUGULAR BULB; PRESSURE; ISCHEMIA	Background: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in trauma patients. Cerebral perfusion pressure (CPP) directed ICU management is recommended for patients with severe TBI. It, however, requires an invasive device to measure intracranial pressure (ICP). Transcranial cerebral oximetry is a noninvasive method utilizing near-infrared technology to indirectly measure cerebral saturation (Stco(2)). Methods: A prospective observational study was performed at a Level I trauma center. Data were collected hourly for the first 6 days on four patients with severe TBI. Each patient had ICP monitoring and Stco(2) (INVOS, Somanetics) assessed from each frontal lobe. CPP directed care was used. Results: Four patients with TBI, with admission GCS scores of 4. 4. 7, and 8. all had subdural hematomas and contusions; three had subarachnoid hemorrhage (SAH); one had an epidural hematoma (the only death; day 6); two had craniotomies. In the first 48 hours when CPP 70, Stco2 was 71 +/- 9, while it was 61 9 when CPP < 70 (p < 0.0001). This relationship was constant for all study days, with p < 0.0001. Moreover, CPP < 70 correlated with Stco(2) with r = 0.81 and r(2) = 0.66. Stco(2) greater than or equal to75 was associated with CPP greater than or equal to 70 96.4% of the time (95% CL, 94.3-98.5%). Stco2 < 55 was associated with CPP < 70 68.2% of the time (95% CL, 57-79.4%). Also, 13.4% of observations with CPP ? 70 had Stco(2) < 60, suggesting the potential of cerebral ischemia in the face of ''normal'' CPP. The Stco(2) patches were user-friendly and not technically finicky. Conclusion: In this pilot study, Stco(2) correlated significantly with CPP. A Stco2 75 suggests that CPP is adequate, while < 55 suggests an inadequate CPP. Although these results should be confirmed in a larger study, Stco(2) may serve as a noninvasive measurement of cerebral perfusion in the patient with a TBI or, at the very least, a sensitive indicator for the need to begin monitoring the ICP.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Surg, Trauma Crit Care Serv,St Elizabeth Hlth Ctr, Youngstown, OH 44501 USA		Dunham, CM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Surg, Trauma Crit Care Serv,St Elizabeth Hlth Ctr, 1044 Belmont Ave, Youngstown, OH 44501 USA.	michael_dunham@hmis.org		Dunham, C. Michael/0000-0002-7842-9750			Bruzzone P, 1998, ACT NEUR S, V71, P111; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gupta AK, 1998, HOSP MED, V59, P704; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1998, ACT NEUR S, V71, P172; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; MCCORMICK PW, 1991, STROKE, V22, P596, DOI 10.1161/01.STR.22.5.596; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Samra SK, 1999, J NEUROSURG ANESTH, V11, P1, DOI 10.1097/00008506-199901000-00001; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; SCHELL RM, 1992, ANESTH ANALG, V74, P627; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P507; The Brain Trauma Foundation American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P479; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; WILLIAMS IM, 1993, SURGERY STROKE, P129; 2000, J NEUROTRAUMA, V17, P453	25	54	60	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2002	52	1					40	46		10.1097/00005373-200201000-00009			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	514PF	WOS:000173449700009	11791050				2022-02-06	
J	Regan, RF; Kumar, N; Gao, F; Guo, Y				Regan, RF; Kumar, N; Gao, F; Guo, Y			Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury	NEUROSCIENCE			English	Article						brain injury; free radical; glia; hemoglobin; iron; mouse	MESSENGER-RNA TRANSLATION; TRAUMATIC BRAIN INJURY; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS; IRON-UPTAKE; IN-VITRO; OXYGENASE-1 EXPRESSION; CELLULAR-DISTRIBUTION; HEMOGLOBIN TOXICITY; FENTON REAGENT	Hemin is released from hemoglobin after CNS hemorrhage and may contribute to its cytotoxic effect. In a prior study, we demonstrated that heme oxygenase-1 induction protected murine cortical astrocytes from hemoglobin toxicity. Since heme metabolism releases iron, this observation suggested that these cells are able to effectively sequester and detoxify free iron. In this study, we tested the hypotheses that astrocytes increased ferritin synthesis after exposure to heme-bound iron, and that this induction protected cells from subsequent exposure to toxic concentrations of hemin. Incubation with low micromolar concentrations of hemin, hemoglobin, or ferrous sulfate increased ferritin expression, as detected on immunoblots stained with a polyclonal antibody that was raised against horse spleen ferritin. Time course studies demonstrated an increase in ferritin levels within 2 h. Weak and scattered cellular staining was detected by immunohistochemistry in control, untreated cultures, while diffuse immunoreactivity was observed in cultures exposed to heme-bound iron. An enhanced ferritin band was detected on immunoblots from cultures that were treated with purified apoferritin, consistent with astrocytic ferritin uptake. Immunoreactivity after apoferritin treatment was not altered by concomitant treatment with cycloheximide. Pretreatment with apoferritin protected astrocytes from hemin toxicity in a concentration-dependent fashion between 1 and 4 mg/ml. At the highest concentration, cell death due to a 6-h exposure to 30 muM hemin was decreased by about 85%. A protective effect was also produced by induction of endogenous ferritin with nontoxic concentrations of ferrous sulfate, hemoglobin, or hemin. These results suggest that cortical astrocytes respond to exogenous heme-bound or free iron by rapidly increasing ferritin synthesis. The combined action of heme oxygenase-1 and ferritin may be a primary astrocytic defense against heme-mediated injury. (C) 2002 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA		Regan, RF (corresponding author), Thomas Jefferson Univ, Dept Surg, 1020 Sansom St,239 Thompson Bldg, Philadelphia, PA 19107 USA.	raymond.f.regan@mail.tju.edu					ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; ADAMS PC, 1990, HEPATOLOGY, V11, P805, DOI 10.1002/hep.1840110514; AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BALLA G, 1991, LAB INVEST, V64, P648; BALLA G, 1992, J BIOL CHEM, V267, P18148; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; BEAUMONT C, 1989, J BIOL CHEM, V264, P7498; BLIGHT GD, 1983, BRIT J HAEMATOL, V55, P59, DOI 10.1111/j.1365-2141.1983.tb01224.x; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; Castellani RJ, 2000, ANTIOXID REDOX SIGN, V2, P137, DOI 10.1089/ars.2000.2.1-137; Cheepsunthorn P, 1998, J COMP NEUROL, V400, P73; CHOI DW, 1987, J NEUROSCI, V7, P357; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; CONNOR JR, 1995, J NEUROCHEM, V65, P717; COZZI A, 1990, FEBS LETT, V277, P119, DOI 10.1016/0014-5793(90)80823-2; Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448; Double KL, 1998, J NEUROCHEM, V70, P2492; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gelvan D, 1996, BLOOD, V88, P3200, DOI 10.1182/blood.V88.8.3200.bloodjournal8883200; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; Halliwell B., 1989, FREE RADICALS BIOL M, VSecond; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HULCRANTZ R, 1987, EXP CELL RES, V171, P203; Hulet SW, 2000, J NEUROSCI RES, V61, P52, DOI 10.1002/1097-4547(20000701)61:1<52::AID-JNR6>3.0.CO;2-T; Hulet SW, 1999, J NEUROCHEM, V72, P868, DOI 10.1046/j.1471-4159.1999.720868.x; JUCKETT MB, 1995, AM J PATHOL, V147, P782; KAJIKAWA H, 1979, Neurologia Medico-Chirurgica, V19, P61, DOI 10.2176/nmc.19.61; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; LIN JJ, 1990, SCIENCE, V247, P74, DOI 10.1126/science.2294594; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Mehindate K, 2001, J NEUROCHEM, V77, P1386, DOI 10.1046/j.1471-4159.2001.00354.x; MOSS D, 1992, J INORG BIOCHEM, V47, P219, DOI 10.1016/0162-0134(92)84067-W; PUPPO A, 1988, BIOCHEM J, V249, P185, DOI 10.1042/bj2490185; Regan RF, 1999, BRAIN RES, V817, P145, DOI 10.1016/S0006-8993(98)01252-9; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Regan RF, 2000, NEUROSCI LETT, V282, P1, DOI 10.1016/S0304-3940(00)00817-X; Regan RF, 2001, J NEUROCHEM, V79, P545, DOI 10.1046/j.1471-4159.2001.00590.x; REIF DW, 1988, ARCH BIOCHEM BIOPHYS, V264, P84322; Robb SJ, 1998, BRAIN RES, V788, P125, DOI 10.1016/S0006-8993(97)01543-6; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; SCHAICH KM, 1992, LIPIDS, V27, P209, DOI 10.1007/BF02536181; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; THEIL EC, 1990, ADV ENZYMOL RAMB, V63, P421; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a	56	54	56	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2002	113	4					985	994	PII S0306-4522(02)00243-9	10.1016/S0306-4522(02)00243-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	592ZL	WOS:000177966700022	12182902				2022-02-06	
J	Hessmann, MH; Rommens, PM				Hessmann, MH; Rommens, PM			Osteosynthesis techniques in proximal humeral fractures	CHIRURG			German	Article						fracture; humerus; fixation; shoulder	SURGICAL NECK FRACTURES; ELDERLY PATIENTS; FIXATION; INTRAMEDULLARY; HEAD; REPLACEMENT; REDUCTION; PEOPLE; 3-PART	Although proximal humeral fractures are common injuries, there is no generally accepted strategy as to how unstable and displaced two- to four-part fractures should be managed. Surgical therapy is in a conflicting situation between the requirement for anatomical fracture reduction and stable fixation, on the one hand, and the necesscity for minimal intraoperative damage to the soft tissue and arterial vascularization of the humeral head in order to avoid avascular necrosis on the other. Whereas minimally invasive procedures using closed or percutaneous reduction and fixation techniques are advantageous for protection of the arterial blood supply of the proximal humerus, plate fixation provides superior fixation stability. Plate fixation seems to be associated with a reduced risk of avascular necrosis when indirect reduction techniques are used. Poor results in the operative management of humeral head fractures are often seen in association with malunion. There is therefore a tendency towards the use of implants with angular stability in order to reduce the risk for secondary loss of reduction during functional after-treatment. Innovative new plates and intramedullary nails that provide superior stability of fixation of the humeral head fragment have been actually introduced into clinical practice. Together with the specific patient and fracture characteristics, the final result of operative management, however, remains mainly related to the knowledge and operative skills of the trauma or orthopaedic surgeon who deals with these proximal humeral fractures.	Johannes Gutenberg Univ Mainz, Klin & Poliklin Unfallchirurg, D-55101 Mainz, Germany		Hessmann, MH (corresponding author), Johannes Gutenberg Univ Mainz, Klin & Poliklin Unfallchirurg, Langenbeckstr 1, D-55101 Mainz, Germany.	Hessmann@unfall.klinik.uni-mainz.de					Adedapo AO, 2001, INJURY, V32, P115, DOI 10.1016/S0020-1383(00)00154-6; BARTSCH S, 2001, AKTUELLE TRAUMATOL, V31, P64; BENGNER U, 1988, CLIN ORTHOP RELAT R, V231, P179; Beredjiklian PK, 1998, J BONE JOINT SURG AM, V80A, P1484, DOI 10.2106/00004623-199810000-00010; Bernard J, 2000, INJURY, V31, P789, DOI 10.1016/S0020-1383(00)00150-9; BLUM J, 2000, HEFTE UNFALLCHIRURG, V279; BONNEVIALLE P, 1996, OPERAT ORTHOP TRAUMA, V8, P243; Boss A, 1997, UNFALLCHIRURG, V100, P867, DOI 10.1007/s001130050206; Chen CY, 1998, J TRAUMA, V45, P1039, DOI 10.1097/00005373-199812000-00011; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Damanakis K, 1996, UNFALLCHIRURG, V99, P561; DARDER A, 1993, J ORTHOP TRAUMA, V7, P497, DOI 10.1097/00005131-199312000-00002; ESSER RD, 1994, CLIN ORTHOP RELAT R, V299, P244; GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486, DOI 10.2106/00004623-199072100-00009; GOTZEN L, 1996, SWISS SURG S2, V3, P27; HABERMEYER P, 1992, ORTHOPADE, V21, P148; HAWKINS RJ, 1987, CLIN ORTHOP RELAT R, V223, P77; Hessmann M, 1999, INJURY, V30, P453, DOI 10.1016/S0020-1383(99)00111-4; HESSMANN MH, 1996, LANGENBECK ARCH CHIR, V381, P907; Hoffmann R, 1998, ZBL CHIR, V123, P1232; JABERG H, 1992, J BONE JOINT SURG AM, V74A, P508, DOI 10.2106/00004623-199274040-00006; JAKOB RP, 1991, J BONE JOINT SURG BR, V73, P295, DOI 10.1302/0301-620X.73B2.2005159; JAKOB RP, 1983, SURG SHOULDER, P330; Kannus P, 1996, BRIT MED J, V313, P1051; KASPERCZYK WJ, 1993, UNFALLCHIRURG, V96, P422; Ko JY, 1996, CLIN ORTHOP RELAT R, P225, DOI 10.1097/00003086-199606000-00028; KOCIALKOWSKI A, 1990, INJURY, V21, P209, DOI 10.1016/0020-1383(90)90003-D; KOFOED H, 1983, CLIN ORTHOP RELAT R, P175; Koval KJ, 1996, J TRAUMA, V40, P778, DOI 10.1097/00005373-199605000-00017; KRISTIANSEN B, 1989, ARCH ORTHOP TRAUM SU, V108, P339, DOI 10.1007/BF00932441; Kuner E H, 1987, Unfallchirurgie, V13, P64, DOI 10.1007/BF02585983; LEE CK, 1981, J TRAUMA, V21, P788, DOI 10.1097/00005373-198109000-00006; Lill H, 1997, UNFALLCHIRURG, V100, P186, DOI 10.1007/s001130050109; LIND T, 1989, ARCH ORTHOP TRAUM SU, V108, P285, DOI 10.1007/BF00932316; LYONS FA, 1990, J BONE JOINT SURG AM, V72A, P1262, DOI 10.2106/00004623-199072080-00023; Matsuda M, 1999, ACTA ORTHOP SCAND, V70, P283, DOI 10.3109/17453679908997808; MEISSNER A, 1987, Aktuelle Traumatologie, V17, P204; MODA SK, 1990, J BONE JOINT SURG BR, V72, P1050, DOI 10.1302/0301-620X.72B6.2246287; NEER CS, 1982, J BONE JOINT SURG AM, V64, P319, DOI 10.2106/00004623-198264030-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; NEUMANN K, 1988, UNFALLCHIRURG, V91, P451; REES J, 1998, CLIN ORTHOP RELAT R, V353, P18; Resch H, 1997, J BONE JOINT SURG BR, V79B, P295, DOI 10.1302/0301-620X.79B2.6958; Ruch DS, 2000, J ORTHOP TRAUMA, V14, P36, DOI 10.1097/00005131-200001000-00008; SAVOIE FH, 1989, ORTHOPEDICS, V12, P65; Schai P, 1993, Z Unfallchir Versicherungsmed, V86, P27; SEIDEL H, 1995, DYNAMISCHE OSTEOSYNT, pS209; Skutek M, 1998, ARCH ORTHOP TRAUM SU, V117, P252, DOI 10.1007/s004020050239; Speck M, 1996, Swiss Surg, P51; SZYSKOWITZ R, 1987, HEFTE UNFALLHEILKD, V186, P165; Togninalli D, 1998, SWISS SURG, V4, P193; Wachtl SW, 2000, ARCH ORTHOP TRAUM SU, V120, P171, DOI 10.1007/s004020050037; Wheeler DL, 1997, J ORTHOP TRAUMA, V11, P363, DOI 10.1097/00005131-199707000-00012; Williams GR, 1997, J SHOULDER ELB SURG, V6, P423, DOI 10.1016/S1058-2746(97)70048-X; Wurm M, 1999, TRAUMA BERUFSKRANKH, V1, P370; ZIFKO B, 1992, ORTHOPADE, V21, P115	57	54	56	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-4722	1433-0385		CHIRURG	Chirurg	NOV	2001	72	11					1235	+		10.1007/s001040170026			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	497CJ	WOS:000172434900003	11766645				2022-02-06	
J	Delaney, JS; Lacroix, VJ; Gagne, C; Antoniou, J				Delaney, JS; Lacroix, VJ; Gagne, C; Antoniou, J			Concussions among university football and soccer players: A pilot study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; soccer; football; university; symptom duration; risk factors	ATHLETIC HEAD-INJURIES; TRAUMATIC BRAIN INJURY; CEREBRAL CONCUSSION; CONTACT SPORTS; CERVICAL-SPINE; GUIDELINES; RETURN	Objective: A pilot study to examine the incidence and characteristics of concussions for one season of university football and soccer. Design: Retrospective survey. Participants: 60 football and 70 soccer players reporting to 1998 fall training camp. Of these, 44 football and 52 soccer players returned a completed questionnaire. Main Outcome Measures: Based on self-reported symptoms, calculations were made to determine the number of concussions experienced during the previous season, the duration of symptoms, the time for return to play and any associated risk factors for concussions. Results: Of all the athletes who returned completed questionnaires, 34.1% of the football players and 46.2% of the soccer players had experienced symptoms of a concussion during the previous season. Only 16.7% of the concussed football players and 29.2% of the concussed soccer players realized they had suffered a concussion. All of the concussed football players and 75.0% of the concussed soccer players experienced more than one concussion during the season. The symptoms from the concussion lasted for at least 1 day in 28.6% of the football players and 18.1% of the soccer players. Variables that increased the odds of suffering a concussion during the previous season for football and soccer players included a past history of a recognized concussion. Conclusion: More university soccer players than football players may be experiencing sport related concussions. Variables that seem to increase the odds of suffering a concussion during the previous season for football and soccer players include a history of a recognized concussion. Despite being relatively common, many players may not recognize the symptoms of a concussion.	McGill Sport Med Clin, Montreal, PQ H2W 1S4, Canada; McGill Univ, McGill Univ Hlth Ctr, Dept Emergency Med, Montreal, PQ, Canada; McGill Univ, Dept Orthoped Surg, Montreal, PQ, Canada		Delaney, JS (corresponding author), McGill Sport Med Clin, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	jdelan2@po-box.mcgill.ca					Autti T, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63019-X; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; Cantu RC., 1997, AM COLL SPORTS MED E, P345; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SCHMIDTOLSEN S, 1991, AM J SPORT MED, V19, P273, DOI 10.1177/036354659101900311; Schneider RC., 1973, HEAD NECK INJURIES F; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; 1988, PHYS SPORTSMED, V16, P165	36	54	55	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	OCT	2001	11	4					234	240		10.1097/00042752-200110000-00005			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	491PV	WOS:000172118200005	11753060				2022-02-06	
J	Milatovic, D; Zivin, M; Gupta, RC; Dettbarn, WD				Milatovic, D; Zivin, M; Gupta, RC; Dettbarn, WD			Alterations in cytochrome c oxidase activity and energy metabolites in response to kainic acid-induced status epilepticus	BRAIN RESEARCH			English	Article						kainic acid; status epilepticus; adenosine triphosphate; phosphocreatine; cytochrome c oxidase; vitamin E; n-tert-butyl-alpha-phenylnitrone; cytochrome c oxidase subunit IV mRNA	TERT-BUTYL-NITRONE; SPIN-TRAPPING AGENTS; NITRIC-OXIDE; ALPHA-TOCOPHEROL; FREE-RADICALS; VITAMIN-E; OXIDATIVE STRESS; INDUCED NEURODEGENERATION; LIPID-PEROXIDATION; NEURONAL INJURY	The effects of kainic acid (KA)-induced limbic seizures have been investigated on cytochrome c oxidase (COx) activity, COx subunit IV mRNA abundance, ATP and phosphocreatine (PCr) levels in amygdala, hippocampus and frontal cortex of rat brain. Rats were killed either 1 h, three days or seven days after the onset of status epilepticus (SE) by CO, and decapitation for the assay of COx activity and by head-focused microwave for the determination of ATP and PCr. Within I h COx activity and COx subunit IV mRNA increased in all brain areas tested between 120% and 130% of control activity, followed by a significant reduction from control, in amygdala and hippocampus on day three and seven, respectively. In amygdala, ATP and PCr levels were reduced to 44% and 49% of control 1 h after seizures. No significant recovery was seen on day three or seven. Pretreatment of rats-with the spin trapping agent N-tert-butyl-alpha -phenylnitrone (PBN, 200 mg kg(-1), i.p.) 30 min before KA administration had no effect on SE, but protected COx activity and attenuated changes in energy metabolites. Pretreatment for three days with the endogenous antioxidant vitamin E (Vit-E, 100 mg/kg, i.p.) had an even greater protective effect than PBN. Both pretreatment regimens attenuated KA-induced neurodegenerative changes, as assessed by histology and prevention of the decrease of COx subunit IV mRNA and COx activity in hippocampus and amygdala, otherwise seen following KA-treatment alone. These findings suggest a close relationship between SE-induced neuronal injury and deficits in energy metabolism due to mitochondrial dysfunction. (C) 2001 Elsevier Science B.V. All rights reserved.	Vanderbilt Univ, Sch Med, Med Ctr S, Dept Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Med Ctr S, Dept Neurol, Nashville, TN 37212 USA; Univ Ljubljana, Sch Med, Inst Pathophysiol, Ljubljana 1000, Slovenia; Murray State Univ, Breathitt Vet Ctr, Dept Toxicol, Hopkinsville, KY 42241 USA		Dettbarn, WD (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr S, Dept Pharmacol, 2100 Pierce Ave, Nashville, TN 37212 USA.	wolf-d.dettbarn@mcmail.vanderbilt.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES004597] Funding Source: NIH RePORTER; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ES 4597] Funding Source: Medline		Andersen KA, 1996, J APPL PHYSIOL, V80, P862, DOI 10.1152/jappl.1996.80.3.862; ANDERSON DE, 1993, BIOCHEM BIOPH RES CO, V193, P878, DOI 10.1006/bbrc.1993.1707; BAST A, 1991, AM J MED, V91, pS2, DOI 10.1016/0002-9343(91)90278-6; BINDOLI A, 1988, FREE RADICAL BIO MED, V5, P247, DOI 10.1016/0891-5849(88)90018-4; BIRKLE DL, 1993, BRAIN RES, V613, P115, DOI 10.1016/0006-8993(93)90461-U; BJORNEBOE A, 1991, J NUTR, V121, P1208, DOI 10.1093/jn/121.8.1208; BONDY SC, 1993, BRAIN RES, V610, P229, DOI 10.1016/0006-8993(93)91405-H; BOSE R, 1992, TOXICOL LETT, V60, P211, DOI 10.1016/0378-4274(92)90276-P; BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B; Boyer PD, 1998, BIOSCIENCE REP, V18, P97, DOI 10.1023/A:1020188311092; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; CARNEY JM, 1991, J MOL NEUROSCI, V3, P47, DOI 10.1007/BF02896848; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; Chow CK, 1999, FREE RADICAL BIO MED, V27, P580, DOI 10.1016/S0891-5849(99)00121-5; Ciani E, 1996, BRAIN RES, V728, P1; COLADO MI, 1995, EUR J PHARMACOL, V280, P343, DOI 10.1016/0014-2999(95)00298-Y; Dettbarn W-D., 2001, INT C ANT, P183; Fallon J, 1997, EXP NEUROL, V144, P193, DOI 10.1006/exnr.1997.6416; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Frantseva MV, 2000, NEUROSCIENCE, V97, P431, DOI 10.1016/S0306-4522(00)00041-5; Fredriksson A, 1997, J NEURAL TRANSM, V104, P579, DOI 10.1007/BF01291877; FREEMAN BA, 1982, LAB INVEST, V47, P412; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; Gupta R. C., 1998, TOXICOL SCI, V42, P156; Gupta R.C., 1999, TOXICOL SCI, V48, P188; Gupta RC, 2000, PFLUG ARCH EUR J PHY, V440, pR160, DOI 10.1007/s004240000047; Gupta RC, 2000, HUM EXP TOXICOL, V19, P297, DOI 10.1191/096032700678815927; He QP, 1997, FREE RADICAL BIO MED, V22, P917, DOI 10.1016/S0891-5849(96)00478-9; HEVNER RF, 1990, J NEUROSCI, V10, P1331; KOTEGAWA M, 1993, J MOL CELL CARDIOL, V25, P1067, DOI 10.1006/jmcc.1993.1119; LAFONCAZAL M, 1993, NEUROPHARMACOLOGY, V32, P1259, DOI 10.1016/0028-3908(93)90020-4; Lancelot E, 1997, FREE RADICAL BIO MED, V23, P1031, DOI 10.1016/S0891-5849(97)00128-7; Lehrer-Graiwer JE, 2000, NEUROSCI LETT, V288, P107, DOI 10.1016/S0304-3940(00)01205-2; LUFT R, 1995, BBA-MOL BASIS DIS, V1271, P1, DOI 10.1016/0925-4439(95)00002-L; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; MARUBAYASHI S, 1986, SURGERY, V99, P184; McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372; Milatovic D, 2000, FREE RADICAL BIO MED, V28, P597, DOI 10.1016/S0891-5849(99)00270-1; MILATOVIC D, 2001, TOXICOLOGIST, V60, P225; MIYAJIMA T, 1995, BIOCHEM BIOPH RES CO, V215, P114, DOI 10.1006/bbrc.1995.2440; Miyajima T, 1997, FREE RADICAL BIO MED, V22, P463, DOI 10.1016/S0891-5849(96)00391-7; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Ong WY, 2000, EXP BRAIN RES, V131, P178, DOI 10.1007/s002219900329; Ong WY, 1996, EXP BRAIN RES, V109, P251; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Pazos AJ, 1999, BRAIN RES, V846, P186, DOI 10.1016/S0006-8993(99)02010-7; Pedersen PL, 1999, J BIOENERG BIOMEMBR, V31, P291, DOI 10.1023/A:1005453700533; Punz A, 1998, CLIN NUTR, V17, P85, DOI 10.1016/S0261-5614(98)80311-7; Sack CA, 1996, NEUROSCI LETT, V205, P181, DOI 10.1016/0304-3940(96)12417-4; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Savolainen KM, 1995, TOXICOL LETT, V82-3, P399; Scanlon JM, 1997, EUR J PHARMACOL, V326, P67, DOI 10.1016/S0014-2999(97)00137-4; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SIRINATHSINGHJI DJS, 1990, NEUROSCIENCE, V34, P675, DOI 10.1016/0306-4522(90)90174-3; SMITH MW, 1980, BIOCHIM BIOPHYS ACTA, V618, P192, DOI 10.1016/0005-2760(80)90025-9; SOUSSI B, 1990, ACTA PHYSIOL SCAND, V138, P107, DOI 10.1111/j.1748-1716.1990.tb08822.x; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Sperlagh B, 1996, SEMIN NEUROSCI, V8, P175, DOI 10.1006/smns.1996.0023; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; TANAKA K, 1994, NEUROCHEM RES, V19, P117, DOI 10.1007/BF00966804; TAYYABA K, 1985, ACTA PHARMACOL TOX, V57, P190, DOI 10.1111/bcpt.1985.57.3.190; Thomas CE, 1997, J NEUROCHEM, V68, P1173; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Tzagoloff, 1967, METHOD ENZYMOL, V10, P245; VANACKER SABE, 1993, FREE RADICAL BIO MED, V15, P311, DOI 10.1016/0891-5849(93)90078-9; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1976, BRAIN RES, V108, P257, DOI 10.1016/0006-8993(76)90185-2; Yang ZP, 1998, J PHYSIOLOGY-PARIS, V92, P157, DOI 10.1016/S0928-4257(98)80002-8; Yang ZP, 1996, TOXICOL APPL PHARM, V138, P48, DOI 10.1006/taap.1996.0096; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	74	54	55	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 31	2001	912	1					67	78		10.1016/S0006-8993(01)02657-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477CR	WOS:000171266000008	11520494				2022-02-06	
J	Klonoff, PS; Lamb, DG; Henderson, SW				Klonoff, PS; Lamb, DG; Henderson, SW			Outcomes from milieu-based neurorehabilitation at up to 11 years post-discharge	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; FOLLOW-UP; WORK; EMPLOYMENT; RETURN; REHABILITATION; PREDICTION; STABILITY	Outcome in patients with brain injury after milieu-based day treatment neurorehabilitation was examined at up to 11 years post-discharge. Follow-up data in this cross-sectional study were sought from all admissions since May 1986 to May 1998 at 3 months, 1, 3, 5, 7, 9, and 11 year intervals. The 164 participants who responded had heterogeneous brain injury aetiologies and represented 73.9% of all patients who were successfully discharged from the programme. Rates of productivity (defined as gainful employment, school, and/or volunteer work) and employment (defined as work for pay) were examined in this follow-up sample. The results demonstrate that 83.5% of patients were productive up to 11 years post-discharge, with 67.1% engaged in work or school, and no decline in productivity was seen over time from discharge. Better vocational/school outcomes were associated with younger age, male gender, and higher staff working alliance ratings of patients and their families.	Barrow Neurol Inst, ADHNR, Catholic Healthcare W, Phoenix, AZ 85013 USA		Klonoff, PS (corresponding author), Barrow Neurol Inst, ADHNR, St Joseph Hosp & Med Ctr, 222 W Thomas Rd,Suite 115, Phoenix, AZ 85013 USA.						Ashley MJ, 1997, BRAIN INJURY, V11, P677; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EAMES P, 1995, BRAIN INJURY, V10, P631; Evans RW, 1997, ARCH PHYS MED REHAB, V78, pS17, DOI 10.1016/S0003-9993(97)90151-9; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fleming J, 1999, BRAIN INJURY, V13, P417; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; Hillier SL, 1997, BRAIN INJURY, V11, P661; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Klonoff P S, 1997, Appl Neuropsychol, V4, P107, DOI 10.1207/s15324826an0402_3; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; KLONOFF PS, 1997, CLIN NEUROPSYCHOLOGY, P219; Klonoff PS, 2000, INT HDB NEUROPSYCHOL, P195; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; SCHALEN W, 1994, BRAIN INJURY, V8, P37, DOI 10.3109/02699059409150957; Sherer M, 1999, BRAIN INJURY, V13, P973; Wall JR, 1998, BRAIN INJURY, V12, P215; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; WILSON B, 1992, J NEUROL NEUROSUR PS, V55, P177, DOI 10.1136/jnnp.55.3.177	30	54	54	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2001	15	5					413	428		10.1080/02699050010005968			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	431TW	WOS:000168648700004	11350655				2022-02-06	
J	Leski, ML; Bao, F; Wu, LQ; Qian, H; Sun, DC; Liu, DX				Leski, ML; Bao, F; Wu, LQ; Qian, H; Sun, DC; Liu, DX			Protein and DNA oxidation in spinal injury: Neurofilaments - An oxidation target	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						protein oxidation; DNA oxidation; protein degradation; neurofilament; spinal cord injury; protein carbonyl content; 8-hydroxy-2-deoxyguanosine; Mn (III) tetrakis (4-benzoic acid) porphyrin; nitro-L-arginine; immunohistochemical staining; HPLC analysis; free radicals	HYDROXYL RADICAL PRODUCTION; METAL-CATALYZED OXIDATION; TRAUMATIC BRAIN INJURY; ACID PORPHYRIN MNTBAP; CORD INJURY; SUPEROXIDE-DISMUTASE; NITRIC-OXIDE; IN-VIVO; PEROXYNITRITE PRODUCTION; LIQUID-CHROMATOGRAPHY	This study measured the time courses of protein and DNA oxidation following spinal cord injury (SCI) in rats and characterized oxidative degradation of proteins. Protein carbonyl content-a marker of protein oxidation-significantly increased at 3-9 h postinjury and the ratio 8-hydroxy-2-deoxyguanosine/deoxyguanosine-an indicator of DNA oxidation-was significantly higher at 3-6 h postinjury in the injured cords than in the sham controls. This suggests that oxidative modification of proteins and DNA contributes to secondary damage in SCI. Densities of selected bands on coomassie-stained gels indicated that most proteins were degraded. Neurofilament protein (NFP) was particularly evaluated immunohistochemically; its light chain (NFP-68) was gradually degraded in nerve fibers, neuron bodies, and large dendrites following SCI. A mixture of Mn (III) tetrakis (4-benzoic acid) porphyrin (10 mg/kg)-a novel SOD mimetic-and nitro-L-arginine (1 mg/kg)-an inhibitor of nitric oxide synthase-injected intraperitoneally, increased NFP-68 immunoreactivity and the numbers of NFP-positive nerve fibers post-SCI, correlating NFP degradation in SCI to free radical-triggered oxidative damage for the first time. Therefore, blockage of protein and DNA oxidation in the secondary injury stage may improve long-term recovery-important information for development of the SCI therapies. (C) 2001 Elsevier Science Inc.	Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA		Liu, DX (corresponding author), Univ Texas, Med Branch, Dept Neurol, 301 Univ Blvd,RT 0653, Galveston, TX 77555 USA.	dliu@utmb.edu		liu, danxia/0000-0001-8172-2344	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 35119, NS 34048] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035119, R29NS034048] Funding Source: NIH RePORTER		Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; AMICI A, 1989, J BIOL CHEM, V264, P3341; Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; ARUOMA OI, 1989, J BIOL CHEM, V264, P13024; BALENTINE JD, 1985, CENTRAL NERVOUS SYST, P455; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BELAND FA, 1979, J CHROMATOGR, V174, P177, DOI 10.1016/S0021-9673(00)87048-X; BIRNBOIM HC, 1988, ANN NY ACAD SCI, V551, P83, DOI 10.1111/j.1749-6632.1988.tb22322.x; CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; CAZEVIEILLE C, 1993, FREE RADICAL BIO MED, V14, P389, DOI 10.1016/0891-5849(93)90088-C; CROSS CE, 1992, FREE RADICAL RES COM, V15, P347, DOI 10.3109/10715769209049150; Cuzzocrea S, 1999, BRIT J PHARMACOL, V128, P1241, DOI 10.1038/sj.bjp.0702826; Cuzzocrea S, 1999, FREE RADICAL BIO MED, V26, P25, DOI 10.1016/S0891-5849(98)00142-7; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Faden AI, 1988, J NEUROTRAUM, V5, P33, DOI 10.1089/neu.1988.5.33; Fitzpatrick MO, 1998, BRIT J NEUROSURG, V12, P313; FLOYD RA, 1990, ANAL BIOCHEM, V188, P155, DOI 10.1016/0003-2697(90)90544-J; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; FLOYD RA, 1988, ARCH BIOCHEM BIOPHYS, V262, P266, DOI 10.1016/0003-9861(88)90188-9; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943; Haghighi SS, 1996, NEUROL RES, V18, P509; HALL ED, 1993, J NEUROSCI RES, V34, P107, DOI 10.1002/jnr.490340111; HALLIWELL B, 1989, ACTA NEUROL SCAND, V80, P23, DOI 10.1111/j.1600-0404.1989.tb01779.x; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; IKEDA Y, 1989, Neurological Research, V11, P213; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; JESBERGER JA, 1991, INT J NEUROSCI, V57, P1, DOI 10.3109/00207459109150342; Keller JN, 1998, J NEUROSCI, V18, P687; Konorev EA, 1999, ARCH BIOCHEM BIOPHYS, V368, P421, DOI 10.1006/abbi.1999.1337; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1993, BRAIN RES, V609, P293, DOI 10.1016/0006-8993(93)90885-Q; LIU DX, 1995, FREE RADICAL BIO MED, V18, P861, DOI 10.1016/0891-5849(94)00214-5; LIU DX, 1994, J NEUROCHEM, V62, P37; LIU DX, 1993, J BIOCHEM BIOPH METH, V27, P281, DOI 10.1016/0165-022X(93)90009-D; LIU DX, 1995, FREE RADICAL BIO MED, V18, P571, DOI 10.1016/0891-5849(94)00154-C; Liu DX, 1999, FREE RADICAL BIO MED, V27, P478, DOI 10.1016/S0891-5849(99)00073-8; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Liu DX, 1998, FREE RADICAL BIO MED, V25, P298, DOI 10.1016/S0891-5849(98)00055-0; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Morin B, 1998, BIOCHEM J, V330, P1059, DOI 10.1042/bj3301059; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSTMANTUR R, 1994, J NEUROTRAUM, V11, P533; POSTMANTUR RM, 1996, J NEUROPATHOL EXP NE, V55, P68; Qian H, 1997, NEUROCHEM RES, V22, P1231, DOI 10.1023/A:1021980929422; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; SHIGENAGA MK, 1990, METHOD ENZYMOL, V186, P521; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; VLIET A, 1994, FEBS LETT, V339, P89; vonEuler M, 1997, ACTA NEUROPATHOL, V94, P232, DOI 10.1007/s004010050698; YAGHMAI A, 1992, J NEUROPATHOL EXP NE, V23, P63; Yang MH, 1996, FREE RADICAL BIO MED, V20, P225, DOI 10.1016/0891-5849(95)02039-X; YANG QN, 1995, BRAIN RES, V696, P49, DOI 10.1016/0006-8993(95)00755-F; Young W, 1988, J Neurotrauma, V5, P219, DOI 10.1089/neu.1988.5.219; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	69	54	58	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	MAR 15	2001	30	6					613	624		10.1016/S0891-5849(00)00500-1			12	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	412BZ	WOS:000167535300004	11295359				2022-02-06	
J	Schmidt, EA; Czosnyka, M; Gooskens, I; Piechnik, SK; Whitfield, PC; Pickard, JD				Schmidt, EA; Czosnyka, M; Gooskens, I; Piechnik, SK; Whitfield, PC; Pickard, JD			Preliminary experience of the estimation of cerebral perfusion pressure using transcranial Doppler ultrasonography	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						cerebral perfusion pressure; transcranial Doppler; non-invasive monitoring	HEAD-INJURED PATIENTS; TRAUMATIC BRAIN INJURY; BLOOD-FLOW; INTRACRANIAL-PRESSURE; JUGULAR BULB	Objective-The direct calculation of cerebral perfusion pressure (CPP) as the difference between mean arterial pressure and intracranial pressure (ICP) produces a number which does not always adequately describe conditions for brain perfusion. A non-invasive method of CPP measurement has previously been reported based on waveform analysis of blood how velocity measured in the middle cerebral artery (MCA) by transcranial Doppler. This study describes the results of clinical tests of the prototype bilateral transcranial Doppler based apparatus for non-invasive CPP measurement (nCPP). Methods-Twenty five consecutive, paralysed, sedated, and ventilated patients with head injury were studied. Intracranial pressure (ICP) and arterial blood pressure (ABP) were monitored continuously. The left and right MCAs were insonated daily (108 measurements) using a purpose built transcranial Doppler monitor (Neuro Q(TM), Deltex Ltd, Chichester, UK) with software capable of the non-invasive estimation of CPP. Time averaged values of mean and diastolic flow velocities (FVm, FVd) and ABP were calculated, nCPP was then computed as: ABPxFVd/FVm+14. Results-The absolute difference between real CPP and nCPP (daily averages) was less than 10 mm Hg in 89% of measurements and less than 13 mm Hg in 92% of measurements. The 95% confidence range for predictors was no wider than +/-12 mm Hg (n=25) for the CPP, varying from 70 to 95 mm Hg. The absolute value of side to side differences in nCPP was significantly greater (p<0.05) when CT based evidence of brain swelling was present and was also positively correlated (p<0.05) with mean ICP. Conclusion-The device is of potential benefit for intermittent or continuous monitoring of brain perfusion pressure in situations where the direct measurement is not available or its reliability is in question.	Addenbrookes Hosp, Acad Neurosurg & Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; CHRU, Dept Neurosurg, F-63000 Clermont Ferrand, France; Addenbrookes Hosp, Dept Anaesthesiol, Cambridge, England		Czosnyka, M (corresponding author), Addenbrookes Hosp, Acad Neurosurg & Wolfson Brain Imaging Ctr, Box 167, Cambridge CB2 2QQ, England.			Piechnik, Stefan K./0000-0002-0268-5221	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		Aaslid R, 1986, INTRACRANIAL PRESSUR, VVI, P229; ALRAWI PG, 1997, ACTA NEUROCHIR     S, V71, P255; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; CZOSNYKA M, 1999, J CEREBRAL BLOOD FLO, V19, pS362; DAHL A, 1992, STROKE, V23, P15, DOI 10.1161/01.STR.23.1.15; Giller CA, 1999, J CEREBR BLOOD F MET, V19, P452, DOI 10.1097/00004647-199904000-00011; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; MARMAROU A, 1991, J NEUROSURG S, V75, pS559; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; Miller J D, 1972, Prog Brain Res, V35, P411; Nagai H, 1997, STROKE, V28, P603, DOI 10.1161/01.STR.28.3.603; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schmidtmann ET, 1999, J MED ENTOMOL, V36, P1; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; ZURYNSKI Y, 1991, Neurological Research, V13, P248	24	54	60	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	FEB	2001	70	2					198	204		10.1136/jnnp.70.2.198			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	395YX	WOS:000166610500011	11160468	Green Published, Bronze			2022-02-06	
J	Berthier, ML; Kulisevsky, J; Gironell, A; Lopez, OL				Berthier, ML; Kulisevsky, J; Gironell, A; Lopez, OL			Obsessive-compulsive disorder and traumatic brain injury: Behavioral, cognitive, and neuroimaging findings	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article; Proceedings Paper	49th Annual Meeting of the American-Academy-of-Neurology	APR 12-19, 1997	BOSTON, MASSACHUSETTS	Amer Acad Neurol			POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD-INJURY; EMISSION TOMOGRAPHY; ANOREXIA-NERVOSA; EVENT SCALE; BLOOD-FLOW; SLOWNESS; SECONDARY; ADOLESCENCE; CATATONIA	Objective: The goal of this study was to evaluate behavior and cognition in a consecutive series of patients who developed obsessive-compulsive disorder (OCD) after suffering a traumatic brain injury (TBI). Background: Because OCD is a rare sequelae of TBI, the phenomenology of obsessions and compulsions, the comorbid psychiatric disorders, the performance on cognitive tests, and the neural correlates have not been well characterized. Methods: Ten adult patients who met DSM-IV diagnostic criteria for OCD after suffering either mild (6 cases), moderate (2 cases), or severe (2 cases) TBI were studied using structured psychiatric rating scales (i.e., Yale-Brown Obsessive Compulsive Scale), cognitive tests, and magnetic resonance imaging (MRI). Results: Global severity of OCD ranged from moderate to severe, and all patients had multiple obsessions and compulsions. There was a high frequency of aggressive, contamination, need for symmetry/exactness, somatic, and sexual obsessions as well as cleaning/washing, checking, and repeating compulsions. Unusual features such as obsessional slowness (3 cases) and compulsive exercising (3 cases) were also documented. Comorbid psychiatric diagnoses were common and included posttraumatic stress disorder, anxiety with panic attacks, depression, and intermittent explosive disorder. Compared with 10 age-matched normal controls, the OCD group had poor performance on tests of general intelligence, attention, learning, memory, word-retrieval, and executive functions; these cognitive deficits were more pervasive among patients displaying obsessional slowness. All OCD patients with mild TBI had normal MRI scans, whereas focal contusions in the frontotemporal cortices, subcortical structures (caudate nucleus), or both were found in OCD patients with moderate and severe TBI. Conclusions: Posttraumatic OCD has a relatively specific pattern of symptoms even in patients with mild TBI and is associated with a variety of other psychiatric disorders, particularly non-OCD anxiety. The patterns of cognitive deficits and MRI findings suggest dysfunction of frontal-subcortical circuits.	Univ Malaga, Fac Med, Dept Med & Dermatol, E-29071 Malaga, Spain; Autonomous Univ Barcelona, St Pau Hosp, Dept Neurol, Barcelona, Spain; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Alzheimers Dis Res Ctr, Pittsburgh, PA 15261 USA		Berthier, ML (corresponding author), Univ Malaga, Fac Med, Dept Med & Dermatol, Campus Univ Teatinos, E-29071 Malaga, Spain.			Gironell, Alexandre/0000-0003-2109-9030			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association Committee on Nomenclature and Statistics, 1994, DIAGN STAT MAN MENT; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Berthier M L, 1998, Depress Anxiety, V8, P43, DOI 10.1002/(SICI)1520-6394(1998)8:1<43::AID-DA9>3.0.CO;2-6; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; BOLL TJ, 1981, HDB CLIN NEUROPSYCHO; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; Cooper J, 1970, Psychol Med, V1, P48; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DAVIDOFF DA, 1993, COGN REHABIL; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DONOVAN NJ, 1994, AM J PSYCHIAT, V151, P618; DRUMMOND LM, 1988, BRIT J PSYCHIAT, V153, P839, DOI 10.1192/bjp.153.6.839; Epstein Richard S., 1994, P285; Fahn S, 1982, Adv Neurol, V35, P349; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FISHER CM, 1989, ARCH NEUROL-CHICAGO, V46, P798, DOI 10.1001/archneur.1989.00520430094024; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1992, PSYCHIAT CLIN N AM, V15, P861; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOLDEN NL, 1990, BRIT J PSYCHIAT, V157, P1, DOI 10.1192/bjp.157.1.1; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HYMAS N, 1991, BRAIN, V114, P2203, DOI 10.1093/brain/114.5.2203; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kant R, 1996, BRAIN INJURY, V10, P55; Kaplan E, 1983, BOSTON NAMING TEST; Krauss JK, 1997, MOVEMENT DISORD, V12, P776, DOI 10.1002/mds.870120527; Leckman JF, 1997, AM J PSYCHIAT, V154, P911; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lopez OL, 1997, NEUROPSY NEUROPSY BE, V10, P120; Lucey JV, 1997, BRIT J PSYCHIAT, V171, P346, DOI 10.1192/bjp.171.4.346; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; Michael AJ, 1988, J ANXIETY DISORD, V4, P353, DOI DOI 10.1016/0887-6185(88)90030-8; MONEY J, 1976, STANDARDIZED ROAD MA; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; OTTO MW, 1992, PSYCHIAT CLIN N AM, V15, P825; RATNASURIYA RH, 1991, BRIT J PSYCHIAT, V159, P273, DOI 10.1192/bjp.159.2.273; ROGERS D, 1991, J NEUROPSYCH CLIN N, V3, P334; ROTHENBERG A, 1990, PSYCHIAT CLIN N AM, V13, P469; SAWLE GV, 1991, BRAIN, V114, P2191, DOI 10.1093/brain/114.5.2191; SHTASEL DL, 1991, ARCH GEN PSYCHIAT, V48, P1022; Spitzer R. L., 1985, STRUCTURED CLIN INTE; Spreen O, 1991, COMPENDIUM NEUROPSYC; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; TEASDALE GM, 1976, LANCET, V2, P1031; TYRER P, 1984, J NEUROL NEUROSUR PS, V47, P970, DOI 10.1136/jnnp.47.9.970; VEALE D, 1993, BRIT J PSYCHIAT, V162, P198, DOI 10.1192/bjp.162.2.198; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; ZILBERG NJ, 1982, J CONSULT CLIN PSYCH, V50, P407, DOI 10.1037/0022-006X.50.3.407	60	54	59	1	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	JAN	2001	14	1					23	31					9	Clinical Neurology; Psychiatry; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	405WP	WOS:000167183800003	11234906				2022-02-06	
J	Connolly, JF; D'Arcy, RCN				Connolly, JF; D'Arcy, RCN			Innovations in neuropsychological assessment using event-related brain potentials	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						event-related potentials; assessment; language; stroke; traumatic brain injury; neuropsychology	RECEPTIVE VOCABULARY; SPOKEN SENTENCES; CEREBRAL-PALSY; APHASIA; WORDS; DETERMINANTS; STROKE; P300	Historically, clinicians have utilized evoked potentials for evaluating sensory functions and neuropsychological tests for evaluating cognitive functions. However, the clinical implementation of event-related brain potentials (ERPs), an on-line index of cognitive processing, remains to be developed fully. We describe a new method for assessing language functions using neuropsychological tests that are formatted for computer presentation with simultaneous ERP recordings. From its inception, there have been two major objectives of this ERP language assessment research. Practically, we have sought to develop assessment techniques that would enable clinicians to evaluate the language functions of individuals with limited behavioral and communicative abilities. Conceptually, we have endeavored to increase the precision of neuropsychological testing through the development of measures that are sensitive to readily identifiable and objective neural responses. This article summarizes the issues central to the development of ERP assessment techniques, reviews recent normative studies with healthy individuals, and suggests some future avenues of research in this area. (C) 2000 Elsevier Science B.V. All rights reserved.	Dalhousie Univ, Dept Psychol, Cognit Clin Neurosci Unit, Life Sci Ctr, Halifax, NS B3H 4J1, Canada; Dalhousie Univ, Div Psychiat, Dept Med, Halifax, NS B3H 4J1, Canada		Connolly, JF (corresponding author), Dalhousie Univ, Dept Psychol, Cognit Clin Neurosci Unit, Life Sci Ctr, Halifax, NS B3H 4J1, Canada.			Connolly, John/0000-0001-8869-5369			BATSHAW ML, 1981, CHILDREN HANDICAPS M; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; Byrne JM, 1999, DEV MED CHILD NEUROL, V41, P740, DOI 10.1017/S0012162299001504; CHIAPPA K, 1997, EVOKED POTENTIALS CL; CONNOLLY JF, 1992, BRAIN LANG, V43, P1, DOI 10.1016/0093-934X(92)90018-A; Connolly JF, 1999, J CLIN EXP NEUROPSYC, V21, P444, DOI 10.1076/jcen.21.4.444.879; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; CONNOLLY JF, 1990, BRAIN LANG, V39, P302, DOI 10.1016/0093-934X(90)90016-A; Connolly JF, 1999, ARCH PHYS MED REHAB, V80, P1309, DOI 10.1016/S0003-9993(99)90035-7; CONNOLLY JF, 1995, ELECTROEN CLIN NEURO, V94, P276, DOI 10.1016/0013-4694(95)98479-R; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; CONNOLLY JF, 2000, UNPUB EVENT RELATED; D'Arcy RCN, 2000, CLIN NEUROPHYSIOL, V111, P40, DOI 10.1016/S1388-2457(99)00210-2; D'Arcy RCN, 1999, NEUROPSYCHOLOGIA, V37, P1477, DOI 10.1016/S0028-3932(99)00057-3; DARCY RCN, 2000, IN PRESS J INT NEURO; DARCY RCN, 1998, THESIS; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Dunn LM., 1981, PEABODY PICTURE VOCA; Enderby P, 1987, Int Rehabil Med, V8, P162; Golden CJ, 1978, DIAGNOSIS REHABILITA; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P337; Ingles JL, 1996, CORTEX, V32, P199, DOI 10.1016/S0010-9452(96)80047-5; Kaplan E., 1991, WAISR NEUROPSYCHOLOG; Kay J., 1992, PSYCHOLINGUISTIC ASS; KEARSLEY RB, 1979, INFANTS RISK ASSESSM; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI [10.1016/B978-012369374-7/50018, DOI 10.1016/B978-012369374-7/50018]; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mangina CA, 2000, INT J PSYCHOPHYSIOL, V35, P11; MANGINA CA, 2000, INT J PSYCHOPHYSIOL; MATARAZZO JD, 1992, AM PSYCHOL, V47, P1007, DOI 10.1037/0003-066X.47.8.1007; MCCARTY SM, 1986, DEV MED CHILD NEUROL, V28, P364; MORSE PA, 1992, CLIN SYNDROMES ADULT, P86; NAATANEN R, 1992, EAR HEARING, V16, P6; NELSON KB, 1989, PEDIAT NEUROLOGY PRI, P363; Osterhout L, 1996, J COGNITIVE NEUROSCI, V8, P507, DOI 10.1162/jocn.1996.8.6.507; PANETH N, 1986, NEW ENGL J MED, V315, P124, DOI 10.1056/NEJM198607103150209; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Rugg Michael D., 1995, P789; Sattler J. M., 1988, ASSESSMENT CHILDREN; STANLEY F, 1984, EPIDEMIOLOGY CEREBRA; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; WECHSLER D, 1991, WECHSLER INTELLIGENC, pR3; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; ZELAZO PR, 1979, INFANTS RISK ASSESSM	51	54	54	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760			INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	JUL	2000	37	1					31	47		10.1016/S0167-8760(00)00093-3			17	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	326ZG	WOS:000087766700004	10828373				2022-02-06	
J	Haji-Michael, PG; Vincent, JL; Degaute, JP; van de Borne, P				Haji-Michael, PG; Vincent, JL; Degaute, JP; van de Borne, P			Power spectral analysis of cardiovascular variability in critically ill neurosurgical patients	CRITICAL CARE MEDICINE			English	Article						heart rate variability; autonomic nervous system; outcome; neurosurgery; spectral analysis; critical illness; baroreflex sensitivity; head injury; death; brain damage	HEART-RATE-VARIABILITY; TRAUMATIC BRAIN INJURY; BAROREFLEX SENSITIVITY; MYOCARDIAL-INFARCTION; AUTONOMIC DYSFUNCTION; BLOOD-PRESSURE; PREDICTION; FAILURE; HUMANS; REFLEX	Objective: Patients with brain damage exhibit a number of changes in heart rate and cardiovascular control. The aim of this study was to relate changes in autonomic cardiovascular control seen in critically ill neurosurgical patients to the quality of subsequent outcome and survival. Design: Prospective, longitudinal, outcome study. Setting: Intensive care department of a university teaching hospital. Patients: A total of 29- consecutive neurosurgical patients admitted for greater than or equal to 2 days to the intensive care department with a Glasgow Coma Scale score <13 who needed electrocardiographic and invasive arterial monitoring, Interventions: Sampling of the electrocardiogram, respiratory rate, and arterial pressure into a personal computer was carried out for greater than or equal to 60 mins, Power spectral analysis was then applied to the data by using a fast Fourier transformation. Arterial baroreflex sensitivity was determined as the gain of the transfer function between systolic arterial blood pressure and electrocardiograph R-R interval (RRI) variability. All surviving patients were followed up at 3 months postadmission to measure quality of outcome. Measurements and Main Results: There were reductions in the total power (p < .01) of RRI variability in those who subsequently died compared with those who survived, This was significant for very low frequency (p < .001) and low-frequency (LF) (p < .05) but not high-frequency (HF) bands (p = .11), Blood pressure variability, however, did not change between groups. Baroreflex sensitivity was 8.7 +/- 2.2 msecs/mm Hg for patients with a good later outcome and 4.4 +/- 1.5 msecs/mm Hg for patients who subsequently died (p = .03), Patients who recovered to a good quality outcome also had a raised LF/HF ratio in RRI (p = .05), Conclusion: A reduction in the total power variability of RRI and a lowered LF/HF ratio of the RRI are associated with a poor quality recovery or death after neurosurgical illness. A reduction in the baroreflex was specifically associated with death in this patient group.	Erasme Univ Hosp, Dept Cardiol, Hypertens Clin, B-1070 Brussels, Belgium; Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium		van de Borne, P (corresponding author), Erasme Univ Hosp, Dept Cardiol, Hypertens Clin, 808 Lennik Rd, B-1070 Brussels, Belgium.			Vincent, Jean-Louis/0000-0001-6011-6951			ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; Camm AJ, 1996, CIRCULATION, V93, P1043; DEFERRARI GM, 1995, AM HEART J, V130, P473, DOI 10.1016/0002-8703(95)90354-2; GARCIALARREA L, 1992, J NEUROL NEUROSUR PS, V55, P792, DOI 10.1136/jnnp.55.9.792; Godin PJ, 1996, CRIT CARE MED, V24, P1117, DOI 10.1097/00003246-199607000-00009; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grimm DR, 1997, AM J PHYSIOL-HEART C, V272, pH835, DOI 10.1152/ajpheart.1997.272.2.H835; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; HNATKOVA K, 1994, COMPUT METH PROG BIO, V42, P147, DOI 10.1016/0169-2607(94)90125-2; HOWELL SJ, 1995, BRIT J ANAESTH, V74, P168, DOI 10.1093/bja/74.2.168; INOUE K, 1995, J AUTONOM NERV SYST, V54, P225, DOI 10.1016/0165-1838(95)00012-M; INOUE K, 1990, AM J PHYSIOL, V258, pH1722, DOI 10.1152/ajpheart.1990.258.6.H1722; JENNETT B, 1975, LANCET, V1, P480; KAREMAKER JM, 1985, PSYCHOPHYSIOLOGY CAR, P55; Kimura T, 1996, ANESTHESIOLOGY, V84, P1068, DOI 10.1097/00000542-199605000-00008; King ML, 1997, BRAIN INJURY, V11, P445; Korpelainen JT, 1996, ACTA NEUROL SCAND, V94, P337, DOI 10.1111/j.1600-0404.1996.tb07076.x; La Rovere MT, 1998, LANCET, V351, P478; LACQUANITI LG, 1993, INT J CLIN MONIT COM, V10, P181, DOI 10.1007/BF01246453; LEIPZIG TJ, 1986, NEUROSURGERY, V19, P356, DOI 10.1227/00006123-198609000-00004; LOWENSOHN RI, 1977, LANCET, V1, P626; MALIK M, 1993, AM J CARDIOL, V72, P821, DOI 10.1016/0002-9149(93)91070-X; MUHLNICKEL V, 1989, ANAESTHESIOL REANIM, V14, P71; MULDER LJM, 1987, COMPUTERS PSYCHOL ME, P30; Parati G, 1997, J HYPERTENS, V15, P1621, DOI 10.1097/00004872-199715120-00063; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; PIEPOLI M, 1995, CLIN SCI, V89, P155, DOI 10.1042/cs0890155; PORGES SW, 1980, PSYCHOL BULL, V88, P580, DOI 10.1037/0033-2909.88.3.580; RaeGrant AD, 1996, J TRAUMA, V40, P401, DOI 10.1097/00005373-199603000-00013; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; Rompelman O., 1980, Study of heart-rate variability, P59; ROMPELMAN O, 1986, AUTOMEDICA, V6, P192; SIMPSON DM, 1988, J GERONTOL, V43, pM21, DOI 10.1093/geronj/43.1.M21; Svigelj V, 1996, ACTA NEUROL SCAND, V94, P120, DOI 10.1111/j.1600-0404.1996.tb07041.x; VANDEBORNE P, 1994, AM J PHYSIOL, V266, pH548, DOI 10.1152/ajpheart.1994.266.2.H548; vandeBorne P, 1997, CIRCULATION, V95, P1449; Watkins LL, 1996, HYPERTENSION, V28, P238, DOI 10.1161/01.HYP.28.2.238; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	41	54	56	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2000	28	7					2578	2583		10.1097/00003246-200007000-00066			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336QW	WOS:000088315300060	10921598				2022-02-06	
J	Mackenzie, C				Mackenzie, C			Adult spoken discourse: the influences of age and education	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						communication; discourse; elderly	CONNECTED SPEECH SAMPLES; TRAUMATIC BRAIN INJURY; SPONTANEOUS LANGUAGE; OLDER ADULTS; PERFORMANCE; COMMUNICATION; POPULATION; APHASIA	Spoken discourse is regarded as an important component of communication assessment, but data on the discourse characteristics of the adult population, and in particular those who fall into the fastest growing section of the population (those aged over 75), are scant. Therefore, detection of deficit is commonly dependent on the assessor's opinion as to what constitutes normal performance. To determine the effects of age, education and gender on spoken discourse, the conversational interaction and picture description skills of 189 neurologically normal adults were examined. Conversation was appraised with reference to five parameters (initiation, topic maintenance, verbosity, turn taking, reference). Picture description was assessed for relevant content, length, efficiency and the inclusion of extraneous information Level of education did not affect conversational interaction but in picture description those not educated beyond minimal school leaving produced shorter and less complete descriptions. Picture description content and length were not affected by advancing age but the older elderly (aged 75 +) conveyed information with reduced efficiency. Conversational interaction style altered with advancing age, with some suggestion of change in the young elderly (age 60-74), but highly significant differences in respect of the old elderly. Gender had no effect on the parameters of conversation and no significant picture description differences were present in males and females though there were trends towards longer and higher content descriptions in females. The results have important diagnostic implications for those concerned with establishing whether pathology such as stroke has affected communication. On a wider scale, awareness of the effects of advancing age and limited education may facilitate successful communication for all who communicate with the public in a professional capacity.	Univ Strathclyde, Dept Speech & Langauge Therapy, Glasgow G13 1PP, Lanark, Scotland		Mackenzie, C (corresponding author), Univ Strathclyde, Dept Speech & Langauge Therapy, Glasgow G13 1PP, Lanark, Scotland.						ARMSTRONG L, 1994, EUR J DISORDER COMM, V29, P371; BLOOM RL, 1992, BRAIN LANG, V42, P153, DOI 10.1016/0093-934X(92)90122-U; BODEN D, 1983, HUM DEV, V26, P308, DOI 10.1159/000272892; BODEN D, 1986, LANG COMMUN, V6, P73, DOI 10.1016/0271-5309(86)90007-8; BROOKSHIRE R, 1992, INTRO NEUROGENIC COM; BURNS MS, 1985, CLIN MANAGEMENT RIGH; CANNITO M P, 1988, Seminars in Speech and Language, V9, P117, DOI 10.1055/s-0028-1082459; Ceccaldi M, 1996, BRAIN LANG, V54, P75, DOI 10.1006/brln.1996.0061; CHAFETZ P K, 1988, Seminars in Speech and Language, V9, P177, DOI 10.1055/s-0028-1082463; Coates Jennifer, 1986, WOMEN MEN LANGUAGE; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; COHEN G, 1979, COGNITIVE PSYCHOL, V11, P412, DOI 10.1016/0010-0285(79)90019-7; COOPER PV, 1990, J GERONTOL B-PSYCHOL, V45, P210; Coupland N., 1991, LANGUAGE SOC ELDERLY; CRAIG HK, 1993, APHASIOLOGY, V7, P155, DOI 10.1080/02687039308249503; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; EMERY OB, 1985, LANGUAGE AGEING MONO, V11; Giles E, 1996, APHASIOLOGY, V10, P395, DOI 10.1080/02687039608248419; Glosser G., 1992, J GERONTOL B-PSYCHOL, V47, P266; GOLD D, 1988, J GERONTOL, V43, P27; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Goren AR, 1996, EUR J DISORDER COMM, V31, P153; GOULET P, 1994, J SPEECH HEAR RES, V37, P629, DOI 10.1044/jshr.3703.629; GRICE P, 1975, SYNTAX SEMANTICS, V3; GRUNDY E., 1998, BROCKLEHURSTS TXB GE, P1; Henwood M., 1992, 14 KINGS FUND I; KAUSLER DH, 1988, COMMUNICATION BEHAVI, P79; Kemper S., 1989, ANN REV APPL LINGUIS ANN REV APPL LINGUIS, V10, P37; KENNEDY MRT, 1994, CLIN APHASIOL, V22, P67; Levinson Stephen., 1983, PRAGMATICS; MACKENZIE C, 1997, RIGHT HEMISPHERE STR; MAXIM J, 1994, LANGUAGE ELDERLY CLI; MENN L, 1994, APHASIOLOGY, V8, P343, DOI 10.1080/02687039408248664; Myers Penelope S., 1979, CLIN APHASIOLOGY C P, P38; Myers Penelope S, 1994, LANGUAGE INTERVENTIO, P514; NEILS J, 1995, J SPEECH HEAR RES, V38, P1143, DOI 10.1044/jshr.3805.1143; NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW; OBLER LK, 1980, LANG COMMUN, P75; OBLER LK, 1994, STUDIES ADULT CLIN P, P00015; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLSHANSKY SJ, 1993, SCI AM           APR, P18; PAYNE JC, 1997, ADULT NEUROGENIC LAN; PERKINS L, 1993, FOUNDATIONS OF APHASIA REHABILITATION, P211; Perkins L., 1997, CONVERSATION ANAL PR; ROBINE JM, 1991, BMJ-BRIT MED J, V302, P457, DOI 10.1136/bmj.302.6774.457; RYAN EB, 1986, LANG COMMUN, V6, P1, DOI 10.1016/0271-5309(86)90002-9; RYAN EB, 1995, DEMENTIA COMMUNICATI, P84; RYFF CD, 1989, PSYCHOL AGING, V4, P195, DOI 10.1037/0882-7974.4.2.195; SCHAIE KW, 1980, LANG COMMUN, P7; Shadden B.B., 1991, CLIN APHASIOLOGY, V20, P327; SHADDEN BB, 1988, COMMUNICATION BEHAV, P3; SHEWAN CM, 1988, J COMMUN DISORD, V21, P139, DOI 10.1016/0021-9924(88)90002-0; SHEWAN CM, 1988, J COMMUN DISORD, V21, P103, DOI 10.1016/0021-9924(88)90001-9; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; STOVER SE, 1989, CLIN LINGUIST PHONET, V3, P137, DOI 10.3109/02699208908985277; SWIHART AA, 1988, NEUROPSYCHOLOGICAL S, P1; TOMPKINS CA, 1993, CLIN APHASIOLOGY, V21, P113; Ulatowska H. K., 1991, HDB GERIATRIC COMMUN, P21; ULATOWSKA HK, 1986, BRAIN LANG, V28, P24, DOI 10.1016/0093-934X(86)90088-X; ULATOWSKA HK, 1995, AGEING BRAIN COMMUNI; WEEKS DJ, 1988, ANOMALOUS SENTENCES; Whitworth A., 1997, CONVERSATION ANAL PR; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27; [No title captured]	64	54	60	0	14	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	1368-2822			INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	APR-JUN	2000	35	2					269	285		10.1080/136828200247188			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	304PE	WOS:000086492000006	10912255				2022-02-06	
J	Patel, NY; Hoyt, DB; Nakaji, P; Marshall, L; Holbrook, T; Coimbra, R; Winchell, RJ; Mikulaschek, AW				Patel, NY; Hoyt, DB; Nakaji, P; Marshall, L; Holbrook, T; Coimbra, R; Winchell, RJ; Mikulaschek, AW			Traumatic brain injury: Patterns of failure of nonoperative management	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	59th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 16-18, 1999	BOSTON, MASSACHUSETTS	Amer Assoc Surgery Trauma			SEVERE HEAD-INJURY; ACUTE EPIDURAL HEMATOMA; ACUTE SUBDURAL-HEMATOMA; INTRACEREBRAL HEMATOMA; EXTRADURAL HEMATOMAS; CONSERVATIVE MANAGEMENT; COMPUTED-TOMOGRAPHY; RAPID RESOLUTION; PATIENT; LESIONS	Objective: The circumstances of failure for nonoperative management of blunt traumatic brain injury have been poorly defined. In this study, all trauma patients identified over a 12-year period with progression of neurologic injury requiring craniotomy were retrospectively reviewed. Methods: Data collected included demographic information, mechanism of injury, field and admission vital signs, and Glasgow Coma Scale score, medications, associated injuries, and coagulopathy. Head computed tomographic scans were reviewed, and anatomic findings were correlated with clinical changes (change in mental status or elevation of intracranial pressure) that led to subsequent CT scan and craniotomy. Results: Of 20,100 patients, there were 852 who had computed tomographic scans with acute intracranial injuries on admission; 462 patients were managed nonoperatively. Fifty-seven patients had progression of neurologic injury (34 < 24 hours = early; 23 > 24 hours = late) that required surgery. Conclusion: Of the variables investigated, only anatomic location of injury was found to be predictive of early failure of nonoperative management. Frontal intraparenchymal hematomas are particularly prone to early failure. Clinical examination and intracranial pressure monitoring are equally important in detecting failure and should be an integral part of nonoperative management.	Univ Calif San Diego, Med Ctr, Dept Surg, Div Trauma, San Diego, CA 92103 USA; Univ Calif San Diego, Med Ctr, Dept Family Med, Div Neurosurg, San Diego, CA 92103 USA		Hoyt, DB (corresponding author), Univ Calif San Diego, Med Ctr, Dept Surg, Div Trauma, 8896,200 W Arbor Dr, San Diego, CA 92103 USA.		Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			Aldrich E F, 1991, Neurosurg Clin N Am, V2, P373; AOKI N, 1988, J NEUROSURG, V68, P149, DOI 10.3171/jns.1988.68.1.0149; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; BROWDER J, 1942, N Y STATE J MED, V42, P230; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; CUCCINIELLO B, 1993, ACTA NEUROCHIR, V120, P47, DOI 10.1007/BF02001469; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ERICSON K, 1981, ACTA RADIOL DIAGN, V22, P513, DOI 10.1177/028418518102200501; EVANS JP, 1946, J NEUROSURG, V3, P101, DOI 10.3171/jns.1946.3.2.0101; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; GUILLERMAIN P, 1986, ADV NEUROTRAUMATOLOG, P1; GURGIAN E, 1974, INJURIES BRAIN SPINA, P282; HOYT DB, 1992, J TRAUMA, V33, P586, DOI 10.1097/00005373-199210000-00016; JACKSON JJ, 1950, J NEUROSURG, V7, P444; JAMIESON KG, 1972, J NEUROSURG, V37, P528, DOI 10.3171/jns.1972.37.5.0528; Jennett B, 1981, MANAGEMENT HEAD INJU; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; MCLAURIN RL, 1964, J NEUROSURG, V21, P364, DOI 10.3171/jns.1964.21.5.0364; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; PAPO I, 1980, NEUROSURGERY, V7, P337, DOI 10.1227/00006123-198010000-00005; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; POZZATI E, 1986, NEUROSURGERY, V18, P696, DOI 10.1227/00006123-198606000-00003; POZZATI E, 1984, NEUROSURGERY, V14, P724, DOI 10.1227/00006123-198406000-00012; Rivano C, 1980, J Neurosurg Sci, V24, P77; ROBERSON FC, 1979, SURG NEUROL, V12, P161; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; TUNCER R, 1993, ACTA NEUROCHIR, V121, P48, DOI 10.1007/BF01405182; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516; ZIMMERMAN RA, 1978, NEURORADIOLOGY, V16, P320, DOI 10.1007/BF00395288	37	54	59	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2000	48	3					367	374		10.1097/00005373-200003000-00001			8	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	295QT	WOS:000085979900001	10744271				2022-02-06	
J	Ruff, RM; Jurica, P				Ruff, RM; Jurica, P			In search of a unified definition for mild traumatic brain injury	BRAIN INJURY			English	Article								Discrepant criteria are utilized by various disciplines for the diagnosis of mild traumatic brain injury (TBI). This study evaluates 76 patients, all of whom were diagnosed as having sustained a mild TBI according to the diagnostic criteria set forth by the American Congress of Rehabilitation Medicine (ACRM); yet only 34% of these patients were classified as having a concussion according to DSM-IV. A unified definition is proposed which is comprised of grades: Type I for ACRM, Type III for DSM-IV, and Type II to bridge the two discrepant definitions. An examination of the patients, subdivided into the three types, revealed no significant differences for (1) number of subjective complaints, (2) neurocognitive performances, and (3) pre-existing emotional risk factors. Thus, the proposed gradation unifies the definitions across the heterogeneity of mild TBI. However, further research is indicated for their clinical validation.	Univ Calif San Francisco, Dept Neurosurg & Psychiat, San Francisco, CA 94143 USA; San Francisco Clin Neurosci, San Francisco, CA USA		Ruff, RM (corresponding author), 909 Hyde St,Suite 620, San Francisco, CA 94109 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baser C A, 1987, Arch Clin Neuropsychol, V2, P13, DOI 10.1016/0887-6177(87)90031-X; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; CAMPBELL DT, 1974, PHILOS K POPP 1, V14, P416; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MILLON T, 1987, MANUAL MCMI II; MILLON T, 1994, MCMI 3 MANUAL; Popper Karl, 1972, OBJECTIVE KNOWLEDGE; Ruff R. M., 1989, MILD HEAD INJURY, P176; RUFF RM, 1991, HDB CLIN TRIALS NEUR, P89; TEASDALE G, 1974, LANCET, V2, P81; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	14	54	55	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1999	13	12					943	952					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	264UJ	WOS:000084200600001	10628500				2022-02-06	
J	Whalen, MJ; Carlos, TM; Kochanek, PM; Clark, RSB; Heineman, S; Schiding, JK; Franicola, D; Memarzadeh, F; Lo, W; Marion, DW; Dekosky, ST				Whalen, MJ; Carlos, TM; Kochanek, PM; Clark, RSB; Heineman, S; Schiding, JK; Franicola, D; Memarzadeh, F; Lo, W; Marion, DW; Dekosky, ST			Neutrophils do not mediate blood-brain barrier permeability early after controlled cortical impact in rats	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Xth International Symposium on Intracranial Pressure and Neuromonitoring in Brain Injury	MAY 25-29, 1997	WILLIAMSBURG, VA			neutrophils; blood-brain barrier; inflammation; traumatic brain injury; adhesion	CEREBRAL-ARTERY OCCLUSION; ENDOTHELIAL ADHESION MOLECULES; TUMOR-NECROSIS-FACTOR; ISCHEMIC CELL-DAMAGE; EXPERIMENTAL MENINGITIS; MONOCLONAL-ANTIBODY; VESICULAR TRANSPORT; LUNG INJURY; COLD INJURY; HEAD-INJURY	Controlled cortical impact (CCI) produces blood-brain barrier (BBB) permeability and an acute inflammatory response in injured brain, associated with upregulation of cell adhesion molecules and accumulation of neutrophils. Nevertheless, the role of acute inflammation in the pathogenesis of BBB permeability after traumatic brain injury (TBI) is undefined. The purpose of this study was to examine the time course of acute inflammation and BBB permeability after CCI in rats and to determine the effect of neutrophil depletion on BBB permeability early after CCI. In the first protocol, four groups of rats (n = 4-7/group) were subjected to CCI. Expression of endothelial (E)-selectin on cerebrovascular endothelium, accumulation of neutrophils, and BBB permeability were measured in brain at 1, 4, 8, and 24 hours after injury by immunohistochemistry or spectrophotometric quantification of Evans blue. E-selectin upregulation and neutrophil accumulation in injured brain occurred at later times than maximal BBB permeability. In a second protocol, rats made neutropenic with a murine monoclonal IgM antibody (RP-3) specific for rat neutrophils were subjected to CCI, given Evans blue at 3.5 hours, and sacrificed at 4 hours after injury. Neutrophil depletion did not affect BBB permeability at 4 hours after CCI. We conclude that events other than those mediated by neutrophils initiate BBB permeability early after CCI.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanek@smtp.anes.upmc.edu	Lo, Warren/E-3531-2011; Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2P50 NS30318-04A21] Funding Source: Medline		ADELSON P, 1997, P 10 INT S INTR PRES; ARFORS KE, 1987, BLOOD, V69, P338; BAKER RN, 1971, J NEUROPATH EXP NEUR, V30, P668, DOI 10.1097/00005072-197110000-00010; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; BEDNAR MM, 1991, STROKE, V22, P44, DOI 10.1161/01.STR.22.1.44; BEGGS JL, 1976, LAB INVEST, V34, P428; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; CARLOS TM, 1994, BLOOD, V84, P2068; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CHEN H, 1992, NEUROSCI RES COMMUN, V11, P93; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DIETRICH WD, 1992, ACTA NEUROPATHOL, V84, P621, DOI 10.1007/BF00227739; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Folkesson HG, 1997, J APPL PHYSIOL, V82, P1743, DOI 10.1152/jappl.1997.82.6.1743; Gidday J. M., 1998, Society for Neuroscience Abstracts, V24, P254; Grady MS, 1999, J NEUROTRAUM, V16, P13, DOI 10.1089/neu.1999.16.13; GRANERT C, 1994, J CLIN INVEST, V93, P929, DOI 10.1172/JCI117098; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; Haring HP, 1996, STROKE, V27, P1386, DOI 10.1161/01.STR.27.8.1386; Hartl R, 1997, ACT NEUR S, V70, P240; HEINEL LA, 1994, BRAIN RES BULL, V34, P137, DOI 10.1016/0361-9230(94)90010-8; HERNANDEZ LA, 1987, AM J PHYSIOL, V253, pH699, DOI 10.1152/ajpheart.1987.253.3.H699; Horwitz LD, 1997, AM J PHYSIOL-HEART C, V272, pH618, DOI 10.1152/ajpheart.1997.272.2.H618; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KOENIG H, 1983, BIOCHEM BIOPH RES CO, V116, P1039, DOI 10.1016/S0006-291X(83)80247-2; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LINDSBERG PJ, 1995, J NEUROSURG, V82, P269, DOI 10.3171/jns.1995.82.2.0269; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mayhan WG, 1996, STROKE, V27, P965, DOI 10.1161/01.STR.27.5.965; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Miller RD, 1996, J NEUROL SCI, V136, P37, DOI 10.1016/0022-510X(95)00309-P; Morikawa E, 1996, STROKE, V27, P951, DOI 10.1161/01.STR.27.5.951; NAWASHIRO H, 1994, ACTA NEUROCHIR, P440; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; QUAGLIARELLO VJ, 1991, J EXP MED, V174, P657, DOI 10.1084/jem.174.3.657; Rodell TC, 1996, IMMUNOPHARMACOLOGY, V33, P279, DOI 10.1016/0162-3109(96)00071-9; ROSOMOFF HL, 1968, ACTA ANAESTH SCAND, VS, P75; ROSOMOFF HL, 1965, ARCH NEUROL-CHICAGO, V13, P337, DOI 10.1001/archneur.1965.00470040003001; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SCHURER L, 1990, ACT NEUR S, V51, P49; SEKIYA S, 1989, J LEUKOCYTE BIOL, V46, P96, DOI 10.1002/jlb.46.2.96; SHIGA Y, 1991, NEUROSCI LETT, V125, P110, DOI 10.1016/0304-3940(91)90003-C; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Soares HD, 1995, J NEUROSCI, V15, P8223; SUZUKI M, 1995, ACTA NEUROPATHOL, V89, P532; Tang T, 1996, J CLIN INVEST, V97, P2485, DOI 10.1172/JCI118695; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; TROUT JJ, 1986, LAB INVEST, V55, P622; TUOMANEN EI, 1989, J EXP MED, V170, P959, DOI 10.1084/jem.170.3.959; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; UNTERBERG A, 1987, ACTA NEUROPATHOL, V73, P209, DOI 10.1007/BF00686613; WAHL M, 1988, J CEREBR BLOOD F MET, V8, P621, DOI 10.1038/jcbfm.1988.109; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; WANG XK, 1995, J NEUROTRAUM, V12, P825, DOI 10.1089/neu.1995.12.825; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zhang RL, 1996, J CEREBR BLOOD F MET, V16, P1126, DOI 10.1097/00004647-199611000-00006; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747	67	54	57	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	1999	16	7					583	594		10.1089/neu.1999.16.583			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	220EN	WOS:000081651700003	10447070				2022-02-06	
J	Zou, LL; Huang, L; Hayes, RL; Black, C; Qiu, YH; Perez-Polo, JR; Le, W; Clifton, GL; Yang, K				Zou, LL; Huang, L; Hayes, RL; Black, C; Qiu, YH; Perez-Polo, JR; Le, W; Clifton, GL; Yang, K			Liposome-mediated NGF gene transfection following neuronal injury: potential therapeutic applications	GENE THERAPY			English	Article						liposomes; NGF; gene therapy; neuronal injury; ChAT; CNS	NERVE GROWTH-FACTOR; SEPTOHIPPOCAMPAL CELL-CULTURES; TRAUMATIC BRAIN INJURY; NUCLEUS BASALIS MAGNOCELLULARIS; SEPTAL CHOLINERGIC NEURONS; FIMBRIA-FORNIX TRANSECTION; IN-VIVO; NEUROTROPHIC FACTOR; CATIONIC LIPOSOMES; HIPPOCAMPAL-NEURONS	We have systematically investigated the therapeutic potential of cationic liposome-mediated neurotrophic gene transfer for treatment of CNS injury. Following determination of optimal transfection conditions, we examined the effects of dimethylaminoethane-carbamoyl-cholesterol (DC-Chol) liposome-mediated NGF cDNA transfection in injured and uninjured primary septo-hippocampal cell cultures and rat brains. In in vitro studies, we detected an increase of NGF mRNA in cultures 1 day after transfection. Subsequent ELISA and PC12 cell biological assays confirmed that cultured cells secreted soluble active NGF into the media from day 2 after gene transfection. Further experiments showed that such NGF gene transfection reduced the loss of choline acetyltransferase (ChAT) activity in cultures following calcium-dependent depolarization injury. In in vivo studies, following intraventricular injections of NGF cDNA complexed with DC-Chol liposomes, ELISA detected nine- to 12-fold increases of NGF in rat CSF. Further studies showed that liposome/NGF cDNA complexes could attenuate the loss of cholinergic neuronal immunostaining in the rat septum after traumatic brain injury (TBI). Since deficits in cholinergic neurotransmission are a major consequence of TBI, our studies demonstrate for the first time that DC-Chol liposome-mediated NGF gene transfection may have therapeutic potential for treatment of brain injury.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Texas, Hlth Sci Ctr, Dept Neurosurg, Houston, TX USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA		Yang, K (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.		Perez-Polo, Jose R./B-6250-2009		NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA064654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035502, R01NS021458] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 64654] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS21458, R01-NS35502] Funding Source: Medline		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; Baumgartner BJ, 1997, J NEUROSCI, V17, P6504; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; CAPLEN NJ, 1995, NAT MED, V1, P39, DOI 10.1038/nm0195-39; CastelBarthe MN, 1996, NEUROBIOL DIS, V3, P76, DOI 10.1006/nbdi.1996.0008; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; DEKKER AJ, 1992, BRAIN RES, V584, P55, DOI 10.1016/0006-8993(92)90877-C; DEKKER AJ, 1994, NEUROSCIENCE, V60, P299, DOI 10.1016/0306-4522(94)90244-5; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DORAN SE, 1995, NEUROSURGERY, V36, P965, DOI 10.1227/00006123-199505000-00012; Fasbender A, 1997, GENE THER, V4, P716, DOI 10.1038/sj.gt.3300459; Felgner PL, 1996, HUM GENE THER, V7, P1791, DOI 10.1089/hum.1996.7.15-1791; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FISCHER W, 1991, EXP NEUROL, V113, P93, DOI 10.1016/0014-4886(91)90167-B; FISCHER W, 1991, J NEUROSCI, V11, P1889; Frick KM, 1997, J NEUROSCI, V17, P2543; Gao X, 1995, GENE THER, V2, P710; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAGG T, 1993, EXP NEUROL, V119, P37, DOI 10.1006/exnr.1993.1005; HAYES RL, 1995, NEUROSCI LETT, V191, P121, DOI 10.1016/0304-3940(95)11561-X; HEFTI F, 1986, J NEUROSCI, V6, P2155; Imaoka T, 1998, HUM GENE THER, V9, P1093, DOI 10.1089/hum.1998.9.7-1093; Iwamoto Y, 1996, NEUROREPORT, V7, P609, DOI 10.1097/00001756-199601310-00056; Karpati G, 1996, TRENDS NEUROSCI, V19, P49; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Lawrence MS, 1997, J CEREBR BLOOD F MET, V17, P740; Lawrence MS, 1996, J NEUROSCI, V16, P486; Le WD, 1996, NEUROREPORT, V7, P710, DOI 10.1097/00001756-199602290-00007; Li S, 1997, GENE THER, V4, P891, DOI 10.1038/sj.gt.3300482; MartinezSerrano A, 1996, EUR J NEUROSCI, V8, P727, DOI 10.1111/j.1460-9568.1996.tb01258.x; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; NABEL GJ, 1993, P NATL ACAD SCI USA, V90, P11307, DOI 10.1073/pnas.90.23.11307; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Qiu YH, 1998, J NEUROSCI RES, V52, P192, DOI 10.1002/(SICI)1097-4547(19980415)52:2<192::AID-JNR7>3.0.CO;2-5; ROESSLER BJ, 1994, NEUROSCI LETT, V167, P5, DOI 10.1016/0304-3940(94)91015-4; RONER S, 1996, J NEUROSCI RES, V45, P40; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; RYLETT RJ, 1993, J NEUROSCI, V13, P3956; SCALI C, 1994, NEUROSCI LETT, V170, P117, DOI 10.1016/0304-3940(94)90253-4; SINSON G, 1995, J NEUROCHEM, V65, P2209; SINSON G, 1996, J NEUROSURG, V84, P665; SUHR ST, 1993, ARCH NEUROL-CHICAGO, V50, P1252, DOI 10.1001/archneur.1993.00540110122012; Thorsell A, 1996, REGUL PEPTIDES, V61, P205, DOI 10.1016/0167-0115(95)00161-1; Tuszynski MH, 1996, GENE THER, V3, P305; TUSZYNSKI MH, 1995, P NATL ACAD SCI USA, V92, P4621, DOI 10.1073/pnas.92.10.4621; WHITSON JS, 1995, BRAIN RES, V694, P213, DOI 10.1016/0006-8993(95)00745-C; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; Yang K, 1996, MOL BRAIN RES, V43, P13, DOI 10.1016/S0169-328X(96)00142-8; Yang K, 1997, J NEUROTRAUM, V14, P281, DOI 10.1089/neu.1997.14.281; YANG K, 1994, NEUROSCI LETT, V182, P287, DOI 10.1016/0304-3940(94)90818-4; YANG K, 1994, NEUROSCI LETT, V182, P291, DOI 10.1016/0304-3940(94)90819-2; YANG K, 1995, PARADIGMS NEURAL INJ, P290; Yang KY, 1997, NEUROREPORT, V8, P2355, DOI 10.1097/00001756-199707070-00050; Yoon SO, 1996, P NATL ACAD SCI USA, V93, P11974, DOI 10.1073/pnas.93.21.11974; Zhang LX, 1997, NEUROSCIENCE, V77, P15, DOI 10.1016/S0306-4522(96)00420-4; ZHANG LX, 1992, NEUROREPORT, V3, P700; ZHU N, 1993, SCIENCE, V261, P209, DOI 10.1126/science.7687073	64	54	57	1	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0969-7128			GENE THER	Gene Ther.	JUN	1999	6	6					994	1005		10.1038/sj.gt.3300936			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	204JA	WOS:000080759700007	10455401	Bronze			2022-02-06	
J	Bogner, JA; Corrigan, JD; Stange, M; Rabold, D				Bogner, JA; Corrigan, JD; Stange, M; Rabold, D			Reliability of the agitated behavior scale	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Agitated Behavior Scale; agitation; brain injury; dementia; long-term care	BRAIN INJURY	Objective: The objective of this study was to investigate the interrater reliability of the Agitated Behavior Scale. Design: Ratings made by research assistants and nursing staff were compared. Participants and setting: Forty-five persons with brain injury and 23 persons with progressive dementia were studied at an acute rehabilitation unit and a long-term-care facility. Results: Ratings of persons with brain injury by research assistants yielded a correlation coefficient for the Total score of .920. The correlation coefficients for the factors Disinhibition, Aggression, and Lability were .902,.909, and .726, respectively. Lower coefficients were obtained when the ratings of the research assistants and nursing staff were correlated; these ranged from .364 to .604. The ratings by research assistants of long-term-care facility residents yielded coefficients ranging from .860 to .906 for the Total and factor scores. Conclusion: This study shows that the Agitated Behavior Scale is a reliable instrument for measuring agitation in persons with traumatic brain injury, as well as with long-term-care facility residents experiencing dementia.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA		Bogner, JA (corresponding author), Dodd Hall,480 W 9th Ave, Columbus, OH 43210 USA.		Corrigan, John D./E-2921-2011				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1995, NEUROREHABILITATION, V5, P205, DOI 10.3233/NRE-1995-5303; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Corrigan JD, 1996, AM J ALZHEIMERS DIS, V11, P20; Kelly G. A., 1955, PSYCHOL PERSONAL CON, V1-2; TERI L, 1992, ALZ DIS ASSOC DIS, V6, P77, DOI 10.1097/00002093-199206020-00003	10	54	54	0	9	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1999	14	1					91	96		10.1097/00001199-199902000-00012			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	165LT	WOS:000078523100012	9949251				2022-02-06	
J	Sliwinski, M; Gordon, WA; Bogdany, J				Sliwinski, M; Gordon, WA; Bogdany, J			The Beck Depression Inventory: Is it a suitable measure of depression for individuals with traumatic brain injury?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							MILD HEAD TRAUMA; POSTSTROKE DEPRESSION; SYMPTOMS	Objective: This study examined the relationship between Beck Depression inventory (BDI) scores and current diagnosis of depression, based on The Structured Clinical interview for DSM-IV Diagnosis (SCID). Design: Correlation. Setting: Community-based sample. Participants: 100 individuals with traumatic brain injury (TBI) participated in this study, 25 of whom were diagnosed as depressed and 75 as not depressed at the time of interview. Main Outcome Measures: BDI scores, number of symptoms reported on a symptom checklist and DSM-IV diagnosis of depression. Results: BDI symptoms correlated significantly with the SCID diagnosis of depression (r = .30) but were more strongly related (r = .67) to the number of non-depression-related problems reported, using the TIRR Symptom Checklist, a list of symptoms frequently found post TBI. The BDI had low sensitivity for discriminating depressed from nondepressed individuals (sensitivity = 36% when specificity was set at 80%). These results suggest that for individuals with TBI, high BDI scores may reflect hyperreactivity to post-TDI symptoms to a greater extent than clinical depression. Conclusions: Further study is needed to (1) understand the physiological! functional, and psychosocial factors that are associated with depression in individuals with TBI; (2) provide the basis for developing better measures of depression; and (3) understand how depression is experienced after TBI.	Mt Sinai Med Ctr, Dept Rehabil Med, New York, NY 10029 USA; Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA		Gordon, WA (corresponding author), Mt Sinai Med Ctr, Dept Rehabil Med, Box 1240,1425 Madison Ave, New York, NY 10029 USA.						Beck AT, 1987, BECK DEPRESSION INVE; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; First M.B., 1996, STRUCTURED CLIN INTE; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; GORDON WA, 1991, REHABIL PSYCHOL, V36, P71, DOI 10.1037/h0079078; Gordon WA, 1997, ARCH PHYS MED REHAB, V78, P658, DOI 10.1016/S0003-9993(97)90433-0; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; RUTHERFORD WH, 1977, LANCET, V1, P1; Stein PN, 1996, CLIN NEUROPSYCHOL, V10, P141, DOI 10.1080/13854049608406674; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	16	54	55	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1998	13	4					40	46		10.1097/00001199-199808000-00004			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	110DZ	WOS:000075366000004	9651238				2022-02-06	
J	Copeland, CE; Mitchell, KA; Brumback, RJ; Gens, DR; Burgess, AR				Copeland, CE; Mitchell, KA; Brumback, RJ; Gens, DR; Burgess, AR			Mortality in patients with bilateral femoral fractures	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						bilateral femoral fractures; blunt trauma; mortality; adult respiratory distress syndrome	PROPHYLACTIC MECHANICAL VENTILATION; RESPIRATORY-DISTRESS SYNDROME; EARLY INTERNAL-FIXATION; INJURY SEVERITY SCORE; MULTIPLE INJURIES; FAT-EMBOLISM; TRAUMA	Objectives: To determine and compare the mortality rates of patients with bilateral versus unilateral femoral fractures and to determine the contribution of the femoral fracture to, and identify risk factors for, such mortality. Study Design: Retrospective analysis using trauma registry data on consecutive blunt trauma patients with unilateral (800 patients, group I) or bilateral (eighty-five patients, group II) femoral fractures. Methods: Univariate data analysis was performed to compare the groups' ages, Injury Severity Scores, Glasgow Coma Scale values, mortality, and the presence of adult respiratory distress syndrome (ARDS). Logistic regression analysis was performed to determine variables statistically associated with mortality. Results: Group II patients had a significantly higher Injury Severity Score (30.2 versus 24.5, p < 0.001), lower Glasgow Coma Scale value (12.3 versus 13.1, p = 0.05), higher mortality rate (25.9 vs 11.7%, p < 0.001), and higher incidence of ARDS (15.7 versus 7.27%, p = 0.014) than group I patients. Group II patients also had significantly more closed head injuries, open skull fractures, intraabdominal injuries requiring surgical intervention, and pelvic fractures; the rates of thoracic injury were similar. Regression analysis of variables evident on admission revealed a significant correlation between bilateral femoral fractures and death; however, other factors (shock, closed head injury, and thoracic injury) had much stronger correlations with mortality. Conclusions: Patients with bilateral femoral fractures have a significantly higher risk of death, ARDS, and associated injuries than patients with unilateral femoral fractures. This increase in mortality is more closely related to associated injuries and physiologic parameters than to the presence of bilateral femoral fractures. The presence of bilateral femoral fractures should alert the clinician to the likelihood of associated injuries, a higher Injury Severity Score, and the potential for a more serious prognosis.	Univ Maryland, Med Syst, R Adams Cowley Shock Trauma Ctr, Sect Orthopaed, Baltimore, MD 21201 USA		Copeland, CE (corresponding author), Care of Bulson EP, Univ Maryland, Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA.						ALLARDYCE DB, 1974, J TRAUMA, V14, P955, DOI 10.1097/00005373-197411000-00008; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BALK R, 1983, MED CLIN N AM, V67, P685, DOI 10.1016/S0025-7125(16)31197-X; BEAM HP, 1980, J TRAUMA, V20, P399, DOI 10.1097/00005373-198020050-00006; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; CARLSON DA, 1995, CLIN ORTHOP RELAT R, P115; DENDRINOS G, 1993, J TRAUMA, V34, P157, DOI 10.1097/00005373-199301000-00032; Dunham C M, 1989, Md Med J, V38, P227; GORIS RJA, 1982, J TRAUMA, V22, P895, DOI 10.1097/00005373-198211000-00002; GORIS RJA, 1982, INJURY, V14, P39, DOI 10.1016/S0020-1383(82)80010-7; GORIS RJA, 1982, J TRAUMA, V22, P141, DOI 10.1097/00005373-198202000-00011; Hosmer D, 1989, APPL LOGISTIC REGRES; Johnson K D, 1990, Instr Course Lect, V39, P565; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; MEEK RN, 1986, INJURY, V17, P2, DOI 10.1016/0020-1383(86)90003-3; RISKA EB, 1982, J TRAUMA, V22, P891, DOI 10.1097/00005373-198211000-00001; RISKA EB, 1977, J TRAUMA, V17, P111, DOI 10.1097/00005373-197702000-00005; RISKA EB, 1976, INJURY, V8, P110, DOI 10.1016/0020-1383(76)90043-7; WU CC, 1992, J TRAUMA, V32, P289, DOI 10.1097/00005373-199203000-00004	20	54	56	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	JUN-JUL	1998	12	5					315	319		10.1097/00005131-199806000-00003			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ZW514	WOS:000074418600003	9671181				2022-02-06	
J	Bleiberg, J; Halpern, EL; Reeves, D; Daniel, JC				Bleiberg, J; Halpern, EL; Reeves, D; Daniel, JC			Future directions for the neuropsychological assessment of sports concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computerized neuropsychological testing; concussion; reaction time	MILD HEAD-INJURY; REACTION-TIME; ATTENTION DEFICITS; PERFORMANCE	This article argues in favor of using newly developed computerized, complex reaction time (RT)-based neuropsychological procedures for the study of sports-related concussion. Recent studies show that by using these complex RT procedures, significant differences between concussed and control samples can be observed. The magnitude of RT differences is 110 ms or less, levels that are not meaningfully measured with stopwatch-based procedures. RT-based procedures also have the advantage of permitting analysis of variability of RT, and several recent studies have shown that brain dysfunction is accompanied by erratic and inconsistent RT. A currently ongoing sports concussion study using measures of complex RT and variability of RT is described.	Natl Rehabil Hosp, Assist Technol Res Ctr, Psychol Serv, Medlant Res Inst, Washington, DC 20010 USA; Nutr Rehabil Ctr, Assist Technol Ctr, Psychol Serv, Washington, DC USA; Naval Med Ctr, Dept Clin Invest, San Diego, CA USA; USN, Med Ctr, Dept Pediat, San Diego, CA 92152 USA		Bleiberg, J (corresponding author), Natl Rehabil Hosp, Assist Technol Res Ctr, Psychol Serv, Medlant Res Inst, 102 Irving St NW, Washington, DC 20010 USA.			Bleiberg, Joseph/0000-0003-0867-5494			Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; HEAD H, 1926, APHASTA KINDRED DISO; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JAKOBSEN J, 1987, ACTA NEUROL SCAND, V75, P341, DOI 10.1111/j.1600-0404.1987.tb05456.x; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; REEVES D, 1989, 891 UTCPAB W REED AR; SEGALOWITZ S, 1997, J INT NEUROPSYCHOL S, V3, P35; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; VANZOMEREN AH, 1989, MILD HEAD INJURY	19	54	54	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1998	13	2					36	44		10.1097/00001199-199804000-00006			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZF451	WOS:000072898800006	9575255				2022-02-06	
J	Hickling, EJ; Gillen, R; Blanchard, EB; Buckley, T; Taylor, A				Hickling, EJ; Gillen, R; Blanchard, EB; Buckley, T; Taylor, A			Traumatic brain injury and posttraumatic stress disorder: a preliminary investigation of neuropsychological test results in PTSD secondary to motor vehicle accidents	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; MEMORY; DEFICITS; CONCUSSION; EVENTS	This study investigated the effect of traumatic brain injury on the development of posttraumatic stress disorder (PTSD). Subjects were 107 motor vehicle accident survivors including 38 individuals who were diagnosed with posttraumatic stress disorder (PTSD). Neuropsychological testing was administered to all subjects during an initial diagnostic evaluation. Results showed that subjects who had lost consciousness during their MVA had greater impairment on speed dependent tests and delayed recall of verbal material. Subjects who suffered traumatic brain injury (TBI) were also found to have developed PTSD as often as those who had not reported TBI. Implications for future research and clinical utility are discussed.	Capital Psychol Associates, Albany, NY 12205 USA; Russell Sage Coll, Albany, NY 12205 USA; SUNY Albany, Ctr Stress & Anxiety Disorders, Albany, NY 12222 USA		Hickling, EJ (corresponding author), Capital Psychol Associates, 4 Atrium Dr,Suite 240, Albany, NY 12205 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Blake D., 1990, CLIN ADMINISTERED PT; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; BLANCHARD EB, 1997, CRASH PSYCHOL ASS TR; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI DOI 10.1097/00001199-199602000-00011; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; CURRY LM, 1991, PHILADELPHIA HEAD IN; EVERLY GS, 1989, PERCEPT MOTOR SKILL, V68, p807N; GOLDEN CJ, 1985, LUNA NEBRASKA NEUROP; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; KLONOFF H, 1976, J NERV MENT DIS, V163, P246, DOI 10.1097/00005053-197610000-00003; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; MILLER L, 1993, J COGNITIVE REHABILI, V11, P18; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Price K. P., 1994, DEF LAW J, V43, P113; Reitan R, 1985, HALSTEAD REITAN NEUR; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHACTER DL, 1992, AM PSYCHOL, V47, P559, DOI 10.1037/0003-066X.47.4.559; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; *US DEP TRANSP, 1995, TRAFF SAF FACTS 1994; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137	30	54	54	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	1998	12	4					265	274		10.1080/026990598122566			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZF942	WOS:000072948700002	9562909				2022-02-06	
J	Chapman, SB; Levin, HS; Wanek, A; Weyrauch, J; Kufera, J				Chapman, SB; Levin, HS; Wanek, A; Weyrauch, J; Kufera, J			Discourse after closed head injury in young children	BRAIN AND LANGUAGE			English	Article							NARRATIVE DISCOURSE; COGNITIVE SEQUELAE; BRAIN INJURY; ADOLESCENTS; APHASIA; CHILDHOOD; COMPREHENSION; HEMISPHERE; RECOVERY; DEFICITS	This study examined narrative discourse in 23 children, ages 6 to 8 years, who sustained a severe closed head injury (CHI) at least 1 year prior to assessment. Narratives were analyzed at multiple levels using language and information structure measures. Results revealed significant discourse impairments in the CHI group on all measures of information structure, whereas differences in the linguistic domain failed to reach significance. In addition, effects of age at injury and lateralization of lesion on discourse were considered. Although no significant differences were found according to age at injury, a consistent pattern of generally poorer discourse scores was found for the early injured group (<5 years). With regard to lesion focus, the group findings were unimpressive. However, preliminary examination of individual CHI cases with relatively large lateralized lesions suggested that the late injured children may show the language-brain patterns reported in brain-injured adults, whereas early injured children may not. (C) 1998 Academic Press.	Univ Texas, Callier Ctr Commun Disorders, Dallas, TX 75235 USA; Univ Maryland, Med Syst, Div Neurol Surg, Baltimore, MD 21201 USA		Chapman, SB (corresponding author), Univ Texas, Callier Ctr Commun Disorders, 1966 Inwood Rd, Dallas, TX 75235 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; Applebee A., 1978, CHILDS CONCEPT STORY; ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; ARAM DM, 1986, BRAIN LANG, V27, P75, DOI 10.1016/0093-934X(86)90006-4; ARAM DM, 1987, BRAIN LANG, V31, P61, DOI 10.1016/0093-934X(87)90061-7; BAMBERG M, 1991, J CHILD LANG, V18, P689, DOI 10.1017/S0305000900011314; BOND S, 1986, THESIS U TEXAS DALLA; BOTVIN GJ, 1977, DEV PSYCHOL, V13, P377, DOI 10.1037/0012-1649.13.4.377; Brownell, 1990, DISCOURSE ABILITY BR, P69, DOI 10.1007/978-1-4612-3262-9_4; BYRNES JP, 1988, CHILD STUDY J, V18, P101; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1989, BRAIN LANG, V36, P651, DOI 10.1016/0093-934X(89)90092-8; DELIS D, 1987, CALIFORNIA VERBAL LE; DENNIS M, 1994, BRAIN LANG, V46, P129, DOI 10.1006/brln.1994.1008; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DENNIS M, 1976, BRAIN LANG, V3, P404, DOI 10.1016/0093-934X(76)90036-5; DENNIS M, 1980, LANGUAGE DEV APHASIA, P45; DENNIS M, 1980, BIOL STUDIES MENTAL, P159; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ehrlich JS, 1994, DISCOURSE ANAL APPL, P149; EWINGCOBBS I, 1985, SPEECH LANGUAGE EVAL, P97; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FELDMAN HM, 1992, BRAIN LANG, V42, P89, DOI 10.1016/0093-934X(92)90058-M; FLETCHER JM, 1988, J CLIN EXP NEUROPSYC, V10, P495, DOI 10.1080/01688638808408255; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; GAIDOLFI E, 1980, ITAL J NEUROL SCI, V1, P65; Goldman PS, 1974, PLASTICITY RECOVERY; Greenough W.T., 1986, DEV NEUROPSYCHOBIOLO, P387; Guttmann E, 1942, BRAIN, V65, P205, DOI 10.1093/brain/65.2.205; Halliday M. K., 1976, COHESION ENGLISH; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HUNT KW, 1965, 4 NAT COUNC TEACH EN; Joanette Y., 1990, DISCOURSE ABILITY BR, DOI [10.1007/978-1-4612-3262-9_6, DOI 10.1007/978-1-4612-3262-9_6]; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; KOLB B, 1989, AM PSYCHOL, V44, P1203, DOI 10.1037/0003-066X.44.9.1203; Labov W., 1972, LANGUAGE INNER CITY; Lenneberg E.H., 1967, BIOL FDN LANGUAGE; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; MENDOLSOHN D, 1992, CHILD NERV SYST, V8, P45; NEWMAN JE, 1986, TOP LANG DISORD, V7, P31, DOI 10.1097/00011363-198612000-00006; SMITH A, 1984, EARLY BRAIN DAMATE, V1; STJAMESROBERTS I, 1979, ADV CHILD DEV BEHAV, P253; TEASDALE G, 1974, LANCET, V2, P81; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; Ulatowska H. K., 1994, DISCOURSE ANAL APPL, P29; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; ULATOWSKA HK, 1983, BRAIN LANG, V19, P317, DOI 10.1016/0093-934X(83)90074-3; VANDIJK R, 1985, HDB DISCOURSE ANAL; WECHSLER D, 1974, WECHSLER INTLELLIGEN; Westby C. E., 1984, LANGUAGE LEARNING DI, P103; WOODS BT, 1979, ANN NEUROL, V6, P405, DOI 10.1002/ana.410060505	57	54	56	0	7	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	FEB 15	1998	61	3					420	449		10.1006/brln.1997.1885			30	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	ZK818	WOS:000073366800006	9570872				2022-02-06	
J	Shafi, S; Gilbert, JC; Loghmanee, F; Allen, JE; Caty, MG; Glick, PL; Carden, S; Azizkhan, RG				Shafi, S; Gilbert, JC; Loghmanee, F; Allen, JE; Caty, MG; Glick, PL; Carden, S; Azizkhan, RG			Impact of bicycle helmet safety legislation on children admitted to a regional pediatric trauma center	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	28th Annual Meeting of the American-Pediatric-Surgical-Association	MAY 18-21, 1997	NAPLES, FLORIDA	Amer Pediat Surg Assoc		injuries; bicycling injuries; injury prevention; legislation; head protective devices; head injuries	HEAD-INJURY; RANDOMIZED TRIAL; UNITED-STATES; USE PATTERNS; PROMOTION; EDUCATION; CAMPAIGN; ONTARIO	Purpose: The regional pediatric trauma center in Buffalo, NY, has been active in pediatric injury prevention programs, including community education and distribution of bicycle helmets, since 1990. Since June 1, 1994, the use of bicycle safety helmets for children under 14 years of age has been mandated by a state law in New York. The authors undertook this study to assess the impact of this legislation on the frequency of helmet use in children involved in bicycle crashes presenting to the regional pediatric trauma center, and to assess the impact of helmet use on the number and severity of head injuries. Methods: Bicycle crash victims (n = 208) admitted to a regional pediatric trauma center from 1993 to 1995 were studied retrospectively. Head injuries were classified as concussion alone, skull fractures, intracranial hemorrhages tie, epidural, subdural, and subarachnoid), cerebral contusions, or diffuse cerebral edema alone (without any other intracranial injury). Helmeted children (HC) were compared with nonhelmeted children (NHC) using chi(2) and Fisher's Exact test. P value less than .05 was considered significant. Results: Only 31 children (15%) wore helmets at the time of the crash. Helmet use increased from 2%, during the period of education alone, to 26% after the legislation went into effect (P < .00001). The proportion of children suffering head injuries was similar in both groups (HC, 68%; NHC, 61%; P = NS). However, the type of head injury was different. HC were more likely to sustain concussion alone (HC, 65%; NHC, 44%; P < .03). HC were less likely to have skull fractures (HC, 0%; NHC, 13%; P < .02), and exhibited a trend toward less intracranial hemorrhages (HC, 0%; NHC, 9%; P = NS), cerebral contusions (HC, 3%; NHC, 5%; P = NS), and cerebral edema (HC, 0%; NHC, 0.6%; P = NS). Excluding the isolated concussions, head injuries were noted in only one HC, compared with 30 NHC (P < .04). None of the three children who died wore helmets at the time of the crash, and all died of multiple head injuries. Conclusions: The bicycle helmet safety law resulted in a 13-fold increase in the use of bicycle helmets among the children admitted to a regional pediatric trauma center after bicycle crashes, but the helmet use remains inadequate. Helmet use reduced the severity of head injuries, and might have prevented deaths caused by head injuries. Copyright (C) 1998 by W.B. Saunders Company.	SUNY Buffalo, Sch Med & Biomed Sci, Div Pediat Surg, Dept Surg, Buffalo, NY 14260 USA; SUNY Buffalo, Sch Med & Biomed Sci, Dept Pathol, Buffalo, NY 14260 USA; SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14260 USA; Off Med Examiner, Buffalo, NY USA		Gilbert, JC (corresponding author), Childrens Hosp, Dept Pediat Surg, Kiwanis Pediatr Trauma Ctr, 219 Bryant St, Buffalo, NY 14222 USA.						BENZ G, 1993, EUR J PEDIATR SURG, V3, P259, DOI 10.1055/s-2008-1063555; BJORNSTIG U, 1992, J TRAUMA, V33, P887; BOYLE WE, 1995, PEDIATRICS, V95, P609; CALLAHAN D, 1989, NEW ENGL J MED, V320, P1412, DOI 10.1056/NEJM198905253202110; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Caplow MP, 1995, AM J PREV MED, V11, P371, DOI 10.1016/S0749-3797(18)30415-X; *CDC, 1995, J SCH HLTH, V6, P133; COTE TR, 1992, PEDIATRICS, V89, P1216; CUSHMAN R, 1991, PEDIATRICS, V88, P43; CUSHMAN R, 1991, AM J PUBLIC HEALTH, V81, P1044, DOI 10.2105/AJPH.81.8.1044; DANNENBERG AL, 1993, AM J PUBLIC HEALTH, V83, P667, DOI 10.2105/AJPH.83.5.667; DANNENBERG AL, 1993, AM J PUBLIC HEALTH, V83, P644, DOI 10.2105/AJPH.83.5.644; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; Farley C, 1996, AM J PUBLIC HEALTH, V86, P46, DOI 10.2105/AJPH.86.1.46; Finvers KA, 1996, CLIN J SPORT MED, V6, P102, DOI 10.1097/00042752-199604000-00007; FRANK E, 1995, ACAD EMERG MED, V2, P200, DOI 10.1111/j.1553-2712.1995.tb03198.x; HATZIANDREU EJ, 1995, PUBLIC HEALTH REP, V110, P251; HU XH, 1993, CAN J PUBLIC HEALTH, V84, P163; LI GH, 1995, J TRAUMA, V38, P871, DOI 10.1097/00005373-199506000-00007; MACKNIN ML, 1994, ARCH PEDIAT ADOL MED, V148, P255, DOI 10.1001/archpedi.1994.02170030025005; Mills N J, 1990, Br J Sports Med, V24, P55; MORRIS BAP, 1991, CAN J PUBLIC HEALTH, V82, P92; RIVARA F P, 1983, Pediatrician, V12, P3; RIVARA FP, 1994, PEDIATRICS, V93, P567; RODGERS GB, 1995, ACCIDENT ANAL PREV, V27, P43, DOI 10.1016/0001-4575(94)00044-M; Rodgers GB, 1996, PEDIATRICS, V97, P166; ROWE BH, 1995, CAN J PUBLIC HEALTH, V86, P57; ROWE BH, 1995, CAN MED ASSOC J, V152, P45; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; SCHEIBER RA, 1996, ARCH PEDIAT ADOLESC, V150, P707; SCHEIDT PC, 1992, PEDIATRICS, V89, P1248; SPENCE LJ, 1993, J PEDIATR SURG, V28, P214, DOI 10.1016/S0022-3468(05)80278-7; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1388, DOI 10.2105/AJPH.80.11.1388; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; WEISS BD, 1986, PEDIATRICS, V77, P677	39	54	55	0	5	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	FEB	1998	33	2					317	320		10.1016/S0022-3468(98)90454-7			4	Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	YX297	WOS:000072026100061	9498409				2022-02-06	
J	Ivanhoe, CB; Lai, JM; Francisco, GE				Ivanhoe, CB; Lai, JM; Francisco, GE			Bruxism after brain injury: Successful treatment with botulinum toxin-A	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							MUSCLE	Bruxism, the rhythmic grinding of teeth-usually during sleep-is not an infrequent complication of traumatic brain injury. Its prevalence in the general population is 21%, but its incidence after brain injury is unknown. Untreated, bruxism causes masseter hypertrophy, headache, temporomandibular joint destruction, and total dental wear. We report a case of complete resolution of postanoxic bruxism after treatment with botulinum toxin-A (BTX-A). The patient was a 28-year-old man with no history of bruxism who sustained an anoxic brain injury secondary to cardiac arrest of unknown etiology. On admission to our rehabilitation unit 2 months after the injury, the patient presented with severe bruxism and heavy dental wear. The patient was injected with a total of 200 units of BTX-A to each masseter and temporalis, There was total resolution of bruxism 2 days after injection, with no complications. On fellow-up 3 months after injection, the patient remained free of bruxism. We propose that botulinum toxin be considered as a treatment for bruxism secondary to anoxic brain injury. Further studies regarding muscle selection and medication dosage are warranted to elucidate the toxin's efficacy in this condition. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	BAYLOR COLL MED,DEPT PHYS MED & REHABIL,HOUSTON,TX 77030; UNIV TEXAS,HLTH SCI CTR,DEPT PHYS MED & REHABIL,HOUSTON,TX		Ivanhoe, CB (corresponding author), TIRR,BRAIN INJURY PROGRAM,1333 MOURSUND,HOUSTON,TX 77030, USA.						GORDON K, 1993, J CHILD NEUROL, V8, P154, DOI 10.1177/088307389300800208; GUI D, 1994, LANCET, V344, P1127, DOI 10.1016/S0140-6736(94)90633-5; HORN AKE, 1993, EXP BRAIN RES, V96, P39, DOI 10.1007/BF00230437; KAUFMAN DM, 1994, J NEUROPSYCH CLIN N, V6, P50; MERELLO M, 1994, MOVEMENT DISORD, V9, P104, DOI 10.1002/mds.870090118; MILLER SC, 1947, AM J ORTHOD ORAL SUR, V33, P675; PASRICHA PJ, 1994, ANN INTERN MED, V121, P590, DOI 10.7326/0003-4819-121-8-199410150-00006; PRATAPCHAND R, 1985, CLIN NEUROL NEUROSUR, V87, P113, DOI 10.1016/0303-8467(85)90107-6; REDDING GR, 1966, J DENT RES, V45, P1198; SCOTT AB, 1980, SURG J PEDIAT OPHTHA, V17, P210; SHAARI CM, 1991, LARYNGOSCOPE, V101, P960; SMYTH AG, 1994, BRIT J ORAL MAX SURG, V32, P29, DOI 10.1016/0266-4356(94)90169-4	12	54	56	1	10	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	1997	78	11					1272	1273		10.1016/S0003-9993(97)90343-9			2	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	YE945	WOS:A1997YE94500018	9365360				2022-02-06	
J	Hinkle, DA; Baldwin, SA; Scheff, SW; Wise, PM				Hinkle, DA; Baldwin, SA; Scheff, SW; Wise, PM			GFAP and S100 beta expression in the cortex and hippocampus in response to mild cortical contusion	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; glial responses; gene expression; immunocytochemistry; rat; GFAP; S100 beta; mRNA; protein; contusion; reactive astrocyte	FIBRILLARY ACIDIC PROTEIN; GROWTH-FACTOR BFGF; REACTIVE ASTROCYTES; CEREBRAL CONTUSION; NEURITE EXTENSION; MESSENGER-RNA; BRAIN INJURY; CNS INJURY; ADULT-RAT; INTERLEUKIN-1	We studied the acute response of glial fibrillary acidic protein (GFAP) and S100 beta gene expression in the cerebral cortex and hippocampus to mild unilateral cortical contusion. Our goal was to evaluate and compare the expression patterns of each gene in the early stages of the astrocytic response to brain injury. RNA was extracted from the cerebral cortex and hippocampus of male rats at 0, 3, 12, 24, or 96 h after lesion or sham-operation, then quantified using an RNase protection assay. Contusion produced a robust elevation in GFAP mRNA by 12 h in both brain regions on the ipsilateral side to the contusion. In the cortex, but not the hippocampus, this elevation was sustained at 96 h. S100 beta mRNA levels were elevated bilaterally in lesioned animals at 24 h ire both brain regions. However, these data are difficult to interpret because sham mRNA levels decreased with time, making it unclear whether contusion stimulates S100 beta gene expression or whether it mitigates the inhibitory effect of sham. We further analyzed the effect of contusion on GFAP and S100 beta immunoreactive astrocyte density at 96 h postlesion or postsham by double-label immunocytochemistry. All detectable astrocytes under all conditions were S100 beta immunoreactive in both brain regions. Furthermore, all S100 beta immunoreactive astrocytes in the lesioned ipsilateral cortex were also GFAP immunoreactive, whereas only about 11% of S100 beta positive cells were also GFAP labeled in the contralateral lesioned or the ipsilateral sham cortex. In the hippocampus, all S100 beta immunoreactive cells were also GFAP immunoreactive under all conditions. These data correlate with the gene expression data at 96 h, and suggest that, at least in the cortex, resident S100 beta-expressing astrocytes produce GFAP at levels that are undetectable by immunocytochemistry until they are activated in response to injury.	UNIV MARYLAND,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21201; UNIV KENTUCKY,SANDERS BROWN CTR AGING,LEXINGTON,KY 40536		Hinkle, DA (corresponding author), UNIV KENTUCKY,COLL MED,DEPT PHYSIOL,800 ROSE ST,LEXINGTON,KY 40536, USA.				NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG02224] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS31220] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG002224, R37AG002224] Funding Source: NIH RePORTER		AUSUBEL F, 1994, CURRENT PROTCOLS MOL; Baldwin SA, 1996, GLIA, V16, P266; BAROTTE C, 1989, NEUROSCI LETT, V101, P197, DOI 10.1016/0304-3940(89)90530-2; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; BIANCHI R, 1993, J BIOL CHEM, V268, P12669; BONTHIUS DJ, 1993, BRAIN RES, V618, P83, DOI 10.1016/0006-8993(93)90432-M; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DUFFY PE, 1983, ASTROCYTES NORMAL RE; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENG LF, 1988, CURRENT ISSUES NEURA, P247; ENGELE J, 1991, J NEUROSCI, V11, P3070; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P394, DOI 10.1007/BF00713531; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; HINKLE DA, 1997, IN PRESS NEUROSCIENC; IWAMOTO Y, 1994, LIFE SCI, V55, P1651, DOI 10.1016/0024-3205(94)00332-7; KINDY MS, 1992, MOL BRAIN RES, V13, P199, DOI 10.1016/0169-328X(92)90027-9; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; NEARY JT, 1994, ACTA NEUROPATHOL, V87, P8; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PETITO CK, 1990, J CEREBR BLOOD F MET, V10, P850, DOI 10.1038/jcbfm.1990.141; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; SELINFREUND RH, 1990, J CELL BIOL, V111, P2021, DOI 10.1083/jcb.111.5.2021; STEWAD O, 1997, J NEUROSCI, V10, P2373; STICHEL CC, 1994, GLIA, V10, P89, DOI 10.1002/glia.440100203; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TODA M, 1994, J NEUROCHEM, V63, P1975; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; ZIMMER DB, 1989, J CELL BIOL, V108, P141, DOI 10.1083/jcb.108.1.141	39	54	58	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1997	14	10					729	738		10.1089/neu.1997.14.729			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YE057	WOS:A1997YE05700004	9383091				2022-02-06	
J	Stanislav, SW				Stanislav, SW			Cognitive effects of antipsychotic agents in persons with traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; SCHIZOPHRENIC-PATIENTS; MEMORY; EFFORTFUL; CLOZAPINE; DEFICITS; DOPAMINE	Over 1 million survivors of traumatic brain injury receive maintenance pharmacotherapy, of which a substantial number receive antipsychotic agents for the treatment of psychoses, agitation and aggression, and other maladaptive behaviours. In spite of the common clinical uses of antipsychotics, the cognitive risks versus benefits are unclear. The purpose of this study was to assess differences in cognitive functioning before, during, and after discontinuation of antipsychotic agents in inpatients undergoing rehabilitation for traumatic brain injury. Neuropsychiatric tests (Reys Auditory-Verbal Learning, Trail Making A&B, Digit Span Forwards and Backwards) evaluating cognitive skills of verbal ability, visuomotor speed, memory, learning, attention, and spatial ability were administered to each subject at baseline (immediately prior to tapering or discontinuing antipsychotic), when taper reached 50% of baseline dose, 1 week after antipsychotic discontinuation, and 3 weeks after discontinuation. These data suggest that select areas of cognition improve alter antipsychotic discontinuation in subjects with traumatic brain injury. The magnitude of improvement appeared to be greater after discontinuation with thioridazine, a low-potency agent, compared to haloperidol, a high-potency agent. Results, although very preliminary, support the hypothesis or cholinergic involvement in regulating cognitive processes, and this underscores the need for more systematic research in this area.	HEALTHCARE REHABIL CTR, AUSTIN, TX USA		Stanislav, SW (corresponding author), UNIV TEXAS, COLL PHARM, AUSTIN, TX 78712 USA.						BAKAY RAE, 1986, NEUROSURGERY, V18, P234, DOI 10.1227/00006123-198602000-00023; BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; DANIEL DG, 1994, BIOL PSYCHIAT, V35, P667, DOI 10.1016/0006-3223(94)90847-8; Grober E, 1989, J Cogn Neurosci, V1, P327, DOI 10.1162/jocn.1989.1.4.327; HAGGER C, 1993, BIOL PSYCHIAT, V34, P702, DOI 10.1016/0006-3223(93)90043-D; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; NEWMAN RP, 1984, NEUROLOGY, V34, P805, DOI 10.1212/WNL.34.6.805; PARROTT AC, 1987, NEUROPSYCHOBIOLOGY, V17, P53, DOI 10.1159/000118371; PERLICK D, 1986, AM J PSYCHIAT, V143, P230; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; SPOHN HE, 1989, J ABNORM PSYCHOL, V98, P367, DOI 10.1037/0021-843X.98.4.367; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; SUNDERLAND T, 1987, ARCH GEN PSYCHIAT, V44, P418; SYNDULKO K, 1981, INT J NEUROSCI, V14, P61, DOI 10.3109/00207458108985816; TUNE LE, 1982, AM J PSYCHIAT, V139, P1460; Vogenthaler D R, 1987, Brain Inj, V1, P113; WEINGARTNER H, 1984, PSYCHIAT RES, V11, P223, DOI 10.1016/0165-1781(84)90071-4	22	54	55	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	1997	11	5					335	341		10.1080/026990597123494			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WW455	WOS:A1997WW45500004	9146839				2022-02-06	
J	Donders, J; Warschausky, S				Donders, J; Warschausky, S			WISC-III factor index score patterns after traumatic head injury in children	CHILD NEUROPSYCHOLOGY			English	Article							ADOLESCENTS	Four subtypes of Wechsler Intelligence Scale for Children-Third Edition (WISC-III) factor index score patterns were identified by means of two-stage cluster analysis in a sample of 153 children with traumatic head injury (THI). Three of these subtypes were differentiated primarily by level of performance, and bore close resemblance to clusters known to be prevalent in the WISC-III standardization sample. One subtype displayed an uncommon pattern of performance, characterized by selective impairment on the Perceptual Organization and Processing Speed factor indexes, which may be clinically significant in children with THI. Support for the reliability and validity of the subtypes is provided. It is concluded that the WISC-III is a useful tool in the evaluation of sequelae of THI in children.	UNIV MICHIGAN,ANN ARBOR,MI 48109		Donders, J (corresponding author), MARY FREE BED HOSP,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BOUCHARD TJ, 1985, HDB INTELLIGENCE THE, P391; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P185, DOI 10.1080/09297049608402251; DONDERS J, 1993, CLIN NEUROPSYCHOL, V7, P430, DOI 10.1080/13854049308401533; DONDERS J, 1995, ASSESSMENT, V2, P219; DONDERS J, 1996, HDB PEDIAT PSYCHOL P; Everitt B. S., 1980, CLUSTER ANAL; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Fuerst DR, 1995, CHILD NEUROPSYCHOL, V1, P38, DOI 10.1080/09297049508401341; Kaufman, 1994, INTELLIGENT TESTING; KAUFMAN AS, 1993, J SCHOOL PSYCHOL, V31, P345, DOI 10.1016/0022-4405(93)90019-F; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LITTLE SG, 1992, SCHOOL PSYCHOL QUART, V7, P136; McDermott P.A., 1989, PSYCHOL ASSESSMENT J, V1, P292, DOI [https://doi.org/10.1037/1040-3590.1.4.292, DOI 10.1037/1040-3590.1.4.292]; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; ROID GH, 1993, J PSYCHOEDUC ASSESS, P6; Rourke BP., 1989, NONVERBAL LEARNING D; ROURKE BP, 1996, ASSESSMENT, V3, P277; *SAS, 1990, SAS STAT US GUID VER, V1; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; [No title captured]; [No title captured]	28	54	55	0	5	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	APR	1997	3	1					71	78		10.1080/09297049708401369			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XE553	WOS:A1997XE55300006					2022-02-06	
J	Givon, U; Pritsch, M; Levy, O; Yosepovich, A; Amit, Y; Horoszowski, H				Givon, U; Pritsch, M; Levy, O; Yosepovich, A; Amit, Y; Horoszowski, H			Monteggia and equivalent lesions - A study of 41 cases	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							FRACTURE-DISLOCATIONS; RADIAL HEAD; CHILDREN	Forty-one patients who suffered from a Monteggia fracture and were treated between 1984 and 1993 were reviewed retrospectively using a new motion score of the elbow joint, There were 14 children and 27 adults of whom 34 were available for review The results in children were significantly better than those of the adults, Among the adults, the final results of the patients who had a Bado Type 1 equivalent injury were significantly worse than those of the other groups, especially when associated with a fracture of the radial head, The type of fracture, open or closed, the presence of a fracture of the olecranon, and the energy level of the trauma did not have any significant prognostic value, Good correlation was shown between the new motion score and the Figgie elbow score, The Bado Type 1 equivalent injuries should be considered as a special subgroup of the Monteggia lesion, necessitating extra attention in treatment and rehabilitation, and a close followup of the patient.			Givon, U (corresponding author), CHAIM SHEBA MED CTR,DEPT ORTHOPAED SURG,IL-52621 TEL HASHOMER,ISRAEL.						Bado J L, 1967, Clin Orthop Relat Res, V50, P71; BARQUET A, 1981, INJURY, V12, P471, DOI 10.1016/0020-1383(81)90166-2; Boyd H B, 1969, Clin Orthop Relat Res, V66, P94; BRUCE HE, 1974, J BONE JOINT SURG AM, VA 56, P1563, DOI 10.2106/00004623-197456080-00003; BRYAN RS, 1971, J TRAUM, V11, P992, DOI 10.1097/00005373-197112000-00002; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P251; ENGBER WD, 1983, CLIN ORTHOP RELAT R, V174, P133; FIGGIE MP, 1989, J BONE JOINT SURG AM, V71A, P1058, DOI 10.2106/00004623-198971070-00013; FOWLES JV, 1983, J BONE JOINT SURG AM, V65, P1276, DOI 10.2106/00004623-198365090-00008; GIUSTRA PE, 1974, RADIOLOGY, V110, P45, DOI 10.1148/110.1.45; HUME AC, 1957, J BONE JOINT SURG BR, V39, P508, DOI 10.1302/0301-620X.39B3.508; JESSING P, 1975, ACTA ORTHOP SCAND, V46, P601, DOI 10.3109/17453677508989242; KAMALI M, 1974, J BONE JOINT SURG AM, VA 56, P841, DOI 10.2106/00004623-197456040-00026; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; LICHTER RL, 1975, J BONE JOINT SURG AM, VA 57, P124, DOI 10.2106/00004623-197557010-00026; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P454, DOI 10.2106/00004623-198163030-00021; MORRIS AH, 1974, J BONE JOINT SURG AM, VA 56, P1744, DOI 10.2106/00004623-197456080-00033; MULLICK S, 1977, J BONE JOINT SURG AM, V59, P543, DOI 10.2106/00004623-197759040-00024; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; PEIRO A, 1977, J BONE JOINT SURG AM, V59, P92, DOI 10.2106/00004623-197759010-00017; RECKLING FW, 1982, J BONE JOINT SURG AM, V64, P857, DOI 10.2106/00004623-198264060-00007; SPAR I, 1977, CLIN ORTHOP RELAT R, V122, P207; SPINNER M, 1968, CLIN ORTHOPAEDICS, V58, P141; STEIN F, 1971, J BONE JOINT SURG AM, VA 53, P1432, DOI 10.2106/00004623-197153070-00022; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; TOMPKINS DG, 1971, J BONE JOINT SURG AM, VA 53, P1109, DOI 10.2106/00004623-197153060-00007; WILEY JJ, 1985, J BONE JOINT SURG BR, V67, P728, DOI 10.1302/0301-620X.67B5.4055870	27	54	57	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	1997		337					208	215					8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	WT707	WOS:A1997WT70700023	9137192				2022-02-06	
J	May, AK; Young, JS; Butler, K; Bassam, D; Brady, W				May, AK; Young, JS; Butler, K; Bassam, D; Brady, W			Coagulopathy in severe closed head injury: Is empiric therapy warranted?	AMERICAN SURGEON			English	Article; Proceedings Paper	64th Annual Scientific Meeting and Postgraduate Course Program, Southeastern-Surgical-Congress	FEB 04-07, 1996	TAMPA, FL	SE Surg Congress			DISSEMINATED INTRAVASCULAR COAGULATION; DISORDERS	Closed head injuries account for a significant portion of the morbidity and mortality following blunt trauma. Severe closed head injuries can be complicated by the development of a coagulopathy that may worsen blood loss and delay invasive neurosurgical procedures. Awaiting the results of coagulation studies prior to initiating treatment of such a coagulopathy introduces an inherent delay that may allow worsening of the coagulation disturbance and negatively influence outcome. This study was undertaken to see if a subgroup of patients with severe closed head injuries had a high probability of developing a coagulopathy and would warrant empiric treatment with fresh frozen plasma. The records of adult patients admitted to our trauma center with a Glasgow coma score (GCS) of less than or equal to 8 and an extracranial abbreviated injury score of less than or equal to 2 during a 9-month period were reviewed. Patients with penetrating trauma or whose altered level of consciousness was due to sedation or shock were excluded. The presence of coagulation abnormalities was determined according to prothrombin time and partial thromboplastin time obtained on admission. The time to invasive neurosurgical procedures for both coagulopathic and noncoagulopathic patients was determined as well as the mean number of hospital days, intensive care unit days, and the mortality for each group. Eighty-one per cent of the patients with a GCS less than or equal to 6 were coagulopathic on admission, and all patients with a GCS of 3 or 4 were coagulopathic. In contrast, no patient with a score of 7 or 8 was coagulopathic. The coagulopathic patients tended to have a higher mortality than the noncoagulopathic patients (53 versus 22%) as well as longer intensive care unit and hospital stays. The mean time to neurosurgical intervention for the coagulopathic group was 226.0+/-190.9 minutes versus 84.8+/-38.4 minutes for the noncoagulopathic patients. We conclude that patients with closed head injuries who present with a GCS of 6 or less are candidates for empiric treatment for coagulopathy. Such treatment will negate the delay of awaiting coagulation studies. Whether or not such therapy shortens the interval between admission and neurosurgical procedures or alters outcome will require prospective study.	UNIV VIRGINIA,HLTH SCI CTR,DEPT SURG,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT EMERGENCY MED,CHARLOTTESVILLE,VA 22908								ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; AUER L, 1978, ACTA NEUROCHIR, V43, P51, DOI 10.1007/BF01809225; AUER LM, 1979, ACTA NEUROCHIR, V49, P219, DOI 10.1007/BF01808961; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; DRAYER BP, 1975, JAMA-J AM MED ASSOC, V231, P174, DOI 10.1001/jama.231.2.174; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PONDAAG W, 1978, ADV NEUROSURG, V6, P159; PRESTON FE, 1974, J NEUROL NEUROSUR PS, V37, P241, DOI 10.1136/jnnp.37.3.241; ROSEMAN B, 1985, ORAL SURG ORAL MED O, V59, P551, DOI 10.1016/0030-4220(85)90179-3; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1981, J NEUROSURG, V55, P718, DOI 10.3171/jns.1981.55.5.0718; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567	16	54	57	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	1776 PEACHTREE RD, NW., SUITE 410N, ATLANTA, GA 30309-2352	0003-1348			AM SURGEON	Am. Surg.	MAR	1997	63	3					233	236					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WK405	WOS:A1997WK40500013	9036890				2022-02-06	
J	Kapur, N; Scholey, K; Moore, E; Barker, S; Brice, J; Thompson, S; Shiel, A; Carn, R; Abbott, P; Fleming, J				Kapur, N; Scholey, K; Moore, E; Barker, S; Brice, J; Thompson, S; Shiel, A; Carn, R; Abbott, P; Fleming, J			Long-term retention deficits in two cases of disproportionate retrograde amnesia	JOURNAL OF COGNITIVE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; CLOSED-HEAD-INJURY; AUTOBIOGRAPHICAL MEMORY; MAGNETIC-RESONANCE; EPISODIC MEMORY; FOLLOW-UP; HIPPOCAMPUS; CONSOLIDATION; IMPAIRMENT; KORSAKOFF	The status of very long-term retention, together with detailed brain imaging correlates, is presented in two patients with disproportionately dense retrograde amnesia. The first patient suffered a severe closed head injury and was left with dense autobiographical amnesia for events that she had experienced prior to her injury. She showed relatively mild, patchy memory impairment on standard anterograde memory tests. Postinjury autobiographical memory was relatively spaced. However, postinjury long-term knowledge acquisition was significantly impaired. The second patient also suffered a severe head injury and was left with marked retrograde amnesia for events that she had experienced prior to her injury. She also showed relatively mild, patchy impairment on standard antero grade memory tests. Using specially designed tests, this patient showed normal immediate learning and delayed recall using a range of materials, but displayed significantly faster rate of Forgetting over a period of 6 weeks than control subjects who were matched on initial delayed levels of retention. In both cases, there was major pathology in the region of the left temporal lobe, with lateral structures being more affected than medial structures. Our findings provide further evidence relating to the independence of certain anterograde and retrograde memory mechanisms,and support recent observations (De Renzi & Lucchelli, 1993) that link some instances of retrograde amnesia to impairment in very long-term retention. The possibility is raised that some forms of retrograde amnesia, such as the present cases, represent a type of ''disconnection syndrome,'' whereby visual-semantic and other associations are disconnected from verbal representations of such associations. Lesions to intrahemispheric fasciculi or similar association fibers, in combination with lesions to critical anterior or posterior cerebral structures, may play an important role in such a disconnection.	UNIV SOUTHAMPTON, SOUTHAMPTON, HANTS, ENGLAND		Kapur, N (corresponding author), SOUTHAMPTON GEN HOSP, WESSEX NEUROL CTR, SOUTHAMPTON SO16 6YD, HANTS, ENGLAND.						AHERN GL, 1994, NEUROLOGY, V44, P1270, DOI 10.1212/WNL.44.7.1270; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; BARR ML, 1988, NERVOUS SYSTEM; BARR WB, 1990, NEUROPSYCHOLOGIA, V28, P243, DOI 10.1016/0028-3932(90)90018-J; Benton A. L., 1975, TEST FACIAL RECOGNIT; DALLABARBA G, 1990, CORTEX, V26, P525, DOI 10.1016/S0010-9452(13)80356-5; Damasio A., 1994, LARGE SCALE NEURONAL; DAMASIO AR, 1994, EXPLORING BRAIN FUNC; DELLASALA S, 1993, NEUROPSYCHOLOGIA, V31, P823; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; DERENZI E, 1993, CORTEX, V29, P449, DOI 10.1016/S0010-9452(13)80253-5; GABRIELI JDE, 1988, BRAIN COGNITION, V7, P157, DOI 10.1016/0278-2626(88)90027-9; Gardiner John M., 1993, P163; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; GROSSI D, 1988, CORTEX, V24, P457, DOI 10.1016/S0010-9452(88)80009-1; HODGES JR, 1993, BRAIN, V116, P921, DOI 10.1093/brain/116.4.921; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; KAPUR N, 1991, BRIT J PSYCHIAT, V159, P872, DOI 10.1192/bjp.159.6.872; KAPUR N, 1994, NEUROPSYCHOLOGIA, V32, P23, DOI 10.1016/0028-3932(94)90066-3; KAPUR N, 1989, CORTEX, V25, P387, DOI 10.1016/S0010-9452(89)80053-X; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; KAPUR N, 1996, IN PRESS MEMORY; KAPUR N, 1996, CLASSIC CASE STUDIES; KOPELMAN MD, 1989, NEUROPSYCHOLOGIA, V27, P437, DOI 10.1016/0028-3932(89)90050-X; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; KRITCHEVSKY M, 1993, NEUROLOGY, V43, P326, DOI 10.1212/WNL.43.2.326; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEZAK M, 1979, EUR M INT NEUR SOC N; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Martin R.C., 1991, NEUROPSYCHOLOGY, V5, P3, DOI [10.1037/0894-4105.5.1.3, DOI 10.1037/0894-4105.5.1.3]; McKenna P., 1983, GRADED NAMING TEST; MILNER PM, 1989, NEUROPSYCHOLOGIA, V27, P23, DOI 10.1016/0028-3932(89)90087-0; MONTALDI D, 1989, DEV CLIN EXPT NEUROP; Nelson H. E, 1982, NATIONAL ADULT READI; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; SALMON DP, 1987, PSYCHOBIOLOGY, V15, P37; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SQUIRE LR, 1989, J NEUROSCI, V9, P828; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1990, J NEUROSCI, V10, P3106; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; Victor M, 1990, J Cogn Neurosci, V2, P246, DOI 10.1162/jocn.1990.2.3.246; Warrington E, 1984, RECOGNITION MEMORY T, V1; WARRINGTON EK, 1988, BRAIN COGNITION, V7, P184, DOI 10.1016/0278-2626(88)90029-2; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WILDER BJ, 1972, EXPT MODELS EPILEPSY, P85; WOOD FB, 1989, BRAIN COGNITION, V10, P76, DOI 10.1016/0278-2626(89)90076-6; YONEDA Y, 1992, EUR NEUROL, V32, P340, DOI 10.1159/000116857; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	54	54	55	0	3	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0898-929X	1530-8898		J COGNITIVE NEUROSCI	J. Cogn. Neurosci.	SEP	1996	8	5					416	434		10.1162/jocn.1996.8.5.416			19	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	VG437	WOS:A1996VG43700004	23961945				2022-02-06	
J	Anderson, CV; Wood, DMG; Bigler, ED; Blatter, DD				Anderson, CV; Wood, DMG; Bigler, ED; Blatter, DD			Lesion volume, injury severity, and thalamic integrity following head injury	JOURNAL OF NEUROTRAUMA			English	Article						magnetic resonance imaging; traumatic brain injury; thalamus	AXONAL INJURY	Magnetic resonance (MR) scans of 63 traumatic brain injury (TBI) patients were analyzed to examine the relationship between injury severity, lesion volume (nonthalamic cortical/subcortical lesions), ventricle-to-brain ratio (VBR), and thalamic volume, For comparison, 33 normal control subjects were used, Patients with visible nonthalamic structural lesions showed significantly smaller thalamic volumes than patients without visible lesions or control subjects. Results also indicated that patients with visible lesions had significantly more severe injuries than patients without lesions, Patients with moderate-severe injuries had significantly smaller thalamic volumes and greater VBRs than patients with mild-moderate injuries. Although several variables related to thalamic volume, the presence of nonthalamic lesions was sufficient to result in smaller thalamic volume. Decreased thalamic volume following head injury suggests that subcortical brain structures may be susceptible to transneuronal degeneration following cortical lesions, and that this can be detected by in vivo MR-based volumetric analysis.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,PROVO,UT 84602; LATTER DAY ST HOSP,DEPT RADIOL,SALT LAKE CITY,UT 84143								ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BIGLER ED, 1994, FUNCTIONAL NEUROIMAG, P121; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GEAN AD, 1994, IMAGING HEAT TRAUMA; JESSELL TM, 1991, PRINCIPLES NEURAL SC, P258; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KUCHARCZYK J, 1994, MAGNETIC RESONANCE I; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; MATTHEWS MA, 1973, J NEUROCYTOL, V2, P265, DOI 10.1007/BF01104030; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; PRAYER LM, 1994, MAGNETIC RESONANCE N; ROBB RA, 1995, 3 DIMENSIONAL BIOMED; ROSENTHAL M, 1993, TRAUMATIC BRAIN INJU; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; STEWARD O, 1989, PRINCIPLES CELL MOL; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29	25	54	55	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	1996	13	2					59	65		10.1089/neu.1996.13.59			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UE544	WOS:A1996UE54400002	9094376				2022-02-06	
J	Stein, SC; Spettell, CM				Stein, SC; Spettell, CM			Delayed and progressive brain injury in children and adolescents with head trauma	PEDIATRIC NEUROSURGERY			English	Article						head injury; CT scanning; children; delayed brain injury	DISSEMINATED INTRAVASCULAR COAGULATION; COMA DATA-BANK; YOUNG-ADULTS; SEVERITY; EXPERIENCE; HEMATOMAS; PRESSURE; LESIONS; SCALE	We performed serial CT scans on 351 children and adolescents with serious closed-head injury. Delayed or progressive lesions were encountered in 145 (41%). The occurrence of such delayed cerebral injuries correlated with the severity of the initial head trauma, with the presence of major extracranial injury and with studies of coagulopathy on admission. The presence of delayed cerebral injury had a profound influence on survival and recovery from head trauma, especially when the initial severity of the head injury was taken into account. We conclude that serial CT scans provide a reliable means of diagnosing and following the progress of delayed cerebral injury in the pediatric population.	UNIV MED & DENT NEW JERSEY,COOPER HOSP,MED CTR,DEPT SURG,NEWARK,NJ; UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,CAMDEN,NJ 08103; THOMAS JEFFERSON UNIV,DEPT RADIOL,PHILADELPHIA,PA 19107								ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Atluru V, 1986, Pediatr Neurol, V2, P297, DOI 10.1016/0887-8994(86)90024-X; Baracchini-Muratorio G, 1985, J Neurosurg Sci, V29, P305; Berkson J, 1944, J AM STAT ASSOC, V39, P357, DOI 10.2307/2280041; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; BURGER MS, 1985, J NEUROSURG, V62, P194; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CORDOBES F, 1987, CHILD NERV SYST, V3, P235, DOI 10.1007/BF00274055; COSTEFF H, 1990, J NEUROSURG, V73, P648; DALENS B, 1981, ACTA NEUROL SCAND, V64, P81; DALENS B, 1983, J PEDIATR, V101, P166; DHARKER SR, 1993, NEUROSURGERY, V33, P863; DOSSANTOS ALM, 1994, PEDIATR NEUROSURG, V21, P50; DRAYER BP, 1975, JAMA-J AM MED ASSOC, V231, P174, DOI 10.1001/jama.231.2.174; DUHAIME AC, 1994, PEDIATR NEUROSURG, V21, P117, DOI 10.1159/000120825; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Gennarelli T A, 1993, Acta Neurochir Suppl (Wien), V57, P49; Gjerris F, 1986, Acta Neurochir Suppl (Wien), V36, P155; GRAEBER JE, 1978, LANCET, V2, P285; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; HAHN YS, 1988, CHILD NERV SYST, V4, P34; HUNEIDI AHS, 1992, ANN ROY COLL SURG, V74, P345; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JENNETT B, 1975, LANCET, V1, P480; KALFF R, 1989, CHILD NERV SYST, V5, P156, DOI 10.1007/BF00272118; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LUERSSEN TG, 1994, PEDIAT NEUROSURGERY, P266; MCGAULEY JL, 1975, J NEUROSURG, V43, P374, DOI 10.3171/jns.1975.43.3.0374; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Nelson C M, 1983, J Neurosurg Nurs, V15, P72; NOAH ZL, 1992, CRIT CARE CLIN, V8, P59, DOI 10.1016/S0749-0704(18)30267-7; Papo I, 1982, J Neurosurg Sci, V26, P193; Parmelee D X, 1989, Psychiatr Med, V7, P11; PASCUCCI RC, 1988, INTENS CARE MED, V14, P185, DOI 10.1007/BF00717985; PFENNINGER J, 1984, EUR J PEDIATR SURG, V39, P223; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Schafermeyer Robert, 1993, Emergency Medicine Clinics of North America, V11, P187; SCHELLER J, 1992, DEV MED CHILD NEUROL, V34, P836; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; SCOTTJUPP R, 1992, ARCH DIS CHILD, V67, P222, DOI 10.1136/adc.67.2.222; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHAPIRO K, 1994, PEDIATR NEUROSURG, V21, P123; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1990, J PEDIATR SURG, V58, P236; Tseng Sheng-Hong, 1992, Journal of the Formosan Medical Association, V91, P585; WALKER ML, 1984, CHILD BRAIN, V11, P387; WARD JD, 1994, PEDIATR NEUROSURG, V20, P183, DOI 10.1159/000120784; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015; 1971, JAMA-J AM MED ASSOC, V215, P277	66	54	54	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	DEC	1995	23	6					299	304		10.1159/000120975			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	UJ892	WOS:A1995UJ89200005	8743998				2022-02-06	
J	ROBERTSON, CS; GOPINATH, SP; CHANCE, B				ROBERTSON, CS; GOPINATH, SP; CHANCE, B			A NEW APPLICATION FOR NEAR-INFRARED SPECTROSCOPY - DETECTION OF DELAYED INTRACRANIAL HEMATOMAS AFTER HEAD-INJURY	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		DELAYED INTRACRANIAL HEMATOMA; NEAR INFRARED SPECTROSCOPY; SECONDARY INSULTS	CEREBRAL BLOOD-VOLUME; TRAUMATIC INTRACEREBRAL HEMATOMA; XE-133 CLEARANCE; PRETERM INFANTS; EARLY DIAGNOSIS; CYTOCHROME AA3; CT SCAN; BRAIN; OXYGENATION; TOMOGRAPHY	Clinical studies have documented the importance of secondary brain insults in determining neurologic outcome after head injury, Delayed intracranial hematomas are one of the most easily remediable causes of secondary injury if identified early, but can cause significant disability or death if not promptly recognized and treated, Early identification and treatment of these lesions that appear or enlarge after the initial CT scan may improve neurological outcome. Serial examinations using near-infrared spectroscopy (NIRS) to detect the development of delayed hematomas were obtained in 167 patients. The difference in absorbance of light (Delta OD) at 760 nm between the normal and the hematoma side was measured serially during the first 3 days after injury, Twenty-seven (16%) of the patients developed some type of late hematoma: an intracerebral hematoma in 8 patients, an extracerebral hematoma in 6 patients, and a postoperative hematoma in 13 patients, Eighteen of the delayed hematomas caused significant mass effect and required surgical evacuation, The hematomas appeared between 2 and 72 h after admission. In 24 of the 27 patients, a significant increase (>0.3) in the Delta OD occurred prior to an increase in intracranial pressure or a change in the neurological examination, or a change on CT scan. Early diagnosis using NIBS may allow early treatment and reduce secondary injury caused by delayed hematomas.	UNIV PENN,PHILADELPHIA,PA 19104		ROBERTSON, CS (corresponding author), BAYLOR COLL MED,DEPT NEUROSURG,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616, NS27346] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027346, P01NS027616] Funding Source: NIH RePORTER		ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; ANDREWS BT, 1986, NEUROSURGERY, V19, P408, DOI 10.1227/00006123-198609000-00012; ANDREWS BT, 1988, CONT NEUROSURG, V10, P6; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BRAZY JE, 1988, J PEDIATR-US, V112, P457, DOI 10.1016/S0022-3476(88)80336-6; BRAZY JE, 1985, PEDIATRICS, V75, P217; BRAZY JE, 1986, J PEDIATR-US, V108, P983, DOI 10.1016/S0022-3476(86)80944-1; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; CHANCE B, 1989, PHOTON MIGRATION IN TISSUES, P121; CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971; CHEONG WF, 1994, IEEE J QUANTUM ELECT, V26, P2166; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CONTANT CF, 1993, J NEUROTRAUMA S1, V10, pS57; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; EDWARDS AD, 1988, J PHYSL, V410, pP50; Ferrari M, 1986, Adv Exp Med Biol, V200, P203; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; FUKAMACHI A, 1985, ACTA NEUROCHIR, V74, P35, DOI 10.1007/BF01413274; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gentleman D, 1989, Br J Neurosurg, V3, P367, DOI 10.3109/02688698909002817; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; GOPINATH SP, 1995, NEUROCHEMICAL MONITO, P160; GOPINATH SP, 1995, IN PRESS NEUROTRAUMA; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KURTH CD, 1992, ANESTHESIOLOGY, V77, P656, DOI 10.1097/00000542-199210000-00007; LIPPER MH, 1979, RADIOLOGY, V133, P645, DOI 10.1148/133.3.645; LIVERA LN, 1991, ARCH DIS CHILD-FETAL, V66, P376, DOI 10.1136/adc.66.4_Spec_No.376; LOBATO RD, 1988, J NEUROSURG, V6, P48; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MCCORMICK PW, 1991, STROKE, V22, P596, DOI 10.1161/01.STR.22.5.596; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Millikan GA, 1942, REV SCI INSTRUM, V13, P434, DOI 10.1063/1.1769941; NIKOKA S, 1990, PEDIATR RES, V28, P54; NINCHOJI T, 1984, ACTA NEUROCHIR, V71, P69, DOI 10.1007/BF01401152; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; PEEBLES DM, 1992, AM J OBSTET GYNECOL, V166, P1369, DOI 10.1016/0002-9378(92)91606-B; PEEBLES DM, 1991, LANCET, V338, P254, DOI 10.1016/0140-6736(91)90396-7; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; PRYDS O, 1990, PEDIATR RES, V27, P445, DOI 10.1203/00006450-199005000-00006; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SAKAI H, 1986, INTRACRANIAL PRESSUR, V6, P6522; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SEELIG JM, 1985, NEW ENGL J MED, V304, P1511; SHAH AR, 1992, J PEDIATR, V126, P769; SKOV L, 1991, PEDIATR RES, V30, P570, DOI 10.1203/00006450-199112000-00016; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; ZIMMERMAN RA, 1977, J COMPUT ASSIST TOMO, V1, P271	57	54	57	0	4	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					591	600		10.1089/neu.1995.12.591			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000010	8683610				2022-02-06	
J	DUVDEVANI, R; ROOF, RL; FULOP, Z; HOFFMAN, SW; STEIN, DG				DUVDEVANI, R; ROOF, RL; FULOP, Z; HOFFMAN, SW; STEIN, DG			BLOOD-BRAIN-BARRIER BREAKDOWN AND EDEMA FORMATION FOLLOWING FRONTAL CORTICAL CONTUSION - DOES HORMONAL STATUS PLAY A ROLE	JOURNAL OF NEUROTRAUMA			English	Article							CLOSED-HEAD-INJURY; CEREBRAL EDEMA; VASCULAR DISRUPTION; COLD INJURY; RAT; DEXAMETHASONE; PERMEABILITY; PEROXIDASE; MOUSE	The present experiment was designed to evaluate and correlate the time course of blood-brain barrier (BBB) integrity and cerebral edema in adult male rats given medial frontal cortex contusions. The effect of sex hormones on BBB integrity in the same injury model was also examined, because previous work has shown that progesterone can reduce cerebral edema (Roof et al., 1993). BBB breakdown was assessed by Evans blue extravasation and albumin immunostaining while edema formation was measured by the wet weight dry weight technique. These processes were examined beginning 2 h and continuing up to 10 days after injury. Our findings show that medial frontal contusion in rats produces changes in cerebral water content and opening of the BBB that endures at least 7 days postinjury. Although pseudopregnancy has been shown to reduce cerebral edema at day 1 postinjury, we did not find any evidence that this hormonal state is associated with BBB repair.	RUTGERS STATE UNIV,INST ANIM BEHAV,BRAIN RES LAB,NEWARK,NJ 07102				Stein, Donald/AAJ-5139-2020		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR208836-01] Funding Source: Medline		Asdell SA, 1946, PATTERNS MAMMALIAN R; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; BODSCH W, 1982, BRAIN RES, V249, P111, DOI 10.1016/0006-8993(82)90175-5; COLE DJ, 1991, ACTA NEUROPATHOL, V82, P266, DOI 10.1007/BF00308811; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Fulop Z., 1992, Society for Neuroscience Abstracts, V18, P178; GALLYAS F, 1970, ACTA NEUROPATHOL, V16, P35, DOI 10.1007/BF00686961; GAMACHE DA, 1986, J NEUROSURG, V65, P686, DOI 10.3171/jns.1986.65.5.0686; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; GUERIN C, 1992, ANN NEUROL, V31, P481, DOI 10.1002/ana.410310504; HEDLEYWHYTE ET, 1986, ANN NEUROL, V19, P373, DOI 10.1002/ana.410190411; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; KARPIAK SE, 1984, J NEUROSCI RES, V12, P485, DOI 10.1002/jnr.490120231; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; KLATZO I, 1980, BRAIN EDEMA, P359; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; MITCHELL J, 1979, ACTA NEUROPATHOL, V46, P45, DOI 10.1007/BF00684803; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; PERSSON L, 1976, ACTA NEUROPATHOL, V35, P333; POLLAY M, 1985, NEUROSURGERY, P322; REID AC, 1983, ANN NEUROL, V13, P28, DOI 10.1002/ana.410130107; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; STERNBER.LA, 1970, J HISTOCHEM CYTOCHEM, V18, P315, DOI 10.1177/18.5.315; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TODD NV, 1990, ACT NEUR S, V51, P296; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; ZIYLAN YZ, 1988, J NEUROCHEM, V51, P1338, DOI 10.1111/j.1471-4159.1988.tb01094.x; ZUCCARELLO M, 1989, STROKE, V20, P367, DOI 10.1161/01.STR.20.3.367	36	54	56	0	5	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	1995	12	1					65	75		10.1089/neu.1995.12.65			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QN638	WOS:A1995QN63800005	7783233				2022-02-06	
J	ZINK, BJ; WALSH, RF; FEUSTEL, PJ				ZINK, BJ; WALSH, RF; FEUSTEL, PJ			EFFECTS OF ETHANOL IN TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article							HEAD-INJURY; CARDIOCIRCULATORY FUNCTION; VENTILATORY RESPONSES; HEMORRHAGIC-SHOCK; ALCOHOL; INTOXICATION; NALOXONE; HYPERCAPNIA; SEVERITY; HYPOXIA	The effects of ethanol intoxication on brain injury and cerebral blood flow (CBF) were investigated in a porcine fluid-percussion model of traumatic brain injury (TBI). Immature swine, under halothane anesthesia (1%), had a TBI delivered with a fluid-percussion device. The experimental group (n = 10) received ethanol (3.5 gm/kg) via gastric tube followed in 1 h by TBI. Two groups of control animals received normal saline and TBI (n = 10) or ethanol and no TBI (n = 5). Mean arterial blood pressure (MAP), intracranial pressure (ICP), arterial blood gases, and serum lactate were monitored for 3 h after the injury. CBF was measured with radiolabelled 15-micron diameter microspheres. Neuropathologic changes were evaluated and graded after formalin perfusion and brain removal at 3 h postinjury. The ethanol level 60 min post-head injury was 198 +/- 70 (SD) mg/dL in the ethanol + TBI group. At 90 min postinjury and thereafter, ethanol + TBI animals compared with TBI only animals had significantly lower MAP (63 +/- 26 mmHg vs 91 +/- 15 mmHg) and lower cerebral perfusion pressure (50 +/- 25 mmHg vs 78 +/- 15), and at 180 min postinjury, lower CBF (87 +/- 37% vs 62 +/- 79% of preinjury levels). Ethanol + TBI animals had higher blood lactates (28 +/- 11 mg/dL vs 13 +/- 6 mg/dL) than TBI only animals. Ethanol + TBI animals also had significantly longer postinjury apneas (11 +/- 8 min vs 0.6 +/- 0.4 min), with three of ten ethanol-treated animals never recovering spontaneous respiration. Ethanol intoxication produced hemodynamic and respiratory changes, which may have a deleterious effect on outcome and mortality after brain injury.	ALBANY MED COLL,DEPT SURG,A-61,47 NEW SCOTLAND AVE,ALBANY,NY 12208; ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208; UNIV MICHIGAN,MED CTR,DEPT EMERGENCY,ANN ARBOR,MI 48109				Feustel, Paul/AAW-5157-2021	Feustel, Paul/0000-0002-6963-4349	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S07RR005394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030303] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S07RR05394-29] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30303] Funding Source: Medline		ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; FEUSTEL PJ, 1987, J SURG RES, V43, P86, DOI 10.1016/0022-4804(87)90051-5; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GARRISON HG, 1984, ANN EMERG MED, V13, P26, DOI 10.1016/S0196-0644(84)80379-0; GETTLER DT, 1963, ANN SURG, V158, P151, DOI 10.1097/00000658-196308000-00001; GORDIS E, 1989, NIAAA ALCOHOL ALERT, V3, P1; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HEYMANN MA, 1977, PROG CARDIOVASC DIS, V20, P55, DOI 10.1016/S0033-0620(77)80005-4; HORTON JW, 1987, CIRC SHOCK, V22, P23; HORTON JW, 1986, SURGERY, V100, P520; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JEHLE D, 1988, ANN EMERG MED, V17, P953, DOI 10.1016/S0196-0644(88)80678-4; KIRN TF, 1988, JAMA-J AM MED ASSOC, V260, P2480, DOI 10.1001/jama.1988.03410170018005; KNOTT DH, 1963, NEW ENGL J MED, V269, P292, DOI 10.1056/NEJM196308082690604; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; MALT SH, 1971, J TRAUM, V11, P76, DOI 10.1097/00005373-197101000-00007; MANKES RF, 1991, ALCOHOL CLIN EXP RES, V15, P80, DOI 10.1111/j.1530-0277.1991.tb00521.x; MARX J, 1990, Emergency Medicine Clinics of North America, V8, P929; MCCAULEY VB, 1988, AM REV RESPIR DIS, V137, P1406, DOI 10.1164/ajrccm/137.6.1406; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; McQueen J D, 1975, Surg Neurol, V4, P375; MICHIELS TM, 1983, J APPL PHYSIOL, V55, P929, DOI 10.1152/jappl.1983.55.3.929; NELSON LR, 1982, HEAD INJURY BASIC CL, P117; OVERGAARD J, 1982, HEAD INJURY BASIC CL, P239; POLLACK CV, 1990, J TRAUMA, V30, P888, DOI 10.1097/00005373-199007000-00021; SAHN SA, 1975, CLIN SCI MOL MED, V49, P33, DOI 10.1042/cs0490033; SANTIAGO TV, 1985, J APPL PHYSIOL, V59, P1675, DOI 10.1152/jappl.1985.59.6.1675; SHOOK JE, 1990, AM REV RESPIR DIS, V142, P895, DOI 10.1164/ajrccm/142.4.895; STEINBROOK RA, 1984, LIFE SCI, V34, P881, DOI 10.1016/0024-3205(84)90205-4; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; ZINK BJ, 1988, ANN EMERG MED, V17, P15, DOI 10.1016/S0196-0644(88)80496-7; ZINK BJ, 1988, CIRC SHOCK, V24, P19	36	54	56	0	5	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FAL	1993	10	3					275	286		10.1089/neu.1993.10.275			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MC021	WOS:A1993MC02100004	8258840				2022-02-06	
J	RAO, N; KILGORE, KM				RAO, N; KILGORE, KM			PREDICTING RETURN TO WORK IN TRAUMATIC BRAIN INJURY USING ASSESSMENT SCALES	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BRAIN INJURIES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE)	SEVERE HEAD-INJURY; DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; RECOVERY	This study compared two frequently used brain injury assessment scales with a comprehensive functional scale in their capability to predict return to work in a traumatic brain injured population. Fifty-seven consecutive admissions to an inpatient brain injury program were rated at admission and discharge using the following scales: Patient Evaluation and Conference System (PECS), Disability Rating Scale, and Levels of Cognitive Functioning Scale. Their relative accuracy in predicting return to work or school up to 26 months after the injury was assessed using hierarchical logistic regression analysis. In each analysis, return to work/school was the dependent variable. The independent variables were initial status and discharge status on each rating scale. Overall these scales predicted return to work with 73.5% to 84.4% accuracy. Total PECS and PECS Cognition scores were the most accurate predictors. Analysis of incorrect predictions revealed the importance of additionally tracking the social factors of substance abuse, family/community support and financial need to return to work.	MARIANJOY REHABIL HOSP,WHEATON,IL								BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CAMPBELL DT, 1963, EXPT QUASI-EXPT DESI; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; Cohen J., 1983, APPL MULTIPLE REGRES, V2nd ed.; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hagan C., 1982, COGNITIVE REHABILITA, P131; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HARVEY RF, 1981, ARCH PHYS MED REHAB, V62, P456; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; SILVERSTEIN B, 1992, ARCH PHYS MED REHAB, V73, P507; SILVERSTEIN B, 1991, ARCH PHYS MED REHAB, V72, P631; SILVERSTEIN B, 1989, IMPLEMENTING PATIENT; [No title captured]; [No title captured]	19	54	54	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1992	73	10					911	916					6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JU061	WOS:A1992JU06100004	1417465				2022-02-06	
J	WINER, JW; ROSENWASSER, RH; JIMENEZ, F				WINER, JW; ROSENWASSER, RH; JIMENEZ, F			ELECTROENCEPHALOGRAPHIC ACTIVITY AND SERUM AND CEREBROSPINAL-FLUID PENTOBARBITAL LEVELS IN DETERMINING THE THERAPEUTIC END-POINT DURING BARBITURATE COMA	NEUROSURGERY			English	Article						BARBITURATE; CEREBRAL PROTECTION; ELECTROENCEPHALOGRAPHY	EPILEPSY; PLASMA; BRAIN	Controversy exists regarding the optimal means for monitoring the patient receiving pentobarbital therapy during medical coma. Serum pentobarbital levels have been used traditionally to gauge cerebral penetration and efficacy of the drug. These peripheral levels have been assumed to reflect pentobarbital concentrations in the cerebrospinal fluid (CSF) and, therefore, the physiological effect on the central nervous system. To determine the relative accuracy of serum versus CSF pentobarbital levels, continuous electroencephalographic (EEG) monitoring in 10 consecutive patients was studied prospectively. Each patient received pentobarbital therapy for cerebral protection in the face of a traumatic injury. Simultaneous serum and CSF pentobarbital levels were obtained 1) before and after the initial barbiturate bolus, 2) every 12 hours during constant infusion therapy, and 3) before and after subsequent boluses necessary because of elevated intracranial pressure (ICP) (ICP > 15 mm Hg) or loss of burst suppression by continuous EEG monitoring (defined as greater than five bursts per minute). ICP and relevant clinical events were recorded hourly. Serum and CSF levels ranged from 33 to 74 mg/L and 4 to 54 mg/L, respectively. There was poor correlation between serum and CSF pentobarbital levels at any given time, although patients remained in burst suppression 73% of the time during their therapy. The EEG monitoring not only provided dynamic physiological monitoring, but it also permitted the lowest pentobarbital dose to maintain burst suppression for a specific patient's metabolism, reducing the likelihood of toxicity. In conclusion, CSF pentobarbital levels are of no greater accuracy than serum pentobarbital levels in predicting physiological effect. Constant EEG monitoring remains the best modality by showing the presence of burst suppression moment-to-moment and thus establishing the minimal necessary dose.	TEMPLE UNIV HOSP & MED SCH,DEPT NEUROSURG,PHILADELPHIA,PA 19140				ROSENWASSER, ROBERT H/L-2482-2014				BRENT DA, 1990, PEDIATRICS, V85, P1086; BROWNE TR, 1988, Q SCI ADV EPILEPSY M, V1, P3; FIRESTONE LL, 1990, CLIN ANESTHESIA PROC, P632; Hauptmann A, 1912, MUNCH MED WOCHENSCHR, V59; ISHII S, 1966, HEAD INJURY, P276; JENNETT B, 1981, MANAGEMENT HEAD INJU, P95; SHERWIN AL, 1988, EPILEPSY RES, V2, P281, DOI 10.1016/0920-1211(88)90035-6; SHERWIN AL, 1973, ARCH NEUROL-CHICAGO, V29, P73, DOI 10.1001/archneur.1973.00490260017001; SHERWIN AL, 1973, ARCH NEUROL-CHICAGO, V28, P178, DOI 10.1001/archneur.1973.00490210058007; SHERWIN AL, CLIN PHARM ANTIEPILE, P274; WOLLMAN H, 1980, GOODMAN GILMANS PHAR, P292	11	54	54	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	NOV	1991	29	5					739	742		10.1227/00006123-199111000-00016			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GL761	WOS:A1991GL76100016	1961405				2022-02-06	
J	DAVIDOFF, G; MORRIS, J; ROTH, E; BLEIBERG, J				DAVIDOFF, G; MORRIS, J; ROTH, E; BLEIBERG, J			COGNITIVE DYSFUNCTION AND MILD CLOSED HEAD-INJURY IN TRAUMATIC SPINAL-CORD INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT REHABIL MED,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT PSYCHIAT,CHICAGO,IL 60611								BLEIBERG J, 1983, ARCH PHYS MED REHAB, V64, P448; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; DUBO H, 1984, P AM SPINAL INJURY A, P35; FITZHUGH KB, 1961, J CONSULT PSYCHOL, V25, P61, DOI 10.1037/h0043344; GUTTMANN L, 1963, P S SPINAL INJURIES, P81; Harris P, 1968, Paraplegia, V5, P215; LYNCH W, 1983, REHABILITATION HEAD, P292; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; Meinecke F W, 1968, Paraplegia, V5, P196; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SCHUENEMAN A, 1982, SCI DIG, V4, P35; Schueneman AL, 1982, SCI DIG, V4, P64; SHAW DJ, 1966, J CLIN PSYCHOL, V22, P176, DOI 10.1002/1097-4679(196604)22:2<176::AID-JCLP2270220215>3.0.CO;2-O; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; WAGNER KA, 1984, P AM SPINAL INJURY A, P96; WILMOT CB, 1984, P AM SPINAL INJURY A, P105; YOUNG JS, 1982, SPINAL CORD INJURY S, P34; [No title captured]; [No title captured]	27	54	57	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.		1985	66	8					489	491					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	APA30	WOS:A1985APA3000293	4026547				2022-02-06	
J	ROWE, MJ; CARLSON, C				ROWE, MJ; CARLSON, C			BRAIN-STEM AUDITORY EVOKED-POTENTIALS IN POST-CONCUSSION DIZZINESS	ARCHIVES OF NEUROLOGY			English	Article									UNIV CALIF IRVINE,DEPT NEUROL,IRVINE,CA 92664		ROWE, MJ (corresponding author), MEMORIAL HOSP,MED CTR,ELECTRODIAGNOST LAB,LONG BEACH,CA 90801, USA.						BALLINGER JJ, 1969, DISEASES NOSE THROAT, P753; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P449, DOI 10.1001/archneur.1961.00450100097012; GAY JR, 1953, JAMA-J AM MED ASSOC, V152, P1698, DOI 10.1001/jama.1953.03690180020006; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; HOWE JR, 1975, NEUROLOGY, V25, P286, DOI 10.1212/WNL.25.3.286; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; MCLAURIN RL, 1973, NEUROLOGICAL SURGERY, V2, P1023; MITCHELL BE, 1973, LANCET, V2, P213; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; ROWE MJ, 1978, ELECTROEN CLIN NEURO, V44, P459, DOI 10.1016/0013-4694(78)90030-5; RUTHERFORD WH, 1977, LANCET, V1, P1; STARR A, 1976, ELECTROEN CLIN NEURO, V41, P595, DOI 10.1016/0013-4694(76)90005-5; STARR A, 1975, ARCH NEUROL-CHICAGO, V32, P761, DOI 10.1001/archneur.1975.00490530083009; STOCKARD JJ, 1977, NEUROLOGY, V27, P316, DOI 10.1212/WNL.27.4.316; SYMUNDS C, 1962, LANCET, V1, P1; TAYLOR AR, 1967, BRIT MED J, V3, P67, DOI 10.1136/bmj.3.5557.67; TOGLIA JU, 1976, NEUROLOGY, V26, P808, DOI 10.1212/WNL.26.9.808; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154	21	54	57	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.		1980	37	11					679	683		10.1001/archneur.1980.00500600027002			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KR819	WOS:A1980KR81900001	7436806				2022-02-06	
J	Sarmiento, K; Thomas, KE; Daugherty, J; Waltzman, D; Haarbauer-Krupa, JK; Peterson, AB; Haileyesus, T; Breiding, MJ				Sarmiento, Kelly; Thomas, Karen E.; Daugherty, Jill; Waltzman, Dana; Haarbauer-Krupa, Juliet K.; Peterson, Alexis B.; Haileyesus, Tadesse; Breiding, Matthew J.			Emergency Department Visits for Sports- and Recreation-Related Traumatic Brain Injuries Among Children - United States, 2010-2016	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article									[Sarmiento, Kelly; Daugherty, Jill; Waltzman, Dana; Haarbauer-Krupa, Juliet K.; Peterson, Alexis B.; Breiding, Matthew J.] CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Thomas, Karen E.; Haileyesus, Tadesse] CDC, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA		Sarmiento, K (corresponding author), CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	KSarmiento@cdc.gov					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Schroeder T., 2001, NEISS SAMPLE DESIGN; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005	9	53	53	1	3	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	MAR 15	2019	68	10					237	242		10.15585/mmwr.mm6810a2			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HO7WI	WOS:000461160300002	30870404	Green Published, Green Submitted, gold			2022-02-06	
J	Halstead, ME; Walter, KD; Moffatt, K				Halstead, Mark E.; Walter, Kevin D.; Moffatt, Kody		Council Sports Med Fitness	Sport-Related Concussion in Children and Adolescents	PEDIATRICS			English	Article							HIGH-SCHOOL FOOTBALL; TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; COMPUTERIZED NEUROCOGNITIVE TEST; DEFICIT HYPERACTIVITY DISORDER; EMERGENCY-DEPARTMENT VISITS; CATASTROPHIC HEAD-INJURIES; TEST-RETEST RELIABILITY; STATES HIGH-SCHOOL; RETURN-TO-PLAY	Sport-related concussion is an important topic in nearly all sports and at all levels of sport for children and adolescents. Concussion knowledge and approaches to management have progressed since the American Academy of Pediatrics published its first clinical report on the subject in 2010. Concussion's definition, signs, and symptoms must be understood to diagnose it and rule out more severe intracranial injury. Pediatric health care providers should have a good understanding of diagnostic evaluation and initial management strategies. Effective management can aid recovery and potentially reduce the risk of long-term symptoms and complications. Because concussion symptoms often interfere with school, social life, family relationships, and athletics, a concussion may affect the emotional well-being of the injured athlete. Because every concussion has its own unique spectrum and severity of symptoms, individualized management is appropriate. The reduction, not necessarily elimination, of physical and cognitive activity is the mainstay of treatment. A full return to activity and/or sport is accomplished by using a stepwise program while evaluating for a return of symptoms. An understanding of prolonged symptoms and complications will help the pediatric health care provider know when to refer to a specialist. Additional research is needed in nearly all aspects of concussion in the young athlete. This report provides education on the current state of sport-related concussion knowledge, diagnosis, and management in children and adolescents.	[Halstead, Mark E.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Walter, Kevin D.] Med Coll Wisconsin, Dept Orthopaed Surg, Pediat Sports Med, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Moffatt, Kody] Creighton Univ, Sch Med, Omaha, NE USA		Halstead, ME (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	mehalstead@wustl.edu					Agel J, 2010, CAN J SURG, V53, P319; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Alsalaheen B, 2016, BRAIN INJURY, V30, P914, DOI 10.3109/02699052.2016.1146965; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2014, PEDIATRICS, V134, P1224, DOI 10.1542/peds.2014-2984; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bey T, 2009, WEST J EMERG MED, V10, P6; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; BOND GR, 1995, PEDIATRICS, V95, P487; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Brandenburg MA, 2002, CLIN J SPORT MED, V12, P360, DOI 10.1097/00042752-200211000-00007; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Caswell S, 2017, BRIT J SPORT MED, V51, P305; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Comstock D, 2012, EPIDEMIOLOGY PREVENT; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Council on Sports Medicine and Fitness, 2015, PEDIATRICS, V136; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Currie DW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2447; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Denny-Brown D E, 1941, Proc R Soc Med, V34, P691; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Downey Daniel J, 2007, Curr Sports Med Rep, V6, P328; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Fukuda O, 2007, NEUROL MED-CHIR, V47, P491, DOI 10.2176/nmc.47.491; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giola G, 2006, ACUTE CONCUSSION EVA; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Green L., 2014, LEGAL PERSPECTIVES R; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Huang WY, 2014, BRIT J CANCER, V110, P2354, DOI 10.1038/bjc.2014.103; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Lee Bruce, 2005, NeuroRx, V2, P372; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer C., 1930, ORAL HYG, V20, P298; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McGuine T, 1996, 1305 ASTM STP, P83; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Petraglia Anthony L, 2011, Surg Neurol Int, V2, P146, DOI 10.4103/2152-7806.85987; Pfaller AY, 2016, AM J SPORT MED, V44, P2941, DOI 10.1177/0363546516651821; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reisner A, 2017, J PEDIATR-US, V184, P26, DOI 10.1016/j.jpeds.2017.01.045; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowhani-Rahbar A, 2016, J NEUROTRAUM, V33, P784, DOI 10.1089/neu.2015.4100; Sabatino M, 2016, AM AC PED NAT C EXH; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Simon LM, 2016, CURR SPORT MED REP, V15, P161, DOI 10.1249/JSR.0000000000000268; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Stocker RPJ, 2017, ARCH CLIN NEUROPSYCH, V32, P349, DOI 10.1093/arclin/acx003; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taubman B, 2016, J CHILD NEUROL, V31, P1607, DOI 10.1177/0883073816667194; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Trojian TH, 2011, CURR SPORT MED REP, V10, P180, DOI 10.1249/JSR.0b013e31822458d5; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; WATTS G, 1954, J AM DENT ASSOC, V49, P7, DOI 10.14219/jada.archive.1954.0132; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Winters Jackson, 2014, General Dentistry, V62, P34; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; WITHNALL C, 2005, BR J SPORTS MED S1, V39, P48; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	268	53	52	2	28	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2018	142	6							e20183074	10.1542/peds.2018-3074			24	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HB8WO	WOS:000451372200058	30420472	Bronze			2022-02-06	
J	Struck, AF; Ustun, B; Ruiz, AR; Lee, JW; LaRoche, SM; Hirsch, LJ; Gilmore, EJ; Vlachy, J; Haider, HA; Rudin, C; Westover, MB				Struck, Aaron F.; Ustun, Berk; Ruiz, Andres Rodriguez; Lee, Jong Woo; LaRoche, Suzette M.; Hirsch, Lawrence J.; Gilmore, Emily J.; Vlachy, Jan; Haider, Hiba Arif; Rudin, Cynthia; Westover, M. Brandon			Association of an Electroencephalography-Based Risk Score With Seizure Probability in Hospitalized Patients	JAMA NEUROLOGY			English	Article							NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; EEG	IMPORTANCE Continuous electroencephalography (EEG) use in critically ill patients is expanding. There is no validated method to combine risk factors and guide clinicians in assessing seizure risk.& para;& para;OBJECTIVE To use seizure risk factors from EEG and clinical history to create a simple scoring system associated with the probability o f seizures in patients with acute illness.& para;& para;DESIGN, SETTING, AND PARTICIPANTS We used a prospective multicenter (Emory University Hospital, Brigham and Women's Hospital, and Yale University Hospital) database containing clinical and electrographic variables on 5427 continuous EEG sessions from eligible patients if they had continuous EEG for clinical indications, excluding epilepsy monitoring unit admissions. We created a scoring system model to estimate seizure risk in acutely ill patients undergoing continuous EEG, The model was built using a new machine learning method (Risks LI M) that is designed to produce accurate, risk-calibrated scoring systems with a limited number of variables and small integer weights. We validated the accuracy and risk calibration of our model using cross-validation and compared its performance with models built with state-of-the-art logistic regression methods. The database was developed by the Critical Care EEG Research Consortium and used data collected over 3 years. The EEG variables were interpreted using standardized terminology by certified reviewers.& para;& para;EXPOSURES All patients had more than 6 hours o f uninterrupted EEG recordings.& para;& para;MAIN OUTCOMES AND MEASURES The main outcome was the average risk calibration error.& para;& para;RESULTS There were 5427 continuous EEGs performed on 4772 participants (2868 men, 49.9%; median age, 61 years) performed at 3 institutions, without further demographic stratification. Our final model, 2HELPS2B, had an area under the curve o f 0.819 and average calibration error of 2.7% (95% Cl, 2.0%-3.6%). It included 6 variables with the following point assignments; (1) brief (ictal) rhythmic discharges (B[l]RDs) (2 points); (2) presence of lateralized periodic discharges, lateralized rhythmic delta activity, or bilateral independent periodic discharges (1 point); (3) prior seizure (1 point); (4) sporadic epileptiform discharges (1 point); (5) frequency greater than 2.0 Hz for any periodic or rhythmic pattern (1 point); and (6) presence o f "plus" features (superimposed, rhythmic, sharp, or fast activity) (1 point). The probable seizure risk of each score was 5% for a score of 0,12% for a score of 1,27% for a score of 2,50% for a score of 3,73% for a score of 4,88% for a score of 5, and greater than 95% for a score of 6 or 7.& para;& para;CONCLUSIONS AND RELEVANCE The 2HELPS2B model is a quick accurate tool to aid clinical judgment of the risk of seizures in critically ill patients.	[Struck, Aaron F.] Univ Wisconsin, Dept Neurol, 7131 MFCB,1685 Highland Ave, Madison, WI 53705 USA; [Ustun, Berk] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Ruiz, Andres Rodriguez; LaRoche, Suzette M.; Haider, Hiba Arif] Emory Univ, Sch Med, Atlanta, GA USA; [Lee, Jong Woo] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [LaRoche, Suzette M.] Mission Hlth, Asheville, NC USA; [Hirsch, Lawrence J.; Gilmore, Emily J.] Yale Univ, Sch Med, New Haven, CT USA; [Vlachy, Jan] Georgia Inst Technol, Atlanta, GA 30332 USA; [Rudin, Cynthia] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA; [Rudin, Cynthia] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Westover, M. Brandon] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA		Struck, AF (corresponding author), Univ Wisconsin, Dept Neurol, 7131 MFCB,1685 Highland Ave, Madison, WI 53705 USA.	afstruck@wisc.edu	Lee, Jongwoo/AAI-3617-2020; Struck, Aaron/AAP-7908-2021	Lee, Jongwoo/0000-0001-5283-7476; Struck, Aaron/0000-0002-9103-1798; Rodriguez Ruiz, Andres/0000-0002-1425-9035; Ustun, Berk/0000-0001-5188-3155; Hirsch, Lawrence/0000-0002-6333-832X; Haider, Hiba/0000-0001-7118-3690	Epilepsy Foundation; American Epilepsy Society; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS090900] Funding Source: NIH RePORTER	This study was supported by a Research Infrastructure Award from the American Epilepsy Society and the Epilepsy Foundation.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Bianca Z, 2002, P 8 ACMSIGKDD INT C, P649; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gaspard N, 2014, EPILEPSIA, V55, P1366, DOI 10.1111/epi.12653; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P332, DOI 10.1097/00004691-199907000-00005; Lee JW, 2016, J CLIN NEUROPHYSIOL, V33, P133, DOI 10.1097/WNP.0000000000000230; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Ruiz AR, 2017, JAMA NEUROL, V74, P181, DOI 10.1001/jamaneurol.2016.4990; Shafi MM, 2012, NEUROLOGY, V79, P1796, DOI 10.1212/WNL.0b013e3182703fbc; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Ustun B, 2015, METHODS MODELS INTER; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Young GB, 1996, NEUROLOGY, V47, P83	22	53	56	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	DEC	2017	74	12					1419	1424		10.1001/jamaneurol.2017.2459			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FP4YK	WOS:000417622700007	29052706	Green Accepted, Green Published, Bronze			2022-02-06	
J	Ma, EL; Smith, AD; Desai, N; Cheung, LM; Hanscom, M; Stoica, BA; Loane, DJ; Shea-Donohue, T; Faden, AI				Ma, Elise L.; Smith, Allen D.; Desai, Neemesh; Cheung, Lumei; Hanscom, Marie; Stoica, Bogdan A.; Loane, David J.; Shea-Donohue, Terez; Faden, Alan I.			Bidirectional brain-gut interactions and chronic pathological changes after traumatic brain injury in mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Mucosal barrier function; Enteric glial cells; Brain-gut axis; Neuroinflammation; Neurodegeneration; Citrobacter rodentium	SPINAL-CORD-INJURY; INCREASED INTESTINAL PERMEABILITY; MUSCARINIC RECEPTORS CONTRIBUTE; CITROBACTER-RODENTIUM INFECTION; ENTERIC NERVOUS-SYSTEM; BARRIER FUNCTION; GLIAL-CELLS; CHRONIC NEUROINFLAMMATION; MICROGLIAL ACTIVATION; EPITHELIAL BARRIER	Objectives: Traumatic brain injury (TBI) has complex effects on the gastrointestinal tract that are associated with TBI-related morbidity and mortality. We examined changes in mucosal barrier properties and enteric glial cell response in the gut after experimental TBI in mice, as well as effects of the enteric pathogen Citrobacter rodentium (Cr) on both gut and brain after injury. Methods: Moderate-level TBI was induced in C57BL/6 mice by controlled cortical impact (CCI). Mucosal barrier function was assessed by transepithelial resistance, fluorescent-labelled dextran flux, and quantification of tight junction proteins. Enteric glial cell number and activation were measured by Sox10 expression and GFAP reactivity, respectively. Separate groups of mice were challenged with Cr infection during the chronic phase of TBI, and host immune response, barrier integrity, enteric glial cell reactivity, and progression of brain injury and inflammation were assessed. Results: Chronic CCI induced changes in colon morphology, including increased mucosal depth and smooth muscle thickening. At day 28 post-CCI, increased paracellular permeability and decreased claudin-1 mRNA and protein expression were observed in the absence of inflammation in the colon. Colonic glial cell GFAP and Sox10 expression were significantly increased 28 days after brain injury. Clearance of Cr and upregulation of Th1/Th17 cytokines in the colon were unaffected by CCI; however, colonic paracellular flux and enteric glial cell GFAP expression were significantly increased. Importantly, Cr infection in chronically-injured mice worsened the brain lesion injury and increased astrocyte- and microglial-mediated inflammation. Conclusion: These experimental studies demonstrate chronic and bidirectional brain-gut interactions after TBI, which may negatively impact late outcomes after brain injury. (C) 2017 Elsevier Inc. All rights reserved.	[Ma, Elise L.; Hanscom, Marie; Stoica, Bogdan A.; Loane, David J.; Faden, Alan I.] Univ Maryland, Dept Anesthesiol, Sch Med, 20 Penn St,S247, Baltimore, MD 21201 USA; [Ma, Elise L.; Hanscom, Marie; Stoica, Bogdan A.; Loane, David J.; Faden, Alan I.] Univ Maryland, Shock Trauma & Anesthesiol Res STAR Ctr, Sch Med, 20 Penn St,S247, Baltimore, MD 21201 USA; [Smith, Allen D.; Cheung, Lumei] ARS, Beltsville Human Nutr Res Ctr, Diet Gen & Immunol Lab, USDA, Beltsville, MD USA; [Desai, Neemesh; Shea-Donohue, Terez] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Desai, Neemesh; Shea-Donohue, Terez] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA		Faden, AI (corresponding author), Univ Maryland, Dept Anesthesiol, Sch Med, 20 Penn St,S247, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Shock Trauma & Anesthesiol Res STAR Ctr, Sch Med, 20 Penn St,S247, Baltimore, MD 21201 USA.; Shea-Donohue, T (corresponding author), Univ Maryland, Sch Med, Dept Radiat Oncol & Med, 10 S Pine St,7-00C, Baltimore, MD 21201 USA.	tdonohue@medicine.umaryland.edu; afaden@anes.umm.edu	Loane, David/ABD-5177-2021; STOICA, BOGDAN/H-9782-2013	Loane, David/0000-0003-0393-3503; STOICA, BOGDAN/0000-0002-2501-6434; Faden, Alan I./0000-0003-0128-2348; Hanscom, Marie/0000-0001-8308-135X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [4R01NS052568, 5R01NS037313-16, 5R01DK083418-05, R01NS082308, T32DK067872]; USDA CRIS project [8040-51000-058]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK067872, R01DK083418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082308, R01NS037313, R01NS052568] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [4R01NS052568 (A.I.F.); 5R01NS037313-16 (A.I.F.); 5R01DK083418-05 (T.S-D.); R01NS082308 (DJ.L.); T32DK067872(E.L.M.)]; and the USDA CRIS project [8040-51000-058 (A.S.)].	Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Machado MCC, 2016, CURR PHARM DESIGN, V22, P4645, DOI 10.2174/1381612822666160510125331; Clairembault T, 2014, J NEUROCHEM, V130, P805, DOI 10.1111/jnc.12742; Da Franceschi R. Cunha, 2017, NEUROSCI RES, V2; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Gulbransen B. D., 2014, C SER NEUROGLIA BIOL, V1, P1; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Houlden A., 2016, BRAIN BEHAV IMMUN; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Katzenberger R., 2015, LIFE, V4; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lopetuso LR, 2015, EUR REV MED PHARMACO, V19, P1068; Mackos AR, 2013, INFECT IMMUN, V81, P3253, DOI 10.1128/IAI.00278-13; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McClain JL, 2014, GASTROENTEROLOGY, V146, P497, DOI 10.1053/j.gastro.2013.10.061; McLean LP, 2016, AM J PHYSIOL-GASTR L, V311, pG130, DOI 10.1152/ajpgi.00461.2014; McLean LP, 2015, INFLAMM BOWEL DIS, V21, P1860, DOI 10.1097/MIB.0000000000000408; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Neunlist M, 2007, AM J PHYSIOL-GASTR L, V292, pG231, DOI 10.1152/ajpgi.00276.2005; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Savidge TC, 2007, LAB INVEST, V87, P731, DOI 10.1038/labinvest.3700600; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Smith AD, 2011, BIOL TRACE ELEM RES, V144, P965, DOI 10.1007/s12011-011-9071-4; Smith AD, 2011, INFECT IMMUN, V79, P1471, DOI 10.1128/IAI.01017-10; Snoek S., 2014, EXPERT REV GASTROENT, V4, P637; Sundman M., 2017, BRAIN BEHAV IMMUNITY, V2; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uesaka T, 2015, J NEUROSCI, V35, P9879, DOI 10.1523/JNEUROSCI.1239-15.2015; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Winek K, 2016, J CEREBR BLOOD F MET, V36, P891, DOI 10.1177/0271678X16636890; Yu YB, 2014, WORLD J GASTROENTERO, V20, P11273, DOI 10.3748/wjg.v20.i32.11273; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144	74	53	63	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	NOV	2017	66						56	69		10.1016/j.bbi.2017.06.018			14	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	FL4YE	WOS:000414236600007	28676351	Green Accepted			2022-02-06	
J	Andrabi, SS; Parvez, S; Tabassum, H				Andrabi, Syed Suhail; Parvez, Suhel; Tabassum, Heena			Progesterone induces neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in rats	DISEASE MODELS & MECHANISMS			English	Article						Progesterone; Cerebral ischemia; Neurobehavior; Mitochondria; Apoptosis; Neuroprotection	INDUCED OXIDATIVE STRESS; TRAUMATIC BRAIN-INJURY; ACETYLCHOLINESTERASE ACTIVITY; PERMEABILITY TRANSITION; ANIMAL-MODELS; CELL-DEATH; COMPLEX I; STROKE; ISCHEMIA/REPERFUSION; OUTCOMES	Organelle damage and increases in mitochondrial permeabilization are key events in the development of cerebral ischemic tissue injury because they cause both modifications in ATP turnover and cellular apoptosis/necrosis. Early restoration of blood flow and improvement of mitochondrial function might reverse the situation and help in recovery following an onset of stroke. Mitochondria and related bioenergetic processes can be effectively used as pharmacological targets. Progesterone (P4), one of the promising neurosteroids, has been found to be neuroprotective in various models of neurological diseases, through a number of mechanisms. This influenced us to investigate the possible role of P4 in the mitochondria-mediated neuroprotective mechanism in an ischemic stroke model of rat. In this study, we have shown the positive effect of P4 administration on behavioral deficits and mitochondrial health in an ischemic stroke injury model of transient middle cerebral artery occlusion (tMCAO). After induction of tMCAO, the rats received an initial intraperitoneal injection of P4 (8 mg/kg body weight) or vehicle at 1 h post-occlusion followed by subcutaneous injections at 6, 12 and 18 h. Behavioral assessment for functional deficits included grip strength, motor coordination and gait analysis. Findings revealed a significant improvement with P4 treatment in tMCAO animals. Staining of isolated brain slices from P4-treated rats with 2,3,5-triphenyltetrazolium chloride (TTC) showed a reduction in the infarct area in comparison to the vehicle group, indicating the presence of an increased number of viable mitochondria. P4 treatment was also able to attenuate mitochondrial reactive oxygen species (ROS) production, as well as block the mitochondrial permeability transition pore (mPTP), in the tMCAO injury model. In addition, it was also able to ameliorate the altered mitochondrial membrane potential and respiration ratio in the ischemic animals, thereby suggesting that P4 has a positive effect on mitochondrial bioenergetics. In conclusion, these results demonstrate that P4 treatment is beneficial in preserving the mitochondrial functions that are altered in cerebral ischemic injury and thus can help in defining better therapies.	[Andrabi, Syed Suhail; Parvez, Suhel] Jamia Hamdard, Dept Med Elementol & Toxicol, New Delhi 110062, India; [Tabassum, Heena] Jamia Hamdard, Dept Biochem, New Delhi 110062, India		Tabassum, H (corresponding author), Jamia Hamdard, Dept Biochem, New Delhi 110062, India.	heenatabassum@jamiahamdard.ac.in		Tabassum, Heena/0000-0001-8699-5309	Department of Biotechnology, Ministry of Science and Technology, Government of IndiaDepartment of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India [BT/Bio-CARe/01/10219/2013-14]; Science and Engineering Research Board (SERB-EMR) [2016/001070/HS]; Senior Research Fellowship from University Grants Commission-Basic Science Research (UGC-BSR) [F.25-1/2013-14(BSR)/7-91/2007(BSR)]	This work was funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India, for the financial grant (DBT BioCARe Program, sanction no. BT/Bio-CARe/01/10219/2013-14 to H.T.); Science and Engineering Research Board (SERB-EMR grant no. 2016/001070/HS to S.P.). S.S.A. is a recipient of a Senior Research Fellowship from University Grants Commission-Basic Science Research (UGC-BSR) [grant no. F.25-1/2013-14(BSR)/7-91/2007(BSR)].	Affonso AC, 2013, METAB BRAIN DIS, V28, P493, DOI 10.1007/s11011-013-9396-0; Aggarwal R, 2008, J PHARM PHARMACOL, V60, P731, DOI 10.1211/jpp.60.6.0008; Andrabi SS, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/384750; Ashafaq M., 2016, MOL NEUROBIOL; Ashafaq M, 2012, NEUROCHEM RES, V37, P1747, DOI 10.1007/s11064-012-0786-1; Ashafaq M, 2012, NUTR RES, V32, P133, DOI 10.1016/j.nutres.2011.12.014; Avasarala J, 2015, STROKE, V46, pE234, DOI 10.1161/STROKEAHA.115.010716; Bennett DA, 2014, GLOB HEART, V9, P107, DOI 10.1016/j.gheart.2014.01.001; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Chaudhary S, 2012, NEUROSCIENCE, V225, P258, DOI 10.1016/j.neuroscience.2012.08.060; Chen Y, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00022; de Lores Arnaiz Georgina Rodriguez, 2014, Int J Biomed Sci, V10, P85; De Nicola AF, 2013, CNS NEUROL DISORD-DR, V12, P1205; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Drose S, 2016, BBA-BIOENERGETICS, V1857, P946, DOI 10.1016/j.bbabio.2015.12.013; Fayaz SM, 2015, CNS NEUROL DISORD-DR, V14, P654, DOI 10.2174/1871527314666150429113239; Gaignard P, 2016, J CEREBR BLOOD F MET, V36, P562, DOI 10.1177/0271678X15610338; Javadov S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00076; Jin Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030351; Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Kim G, 2013, J PHYS THER SCI, V25, P1227, DOI 10.1589/jpts.25.1227; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033860; Liang JM, 2013, J INT MED RES, V41, P618, DOI 10.1177/0300060513476587; Liu Y, 2009, CELL ADHES MIGR, V3, P94, DOI 10.4161/cam.3.1.7516; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; McCann SK, 2014, STROKE, V45, P3055, DOI 10.1161/STROKEAHA.114.006304; Morton RA, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0079-15.2015; Nicholls DG, 2015, J BIOENERG BIOMEMBR, V47, P63, DOI 10.1007/s10863-014-9573-9; Novgorodov SA, 2016, J BIOL CHEM, V291, P1957, DOI 10.1074/jbc.M115.668228; Peplow PV, 2015, NEURAL REGEN RES, V10, P1186, DOI 10.4103/1673-5374.162687; Rasheed MZ, 2017, PROTOPLASMA, V254, P33, DOI 10.1007/s00709-015-0930-2; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Tabassum H, 2007, HUM EXP TOXICOL, V26, P509, DOI 10.1177/0960327107072392; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vaibhav K, 2013, PHARMACOL BIOCHEM BE, V113, P53, DOI 10.1016/j.pbb.2013.10.008; Vishnoi S, 2015, NEUROSCIENCE, V311, P22, DOI 10.1016/j.neuroscience.2015.10.008; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Waseem M, 2016, MITOCHONDRION, V31, P1, DOI 10.1016/j.mito.2016.08.005; Waseem M, 2016, PROTOPLASMA, V253, P417, DOI 10.1007/s00709-015-0821-6; Wasik A, 2014, NEUROTOX RES, V25, P323, DOI 10.1007/s12640-013-9425-0; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Weinreb O, 2016, BRIT J PHARMACOL, V173, P2080, DOI 10.1111/bph.13318; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198	55	53	54	0	13	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	JUN 1	2017	10	6					787	796		10.1242/dmm.025692			10	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	EX4FT	WOS:000403189500010	28363987	Green Published, gold			2022-02-06	
J	McMillan, TM; McSkimming, P; Wainman-Lefley, J; Maclean, LM; Hay, J; McConnachie, A; Stewart, W				McMillan, T. M.; McSkimming, P.; Wainman-Lefley, J.; Maclean, L. M.; Hay, J.; McConnachie, A.; Stewart, W.			Long-term health outcomes after exposure to repeated concussion in elite level: rugby union players	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL PLAYERS; SELF-REPORTED CONCUSSIONS; MILD COGNITIVE IMPAIRMENT; HEAD-INJURY; RECURRENT CONCUSSION; LEAGUE PLAYERS; BRAIN-INJURY; DIAGNOSIS; SYMPTOMS	Background There is continuing concern about effects of concussion in athletes, including risk of the neurodegenerative disease chronic traumatic encephalopathy. However, information on long-term health and wellbeing in former athletes is limited. Method Outcome after exposure to repeated brain injury was investigated in 52 retired male Scottish international rugby players (RIRP) and 29 male controls who were similar in age and social deprivation. Assessment included history of playing rugby and traumatic brain injury, general and mental health, life stress, concussion symptoms, cognitive function, disability and markers of chronic stress (allostatic load). Results The estimated number of concussions in RIRP averaged 14 (median=7; IQR 5-40). Performance was poorer in RIRP than controls on a test of verbal learning (p=0.022) and of fine co-ordination of the dominant hand (p=0.038) and not significantly different on other cognitive tests (p>0.05). There were no significant associations between number of concussions and performance on cognitive tests. Other than a higher incidence of cardiovascular disease in controls, no group differences were detected in general or mental health or estimates of allostatic load. In RIRP, persisting symptoms attributed to concussion were more common if reporting more than nine concussions (p=0.028), although these symptoms were not perceived to affect social or work functioning. Conclusions Despite a high number of concussions in RIRP, differences in mental health, social or work functioning were not found late after injury. Subtle group differences were detected on two cognitive tests, the cause of which is uncertain. Prospective group comparison studies on representative cohorts are required.	[McMillan, T. M.; Wainman-Lefley, J.; Maclean, L. M.] Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, Glasgow G120XH, Lanark, Scotland; [McSkimming, P.; McConnachie, A.] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Hay, J.; Stewart, W.] Queen Elizabeth Univ Hosp, Dept Neuropathol, Lab Med Bldg, Glasgow, Lanark, Scotland; [Stewart, W.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, Glasgow G120XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk		Stewart, William/0000-0003-2199-2582; McSkimming, Paula/0000-0002-7330-5425	Sackler Foundation; Chief Scientist Office [DTF/12/13]; NHS Research Scotland Career Researcher Fellowship	LMM and JH were partly funded by the Sackler Foundation. JW-L was funded by the Chief Scientist Office (DTF/12/13). WS was supported by an NHS Research Scotland Career Researcher Fellowship.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Carroll JD, 2004, J REHABIL MED S 43, P28; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; England Professional Rugby Injury Surveillance Project Steering Group. England Professional Rugby Injury Surveillance Project, 2016, ENGL PROF RUDB INJ S; Grant M., 1992, AUDIT ALCOHOL USE DI; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lees R, 2014, STROKE, V45, P3008, DOI 10.1161/STROKEAHA.114.005842; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Matthews CG, 1964, INSTRUCTION BATTERY; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Scottish Executive, 2012, SCOTT IND MULT DEPR; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Snaith RP, 1984, HOSP ANXIETY DEPRESS; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	44	53	53	2	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2017	88	6					505	511		10.1136/jnnp-2016-314279			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	EX0JI	WOS:000402906000009	27951526	Bronze, Green Submitted, Green Accepted			2022-02-06	
J	Hammond, NE; Taylor, C; Finfer, S; Machado, FR; An, YZ; Billot, L; Bloos, F; Bozza, F; Cavalcanti, AB; Correa, M; Du, B; Hjortrup, PB; Li, Y; McIntryre, L; Saxena, M; Schortgen, F; Watts, NR; Myburgh, J				Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Machado, Flavia R.; An, YouZhong; Billot, Laurent; Bloos, Frank; Bozza, Fernando; Cavalcanti, Alexandre Biasi; Correa, Maryam; Du, Bin; Hjortrup, Peter B.; Li, Yang; McIntryre, Lauralyn; Saxena, Manoj; Schortgen, Frederique; Watts, Nicola R.; Myburgh, John		Fluid-TRIPS Fluidos Investigators; George Inst Global Hlth; ANZICS Clinical Trials Grp; BRICNet; REVA Res Network	Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; HYDROXYETHYL STARCH 130/0.4; CRITICALLY-ILL ADULTS; KIDNEY INJURY; ASSOCIATION; SEPSIS; SALINE; CHOICE; SCORE; SHOCK	Background In 2007, the Saline versus Albumin Fluid Evaluation D Translation of Research Into Practice Study (SAFE-TRIPS) reported that 0.9% sodium chloride (saline) and hydroxyethyl starch (HES) were the most commonly used resuscitation fluids in intensive care unit (ICU) patients. Evidence has emerged since 2007 that these fluids are associated with adverse patient-centred outcomes. Based on the published evidence since 2007, we sought to determine the current type of fluid resuscitation used in clinical practice and the predictors of fluid choice and determine whether these have changed between 2007 and 2014. Methods In 2014, an international, cross-sectional study was conducted (Fluid-TRIPS) to document current patterns of intravenous resuscitation fluid use and determine factors associated with fluid choice. We examined univariate and multivariate associations between patients and prescriber characteristics, geographical region and fluid type. Additionally, we report secular trends of resuscitation fluid use in a cohort of ICUs that participated in both the 2007 and 2014 studies. Regression analysis were conducted to determine changes in the administration of crystalloid or colloid between 2007 and 2014. Findings In 2014, a total of 426 ICUs in 27 countries participated. Over the 24 hour study day, 1456/ 6707 (21.7%) patients received resuscitation fluid during 2716 resuscitation episodes. Crystalloids were administered to 1227/1456 (84.3%) patients during 2208/2716 (81.3%) episodes and colloids to 394/1456 (27.1%) patients during 581/2716 (21.4%) episodes. In multivariate analyses, practice significantly varied between geographical regions. Additionally, patients with a traumatic brain injury were less likely to receive colloid when compared to patients with no trauma (adjusted OR 0.24; 95% CI 0.1 to 0.62; p = 0.003). Patients in the ICU for one or more days where more likely to receive colloid compared to patients in the ICU on their admission date (adjusted OR 1.75; 95% CI 1.27 to 2.41; p = < 0.001). For secular trends in fluid resuscitation, 84 ICUs in 17 countries contributed data. In 2007, 527/1663 (31.7%) patients received fluid resuscitation during 1167 episodes compared to 491/1763 (27.9%) patients during 960 episodes in 2014. The use of crystalloids increased from 498/1167 (42.7%) in 2007 to 694/960 (72.3%) in 2014 (odds ratio (OR) 3.75, 95% confidence interval (CI) 2.95 to 4.77; p = < 0.001), primarily due to a significant increase in the use of buffered salt solutions. The use of colloids decreased from 724/1167 (62.0%) in 2007 to 297/960 (30.9%) in 2014 (OR 0.29, 95% CI 0.19 to 0.43; p = < 0.001), primarily due to a decrease in the use of HES, but an overall increase in the use of albumin. Conclusions Clinical practices of intravenous fluid resuscitation have changed between 2007 and 2014. Geographical location remains a strong predictor of the type of fluid administered for fluid resuscitation. Overall, there is a preferential use of crystalloids, specifically buffered salt solutions, over colloids. There is now an imperative to conduct a trial determining the safety and efficacy of these fluids on patient-centred outcomes.	[Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Correa, Maryam; Li, Yang; Saxena, Manoj; Watts, Nicola R.; Myburgh, John] George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia; [Hammond, Naomi E.; Finfer, Simon] Royal North Shore Hosp, Malcolm Fisher Dept Intens Care Med, Sydney, NSW, Australia; [Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Billot, Laurent] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Hammond, Naomi E.; Saxena, Manoj; Myburgh, John] Univ New South Wales, Fac Med, St George Clin Sch, Sydney, NSW, Australia; [Machado, Flavia R.] Univ Fed Sao Paulo, Pain & Intens Care Dept, Anesthesiol, Sao Paulo, Brazil; Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing, Peoples R China; George Inst Global Hlth, Stat Div, Sydney, NSW, Australia; Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; DOr Inst Res & Educ, Rio De Janeiro, Brazil; Hosp Coracao, Res Inst, Sao Paulo, Brazil; Peking Union Med Coll Hosp, Med Intens Care Unit, Beijing, Peoples R China; Copenhagen Univ Hosp, Rigshosp, Dept Intens Care, Copenhagen, Denmark; Ottawa Hosp, Res Inst, Dept Med Crit Care, Ottawa, ON, Canada; St George Hosp, Dept Intens Care Med, Sydney, NSW, Australia; Reanimat Med Grp Hosp Henri Mondor, Assistance Publ Hop Paris, Creteil, France		Hammond, NE (corresponding author), George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Royal North Shore Hosp, Malcolm Fisher Dept Intens Care Med, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Univ New South Wales, Fac Med, St George Clin Sch, Sydney, NSW, Australia.	nhammond@georgeinstitute.org.au	Christian, Mike/AAO-6338-2020; Bozza, Fernando A/A-2618-2013; Bloos, Frank/AAY-8265-2020; Billot, Laurent/Y-1241-2019; Colombo, Riccardo/AAK-9081-2020; Biondi, Rodrigo S/H-5212-2016; Christian, Michael/AAZ-4452-2020; Du, Bin/K-4283-2013; Cavalcanti, Alexandre/K-5529-2013	Christian, Mike/0000-0001-9644-9950; Bozza, Fernando A/0000-0003-4878-0256; Bloos, Frank/0000-0002-0767-7941; Billot, Laurent/0000-0002-4975-9793; Colombo, Riccardo/0000-0002-9616-803X; Biondi, Rodrigo S/0000-0002-9242-6062; Christian, Michael/0000-0001-9644-9950; Deeb, Ahmad/0000-0002-3680-7338; Finfer, Simon/0000-0002-2785-5864; Schortgen, Frederique/0000-0003-1756-7508; Du, Bin/0000-0001-6237-2895; Micallef, Sharon/0000-0002-8496-2324; Cavalcanti, Alexandre/0000-0003-2798-6263; Banner-Goodspeed, Valerie/0000-0002-7644-2521; Hammond, Naomi/0000-0002-6559-7747; Saxena, Manoj/0000-0002-0385-6731	Baxter Healthcare; CSL Behring; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1039312]	This study was partially supported by unrestricted fluid grants from Baxter Healthcare and CSL Behring paid to The George Institute for Global Health. NH received a National Health and Medical Research Council of Australia Postgraduate Scholarship (2012-2014) that has supported part of this work [APP1039312]. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the manuscript; or decision to submit the manuscript for publication.	Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Cecconi M, 2015, INTENS CARE MED, V41, P1529, DOI 10.1007/s00134-015-3850-x; EMA, 2013, PRAC REC SUSP MARK A; FDA, 2013, HYDR STARCH SOL FDA; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Hammond NE, 2015, INTENS CARE MED, V41, P1611, DOI 10.1007/s00134-015-3878-y; Hammond Naomi, 2015, Rev. bras. ter. intensiva, V27, P309, DOI 10.5935/0103-507X.20150053; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MHRA, 2013, HYDR STARCH HES PROD; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; R Core Team, 2018, R LANGUAGE ENV STAT; Raghunathan K, 2015, ANESTHESIOLOGY, V123, P1385, DOI 10.1097/ALN.0000000000000861; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; Shaw AD, 2014, INTENS CARE MED, V40, P1897, DOI 10.1007/s00134-014-3505-3; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; TGA, 2014, HYDR STRACH VOL VOL; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	30	53	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176292	10.1371/journal.pone.0176292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	WOS:000401314500003	28498856	gold, Green Published, Green Submitted			2022-02-06	
J	Barlow, KM; Marcil, LD; Dewey, D; Carlson, HL; MacMaster, FP; Brooks, BL; Lebel, RM				Barlow, Karen M.; Marcil, Lorenzo D.; Dewey, Deborah; Carlson, Helen L.; MacMaster, Frank P.; Brooks, Brian L.; Lebel, R. Marc			Cerebral Perfusion Changes in Post-Concussion Syndrome: A Prospective Controlled Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						arterial spin labeling; cerebral blood flow; pediatric brain injury; recovery; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; SPORTS-RELATED CONCUSSION; BLOOD-FLOW; POSTCONCUSSION SYNDROME; VASCULAR INJURY; STRESS TEST; MILD TBI; CHILDREN; SYMPTOMS	The biology of post-concussive symptoms is unclear. Symptoms are often increased during activities, and have been linked to decreased cerebrovascular reactivity and perfusion. The aim of this study was to examine cerebral blood flow (CBF) in children with different clinical recovery patterns following mild traumatic brain injury (mTBI). This was a prospective controlled cohort study of children with mTBI (ages 8 to 18 years) who were symptomatic with post-concussive symptoms at one month post-injury (symptomatic, n=27) and children who had recovered quickly (asymptomatic, n=24). Pseudo continuous arterial spin labeling magnetic resonance imaging (MRI) was used to quantify CBF. The mTBI groups were imaged at 40 days post-injury. Global and regional CBF were compared with healthy controls of similar age and sex but without a history of mTBI (n=21). Seventy-two participants (mean age: 14.1 years) underwent neuroimaging. Significant differences in CBF were found: global CBF was higher in the symptomatic group and lower in the asymptomatic group compared with controls, (F(2,69) 9.734; p<0.001). Post-injury symptom score could be predicted by pre-injury symptoms and CBF in presence of mTBI (adjusted R-2=0.424; p<0.001). Altered patterns of cerebral perfusion are seen following mTBI and are associated with the recovery trajectory. Symptomatic children have higher CBF. Children who recovered quickly, have decreased CBF suggesting that clinical recovery precedes the cerebral recovery. Further longitudinal studies are required to determine if these perfusion patterns continue to change over time.	[Barlow, Karen M.; Dewey, Deborah; MacMaster, Frank P.; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Barlow, Karen M.; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Marcil, Lorenzo D.] Univ Calgary, Hlth Sci, Calgary, AB, Canada; [Dewey, Deborah] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [MacMaster, Frank P.] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Lebel, R. Marc] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Lebel, R. Marc] Univ Calgary, Biomed Engn, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Barlow, Karen M.; Dewey, Deborah; Carlson, Helen L.; MacMaster, Frank P.; Brooks, Brian L.; Lebel, R. Marc] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Carlson, Helen L.; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [MacMaster, Frank P.] Alberta Hlth Serv, Strateg Clin Network Addict & Mental Hlth, Edmonton, AB, Canada; [MacMaster, Frank P.] Hotchkiss Brain Inst, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada; [Lebel, R. Marc] GE Healthcare, Calgary, AB, Canada		Barlow, KM (corresponding author), Univ Calgary, Alberta Childrens Hosp, Neurol Sect, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	Karen.Barlow@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Carlson, Helen/0000-0002-5788-0542; MacMaster, Frank/0000-0002-7159-7583; Dewey, Deborah/0000-0002-1323-5832	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Faculty of Medicine, University of Calgary; Markin Undergraduate Student Research Program, University of Calgary	Drs. Barlow, Dewey, MacMaster, and Mr. Marcil have no competing financial interests. Dr. Brooks receives royalties for the sales of a pediatric forensic textbook (Oxford University Press) and pediatric neuropsychological tests (PAR Inc.). He has previously received support (in-kind test credits) from CNS Vital Signs. Dr. Lebel is a stakeholder in GE Healthcare. This study was funded by the Canadian Institutes of Health Research (grant number: 293375); the Faculty of Medicine, University of Calgary; and the Markin Undergraduate Student Research Program, University of Calgary. These funding sources had no role in the design of this study and did not have any role during its execution, analyses, interpretation of the data, or decision to submit results. The design, management, analysis, and reporting of the study were entirely independent of any manufacturers of melatonin.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2014, J NEUROTRAUM, V31, pA59; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Churchill N, 2016, J NEUROTRAUMA; Cohen J., 2013, STAT POWER ANAL BEHA; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim BN, 2010, J PSYCHIATR NEUROSCI, V35, P330, DOI 10.1503/jpn.090168; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Ku D. N., 1993, HEMODYNAMIC FORCES V; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Lorberboym M, 2004, J CHILD NEUROL, V19, P91, DOI 10.1177/08830738040190020201; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Urban KJ, 2014, J NEUROTRAUM, V31, pA64; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Venkat P, 2016, CROAT MED J, V57, P223, DOI 10.3325/cmj.2016.57.223; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Wang J, 2006, NEUROIMAG CLIN N AM, V16, P149, DOI 10.1016/j.nic.2005.10.002; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008	53	53	54	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					996	1004		10.1089/neu.2016.4634			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200004	27554429	Bronze, Green Published			2022-02-06	
J	Kerr, ZY; Roos, KG; Djoko, A; Dalton, SL; Broglio, SP; Marshall, SW; Dompier, TP				Kerr, Zachary Y.; Roos, Karen G.; Djoko, Aristarque; Dalton, Sara L.; Broglio, Steven P.; Marshall, Stephen W.; Dompier, Thomas P.			Epidemiologic Measures for Quantifying the Incidence of Concussion in National Collegiate Athletic Association Sports	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injury; collegiate sports; risk	INJURY SURVEILLANCE SYSTEM; STATES HIGH-SCHOOL; LEAGUE; RATES	Context: Injury rates compare the relative frequency of sport-related concussions across groups. However, they may not be intuitive to policy makers, parents, or coaches in understanding the likelihood of concussion. Objective: To describe 4 measures of incidence (athlete-based rate, athlete-based risk, team-based rate, and team-based risk) during the 2011-2012 through 2014-2015 academic years. Design: Descriptive epidemiology study. Setting: Aggregate injury and exposure data collected from the National Collegiate Athletic Association Injury Surveillance Program in 13 sports (men's baseball, basketball, football, ice hockey, lacrosse, soccer, and wrestling and women's basketball, ice hockey, lacrosse, soccer, softball, and volleyball). Patients or Other Participants: Collegiate student-athletes. Main Outcome Measure(s): Sport-related concussion data from the National Collegiate Athletic Association Injury Surveillance Program during the 2011-2012 through 2014-2015 academic years were analyzed. We calculated concussion rates per 1000 athlete-exposures (AEs), concussion risk, average number of concussions per team, and percentage of teams with at least 1 concussion. Results: During the 2011-2012 through 2014-2015 academic years, 1485 concussions were sustained by 1410 student-athletes across 13 sports. Concussion rates ranged from 0.09/1000 AEs in men's baseball to 0.89/1000 AEs in men's wrestling. Concussion risk ranged from 0.74% in men's baseball to 7.92% in men's wrestling. The average +/- SD number of concussions per team ranged from 0.25 +/- 6 0.43 in men's baseball to 5.63 +/- 6 5.36 in men's football. The percentage of teams with a concussion ranged from 24.5% in men's baseball to 80.6% in men's football. Conclusions: Although men's wrestling had a higher concussion rate and risk, men's football had the largest average number of concussions per team and the largest percentage of teams with at least 1 concussion. The risk of concussion, average number of concussions per team, and percentage of teams with concussions may be more intuitive measures of incidence for decision makers. Calculating these additional measures is feasible within existing injury surveillance programs, and this method can be applied to other injury types.	[Kerr, Zachary Y.; Roos, Karen G.; Djoko, Aristarque; Dalton, Sara L.; Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Marshall, Stephen W.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA		Kerr, ZY (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	zkerr@datalyscenter.org		Kerr, Zachary/0000-0003-1423-1259	NCAA	The National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The ISP was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCAA. We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes.	Agel J, 2007, J ATHL TRAINING, V42, P249; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Berry JW, 2013, RES SPORTS MED, V21, P159, DOI 10.1080/15438627.2012.757229; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Epstein DM, 2013, AM J SPORT MED, V41, P343, DOI 10.1177/0363546512467612; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Messina DF, 1999, AM J SPORT MED, V27, P294, DOI 10.1177/03635465990270030401; National Collegiate Athletic Association, FOOTB PRACT GUID; National Collegiate Athletic Association, STUD ATHL PART 1981; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	53	53	1	9	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2017	52	3					167	174		10.4085/1062-6050-51.6.05			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ES0NE	WOS:000399222500003	27331336	Green Published, Green Submitted, Bronze			2022-02-06	
J	Palacios, EM; Martin, AJ; Boss, MA; Ezekiel, F; Chang, YS; Yuh, EL; Vassar, MJ; Schnyer, DM; MacDonald, CL; Crawford, KL; Irimia, A; Toga, AW; Mukherjee, P				Palacios, E. M.; Martin, A. J.; Boss, M. A.; Ezekiel, F.; Chang, Y. S.; Yuh, E. L.; Vassar, M. J.; Schnyer, D. M.; MacDonald, C. L.; Crawford, K. L.; Irimia, A.; Toga, A. W.; Mukherjee, P.		TRACK-TBI Investigators	Toward Precision and Reproducibility of Diffusion Tensor Imaging: A Multicenter Diffusion Phantom and Traveling Volunteer Study	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; FRACTIONAL ANISOTROPY; FIBER TRACTOGRAPHY; RELIABILITY; 3T; IMPLEMENTATION; MEDICINE; SCANNERS	BACKGROUND AND PURPOSE: Precision medicine is an approach to disease diagnosis, treatment, and prevention that relies on quantitative biomarkers that minimize the variability of individual patient measurements. The aim of this study was to assess the intersite variability after harmonization of a high-angular-resolution 3T diffusion tensor imaging protocol across 13 scanners at the 11 academic medical centers participating in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury multisite study. MATERIALS AND METHODS: Diffusion MR imaging was acquired from a novel isotropic diffusion phantom developed at the National Institute of Standards and Technology and from the brain of a traveling volunteer on thirteen 3T MR imaging scanners representing 3 major vendors (GE Healthcare, Philips Healthcare, and Siemens). Means of the DTI parameters and their coefficients of variation across scanners were calculated for each DTI metric and white matter tract. RESULTS: For the National Institute of Standards and Technology diffusion phantom, the coefficients of variation of the apparent diffusion coefficient across the 13 scanners was <3.8% for a range of diffusivities from 0.4 to 1.1 x 10(-6) mm(2)/s. For the volunteer, the coefficients of variations across scanners of the 4 primary DTI metrics, each averaged over the entire white matter skeleton, were all <5%. In individual white matter tracts, large central pathways showed good reproducibility with the coefficients of variation consistently below 5%. However, smaller tracts showed more variability, with the coefficients of variation of some DTI metrics reaching 10%. CONCLUSIONS: The results suggest the feasibility of standardizing DTI across 3T scanners from different MR imaging vendors in a large-scale neuroimaging research study.	[Palacios, E. M.; Martin, A. J.; Ezekiel, F.; Chang, Y. S.; Yuh, E. L.; Mukherjee, P.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Palacios, E. M.; Martin, A. J.; Ezekiel, F.; Chang, Y. S.; Yuh, E. L.; Mukherjee, P.] Univ Calif San Francisco, Dept Biomed Imaging, San Francisco, CA 94143 USA; [Vassar, M. J.] Univ Calif San Francisco, Neurol Surg & Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Mukherjee, P.] Univ Calif San Francisco, Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Boss, M. A.] NIST, Boulder, CO USA; [Yuh, E. L.; Vassar, M. J.; Mukherjee, P.] San Francisco Gen Hosp, Brain & Spinal Cord Injury Ctr, San Francisco, CA 94110 USA; Ctr Trauma, San Francisco, CA USA; [Schnyer, D. M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [MacDonald, C. L.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Crawford, K. L.; Irimia, A.; Toga, A. W.] Univ Southern Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Los Angeles, CA USA		Mukherjee, P (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 185 Berry St, San Francisco, CA 94107 USA.	pratik.mukherjee@ucsf.edu	Irimia, Andrei/B-8275-2008; Yue, John K/P-1348-2015; Schnyer, David/ABD-6372-2021; Boss, Michael/I-2904-2019	Irimia, Andrei/0000-0002-9254-9388; Yue, John K/0000-0001-9694-7722; Schnyer, David/0000-0002-7472-2853; Boss, Michael/0000-0002-9492-767X; Ferguson, Adam/0000-0001-7102-1608; Crawford, Karen/0000-0002-3294-0828; Martin, Alastair/0000-0002-7963-4000; Sergot, Paulina/0000-0003-0796-8009	Voyager Therapeutics; Quest Diagnostics Incorporated;  [NIH R01EB012031];  [NIH U01NS086090];  [NIH R21CA186140];  [NIH R01CA194533];  [NIH U01 NS086090];  [DoD W81XWH-14-2-0176];  [DoD-Navy W911QY-14-C-0070];  [NIH R01AG046460];  [NIH R01HD083126];  [DoD PT108802-SC104833-S1];  [NIH R44 NS 081792];  [NIH R01MH094343];  [NIH P41EB015922];  [NIH R24MH106096];  [NIH R01HD072074];  [DoD W81XWH-13-1-0494];  [GE 114-2014-GES-0001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD072074] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD031526] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA186140, R01CA194533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922, R01EB012031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH094343, R24MH106096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060776, R44NS081792, U01NS086090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG046460] Funding Source: NIH RePORTER	A.J.M., NIH R01EB012031, NIH U01NS086090, NIH R21CA186140, NIH R01CA194533, Voyager Therapeutics, Quest Diagnostics Incorporated; E.L.Y., NIH U01 NS086090, DoD W81XWH-14-2-0176, D.M.S., DoD-Navy W911QY-14-C-0070, NIH U01NS086090, NIH R01AG046460; C.L.M., NIH R01HD083126, DoD PT108802-SC104833-S1, NIH U01NS086090, DoD W81XWH-14-2-0176; A. I., NIH R44 NS 081792, NIH U01NS086090; A.W.T., NIH R01MH094343, NIH P41EB015922, NIH U01NS086090; and P.M., NIH R24MH106096, NIH R01HD072074, NIH U01 NS086090, DoD W81XWH-14-2-0176, DoD W81XWH-13-1-0494, GE 114-2014-GES-0001.	Andersson JLR, TR07JA2 FMRIB; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Fox RJ, 2012, AM J NEURORADIOL, V33, P695, DOI 10.3174/ajnr.A2844; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Grech-Sollars M, 2015, NMR BIOMED, V28, P468, DOI 10.1002/nbm.3269; Hsu W, 2013, J AM MED INFORM ASSN, V20, P1010, DOI 10.1136/amiajnl-2013-002315; Huang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047684; Jansen JFA, 2007, INVEST RADIOL, V42, P327, DOI 10.1097/01.rli.0000262757.10271.e5; Kamagata K, 2015, MAGN RESON MED SCI, V14, P227, DOI 10.2463/mrms.2014-0077; Magnotta VA, 2012, BRAIN CONNECT, V2, P345, DOI 10.1089/brain.2012.0112; Mirzaalian H, 2015, LECT NOTES COMPUT SC, V9349, P12, DOI 10.1007/978-3-319-24553-9_2; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pagani E, 2010, J MAGN RESON IMAGING, V31, P1458, DOI 10.1002/jmri.22186; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Pierpaoli C, 2009, P 17 ANN M ISMRM HON, P1414; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Takao H, 2012, HUM BRAIN MAPP, V33, P466, DOI 10.1002/hbm.21225; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Venkatraman VK, 2015, NEUROIMAGE, V119, P406, DOI 10.1016/j.neuroimage.2015.06.078; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Walker L, 2013, HUM BRAIN MAPP, V34, P2439, DOI 10.1002/hbm.22081; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhu T, 2011, NEUROIMAGE, V56, P1398, DOI 10.1016/j.neuroimage.2011.02.010	32	53	53	0	10	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAR	2017	38	3					537	545		10.3174/ajnr.A5025			9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EN6JB	WOS:000396109200024	28007768	Green Published, Green Accepted, hybrid			2022-02-06	
J	Wallace, J; Covassin, T; Nogle, S; Gould, D; Kovan, J				Wallace, Jessica; Covassin, Tracey; Nogle, Sally; Gould, Daniel; Kovan, Jeffrey			Knowledge of Concussion and Reporting Behaviors in High School Athletes With or Without Access to an Athletic Trainer	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; secondary school; health care	SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; SECONDARY-SCHOOLS; ASSOCIATION; STATEMENT; BENCHMARK	Context: Increased sport participation and sport-related concussion incidence has led to an emphasis on having an appropriate medical professional available to high school athletes. The medical professional best suited to provide medical care to high school athletes is a certified athletic trainer (AT). Access to an AT may influence the reporting of sport-related concussion in the high school athletic population; however, little is known about how the presence of an AT affects concussion knowledge, prevention, and recognition. Objective: To evaluate knowledge of concussion and reporting behaviors in high school athletes who did or did not have access to an AT. Design: Cross-sectional study. Setting: Survey. Patients or Other Participants: A total of 438 athletes with access to an AT and 277 without access to an AT. Intervention(s): A validated knowledge-of-concussion survey consisting of 83 items addressing concussion history, concussion knowledge, scenario questions, signs and symptoms of a concussion, and reasons why an athlete would not report a concussion. The independent variable was access to an AT. Main Outcome Measure(s): We examined the proportion of athletes who correctly identified knowledge of concussion, signs and symptoms of concussion, and reasons why high school student-athletes would not disclose a potential concussive injury by access to an AT. Frequency statistics, chi(2) tests, independent t tests, and linear regression were conducted to analyze the data. Results: The underreporting of concussion among high school athletes was 55%. Athletes with access to an AT had more knowledge of concussion than did athletes without such access (P < .001). Chi-square tests did not demonstrate a significant relationship between AT access and a higher percentage reporting concussions. Conclusions: High school athletes with access to an AT had more concussion knowledge, but they did not report suspected concussions to an authority figure more frequently than athletes without access to an AT.	[Wallace, Jessica] Youngstown State Univ, 1 Univ Plaza,Beeghly Ctr 307L, Youngstown, OH 44555 USA; [Wallace, Jessica; Covassin, Tracey; Nogle, Sally; Gould, Daniel; Kovan, Jeffrey] Michigan State Univ, E Lansing, MI 48824 USA		Wallace, J (corresponding author), Youngstown State Univ, 1 Univ Plaza,Beeghly Ctr 307L, Youngstown, OH 44555 USA.	jwallace02@ysu.edu					Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lyznicki JM, 1999, J ATHL TRAINING, V34, P272; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2013, J ATHL TRAINING, V48, P483, DOI 10.4085/1062-6050-48.4.04; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Ransone J, 1999, J ATHL TRAINING, V34, P267; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511	23	53	53	2	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2017	52	3					228	235		10.4085/1062-6050-52.1.07			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ES0NE	WOS:000399222500008	28387561	Green Published, Bronze			2022-02-06	
J	Wooten, DW; Guehl, NJ; Verwer, EE; Shoup, TM; Yokell, DL; Zubcevik, N; Vasdev, N; Zafonte, RD; Johnson, KA; El Fakhri, G; Normandin, MD				Wooten, Dustin W.; Guehl, Nicolas J.; Verwer, Eline E.; Shoup, Timothy M.; Yokell, Daniel L.; Zubcevik, Nevena; Vasdev, Neil; Zafonte, Ross D.; Johnson, Keith A.; El Fakhri, Georges; Normandin, Marc D.			Pharmacokinetic Evaluation of the Tau PET Radiotracer F-18-T807 (F-18-AV-1451) in Human Subjects	JOURNAL OF NUCLEAR MEDICINE			English	Article						tau; PET; F-18-T807; pharmacokinetics; kinetic modeling	POSITRON-EMISSION-TOMOGRAPHY; CHRONIC TRAUMATIC ENCEPHALOPATHY; ALZHEIMERS-DISEASE; NEUROFIBRILLARY PATHOLOGY; GRAPHICAL ANALYSIS; RADIOLIGAND; BINDING; TRACER; BRAIN; RADIOSYNTHESIS	F-18-T807 is a PET radiotracer developed for imaging tau protein aggregates, which are implicated in neurologic disorders including Alzheimer disease and traumatic brain injury (TBI). The current study characterizes F-18-T807 pharmacokinetics in human subjects using dynamic PET imaging and metabolite-corrected arterial input functions. Methods: Nine subjects (4 controls, 3 with a history of TBI, 2 with mild cognitive impairment due to suspected Alzheimer disease) underwent dynamic PET imaging for up to 120 min after bolus injection of F-18-T807 with arterial blood sampling. Total volume of distribution (V-T) was estimated using compartmental modeling (1- and 2-tissue configurations) and graphical analysis techniques (Logan and multilinear analysis 1 [MA1] regression methods). Reference region-based methods of quantification were explored including Logan distribution volume ratio (DVR) and static SUV ratio (SUVR) using the cerebellum as a reference tissue. Results: The percentage of unmetabolized F-18-T807 in plasma followed a single exponential with a half-life of 17.0 +/- 4.2 min. Metabolite-corrected plasma radioactivity concentration fit a biexponential (half-lives, 18.1 +/- 5.8 and 2.4 +/- 0.5 min). F-18-T807 in gray matter peaked quickly (SUV > 2 at similar to 5 min). Compartmental modeling resulted in good fits, and the 2-tissue model with estimated blood volume correction (2Tv) performed best, particularly in regions with elevated binding. V-T was greater in mild cognitive impairment subjects than controls in the occipital, parietal, and temporal cortices as well as the posterior cingulate gyrus, precuneus, and mesial temporal cortex. High focal uptake was found in the posterior corpus callosum of a TBI subject. Plots from Logan and MA1 graphical methods became linear by 30 min, yielding regional estimates of V-T in excellent agreement with compartmental analysis and providing high-quality parametric maps when applied in voxelwise fashion. Reference region-based approaches including Logan DVR (t* 5 55 min) and SUVR (80-to 100-min interval) were highly correlated with DVR estimated using 2Tv (R-2 - 0.97, P < 0.0001). Conclusion: F-18-T807 showed rapid clearance from plasma and properties suitable for tau quantification with PET. Furthermore, simplified approaches using DVR (t* 5 55 min) and static SUVR (80-100 min) with cerebellar reference tissue were found to correlate highly with compartmental modeling outcomes.	[Wooten, Dustin W.; Guehl, Nicolas J.; Verwer, Eline E.; Shoup, Timothy M.; Yokell, Daniel L.; Vasdev, Neil; El Fakhri, Georges; Normandin, Marc D.] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Harvard Med Sch, Boston, MA USA; [Wooten, Dustin W.; Guehl, Nicolas J.; Verwer, Eline E.; Shoup, Timothy M.; Yokell, Daniel L.; Vasdev, Neil; Johnson, Keith A.; El Fakhri, Georges; Normandin, Marc D.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA USA; [Zubcevik, Nevena; Zafonte, Ross D.] Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.] Brigham & Womens Hosp, Harvard Med Sch, Boston, MA USA		Normandin, MD (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,White 427, Boston, MA 02114 USA.	normandin@mgh.harvard.edu	Normandin, Marc/C-6728-2015	Normandin, Marc/0000-0003-1645-523X	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG036694, P50AG005134] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01 AG036694, P50 AG005134] Funding Source: Medline		Agdeppa ED, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0004.2001; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alpert NM, 1996, NEUROIMAGE, V3, P10, DOI 10.1006/nimg.1996.0002; Ariza M, 2015, J MED CHEM, V58, P4365, DOI 10.1021/jm5017544; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; Burnham KP., 2002, MODEL SELECTION MULT; CARSON RE, 1993, J CEREBR BLOOD F MET, V13, P24, DOI 10.1038/jcbfm.1993.6; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Collier T., 2013, SOC NUCL MED ANN MEE, V54, P1133; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Harada R, 2016, J NUCL MED, V57, P208, DOI 10.2967/jnumed.115.164848; Hashimoto H, 2014, J NUCL MED, V55, P1532, DOI 10.2967/jnumed.114.139550; Hilton J, 2000, NUCL MED BIOL, V27, P627, DOI 10.1016/S0969-8051(00)00125-6; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; James OG, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00038; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Kimura Y, 2015, J NUCL MED, V56, P1359, DOI 10.2967/jnumed.115.160127; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Shcherbinin S, 2016, J NUCL MED, V57, P1535, DOI 10.2967/jnumed.115.170027; Shoup TM, 2013, J LABELLED COMPD RAD, V56, P736, DOI 10.1002/jlcr.3098; Slifstein M, 2008, J NUCL MED, V49, P176, DOI 10.2967/jnumed.107.046631; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712	35	53	53	1	18	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	MAR 1	2017	58	3					484	491		10.2967/jnumed.115.170910			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	EN1AN	WOS:000395742700024	27660144	Green Accepted, Bronze, Green Published			2022-02-06	
J	Marussich, L; Lu, KH; Wen, HG; Liu, ZM				Marussich, Lauren; Lu, Kun-Han; Wen, Haiguang; Liu, Zhongming			Mapping white-matter functional organization at rest and during naturalistic visual perception	NEUROIMAGE			English	Article							TRAUMATIC BRAIN-INJURY; SENSORY STIMULATION; FIELD POTENTIALS; CORPUS-CALLOSUM; FMRI ACTIVATION; CONNECTIVITY; CORTEX; SIGNAL; BOLD; MRI	Despite the wide applications of functional magnetic resonance imaging (fMRI) to mapping brain activation and connectivity in cortical gray matter, it has rarely been utilized to study white-matter functions. In this study, we investigated the spatiotemporal characteristics of fMRI data within the white matter acquired from humans both in the resting state and while watching a naturalistic movie. By using independent component analysis and hierarchical clustering, resting-state fMRI data in the white matter were de-noised and decomposed into spatially independent components, which were further assembled into hierarchically organized axonal fiber bundles. Interestingly, such components were partly reorganized during natural vision. Relative to resting state, the visual task specifically induced a stronger degree of temporal coherence within the optic radiations, as well as significant correlations between the optic radiations and multiple cortical visual networks. Therefore, fMRI contains rich functional information about the activity and connectivity within white matter at rest and during tasks, challenging the conventional practice of taking white-matter signals as noise or artifacts.	[Marussich, Lauren; Liu, Zhongming] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Lu, Kun-Han; Wen, Haiguang; Liu, Zhongming] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Liu, Zhongming] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA		Liu, ZM (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	zmliu@purdue.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH104402]; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TL1 TR001107, UL1 TR001108]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108, TL1TR001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH104402] Funding Source: NIH RePORTER	The research was supported in part by NIH R01MH104402 (Z Liu, PI), and a predoctoral fellowship to Lauren Marussich as supported by TL1 TR001107 and UL1 TR001108 (A. Shekhar, PI) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The authors would also like to thank Yu Tang for her assistance with data analysis during the exploratory phase of this project.	Astafiev SV, 2016, NEUROIMAGE-CLIN, V11, P10, DOI 10.1016/j.nicl.2016.01.004; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dasgupta S, 2005, J COMPUT SYST SCI, V70, P555, DOI 10.1016/j.jcss.2004.10.006; Ding Z., 2013, PLOS ONE, V8; Ding ZH, 2016, MAGN RESON IMAGING, V34, P8, DOI 10.1016/j.mri.2015.10.003; Duyn J, 2013, J MAGN RESON, V229, P198, DOI 10.1016/j.jmr.2012.11.013; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Ffytche DH, 2005, PHILOS T R SOC B, V360, P767, DOI 10.1098/rstb.2005.1621; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gawryluk JR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-56; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Jensen JH, 2006, MAGN RESON MED, V56, P1145, DOI 10.1002/mrm.21052; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lee J, 2011, NEUROIMAGE, V57, P225, DOI 10.1016/j.neuroimage.2011.04.026; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; LIERSE W, 1965, ACTA NEUROL SCAND, VS 41, P15; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Makedonov I, 2016, NEUROBIOL AGING, V37, P12, DOI 10.1016/j.neurobiolaging.2015.09.010; Mandl RCW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003631; Mazerolle EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058130; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; McMahon DBT, 2015, J NEUROSCI, V35, P5537, DOI 10.1523/JNEUROSCI.3825-14.2015; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mosier KM, 1999, AM J NEURORADIOL, V20, P1520; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pelled G, 2009, P NATL ACAD SCI USA, V106, P14114, DOI 10.1073/pnas.0903153106; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Rash JE, 2010, NEUROSCIENCE, V168, P982, DOI 10.1016/j.neuroscience.2009.10.028; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Rostrup E, 2000, NEUROIMAGE, V11, P87, DOI 10.1006/nimg.1999.0526; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spees WM, 2013, NEUROIMAGE, V65, P209, DOI 10.1016/j.neuroimage.2012.10.021; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Thomas BP., 2014, J CEREB BLOOD FLOW M; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Wang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076315; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Weber B, 2002, NEUROIMAGE, V16, P993, DOI 10.1006/nimg.2002.1104; Wilf M., 2015, CEREB CORTEX	73	53	53	1	18	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	FEB 1	2017	146						1128	1141		10.1016/j.neuroimage.2016.10.005			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EL3ZX	WOS:000394560700098	27720819	Green Accepted			2022-02-06	
J	Bodart, O; Gosseries, O; Wannez, S; Thibaut, A; Annen, J; Boly, M; Rosanova, M; Casali, AG; Casarotto, S; Tononi, G; Massimini, M; Laureys, S				Bodart, Olivier; Gosseries, Olivia; Wannez, Sarah; Thibaut, Aurore; Annen, Jitka; Boly, Melanie; Rosanova, Mario; Casali, Adenauer G.; Casarotto, Silvia; Tononi, Giulio; Massimini, Marcello; Laureys, Steven			Measures of metabolism and complexity in the brain of patients with disorders of consciousness	NEUROIMAGE-CLINICAL			English	Article						Transcranial magnetic stimulation; Electroencephalography; Positron emission tomography; Disorders of consciousness; Unresponsive wakefulness syndrome minimally conscious state; Brain injury	CORTICAL EFFECTIVE CONNECTIVITY; PLACEBO-CONTROLLED TRIAL; VEGETATIVE STATE; INJURY; AWARENESS; RESPONSES; COMA; STIMULATION; REACTIVITY; BREAKDOWN	Background: Making an accurate diagnosis in patients with disorders of consciousness remains challenging. F-18-fluorodeoxyglucose (FDG)-PET has been validated as a diagnostic tool in this population, and allows identifying unresponsive patients with a capacity for consciousness. In parallel, the perturbational complexity index (PCI), a new measure based on the analysis of the electroencephalographic response to transcranial magnetic stimulation, has also been suggested as a tool to distinguish between unconscious and conscious states. The aim of the study was to cross-validate FDG-PET and PCI, and to identify signs of consciousness in otherwise unresponsive patients. Methods: We jointly applied the Coma Recovery Scale-Revised, FDG-PET and PCI to assess 24 patients with non-acute disorders of consciousness or locked-in syndrome(13 male; 19-54 years old; 12 traumatic; 9 unresponsive wakefulness syndrome, 11 minimally conscious state; 2 emergence from the minimally conscious state, and 2 locked-in syndrome). Results: FDG-PET and PCI provided congruent results in 22 patients, regardless of their behavioural diagnosis. Notably, FDG-PET and PCI revealed preserved metabolic rates and high complexity levels in four patients who were behaviourally unresponsive. Conclusion: We propose that jointly measuring the metabolic activity and the electrophysiological complexity of cortical circuits is a useful complement to the diagnosis and stratification of patients with disorders of consciousness. (C) 2017 The Authors. Published by Elsevier Inc.	[Bodart, Olivier; Gosseries, Olivia; Wannez, Sarah; Thibaut, Aurore; Annen, Jitka; Boly, Melanie; Laureys, Steven] Univ Liege, Gigo Consciousness, Coma Sci Grp, Liege, Belgium; [Bodart, Olivier; Gosseries, Olivia; Wannez, Sarah; Thibaut, Aurore; Annen, Jitka; Boly, Melanie; Laureys, Steven] Univ Liege, Neurol Dept, Liege, Belgium; [Bodart, Olivier; Gosseries, Olivia; Wannez, Sarah; Thibaut, Aurore; Annen, Jitka; Boly, Melanie; Laureys, Steven] Univ Hosp Liege, Liege, Belgium; [Gosseries, Olivia; Boly, Melanie; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Rosanova, Mario; Casali, Adenauer G.; Casarotto, Silvia; Massimini, Marcello] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy; [Casali, Adenauer G.] Fed Univ Sao Paolo, Inst Sci & Technol, Sao Jose Dos Campos, Brazil; [Massimini, Marcello] Fdn Don Carlo Gnocchi, Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Rosanova, Mario] FERB Onlus, Fdn Europea Ric Biomed, Milan, Italy		Bodart, O (corresponding author), Coma Sci Grp, Giga Consciousness, B34,1 Ave Hop, B-4000 Liege, Belgium.	coma@chu.ulg.ac.be	Laureys, Steven/A-3349-2011; Annen, Jitka/ABH-5297-2020; Gosseries, Olivia/AAB-6469-2020; Casarotto, Silvia/Q-9402-2019; Laureys, Steven/AAN-2097-2021; Casali, Adenauer G/G-9911-2012; Thibaut, Aurore/U-8101-2019; Rosanova, Mario/S-8440-2017; Massimini, Marcello/T-8115-2017	Annen, Jitka/0000-0002-7459-4345; Gosseries, Olivia/0000-0001-9011-7496; Casarotto, Silvia/0000-0002-7548-7664; Laureys, Steven/0000-0002-3096-3807; Casali, Adenauer G/0000-0001-7024-9029; Rosanova, Mario/0000-0001-7486-7617; Massimini, Marcello/0000-0003-2271-957X	Belgian National Fund for Scientific Research (FNRS)Fonds de la Recherche Scientifique - FNRS; Human Brain ProjectUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [EU-H2020-FETFLAGSHIP-HBP-SGA1-GA720270]; Luminous project [EU-H2020-FETOPEN-GA686764]; Belgian American Education Foundation; Wallonie-Bruxelles International; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Fonds Leon Fredericq; James S. McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action [ARC-06/11-340]; University and University Hospital of Liege	This research was supported by the Belgian National Fund for Scientific Research (FNRS), Human Brain Project (EU-H2020-FETFLAGSHIP-HBP-SGA1-GA720270), Luminous project (EU-H2020-FETOPEN-GA686764), the Belgian American Education Foundation, the Wallonie-Bruxelles International, the European Commission, the Fonds Leon Fredericq, the James S. McDonnell Foundation, the Mind Science Foundation, the French Speaking Community Concerted Research Action (ARC-06/11-340), and the University and University Hospital of Liege.	Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Bodart O, 2013, SEMIN NEUROL, V33, P83, DOI 10.1055/s-0033-1348965; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Casarotto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010281; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Gantner IS, 2013, FUTUR NEUROL, V8, P43, DOI 10.2217/FNL.12.77; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Gosseries O, 2015, BRAIN STIMUL, V8, P142, DOI 10.1016/j.brs.2014.10.008; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2012, ARCH ITAL BIOL, V150, P44, DOI 10.4449/aib.v150i2.1361; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; Massimini M, 2009, PROG BRAIN RES, V177, P201, DOI 10.1016/S0079-6123(09)17714-2; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sarasso S, 2015, CURR BIOL, V25, P3099, DOI 10.1016/j.cub.2015.10.014; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2016, CURR BIOL, V26, pR572, DOI 10.1016/j.cub.2016.02.027; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stender J, 2014, LANCET NEUROL, V6736, P8, DOI DOI 10.1016/S0140-6736(14)60042-8; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0	36	53	58	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	14						354	362		10.1016/j.nicl.2017.02.002			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB2OY	WOS:000405984300038	28239544	Green Published, gold			2022-02-06	
J	Aisiku, IP; Yamal, JM; Doshi, P; Benoit, JS; Gopinath, S; Goodman, JC; Robertson, CS				Aisiku, Imo P.; Yamal, Jose-Miguel; Doshi, Pratik; Benoit, Julia S.; Gopinath, Shankar; Goodman, Jerry C.; Robertson, Claudia S.			Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury	CRITICAL CARE			English	Article						TBI; ARDS; ALI; Cytokines; Plasma; CSF	TUMOR-NECROSIS-FACTOR; ACUTE LUNG INJURY; RISK PATIENTS; BRONCHOALVEOLAR; INTERLEUKIN-1; INFLAMMATION; MORTALITY; FAILURE; SEPSIS	Background: Patients with severe traumatic brain injury (TBI) are at risk of the development of acute respiratory distress syndrome (ARDS). TBI and ARDS pathophysiologic mechanisms are known to independently involve significant inflammatory responses. The literature on the association between plasma inflammatory cytokines and ARDS in patients with TBI is sparse. Methods: The study was a secondary analysis of the safety of a randomized trial of erythropoietin and transfusion threshold in patients with severe TBI. Inflammatory markers within the first 24 hours after injury were compared in patients who developed ARDS and patients without ARDS, using Cox proportional hazards models. Results: There were 200 patients enrolled in the study. The majority of plasma and cerebrospinal fluid (CSF) cytokine levels were obtained within 6 hours. Plasma proinflammatory markers IL-6 and IL-8 and anti-inflammatory marker IL-10 were associated with the development of ARDS (adjusted hazard ratio (HR) = 1.55, confidence interval (CI) = 1.14, 2.11, P = 0.005 for IL-6; adjusted HR = 1.32, CI = 1.10, 1.59, P = 0.003 for IL-8). Conclusion: Plasma markers of IL-6, IL-8, and IL-10 are associated with ARDS in patients with severe TBI.	[Aisiku, Imo P.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Yamal, Jose-Miguel] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Doshi, Pratik] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med & Internal Med, Houston, TX 77030 USA; [Benoit, Julia S.] Univ Houston, Coll Optometry, Texas Inst Measurement Evaluat & Stat, Dept Basic Vis Sci, Houston, TX USA; [Gopinath, Shankar; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, Jerry C.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA		Aisiku, IP (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	iaisiku@partners.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-NS38660]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	NIH Grant: P01-NS38660.	Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Donnelly SC, 1996, ANN INTERN MED, V125, P191, DOI 10.7326/0003-4819-125-3-199608010-00005; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; GORIS RJA, 1990, INTENS CARE MED, V16, pS192, DOI 10.1007/BF01709699; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kuchnicka K, 2013, ANAESTH INTENSIVE TH, V45, P164, DOI 10.5603/AIT.2013.0034; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maier S, 2000, SHOCK, V14, P187, DOI 10.1097/00024382-200014020-00019; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Parsons PE, 1997, AM J RESP CRIT CARE, V155, P1469, DOI 10.1164/ajrccm.155.4.9105096; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schutte H, 1996, EUR RESPIR J, V9, P1858, DOI 10.1183/09031936.96.09091858; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; SILER TM, 1989, EXP LUNG RES, V15, P881, DOI 10.3109/01902148909069633; Soriano SG, 2008, EUR J ANAESTH, V25, P154, DOI 10.1017/S0265021507003390; SUTER PM, 1992, AM REV RESPIR DIS, V145, P1016, DOI 10.1164/ajrccm/145.5.1016; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x	29	53	62	1	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	SEP 15	2016	20								288	10.1186/s13054-016-1470-7			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW6ME	WOS:000383764400001	27630085	Green Published, gold			2022-02-06	
J	Sahoo, D; Deck, C; Willinger, R				Sahoo, Debasis; Deck, Caroline; Willinger, Remy			Brain injury tolerance limit based on computation of axonal strain	ACCIDENT ANALYSIS AND PREVENTION			English	Article						DTI; Brain modeling; Head trauma simulation; Axonal strain; Brain injury tolerance limit	ELEMENT HEAD MODELS; DYNAMIC-RESPONSE; SKULL FRACTURE; DIFFUSION; IMPACT; VALIDATION; GENERATION; CRITERION; BEHAVIOR; SIMON	Traumatic brain injury (TBI) is the leading cause of death and permanent impairment over the last decades. In both the severe and mild TBIs, diffuse axonal injury (DAI) is the most common pathology and leads to axonal degeneration. Computation of axonal strain by using finite element head model in numerical simulation can enlighten the DAI mechanism and help to establish advanced head injury criteria. The main objective of this study is to develop a brain injury criterion based on computation of axonal strain. To achieve the objective a state-of-the-art finite element head model with enhanced brain and skull material laws, was used for numerical computation of real world head trauma. The implementation of new medical imaging data such as, fractional anisotropy and axonal fiber orientation from Diffusion Tensor Imaging (DTI) of 12 healthy patients into the finite element brain model was performed to improve the brain constitutive material law with more efficient heterogeneous anisotropic visco hyper-elastic material law. The brain behavior has been validated in terms of brain deformation against Hardy et al. (2001), Hardy et al. (2007), and in terms of brain pressure against Nahum et al. (1977) and Trosseille et al. (1992) experiments. Verification of model stability has been conducted as well. Further, 109 well-documented TBI cases were simulated and axonal strain computed to derive brain injury tolerance curve. Based on an in-depth statistical analysis of different intra-cerebral parameters (brain axonal strain rate, axonal strain, first principal strain, Von Mises strain, first principal stress, Von Mises stress, CSDM (0.10), CSDM (0.15) and CSDM (0.25)), it was shown that axonal strain was the most appropriate candidate parameter to predict DAI. The proposed brain injury tolerance limit for a 50% risk of DAI has been established at 14.65% of axonal strain. This study provides a key step for a realistic novel injury metric for DAI. (C) 2016 Elsevier Ltd. All rights reserved.	[Sahoo, Debasis; Deck, Caroline; Willinger, Remy] Univ Strasbourg ICube, UNISTRA CNRS, 2 Rue Boussingault, F-67000 Strasbourg, France		Sahoo, D; Deck, C (corresponding author), Univ Strasbourg ICube, UNISTRA CNRS, 2 Rue Boussingault, F-67000 Strasbourg, France.	deb4uinl@gmail.com; deck.caroline@gmail.com; remy.willinger@unistra.fr	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; DECK, Caroline/0000-0003-2289-1222			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F. A., 1995, P 38 STAPP CAR CRASH; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bourdet N, 2012, INT J CRASHWORTHINES, V17, P51, DOI 10.1080/13588265.2011.625676; Bourdet N., 2013, INT J CRASHWORTHINES; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; COST, 2001, MOT SAF HELM EUR COO; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deck C., 2008, P 7 EUR LS DYNA C SA; EVANS FG, 1957, J APPL PHYSIOL, V10, P493, DOI 10.1152/jappl.1957.10.3.493; Faul M, 2010, TRAUMATIC BRAIN INJU; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gennarelli T.A., 1990, 34 ANN P ASS ADV AUT; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Gray's anatomy, 2008, ANATOMICAL BASIS CLI; HAFTEK J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P354; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2009, INT J CRASHWORTHINES, V14, P555, DOI 10.1080/13588260902895708; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Hynd D., 2004, AP SP; Kang HS, 1997, P STAPP CAR CRASH J, V41, P329; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; King A., 2003, P IRCOBI C LISB PORT; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleiven S., 2007, P 51 STAPP CAR CRASH, P81; Kraft R.H., 2012, PLOS COMPUT BIOL, V30, P102; Langlois J.A., 2004, TRAUMATIC BRAIN INJU, P1; Longhitano D., 2005, P 19 INT C ENH SAF V; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231, DOI 10.1152/jappl.1966.21.4.1231; Mellor A., 2000, SOC AUTOMOT ENG; Melvin JW., 1969, DEV, V5, P811; METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Munsch M., 2009, P IRCOBI C YORK UK; Nahum AM, 1977, P 21 STAPP CAR CRASH; Nakadate H., 2014, J BIOMECH SCI ENG; Newman J., 1999, P IRCOBI C SITG SPAI; Newman J. A., 2000, P IRCOBI C MONTP FRA; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Peng Y, 2013, TRAFFIC INJ PREV, V14, P639, DOI 10.1080/15389588.2012.733841; Peng Y, 2013, INT J IMPACT ENG, V57, P27, DOI 10.1016/j.ijimpeng.2013.01.010; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; RYDEVIK BL, 1990, J ORTHOPAED RES, V8, P694, DOI 10.1002/jor.1100080511; Sahoo D., 2014, P INT RES C BIOM INJ; Sahoo D, 2016, J MECH BEHAV BIOMED, V57, P24, DOI 10.1016/j.jmbbm.2015.11.014; Sahoo D, 2015, MED BIOL ENG COMPUT, V53, P869, DOI 10.1007/s11517-015-1295-6; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sahoo D, 2013, J MECH BEHAV BIOMED, V28, P340, DOI 10.1016/j.jmbbm.2013.08.010; Shaoo D, 2015, ACCIDENT ANAL PREV, V80, P97, DOI 10.1016/j.aap.2015.04.004; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, P 36 STAPP CAR CRASH; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369	74	53	57	2	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2016	92						53	70		10.1016/j.aap.2016.03.013			18	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	DM9NW	WOS:000376694000007	27038501				2022-02-06	
J	Wasserman, EB; Bazarian, JJ; Mapstone, M; Block, R; van Wijngaarden, E				Wasserman, Erin B.; Bazarian, Jeffrey J.; Mapstone, Mark; Block, Robert; van Wijngaarden, Edwin			Academic Dysfunction After a Concussion Among US High School and College Students	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; MILD HEAD-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PERFORMANCE; ADOLESCENTS; CHILDREN; ACCOMMODATIONS	Objectives. To determine whether concussed students experience greater academic dysfunction than students who sustain other injuries. Methods. We conducted a prospective cohort study from September 2013 through January 2015 involving high school and college students who visited 3 emergency departments in the Rochester, New York, area. Using telephone surveys, we compared self-reported academic dysfunction between 70 students with concussions and a comparison group of 108 students with extremity injuries at 1 week and 1 month after injury. Results. At 1 week after injury, academic dysfunction scores were approximately 16 points higher (b = 16.20; 95% confidence interval = 6.39, 26.00) on a 174-point scale in the concussed group than in the extremity injury group. Although there were no differences overall at 1-month after injury, female students in the concussion group and those with a history of 2 or more prior concussions were more likely to report academic dysfunction. Conclusions. Our results showed academic dysfunction among concussed students, especially female students and those with multiple prior concussions, 1 week after their injury. Such effects appeared to largely resolve after 1 month. Our findings support the need for academic adjustments for concussed students.	[Wasserman, Erin B.; Bazarian, Jeffrey J.; Mapstone, Mark; Block, Robert; van Wijngaarden, Edwin] Univ Rochester, Sch Med & Dent, Rochester, NY USA		Wasserman, EB (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, 2207 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	ebw@email.unc.edu	van Wijngaarden, Edwin/Q-2073-2019	van Wijngaarden, Edwin/0000-0001-7583-4630; Wasserman, Erin/0000-0001-5957-5878			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Bigal ME, 2001, HEADACHE, V41, P710, DOI 10.1046/j.1526-4610.2001.041007710.x; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cantu R., 2012, CONCUSSIONS OUR KIDS; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, HEADS SCH KNOW YOUR; Cobaugh DJ, 1997, ACAD EMERG MED, V4, P231, DOI 10.1111/j.1553-2712.1997.tb03748.x; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DeRoma V., 2009, COLL STUD J, V43, P325; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; FERGUSSON DM, 1992, J CHILD PSYCHOL PSYC, V33, P375, DOI 10.1111/j.1469-7610.1992.tb00873.x; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gabbe BJ, 2014, J EPIDEMIOL COMMUN H, V68, P466, DOI 10.1136/jech-2013-203427; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007	45	53	53	0	17	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	JUL	2016	106	7					1247	1253		10.2105/AJPH.2016.303154			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DO7CL	WOS:000377939700046	27196651	Green Published			2022-02-06	
J	Wade, SL; Zhang, N; Yeates, KO; Stancin, T; Taylor, HG				Wade, Shari L.; Zhang, Nanhua; Yeates, Keith Owen; Stancin, Terry; Taylor, H. Gerry			Social Environmental Moderators of Long-term Functional Outcomes of Early Childhood Brain Injury	JAMA PEDIATRICS			English	Article							FAMILY ASSESSMENT DEVICE; EXECUTIVE DYSFUNCTION; PARENTING PRACTICES; BEHAVIOR PROBLEMS; ASSESSMENT SCALE; YOUNG-CHILDREN; RELIABILITY; PREDICTORS; RECOVERY; VALIDITY	IMPORTANCE Pediatric traumatic brain injury (TBI) contributes to impairments in behavior and academic performance. However, the long-term effects of early childhood TBI on functioning across settings remain poorly understood. OBJECTIVE To examine the long-term functional outcomes of early childhood TBI relative to early childhood orthopedic injuries (OIs). We also examine the moderating role of the social environment as defined by parent report and observational measures of family functioning, parenting practices, and home environment. DESIGN, SETTING, AND PARTICIPANTS A prospective, longitudinal, observational cohort study conducted at each child's home, school, and hospital, including 3 children's hospitals and 1 general hospital in the Midwest. Patients were enrolled in the initial study between January 2003 and October 2006. Follow-ups were completed between January 2010 and April 2015. Fifty-eight children who sustained a TBI (67% of original enrolled cohort) and 72 children who sustained an OI (61% of the original enrolled cohort) were prospectively followed up from shortly after injury (between the ages of 3 and 7 years at enrollment) to an average of 6.7 years after injury, with assessments occurring at multiple points. MAIN OUTCOMES AND MEASURES Long-term functional outcomes in everyday settings, as assessed through the Child and Adolescent Functional Assessment Scale (CAFAS). RESULTS Of the 130 children included, the median age for those with OIs was 11.72 years and 11.97, 12.21, and 11.72 years for those with complicated mild, moderate, and severe TBIs, respectively. Children with moderate and severe TBI were rated as having more functional impairments in multiple domains than those with OIs (P <.05). Children with complicated mild TBI had greater impairments in school (odds ratio = 2.93; 95% CI = 1.10-7.82) and with thinking (odds ratio = 15.72; 95% CI = 3.31-74.73) than those with OIs. Functional impairments in children with TBI were more pronounced among children from families with higher levels of permissive (mean CAFAS of 49.71, 35.74, 58.14, and 16.16 for severe TBI, moderate TBI, complicated mild TBI, and OI, respectively, with significant difference between severe TBI and OI [difference = 33.55; P <.001] and complicated mild TBI and OI [difference = 41.98; P <.001]) or authoritarian (mean CAFAS of 56.45, 41.80, 54.90, and 17.12 for severe TBI, moderate TBI, complicated mild TBI, and OI, respectively, with significant difference between severe TBI and OI [difference = 39.33; P <.001], moderate TBI and OI [difference = 24.68; P =.003], and complicated mild TBI and OI [difference = 37.78; P <.001]) parenting or with fewer home resources (mean CAFAS of 69.57, 47.45, 49.00, and 23.81 for severe TBI, moderate TBI, complicated mild TBI, and OI, respectively, with significant difference between severe TBI and OI [difference = 45.77; P <.001], moderate TBI and OI [difference = 23.64; P <.001], and complicated mild TBI and OI [difference = 25.20; P <.001]). CONCLUSIONS AND RELEVANCE Even children with relatively mild early TBI experience long-term functional impairments, particularly in the context of less favorable home environments. These findings suggest that improving parenting skills and the quality of the home environment may promote functional recovery following early TBI.	[Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Wade, Shari L.; Zhang, Nanhua] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med, Calgary, AB, Canada; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Div Child & Adolescent Psychiat & Psychol, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Zhang, Nanhua/0000-0001-5796-3404; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; Trauma Research grants from the State of Ohio Emergency Medical Services; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [F30AI109893] Funding Source: NIH RePORTER	This publication was supported by grant R01 HD42729 from the National Institute of Child Health and Human Development and by Trauma Research grants from the State of Ohio Emergency Medical Services. Additional support was provided through grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; BRADLEY RH, 1984, DEV PSYCHOL, V20, P315, DOI 10.1037/0012-1649.20.2.315; Bradley RH, 2000, J RES ADOLESCENCE, V10, P247, DOI 10.1207/SJRA1003_1; Brown FL, 2014, J CHILD PSYCHOL PSYC, V55, P1172, DOI 10.1111/jcpp.12227; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Hodges K, 1998, J BEHAV HEALTH SER R, V25, P325, DOI 10.1007/BF02287471; Hodges K, 1997, J MENT HEALTH ADMIN, V24, P278, DOI 10.1007/BF02832662; Hodges K., 1994, CHILD ADOLESCENT FUN; Hodges K., 2003, CAFAS MANUAL TRAININ; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Robinson C.C., 2001, HDB FAMILY MEASUREME; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Totsika Vasiliki, 2004, Child Adolesc Ment Health, V9, P25, DOI 10.1046/j.1475-357X.2003.00073.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Woods DT, 2013, SOCIAL CARE NEURODIS, V4, P94, DOI DOI 10.1108/SCN-01-2013-0003; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	43	53	53	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	APR	2016	170	4					343	349		10.1001/jamapediatrics.2015.4485			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DI3EI	WOS:000373380800014	26902662	Bronze, Green Accepted			2022-02-06	
J	Yang, T; Song, JX; Bu, XM; Wang, C; Wu, J; Cai, JL; Wan, SJ; Fan, CL; Zhang, CN; Wang, JJ				Yang, Ting; Song, Jiaxi; Bu, Xiaomin; Wang, Cheng; Wu, Jia; Cai, Jialu; Wan, Shujun; Fan, Chunli; Zhang, Chunni; Wang, Junjun			Elevated serum miR-93, miR-191, and miR-499 are noninvasive biomarkers for the presence and progression of traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						biomarkers; diagnosis; microRNA; qRT-PCR; traumatic brain injury	GLASGOW COMA SCALE; MICRORNA EXPRESSION; OUTCOME PREDICTION; BREAKDOWN PRODUCTS; TUMOR-SUPPRESSOR; MILD; IDENTIFICATION; PROLIFERATION; REGULATORS; DIAGNOSIS	The levels of miR-93, miR-191, and miR-499 have been reported to be up-regulated in the tissues of experimental traumatic brain injury (TBI) rat models. However, the clinical diagnostic and prognostic values of the serum signatures of these 3 miRNAs in TBI remain unclear. The purpose of this study was to determine the expression levels of these 3 microRNAs (miRNAs) in the sera of TBI patients and to evaluate their relationships with the severity and clinical outcome of TBI. The serum levels of these miRNAs were assessed in TBI patients (n=76) and healthy controls (n=38) by quantitative reverse-transcription PCR. The severities and clinical outcomes of the TBI patients were evaluated with the Glasgow coma scale and the Glasgow outcome scale. The serum miR-93, miR-191, and miR-499 levels were significantly increased in the TBI patients compared with the controls at all examined time points, and these levels were significantly higher in the patients with severe TBI than in those with moderate or mild TBI (p<0.05). The serum miR-93, miR-191, and miR-499 levels were significantly higher in the patients with a poor outcome than in those with a good outcome (p<0.05). The AUCs of miR-93, miR-191, and miR-499 for distinguishing the TBI patients from the healthy controls were 1.000 (p<0.001), 0.727 (p<0.001) and 0.801 (p<0.001), respectively. Interestingly, the AUCs of miR-93, miR-191, and miR-499 for distinguishing the mild TBI patients from the healthy controls were 1.000 (p<0.001), 0.742 (p<0.001) and 0.819 (p<0.001), respectively. Taken together, these results indicate that miR-93, miR-191, and miR-499 are potentially valuable indicators of the diagnosis, severity, and prognosis of TBI.	[Yang, Ting; Song, Jiaxi; Bu, Xiaomin; Wang, Cheng; Wu, Jia; Cai, Jialu; Wan, Shujun; Fan, Chunli; Zhang, Chunni; Wang, Junjun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Clin Lab, Nanjing 210008, Jiangsu, Peoples R China		Wang, JJ (corresponding author), Jinling Hosp, Dept Clin Lab, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	wangjunjun9202@163.com	jiaxi, song/H-1622-2013; Wang, Cheng/O-7206-2016	Wang, Cheng/0000-0002-1834-2119; Zhang, Chunni/0000-0002-7329-7162	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [812711904, 81401742, 81572073, 81572074]; Special-funded Program on National Key Scientific Instruments and Equipment Development of China [2012YQ030261]; Medical Scientific Research Foundation of Nanjing Military Command [12Z28]	This study was generously funded by the National Natural Science Foundation of China (No. 812711904, 81401742, 81572073 and 81572074), the Special-funded Program on National Key Scientific Instruments and Equipment Development of China (2012YQ030261), and the Medical Scientific Research Foundation of Nanjing Military Command (no. 12Z28). The authors declare no conflict of interest.	Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bilgin S, 2012, NEURAL REGEN RES, V7, P1978, DOI 10.3969/j.issn.1673-5374.2012.25.009; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer H., 2013, CRS REP C, P7; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; He Y, 2015, INT J CLIN EXP MED, V8, P674; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang LL, 2015, J CLIN ENDOCR METAB, V100, pE729, DOI 10.1210/jc.2014-3827; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kok MGM, 2015, FASEB J, V29, P3853, DOI 10.1096/fj.15-271312; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leach Paul, 2009, J Trauma Manag Outcomes, V3, P5, DOI 10.1186/1752-2897-3-5; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li XL, 2013, ELECTRON J QUAL THEO; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Luo Y, 2013, CLIN CHEM, V59, P658, DOI 10.1373/clinchem.2012.195297; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Montalban E, 2014, NEUROMOL MED, V16, P415, DOI 10.1007/s12017-014-8292-z; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ogata K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120526; Ohta K, 2015, ONCOTARGET, V6, P3211, DOI 10.18632/oncotarget.3085; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Varendi K, 2014, CELL MOL LIFE SCI, V71, P4443, DOI 10.1007/s00018-014-1628-x; Wu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092292; Wu J, 2014, INT J CARDIOL, V172, P232, DOI 10.1016/j.ijcard.2013.12.214; Yang CH, 2013, INT J CANCER, V132, P116, DOI 10.1002/ijc.27657; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	46	53	55	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	APR	2016	137	1					122	129		10.1111/jnc.13534			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DH7NG	WOS:000372980100011	26756543	Bronze			2022-02-06	
J	Yengo-Kahn, AM; Hale, AT; Zalneraitis, BH; Zuckerman, SL; Sills, AK; Solomon, GS				Yengo-Kahn, Aaron M.; Hale, Andrew T.; Zalneraitis, Brian H.; Zuckerman, Scott L.; Sills, Allen K.; Solomon, Gary S.			The Sport Concussion Assessment Tool: a systematic review	NEUROSURGICAL FOCUS			English	Article						sideline assessment; Sport Concussion Assessment Tool; Standardized Assessment of Concussion; modified Balance Error Scoring System; sport-related concussion	BASE-LINE ASSOCIATIONS; ERROR SCORING SYSTEM; AMATEUR RUGBY UNION; HIGH-SCHOOL; ICE HOCKEY; STANDARDIZED ASSESSMENT; KING-DEVICK; SIDELINE; SCAT2; YOUTH	Objective Over the last 2 decades, sport-related concussion (SRC) has garnered significant attention. Even with increased awareness and athlete education, sideline recognition and real-time diagnosis remain crucial. The need for an objective and standardized assessment of concussion led to the eventual development of the Sport Concussion Assessment Tool (SCAT) during the Second International Conference on Concussion in Sport in 2004, which is now in its third iteration (SCAT3). In an effort to update our understanding of the most well-known sideline concussion assessment, the authors conducted a systematic review of the SCAT and the evidence supporting its use to date. METHODS English-language titles and abstracts published between 1995 and October 2015 were searched systematically across 4 electronic databases and a review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines adapted for the review of a heterogeneous collection of study designs. Peer-reviewed journal articles were included if they reported quantitative data on any iteration of the SCAT, Standardized Assessment of Concussion (SAC), or modified Balance Error Scoring System (mBESS) data at baseline or following concussion in an exclusively athlete population with any portion older than 13 years of age. Studies that included nonathletes, only children less than 13 years old, exclusively BESS data, exclusively symptom scale data, or a non-SCAT-related assessment were excluded. RESULTS The database search process yielded 549 abstracts, and 105 full-text articles were reviewed with 36 meeting criteria for inclusion. Nineteen studies were associated with the SAC, 1 was associated with the mBESS exclusively, and 16 studies were associated with a full iteration of the SCAT. The majority of these studies (56%) were prospective cohort studies. Male football players were the most common athletes studied. An analysis of the studies focused on baseline differences associated with age, sex, concussion history, and the ability to detect an SRC. CONCLUSIONS Looking toward the upcoming Concussion in Sport Group meeting in fall 2016, one may expect further revision to the SCAT3. However, based on this systematic review, the authors propose further, in-depth study of an already comprehensive concussion test, with acute, diagnostic, as well as long-term use.	[Yengo-Kahn, Aaron M.; Hale, Andrew T.; Zalneraitis, Brian H.; Zuckerman, Scott L.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 1500 21st Ave S,Ste 1506, Nashville, TN 37232 USA; [Zuckerman, Scott L.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37232 USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 1500 21st Ave S,Ste 1506, Nashville, TN 37232 USA.	aaron.m.yengo-kahn@vanderbilt.edu	Solomon, Gary/K-9011-2019; Yengo-Kahn, Aaron/AAV-7647-2020; Meijer, Anna/K-5118-2016	Yengo-Kahn, Aaron/0000-0002-5989-3064; Hale, Andrew/0000-0003-3182-2966	Tennessee Titans; Nashville Predators	Dr. Solomon receives consulting fees from the Tennessee Titans (NFL), the Nashville Predators (NHL), and the athletic departments for several universities. In addition he is a member of the ImPACT advisory board and receives reimbursement for expenses related to board meetings, and also receives royalties from book sales. Dr. Sills is a consulting physician to the Nashville Predators (uncompensated) and also serves as an unaffiliated neurotrauma consultant for the NFL.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bonfield CM, 2014, PROG NEUROL SURG, V28, P161, DOI 10.1159/000358777; Curaudeau GA, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11186; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12286; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanninen T, 2015, J SCI MED SPORT; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nassiri JD, 2002, MIL MED, V167, P873, DOI 10.1093/milmed/167.10.873; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Wang Y, 2015, J NEUROTRAUMA; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07; Yengo-Kahn AM, 2015, AM J SPORTS MED; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	59	53	54	4	35	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4							E6	10.3171/2016.1.FOCUS15611			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500007	27032923	gold			2022-02-06	
J	Ono, KE; Burns, TG; Bearden, DJ; McManus, SM; King, H; Reisner, A				Ono, Kim E.; Burns, Thomas G.; Bearden, Donald J.; McManus, Susan M.; King, Harold; Reisner, Andrew			Sex-Based Differences as a Predictor of Recovery Trajectories in Young Athletes After a Sports-Related Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						sex-based difference; concussion; trajectories of recovery; adolescents	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL FUNCTION; CLINICAL ARTICLE; HIGH-SCHOOL; SYMPTOMS; GENDER; AGE; PLAYERS; SCALE; LINE	Background: To date, few studies have delineated clear sex-based differences in symptom resolution after a sports-related concussion (SRC), and equivocal results have been identified in sex-based differences on baseline assessments. Purpose: To assess whether female athletes displayed prolonged recovery and more symptoms at baseline and after an SRC compared with male athletes. Study Design: Cohort study; Level of evidence, 3. Methods: The current study assessed 135 male and 41 female athletes (10-18 years old) who participated in high-impact sports in metropolitan Atlanta middle and high schools. All athletes completed a baseline assessment and at least 1 postconcussion assessment from the Immediate Post-Concussion Assessment and Cognitive Testing battery. Longitudinal hierarchical linear modeling was employed to examine individual-level variables and their associations with adolescents' rates of recovery in concussive symptoms after controlling for age and number of prior concussions. Results: Aggregate symptoms were rated as higher in female athletes compared with male athletes at baseline (mean SD: females, 13.49 +/- 11.20; males, 4.88 +/- 8.74; F(1,175) = 10.59, P < .001) and immediately after a concussion (females: 16.75 +/- 18.08; males: 10.58 +/- 14.21; F(1,175) = 3.99, P = .05). There were no group differences in the slope of recovery between male and female athletes, indicating generally similar trajectories of change for both groups. Post hoc analyses revealed higher baseline levels of migraine and neuropsychological symptoms in female athletes. Conclusion: Although female athletes in the current study reported increased symptoms, identical recovery patterns were observed in both sexes, suggesting that sex-based differences in concussion recovery are better explained by increased symptom frequency among female athletes when compared with their male counterparts.	[Ono, Kim E.; Burns, Thomas G.; Bearden, Donald J.; McManus, Susan M.; King, Harold; Reisner, Andrew] Childrens Healthcare Atlanta, 1547 Clifton Rd Northeast,Suite 200, Atlanta, GA 30322 USA; [Bearden, Donald J.] Boston Childrens Hosp, Boston, MA USA		Ono, KE (corresponding author), Childrens Healthcare Atlanta, 1547 Clifton Rd Northeast,Suite 200, Atlanta, GA 30322 USA.	kim.ono@choa.org	Meijer, Anna/K-5118-2016	Bearden, Donald/0000-0003-1306-5615	Children's Healthcare of Atlanta	One or more of the authors has declared the following potential conflict of interest or source of funding: Children's Healthcare of Atlanta supplied the stipend for the authors as employees as well as data used for analyses.	Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown CN, 2007, J ATHL TRAINING, V42, P515; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2001, CLIN SPORTS MED, V30, P125; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Farace E, 2000, NEUROSURG FOCUS, V8, pe8; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Hancock GR, 2006, QUANT METH EDUC BEHA, P1; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lindvall HF, 1974, ACTA NEUROL SCAND  S, V56, P3; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCartney Kathleen, 2006, Monogr Soc Res Child Dev, V71, P1, DOI 10.1111/j.1540-5834.2006.07103001.x; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Raudenbush SW, 2004, HIERARCHICAL LINEAR; RUTHERFORD WH, 1977, LANCET, V1, P1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	32	53	53	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2016	44	3					748	752		10.1177/0363546515617746			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	DF9CQ	WOS:000371658300030	26672026				2022-02-06	
J	Takala, RSK; Posti, JP; Runtti, H; Newcombe, VF; Outtrim, J; Katila, AJ; Frantzen, J; Ala-Seppala, H; Kyllonen, A; Maanpaa, HR; Tallus, J; Hossain, MI; Coles, JP; Hutchinson, P; van Gils, M; Menon, DK; Tenovuo, O				Takala, Riikka S. K.; Posti, Jussi P.; Runtti, Hilkka; Newcombe, Virginia F.; Outtrim, Joanne; Katila, Ari J.; Frantzen, Janek; Ala-Seppala, Henna; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Hossain, Md. Iftakher; Coles, Jonathan P.; Hutchinson, Peter; van Gils, Mark; Menon, David K.; Tenovuo, Olli			Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Biomarkers; GFAP; Outcome; Traumatic brain injury; UCH-L1	INTRACRANIAL LESIONS; COMPUTED-TOMOGRAPHY; SERUM BIOMARKERS; GFAP; S100B; MILD; PROGNOSIS; MODERATE; S100-BETA; DIAGNOSIS	OBJECTIVE: Biomarkers ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) may help detect brain injury, assess its severity, and improve outcome prediction. This study aimed to evaluate the prognostic value of these biomarkers during the first days after brain injury. METHODS: Serum UCH-L1 and GFAP were measured hi 324 patients with traumatic brain injury (TBI) enrolled in a prospective study. The outcome was assessed using the Glasgow Outcome Scale (GOS) or the extended version, Glasgow Outcome Scale-Extended (GOSE). RESULTS: Patients with full recovery had lower UCH-L1 concentrations on the second day and patients with favorable outcome had lower UCH-L1 concentrations during the first 2 days compared with patients with incomplete recovery and unfavorable outcome. Patients with full recovery and favorable outcome had significantly lower GFAP concentrations in the first 2 days than patients with incomplete recovery or unfavorable outcome. There was a strong negative correlation between outcome and UCH-L1 in the first 3 days and GFAP levels in the first 2 days. On arrival, both UCH-L1 and GFAP distinguished patients with GOS score 1-3 from patients with GOS score 4-5, but not patients with GOSE score 8 from patients with GOSE score 1-7. For UCH-L1 and GFAP to predict unfavorable outcome (GUS score <= 3), the area under the receiver operating characteristic curve was 0.727, and 0323, respectively. Neither UCHL-1 nor GFAP was independently able to predict the outcome when age, worst Glasgow Coma Scale score, pupil reactivity, Injury Severity Score, and Marshall score were added into the multivariate logistic regression model. CONCLUSIONS: GFAP and UCH-L1 are significantly associated with outcome, but they do not add predictive power to commonly used prognostic variables in a population of patients with TBI of varying severities.	[Takala, Riikka S. K.; Katila, Ari J.] Turku Univ Hosp, Intens Care Med & Pain Management, Perioperat Serv, FIN-20520 Turku, Finland; [Posti, Jussi P.; Frantzen, Janek] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, FIN-20520 Turku, Finland; [Posti, Jussi P.; Frantzen, Janek; Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, FIN-20520 Turku, Finland; Univ Turku, Turku, Finland; [Posti, Jussi P.; Ala-Seppala, Henna; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Hossain, Md. Iftakher; Tenovuo, Olli] Univ Turku, Dept Neurol, FIN-20520 Turku, Finland; [Runtti, Hilkka; van Gils, Mark] VTT Tech Res Ctr Finland, Syst Med, Tampere, Finland; [Newcombe, Virginia F.; Outtrim, Joanne; Coles, Jonathan P.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge CB2 2QQ, England; [Hutchinson, Peter] Univ Cambridge, Addenbrookes Hosp, Neurosurg Unit, Dept Clin Neurosci, Cambridge CB2 2QQ, England		Takala, RSK (corresponding author), Turku Univ Hosp, Intens Care Med & Pain Management, Perioperat Serv, FIN-20520 Turku, Finland.	riikka.takala@gmail.com	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Liedes, Hilkka/0000-0003-4655-7675; Hossain, Iftakher/0000-0003-4836-1158; Hutchinson, Peter/0000-0002-2796-1835; Ala-Seppala, Henna/0000-0002-1577-3028; Coles, Jonathan/0000-0003-4013-679X; Newcombe, Virginia/0000-0001-6044-9035; van Gils, Mark/0000-0002-0029-1771	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7-270259-TBlcare]; United Kingdom National Institute of Health Research Biomedical Research Centre at Cambridge; EVO grant from Hospital District of South-West Finland; Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship; United Kingdom National Institute of Health ResearchNational Institute for Health Research (NIHR); AbbottAbbott Laboratories; Baxter; Fresenius-Kabi; UCBUCB Pharma SA; PfizerPfizer; Skulle Implants Ltd.; Orion; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-CSF4-Newcombe] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, NF-SI-0508-10327, NIHR-RP-R3-12-013, ACF-2009-14-007] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI	This work was partially funded by the European Commission under the 7th Framework Programme (FP7-270259-TBlcare), the United Kingdom National Institute of Health Research Biomedical Research Centre at Cambridge, and a personal EVO grant (R.S.K.T.) from Hospital District of South-West Finland. V.F.N. is supported by a Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship. J.O., J.P.C., P.H., and D.K.M. were supported by the United Kingdom National Institute of Health Research Biomedical Research Centre at Cambridge, and D.K.M. was also supported by a Senior Investigator Award from the United Kingdom National Institute of Health Research.; R.S.K.T has received speaker's fees from Abbott, Baxter, Fresenius-Kabi, and UCB; has received financial support in the form of a congress fee and travel expenses paid by Pfizer; and is a stockholder of Orion. J.P.P. has received financial support in the form of a congress fee and travel expenses paid by Skulle Implants Ltd., J.E is member of the board of directors in BonAlive Biomaterials Ltd., P.J.H. is a director of Technicam. O.T. has received speaker's fees from Orion. The remaining authors have no financial disclosures.	Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; JENNETT B, 1976, LANCET, V1, P1031; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Shoemaker LD, 2012, NEUROSURGERY, V70, P518, DOI 10.1227/NEU.0b013e3182333a26; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c	37	53	59	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2016	87						8	20		10.1016/j.wneu.2015.10.066			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3HR	WOS:000373390200003	26547005	Green Submitted			2022-02-06	
J	Greene, NH; Kernic, MA; Vavilala, MS; Rivara, FP				Greene, Nathaniel H.; Kernic, Mary A.; Vavilala, Monica S.; Rivara, Frederick P.			Validation of ICDPIC software injury severity scores using a large regional trauma registry	INJURY PREVENTION			English	Article							BRAIN-INJURY; UNITED-STATES; OUTCOMES; CARE	Background Administrative or quality improvement registries may or may not contain the elements needed for investigations by trauma researchers. International Classification of Diseases Program for Injury Categorisation (ICDPIC), a statistical program available through Stata, is a powerful tool that can extract injury severity scores from ICD-9-CM codes. We conducted a validation study for use of the ICDPIC in trauma research. Methods We conducted a retrospective cohort validation study of 40 418 patients with injury using a large regional trauma registry. ICDPIC-generated AIS scores for each body region were compared with trauma registry AIS scores (gold standard) in adult and paediatric populations. A separate analysis was conducted among patients with traumatic brain injury (TBI) comparing the ICDPIC tool with ICD-9-CM embedded severity codes. Performance in characterising overall injury severity, by the ISS, was also assessed. Results The ICDPIC tool generated substantial correlations in thoracic and abdominal trauma (weighted kappa 0.87-0.92), and in head and neck trauma (weighted kappa 0.76-0.83). The ICDPIC tool captured TBI severity better than ICD-9-CM code embedded severity and offered the advantage of generating a severity value for every patient (rather than having missing data). Its ability to produce an accurate severity score was consistent within each body region as well as overall. Conclusions The ICDPIC tool performs well in classifying injury severity and is superior to ICD-9-CM embedded severity for TBI. Use of ICDPIC demonstrates substantial efficiency and may be a preferred tool in determining injury severity for large trauma datasets, provided researchers understand its limitations and take caution when examining smaller trauma datasets.	[Greene, Nathaniel H.] Duke Univ, Dept Anesthesiol & Pediat, Sch Med, Durham, NC 27710 USA; [Kernic, Mary A.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Sch Med, Seattle, WA 98195 USA; [Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Greene, NH (corresponding author), Duke Univ, Dept Anesthesiol & Pediat, Sch Med, DUMC Box 3094, Durham, NC 27710 USA.	nathaniel.greene@dm.duke.edu	Greene, Nathaniel/J-3450-2014	Greene, Nathaniel/0000-0003-0230-0499	Department of Anesthesiology and Pain Medicine at the University of Washington School of Medicine	This project was funded internally by the Department of Anesthesiology and Pain Medicine at the University of Washington School of Medicine.	Agency for Healthcare Research and Quality, 2014, OV STAT INP DAT SID; Arroyo AC, 2012, ACAD EMERG MED, V19, P541, DOI 10.1111/j.1553-2712.2012.01356.x; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Centers for Medicare and Medicaid Services, 2014, EHR INC PROGR SEC EH; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Clark DE., ICDPIC STATA MODULE; Cook Alan, 2012, Proc (Bayl Univ Med Cent), V25, P6; Di Bartolomeo S, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-17; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; Newgard C, 2012, ACAD EMERG MED, V19, P469, DOI 10.1111/j.1553-2712.2012.01324.x; Sanchez AI, 2012, J HEAD TRAUMA REHAB, V27, P159, DOI 10.1097/HTR.0b013e3182074c41; Scher AI, 2011, J NEUROTRAUM, V28, P1739, DOI 10.1089/neu.2011.1982; Sears JM, 2013, J OCCUP REHABIL, V23, P19, DOI 10.1007/s10926-012-9377-x; Weiss H, 2010, PEDIATRICS, V126, P1149, DOI 10.1542/peds.2010-0902	18	53	55	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	OCT	2015	21	5					325	330		10.1136/injuryprev-2014-041524			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CT4MC	WOS:000362779600007	25985974	Green Submitted			2022-02-06	
J	Choi, HJ; Sun, D; Jakobs, TC				Choi, Hee Joo; Sun, Daniel; Jakobs, Tatjana C.			Astrocytes in the optic nerve head express putative mechanosensitive channels	MOLECULAR VISION			English	Article							RETINAL GANGLION-CELLS; ELEVATED HYDROSTATIC-PRESSURE; RETROGRADE AXOPLASMIC-TRANSPORT; STRETCH-ACTIVATED CHANNELS; POLYCYSTIC KIDNEY-DISEASE; EPIDERMAL MERKEL CELLS; TUMOR-NECROSIS-FACTOR; INTRAOCULAR-PRESSURE; GENE-EXPRESSION; EPITHELIAL-CELLS	Purpose: To establish whether optic nerve head astrocytes express candidate molecules to sense tissue stretch. Methods: We used conventional PCR, quantitative PCR, and single-cell reverse transcription PCR (RT-PCR) to assess the expression of various members of the transient receptor potential (TRP) channel family and of the recently characterized mechanosensitive channels Piezo1 and 2 in optic nerve head tissue and in single, isolated astrocytes. Results: Most TRP subfamilies (TRPC, TRPM, TRPV, TRPA, and TRPP) and Piezo1 and 2 were expressed in the optic nerve head of the mouse. Quantitative real-time PCR analysis showed that TRPC1, TRPM7, TRPV2, TRPP2, and Piezo1 are the dominant isoforms in each subfamily. Single-cell RT-PCR revealed that many TRP isoforms, TRPC1-2, TRPC6, TRPV2, TRPV4, TRPM2, TRPM4, TRPM6-7, TRPP1-2, and Piezo1-2, are expressed in astrocytes of the optic nerve head, and that most astrocytes express TRPC1 and TRPP1-2. Comparisons of the TRPP and Piezo expression levels between different tissue regions showed that Piezo2 expression was higher in the optic nerve head and the optic nerve proper than in the brain and the corpus callosum. TRPP2 also showed higher expression in the optic nerve head. Conclusions: Astrocytes in the optic nerve head express multiple putative mechanosensitive channels, in particular the recently identified channels Piezo1 and 2. The expression of putative mechanosensitive channels in these cells may contribute to their responsiveness to traumatic or glaucomatous injury.	[Choi, Hee Joo; Sun, Daniel; Jakobs, Tatjana C.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA		Jakobs, TC (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	Tatjana_Jakobs@meei.harvard.edu		Jakobs, Tatjana/0000-0002-8104-9206	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY019703, R01EY022092]; Lefler Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY022092, R01EY019703] Funding Source: NIH RePORTER	This work was supported by NIH grants R01EY019703 and R01EY022092, and the Lefler Foundation. The authors wish to thank Dr. Richard Masland for critically reading the manuscript, and Rong Guo, MS, for advice on statistical tests.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Bron R, 2014, J COMP NEUROL, V522, P2967, DOI 10.1002/cne.23560; Chauhan BC, 2008, CAN J OPHTHALMOL, V43, P356, DOI 10.3129/i08-060; Chauhan BC, 2004, INVEST OPHTH VIS SCI, V45, P144, DOI 10.1167/iovs.03-0687; Choi HJ, 2015, EXP EYE RES IN PRESS; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Djenoune L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00026; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; Gees M, 2010, COLD SPRING HARB PER, V2; Gilliam JC, 2011, VISION RES, V51, P2440, DOI 10.1016/j.visres.2011.10.009; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Guo L, 2000, GENOMICS, V64, P241, DOI 10.1006/geno.2000.6131; Hernandez MR, 2000, GLIA, V32, P122, DOI 10.1002/1098-1136(200011)32:2<122::AID-GLIA20>3.0.CO;2-J; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Ho KW, 2014, GLIA, V62, P1435, DOI 10.1002/glia.22691; Ho Karen W, 2012, Am J Neurodegener Dis, V1, P1; Ho KW, 2011, ARVO ANN M; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Hu HL, 2010, EXP EYE RES, V91, P425, DOI 10.1016/j.exer.2010.06.017; Ikeda R, 2014, NEUROSCI LETT, V583, P210, DOI 10.1016/j.neulet.2014.05.055; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Jakobs TC, 2007, MOL VIS, V13, P933; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jakobs TC, 2003, J COMP NEUROL, V465, P361, DOI 10.1002/cne.10845; JOHANSSON JO, 1983, INVEST OPHTH VIS SCI, V24, P1552; JOHANSSON JO, 1988, EXP EYE RES, V46, P223, DOI 10.1016/S0014-4835(88)80079-4; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Kaja S, 2012, NEUROSCIENCE, V202, P99, DOI 10.1016/j.neuroscience.2011.11.047; Kalapesi FB, 2005, CLIN EXP OPHTHALMOL, V33, P210, DOI 10.1111/j.1442-9071.2005.00981.x; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lambertsen KL, 2005, J CEREBR BLOOD F MET, V25, P119, DOI 10.1038/sj.jcbfm.9600014; Lambertsen KL, 2001, BRAIN RES PROTOC, V7, P175, DOI 10.1016/S1385-299X(01)00062-9; Leonelli M, 2013, CELL MOL NEUROBIOL, V33, P379, DOI 10.1007/s10571-012-9904-5; Leonelli M, 2009, INT J DEV NEUROSCI, V27, P709, DOI 10.1016/j.ijdevneu.2009.07.003; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Ma X, 2011, CELL CALCIUM, V50, P502, DOI 10.1016/j.ceca.2011.08.006; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Malone P, 2007, GLIA, V55, P1085, DOI 10.1002/glia.20527; Mandal A, 2010, INVEST OPHTH VIS SCI, V51, P3129, DOI 10.1167/iovs.09-4614; Mandal A, 2009, AM J PHYSIOL-CELL PH, V297, pC111, DOI 10.1152/ajpcell.00539.2008; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; McHugh BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040346; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Morcos Y, 2000, J NEUROCYTOL, V29, P665, DOI 10.1023/A:1010835404754; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nakatani M, 2015, PFLUG ARCH EUR J PHY, V467, P101, DOI 10.1007/s00424-014-1569-0; Niggel J, 2000, J MEMBRANE BIOL, V174, P121, DOI 10.1007/s002320001037; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; Numata T, 2007, CELL PHYSIOL BIOCHEM, V19, P1, DOI 10.1159/000099187; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Ostrow LW, 2011, BIOCHEM BIOPH RES CO, V410, P81, DOI 10.1016/j.bbrc.2011.05.109; Peyronnet R, 2013, EMBO REP, V14, P1143, DOI 10.1038/embor.2013.170; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Qu J, 2013, PLOS ONE, V8; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Resta V, 2007, EUR J NEUROSCI, V25, P2741, DOI 10.1111/j.1460-9568.2007.05528.x; Reyes JP, 2009, BIOCHEM BIOPH RES CO, V380, P50, DOI 10.1016/j.bbrc.2009.01.021; Rogers R, 2012, INVEST OPHTH VIS SCI, V53, P3806, DOI 10.1167/iovs.11-8480; Rogers RS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012302; Roy B, 2014, INTEGR BIOL-UK, V6, P289, DOI [10.1039/c3ib40174j, 10.1039/C3IB40174J]; Ryskamp Daniel A, 2014, Cells, V3, P914, DOI 10.3390/cells3030914; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Salvador-Silva M, 2001, J NEUROSCI RES, V66, P59, DOI 10.1002/jnr.1197; Sappington RM, 2008, INVEST OPHTH VIS SCI, V49, P3004, DOI 10.1167/iovs.07-1355; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Takumida M, 2010, ACTA OTO-LARYNGOL, V130, P196, DOI 10.3109/00016480903013593; Verkhratsky A, 2014, REV PHYSIOL BIOCH P, V166, P1, DOI 10.1007/112_2013_15; Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Ward NJ, 2014, J NEUROSCI, V34, P3161, DOI 10.1523/JNEUROSCI.4089-13.2014; Weitlauf C, 2014, J NEUROSCI, V34, P15369, DOI 10.1523/JNEUROSCI.3424-14.2014; Wheeler-Schilling TH, 2001, MOL BRAIN RES, V92, P177, DOI 10.1016/S0169-328X(01)00160-7; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Xia JS, 2012, J PHYSIOL-LONDON, V590, P2285, DOI 10.1113/jphysiol.2012.227983; Yang P, 2004, PHYSIOL GENOMICS, V17, P157, DOI 10.1152/physiolgenomics.00182.2003; Yang XN, 2014, DIGEST DIS SCI, V59, P1428, DOI 10.1007/s10620-014-3044-3; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052; Zimov S, 2004, J NEUROCYTOL, V33, P441, DOI 10.1023/B:NEUR.0000046574.72380.e8; Zimov S, 2007, VISUAL NEUROSCI, V24, P581, DOI 10.1017/S095252380707054X	113	53	53	2	8	MOLECULAR VISION	ATLANTA	C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322 USA	1090-0535			MOL VIS	Mol. Vis.	JUL 14	2015	21												18	Biochemistry & Molecular Biology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Ophthalmology	CO2VR	WOS:000359015400001	26236150				2022-02-06	
J	Song, J; Wang, L; Cai, CB; Qi, XQ				Song, Jia; Wang, Lun; Cai, Cuobiao; Qi, Xiaoqiang			Nonlinear fractional order proportion-integral-derivative active disturbance rejection control method design for hypersonic vehicle attitude control	ACTA ASTRONAUTICA			English	Article						Hypersonic vehicle; (NFOPID mu)-D-lambda; Active disturbance rejection control; Natural selection particle swarm algorithm; Control	MODEL	Near space hypersonic vehicle model is nonlinear, multivariable and couples in the reentry process, which are challenging for the controller design. In this paper, a nonlinear fractional order proportion integral derivative ((NFOPID mu)-D-lambda) active disturbance rejection control (ADRC) strategy based on a natural selection particle swarm (NSPSO) algorithm is proposed for the hypersonic vehicle flight control. The (NFOPID mu)-D-lambda ADRC method consists of a tradting-differentiator (TD), an (NFOPID mu)-D-lambda controller and an extended state observer (ESO). The (NFOPID mu)-D-lambda controller designed by combining an (FOPID mu)-D-lambda method and a nonlinear states error feedback control law (NLSEF) is to overcome concussion caused by the NLSEF and conversely compensate the insufficiency for relatively simple and rough signal processing caused by the (FOPID mu)-D-lambda method. The TD is applied to coordinate the contradiction between rapidity and overshoot By attributing all uncertain factors to unknown disturbances, the ESO can achieve dynamic feedback compensation for these disturbances and thus reduce their effects. Simulation results show that the (NFOPID mu)-D-lambda ADRC method can make the hypersonic vehicle six-degree-of-freedom nonlinear model track desired nominal signals accurately and fast, has good stability, dynamic properties and strong robustness against external environmental disturbances. (C) 2015 IAA Published by Elsevier Ltd. All rights reserved.	[Song, Jia; Wang, Lun; Cai, Cuobiao] Beihang Univ, Sch Astronaut, Beijing 100191, Peoples R China; [Qi, Xiaoqiang] Beijing Inst Mech & Elect Engn, Beijing 100074, Peoples R China		Song, J (corresponding author), Beihang Univ, Sch Astronaut, Beijing 100191, Peoples R China.	songjia@buaa.edu.cn			National Science FoundationNational Science Foundation (NSF) [51206007]; Aeronautical Science Foundation of China [2013ZC51]	This work was supported by National Science Foundation (No. 51206007) and Aeronautical Science Foundation of China (2013ZC51).	Albano M, 2013, ACTA ASTRONAUT, V87, P30, DOI 10.1016/j.actaastro.2013.02.003; Duan HB, 2012, SCI CHINA TECHNOL SC, V55, P2965, DOI 10.1007/s11431-012-5036-x; Han J., 2008, ACTIVE DISTURBANCE R; Han Jing-qing, 2002, Control Engineering China, V9, P13; Han JQ, 2009, IEEE T IND ELECTRON, V56, P900, DOI 10.1109/TIE.2008.2011621; HUANG Y, 2000, CHINESE SCI BULL, V45, P1373; Huang YQ, 2013, CHINESE J AERONAUT, V26, P948, DOI 10.1016/j.cja.2013.04.036; Huang YQ, 2013, J SYST ENG ELECTRON, V24, P118, DOI 10.1109/JSEE.2013.00015; Jiang B., 2011, P IMECHE 1, V225; Lian C. B., 2013, J CENT S U SCI TECHN, V44, P92; Podlubny I, 1999, IEEE T AUTOMAT CONTR, V44, P208, DOI 10.1109/9.739144; Pu ZQ, 2014, ACTA ASTRONAUT, V101, P16, DOI 10.1016/j.actaastro.2014.01.025; Qi Naiming, 2012, Journal of Projectiles, Rockets, Missiles and Guidance, V32, P49; Qin Changmao, 2011, Transactions of Nanjing University of Aeronautics & Astronautics, V28, P240; Shahriar K., 2005, P AIAA GUID NAV CONT; Shaughnessy J.D., 1990, TM102610 NASA; SHAUGHNESSY JD, 1990, 102610 NASA; Voland RT, 2006, ACTA ASTRONAUT, V59, P181, DOI 10.1016/j.actaastro.2006.02.021; Wang J, 2013, J SYST ENG ELECTRON, V24, P288, DOI 10.1109/JSEE.2013.00036; Wei J. X., 2009, EVOLUTIONARY ALGORIT, P24; Xu B, 2013, NONLINEAR DYNAM, V73, P1849, DOI 10.1007/s11071-013-0908-6; [薛定宇 XUE Dingyu], 2007, [控制理论与应用, Control Theory & Applications], V24, P771; Zhang X. B., 2013, P 25 CHIN CONTR DEC; Zhang Z, 2012, SCI CHINA INFORM SCI, V55, P2243, DOI 10.1007/s11432-011-4455-9; [周啟航 Zhou Qihang], 2012, [计算机仿真, Computer Simulation], V29, P90	25	53	57	6	105	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	JUN-JUL	2015	111						160	169		10.1016/j.actaastro.2015.02.026			10	Engineering, Aerospace	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CI2NY	WOS:000354585500014					2022-02-06	
J	Katzenberger, RJ; Chtarbanova, S; Rimkus, SA; Fischer, JA; Kaur, G; Seppala, JM; Swanson, LC; Zajac, JE; Ganetzky, B; Wassarman, DA				Katzenberger, Rebeccah J.; Chtarbanova, Stanislava; Rimkus, Stacey A.; Fischer, Julie A.; Kaur, Gulpreet; Seppala, Jocelyn M.; Swanson, Laura C.; Zajac, Jocelyn E.; Ganetzky, Barry; Wassarman, David A.			Death following traumatic brain injury in Drosophila is associated with intestinal barrier dysfunction	ELIFE			English	Article							SENSITIVE PARALYTIC MUTANTS; TRANSCRIPTION FACTOR RELISH; GENETIC REFERENCE PANEL; INNATE IMMUNE-RESPONSE; EPITHELIAL MORPHOGENESIS; INCREASED MORTALITY; PREDICTIVE FACTORS; TIGHT JUNCTIONS; BLOOD-BRAIN; HEAD-INJURY	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Unfavorable TBI outcomes result from primary mechanical injuries to the brain and ensuing secondary non-mechanical injuries that are not limited to the brain. Our genome-wide association study of Drosophila melanogaster revealed that the probability of death following TBI is associated with single nucleotide polymorphisms in genes involved in tissue barrier function and glucose homeostasis. We found that TBI causes intestinal and blood-brain barrier dysfunction and that intestinal barrier dysfunction is highly correlated with the probability of death. Furthermore, we found that ingestion of glucose after a primary injury increases the probability of death through a secondary injury mechanism that exacerbates intestinal barrier dysfunction. Our results indicate that natural variation in the probability of death following TBI is due in part to genetic differences that affect intestinal barrier dysfunction.	[Katzenberger, Rebeccah J.; Rimkus, Stacey A.; Fischer, Julie A.; Kaur, Gulpreet; Seppala, Jocelyn M.; Swanson, Laura C.; Zajac, Jocelyn E.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Chtarbanova, Stanislava; Ganetzky, Barry] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Kaur, Gulpreet] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA; [Swanson, Laura C.] Univ Wisconsin, Sch Med & Publ Hlth, Med Scientist Training Program, Madison, WI 53706 USA		Ganetzky, B (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	ganetzky@wisc.edu; dawassarman@wisc.edu		Chtarbanova, Stanislava/0000-0001-7865-028X; Swanson, Laura/0000-0002-9438-7546	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG033620]; University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033620] Funding Source: NIH RePORTER	National Institutes of Health (NIH) R01 AG033620 Barry Ganetzky; University of Wisconsin-Madison Robert Draper Technology Innovation Funding David A Wassarman	Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Arroyo DS, 2011, INT IMMUNOPHARMACOL, V11, P1415, DOI 10.1016/j.intimp.2011.05.006; Babcock DT, 2015, GENETICS, V199, P511, DOI 10.1534/genetics.114.172403; Balsiger Z, 2014, HIT DEVICE HIGH SPEE; Banerjee S, 2008, DEV BIOL, V317, P585, DOI 10.1016/j.ydbio.2008.03.007; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Bastide H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0179-y; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bonnay F, 2013, P NATL ACAD SCI USA, V110, P2957, DOI 10.1073/pnas.1221910110; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Burg MG, 2012, J NEUROGENET, V26, P189, DOI 10.3109/01677063.2012.690011; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Chinchore Y, 2012, P NATL ACAD SCI USA, V109, pE605, DOI 10.1073/pnas.1110666109; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Desalvo MK, 2011, GLIA, V59, P1322, DOI 10.1002/glia.21147; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Dionex, 2003, DET SUG MOL HIGH PER; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Elkon B, 2014, PEDIATR CRIT CARE ME, V15, P623, DOI 10.1097/PCC.0000000000000170; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Falconer D. S., 1996, INTRO QUANTITATIVE G, V4th; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fergestad T, 2008, GENETICS, V178, P947, DOI 10.1534/genetics.107.082115; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gnerer JP, 2006, P NATL ACAD SCI USA, V103, P14987, DOI 10.1073/pnas.0606887103; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Greco T, 2013, J CHILD NEUROL, V28, P983, DOI 10.1177/0883073813487594; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Handke B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067208; Haron RH, 2011, MALAYS J MED SCI, V18, P69; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; Lustenberger T, 2013, BRAIN INJURY, V27, P281, DOI 10.3109/02699052.2012.743178; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Palladino MJ, 2002, GENETICS, V161, P1197; Pare A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036254; Parker L, 2011, INT REV NEUROBIOL, V99, P1, DOI 10.1016/B978-0-12-387003-2.00001-X; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Pinsonneault RL, 2011, METHODS MOL BIOL, V686, P357, DOI 10.1007/978-1-60761-938-3_17; Piton G, 2011, INTENS CARE MED, V37, P911, DOI 10.1007/s00134-011-2172-x; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Reintam A, 2009, ACTA ANAESTH SCAND, V53, P318, DOI 10.1111/j.1399-6576.2008.01860.x; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salim A, 2009, AM SURGEON, V75, P25; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; SIDDIQI O, 1976, P NATL ACAD SCI USA, V73, P3253, DOI 10.1073/pnas.73.9.3253; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tan LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003966; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Yu ZQ, 2008, DEV BIOL, V319, P56, DOI 10.1016/j.ydbio.2008.04.001; Yuan Q, 2014, NEUROCRIT CARE, V20, P69, DOI 10.1007/s12028-012-9730-0; Zhang LP, 2010, J BIOL CHEM, V285, P34477, DOI 10.1074/jbc.M110.133561	104	53	53	0	11	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAR 5	2015	4								e04790	10.7554/eLife.04790			24	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	CE5ID	WOS:000351863900002	25742603	Green Published, gold			2022-02-06	
J	Rubenstein, R; Chang, BG; Davies, P; Wagner, AK; Robertson, CS; Wang, KKW				Rubenstein, Richard; Chang, Binggong; Davies, Peter; Wagner, Amy K.; Robertson, Claudia S.; Wang, Kevin K. W.			A Novel, Ultrasensitive Assay for Tau: Potential for Assessing Traumatic Brain Injury in Tissues and Biofluids	JOURNAL OF NEUROTRAUMA			English	Article						severe traumatic brain injury; EIMAF; rolling circle amplification; total and phosphorylated tau; brain and biofluids	FIBRILLARY ACIDIC PROTEIN; PAIRED HELICAL FILAMENTS; NEURON-SPECIFIC ENOLASE; CORTICAL IMPACT INJURY; SERUM S-100B PROTEIN; C-TERMINAL HYDROLASE; ALZHEIMERS-DISEASE; HEAD-INJURY; NEUROFIBRILLARY TANGLES; RISK-FACTOR	Traumatic brain injury (TBI) is a cause of death and disability and can lead to tauopathy-related dementia at an early age. Pathologically, TBI results in axonal injury that is coupled to tau hyperphosphorylation, leading to microtubule instability and tau-mediated neurodegeneration. This suggests that the forms of this protein might serve as neuroinjury-related biomarkers for diagnosis of injury severity and prognosis of the neurological damage prior to clinical expression. We initially determined whether we could detect tau in body fluids using a highly sensitive assay. We used a novel immunoassay, enhanced immunoassay using multi-arrayed fiberoptics (EIMAF) either alone or in combination with rolling circle amplification (a-EIMAF) for the detection of total (T) and phosphorylated (P) tau proteins from brains and biofluids (blood, CSF) of rodents following controlled cortical impact (CCI) and human patients post severe TBI (sTBI). This assay technology for tau is the most sensitive to date with a detection limit of approximately 100 ag/mL for either T-tau and P-tau. In the rodent models, T-tau and P-tau levels in brain and blood increased following CCI during the acute phase and remained high during the chronic phase (30 d). In human CSF samples, T-tau and P-tau increased during the sampling period (5-6 d). T-tau and P-tau in human serum rose during the acute phase and decreased during the chronic stage but was still detectable beyond six months post sTBI. Thus, EIMAF has the potential for assessing both the severity of the proximal injury and the prognosis using easily accessible samples.	[Rubenstein, Richard; Chang, Binggong] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Chang, Binggong] Suny Downstate Med Ctr, Dept Physiol Pharmacol, Brooklyn, NY 11203 USA; [Davies, Peter] Litwin Zucker Ctr Res Alzheimers Dis, Feinstein Inst Med Res, Manhasset, NY USA; [Wagner, Amy K.] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA		Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Box 1213,450 Clarkson Ave, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu		Wang, Kevin/0000-0002-9343-6473			Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Chang BG, 2009, J VIROL METHODS, V159, P15, DOI 10.1016/j.jviromet.2009.02.019; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Davies P, 2000, METH MOLEC MED, V32, P361, DOI 10.1385/1-59259-195-7:361; Dawson HN, 2001, J CELL SCI, V114, P1179; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ihara Y, 2001, NEUROBIOL AGING, V22, P123, DOI 10.1016/S0197-4580(00)00200-1; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mattsson N, 2012, BIOMARK MED, V6, P409, DOI [10.2217/bmm.12.39, 10.2217/BMM.12.39]; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rubenstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066352; Rubenstein R, 2012, J GEN VIROL, V93, P1375, DOI 10.1099/vir.0.038802-0; Rubenstein R, 2011, J VIROL, V85, P9031, DOI 10.1128/JVI.05111-11; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Santpere G, 2009, ACTA NEUROPATHOL, V117, P227, DOI 10.1007/s00401-008-0478-8; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Woertgen C, 2002, ACT NEUR S, V81, P205; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040	87	53	55	2	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					342	352		10.1089/neu.2014.3548			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700006	25177776	Green Published			2022-02-06	
J	Drexel, M; Puhakka, N; Kirchmair, E; Hortnagl, H; Pitkanen, A; Sperk, G				Drexel, Meinrad; Puhakka, Noora; Kirchmair, Elke; Hoertnagl, Heide; Pitkanen, Asla; Sperk, Guenther			Expression of GABA receptor subunits in the hippocampus and thalamus after experimental traumatic brain injury	NEUROPHARMACOLOGY			English	Article						Epilepsy; GABA; Lateral fluid-percussion injury; Neurosteroid	RAT HIPPOCAMPUS; DENTATE GYRUS; IMMUNOCYTOCHEMICAL DISTRIBUTION; POSTTRAUMATIC EPILEPSY; MESSENGER-RNAS; CARDIAC-ARREST; INHIBITION; NEURONS; MODEL; GAMMA	Traumatic brain injury is a major cause of death and disability worldwide and often associated with post-traumatic epilepsy. We recently demonstrated that TBI induces acquired GABA(A) receptors channelopathy that associates with hyperexcitability in granule cell layer (GCL). We now assessed the expression of GABA(A) and GABA(B) receptor subunit mRNAs between 6 h and 6 months post-TBI in the hippocampus and thalamus. The expression of major GABA(A) receptor subunit mRNAs (alpha 1, alpha 2, alpha 5, beta 2, beta 3, gamma 2 and delta) was, often bilaterally, down-regulated in the GCL and in the CA3 pyramidal cells. Instead, expression of alpha 4 (GCL, CA3, CA1), alpha 5 (CA1) and gamma 2 (GCL, CA3, CA1) mRNA was up-regulated after 10 d and/or 4 months. Many of these changes were reversible. In the thalamus, we found decreases in alpha 1, alpha 4, beta 2, gamma 2 and delta mRNAs in the laterodorsal thalamus and in the area combining the posterior thalamic nuclear group, ventroposterolateral and ventroposteromedial complex at 6 h to 4 months post-TBI. Unlike in the hippocampus, thalamic subunit down-regulations were irreversible and limited to the ipsilateral side. However, contralaterally there was up-regulation of the subunits delta and alpha 4 6 h and 4 months after TBI, respectively. PCR array analysis suggested a mild long-lasting GABA(A) receptor channelopathy in the GCL and thalamus after TBI. Whereas TBI induces transient changes in the expression of GABAA receptor subunits in the hippocampus (presumably representing compensatory mechanisms), alterations of GABA(A) receptor subunit mRNAs in the thalamus are long-lasting and related to degeneration of receptor-containing neurons in thalamo-cortical relay nuclei. This article is part of the Special Issue entitled 'GABAergic Signaling in Health and Disease'. (C) 2014 The Authors. Published by Elsevier Ltd.	[Drexel, Meinrad; Kirchmair, Elke; Hoertnagl, Heide; Sperk, Guenther] Med Univ Innsbruck, Dept Pharmacol, A-6020 Innsbruck, Austria; [Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, FI-40211 Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, FI-70211 Kuopio, Finland		Drexel, M (corresponding author), Med Univ Innsbruck, Dept Pharmacol, Peter Mayr Str 1a, A-6020 Innsbruck, Austria.	Meinrad.drexel@i-med.ac.at		Drexel, Meinrad/0000-0002-2705-9673	European UnionEuropean Commission [LSH-CT-2006-037315]; Austrian Research FundsAustrian Science Fund (FWF) [I00660, P26680]; Academy of FinlandAcademy of FinlandEuropean Commission; European Science FoundationEuropean Science Foundation (ESF)European Commission	The study was supported by the European Union Grant FP6 EPICURE (LSH-CT-2006-037315), by the Austrian Research Funds (I00660, P26680, to G.S.), by the Academy of Finland (A.P.), and the European Science Foundation EUROCORES Programme Euro-Epinomics (Epigennet). We thank Prof. Werner Sieghart (Medical University Vienna) for providing the GABA<INF>A</INF> receptor antibodies. We want to thank Dr. Jari Nissinen and Mr. Jarmo Hartikainen for help with the experiments.	Bailey MES, 1999, BBA-GENE STRUCT EXPR, V1447, P307, DOI 10.1016/S0167-4781(99)00167-0; Ben-Ari Y, 2011, EPILEPSY CURR, V11, P192, DOI 10.5698/1535-7511-11.6.192; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Campagna-Slater V, 2007, J MOL GRAPH MODEL, V25, P721, DOI 10.1016/j.jmgm.2006.06.001; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Connelly WM, 2013, J NEUROSCI, V33, P3780, DOI 10.1523/JNEUROSCI.4989-12.2013; Drexel M, 2011, NEUROSCIENCE, V189, P316, DOI 10.1016/j.neuroscience.2011.05.021; Drexel M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00142; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Fritschy JM, 1999, NEUROCHEM INT, V34, P435, DOI 10.1016/S0197-0186(99)00040-6; Furtinger S, 2003, MOL BRAIN RES, V113, P107, DOI 10.1016/S0169-328X(03)00097-4; Furtinger S, 2003, NEUROSCI LETT, V352, P141, DOI 10.1016/j.neulet.2003.08.046; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; GRUBER B, 1993, SYNAPSE, V15, P221, DOI 10.1002/syn.890150307; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Huusko N., 2014, NEUROSCIENCE; Huusko N., 2013, BRAIN STRUCT FUNCT; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KAWAI K, 1995, ACTA NEUROPATHOL, V89, P262; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loup F, 2000, J NEUROSCI, V20, P5401, DOI 10.1523/JNEUROSCI.20-14-05401.2000; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; MATHERN GW, 1994, EPILEPSY RES, V19, P129, DOI 10.1016/0920-1211(94)90023-X; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mohler H, 1998, LIFE SCI, V62, P1611, DOI 10.1016/S0024-3205(98)00116-7; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nishimura T, 2005, NEUROSCIENCE, V134, P691, DOI 10.1016/j.neuroscience.2005.04.013; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Nymann-Andersen J, 2002, J NEUROCHEM, V80, P815, DOI 10.1046/j.0022-3042.2002.00762.x; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pirker S, 2003, J NEUROPATH EXP NEUR, V62, P820, DOI 10.1093/jnen/62.8.820; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reddy Doodipala Samba, 2011, Front Endocrinol (Lausanne), V2, P38, DOI 10.3389/fendo.2011.00038; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; ROSS DT, 1995, BRAIN RES, V683, P117, DOI 10.1016/0006-8993(95)00344-P; Schwarzer C, 1997, NEUROSCIENCE, V80, P1001, DOI 10.1016/S0306-4522(97)00145-0; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sperk G, 1998, EPILEPSY RES, V32, P129, DOI 10.1016/S0920-1211(98)00046-1; Sperk G, 2004, ADV EXP MED BIOL, V548, P92; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Swanson LW, 1992, BRAIN MAPS STRUCTURE; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tao WC, 2013, J NEUROSCI, V33, P3738, DOI 10.1523/JNEUROSCI.4829-12.2013; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth Z, 1997, J NEUROSCI, V17, P8106; Tsunashima K, 1997, NEUROSCIENCE, V80, P1019, DOI 10.1016/S0306-4522(97)00144-9; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	69	53	55	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JAN	2015	88				SI		122	133		10.1016/j.neuropharm.2014.08.023			12	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AU9ZD	WOS:000345949500015	25229716	Green Published, hybrid			2022-02-06	
J	Hayes, JP; Miller, DR; Lafleche, G; Salat, DH; Verfaellie, M				Hayes, Jasmeet P.; Miller, Danielle R.; Lafleche, Ginette; Salat, David H.; Verfaellie, Mieke			The nature of white matter abnormalities in blast-related mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Fractional anisotropy; PTSD; Diffusion tensor imaging; OEF/OIF; Loss of consciousness	POSTTRAUMATIC-STRESS-DISORDER; OEF/OIF VETERANS; IRAQI FREEDOM; SELF-REPORT; PTSD; CONCUSSION; INTEGRITY; SYMPTOMS; DEFICITS; AFGHANISTAN	Blast-related traumatic brain injury (TBI) has been a common injury among returning troops due to the widespread use of improvised explosive devices in the Iraq and Afghanistan Wars. As most of the TBIs sustained are in the mild range, brain changes may not be detected by standard clinical imaging techniques such as CT. Furthermore, the functional significance of these types of injuries is currently being debated. However, accumulating evidence suggests that diffusion tensor imaging (DTI) is sensitive to subtle white matter abnormalities and may be especially useful in detecting mild TBI (mTBI). The primary aim of this study was to use DTI to characterize the nature of white matter abnormalities following blast-related mTBI, and in particular, examine the extent to which mTBI-related white matter abnormalities are region-specific or spatially heterogeneous. In addition, we examined whether mTBI with loss of consciousness (LOC) was associated with more extensive white matter abnormality than mTBI without LOC, as well as the potential moderating effect of number of blast exposures. A second aim was to examine the relationship between white matter integrity and neurocognitive function. Finally, a third aim was to examine the contribution of PTSD symptom severity to observed white matter alterations. One hundred fourteen OEF/OIF veterans underwent DTI and neuropsychological examination and were divided into three groups including a control group, blast-related mTBI without LOC (mTBI-LOC) group, and blast-related mTBI with LOC (mTBI + LOC) group. Hierarchical regression models were used to examine the extent to which mTBI and PTSD predicted white matter abnormalities using two approaches: 1) a region-specific analysis and 2) a measure of spatial heterogeneity. Neurocognitive composite scores were calculated for executive functions, attention, memory, and psychomotor speed. Results showed that blast-related mTBI + LOC was associated with greater odds of having spatially heterogeneous white matter abnormalities. Region-specific reduction in fractional anisotropy (FA) in the left retrolenticular part of the internal capsule was observed in the mTBI + LOC group as the number of blast exposures increased. A mediation analysis revealed that mTBI + LOC indirectly influenced verbal memory performance through its effect on white matter integrity. PTSD was not associated with spatially heterogeneous white matter abnormalities. However, there was a suggestion that at higher levels of PTSD symptom severity, LOC was associated with reduced FA in the left retrolenticular part of the internal capsule. These results support postmortem reports of diffuse axonal injury following mTBI and suggest that injuries with LOC involvement may be particularly detrimental to white matter integrity. Furthermore, these results suggest that LOC-associatedwhitematter abnormalities in turn influence neurocognitive function. Published by Elsevier Inc.	[Hayes, Jasmeet P.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Hayes, Jasmeet P.; Lafleche, Ginette; Verfaellie, Mieke] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Hayes, Jasmeet P.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA 02130 USA; [Miller, Danielle R.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Miller, Danielle R.; Lafleche, Ginette; Verfaellie, Mieke] VA Boston Healthcare Syst, Memory Disorders Res Ctr, Boston, MA 02130 USA; [Salat, David H.] Harvard Univ, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02115 USA; [Salat, David H.] Harvard Univ, Sch Med, Boston, MA USA		Hayes, JP (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD 116B2, 150 S Huntington Ave, Boston, MA 02130 USA.	jphayes@bu.edu	Hayes, Jasmeet/AAN-4150-2020	Hayes, Jasmeet/0000-0002-5157-0666; Sullivan, Danielle R./0000-0002-0141-5887; Verfaellie, Mieke/0000-0001-5535-4584	VA Merit ReviewUS Department of Veterans Affairs [822-MR-18176]; NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23MH084013]; National Center for PTSD; VA Clinical Science Research and Development Service; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH084013] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000216] Funding Source: NIH RePORTER	This work was supported by VA Merit Review 822-MR-18176 (awarded to M.V.), NIH grant K23MH084013 (awarded to J.P.H.), the National Center for PTSD, and the VA Clinical Science Research and Development Service.	Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Bruce ML, 2010, ANN NY ACAD SCI, V1208, P98, DOI 10.1111/j.1749-6632.2010.05697.x; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hayes A. F., 2014, BRIT J MATH STAT PSY; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kanagaratnam P, 2007, J ANXIETY DISORD, V21, P510, DOI 10.1016/j.janxdis.2006.06.008; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Taber K. H., 2015, J HEAD TRAUMA REHABI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Ursano RJ, 2010, ANN NY ACAD SCI, V1208, P72, DOI 10.1111/j.1749-6632.2010.05721.x; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Weathers F.W., 1991, PTSD CHECKLIST MILIT; WechslerD, 2001, WECHSLER TEST ADULT; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	45	53	54	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2015	8						148	156		10.1016/j.nicl.2015.04.001			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DI0LE	WOS:000373187100016	26106539	Green Published, gold			2022-02-06	
J	Miller, RS; Weaver, LK; Bahraini, N; Churchill, S; Price, RC; Skiba, V; Caviness, J; Mooney, S; Hetzell, B; Liu, J; Deru, K; Ricciardi, R; Fracisco, S; Close, NC; Surrett, GW; Bartos, C; Ryan, M; Brenner, LA				Miller, R. Scott; Weaver, Lindell K.; Bahraini, Nazanin; Churchill, Susan; Price, Robert C.; Skiba, Virginia; Caviness, James; Mooney, Scott; Hetzell, Brian; Liu, Jun; Deru, Kayla; Ricciardi, Richard; Fracisco, Susan; Close, Nicole C.; Surrett, Gerald W.; Bartos, Corinna; Ryan, Margaret; Brenner, Lisa A.		HOPPS Trial Team	Effects of Hyperbaric Oxygen on Symptoms and Quality of Life Among Service Members With Persistent Postconcussion Symptoms A Randomized Clinical Trial	JAMA INTERNAL MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; MILD TBI; MILITARY; COMPLAINTS; BLAST; RELIABILITY; VALIDITY; DESIGN	IMPORTANCE Improvement has been anecdotally observed in patients with persistent postconcussion symptoms (PCS) after mild traumatic brain injury following treatment with hyperbaric oxygen (HBO). The effectiveness of HBO as an adjunctive treatment for PCS is unknown to date. OBJECTIVES To compare the safety of and to estimate the efficacy for symptomatic outcomes from standard PCS care alone, care supplemented with HBO, or a sham procedure. DESIGN, SETTING, AND PARTICIPANTS Multicenter, double-blind, sham-controlled clinical trial of 72 military service members with ongoing symptoms at least 4 months after mild traumatic brain injury enrolled at military hospitals in Colorado, North Carolina, California, and Georgia between April 26, 2011, and August 24, 2012. Assessments occurred before randomization, at the midpoint, and within 1 month after completing the interventions. INTERVENTIONS Routine PCS care was provided in specialized clinics. In addition, participants were randomized 1: 1: 1 to 40 HBO sessions administered at 1.5 atmospheres absolute (ATA), 40 sham sessions consisting of room air at 1.2 ATA, or no supplemental chamber procedures. MAIN OUTCOMES AND MEASURES The Rivermead Post-Concussion Symptoms Questionnaire (RPQ) served as the primary outcome measure. A change score of at least 2 points on the RPQ-3 subscale (range, 0-12) was defined as clinically significant. Change scores from baseline were calculated for the RPQ-3 and for the total RPQ. Secondary measures included additional patient-reported outcomes and automated neuropsychometric testing. RESULTS On average, participants had sustained 3 lifetime mild traumatic brain injuries; the most recent occurred 23 months before enrollment. No differences were observed between groups for improvement of at least 2 points on the RPQ-3 subscale (25% in the no intervention group, 52% in the HBO group, and 33% in the sham group; P=.24). Compared with the no intervention group (mean change score, 0.5; 95% CI, -4.8 to 5.8; P=.91), both groups undergoing supplemental chamber procedures showed improvement in symptoms on the RPQ (mean change score, 5.4; 95% CI, -0.5 to 11.3; P=.008 in the HBO group and 7.0; 95% CI, 1.0-12.9; P=.02 in the sham group). No difference between the HBO group and the sham group was observed (P=.70). Chamber sessions were well tolerated. CONCLUSIONS AND RELEVANCE Among service members with persistent PCS, HBO showed no benefits over sham compressions. Both intervention groups demonstrated improved outcomes compared with PCS care alone. This finding suggests that the observed improvements were not oxygen mediated but may reflect nonspecific improvements related to placebo effects.	[Miller, R. Scott; Fracisco, Susan] US Army Med Mat Dev Act, Ft Detrick, MD USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Weaver, Lindell K.; Churchill, Susan; Deru, Kayla] LDS Hosp, Dept Hyperbar Med, Salt Lake City, UT USA; [Bahraini, Nazanin; Brenner, Lisa A.] Univ Colorado, Aurora, CO USA; [Bahraini, Nazanin; Brenner, Lisa A.] Mental Illness Res Educ & Clin Ctr, Vet Integrated Serv Network 19, Denver, CO USA; [Price, Robert C.; Surrett, Gerald W.] Evans Army Community Hosp, Ft Carson, CO USA; [Skiba, Virginia; Bartos, Corinna] Naval Hosp Camp Lejeune, Camp Lejeune, NC USA; [Caviness, James; Ryan, Margaret] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA; [Mooney, Scott] Eisenhower Army Med Ctr, Ft Gordon, GA USA; [Hetzell, Brian; Liu, Jun] Pharmaceut Prod Dev LLC, Wilmington, NC USA; [Ricciardi, Richard] Def Ctr Excellence Psychol Hlth & Traumat Brain I, Silver Spring, MD USA; [Close, Nicole C.] EmpiriStat Inc, Mt Airy, MD USA		Miller, RS (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	robert.s.miller@us.army.mil	Brenner, Lisa A./AAG-2442-2019; Skiba, Virginia/ABC-1543-2021		Defense Health Program	The HOPPS trial was funded by the Defense Health Program and was managed by the US Army Medical Materiel Development Activity. The Naval Health Research Center and Army Contracting Command contracted support throughout this trial.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Craen AJM, 2000, J NEUROL, V247, P183, DOI 10.1007/s004150050560; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Harch PG, 2013, UNDERSEA HYPERBAR M, V40, P469; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harch Paul G, 2009, Cases J, V2, P6538, DOI 10.4076/1757-1626-2-6538; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067485; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Linde K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-75; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Reeves D, 1993, AUTOMATED NEUROPSYCH; Reynolds SK, 2006, SUICIDE LIFE-THREAT, V36, P19, DOI 10.1521/suli.2006.36.1.19; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Warriner RA, 2008, HYPERBARIC OXYGEN TH; Weaver LK, 2013, UNDERSEA HYPERBAR M, V40, P439; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P801; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Weaver LK, 2009, J APPL PHYSIOL, V107, P336, DOI 10.1152/japplphysiol.91012.2008; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391	38	53	56	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6106	2168-6114		JAMA INTERN MED	JAMA Intern. Med.	JAN	2015	175	1					43	52		10.1001/jamainternmed.2014.5479			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY1BM	WOS:000347328500013	25401463	Bronze			2022-02-06	
J	Hammond, FM; Bickett, AK; Norton, JH; Pershad, R				Hammond, Flora M.; Bickett, Allison K.; Norton, James H.; Pershad, Rashmi			Effectiveness of Amantadine Hydrochloride in the Reduction of Chronic Traumatic Brain Injury Irritability and Aggression	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; agitation; amantadine; brain injuries; dopamine; irritability	NMDA RECEPTOR ANTAGONIST; NEUROPSYCHIATRIC INVENTORY; NEUROTROPHIC FACTOR; MEMANTINE; EXPRESSION; PERSPECTIVES; ENHANCEMENT; COGNITION; SYMPTOMS; RECOVERY	Background: Following traumatic brain injury (TBI), individuals may experience chronic problems with irritability or aggression, which may need treatment to minimize the negative impact on their relationships, home life, social interactions, community participation, and employment. Objective: To test the a priori hypothesis that amantadine reduces irritability (primary hypothesis) and aggression (secondary hypothesis) among individuals greater than 6 months post-TBI. Methods: A total of 76 individuals greater than 6 months post-TBI referred for irritability management were enrolled in a parallel-group, randomized, double-blind, placebo-controlled trial of amantadine (n = 38) versus placebo (n = 38). Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days. Symptoms of irritability and aggression were measured before and after treatment using the Neuropsychiatric Inventory Irritability (NPI-I) and Aggression (NPI-A) domains, as well as the NPI-Distress for these domains. Results: In the amantadine group, 80.56% improved at least 3 points on the NPI-I, compared with 44.44% in the group that received placebo (P = .0016). Mean change in NPI-I was -4.3 in the amantadine group and -2.6 in the placebo group (P = .0085). When excluding individuals with minimal to no baseline aggression, mean change in NPI-A was -4.56 in the amantadine group and -2.46 in the placebo group (P = .046). Mean changes in NPI-I and NPI-A Distress were not statistically significant between the amantadine and placebo groups. Adverse event occurrence did not differ between the 2 groups. Conclusions: Amantadine 100 mg every morning and at noon appears an effective and safe means of reducing frequency and severity of irritability and aggression among individuals with TBI and sufficient creatinine clearance.	[Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46254 USA; Rehabil Hosp Indiana, Indianapolis, IN USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com			US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133A20016]	The research reported in this article was supported by US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability and Rehabilitation Research grant H133A20016. The study sponsor had no role in the design and conduct of this study; the collection, management, analysis, and interpretation of the data; or the preparation review, or approval of the manuscript.	ALLEN RM, 1983, CLIN NEUROPHARMACOL, V6, pS64; Andersson Stein, 1992, Tidsskrift for den Norske Laegeforening, V112, P2070; AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Berwick DM, 1991, MED CARE, V29, P87; Bradley PB, 1989, INTRO NEUROPHARMACOL; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Caumont AS, 2006, NEUROSCI LETT, V394, P196, DOI 10.1016/j.neulet.2005.10.027; Chandler M C, 1988, Brain Inj, V2, P309; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Derogatis LR, 2000, BSI 18 BRIEF SYMPTOM; Evans SM, 2007, ALCOHOL CLIN EXP RES, V31, P775, DOI 10.1111/j.1530-0277.2007.00360.x; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; Glennon RA, 2000, PHARMACOL BIOCHEM BE, V66, P483, DOI 10.1016/S0091-3057(00)00174-X; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Hammond F, 2006, J HEAD TRAUMA REHAB, V21, P412, DOI 10.1097/00001199-200609000-00014; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; KASAMATSU T, 1979, J COMP NEUROL, V185, P139, DOI 10.1002/cne.901850109; Kasamatusu T, 1981, J NEUROPHYSIOL, V45, P139; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Moresco RM, 2002, J NEURAL TRANSM, V109, P1265, DOI 10.1007/s00702-002-0694-7; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Peeters M, 2003, NEUROSCI LETT, V343, P205, DOI 10.1016/S0304-3940(03)00398-7; Rogoz Z, 2007, J PHYSIOL PHARMACOL, V58, P219; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schneider WN, 1999, BRAIN INJURY, V13, P863; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Wyman PA, 1999, CHILD DEV, V70, P645, DOI 10.1111/1467-8624.00047; Zafonte RD, 1998, BRAIN INJURY, V12, P617; ZASLER N D, 1992, Brain Injury, V6, P1, DOI 10.3109/02699059209008117	49	53	53	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					391	399		10.1097/01.HTR.0000438116.56228.de			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700007	24263176				2022-02-06	
J	Erdodi, LA; Roth, RM; Kirsch, NL; Lajiness-O'neill, R; Medoff, B				Erdodi, Laszlo A.; Roth, Robert M.; Kirsch, Ned L.; Lajiness-O'neill, Renee; Medoff, Brent			Aggregating Validity Indicators Embedded in Conners' CPT-II Outperforms Individual Cutoffs at Separating Valid from Invalid Performance in Adults with Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ADHD; Forensic neuropsychology; Performance validity testing; Assessment	MALINGERED NEUROCOGNITIVE DYSFUNCTION; WORD MEMORY TEST; SYMPTOM VALIDITY; RESPONSE BIAS; DIGIT SPAN; NEUROPSYCHOLOGICAL ASSESSMENT; EXAGGERATION; SPECIFICITY; VARIABLES; FAILURE	Continuous performance tests (CPT) provide a useful paradigm to assess vigilance and sustained attention. However, few established methods exist to assess the validity of a given response set. The present study examined embedded validity indicators (EVIs) previously found effective at dissociating valid from invalid performance in relation to well-established performance validity tests in 104 adults with TBI referred for neuropsychological testing. Findings suggest that aggregating EVIs increases their signal detection performance. While individual EVIs performed well at their optimal cutoffs, two specific combinations of these five indicators generally produced the best classification accuracy. A CVI-5A a parts per thousand yen3 had a specificity of .92-.95 and a sensitivity of .45-.54. At a parts per thousand yen4 the CVI-5B had a specificity of .94-.97 and sensitivity of .40-.50. The CVI-5s provide a single numerical summary of the cumulative evidence of invalid performance within the CPT-II. Results support the use of a flexible, multivariate approach to performance validity assessment.	[Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; [Erdodi, Laszlo A.] London Hlth Sci Ctr, Univ Hosp, Clin Neuropsychol Serv, London, ON, Canada; [Erdodi, Laszlo A.; Roth, Robert M.] Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Serv, Lebanon, NH 03756 USA; [Kirsch, Ned L.; Medoff, Brent] Univ Michigan, Dept Phys Med & Rehabil, Adult Neurorehabil Day Treatment Program, Ann Arbor, MI 48109 USA; [Lajiness-O'neill, Renee] Eastern Michigan Univ, Dept Psychol, Ypsilanti, MI 48197 USA		Erdodi, LA (corresponding author), Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Serv, One Med Ctr Dr, Lebanon, NH 03756 USA.	lerdodi@gmail.com					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Balint Sara, 2008, Psychiatr Hung, V23, P324; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Conners, 2004, CONNERS CONTINUOUS P; Erdodi LA, 2014, APPL NEUROPSYCH-ADUL, V21, P43, DOI 10.1080/09084282.2012.724036; Erdodi LA, 2010, J ATTEN DISORD, V14, P43, DOI 10.1177/1087054709347199; FEINSTEIN AR, 1977, CLIN BIOSTATISTICS; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P., 1996, WORD MEMORY TEST USE; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2005, CLIN NEUROPSYCHOL, V19, P121, DOI 10.1080/13854040490516604; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Leark RA, 2002, ARCH CLIN NEUROPSYCH, V17, P335, DOI 10.1016/S0887-6177(01)00118-4; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003	38	53	54	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2014	29	5					456	466		10.1093/arclin/acu026			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AM6AZ	WOS:000339944200006	24957927	Bronze, Green Published			2022-02-06	
J	Holowka, DW; Marx, BP; Gates, MA; Litman, HJ; Ranganathan, G; Rosen, RC; Keane, TM				Holowka, Darren W.; Marx, Brian P.; Gates, Margaret A.; Litman, Heather J.; Ranganathan, Gayatri; Rosen, Raymond C.; Keane, Terence M.			PTSD Diagnostic Validity in Veterans Affairs Electronic Records of Iraq and Afghanistan Veterans	JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY			English	Article						PTSD; veterans; diagnosis; electronic medical record; electronic health record	HEALTH INFORMATION-TECHNOLOGY; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; ADMINISTRATIVE DATA; PRIMARY-CARE; AMBULATORY-CARE; MEDICAL-CARE; QUALITY; SCALE; PREVALENCE	Objective: Administrative planning and policy decisions frequently rely on diagnostic data extracted from large electronic databases. However, the accuracy of this diagnostic information is uncertain. The present study examined the degree to which various diagnoses of posttraumatic stress disorder (PTSD) within Department of Veterans Affairs (VA) electronic databases were concordant with PTSD diagnostic status determined by standardized diagnostic interview. Method: We interviewed 1,649 veterans of the Iraq and Afghanistan wars using the PTSD Module of the Structured Clinical Interview for DSM-IV (SCID). Participants also completed other interview-based and self-report measures of psychopathology and provided consent to access their electronic medical records (EMRs). Results: Concordance between database diagnosis and SCID diagnosis was 72.3% for current PTSD and 79.4% for lifetime PTSD. We observed associations between concordance status and combat exposure, PTSD symptom presentation, comorbid anxiety and depression, and psychosocial impairment. Veterans with false-negative PTSD diagnoses in the EMR were more likely to report lower levels of combat exposure, panic, and PTSD avoidance symptoms. Veterans with false-positive PTSD diagnoses in the EMR were more likely to report treatment seeking for emotional problems and less overall functional impairment. Conclusions: Although the majority of participants were concordant for PTSD status, over 25% of EMR diagnoses differed from those obtained in the diagnostic interview, with varying proportions of false positives and false negatives. Overall, those individuals with the most and least severe symptom presentations in the diagnostic interview were more likely to be accurately classified.	[Holowka, Darren W.; Marx, Brian P.; Keane, Terence M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Holowka, Darren W.; Marx, Brian P.; Keane, Terence M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Gates, Margaret A.; Litman, Heather J.; Ranganathan, Gayatri; Rosen, Raymond C.] New England Res Inst, Watertown, MA 02172 USA		Holowka, DW (corresponding author), Rhode Isl Hosp, Dept Psychiat, Potter 2,593 Eddy St, Providence, RI 02903 USA.	dholowka@lifespan.org	Marx, Brian/AAK-5072-2020; Keane, Terence/I-8253-2014	Keane, Terence/0000-0002-0482-3149; Gates Kuliszewski, Margaret/0000-0002-2111-6227			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blumenthal D, 2011, NEW ENGL J MED, V365, P2426, DOI 10.1056/NEJMsr1112158; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Brown SH, 2003, INT J MED INFORM, V69, P135, DOI 10.1016/S1386-5056(02)00131-4; Byrne CM, 2010, HEALTH AFFAIR, V29, P629, DOI 10.1377/hlthaff.2010.0119; Castro F., 2011, TREATING PTSD MILITA, P23; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Dick R, 1991, COMPUTER BASED PATIE; Dick RS, 1997, COMPUTER BASED PATIE; Farmer SA, 2013, JAMA-J AM MED ASSOC, V309, P349, DOI 10.1001/jama.2012.191276; First M.B., 2004, COMPREHENSIVE HDB PS, V2, P134, DOI DOI 10.1002/9780471726753; Ford EW, 2009, J AM MED INFORM ASSN, V16, P274, DOI 10.1197/jamia.M3042; Frayne SM, 2010, AM J MED QUAL, V25, P42, DOI 10.1177/1062860609346347; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Harris SB, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-347; Hawthorne G, 2006, SOC PSYCH PSYCH EPID, V41, P164, DOI 10.1007/s00127-005-0986-y; Holowka DW, 2012, PSYCHOL TRAUMA-US, V4, P285, DOI 10.1037/a0023267; Jackson JC, 2011, J TRAUMA STRESS, V24, P609, DOI 10.1002/jts.20688; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Liaw S.-T., 2012, ELECT J HLTH INFORM, V7, pe1; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Marx B. P., 2009, ANN M INT SOC TRAUM; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Norman GR, 2010, MED EDUC, V44, P94, DOI 10.1111/j.1365-2923.2009.03507.x; Rosen CS, 2004, J TRAUMA STRESS, V17, P213, DOI 10.1023/B:JOTS.0000029264.23878.53; Rosen RC, 2012, INT J METH PSYCH RES, V21, P5, DOI 10.1002/mpr.355; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schiff GD, 2010, NEW ENGL J MED, V362, P1066, DOI 10.1056/NEJMp0911734; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Szeto HC, 2002, AM J MANAG CARE, V8, P37; Trinh NHT, 2011, INT J MED INFORM, V80, P533, DOI 10.1016/j.ijmedinf.2011.03.014; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575; U.S. Department of Veterans Affairs, 2013, MILL VET PROGR PARTN; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Wright A, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-36; Yuan Y, 2011, J STAT SOFTW, V45, P1	49	53	53	0	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0022-006X	1939-2117		J CONSULT CLIN PSYCH	J. Consult. Clin. Psychol.	AUG	2014	82	4					569	579		10.1037/a0036347			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AS3FY	WOS:000344164000003	24731235				2022-02-06	
J	Ilvesmaki, T; Luoto, TM; Hakulinen, U; Brander, A; Ryymin, P; Eskola, H; Iverson, GL; Ohman, J				Ilvesmaki, Tero; Luoto, Teemu M.; Hakulinen, Ullamari; Brander, Antti; Ryymin, Pertti; Eskola, Hannu; Iverson, Grant L.; Ohman, Juha			Acute mild traumatic brain injury is not associated with white matter change on diffusion tensor imaging	BRAIN			English	Article						concussion; traumatic brain injury; magnetic resonance imaging; diffusion tensor imaging; statistical analysis	POSTTRAUMATIC AMNESIA; AXONAL INJURY; HEAD-INJURY; CONCUSSION; SCALE; DTI	Methodological limitations can confound DTI studies of traumatic brain injury. Using strict enrolment criteria to obtain an exceptionally homogeneous patient sample, Ilvesmaki et al. reveal that mild traumatic brain injury is not associated with DTI abnormalities detectable with tract-based spatial statistics. Changes in DTI measures are, however, seen with age.This study was designed to (i) evaluate the influence of age on diffusion tensor imaging measures of white matter assessed using tract-based spatial statistics; (ii) determine if mild traumatic brain injury is associated with microstructural changes in white matter, in the acute phase following injury, in a large homogenous sample that was carefully screened for pre-injury medical, psychiatric, or neurological problems; and (iii) examine if injury severity is related to white matter changes. Participants were 75 patients with acute mild traumatic brain injury (age = 37.2 +/- 12.0 years, 45 males and 30 females) and 40 controls (age = 40.6 +/- 12.2 yrs, 20 males and 20 females). Age effects were analysed by comparing control subgroups aged 31-40, 41-50, and 51-60 years against a group of 18-30-year-old control subjects. Widespread statistically significant areas of abnormal diffusion tensor measures were observed in older groups. Patients and controls were compared using age and gender as covariates and in age- and gender-matched subgroups. Subgroups of patients with more severe injuries were compared to age-and gender-matched controls. No significant differences were detected in patient-control or severity analyses (all P-value > 0.01). In this large, carefully screened sample, acute mild traumatic brain injury was not associated with diffusion tensor imaging abnormalities detectable with tract-based spatial statistics.	[Ilvesmaki, Tero; Brander, Antti; Eskola, Hannu] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland; [Ilvesmaki, Tero; Hakulinen, Ullamari; Eskola, Hannu] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Luoto, Teemu M.; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Hakulinen, Ullamari; Ryymin, Pertti] Tampere Univ Hosp, Dept Radiol & Med Phys, Med Imaging Ctr, Tampere, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA		Ilvesmaki, T (corresponding author), Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland.	tero.ilvesmaki@pshp.fi	Eskola, Hannu/G-4279-2014; Luoto, Teemu/W-6468-2018	Eskola, Hannu/0000-0003-1673-2305; Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367; Iverson, Grant/0000-0001-7348-9570	Emil Aaltonen foundation	This work was supported by a grant by the Emil Aaltonen foundation to T.I.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yoon B, 2008, ARCH GERONTOL GERIAT, V47, P129, DOI 10.1016/j.archger.2007.07.004	25	53	53	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2014	137		7				1876	1882		10.1093/brain/awu095			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK7ZL	WOS:000338646800015	24818956	Bronze			2022-02-06	
J	Wade, SL; Stancin, T; Kirkwood, M; Brown, TM; McMullen, KM; Taylor, HG				Wade, Shari L.; Stancin, Terry; Kirkwood, Michael; Brown, Tanya Maines; McMullen, Kendra M.; Taylor, H. Gerry			Counselor-Assisted Problem Solving (CAPS) Improves Behavioral Outcomes in Older Adolescents With Complicated Mild to Severe TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; behavior; telehealth; traumatic brain injury; problem solving	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; FAMILY INTERVENTION; SOCIAL COMPETENCE; CHILDREN; PREVALENCE; PREDICTORS; CAREGIVERS; EFFICACY; SKILLS	Objective: To test the efficacy of Counselor-Assisted Problem Solving (CAPS) versus an Internet resource comparison (IRC) condition in reducing behavior problems in adolescents following traumatic brain injury (TBI). Design: Randomized clinical trial with interviewers naive to treatment condition. Setting: Three large tertiary children's hospitals and 2 general hospitals with pediatric commitment. Participants: A total of 132 children and adolescents aged 12 to 17 years hospitalized during the previous 6 months for moderate to severe TBI. Interventions: Participants in CAPS (n = 65) completed 8 to 12 online modules providing training in problem solving, communication skills, and self-regulation and subsequent synchronous videoconferencing with a therapist. Participants in the IRC group (n = 67) received links to Internet resources about pediatric TBI. Main Outcome Measures: Child Behavior Checklist administered before and after completion of treatment (ie, approximately 6 months after treatment initiation). Results: Post hoc analysis of covariance, controlling for pretreatment scores, was used to examine group differences in behavior problems in the entire sample and among older (n = 59) and younger adolescents (n = 53). Among older but not younger adolescents, CAPS resulted in greater improvements on multiple dimensions of externalizing behavior problems than IRC. Conclusion: Online problem-solving therapy may be effective in reducing behavior problems in older adolescent survivors of moderate-severe TBI.	[Wade, Shari L.; McMullen, Kendra M.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Wade, Shari L.; McMullen, Kendra M.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Stancin, Terry] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Kirkwood, Michael] Childrens Hosp Colorado, Aurora, CO USA; [Kirkwood, Michael] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Tanya Maines] Mayo Clin, Rochester, MN USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Stancin, Terry/L-7993-2019		NIH grant from the National Institute of Mental Health [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (1) NIH grant R01-MH073764 from the National Institute of Mental Health and (2) a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program. The authors acknowledge the contributions of Robert Blaha, Elizabeth Hagesfeld, Michelle Jacobs, Daniel Maier, and Nina Fox in data collection and entry, Amy Cassedy in data management, and John Stullenberger in Website support. The authors also acknowledge the contributions of the therapists JoAnne Carey, PsyD, Britt Nielsen, PsyD, and Brad Jackson, PhD.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Cohen J., 2013, STAT POWER ANAL BEHA; Department of Veterans Affairs, 2010, STR PLAN FY 2010 201; DZurilla TJ, 2006, PROBLEM SOLVING THER; Elliott TR, 2009, BEHAV RES THER, V47, P548, DOI 10.1016/j.brat.2009.03.006; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Faul M, 2010, TRAUMATIC BRAIN INJU; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; NEZU AM, 1989, J CONSULT CLIN PSYCH, V57, P408, DOI 10.1037/0022-006X.57.3.408; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Robin AL, 1989, NEGOTIATING PARENT A; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	25	53	53	1	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					198	207		10.1097/HTR.0b013e31828f9fe8			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100007	23640543	Green Accepted			2022-02-06	
J	Gerber, MR; Iverson, KM; Dichter, ME; Klap, R; Latta, RE				Gerber, Megan R.; Iverson, Katherine M.; Dichter, Melissa E.; Klap, Ruth; Latta, Rachel E.			Women Veterans and Intimate Partner Violence: Current State of Knowledge and Future Directions	JOURNAL OF WOMENS HEALTH			English	Article							CARDIOVASCULAR-DISEASE; HIGH-RISK; QUITLINES; HEALTH	Intimate partner violence (IPV) is a serious public health concern for all; however, women who experience IPV are more likely to sustain injury and report adverse health consequences. An expanding body of research suggests that experience of IPV is common in women veterans (WV), particularly those who access Veterans Health Administration (VA) services. With unprecedented numbers of women serving in the military and subsequently becoming veterans, it is critical that clinicians and advocates caring for WV understand the impact of IPV on this population. WV have unique risk factors for experiencing IPV, including high rates of premilitary trauma, as well as military sexual trauma and posttraumatic stress disorder (PTSD). Correlates of IPV, traumatic brain injury (TBI) and homelessness, are common among this group. Although research on WV health and IPV is emergent, evidence suggests that IPV results in multiple health sequelae and increased healthcare utilization. In this context, we next discuss clinical and policy implications for VA. A number of targeted interventions and treatments are available for WV who experience IPV, including evidence-based mental health services. VA is well situated to implement screening programs for WV to facilitate referral to needed services and treatments available both within and outside its facilities. As the population of WV expands, future research will be needed to determine best practices; many avenues of inquiry exist. Finally, WV are strong and resilient; it is crucial that those who work with them recognize evidence of IPV and refer to needed services and evidence-based treatment to enable strength-based recovery.	[Gerber, Megan R.] VA Boston Healthcare Syst, Women Vet Hlth Program, Boston, MA USA; [Gerber, Megan R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Dichter, Melissa E.] Philadelphia VA Med Ctr, VA Ctr Hlth Equ Res & Promot CHERP, Philadelphia, PA USA; [Klap, Ruth] VA Greater Los Angeles Healthcare Syst, VA HSR&D Ctr Study Healthcare Innovat Implementat, Los Angeles, CA USA; [Latta, Rachel E.] Edith Nourse Rogers Mem Vet Adm Hosp, New England Mental Illness Res Educ & Clin Ctr MI, Bedford, MA 01730 USA		Gerber, MR (corresponding author), VA Boston Healthcare Syst, Women Vet Hlth Program, 150 South Huntington Ave PC11, Jamaica Plain, MA 01230 USA.	Megan.gerber@va.gov	Dichter, Melissa/AAC-5054-2021; Gerber, Megan/N-1418-2016	Gerber, Megan/0000-0002-8444-5554	VA Health Services Research and Development (HSRD)US Department of Veterans Affairs [CDA-10-029]; VA HSR&D Career Development Award [CDA-10-202]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, HSRD SDR [10-012]; Department of Veterans Affairs, Patient Care Services, Women's Health ServicesUS Department of Veterans Affairs	Funding was provided by VA Health Services Research and Development (HSR&D) Career Development Award CDA-10-029 (KI); VA HSR&D Career Development Award CDA-10-202 (MD); and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, HSR&D SDR 10-012 (RK). This work was also supported in part by the Department of Veterans Affairs, Patient Care Services, Women's Health Services (RK). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.	American Heart Association, 2013, STAT FACT SHEET WOM; Centers for Disease Control and Prevention, GLANC 2011 TOB US TA; Centers for Disease Control and Prevention, 2013, WOM HEART DIS FACT S; Centers for Disease Control and Prevention, 2014, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention, 2010, EL DISP CARD HLTH CV; Fiore MC, 2008, TREATING TOBACCO USE; Heisch J, 2009, JUNEAU EMPIRE   1007; Hemingway H, 2008, CIRCULATION, V117, P1526, DOI 10.1161/CIRCULATIONAHA.107.720953; Howard G, 2008, STROKE, V39, P283, DOI 10.1161/STROKEAHA.107.510529; Howard G, 2007, ANN EPIDEMIOL, V17, P689, DOI 10.1016/j.annepidem.2007.03.019; Juneau Borough Clerk, 2009, OCT OFF EL RES; Keller PA, 2010, PREV CHRONIC DIS, V7; Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001; Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONS SMOK 50 YE; North American Quitline Consortium, OV NAQC 2009 ANN SUR; Ossip-Klein DJ, 2003, AM J MED SCI, V326, P201, DOI 10.1097/00000441-200310000-00010; Vaid I, 2011, J WOMENS HEALTH, V20, P977, DOI 10.1089/jwh.2011.2850; Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751; Warner DD, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110343	20	53	53	0	25	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	APR 1	2014	23	4					302	309		10.1089/jwh.2013.4513			8	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	AE4EO	WOS:000333934900132	24506440	Green Submitted			2022-02-06	
J	Greig, NH; Tweedie, D; Rachmany, L; Li, YZ; Rubovitch, V; Schreiber, S; Chiang, YH; Hoffer, BJ; Miller, J; Lahiri, DK; Sambamurti, K; Becker, RE; Pick, CG				Greig, Nigel H.; Tweedie, David; Rachmany, Lital; Li, Yazhou; Rubovitch, Vardit; Schreiber, Shaul; Chiang, Yung-Hsiao; Hoffer, Barry J.; Miller, Jonathan; Lahiri, Debomoy K.; Sambamurti, Kumar; Becker, Robert E.; Pick, Chaim G.			Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury	ALZHEIMERS & DEMENTIA			English	Article							GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; FOCAL CEREBRAL-ISCHEMIA; MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; GLP-1 RECEPTOR; AMYLOID-BETA; PARKINSONS-DISEASE; DENTATE GYRUS	Traumatic brain injury (TBI), either as an isolated injury or in conjunction with other injuries, is an increasingly common event. An estimated 1.7 million injuries occur within the USA each year and 10 million people are affected annually worldwide. Indeed, nearly one third (30.5%) of all injury-related deaths in the USA are associated with TBI, which will soon outpace many common diseases as the major cause of death and disability. Associated with a high morbidity and mortality and no specific therapeutic treatment, TBI has become a pressing public health and medical problem. The highest incidence of TBI occurs in young adults (15-24 years age) and in the elderly (>= 75 years of age). Older individuals are particularly vulnerable to these types of injury, often associated with falls, and have shown increased mortality and worse functional outcome after lower initial injury severity. In addition, a new and growing form of TBI, blast injury, associated with the detonation of improvised explosive devices in the war theaters of Iraq and Afghanistan, are inflicting a wave of unique casualties of immediate impact to both military personnel and civilians, for which long-term consequences remain unknown and may potentially be catastrophic. The neuropathology underpinning head injury is becoming increasingly better understood. Depending on severity, TBI induces immediate neuropathologic effects that, for the mildest form, may be transient; however, with increasing severity, these injuries cause cumulative neural damage and degeneration. Even with mild TBI, which represents the majority of cases, a broad spectrum of neurologic deficits, including cognitive impairments, can manifest that may significantly influence quality of life. Further, TBI can act as a conduit to longer term neurodegenerative disorders. Prior studies of glucagon-like peptide-1 (GLP-1) and long-acting GLP-1 receptor agonists have demonstrated neurotrophic/neuroprotective activities across a broad spectrum of cellular and animal models of chronic neurodegenerative (Alzheimer's and Parkinson's diseases) and acute cerebrovascular (stroke) disorders. In view of the mechanisms underpinning these disorders as well as TBI, we review the literature and recent studies assessing GLP-1 receptor agonists as a potential treatment strategy for mild to moderate TBI. (C) 2014 The Alzheimer's Association. All rights reserved.	[Greig, Nigel H.; Tweedie, David; Li, Yazhou; Becker, Robert E.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Rachmany, Lital; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Rachmany, Lital; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-69978 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Hoffer, Barry J.; Miller, Jonathan] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Sambamurti, Kumar] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Becker, Robert E.] Aristea Translat Med, Park City, UT USA		Greig, NH (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.	greign@grc.nia.nih.gov	Sambamurti, Kumar/A-1620-2012; Schreiber, Shaul/E-5821-2010	Sambamurti, Kumar/0000-0001-9507-9214; Schreiber, Shaul/0000-0002-2189-0693	National Institute on Aging, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Michael J. Fox Foundation; Sackler School of Medicine, Tel-Aviv University; Israeli Science FoundationIsrael Science Foundation [108/09]; Alzheimer's AssociationAlzheimer's Association [IIRG 10-173-180 IIRG 10-173180, IIRG-11-206418]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG022103 R21AG046200, AG18379, AG18884, AG42804]; Lincoln Scholar Award; Taiwan NSCMinistry of Science and Technology, Taiwan [98-2321-B-038-002-MY3]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG022103, R01AG018379, ZIAAG000333, R21AG042804, R01AG018884, R21AG046200] Funding Source: NIH RePORTER	N.H.G., D.T., and Y.L. were supported by the Intramural Research Program, National Institute on Aging, National Institutes of Health, and in part by the Michael J. Fox Foundation. C.G.P., L.R., and V.R. were supported by the Sackler School of Medicine, Tel-Aviv University, and in part by a grant from the Israeli Science Foundation (108/09). K.S. received grant support from the Alzheimer's Association (IIRG 10-173-180 IIRG 10-173180) and the National Institute on Aging (AG022103 R21AG046200). D.K.L. received grant support from the National Institute on Aging (AG18379, AG18884 and AG42804) and Alzheimer's Association (IIRG-11-206418). J.M. was supported by the Lincoln Scholar Award and Y.-H.C. was supported by Taiwan NSC (98-2321-B-038-002-MY3). R.E.B. is President of Aristea Translational Medicine Corp., but has received no support in relation to this article.	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Alvarez E, 1996, J NEUROCHEM, V66, P920; [Anonymous], 2008, MULTINATIONAL CORPS; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Bak AM, 2011, EXPERT OPIN THER TAR, V15, P1153, DOI 10.1517/14728222.2011.600691; Banks WA, 2004, J PHARMACOL EXP THER, V309, P469, DOI 10.1124/jpet.103.063222; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Becker RE., 2013, NAT REV DRUG DISCOV; Becker RE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000446; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; CALVO JC, 1995, BRAIN RES BULL, V38, P435, DOI 10.1016/0361-9230(95)02010-O; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; CAMPOS RV, 1994, ENDOCRINOLOGY, V134, P2156, DOI 10.1210/en.134.5.2156; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; CHOI DW, 1987, J NEUROSCI, V7, P357; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Chowen JA, 1999, NEUROPEPTIDES, V33, P212, DOI 10.1054/npep.1999.0757; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cui Qi, 2004, Anatomical Science International, V79, P209, DOI 10.1111/j.1447-073x.2004.00089.x; Dailey MJ, 2013, TRENDS ENDOCRIN MET, V24, P85, DOI 10.1016/j.tem.2012.11.008; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; DeOre K, 1997, J GERONTOL A-BIOL, V52, pB245, DOI 10.1093/gerona/52A.5.B245; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Doyle ME, 2005, ENDOCRINE, V27, P1, DOI 10.1385/ENDO:27:1:001; Doyle ME, 2003, REGUL PEPTIDES, V114, P153, DOI 10.1016/S0167-0115(03)00120-4; Doyle ME, 2001, ENDOCRINOLOGY, V142, P4462, DOI 10.1210/en.142.10.4462; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Drucker DJ, 2011, J CLIN ENDOCR METAB, V96, P2027, DOI 10.1210/jc.2011-0599; Duarte AI, 2013, BBA-MOL BASIS DIS, V1832, P527, DOI 10.1016/j.bbadis.2013.01.008; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; ENG J, 1992, J BIOL CHEM, V267, P7402; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Faul M, 2010, TRAUMATIC BRAIN INJU; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; GOKE R, 1993, J BIOL CHEM, V268, P19650; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greig NH, 1999, DIABETOLOGIA, V42, P45, DOI 10.1007/s001250051111; Greig NH, 2004, ANN NY ACAD SCI, V1035, P290, DOI 10.1196/annals.1332.018; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hadjiyanni I, 2010, DIABETOLOGIA, V53, P730, DOI 10.1007/s00125-009-1643-x; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Han WN, 2013, NEUROBIOL AGING, V34, P576, DOI 10.1016/j.neurobiolaging.2012.04.009; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Himeno T, 2011, DIABETES, V60, P2397, DOI 10.2337/db10-1462; Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000; Holscher C, 2010, VITAM HORM, V84, P331, DOI [10.1016/S0083-6729(10)84005-1, 10.1016/B978-0-12-381517-0.00013-8]; Holscher C, 2010, NEUROBIOL AGING, V31, P1495, DOI 10.1016/j.neurobiolaging.2008.08.023; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hogan AE, 2011, DIABETOLOGIA, V54, P2745, DOI 10.1007/s00125-011-2232-3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holst JJ, 2011, CURR MED RES OPIN, V27, P547, DOI 10.1185/03007995.2010.549466; Hong LZ, 2010, NEUROSCI BULL, V26, P232, DOI 10.1007/s12264-010-1111-0; Hosek B, 2011, IS DEPLOYMENT IRAQ A; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Jolivalt CG, 2011, DIABETES OBES METAB, V13, P990, DOI 10.1111/j.1463-1326.2011.01431.x; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Klinge PM, 2011, NEUROSCI LETT, V497, P6, DOI 10.1016/j.neulet.2011.03.092; Knippenberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036857; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kwon YK, 2002, J BIOCHEM MOL BIOL, V35, P87; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Lazarov O, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00043; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Li Y., 2000, P NATL ACAD SCI USA, V106, P1285; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lim JG, 2010, NEUROSCI LETT, V479, P13, DOI 10.1016/j.neulet.2010.05.017; Liu WJ, 2011, BRIT J PHARMACOL, V164, P1410, DOI 10.1111/j.1476-5381.2011.01272.x; Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Markakis EA, 1999, J COMP NEUROL, V406, P449; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntyre RS, 2013, BEHAV BRAIN RES, V237, P164, DOI 10.1016/j.bbr.2012.09.021; Meneilly GS, 2003, DIABETES CARE, V26, P2835, DOI 10.2337/diacare.26.10.2835; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Mossello E, 2011, EXP DIABETES RES, DOI 10.1155/2011/281674; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Parthsarathy V., 2013, PLOS ONE, V8; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry TA, 2004, CURR DRUG TARGETS, V5, P565, DOI 10.2174/1389450043345245; Perry Tracy Ann, 2005, Current Alzheimer Research, V2, P377, DOI 10.2174/1567205054367892; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Perry T, 2002, J ALZHEIMERS DIS, V4, P487; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Prakash A, 2008, CURR OPIN ANESTHESIO, V21, P565, DOI 10.1097/ACO.0b013e32830f44e4; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; RITZEL R, 1995, DIABETOLOGIA, V38, P720, DOI 10.1007/BF00401846; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Sun H, 2013, CELL MOL NEUROBIOL, V33, P347, DOI 10.1007/s10571-012-9900-9; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tourrel C, 2001, DIABETES, V50, P1562, DOI 10.2337/diabetes.50.7.1562; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Urusova IA, 2004, TRENDS ENDOCRIN MET, V15, P27, DOI 10.1016/j.tem.2003.11.006; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang MD, 2012, NEUROSCIENCE, V226, P388, DOI 10.1016/j.neuroscience.2012.09.025; Wang XH, 2010, NEUROSCIENCE, V170, P1239, DOI 10.1016/j.neuroscience.2010.08.028; Wang X, 2013, J LABELLED COMPD RAD, V56, pS77; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong H, 2013, J ALZHEIMERS DIS, V37, P623, DOI 10.3233/JAD-130584; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Yang Y, 2013, J ALZHEIMERS DIS, V37, P637, DOI 10.3233/JAD-130491; Yu JH, 2012, DIABETES METAB J, V36, P391, DOI 10.4093/dmj.2012.36.6.391; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	184	53	56	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	FEB	2014	10			1			S62	S75		10.1016/j.jalz.2013.12.011			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN6OW	WOS:000358555100009	24529527	Green Accepted, Green Submitted			2022-02-06	
J	Sorg, SF; Delano-Wood, L; Luc, N; Schiehser, DM; Hanson, KL; Nation, DA; Lanni, E; Jak, AJ; Lu, K; Meloy, MJ; Frank, LR; Lohr, JB; Bondi, MW				Sorg, Scott F.; Delano-Wood, Lisa; Luc, Norman; Schiehser, Dawn M.; Hanson, Karen L.; Nation, Daniel A.; Lanni, Elisa; Jak, Amy J.; Lu, Kun; Meloy, M. J.; Frank, Lawrence R.; Lohr, James B.; Bondi, Mark W.			White Matter Integrity in Veterans With Mild Traumatic Brain Injury: Associations With Executive Function and Loss of Consciousness	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury; diffusion tensor imaging; white matter; executive functions	DIFFUSION-TENSOR; POSTCONCUSSIVE SYMPTOMS; FRACTIONAL ANISOTROPY; VERBAL FLUENCY; BLAST; MODERATE; MILITARY; PERFORMANCE; CONCUSSION; MECHANISMS	Objective: We investigated using diffusion tensor imaging (DTI) and the association between white matter integrity and executive function (EF) performance in postacute mild traumatic brain injury (mTBI). In addition, we examined whether injury severity, as measured by loss of consciousness (LOC) versus alterations in consciousness (AOC), is related to white matter microstructural alterations and neuropsychological outcome. Participants: Thirty Iraq and Afghanistan War era veterans with a history of mTBI and 15 healthy veteran control participants. Results: There were no significant overall group differences between control and mTBI participants on DTI measures. However, a subgroup of mTBI participants with EF decrements (n = 13) demonstrated significantly decreased fractional anisotropy of prefrontal white matter, corpus callosum, and cingulum bundle structures compared with mTBI participants without EF decrements (n = 17) and control participants. Participants having mTBI with LOC were more likely to evidence reduced EF performances and disrupted ventral prefrontal white matter integrity when compared with either mTBI participants without LOC or control participants. Conclusions: Findings suggest that altered white matter integrity contributes to reduced EF in subgroups of veterans with a history of mTBI and that LOC may be a risk factor for reduced EF as well as associated changes to ventral prefrontal white matter.	[Sorg, Scott F.] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA; [Delano-Wood, Lisa; Luc, Norman; Schiehser, Dawn M.; Hanson, Karen L.; Nation, Daniel A.; Lanni, Elisa; Jak, Amy J.; Meloy, M. J.; Frank, Lawrence R.; Lohr, James B.; Bondi, Mark W.] VASDHS, San Diego, CA USA; [Delano-Wood, Lisa; Schiehser, Dawn M.; Hanson, Karen L.; Jak, Amy J.; Frank, Lawrence R.; Lohr, James B.; Bondi, Mark W.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Delano-Wood, Lisa; Schiehser, Dawn M.; Hanson, Karen L.; Jak, Amy J.; Meloy, M. J.; Lohr, James B.; Bondi, Mark W.] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Lu, Kun; Frank, Lawrence R.] Univ Calif San Diego, Sch Med, Dept Radiol, San Diego, CA 92103 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, La Jolla, CA 92161 USA.	ldelano@ucsd.edu	Nation, Daniel/AAD-1019-2019	Lu, Quin/0000-0001-9526-1614	Veterans Affairs (Career Development Awards)US Department of Veterans Affairs; Department of DefenseUnited States Department of Defense; Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH); National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH096100-01]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH096100] Funding Source: NIH RePORTER	This work was supported by grants awarded by the Veterans Affairs (Career Development Awards [CDA]: L.D.-W., D.S.) as well as the Department of Defense (Investigator-Initiated Research Grant [IIRG]: L.D.-W.). This material is further supported with resources of the Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH: L.D.-W., A.J.J., K.L.H) and a National Institute of Health grant awarded to Dr Lawrence Frank (R01 MH096100-01). The coauthors report no conflicts of interest.	Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Casscells SW., 2007, TRAUMATIC BRAIN INJU; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fox RJ, 2012, AM J NEURORADIOL, V33, P695, DOI 10.3174/ajnr.A2844; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heaton R., 2000, WISCONSIN CARD SORTI; Heaton R.K., 1981, WISCONSIN CARD SORTI; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kaplan, 1999, NEUROPSYCHOLOGICAL D, P163; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P327; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Traumatic Brain Injury Task Force, 2008, REP SURG GEN TRAUM B; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	70	53	54	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					21	32		10.1097/HTR.0b013e31828a1aa4			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400006	23640539	Green Accepted			2022-02-06	
J	Zhu, J; Qu, C; Lu, X; Zhang, S				Zhu, Jin; Qu, Chen; Lu, Xiang; Zhang, Shu			Activation of Microglia by Histamine and Substance P	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Microglial activation; Histamine; Substance P; CNS immune inflammation	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; MAST-CELL; INFLAMMATORY RESPONSE; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; RECEPTORS; EXPRESSION; DISEASE	Background: Activated microglia perform many of the immune effector functions typically associated with macrophages. However, the regulators involved in microglial activation are not well defined. Because microglia play a pivotal role in immune surveillance of the CNS, we studied the effect of the neuromediators histamine and substance P on microglia. Methods: The induction of microglial activation by histamine and substance P was examined using primary cultured microglia. Fluorescent images were acquired with a confocal microscope. The levels of TNF-alpha and IL-6 were measured with a commercial ELISA kit. Intracellular reactive oxygen species (ROS) levels were determined by dichlorodihydrofluorescein oxidation. The mitochondrial membrane potential was assessed with the MitoProbe (TM) JC-1 assay kit. Results: We found that the neuromediators histamine and substance P were able to stimulate microglial activation and the subsequent production of ROS and proinflammatory factors TNF-alpha and IL-6, These effects were partially abolished by antagonists of the histamine receptors H1 and H4 and of the substance P receptors NK-1, NK-2 and NK-3. Histamine induced mitochondrial membrane depolarization in microglia. Conclusions: These results indicate that the neuromediators histamine and SP can trigger microglial activation and release of pro inflammatory factors from microglia, thus contributing to the development of microglia-mediated inflammation in the brain. Copyright (C) 2014 S. Karger AG, Basel	[Zhu, Jin; Zhang, Shu] Nanjing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, Jin] Nanjing Med Univ, Nanjing Affiliated Hosp 1, Dept Emergency, Nanjing 210029, Jiangsu, Peoples R China; [Qu, Chen; Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing 210029, Jiangsu, Peoples R China		Zhang, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Nanjing 210029, Jiangsu, Peoples R China.	luxiang66@njmu.edu.cn; zszqs@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102422, 81373398]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2010020]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This project was sponsored the National Natural Science Foundation of China (No. 81102422, 81373398); the Natural Science Foundation of Jiangsu Province (BK2010020); and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Akdis CA, 2006, EUR J PHARMACOL, V533, P69, DOI 10.1016/j.ejphar.2005.12.044; Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; Ciallella JR, 2005, EUR J PHARMACOL, V515, P179, DOI 10.1016/j.ejphar.2005.04.016; Crivellato E, 2004, HISTOL HISTOPATHOL, V19, P259, DOI 10.14670/HH-19.259; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Ebner K, 2006, AMINO ACIDS, V31, P251, DOI 10.1007/s00726-006-0335-9; Ferreira R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-90; Friberg H, 2002, NEUROSCI LETT, V334, P111, DOI 10.1016/S0304-3940(02)01116-3; Galient RA, 1997, PROG NEUROBIOL, V52, P379; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; HARTUNG HP, 1986, J IMMUNOL, V136, P3856; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herrera AJ, 2005, J NEURAL TRANSM, V112, P111, DOI 10.1007/s00702-004-0121-3; HOLZER P, 1995, J PHARMACOL EXP THER, V274, P322; Holzer P, 1997, PHARMACOL THERAPEUT, V73, P219, DOI 10.1016/S0163-7258(96)00196-9; Huang JF, 2008, CURR ALLERGY ASTHM R, V8, P21, DOI 10.1007/s11882-008-0005-y; Ikarashi Y, 2002, PHARMACOL BIOCHEM BE, V72, P437, DOI 10.1016/S0091-3057(02)00708-6; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; KincyCain T, 1996, J IMMUNOL, V157, P255; Lai JP, 2000, NEUROSCIENCE, V101, P1137, DOI 10.1016/S0306-4522(00)00398-5; LAURENZI MA, 1990, SCAND J IMMUNOL, V31, P529, DOI 10.1111/j.1365-3083.1990.tb02801.x; Linker RA, 2008, J NEUROIMMUNOL, V205, P64, DOI 10.1016/j.jneuroim.2008.09.007; Lotz M, 1988, SCIENC, V241, P1218; LUBERNAROD J, 1994, J IMMUNOL, V152, P819; Lund S, 2005, J NEUROCHEM, V92, P1439, DOI 10.1111/j.1471-4159.2005.03014.x; Maggi CA, 2000, REGUL PEPTIDES, V93, P53, DOI 10.1016/S0167-0115(00)00177-4; Marriott I, 2000, J IMMUNOL, V165, P182, DOI 10.4049/jimmunol.165.1.182; Marriott I, 2001, ADV EXP MED BIOL, V493, P247; Marriott I, 2001, J NEUROIMMUNOL, V114, P131, DOI 10.1016/S0165-5728(00)00466-5; Mecia L, 1999, J NEUROIMMUNOL, V93, P45; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Popovich PG, 2000, PROG BRAIN RES, V128, P43; Quintana A, 2009, J IMMUNOL, V183, P2079, DOI 10.4049/jimmunol.0900242; Raley A, 2004, J IMMUNOL, V172, P5707; Rasley A, 2002, GLIA, V37, P258, DOI 10.1002/glia.10034; Repka-Ramirez M Susana, 2002, Clin Allergy Immunol, V17, P1; Saligrama N, 2012, EUR J IMMUNOL, V42, P1536, DOI 10.1002/eji.201141859; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Tiligada E, 2009, EXPERT OPIN INV DRUG, V18, P1519, DOI 10.1517/14728220903188438; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52; Wei J, 2013, PARASITOL RES, V112, P207, DOI 10.1007/s00436-012-3127-z; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029	54	53	55	0	13	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2014	34	3					768	780		10.1159/000363041			13	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	AR7NA	WOS:000343765200015	25170632	gold			2022-02-06	
J	Selwyn, R; Hockenbury, N; Jaiswal, S; Mathur, S; Armstrong, RC; Byrnes, KR				Selwyn, Reed; Hockenbury, Nicole; Jaiswal, Shalini; Mathur, Sanjeev; Armstrong, Regina C.; Byrnes, Kimberly R.			Mild Traumatic Brain Injury Results in Depressed Cerebral Glucose Uptake: An (18)FDG PET Study	JOURNAL OF NEUROTRAUMA			English	Article						glucose uptake; LFP; motor function; PET; rat	FLUID PERCUSSION INJURY; HEAD-INJURY; BLOOD-FLOW; NERVOUS-SYSTEM; AXONAL INJURY; F-18-FDG PET; IN-VIVO; RAT; MODEL; METABOLISM	Moderate to severe traumatic brain injury (TBI) in humans and rats induces measurable metabolic changes, including a sustained depression in cerebral glucose uptake. However, the effect of a mild TBI on brain glucose uptake is unclear, particularly in rodent models. This study aimed to determine the glucose uptake pattern in the brain after a mild lateral fluid percussion (LFP) TBI. Briefly, adult male rats were subjected to a mild LFP and positron emission tomography (PET) imaging with F-18-fluorodeoxyglucose ((18)FDG), which was performed prior to injury and at 3 and 24 h and 5, 9, and 16 days post-injury. Locomotor function was assessed prior to injury and at 1, 3, 7, 14, and 21 days after injury using modified beam walk tasks to confirm injury severity. Histology was performed at either 10 or 21 days post-injury. Analysis of function revealed a transient impairment in locomotor ability, which corresponds to a mild TBI. Using reference region normalization, PET imaging revealed that mild LFP-induced TBI depresses glucose uptake in both the ipsilateral and contralateral hemispheres in comparison with sham-injured and naive controls from 3 h to 5 days post-injury. Further, areas of depressed glucose uptake were associated with regions of glial activation and axonal damage, but no measurable change in neuronal loss or gross tissue damage was observed. In conclusion, we show that mild TBI, which is characterized by transient impairments in function, axonal damage, and glial activation, results in an observable depression in overall brain glucose uptake using (18)FDG-PET.	[Selwyn, Reed; Jaiswal, Shalini; Mathur, Sanjeev] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA; [Hockenbury, Nicole; Armstrong, Regina C.; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Selwyn, Reed; Jaiswal, Shalini; Mathur, Sanjeev; Armstrong, Regina C.; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Room B2048,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	kimberly.byrnes@usuhs.edu	mathur, sanjeev k/A-5937-2012	Byrnes, Kimberly/0000-0002-7501-7734	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This work was funded by the Department of Defense in the Center for Neuroscience and Regenerative Medicine. The authors thank Yujia Zhao, Guzal Khayrullina, and Alexander Gordon for technical assistance, and the Uniformed Services University Biomedical Instrumentation Center/Histopathology department for assistance with the Fast blue and silver staining procedures.	Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buck D, 2012, J NUCL MED, V53, P1269, DOI 10.2967/jnumed.111.102608; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fueger BJ, 2006, J NUCL MED, V47, P999; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marklund N, 2009, J NEUROTRAUM, V26, P1281, DOI [10.1089/neu.2008.0827, 10.1089/neu.2008-0827]; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prieto R, 2011, BRAIN RES, V1404, P39, DOI 10.1016/j.brainres.2011.06.006; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Shimoji K, 2004, J NUCL MED, V45, P665; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	54	53	54	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1943	1953		10.1089/neu.2013.2928			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400003	23829400				2022-02-06	
J	Scopaz, KA; Hatzenbuehler, JR				Scopaz, Kristen A.; Hatzenbuehler, John R.			Risk Modifiers for Concussion and Prolonged Recovery	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; postconcussive syndrome; risk factors; risk modifiers		Context: Currently, no consensus exists for grading the severity of concussions. Identification of risk factors that may affect concussion risk and the likelihood of prolonged recovery can be of value to providers who manage concussion. Evidence Acquisition: Relevant studies were identified through MEDLINE (1996-2011) using the keywords concussion, postconcussive syndrome, and risk or risk factor. Targeted searches for specific risk factors were conducted with additional keywords, such as gender and migraine. Manual review of reference lists was also performed to identify pertinent literature. Results: For risk factors of concussion, history of prior concussion and female sex have the most supporting evidence. Sports with consistently high risk for sustaining a concussion include football, men's ice hockey, and women's soccer. Younger athletes appear to be more susceptible to concussion, but data are limited and inconsistent. Protective equipment does not definitively alter concussion risk, though it protects against other injuries. Symptoms such as long headaches, migraines, amnesia, and multiple symptoms appear to be associated with prolonged recovery. Younger age may also increase the risk of prolonged concussion. Conclusion: High-quality evidence for risk modifiers in concussion remains sparse. Prior concussion, collision sports, female sex, and women's soccer are the strongest known risk factors. Evidence for most other factors is inconclusive.	[Scopaz, Kristen A.; Hatzenbuehler, John R.] Maine Med Ctr Sports Med, 272 Congress St, Portland, ME 04101 USA		Scopaz, KA (corresponding author), Maine Med Ctr Sports Med, 272 Congress St, Portland, ME 04101 USA.	scopak1@mmc.org					Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gordon KE, 2006, BR J SPORTS MED, V40; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JENNETT B, 1975, LANCET, V1, P480; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrell T, 2005, CLIN J SPORT MED, V15, P280; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	51	53	53	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV-DEC	2013	5	6					537	541		10.1177/1941738112473059			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V20BI	WOS:000214861700008	24427429	Green Published			2022-02-06	
J	Vakhtin, AA; Calhoun, VD; Jung, RE; Prestopnik, JL; Taylor, PA; Ford, CC				Vakhtin, Andrei A.; Calhoun, Vince D.; Jung, Rex E.; Prestopnik, Jillian L.; Taylor, Paul A.; Ford, Corey C.			Changes in intrinsic functional brain networks following blast-induced mild traumatic brain injury	BRAIN INJURY			English	Article						Blast; cognition; functional magnetic resonance imaging (fMRI); independent component analysis (ICA); mild traumatic brain injury (mTBI); resting state networks (RSN)	DIFFUSE AXONAL INJURY; WHITE-MATTER; POSTCONCUSSIVE SYMPTOMS; IRAQ; CONNECTIVITY; ATTENTION; AFGHANISTAN; MECHANISMS; COMPONENTS; SEQUELAE	Objective: Blast-induced mild traumatic brain injuries (mTBI) commonly go undetected by computed tomography and conventional magnetic resonance imaging (MRI). This study was used to investigate functional brain network abnormalities in a group of blast-induced mTBI subjects using independent component analysis (ICA) of resting state functional MRI (fMRI) data. Methods: Twenty-eight resting state networks of 13 veterans who sustained blast-induced mTBI were compared with healthy controls across three fMRI domains: blood oxygenation level-dependent spatial maps, time course spectra and functional connectivity. Results: The mTBI group exhibited hyperactivity in the temporo-parietal junctions and hypoactivity in the left inferior temporal gyrus. Abnormal frequencies in default-mode (DMN), sensorimotor, attentional and frontal networks were detected. In addition, functional connectivity was disrupted in six network pairs: DMN-basal ganglia, attention-sensorimotor, frontal-DMN, attention-sensorimotor, attention-frontal and sensorimotor-sensorimotor. Conclusions: The results suggest white matter disruption across certain attentional networks. Additionally, given their elevated activity relative to controls', the temporo-parietal junctions of blast mTBI subjects may be compensating for diffuse axonal injury in other cortical regions.	[Vakhtin, Andrei A.; Prestopnik, Jillian L.; Ford, Corey C.] Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; [Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Calhoun, Vince D.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Calhoun, Vince D.; Ford, Corey C.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Calhoun, Vince D.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Jung, Rex E.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Taylor, Paul A.] Sandia Natl Labs, Multiscale Dynam Mat Modeling Dept, Albuquerque, NM 87185 USA		Ford, CC (corresponding author), 1 Univ New Mexico, Hlth Sci Ctr, Dept Neurol, MSC10 5620, Albuquerque, NM 87131 USA.	cford@salud.unm.edu		Jung, Rex/0000-0003-3718-0597	US Naval Health Research Center, Office of Naval Research; United States Department of Energy's National Nuclear Security AdministrationNational Nuclear Security Administration [DE-AC04-94AL85000]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB006841] Funding Source: NIH RePORTER	This work was funded through the US Naval Health Research Center, Office of Naval Research, through project funding manager Mr James Mackiewicz. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the United States Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. The authors report no conflicts of interest.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bockholt Henry J, 2010, Front Neuroinform, V3, P36, DOI 10.3389/neuro.11.036.2009; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2011, FRONT PSYCHIATRY, V2, P1; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Delis D.C., 2000, CALIFORNIA VERBAL LE; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Faul M, 2010, TRAUMATIC BRAIN INJU; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nardo D, 2011, NEURON, V69, P1015, DOI 10.1016/j.neuron.2011.02.020; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott Adam, 2011, Front Neuroinform, V5, P33, DOI 10.3389/fninf.2011.00033; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519	43	53	54	0	27	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1304	1310		10.3109/02699052.2013.823561			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800010	24020442	Green Accepted			2022-02-06	
J	Randolph, C; Karantzoulis, S; Guskiewicz, K				Randolph, Christopher; Karantzoulis, Stella; Guskiewicz, Kevin			Prevalence and Characterization of Mild Cognitive Impairment in Retired National Football League Players	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Concussion; Football; Sports; CTE; MCI	CHRONIC TRAUMATIC ENCEPHALOPATHY; RECURRENT CONCUSSION; HEAD IMPACTS; ASSOCIATION; DEMENTIA; DISEASE; AFTERMATH; INJURY; RBANS; SPORT	It has been hypothesized that exposure to repetitive head trauma from contact sports over a long-playing career may eventuate in an increased risk of late-life cognitive impairment. There are currently two competing hypotheses about the possible mechanism underlying such impairment. One is the presence of a unique neurodegenerative disorder known as "chronic traumatic encephalopathy" (CTE). The other is diminished cerebral reserve leading to the earlier clinical expression of age-related neurodegenerative diseases such as mild cognitive impairment (MCI) and Alzheimer's disease (AD). The present study examined informant AD8 inventory data in a sample of 513 retired National Football League (NFL) players. These data were indicative of possible cognitive impairment in 35.1% of this relatively young sample. A comparison of neurocognitive profiles in a subsample of this group to a clinical sample of patients with a diagnosis of MCI due to AD revealed a highly similar profile of impairments. Overall, the data suggest that there may be an increased prevalence of late-life cognitive impairment in retired NFL players, which may reflect diminished cerebral reserve. The findings are considered preliminary, but emphasize the need for larger, controlled studies on this issue.	[Randolph, Christopher] Loyola Univ, Med Ctr, Dept Neurol, Maywood, IL 60153 USA; [Karantzoulis, Stella] NYU, Langone Med Ctr, Dept Neurol, New York, NY USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC USA; [Guskiewicz, Kevin] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC USA		Randolph, C (corresponding author), 1 East Erie,Suite 353, Chicago, IL 60611 USA.	crandol@lumc.edu		Guskiewicz, Kevin/0000-0002-8682-2130	Martek Biosciences Corporation	This study was funded in part by Martek Biosciences Corporation. We thank Candice Goerger, Amy Matthews, Karla Thompson, and Daniel Kaufer for their contributions. Dr. Randolph is the author of the RBANS, and receives royalties from sales of this test. The authors have no other conflicts to disclose	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Beatty WW, 2003, ARCH CLIN NEUROPSYCH, V18, P509, DOI 10.1016/S0887-6177(02)00148-8; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Donnell AJ, 2007, ARCH CLIN NEUROPSYCH, V22, P917, DOI 10.1016/j.acn.2007.06.007; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C., 1998, REPEATABLE BATTERY A; Randolph C, 2012, ALZHEIMERS DEMENT, V8, P172; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Roberts RO, 2012, NEUROLOGY, V78, P342, DOI 10.1212/WNL.0b013e3182452862; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Tervo S, 2004, DEMENT GERIATR COGN, V17, P196, DOI 10.1159/000076356; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103	31	53	53	6	93	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2013	19	8					873	880		10.1017/S1355617713000805			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	209AQ	WOS:000323725800004	23902607	Green Submitted			2022-02-06	
J	[Anonymous]				[Anonymous]			Team Physician Consensus Statement: 2013 Update	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article							CONTINUING MEDICAL-EDUCATION; SPORTS-MEDICINE; SCHOOL-HEALTH; CONCUSSION; ILLNESSES										Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; [Anonymous], 2008, MED SCI SPORT EXER, V40, P1997, DOI 10.1249/MSS.0b013e31818acdcb; [Anonymous], 2001, MED SCI SPORT EXER, V33, P1789; [Anonymous], 2006, MED SCI SPORT EXER, V38, P2030, DOI 10.1249/MSS.0b013e31802b37a6; [Anonymous], 2000, MED SCI SPORT EXER, V32, P877; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 2004, MED SCI SPORT EXER, V36, P2004; [Anonymous], 2007, MED SCI SPORT EXER, V39, P2058, DOI 10.1249/mss.0b013e31815a76ea; [Anonymous], 2010, MED SCI SPORT EXER, V42, P820, DOI 10.1249/MSS.0b013e3181d19a0b; Barrow MW, 1998, AM FAM PHYSICIAN, V58, P749; Binkley HM, 2002, J ATHL TRAINING, V37, P329; BLACK JL, 1991, J SCHOOL HEALTH, V61, P245, DOI 10.1111/j.1746-1561.1991.tb07392.x; Dikic N, 2013, BRIT J SPORT MED, V47, P701, DOI 10.1136/bjsports-2012-091838; Dunn WR, 2007, AM J SPORT MED, V35, P840, DOI 10.1177/0363546506295177; Griffin LY, 2003, MED SCI SPORT EXER, V35, P1785; Hart KA, 1999, AM J PHYS MED REHAB, V78, P561, DOI 10.1097/00002060-199911000-00014; Herring Stanley A, 2012, Med Sci Sports Exerc, V44, P2446, DOI 10.1249/MSS.0b013e3182750534; Holm S, 2011, BRIT J SPORT MED, V45, P1170, DOI 10.1136/bjsm.2011.086124; Hsu AC, 2012, MED SCI SPORT EXER, V44, P178, DOI 10.1249/MSS.0b013e318275044f; Kane SM, 2009, CLIN ORTHOP RELAT R, V467, P412, DOI 10.1007/s11999-008-0589-5; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; McCrory P, 2003, BRIT J SPORT MED, V37, P472, DOI 10.1136/bjsm.37.6.472; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mitten MJ, 2002, ST JOHNS LAW REV, P76; MUHLEMANN R, 1984, SOZ PRAVENTIV MED, V29, P227, DOI 10.1007/BF02075890; Murthy AM, 2012, BULL HOSP JT DIS, V70, P56; Olson DE, 2013, BRIT J SPORT MED, V47, P5, DOI 10.1136/bjsports-2012-091936; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Ribbans B, 2013, BRIT J SPORT MED, V47, P40, DOI 10.1136/bjsports-2011-090439; Stockard A R, 1997, J Am Osteopath Assoc, V97, P89; Stovitz Steven D, 2006, Curr Sports Med Rep, V5, P120; Viola T, 2013, BRIT J SPORT MED, V47, P60, DOI 10.1136/bjsports-2012-091460	33	53	53	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	AUG	2013	45	8					1618	1622		10.1249/MSS.0b013e31829ba437			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	300KT	WOS:000330463500024	23860390				2022-02-06	
J	Sripada, RK; Rauch, SAM; Tuerk, PW; Smith, E; Defever, AM; Mayer, RA; Messina, M; Venners, M				Sripada, Rebecca K.; Rauch, Sheila A. M.; Tuerk, Peter W.; Smith, Erin; Defever, Andrew M.; Mayer, Rebecca A.; Messina, Michael; Venners, Margaret			Mild Traumatic Brain Injury and Treatment Response in Prolonged Exposure for PTSD	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; RANDOMIZED CONTROLLED-TRIAL; THERAPY; VETERANS; IRAQ; METAANALYSIS; AFGHANISTAN; MECHANISMS; CLINICIAN	A proportion of U.S. veterans returning from Iraq and Afghanistan have experienced mild traumatic brain injury (mTBI), which is associated with increased risk for developing posttraumatic stress disorder (PTSD). Prolonged Exposure (PE) has proven effectiveness in the treatment of PTSD; however, some clinicians have reservations about using PE with individuals with a history of mTBI. We examined the impact of PE for veterans with PTSD and with or without a history of mTBI in a naturalistic sample of 51 veterans who received PE at a Veterans Health Administration PTSD clinic. We also analyzed previously collected data from a controlled trial of 22 veterans randomly assigned to PE or present centered therapy. For both sets of data, we found that PE reduced symptom levels and we also did not detect an effect for mTBI, suggesting that PE may be helpful for individuals with PTSD and a history of mTBI.	[Sripada, Rebecca K.; Rauch, Sheila A. M.; Smith, Erin; Defever, Andrew M.; Mayer, Rebecca A.; Messina, Michael; Venners, Margaret] Univ Michigan, Sch Med, VA Ann Arbor Hlth Care Syst, Ann Arbor, MI USA; [Tuerk, Peter W.] Med Univ S Carolina, Ralph H Johnson VAMC, Charleston, SC 29425 USA		Sripada, RK (corresponding author), VA Serious Mental Illness Treatment Resource & Ev, Ann Arbor, MI USA.	rekaufma@umich.edu	Rauch, Sheila A.M./K-4450-2015	Sripada, Rebecca/0000-0002-2844-3458			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2006, COGN BEHAV PRACT, V13, P17, DOI 10.1016/j.cbpra.2005.03.002; Carlson K, 2009, ASSESSMENT TREATMENT; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Defense Manpower Data Center, 2009, CONT TRACK SYST; Du Toit M., 2004, HLM 6 HIERARCHICAL L; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Foa E. B., 2007, PROL EXP THER PTSD T; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Gilboa-Schechtman E, 2010, J AM ACAD CHILD PSY, V49, P1034, DOI 10.1016/j.jaac.2010.07.014; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Independent Review G. Rebuilding the Trust, 2007, REB TRUST REP REH CA; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rauch S. A. M., 2013, CHANGES SYMPTO UNPUB; Rauch S, 2006, J CONTEMP PSYCHOTHER, V36, P61, DOI 10.1007/s10879-006-9008-y; Rauch SAM, 2012, J REHABIL RES DEV, V49, P679, DOI 10.1682/JRRD.2011.08.0152; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thorp SR, 2012, AM J GERIAT PSYCHIAT, V20, P276, DOI 10.1097/JGP.0b013e3182435ee9; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Tuerk PW, 2010, J TRAUMA STRESS, V23, P116, DOI 10.1002/jts.20494; U.S. Department of Defense, 1998, JOINT TACTICS TECHNI, V3-07.2; U.S. Department of Veterans Affairs & Department of Defense (VA/DoD), 2010, VA DOD CLIN PRACTICE; Verfaellie M, 2012, PTSD MILD TRAUMATIC, P83; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers F. W., 1991, PCL S DSM 4; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	48	53	54	0	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867			J TRAUMA STRESS	J. Trauma Stress	JUN	2013	26	3					369	375		10.1002/jts.21813			7	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	157GA	WOS:000319882800009	23696427	Green Submitted			2022-02-06	
J	Arbogast, KB; McGinley, AD; Master, CL; Grady, MF; Robinson, RL; Zonfrillo, MR				Arbogast, Kristy B.; McGinley, Alexander D.; Master, Christina L.; Grady, Matthew F.; Robinson, Roni L.; Zonfrillo, Mark R.			Cognitive Rest and School-Based Recommendations Following Pediatric Concussion: The Need for Primary Care Support Tools	CLINICAL PEDIATRICS			English	Article						concussion; mild traumatic brain injury; primary care; cognitive rest; school	INTERNATIONAL-CONFERENCE; STATEMENT; SPORT	Objectives. (1) Assess pediatric primary care providers' understanding of cognitive rest for concussion and (2) describe their concussion management practices. Methods. This study included (1) a survey of general pediatric providers and (2) an electronic medical record (EMR) review of children 5 to 18 years old treated for concussion from September 1, 2010, to May 31, 2011. The survey asked about treatment recommendations for concussion, and results were coded to identify cognitive rest recommendations. The EMR review included the following: injury details, medical evaluation, and recommendations for resuming school and sports/recreation. Results. In all, 89 of 201 providers responded to the survey, and 52 of the 84 clinicians who included comments about concussion management mentioned cognitive rest (62%, 95% confidence interval [CI] = 51%-72%). Of the 91 EMRs reviewed for patients' first visits following the concussion, only 10 (11%, 95% CI = 6%-19%) included written cognitive rest recommendations. Conclusions. Although the majority of pediatric providers identified cognitive rest as important in pediatric concussion management, few provided written recommendations in the EMR.	[Arbogast, Kristy B.; McGinley, Alexander D.; Master, Christina L.; Grady, Matthew F.; Robinson, Roni L.; Zonfrillo, Mark R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.; Master, Christina L.; Grady, Matthew F.; Zonfrillo, Mark R.] Univ Penn, Philadelphia, PA 19104 USA		Arbogast, KB (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 3535 Market St,Suite 1150, Philadelphia, PA 19104 USA.	arbogast@email.chop.edu	Zonfrillo, Mark R./H-9403-2017; Meijer, Anna/K-5118-2016	Zonfrillo, Mark R./0000-0002-0610-9563; Arbogast, Kristy/0000-0002-1694-4562; Master, Christina/0000-0002-6717-4270	Children's Hospital of Philadelphia; University of Pennsylvania Perelman School of Medicine Department of Pediatrics Chair's Initiatives program	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine Department of Pediatrics Chair's Initiatives program.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, P362, DOI 10.3928/00904481-20120827-07; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan Iii WP, 2010, J PEDIAT, V157; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Samuels-Kalow ME, 2012, ANN EMERG MED, V60, P152, DOI 10.1016/j.annemergmed.2011.10.023; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	15	53	53	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	MAY	2013	52	5					397	402		10.1177/0009922813478160			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	134XN	WOS:000318249200003	23447397				2022-02-06	
J	Mehta, SP; Bhananker, SM; Posner, KL; Domino, KB				Mehta, Sonya P.; Bhananker, Sanjay M.; Posner, Karen L.; Domino, Karen B.			Operating Room Fires A Closed Claims Analysis	ANESTHESIOLOGY			English	Article							OPTIMIZING SAFETY; FACIAL SURGERY; AIRWAY FIRE; ANESTHESIA; ELECTROCAUTERY; OXYGEN; TRACHEOSTOMY; PREVENTION; LIABILITY; IGNITION	Background: To assess patterns of injury and liability associated with operating room (OR) fires, closed malpractice claims in the American Society of Anesthesiologists Closed Claims Database since 1985 were reviewed. Methods: All claims related to fires in the OR were compared with nonfire-related surgical anesthesia claims. An analysis of fire-related claims was performed to identify causative factors. Results: There were 103 OR fire claims (1.9% of 5,297 surgical claims). Electrocautery was the ignition source in 90% of fire claims. OR fire claims more frequently involved older outpatients compared with other surgical anesthesia claims (P < 0.01). Payments to patients were more often made in fire claims (P < 0.01), but payment amounts were lower (median $120,166) compared to nonfire surgical claims (median $250,000, P < 0.01). Electrocautery-induced fires (n = 93) increased over time (P < 0.01) to 4.4% claims between 2000 and 2009. Most (85%) electrocautery fires occurred during head, neck, or upper chest procedures (high-fire-risk procedures). Oxygen served as the oxidizer in 95% of electrocautery-induced OR fires (84% with open delivery system). Most electrocautery-induced fires (n = 75, 81%) occurred during monitored anesthesia care. Oxygen was administered via an open delivery system in all high-risk procedures during monitored anesthesia care. In contrast, alcohol-containing prep solutions and volatile compounds were present in only 15% of OR fires during monitored anesthesia care. Conclusions: Electrocautery-induced fires during monitored anesthesia care were the most common cause of OR fires claims. Recognition of the fire triad (oxidizer, fuel, and ignition source), particularly the critical role of supplemental oxygen by an open delivery system during use of the electrocautery, is crucial to prevent OR fires. Continuing education and communication among OR personnel along with fire prevention protocols in high-fire-risk procedures may reduce the occurrence of OR fires.	[Mehta, Sonya P.; Bhananker, Sanjay M.; Posner, Karen L.; Domino, Karen B.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA USA		Domino, KB (corresponding author), Dept Anesthesiol & Pain Med, Box 356540,1959 NE Pacific St, Seattle, WA 98195 USA.	kdomino@uw.edu			American Society of Anesthesiologists (ASA), Park Ridge, Illinois	Supported by the American Society of Anesthesiologists (ASA), Park Ridge, Illinois. All opinions expressed are those of the authors and do not reflect the policy of the ASA.	ALY A, 1991, ANN OTO RHINOL LARYN, V100, P31, DOI 10.1177/000348949110000105; [Anonymous], 2012, APSF NEWSL, V26, P41; BAILEY MK, 1990, ANESTH ANALG, V71, P702; Barker SJ, 2001, ANESTH ANALG, V93, P960, DOI 10.1097/00000539-200110000-00031; Barnes A M, 2000, AANA J, V68, P153; Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005; BOYD CH, 1969, ANAESTHESIA, V24, P441, DOI 10.1111/j.1365-2044.1969.tb02883.x; Caplan RA, 2008, ANESTHESIOLOGY, V108, P786; Chee WK, 1998, ANESTHESIOLOGY, V89, P1576, DOI 10.1097/00000542-199812000-00040; CHENEY FW, 1989, JAMA-J AM MED ASSOC, V261, P1599, DOI 10.1001/jama.261.11.1599; Dini GM, 2006, PLAST RECONSTR SURG, V117, P325, DOI 10.1097/01.prs.0000196235.01758.f6; ECRI Institute, 2009, HLTH DEVICES, V328, P314; Engel SJ, 2012, PLAST RECONSTR SURG, V130, P681, DOI 10.1097/PRS.0b013e31825dc14a; Goldberg Jessica, 2006, AANA J, V74, P352; GRECO RJ, 1995, PLAST RECONSTR SURG, V95, P978, DOI 10.1097/00006534-199505000-00004; Greene BA, 1941, ANESTHESIOLOGY, V2, P141; Greene BA., 1942, SURG GYNECOL OBSTET, V74, P895; Howard BK, 1997, ANN OTO RHINOL LARYN, V106, P248, DOI 10.1177/000348949710600313; Kaddoum RN, 2006, J CLIN ANESTH, V18, P129, DOI 10.1016/j.jclinane.2005.09.032; Lampotang S, 2005, ANESTH ANALG, V101, P1407, DOI 10.1213/01.ANE.0000180215.50589.02; Le Clair J, 1990, AANA J, V58, P259; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Meneghetti SC, 2007, PLAST RECONSTR SURG, V120, P1701, DOI 10.1097/01.prs.0000282729.23202.da; Orhan-Sungur M, 2009, ANAESTHESIA, V64, P521, DOI 10.1111/j.1365-2044.2008.05820.x; POSNER KL, 1990, STAT MED, V9, P1103, DOI 10.1002/sim.4780090917; Roy S, 2011, INT J PEDIATR OTORHI, V75, P227, DOI 10.1016/j.ijporl.2010.11.005; SIMPSON JI, 1986, ANESTHESIOLOGY, V65, P76, DOI 10.1097/00000542-198607000-00012; Smith LP, 2011, AM J OTOLARYNG, V32, P109, DOI 10.1016/j.amjoto.2009.11.004; Wolf GL, 2004, ANESTHESIOLOGY, V100, P1167, DOI 10.1097/00000542-200405000-00019	29	53	55	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-3022			ANESTHESIOLOGY	Anesthesiology	MAY	2013	118	5					1133	1139		10.1097/ALN.0b013e31828afa7b			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	131BA	WOS:000317964300019	23422795				2022-02-06	
J	Colville, GA; Pierce, CM				Colville, Gillian A.; Pierce, Christine M.			Children's Self-Reported Quality of Life After Intensive Care Treatment	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						outcomes; posttraumatic stress; quality of life; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; GENERIC CORE SCALES; EVENT SCALE; THE-LITERATURE; HEALTH; SURVIVORS; UNIT; VALIDITY; IMPACT; RELIABILITY	Objectives: Study was to establish children's own views of their outcome. Design: Prospective cohort study: A number of studies have reported on parental/clinician reports of children's quality of life after intensive care treatment. The aim of this Setting: Twenty-one bed PICU in a tertiary Children's Hospital. Patients: Ninety-seven children aged over 7 yr, with no preexisting learning difficulties, consecutively admitted to PICU over an 18 month period Interventions: Patients completed the Pediatric Quality of Life Inventory and a post-traumatic stress screener, at 3 months and again at 1 year (n = 72) after discharge from PICU. Measurements and Main Results: At 3 months post-discharge, the mean total Pediatric Quality of Life Inventory score reported by the PICU group was lower than that reported in the literature for a non-clinical community sample (PICU mean = 79.1 vs community mean = 83.9, p = 0.003), but by 1 year, they were comparable (82.2, p = 0.388). The mean physical functioning subscale score remained lower (PICU mean=81.6 vs. community mean=88.5, p = 0.01), but improved significantly from 73.4 at 3 months (p = 0.001). Sub-group analyses revealed that the elective group reported higher emotional functioning than the community sample (91.0, p = 0.005 at 3 months and 88.2, p = 0.038 at 1 year vs community mean=78.5), and made significant gains in social functioning between timepoints (79.1 to 91.4, p = 0.015). Finally, although total PedsQL scores at 1 year were not associated with measures of severity of illness during admission, they were significantly negatively associated with concurrent post-traumatic stress symptom scores (r = -0.40, p = 0.001). Conclusions: The self-report version of the Pediatric Quality of Life Inventory proved to be a feasible and sensitive tool for assessing health related quality of life in this group of PICU survivors. (Pediatr Crit Care Med 2013; 14:e85-e92)	[Colville, Gillian A.; Pierce, Christine M.] Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London WC1N 3JH, England; [Colville, Gillian A.] St George Hosp, Paediat Psychol Serv, London, England		Colville, GA (corresponding author), Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, Great Ormond St, London WC1N 3JH, England.	gcolvill@sgul.ac.uk	Colville, Gillian/ABH-3180-2020	Colville, Gillian/0000-0001-8530-2822	Health Foundation, United Kingdom	This research was funded by a Leading Practice Through Research award to the first author, from The Health Foundation, United Kingdom. We gratefully acknowledge comments on earlier drafts of this manuscript from Dr Mark Peters at Great Ormond Street Children's Hospital.	Ambuehl J, 2007, SWISS MED WKLY, V137, P312; Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; Colville G, 2008, AM J RESP CRIT CARE, V177, P976, DOI 10.1164/rccm.200706-857OC; Colville G, 2008, PEDIATR CLIN N AM, V55, P605, DOI 10.1016/j.pcl.2008.02.006; Colville G, 2012, INTENS CARE MED, V38, P1523, DOI 10.1007/s00134-012-2612-2; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Davydow DS, 2010, ARCH PEDIAT ADOL MED, V164, P377, DOI 10.1001/archpediatrics.2010.10; Dossetor DR, 1996, J PAEDIATR CHILD H, V32, P519, DOI 10.1111/j.1440-1754.1996.tb00966.x; Eiser C, 2001, J DEV BEHAV PEDIATR, V22, P248, DOI 10.1097/00004703-200108000-00007; FEENY D, 1992, J CLIN ONCOL, V10, P923, DOI 10.1200/JCO.1992.10.6.923; GEMKE RJBJ, 1995, ARCH DIS CHILD, V73, P196, DOI 10.1136/adc.73.3.196; Graham RJ, 2009, CRIT CARE MED, V37, P2064, DOI 10.1097/CCM.0b013e3181a00578; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Janssens L, 2008, QUAL LIFE RES, V17, P701, DOI 10.1007/s11136-008-9339-0; Jayshree M, 2003, Indian Pediatr, V40, P303; Jones S, 2006, PEDIATRICS, V118, P2101, DOI 10.1542/peds.2006-1455; Knoester H, 2007, EUR J PEDIATR, V166, P1119, DOI 10.1007/s00431-007-0573-1; Knoester H, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-21; Landolt MA, 2009, J PEDIATR PSYCHOL, V34, P14, DOI 10.1093/jpepsy/jsm088; Mistry RD, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-5; Morrison Anne L, 2002, Pediatr Crit Care Med, V3, P1, DOI 10.1097/00130478-200201000-00001; Morrison W, 2010, PEDIATR CRIT CARE ME, V11, P630, DOI 10.1097/PCC.0b013e3181d50462; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Noyes J, 2000, J ADV NURS, V31, P1206, DOI 10.1046/j.1365-2648.2000.01376.x; Noyes J, 2007, J ADV NURS, V58, P1, DOI 10.1111/j.1365-2648.2006.04191.x; Pearson GA, 2001, ARCH DIS CHILD, V84, P125, DOI 10.1136/adc.84.2.125; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; Rennick JE, 2009, J CHILD HEALTH CARE, V13, P128, DOI 10.1177/1367493509102472; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Stallard P, 1999, J CHILD PSYCHOL PSYC, V40, P1075, DOI 10.1017/S0021963099004473; Taylor A, 2003, INTENS CARE MED, V29, P795, DOI 10.1007/s00134-003-1690-6; Taylor A, 2000, CLIN INTENSIVE CARE, V11, P239; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Townsend P, 1988, HLTH DEPRIVATION INE; Upton Penney, 2005, Health Qual Life Outcomes, V3, P22, DOI 10.1186/1477-7525-3-22; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; Varni JW, 2004, J BEHAV MED, V27, P297, DOI 10.1023/B:JOBM.0000028500.53608.2c; World Health Organization, 1948, CONST WHO CONST BAS; Yule W., 1997, CHILD PSYCHOL PORTFO	45	53	55	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2013	14	2					E85	E92		10.1097/PCC.0b013e3182712997			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pediatrics	088GC	WOS:000314820800004	23337805				2022-02-06	
J	Genet, GF; Johansson, PI; Meyer, MAS; Solbeck, S; Sorensen, AM; Larsen, CF; Welling, KL; Windelov, NA; Rasmussen, LS; Ostrowski, SR				Genet, Gustav Folmer; Johansson, Par Ingemar; Meyer, Martin Abild Stengaard; Solbeck, Sacha; Sorensen, Anne Marie; Larsen, Claus Falck; Welling, Karen Lise; Windelov, Nis Agerlin; Rasmussen, Lars S.; Ostrowski, Sisse Rye			Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						coagulopathy; pathogenesis; TBI; trauma	DISSEMINATED INTRAVASCULAR COAGULATION; SYMPATHOADRENAL ACTIVATION; GLYCOCALYX DEGRADATION; EARLY RELEASE; HYPOPERFUSION; MORTALITY; SHOCK; INFLAMMATION; SEVERITY; RECEPTOR	It remains to be debated whether traumatic brain injury (TBI) induces a different coagulopathy than does non-TBI. This study investigated traditional coagulation tests, biomarkers of coagulopathy, and endothelial damage in trauma patients with and without TBI. Blood from 80 adult trauma patients was sampled (median of 68 min [IQR 48-88] post-injury) upon admission to our trauma center. Plasma/serum were retrospectively analyzed for biomarkers reflecting sympathoadrenal activation (adrenaline, noradrenaline), coagulation activation/inhibition and fibrinolysis (protein C, activated protein C, tissue factor pathway inhibitor, antithrombin, prothrombin fragment 1 + 2, thrombin/antithrombin complex, von Willebrand factor, factor XIII, d-dimer, tissue-type plasminogen activator, plasminogen activator inhibitor-1), immunology (interleukin [IL]6), endothelial cell/glycocalyx damage (soluble thrombomodulin, syndecan-1), and vasculogenesis (angiopoietin-1, -2). Patients were stratified according to: 1) isolated severe head/neck injuries (Abbreviated Injury Score [AIS]-head/neck >= 3, AIS-other < 3) (isoTBI); 2) severe head/neck and extracranial injuries (AIS-head/neck >= 3, AIS-other > 3) (sTBI + other); and 3) injuries without significant head/neck injuries (AIS-head/neck < 3, including all AIS-other scores) (non-TBI). Twenty-three patients presented with isoTBI, 15 with sTBI + other and 42 with non-TBI. Acute coagulopathy of trauma shock, defined as activated partial thromboplastin time (APTT) and/or international normalized ratio (INR) > 35 sec and > 1.2, was found in 13%, 47%, and 5%, respectively (p = 0.000). sTBI + other had significantly higher plasma levels of adrenaline, noradrenaline, annexin V, d-dimer, IL-6, syndecan-1, soluble thrombomodulin, and reduced protein C and factor XIII levels (all p < 0.05). No significant biomarker differences were found between isoTBI and non-TBI patients. Injury Severity Scale (ISS) rather than the presence or absence of head/neck injuries determined the hemostatic and biomarker response to the injury. The coagulopathy identified thus reflected the severity of injury rather than its localization.	[Genet, Gustav Folmer; Johansson, Par Ingemar; Meyer, Martin Abild Stengaard; Solbeck, Sacha; Windelov, Nis Agerlin; Ostrowski, Sisse Rye] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Transfus Med Sect,Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark; [Sorensen, Anne Marie; Windelov, Nis Agerlin; Rasmussen, Lars S.] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Dept Anaesthesia, DK-2100 Copenhagen, Denmark; [Sorensen, Anne Marie; Larsen, Claus Falck] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Ctr Trauma,Ctr Head & Orthopaed, DK-2100 Copenhagen, Denmark; [Welling, Karen Lise] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Dept Neurointens Care, DK-2100 Copenhagen, Denmark; [Johansson, Par Ingemar] Univ Texas Houston, Sch Med, Dept Surg, Ctr Translat Injury Res, Houston, TX USA		Genet, GF (corresponding author), Univ Copenhagen, Capital Reg Blood Bank, Rigshosp, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	gustavgenet@hotmail.com	Johansson, Par I/P-9283-2015; Solbeck, Sacha/A-2220-2016; Ostrowski, Sisse R/E-7423-2011; Meyer, Martin A. S./J-2951-2013	Johansson, Par I/0000-0001-9778-5964; Ostrowski, Sisse R/0000-0001-5288-3851; Meyer, Martin A. S./0000-0002-6312-2457; Rasmussen, Lars/0000-0002-7480-3004	Danish Council for Independent Research (Medical Sciences)Det Frie Forskningsrad (DFF); Lundbeck FoundationLundbeckfonden; Aase and Ejnar Danielsens Foundation; L. F. Foghts Foundation; A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Medical Sciences); Haemonectics Corp. (MA, USA); University of Copenhagen (Faculty of Health Sciences)	We thank Karen Dyerermose and Marie Helena Andersson for their skilled technical assistance. This work was supported by The Danish Council for Independent Research (Medical Sciences), The Lundbeck Foundation, Aase and Ejnar Danielsens Foundation, L. F. Foghts Foundation, A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Medical Sciences), Haemonectics Corp. (MA, USA) and University of Copenhagen (Faculty of Health Sciences).	Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cohen MJ, 2010, J TRAUMA, V68, P1273, DOI 10.1097/TA.0b013e3181db323e; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Dirks J, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-65; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Frith D, 2012, THROMB RES, V129, P551, DOI 10.1016/j.thromres.2011.11.053; Frith D, 2012, CURR OPIN ANESTHESIO, V25, P229, DOI 10.1097/ACO.0b013e3283509675; Frith D, 2010, SURG-J R COLL SURG E, V8, P159, DOI 10.1016/j.surge.2009.10.022; Ganter MT, 2008, ANN SURG, V247, P320, DOI 10.1097/SLA.0b013e318162d616; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson PI, 2012, CRIT CARE MED, V40, P1844, DOI 10.1097/CCM.0b013e31823e9d15; Johansson PI, 2011, CRIT CARE, V15, DOI 10.1186/cc10553; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; Ostrowski SR, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-27; Ostrowski SR, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-64; Skaga N.O., 2012, INJURY; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	29	53	61	0	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					301	306		10.1089/neu.2012.2612			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300007	23134525				2022-02-06	
J	Bryan, CJ; Clemans, TA; Hernandez, AM; Rudd, MD				Bryan, Craig J.; Clemans, Tracy A.; Hernandez, Ann Marie; Rudd, Michael David			Loss of Consciousness, Depression, Posttraumatic Stress Disorder, and Suicide Risk Among Deployed Military Personnel With Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; depression; insomnia; loss of consciousness; military; posttraumatic stress disorder; suicide; traumatic brain injury	MENTAL-HEALTH-SERVICES; MAJOR DEPRESSION; INDIVIDUALS; PREVALENCE; VALIDATION	Objective: To identify clinical variables associated with suicidality in military personnel with mild traumatic brain injury (mTBI) while deployed to Iraq. Setting: Outpatient TBI clinic on a US military base in Iraq. Participants: Military personnel (N = 158) referred to an outpatient TBI clinic for a standardized intake evaluation, 135 (85.4%) who had a diagnosis of mTBI and 23 (14.6%) who did not meet criteria for TBI. Main Measures: Suicidal Behaviors Questionnaire-Revised, Depression subscale of the Behavioral Health Measure-20, Posttraumatic Stress Disorder Checklist-Military Version, Insomnia Severity Index, self-report questionnaire, and clinical interview addressing TBI-related symptoms. Results: Among patients with mTBI, increased suicidality was significantly associated with depression and the interaction of depression with posttraumatic stress disorder symptoms. Longer duration of loss of consciousness was associated with decreased likelihood for any suicidality. Conclusion: Assessment after TBI in a combat zone may assist providers in identifying those at risk for suicidality and making treatment recommendations for service members with mTBI.	[Bryan, Craig J.; Rudd, Michael David] Univ Utah, Natl Ctr Vet Studies, Salt Lake City, UT 84112 USA; [Clemans, Tracy A.] Univ Colorado, Sch Med, Dept Psychiat, VISN Mental Illness Res Educ Clin Ctr 19, Denver, CO 80262 USA; [Hernandez, Ann Marie] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA		Bryan, CJ (corresponding author), Univ Utah, Natl Ctr Vet Studies, 260 S Cent Campus Dr,Room 205, Salt Lake City, UT 84112 USA.	craig.bryan@utah.edu	Rudd, M. David/AAF-1359-2019	Bryan, Craig/0000-0002-9714-0733; Clemans, Tracy/0000-0001-5994-1508			ANSTEY K, 2002, J CLIN EPIDEMIOL, V57, P1202; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blount TH, 2011, ANN M ASS BEH COGN T; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Carrion J, 2001, BRAIN INJURY, V15, P175; Deb S, 1999, AM J PSYCHIAT, V156, P374; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fischer H, 2010, US MILITARY CASUALTY; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kishi Y, 2001, J NERV MENT DIS, V189, P623, DOI 10.1097/00005053-200109000-00009; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; Martin J., 2009, J MENTAL HEALTH COUN, V31, P101, DOI DOI 10.17744/MEHC.31.2.A6338384R2770383; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Rudd MD, 2011, PROF PSYCHOL-RES PR, V42, P354, DOI 10.1037/a0025164; Sher L, 2009, EXPERT REV NEUROTHER, V9, P921, DOI [10.1586/ern.09.61, 10.1586/ERN.09.61]; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Army, 2009, ARM HLTH PROM RISK R; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Weathers FW, 2011, 9 ANN C INT SOC TRAU; Westat, 2010, NAT SURV VET ACT DUT	31	53	53	1	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2013	28	1					13	20		10.1097/HTR.0b013e31826c73cc			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	070ZW	WOS:000313555400002	23076097				2022-02-06	
J	Xu, JG; Wang, HD; Ding, K; Lu, XY; Li, T; Wang, JW; Wang, CX; Wang, J				Xu, Jianguo; Wang, Handong; Ding, Ke; Lu, Xinyu; Li, Tao; Wang, Jiawei; Wang, Chunxi; Wang, Jian			Inhibition of Cathepsin S Produces Neuroprotective Effects after Traumatic Brain Injury in Mice	MEDIATORS OF INFLAMMATION			English	Article							MHC CLASS-II; CYSTEINE PROTEASE; POSTTRAUMATIC EPILEPSY; INCREASED EXPRESSION; MESSENGER-RNA; MECHANISM; MODEL	Cathepsin S (CatS) is a cysteine protease normally present in lysosomes. It has long been regarded as an enzyme that is primarily involved in general protein degradation. More recently, mounting evidence has shown that it is involved in Alzheimer disease, seizures, age-related inflammatory processes, and neuropathic pain. In this study, we investigated the time course of CatS protein and mRNA expression and the cellular distribution of CatS in a mouse model of traumatic brain injury (TBI). To clarify the roles of CatS in TBI, we injected the mice intraventricularly with LHVS, a nonbrain penetrant, irreversible CatS inhibitor, and examined the effect on inflammation and neurobehavioral function. We found that expression of CatS was increased as early as 1 h after TBI at both protein and mRNA levels. The increased expression was detected in microglia and neurons. Inhibition of CatS significantly reduced the level of TBI-induced inflammatory factors in brain tissue and alleviated brain edema. Additionally, administration of LHVS led to a decrease in neuronal degeneration and improved neurobehavioral function. These results imply that CatS is involved in the secondary injury after TBI and provide a new perspective for preventing secondary injury after TBI.	[Xu, Jianguo; Wang, Handong; Ding, Ke; Lu, Xinyu; Li, Tao; Wang, Jiawei; Wang, Chunxi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA		Wang, HD (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070974]; Key Subject of Jiangsu Province [X4200722]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01AG031926]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG031926] Funding Source: NIH RePORTER	This work was supported by Grants from the National Natural Science Foundation of China (no. 81070974), the Key Subject of Jiangsu Province (no. X4200722), and NIH (K01AG031926). The authors thank Claire Levine, MS, ELS, for assistance with this paper.	Akahoshi N, 2007, NEUROSCI LETT, V429, P136, DOI 10.1016/j.neulet.2007.10.007; Arnlov J, 2012, BIOMARK MED, V6, P9, DOI [10.2217/bmm.11.102, 10.2217/BMM.11.102]; Barclay J, 2007, PAIN, V130, P225, DOI 10.1016/j.pain.2006.11.017; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Cattaruzza F, 2011, GASTROENTEROLOGY, V141, P1864, DOI 10.1053/j.gastro.2011.07.035; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen H., 2013, CARDIOVASCULAR RES; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Chen KL, 2012, CANCER LETT, V317, P89, DOI 10.1016/j.canlet.2011.11.015; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Clark AK, 2012, ARTHRITIS RHEUM-US, V64, P2038, DOI 10.1002/art.34351; Clark AK, 2012, EXP NEUROL, V234, P283, DOI 10.1016/j.expneurol.2011.09.012; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; de Nooijer R, 2009, ARTERIOSCL THROM VAS, V29, P188, DOI 10.1161/ATVBAHA.108.181578; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Huang C. C., 2013, FREE RADICAL BIOL ME; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; LEMERE CA, 1995, AM J PATHOL, V146, P848; Liu J, 2006, ATHEROSCLEROSIS, V186, P411, DOI 10.1016/j.atherosclerosis.2005.08.001; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Phipps-Yonas H, 2013, EUR J IMMUNOL, V43, P65, DOI 10.1002/eji.201242379; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Small DM, 2011, CLIN REV BONE MINER, V9, P122, DOI 10.1007/s12018-011-9095-5; Spielmann N, 2008, CLIN GENET, V74, P155, DOI 10.1111/j.1399-0004.2008.01043.x; Taleb S, 2006, J CLIN ENDOCR METAB, V91, P1042, DOI 10.1210/jc.2005-1601; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wang J, 2005, STROKE, V36, P613, DOI 10.1161/01.STR.0000155729.12931.8f; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wendt W, 2008, BRAIN RES, V1232, P7, DOI 10.1016/j.brainres.2008.07.067; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AS, 2009, PULM PHARMACOL THER, V22, P27, DOI 10.1016/j.pupt.2008.11.002; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	52	53	53	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2013	2013								187873	10.1155/2013/187873			11	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	246HI	WOS:000326528300001	24282339	gold, Green Published, Green Submitted			2022-02-06	
J	Bouwes, A; Robillard, LBM; Binnekade, JM; de Pont, ACJM; Wieske, L; den Hartog, AW; Schultz, MJ; Horn, J				Bouwes, Aline; Robillard, Laure B. M.; Binnekade, Jan M.; de Pont, Anne-Cornelie J. M.; Wieske, Luuk; den Hartog, Alexander W.; Schultz, Marcus J.; Horn, Janneke			The influence of rewarming after therapeutic hypothermia on outcome after cardiac arrest	RESUSCITATION			English	Article						Cardiac arrest; Hypothermia; Rewarming; Fever; Outcome	EMERGENCY CARDIOVASCULAR CARE; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; MODERATE HYPOTHERMIA; FEVER CONTROL; HYPERTHERMIA; DAMAGE; RATS; ISCHEMIA	Introduction: Treatment with hypothermia has been shown to improve outcome after cardiac arrest (CA). Current consensus is to rewarm at 0.25-0.5 degrees C/h and avoid fever. The aim of this study was to investigate whether active rewarming, the rate of rewarming or development of fever after treatment with hypothermia after CA was correlated with poor outcome. Methods: This retrospective cohort study included adult patients treated with hypothermia after CA and admitted to the intensive care unit between January 2006 and January 2009. The average rewarming rate from end of hypothermia treatment (passive rewarming) or start active rewarming until 36 degrees C was dichotomized in a high (>= 0.5 degrees C/h) or normal rate (<0.5 degrees C/h). Fever was defined as >38 degrees C within 72 h after admission. Poor outcome was defined as death, vegetative state, or severe disability after 6 months. Results: From 128 included patients, 56% had a poor outcome. Actively rewarmed patients (38%) had a higher risk for poor outcome, OR 2.14 (1.01-4.57), p < 0.05. However, this effect disappeared after adjustment for the confounders age and initial rhythm, OR 1.51 (0.64-3.58). A poor outcome was found in 15/21 patients (71%) with a high rewarming rate, compared to 54/103 patients (52%) with a normal rewarming rate, OR 2.61 (0.88-7.73), p = 0.08. Fever was not associated with outcome, OR 0.64 (0.31-1.30), p = 0.22. Conclusions: This study showed that patients who needed active rewarming after therapeutic hypothermia after CA did not have a higher risk for a poor outcome. In addition, neither speed of rewarming, nor development of fever had an effect on outcome. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Bouwes, Aline; Robillard, Laure B. M.; Binnekade, Jan M.; de Pont, Anne-Cornelie J. M.; Wieske, Luuk; den Hartog, Alexander W.; Schultz, Marcus J.; Horn, Janneke] Acad Med Ctr, Dept Intens Care, NL-1100 DD Amsterdam, Netherlands; [Wieske, Luuk] Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; [Schultz, Marcus J.] Acad Med Ctr, LEICA, NL-1100 DD Amsterdam, Netherlands		Bouwes, A (corresponding author), Acad Med Ctr, Dept Intens Care, Room C3-423,POB 22660, NL-1100 DD Amsterdam, Netherlands.	a.bouwes@amc.uva.nl	Wieske, Luuk/AAF-1899-2020; Schultz, Marcus J/K-6147-2012	Schultz, Marcus/0000-0003-3969-7792	Dutch Heart FoundationNetherlands Heart Foundation [2007B039]	Part of this work was previously presented as a poster at the 3rd International Hypothermia Symposium, Lund, Sweden, September 2009. Dr. Bouwes, Mrs. Robillard, Dr. Binnekade, Dr. de Pont, Dr. Wieske, Dr. den Hartog and Dr. Schultz report no conflicts of interest. Dr. Horn received a research grant from the Dutch Heart Foundation (2007B039).	Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Baena RC, 1997, NEUROLOGY, V48, P768, DOI 10.1212/WNL.48.3.768; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bouwes A, 2012, ANN NEUROL, V71, P206, DOI 10.1002/ana.22632; Chester JG, 2011, J AM MED DIR ASSOC, V12, P337, DOI 10.1016/j.jamda.2010.04.009; De Tanti A, 2005, BRAIN INJURY, V19, P1277, DOI 10.1080/02699050500309270; Deakin CD, 2010, RESUSCITATION, V81, pE93, DOI 10.1016/j.resuscitation.2010.08.027; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; Georgiadis D, 2002, STROKE, V33, P1584, DOI 10.1161/01.STR.0000016970.51004.D9; Gordan ML, 2010, PERFUSION-UK, V25, P349, DOI 10.1177/0267659110377946; Grigore AM, 2002, ANESTH ANALG, V94, P4, DOI 10.1097/00000539-200201000-00002; Hickey RW, 2003, CRIT CARE MED, V31, P531, DOI 10.1097/01.CCM.0000050323.84293.11; Holzer M, 2002, NEW ENGL J MED, V346, P549; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Langhelle A, 2003, RESUSCITATION, V56, P247, DOI 10.1016/S0300-9572(02)00409-4; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Suffoletto B, 2009, RESUSCITATION, V80, P1365, DOI 10.1016/j.resuscitation.2009.08.020; Takasu A, 2001, RESUSCITATION, V49, P273, DOI 10.1016/S0300-9572(00)00360-9; TAKINO M, 1991, INTENS CARE MED, V17, P419, DOI 10.1007/BF01720680; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	32	53	57	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	AUG	2012	83	8					996	1000		10.1016/j.resuscitation.2012.04.006			5	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	009TL	WOS:000309048000026	22521448				2022-02-06	
J	Hanks, RA; Rapport, LJ; Wertheimer, J; Koviak, C				Hanks, Robin A.; Rapport, Lisa J.; Wertheimer, Jeffrey; Koviak, Carole			Randomized Controlled Trial of Peer Mentoring for Individuals With Traumatic Brain Injury and Their Significant Others	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Caregivers; Depression; Mentors; Quality of life; Rehabilitation; Social support	SPINAL-CORD-INJURY; SOCIAL SUPPORT; COMMUNITY INTEGRATION; PROGRAM; ADJUSTMENT; VALIDITY; ADULTS	Hanks RA, Rapport LJ, Wertheimer J, Koviak C. Randomized controlled trial of peer mentoring for individuals with traumatic brain injury and their significant others. Arch Phys Med Rehabil 2012;93:1297-1304. Objectives: for persons with traumatic brain injury (TBI) and their significant others, and to determine the relationship of this mentoring program to 3 main outcomes: (1) emotional wellbeing; (2) post-TBI quality of life; and (3) community integration. Design: Randomized controlled trial. Setting: Midwestern rehabilitation hospital. Participants: Persons with TBI (n = 96) and significant others/caregiver; (n = 62). Interventions: Persons with TBI and friends/caregivers who knew the person prior to their injury were randomly assigned to a treatment (mentored) or no-treatment (no mentoring) control group immediately prior to discharge from the rehabilitation unit and were mentored for up to 2 years. Main Outcome Measures: Peer Mentoring Questionnaire; Brief Symptom Inventory-18; Family Assessment Device; Coping Inventory for Stressful Situations; Short Michigan Alcohol ScreeningTest; Medical Outcomes Study 12-Item Short-Form Health Survey; and Community Integration Measure. Result: Eighty-eight percent of individuals who were involved in the mentoring program reported positive experiences. t tests revealed that among persons with TBI, individuals who received mentoring had significantly better behavioral control and less chaos in the living environment (P = .04), lower alcohol use (P = .01), less emotion-focused (P = .04) and avoidance coping (P = .03), and good physical quality of life (P = .04) compared with those who did not receive mentoring. Among significant others, mentored individuals demonstrated greater community integration (P = .03) than the nonmentored control group. Conclusions: Mentoring can be an effective way to benefit mood and healthy coping after TBI, and it can help to prevent maladaptive behaviors, such as substance abuse and behavioral dyscontrol, in the living situation.	[Hanks, Robin A.] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI 48201 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Rapport, Lisa J.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Wertheimer, Jeffrey] Cedars Sinai Med Ctr, Dept Psychol, Los Angeles, CA 90048 USA; [Koviak, Carole] Rehabil Inst Michigan, Dept Res, Detroit, MI USA		Hanks, RA (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, 261 Mack Blvd, Detroit, MI 48201 USA.	rhanks@med.wayne.edu	Janson, Patrick/AAC-7581-2022	Rapport, Lisa/0000-0001-8014-9523	U.S. Department of Education-National Institute of Disability Research and Rehabilitation-The Traumatic Brain Injury Model Systems Project [H133A020515]	Supported by the U.S. Department of Education-National Institute of Disability Research and Rehabilitation-The Traumatic Brain Injury Model Systems Project (grant no. H133A020515).	Allen TD, 2004, J APPL PSYCHOL, V89, P127, DOI 10.1037/0021-9010.89.1.127; Boschen KA, 2003, INT J REHABIL RES, V26, P157, DOI 10.1097/00004356-200309000-00001; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Endler E, 1990, J PERS SOC PSYCHOL, V58, P844; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hopman-Rock M, 2002, J AGING PHYS ACTIV, V10, P364, DOI 10.1123/japa.10.4.364; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Quine S, 1998, EDUC GERONTOL, V24, P661, DOI 10.1080/0360127980240704; Rini C, 2007, J CLIN ONCOL, V25, P163, DOI 10.1200/JCO.2006.08.8567; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Shem K, 2011, SPINAL CORD, V49, P544, DOI 10.1038/sc.2010.166; Sherman JE, 2004, REHABIL PSYCHOL, V49, P140, DOI 10.1037/0090-5550.49.2.140; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; TEASDALE G, 1974, LANCET, V2, P81; Thoits PA, 2000, HEALTH PSYCHOL, V19, P264, DOI 10.1037//0278-6133.19.3.264; Veith EM, 2006, REHABIL PSYCHOL, V51, P289, DOI 10.1037/0090-5550.51.4.289; Ware J., 1998, SF 12 SCORE SF 12 PH, V2nd Ed; Whittemore R, 2000, QUAL HEALTH RES, V10, P260, DOI 10.1177/104973200129118408; Whyte W. F. E, 1991, PARTICIPATORY ACTION	25	53	53	0	27	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8					1297	1304		10.1016/j.apmr.2012.04.027			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	983XJ	WOS:000307151700001	22840826				2022-02-06	
J	Kenning, TJ; Willcox, TO; Artz, GJ; Schiffmacher, P; Farrell, CJ; Evans, JJ				Kenning, Tyler J.; Willcox, Thomas O.; Artz, Gregory J.; Schiffmacher, Paul; Farrell, Christopher J.; Evans, James J.			Surgical management of temporal meningoencephaloceles, cerebrospinal fluid leaks, and intracranial hypertension: treatment paradigm and outcomes	NEUROSURGICAL FOCUS			English	Article						cerebrospinal fluid; otorrhea; otorhinorrhea; tegmen repair; temporal meningoencephalocele; mastoidectomy; intracranial hypertension	EMPTY SELLA; BONE; REPAIR; OTORRHEA; ENCEPHALOCELES	Object. Thinning of the tegmen tympani and mastoideum components of the temporal bone may predispose to the development of meningoencephaloceles and spontaneous CSF leaks. Surgical repair of these bony defects and associated meningoencephaloceles aids in the prevention of progression and meningitis. Intracranial hypertension may be a contributing factor to this disorder and must be fully evaluated and treated when present. The purpose of this study was to establish a treatment paradigm for tegmen defects and elucidate causative factors. Methods. The authors conducted a retrospective review of 23 patients undergoing a combined mastoidectomy and middle cranial fossa craniotomy for the treatment of a tegmen defect. Results. The average body mass index (BMI) among all patients was 33.2 +/- 7.2 kg/m(2). Sixty-five percent of the patients (15 of 23) were obese (BMI > 30 kg/m(2)). Preoperative intracranial pressures (ICPs) averaged 21.8 +/- 6.0 cm H2O, with 10 patients (43%) demonstrating an ICP > 20 cm H2O. Twenty-two patients (96%) had associated encephaloceles. Five patients underwent postoperative ventriculoperitoneal shunting. Twenty-two CSF leaks (96%) were successfully repaired at the first attempt (average follow-up 10.4 months). Conclusions. Among all etiologies for CSF leaks, those occurring spontaneously have the highest rate of recurrence. The surgical treatment of temporal bone defects, as well as the recognition and treatment of accompanying intracranial hypertension, provides the greatest success rate in preventing recurrence. After tegmen dehiscence repair, ventriculoperitoneal shunting should be considered for patients with any combination of the following high-risk factors for recurrence: spontaneous CSF leak not caused by another predisposing condition (that is, trauma, chronic infections, or prior surgery), high-volume leaks, CSF opening pressure > 20 cm H2O, BMI > 30 kg/m(2), preoperative imaging demonstrating additional cranial base cortical defects (that is, contralateral tegmen or anterior cranial base) and/or an empty sella turcica, and any history of an event that leads to inflammation of the arachnoid granulations and impairment of CSF absorption (that is, meningitis, intracranial hemorrhage, significant closed head injury, and so forth). (http://thejns.org/doi/abs/10.3171/2012.4.FOCUS1265)	[Kenning, Tyler J.; Farrell, Christopher J.; Evans, James J.] Thomas Jefferson Univ Hosp, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Willcox, Thomas O.; Artz, Gregory J.; Evans, James J.] Thomas Jefferson Univ Hosp, Dept Otolaryngol, Philadelphia, PA 19107 USA; [Schiffmacher, Paul] Thomas Jefferson Univ Hosp, Dept Med Media Serv, Philadelphia, PA 19107 USA		Kenning, TJ (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurol Surg, 909 Walnut St,2nd Floor, Philadelphia, PA 19107 USA.	tyler.kenning@jeffersonhospital.org					Brown NE, 2004, LARYNGOSCOPE, V114, P800, DOI 10.1097/00005537-200405000-00002; Kari E, 2011, ACTA OTO-LARYNGOL, V131, P391, DOI 10.3109/00016489.2011.557836; Kutz JW, 2008, LARYNGOSCOPE, V118, P2195, DOI 10.1097/MLG.0b013e318182f833; Merchant SN, 2000, AM J OTOL, V21, P234, DOI 10.1016/S0196-0709(00)80015-0; Mirza S, 2005, LARYNGOSCOPE, V115, P1774, DOI 10.1097/01.mlg.0000175679.68452.75; Nahas Z, 2008, ARCH OTOLARYNGOL, V134, P509, DOI 10.1001/archotol.134.5.509; Prichard CN, 2006, OTOLARYNG HEAD NECK, V134, P767, DOI 10.1016/j.otohns.2006.01.002; Sanna M, 2010, LARYNGOSCOPE, V120, P217; Sanna M, 2009, LARYNGOSCOPE, V119, P1579, DOI 10.1002/lary.20510; Savva A, 2003, LARYNGOSCOPE, V113, P50, DOI 10.1097/00005537-200301000-00010; Schlosser RJ, 2004, OTOLARYNG HEAD NECK, V130, P443, DOI 10.1016/j.otohns.2003.12.018; Schlosser RJ, 2003, OTOLARYNG HEAD NECK, V128, P32, DOI 10.1067/mhn.2003.43; Scurry WC, 2007, OTOLARYNG HEAD NECK, V136, P961, DOI 10.1016/j.otohns.2006.11.036; Semaan MT, 2011, LARYNGOSCOPE, V121, P1765, DOI 10.1002/lary.21887; Souliere CR, 1998, SKULL BASE SURG, V8, P185, DOI 10.1055/s-2008-1058181; Wind JJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.12.E11; Woodworth BA, 2008, OTOLARYNG HEAD NECK, V138, P715, DOI 10.1016/j.otohns.2008.02.010	17	53	54	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUN	2012	32	6							E6	10.3171/2012.4.FOCUS1265			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	954DQ	WOS:000304927100008	22655695				2022-02-06	
J	Zafar, SN; Khan, AA; Ghauri, AA; Shamim, MS				Zafar, Syed Nabeel; Khan, Abdul Ahad; Ghauri, Asfar Ayaz; Shamim, Muhammad Shahzad			Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury - a meta analysis	BMC NEUROLOGY			English	Article						Levetiracetam; Phenytoin; Meta-analysis; Brain injury; Seizures; Prophylaxis; Anti-epileptic drugs	SUBARACHNOID HEMORRHAGE; LEVETIRACETAM; TUMORS; EPILEPSY; METAANALYSIS; THERAPY; SURGERY; GLIOMAS; SAFETY; TRIAL	Background: Current standard therapy for seizure prophylaxis in Neuro-surgical patients involves the use of Phenytoin (PHY). However, a new drug Levetiracetam (LEV) is emerging as an alternate treatment choice. We aimed to conduct a meta-analysis to compare these two drugs in patients with brain injury. Methods: An electronic search was performed in using Pubmed, Embase, and CENTRAL. We included studies that compared the use of LEV vs. PHY for seizure prophylaxis for brain injured patients (Traumatic brain injury, intracranial hemorrhage, intracranial neoplasms, and craniotomy). Data of all eligible studies was extracted on to a standardized abstraction sheet. Data about baseline population characteristics, type of intervention, study design and outcome was extracted. Our primary outcome was seizures. Results: The literature search identified 2489 unduplicated papers. Of these 2456 papers were excluded by reading the abstracts and titles. Another 25 papers were excluded after reading their complete text. We selected 8 papers which comprised of 2 RCTs and 6 observational studies. The pooled estimate's Odds Ratio 1.12 (95% CI = 0.34, 3.64) demonstrated no superiority of either drug at preventing the occurrence of early seizures. In a subset analysis of studies in which follow up for seizures lasted either 3 or 7 days, the effect estimate remained insignificant with an odds ratio of 0.96 (95% CI = 0.34, 2.76). Similarly, 2 trials reporting seizure incidence at 6 months also had insignificant pooled results while comparing drug efficacy. The pooled odds ratio was 0.96 (95% CI = 0.24, 3.79). Conclusions: Levetiracetam and Phenytoin demonstrate equal efficacy in seizure prevention after brain injury. However, very few randomized controlled trials (RCTs) on the subject were found. Further evidence through a high quality RCT is highly recommended.	[Zafar, Syed Nabeel; Shamim, Muhammad Shahzad] Aga Khan Univ, Dept Surg, Karachi, Pakistan; [Khan, Abdul Ahad; Ghauri, Asfar Ayaz] Aga Khan Univ, Coll Med, Karachi, Pakistan		Shamim, MS (corresponding author), Aga Khan Univ, Dept Surg, Karachi, Pakistan.	shahzad.shamim@aku.edu		Zafar, Syed Nabeel/0000-0003-3843-9687; Khan, Abdul Ahad/0000-0002-3915-9102			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ALLEN JP, 1979, CLIN PHARMACOL THER, V26, P445, DOI 10.1002/cpt1979264445; Brouwers MC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-23; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Byrne T N, 1983, J Neurooncol, V1, P313, DOI 10.1007/BF00165714; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; De Santis A, 2002, EPILEPSIA, V43, P175, DOI 10.1046/j.1528-1157.2002.24801.x; DEUTSCHMAN CS, 1985, NEUROSURGERY, V17, P510, DOI 10.1227/00006123-198509000-00021; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Forsyth PA, 2003, CAN J NEUROL SCI, V30, P106, DOI 10.1017/S0317167100053361; FOY PM, 1981, ACTA NEUROCHIR, V57, P15, DOI 10.1007/BF01665108; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; HAGEN NA, 1990, NEUROLOGY, V40, P158, DOI 10.1212/WNL.40.1.158; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildebrand J, 2005, NEUROLOGY, V65, P212, DOI 10.1212/01.wnl.0000168903.09277.8f; JONES GL, 1983, MED RES REV, V3, P383, DOI 10.1002/med.2610030403; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Ketz E., 1974, HDB CLIN NEUROLOGY, V16, P254; Klimek M, 2010, CURR OPIN ANESTHESIO, V23, P564, DOI 10.1097/ACO.0b013e32833e14f2; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; MAHALEY MS, 1981, SURG NEUROL, V16, P399, DOI 10.1016/0090-3019(81)90227-5; Milligan TA, 2008, NEUROLOGY, V71, P665, DOI 10.1212/01.wnl.0000324624.52935.46; MOOTS PL, 1995, ARCH NEUROL-CHICAGO, V52, P717, DOI 10.1001/archneur.1995.00540310091021; Murphy-Human T, 2011, WORLD NEUROSURG, V75, P269, DOI 10.1016/j.wneu.2010.09.002; Naidech AM, 2009, STROKE, V40, P3810, DOI 10.1161/STROKEAHA.109.559948; NORTH JB, 1983, J NEUROSURG, V58, P672, DOI 10.3171/jns.1983.58.5.0672; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; Sahin S, 2008, CLIN NEUROPHARMACOL, V31, P93, DOI 10.1097/WNF.0b013e31806ad6cb; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Shah D, 2009, SEIZURE-EUR J EPILEP, V18, P676, DOI 10.1016/j.seizure.2009.09.003; Siomin V, 2005, J NEURO-ONCOL, V74, P211, DOI 10.1007/s11060-004-6912-4; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szaflarski JP, 2007, NEUROCRIT CARE, V7, P140, DOI 10.1007/s12028-007-0042-8; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Taylor S, 2011, NEUROCRIT CARE, V15, P80, DOI 10.1007/s12028-010-9341-6; Temkin Nancy R., 2002, Epilepsy Curr, V2, P105, DOI 10.1046/j.1535-7597.2002.00038.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tremont-Lukats IW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004424.pub2	39	53	56	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	MAY 29	2012	12								30	10.1186/1471-2377-12-30			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	980SN	WOS:000306913400001	22642837	Green Published, gold			2022-02-06	
J	Abo-Zaid, G; Sauerbrei, W; Riley, RD				Abo-Zaid, Ghada; Sauerbrei, Willi; Riley, Richard D.			Individual participant data meta-analysis of prognostic factor studies: state of the art?	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						Meta-analysis; Prognostic factor; Prognosis; Individual participant (patient) data; Systematic review; Reporting	TRAUMATIC BRAIN-INJURY; PATIENT DATA; MICROVESSEL DENSITY; IMPACT DATABASE; CANCER; MARKERS; QUALITY; DESIGN; TRIALS; PREDICTORS	Background: Prognostic factors are associated with the risk of a subsequent outcome in people with a given disease or health condition. Meta-analysis using individual participant data (IPD), where the raw data are synthesised from multiple studies, has been championed as the gold-standard for synthesising prognostic factor studies. We assessed the feasibility and conduct of this approach. Methods: A systematic review to identify published IPD meta-analyses of prognostic factors studies, followed by detailed assessment of a random sample of 20 articles published from 2006. Six of these 20 articles were from the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in traumatic brain injury) collaboration, for which additional information was also used from simultaneously published companion papers. Results: Forty-eight published IPD meta-analyses of prognostic factors were identified up to March 2009. Only three were published before 2000 but thereafter a median of four articles exist per year, with traumatic brain injury the most active research field. Availability of IPD offered many advantages, such as checking modelling assumptions; analysing variables on their continuous scale with the possibility of assessing for non-linear relationships; and obtaining results adjusted for other variables. However, researchers also faced many challenges, such as large cost and time required to obtain and clean IPD; unavailable IPD for some studies; different sets of prognostic factors in each study; and variability in study methods of measurement. The IMPACT initiative is a leading example, and had generally strong design, methodological and statistical standards. Elsewhere, standards are not always as high and improvements in the conduct of IPD meta-analyses of prognostic factor studies are often needed; in particular, continuous variables are often categorised without reason; publication bias and availability bias are rarely examined; and important methodological details and summary results are often inadequately reported. Conclusions: IPD meta-analyses of prognostic factors are achievable and offer many advantages, as displayed most expertly by the IMPACT initiative. However such projects face numerous logistical and methodological obstacles, and their conduct and reporting can often be substantially improved.	[Riley, Richard D.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Abo-Zaid, Ghada] Univ Exeter, European Ctr Environm & Human Hlth, Peninsula Coll Med & Dent, Knowledge Spa Royal Cornwall Hosp Truro, Truro TR1 3HD, Cornwall, England; [Sauerbrei, Willi] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Freiburg, Germany		Riley, RD (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.d.riley@bham.ac.uk	Riley, Richard David/ABE-5877-2020; Riley, Richard/G-2406-2011; Abo-Zaid, Ghada/AAY-7516-2020	Riley, Richard David/0000-0001-8699-0735; 	MRC Midlands Hub for Trials Methodology Research, at The University of Birmingham (Medical Research Council Grant)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800808]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800808] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800808] Funding Source: UKRI	Whilst undertaking this work, GA-Z and RDR were supported by funding from the MRC Midlands Hub for Trials Methodology Research, at The University of Birmingham (Medical Research Council Grant ID G0800808). We thank the two reviewers for their constructive comments and suggestions, which have helped improve the manuscript considerably.	Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; Altman DG, 2007, STAT IND TECHNOL, P3, DOI 10.1007/978-0-8176-4542-7_1; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Broeze KA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-22; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doughty RN, 2008, EUR J HEART FAIL, V10, P786, DOI 10.1016/j.ejheart.2008.06.005; Downing M, 2007, J PALLIAT CARE, V23, P245, DOI 10.1177/082585970702300402; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hollander N, 2007, STAT IND TECHNOL, P19, DOI 10.1007/978-0-8176-4542-7_2; Illmer T, 2007, HAEMATOL-HEMATOL J, V92, P137, DOI 10.3324/haematol.10489; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; Koopman L, 2008, ARCH OTOLARYNGOL, V134, P128, DOI 10.1001/archoto.2007.3; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Lanterna LA, 2007, NEUROLOGY, V69, P766, DOI 10.1212/01.wnl.0000267640.03300.6b; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; McKibbon KA, 1998, B MED LIBR ASSOC, V86, P396; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1023, DOI 10.1093/jnci/dji193; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Meert AP, 2002, BRIT J CANCER, V87, P694, DOI 10.1038/sj.bjc.6600551; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Moller JE, 2008, CIRCULATION, V117, P2591, DOI 10.1161/CIRCULATIONAHA.107.738625; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Noordzij JP, 2007, J AM COLL SURGEONS, V205, P748, DOI 10.1016/j.jamcollsurg.2007.06.298; Riley RD, 2009, BRIT J CANCER, V100, P1219, DOI 10.1038/sj.bjc.6604999; Riley RD, 2003, BRIT J CANCER, V88, P1191, DOI 10.1038/sj.bjc.6600886; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2010, RES SYNTH METHODS, V1, P2, DOI 10.1002/jrsm.4; Riley RD, 2010, INT J EPIDEMIOL, V39, P1359, DOI 10.1093/ije/dyq129; Rovers MM, 2007, PEDIATRICS, V119, P579, DOI 10.1542/peds.2006-2092; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sauerbrei W, 2005, ADV OTO-RHINO-LARYNG, V62, P184; Sauerbrei W, 2001, J CLIN EPIDEMIOL, V54, P537, DOI 10.1016/S0895-4356(00)00246-8; Sauerbrei W, 2007, WILEY ENCY CLIN TRIA, P1; Sauerbrei W, 2006, COMMUN STAT-THEOR M, V35, P1333, DOI 10.1080/03610920600629666; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Steyerberg E. W., 2009, CLIN PREDICTION MODE, DOI [10.1007/978-0-387-77244-8, 10. 1007/978-0-387-77244-8., DOI 10.1007/978-0-387-77244-8]; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutcliffe P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13050; Sutton A.J., 2000, METHODS METAANALYSIS; Sylaja PN, 2007, NEUROCRIT CARE, V6, P181, DOI 10.1007/s12028-007-0018-8; Thakkinstian A, 2008, NEPHROL DIAL TRANSPL, V23, P3017, DOI 10.1093/ndt/gfn185; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Trivella M, 2007, LANCET ONCOL, V8, P488, DOI 10.1016/S1470-2045(07)70145-6; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Warkentin TE, 2006, BLOOD, V108, P2937, DOI 10.1182/blood-2005-11-012450; Yap YG, 2008, INT J CARDIOL, V126, P101, DOI 10.1016/j.ijcard.2007.03.122	73	53	53	1	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	APR 24	2012	12								56	10.1186/1471-2288-12-56			16	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	984YJ	WOS:000307229500001	22530717	gold, Green Published			2022-02-06	
J	Yamada, KH; Kozlowski, DA; Seidl, SE; Lance, S; Wieschhaus, AJ; Sundivakkam, P; Tiruppathi, C; Chishti, I; Herman, IM; Kuchay, SM; Chishti, AH				Yamada, Kaori H.; Kozlowski, Dorothy A.; Seidl, Stacey E.; Lance, Steven; Wieschhaus, Adam J.; Sundivakkam, Premanand; Tiruppathi, Chinnaswamy; Chishti, Imran; Herman, Ira M.; Kuchay, Shafi M.; Chishti, Athar H.			Targeted Gene Inactivation of Calpain-1 Suppresses Cortical Degeneration Due to Traumatic Brain Injury and Neuronal Apoptosis Induced by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MU-CALPAIN; CROSS-TALK; CLEAVAGE; ACTIVATION; INHIBITOR; CASPASE; CALCIUM; PROTEIN; IMPACT	Calpains are calcium-regulated cysteine proteases that have been implicated in the regulation of cell death pathways. Here, we used our calpain-1 null mouse model to evaluate the function of calpain-1 in neural degeneration following a rodent model of traumatic brain injury. In vivo, calpain-1 null mice show significantly less neural degeneration and apoptosis and a smaller contusion 3 days post-injury than wild type littermates. Protection from traumatic brain injury corroborated with the resistance of calpain-1 neurons to apoptosis induced by oxidative stress. Biochemical analysis revealed that caspase-3 activation, extracellular calcium entry, mitochondrial membrane permeability, and release of apoptosis-inducing factor from mitochondria are partially blocked in the calpain-1 null neurons. These findings suggest that the calpain-1 knock-out mice may serve as a useful model system for neuronal protection and apoptosis in traumatic brain injury and other neurodegenerative disorders in which oxidative stress plays a role.	[Yamada, Kaori H.; Wieschhaus, Adam J.; Herman, Ira M.; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Wieschhaus, Adam J.; Chishti, Athar H.] Univ Illinois, Coll Med, Sackler Sch Program Physiol, Chicago, IL 60612 USA; [Wieschhaus, Adam J.; Chishti, Imran] Univ Illinois, Coll Med, Sackler Sch Program Pharmacol, Chicago, IL 60612 USA; [Wieschhaus, Adam J.; Chishti, Imran] Univ Illinois, Coll Med, Sackler Sch Program Microbiol, Chicago, IL 60612 USA; [Yamada, Kaori H.; Wieschhaus, Adam J.; Sundivakkam, Premanand; Tiruppathi, Chinnaswamy; Chishti, Imran; Kuchay, Shafi M.; Chishti, Athar H.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Kozlowski, Dorothy A.; Seidl, Stacey E.; Lance, Steven] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA		Chishti, AH (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA.	athar.chishti@tufts.edu		Yamada, Kaori/0000-0003-4075-9866	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL089517, HL095050, HL051445]; DePaul University Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL089517, R56HL051445, R01HL095050, R01HL051445] Funding Source: NIH RePORTER	This work was supported, in whole or in part, by National Institutes of Health Grants HL089517, HL095050, and HL051445 (to A. H. C.). This work was also supported by DePaul University Research Council (to D. A. K.).	Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bertipaglia I., 2007, V45, P29; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dixon C. E., 1996, FLUID PERCUSSION COR, P1337; Fedrizzi L, 2011, BIOFACTORS, V37, P189, DOI 10.1002/biof.157; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; Gao G, 2000, J CELL BIOCHEM, V80, P53; Geddes JW, 2010, EXP NEUROL, V226, P6, DOI 10.1016/j.expneurol.2010.07.025; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harper AGS, 2007, CELL CALCIUM, V41, P169, DOI 10.1016/j.ceca.2006.05.008; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Kuwako K, 2002, MOL BRAIN RES, V107, P166, DOI 10.1016/S0169-328X(02)00489-8; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Waters SL, 1997, J PHARMACOL EXP THER, V283, P1177; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	57	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13182	13193		10.1074/jbc.M111.302612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	WOS:000302903700056	22367208	Green Published, hybrid			2022-02-06	
J	Raja Beharelle, A; Kovcevic, N; McIntosh, AR; Levine, B				Raja Beharelle, Anjali; Kovcevic, Natasa; McIntosh, Anthony R.; Levine, Brian			Brain signal variability relates to stability of behavior after recovery from diffuse brain injury	NEUROIMAGE			English	Article						Variability; Noise; Multiscale entropy; Magnetoencephalography; Traumatic brain injury; Attention	PARTIAL LEAST-SQUARES; FUNCTIONAL CONNECTIVITY; APPROXIMATE ENTROPY; CEREBRAL-CORTEX; NERVOUS-SYSTEM; QUANTIFIED MRI; NOISE; FLUCTUATIONS; TIME; NEUROPATHOLOGY	Variability or noise is an unmistakable feature of neural signals; however such fluctuations have been regarded as not carrying meaningful information or as detrimental for neural processes. Recent empirical and computational work has shown that neural systems with a greater capacity for information processing are able to explore a more varied dynamic repertoire, and the hallmark of this is increased irregularity or variability in the neural signal. How this variability in neural dynamics affects behavior remains unclear. Here, we investigated the role of variability of magnetoencephalography signals in supporting healthy cognitive functioning, measured by performance on an attention task, in healthy adults and in patients with traumatic brain injury. As an index of variability, we calculated multiscale entropy, which quantifies the temporal predictability of a time series across progressively more coarse time scales. We found lower variability in traumatic brain injury patients compared to controls, arguing against the idea that greater variability reflects dysfunctional neural processing. Furthermore, higher brain signal variability indicated improved behavioral performance for all participants. This relationship was statistically stronger for people with brain injury, demonstrating that those with higher brain signal variability were also those who had recovered the most cognitive ability. Rather than impede neural processing, cortical signal variability within an optimal range enables the exploration of diverse functional configurations, and may therefore play a vital role in healthy brain function. Crown Copyright (c) 2012 Published by Elsevier Inc. All rights reserved.	[Raja Beharelle, Anjali; Kovcevic, Natasa; McIntosh, Anthony R.; Levine, Brian] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Raja Beharelle, Anjali; McIntosh, Anthony R.; Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada		Raja Beharelle, A (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	anjali.raja@utoronto.ca	Levine, Brian/O-2725-2019; Raja Beharelle, Anjali/A-3756-2013; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; McIntosh, Anthony/0000-0002-1784-5662	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01 HD42385-01]; J.S. McDonnell Foundation; University of TorontoUniversity of Toronto; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042385] Funding Source: NIH RePORTER	This work was supported by NIH 1R01 HD42385-01 to Brian Levine, a grant from the J.S. McDonnell Foundation, and a University of Toronto fellowship. We wish to thank Aaron Beharelle, Wilkin Chau, Marina Mandic, Bratislav Misic, Irina Nica, Daniela Palombo, Jimmy Shen, and Danielle Tisserand.	Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Edgington E. S., 1980, RANDOMIZATION TESTS; Efron B, 1986, STAT SCI, V1; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Zou GY, 2007, PSYCHOL METHODS, V12, P399, DOI 10.1037/1082-989X.12.4.399; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; KATZ B, 1970, NATURE, V226, P962, DOI 10.1038/226962a0; Kleppe IC, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041909; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Lippe S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.048.2009; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 1998, J NEUROPHYSIOL, V80, P3148, DOI 10.1152/jn.1998.80.6.3148; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; Misic B, 2010, J NEUROPHYSIOL, V104, P2667, DOI 10.1152/jn.00648.2010; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Neumann J, 2003, NEUROIMAGE, V19, P784, DOI 10.1016/S1053-8119(03)00177-0; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raja Beharelle A., 2011, FRONT HUM NEUROSCI, V5; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Robinson S., 1999, RECENT ADV BIOMAGNET; SAMPSON PD, 1989, NEUROTOXICOL TERATOL, V11, P477, DOI 10.1016/0892-0362(89)90025-1; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; SPORNS O, 1991, P NATL ACAD SCI USA, V88, P129, DOI 10.1073/pnas.88.1.129; Steinmetz PN, 2000, J COMPUT NEUROSCI, V9, P133, DOI 10.1023/A:1008967807741; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; TONONI G, 1992, CEREB CORTEX, V2, P310, DOI 10.1093/cercor/2.4.310; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vakorin VA, 2011, J NEUROSCI, V31, P6405, DOI 10.1523/JNEUROSCI.3153-10.2011; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Winterer G, 2006, BIOL PSYCHIAT, V60, P578, DOI 10.1016/j.biopsych.2006.03.023; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zachary R. A., 1986, SHIPLEY I LIVING SCA	57	53	54	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 2	2012	60	2					1528	1537		10.1016/j.neuroimage.2012.01.037			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	932ED	WOS:000303272300063	22261371	Green Accepted			2022-02-06	
J	Kourbeti, IS; Vakis, AF; Papadakis, JA; Karabetsos, DA; Bertsias, G; Filippou, M; Ioannou, A; Neophytou, C; Anastasaki, M; Samonis, G				Kourbeti, I. S.; Vakis, A. F.; Papadakis, J. A.; Karabetsos, D. A.; Bertsias, G.; Filippou, M.; Ioannou, A.; Neophytou, C.; Anastasaki, M.; Samonis, G.			Infections in traumatic brain injury patients	CLINICAL MICROBIOLOGY AND INFECTION			English	Article						Head injury; infections; meningitis; trauma	VENTRICULOSTOMY-RELATED INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; RISK-FACTORS; SITE INFECTIONS; MENINGITIS; SURVEILLANCE; CRANIOTOMY; MANAGEMENT; CRITERIA; ADULT	Traumatic brain injury (TBI) victims are considered to be at high risk for infection. The purpose of this cohort study was to delineate the rates, types and risk factors for infection in TBI patients. Retrospective surveillance of infections was conducted for all TBI patients, aged =18 years, cared for at the Department of Neurosurgery of the University Hospital of Heraklion, Greece, between 1999 and 2005. A total of 760 patients (75% men) with a median age of 41 years were included. Most (59%) were injured in a motor vehicle accident. One third of them underwent a surgical procedure. Two hundred and fourteen infections were observed. The majority were infections of the lower respiratory tract (47%), followed by surgical site infections (SSI) (17%). Multivariate analysis showed that SSI development was independently associated with the performance of =2 surgical procedures (OR 16.7), presence of concomitant infections, namely VAP (OR 5.7) and UTI (OR 8.8), insertion of lumbar (OR 34.5) and ventricular drains (OR 4.0), and cerebrospinal fluid (CSF) leak (OR 3.8). Development of meningitis was associated with prolonged hospitalization (OR 1.02), especially >7 days ICU stay (OR 25.5), and insertion of lumbar (OR 297) and ventricular drains (OR 9.1). There was a notable predominance of Acinetobacter spp. as a VAP pathogen; gram-positive organisms remained the most prevalent in SSI cases. Respiratory tract infections were the most common among TBI patients. Device-related communication of the CSF with the environment and prolonged hospitalization, especially in the ICU setting, were independent risk factors for SSIs and meningitis cases.	[Kourbeti, I. S.; Papadakis, J. A.; Bertsias, G.; Samonis, G.] Univ Hosp Heraklion, Dept Internal Med Infect Dis, Iraklion, Greece; [Kourbeti, I. S.; Bertsias, G.; Ioannou, A.; Samonis, G.] Univ Crete, Sch Med, Grad Programme, Iraklion, Greece; [Vakis, A. F.; Karabetsos, D. A.; Filippou, M.; Ioannou, A.; Neophytou, C.] Univ Hosp Heraklion, Dept Neurosurg, Iraklion, Greece; [Anastasaki, M.] Univ Hosp Heraklion, Intens Care Unit, Iraklion, Greece		Kourbeti, IS (corresponding author), Community Hosp Chalkida, Dept Internal Med, 48 Gazepi St, Chalkida 34100, Greece.	irenekourbeti@hotmail.com	Karabetsos, Dimitris/AAA-2753-2021	Filippou-Frye, Maria/0000-0001-5516-0384; Karabetsos, Dimitris/0000-0003-1960-945X			Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Boque M C, 2000, Semin Respir Infect, V15, P280; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; BROWN EM, 1994, LANCET, V344, P1547; Coplin WM, 1999, J NEUROL NEUROSUR PS, V67, P468, DOI 10.1136/jnnp.67.4.468; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Espinosa-Aguilar A, 2008, J TRAUMA, V64, P1327, DOI 10.1097/TA.0b013e3181469ebe; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hebb MO, 2007, CAN J SURG, V50, P187; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kaufman B A, 1990, Infect Dis Clin North Am, V4, P677; Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MCRITCHIE DI, 1995, CLIN CHEST MED, V16, P135; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; PATIR R, 1992, ACTA NEUROCHIR, V119, P80, DOI 10.1007/BF01541786; Pelosi P, 2005, CURR OPIN CRIT CARE, V11, P37, DOI 10.1097/00075198-200502000-00006; Pelosi P, 2008, CHEST, V134, P101, DOI 10.1378/chest.07-2546; Reichert MCF, 2002, AM J INFECT CONTROL, V30, P158, DOI 10.1067/mic.2002.119925; RELLO J, 1992, CHEST, V102, P525, DOI 10.1378/chest.102.2.525; Roumbelaki M, 2008, AM J INFECT CONTROL, V36, P732, DOI 10.1016/j.ajic.2007.11.009; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	29	53	62	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1198-743X	1469-0691		CLIN MICROBIOL INFEC	Clin. Microbiol. Infect.	APR	2012	18	4					359	364		10.1111/j.1469-0691.2011.03625.x			6	Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology	910NJ	WOS:000301646100016	21851488	Bronze			2022-02-06	
J	Chourdakis, M; Kraus, MM; Tzellos, T; Sardeli, C; Peftoulidou, M; Vassilakos, D; Kouvelas, D				Chourdakis, Michael; Kraus, Michaela M.; Tzellos, Thrasivoulos; Sardeli, Chrysanthi; Peftoulidou, Maria; Vassilakos, Dimitrios; Kouvelas, Dimitrios			Effect of Early Compared With Delayed Enteral Nutrition on Endocrine Function in Patients With Traumatic Brain Injury: An Open-Labeled Randomized Trial	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						traumatic brain injury; early enteral nutrition; endocrine function; thyroid-stimulating hormone; triiodothyronine (T3); thyroxine (T4); cortisol; testosterone	HEAD-INJURY; ILL PATIENTS; UNITED-STATES; MORTALITY; RESPONSES; ABNORMALITIES; HYPOGONADISM; DYSFUNCTION; SECONDARY; SEPSIS	Background: Traumatic brain injury (TBI) results in a hypermetabolic and hypercatabolic status in which adequate nutrition support is essential to improve clinical outcome. The endocrine system of a patient with TBI is also affected and may play a critical role in either the metabolic or the immunologic response to the trauma. In the present study, the effect of standard, delayed enteral feeding (DEF), compared with early (within 24-48 hours) enteral feeding (EEF), on the endocrine function of patients with TBI was investigated. Methods: This comparative, prospective, open-labeled, randomized study included TBI patients admitted to the intensive care unit (ICU). Injury severity was assessed by the Glasgow Coma Scale and predicted mortality by the Acute Physiology and Chronic Health Evaluation II. Twenty-five patients received DEF and 34 patients received EEF. The effect of the onset of nutrition on pituitary, thyroidal, gonadal, and adrenal function was investigated on days 6 and 12 after admission to the hospital. Results: Levels of thyroid-stimulating hormone, free triiodothyronine, free thyroxine, and testosterone (in males) of DEF patients declined in comparison to levels of the day of admission to the ICU. The decrease of hormonal values was less pronounced in the EEF group. Cortisol concentrations rose in the DEF group; a lesser hormonal change was found in the EEF group. Deaths during the study for the DEF group and EEF group were 2 and 3, respectively. Conclusions: EEF may exert beneficial effects on the hormonal profile of TBI patients, possibly contributing to a better clinical outcome in this patient group. (JPEN J Parenter Enteral Nutr. 2012; 36: 108-116)	[Chourdakis, Michael; Kraus, Michaela M.; Tzellos, Thrasivoulos; Sardeli, Chrysanthi; Kouvelas, Dimitrios] Aristotle Univ Thessaloniki, Dept Pharmacol, Sch Med, GR-54006 Thessaloniki, Greece; [Chourdakis, Michael; Peftoulidou, Maria; Vassilakos, Dimitrios] Aristotle Univ Thessaloniki, Dept Anesthesiol, Sch Med, AHEPA Hosp, GR-54006 Thessaloniki, Greece; [Chourdakis, Michael; Peftoulidou, Maria; Vassilakos, Dimitrios] Aristotle Univ Thessaloniki, ICU, Sch Med, AHEPA Hosp, GR-54006 Thessaloniki, Greece		Kouvelas, D (corresponding author), Aristotle Univ Thessaloniki, Dept Pharmacol, Sch Med, POB 1532, GR-54006 Thessaloniki, Greece.	kouvelas@auth.gr	Sardeli, Chrysanthi/ABF-1093-2020	Sardeli, Chrysanthi/0000-0002-6410-2992; Chourdakis, Michael/0000-0002-9490-8356; Kouvelas, Dimitrios/0000-0003-3615-9745			Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Antonelli M, 2009, INTENS CARE MED, V35, P30, DOI 10.1007/s00134-008-1371-6; BAUE AE, 1984, ARCH SURG-CHICAGO, V119, P1125; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cameron P, 1995, AUST NZ J SURG, V65, P848, DOI 10.1111/j.1445-2197.1995.tb00574.x; Carlotti APCP, 2008, QJM-INT J MED, V101, P197, DOI 10.1093/qjmed/hcm127; Cernak I, 1999, BRAIN INJURY, V13, P1005; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiolero R, 1994, New Horiz, V2, P432; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; Cohen J, 1977, STAT POWER ANAL BEHA; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; DOCTER R, 1993, CLIN ENDOCRINOL, V39, P499, DOI 10.1111/j.1365-2265.1993.tb02401.x; Doig GS, 2009, INTENS CARE MED, V35, P2018, DOI 10.1007/s00134-009-1664-4; Eskelinen Seija I, 2007, Endocr Pract, V13, P743; Frankenfield David, 2006, Nutr Clin Pract, V21, P430, DOI 10.1177/0115426506021005430; Galanos AN, 1997, CRIT CARE MED, V25, P1962, DOI 10.1097/00003246-199712000-00010; KALSBEEK WD, 1980, J NEUROSURG S, pS19; KAPTEIN EM, 1982, J CLIN INVEST, V69, P526, DOI 10.1172/JCI110478; LEE SC, 1994, BRAIN INJURY, V8, P571; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Ligtenberg JJM, 2001, INTENS CARE MED, V27, P1567, DOI 10.1007/s001340101050; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; McClave SA, 2009, NUTR CLIN PRACT, V24, P305, DOI 10.1177/0884533609335176; Miller KK, 2009, PITUITARY, V12, P116, DOI 10.1007/s11102-008-0121-7; Misra M, 2010, ENDOCR DEV, V17, P197, DOI 10.1159/000262540; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Roberts P R, 1995, New Horiz, V3, P506; Shulga A, 2009, MOL CELL NEUROSCI, V42, P408, DOI 10.1016/j.mcn.2009.09.002; Shutov A A, 1980, Zh Vopr Neirokhir Im N N Burdenko, P23; Siafakas N M, 1999, Monaldi Arch Chest Dis, V54, P154; Smrcka M, 2007, BRATISL MED J, V108, P144; STERNBACH H A, 1983, Journal of the American Medical Association, V249, P1618, DOI 10.1001/jama.249.12.1618; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Van den Berghe G, 2003, ENDOCRIN METAB CLIN, V32, P385, DOI 10.1016/S0889-8529(03)00005-7; VANDENBERGHE G, 1994, CLIN ENDOCRINOL, V41, P563; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; Wilson RF, 2001, NEUROL RES, V23, P121, DOI 10.1179/016164101101198451; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	50	53	64	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JAN	2012	36	1					108	116		10.1177/0148607110397878			9	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	874XS	WOS:000298992000014	21965459				2022-02-06	
J	Mihalik, JP; Guskiewicz, KM; Marshall, SW; Blackburn, JT; Cantu, RC; Greenwald, RM				Mihalik, Jason P.; Guskiewicz, Kevin M.; Marshall, Stephen W.; Blackburn, J. Troy; Cantu, Robert C.; Greenwald, Richard M.			Head Impact Biomechanics in Youth Hockey: Comparisons Across Playing Position, Event Types, and Impact Locations	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Injury prevention; Kinematics; Mild traumatic brain injury; Pediatric; Sports biomechanics	COLLEGIATE FOOTBALL PLAYERS; INJURY SURVEILLANCE SYSTEM; ICE HOCKEY; DESCRIPTIVE EPIDEMIOLOGY; SEVERITY; RISK	The age at which young hockey players should safely body check is unknown. We sought to determine if playing position (defensemen vs. forwards), event type (practice vs. game), or head impact location (top vs. back vs. front vs. sides) had an effect on head impact biomechanics in youth hockey. A total of 52 Bantam (13-14 years old) and Midget (15-16 years old) ice hockey players wore accelerometer-instrumented helmets for two seasons. Biomechanical data were captured for 12,253 head impacts during 151 games and 137 practices. Random intercepts general mixed linear models were employed to analyze differences in linear acceleration, rotational acceleration, and HITsp by player position, event type, and head impact location. Head impacts sustained during games resulted in greater rotational acceleration and HITsp than those sustained during practices. No event type or playing position differences in linear acceleration were observed. Impacts to the top of the head resulted in greater linear acceleration, but lower rotational acceleration and HITsp, than impacts to back, front, or side of the head. Side head impacts yielded greater rotational acceleration and HITsp compared to the other head impact locations. Since linear and rotational accelerations were observed in all impacts, future hockey helmet design standards should include rotational acceleration limits in addition to the current linear acceleration standards.	[Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Blackburn, J. Troy] Univ N Carolina, Neuromuscular Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Cantu, Robert C.] Emerson Hosp, Dept Sport Med, Concord, MA USA; [Greenwald, Richard M.] Simbex, Lebanon, NH USA; [Greenwald, Richard M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Mihalik, JP (corresponding author), Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Complex,Campus Bo, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130; Mihalik, Jason/0000-0001-6085-8322	Ontario Neurotrauma Foundation [2005-PREV-BANT-387]; USA Hockey Foundation; National Operating Committee on Standards for Athletic Equipment (NOCSAE); Simbex; HIT System technology	This study was supported in part by a grant from the Ontario Neurotrauma Foundation to The University of North Carolina at Chapel Hill Injury Prevention Research Center (Grant #2005-PREV-BANT-387). The USA Hockey Foundation and the National Operating Committee on Standards for Athletic Equipment (NOCSAE) also provided financial support. We would also like to thank the engineering team at Simbex for their continued support of this project. Dr. Greenwald has a financial interest in the HIT System technology used to collect data for this study.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hodgson VR, 1983, P 27 STAPP CAR CRASH, P225; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; USA Hockey, 2011, MEMB STAT	26	53	54	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		141	149		10.1007/s10439-011-0405-3			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700013	22012083				2022-02-06	
J	Oleksiak, M; Smith, BM; St Andre, JR; Caughlan, CM; Steiner, M				Oleksiak, Michael; Smith, Bridget M.; St Andre, Justin R.; Caughlan, Carly M.; Steiner, Monica			Audiological issues and hearing loss among Veterans with mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						adult; audiology; auditory dysfunction; blast injuries; brain injuries; hearing; hearing loss; mTBI; tinnitus; Veterans; wounds and injuries	TYMPANIC MEMBRANE PERFORATION; OPERATION ENDURING FREEDOM; IRAQI FREEDOM; WAR VETERANS; IMPAIRMENT; DYSFUNCTION	We examined the prevalence, severity, etiology, and treatment of audiology problems among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans with mild traumatic brain injury (TBI). A retrospective chart review was performed of 250 Veterans with mild TBI. Results of a comprehensive second-level mild TBI evaluation and subsequent visits to audiology were evaluated. We found the vast majority (87%) of Veterans reported some level of hearing disturbance and those involved in blast injuries reported a higher incidence of hearing disturbance than those with other injury etiologies. Audiology referrals were given to 75 Veterans and 37 attended. At this visit, Veterans reported tinnitus (75.7%) and hearing loss (59.8%). Nearly half (48.6%) of Veterans were diagnosed with conductive hearing loss, sensorineural hearing loss, or central auditory dysfunction. An additional 24.3% of Veterans had subclinical levels of auditory dysfunction. Our study has highlighted the increased prevalence of hearing loss among OIF/OEF Veterans and, thus, the need for appropriate referrals and treatment. Strategies to address perceived stigma associated with hearing loss may increase attendance at follow-up visits. Additionally, while only a third of audiograms were found to be abnormal, advanced testing resulted in a significant percentage of our population being diagnosed with auditory dysfunction.	[Oleksiak, Michael; Smith, Bridget M.; St Andre, Justin R.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA Ctr Management Complex Chron, Spinal Cord Injury Qual Enhancement Res Initiat, Hines, IL 60141 USA; [Oleksiak, Michael; Smith, Bridget M.] Loyola Univ Chicago, Stritch Sch Med, Program Hlth Serv Res, Maywood, IL USA; [Caughlan, Carly M.; Steiner, Monica] Edward Hines Jr VA Hosp, Hines, IL 60141 USA		Oleksiak, M (corresponding author), Edward Hines Jr VA Hosp, Res Serv, 5000 South 5th Ave 151H, Hines, IL 60141 USA.	MichaelOleksiak@gmail.com			VA Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [IIR 07-188-3]	This study was supported by the VA Office of Research and Development, Health Services Research and Development Service (grant IIR 07-188-3).	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Chandler D., 2006, BLAST RELATED EAR IN; Chermak GD, 2007, J AM ACAD AUDIOL, V18, P428, DOI 10.3766/jaaa.18.5.7; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Erler Susan F, 2002, Am J Audiol, V11, P83, DOI 10.1044/1059-0889(2002/020); Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Henry JA, PROGR AUDIOLOGIC TIN; HERBST KG, 1980, BMJ-BRIT MED J, V281, P903, DOI 10.1136/bmj.281.6245.903; HETU R, 1993, AUDIOLOGY, V32, P363; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Myers P, 2009, ASHA ACCESS AUDIOLOG, V8; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; Myers PJ, 2008, PERSPECT AUDIOL, V4, P21; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; PATOW CA, 1994, OTOLARYNG HEAD NECK, V110, P211, DOI 10.1177/019459989411000211; RICHARDSON ED, 1994, CLIN NEUROPSYCHOL, V8, P416, DOI 10.1080/13854049408402044; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Wallhagen MI, 2010, GERONTOLOGIST, V50, P66, DOI 10.1093/geront/gnp107; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03	27	53	57	0	15	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					995	1003		10.1682/JRRD.2011.01.0001			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100005	23341275	Bronze			2022-02-06	
J	Rasulo, FA; Girardini, A; Lavinio, A; De Peri, E; Stefini, R; Cenzato, M; Nodari, I; Latronico, N				Rasulo, Frank Anthony; Girardini, Alan; Lavinio, Andrea; De Peri, Elena; Stefini, Roberto; Cenzato, Marco; Nodari, Ilaria; Latronico, Nicola			Are Optimal Cerebral Perfusion Pressure and Cerebrovascular Autoregulation Related to Long-term Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage?	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						subarachnoid hemorrhage; cerebrovascular autoregulation; cerebral perfusion pressure	BRAIN-INJURY; BLOOD-FLOW; REACTIVITY; VALIDATION; MANAGEMENT	Background and Objectives: Continuous assessment of the cerebrovascular autoregulation (CVA) through use of the pressure reactivity index (PRx), a moving linear correlation coefficient between mean arterial blood pressure and intracranial pressure, has been effective in optimizing cerebral perfusion pressure (CPPopt) in traumatic brain injured (TBI) patients. This study investigates the feasibility of measuring CPPopt in patients with aneurysmal subarachnoid hemorrhage (aSAH) by continuously assessing the CVA. Methods: Twenty-nine aSAH patients were enrolled, and data from CVA status, CPPopt, and periods when CPP was below, within, or above CPPopt were computed daily. Outcome was assessed at 6 months with the Glasgow Outcome Scale. Mann-Whitney U test was used to analyze differences in the duration of impaired CVA and duration of CPP below CPPopt in patients with good and poor outcomes. Multivariable logistic regression analysis was used to identify independent predictors of outcome. Results: CVA monitoring data were available for all 29 patients with a total monitoring time of 2757 h. The duration of impaired CVA was 36.5% (interquartile range: 24.6 to 49.8) of the total monitoring time in 15 patients with good outcome and 71.6% of the total monitoring time (51.2 to 80.0) in 14 patients with poor outcome (Mann-Whitney U test 3.295, P= 0.0010). PRx-based CPPopt could be identified in 26 patients (89.6%) with a total monitoring time of 2691 h. The duration of CPP below the CPPopt range was 28.0% (interquartile range: 18.0 to 47.0) of the total monitoring time in patients with good outcome and 76.0% (48.5 to 82.5) in patients with poor outcome (Mann-Whitney U test 2.779, P - 0.0054). Glasgow Coma Scale score and duration of impaired CVA were independently associated with 6-month outcome (Glasgow Coma Scale score odds ratio: 1.95, 95% confidence interval: 1.01-3.75; duration of impaired CVA odds ratio: 0.88, 95% confidence interval: 0.78-0.99). Conclusions: The assessment of CVA and CPPopt is feasible in aSAH patients and may provide important information regarding long-term outcome. A PRx above the 0.2 threshold and a CPP below the CPPopt range are associated with worse outcome.	[Rasulo, Frank Anthony; Girardini, Alan; Lavinio, Andrea; De Peri, Elena; Nodari, Ilaria; Latronico, Nicola] Univ Brescia, Spedali Civili, Dept Neuroanesthesia Neurointens Care, Brescia, Italy; [Stefini, Roberto; Cenzato, Marco] Univ Brescia, Spedali Civili, Dept Neurosurg, Brescia, Italy; [Lavinio, Andrea; Nodari, Ilaria] Cambridge Univ Hosp Fdn Trust, Dept Anaesthesia, Cambridge, England		Rasulo, FA (corresponding author), Spedali Civili Brescia, Policlin Satellite, Dept Anesthesiol Intens Care & Perioperat Med, Piazzale Osped Civili 1, I-25123 Brescia, Italy.	rasulo@med.unibs.it	Lavinio, Andrea/M-1778-2016; Cenzato, Marco/Q-7546-2016; LATRONICO, Nicola/F-1557-2010	Cenzato, Marco/0000-0003-0283-7421; RASULO, Francesco Antonio/0000-0002-7187-5168; LATRONICO, Nicola/0000-0002-2521-5871	University of Brescia	This study used internal funds of the University of Brescia.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, ACT NEUR S, V71, P74; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; Diehl Rolf R, 2002, Eur J Ultrasound, V16, P31, DOI 10.1016/S0929-8266(02)00048-4; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fujii Y, 1996, J NEUROSURG, V84, P35, DOI 10.3171/jns.1996.84.1.0035; Hartman JM, 2002, LARYNGOSCOPE, V112, P23, DOI 10.1097/00005537-200201000-00005; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Myburgh J A, 2005, Crit Care Resusc, V7, P206; Naval NS, 2006, CRIT CARE MED, V34, P511, DOI 10.1097/01.CCM.0000198331.45998.85; Ogawa Y, 2007, ANESTH ANALG, V105, P1389, DOI 10.1213/01.ane.0000281910.95740.e4; Ohkuma H, 2001, STROKE, V32, P1176, DOI 10.1161/01.STR.32.5.1176; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; SOLOMON RA, 1988, NEUROSURGERY, V23, P699, DOI 10.1227/00006123-198812000-00002; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; WIJDICKS EFM, 1990, CLIN NEUROL NEUROSUR, V92, P111, DOI 10.1016/0303-8467(90)90085-J	29	53	53	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2012	24	1					3	8		10.1097/ANA.0b013e318224030a			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	863EB	WOS:000298144500002	21709587				2022-02-06	
J	Resnik, L; Bradford, DW; Glynn, SM; Jette, AM; Hernandez, CJ; Wills, S				Resnik, Linda; Bradford, Daniel W.; Glynn, Shirley M.; Jette, Alan M.; Hernandez, Caitlin Johnson; Wills, Sharon			Issues in defining and measuring veteran community reintegration: Proceedings of the Working Group on Community Reintegration, VA Rehabilitation Outcomes Conference, Miami, Florida	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						community integration; community reintegration; disability evaluation; International Classification of Health, Disability, and Functioning; measurement; OIF/OEF; outcome assessment; role functioning; social functioning; veteran	DEVELOPING CORE SETS; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; INTERNATIONAL CLASSIFICATION; BIPOLAR DISORDER; MEASURING PARTICIPATION; ENVIRONMENTAL-FACTORS; MULTIPLE-SCLEROSIS; PHYSICAL-THERAPY	In January 2010, the Department of Veterans Affairs (VA) Rehabilitation Research and Development Service convened a State of the Art (SOTA) conference to advance the field of outcome measurement for rehabilitation-related studies. This article reports on the proceedings of the SOTA Working Group on Community Reintegration. We explored the use of the International Classification of Health, Disability, and Functioning as a theoretical framework for measuring community reintegration; identified key dimensions of community reintegration that could and/or should be measured; discussed challenges in measuring community reintegration; suggested steps to enhance community reintegration measurement; proposed future research that focuses on outcomes measures for community reintegration and the study of community reintegration outcomes; and made policy recommendations that would facilitate community reintegration research within the VA.	[Resnik, Linda] Providence Dept Vet Affairs VA Med Ctr, Providence, RI USA; [Resnik, Linda] Brown Univ, Dept Community Hlth, Publ Hlth Program, Providence, RI 02912 USA; [Bradford, Daniel W.] Durham VA Med Ctr, Psychosocial Rehabil & Recovery Ctr, Durham, NC USA; [Bradford, Daniel W.] Duke Univ Hosp, Durham, NC USA; [Glynn, Shirley M.] VA Greater Angeles Healthcare Syst, West Los Angeles Med Ctr, Los Angeles, CA USA; [Glynn, Shirley M.] Univ Calif Los Angeles Hlth Syst, Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Jette, Alan M.] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Boston, MA USA; [Hernandez, Caitlin Johnson] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; [Wills, Sharon] Cent Texas Vet Hlth Care Syst, Ctr Trauma Recovery, Posttraumat Stress Disorder Clin Team, Austin Outpatient Clin, Austin, TX USA; [Wills, Sharon] Texas A&M Hlth Sci Ctr, Sch Med, Bryan, TX USA		Resnik, L (corresponding author), Providence VA Med Ctr, 830 Chalkstone Ave, Providence, RI 02908 USA.	Linda.Resnik@va.gov		Jette, Alan/0000-0002-2117-9973	VA RRD	This material is the result of work supported by VA RR&D.	[Anonymous], 2001, INT CLASS FUNCT DIS; Biering-Sorensen F, 2006, SPINAL CORD, V44, P541, DOI 10.1038/sj.sc.3101918; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown M, 2009, ARCH PHYS MED REHAB, V90, pS36, DOI 10.1016/j.apmr.2009.04.024; BRUSTEIN J, 2006, GOTHAM GAZETTE   MAR, P4; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Cardol M, 1999, DISABIL REHABIL, V21, P97, DOI 10.1080/096382899297819; Cardol M, 1999, CLIN REHABIL, V13, P411, DOI 10.1191/026921599668601325; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cieza A, 2004, J REHABIL MED, V36, P128, DOI 10.1080/16501960410016055; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Falloon I.R.H., 1984, FAMILY CARE SCHIZOPH; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Freeman TW, 2001, J NERV MENT DIS, V189, P317, DOI 10.1097/00005053-200105000-00008; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Jette AM, 2007, DISABIL REHABIL, V29, P1742, DOI 10.1080/09638280601164790; JETTE AM, 1994, PHYS THER, V74, P380, DOI 10.1093/ptj/74.5.380; Johnston Mark, 2002, J Spinal Cord Med, V25, P11; Kesselring J, 2008, MULT SCLER J, V14, P252, DOI 10.1177/1352458507082615; Khan F, 2007, J REHABIL MED, V39, P63, DOI 10.2340/16501977-0002; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreuter M, 2000, SPINAL CORD, V38, P2, DOI 10.1038/sj.sc.3100933; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; MCFARLANE WR, 1995, FAM PROCESS, V34, P127, DOI 10.1111/j.1545-5300.1995.00127.x; MCFARLANE WR, 1994, NEW DIRECTIONS MENTA, V62, P13, DOI DOI 10.1002/YD.23319946204; Miklowitz DJ, 2000, BIOL PSYCHIAT, V48, P582, DOI 10.1016/S0006-3223(00)00931-8; Miklowitz DJ, 2003, ARCH GEN PSYCHIAT, V60, P904, DOI 10.1001/archpsyc.60.9.904; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; *NATL COAL HOM VET, 2011, NCHV PLAN END HOM VE; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; *PRES NEW FREED CO, 2003, ACH PROM TRANSF MENT; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; ROSENHECK R, 1994, AM J PSYCHIAT, V151, P421; *SAB CTR MIDDL EAS, 2011, IR IND; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schooler N.H., 1979, RESOURCE MAT COMMUNI; Schuntermann MF, 2005, INT J REHABIL RES, V28, P93, DOI 10.1097/00004356-200506000-00001; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Stucki A, 2004, J REHABIL MED, V36, P107, DOI 10.1080/16501960410016064; STUCKI A, 2008, DISABILITY HLTH SLEE, V9, P191, DOI DOI 10.1016/J.SLEEP.2007.01.019; Szkudlarek B, 2010, INT J INTERCULT REL, V34, P1, DOI 10.1016/j.ijintrel.2009.06.006; Trigg R, 2000, CLIN REHABIL, V14, P288, DOI 10.1191/026921500678119607; Tschiesner U, 2007, EUR ARCH OTO-RHINO-L, V264, P1215, DOI 10.1007/s00405-007-0335-8; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Vieta E, 2007, BIPOLAR DISORD, V9, P16, DOI 10.1111/j.1399-5618.2007.00322.x; Vincent C., 2002, TECHNOLOGY DISABILIT, V14, P113, DOI DOI 10.3233/TAD-2002-14306; Whiteneck G., 2006, WORKSH DIS AM NEW LO; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; 2008, VA HDB, V1160	63	53	55	1	8	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	1					87	100		10.1682/JRRD.2010.06.0107			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149ES	WOS:000319302400010	22492341	Bronze			2022-02-06	
J	Shields, CG; Finley, MA; Chawla, N; Meadors, P				Shields, Cleveland G.; Finley, Michelle A.; Chawla, Neelu; Meadors, Patrick			Couple and Family Interventions in Health Problems	JOURNAL OF MARITAL AND FAMILY THERAPY			English	Article							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; IMPROVE REGIMEN ADHERENCE; POOR METABOLIC-CONTROL; EARLY-STAGE BREAST; CHRONIC CARE MODEL; MULTISYSTEMIC THERAPY; EDUCATION-PROGRAM	Intervention research for couples and families managing chronic health problems is in an early developmental stage. We reviewed randomized clinical trials of family interventions for common neurological diseases, cardiovascular diseases, cancer, and diabetes, which is similar to the content of previous reviews discussed later. One overriding theme of these studies is that patients with chronic illnesses and their families face a variety of challenges to which researchers have responded with an array of treatment modalities. Very few of the interventions reviewed, with the exception of treatment for adolescents with diabetes, tested family psychotherapy models. Most interventions were time-limited therapeutic interventions that trained families to improve their communication and problem-solving skills, individual and family coping skills, and medical management. Researchers more clearly described mechanisms of change in intervention studies with cancer and diabetes than with other diseases, and not surprisingly, they found greater empirical support for their interventions. Family interventions show promise to help patients and family members manage chronic illnesses. To develop an empirical base for family approaches to managing chronic illnesses, interventions must be based on theories that delineate mechanisms of change in family processes and skills in medical management necessary to maintain patients and family members health.	[Shields, Cleveland G.] Purdue Univ, Human Dev & Family Studies Dept, Marriage & Family Therapy Program, W Lafayette, IN 47907 USA		Shields, CG (corresponding author), Fowler Mem House,1200 W State St, W Lafayette, IN 47907 USA.	cgshields@purdue.edu		Shields, Cleveland/0000-0003-3709-6969			Aggarwal B, 2010, J CARDIOVASC NURS, V25, P444, DOI 10.1097/JCN.0b013e3181defd3e; ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477; [Anonymous], 2008, SPINAL CORD INJURY F; Askins MA, 2009, J PEDIATR PSYCHOL, V34, P551, DOI 10.1093/jpepsy/jsn124; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bowman KF, 2006, PSYCHO-ONCOL, V15, P834, DOI 10.1002/pon.1039; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Budin WC, 2008, NURS RES, V57, P199, DOI 10.1097/01.NNR.0000319496.67369.37; Burton J, 2010, AIDS BEHAV, V14, P1, DOI 10.1007/s10461-008-9471-4; Campbell TL, 2003, J MARITAL FAM THER, V29, P263, DOI 10.1111/j.1752-0606.2003.tb01204.x; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; Chaney J. M., 2005, FAMILIES SYSTEMS HLT, V23, P329, DOI DOI 10.1037/1091-7527.23.3.329; Clayton JM, 2007, J CLIN ONCOL, V25, P715, DOI 10.1200/JCO.2006.06.7827; Cohen D., 2009, DIABETIC MED, V8, P928; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Cox MJ, 2003, CURR DIR PSYCHOL SCI, V12, P193, DOI 10.1111/1467-8721.01259; D'Zurilla T.J., 2007, PROBLEM SOLVING THER, V3rd ed.; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Doherty W.J., 1992, MED FAMILY THERAPY B; Donenberg GR, 2006, J PEDIATR PSYCHOL, V31, P869, DOI 10.1093/jpepsy/jsj102; Driscoll WD, 2004, PRIMARY CARE PSYCHOLOGY, P133, DOI 10.1037/10651-007; Dzewaltowski DA, 2004, ANN BEHAV MED, V28, P75, DOI 10.1207/s15324796abm2802_1; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Ellis DA, 2005, PEDIATRICS, V116, pE826, DOI 10.1542/peds.2005-0638; Ellis DA, 2005, J PEDIATR PSYCHOL, V30, P656, DOI 10.1093/jpepsy/jsi052; Ellis DA, 2005, DIABETES CARE, V28, P1604, DOI 10.2337/diacare.28.7.1604; Ellis DA, 2004, J CLIN PSYCHOL MED S, V11, P315, DOI 10.1023/B:JOCS.0000045351.98563.4d; Ellis D, 2008, DIABETES CARE, V31, P1746, DOI 10.2337/dc07-2094; Ellis DA, 2007, J PEDIATR PSYCHOL, V32, P194, DOI 10.1093/jpepsy/jsj116; Frank R. G., 2004, PRIMARY CARE PSYCHOL; Franks MM, 2006, J FAM PSYCHOL, V20, P311, DOI 10.1037/0893-3200.20.2.311; Franzen-Dahlin A, 2008, CLIN REHABIL, V22, P722, DOI 10.1177/0269215508090161; Geffken GR, 2008, REHABIL PSYCHOL, V53, P231, DOI 10.1037/0090-5550.53.2.231; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2001, MILBANK Q, V79, P579, DOI 10.1111/1468-0009.00222; Glass TA, 2004, PSYCHOSOM MED, V66, P889, DOI 10.1097/01.psy.0000146326.01642.ca; Goudas LC, 2005, CANCER INVEST, V23, P182, DOI 10.1081/CNV-200050482; Grey M, 2009, RES NURS HEALTH, V32, P405, DOI 10.1002/nur.20336; Haley W E, 2001, Hosp J, V15, P1, DOI 10.1300/J011v15n04_01; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Harrington R, 2010, CLIN REHABIL, V24, P3, DOI 10.1177/0269215509347437; Henggeler S. W., 1999, CHILD PSYCHOL PSYCHI, V4, P2, DOI DOI 10.1017/S1360641798001786; Howe Carol J, 2005, J Pediatr Nurs, V20, P83, DOI 10.1016/j.pedn.2004.12.010; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalaitzi C, 2007, J SURG ONCOL, V96, P235, DOI 10.1002/jso.20811; Kazak AE, 2005, J PEDIATR PSYCHOL, V30, P644, DOI 10.1093/jpepsy/jsi051; Kazak AE, 2004, J FAM PSYCHOL, V18, P493, DOI 10.1037/0893-3200.18.3.493; Keefe FJ, 2005, J PAIN SYMPTOM MANAG, V29, P263, DOI 10.1016/j.jpainsymman.2004.06.014; Kissane DW, 2006, AM J PSYCHIAT, V163, P1208, DOI 10.1176/appi.ajp.163.7.1208; Kuijer RG, 2004, PSYCHO-ONCOLOGY, V13, P321, DOI 10.1002/pon.749; Kurtz ME, 2005, J PAIN SYMPTOM MANAG, V30, P112, DOI 10.1016/j.jpainsymman.2005.02.008; Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138; Larson J, 2005, J CLIN NURS, V14, P995, DOI 10.1111/j.1365-2702.2005.01206.x; Lazarus R, 1984, STRESS COPING APPRAI; Lazarus RS, 2000, AM PSYCHOL, V55, P665, DOI 10.1037//0003-066X.55.6.665; Lett H, 2008, PSYCHOSOM MED, V70, P444, DOI 10.1097/PSY.0b013e31816c3c5c; Levine C, 2010, HEALTH AFFAIR, V29, P116, DOI 10.1377/hlthaff.2009.0520; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Lincoln NB, 2003, STROKE, V34, P116, DOI 10.1161/01.STR.0000047850.33686.32; Lind M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004412; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lucke KT, 2004, QUAL LIFE RES, V13, P97, DOI 10.1023/B:QURE.0000015284.95515.17; Manne S, 2004, J CONSULT CLIN PSYCH, V72, P660, DOI 10.1037/0022-006X.72.4.660; Manne S, 2004, PSYCHO-ONCOL, V13, P37, DOI 10.1002/pon.724; Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599; MCDANIEL SH, 1992, AM J FAM THER, V20, P101, DOI 10.1080/01926189208250882; McMillan SC, 2006, CANCER, V106, P214, DOI 10.1002/cncr.21567; MILLER L, 1993, AM J FAM THER, V21, P111, DOI 10.1080/01926189308250910; MILLERJOHNSON S, 1994, J CONSULT CLIN PSYCH, V62, P603, DOI 10.1037/0022-006X.62.3.603; Modi AC, 2009, EPILEPSY BEHAV, V14, P237, DOI 10.1016/j.yebeh.2008.10.009; Molton IR, 2009, J REHABIL RES DEV, V46, P31, DOI 10.1682/JRRD.2008.03.0044; Moos R. H., 1981, MANUAL FAMILY ENV SC, V50, P33; Morris AD, 1997, LANCET, V350, P1505, DOI 10.1016/S0140-6736(97)06234-X; Mosca L, 2008, CIRC-CARDIOVASC QUAL, V1, P98, DOI 10.1161/CIRCOUTCOMES.108.825786; Murphy HR, 2007, DIABETIC MED, V24, P1261, DOI 10.1111/j.1464-5491.2007.02229.x; Naar-King S., 2007, FAMILIES SYSTEMS HLT, V25, p[178, 112], DOI [10.1037/1091-7527.25.2.178, DOI 10.1037/1091-7527.25.2.178]; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; Nijboer C, 1998, PSYCHO-ONCOL, V7, P3, DOI 10.1002/(SICI)1099-1611(199801/02)7:1<3::AID-PON320>3.0.CO;2-5; NINDS, 2009, NAT I NEUR DIS STRAT; Northouse L, 2005, PSYCHO-ONCOLOGY, V14, P478, DOI 10.1002/pon.871; Northouse LL, 2007, CANCER-AM CANCER SOC, V110, P2809, DOI 10.1002/cncr.23114; Pattison HM, 2006, ARCH DIS CHILD, V91, P487, DOI 10.1136/adc.2004.061416; Reisner Sari L, 2009, Top HIV Med, V17, P14; Rewers M, 2007, PEDIATR DIABETES, V8, P408, DOI 10.1111/j.1399-5448.2007.00352.x; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272; Schulz R, 2009, REHABIL PSYCHOL, V54, P1, DOI 10.1037/a0014932; Schure LM, 2006, PATIENT EDUC COUNS, V62, P46, DOI 10.1016/j.pec.2005.05.015; Scott JL, 2004, J CONSULT CLIN PSYCH, V72, P1122, DOI 10.1037/0022-006X.72.6.1122; Seaburn D., 2007, J MARITAL FAMILY THE, V19, P177; SHIELDS CG, 1994, J MARITAL FAM THER, V20, P117, DOI 10.1111/j.1752-0606.1994.tb01021.x; Smith J, 2004, CLIN REHABIL, V18, P726, DOI 10.1191/0269215504cr790oa; Song MK, 2005, MED CARE, V43, P1049, DOI 10.1097/01.mlr.0000178192.10283.b4; Stehl ML, 2009, J PEDIATR PSYCHOL, V34, P803, DOI 10.1093/jpepsy/jsn130; Swift EE, 2006, ANN BEHAV MED, V32, P39, DOI 10.1207/s15324796abm3201_5; Tsouna-Hadjis E, 2000, ARCH PHYS MED REHAB, V81, P881, DOI 10.1053/apmr.2000.4435; Uchino B. N., 2004, SOCIAL SUPPORT PHYS; van Zyl LT, 2009, J THROMB THROMBOLYS, V27, P48, DOI 10.1007/s11239-007-0189-3; Visser-Meily A, 2008, PATIENT EDUC COUNS, V73, P153, DOI 10.1016/j.pec.2008.03.011; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Ward SE, 2009, HEALTH PSYCHOL, V28, P588, DOI 10.1037/a0015216; Wysocki T, 2008, J PEDIATR PSYCHOL, V33, P875, DOI 10.1093/jpepsy/jsn024; Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613; Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P928, DOI 10.1093/jpepsy/jsj098	116	53	53	0	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0194-472X	1752-0606		J MARITAL FAM THER	J. Marital Fam. Ther.	JAN	2012	38	1					265	280		10.1111/j.1752-0606.2011.00269.x			16	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	883KO	WOS:000299633100013	22283390				2022-02-06	
J	Siopi, E; Cho, AH; Homsi, S; Croci, N; Plotkine, M; Marchand-Leroux, C; Jafarian-Tehrani, M				Siopi, Eleni; Cho, Angelo H.; Homsi, Shadi; Croci, Nicole; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz			Minocycline Restores sAPP alpha Levels and Reduces the Late Histopathological Consequences of Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						astrogliosis; atrophy; minocycline; sAPP alpha; traumatic brain injury; white matter	AMYLOID-PRECURSOR-PROTEIN; CLOSED-HEAD-INJURY; HIPPOCAMPAL-NEURONS; PROGRESSIVE ATROPHY; SECRETED FORMS; ACTIVATION; MODEL; RECEPTOR; WHITE; RATS	Traumatic brain injury (TBI) induces both focal and diffuse lesions that are concurrently responsible for the ensuing morbidity and mortality and for which no established treatment is available. It has been recently reported that an endogenous neuroprotector, the soluble form alpha of the amyloid precursor protein (sAPP alpha), exerts neuroprotective effects following TBI. However, the emergent post-traumatic neuroinflammatory environment compromises sAPP alpha production and may promote neuronal degeneration and consequent brain atrophy. Hence, the aim of this study was to examine the effects of the anti-inflammatory drug minocycline on sAPP alpha levels, as well as on long-term histological consequences post-TBI. The weight-drop model was used to induce TBI in mice. Minocycline or its vehicle were administered three times: at 5 min (90mg/ kg, i.p.) and at 3 and 9 h (45 mg/kg, i.p.) post-TBI. The levels of sAPP alpha, the extent of brain atrophy, and reactive gliosis were evaluated by ELISA, cresyl violet, and immunolabeling of GFAP and CD11b, respectively. Our results revealed a post-TBI sAPP alpha decrease that was significantly attenuated by minocycline. Additionally, corpus callosum and striatal atrophy, ventriculomegaly, astrogliosis, and microglial activation were observed at 3 months post-TBI. All the above consequences were significantly reduced by minocycline. In conclusion, inhibition of the acute phase of post-TBI neuroinflammation was associated with the sparing of sAPP alpha and the protection of brain tissue in the long-term, emphasizing the potential role of minocycline as an effective treatment for TBI.	[Siopi, Eleni; Cho, Angelo H.; Homsi, Shadi; Croci, Nicole; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale EA 4475, F-75006 Paris, France		Jafarian-Tehrani, M (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale EA 4475, 4 Ave Observ, F-75006 Paris, France.	mehrnaz.jafarian@parisdescartes.fr	MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856	nonprofit organization Fondation des Gueules Cassees	This work was supported by the nonprofit organization Fondation des Gueules Cassees (grants to E.S. and M.J.T.).	Antonenko YN, 2010, J BIOENERG BIOMEMBR, V42, P151, DOI 10.1007/s10863-010-9271-1; Avramovich Y, 2002, J BIOL CHEM, V277, P31466, DOI 10.1074/jbc.M201308200; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Claasen AM, 2009, NEUROSCI LETT, V460, P92, DOI 10.1016/j.neulet.2009.05.040; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Czeiter E, 2009, MOLECULES, V14, P5115, DOI 10.3390/molecules14125115; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; Furukawa K, 1998, NEUROSCIENCE, V83, P429, DOI 10.1016/S0306-4522(97)00398-9; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gunther A, 2005, EUR J NEUROSCI, V21, P3189, DOI 10.1111/j.1460-9568.2005.04151.x; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; JAFFE AB, 1994, J BIOL CHEM, V269, P13065; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; KOSTRZEWA RM, 1994, BRAIN RES BULL, V34, P161, DOI 10.1016/0361-9230(94)90013-2; Kovesdi E, 2010, INT J MOL SCI, V11, P1253, DOI 10.3390/ijms11041253; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Magara F, 2000, NEUROSCI BIOBEHAV R, V24, P45, DOI 10.1016/S0149-7634(99)00051-2; Mahmood A., 2009, NEUROSURGERY, V65, P191, DOI DOI 10.1227/01.NEU.0000343540.24780.D6; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Matute C, 2010, CELL CALCIUM, V47, P150, DOI 10.1016/j.ceca.2009.12.004; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schwab JM, 2001, J NEUROTRAUM, V18, P377, DOI 10.1089/089771501750170930; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Verger K, 2001, BRAIN INJURY, V15, P211; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	61	53	53	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2011	28	10					2135	2143		10.1089/neu.2010.1738			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	839OX	WOS:000296378500014	21770756				2022-02-06	
J	Longhi, L; Gesuete, R; Perego, C; Ortolano, F; Sacchi, N; Villa, P; Stocchetti, N; De Simoni, MG				Longhi, Luca; Gesuete, Raffaella; Perego, Carlo; Ortolano, Fabrizio; Sacchi, Noemi; Villa, Pia; Stocchetti, Nino; De Simoni, Maria-Grazia			Long-lasting protection in brain trauma by endotoxin preconditioning	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						inflammation; neuroprotection; pathophysiology; preconditioning; traumatic brain injury	CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; CLOSED-HEAD INJURY; INFLAMMATORY RESPONSE; BLOOD-FLOW; TNF-ALPHA; TOLERANCE; MICE; LIPOPOLYSACCHARIDE; RATS	We investigated the occurrence of endotoxin (lipopolysaccharide, LPS) preconditioning in traumatic brain injury (TBI), evaluating the time window of LPS-induced protection, its persistence, and the associated molecular mechanisms. Mice received 0.1 mg/kg LPS or saline intraperitoneally and subsequently TBI (by controlled cortical impact brain injury) at various time intervals. Mice receiving LPS 3, 5, or 7 days before TBI showed attenuated motor deficits at 1 week after injury compared with mice receiving saline. Those receiving LPS 5 days before injury had also a reduced contusion volume (7.9 +/- 1.3 versus 12 +/- 2.3 mm(3)) and decreased cell death. One month after injury, the protective effect of LPS on contusion volume (14.5 +/- 1.2 versus 18.2 +/- 1.2 mm(3)) and neurologic function was still present. Traumatic brain injury increased glial fibrillary acidic protein, CD11b, CD68, tumor necrosis factor-cc, interleukin (IL)-10, and IL-6 mRNA expression 24 hours after injury. Lipopolysaccharide administered 5 (but not 9) days before injury increased the expression of CD11b (233%) and of interferon beta (500%) in uninjured mice, while it reduced the expression of CD68 (by 46%) and increased that of IL-6 (by 52%) in injured mice. Lipopolysaccharide preconditioning conferred a long-lasting neuroprotection after TBI, which was associated with a modulation of microglia/macrophages activity and cytokine production. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 1919-1929; doi:10.1038/jcbfm.2011.42; published online 6 April 2011	[Longhi, Luca; Gesuete, Raffaella; Perego, Carlo; Villa, Pia; De Simoni, Maria-Grazia] Mario Negri Inst Pharmacol Res, Dept Neurosci, Lab Inflammat & Nervous Syst Dis, I-20156 Milan, Italy; [Longhi, Luca; Ortolano, Fabrizio; Sacchi, Noemi; Stocchetti, Nino] Univ Milan, Dept Anesthesia & Crit Care Med, Neurosurg Intens Care Unit, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Villa, Pia] CNR, Inst Neurosci, I-20133 Milan, Italy		De Simoni, MG (corresponding author), Mario Negri Inst Pharmacol Res, Dept Neurosci, Lab Inflammat & Nervous Syst Dis, I-20156 Milan, Italy.	desimoni@marionegri.it	Stocchetti, Nino/O-7444-2017; De Simoni, Maria Grazia/I-6021-2012; Perego, Carlo/AAA-6513-2020; Longhi, Luca/AAF-9903-2021	Stocchetti, Nino/0000-0003-3250-6834; De Simoni, Maria Grazia/0000-0001-6695-5297; Perego, Carlo/0000-0002-0259-0003; Longhi, Luca/0000-0001-9894-8788; Ortolano, Fabrizio/0000-0003-1996-948X	Fondazione CariploFondazione Cariplo [2006.0864]	This study was supported by the Fondazione Cariplo, Grant # 2006.0864.	Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Bastide M, 2003, J CEREBR BLOOD F MET, V23, P399, DOI 10.1097/01.WCB.0000050064.57184.F2; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Dawson DA, 1999, J CEREBR BLOOD F MET, V19, P616, DOI 10.1097/00004647-199906000-00004; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Furuya K, 2005, J NEUROSURG, V103, P715, DOI 10.3171/jns.2005.103.4.0715; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Marsh BJ, 2008, CURR OPIN PHARMACOL, V8, P8, DOI 10.1016/j.coph.2007.09.009; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Penkowa M, 1999, GLIA, V25, P343; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Pignataro G, 2009, FEBS J, V276, P46, DOI 10.1111/j.1742-4658.2008.06769.x; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Shein NA, 2008, J NEUROTRAUM, V25, P112, DOI 10.1089/neu.2007.0358; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Storini C, 2005, NEUROBIOL DIS, V19, P10, DOI 10.1016/j.nbd.2004.11.001; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Troglio F, 2004, P NATL ACAD SCI USA, V101, P15476, DOI 10.1073/pnas.0403283101; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	41	53	56	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2011	31	9					1919	1929		10.1038/jcbfm.2011.42			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	815KK	WOS:000294524300010	21468087	Green Published, Bronze			2022-02-06	
J	Thomas, M; Haas, TS; Doerer, JJ; Hodges, JS; Aicher, BO; Garberich, RF; Mueller, FO; Cantu, RC; Maron, BJ				Thomas, Mathew; Haas, Tammy S.; Doerer, Joseph J.; Hodges, James S.; Aicher, Brittany O.; Garberich, Ross F.; Mueller, Frederick O.; Cantu, Robert C.; Maron, Barry J.			Epidemiology of Sudden Death in Young, Competitive Athletes Due to Blunt Trauma	PEDIATRICS			English	Article						sudden death; trauma; athletes	BRAIN-INJURY; HIGH-SCHOOL; CONTACT-SPORTS; CONCUSSION; FOOTBALL; MANAGEMENT; COLLEGIATE	BACKGROUND: Sudden deaths of young competitive athletes are highly visible events that have a substantial effect on families and communities. Recent attention has focused predominantly on cardiovascular causes, and less on traumatic organ damage. OBJECTIVE: To define the clinical profile, epidemiology, and frequency of trauma-related deaths in young US athletes. METHODS: We analyzed the 30-year US National Registry of Sudden Death in Young Athletes (1980-2009) by using systematic identification and tracking strategies. RESULTS: Of 1827 deaths of athletes aged 21 years or younger, 261 (14%) were caused by trauma-related injuries, usually involving the head and/ or neck (mean: 16 +/- 2 years; 90% male) in 22 sports. The highest number of events in a single year was 16 (1986), with an average of 9 per year throughout 30 years. The mortality rate was 0.11 in 100 000 participations (95% confidence interval: 0.08-0.15). The largest number of deaths was in football (148 [57%]), including 17 high school athletes who sustained concussions shortly before fatal head trauma ("second-impact syndrome"). Football deaths were more frequent in defensive players, although the single most common position involved was running back (61% of offensive players). CONCLUSIONS: In a large community-based national registry, sudden deaths caused by blunt trauma in young athletes aged 21 years or younger were relatively uncommon with 16 or fewer per year, about fourfold less than cardiovascular deaths. These fatalities were most frequent in football, and an important proportion of deaths after head blows in high school football were associated with a recent history of symptomatic concussion. Pediatrics 2011;128:e1-e8	[Maron, Barry J.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; [Hodges, James S.] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Mueller, Frederick O.] Natl Ctr Catastroph Sports Injury Res, Chapel Hill, NC USA; [Cantu, Robert C.] Emerson Hosp, Concord, MA USA		Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Suite 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org			Hearst Foundations (New York, NY)	This work was supported by the Hearst Foundations (New York, NY).	[Anonymous], 2010, NY TIMES        1021; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2001, AM J SPORT MED, V29, P50, DOI 10.1177/03635465010290011301; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Epstein D, 2010, SPORTS ILLUSTRA 1101; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GREGORY S, 2010, TIME MAGAZINE   1022; GREGORY S, 2010, TIME MAGAZINE   0128; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; Harris KM, 2006, ANN INTERN MED, V145, P507, DOI 10.7326/0003-4819-145-7-200610030-00008; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Kelly JP, 1997, NEUROLOGY, V48, P581; King P, 2010, SPORTS ILLUSTRA 1101; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Maron BJ, 2010, NEW ENGL J MED, V362, P917, DOI 10.1056/NEJMra0910111; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1142, DOI 10.1001/jama.287.9.1142; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2003, J AM COLL CARDIOL, V41, P974, DOI 10.1016/S0735-1097(02)02976-5; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 2000, MED J AUSTRALIA, V172, P217, DOI 10.5694/j.1326-5377.2000.tb123912.x; Metzl JD, 2006, PEDIATRICS, V117, P1813, DOI 10.1542/peds.2006-0480; *NAT FED HIGH SCH, NFHS PART FIG SEARCH; *NAT LIGHTN SAF I, LIGHTN FAT INJ DAM R; National Collegiate Athletic Association, NCAA SPORTS SPONS PA; PEGULA SM, FATAL OCCUPATIONAL I; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schneider R C, 1964, Clin Neurosurg, V12, P226; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; SCHWARZ A, 2009, NY TIMES        1126; SCHWARZ A, 2010, NY TIMES        0420; *US DEP HHS, 2008, MEN VACC INF STAT IN; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; VanCamp SP, 1996, CATASTROPHIC INJURIE, V8	45	53	53	0	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL	2011	128	1					E1	E8		10.1542/peds.2010-2743			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	786IV	WOS:000292299500001	21690117				2022-02-06	
J	Bryant, RA; Felmingham, KL; Silove, D; Creamer, M; O'Donnell, M; McFarlane, AC				Bryant, Richard A.; Felmingham, Kim L.; Silove, Derrick; Creamer, Mark; O'Donnell, Meaghan; McFarlane, Alexander C.			The association between menstrual cycle and traumatic memories	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Posttraumatic stress disorder; Flashback; Trauma memory; Menstrual; Glucocorticoid	POSTTRAUMATIC-STRESS-DISORDER; PITUITARY-ADRENAL AXIS; SEX-DIFFERENCES; CORTISOL; WOMEN	Background: Women in the mid-luteal phase of the menstrual cycle have been shown to have stronger emotional memories than other women. We investigated the extent to which experiencing a traumatic event during the luteal phase of the menstrual cycle is associated with stronger traumatic flashback memories. Methods: Consecutive female patients admitted to hospital after traumatic injury (n = 138) were assessed for days since last menstruation, as well as assessment of flashbacks. Twenty three (17%) women were in the mid-luteal phase (18-24) days at the time of trauma exposure and 29 (21%) were in the mid-luteal phase at the time of assessment. Results: Women were more likely to experience flashback memories if they were in the luteal phase during the trauma (22% vs. 9%), adjusted OR: 3.64 [95%CI: 0.99-13.29] after controlling for injury severity, age, trauma type, and mild traumatic brain injury. Women in the luteal phase at assessment were 4.89 times more likely to have flashbacks. Adjusted OR: 4.89 [95%CI: 1.39-17.86]. Conclusions: Increased glucocorticoid release associated with the luteal phase of the menstrual cycle may facilitate consolidation of trauma memories. (C) 2010 Elsevier B.V. All rights reserved.	[Bryant, Richard A.; Felmingham, Kim L.; Silove, Derrick] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Creamer, Mark; O'Donnell, Meaghan] Univ Melbourne, Melbourne, Vic 3010, Australia; [McFarlane, Alexander C.] Univ Adelaide, Adelaide, SA 5005, Australia		Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; O'Donnell, Meaghan/0000-0003-4349-0022	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian Research CouncilAustralian Research Council	This research was supported by a National Health and Medical Research Council Program Grant and an Australian Research Council Discovery Grant.	Abercrombie HC, 2003, BEHAV NEUROSCI, V117, P505, DOI 10.1037/0735-7044.117.3.505; Andreano JM, 2008, PSYCHONEUROENDOCRINO, V33, P874, DOI 10.1016/j.psyneuen.2008.03.009; Andreano JM, 2009, LEARN MEMORY, V16, P248, DOI 10.1101/lm.918309; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Ferree NK, 2009, CONSCIOUS COGN, V18, P126, DOI 10.1016/j.concog.2008.11.008; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Kuhlmann S, 2005, PSYCHOPHARMACOLOGY, V183, P65, DOI 10.1007/s00213-005-0143-z; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Roca CA, 2003, J CLIN ENDOCR METAB, V88, P3057, DOI 10.1210/jc.2002-021570; Roozendaal B, 1997, ANN NY ACAD SCI, V821, P247, DOI 10.1111/j.1749-6632.1997.tb48284.x	17	53	53	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327			J AFFECT DISORDERS	J. Affect. Disord.	JUN	2011	131	1-3					398	401		10.1016/j.jad.2010.10.049			4	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	775KI	WOS:000291457800052	21093927				2022-02-06	
J	Otis, JD; McGlinchey, R; Vasterling, JJ; Kerns, RD				Otis, John D.; McGlinchey, Regina; Vasterling, Jennifer J.; Kerns, Robert D.			Complicating Factors Associated with Mild Traumatic Brain Injury: Impact on Pain and Posttraumatic Stress Disorder Treatment	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						Pain; Posttraumatic stress disorder; Traumatic brain injury; Polytrauma; Integrated intervention	PERSISTENT POSTCONCUSSIVE SYMPTOMS; COGNITIVE-PROCESSING THERAPY; OPERATIONS ENDURING FREEDOM; POST-CONCUSSION SYMPTOMS; LOW-BACK-PAIN; IRAQI FREEDOM; OIF/OEF VETERANS; HEAD-INJURY; AFGHANISTAN; HEALTH	The nature of combat in Iraq and Afghanistan has resulted in high rates of comorbidity among chronic pain, posttraumatic stress disorder (PTSD), and mild traumatic brain injury (mTBI) in Veterans of Operations Enduring Freedom and Iraqi Freedom (OEF/OIF). Although separate evidence-based psychological treatments have been developed for chronic pain and PTSD, far less is known about how to approach treatment when these conditions co-occur, and especially when they co-occur with mTBI. To provide the best care possible for OEF/OIF Veterans, clinicians need to have a clearer understanding of how to identify these conditions, ways in which these conditions may interact with one another, and ways in which existing evidence-based treatments can be modified to meet the needs of individuals with mTBI. The purpose of the present paper is to review the comorbidity of pain, PTSD, and mTBI in OEF/OIF Veterans, and provide recommendations to clinicians who provide care to Veterans with these conditions. First, we will begin with an overview of the presentation, symptomatology, and treatment of chronic pain and PTSD. The challenges associated with mTBI in OEF/OIF Veterans will be reported and data will be presented on the comorbidity among all three of these conditions in OEF/OIF Veterans. Second, we will present recommendations for providing psychological treatment for chronic pain and PTSD when comorbid with mTBI. Finally, the paper concludes with a discussion of the need for a multidisciplinary treatment approach, as well as a call for continued research to further refine existing treatments for these conditions.	[Otis, John D.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Kerns, Robert D.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Otis, John D.; Vasterling, Jennifer J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Otis, John D.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [McGlinchey, Regina] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Kerns, Robert D.] Yale Univ, Dept Psychiat, West Haven, CT USA; [McGlinchey, Regina] VA Boston Healthcare Syst, Geriatr Educ Clin & Res Ctr, Boston, MA 02130 USA; [McGlinchey, Regina] VA Boston Healthcare Syst, VA RR&D Translat Res Ctr TBI & Stress Disorders T, Boston, MA 02130 USA		Otis, JD (corresponding author), VA Boston Healthcare Syst, Res Serv, 150 S Huntington Ave, Boston, MA 02130 USA.	John.otis@va.gov		Otis, John/0000-0002-5441-7421			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barrow IM, 2006, J TRAUMA, V61, P1142, DOI 10.1097/01.ta.0000241238.70269.c1; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bilmes L, 2007, SOLDIERS RETURNING I; Bruner E. F., 2006, MILITARY FORCES WHAT; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Buffum MD, 2007, J REHABIL RES DEV, V44, P315, DOI 10.1682/JRRD.2006.06.0064; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CHARD KM, 2010, ISTSS 26 ANN M MONTR; Chibnall JT, 2001, PAIN, V92, P173, DOI 10.1016/S0304-3959(00)00485-1; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; *DEF MANP DAT CTR, GLOB WAR TERR OP IR; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Fisher SE, 2002, J AM GERIATR SOC, V50, P152, DOI 10.1046/j.1532-5415.2002.50021.x; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; HASKELL SG, CLIN J PAIN IN PRESS; HEINRICH RL, 1985, J BEHAV MED, V8, P61, DOI 10.1007/BF00845512; Herr K, 2006, PAIN MANAG NURS, V7, P44, DOI 10.1016/j.pmn.2006.02.003; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Horgas AL, 2009, J AM GERIATR SOC, V57, P126, DOI 10.1111/j.1532-5415.2008.02071.x; Iverson GI, 2007, POSTCONCUSSION DISOR; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KEANE TM, 1982, J CONSULT CLIN PSYCH, V50, P138, DOI 10.1037/0022-006X.50.1.138; KEANE TM, 1989, BEHAV THER, V20, P245, DOI 10.1016/S0005-7894(89)80072-3; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; King LA, 2008, J REHABIL RES DEV, V45, P395, DOI 10.1682/JRRD.2007.06.0081; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Linton SJ, 2001, PAIN, V90, P83, DOI 10.1016/S0304-3959(00)00390-0; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCCREA M, 2008, MILD TRAUMATIC BRAIN, P84; Merskey H., 1994, CLASSIFICATION CHRON; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Otis J., 2007, MANAGING CHRONIC PAI; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pautex S, 2006, J AM GERIATR SOC, V54, P1040, DOI 10.1111/j.1532-5415.2006.00766.x; Resick P. A., 1993, COGNITIVE PROCESSING; RESICK PA, 1988, BEHAV THER, V19, P385, DOI 10.1016/S0005-7894(88)80011-X; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Soo C, 2007, COCHRANE DB SYST REV, V3; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; *VA CONS C, 2010, PRACT REC TREATM VET; *VADOD EV BAS GUID, EV MAN CONCUSSIONMTB; van Tulder MW, 2000, SPINE, V25, P2688, DOI 10.1097/00007632-200010150-00024; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; *VHA HDB 1160 01, 2008, UN MENT HLTH SERV VA; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1016/S1525-8610(04)70258-3; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wong D., 1998, PEDIAT NURS, V14, P9; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	78	53	53	0	13	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583	1573-3572		J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	JUN	2011	18	2					145	154		10.1007/s10880-011-9239-2			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	775SQ	WOS:000291484100005	21626354				2022-02-06	
J	de Witt, BW; Ehrenberg, KM; McAloon, RL; Panos, AH; Shaw, KE; Raghavan, PV; Skidmore, ER; Kline, AE				de Witt, Benjamin Wells; Ehrenberg, Kathryn M.; McAloon, Rose L.; Panos, Amanda H.; Shaw, Kaitlyn E.; Raghavan, Priya V.; Skidmore, Elizabeth R.; Kline, Anthony E.			Abbreviated Environmental Enrichment Enhances Neurobehavioral Recovery Comparably to Continuous Exposure After Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						controlled cortical impact; environmental enrichment; functional recovery; galantamine; learning and memory; Morris water maze	RECEPTOR AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; CONTROLLED CORTICAL IMPACT; 5-HT1A RECEPTOR; COGNITIVE DEFICITS; POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; VOLUNTARY EXERCISE; TREATMENT REGIMEN; UNITED-STATES; GROWTH	Background. Environmental enrichment (EE) is a complex living milieu that has been shown to enhance functional recovery versus standard (STD) housing after experimental traumatic brain injury (TBI) and therefore may be considered a rodent correlate of rehabilitation. However, the typical EE paradigm consists of continuous exposure to enrichment after TBI, which is inconsistent with the limited time frame in clinical rehabilitation. Objective. To determine whether abbreviated EE (ie, rehabilitation-relevant dose response) confers benefits similar to typical EE after TBI. Methods. Adult male rats received either a controlled cortical impact (2.8 mm depth at 4 m/s) or sham injury and were then randomly assigned to TBI + EE, TBI + EE (2 hours), TBI + EE (4 hours), TBI + EE (6 hours), TBI + STD, and respective sham controls. Motor (beam balance/beam walk) and cognitive (Morris water maze) performance was assessed on postoperative days 1 to 5 and 14 to 19, respectively. Results. The TBI + EE (2 hours) and TBI + EE (4 hours) groups were not statistically different from the TBI + STD group in any behavioral assessment. In contrast, the TBI + EE (6 hours) group exhibited significant enhancement of motor and cognitive performance when compared with the TBI + STD group, as well as the TBI + EE (2 hours) and TBI + EE (4 hours) groups (P < .003), and did not differ from the TBI + EE (typical) group. Conclusions. These data demonstrate that abbreviated EE (6 hours) produces motor and cognitive benefits similar to continuous EE after TBI and thus may be considered a dose-relevant rehabilitation paradigm.	[de Witt, Benjamin Wells; Ehrenberg, Kathryn M.; McAloon, Rose L.; Panos, Amanda H.; Shaw, Kaitlyn E.; Raghavan, Priya V.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD046700, NS060005, K12 HD055931]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931, R01HD069620] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD046700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: This work was supported, in part, by National Institutes of Health grants HD046700 and NS060005 awarded to AEK and K12 HD055931 (ERS).	BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; National Research Council, 1996, GUID CAR US LAB AN; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Parton A, 2005, CURR OPIN NEUROL, V18, P675, DOI 10.1097/01.wco.0000189872.54245.13; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; WILL BE, 1977, J COMP PHYSIOL PSYCH, V91, P33, DOI 10.1037/h0077306; Wilson MS, 2002, AM J PHYS MED REHAB, V81, P364, DOI 10.1097/00002060-200205000-00009; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	50	53	53	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2011	25	4					343	350		10.1177/1545968310390520			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	742KJ	WOS:000288940900005	21186330	Green Accepted			2022-02-06	
J	Fraser, DD; Close, TE; Rose, KL; Ward, R; Mehl, M; Farrell, C; Lacroix, J; Creery, D; Kesselman, M; Stanimirovic, D; Hutchison, JS				Fraser, Douglas D.; Close, Taylor E.; Rose, Keeley L.; Ward, Roxanne; Mehl, Martin; Farrell, Catherine; Lacroix, Jacques; Creery, David; Kesselman, Murray; Stanimirovic, Danica; Hutchison, James S.		Canadian Critical Care Translati	Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; glial fibrillary acidic protein; biomarker; cerebrospinal fluid; serum; therapeutic hypothermia	MODERATE HYPOTHERMIA; SENSITIVE ELISA; HEAD-INJURY; S100B; CSF; GFAP; BIOMARKER; DISEASE; MARKERS; DAMAGE	Objectives: 1) To determine the levels of glial fibrillary acidic protein (GFAP) in both cerebrospinal fluid and serum; 2) to determine whether serum GFAP levels correlate with functional outcome; and 3) to determine whether therapeutic hypothermia, as compared with normothermia, alters serum GFAP levels in children with severe traumatic brain injury (TBI). Design: Laboratory-based analyses; postrandomized, controlled trial. Setting: Four Canadian pediatric intensive care units and a university-affiliated laboratory. Patients: Twenty-seven children, aged 2-17 yrs, with severe TBI (Glasgow Coma Scale score of <= 8). Interventions: Hypothermia therapy (32.5 degrees C) for 24 hrs with cooling started within 8 hrs of injury and rewarming at a rate of 0.5 degrees C every 2 hrs or normothermia (37.0 degrees C). Measurements and Main Results: GFAP was measured in cerebrospinal fluid and serum, using enzyme-linked immunosorbent assay. Levels of GFAP were maximal on day 1 post-TBI, with cerebrospinal fluid GFAP (15.5 +/- 6.1 ng/mL) 25-fold higher than serum GFAP (0.6 +/- 0.2 ng/mL). Cerebro-spinal fluid GFAP normalized by day 7, whereas serum GFAP decreased gradually to reach a steady state by day 10. Serum GFAP measured on day 1 correlated with Pediatric Cerebral Performance Category scores determined at 6 months post-TBI rho = 0.527; p = .008) but failed to correlate with the injury scoring on admission, physiologic variables, or indices of injury measured on computerized tomography imaging. The areas under the receiver operating characteristic curves for pediatric intensive care unit day 1 serum GFAP in determining good outcome were 0.80 (pediatric cerebral performance category, 1-2; normal-mild disability) and 0.91 (pediatric cerebral performance category, 1-3; normal-moderate disability). For a serum GFAP cutoff level of 0.6 ng/mL, sensitivity and specificity were 88% to 90% and 43% to 71%, respectively. Serum GFAP levels were similar among children randomized to either therapeutic hypothermia or normothermia. Conclusions: GFAP was markedly elevated in cerebrospinal fluid and serum in children after severe TBI and serum GFAP measured on pediatric intensive care unit day 1 correlated with functional outcome at 6 months. Hypothermia therapy did not alter serum GFAP levels compared with normothermia after severe TBI in children. Serum GFAP concentration, together with other biomarkers, may have prognostic value after TBI in children. (Pediatr Crit Care Med 2011; 12:319-324)	[Fraser, Douglas D.] Univ Western Ontario, Dept Pediat, Div Crit Care Med, London, ON N6A 3K7, Canada; [Fraser, Douglas D.; Close, Taylor E.; Rose, Keeley L.] Univ Western Ontario, Dept Physiol, London, ON, Canada; [Fraser, Douglas D.; Close, Taylor E.; Rose, Keeley L.] Univ Western Ontario, Dept Pharmacol, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Fraser, Douglas D.; Close, Taylor E.; Rose, Keeley L.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Ctr Crit Illness Res, London, ON, Canada; [Ward, Roxanne] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Mehl, Martin] R Biopharm AG, Darmstadt, Germany; [Farrell, Catherine; Lacroix, Jacques] St Justine Hosp, Div Intens Care, Dept Pediat, Montreal, PQ, Canada; [Creery, David] Childrens Hosp Eastern Ontario, Dept Pediat, Div Intens Care, Ottawa, ON K1H 8L1, Canada; [Kesselman, Murray] Childrens Hosp, Div Intens Care, Dept Pediat, Winnipeg, MB R3A 1S1, Canada; [Stanimirovic, Danica] CNR, Inst Biol Sci, Ottawa, ON, Canada; [Hutchison, James S.] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Hutchison, James S.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Hutchison, James S.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Res Program, Toronto, ON M5G 1X8, Canada; [Hutchison, James S.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada		Fraser, DD (corresponding author), Univ Western Ontario, Dept Pediat, Div Crit Care Med, London, ON N6A 3K7, Canada.	douglas.fraser@lhsc.on.ca			Children's Health Research Institute; Centre for Critical Illness Research; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MCT50398]; Canadian Diabetic Association; National Research Council of Canada Genomics and Health Initiative; Ontario Neurotrauma Foundation [ONBO-00009, ONRO-41]; Rick Hansen Institute [XG 99-057]; Hospital for Sick Children Foundation; Physicians Services Incorporated [98-62]; Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec [004095-104]; Children's Hospital of Eastern Ontario Research Institute [98/16S[E]]	Douglas D. Fraser was supported, in part, by the Children's Health Research Institute and the Centre for Critical Illness Research. He is a Canadian Institutes of Health Research Strategic Training Fellow in the Canadian Child Health Clinician Scientist Program. Taylor E. Close was supported, in part, by a Canadian Institutes of Health Research Doctoral Scholarship. Keeley L. Rose was supported, in part, by a Canadian Diabetic Association Doctoral Scholarship. The remaining authors have not disclosed any potential conflicts of interest. The biomarker research program within HyP-HIT was supported, in part, by a National Research Council of Canada Genomics and Health Initiative funding (D.S.).; The Hypothermia Pediatric Head Injury Trial (HyP-HIT) was supported by grant MCT50398 from the Canadian Institutes of Health Research (Canadian Neurotrauma Research Program), grants ONBO-00009 and ONRO-41 from the Ontario Neurotrauma Foundation, grant XG 99-057 from the Rick Hansen Institute, the Hospital for Sick Children Foundation, grant 98-62 from Physicians Services Incorporated, grant 004095-104 from Fonds de la Recherche en Sante du Quebec, and grant 98/16S[E] from Children's Hospital of Eastern Ontario Research Institute.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Bishop Naomi B, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P318, DOI 10.1016/j.cppeds.2006.05.004; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CROLS R, 1986, J NEUROL, V233, P157, DOI 10.1007/BF00314423; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hsu AA, 2008, PEDIATR CRIT CARE ME, V9, P245, DOI 10.1097/PCC.0b013e3181727b22; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; MARTIN PM, 1995, J NEUROSCI METH, V58, P181, DOI 10.1016/0165-0270(94)00175-G; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Missler U, 1999, CLIN CHEM, V45, P138; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; NOPPE M, 1986, CLIN CHIM ACTA, V155, P143, DOI 10.1016/0009-8981(86)90275-5; Notturno F, 2009, MUSCLE NERVE, V40, P50, DOI 10.1002/mus.21323; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; ROSENGREN LE, 1992, J NEUROSCI METH, V44, P113, DOI 10.1016/0165-0270(92)90004-W; Shafi NI, 2006, PEDIATR CRIT CARE ME, V7, P468, DOI 10.1097/01.PCC.0000235258.79253.8C; SIMPSON D, 1982, LANCET, V2, P450; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4	39	53	54	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2011	12	3					319	324		10.1097/PCC.0b013e3181e8b32d			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	759MB	WOS:000290248500022	20625342				2022-02-06	
J	Schofield, P; Butler, T; Hollis, S; D'Este, C				Schofield, Peter; Butler, Tony; Hollis, Stephanie; D'Este, Catherine			Are prisoners reliable survey respondents? A validation of self-reported traumatic brain injury (TBI) against hospital medical records	BRAIN INJURY			English	Article						Traumatic brain injury; prisoners; validation; medical records	DRUG-USE; HAIR ANALYSIS; HEAD-INJURY; ALCOHOL-USE; VALIDITY; RELIABILITY; AGREEMENT; SAMPLE; USERS; MEN	Aims: To compare prisoners' self-reported history of TBI associated with hospital attendance with details extracted from relevant hospital medical records and to identify factors associated with the level of agreement between the two sources. Methods: From a sample of prison entrants, this study obtained a history of TBIs for which medical attention was sought at a hospital. Audit tools were developed for data extraction relevant to any possible TBI from records at a total of 23 hospitals located within New South Wales, Australia. The level of agreement between self-report and hospital records was compared in relation to demographic, psychological and criminographic characteristics. Results: Of the 200 participants in the study, 164 (82%) reported having sustained a past TBI giving a total of 420 separate TBI incidents. Of these, 156 (37%) were alleged to have resulted in attendance at a hospital emergency department including 112 (72%) at a hospital accessible for the validation exercise. For 93/112 (83%) of reported TBIs, a corresponding hospital medical record was located of which 78/112 (70%) supported the occurrence of a TBI. Lower education and a lifetime history of more than seven TBIs were associated with less agreement between self-report and medical record data with regard to specific details of the TBI. Conclusions: Overall, these findings suggest that prisoners' self-report of TBI is generally accurate when compared with the 'gold standard' of hospital medical record. This finding is contrary to the perception of this group as 'dishonest' and 'unreliable'.	[Schofield, Peter] Hunter New England Hlth, Neuropsychiat Serv, Newcastle, NSW 2300, Australia; [Schofield, Peter] Univ Newcastle, Ctr Brain & Mental Hlth Res, Callaghan, NSW 2308, Australia; [Butler, Tony] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia; [Hollis, Stephanie; D'Este, Catherine] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia		Schofield, P (corresponding author), Hunter New England Hlth, Neuropsychiat Serv, POB 833, Newcastle, NSW 2300, Australia.	peter.schofield@hnehealth.nsw.gov.au	Hollis, Stephanie J/B-5977-2011; Butler, Tony/F-4614-2012; D'ESTE, CATHERINE ANNE/G-7392-2013; Schofield, Peter/J-7133-2013	Butler, Tony/0000-0002-2679-2769; Schofield, Peter/0000-0001-8298-8590			Aitken JF, 2004, AM J EPIDEMIOL, V159, P1098, DOI 10.1093/aje/kwh143; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Butler T, 1999, AUST NZ J PUBL HEAL, V23, P377, DOI 10.1111/j.1467-842X.1999.tb01278.x; Butler T, 2000, INT J STD AIDS, V11, P743, DOI 10.1258/0956462001915174; BUTLER T, 2003, 2001 INMATE HLTH SUR; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Caplan LS, 2003, CANCER EPIDEM BIOMAR, V12, P1182; CARLSSON GS, 1983, J NEUROL NEUROSUR PS, V46, P818, DOI 10.1136/jnnp.46.9.818; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; de Boer EJ, 2005, AM J EPIDEMIOL, V161, P978, DOI 10.1093/aje/kwi120; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Fishbain DA, 1999, CLIN J PAIN, V15, P184, DOI 10.1097/00002508-199909000-00005; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GRONWALL D, 1975, LANCET, V2, P995; Harrison L, 1997, NIDA Res Monogr, V167, P17; HORWITZ RI, 1984, J CHRON DIS, V37, P825, DOI 10.1016/0021-9681(84)90015-8; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; Ivers RQ, 2002, J CLIN EPIDEMIOL, V55, P452, DOI 10.1016/S0895-4356(01)00518-2; KESSLER RC, 1991, PSYCHOL MED, V21, P723, DOI 10.1017/S0033291700022364; Klabunde CN, 2005, MED CARE, V43, P391, DOI 10.1097/01.mlr.0000156851.80900.d1; Langenbucher J, 2001, EVALUATION REV, V25, P184, DOI 10.1177/0193841X0102500204; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Louie AD, 2000, BONE MARROW TRANSPL, V25, P1191, DOI 10.1038/sj.bmt.1702419; Lu NT, 2001, AM J DRUG ALCOHOL AB, V27, P399, DOI 10.1081/ADA-100104509; Magura S, 1996, SUBST USE MISUSE, V31, P1131, DOI 10.3109/10826089609063969; MCKENNA MT, 1992, AM J PREV MED, V8, P287, DOI 10.1016/S0749-3797(18)30793-1; Mieczkowski T, 1998, SUBST USE MISUSE, V33, P1547, DOI 10.3109/10826089809069812; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shearer J, 2006, DRUG ALCOHOL REV, V25, P425, DOI 10.1080/09595230600868512; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; [No title captured]	41	53	53	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2011	25	1					74	82		10.3109/02699052.2010.531690			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700009	21117913				2022-02-06	
J	Rangel-Castilla, L; Lara, LR; Gopinath, S; Swank, PR; Valadka, A; Robertson, C				Rangel-Castilla, Leonardo; Lara, Lucia Rivera; Gopinath, Shankar; Swank, Paul R.; Valadka, Alex; Robertson, Claudia			Cerebral Hemodynamic Effects of Acute Hyperoxia and Hyperventilation after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; hyperoxia; hyperventilation; traumatic brain injury	SEVERE HEAD-INJURY; BLOOD-FLOW VELOCITY; CEREBROVASCULAR CO2 REACTIVITY; TISSUE OXYGEN-TENSION; TRANSCRANIAL DOPPLER; AUTOREGULATION; PRESSURE; METABOLISM; HUMANS; INHALATION	The purpose of this study was to examine the effects of hyperventilation or hyperoxia on cerebral hemodynamic parameters over time in patients with severe traumatic brain injury (TBI). We prospectively studied 186 patients with severe TBI. CO2 and O-2 reactivity tests were conducted twice a day on days 1-5 and once daily on days 6-10 after injury. During hyperventilation there was a significant decrease in intracranial pressure (ICP), mean arterial pressure (MAP), jugular venous oxygen saturation (Sjvo(2)), brain tissue Po-2 (Pbto(2)), and flow velocity (FV). During hyperoxia there was an increase in Sjvo(2) and Pbto(2), and a small but consistent decrease in ICP, end-tidal carbon dioxide (ETCO2), partial arterial carbon dioxide pressure (Paco(2)), and FV. Brain tissue oxygen reactivity during the first 12 h after injury averaged 19.7 +/- 3.0%, and slowly decreased over the next 7 days. The autoregulatory index (ARI; normal = 5.3 +/- 1.3) averaged 2.2 +/- 1.5 on day 1 post-injury, and gradually improved over the 10 days of monitoring. The ARI significantly improved during hyperoxia, by an average of 0.4 +/- 1.8 on the left, and by 0.5 +/- 1.8 on the right. However, the change in ARI with hyperoxia was much smaller than that observed with hyperventilation. Hyperventilation increased ARI by an average of 1.3 +/- 1.9 on the left, and 1.5 +/- 2.0 on the right. Pressure autoregulation, as assessed by dynamic testing, was impaired in these head-injured patients. Acute hyperoxia significantly improved pressure autoregulation, although the effect was smaller than that induced by hyperventilation. The very small change in Paco(2) induced by hyperoxia does not appear to explain this finding. Rather, the vasoconstriction induced by acute hyperoxia may allow the cerebral vessels to respond better to transient hypotension. Further studies are needed to define the clinical significance of these observations.	[Lara, Lucia Rivera; Gopinath, Shankar; Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Rangel-Castilla, Leonardo] Methodist Hosp, Methodist Neurol Inst, Dept Neurosurg, Houston, TX 77030 USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Houston, TX USA; [Valadka, Alex] Seton Brain & Spine Inst, Austin, TX USA		Robertson, C (corresponding author), Baylor Coll Med, Dept Neurosurg, 1709 Dryden,Suite 750,MS BCM650, Houston, TX 77030 USA.	Claudiar@Bcm.Tmc.Edu	Rivera-Lara, Lucia/AAX-8233-2020	Rivera-Lara, Lucia/0000-0002-9053-2283	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-NS38660]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health grant P01-NS38660.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; AMANO T, 1983, ARCH NEUROL-CHICAGO, V40, P277, DOI 10.1001/archneur.1983.04050050045005; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Djurberg HG, 1998, J CLIN ANESTH, V10, P646, DOI 10.1016/S0952-8180(98)00107-X; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; Kastrup A, 1998, STROKE, V29, P1311, DOI 10.1161/01.STR.29.7.1311; Kawamura Shingo, 1996, Neurologia Medico-Chirurgica, V36, P156, DOI 10.2176/nmc.36.156; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Longhi L, 2002, ACT NEUR S, V81, P315; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCulloch TJ, 2005, ANESTH ANALG, V100, P1463, DOI 10.1213/01.ANE.0000148623.06596.7E; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; NAKAJIMA S, 1983, ARCH NEUROL-CHICAGO, V40, P271, DOI 10.1001/archneur.1983.04050050039004; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; Nishimura N, 2007, AVIAT SPACE ENVIR MD, V78, P1121, DOI 10.3357/ASEM.2177.2007; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Omae T, 1998, STROKE, V29, P94, DOI 10.1161/01.STR.29.1.94; Rangel-Castillo L, 2006, CRIT CARE CLIN, V22, P713, DOI 10.1016/j.ccc.2006.06.003; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; SCHULTHEISS R, 1987, ANGIOLOGY, V38, P221, DOI 10.1177/000331978703800303; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x	36	53	53	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2010	27	10					1853	1863		10.1089/neu.2010.1339			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	665OZ	WOS:000283046600009	20684672	Green Published			2022-02-06	
J	Wagner, AK; Miller, MA; Scanlon, J; Ren, DX; Kochanek, PM; Conley, YP				Wagner, Amy K.; Miller, Megan A.; Scanlon, Joelle; Ren, Dianxu; Kochanek, Patrick M.; Conley, Yvette P.			Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI	EPILEPSY RESEARCH			English	Article						A1AR; Adenosine; ADORA1; Brain injury; Genetic susceptibility; Post-traumatic seizure	TRAUMATIC BRAIN-INJURY; STATUS EPILEPTICUS; RAT HIPPOCAMPUS; RISK-FACTORS; ADENOSINE; EPILEPSY; RECEPTORS; PHENYTOIN; MULTICENTER; INCREASE	Post-traumatic seizures (PTS) are a significant complication from traumatic brain injury (TBI). Adenosine, a major neuroprotective and neuroinhibitory molecule, is important in experimental epilepsy models. Thus, we investigated the adenosine A1 receptor (A1AR) gene and linked it with clinical data extracted for 206 subjects with severe TBI. Tagging SNPs rs3766553, rs903361, rs10920573, rs6701725, and rs17511192 were genotyped, and variant and haplotype associations with PTS were explored. We investigated further genotype, grouped genotype, and allelic associations with PTS for rs3766553 and rs10920573. Multivariate analysis of rs3766553 demonstrated an association between the AA genotype and increased early PTS incidence. In contrast, the GG genotype was associated with increased late and delayed-onset PTS rates. Multivariate analysis of rs10920573 revealed an association between the CT genotype and increased late PTS. Multiple risk genotype analysis showed subjects with both risk genotypes had a 46.7% chance of late PTS. To our knowledge, this is the first report implicating genetic variability in the A1AR with PTS, or any type of seizure disorder. These results provide a rationale for further studies investigating how adenosine neurotransmission impacts PTS, evaluating anticonvulsants in preventing and treating PTS, and developing and testing targeted adenosinergic therapies aimed at reducing PTS. (C) 2010 Elsevier B.V. All rights reserved.	[Wagner, Amy K.; Miller, Megan A.; Scanlon, Joelle] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, Amy K.; Kochanek, Patrick M.; Conley, Yvette P.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Ren, Dianxu; Conley, Yvette P.] Univ Pittsburgh, Dept Hlth Promot & Dev, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu; millerm8@upmc.edu; scanjm2@upmc.edu; dir8@pitt.edu; kochanekpm@ccm.upmc.edu; yconley@pitt.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048162, R01NR008424, 5P01NS030318-16, NIHR01NS38087]; DODUnited States Department of Defense [W81XWH-07-1-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, R01NS038087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors wish to thank Sandra Des touches for her genotyping efforts, Candace Kammerer, PhD for haplotype consultation, and the subjects and their families for their generous participation. This work was supported by NIH R01HD048162 and DOD W81XWH-07-1-0701 to AKW, NIH R01NR008424 and DOD W81XWH-07-1-0701 to YPC, and NIH 5P01NS030318-16 and NIHR01NS38087 to PMK.	ANDINE P, 1990, BRIT J PHARMACOL, V100, P814, DOI 10.1111/j.1476-5381.1990.tb14097.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Avsar E, 2004, NEUROPHARMACOLOGY, V47, P427, DOI 10.1016/j.neuropharm.2004.04.015; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cavalleri GL, 2007, EPILEPSIA, V48, P706, DOI 10.1111/j.1528-1167.2007.00977.x; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DECKERT J, 1988, BRAIN RES, V446, P161, DOI 10.1016/0006-8993(88)91308-X; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fedele DE, 2005, BRAIN, V128, P2383, DOI 10.1093/brain/awh555; Fedele DE, 2006, EXP NEUROL, V200, P184, DOI 10.1016/j.expneurol.2006.02.133; Franco R, 2000, NEUROPSYCHOPHARMACOL, V23, pS50, DOI 10.1016/S0893-133X(00)00144-5; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hernandez-Saavedra D, 2009, CELL BIOCHEM FUNCT, V27, P223, DOI 10.1002/cbf.1560; Herzog AG, 2008, SEIZURE-EUR J EPILEP, V17, P151, DOI 10.1016/j.seizure.2007.11.014; Hung CC, 2005, PHARMACOGENOMICS, V6, P411, DOI 10.1517/14622416.6.4.411; JENNETT B, 1975, LANCET, V1, P480; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Olah ME, 2000, PHARMACOL THERAPEUT, V85, P55, DOI 10.1016/S0163-7258(99)00051-0; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P320, DOI 10.1016/j.yebeh.2005.02.006; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; Rosen N, 2003, BIOINFORMATICS, V19, pi222, DOI 10.1093/bioinformatics/btg1030; RUDOLPHI KA, 1992, CEREBROVAS BRAIN MET, V4, P346; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Temkin Nancy R., 2002, Epilepsy Curr, V2, P105, DOI 10.1046/j.1535-7597.2002.00038.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VAUGHAN KT, 1993, GENOMICS, V16, P34, DOI 10.1006/geno.1993.1136; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC	42	53	57	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	AUG	2010	90	3					259	272		10.1016/j.eplepsyres.2010.06.001			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	638IB	WOS:000280885900012	20609566	Green Accepted, Green Published			2022-02-06	
J	Leventhal, JM; Martin, KD; Asnes, AG				Leventhal, John M.; Martin, Kimberly D.; Asnes, Andrea G.			Fractures and Traumatic Brain Injuries: Abuse Versus Accidents in a US Database of Hospitalized Children	PEDIATRICS			English	Article						accidents; injury; maltreatment	YOUNG-CHILDREN	OBJECTIVE: The goal was to use a national database to determine the incidence of abusive traumatic brain injuries (TBIs) and/or fractures and the frequency of abuse versus accidents among children <36 months of age. METHODS: We used the 2006 Kids' Inpatient Database and classified cases into 3 types of injuries, that is, (1) TBI only, (2) TBI and fracture, or (3) fracture only. Groups 2 and 3 were divided into 3 patterns, that is, (1) skull fractures, (2) skull and nonskull fractures, or (3) nonskull fractures. For each type and pattern, we compared abuse, accidental falls, other accidents, and motor vehicle accidents. RESULTS: The incidence of TBIs and/or fractures attributable to abuse was 21.9 cases per 100 000 children <36 months of age and 50.0 cases per 100 000 children <12 months of age. In the abuse group, 29.9% of children had TBIs only, 28.3% TBIs and fractures, and 41.8% fractures only. Abused children were younger and were more likely to be enrolled in Medicaid. For TBI only, falls were more common than abuse in the first 2 months of life but abuse was more common from 2 to 7 months. For TBI and skull fracture, falls were more common during the first year of life. For skull fracture only, almost all injuries were attributable to falls. CONCLUSIONS: There was overlap in TBIs and fractures attributable to abuse. Among <12-month-old children, TBIs and/or fractures attributable to abuse occurred in 1 of 2000. Falls occurred more commonly than abuse, even among very young children. Pediatrics 2010; 126: e104-e115	[Leventhal, John M.; Asnes, Andrea G.] Yale Univ, Dept Pediat, Sch Med, New Haven, CT 06520 USA; [Martin, Kimberly D.] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Med, New Haven, CT 06520 USA		Leventhal, JM (corresponding author), Yale Univ, Dept Pediat, Sch Med, POB 208064,333 Cedar St, New Haven, CT 06520 USA.	john.leventhal@yale.edu			Department of Pediatrics, School of Medicine, Yale University	Funding was provided by the Child Abuse Funds, Department of Pediatrics, School of Medicine, Yale University.	*AG HEALTHC RES QU, AG HEALTHC RES QUAL; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Berger LM, 2005, CHILD ABUSE NEGLECT, V29, P107, DOI 10.1016/j.chiabu.2004.02.006; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KING J, 1988, J PEDIATR ORTHOPED, V8, P585; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Leventhal JM, 2005, CHILD ABUSE NEGLECT, V29, P209, DOI 10.1016/j.chiabu.2005.02.008; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; National Center for Health Statistics Centers for Medicare and Medicaid Services, 1999, INT CLASS DIS 9 REV; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; *US BUR CENS, POP EST; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467	21	53	53	0	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL	2010	126	1					E104	E115		10.1542/peds.2009-1076			12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	619LF	WOS:000279431000037	20530077				2022-02-06	
J	Hanly, JG; Omisade, A; Su, L; Farewell, V; Fisk, JD				Hanly, John G.; Omisade, Antonina; Su, Li; Farewell, Vernon; Fisk, John D.			Assessment of Cognitive Function in Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Multiple Sclerosis by Computerized Neuropsychological Tests	ARTHRITIS AND RHEUMATISM			English	Article							TRAUMATIC BRAIN-INJURY; ASSESSMENT METRICS; NEUROPSYCHIATRIC EVENTS; INITIAL VALIDATION; DYSFUNCTION; IMPAIRMENT; PERFORMANCE; PREVALENCE; CRITERIA; INDEX	Objective. Computerized neuropsychological testing may facilitate screening for cognitive impairment in systemic lupus erythematosus (SLE). This study was undertaken to compare patients with SLE, patients with rheumatoid arthritis (RA), and patients with multiple sclerosis (MS) with healthy controls using the Automated Neuropsychological Assessment Metrics (ANAM). Methods. Patients with SLE (n = 68), RA (n = 33), and MS (n = 20) were compared with healthy controls (n = 29). Efficiency of cognitive performance on 8 ANAM subtests was examined using throughput (TP), inverse efficiency (IE), and adjusted IE scores. The latter is more sensitive to higher cognitive functions because it adjusts for the impact of simple reaction time on performance. The results were analyzed using O'Brien's generalized least squares test. Results. Control subjects were the most efficient in cognitive performance. MS patients were least efficient overall (as assessed by TP and IE scores) and were less efficient than both SLE patients (P = 0.01) and RA patients (P < 0.01), who did not differ. Adjusted IE scores were similar between SLE patients, RA patients, and controls, reflecting the impact of simple reaction time on cognitive performance. Thus, 50% of SLE patients, 61% of RA patients, and 75% of MS patients had impaired performance on >= 1 ANAM subtest. Only 9% of RA patients and 11% of SLE patients had impaired performance on >= 4 subtests, whereas this was true for 20% of MS patients. Conclusion. ANAM is sensitive to cognitive impairment. While such computerized testing may be a valuable screening tool, our results emphasize the lack of specificity of slowed performance as a reliable indicator of impairment of higher cognitive function in SLE patients.	[Hanly, John G.; Omisade, Antonina; Fisk, John D.] Dalhousie Univ, Halifax, NS, Canada; [Su, Li; Farewell, Vernon] Univ Cambridge, Cambridge, England; [Su, Li; Farewell, Vernon] Inst Publ Hlth, Cambridge, England		Hanly, JG (corresponding author), Nova Scotia Rehabil Ctr, Div Rheumatol, 2nd Floor,1341 Summer St, Halifax, NS B3H 4K4, Canada.	john.hanly@cdha.nshealth.ca	Fisk, John D/N-7796-2015	Fisk, John D/0000-0003-3512-8015; Farewell, Vernon/0000-0001-6704-5295; Su, Li/0000-0003-0919-3462	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-57752]; Capital Health Research Fund, Canada; Multiple Sclerosis Society of Canada; Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [U.1052.00.009]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105261167] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U105261167] Funding Source: researchfish	Dr. Hanly's work was supported by the Canadian Institutes of Health Research (grant MOP-57752) and the Capital Health Research Fund, Canada. Dr. Omisade is recipient of a Multiple Sclerosis Society of Canada research studentship. Drs. Su and Farewell's work was supported by the Medical Research Council, UK (grant U.1052.00.009). Dr. Fisk's work was supported by the Multiple Sclerosis Society of Canada and the Capital Health Research Fund, Canada (pilot grant).	Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Brunner HI, 2007, ARTHRIT RHEUM-ARTHR, V57, P1174, DOI 10.1002/art.23005; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; Carlomagno S, 2000, J NEUROL, V247, P273, DOI 10.1007/s004150050583; CHRISTIE J, 1995, MEM COGNITION, V23, P547, DOI 10.3758/BF03197256; Correa Denise D, 2007, Curr Opin Support Palliat Care, V1, P57, DOI 10.1097/SPC.0b013e32813a328f; Dallow NS, 2008, PHARM STAT, V7, P53, DOI 10.1002/pst.268; Denburg SD, 2003, LUPUS, V12, P883, DOI 10.1191/0961203303lu497oa; GINSBURG KS, 1992, ARTHRITIS RHEUM, V35, P776, DOI 10.1002/art.1780350711; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hanly JG, 2007, ARTHRITIS RHEUM-US, V56, P265, DOI 10.1002/art.22305; Hanly JG, 2005, BEST PRACT RES CL RH, V19, P799, DOI 10.1016/j.berh.2005.04.003; HANLY JG, 1992, J RHEUMATOL, V19, P562; Hanly JG, 1997, ANN NY ACAD SCI, V823, P60, DOI 10.1111/j.1749-6632.1997.tb48379.x; Hanly JG, 1997, ARTHRITIS RHEUM, V40, P1542, DOI 10.1002/art.1780400825; Hanly JG, 2009, J RHEUMATOL, V36, P1449, DOI 10.3899/jrheum.081133; HAY EM, 1994, ANN RHEUM DIS, V53, P298, DOI 10.1136/ard.53.5.298; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lofstad GE, 2009, ACTA PAEDIATR, V98, P180, DOI 10.1111/j.1651-2227.2008.01055.x; McLaurin EY, 2005, NEUROLOGY, V64, P297, DOI 10.1212/01.WNL.0000149640.78684.EA; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Petri M, 2008, J RHEUMATOL, V35, P1776; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Reeves D, 1996, NCRFSR9601; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Townsend J.T., 1983, STOCHASTIC MODELING; Waterloo K, 2002, RHEUMATOLOGY, V41, P411, DOI 10.1093/rheumatology/41.4.411; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	53	56	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-3591	1529-0131		ARTHRITIS RHEUM-US	Arthritis Rheum.	MAY	2010	62	5					1478	1486		10.1002/art.27404			9	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rheumatology	619LT	WOS:000279432400032	20155829	Green Accepted, Bronze			2022-02-06	
J	Rueda, MAF; Halley, WL; Gilchrist, MD				Rueda, Manuel A. Forero; Halley, Walter L.; Gilchrist, Michael D.			Fall and injury incidence rates of jockeys while racing in Ireland, France and Britain	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Jockey; Horse racing; Equestrian; Head injury; Concussion	TRAUMATIC BRAIN-INJURY; HORSE-RELATED INJURIES; GREAT-BRITAIN; HEAD; RECONSTRUCTION; SEVERITY; CHILDREN; HELMETS; IMPACTS; SPORT	This article presents and analyses injury incidence rates for amateur and professional racing jockeys in Ireland, France and Britain by means of a retrospective study and review of published data. Amateur jump racing was seen to have the highest fall risk in these three countries (between 115 and 140 falls/1000 rides). Jump racing also had the highest rates of injury/ride amongst both amateur and professional jockeys. Flat racing, however, had the highest rates of injuries/fall (34-44%). Of all the injuries in both jump and flat racing populations of amateur and professional jockeys, 15% were concussive head injuries, and more than half of these involved loss of consciousness. Professional jump jockeys in Ireland fell less frequently than those in France or Britain. Their injury/fall rate and injury/ride rate were highest in Britain. Professional flat racing jockeys in France had the lowest rates of injuries/fall and injuries/ride, while those in Ireland had the highest. (C) 2009 Elsevier Ltd. All rights reserved.	[Rueda, Manuel A. Forero; Gilchrist, Michael D.] Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X	Turf Club	Financial support in the form of a PhD stipend was provided to MAFR by the Turf Club during the course of this research. Dr. Benoit LeMasson of France Galop kindly provided the authors with French jockey injury data. The assistance of Mr. Peter T. O'Neill of the UCD School of Electrical, Electronic & Mechanical Engineering with the R statistical analysis software is gratefully acknowledged.	Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; Balendra G, 2007, BRIT J SPORT MED, V41, P162, DOI 10.1136/bjsm.2006.033894; BROOKS WH, 1988, PHYSICIAN SPORTSMED, V16, P84, DOI 10.1080/00913847.1988.11709646; Chapman M A, 1991, Br J Sports Med, V25, P121; CONDIE C, 1993, PUBLIC HEALTH REP, V108, P121; CRIPPS RA, 2000, AUSTR INJURY PRE MAY, P24; DABREU F, 1976, LANCET, V7971, P1241; DEBENEDETTE V, 1989, Physician and Sportsmedicine, V17, P251; Dekker R, 2004, DISABIL REHABIL, V26, P91, DOI 10.1080/09638280310001629688; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; FINCH C, 1996, LOCKING STABLE DOOR, P1; Gabbe BJ, 2005, BRIT J SPORT MED, V39, P573, DOI 10.1136/bjsm.2004.015750; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; HARRISON TI, 1996, IRCOBI C DUBL, P49; Holland AJA, 2001, MED J AUSTRALIA, V175, P609, DOI 10.5694/j.1326-5377.2001.tb143746.x; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hunt H., 1989, IRCOBI C STOCKHOLM, P157; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; *IS EN, 1996, 1384 IS EN; LEVY AS, 2000, CNI REV MED J, P11; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; MILLS NJ, 1989, INJURY, V20, P189, DOI 10.1016/0020-1383(89)90108-3; NICHOLL JP, 1990, BRIT MED J, V301, P496, DOI 10.1136/bmj.301.6750.496-b; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Paix BR, 1999, BRIT J SPORT MED, V33, P46, DOI 10.1136/bjsm.33.1.46; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Sahai H., 1996, STAT EPIDEMIOLOGY ME; The Turf Club, 2007, RUL RAC IR NAT HUNT; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	32	53	55	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2010	41	5					533	539		10.1016/j.injury.2009.05.009			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	596QJ	WOS:000277699800020	19524903	Green Submitted			2022-02-06	
J	Glang, A; Koester, MC; Beaver, S; Clay, J; McLaughlin, K				Glang, Ann; Koester, Michael C.; Beaver, Sherry; Clay, Janet; McLaughlin, Karen			Online Training in Sports Concussion for Youth Sports Coaches	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Coach Education; E-Learning; Traumatic Brain Injury	TRAUMATIC BRAIN-INJURY; CONTINUING MEDICAL-EDUCATION; HIGH-SCHOOL; INTERACTIVE MULTIMEDIA; PHYSICAL-ACTIVITY; FOOTBALL PLAYERS; CONTROLLED-TRIAL; HEAD-INJURY; MANAGEMENT; TECHNOLOGY	The purpose of this study was to evaluate ACTive: Athletic Concussion Training using Interactive Video Education, an interactive e-learning program designed to train community coaches of youth ages 10-18 in effective sports concussion prevention and management practices. Seventy-five youth sports coaches from across the country completed the study over the Internet. Results of a randomized control trial demonstrated significant differences between treatment and control participants on measures of: (a) knowledge about sports concussion, management, and prevention; (b) attitudes about the importance of preventing sports concussion; and (c) intention and self-efficacy in sports concussion management and prevention. The results suggest that ACTive is an effective method of training youth sports coaches who are in an important position to reduce risks associated with sports concussion.	[Glang, Ann; Beaver, Sherry; Clay, Janet; McLaughlin, Karen] Oregon Ctr Appl Sci Inc, Eugene, OR 97401 USA; [Koester, Michael C.] Slocum Ctr Orthoped & Sports Med, Eugene, OR 97401 USA		Glang, A (corresponding author), Oregon Ctr Appl Sci Inc, 260 E 11th Ave, Eugene, OR 97401 USA.	aglang@orcasinc.com		Glang, Ann/0000-0002-3057-1977	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43 HD056610, R43 HD056610-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R44HD056610, R43HD056610] Funding Source: NIH RePORTER		AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1973, J PERS SOC PSYCHOL, V27, P41, DOI 10.1037/h0034440; Ajzen I., 1980, UNDERSTANDING ATTITU; *ASTD, 2001, STAT IND REP 2001; BAILEY B, GETTING COMPLETE PIC; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1969, PRINCIPLES BEHAV MOD; Bandura A, 1997, SELFEFFICACY EXERCIS; BECKER MH, 1974, HLTH ED MONOGR, V2, P342; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Casebeer L, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-37; Chambers M, 2002, TELEMED J E-HEALTH, V8, P343, DOI 10.1089/15305620260353234; Cohen J., 1988, STAT POWER BEHAV SCI; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Danaher BG, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e12; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fordis M, 2005, JAMA-J AM MED ASSOC, V294, P1043, DOI 10.1001/jama.294.9.1043; Fotheringham MJ, 2000, AM J PREV MED, V19, P111, DOI 10.1016/S0749-3797(00)00185-9; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Hugenholtz NIR, 2008, OCCUP MED-OXFORD, V58, P370, DOI 10.1093/occmed/kqn053; Irvine AB, 2003, J APPL GERONTOL, V22, P269, DOI 10.1177/0733464803022002006; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kobb R, 2003, TELEMED J E-HEALTH, V9, P189, DOI 10.1089/153056203766437525; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Marcus BH, 2000, AM J PREV MED, V19, P121, DOI 10.1016/S0749-3797(00)00186-0; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McLeod TCV, 2005, J ATHL TRAINING, V40, P123; National Federation of State High School Associations, 2006, PART HIGH SCH SPORTS; Noell J, 1999, AM J PREV MED, V17, P269, DOI 10.1016/S0749-3797(99)00093-8; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OSBORN ZH, 2005, ANN M AM PSYCH ASS W; Patel DR, 2000, MED CLIN N AM, V84, P983, DOI 10.1016/S0025-7125(05)70270-4; Peterson L, 1996, HEALTH PSYCHOL, V15, P124; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Russ-Eft D., 2002, HUMAN RESOURCE DEV R, V1, P45, DOI DOI 10.1177/1534484302011003; Schwebel DC, 2002, J SAFETY RES, V33, P301, DOI 10.1016/S0022-4375(02)00028-2; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; U.S. Department of Health and Human Services, 2006, RES BAS WEB DES US G; Vandelanotte C, 2005, ANN BEHAV MED, V29, P138, DOI 10.1207/s15324796abm2902_8; *WAMMI, 1997, NOM MAN AG; Wiersma LD, 2005, RES Q EXERCISE SPORT, V76, P324; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; [No title captured]	63	53	53	1	31	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.		2010	5	1					1	11		10.1260/1747-9541.5.1.1			11	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	581XM	WOS:000276559100002	20640175	Green Accepted			2022-02-06	
J	Benzinger, TLS; Brody, D; Cardin, S; Curley, KC; Mintun, MA; Mun, SK; Wong, KH; Wrathall, JR				Benzinger, Tammie L. S.; Brody, David; Cardin, Sylvain; Curley, Kenneth C.; Mintun, Mark A.; Mun, Seong K.; Wong, Kenneth H.; Wrathall, Jean R.		Workshop Sci Organizing Team Prese	Blast-Related Brain Injury: Imaging for Clinical and Research Applications: Report of the 2008 St. Louis Workshop	JOURNAL OF NEUROTRAUMA			English	Article						animal models of blast-related injury; blast physics; blast-related traumatic brain injury; brain imaging; post-traumatic stress disorder	MAGNETIC-RESONANCE-SPECTROSCOPY; WHITE-MATTER; HEAD-INJURY; TEMPORAL WINDOW; VULNERABILITY; ASSOCIATION; CONCUSSION; NIGHTMARES; PROTECTION; MORTALITY	Blast-related traumatic brain injury (bTBI) and post-traumatic stress disorder (PTSD) have been of particular relevance to the military and civilian health care sectors since the onset of the Global War on Terror, and TBI has been called the "signature injury'' of this war. Currently there are many questions about the fundamental nature, diagnosis, and long-term consequences of bTBI and its relationship to PTSD. This workshop was organized to consider these questions and focus on how brain imaging techniques may be used to enhance current diagnosis, research, and treatment of bTBI. The general conclusion was that although the study of blast physics in non-biological systems is mature, few data are presently available on key topics such as blast exposure in combat scenarios, the pathological characteristics of human bTBI, and imaging signatures of bTBI. Addressing these gaps is critical to the success of bTBI research. Foremost among our recommendations is that human autopsy and pathoanatomical data from bTBI patients need to be obtained and disseminated to the military and civilian research communities, and advanced neuroimaging used in studies of acute, subacute, and chronic cases, to determine whether there is a distinct pathoanatomical signature that correlates with long-term functional impairment, including PTSD. These data are also critical for the development of animal models to illuminate fundamental mechanisms of bTBI and provide leads for new treatment approaches. Brain imaging will need to play an increasingly important role as gaps in the scientific knowledge of bTBI and PTSD are addressed through increased coordination, cooperation, and data sharing among the academic and military biomedical research communities.	[Wong, Kenneth H.; Wrathall, Jean R.] Georgetown Univ, Med Ctr, Washington, DC 20057 USA; [Benzinger, Tammie L. S.; Brody, David; Mintun, Mark A.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA; [Cardin, Sylvain; Curley, Kenneth C.] USA, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA; [Mun, Seong K.] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Curley, Kenneth C.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Walter Reed Army Inst Res, Silver Spring, MD USA; Naval Med Res Ctr, Silver Spring, MD USA; Univ Texas Galveston, Med Branch, Galveston, TX 77550 USA; Univ Maryland, College Pk, MD 20742 USA; James S McDonnell Fdn, St Louis, MO USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Weill Cornell Med Coll, New York, NY USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Pittsburgh, Pittsburgh, PA USA; St Louis Vet Adm, Med Ctr, St Louis, MO USA; Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA; Univ Illinois, Coll Med, Chicago, IL USA; Def & Vet Brain Injury Ctr, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA USA; Virginia Commonwealth Univ, Richmond, VA USA; Vet Adm Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Washington, Med Ctr, Seattle, WA 98195 USA; Virginia Hosp Ctr, Arlington, VA USA; Dyn FX Consulting Ltd, Toronto, ON, Canada; Univ Penn, Philadelphia, PA 19104 USA; Banyan Biomarkers Inc, Alachua, FL USA; Wayne State Univ, Detroit, MI USA; [Cardin, Sylvain; Curley, Kenneth C.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA		Wrathall, JR (corresponding author), Georgetown Univ, Med Ctr, 3970 Reservoir Rd,NW, Washington, DC 20057 USA.	Wrathali_@georgetown.edu	Benzinger, Tammie/L-6104-2013; Benzinger, Tammie L. S./ABA-8534-2020; Pancrazio, Joseph/M-3206-2015	Benzinger, Tammie L. S./0000-0002-8114-0552; Kochanek, Patrick/0000-0002-2627-913X; Pancrazio, Joseph/0000-0001-8276-3690; CORBETTA, MAURIZIO/0000-0001-8295-3304; Mukherjee, Pratik/0000-0001-7473-7409; Bayly, Philip/0000-0003-4303-0704			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; ASKENASY JJM, 1989, ACTA NEUROL SCAND, V79, P47, DOI 10.1111/j.1600-0404.1989.tb03708.x; Benzinger T., 1950, GERMAN AVIATION MED, V2, P1225; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Cripps NPJ, 1996, J TRAUMA, V40, pS206, DOI 10.1097/00005373-199603001-00045; Culver J, 2008, J NUCL MED, V49, P169, DOI 10.2967/jnumed.107.043331; CURCIO CK, 2002, 00402 CETO MAR CORPS; Daly CM, 2005, MIL MED, V170, P513, DOI 10.7205/MILMED.170.6.513; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DESAGA H, 1943, 15 AER RES I GERM AI; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; DOUKAS AG, 1995, ULTRASOUND MED BIOL, V21, P961, DOI 10.1016/0301-5629(95)00027-O; DRAEGER RH, 1945, 1 NAV MED RES I NAT; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; FINE JE, 1998, ARLTR1690; Garner E, 2000, J BIOMECH ENG-T ASME, V122, P166, DOI 10.1115/1.429638; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kelly B., 1993, P14 LOS AL NAT LAB; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Peles E, 2001, Harefuah, V140, P381; PHILLIPS Y, 1990, TXB MILITARY MED CON, P221; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; RICHMOND DR, 1992, COMPENDIUM BIOL EFFE; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Schwartz I, 2007, ARCH PHYS MED REHAB, V88, P440, DOI 10.1016/j.apmr.2007.01.001; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; STERNBERG HM, 1976, P 6 INT S DET COR CA, V24, P528; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Thali Michael J., 2007, Legal Medicine, V9, P100, DOI 10.1016/j.legalmed.2006.11.011; Toth C, 2005, J NEURO-OPHTHALMOL, V25, P1, DOI 10.1097/00041327-200503000-00001; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; VAWTER DL, 1978, J APPL PHYSIOL, V45, P261, DOI 10.1152/jappl.1978.45.2.261; VIANO DC, 1988, J BIOMECH, V21, P387, DOI 10.1016/0021-9290(88)90145-5; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Wetherbe M., 1959, TID6056 USAEC DEP CO; WHITE CLAYTON S., 1964, HLTH PHYS, V10, P89, DOI 10.1097/00004032-196403000-00001; WHITE CS, 1961, 1271 DASA DEP DEF; WHITE CS, 1965, CEX654 US AT EN COMM, P20; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG MW, 1945, WAR MED, V8, P73; Zuckerman S, 1940, LANCET, V2, P219	76	53	54	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2127	2144		10.1089/neu.2009.0885			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200001	19508154	Green Submitted, Green Published			2022-02-06	
J	Honeybul, S; Ho, KM; Lind, CRP; Corcoran, T; Gillett, GR				Honeybul, Stephen; Ho, Kwok M.; Lind, Christopher R. P.; Corcoran, Tomas; Gillett, Grant R.			The Retrospective Application of a Prediction Model to Patients Who Have Had a Decompressive Craniectomy for Trauma	JOURNAL OF NEUROTRAUMA			English	Article						decompressive craniectomy; intracranial hypertension; neurotrauma; outcome	SEVERE HEAD-INJURIES; CEREBRAL-ARTERY INFARCTION; BRAIN-INJURY; RANDOMIZED-TRIAL; INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; MANAGEMENT; EDEMA; MULTICENTER; VALIDATION	There is currently a resurgence of interest in the use of decompressive craniectomy. As the procedure is used more frequently, there may be an increasing number of patients surviving a severe traumatic brain injury with severe neurological impairment. The aim of this study was to determine if we could predict those cases that fall into this category. We used the web-based prediction model prepared by the CRASH collaborators and applied it to a cohort of patients who had a decompressive craniectomy in 2006 and 2007 at the two major trauma hospitals in Western Australia. All clinical and radiological data were reviewed and entered into the model, and predicted outcome and actual outcome were compared. Our analysis indicated that a significant cut-off point appeared at which the model predicted a 75% risk of an unfavorable outcome at 6 months; 19 of 27 patients with CRASH scores <75% returned to work, whereas none of the 14 patients with higher scores achieved this degree of rehabilitation at 18 months. Statistical analysis of the outcomes in our cohort confirmed that the CRASH model reliably predicted unfavorable outcome. This study demonstrated that our ability to predict poor outcome has improved.	[Honeybul, Stephen; Lind, Christopher R. P.] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA 6019, Australia; [Corcoran, Tomas] Univ Western Australia, Dept Anesthesia, Royal Perth Hosp, Perth, WA 6009, Australia; [Lind, Christopher R. P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6019, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010; Lind, Christopher/K-3629-2012	Ho, Kwok M./0000-0002-6705-6004; Lind, Christopher/0000-0001-9991-1725			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Meier U, 2005, ACT NEUR S, V95, P55; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	27	53	54	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2179	2183		10.1089/neu.2009.0989			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200005	19645531				2022-02-06	
J	Scott, D; Tonmyr, L; Fraser, J; Walker, S; McKenzie, K				Scott, Debbie; Tonmyr, Lil; Fraser, Jenny; Walker, Sue; McKenzie, Kirsten			The utility and challenges of using ICD codes in child maltreatment research: A review of existing literature	CHILD ABUSE & NEGLECT			English	Article						Child maltreatment; ICD; Health data	SHAKEN-BABY-SYNDROME; PUBLIC-HEALTH SURVEILLANCE; TRAUMATIC BRAIN-INJURIES; YOUNG-CHILDREN; PHYSICAL ABUSE; UNITED-STATES; HOSPITALIZED CHILDREN; PEDIATRIC INJURIES; HEAD-INJURY; INFANTS	Objective: The objectives of this article are to explore the extent to which the International Statistical Classification of Diseases and Related Health Problems (ICD) has been used in child abuse research, to describe how the ICD system has been applied, and to assess factors affecting the reliability of ICD coded data in child abuse research. Methods: PubMed, CINAHL, PsychInfo and Google Scholar were searched for peer reviewed articles written since 1989 that used ICD as the classification system to identify cases and research child abuse using health databases. Snowballing strategies were also employed by searching the bibliographies of retrieved references to identify relevant associated articles. The papers identified through the search were independently screened by two authors for inclusion, resulting in 47 studies selected for the review. Due to heterogeneity of studies meta-analysis was not performed. Results: This paper highlights both utility and limitations of ICD coded data. ICD codes have been widely used to conduct research into child maltreatment in health data systems. The codes appear to be used primarily to determine child maltreatment patterns within identified diagnoses or to identify child maltreatment cases for research. Conclusions: A significant impediment to the use of ICD codes in child maltreatment research is the under ascertainment of child maltreatment by using coded data alone. This is most clearly identified and, to some degree, quantified, in research where data linkage is used. Practice implications: The importance of improved child maltreatment identification will assist in identifying risk factors and creating programs that can prevent and treat child maltreatment and assist in meeting reporting obligations under the CRC. (C) 2009 Elsevier Ltd. All rights reserved.	[Scott, Debbie; Walker, Sue; McKenzie, Kirsten] Queensland Univ Technol, Natl Ctr Hlth Informat Res & Training, Sch Publ Hlth, Brisbane, Qld 4059, Australia; [Tonmyr, Lil] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada; [Fraser, Jenny] Queensland Univ Technol, Sch Nursing & Midwifery, Brisbane, Qld 4059, Australia		Scott, D (corresponding author), Queensland Univ Technol, Natl Ctr Hlth Informat Res & Training, Sch Publ Hlth, Victoria Pk Rd, Brisbane, Qld 4059, Australia.		Vallmuur, Kirsten/I-9833-2012; Fraser, Jennifer/B-1120-2015; Vallmuur, Kirsten/AAL-9526-2021; Walker, Susan/V-8101-2019; Scott, Deborah/ABB-9055-2020	Vallmuur, Kirsten/0000-0002-3760-0822; Fraser, Jennifer/0000-0003-0111-9137; Vallmuur, Kirsten/0000-0002-3760-0822; Walker, Susan/0000-0002-3953-7724; Scott, Deborah/0000-0002-4530-584X			Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barlow KM, 1998, SCOT MED J, V43, P112, DOI 10.1177/003693309804300407; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Benger JR, 2002, BRIT MED J, V324, P780, DOI 10.1136/bmj.324.7340.780; Brown D, 2004, AM J PUBLIC HEALTH, V94, P558, DOI 10.2105/AJPH.94.4.558; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; Chang DC, 2005, J PEDIATR SURG, V40, P114, DOI 10.1016/j.jpedsurg.2004.09.019; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; Ellison K, 2008, MICH HIST REV, V34, P162; EWIGMAN B, 1993, PEDIATRICS, V91, P330; Guenther E, 2009, J PEDIATR-US, V154, P272, DOI 10.1016/j.jpeds.2008.07.047; Herman-Giddens M E, 1991, N C Med J, V52, P634; Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463; Jaudes PK, 2008, CHILD ABUSE NEGLECT, V32, P671, DOI 10.1016/j.chiabu.2007.08.007; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; King WJ, 2003, CAN MED ASSOC J, V168, P155; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Leslie LK, 2000, CHILD ABUSE NEGLECT, V24, P465, DOI 10.1016/S0145-2134(00)00116-2; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Leventhal JM, 2007, CHILD ABUSE NEGLECT, V31, P311, DOI 10.1016/j.chiabu.2006.07.004; Libby AM, 2003, PEDIATRICS, V112, P58, DOI 10.1542/peds.112.1.58; Limbos MAP, 1998, PEDIATRICS, V102, P53, DOI 10.1542/peds.102.1.53; Loder RT, 2007, J PEDIATR ORTHOPED, V27, P421, DOI 10.1097/01.bpb.0000271328.79481.07; McPhilips H, 2001, Inj Prev, V7, P150, DOI 10.1136/ip.7.2.150; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; Olsen SJ, 1996, EPIDEMIOLOGY, V7, P644, DOI 10.1097/00001648-199611000-00015; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; PECLET MH, 1990, J PEDIATR SURG, V25, P85, DOI 10.1016/S0022-3468(05)80169-1; Petridou E, 2001, SCAND J PUBLIC HEALT, V29, P279, DOI 10.1177/14034948010290041301; Ricci L, 2003, CHILD ABUSE NEGLECT, V27, P271, DOI 10.1016/S0145-2134(03)00006-1; Rovi S, 1999, J Am Med Womens Assoc (1972), V54, P211; Rovi S, 2004, AM J PUBLIC HEALTH, V94, P586, DOI 10.2105/AJPH.94.4.586; Rovi Sue, 2003, Violence Vict, V18, P491, DOI 10.1891/vivi.2003.18.5.491; Saluja G, 2007, Int J Inj Contr Saf Promot, V14, P19, DOI 10.1080/17457300601049618; Sanders T., 2003, CHILD ABUSE REV, V12, P358; Schnitzer PG, 2008, AM J PUBLIC HEALTH, V98, P296, DOI 10.2105/AJPH.2006.087783; Schnitzer PG, 2004, AM J PREV MED, V27, P379, DOI 10.1016/j.amepre.2004.08.007; Siegel CD, 1996, ARCH PEDIAT ADOL MED, V150, P1077, DOI 10.1001/archpedi.1996.02170350079014; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; SMITH JAS, 1991, CHILD ABUSE NEGLECT, V15, P437, DOI 10.1016/0145-2134(91)90027-B; Spencer N, 2005, PEDIATRICS, V116, P609, DOI 10.1542/peds.2004-1882; SPIVEY MI, 2008, J EMERGENCY MED; STRAIT RT, 1995, PEDIATRICS, V96, P667; Thyen U, 1997, CHILD ABUSE NEGLECT, V21, P187, DOI 10.1016/S0145-2134(96)00144-5; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Trokel M, 2004, CHILD MALTREATMENT, V9, P111, DOI 10.1177/1077559503260310; Truman Thomas L, 2002, Child Maltreat, V7, P138; UN, 1990, CONV RIGHTS CHILD; WINN DG, 1995, PUBLIC HEALTH REP, V110, P277; World Health Organization, 2005, CHILD AD INJ PREV GL; World Health Organization, 2006, PREVENTING CHILD MAL	55	53	53	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	NOV	2009	33	11			SI		791	808		10.1016/j.chiabu.2009.08.005			18	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	523FL	WOS:000272057400004	19853915	Green Published			2022-02-06	
J	Park, JH; Park, SW; Kang, SH; Nam, TK; Min, BK; Hwang, SN				Park, Jong-Hwa; Park, Seung-Won; Kang, Suk-Hyung; Nam, Taek-Kyun; Min, Byung-Kook; Hwang, Sung-Nam			Detection of Traumatic Cerebral Microbleeds by Susceptibility-Weighted Image of MRI	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Susceptibility-weighted image; Microbleeds	DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; CHILDREN; LESIONS; ADOLESCENTS; VENOGRAPHY; MODERATE	Objective : Susceptibility-weighted image (SWI) is a sensitive magnetic resonance image (MRI) technique to detect cerebral microbleeds (MBLs), which would not be detected by conventional MRI. We performed SWI to detect MBLs and investigated its usefulness in the evaluation of mild traumatic brain injury (MTBI) patients. Methods : From December 2006 to June 2007, twenty-one MTBI patients without any parenchymal hemorrhage on conventional MRI were selected. Forty-two patients without trauma were selected for control group. According to the presence of MBLs, we divided the MTBI group into MBLs positive [SWI (+)] and negative [SWI (-)] group. Regional distribution of MBLs and clinical factors were compared between groups. Results : Fifty-one MBLs appeared in 16 patients of SWI (+) group and 16 MBLs in 10 patients of control group [control (+)], respectively. In SWI (+) group, MBLs were located more frequently in white matters than in deep nucleus different from the control (+) group (p < 0.05). Nine patients (56.3%) of SWI (+) group had various neurological deficits (disorientation in 4, visual field defect in 2, hearing difficulty in 2 and Parkinson syndrome in 1). Initial Glasgow Coma Scale (GCS)/mean Glasgow Outcome Scale (GOS) were 13.9 +/- 1.5/4.7 +/- 0.8 and 15.0 +/- 0.0/5.0 +/- 0.0 in SWI (+) and SWI (-) groups, respectively (p < 0.05). Conclusion : Traumatic cerebral MBLs showed characteristic regional distribution, and seemed to have an importance on the initial neurological status and the prognosis. SWI is useful for detection of traumatic cerebral MBLs, and can provide etiologic evidences for some post-traumatic neurologic deficits which were unexplainable with conventional MRI.	[Park, Jong-Hwa; Park, Seung-Won; Kang, Suk-Hyung; Nam, Taek-Kyun; Min, Byung-Kook; Hwang, Sung-Nam] Chung Ang Univ, Coll Med, Dept Neurosurg, Yongsan Hosp, Seoul 140757, South Korea		Park, SW (corresponding author), Chung Ang Univ, Coll Med, Dept Neurosurg, Yongsan Hosp, 65-207 Hangangro 3 Ga, Seoul 140757, South Korea.	nspsw@hanmail.net	Kang, Sukhyung/R-6333-2019; Won, Park Seung/F-2877-2014	Won, Park Seung/0000-0001-8305-7501; Park, Jong-Hwa/0000-0002-8008-6785; Kang, Sukhyung/0000-0002-1130-9754			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; GENTRY LR, 1994, RADIOLOGY, V191, P1; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; HAACKE EM, 2002, SUSCEPTIBILITY WEIGH; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Lee BCP, 1999, AM J NEURORADIOL, V20, P1239; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Matsushita T, 2008, ACTA MED OKAYAMA, V62, P159; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176	18	53	66	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	OCT	2009	46	4					365	369		10.3340/jkns.2009.46.4.365			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	513FT	WOS:000271308600015	19893728	Green Published, gold			2022-02-06	
J	King, DR; Ogilvie, MP; Pereira, BMT; Chang, YC; Manning, RJ; Conner, JA; Schulman, CI; McKenney, MG; Proctor, KG				King, David R.; Ogilvie, Michael P.; Pereira, Bruno M. T.; Chang, Yuchiao; Manning, Ronald J.; Conner, Jeffrey A.; Schulman, Carl I.; McKenney, Mark G.; Proctor, Kenneth G.			Heart Rate Variability as a Triage Tool in Patients With Trauma During Prehospital Helicopter Transport	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	22nd Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 13-17, 2009	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Combat casualty care; Base deficit; Vital sign monitor	BRAIN-INJURY; MORTALITY; ASSOCIATION; COMPLEXITY; PREDICTOR; INTERVAL; DEATH	Background: Prehospital triage of patients with trauma is routinely challenging, but more so in mass casualty situations and military operations. The purpose of this study was to prospectively test whether heart rate variability (HRV) could be used as a triage tool during helicopter transport of civilian patients with trauma. Methods: After institutional review board approval and waiver of informed consent, 75 patients with trauma requiring prehospital helicopter transport to our level I center (from December 2007 to November 2008) were prospectively instrumented with a 2-Channel SEER Light recorder (GE Healthcare, Milwaukee, WI). HRV was analyzed with a Mars Holter monitor system and proprietary software. SDNN (standard deviation [SD] of the normal-to-normal R-R interval), as an index of HRV, was correlated with prehospital trauma triage criteria, base deficit, seriousness Of injury, operative interventions, outcome, and other data extracted from the patients' medical records. There were no interventions or medical decisions based on HRV. Data were excluded only if there was measurement artifact or technical problems with the recordings. Results: The demographics were mean age 47 years, 63% men, 88% blunt, 25% traumatic brain injury, 9% mortality. Prehospital SDNN predicted patients with base excess <=-6, those defined as seriously injured and benefiting front trauma center care, as well as patients requiring a life-saving procedure in the operating room. No other available data, including prehospital en-route vital signs, predicted any of these. The sensitivity, specificity, positive predictive value, and negative predictive value were 80%, 75%, 33%, 96%, respectively, with and an overall accuracy of 76% for predicting a life-saving intervention in the operating room. Conclusions: This, is the first demonstration that prehospital HRV (specifically SDNN) predicts base excess and operating room life-saving opportunities. HRV triages and discriminates severely injured patients better than routine trauma criteria or en-route prehospital vital signs. HRV may be a useful civilian or military triage tool to avoid unnecessary helicopter evacuation for minimally injured patients. A prospective, randomized trial in a larger patient population is indicated.	[King, David R.; Ogilvie, Michael P.; Pereira, Bruno M. T.; Manning, Ronald J.; Conner, Jeffrey A.; Schulman, Carl I.; McKenney, Mark G.; Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Daughtry Family Dept Surg, Div Trauma & Surg Crit Care, Miami, FL 33136 USA; [King, David R.; Chang, Yuchiao] Harvard Univ, Massachusetts Gen Hosp, Sch Med,,Dept Surg, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02141 USA; [Conner, Jeffrey A.] GE Healthcare Diagnost Cardiol, Marquette, MI USA		King, DR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,,Dept Surg, Div Trauma Emergency Surg & Surg Crit Care, 165 Cambrige St,Suite 810, Boston, MA 02141 USA.	Dking3@partners.org	Pereira, Bruno M/D-4542-2015; Schulman, Carl/AAE-7448-2021; Proctor, Kenneth/AAA-2199-2022	Pereira, Bruno M/0000-0003-3763-1749; Proctor, Kenneth/0000-0003-1326-6628; King, David/0000-0003-1028-1478; Schulman, Carl/0000-0001-8899-4350			Batchinsky AL, 2007, J TRAUMA, V63, P512, DOI 10.1097/TA.0b013e318142d2f0; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Grogan EL, 2005, J TRAUMA, V58, P7, DOI 10.1097/01.TA.0000151179.74839.98; Grogan EL, 2004, ANN SURG, V240, P547, DOI 10.1097/01.sla.0000137143.65540.9c; Henry MC, 1996, ACAD EMERG MED, V3, P992, DOI 10.1111/j.1553-2712.1996.tb03340.x; Kann SH, 2007, ACTA ANAESTH SCAND, V51, P1172, DOI 10.1111/j.1399-6576.2007.01354.x; King ML, 1997, BRAIN INJURY, V11, P445; Ko SH, 2008, DIABETIC MED, V25, P1171, DOI 10.1111/j.1464-5491.2008.02567.x; Leach SR, 2008, PREHOSP EMERG CARE, V12, P467, DOI 10.1080/10903120802290836; Maule S, 2008, HYPERTENS RES, V31, P2003, DOI 10.1291/hypres.31.2003; MORRIS JA, 2006, ANN SURG, V243, P812; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Morris John A Jr, 2005, Adv Surg, V39, P77, DOI 10.1016/j.yasu.2005.04.004; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Proctor KG, 2007, J TRAUMA, V63, P33, DOI 10.1097/01.ta.0000251593.32396.df; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Rapenne T, 2000, ANESTH ANALG, V91, P329, DOI 10.1097/00000539-200008000-00018; Stein PK, 2001, CRIT CARE MED, V29, P1738, DOI 10.1097/00003246-200109000-00014; Thompson EC, 2005, J TRAUMA, V58, P12; Tiamfook-Morgan TO, 2008, PREHOSP EMERG CARE, V12, P443, DOI 10.1080/10903120802290794; Tinkoff GH, 2002, J TRAUMA, V52, P1153, DOI 10.1097/00005373-200206000-00022; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010	30	53	53	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2009	67	3					436	440		10.1097/TA.0b013e3181ad67de			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	493IL	WOS:000269729900003	19741382				2022-02-06	
J	Lindstrom, B; Roding, J; Sundelin, G				Lindstrom, Britta; Roding, Jenny; Sundelin, Gunnevi			POSITIVE ATTITUDES AND PRESERVED HIGH LEVEL OF MOTOR PERFORMANCE ARE IMPORTANT FACTORS FOR RETURN TO WORK IN YOUNGER PERSONS AFTER STROKE: A NATIONAL SURVEY	JOURNAL OF REHABILITATION MEDICINE			English	Article						questionnaire; rehabilitation; stroke; work; young adults	TRAUMATIC BRAIN-INJURY; PATIENTS EXPERIENCES; QUALITY REGISTER; RECOVERY	Objective: Significant numbers of younger persons with stroke should be given the opportunity to return to work. The aim of this study was to investigate factors of importance for return to work among persons after first ever stroke, in the age range 18-55 years. Methods: A questionnaire was sent to all persons who had experienced a first ever stroke, 18-55 years of age, registered in the Swedish national quality register for stroke care, Riks-Stroke. Of the 1068 who answered the questionnaire, 855 (539 men and 316 women) were in paid employment before their stroke, and were included in this study. Results: Sixty-five percent returned to work and, of these, an equal proportion were men and women. Significant factors associated with return to work were the perceived importance of work (odds ratio (OR) 5.10), not perceiving themselves as a burden on others (OR 3.33), support from others for return to work (OR 3.66), retaining the ability to run a short distance (OR 2.77), and higher socioeconomic codes (OR 2.12). A negative association was found between those rehabilitated in wards intended for younger persons and return to work (OR 0.37). Conclusion: External support from others, and positive attitudes towards return to work, were factors associated with successful return to work after stroke. Contrary to what was expected, independence in personal activities of daily living and cognitive factors were not associated with return to work to the same extent as persistent higher level of physical functions, such as ability to run a short distance.	[Lindstrom, Britta; Roding, Jenny; Sundelin, Gunnevi] Umea Univ, Dept Community Med & Rehabil, SE-90187 Umea, Sweden; [Roding, Jenny] Lulea Univ Technol, Dept Hlth Sci, S-95187 Lulea, Sweden		Lindstrom, B (corresponding author), Umea Univ, Dept Community Med & Rehabil, SE-90187 Umea, Sweden.	britta.lindstrom@physiother.umu.se		Sundelin, Gunnevi/0000-0002-0198-7033	Norrlandska Strokefonden	Ellinor Flink and Helena Forsen are gratefully acknowledged for assistance in data collection and preparation. We also thank Norrlandska Strokefonden for financial Support and Riks-Stroke for access to the national quality register.	Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; Asplund K, 2003, CEREBROVASC DIS, V15, P5, DOI 10.1159/000068203; Eriksson M, 2007, STROKE, V38, P1384, DOI 10.1161/01.STR.0000260102.97954.9c; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Glozier N, 2008, STROKE, V39, P1526, DOI 10.1161/STROKEAHA.107.503219; Hamedani AG, 2001, STROKE, V32, P687, DOI 10.1161/01.STR.32.3.687; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Medin J, 2006, DISABIL REHABIL, V28, P1051, DOI 10.1080/09638280500494819; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Puolakka K, 2008, EUR SPINE J, V17, P386, DOI 10.1007/s00586-007-0552-2; Roding J, 2003, DISABIL REHABIL, V25, P867, DOI 10.1080/0963828031000122276; Roding J, 2009, DISABIL REHABIL, V31, P1092, DOI 10.1080/09638280802510965; SAEKI S, 1995, STROKE, V26, P399, DOI 10.1161/01.STR.26.3.399; Saeki Satoru, 2004, Journal of UOEH, V26, P41; *SCB, REG ARB RAMS STAT SW; *SCB, UND LEV ULF; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; *SOC, RAPP RIKS STROK 2006; *SOC, LIVSS IV AR EFT STRO; *SVENSKT NAR, CONF SWED ENT; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wozniak MA, 1999, STROKE, V30, P2568, DOI 10.1161/01.STR.30.12.2568; Wozniak MA, 2002, NEUROEPIDEMIOLOGY, V21, P159, DOI 10.1159/000059516	26	53	55	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2009	41	9					714	718		10.2340/16501977-0423			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	510PK	WOS:000271102200004	19774303	Green Submitted, gold			2022-02-06	
J	Franike, H; Sauer, C; Rudolph, C; Krugel, U; Hengstler, JG; Illes, P				Franike, H.; Sauer, C.; Rudolph, C.; Kruegel, U.; Hengstler, J. G.; Illes, P.			P2 Receptor-Mediated Stimulation of the PI3-K/Akt-Pathway In Vivo	GLIA			English	Article						apoptosis; astrocytes; ATP; active caspase 3; MAPK/ERK-pathway; proliferation; trauma	ACTIVATED PROTEIN-KINASE; TRAUMATIC BRAIN-INJURY; SIGNAL-REGULATED KINASE; PURINERGIC RECEPTORS; NEURONAL SURVIVAL; EXTRACELLULAR ATP; CELL-DEATH; NUCLEOTIDE RECEPTORS; AKT PHOSPHORYLATION; ISCHEMIC TOLERANCE	ATP acts as a growth factor as well as a toxic agent by stimulating P2 receptors. The P2 receptor-activated signaling cascades mediating cellular growth and cell survival after injury are only incompletely understood. Therefore, the aim of the present study was to identify the role of the phosphoinositide 3 kinase (PI3-K/Akt) and the mitogen-activated protein kinase/extracellular signal regulated protein kinase (MAPK/ERK) pathways in P2Y receptor-mediated astrogliosis after traumatic injury and after microinfusion of ADP beta S (P2Y(1,12,13) receptor agonist) into the rat nucleus accumbens (NAc). Mechanical damage and even more the concomitant treatment with ADP beta S, enhanced P2Y, receptor-expression in the NAc, which could be reduced by pretreatment with the P2X/Y receptor antagonist PPADS. Quantitative Western blot analysis indicated a significant increase in phosphorylated (p)Akt and pERK1/2 2 h after ADP beta S-microinjection. Pretreatment with PPADS or wortmannin abolished the up-regulation of pAkt by injury alone or ADP beta S-treatment. The ADP beta S-enhanced expression of the early apoptosis marker active caspase 3 was reduced by PPADS and PD98059, but not by wortmannin. Multiple immunofluorescence labeling indicated a time-dependent expression of pAkt and pMAPK on astrocytes and neurons and additionally the colocalization of pAkt, pMAPK, and active caspase 3 with the P2Y, receptor especially at astrocytes. In conclusion, the data show for the first time the involvement of PI3-K/Akt-pathway in processes of injury-induced astroglial proliferation and anti-apoptosis via activation of P2Y1 receptors in vivo, suggesting specific roles of P2 receptors in glial cell pathophysiology in neurodegenerative diseases. (C) 2008 Wiley-Liss, Inc.	[Franike, H.; Sauer, C.; Kruegel, U.; Illes, P.] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Rudolph, C.; Hengstler, J. G.] Univ Dortmund, Inst Arbeitsphysiol, Leibniz Res Ctr Working Environm & Human Factors, D-4600 Dortmund, Germany		Franike, H (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Hartelstr 16-18, D-04107 Leipzig, Germany.	frah@medizin.uni-leipzig.de	Hengstler, Jan G./O-1415-2013	Krugel, Ute/0000-0002-2317-2302; Hengstler, Jan/0000-0002-1427-5246	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [KI 677/2-4, FR 1253/3-1]; Medical Faculty of the University of Leipzig [Z10, C31]	Deutsche Forschungsgemeinschaft; Grant number: KI 677/2-4, FR 1253/3-1; Grant sponsor: "Interdisciplinary Center for Clinical Research" at the Medical Faculty of the University of Leipzig; Grant number: Projects Z10, C31.	Abbracchio MP, 1999, PROG BRAIN RES, V120, P333; Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Arthur DB, 2006, J NEUROSCI, V26, P3798, DOI 10.1523/JNEUROSCI.5338-05.2006; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Brambilla R, 2002, J NEUROCHEM, V83, P1285, DOI 10.1046/j.1471-4159.2002.01239.x; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Burgos M, 2007, J NEUROCHEM, V103, P1785, DOI 10.1111/j.1471-4159.2007.04872.x; Carbonell WS, 2003, J NEUROTRAUM, V20, P327, DOI 10.1089/089771503765172282; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Fischer W, 2007, CURR MED CHEM, V14, P2429, DOI 10.2174/092986707782023695; Franke H, 2007, PURINERG SIGNAL, V3, P435, DOI 10.1007/s11302-007-9082-y; Franke H, 2006, INT J DEV NEUROSCI, V24, P123, DOI 10.1016/j.ijdevneu.2005.11.016; Franke H, 1999, GLIA, V28, P190, DOI 10.1002/(SICI)1098-1136(199912)28:3<190::AID-GLIA3>3.3.CO;2-S; Franke H, 2004, NEUROSCIENCE, V127, P431, DOI 10.1016/j.neuroscience.2004.05.003; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Franke H, 2001, BRIT J PHARMACOL, V134, P1180, DOI 10.1038/sj.bjp.0704353; Gendron Fernand-Pierre, 2003, Biomedical Research (Aligarh), V14, P47; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Huwiler A, 2002, BRIT J PHARMACOL, V136, P520, DOI 10.1038/sj.bjp.0704748; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Khreiss T, 2002, J BIOL CHEM, V277, P40775, DOI 10.1074/jbc.M205378200; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Mamedova LK, 2006, BIOCHEM PHARMACOL, V72, P1031, DOI 10.1016/j.bcp.2006.07.017; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Milenkovic I, 2004, GRAEF ARCH CLIN EXP, V242, P944, DOI 10.1007/s00417-004-0954-3; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Muscella A, 2003, J CELL PHYSIOL, V195, P234, DOI 10.1002/jcp.10242; Namikawa K, 2000, J NEUROSCI, V20, P2875; Namura S, 2000, J CEREBR BLOOD F MET, V20, P1301, DOI 10.1097/00004647-200009000-00004; Neary JT, 2006, J NEUROSCI RES, V84, P515, DOI 10.1002/jnr.20969; Neary JT, 2005, MOL NEUROBIOL, V31, P95, DOI 10.1385/MN:31:1-3:095; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Neary JT, 1996, TRENDS NEUROSCI, V19, P13, DOI 10.1016/0166-2236(96)81861-3; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Sellers LK, 2001, J BIOL CHEM, V276, P16379, DOI 10.1074/jbc.M006617200; Sutor SL, 1999, J BIOL CHEM, V274, P7002, DOI 10.1074/jbc.274.11.7002; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Weisman GA, 2005, MOL NEUROBIOL, V31, P169, DOI 10.1385/MN:31:1-3:169; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Yang Xinyu, 2002, Chin J Traumatol, V5, P250; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	53	53	57	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	AUG 1	2009	57	10					1031	1045		10.1002/glia.20827			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	466FS	WOS:000267647100001	19115395				2022-02-06	
J	Puccio, AM; Fischer, MR; Jankowitz, BT; Yonas, H; Darby, JM; Okonkwo, DO				Puccio, Ava M.; Fischer, Michael R.; Jankowitz, Brian T.; Yonas, Howard; Darby, Joseph M.; Okonkwo, David O.			Induced Normothermia Attenuates Intracranial Hypertension and Reduces Fever Burden after Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Fever; Normothermia; Intracranial pressure; Critical care medicine	INTENSIVE-CARE-UNIT; MILD HYPOTHERMIA THERAPY; MODERATE HYPOTHERMIA; HEAD-INJURY; TEMPERATURE; PRESSURE; CHILDREN; ADULTS; RISK	Hyperthermia following a severe traumatic brain injury (TBI) is common, potentiates secondary injury, and worsens neurological outcome. Conventional fever treatment is often ineffective. An induced normothermia protocol, utilizing intravascular cooling, was used to assess the impact on fever incidence and intracranial pressure (ICP) in patients with severe TBI. A comparative cohort study of 21 adult patients with severe TBI (GCS a parts per thousand currency sign 8) treated with induced normothermia [36-36.5A degrees C rectal probe setting; intravascular cooling catheter (CoolLine(A (R)), Alsius Corporation, Irvine, CA)] were matched by age, gender, and severity of injury to 21 historical control severe TBI patients treated with conventional fever control methods. ICP was measured via an external ventricular catheter and time duration for ICP > 25 mmHg was calculated for the initial 72-h monitoring period. Non-parametric rank tests were performed. Mean (+/- SD) or median [range] demographics did not differ between groups [total N = 42 (6 female, 36 male, age 36.4 +/- A 14.8 years and initial GCS 7 [3-8], median and range]. Fever burden in the first 3 days (time > 38A degrees C) in the induced normothermia versus control group was significantly less at 1.6% versus 10.6%, respectively (P = 0.03). Mean ICP for patients with induced normothermia versus control was 12.74 +/- A 4.0 and 16.37 +/- A 6.9 mmHg, respectively. Furthermore, percentage of time with ICP > 25 mmHg was significantly less in the induced normothermia group (P = 0.03). Induced normothermia (fever prophylaxis via intravascular cooling catheter) is effective in reducing fever burden and may offer a means to attenuate secondary injury, as evidenced by a reduction in the intracranial hypertension burden.	[Puccio, Ava M.; Fischer, Michael R.; Jankowitz, Brian T.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Yonas, Howard] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Darby, Joseph M.] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA 15213 USA		Puccio, AM (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St,B-4 PUH, Pittsburgh, PA 15213 USA.	puccioam@upmc.edu; fischermr@upmc.edu; jankowitzbt@upmc.edu; HYonas@salud.unm.edu; darbyjm@upmc.edu; okonkwodo@upmc.edu			University of Pittsburgh Brain Trauma Research CenterUniversity of Pittsburgh; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ProNS30318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P01NS030318, P20NS030318] Funding Source: NIH RePORTER	This research was supported by the University of Pittsburgh Brain Trauma Research Center (C. E. D.; NIH ProNS30318). We thank the nurses and residents for excellent patient care at the University of Pittsburgh Medical Center.	Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Nara I, 1998, ACT NEUR S, V71, P22; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Takahashi I, 2000, NEUROL SURG TOKYO, V28, P983; Tateishi A, 1998, NEUROSURGERY, V42, P1065, DOI 10.1097/00006123-199805000-00066; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	31	53	61	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2009	11	1					82	87		10.1007/s12028-009-9213-0			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	468AU	WOS:000267786400015	19337864	Green Accepted			2022-02-06	
J	Zebrack, M; Dandoy, C; Hansen, K; Scaife, E; Mann, NC; Bratton, SL				Zebrack, Michelle; Dandoy, Christopher; Hansen, Kristine; Scaife, Eric; Mann, N. Clay; Bratton, Susan L.			Early Resuscitation of Children With Moderate-to-Severe Traumatic Brain Injury	PEDIATRICS			English	Article						traumatic brain injury; secondary brain injury; outcome; emergency department; emergency resuscitation; treatment; emergency medical services	SEVERE HEAD-INJURY; HYPOTENSION; HYPOXIA; EPIDEMIOLOGY; EXPERIENCE; ADULTS; CARE	OBJECTIVES: Traumatic brain injury is a leading cause of death and disability in children. Guidelines have been established to prevent secondary brain injury caused by hypotension or hypoxia. The purpose of this study was to identify the prevalence, monitoring, and treatment of hypotension and hypoxia during "early" (prehospital and emergency department) care and to evaluate their relationship to vital status and neurologic outcomes at hospital discharge. METHODS: This was a retrospective study of 299 children with moderate-to-severe traumatic brain injury presenting to a level 1 pediatric trauma center. We recorded vital signs and medical provider response to hypotension and/or hypoxia during all portions of early care. RESULTS: Blood pressure (31%) and oxygenation (34%) were not recorded during some portion of "early care." Documented hypotension occurred in 118 children (39%). An attempt to treat documented hypotension was made in 48% (57 of 118 children). After adjusting for severity of illness, children who did not receive an attempt to treat hypotension had an increased odds of death of 3.4 and were 3.7 times more likely to suffer disability compared with treated hypotensive children. Documented hypoxia occurred in 131 children (44%). An attempt to treat hypoxia was made in 92% (121 of 131 children). Untreated hypoxia was not significantly associated with death or disability, except in the setting of hypotension. CONCLUSIONS: Hypotension and hypoxia are common events in pediatric traumatic brain injury. Approximately one third of children are not properly monitored in the early phases of their management. Attempts to treat hypotension and hypoxia significantly improved outcomes. Pediatrics 2009;124:56-64	[Mann, N. Clay] Univ Utah, Sch Med, Intermt Injury Control Res Ctr, Salt Lake City, UT USA; [Zebrack, Michelle; Bratton, Susan L.] Univ Utah, Sch Med, Div Pediat Crit Care, Salt Lake City, UT USA; [Zebrack, Michelle; Bratton, Susan L.] Univ Utah, Sch Med, Dept Pediat Surg, Salt Lake City, UT USA; [Dandoy, Christopher] Miami Childrens Hosp, Div Pediat, Miami, FL USA; [Hansen, Kristine] Primary Childrens Med Ctr, Trauma Program, Salt Lake City, UT 84103 USA		Zebrack, M (corresponding author), 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	michelle.zebrack@hsc.utah.edu	Bratton, Susan L./O-2353-2013; Dandoy, Christopher/I-9883-2019	Bratton, Susan L./0000-0002-4605-8078; Dandoy, Christopher/0000-0002-4001-9203	Emergency Medical Services for Children Program in the Health Resources and Services Administration (Rockville, MD)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [U07MC05036]	We acknowledge and extend our gratitude to the trauma service nurse practitioners at Primary Children's Medical Center who worked diligently to help complete this project.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Banerjee S, 1994, Indian Pediatr, V31, P1511; Buck ML, 2007, ANN PHARMACOTHER, V41, P1679, DOI 10.1345/aph.1K168; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; GLAESER PW, 1993, ANN EMERG MED, V22, P1119, DOI 10.1016/S0196-0644(05)80975-8; *I MED COMM FUT EM, 2007, EM CAR CHILDR GROW P, pR22; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Su E, 2000, ACAD EMERG MED, V7, P779, DOI 10.1111/j.1553-2712.2000.tb02270.x; Su E, 1997, Prehosp Emerg Care, V1, P123, DOI 10.1080/10903129708958803; TSAI A, 1987, ANN EMERG MED, V16, P284; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; 2005, CIRCULATION S, V112, P167	23	53	54	0	1	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JUL	2009	124	1					56	64		10.1542/peds.2008-1006			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	463QY	WOS:000267448100008	19564283				2022-02-06	
J	Rhodes, JKJ; Sharkey, J; Andrews, PJD				Rhodes, Jonathan K. J.; Sharkey, John; Andrews, Peter J. D.			The Temporal Expression, Cellular Localization, and Inhibition of the Chemokines MIP-2 and MCP-1 after Traumatic Brain Injury in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						brain; MCP-1/CCL2; MIP-2/CXCL2; trauma	MONOCYTE CHEMOATTRACTANT PROTEIN-1; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MACROPHAGE INFLAMMATORY PROTEIN-2; MICROVASCULAR ENDOTHELIAL-CELLS; FACTOR-KAPPA-B; MESSENGER-RNA; AXONAL INJURY; GLIAL-CELLS; CYCLOSPORINE-A	The expression of the neutrophil chemokine macrophage inflammatory protein-2 (MIP-2/CXCL2) and the monocyte chemokine monocyte chemotactic protein-1 (MCP-1/CCL2) have been described in glial cells in vitro but their origin following TBI has not been established. Furthermore, little is known of the modulation of these chemokines. Chemokine expression was investigated in male Sprague-Dawley rats following moderate lateral fluid percussion injury (LFPI). At 0, 4, 8, 12, and 24 h after injury, brains were harvested and MIP-2/CXCL2 and MCP=1/CCL2 levels measured by ELISA. To investigate the inhibition of chemokine expression a second cohort of animals received dexamethasone (1-15 mg/kg), FK506 (1 mg/kg), or vehicle, systemically, immediately after injury. These animals were sacrificed at the time of peak chemokine expression. A third cohort of animals was also sacrificed at the time of peak chemokine expression and immunohistochemistry performed for MIP-2/CXCL2 and MCP-1/CCL2. Following LFPI, chemokines were increased in the ipsilateral hemisphere, MIP-2/CXCL2 peaking at 4 h and MCP-1/CCL2 peaking at 8-12 h post-injury. Dexamethasone significantly reduced cortical MCP-1/CCL2, but not MIP-2/CXCL2 concentrations. FK506 did not inhibit chemokine expression. In undamaged brain, chemokine expression was localized to cells with a neuronal morphology. For MIP-2/CXCL2 this was supported by double staining for the neuronal antigen NeuN. In contused tissue, increased MIP-2/CXCL2 and MCP-1/CCL2 staining was visible in cells with the morphology of degenerating neurons. MIP-2/CXCL2 and MCP-1/CCL2 are increased after injury, and neurons appear to be the source of this expression. Chemokine expression was selectively inhibited by dexamethasone. The implications of this are discussed.	[Rhodes, Jonathan K. J.] Univ Edinburgh, Western Gen Hosp, Dept Anaesthesia, Edinburgh EH4 2XU, Midlothian, Scotland; [Andrews, Peter J. D.] Western Gen Hosp, Intens Care Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Sharkey, John] Univ Dundee, Ninewells Hosp & Med Sch, Sch Life Sci Res, Translat Med Res Collaborat, Dundee DD1 9SY, Scotland		Rhodes, JKJ (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Anaesthesia, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	J.K.J.Rhodes@sms.ed.ac.uk		Sharkey, John/0000-0001-8288-1857			AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; ALDERSON P, 2000, COCHRANE DB SYST REV; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; Berman JW, 1996, J IMMUNOL, V156, P3017; Borger P, 2000, TRANSPLANTATION, V69, P1408, DOI 10.1097/00007890-200004150-00034; Butcher SP, 1997, J NEUROSCI, V17, P6939; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; COLOTTA F, 1992, J IMMUNOL, V148, P760; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; COX G, 1995, J IMMUNOL, V154, P4719; de Haij S, 2002, BRIT J PHARMACOL, V137, P197, DOI 10.1038/sj.bjp.0704866; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Ehrlich LC, 1998, J IMMUNOL, V160, P1944; FAN L, 1995, MOL BRAIN RES, V30, P125; GALICICH JH, 1961, AM PRACT DIG TREAT, V12, P169; Gilmour PS, 2004, TOXICOL APPL PHARM, V195, P35, DOI 10.1016/j.taap.2003.10.003; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Harkness KA, 2003, J NEUROIMMUNOL, V142, P1, DOI 10.1016/S0165-5728(03)00251-0; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; HAYASHI M, 1995, J NEUROIMMUNOL, V60, P143, DOI 10.1016/0165-5728(95)00064-9; Heasman SJ, 2003, J ENDOCRINOL, V178, P29, DOI 10.1677/joe.0.1780029; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; KAPLAN A, 1995, J DERMATOL SCI, V10, P130, DOI 10.1016/0923-1811(95)00395-9; KIM JS, 1995, J NEUROL SCI, V128, P28, DOI 10.1016/0022-510X(94)00217-C; Kono H, 2004, AM J PHYSIOL-GASTR L, V286, pG1081, DOI 10.1152/ajpgi.00457.2003; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; KUBES P, 1991, DIGEST DIS SCI, V36, P1469, DOI 10.1007/BF01296817; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; McCarter JF, 2001, TRANSPL P, V33, P2390, DOI 10.1016/S0041-1345(01)02033-4; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; Muessel MJ, 2000, BRAIN RES, V870, P211, DOI 10.1016/S0006-8993(00)02450-1; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NISHINAKA Y, 1993, J CARDIOVASC PHARM, V21, P448, DOI 10.1097/00005344-199303000-00015; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; Nygardas PT, 2000, EUR J IMMUNOL, V30, P1911, DOI 10.1002/1521-4141(200007)30:7<1911::AID-IMMU1911>3.0.CO;2-E; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Otto VI, 2000, J NEUROSCI RES, V60, P733, DOI 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Rhodes JKJ, 2002, NEUROSCI LETT, V335, P1, DOI 10.1016/S0304-3940(02)00811-X; Saitoh O, 1997, J GASTROENTEROL, V32, P605, DOI 10.1007/BF02934109; Sasakawa Y, 2000, EUR J PHARMACOL, V403, P281, DOI 10.1016/S0014-2999(00)00592-6; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schramm R, 2003, INFECT IMMUN, V71, P2542, DOI 10.1128/IAI.71.5.2542-2547.2003; Schwartz D, 1998, J NEUROL SCI, V155, P13, DOI 10.1016/S0022-510X(97)00268-2; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Soares HD, 1995, J NEUROSCI, V15, P8223; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TOBLER A, 1992, BLOOD, V79, P45; Tsujikawa A, 1998, STROKE, V29, P1431, DOI 10.1161/01.STR.29.7.1431; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Zwijnenburg PJG, 2003, IMMUNOL LETT, V85, P1, DOI 10.1016/S0165-2478(02)00200-6	68	53	54	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2009	26	4					507	525		10.1089/neu.2008.0686			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	430OV	WOS:000264999300004	19210118				2022-02-06	
J	Percy, A; Widman, S; Rizzo, JA; Tranquilli, M; Elefteriades, JA				Percy, Andrew; Widman, Shannon; Rizzo, John A.; Tranquilli, Maryann; Elefteriades, John A.			Deep Hypothermic Circulatory Arrest in Patients With High Cognitive Needs: Full Preservation of Cognitive Abilities	ANNALS OF THORACIC SURGERY			English	Article							DYSFUNCTION; PROTECTION; INJURY	Background. Owing to controversy regarding the efficacy and safety of deep hypothermic circulatory arrest (DHCA) during thoracic aortic surgery, we conducted a psychometric study in which high-cognitive patients and their informants were interviewed to determine whether DHCA had any adverse effect on their daily activities or work performance. Methods. A total of 29 patients (18 males, 11 females; age, 26 to 75 years; mean 52.6 years) whose jobs require high cognitive capability and who had undergone aortic surgery using DHCA (range, 17 to 54 minutes; mean arrest time, 27.4 minutes) at Yale-New Haven Hospital were retrospectively studied. These 29 patients represented the responders among 45 such patients to whom questionnaires were mailed. A control group of 21 high-cognitive patients (20 males, 1 female; ages, 36 to 77 years; mean, 54.7 years) who underwent aortic surgery without DHCA were surveyed as well. During surgery, DHCA was used as the sole means of cerebral protection. The head was packed in ice, and carbon dioxide flooding of the field was used in all cases. The ascending aorta was resected with an open distal anastomosis and a hemiarch or total arch replacement. A 21-part questionnaire (adapted from A. F. Jorm's Short Form IQCODE and supplemented by our own questions) was distributed postoperatively to subjects and to their informants (generally a spouse). A value of 3 on the questionnaire indicated "not much change" from preoperative status (1 indicated much worse and 5 indicated much improved). Results. There were no statistically significant differences in any functional outcomes by study group (by patient: DHCA 3.01, control 3.09; by informant: DHCA 3.00, control 3.03; p > 0.05). Mean values of the outcomes for study groups and control subjects were essentially identical and quite close to 3 (the value assigned to " not much change") for overall score, for occupational score, and for memory-related score. Conclusions. These data indicate that high-cognitive patients experienced very little cognitive change as a result of undergoing DHCA. Our assessment strongly supports the adequacy of straight DHCA as a cerebral protectant strategy during short- to moderate-duration circulatory arrest. We found excellent preservation of functional state and no difference from patients undergoing aortic surgery without DHCA.	[Elefteriades, John A.] Yale Univ, Sch Med, Sect Cardiothorac Surg, New Haven, CT 06437 USA; SUNY Stony Brook, Sch Med, Dept Prevent Med, Stony Brook, NY 11794 USA		Elefteriades, JA (corresponding author), Yale Univ, Sch Med, Sect Cardiothorac Surg, 121 FMB,333 Cedar St, New Haven, CT 06437 USA.	john.elefteriades@yale.edu		Widman, Shannon/0000-0002-0594-1884			Ahonen J, 2004, ACTA ANAESTH SCAND, V48, P4, DOI 10.1111/j.1399-6576.2004.00275.x; Amir G, 2005, ANN THORAC SURG, V80, P1955, DOI 10.1016/j.athoracsur.2004.12.040; CHRISTENSEN H, 1992, INT J GERIATR PSYCH, V7, P159, DOI 10.1002/gps.930070304; Cooper WA, 2000, ANN THORAC SURG, V69, P696, DOI 10.1016/S0003-4975(99)01524-6; Ergin MA, 1999, ANN THORAC SURG, V67, P1887, DOI 10.1016/S0003-4975(99)00432-4; Gega A, 2007, ANN THORAC SURG, V84, P759, DOI 10.1016/j.athoracsur.2007.04.107; Haverich A, 2003, J THORAC CARDIOV SUR, V125, P460, DOI 10.1067/mtc.2003.291; Immer FF, 2004, CIRCULATION, V110, pII250, DOI 10.1161/01.CIR.0000138387.61103.a0; Jorm AF, 1996, CLIN PSYCHOL REV, V16, P51, DOI 10.1016/0272-7358(95)00056-9; Jorm AF, 1996, INT J GERIATR PSYCH, V11, P131; Jorm AF, 2002, PRINCIPLES PRACTICE, P141; Kumral E, 2001, TEX HEART I J, V28, P83; Mendelowitsch A, 1998, J NEUROL NEUROSUR PS, V64, P611, DOI 10.1136/jnnp.64.5.611; MORAMANGANO CT, 2001, CIRCULATION S1, V104, P276; Reich DL, 1999, J THORAC CARDIOV SUR, V117, P156, DOI 10.1016/S0022-5223(99)70481-2; SVENSSON LG, 1997, CARDIOVASCULAR VASCU; Welz A, 1997, EUR J CARDIO-THORAC, V11, P650, DOI 10.1016/S1010-7940(96)01129-3	17	53	54	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2009	87	1					117	123		10.1016/j.athoracsur.2008.10.025			7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cardiovascular System & Cardiology; Respiratory System; Surgery	385SN	WOS:000261834000026	19101283				2022-02-06	
J	Sanchez-Carrion, R; Fernandez-Espejo, D; Junque, C; Falcon, C; Bargallo, N; Roig, T; Bernabeu, M; Tormos, JM; Vendrell, P				Sanchez-Carrion, Rocio; Fernandez-Espejo, Davinia; Junque, Carme; Falcon, Carles; Bargallo, Nuria; Roig, Teresa; Bernabeu, Montserrat; Tormos, Jose M.; Vendrell, Pere			A longitudinal fMRI study of working memory in severe TBI patients with diffuse axonal injury	NEUROIMAGE			English	Article						Traumatic brain injury; Longitudinal; Functional MRI; Ddiffuse axonal injury; Working memory	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; COGNITIVE REHABILITATION THERAPY; MULTIPLE-SCLEROSIS; FUNCTIONAL MRI; HEAD-INJURY; NEUROPSYCHOLOGICAL REHABILITATION; CORTICAL REORGANIZATION; MOTOR RECOVERY; MS PATIENTS	Traumatic brain injury (TBI) patients have working memory deficits and altered patterns of brain activation during this function. The evolution of the impairment has not been examined to date. This study investigated longitudinal changes in brain activation during a working memory task. Twelve patients with severe and diffuse TBI and ten healthy matched controls were fMRI scanned twice at a 6-month interval during an n-back task (0-, 2- and 3-back). All the TBI patients selected presented signs of diffuse axonal injury on CT but had no evidence of focal lesions on MRI clinical examination. Significant changes in brain activation over time were observed in patients, but not in controls. During the first examination, though both groups engaged bilateral fronto-parietal regions known to be involved in working memory, activation of the right superior frontal gyrus was low in the TBI group. However, the difference between TBI and controls had decreased significantly after 6 months. A factor analysis confirmed the greater increase in activation in the right superior frontal cortex in the TBI group than in healthy controls, leading to normalization of the brain activation pattern. In conclusion, this longitudinal study provides evidence of a progressive normalization of the working memory activation pattern after diffuse axonal injury in severe TBI, coinciding with an improvement in performance on this function. (C) 2008 Elsevier Inc. All rights reserved.	[Junque, Carme; Vendrell, Pere] Univ Barcelona, IDIBAPS, Dept Psychiat & Clin Psychobiol, E-08036 Barcelona, Spain; [Sanchez-Carrion, Rocio; Roig, Teresa] Inst Univ Neurorehabil Guttmann, Dept Neuropsychol, Badalona, Spain; [Junque, Carme; Falcon, Carles; Bargallo, Nuria; Vendrell, Pere] Inst Biomed Res August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Falcon, Carles; Bargallo, Nuria] Hosp Clin Barcelona, CDI, Neuroradiol Sect, Dept Radiol, Barcelona, Spain; [Bernabeu, Montserrat] Inst Univ Neurorehabil Guttmann, Head Injury Unit, Badalona, Spain		Junque, C (corresponding author), Univ Barcelona, IDIBAPS, Dept Psychiat & Clin Psychobiol, Casanova 143, E-08036 Barcelona, Spain.	cjunque@ub.edu	Fernandez-Espejo, Davinia/AAT-5481-2021; Vendrell, Pere/B-4392-2011; Bargallo, Nuria/G-6854-2016; Junque, Carme/B-4400-2011	Fernandez-Espejo, Davinia/0000-0001-5941-7546; Vendrell, Pere/0000-0001-8918-5440; Bargallo, Nuria/0000-0001-6284-5402; Junque, Carme/0000-0002-6381-3063; Tormos Munoz, Jose Maria/0000-0002-8764-2289; falcon, carles/0000-0001-5564-2025	Distincio per a la Promocio de Recerca Universitaria [2005SGR00836]; Generalitat de Catalunya to Neuropsychology research groupGeneralitat de Catalunya	This study was supported by the grants: Award "Distincio per a la Promocio de Recerca Universitaria" Generalitat de Catalunya to C. Junque and 2005SGR00836 Generalitat de Catalunya to Neuropsychology research group.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; BACHYRITA P, 1981, ARCH PHYS MED REHAB, V62, P413; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 1996, J LEARN DISABIL-US, V29, P515, DOI 10.1177/002221949602900507; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brett M, 2002, 8 INT CONFERANCE FUN REGION INTEREST ANAL, V16; Buckle GJ, 2005, J NEUROIMAGING, V15, p82S, DOI 10.1177/1051228405284093; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Caramia MD, 1998, NEUROLOGY, V51, P196, DOI 10.1212/WNL.51.1.196; Cardebat D, 2003, STROKE, V34, P2900, DOI 10.1161/01.STR.0000099965.99393.83; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cifelli A, 2002, MULT SCLER, V8, P193, DOI 10.1191/1352458502ms820oa; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; de Boissezon X, 2005, STROKE, V36, P1467, DOI 10.1161/01.STR.0000169947.08972.4f; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Forn C, 2006, NEUROIMAGE, V31, P686, DOI 10.1016/j.neuroimage.2005.12.030; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GIANUTSOS R, 1991, Brain Injury, V5, P353, DOI 10.3109/02699059109008108; Grady C. L., 1999, COGNITIVE NEUROREHAB, P47; HEISS WD, 1993, ARCH NEUROL-CHICAGO, V50, P958, DOI 10.1001/archneur.1993.00540090059011; Heiss WD, 1997, J NEUROL SCI, V145, P213, DOI 10.1016/S0022-510X(96)00252-3; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P965, DOI 10.1076/jcen.25.7.965.16490; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Honey GD, 1999, P NATL ACAD SCI USA, V96, P13432, DOI 10.1073/pnas.96.23.13432; Jang SH, 2003, NEUROREPORT, V14, P1305, DOI 10.1097/01.wnr.0000078700.79393.09; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; Jones JA, 2003, NEUROREPORT, V14, P1129, DOI 10.1097/00001756-200306110-00006; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Laatsch L, 1997, BRAIN INJURY, V11, P851; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Laatsch LK, 2004, BRAIN INJURY, V18, P957, DOI 10.1080/02699050410001672369; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Mainero C, 2006, J NEUROL SCI, V245, P93, DOI 10.1016/j.jns.2005.08.024; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matthews PM, 2004, RESTOR NEUROL NEUROS, V22, P245; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meisenzahl EM, 2006, EUR ARCH PSY CLIN N, V256, P522, DOI 10.1007/s00406-006-0687-x; MEZZAPESA DM, 2007, FUNCTIONAL CORTICAL, DOI DOI 10.1002/HBM.20418; Mountz J M, 2007, Eura Medicophys, V43, P221; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Ohyama M, 1996, STROKE, V27, P897, DOI 10.1161/01.STR.27.5.897; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pantano P, 2005, BRAIN, V128, P2146, DOI 10.1093/brain/awh549; PANTANO P, 1992, INT J NEUROSCI, V66, P153; Penades R, 2000, PSYCHIAT RES-NEUROIM, V98, P127, DOI 10.1016/S0925-4927(99)00050-5; Penades R, 2002, ACTA PSYCHIAT SCAND, V105, P202, DOI 10.1034/j.1600-0447.2002.1o421.x; Penner IK, 2007, J NEUROL, V254, P53, DOI 10.1007/s00415-007-2013-6; Penner IK, 2006, J PHYSIOL-PARIS, V99, P455, DOI 10.1016/j.jphysparis.2006.03.008; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Poldrack Russell A, 2002, Top Magn Reson Imaging, V13, P61, DOI 10.1097/00002142-200202000-00005; Rausch M, 2000, EXP BRAIN RES, V135, P34, DOI 10.1007/s002210000499; Reddy H, 2000, NEUROLOGY, V54, P236, DOI 10.1212/WNL.54.1.236; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rijntjes M, 2002, PROG NEUROBIOL, V66, P109, DOI 10.1016/S0301-0082(01)00027-2; Rios-Lago M, 2004, REV NEUROLOGIA, V38, P366, DOI 10.33588/rn.3804.2003559; Rocca MA, 2007, J NEUROIMAGING, V17, p36S, DOI 10.1111/j.1552-6569.2007.00135.x; Roux FE, 2000, J NEUROL NEUROSUR PS, V69, P453, DOI 10.1136/jnnp.69.4.453; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Schlosser MJ, 1997, STROKE, V28, P1130, DOI 10.1161/01.STR.28.6.1130; SEITZ RJ, 1995, NEUROREPORT, V6, P742, DOI 10.1097/00001756-199503270-00009; Sohlberg M., 2001, COGNITIVE REHABILITA; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Talairach J., 1988, COPLANAR STEREOTAXIC; Thimm M, 2006, NEUROPSYCHOLOGIA, V44, P1230, DOI 10.1016/j.neuropsychologia.2005.09.008; WALSH ND, 2007, LONGITUDINAL FUNCTIO, DOI DOI 10.1016/J.BIOPSYCH.2006.12.022; WECHSLER D, 1999, ESCALA INTENTELIGENC; Weiller C, 1998, EXP BRAIN RES, V123, P13, DOI 10.1007/s002210050539; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694; Wishart HA, 2004, NEUROLOGY, V62, P234, DOI 10.1212/01.WNL.0000103238.91536.5F; Wykes T, 2002, BRIT J PSYCHIAT, V181, P144	98	53	53	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV 15	2008	43	3					421	429		10.1016/j.neuroimage.2008.08.003			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	392JY	WOS:000262300200001	18771738	hybrid			2022-02-06	
J	Guzel, A; Er, U; Tatli, M; Aluclu, U; Ozkan, U; Duzenli, Y; Satici, O; Guzel, E; Kemaloglu, S; Ceviz, A; Kaplan, A				Guzel, Aslan; Er, Uygur; Tatli, Mehmet; Aluclu, Ufuk; Ozkan, Umit; Duzenli, Yucel; Satici, Omer; Guzel, Ebru; Kemaloglu, Serdar; Ceviz, Adnan; Kaplan, Abdurrahman			Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury	NEUROSURGICAL REVIEW			English	Article						neuron-specific enolase; Glasgow Coma Scale; outcome; prognosis; traumatic brain injury	SEVERE HEAD-INJURY; ACUTE ISCHEMIC-STROKE; CEREBROSPINAL-FLUID; S-100 PROTEIN; MARKERS; CHILDREN; DAMAGE; BIOMARKERS; BLOOD	Elevated serum neuron-specific enolase levels are correlated with brain cell damage. Low scores according to Glasgow Coma Scale are also considered as serious poor prognostic factor. The aims of the study were to investigate whether there is a correlation between the two measurements in patients with traumatic brain injury and whether serum neuron-specific enolase levels have potential as a screening test to predict outcome. A total of 169 consecutive patients with traumatic brain injury admitted to our clinic between 2002 and 2005 are included in this study. Those patients, who had any major health problem before trauma, were excluded from the study. However, patients with isolated head injury were included in the study. Serial serum neuron-specific enolase concentrations taken at the first 2, 24, and 48 h after traumatic brain injury were analyzed. A computed tomography was performed on each patient on admission. Their Glasgow Coma Scale scores were recorded serially. The relationship between Glasgow Coma Scale scores and the serum neuron-specific enolase levels were assessed by statistical methods. There was a significant negative correlation between the serum neuron-specific enolase levels and Glasgow Coma Scale scores. The levels of neuron-specific enolase were significantly higher in the patients who died in 30 days after trauma and whose scores were lower than or equal to 8 points in Glasgow Coma Scale. Although there are several serious limitations of the use of neuron-specific enolase as a biomarker in traumatic brain injury (i.e., hypoperfusion, extracranial trauma, bleeding, liver, or kidney damage also increase the level of neuron-specific enolase), its concentrations may be useful as a practical and helpful screening test to identify neurotrauma patients who are at increased risk and may provide supplementary estimation with radiological and clinical findings.	[Guzel, Aslan; Tatli, Mehmet; Ozkan, Umit; Duzenli, Yucel; Kemaloglu, Serdar; Ceviz, Adnan] Dicle Univ, Fac Med, Dept Neurosurg, Diyarbakir, Turkey; [Er, Uygur] Diskapi Yildirim Bayezit Training & Res Hosp, Neusurg Clin 2, Ankara, Turkey; [Aluclu, Ufuk] Dicle Univ, Fac Med, Dept Neurol, Diyarbakir, Turkey; [Satici, Omer] Dicle Univ, Fac Med, Dept Biostat, Diyarbakir, Turkey; [Guzel, Ebru] Veni Vidi Hosp, Radiol Clin, Diyarbakir, Turkey; [Kaplan, Abdurrahman] Dicle Univ, Fac Med, Dept Biochem, Diyarbakir, Turkey		Er, U (corresponding author), Sogutozu C,4th Sk 22-7, TR-06510 Ankara, Turkey.	uygurer@gmail.com	ALUCLU, MEHMET/A-6726-2016				Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Beems T, 2003, ACTA NEUROCHIR, V145, P37, DOI 10.1007/s00701-002-1019-1; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Casmiro M, 2005, EUR J NEUROL, V12, P369, DOI 10.1111/j.1468-1331.2004.01021.x; Cho T, 2006, CRIT CARE MED, V34, pA2, DOI 10.1097/00003246-200612002-00007; Guan Wei, 2003, Chin J Traumatol, V6, P218; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Kruijk J.R., 2001, ACTA NEUROL SCAND, V103, P175; Li Ning, 2004, Chin J Traumatol, V7, P156; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2004, SHOCK, V22, P88, DOI 10.1097/01.shk.0000130157.34382.3f; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; SCHAARSCHMIDT H, 1994, STROKE, V25, P558, DOI 10.1161/01.STR.25.3.558; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 2000, J TRAUMA, V49, P570, DOI 10.1097/00005373-200009000-00033; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	28	53	57	2	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	OCT	2008	31	4					439	444		10.1007/s10143-008-0148-2			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	344YF	WOS:000258962500017	18560914				2022-02-06	
J	Deguise, E; LeBlanc, J; Feyz, M; Meyer, K; Duplantie, J; Thomas, H; Abouassaly, M; Champoux, MC; Couturier, C; Lin, H; Lu, L; Robinson, C; Roger, E				deGuise, Elaine; LeBlanc, Joanne; Feyz, Mitra; Meyer, Kim; Duplantie, Jennifer; Thomas, Harle; Abouassaly, Michel; Champoux, Marie-Claude; Couturier, Celine; Lin, Howell; Lu, Lucy; Robinson, Cathlyn; Roger, Eric			Long-term outcome after severe traumatic brain injury: The McGill Interdisciplinary Prospective Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; functional; multidisciplinary; outcome; physical; psychosocial; traumatic brain injury	SEVERE HEAD-INJURY; FOLLOW-UP; ACUTE PREDICTORS; VARIABLES; SCALE; DISABILITY; MODERATE	Objective: To obtain a comprehensive understanding of long-term outcome after severe traumatic brain injury (sTBI). Participants: Forty-six patients with sTBI. Design: Comparison of interdisciplinary evaluation results at discharge from acute care and at 2 to 5 year follow-up. Main Measures: Extended Glasgow Outcome Scale, the FIM (TM) instrument, and the Neurobehavioral Rating Scale-Revised. Results: Significant improvement was observed on the FIM (TM) instrument, the Extended Glasgow Outcome Scale, and on 3 factors of the Neurobehavioral Rating Scale-Revised. These measures at discharge were significant predictors of outcome. Conclusion: Patients with sTBI 2 to 5 years postinjury showed relatively good physical and functional outcome but poorer cognitive and emotional outcome.	[deGuise, Elaine; LeBlanc, Joanne; Feyz, Mitra; Meyer, Kim; Duplantie, Jennifer; Thomas, Harle; Abouassaly, Michel; Champoux, Marie-Claude; Couturier, Celine; Lin, Howell; Robinson, Cathlyn] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Roger, Eric] SUNY Buffalo, Buffalo, NY 14260 USA		LeBlanc, J (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Local D13-124,1650 Ave, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca					Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	29	53	55	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2008	23	5					294	303		10.1097/01.HTR.0000336842.53338.f4			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	357GN	WOS:000259834400004	18815506				2022-02-06	
J	Halpern, CH; Reilly, PM; Turtz, AR; Stein, SC				Halpern, Casey H.; Reilly, Patrick M.; Turtz, Alan R.; Stein, Sherman C.			Traumatic coagulopathy: The effect of brain injury	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	56th Annual Meeting of the Congress-of-Neurological-Surgeons	OCT 07-12, 2006	Chicago, IL	Congress Neurol Surg		disseminated intravascular coagulation; prothrombin time; tissue factor; trauma; traumatic brain injury	DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE FACTOR; HEAD-INJURY; HEMORRHAGE; BARRIER; PATIENT; ABNORMALITIES; DYSFUNCTION; EXPRESSION; DISORDERS	Traumatic coagulopathy has several possible mechanisms. In traumatic brain injury (TBI), the principal process involves the release of tissue factor (TF). There is no agreement how common this mechanism is following general trauma. Furthermore, when TF-induced coagulopathy occurs, it is unknown whether the source of TF (TBI or extracranial trauma) influences the course of coagulopathy. We undertook this investigation to address both questions. The temporal course of prothrombin times (PTs) were recorded in a group (n = 441) with isolated TBI (head Abbreviated Injury Scale [AIS] >= 3, non-head AIS < 3) and a group (n = 101) with extracranial trauma (non-TBI; non-head AIS >= 3; head AIS < 3). Data were arranged according to preset time intervals after injury. The PT values in both groups were elevated and not significantly different for the first 12 h after trauma. Values then fell to normal in TBI patients, but remained elevated in non-TBI injury. Traumatic coagulopathy can be explained at least in part by TF release into the general circulation with activation of the coagulation cascade in both TBI and non-TBI. We hypothesize that the different time courses of coagulopathy represented by PT values in these populations were due to reconstitution of the blood-brain barrier, although further investigation is warranted. Peripheral hematologic studies may not reflect persistent coagulopathy in cerebral circulation.	[Halpern, Casey H.; Stein, Sherman C.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Reilly, Patrick M.] Hosp Univ Penn, Div Trauma & Surg Crit Care, Philadelphia, PA 19104 USA; [Turtz, Alan R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Hosp Univ Med Ctr, Dept Surg Neurosurg, Camden, NJ 08103 USA		Halpern, CH (corresponding author), Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St,3rd Floor,Silverstein Pavil, Philadelphia, PA 19104 USA.	casey.halpern@uphs.upenn.edu					Adelson PD, 1998, ACT NEUR S, V71, P104; Anderson CA, 2002, NURS OUTLOOK, V50, P85, DOI 10.1067/mno.2002.125271; ATTAR S, 1969, J TRAUM, V9, P939, DOI 10.1097/00005373-196911000-00004; AUER L, 1978, ACTA NEUROCHIR, V43, P51, DOI 10.1007/BF01809225; Beaumont A, 2002, ACT NEUR S, V81, P217; BREDBACKA S, 1992, J NEUROSURG ANESTH, V4, P128, DOI 10.1097/00008506-199204000-00008; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; CLARK JA, 1980, J NEUROSURG, V52, P266, DOI 10.3171/jns.1980.52.2.0266; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cortiana M, 1986, J Neurosurg Sci, V30, P133; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; DeLoughery TG, 2004, CRIT CARE CLIN, V20, P13, DOI 10.1016/S0749-0704(03)00089-7; DRAKE TA, 1989, AM J PATHOL, V134, P1087; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Gando S, 1997, CRIT CARE MED, V25, P1820, DOI 10.1097/00003246-199711000-00019; Gando S, 2006, SEMIN THROMB HEMOST, V32, P48, DOI 10.1055/s-2006-933340; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Gando S, 1999, ANN SURG, V229, P121, DOI 10.1097/00000658-199901000-00016; Garrison JR, 1996, J TRAUMA, V40, P923, DOI 10.1097/00005373-199606000-00010; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Ho AMH, 2005, AM J SURG, V190, P479, DOI 10.1016/j.amjsurg.2005.03.034; Holcomb JB, 2005, MIL MED, V170, P287, DOI 10.7205/MILMED.170.4.287; HOOTS WK, 1996, NEUROTRAUMA, P673; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; ORDOG GJ, 1985, ANN EMERG MED, V14, P650, DOI 10.1016/S0196-0644(85)80881-7; Osterud B, 1997, THROMB HAEMOSTASIS, V78, P755; Osterud B, 2001, SEMIN THROMB HEMOST, V27, P605, DOI 10.1055/s-2001-18866; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Schreiber MA, 2005, CURR OPIN CRIT CARE, V11, P590, DOI 10.1097/01.ccx.0000186374.49320.ab; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Utter GH, 2002, J TRAUMA, V52, P1071, DOI 10.1097/00005373-200206000-00008; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357	44	53	66	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2008	25	8					997	1001		10.1089/neu.2008.0548			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	343ZT	WOS:000258895700005	18687038				2022-02-06	
J	Ruchelsman, DE; Tejwani, NC; Kwon, YW; Egol, KA				Ruchelsman, David E.; Tejwani, Nirmal C.; Kwon, Young W.; Egol, Kenneth A.			Open reduction and internal fixation of capitellar fractures with headless screws	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							CORONAL SHEAR FRACTURES; DISTAL END; HUMERUS	Background: The outcome of operatively treated capitellar fractures has not been reported frequently. The purpose of the present study was to evaluate the clinical, radiographic, and functional outcomes following open reduction and internal fixation of capitellar fractures that were treated with a uniform surgical approach in order to further define the impact on the outcome of fracture type and concomitant lateral column osseous and/or ligamentous injuries. Methods: A retrospective evaluation of the upper extremity database at our institution identified sixteen skeletally mature patients (mean age, 40 +/- 17 years) with a closed capitellar fracture. In all cases, an extensile lateral exposure and articular fixation with buried cannulated variable-pitch headless compression screws was performed at a mean of ten days after the injury. Clinical, radiographic, and elbow-specific outcomes, including the Mayo Elbow Performance Index, were evaluated at a mean of 27 +/- 19 months postoperatively. Results: Six Type-I, two Type-III, and eight Type-IV fractures were identified with use of the Bryan and Morrey classification system. Four of five ipsilateral radial head fractures occurred in association with a Type-IV fracture. The lateral collateral ligament was intact in fifteen of the sixteen elbows. Metaphyseal comminution was observed in association with five fractures (including four Type-IV fractures and one Type-III fracture). Supplemental mini-fragment screws were used for four of eight Type-IV fractures and one of two Type-III fractures. All fractures healed, and no elbow had instability or weakness. Overall, the mean ulnohumeral motion was 123 degrees (range, 70 degrees to 150 degrees). Fourteen of the sixteen patients achieved a functional arc of elbow motion, and all patients had full forearm rotation. The mean Mayo Elbow Performance Index score was 92 +/- 10 points, with nine excellent results, six good results, and one fair result. Patients with a Type-IV fracture had a greater magnitude of flexion contracture (p = 0.04), reduced terminal flexion (p = 0.02), and a reduced net ulnohumeral arc (p = 0.01). An ipsilateral radial head fracture did not appear to affect ulnohumeral motion or the functional outcome. Conclusions: Despite the presence of greater flexion contractures at the time of follow-up in elbows with Type-IV fractures or fractures with an ipsilateral radial head fracture, good to excellent outcomes with functional ulnohumeral motion can be achieved following internal fixation of these complex fractures. Type-IV injuries may be more common than previously thought; such fractures often are associated with metaphyseal comminution or a radial head fracture and may require supplemental fixation. Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.	[Ruchelsman, David E.; Tejwani, Nirmal C.; Kwon, Young W.; Egol, Kenneth A.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10003 USA		Ruchelsman, DE (corresponding author), NYU, Hosp Joint Dis, Dept Orthopaed Surg, 301 E 17th St,14th Floor, New York, NY 10003 USA.	David.Ruchelsman@nyumc.org; Nirmal.Tejwani@nyumc.org; Young.Kwon@nyumc.org; egolk01@nyumc.org		Tejwani, Nirmal/0000-0001-8578-6556; Kwon, Young/0000-0003-2465-9945			ALVAREZ E, 1975, J BONE JOINT SURG AM, V57, P1093, DOI 10.2106/00004623-197557080-00010; [Anonymous], 1996, J ORTHOP TRAUMA, V10, pV; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; Bryan R., 1985, ELBOW ITS DISORDERS, P325; Doornberg JN, 2007, J BONE JOINT SURG AM, V89A, P1524, DOI 10.2106/JBJS.F.00369; Dubberley JH, 2006, J BONE JOINT SURG AM, V88A, P46, DOI 10.2106/JBJS.D.02954; DUSHUTTLE RP, 1985, J TRAUMA, V25, P317, DOI 10.1097/00005373-198504000-00006; Elkowitz SJ, 2002, J ORTHOP TRAUMA, V16, P503, DOI 10.1097/00005131-200208000-00009; Elkowitz Stuart J, 2003, Bull Hosp Jt Dis, V61, P123; FOWLES JV, 1974, J BONE JOINT SURG AM, VA 56, P794, DOI 10.2106/00004623-197456040-00013; Goodman HJ, 2005, BULL HOSP JT DIS, V62, P85; GRANTHAM SA, 1981, CLIN ORTHOP RELAT R, P262; Imatani J, 2001, J SHOULDER ELB SURG, V10, P554, DOI 10.1067/mse.2001.118005; King GJW, 1999, J SHOULDER ELB SURG, V8, P351; MA YZ, 1984, CLIN ORTHOP RELAT R, P17; Mahirogullari M, 2006, J HAND SURG-BRIT EUR, V31B, P320, DOI 10.1016/j.jhsb.2006.02.002; Matelic TM, 1996, J ORTHOP TRAUMA, V10, P1, DOI 10.1097/00005131-199601000-00001; McKee MD, 1996, J BONE JOINT SURG AM, V78A, P49, DOI 10.2106/00004623-199601000-00007; Mighell MA, 2006, J ORTHOP TRAUMA, V20, P699, DOI 10.1097/01.bot.0000246411.33047.80; Morrey BF, 1985, ELBOW ITS DISORDERS, V3rd, P73; Ochner RS, 1996, J TRAUMA, V40, P199, DOI 10.1097/00005373-199602000-00005; ODRISCOLL SW, 1992, CLIN ORTHOP RELAT R, P186; Ring D, 2003, J BONE JOINT SURG AM, V85A, P232, DOI 10.2106/00004623-200302000-00008; Sano S, 2005, J SHOULDER ELB SURG, V14, P307, DOI 10.1016/j.jse.2004.09.005; Stamatis E, 2003, J ORTHOP TRAUMA, V17, P279, DOI 10.1097/00005131-200304000-00006	26	53	59	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	JUN	2008	90A	6					1321	1329		10.2106/JBJS.G.00940			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	309JL	WOS:000256456400020	18519327				2022-02-06	
J	Hu, K; Peng, CK; Czosnyka, M; Zhao, P; Novak, V				Hu, Kun; Peng, C. K.; Czosnyka, Marek; Zhao, Peng; Novak, Vera			Nonlinear assessment of cerebral autoregulation from spontaneous blood pressure and cerebral blood flow fluctuations	CARDIOVASCULAR ENGINEERING			English	Article; Proceedings Paper	Workshop on Short-Term Cardiovascular-Respiratory Control Mechanisms	OCT 09-13, 2006	Amer Inst Math, Palo Alto, CA		Amer Inst Math	spontaneous oscillations; instantaneous phase shift; Valsalva maneuver; baseline resting condition; stroke; hypertension; traumatic brain injury	ARTERIAL-PRESSURE; VELOCITY; VARIABILITY; COHERENCE; FINAPRES; DYNAMICS	Cerebral autoregulation ( CA) is an most important mechanism responsible for the relatively constant blood flow supply to brain when cerebral perfusion pressure varies. Its assessment in nonacute cases has been relied on the quantification of the relationship between noninvasive beat-to-beat blood pressure ( BP) and blood flow velocity (BFV). To overcome the nonstationary nature of physiological signals such as BP and BFV, a computational method called multimodal pressure-flow (MMPF) analysis was recently developed to study the nonlinear BP-BFV relationship during the Valsalva maneuver (VM). The present study aimed to determine (i) whether this method can estimate autoregulation from spontaneous BP and BFV fluctuations during baseline rest conditions; (ii) whether there is any difference between the MMPF measures of autoregulation based on intra-arterial BP (ABP) and based on cerebral perfusion pressure (CPP); and (iii) whether the MMPF method provides reproducible and reliable measure for noninvasive assessment of autoregulation. To achieve these aims, we analyzed data from existing databases including: ( i) ABP and BFV of 12 healthy control, 10 hypertensive, and 10 stroke subjects during baseline resting conditions and during the Valsalva maneuver, and ( ii) ABP, CPP, and BFV of 30 patients with traumatic brain injury (TBI) who were being paralyzed, sedated, and ventilated. We showed that autoregulation in healthy control subjects can be characterized by specific phase shifts between BP and BFV oscillations during the Valsalva maneuver, and the BP-BFV phase shifts were reduced in hypertensive and stroke subjects (P < 0.01), indicating impaired autoregulation. Similar results were found during baseline condition from spontaneous BP and BFV oscillations. The BP-BFV phase shifts obtained during baseline and during VM were highly correlated (R > 0.8, P < 0.0001), showing no statistical difference (paired-t test P > 0.47). In TBI patients there were strong correlations between phases of ABP and CPP oscillations (R = 0.99, P < 0.0001) and, thus, between ABP-BFV and CPP-BFV phase shifts (P < 0.0001, R = 0.76). By repeating the MMPF 4 times on data of TBI subjects, each time on a selected cycle of spontaneous BP and BFV oscillations, we showed that MMPF had better reproducibility than traditional autoregulation index. These results indicate that the MMPF method, based on instantaneous phase relationships between cerebral blood flow velocity and peripheral blood pressure, has better performance than the traditional standard method, and can reliably assess cerebral autoregulation dynamics from ambulatory blood pressure and cerebral blood flow during supine rest conditions.	[Hu, Kun; Zhao, Peng; Novak, Vera] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02115 USA; [Peng, C. K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02115 USA; [Peng, C. K.] Harvard Univ, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02115 USA; [Czosnyka, Marek] Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge, England		Hu, K (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, 812 Stoneman Bldg,330 Brookline Ave, Boston, MA 02115 USA.	khu@bidmc.harvard.edu; vnovak@bidmc.harvard.edu	Peng, Chung-Kang/N-1308-2019; Hu, Kun/AAJ-1897-2020; Peng, Chung-Kang/E-1489-2011	Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833; Hu, Kun/0000-0003-0350-3132	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390, G0600986] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR013622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS053128, R01NS045745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P60AG008812, P01AG004390] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41 RR013622-076028, P41 RR013622] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P60 AG008812, P01 AG004390-250015, P60 AG008812-15S2, P01 AG004390] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045745, R01 NS045745-04, R41 NS053128-01A2, R41 NS053128] Funding Source: Medline		Aaslid R, 1992, TRANSCRANIAL DOPPLER, P49; Altman D.G., 1990, PRACTICAL STAT MED R; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carey BJ, 2003, STROKE, V34, P1871, DOI 10.1161/01.STR.0000081981.99908.F3; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dawson SL, 1999, J APPL PHYSIOL, V86, P675, DOI 10.1152/jappl.1999.86.2.675; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Giller CA, 1997, NEUROL RES, V19, P634; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Hamner JW, 2004, J PHYSIOL-LONDON, V559, P965, DOI 10.1113/jphysiol.2004.066969; HU K, 2007, PHYSICA A IN PRESS; Hu K, 2007, DIABETES, V56, pA585; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang W, 1998, P NATL ACAD SCI USA, V95, P4816, DOI 10.1073/pnas.95.9.4816; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Lipsitz LA, 2000, STROKE, V31, P1897, DOI 10.1161/01.STR.31.8.1897; Mitsis GD, 2004, IEEE T BIO-MED ENG, V51, P1932, DOI 10.1109/TBME.2004.834272; NOVAK V, 1994, J CLIN MONITOR, V10, P118, DOI 10.1007/BF02886824; Novak V, 1998, STROKE, V29, P1876, DOI 10.1161/01.STR.29.9.1876; Novak V, 2003, NEUROLOGY, V60, P1657, DOI 10.1212/01.WNL.0000068023.14587.06; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; Olufsen MS, 2002, AM J PHYSIOL-REG I, V282, pR611, DOI 10.1152/ajpregu.00285.2001; OMBONI S, 1993, HYPERTENSION, V22, P26, DOI 10.1161/01.HYP.22.1.26; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; Panerai RB, 2006, AM J PHYSIOL-HEART C, V291, pH251, DOI 10.1152/ajpheart.01348.2005; Pinna GD, 1996, PHYSIOL MEAS, V17, P147, DOI 10.1088/0967-3334/17/3/002; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; TIECKS FP, 1995, STROKE, V26, P1386, DOI 10.1161/01.STR.26.8.1386; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; WU Z, 2005, 193 CTR OC LAND ATM; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	35	53	53	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1567-8822	1573-6806		CARDIOVASC ENG	Cardiovasc. Eng.	MAR	2008	8	1					60	71		10.1007/s10558-007-9045-5			12	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology; Engineering	343SU	WOS:000258876200007	18080758	Green Accepted			2022-02-06	
J	Yang, SH; Xing, D; Lao, YQ; Yang, DW; Zeng, LM; Xiang, LZ; Chen, WR				Yang, Sihua; Xing, Da; Lao, Yeqi; Yang, Diwu; Zeng, Lvming; Xiang, Liangzhong; Chen, Wei R.			Noninvasive monitoring of traumatic brain injury and post-traumatic rehabilitation with laser-induced photoacoustic imaging	APPLIED PHYSICS LETTERS			English	Article								A photoacoustic imaging system was used for noninvasive monitoring of traumatic mouse brain in vivo with high-quality reconstructed images. Traumatic lesions accompanying with hemorrhage in the mouse cortical surface were accurately mapped, and foreign bodies of two small copper wires inserted in the mouse brain were also detected. Furthermore, the time course of morphological changes of cerebral blood during rehabilitation process of a mouse brain with traumatic brain injury was obtained using a series of photoacoustic images. Experimental results demonstrate that photoacoustic technique holds the potential for clinical applications in brain trauma and cerebrovascular disease detection. (c) 2007 American Institute of Physics.	S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China; S China Normal Univ, Inst Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China		Xing, D (corresponding author), S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China.	xingda@scnu.edu.cn	Xiang, Liangzhong/C-8458-2016	Xiang, Liangzhong/0000-0002-7228-0510			Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Kruger RA, 1999, RADIOLOGY, V211, P275, DOI 10.1148/radiology.211.1.r99ap05275; Siphanto RI, 2005, OPT EXPRESS, V13, P89, DOI 10.1364/OPEX.13.000089; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804; Wang Y, 2004, PHYS MED BIOL, V49, P3117, DOI 10.1088/0031-9155/49/14/006; Xiang LZ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2437752; Yang DW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198488; Yang DW, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2119417; Yang SH, 2007, EUR PHYS J-APPL PHYS, V37, P87, DOI 10.1051/epjap:2006136; Yuan Z, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209883; Zeng YG, 2004, OPT LETT, V29, P1760, DOI 10.1364/OL.29.001760	13	53	63	3	33	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	JUN 11	2007	90	24							243902	10.1063/1.2749185			3	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	179QR	WOS:000247305400109					2022-02-06	
J	McEwen, ML; Sullivan, PG; Springer, JE				McEwen, Melanie L.; Sullivan, Patrick G.; Springer, Joe E.			Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats	JOURNAL OF NEUROTRAUMA			English	Article						cyclosporin A; mitochondria; permeability transition; reactive oxygen species; spinal cord injury	PERMEABILITY TRANSITION PORE; INTERMEMBRANE JUNCTIONAL COMPLEXES; TRAUMATIC BRAIN-INJURY; P-GLYCOPROTEIN; CYCLOPHILIN-D; THERAPEUTIC TARGET; COMPRESSION TRAUMA; AXONAL DAMAGE; CELL-DEATH; BLOOD	Trauma to the spinal cord causes a cascade of secondary events, such as mitochondrial dysfunction, which disrupts cellular functions and ultimately leads to cell death. Cyclosporin A (CsA) is a potent immunosuppressant that promotes mitochondrial function by inhibiting mitochondrial permeability transition (mPT). Clinical trials examining CsA in traumatic brain injury are currently underway, but CsA is potentially neurotoxic. NIM811 is a non-immunosuppressive CsA derivative that inhibits mPT at nanomolar concentrations and with significantly less cytotoxicity than CsA. In the present study, we investigated the effects of NIM811 treatment on mitochondrial bioenergetics and the production of reactive oxygen species following spinal cord injury (SCI) in rats. Rats were pre-treated with NIM811 or vehicle, and after 15 min the rats received a "mild/moderate" spinal cord contusion. After 24 h, the spinal cords were rapidly removed and synaptosomal mitochondria were isolated. NIM811 pretreatment significantly improved mitochondrial respiratory control ratios, and the maximal electron transport capacity of complex I and II, as well as their ATP-producing capacity. Consistent with the improvements in mitochondrial function, NIM811 pretreatment significantly decreased free radical production in isolated mitochondria. These studies are the first to demonstrate the therapeutic potential of CsA derivatives in a model of SCI, and support the need for continued investigation of compounds like NIM811 as an acute treatment for human SCI.	Univ Kentucky, Ctr Med, Dept Phys Med & Rehabil, Lexington, KY 40536 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		McEwen, ML (corresponding author), Univ Kentucky, Ctr Med, Dept Phys Med & Rehabil, 800 Rose St,MN225, Lexington, KY 40536 USA.	mlmcew2@uky.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS46380] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046380] Funding Source: NIH RePORTER		Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bao F, 2005, J NEUROCHEM, V94, P1361, DOI 10.1111/j.1471-4159.2005.03280.x; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BEGLEY DJ, 1990, J NEUROCHEM, V55, P1222, DOI 10.1111/j.1471-4159.1990.tb03128.x; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H; CEFALU WT, 1985, J NEUROCHEM, V45, P1954, DOI 10.1111/j.1471-4159.1985.tb10557.x; CHOI DW, 1987, J NEUROSCI, V7, P369; Crompton M, 2003, CURR MED CHEM, V10, P1473, DOI 10.2174/0929867033457197; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; DYKENS JA, 1994, J NEUROCHEM, V63, P584; Faden A I, 1997, Adv Neurol, V72, P377; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; FOXWELL BMJ, 1989, MOL PHARMACOL, V36, P543; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Ibarra A, 2003, BRAIN RES, V979, P165, DOI 10.1016/S0006-8993(03)02898-1; Jemmerson R, 2005, ANTIOXID REDOX SIGN, V7, P1158, DOI 10.1089/ars.2005.7.1158; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; Khodorov B, 1996, FEBS LETT, V393, P135, DOI 10.1016/0014-5793(96)00873-3; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; LEMAIRE M, 1988, J PHARMACOL EXP THER, V244, P740; LEONG SF, 1984, J NEUROCHEM, V42, P1306, DOI 10.1111/j.1471-4159.1984.tb02788.x; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Liu XZ, 1997, J NEUROSCI, V17, P5395; Luo J, 2005, NEUROCHEM RES, V30, P291, DOI 10.1007/s11064-005-2602-7; Maragos WF, 2004, J NEUROCHEM, V91, P257, DOI 10.1111/j.1471-4159.2004.02736.x; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; NIEDERBERGER W, 1983, TRANSPLANT P, V15, P2419; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Peng TI, 1998, MOL PHARMACOL, V53, P974; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; RYFFEL B, 1991, J RECEPTOR RES, V11, P675, DOI 10.3109/10799899109066435; SAEKI T, 1993, J BIOL CHEM, V268, P6077; SAKATA A, 1994, BIOCHEM PHARMACOL, V48, P1989, DOI 10.1016/0006-2952(94)90601-7; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TSUJI A, 1993, BIOCHEM PHARMACOL, V46, P1096, DOI 10.1016/0006-2952(93)90677-O; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WAGNER O, 1987, J PHARMACOL EXP THER, V244, P740; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	95	53	56	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2007	24	4					613	624		10.1089/neu.2006.9969			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	159NE	WOS:000245872000004	17439345				2022-02-06	
J	Stone, TW; Behan, WMH				Stone, Trevor W.; Behan, Wilhelmina M. H.			Interleukin-1 beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: Protection by an adenosine A(2A) receptor antagonist	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						kynurenines; kynurenic acid; quinolinic acid; excitotoxicity; cytokines; interleukin-1 beta; tumor necrosis factor-alpha; TNF-alpha; hippocampus	HIPPOCAMPAL SLICE CULTURES; CENTRAL-NERVOUS-SYSTEM; TRANSIENT CEREBRAL-ISCHEMIA; EXCITOTOXIC BRAIN-DAMAGE; CONVERT L-TRYPTOPHAN; TNF-ALPHA; RAT-BRAIN; CELL-DEATH; CEREBROSPINAL-FLUID; INFLAMMATORY CYTOKINES	Quinolinic acid is an agonist at glutamate receptors sensitive to N-methyl-D-aspartate (NMDA). It has been implicated in neural dysfunction associated with infections, trauma, and ischemia, although its neurotoxic potency is relatively low. This study was designed to examine the effects of a combination of quinolinic acid and the proinflammatory cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor-a (TNF-alpha). Compounds were administered to the hippocampus of anesthetized male rats, animals being allowed to recover for 7 days before histological analysis of the hippocampus for neuronal damage estimated by counting of intact, healthy neurons. A low dose of quinolinic acid or IL-1 beta produced no damage by itself, but the two together induced a significant loss of pyramidal neurons in the hippocampus. Higher doses produced almost total loss of pyramidal cells. Intrahippocampal TNF-alpha produced no effect alone but significantly reduced the neuronal loss produced by quinolinic acid. The adenosine A(2A) receptor antagonist ZM241385 reduced neuronal loss produced by the combinations of quinolinic acid and IL-1 beta P. The results suggest that simultaneous quinolinic acid and IL-1 P, both being induced by cerebral infection or injury, are synergistic in the production of neuronal damage and could together contribute substantially to traumatic, infective, or ischemic cerebral damage. Antagonism of adenosine A(2A) receptors protects neurons against the combination of quinolinic acid and IL-1 beta. (c) 2007 Wiley-Liss, Inc.	Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Pathol, Glasgow G12 8QQ, Lanark, Scotland		Stone, TW (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, W Med Bldg, Glasgow G12 8QQ, Lanark, Scotland.	t.w.stone@bio.gla.ac.uk	Stone, Trevor/M-7904-2015	Stone, Trevor/0000-0002-5532-0031			Alexeev AM, 2001, PHYS LOW-DIMENS STR, V3-4, P1; Allan SM, 2002, J NEUROSCI RES, V67, P428, DOI 10.1002/jnr.10142; Allan SM, 1998, MOL PSYCHIATR, V3, P178, DOI 10.1038/sj.mp.4000351; Angstwurm K, 1998, NEUROSCIENCE, V86, P627, DOI 10.1016/S0306-4522(98)00032-3; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Behan WMH, 1999, BRIT J PHARMACOL, V128, P1754, DOI 10.1038/sj.bjp.0702940; Behan WMH, 2000, BRIT J PHARMACOL, V129, P1764, DOI 10.1038/sj.bjp.0703250; Behan WMH, 2002, BRIT J PHARMACOL, V135, P1435, DOI 10.1038/sj.bjp.0704613; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Canellada A, 2006, MOL CELL NEUROSCI, V31, P692, DOI 10.1016/j.mcn.2005.12.008; Carlson NG, 1999, J IMMUNOL, V163, P3963; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Chiarugi A, 2001, J NEUROIMMUNOL, V120, P190, DOI 10.1016/S0165-5728(01)00418-0; CHUNG IY, 1990, J IMMUNOL, V144, P2999; CUNHA RA, 1994, BRAIN RES, V649, P208, DOI 10.1016/0006-8993(94)91066-9; De A, 2003, BRAIN RES, V981, P133, DOI 10.1016/S0006-8993(03)02997-4; Dimopoulos N, 2006, NEUROSCI LETT, V398, P118, DOI 10.1016/j.neulet.2005.12.064; Eriksson C, 2000, J NEUROSCI RES, V60, P266, DOI 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P; Espey MG, 1997, NEUROREPORT, V8, P431, DOI 10.1097/00001756-199701200-00011; GALARRAGA E, 1990, BRAIN RES, V512, P269, DOI 10.1016/0006-8993(90)90636-P; GAO Y, 1994, LIFE SCI, V55, pPL61, DOI 10.1016/0024-3205(94)00889-2; GIULIAN D, 1990, SCIENCE, V250, P1593, DOI 10.1126/science.2148832; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Grundy RI, 2002, BRAIN RES, V926, P142, DOI 10.1016/S0006-8993(01)03325-X; Hailer NP, 2005, EUR J NEUROSCI, V21, P2347, DOI 10.1111/j.1460-9568.2005.04067.x; Harada N, 2000, J PHARMACOL EXP THER, V294, P1034; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; HEYES MP, 1991, ANN NEUROL, V29, P202, DOI 10.1002/ana.410290215; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; HEYES MP, 1992, BRAIN RES, V570, P237, DOI 10.1016/0006-8993(92)90587-Y; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; HEYES MP, 1989, ANN NEUROL, V26, P275; HEYES MP, 1990, J CEREBR BLOOD F MET, V10, P660, DOI 10.1038/jcbfm.1990.119; HEYES MP, 1990, ANN NEUROL, V27, P666, DOI 10.1002/ana.410270614; Jones PA, 1998, BRAIN RES, V800, P328, DOI 10.1016/S0006-8993(98)00540-X; Jones PA, 1998, NEUROSCIENCE, V85, P229, DOI 10.1016/S0306-4522(97)00613-1; Kerr SJ, 1998, AIDS, V12, P355, DOI 10.1097/00002030-199804000-00003; KHASPEKOV L, 1989, J NEUROSCI RES, V22, P150, DOI 10.1002/jnr.490220207; Koller H, 2001, BRAIN RES, V893, P237, DOI 10.1016/S0006-8993(00)03318-7; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lukashev DE, 2005, DRUG DEVELOP RES, V64, P172, DOI 10.1002/ddr.10428; Mascarucci P, 1998, NEUROSCIENCE, V86, P1285, DOI 10.1016/S0306-4522(98)00105-5; Meistrell ME, 1997, SHOCK, V8, P341; MOFFETT JR, 1994, CELL TISSUE RES, V278, P461; MOFFETT JR, 1993, BRAIN RES, V623, P337, DOI 10.1016/0006-8993(93)91450-7; Monopoli A, 1998, NEUROREPORT, V9, P3955, DOI 10.1097/00001756-199812010-00034; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Palmer TM, 1995, MOL PHARMACOL, V48, P970; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Pelidou SH, 2002, J NEUROIMMUNOL, V133, P108, DOI 10.1016/S0165-5728(02)00369-7; Pemberton LA, 1997, J INTERF CYTOK RES, V17, P589, DOI 10.1089/jir.1997.17.589; Perry RT, 2001, NEUROBIOL AGING, V22, P873, DOI 10.1016/S0197-4580(01)00291-3; Platenik J, 2001, FREE RADICAL RES, V34, P445, DOI 10.1080/10715760100300391; Pringle AK, 2001, NEUROSCI LETT, V305, P29, DOI 10.1016/S0304-3940(01)01795-5; Radesater AC, 2003, NEUROTOX RES, V5, P433, DOI 10.1007/BF03033173; RIOS C, 1991, NEUROCHEM RES, V16, P1139, DOI 10.1007/BF00966592; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; SAITO K, 1993, J NEUROCHEM, V60, P180, DOI 10.1111/j.1471-4159.1993.tb05836.x; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; Santamaria A, 2001, NEUROREPORT, V12, P2693, DOI 10.1097/00001756-200108280-00020; Santamaria A, 2001, NEUROREPORT, V12, P871, DOI 10.1097/00001756-200103260-00049; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Sheardown MJ, 1996, DRUG DEVELOP RES, V39, P108; Shen Y, 1997, J BIOL CHEM, V272, P3550, DOI 10.1074/jbc.272.6.3550; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Sipe KJ, 1996, MOL BRAIN RES, V38, P222, DOI 10.1016/0169-328X(95)00310-O; Stipek S, 1997, NEUROCHEM INT, V30, P233, DOI 10.1016/S0197-0186(97)90002-4; STONE TW, 1993, PHARMACOL REV, V45, P309; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; STRIJBOS JP, 1995, J NEUROSCI, V15, P3468; Stroemer RP, 1998, J CEREBR BLOOD F MET, V18, P833, DOI 10.1097/00004647-199808000-00003; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Viviani B, 2003, J NEUROSCI, V23, P8692; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; WHETSELL WO, 1989, NEUROSCI LETT, V97, P271, DOI 10.1016/0304-3940(89)90609-5; Wilde GJC, 2000, EUR J NEUROSCI, V12, P3863, DOI 10.1046/j.1460-9568.2000.00273.x; Yu ACH, 2000, NEUROCHEM INT, V36, P369, DOI 10.1016/S0197-0186(99)00145-X; Yu ZF, 2002, NEUROBIOL DIS, V11, P199, DOI 10.1006/nbdi.2002.0530; Zhu YY, 2006, NEUROSCI LETT, V393, P122, DOI 10.1016/j.neulet.2005.08.072; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	92	53	56	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	APR	2007	85	5					1077	1085		10.1002/jnr.21212			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	157NK	WOS:000245726700015	17304576				2022-02-06	
J	Friess, SH; Ichord, RN; Owens, K; Ralston, J; Rizol, R; Overall, KL; Smith, C; Helfaer, MA; Margulies, SS				Friess, Stuart H.; Ichord, Rebecca N.; Owens, Kristin; Ralston, Jill; Rizol, Rebecca; Overall, Karen L.; Smith, Colin; Helfaer, Mark A.; Margulies, Susan S.			Neurobehavioral functional deficits following closed head injury in the neonatal pig	EXPERIMENTAL NEUROLOGY			English	Article						head injury; neurobehavioral assessment; axonal injury	HYPOTHERMIC CIRCULATORY ARREST; TRAUMATIC BRAIN-INJURY; ASPHYXIC CARDIAC-ARREST; OPEN-FIELD ACTIVITY; HYPOXIA-ISCHEMIA; NEWBORN PIGS; CARDIOPULMONARY BYPASS; AXONAL INJURY; RAT; METABOLISM	Neurobehavioral deficits in higher cortical systems have not been described previously in a large animal model of diffuse brain injury. Anesthetized 3-5 day old piglets were subjected to either mild (142 rad/s) or moderate (188 rad/s) rapid non-impact axial rotations of the head. Multiple domains of cortical function were evaluated 5 times during the 12 day post-injury period using tests of neurobehavioral function devised for piglets. There were no observed differences in neurobehavioral outcomes between mild injury pigs (N=8) and instrumented shams (N=4). Moderately injured piglets (N=7) had significantly lower interest in exploring their environment and had higher failure rates in visual-based problem solving compared to instrumented shams (N=5) on days 1 and 4 after injury. Neurobehavioral functional deficits correlated with neuropathologic damage in the neonatal pigs after inertial head injury. Injured axons detected by immunohistochemistry (beta-APP) were absent in mild injury and sham piglets, but were observed in moderately injured piglet brains. In summary, we have developed a quantitative battery of neurobehavioral functional assessments for large animals that correlate with neuropathologic axonal damage and may have wide applications in the fields of cardiac resuscitation, stroke, and hypoxic-ischemic brain injury. (c) 2006 Elsevier Inc. All rights reserved.	Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Dept Bioengn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Western Gen Hosp, Dept Neuropathol, Edinburgh, Midlothian, Scotland		Margulies, SS (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS39679, R01 NS039679] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER		Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Agnew DM, 2003, PEDIATR RES, V54, P253, DOI 10.1203/01.PDR.0000072783.22373.FF; Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Bona E, 1997, PEDIATR RES, V42, P678, DOI 10.1203/00006450-199711000-00021; Brambrink AM, 1999, J CEREBR BLOOD F MET, V19, P927, DOI 10.1097/00004647-199908000-00012; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; Fisher M D, 1997, Crit Care Nurs Q, V20, P36; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; HAMMELL DL, 1975, J ANIM SCI, V40, P573, DOI 10.2527/jas1975.403573x; Head E, 1997, PHYSIOL BEHAV, V62, P963, DOI 10.1016/S0031-9384(97)00198-4; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Kurth CD, 1999, J THORAC CARDIOV SUR, V118, P1068, DOI 10.1016/S0022-5223(99)70103-0; Martin LJ, 1997, J COMP NEUROL, V377, P262, DOI 10.1002/(SICI)1096-9861(19970113)377:2<262::AID-CNE8>3.0.CO;2-1; MIDULLA PS, 1994, J CARDIAC SURG, V9, P560; OMMAYA A, 1966, P 11 STAPP CAR CRASH, P73; Ozden S, 2004, J NEUROTRAUM, V21, P73, DOI 10.1089/089771504772695968; PIERCE K, 2001, PHYSIOL BEHAV, V68, P571; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Priestley MA, 2001, J THORAC CARDIOV SUR, V121, P336, DOI 10.1067/mtc.2001.112338; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Puppe B, 1999, LAB ANIM, V33, P215, DOI 10.1258/002367799780578110; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rossier J, 2003, BEHAV NEUROSCI, V117, P412, DOI 10.1037/0735-7044.117.3.412; Schultz S, 2004, ANN THORAC SURG, V77, P2138, DOI 10.1016/j.athoracsur.2003.12.047; Slotnick B, 2001, TRENDS COGN SCI, V5, P216, DOI 10.1016/S1364-6613(00)01625-9; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; YOUNG JK, 1986, PHYSIOL BEHAV, V36, P881, DOI 10.1016/0031-9384(86)90447-6	35	53	56	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	MAR	2007	204	1					234	243		10.1016/j.expneurol.2006.10.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	148PC	WOS:000245086100023	17174304	Green Accepted			2022-02-06	
J	Tisdall, MM; Tachtsidis, I; Leung, TS; Elwell, CE; Smith, M				Tisdall, Martin M.; Tachtsidis, Ilias; Leung, Terence S.; Elwell, Clare E.; Smith, Martin			Near-infrared spectroscopic quantification of changes in the concentration of oxidized cytochrome c oxidase in the healthy human brain during hypoxemia	JOURNAL OF BIOMEDICAL OPTICS			English	Article						cytochrome c oxidase; near infrared spectroscopy; cerebral monitoring	CARDIOPULMONARY BYPASS; REDOX STATE; ADULT BRAIN; REDUCTION; TISSUE; OXYGENATION; DYSFUNCTION; SURGERY	The near-IR cytochrome c oxidase (CCO) signal has potential as a clinical marker of changes in mitochondrial oxygen utilization. We examine the CCO signal response to reduced oxygen delivery in the healthy human brain. We induced a reduction in arterial oxygen saturation from baseline levels to 80% in eight healthy adult humans, while minimizing changes in end tidal carbon dioxide tension. We measured changes in the cerebral concentrations of oxidized CCO (Delta[oxCCO], oxyhemoglobin (Delta[HbO(2)]), and deoxyhemoglobin bin (Delta[HHb]) using broadband near-IR spectroscopy (NIRS), and estimated changes in cerebral oxygen delivery (ecDO(2)) using pulse oximetry and transcranial Doppler ultrasonography. Results are presented as median (interquartile range). At the nadir of hypoxemia ecDO2 decreased by 9.2 (5.4 to 12.1)% (p< 0.0001), Delta[oxCCO] decreased by 0.24 (0.06 to 0.28) micromoles/l (p < 0.01), total hemoglobin concentration increased by 2.83 (2.27 to 4.46) micromoles/I (p < 0.0001), and change in hemoglobin difference concentration (Delta[Hbdiff] = Delta[HbO(2)]- Delta[HHb]) decreased by 12.72 (11.32 to 16.34) micromoles/I (p < 0.0001). Change in ecDO(2) correlated with Delta[oxCCO] (r=0.78, p < 0.001), but not with either change in total hemoglobin concentration or Delta[Hbdiff]. This is the first description of cerebral Delta[oxCCO] during hypoxemia in healthy adults. Studies are ongoing to investigate the clinical relevance of this signal in patients with traumatic brain injury. (C) 2007 Society of Photo-Optical Instrumentation Engineers.	Natl Hosp Neurol & Neurosurg, Dept Neuroanesthesia & Neurocrit Care, London WC1N 3BG, England; UCL, Dept Med Phys & Bioengn, London WC1E 6BT, England		Tisdall, MM (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Neuroanesthesia & Neurocrit Care, Queen Sq, London WC1N 3BG, England.	m.tisdall@ion.ucl.ac.uk	Smith, Martin/B-2616-2009; Tachtsidis, Ilias/N-2747-2018	Tachtsidis, Ilias/0000-0002-8125-0313; Elwell, Clare/0000-0002-7281-7234; Tisdall, Martin/0000-0001-8880-8386	EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/D060982/1] Funding Source: UKRI		BROWN GC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P273, DOI 10.1016/S0005-2728(05)80109-4; COOPER CE, 1994, BIOCHEM SOC T, V22, P974, DOI 10.1042/bst0220974; Cooper CE, 1999, J CEREBR BLOOD F MET, V19, P27, DOI 10.1097/00004647-199901000-00003; Cooper CE, 1998, BIOCHEM J, V332, P627, DOI 10.1042/bj3320627; Cooper CE, 1997, PHILOS T R SOC B, V352, P669, DOI 10.1098/rstb.1997.0048; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; DRABKIN DL, 1951, PHYSIOL REV, V31, P345, DOI 10.1152/physrev.1951.31.4.345; EDWARDS AD, 1991, J APPL PHYSIOL, V71, P1907, DOI 10.1152/jappl.1991.71.5.1907; FERRARI M, 1990, AM J PHYSIOL, V258, pH1706, DOI 10.1152/ajpheart.1990.258.6.H1706; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kakihana Y, 2002, EUR J CARDIO-THORAC, V21, P434, DOI 10.1016/S1010-7940(01)01139-3; Kirkpatrick PJ, 1998, J NEUROSURG, V89, P389, DOI 10.3171/jns.1998.89.3.0389; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; MATCHER SJ, 1994, PHYS MED BIOL, V39, P177, DOI 10.1088/0031-9155/39/1/011; McGown AD, 2003, SLEEP, V26, P710, DOI 10.1093/sleep/26.6.710; NOLLERT G, 1995, THORAC CARDIOV SURG, V43, P260, DOI 10.1055/s-2007-1013224; Quaresima V, 1998, BBA-BIOENERGETICS, V1366, P291, DOI 10.1016/S0005-2728(98)00129-7; Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0; Sakamoto T, 2001, PEDIATR RES, V49, P770, DOI 10.1203/00006450-200106000-00010; SKOV L, 1994, PHYSIOL MEAS, V15, P447, DOI 10.1088/0967-3334/15/4/006; Springett R, 2000, AM J PHYSIOL-HEART C, V279, pH2202, DOI 10.1152/ajpheart.2000.279.5.H2202; Springett RJ, 2003, ADV EXP MED BIOL, V530, P555; Stingele R, 1996, AM J PHYSIOL-HEART C, V271, pH579, DOI 10.1152/ajpheart.1996.271.2.H579; TSUJI M, 1995, PEDIATR RES, V37, P253, DOI 10.1203/00006450-199503000-00001; Uludag K, 2004, NEUROIMAGE, V22, P109, DOI 10.1016/j.neuroimage.2003.09.053; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929	26	53	53	0	5	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	MAR-APR	2007	12	2							024002	10.1117/1.2718541			7	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	173FW	WOS:000246859900018	17477717				2022-02-06	
J	Etemadrezaie, H; Baharvahdat, H; Shariati, Z; Lari, SM; Shakeri, MT; Ganjeifar, B				Etemadrezaie, Hamid; Baharvahdat, Humain; Shariati, Zhaleh; Lari, Shahrzad M.; Shakeri, Mohammad T.; Ganjeifar, Babak			The effect of fresh frozen plasma in severe closed head injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						coagulopathy; delayed traumatic intracerebral hematoma; fresh frozen plasma; traumatic brain injury; severe closed head injury	DISSEMINATED INTRAVASCULAR COAGULATION; TRAUMATIC INTRACEREBRAL HEMATOMA; BRAIN-INJURY; COAGULOPATHY; HEMORRHAGE; FIBRINOLYSIS	Objective: Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality. Coagulopathy, commonly occurring after severe TBI, is associated with poor outcome and secondary complications, especially delayed traumatic intracerebral hematoma (DTICH). In this study we evaluated the effect of fresh frozen plasma (FFP) on the reduction in the incidence of DTICH in severe closed head injury victims. Methods: This study was carried out as a double-blind randomized clinical trial. Ninety patients were entered in two parallel groups taking either FFP or normal saline (N/S). Patients' selection criteria for both groups were: severe closed head injury (Glasgow coma scale <= 8), no mass lesion required evacuation and no history of coagulopathy. The clinical findings, laboratory data, computed tomography (CT) scans and Glasgow outcome scale after I month were assessed and compared in two groups. Results: Out of 90 patients, 44 received FFP and 46 received N/S. The development of new intracerebral hematoma in follow-up CT scans were more common in the FFP group than the N/S group (p = 0.012). Both groups showed similar frequency of poor outcome (P = 0.343). The mortality was significantly more common in the FFP group than in the N/S group (63% versus 35%, p = 0.006). Conclusion: The result of this study revealed that early empirical infusion of FFP in patients with severe head injury may lead to adverse effects, such as an increase in the frequency of DTICH and an increase in the mortality. (c) 2006 Elsevier B.V. All rights reserved.	Mashhad Univ Med Sci, Shahid Kamyab Emdadi Hosp, Dept Neurosurg, Mashhad, Iran; MUMS, Hasheminejad Hosp, Dept Neurosurg, Mashhad, Iran; MUMS, Emam Reza Hosp, Dept Internal Med, Mashhad, Iran; MUMS, Emam Reza Hosp, Intens Care Unit, Mashhad, Iran; MUMS, Ghaem Hosp, Community Med & Publ Hlth Dept, Mashhad, Iran		Baharvahdat, H (corresponding author), 115,31 Abouzar Ghaffari Ave,Ahmadabad St, Mashhad 91768, Iran.	etemadrezaiens@yahoo.com; humainbv@yahoo.fr; jshariati@yahoo.com; s-lari@mums.ac.ir; m_t_shakeri@yahoo.com; b_ganjeifar@yahoo.com	Lari, Shahrzad/AAN-3015-2020; Baharvahdat, Humain/O-2086-2013; shakeri, Mohammad Taghi/Q-4293-2017	Baharvahdat, Humain/0000-0002-1154-8843; shakeri, Mohammad Taghi/0000-0002-8287-9594; Ganjeifar, Babak/0000-0002-5212-5791			AUER LM, 1979, ACTA NEUROCHIR, V49, P219, DOI 10.1007/BF01808961; BECKE RS, 1999, EU J PEDIAT, V158, pS197; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Cortiana M, 1986, J Neurosurg Sci, V30, P133; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; GRAHAM DI, 1971, LANCET, V1, P265; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Lee KR, 1996, ACTA NEUROCHIR, V138, P396, DOI 10.1007/BF01420301; May AK, 1997, AM SURGEON, V63, P233; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; Pondaag W, 1979, Acta Neurochir Suppl (Wien), V28, P98; PRETORIUS ME, 1992, ACTA NEUROCHIR, V65, P103; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; Sawauchi S, 2001, NEUROL SURG TOKYO, V29, P131; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Winn HR, 2004, YOUMANS NEUROLOGICAL, V5	27	53	55	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	FEB	2007	109	2					166	171		10.1016/j.clineuro.2006.09.001			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	135QP	WOS:000244168400008	17029771				2022-02-06	
J	Bruce-Keller, AJ; Dimayuga, FO; Reed, JL; Wang, CM; Angers, R; Wilson, ME; Dimayuga, VM; Scheff, SW				Bruce-Keller, Annadora J.; Dimayuga, Filomena O.; Reed, Janelle L.; Wang, Chunmei; Angers, Rachel; Wilson, Melinda E.; Dimayuga, Vanessa M.; Scheff, Stephen W.			Gender and estrogen manipulation do not affect traumatic brain injury in mice	JOURNAL OF NEUROTRAUMA			English	Article						cytokines; inflammation; neurodegeneration; sex steroids	CELL-DEATH; INFLAMMATORY RESPONSE; MULTIPLE-SCLEROSIS; ESTRADIOL PROTECTS; PROGESTERONE; PREGNANCY; EXPRESSION; TAT; NORETHISTERONE; MECHANISMS	As epidemiological data have suggested that female patients may have improved clinical prognoses following traumatic brain injury (TBI) compared to males, we designed experiments to determine the role of gender and estrogen in TBI-induced brain injury and inflammation in rodents. To this end, male and female C57111/6 mice were separated into the following four groups: intact males, intact females with vehicle supplementation, ovariectomized females with vehicle supplementation, and ovariectomized females with estrogen supplementation. All mice were subjected to a controlled cortical impact model of TBI, and cortical injury, hippocampal degeneration, microglial activation, and brain cytokine expression were analyzed after injury. Additionally, the spleens were harvested and cytokine release from cultured splenic cells was measured in response to specific stimuli. Data indicate that TBI-induced cortical and hippocampal injury, as well as injury-related microglial activation were not significantly affected by gender or estrogen manipulation. Conversely, brain levels of MCP-1 and IL-6 were significantly increased in males and intact females following TBI, but not in female mice that had been ovariectomized and supplemented with either estrogen or vehicle. Evaluation of splenic responses showed that the spleen was only moderately affected by TBI, and furthermore that spleens isolated from mice that had been given estrogen supplementation showed significantly higher release of the anti-inflammatory cytokine IL-4, regardless of the presence of absence of TBI. Overall, these data indicate that while estrogen can modulate immune responses, and indeed can predispose splenic responses towards and anti-inflammatory phenotype, these effects do not translate to decreased brain injury or inflammation following TBI in mice.	Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40536 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Bruce-Keller, AJ (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Mn 222 Chandler Med Ctr, Lexington, KY 40536 USA.	abruce@uky.edu	Bruce-Keller, Annadora/N-1954-2017		NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR 15592] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 046267, NS 45601] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046267, R01NS045601] Funding Source: NIH RePORTER		Adamski J, 2004, MOL ENDOCRINOL, V18, P1963, DOI 10.1210/me.2004-0098; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Bruce-Keller AJ, 2003, J NEUROSCI, V23, P8417; Bruce-Keller AJ, 2001, J NEUROCHEM, V78, P1315, DOI 10.1046/j.1471-4159.2001.00511.x; CUTOLO M, 1995, CLIN EXP RHEUMATOL, V13, P217; Cutolo M, 2000, RHEUM DIS CLIN N AM, V26, P825, DOI 10.1016/S0889-857X(05)70171-X; DEKOSKY ST, 1984, NEUROENDOCRINOLOGY, V38, P33, DOI 10.1159/000123862; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Doria A, 2006, ANN NY ACAD SCI, V1069, P247, DOI 10.1196/annals.1351.022; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Elenkov IJ, 1997, MOL MED TODAY, V3, P379; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Ito A, 2001, J IMMUNOL, V167, P542, DOI 10.4049/jimmunol.167.1.542; Kim HS, 2005, J TOXICOL ENV HEAL A, V68, P2249, DOI 10.1080/15287390500182354; Knoferl MW, 2002, ANN SURG, V235, P105, DOI 10.1097/00000658-200201000-00014; Knoferl MW, 2001, AM J PHYSIOL-CELL PH, V281, pC1131, DOI 10.1152/ajpcell.2001.281.4.C1131; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; Lee YW, 2004, CARDIOVASC RES, V63, P139, DOI 10.1016/j.cardiores.2004.03.006; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Mor G, 1999, J NEUROBIOL, V40, P484, DOI 10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C; Mueck AO, 2002, MENOPAUSE, V9, P273, DOI 10.1097/00042192-200207000-00008; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P218; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Owens W, 2003, ENVIRON HEALTH PERSP, V111, P1527, DOI 10.1289/ehp.6413; PAXINOS G, 2004, MOUSE BRAIN STEOREOT; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Raivich Gennadij, 1996, Keio Journal of Medicine, V45, P239; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Salem Mohamed Labib, 2004, Current Drug Targets - Inflammation and Allergy, V3, P97, DOI 10.2174/1568010043483944; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; Vegeto E, 2000, EXP GERONTOL, V35, P1309, DOI 10.1016/S0531-5565(00)00161-3; Viviani B, 2002, J NEUROCHEM, V83, P1180, DOI 10.1046/j.1471-4159.2002.01235.x; Voskuhl R R, 2003, Int MS J, V10, P60; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wilson ME, 2000, BRAIN RES, V873, P235, DOI 10.1016/S0006-8993(00)02479-3; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; Zitzmann M, 2005, J CLIN ENDOCR METAB, V90, P6603, DOI 10.1210/jc.2005-0847	64	53	54	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					203	215		10.1089/neu.2006.0163			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100020	17263684				2022-02-06	
J	Segalowitz, SJ; Mahaney, P; Santesso, DL; MacGregor, L; Dywan, J; Willer, B				Segalowitz, Sidney J.; Mahaney, Patrick; Santesso, Diane L.; MacGregor, Leslie; Dywan, Jane; Willer, Barry			Retest reliability in adolescents of a computerized neuropsychological battery used to assess recovery from concussion	NEUROREHABILITATION			English	Article							SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; BRAIN-INJURY; MANAGEMENT; DIAGNOSIS; DISCHARGE	We examined in a group of 15-year-old adolescents the retest reliability over one week of 7 subscales of the Automated Neuropsychological Metrics (ANAM), a computerized battery based on standard neuropsychological test measures that is one of several such batteries available to assess concussion effects. Since the principle behind these computerized batteries is to assess athletes before injury and after injury to determine the level of deficit and whether the individual is safe to return to play, it is critical that such batteries have excellent retest reliability. Retest reliability of the ANAM was good, especially for the aggregate of throughput scores, reaching 0.87, but lower for individual subtests, especially for those measuring only speed of processing. Thus, the ANAM aggregated score appears to have robust reliability for cognitive measures involving memory and attention in 15-year-olds. Limitations related to assessing return-to-baseline after concussion in adolescents are discussed.	Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; Harvard Univ, Dept Psychol, Affect Neurosci Lab, Cambridge, MA 02138 USA; SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA		Segalowitz, SJ (corresponding author), Brock Univ, Dept Psychol, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	sid.segalowitz@brocku.ca					Barth J T, 2000, Dent Clin North Am, V44, P67; Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yaghi HM, 1997, J EDUC COMPUT RES, V16, P237, DOI 10.2190/X668-LXE1-4X00-PARW	29	53	53	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	3					243	251					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216NM	WOS:000249884800010	17917174				2022-02-06	
J	Sperry, JL; Gentilello, LM; Minei, JP; Diaz-Arrastia, RR; Friese, RS; Shafi, S				Sperry, Jason L.; Gentilello, Larry M.; Minei, Joseph P.; Diaz-Arrastia, Ramon R.; Friese, Randall S.; Shafi, Shahid			Waiting for the patient to "sober up": Effect of alcohol intoxication on Glasgow Coma Scale score of brain injured patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	36th Annual Meeting of the Western-Trauma-Association	FEB 26-MAR 03, 2006	Big Sky, MT	Western Trauma Assoc		alcohol; intoxication; traumatic brain injury; Glasgow Coma Scale	TRAUMA PATIENTS; BASE DEFICIT; HEAD-INJURY; LEVEL; SEVERITY	Background: Between 35% to 50% of traumatic brain injury (TBI) patients are under the influence of alcohol. Alcohol intoxication may limit the ability of the Glasgow Coma Scale (GCS) to accurately assess severity of TBI. We hypothesized that alcohol intoxication significantly depresses GCS scores of TBI patients. Methods. A 10-year, retrospective analysis of a Level I trauma center registry was undertaken. The study population consisted of all blunt injured TBI patients tested for blood alcohol concentration (BAC, n = 1,075). Patients were divided into two groups; intoxicated (mean BAC 202 +/- 77 mg/dL, n = 504) and nonintoxicated (BAC = 0, n = 571). TBI was classified using ICD-9 codes as concussion alone (ICD-9 850, n = 90) and intracranial injury (ICI, ICD-9 851-854, n = 985). Severity was further classified using the Abbreviated Injury Score (AIS). Mean GCS score was compared between the two groups. Patients who were either intubated or hypotensive upon arrival were analyzed separately to rule out confounding effects on GCS score. Severely intoxicated patients (BAC > 250 mg/dL, [mean +/- SD] 309 +/- 54 SD, n = 118) were similarly compared. Finally, multivariate linear regression analysis was undertaken to determine whether BAC level was an independent predictor of GCS score while controlling for confounding factors. Results: Intoxicated and nonintoxicated TBI patients were clinically similar. Alcohol intoxication had little effect on GCS score, with less than a single point difference in all types of TBI, except the most severely injured (AIS 5 injuries, GCS score difference 1.4 points). These results were not altered by endotracheal intubation, systemic hypotension, or severe intoxication. Similarly, BAC was not a significant independent predictor of GCS score in a. multivariate model. Conclusions: Alcohol intoxication does not result in clinically significant changes in GCS score for patients with blunt TBI. Hence, alterations in GCS score after TBI should not be attributed to alcohol intoxication, as doing so might result in inappropriate delays in monitoring and therapeutic interventions.	Univ Texas, SW Med Ctr, Dept Surg, Div Burns Trauma & Crit Care, Dallas, TX 75390 USA		Shafi, S (corresponding author), Univ Texas, SW Med Ctr, Dept Surg, Div Burns Trauma & Crit Care, 5323 Harry Hines Blvd,Mail Stop 9158, Dallas, TX 75390 USA.	shahid.shafi@utsouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594			Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; *AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P463; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; ChathamShowalter PE, 1996, PSYCHOSOMATICS, V37, P285, DOI 10.1016/S0033-3182(96)71567-0; Committee on Medical Aspect of Automotive Safety, 1971, JAMA-J AM MED ASSOC, V215, P277; DELANEY KA, 2000, HEAD INJURY; Dunham CM, 2000, J EMERG MED, V18, P165, DOI 10.1016/S0736-4679(99)00188-2; Dunne JR, 2005, J TRAUMA, V58, P959, DOI 10.1097/01.TA.0000158508.84009.49; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Gentilello LM, 1999, J TRAUMA, V47, P1131, DOI 10.1097/00005373-199912000-00027; HOLT S, 1980, BRIT MED J, V281, P638, DOI 10.1136/bmj.281.6241.638; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; MINION GE, 1989, J TOXICOL-CLIN TOXIC, V27, P375, DOI 10.3109/15563658909000358; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; TEASDALE G, 1974, LANCET, V2, P81; *TRAUM ACOS CO, 1997, ADV TRAUM LIF SUPP; TRENO AJ, 1994, ALCOHOL CLIN EXP RES, V18, P1306, DOI 10.1111/j.1530-0277.1994.tb01428.x; Valadka A, 2000, TRAUMA, P377; WISNER DH, 1992, ARCH SURG-CHICAGO, V127, P111	23	53	54	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2006	61	6					1305	1311		10.1097/01.ta.0000240113.13552.96			7	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	119CI	WOS:000242989400003	17159670				2022-02-06	
J	Klemen, P; Grmec, S				Klemen, P.; Grmec, S.			Effect of pre-hospital advanced life support with rapid sequence intubation on outcome of severe traumatic brain injury	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						emergency medical system; pre-hospital trauma care; rapid sequence intubation; severe traumatic brain injury; outcome	SEVERE HEAD-INJURY; NEUROMUSCULAR BLOCKING-AGENTS; TRACHEAL TUBE PLACEMENT; ENDOTRACHEAL INTUBATION; CARE; IMPACT; MANAGEMENT; PHYSICIANS; EFFICACY; MODERATE	Background: The role of pre-hospital trauma care and the effect of pre-hospital rapid sequence intubation (RSI) on patient outcome are still not clear. This study evaluated the impact of pre-hospital trauma care by emergency physicians (EP) on mortality from severe traumatic brain injury (TBI) and a 180-day Glasgow Outcome Scale (GOS). Methods: A 48-month parallel non-controlled cohort study compared a group of 64 patients with severe TBI [Glasgow Coma Scale (GCS) < 9; Injury Severity Score (ISS) > 151 who received pre-hospital advanced life support (ALS) with RSI and were transported to the hospital by EPs (EP group), with a group of 60 patients who did not receive pre-hospital ALS with RSI [emergency medical technicians (EMT) group]. Results: There were no significant statistical differences between the groups in age (P = 0.79), mechanism of injury W = 0.68), gender W = 0.82), initial GCS (P = 0.63), initial SaO(2) in the field (P = 0.63), initial systolic blood pressure in the field (P = 0.47) and on-scene time (P = 0.41). In the EP group, there was significantly better first hour survival (97% vs. 79%, P = 0.02), first day survival (90% vs. 72%, P = 0.02), better functional outcome (GOS 4-5: 53% vs. 33%, P < 0.01; GOS 2-3: 8% vs. 20%, P < 0.01) and shortened hospitalization time in intensive Care unit (ICU) W = 0.03) and other departments (P - 0.04). In total hospital mortality, we detected no differences between both groups [EP group: 40% (95% CI: 34-45%) vs.EMT group 42% (95% CI: 36-47%, P = 0.761, except in a subgroup of patients with GCS 6-8 where there was significantly lower total hospital mortality in the EP group (24% vs. 78%, P < 0.01). Conclusion: After starting the trauma care system with emergency physicians in our region, there was a decrease in the number of deaths on hospital admission, a reduction in hospital mortality in the GCS group 6-8, a change in the temporal distribution of deaths, an improvement in functional neurological outcome and shortened hospitalization time.	Univ Maribor, Ctr Emergency Med Maribor, Fac Med, Maribor 2000, Slovenia		Klemen, P (corresponding author), Univ Maribor, Ctr Emergency Med Maribor, Fac Med, Ulica Talcev 9, Maribor 2000, Slovenia.	petraklemen@email.si					Adnet F, 2001, CRIT CARE, V5, P290; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Deakin C D, 2001, Curr Opin Anaesthesiol, V14, P191, DOI 10.1097/00001503-200104000-00011; di Bartolomeo S, 2003, EUR J EMERG MED, V10, P268, DOI 10.1097/01.mej.0000103466.32882.7b; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Garner A, 2001, INJURY, V32, P455, DOI 10.1016/S0020-1383(01)00013-4; Grmec S, 2004, EMERG MED J, V21, P518, DOI 10.1136/emj.2002.001974; Grmec S, 2002, INTENS CARE MED, V28, P701, DOI 10.1007/s00134-002-1290-x; Hsiao A K, 1993, Prehosp Disaster Med, V8, P229; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Kwan Irene, 2002, Prehosp Emerg Care, V6, P27, DOI 10.1080/10903120290938733; LANGERON O, 2000, CURR OPIN CRIT CARE, V6, P383; LIBERMAN M, 2000, J TRAUMA, V48, P643; Lossius HM, 2002, ACTA ANAESTH SCAND, V46, P771, DOI 10.1034/j.1399-6576.2002.460703.x; Ma OJ, 1998, AM J EMERG MED, V16, P125, DOI 10.1016/S0735-6757(98)90027-4; Mackay CA, 2001, EMERG MED J, V18, P20, DOI 10.1136/emj.18.1.20; MYLES PS, 2000, STAT METHODS ANAESTH, P87; PIEK J, 1999, NEUROTRAUMA MODULE 1, P1; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Schuttler J, 1995, ANAESTHESIST, V44, P850, DOI 10.1007/s001010050221; SILVERSTON P, 1989, BRIT MED J, V298, P711, DOI 10.1136/bmj.298.6675.711; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Stocchetti N, 2001, Eur J Emerg Med, V8, P215, DOI 10.1097/00063110-200109000-00009; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Ummenhofer Wolfgang, 2002, Curr Opin Crit Care, V8, P559, DOI 10.1097/00075198-200212000-00013; WINTCHELL RJ, 1997, ARCH SURG-CHICAGO, V132, P592	35	53	53	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	NOV	2006	50	10					1250	1254		10.1111/J.1399-6576.2006.01039.X			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	104JL	WOS:000241954600013	17067325				2022-02-06	
J	Yard, EE; Comstock, RD				Yard, Ellen Elizabeth; Comstock, R. Dawn			Injuries sustained by pediatric ice hockey, lacrosse, and field hockey athletes presenting to United States emergency departments, 1990-2003	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; athletic injuries; protective equipment	WOMENS LACROSSE; NECK INJURIES; HEAD-INJURIES; EYE INJURIES; FACE MASKS; PLAYERS; FOOTBALL; EPIDEMIOLOGY; SPORTS; SOCCER	Context. Ice hockey, lacrosse, and field hockey are increasingly popular sports among US youth athletes, but no authors to date have compared injuries in male and female pediatric (ages 2 through 18 years) participants. Objective: To compare patterns of injury among pediatric ice hockey, lacrosse, and field hockey players. Design: A descriptive analysis of all pediatric (ages 2 through 18 years) ice hockey, lacrosse, and field hockey injuries captured by the US Consumer Product Safety Commission's National Electronic Injury Surveillance System. Setting: US Consumer Product Safety Commission's National Electronic Injury Surveillance System. Patients or Other Participants: Children with ice hockey, lacrosse, or field hockey injuries presenting to emergency departments participating in the National Electronic Injury Surveillance System. Main Outcome Measure(s): We reviewed all ice hockey, lacrosse, and field hockey injuries captured by the National Electronic Injury Surveillance System and categorized them by sex, age, injury site, and injury diagnosis. Results: An estimated 321237 pediatric participants in ice hockey, lacrosse, and field hockey presented to US emergency departments from 1990 through 2003. The injured were primarily male (74.4%) and aged 10 through 18 years (95.4%). Ice hockey accounted for more injuries (53.6%) than lacrosse (26.5%) or field hockey (19.9%). Children aged 2 through 9 years sustained twice the proportion of head and face injuries (53.1%) as children aged 10 through 18 years (23.2%) (incidence rate ratio [IRR] = 2.25, 95% confidence interval [CI] 1.94 to 2.62). Males incurred a higher proportion of shoulder and upper arm injuries (14.1%) than females (3.1%) (IRR = 4.51, 95% Cl = 3.07 to 6.62). The proportion of concussion was higher in ice hockey players (3.9%) than in field hockey players (1.4%) (IRR = 2.75, 95% Cl = 1.17 to 6.46). Females in lacrosse had twice the proportion of facial injuries (20.9%) as males (10.5%) (IRR = 1.95, 95% Cl = 1.46 to 2.60). In all sports, the ball or puck caused a greater proportion of face injuries in females than in males (IRR = 2.48, 95% Cl = 2.03 to 3.05). Facial injuries from falls occurred in higher proportions in ice hockey players (10.6%) than in lacrosse (2.4%) (IRR = 4.32, 95% Cl = 1.53 to 12.18) and field hockey (0.4%) players (IRR = 28.38, 95% Cl = 6.71 to 120.01). Conclusions: Pediatric ice hockey, lacrosse, and field hockey injuries differed by age and sport and, within each sport, by sex. An understanding of sport-specific patterns of injury should assist coaches and certified athletic trainers in developing targeted preventive interventions.	Childrens Hosp, Ctr Injury Res & Policy, Columbus Childrens Res Inst, Columbus, OH 43205 USA; Ohio State Univ, Columbus, OH 43210 USA		Yard, EE (corresponding author), Childrens Hosp, Ctr Injury Res & Policy, Columbus Childrens Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	YardE@ccri.net					Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Bolhuis J H, 1987, Br J Sports Med, V21, P174; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Delaney JS, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.015735; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; DELOES M, 1988, INT J SPORTS MED, V9, P461, DOI 10.1055/s-2007-1025052; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dryden DM, 2000, MED SCI SPORT EXER, V32, P1378, DOI 10.1097/00005768-200008000-00004; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; LAPIDUS CS, 1992, J TRAUMA, V32, P555, DOI 10.1097/00005373-199205000-00003; LAPRADE RF, 1995, AM J SPORT MED, V23, P773, DOI 10.1177/036354659502300624; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Matz SO, 2004, AM J SPORT MED, V32, P608, DOI 10.1177/0363546503262172; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; MURRAY TM, 1995, PEDIATRICS, V95, P419; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; *NAT FED STAT HIGH, NFHS 2003 04 HIGH SC; National Federation of State High School Associations, PART FIG HIST; Reid SR, 1999, PEDIATR EMERG CARE, V15, P310, DOI 10.1097/00006565-199910000-00002; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188; *US CENS BUR, NAT POP DAT; *US CONS PROD SAF, 1997, NEISS SAMPL DES IMPL; *US FIELD HOCK, US FIELD HOCK FACT S; *US HOCK, US HOCK 2003 2004 FI; *US LACR, 2004, US LACR PART SURG; Waicus KM, 2002, CLIN J SPORT MED, V12, P24, DOI 10.1097/00042752-200201000-00008; Webster DA, 1999, MED SCI SPORT EXER, V31, P938, DOI 10.1097/00005768-199907000-00004	30	53	53	0	18	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	OCT-DEC	2006	41	4					441	449					9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	124QU	WOS:000243385800016	17273471				2022-02-06	
J	Singh, M				Singh, M			Progesterone-induced neuroprotection	ENDOCRINE			English	Article						progestins; progesterone; neuroprotection; signal transduction	TRAUMATIC BRAIN-INJURY; SPRAGUE-DAWLEY RATS; MEDROXYPROGESTERONE ACETATE; BINDING PROTEIN; MEMBRANE; EXPRESSION; ESTROGEN; STEROIDS; RECEPTOR; CELL	Estrogen and progesterone are two steroid hormones whose biology has been greatly studied within the confines of reproductive function. As a consequence, the effects of these hormones on the brain have focused primarily on the hypothalamus. Growing evidence, however, forces us to recognize that various extrahypothalamic brain regions, including the cerebral cortex and hippocampus, are equally important targets of these hormones. As such, hormones are involved in numerous aspects of brain function, and elicit effects ranging from the regulation of mood and cognition to the regulation of neuronal survival. While estrogen exerts neuroprotective effects in various experimental models, the potential for progesterone as a protective agent has, until recently, been greatly understudied. Here, we review the data from various laboratories including our own that support the protective role of progesterone and describe the multiplicity of mechanisms by which progesterone elicits these protective effects. Finally, we contrast the neurobiology of progesterone with that of the clinically used progestin, medroxyprogesterone acetate (MPA), and suggest that the "natural" progesterone may be the better choice when considering which progestin to use for future therapeutic/palliative purposes in CNS-related disorders.	Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA		Singh, M (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	msingh@hsc.unt.edu		Singh, Meharvan/0000-0002-8072-1769	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG023330, P01AG022550] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 22550, AG 23330] Funding Source: Medline		Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; BELLHORNER C, 2004, 34 ANN SOC NEUR M SA; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; COLLADO ML, 1985, PHARMACOL BIOCHEM BE, V23, P501, DOI 10.1016/0091-3057(85)90408-3; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; DEUTSCH SI, 1992, CLIN NEUROPHARMACOL, V15, P352, DOI 10.1097/00002826-199210000-00002; Falkenstein E, 1998, CELL MOL BIOL, V44, P571; GAMBRELL RD, 1986, CLIN OBSTET GYNAECOL, V13, P695; Goodman YD, 1996, J NEUROCHEM, V66, P1836; HIRVONEN E, 1996, MATURITAS S, V23, P13; Hoffman GE, 2003, EXP NEUROL, V182, P124, DOI 10.1016/S0014-4886(03)00104-3; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; KAUR P, 2004, 34 ANN SOC NEUR M SA; KE FC, 1990, J NEUROCHEM, V54, P467, DOI 10.1111/j.1471-4159.1990.tb01895.x; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; LUINE VN, 1985, EXP NEUROL, V89, P484, DOI 10.1016/0014-4886(85)90108-6; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Min L, 2004, MOL CELL ENDOCRINOL, V215, P143, DOI 10.1016/j.mce.2003.11.025; Miyagawa K, 1997, AM J PHYSIOL-HEART C, V272, pH2645, DOI 10.1152/ajpheart.1997.272.6.H2645; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosano GMC, 2000, J AM COLL CARDIOL, V36, P2154, DOI 10.1016/S0735-1097(00)01007-X; Sakamoto H, 2004, NEUROSCIENCE, V126, P325, DOI 10.1016/j.neuroscience.2004.04.003; SINGH M, 1995, ENDOCRINOLOGY, V136, P2320, DOI 10.1210/en.136.5.2320; SINGH M, 1994, BRAIN RES, V644, P305, DOI 10.1016/0006-8993(94)91694-2; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; TOWLE AC, 1983, J STEROID BIOCHEM, V18, P135, DOI 10.1016/0022-4731(83)90079-1; Vasan R., 2003, 33 ANN SOC NEUR M NE; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	35	53	54	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0969-711X			ENDOCRINE	Endocrine	APR	2006	29	2					271	274		10.1385/ENDO:29:2:271			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	050LM	WOS:000238088900010	16785602				2022-02-06	
J	Dhaliwal, A; West, AL; Trobe, JD; Musch, DC				Dhaliwal, A; West, AL; Trobe, JD; Musch, DC			Third, fourth, and sixth cranial nerve palsies following closed head injury	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							SUPERIOR OBLIQUE PALSY; 6TH CRANIAL NERVES; OCULOMOTOR NERVE; CERVICAL-SPINE; INITIAL SIGN; TRAUMA; PARALYSIS; 3RD; TROCHLEAR; 4TH	Background: The relationship between the circumstances and severity of closed head injury (CHI) and the clinical and imaging features of cranial nerve 3, 4, and 6 palsies has not been rigorously addressed in a large study. Methods: Retrospective chart review of 210 consecutive patients with CHI examined at a single tertiary care center from 1987 to 2002. Patients were located by searching the ophthalmology inpatient consultation and neuro-ophthalmology outpatient databases and hospital emergency room billing codes for a diagnosis of traumatic 3, 4, or 6 cranial nerve palsy (Cranial Nerve Injury Group) and a diagnosis of CHI without traumatic 3, 4, or 6 nerve palsy (Control Group). The Cranial Nerve Injury Group was then subdivided into two groups: those with injuries to an individual cranial nerve and those with multiple (including bilateral) cranial nerve injuries. Comparisons between groups were based on age, gender, type of accident, Glasgow Coma Scale (GCS), documented loss of consciousness (LOC), type of ocular injury, presence of systemic injury, need for rehabilitation, physical therapy and cognitive scores, and imaging features. Results: The Cranial Nerve Injury Group had a significantly higher severity of head injury, more CT abnormalities, and worse short-term neurologic outcomes as compared with the Control Group. These trends were also found when each cranial nerve injury subgroup was compared with the Control Group. Those with cranial nerve 3 palsy had the most severe head injury; those with cranial nerve 4 palsy had an intermediate level of head injury; and those with cranial nerve 6 palsy had the lowest level of head injury. There were no consistent associations between the location of the imaging abnormalities and which cranial nerve was damaged. Conclusions: CHI with palsy of an ocular motor nerve was more severe than CHI without ocular motor nerve palsy, as measured by the GCS, intracranial and skull imaging abnormalities, and a greater frequency of inpatient rehabilitation. Palsy of cranial nerve 3 was associated with relatively more severe CHI than was palsy of cranial nerves 4 or 6. The location of the imaging abnormalities did not correlate with a particular cranial nerve injury.	Univ Michigan, Med Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA		Trobe, JD (corresponding author), Univ Michigan, Med Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	jdtrobe@umich.edu		Musch, David/0000-0002-4164-3841; Trobe, Jonathan/0000-0003-0728-6729			Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Balcer LJ, 1996, AM J OPHTHALMOL, V122, P437, DOI 10.1016/S0002-9394(14)72078-1; BURGER LJ, 1970, BRAIN, V93, P567, DOI 10.1093/brain/93.3.567; BURGERMAN RS, 1989, NEUROSURGERY, V25, P978, DOI 10.1227/00006123-198912000-00023; CHAPMAN L I, 1970, Archives of Ophthalmology, V84, P137; COPPETO JR, 1983, ANN OPHTHALMOL, V15, P681; CROUCH ER, 1975, AM J OPHTHALMOL, V79, P990, DOI 10.1016/0002-9394(75)90683-2; ELSTON JS, 1984, BRIT J OPHTHALMOL, V68, P538, DOI 10.1136/bjo.68.8.538; EYSTER EF, 1972, J AMER MED ASSOC, V220, P1083, DOI 10.1001/jama.220.8.1083; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GREEN WR, 1964, ARCH OPHTHALMOL-CHIC, V72, P154; HEINZE J, 1969, MED J AUSTRALIA, V2, P1246, DOI 10.5694/j.1326-5377.1969.tb103371.x; Holmes JM, 1999, AM J OPHTHALMOL, V127, P388, DOI 10.1016/S0002-9394(98)00424-3; HOOPER RS, 1951, BRIT J SURG, V39, P126, DOI 10.1002/bjs.18003915406; ING EB, 1992, J PEDIATR OPHTHALMOL, V29, P331; JACOBSON DM, 1988, J CLIN NEURO-OPHTHAL, V8, P263; KEEFE WP, 1960, ARCH OPHTHALMOL-CHIC, V63, P585; KHAWAM E, 1967, ARCH OPHTHALMOL-CHIC, V77, P761, DOI 10.1001/archopht.1967.00980020763009; KODSI SR, 1992, AM J OPHTHALMOL, V114, P568, DOI 10.1016/S0002-9394(14)74484-8; KROHEL GB, 1979, AM J OPHTHALMOL, V88, P598, DOI 10.1016/0002-9394(79)90521-X; LAVIN PJM, 1984, ARCH NEUROL-CHICAGO, V41, P679, DOI 10.1001/archneur.1984.04210080091022; LEPORE FE, 1995, ARCH NEUROL-CHICAGO, V52, P924, DOI 10.1001/archneur.1995.00540330106022; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; Lindenberg R, 1964, Clin Neurosurg, V12, P129; MEMON MY, 1971, J NEUROSURG, V35, P461, DOI 10.3171/jns.1971.35.4.0461; MOSTER ML, 1984, ARCH OPHTHALMOL-CHIC, V102, P1328; Neetens A, 1981, Bull Soc Belge Ophtalmol, V193, P161; ROSA L, 1984, J NEUROSURG, V61, P172, DOI 10.3171/jns.1984.61.1.0172; RUCKER CW, 1958, AM J OPHTHALMOL, V46, P787, DOI 10.1016/0002-9394(58)90989-9; RUCKER CW, 1966, AM J OPHTHALMOL, V61, P1293, DOI 10.1016/0002-9394(66)90258-3; RUSH JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P76, DOI 10.1001/archopht.1981.03930010078006; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; SCHNEIDER RC, 1971, J NEUROSURG, V34, P33, DOI 10.3171/jns.1971.34.1.0033; SUMMERS CG, 1979, J NEUROSURG, V50, P508, DOI 10.3171/jns.1979.50.4.0508; SYDNOR CF, 1982, OPHTHALMOLOGY, V89, P134; TELLER J, 1988, ANN OPHTHALMOL, V20, P424; WALTER KA, 1994, NEUROLOGY, V44, P148, DOI 10.1212/WNL.44.1.148; YOUNGE BR, 1977, MAYO CLIN PROC, V52, P11	41	53	53	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	MAR	2006	26	1					4	10		10.1097/01.wno.0000204661.48806.1d			7	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	020TB	WOS:000235932200002	16518159				2022-02-06	
J	Kelly, G; Todd, J; Simpson, G; Kremer, P; Martin, C				Kelly, G; Todd, J; Simpson, G; Kremer, P; Martin, C			The overt behaviour scale (OBS): A tool for measuring challenging behaviours following ABI in community settings	BRAIN INJURY			English	Article						acquired brain injury; challenging behaviour; community settings; outcome measures	NEUROBEHAVIORAL RATING-SCALE; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; AGGRESSION; MANAGEMENT; VALIDITY; OUTCOMES	Objectives: The Overt Behaviour Scale (OBS) was designed as a comprehensive measure of common challenging behaviours observed after acquired brain injury (ABI) in community settings. The OBS comprises 34 items in nine categories that measure aggression, inappropriate sexual behaviour, perseveration, wandering, inappropriate social behaviour and lack of initiation. The aim of the current study was to determine the reliability, validity and responsiveness of the OBS. Method: Two adult community-based samples of people with ABI were recruited. Sample 1 ( n = 30) were concurrently evaluated on the OBS by two raters and again 1 week later to test stability. Other validating scales were also administered. Sample 2 ( n 28) were clients of the ABI Behaviour Consultancy who were treated for challenging behaviours and were administered the OBS before treatment commenced and then again 4 months later. Results: Inter-rater reliability and stability coefficients for the OBS total score was strong ( 0.97 and 0.77, respectively). Initial evidence of convergent and divergent validity was shown by the differential pattern of correlations with other measures. Moderate-to-strong coefficients ( range 0.37 - 0.66) were observed between the OBS and other measures that had behavioural content ( i. e. Mayo-Portland Adaptability Inventory, Current Behaviour Scale, Neurobehavioural Rating Scale - Revised). Divergent validity was shown by the lack of correlation between the OBS and the sub-scales of these tools that do not measure challenging behaviour. Finally, responsiveness was demonstrated with a significant decrease in OBS scores in the expected direction over the 4-month period. This improvement was confirmed by corroborating evidence from key informants. Conclusion: The OBS shows promise as a reliable, valid and responsive measure that can be used for the systematic assessment of challenging behaviours in community settings.	Epworth Med Fdn, ABI Behav Consultancy, Fitzroy, Vic 3068, Australia; Liverpool Hosp, Brain Injury Rehabil Unit, Liverpool, NSW, Australia; Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic 3217, Australia		Kelly, G (corresponding author), Epworth Med Fdn, ABI Behav Consultancy, POB 1228, Fitzroy, Vic 3068, Australia.	glenn.kelly@abibehaviour.org.au	Kremer, Peter/I-8202-2019; Simpson, Grahame K/W-1074-2019; Kelly, Glenn/AAA-6894-2021	Kremer, Peter/0000-0003-2476-1958; Simpson, Grahame K/0000-0001-8156-9060; Kelly, Glenn/0000-0003-1670-3344			Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Alderman N, 1999, BRAIN INJURY, V13, P669; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Barnes MP, 2001, J REHABIL MED, V33, P244; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Frosch S, 1997, BRAIN INJURY, V11, P891; Gardner RM, 2003, J HEAD TRAUMA REHAB, V18, P52, DOI 10.1097/00001199-200301000-00007; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; HULSE SH, 1958, PSYCHOL LEARNING; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; KAY SR, 1988, J NERV MENT DIS, V176, P539, DOI 10.1097/00005053-198809000-00007; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LANDIS JR, 1977, BIOMETRICS, V33, P174; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Pender N, 1999, NEUROPSYCHOL REHABIL, V9, P345, DOI 10.1080/096020199389428; PETERS M D, 1992, Brain Injury, V6, P299, DOI 10.3109/02699059209034944; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; RAY WA, 1992, J GERONTOL, V47, pM9, DOI 10.1093/geronj/47.1.M9; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; STRETTLES B, 2005, FORCED CHOICES ACCOM; Swan L, 2004, BRAIN INJURY, V18, P143, DOI 10.1080/02699050310001596923; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2003, STUD NEUROPSYCHOL DE, P137; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; Todd J, 2002, AUST J PSYCHOL, V54, P79; Tustin R. Don, 1991, Australia and New Zealand Journal of Developmental Disabilities, V17, P285; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Willis TJ, 2003, J HEAD TRAUMA REHAB, V18, P75, DOI 10.1097/00001199-200301000-00008; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; Woodcock R, 1986, INVENTORY CLIENT AGE; World Health Organization, 2007, INT CLASS FUNCT DIS; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; [No title captured]; [No title captured]	40	53	54	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2006	20	3					307	319		10.1080/02699050500488074			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	021GT	WOS:000235972400010	16537272				2022-02-06	
J	Williams, G; Robertson, V; Greenwood, K; Goldie, P; Morris, ME				Williams, G; Robertson, V; Greenwood, K; Goldie, P; Morris, ME			The concurrent validity and responsiveness of the High-Level Mobility Assessment Tool for measuring the mobility limitations of people with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	International Symposium on Measurement and Evaluation of Outcomes in Rehabilitation	SEP 27-28, 2004	Stockholm, SWEDEN			brain injuries; gait disorders, neurologic; rehabilitation; reproducibility of results; running	FUNCTIONAL INDEPENDENCE MEASURE; RIVERMEAD MOTOR-ASSESSMENT; STROKE PATIENTS; REHABILITATION; RELIABILITY; OUTCOMES; SCALABILITY; INSTRUMENTS; IMPAIRMENT; DISABILITY	Objective: To investigate the concurrent validity and responsiveness of the High-Level Mobility Assessment Tool (HiMAT) in people after traumatic brain injury (TBI). Design: This study compared the concurrent validity and responsiveness of the motor subsection of the FIM instrument and the gross function component of the Riverinead Motor Assessment (RMA) with the HiMAT, a new measure of highlevel mobility developed for use in TBI. Setting: A major rehabilitation hospital. Participants: A convenience sample of 103 participants with TBI were recruited from a major rehabilitation hospital. Interventions: Not applicable. Main Outcome Measures: HiMAT, motor FIM, and the gross function RMA. Results: The correlation between the HiMAT and motor FIM Was moderate (r=.53, P <.001), largely because of a ceiling effect in the motor FIM. The correlation between the HiMAT and gross function RMA was strong (r=.87, P <.001), yet the gross function RMA was also susceptible to a ceiling effect. with 51.5% of subjects achieving the maximum score. The HiMAT was more responsive than the motor FIM and the gross function RMA on all indices. Conclusions: The HiMAT is a new unidimensional scale with moderate concurrent validity for measuring high-level mobility. The HiMAT is more responsive and has less of a ceiling effect than either the motor FIM or the gross function RMA.	Epworth Med Fdn, Richmond, Vic 3121, Australia; La Trobe Univ, Sch Physiotherapy, Bundoora, Vic, Australia; La Trobe Univ, Sch Psychol Sci, Bundoora, Vic, Australia; Univ Newcastle, Newcastle, NSW 2308, Australia; Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Greenwood, Kenneth M/J-8993-2015	Greenwood, Kenneth M/0000-0002-8420-6588; Williams, Gavin/0000-0003-2758-7473; Morris, Meg/0000-0002-0114-4175			Adams SA, 1997, CLIN REHABIL, V11, P52, DOI 10.1177/026921559701100108; Adams SA, 1997, CLIN REHABIL, V11, P42, DOI 10.1177/026921559701100107; Beaton DE, 2001, J CLIN EPIDEMIOL, V54, P1204, DOI 10.1016/S0895-4356(01)00407-3; Brock KA, 2002, ARCH PHYS MED REHAB, V83, P92, DOI 10.1053/apmr.2002.27348; Cohen J, 1977, STAT POWER ANAL BEHA; Collen F M, 1991, Int Disabil Stud, V13, P50; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Davidson M, 2002, PHYS THER, V82, P8, DOI 10.1093/ptj/82.1.8; Dillon H, 2000, EAR HEARING, V21, p2S, DOI 10.1097/00003446-200008001-00002; Fisher K, 2002, CLIN REHABIL, V16, P871, DOI 10.1191/0269215502cr554oa; Goldie PA, 1996, ARCH PHYS MED REHAB, V77, P1074, DOI 10.1016/S0003-9993(96)90072-6; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Granger CV, 1983, GUIDE USE UNIFORM DA; Guttman L, 1944, AM SOCIOL REV, V9, P139, DOI 10.2307/2086306; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lincoln N, 1979, Physiotherapy, V65, P48; Ponte-Allan M, 1999, AM J OCCUP THER, V53, P646, DOI 10.5014/ajot.53.6.646; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; WILLIAMS G, IN PRESS PHYS THER; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; [No title captured]	28	53	53	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2006	87	3					437	442		10.1016/j.apmr.2005.10.028			6	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	021XZ	WOS:000236020500020	16500181	Green Published			2022-02-06	
J	Bulut, M; Koksal, O; Dogan, S; Bolca, N; Ozguc, H; Korfali, E; Ilcoll, YO; Parlak, M				Bulut, M; Koksal, O; Dogan, S; Bolca, N; Ozguc, H; Korfali, E; Ilcoll, YO; Parlak, M			Tau protein as a serum marker of brain damage in mild traumatic brain injury: Preliminary results	ADVANCES IN THERAPY			English	Article						mild traumatic brain injury; serum tau protein; high risk; cranial CT	MINOR HEAD-INJURY; CEREBROSPINAL-FLUID; COMPUTED-TOMOGRAPHY; NEURONAL DAMAGE; SERIAL S-100; CSF	The objective of this study was to investigate the diagnostic value of serum tau protein in determining the severity of traumatic brain injury in patients with mild traumatic brain injury (mTBI) and high-risk patients. Adult patients who presented to our emergency department (ED) with mTBI over I year were prospectively enrolled. Patients underwent cranial computed tomography (CT) and were subdivided into high- and low-risk groups, according to the probability of resultant intracranial injury. Serum tau levels of 60 patients and 20 healthy volunteers, who served as a control group, were measured. The mean age of the 60 patients (45 males, 15 females) was 32.5 years (range, 15-66 y). Mean Glasgow Coma Scale (GCS) score was 14 +/- 0.6. CT scans demonstrated intracranial injury in 11 patients (18.3%) and depressed fracture in 4 patients (6.7%). Serum tau levels of patients (188 +/- 210 pg/mL), compared with those of controls (86 48 pg/mL), were relatively higher; however, differences were not statistically significant (P = .445).	Uludag Univ, Dept Emergency Med, Sch Med, TR-16059 Bursa, Turkey; Uludag Univ, Dept Radiol, Sch Med, TR-16059 Bursa, Turkey; Uludag Univ, Dept Neurosurg, Sch Med, TR-16059 Bursa, Turkey; Uludag Univ, Dept Gen Surg, Sch Med, TR-16059 Bursa, Turkey; Uludag Univ, Dept Neurosurg, Sch Med, TR-16059 Bursa, Turkey; Uludag Univ, Dept Biochem, Sch Med, TR-16059 Bursa, Turkey		Bulut, M (corresponding author), Uludag Univ, Dept Emergency Med, Sch Med, TR-16059 Bursa, Turkey.		koksal, ozlem/AAK-8332-2020	koksal, ozlem/0000-0003-2271-5659			Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Biros MH., 1998, EMERGENCY MED CONCEP, P416; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; GEIJERSTAM JLA, 2004, EMERG MED J, V21, P54; GOTTESFELD SH, 2001, TURK J EMERG MED, V1, P87; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Ingelson M, 1999, DEMENT GERIATR COGN, V10, P442, DOI 10.1159/000017187; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; McKeating EG, 1998, ACT NEUR S, V71, P117; Mehta PD, 1999, NEUROSCI LETT, V275, P159, DOI 10.1016/S0304-3940(99)00754-5; Neumar RW, 2002, ANN EMERG MED, V39, P342, DOI 10.1067/mem.2002.122007; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Sjogren M, 2001, CLIN CHEM, V47, P1776; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zemlan FP, 1999, J NEUROCHEM, V73, P437	27	53	53	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0741-238X	1865-8652		ADV THER	Adv. Ther.	JAN-FEB	2006	23	1					12	22		10.1007/BF02850342			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	037AK	WOS:000237118900002	16644603				2022-02-06	
J	Poca, MA; Sahuquillo, J; Mataro, M; Benejam, B; Arikan, F; Baguena, M				Poca, MA; Sahuquillo, J; Mataro, M; Benejam, B; Arikan, F; Baguena, M			Ventricular enlargement after moderate or severe head injury: A frequent and neglected problem	JOURNAL OF NEUROTRAUMA			English	Article						head injury; incidence; outcome; post-traumatic hydrocephalus; ventricular dilation; ventriculomegaly	PROLONGED POSTTRAUMATIC UNAWARENESS; INTRACRANIAL-PRESSURE; COMPUTERIZED-TOMOGRAPHY; TRAUMATIC COMA; CSF DYNAMICS; BRAIN-INJURY; HYDROCEPHALUS; DIAGNOSIS; CLASSIFICATION; MANAGEMENT	The primary goal of this study was to determine the incidence of post-traumatic ventriculomegaly (Evans' index >= 0.30) in 95 head-injured patients with a Glasgow Coma Scale (GCS) score of <= 13 at admission. Additional objectives were to determine the relationship between an increase in ventricular size and several clinical and radiological features and outcome. A planimetric study was carried out in the sequential control computed tomography (CT) scans of 34 moderately head-injured (GCS 9-13) and 61 severely head-injured (GCS 3-8) patients with a minimum follow-up of 2 months. Between two and six CT scans were evaluated in each patient. The presence of subarachnoid hemorrhage (SAH) was registered. Evans' index was determined in all CT scans. In the final CT scan of each patient, ventricular size was related to the admission GCS score, age, the presence of SAH in the initial CT scans, type of brain lesion (classified according to the final diagnosis in the Traumatic Coma Data Bank classification), and outcome. Ventriculomegaly was found in 39.3% of patients with severe head injury and in 27.3 % of those with a moderate head injury. Increased ventricular size was evident 4 weeks after injury in 57.6% and 2 months after injury in 69.7%. No relationship was found between post-traumatic ventriculomegaly and age, initial GCS score, the presence of SAH, or type of lesion (focal or diffuse). Post-traumatic ventriculomegaly was significantly correlated with outcome. Post-traumatic ventriculomegaly is a frequent and early finding in patients with moderate or severe traumatic brain injury.	Autonomous Univ Barcelona, Hosp Gen Valle Hebron, Dept Neurosurg, Barcelona, Spain; Autonomous Univ Barcelona, Hosp Gen Valle Hebron, Neurotraumatol Res Unit, Barcelona, Spain; Autonomous Univ Barcelona, Hosp Gen Valle Hebron, Neurotraumatol Intens Care Unit, Barcelona, Spain; Univ Barcelona, Fac Psychol, Dept Psychiat & Clin Psychobiol, Barcelona, Spain		Poca, MA (corresponding author), Univ Barcelona, Hosp Gen Valle Hebron, Dept Neurosurg, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	pocama@neurotrauma.net	Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Arikan, Fuat/F-8900-2016; Martinez, Marcelino Baguena/AAG-7379-2019; Mataro, Maria/B-4524-2011	Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Arikan, Fuat/0000-0002-9459-0915; Martinez, Marcelino Baguena/0000-0001-9598-4791; Mataro, Maria/0000-0002-9946-2656			Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; Ariza M, 2004, J NEUROTRAUM, V21, P864, DOI 10.1089/0897715041526203; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; BORISENKO VV, 1997, LIK SPRAVA, V4, P91; BORISENKO VV, 1998, LIK SPRAVA, V5, P77; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; DOBROKHOTOVA TA, 1997, ZH VOPR NEIROKHIR N, V4, P12; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; JENNETT B, 1975, LANCET, V1, P480; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KATZ RT, 1989, AM J PHYS MED REHAB, V68, P91, DOI 10.1097/00002060-198904000-00009; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; Licata C, 2001, J Neurosurg Sci, V45, P141; LOSHAKOV VA, 1993, ZH VOPR NEIROKHIR N, V3, P18; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Matsushita H, 2000, NEUROL SURG TOKYO, V28, P773; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Meier U, 1987, Psychiatr Neurol Med Psychol (Leipz), V39, P754; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Paoletti P, 1983, J Neurosurg Sci, V27, P171; Poca MA, 2004, J NEUROSURG, V100, P855, DOI 10.3171/jns.2004.100.5.0855; Poca MA, 2004, J NEUROSURG, V100, P260, DOI 10.3171/jns.2004.100.2.0260; Poca MA, 2001, NEUROLOGIA, V16, P303; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; VANDONGEN KJ, 1980, NEUROSURGERY, V7, P14, DOI 10.1227/00006123-198007000-00003; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	40	53	64	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2005	22	11					1303	1310		10.1089/neu.2005.22.1303			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	989OI	WOS:000233683000004	16305318				2022-02-06	
J	Itoh, T; Satou, T; Hashimoto, S; Ito, H				Itoh, T; Satou, T; Hashimoto, S; Ito, H			Isolation of neural stem cells from damaged rat cerebral cortex after traumatic brain injury	NEUROREPORT			English	Article						culture; nestin; neural stem cell; neurosphere; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; CORTICAL IMPACT INJURY; ADULT-RAT; PROLIFERATION; EXPRESSION; NESTIN; NEUROGENESIS; ASTROCYTES; NEURONS	Nestin-positive cells were seen around the damaged area at 24 h, 72 In and 7 days after rat traumatic brain injury. Tissue was isolated from around the damaged area at 72 h after injury and spheres were cultured with basic fibroblast growth factor and epidermal growth factor. These spheres could not be isolated at 24 h and 7 days after injury. Isolated spheres consisted of nestin-positive neural stem cells. Neurospheres differentiated into Tujl-positive, glial fibrillary acidic protein-positive and O4-positive cells after 4 days in culture without basic fibroblast growth factor and epidermal growth factor. These results indicate that isolated and cultured neurospheres can differentiate into neurons and glia. An increase in nestin-positive cells around a cerebral cortical damaged area might contribute to neurogenesis and neuroplasticity.	Kinki Univ, Sch Med, Dept Pathol, Osaka 589, Japan; Kinki Univ, Sch Med, Div Hosp Pathol, Osaka, Japan; Kinki Univ, Div Sports Med, Inst Life Sci, Osaka, Japan; PL Hosp, Div Pathol, Osaka, Japan		Itoh, T (corresponding author), 377-2,Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp					Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Johansson CB, 2002, J NEUROSCI RES, V69, P784, DOI 10.1002/jnr.10376; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yanagisawa M, 2000, J NEUROCHEM, V74, P1498, DOI 10.1046/j.1471-4159.2000.0741498.x	17	53	71	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	OCT 17	2005	16	15					1687	1691		10.1097/01.wnr.0000183330.44112.ab			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	981FW	WOS:000233073900015	16189478				2022-02-06	
J	Hadjigeorgiou, GM; Paterakis, K; Dardiotis, E; Dardioti, M; Aggelakis, K; Tasiou, A; Xiromerisiou, G; Komnos, A; Zintzaras, E; Scarmeas, N; Papadimitriou, A; Karantanas, A				Hadjigeorgiou, GM; Paterakis, K; Dardiotis, E; Dardioti, M; Aggelakis, K; Tasiou, A; Xiromerisiou, G; Komnos, A; Zintzaras, E; Scarmeas, N; Papadimitriou, A; Karantanas, A			IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury	NEUROLOGY			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; HUMAN-ENDOTHELIAL-CELLS; SEVERE HEAD-INJURY; MULTIPLE-SCLEROSIS; HUMAN MONOCYTES; INNATE IMMUNE; ASSOCIATION; DISEASE; INFLAMMATION; COAGULATION	Objective: To investigate the association of (variable number tandem repeat) interleukin (IL) 1RN and (-511) IL-1B gene polymorphisms with brain hemorrhagic events after traumatic brain injury (TBI). Methods: Data from brain CT, Glasgow Coma Scale (GCS) at admission, and 6-month Glasgow Outcome Scale (GOS) and modified Rankin Scale (mRS) were collected for 151 prospectively recruited patients with TBI. IL-1RN and IL-1B genotypes were determined using standard methods. Presence vs absence of any type of brain hemorrhage was the main outcome. Type of brain hemorrhage, GCS at admission, and 6-month GOS and mRS were secondary outcomes. Odd ratios (ORs) and corresponding 95% CI were calculated using logistic regression analyses. In adjusted models, the associations were controlled for age, gender, diffuse brain edema, volume of intracranial hematoma, neurosurgical intervention, and GCS at admission. p values less than 0.01 were considered significant. Results: Compared with noncarriers, IL-1RN allele 2 carriers had higher odds of having cerebral hemorrhages after TBI ( adjusted OR = 4.57; 95% CI = 1.67 to 12.96; p = 0.004). The associations for (-511) IL-1B polymorphism were not significant. Conclusion: There is an association between the presence of interleukin-1RN allele 2 and posttraumatic brain hemorrhage.	Univ Thessaly, Sch Med, Dept Neurol, Neurogenet Unit, Larisa 41222, Greece; Univ Thessaly, Sch Med, Univ Hosp Larissa, Dept Neurosurg, Larisa 41222, Greece; Univ Thessaly, Sch Med, ICU, Larisa 41222, Greece; Univ Thessaly, Sch Med, CT & MRI Unit, Gen Hosp Larissa, Larisa 41222, Greece; Univ Thessaly, Sch Med, Dept Biomath, Larisa 41222, Greece; Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; Columbia Univ, Med Ctr, Taub Inst, New York, NY USA		Hadjigeorgiou, GM (corresponding author), Univ Thessaly, Sch Med, Dept Neurol, Neurogenet Unit, Papakyriazi 22 St, Larisa 41222, Greece.	gmhadji@med.uth.gr	Paterakis, Konstantinos/AAH-4554-2019; Scarmeas, Nikolaos/AAD-2512-2020; Scarmeas, Nikolaos/AAD-2517-2020; Karantanas, Apostolos/AAE-6820-2020	Scarmeas, Nikolaos/0000-0001-6453-8908; Scarmeas, Nikolaos/0000-0001-6453-8908; Karantanas, Apostolos/0000-0002-0927-2403; Xiromerisiou, Georgia/0000-0001-7162-3588; Dardiotis, Efthimios/0000-0003-2957-641X			Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Bird TD, 2001, NEUROLOGY, V57, P1153, DOI 10.1212/WNL.57.7.1153; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; CONWAY EM, 1988, MOL CELL BIOL, V8, P5588, DOI 10.1128/MCB.8.12.5588; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Di Giovine F. S., 1992, Human Molecular Genetics, V1, P450; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; Francis SE, 1999, CIRCULATION, V99, P861, DOI 10.1161/01.CIR.99.7.861; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GRAMSE M, 1986, BIOCHEM BIOPH RES CO, V139, P720, DOI 10.1016/S0006-291X(86)80050-X; Hall SK, 2004, ARTHRITIS RHEUM-US, V50, P1976, DOI 10.1002/art.20310; HASKILL S, 1991, P NATL ACAD SCI USA, V88, P3681, DOI 10.1073/pnas.88.9.3681; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; JENNETT B, 1975, LANCET, V1, P480; Joseph L, 2002, BLOOD COAGUL FIBRIN, V13, P105, DOI 10.1097/00001721-200203000-00005; Kantarci OH, 2000, J NEUROIMMUNOL, V106, P220, DOI 10.1016/S0165-5728(00)00202-2; Kastrati A, 2000, J AM COLL CARDIOL, V36, P2168, DOI 10.1016/S0735-1097(00)01014-7; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lawton MT, 2005, NEUROSURGERY, V56, P485, DOI 10.1227/01.NEU.0000153924.67360.EA; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Mann CLA, 2002, J NEUROIMMUNOL, V129, P197, DOI 10.1016/S0165-5728(02)00181-9; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; McGeer PL, 2002, NEUROSCI LETT, V326, P67, DOI 10.1016/S0304-3940(02)00300-2; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Osnes LTN, 1996, CYTOKINE, V8, P822, DOI 10.1006/cyto.1996.0110; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Paterniti S, 1998, ACTA NEUROCHIR, V140, P953, DOI 10.1007/s007010050198; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Rhodes Jonathan K J, 2003, Curr Opin Crit Care, V9, P86; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; SCHORER AE, 1989, THROMB RES, V56, P515, DOI 10.1016/0049-3848(89)90235-1; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Stein Deborah M, 2004, Curr Opin Crit Care, V10, P520, DOI 10.1097/01.ccx.0000144770.96342.65; TARLOW JK, 1993, HUM GENET, V91, P403; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Weir BS, 1996, DATA ANAL; Wilson JTL, 2001, CURR PHARM DESIGN, V7, P1537, DOI 10.2174/1381612013397276; Worrall BB, 2003, STROKE, V34, P790, DOI 10.1161/01.STR.0000057815.79289.EC	59	53	56	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	OCT 11	2005	65	7					1077	1082		10.1212/01.wnl.0000178890.93795.0e			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972RF	WOS:000232470200020	16217062				2022-02-06	
J	Feinstein, AJ; Patel, MB; Sanui, M; Cohn, SM; Majetschak, M; Proctor, KG				Feinstein, AJ; Patel, MB; Sanui, M; Cohn, SM; Majetschak, M; Proctor, KG			Resuscitation with pressors after traumatic brain injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	Annual Meeting of the American-College-of-Surgeons-Florida-Committee-on-Trauma	NOV, 2004	Miami Beach, FL	Amer Coll Surg FL Comm Trauma			UNCONTROLLED HEMORRHAGIC-SHOCK; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; ARGININE-VASOPRESSIN; FLUID RESUSCITATION; VASODILATORY SHOCK; LIVER TRAUMA; EPINEPHRINE; PHASE; NOREPINEPHRINE	BACKGROUND: The purpose of the study was to compare initial resuscitation with arginine vasopressin (AVP), phenylephrine (PE), or isotonic crystalloid fluid alone after traumatic brain injury and vasodilatory shock. STUDY DESIGN: Anesthetized, ventilated swine (n = 39, 30 +/- 2 kg) underwent fluid percussion traumatic brain injury followed by hemorrhage (30 +/- 2 mL/kg) to a mean arterial pressure < 30 mmHg, then were randomized to 1 of 5 groups to maintain mean arterial pressure > 60 mmHg for 30 to 60 minutes, then cerebral perfusion pressure > 60 mmHg for 60 to 300 minutes, either unlimited crystalloid fluid only (n = 9), arginine vasopressin + fluid (n = 9), phenylephrine + fluid (n = 9), arginine vasopressin only (n = 5), or phenylephrine only (n = 5). Heterologous transfusions were administered if hematocrit was < 13, and mannitol was administered if intracranial pressure was > 20 mmHg. Cerebrovascular reactivity was evaluated with serial CO2 challenges. RESULTS: In all groups, physiologic variables were similar at baseline and at the end of shock. On resuscitation, all achieved mean arterial pressure and cerebral perfusion pressure goals. Brain tissue PO(2)s were similar. With fluid only, more blood and mannitol were required, intracranial pressure and peak inspiratory pressure were higher, and cerebrovascular reactivity was decreased (all p < 0.05 versus pressor + fluid). With either pressor + fluid, cardiac output, heart rate, lactate, and mixed venous O-2 saturation were similar to fluid only, but total fluid requirements and urine output were both reduced (p < 0.05). With either pressor only, intracranial. pressure remained low, but mixed venous O-2 saturation, cardiac output, and urine output were decreased (all p < 0.05 versus other groups). CONCLUSIONS: To correct vasodilatory shock after traumatic brain injury, a resuscitation strategy that combined either phenylephrine or arginine vasopressin plus crystalloid was superior to either fluid alone or pressor alone.	Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Dewitt Daughtry Family Dept Surg,Div Trauma, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Surg Crit Care, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Dewitt Daughtry Family Dept Surg,Div Trauma, 1800 NW 10th Ave, Miami, FL 33136 USA.		Patel, Mayur/K-2363-2013; Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628; Feinstein, Ara/0000-0001-6214-5334	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008749] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM08749-01] Funding Source: Medline		Alspaugh DM, 2000, J TRAUMA, V48, P851, DOI 10.1097/00005373-200005000-00008; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Crookes BA, 2005, J TRAUMA, V58, P806, DOI 10.1097/01.TA.0000158269.68409.1C; Crookes BA, 2004, SURGERY, V135, P662, DOI 10.1016/j.surg.2003.11.017; DeWitt DS, 2000, CRIT CARE MED, V28, P3933, DOI 10.1097/00003246-200012000-00036; Dunser MW, 2003, CRIT CARE MED, V31, P1394, DOI 10.1097/01.CCM.0000059722.94182.79; Dunser MW, 2004, ANESTH ANALG, V99, P201, DOI 10.1213/01.ANE.0000118105.85933.8A; FEINSTEIN AJ, 2004, J TRAUMA, V57, P1377; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Hilwig RW, 2000, RESUSCITATION, V47, P203, DOI 10.1016/S0300-9572(00)00261-6; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Landry DW, 1997, CIRCULATION, V95, P1122; Liu LM, 2003, J TRAUMA, V54, pS159, DOI 10.1097/01.TA.0000054649.46525.A5; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; MATTOX KL, 1996, TRAUMA; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Pope A, 1999, FLUID RESUSCITATION; Potas JR, 2004, AUTON NEUROSCI-BASIC, V111, P1, DOI 10.1016/j.autneu.2003.12.003; RABINOVICI R, 1992, SURG GYNECOL OBSTET, V175, P341; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; REMINGTON JW, 1950, AM J PHYSIOL, V161, P116, DOI 10.1152/ajplegacy.1950.161.1.116; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; SANUI M, 2004, ANESTHESIOLOGY, V101, pA414; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; WIGGERS HC, 1950, CIRCULATION, V2, P179, DOI 10.1161/01.CIR.2.2.179	32	53	53	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515			J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2005	201	4					536	545		10.1016/j.jamcollsurg.2005.05.031			10	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	972DF	WOS:000232433500008	16183491				2022-02-06	
J	Stiefel, MF; Tomita, Y; Marmarou, A				Stiefel, MF; Tomita, Y; Marmarou, A			Secondary ischemia impairing the restoration of ion homeostasis following traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; ischemia; ion-selective electrode; potassium; sodium; rat	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; TRANSIENT FOREBRAIN ISCHEMIA; COMA DATA-BANK; EXTRACELLULAR POTASSIUM; RAT-BRAIN; PHOSPHATE-METABOLISM; IN-VIVO; HYPOXIA; EDEMA	Object. It is well established that posttraumatic secondary ischemia contributes to poor outcome. Ion dysfunction leading to cytotoxic edema is a primary force in the formation of ischemic brain edema and is a principal component of traumatic brain swelling. Because cell swelling is the result of net ion and water movement, it is crucial to have a thorough understanding of these transient phenomena. The purpose of this study was to characterize the effects of secondary ischemia following traumatic brain injury (TBI) on the ability to restore ion homeostasis. Methods. Twenty-four Sprague-Dawley rats were divided into four groups of six animals each. The rats underwent transient forebrain ischemia via bilateral carotid artery occlusion combined with hypotension: 15 minutes of forebrain ischemia (Group 1); 60 minutes of forebrain ischemia (Group 2); impact acceleration/TBI (Group 3); and impact acceleration/TBI followed by 15 minutes of ischemia (Group 4). Ischemia resulted in a rapid accumulation of [K+](e): 41.94 +/- 13.65 and 66.33 +/- 6.63 mM, respectively, in Groups I and 2, with a concomitant decrease of (Na+],: 64 +/- 18 mM and 72 +/- 11 mM in Groups I and 2. Traumatic brain injury resulted in a less severe although identical trend in ion dysfunction ([K+](e) 30.42 +/- 11.67 mM and [Na+](e) 63 +/- 33 mM). Secondary ischemia resulted in prolonged and sustained ion dysfunction with a concomitant elevation of intracranial pressure (ICP). Conclusions. Analysis of these results indicates that ischemia and TBI are sublethal in isolation; however, when TBI is associated with secondary ischemia, ion dysfunction is sustained and is associated with elevated ICP.	Virginia Commonwealth Univ, Dept Neurosurg, Hlth Syst, Richmond, VA 23298 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Marmarou, A (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, Hlth Syst, POB 980508,1001 E Broad St,Old City Hall, Suite 5, Richmond, VA 23298 USA.	marmarou@hsc.vcu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587] Funding Source: NIH RePORTER		ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Chappell JE, 1996, J TRAUMA, V41, P781, DOI 10.1097/00005373-199611000-00003; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; HANSEN AJ, 1980, PFLUG ARCH EUR J PHY, V389, P1, DOI 10.1007/BF00587921; HANSEN AJ, 1977, ACTA PHYSIOL SCAND, V101, P438, DOI 10.1111/j.1748-1716.1977.tb06027.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HILLERED L, 1984, J CEREBR BLOOD F MET, V4, P438, DOI 10.1038/jcbfm.1984.63; HOSSMANN KA, 1977, STROKE, V8, P77, DOI 10.1161/01.STR.8.1.77; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; ITO U, 1975, ACTA NEUROPATHOL, V34, P1; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1991, BRAIN RES, V567, P57, DOI 10.1016/0006-8993(91)91435-4; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1991, BRAIN RES, V568, P294, DOI 10.1016/0006-8993(91)91412-T; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KITA H, 1994, ACTA NEUROCHIR, P452; LJUNGGREN B, 1974, BRAIN RES, V73, P291, DOI 10.1016/0006-8993(74)91050-6; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MENZIES SA, 1993, J NEUROSURG, V78, P257, DOI 10.3171/jns.1993.78.2.0257; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; PULSINELLI WA, 1982, ANN NEUROL, V11, P499, DOI 10.1002/ana.410110510; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319; Stiefel MF, 2002, J NEUROSURG, V97, P97, DOI 10.3171/jns.2002.97.1.0097; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; TSUJI O, 1994, INTRACRANIAL PRESSUR, V9, P268; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WALZ W, 1983, PROG NEUROBIOL, V20, P133, DOI 10.1016/0301-0082(83)90013-8; WALZ W, 1984, J CEREBR BLOOD F MET, V4, P301, DOI 10.1038/jcbfm.1984.42; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yamamoto T, 1997, ACT NEUR S, V70, P71; YOUNG W, 1987, STROKE, V18, P751, DOI 10.1161/01.STR.18.4.751	51	53	53	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2005	103	4					707	714		10.3171/jns.2005.103.4.0707			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	971LG	WOS:000232385000019	16266054				2022-02-06	
J	Toro, K; Hubay, M; Sotonyi, P; Keller, E				Toro, K; Hubay, M; Sotonyi, P; Keller, E			Fatal traffic injuries among pedestrians, bicyclists and motor vehicle occupants	FORENSIC SCIENCE INTERNATIONAL			English	Article						road accidents; pedestrians; drivers; trauma	ALCOHOL; ACCIDENTS; MANAGEMENT; FRACTURES; DRIVERS; TRAUMA; FRANCE; AGE	The objective of this study was to investigate characteristic injuries of pedestrians and bicyclists (unprotected) compared to motor vehicle occupants' (protected) in fatal traffic accidents. Cases of 664 fatal traffic accidents (371 pedestrians, 45 bicyclists, and 248 motor vehicle occupants) were collected from 1999 to 2001 using the database of the Forensic Institute in Budapest. Autopsy reports were analyzed. Location of injuries, blood alcohol levels, seasonal distribution and natural diseases influencing accident outcome were evaluated. For statistical analysis, odds ratio (OR) with 95% confidence interval (CI) was used by a conditional logistic regression. There were substantial differences in distribution of injuries suffered by pedestrians, bicyclists and motor vehicle occupants. Among pedestrians and bicyclists there was a higher rate of head injuries, such as skull fractures, epidural haemorrhage, subdural haemorrhage, brain contusion, and injuries of the lower extremities. Thoracic damages, such as traumatic aortic rupture, hemothorax, and abdominal damages, like liver rupture were dominant in motor vehicle occupants. Considering existing natural diseases, coronary artery disease was the only one with higher occurrence among motor vehicle occupants 24 (9.7%) compared with pedestrians and bicyclist 36 (8.6%). These results underline the importance of preventive strategies in transportation, pointing out that different methods are necessary to reduce fatal injuries of various traffic participants. (c) 2005 Elsevier Ireland Ltd. All rights reserved.	Semmelweis Univ, Fac Med, Dept Forens Med, H-1091 Budapest, Hungary		Toro, K (corresponding author), Semmelweis Univ, Fac Med, Dept Forens Med, Ulloi 93, H-1091 Budapest, Hungary.	torok@igaz.sote.hu		Hubay, Marta/0000-0003-2193-1325			Aronson S C, 1984, R I Med J, V67, P485; Ballesteros MF, 2004, ACCIDENT ANAL PREV, V36, P73, DOI 10.1016/S0001-4575(02)00129-X; Barreto SM, 1996, OCCUP ENVIRON MED, V53, P343, DOI 10.1136/oem.53.5.343; BERTELSEN S, 1972, THORAX, V27, P188, DOI 10.1136/thx.27.2.188; Bhandari M, 2003, CLIN ORTHOP RELAT R, P187, DOI 10.1097/01.blo.0000043051.62337.bd; *CDC PREV, 1999, JAMA-J AM MED ASSOC, V281, P2080; del Rio MC, 1999, FORENSIC SCI INT, V104, P117, DOI 10.1016/S0379-0738(99)00101-2; DERLET R W, 1989, Journal of Emergency Medicine, V7, P5; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; *EEVC WORK GROUP 1, 1998, IMPR TEST METH EV PE; FERRANDO J, 2000, P ANN C ASSOC ADV AU, V44, P445; Fontaine H, 1997, ACCIDENT ANAL PREV, V29, P303, DOI 10.1016/S0001-4575(96)00084-X; Harruff RC, 1998, ACCIDENT ANAL PREV, V30, P11, DOI 10.1016/S0001-4575(97)00057-2; HOLUBOWYCZ OT, 1995, ACCIDENT ANAL PREV, V27, P417, DOI 10.1016/0001-4575(94)00064-S; JOHNSON CL, 1994, AM SURGEON, V60, P899; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; Laapotti S, 1998, ACCIDENT ANAL PREV, V30, P435, DOI 10.1016/S0001-4575(97)00121-8; Landen MG, 1997, JAMA-J AM MED ASSOC, V278, P1755, DOI 10.1001/jama.278.21.1755; MACLAUGHLIN TF, 1993, VEHICLE INTERACTIONS, P539; Macpherson A, 1998, AM J PUBLIC HEALTH, V88, P1840, DOI 10.2105/AJPH.88.12.1840; MASAHITO H, 1999, AM J FOREN MED PATH, V20, P251; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MATSUI Y, 1998, P 16 TECHN C ENH SAF, P2152; Meliker JR, 2004, ACCIDENT ANAL PREV, V36, P1129, DOI 10.1016/j.aap.2004.06.002; MOHAN D, 1995, P 1995 INT IRCOBI C; *NAT CTR STAT AN T, 2001, FAT AN REP SYST; *NHTSA TRAFF SAF F, 1995, NAT HIGHW TRAFF SAF; Nordrum I, 2000, FORENSIC SCI INT, V110, P127, DOI 10.1016/S0379-0738(00)00163-8; OSTROM M, 1993, ACCIDENT ANAL PREV, V25, P171, DOI 10.1016/0001-4575(93)90057-4; Ostrom M, 2001, ACCIDENT ANAL PREV, V33, P173, DOI 10.1016/S0001-4575(00)00028-2; OSTROM M, 1992, ACCIDENT ANAL PREV, V24, P539, DOI 10.1016/0001-4575(92)90062-N; Peng RY, 1999, J AM COLL SURGEONS, V189, P343, DOI 10.1016/S1072-7515(99)00166-0; Reynaud M, 2002, ALCOHOL CLIN EXP RES, V26, P1833, DOI 10.1097/01.ALC.00000420008.34422.54; Rossbach MM, 1998, ANN THORAC SURG, V65, P182, DOI 10.1016/S0003-4975(97)01001-1; Simoncic M, 2001, ACCIDENT ANAL PREV, V33, P147, DOI 10.1016/S0001-4575(00)00025-7; SJOGREN H, 1993, P 37 ANN C AAAM, P237; Swan KG, 2001, J TRAUMA, V51, P970, DOI 10.1097/00005373-200111000-00023; SWEEDLER B, 1997, ALCOHOL DRUGS TRAFFI, P1206; Tatou E, 2000, ANN THORAC SURG, V69, P70, DOI 10.1016/S0003-4975(99)01054-1; Varga T, 1999, FORENSIC SCI INT, V103, pS25, DOI 10.1016/S0379-0738(99)00068-7; VESTRUP JA, 1989, J TRAUMA, V29, P741, DOI 10.1097/00005373-198906000-00007; Yavuz MS, 2003, AM J FOREN MED PATH, V24, P339, DOI 10.1097/01.paf.0000103011.14578.c3; YOSHIDA S, SAE INT C EXP; ZVULUN F, 1996, AM J FOREN MED PATH, V17, P233	44	53	57	0	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JUL 16	2005	151	2-3					151	156		10.1016/j.forsciint.2005.01.014			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	940OZ	WOS:000230155100004	15939146				2022-02-06	
J	Clarke, NMP; Jowett, AJL; Parker, L				Clarke, NMP; Jowett, AJL; Parker, L			The surgical treatment of established congenital dislocation of the hip - Results of surgery after planned delayed intervention following the appearance of the capital femoral ossific nucleus	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						congenital dislocation of the hip; surgical treatment; ossific nucleus	AVASCULAR NECROSIS; CLOSED REDUCTION; DEVELOPMENTAL DYSPLASIA; OPERATIVE TREATMENT; PAVLIK HARNESS; CHILDREN; TRACTION; HEAD; AGE; COMPLICATION	It has been proposed that the presence of the capital femoral ossific nucleus confers protection against ischemic injury or avascular necrosis (AVN) at the time of reduction of a congenitally dislocated hip. The current literature is contradictory. A prospective study was undertaken of the clinical and radiologic outcomes following closed or open reduction. Fifty hips were included in the study. These cases had presented late or had failed conservative treatment. In 28 hips treatment was intentionally delayed until the appearance of the ossific nucleus (but not beyond 13 months) and in 22 the ossific nucleus was present at clinical presentation. Six hips reached the age of 13 months without an ossific nucleus appearing and progressed to treatment. The significant AVN rate (more than grade 1) was 7 % for closed reduction and 14 % for open. However, the amended rate if hips were excluded that had failed Pavlik harness treatment was 0.0 % and 9 %, respectively (4 % overall). Further surgical procedures were necessary in 57 % of hips undergoing closed reduction and 41 % after open, which compares favorably with other series. The authors conclude that the presence of the ossific nucleus is an important factor in the prevention of AVN, particularly after late closed reduction. Intentional delay in the timing of surgery does not condemn a hip to open surgery, but there is a comparable rate of secondary procedures becoming necessary, particularly after closed reduction. A simultaneous pelvic procedure may be appropriate after late closed reduction. The delayed strategy to await the appearance of the ossific nucleus for previously untreated dislocation allows a simple treatment algorithm to be employed that produces good clinical and radiologic outcomes.	Univ Southampton, Univ Orthopaed, Southampton, Hants, England		Clarke, NMP (corresponding author), Univ Orthopaed, Southampton Gen Hosp, MP 817,Tremona Rd, Southampton SO16 6YD, Hants, England.	ortho@soton.ac.uk					BERKELEY ME, 1984, J BONE JOINT SURG AM, V66A, P412, DOI 10.2106/00004623-198466030-00014; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BORGES JLP, 1995, J BONE JOINT SURG AM, V77A, P975, DOI 10.2106/00004623-199507000-00001; BROUGHAM DI, 1990, J BONE JOINT SURG BR, V72, P557, DOI 10.1302/0301-620X.72B4.2380203; Cashman JP, 2002, J BONE JOINT SURG BR, V84B, P418, DOI 10.1302/0301-620X.84B3.12230; Clarke NMP, 1988, BEHAV GROWTH PLATE, P371; COOPERMAN DR, 1980, J BONE JOINT SURG AM, V62, P247, DOI 10.2106/00004623-198062020-00012; DHAR S, 1990, J BONE JOINT SURG BR, V72, P175, DOI 10.1302/0301-620X.72B2.2312552; DIMEGLIO A, 1994, J PEDIATR ORTHOP B, V3, P135, DOI 10.1097/01202412-199403020-00003; ESTEVE R, 1960, J BONE JOINT SURG BR, V42, P253, DOI 10.1302/0301-620X.42B2.253; FISHER RL, 1978, INT ORTHOP, V2, P229, DOI 10.1007/BF00266083; FLEISSNER PR, 1994, J PEDIATR ORTHOPED, V14, P631, DOI 10.1097/01241398-199409000-00016; GAGE JR, 1972, J BONE JOINT SURG AM, VA 54, P373, DOI 10.2106/00004623-197254020-00015; GIBSON PH, 1982, J BONE JOINT SURG BR, V64, P169, DOI 10.1302/0301-620X.64B2.7068735; GREGOSIEWICZ A, 1988, J PEDIATR ORTHOPED, V8, P17, DOI 10.1097/01241398-198801000-00004; Huang SC, 1997, J PEDIATR ORTHOPED, V17, P181, DOI 10.1097/00004694-199703000-00009; ISHII Y, 1978, CLIN ORTHOP RELAT R, P167; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; Langenskiold A, 2000, J PEDIATR ORTHOPED, V20, P471, DOI 10.1097/00004694-200007000-00009; Luhmann SJ, 1998, J BONE JOINT SURG AM, V80A, P1719, DOI 10.2106/00004623-199812000-00001; Luhmann SJ, 2003, J BONE JOINT SURG AM, V85A, P239, DOI 10.2106/00004623-200302000-00009; Morcuende JA, 1997, J BONE JOINT SURG AM, V79A, P810, DOI 10.2106/00004623-199706000-00002; NAITO M, 1992, J ORTHOPAED RES, V10, P800, DOI 10.1002/jor.1100100608; OGDEN JA, 1975, J PEDIATR-US, V86, P732, DOI 10.1016/S0022-3476(75)80358-1; RACE C, 1983, J PEDIATR ORTHOPED, V3, P166, DOI 10.1097/01241398-198305000-00004; RAMSEY PL, 1976, J BONE JOINT SURG AM, V58, P1000, DOI 10.2106/00004623-197658070-00017; ROSS ERS, 1988, J BONE JOINT SURG BR, V70, P680; SALTER RB, 1969, CAN J SURG, V12, P44; Segal LS, 1999, J PEDIATR ORTHOPED, V19, P177, DOI 10.1097/00004694-199903000-00008; Segal LS, 1999, J PEDIATR ORTHOPED, V19, P433, DOI 10.1097/00004694-199907000-00003; Severin E., 1941, ACTA CHIR SCAND, V84, P1; SHERLOCK DA, 1985, J BONE JOINT SURG BR, V67, P390, DOI 10.1302/0301-620X.67B3.3997947; Sugimoto Nobuyuki, 1993, Bulletin Hospital for Joint Diseases, V53, P30; THOMAS IH, 1989, J PEDIATR ORTHOPED, P9525; Tonnis D, 1990, Acta Orthop Belg, V56, P195; TREVOR D, 1957, J BONE JOINT SURG BR, V39, P611; Ward WT, 1997, J BONE JOINT SURG AM, V79A, P656, DOI 10.2106/00004623-199705000-00004; WEINER DS, 1977, J BONE JOINT SURG AM, V59, P306, DOI 10.2106/00004623-197759030-00002; WILKINSON JA, 1995, CONGENITAL DISPLACEM; ZIONTS LE, 1986, J BONE JOINT SURG AM, V68A, P829, DOI 10.2106/00004623-198668060-00005	40	53	57	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JUL-AUG	2005	25	4					434	439		10.1097/01.bpo.0000158003.68918.28			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	939CJ	WOS:000230049600005	15958890				2022-02-06	
J	Ryser, DK; Egger, MJ; Horn, SD; Handrahan, D; Gandhi, P; Bigler, EA				Ryser, DK; Egger, MJ; Horn, SD; Handrahan, D; Gandhi, P; Bigler, EA			Measuring medical complexity during inpatient rehabilitation after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; diaonosis-related groups; rehabilitation; severity of illness index	MIX CLASSIFICATION-SYSTEM; UNIFORM DATA SYSTEM; LENGTH-OF-STAY; SEVERITY; ADMISSIONS; DISABILITY; RECOVERY; CHARGES	Objective: To compare the performance of 3 severity of illness (SOI) indices-the Comprehensive Severity Index (CSI), All Patient Refined Diagnosis Related Groups Severity of Illness, case-mix group (CMG)-and 5 well-known neurologic parameters, as measures of medical complexity. Design: Retrospective chart review. Setting: Inpatient rehabilitation center within a level I trauma center. Participants: Consecutive traumatic brain injury (TBI) admissions (N=212). Intervention: Acute inpatient TBI rehabilitation. CSI and neurologic parameters were scored by chart extraction. SOI was based on diagnosis codes by using 3M PC Grouper software, version 15. Main Outcome Measures: Adjusted R-2 was used to predict rehabilitation charges as a proxy of medical complexity. Results: The highest adjusted R-2 values for single variables predicting charges were: CMG .349, CSI .293, duration of post-traumatic amnesia .260. Adjusted R-2 values for the CMG combined with the CSI, 5 neurologic parameters, and SOI to predict charges were .446, .431, and .365, respectively. Conclusions: The CMG was the best single predictor of rehabilitation charges for TBI. Predictive ability was better when the CMG was combined with the CSI or a combination of the 5 neurologic parameters. A severity index based on objective clinical findings rather than diagnostic codes may have distinct advantages for rehabilitation outcome studies and reimbursement methodology.	Latter Day St Hosp, Neuro Specialty Rehabil Unit, Div PM&R, Salt Lake City, UT 84143 USA; Latter Day St Hosp, Stat Data Ctr, Salt Lake City, UT 84143 USA; Univ Utah, Publ Hlth Programs, Salt Lake City, UT USA; Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; Int Sever Informat Syst, Salt Lake City, UT USA		Ryser, DK (corresponding author), Latter Day St Hosp, Neuro Specialty Rehabil Unit, Div PM&R, 8th Ave & C St, Salt Lake City, UT 84143 USA.	lddryser@ihc.com		Egger, Marlene/0000-0001-8886-7837			ALEMI F, 1990, MED CARE, V28, P762, DOI 10.1097/00005650-199009000-00006; AVERILL RF, 1992, HEALTH SERV RES, V27, P587; Centers for Medicare & Medicaid Services, 2001, FED REGISTER, V66, P41316; Clayton PD, 2003, METHOD INFORM MED, V42, P1; *CTR MED MED SERV, 2001, FED REGISTER, V66, P41345; *CTR MED MED SERV, 2001, FED REGISTER, V66, P41353; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; Fiedler RC, 1996, AM J PHYS MED REHAB, V75, P125, DOI 10.1097/00002060-199603000-00010; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P33, DOI 10.1097/00002060-199302000-00008; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; IEZZONI L, 1979, ANN INTERN MED, V127, P666; Iezzoni LI, 2002, MILBANK Q, V80, P347, DOI 10.1111/1468-0009.t01-1-00007; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Iezzoni LI, 1997, RISK ADJUSTMENT MEAS; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; NETER J, 1996, APPL LINEAR STAT MOD, P339; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; RYSER DK, 1995, ARCH PHYS MED REHAB, V76, P1042; Stinchcombe AL, 2000, J POLIT PHILOS, V8, P1, DOI 10.1111/1467-9760.00090; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; Stineman MG, 1998, ARCH PHYS MED REHAB, V79, P241, DOI 10.1016/S0003-9993(98)90001-6; Stineman MG, 1997, HEALTH SERV RES, V32, P529; Stineman MG, 1996, AM J PHYS MED REHAB, V75, P68, DOI 10.1097/00002060-199601000-00018; STINEMAN MG, 1994, ARCH PHYS MED REHAB, V75, P1277; Stineman MG, 2002, ARCH PHYS MED REHAB, V83, P1802, DOI 10.1053/apmr.2002.36067; STINEMAN MG, 1990, ARCH PHYS MED REHAB, V71, P881; Stineman MG, 1997, HEALTH CARE FINANC R, V19, P87; Stineman MG, 2001, ARCH PHYS MED REHAB, V82, P553, DOI 10.1053/apmr.2001.24088; STINEMAN MG, 1995, ARCH PHYS MED REHAB, V76, P1163, DOI 10.1016/S0003-9993(95)80127-8; Stineman MG, 1997, MED CARE, V35, pJS90, DOI 10.1097/00005650-199706001-00018; Stineman MG, 1997, MED CARE, V35, pJS106; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Zafonte RD, 1997, BRAIN INJURY, V11, P403	37	53	53	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2005	86	6					1108	1117		10.1016/j.apmr.2004.11.041			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	934EK	WOS:000229689500007	15954048				2022-02-06	
J	Runyan, JD; Moore, AN; Dash, PK				Runyan, JD; Moore, AN; Dash, PK			A role for prefrontal calcium-sensitive protein phosphatase and kinase activities in working memory	LEARNING & MEMORY			English	Article							LONG-TERM POTENTIATION; TRAUMATIC BRAIN INJURY; DOPAMINE-RECEPTORS; C ACTIVATION; D-1; CORTEX; PHOSPHORYLATION; INDUCTION; DEFICITS; NEURONS	The prefrontal cortex is involved in the integration and interpretation of information for directing thoughts and planning action. Working memory is defined as the active maintenance of information in mind and is thought to lie at the core of many prefrontal functions. Although dopamine and other neurotransmitters have been implicated, the intracellular events activated by their receptors that influence working memory are poorly understood. We demonstrate that working memory involves transient changes in prefrontal G(q/11)-signaling and in calcium-dependent intracellular protein phosphatase and kinase activity. Interestingly, inhibition of the calcium activated phosphatase calcineurin impaired, while calcium/calmodulin dependent kinase II (CaMKII) and calcium-dependent protein kinase C (PKC) enhanced, working memory. Our findings suggest that the active maintenance of information required for working memory involves transient changes in the balance of these enzymes' activities.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA.	p.dash@uth.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS035457, NS 35457] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035457] Funding Source: NIH RePORTER		ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; Arthur JM, 1999, AM J PHYSIOL-RENAL, V276, pF528, DOI 10.1152/ajprenal.1999.276.4.F528; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Camodeca N, 1999, NEUROPHARMACOLOGY, V38, P1597, DOI 10.1016/S0028-3908(99)00093-3; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; d'Alcantara P, 2003, EUR J NEUROSCI, V17, P2521, DOI 10.1046/j.1460-9568.2003.02693.x; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; Day M, 2002, J NEUROPHYSIOL, V87, P2490, DOI 10.1152/jn.00843.2001; Edagawa Y, 2000, EUR J NEUROSCI, V12, P1391, DOI 10.1046/j.1460-9568.2000.00007.x; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HYTTEL J, 1983, EUR J PHARMACOL, V91, P153, DOI 10.1016/0014-2999(83)90381-3; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Kozlov A P, 2001, Neurosci Behav Physiol, V31, P405, DOI 10.1023/A:1010488612338; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LI W, 1993, J BIOL CHEM, V268, P14040; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Margrie TW, 1998, NAT NEUROSCI, V1, P378, DOI 10.1038/1589; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Miyoshi E, 2002, BRAIN RES BULL, V58, P41, DOI 10.1016/S0361-9230(02)00754-2; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; MUKHERJI S, 1994, J BIOL CHEM, V269, P20733; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Robbins TW, 2000, SCIENCE, V290, P2275, DOI 10.1126/science.290.5500.2275; Roeper J, 1997, J NEUROSCI, V17, P3379; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; Runyan JD, 2004, NEUROBIOL LEARN MEM, V82, P65, DOI 10.1016/j.nlm.2004.04.006; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Sawaguchi T, 2001, NEUROSCI RES, V41, P115, DOI 10.1016/S0168-0102(01)00270-X; Seamans JK, 1998, J NEUROSCI, V18, P1613; SIBLEY DR, 1982, LIFE SCI, V31, P637, DOI 10.1016/0024-3205(82)90764-0; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Taylor AM, 1999, J CARDIOV MAGN RESON, V1, P23, DOI 10.3109/10976649909080830; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31, DOI DOI 10.1007/s00429-005-0042-4; Waters NS, 1997, BEHAV BRAIN RES, V84, P23, DOI 10.1016/S0166-4328(96)00130-1; Young CE, 2004, J NEUROSCI, V24, P8, DOI 10.1523/JNEUROSCI.1650-03.2004; YULE DI, 1992, J BIOL CHEM, V267, P13830; Zahrt J, 1997, J NEUROSCI, V17, P8528	56	53	54	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1072-0502	1549-5485		LEARN MEMORY	Learn. Mem.	MAR-APR	2005	12	2					103	110		10.1101/lm.89405			8	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	912KV	WOS:000228077800006	15805309	Green Published, gold			2022-02-06	
J	Shinozaki, Y; Koizumi, S; Ishida, S; Sawada, JI; Ohno, Y; Inoue, K				Shinozaki, Y; Koizumi, S; Ishida, S; Sawada, JI; Ohno, Y; Inoue, K			Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y(1) receptors	GLIA			English	Article						ATP; P2Y(1) receptors; astrocytes; oxidative stress	DORSAL SPINAL-CORD; ALZHEIMERS-DISEASE; THIOREDOXIN REDUCTASE; INTRACELLULAR CALCIUM; IMMUNOHISTOCHEMICAL LOCALIZATION; CULTURED ASTROCYTES; CARBONYL REDUCTASE; ADENOSINE-TRIPHOSPHATE; SYNAPTIC-TRANSMISSION; GLUCOSE DEPRIVATION	Oxidative stress is the main cause of neuronal damage in traumatic brain injury, hypoxia/reperfusion injury, and neurodegenerative disorders. Although extracellular nucleosides, especially adenosine, are well known to protect against neuronal damage in such pathological conditions, the effects of these nucleosides or nucleotides on glial cell damage remain largely unknown. We report that ATP but not adenosine protects against the cell death of cultured astrocytes induced by hydrogen peroxide (H2O2). ATP ameliorated the H2O2-induced decrease in cell viability of astrocytes in an incubation time- and concentration-dependent fashion. Protection by ATP was inhibited by P2 receptor antagonists and was mimicked by P2Y(1) receptor agonists but not by adenosine. The expressions of P2Y(1) mRNAs and functional P2Y(1) receptors in astrocytes were confirmed. Thus, ATP, acting on P2Y(1) receptors in astrocytes, showed a protective action against H2O2. The astrocytic protection by the P2Y(1) receptor agonist 2-methylthio-ADP was inhibited by an intracellular Ca2+ chelator and a blocker of phospholipase C, indicating the involvement of intracellular signals mediated by Gq/11-coupled P2Y(1) receptors. The ATP-induced protection was inhibited by cycloheximide, a protein synthesis inhibitor, and it took more than 12 h for the onset of the protective action. In the DNA microarray analysis, ATP induced a dramatic upregulation of various oxidoreductase genes. Taken together, ATP acts on P2Y(1) receptors coupled to Gq/11, resulting in the upregulation of oxidoreductase genes, leading to the protection of astrocytes against H2O2. (C) 2004 Wiley-Liss. Inc.	Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, Tokyo 1588501, Japan; Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan; Natl Inst Hlth Sci, Div Biochem & Immunochem, Setagaya Ku, Tokyo 1588501, Japan; Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 812, Japan		Inoue, K (corresponding author), Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	inoue@nihs.go.jp	Koizumi, Schuichi/E-8568-2010; Shinozaki, Youichi/E-8594-2010; Shinozaki, Youichi/AAC-9431-2019	Koizumi, Schuichi/0000-0001-6184-3106; Shinozaki, Youichi/0000-0002-6448-1304; Shinozaki, Youichi/0000-0002-6448-1304			ABBRACCHIO MP, 1995, BIOCHEM BIOPH RES CO, V213, P908, DOI 10.1006/bbrc.1995.2215; ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; AGARDH CD, 1991, INT J DEV NEUROSCI, V9, P127, DOI 10.1016/0736-5748(91)90003-5; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Aihara H, 2002, BRAIN RES, V952, P31, DOI 10.1016/S0006-8993(02)03185-2; Akbar GKM, 1996, J BIOL CHEM, V271, P18363, DOI 10.1074/jbc.271.31.18363; ALTMAN FP, 1976, HISTOCHEM J, V8, P471, DOI 10.1007/BF01003837; Appel E, 2001, J MOL NEUROSCI, V17, P285, DOI 10.1385/JMN:17:3:285; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Araque A, 1999, CAN J PHYSIOL PHARM, V77, P699, DOI 10.1139/cjpp-77-9-699; Ayyanathan K, 1996, BIOCHEM BIOPH RES CO, V218, P783, DOI 10.1006/bbrc.1996.0139; Balcz B, 2001, J NEURAL TRANSM-SUPP, P193; Behan WMH, 2002, BRIT J PHARMACOL, V135, P1435, DOI 10.1038/sj.bjp.0704613; Brambilla R, 1999, BRIT J PHARMACOL, V126, P563, DOI 10.1038/sj.bjp.0702333; Braun N, 1998, J NEUROSCI, V18, P4891; Braun N, 1997, BRAIN RES, V766, P213, DOI 10.1016/S0006-8993(97)00559-3; Butterfield DA, 2003, J NEUROCHEM, V86, P1313, DOI 10.1046/j.1471-4159.2003.01948.x; Ceruti S, 2000, J NEUROSCI RES, V60, P388, DOI 10.1002/(SICI)1097-4547(20000501)60:3<388::AID-JNR14>3.0.CO;2-V; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Chen JG, 1997, J NEUROSCI, V17, P7278; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Desagher S, 1996, J NEUROSCI, V16, P2553; Di Iorio P, 2002, GLIA, V38, P179, DOI 10.1002/glia.10055; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Eftekharpour E, 2000, GLIA, V31, P241, DOI 10.1002/1098-1136(200009)31:3<241::AID-GLIA50>3.0.CO;2-9; Fam SR, 2000, J NEUROSCI, V20, P2800; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Forrest GL, 2000, CHEM-BIOL INTERACT, V129, P21, DOI 10.1016/S0009-2797(00)00196-4; Franke H, 2001, NEUROSCIENCE, V108, P421, DOI 10.1016/S0306-4522(01)00416-X; Franke H, 2001, BRIT J PHARMACOL, V134, P1180, DOI 10.1038/sj.bjp.0704353; FREDHOLM BB, 1988, TRENDS PHARMACOL SCI, V9, P130, DOI 10.1016/0165-6147(88)90194-0; Fumagalli M, 2003, GLIA, V43, P218, DOI 10.1002/glia.10248; FURUTA A, 1995, AM J PATHOL, V146, P357; Gallagher CJ, 2003, J NEUROSCI, V23, P6728; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; HANSSON HA, 1989, EXP EYE RES, V48, P411, DOI 10.1016/S0014-4835(89)80009-0; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hentschel S, 2003, RESTOR NEUROL NEUROS, V21, P55; HO C, 1995, BRIT J PHARMACOL, V116, P2909, DOI 10.1111/j.1476-5381.1995.tb15944.x; Huang XD, 2000, J NUTR, V130, p1488S, DOI 10.1093/jn/130.5.1488S; Idestrup CP, 1998, NEUROSCIENCE, V86, P913, DOI 10.1016/S0306-4522(98)00128-6; INAZU N, 1992, BIOCHIM BIOPHYS ACTA, V1116, P50, DOI 10.1016/0304-4165(92)90127-G; Innocenti B, 2000, J NEUROSCI, V20, P1800; INOUE K, 1995, NEUROREPORT, V6, P437; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Jones PA, 1998, BRAIN RES, V800, P328, DOI 10.1016/S0006-8993(98)00540-X; Jurkowitz MS, 1998, J NEUROCHEM, V71, P535; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kim SG, 2003, BIOCHEM PHARMACOL, V65, P923, DOI 10.1016/S0006-2952(02)01614-3; Kim SH, 2001, LIFE SCI, V68, P2741, DOI 10.1016/S0024-3205(01)01074-8; Koizumi S, 1997, BRIT J PHARMACOL, V122, P51, DOI 10.1038/sj.bjp.0701344; Koizumi S, 2002, LIFE SCI, V72, P431, DOI 10.1016/S0024-3205(02)02273-7; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Lei BP, 1997, NEUROSCI LETT, V222, P91, DOI 10.1016/S0304-3940(97)13349-3; Lenz G, 2000, BRIT J PHARMACOL, V129, P927, DOI 10.1038/sj.bjp.0703138; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; Lutz PL, 1997, BRAIN RES, V769, P281, DOI 10.1016/S0006-8993(97)00719-1; Moore D, 2000, NEUROREPORT, V11, P3799, DOI 10.1097/00001756-200011270-00041; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Parkinson FE, 2002, NEUROPHARMACOLOGY, V43, P836, DOI 10.1016/S0028-3908(02)00083-7; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 1997, J NEUROSCI, V17, P7817; PEAKMAN MC, 1994, BRIT J PHARMACOL, V111, P191, DOI 10.1111/j.1476-5381.1994.tb14043.x; PORTER JT, 1995, J NEUROCHEM, V65, P1515, DOI 10.1046/j.1471-4159.1995.65041515.x; Porter JT, 1996, J NEUROSCI, V16, P5073; Queiroz G, 1999, NEUROSCIENCE, V91, P1171, DOI 10.1016/S0306-4522(98)00644-7; ROZELL B, 1985, EUR J CELL BIOL, V38, P79; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; SCHWARZCHILD MA, 2003, NEUROLOGY S, V61, pS56; Servitja JM, 2000, J NEUROCHEM, V75, P788, DOI 10.1046/j.1471-4159.2000.0750788.x; Shahidullah M, 1997, CURR EYE RES, V16, P1006, DOI 10.1076/ceyr.16.10.1006.9018; Shin CY, 2002, GLIA, V37, P268, DOI 10.1002/glia.10032; Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822; Tamagno E, 2003, EXP NEUROL, V180, P144, DOI 10.1016/S0014-4886(02)00059-6; TOKUYAMA Y, 1995, BIOCHEM BIOPH RES CO, V211, P211, DOI 10.1006/bbrc.1995.1798; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Viana F, 1998, CELL CALCIUM, V24, P117, DOI 10.1016/S0143-4160(98)90079-3; Webb TE, 1998, NEUROSCIENCE, V84, P825, DOI 10.1016/S0306-4522(97)00478-8; WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2; WIRTH H, 1992, J HISTOCHEM CYTOCHEM, V40, P1857, DOI 10.1177/40.12.1453004; Yamakuni H, 2002, J NEUROIMMUNOL, V129, P43, DOI 10.1016/S0165-5728(02)00179-0; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3	93	53	57	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JAN 15	2005	49	2					288	300		10.1002/glia.20118			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885RN	WOS:000226174700011	15494980				2022-02-06	
J	Boockvar, JA; Schouten, J; Royo, N; Millard, M; Spangler, Z; Castelbuono, D; Snyder, E; O'Rourke, D; McIntosh, T				Boockvar, JA; Schouten, J; Royo, N; Millard, M; Spangler, Z; Castelbuono, D; Snyder, E; O'Rourke, D; McIntosh, T			Experimental traumatic brain injury modulates the survival migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells	NEUROSURGERY			English	Article						epidermal growth factor receptor; epidermal growth factor receptor vIII; neural stem cells; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD INJURY; PROGENITOR CELLS; RAT-BRAIN; ADULT-RAT; MAGNETIC-RESONANCE; IN-VIVO; PROLIFERATION; ASTROCYTES; INFUSION	OBJECTIVE: We have previously shown that constitutively active epidermal growth factor receptor signaling enhances the survival and motility of engrafted neural stem cells (NSCs) when transplanted into normal adult brain. In the present study, using the C17.2 NSC line stably transfected with the constitutively active epidermal growth factor receptor vIII, we sought to evaluate the phenotype of INKS after engraftment into the milieu of traumatic head injury. METHODS: We performed intracerebral NSC transplantation with C17.2 NSCs overexpressing the active epidermal growth factor receptor vIII receptor into the ipsilateral (n = 17) or contralateral (n = 19) corpus Callosum at 48 hours after severe experimental traumatic brain injury (TBI) or after sham injury (n = 12) in rats. RESULTS: All sham-injured animals (100%) showed NSC graft survival, compared with 65% of brain-injured animals receiving ipsilateral NSC transplants, and only 10% of brain-injured animals had surviving transplants after engraftment into the contralateral uninjured corpus callosum. A marked elevation of nerve growth factor (pg/mg protein) was observed at 72 hours after injury in the injured hemisphere (x = 80 +/- 10 pg/mg) compared with the contralateral uninjured hemisphere (35 +/- 0 pg/mg) (P < 0.05), and this elevation of nerve growth factor may have contributed to enhanced survival of engrafted NSCs. In uninjured control animals, NSC transplants proliferated actively, as evidenced by incorporation of bromodeoxyuridine. After TBI, however, transplanted NSCs failed to proliferate, regardless of the site of implantation. Morphologically, NSCs transplanted into the injured brain showed extensive process formation suggestive of a more differentiated phenotype, in contrast to INKS engrafted into uninjured brain that appear undifferentiated, with round soma and no processes. NSCs transplanted into the corpus callosum of brain-injured animals also expressed NG2, a pro-oligodendrocyte marker that was not seen in cells transplanted into uninjured brain. Although migration of NSCs was much more pronounced in the uninjured brain, 2 weeks after TBI, NSCs transplanted into the ipsilateral corpus callosum were found to have migrated to the injury cavity. Moreover, NSCs transplanted into the corpus callosum contralateral to the site of injury were observed crossing the corpus callosum by 2 weeks after transplantation. CONCLUSION: Our results suggest that the environment associated with acute experimental TBI can significantly modulate the phenotype and migratory patterns of the engrafted NSC. These findings have particularly important implications for transplantation of NSCs into the traumatically injured nervous system.	Weill Cornell Med Coll, Dept Neurosurg, New York, NY 10021 USA; Univ Penn, Head Injury Ctr, Dept Neurosurg, Sch Med, Philadelphia, PA 19104 USA; Burnham Inst, Program Dev & Regenerat Cell Biol, La Jolla, CA 92037 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		Boockvar, JA (corresponding author), Weill Cornell Med Coll, Dept Neurosurg, 1300 York Ave, New York, NY 10021 USA.	jab2029@med.cornell.edu	O'Rourke, Donald/AAC-3376-2021	O'Rourke, Donald/0000-0002-8479-7314	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01-CA90586] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-40978] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [F32-044750, N508803] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA090586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978] Funding Source: NIH RePORTER		Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Fricker-Gates RA, 2000, EXP NEUROL, V165, P237, DOI 10.1006/exnr.2000.7482; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Lee VMY, 2000, PROG BRAIN RES, V128, P299; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu Y, 1999, EXP NEUROL, V158, P9, DOI 10.1006/exnr.1999.7079; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lynch WP, 1999, J VIROL, V73, P6841, DOI 10.1128/JVI.73.8.6841-6851.1999; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; ORourke DM, 1997, P NATL ACAD SCI USA, V94, P3250, DOI 10.1073/pnas.94.7.3250; Philips MF, 1999, J NEUROSURG, V90, P116, DOI 10.3171/jns.1999.90.1.0116; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rosario CM, 1997, DEVELOPMENT, V124, P4213; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Snyder EY, 1996, CURR OPIN NEUROL, V9, P126, DOI 10.1097/00019052-199604000-00013; Snyder EY, 2002, NAT MED, V8, P928, DOI 10.1038/nm0902-928; SNYDER EY, 1992, SEMIN PERINATOL, V16, P106; SOARES H, 1991, Journal of Neural Transplantation and Plasticity, V2, P207; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; Tanaka K, 2001, NEUROREPORT, V12, P2169, DOI 10.1097/00001756-200107200-00025; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Vescovi AL, 1999, BRAIN PATHOL, V9, P569, DOI 10.1111/j.1750-3639.1999.tb00542.x; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wells A, 1998, MICROSC RES TECHNIQ, V43, P395, DOI 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T; Wu JP, 2000, NEUROSCI LETT, V292, P203, DOI 10.1016/S0304-3940(00)01472-5; Yip S, 2003, CANCER J, V9, P189, DOI 10.1097/00130404-200305000-00007	41	53	57	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2005	56	1					163	171		10.1227/01.NEU.0000145866.25433.FF			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	884FD	WOS:000226069300049	15617599				2022-02-06	
J	Ha, Y; Kim, YS; Cho, JM; Yoon, SH; Park, SR; Yoon, DH; Kim, EY; Park, HC				Ha, Y; Kim, YS; Cho, JM; Yoon, SH; Park, SR; Yoon, DH; Kim, EY; Park, HC			Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal cord injury; granulocyte-macrophage colony-stimulating factor; apoptosis; rat	TRAUMATIC BRAIN INJURY; MARROW STROMAL CELLS; BONE-MARROW; STEM-CELLS; IN-VIVO; GM-CSF; NEURONS; RAT; INTERLEUKIN-3; CYTOKINES	Object. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent hemopoietic cytokine that stimulates stem cell proliferation in the bone marrow and inhibits apoptotic cell death in leukocytes. Its effects in the central nervous system, however, are still unclear. The present study was undertaken to determine if GM-CSF can rescue neuronal cells from apoptosis and improve neurological function in a spinal cord injury (SCI) model. Methods. To study the effect of GM-CSF on apoptotic neuronal death, the authors used a staurosporine-induced neuronal death model in an N2A cell line (in vitro) and in a rat SCI model (in vivo). The N2A cells were preincubated with GM-CSF for 60 minutes before being exposed to staurosporine for 24 hours. To inhibit GM-CSF, N2A cells were pretreated with antibodies against the GM-CSF receptor for 60 minutes. Clip compression was used to induce SCI. Animals were treated with daily doses of GM-CSF (20 mug/day) for 5 days. The number of apoptotic cells in the spinal cord and neurological improvements were assessed. Pretreatment with GM-CSF was found to protect N2A cells significantly from apoptosis, and neutralizing antibodies for the GM-CSF receptors inhibited the rescuing effect of GM-CSF on apoptosis. In the rat SCI model, neurological function improved significantly in the GM-CSF-treated group compared with controls treated with phosphatebuffered saline. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling staining showed that GM-CSF administration reduced apoptosis in the injured spinal cord. Conclusions. Treatment of SCI with GM-CSF showed beneficial effects. Neuronal protection against apoptosis is viewed as a likely mechanism underlying the therapeutic effect of GM-CSF in SCI.	Inha Univ, Coll Med, Dept Neurosurg, Inchon, South Korea; Inha Univ, Coll Med, Dept Physiol, Inchon, South Korea; Yonsei Univ, Coll Med, Dept Neurosurg, Seoul, South Korea		Ha, Y (corresponding author), Inha Univ, Coll Med, Dept Neurosurg, 7-206 Shiheung Dong 3Ga, Inchon, South Korea.	hayoon@inha.ac.kr					Armitage JO, 1998, BLOOD, V92, P4491, DOI 10.1182/blood.V92.12.4491; Be'eri M, 1998, EUR J NEUROSCI, V10, P2707; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; Corti S, 2002, EXP NEUROL, V177, P443, DOI 10.1006/exnr.2002.8004; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; KAMEGAI M, 1990, NEURON, V4, P429, DOI 10.1016/0896-6273(90)90055-K; Kannan Y, 2000, NEUROIMMUNOMODULAT, V8, P132, DOI 10.1159/000054273; Kessinger A, 1998, Stem Cells, V16 Suppl 1, P139; Krause DS, 2002, GENE THER, V9, P754, DOI 10.1038/sj.gt.3301760; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mehler MF, 1997, TRENDS NEUROSCI, V20, P357, DOI 10.1016/S0166-2236(96)01045-4; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Schuster N, 2002, GLIA, V40, P95, DOI 10.1002/glia.10110; TABIRA T, 1995, INT J DEV NEUROSCI, V13, P241, DOI 10.1016/0736-5748(94)00020-4; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Vescovi AL, 2002, NAT MED, V8, P535, DOI 10.1038/nm0602-535a; Wada S, 1999, J NEUROSURG, V91, P98, DOI 10.3171/spi.1999.91.1.0098	25	53	57	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JAN	2005	2	1					55	61		10.3171/spi.2005.2.1.0055			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	895OZ	WOS:000226874100011	15658127				2022-02-06	
J	Gall, B; Parkhouse, WS; Goodman, D				Gall, B; Parkhouse, WS; Goodman, D			Exercise following a sport induced concussion	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SYMPTOMS	Objective: To determine if an athlete's capacity to perform exercise is impaired following concussion and whether this would be reflected by an altered heart rate response. Methods: Of the 14 concussed athletes, nine missed playing time as a direct result of their concussion and five did not. The concussed athletes performed an exercise protocol on a cycle ergometer within 72 hours of being asymptomatic at rest and a second test at 5 days following the previous assessment. Matched controls (n = 14) were tested using the same time line. The exercise protocol consisted of a 2 minute warm up, 10 minute, low-moderate intensity, steady state exercise session, and a high intensity interval protocol. The interval protocol consisted of a 40 second high intensity bout, followed by a 40 second rest period. This protocol continued until the participant had reached volitional fatigue. Results: The number of exercise bouts completed was not significantly different from their matched controls. However, concussed athletes who missed playing time had a significantly higher heart rate during the steady state exercise session. During this same period, they also exhibited a greater rise in heart rate over time. Conclusion: These findings indicate that exercise capacity is unaffected in concussed athletes who are asymptomatic at rest. However, their heart rate response to submaximal exercise is increased.	Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada		Parkhouse, WS (corresponding author), Simon Fraser Univ, Sch Kinesiol, 8888 Univ Blvd, Burnaby, BC V5A 1S6, Canada.	parkhouse@sfu.ca					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baker Robert J., 2000, Indian Journal of Pediatrics, V67, P317, DOI 10.1007/BF02820676; *CAN HOCK ASS, 1999, GAT CAN HOCK SAF PRO; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FARDY PS, 1969, RES QUART, V40, P502, DOI 10.1080/10671188.1969.10614869; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; GRONWALL D, 1975, LANCET, V2, P995; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrory PR, 2002, PHYSICIAN SPORTSMED, V30, P43, DOI 10.3810/psm.2002.08.403; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Mujika I, 2001, MED SCI SPORT EXER, V33, P413, DOI 10.1097/00005768-200103000-00013; Penny G D, 1975, J Sports Med Phys Fitness, V15, P223; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011	22	53	53	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC 1	2004	38	6					773	777		10.1136/bjsm.2003.009530			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	873SH	WOS:000225300700022	15562179	Bronze, Green Published			2022-02-06	
J	Hurley, RA; McGowan, JC; Arfanakis, K; Taber, KH				Hurley, RA; McGowan, JC; Arfanakis, K; Taber, KH			Traumatic axonal injury: Novel insights into evolution and identification	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							NEURON-SPECIFIC ENOLASE; BRAIN-INJURY; HEAD-INJURY; SERUM; DAMAGE; RELEASE; S-100B; SPECTROSCOPY; PREDICTION; PATHOLOGY		Salisbury Vet Affairs Med Ctr, Mental Hlth Serv Line, Salisbury, NC USA; Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA; Univ Texas, Hlth Sci Ctr, Sch Hlth Informat Sci, Houston, TX USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA		Hurley, RA (corresponding author), Hefner VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Robin.Hurley@med.va.gov	Taber, Katherine H/B-8260-2011; Arfanakis, Konstantinos/AAN-3148-2021	Taber, Katherine H/0000-0001-7382-6151; Arfanakis, Konstantinos/0000-0001-9705-597X			Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; ARFANAKIS K, 2002, AM J NEURORADIOL, V97, P568; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Kuzma BB, 2000, SURG NEUROL, V53, P400; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Sahuquillo J, 2002, ADV TECH STAND NEUR, V27, P23; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Woertgen C, 2002, BRAIN INJURY, V16, P807, DOI 10.1080/02699050210128933; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; ZI L, 2003, AM J PHYS MED REHABI, V82, P556	36	53	58	0	1	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2004	16	1					1	7		10.1176/appi.neuropsych.16.1.1			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	777PM	WOS:000189186800001	14990753				2022-02-06	
J	Mauler, F; Hinz, V; Horvath, E; Schuhmacher, J; Hofmann, HA; Wirtz, S; Hahn, MG; Urbahns, K				Mauler, F; Hinz, V; Horvath, E; Schuhmacher, J; Hofmann, HA; Wirtz, S; Hahn, MG; Urbahns, K			Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						brain water content; ICP; neuroprotection; rat	CANNABINOID RECEPTOR AGONIST; BARRIER BREAKDOWN; K+ TRANSPORT; INHIBITION; RAT; CLOTRIMAZOLE; MODEL; RESUSCITATION; ERYTHROCYTES; DEHYDRATION	Early deterioration and death after brain injury is often the result of oedema in the injured and peri-lesional tissue. So far, no pharmacotherapy is available that exhibits significant brain oedema-reducing efficacy in patients. We selected two low molecular weight compounds from different chemical classes, a triazole (1-[(2-chlorophenyl)diphenylmethyl]-1,2,3-triazole) and a cyclohexadiene (methyl 4-[4-chloro-3-(trifluoromethyl)phenyl]-6-methyl-3-oxo-1,4,7-tetrahydroisobenzofuran-5-carboxylate) to characterize their pharmacological properties on KCNN4 channels (intermediate/small conductance calcium-activated potassium channel, subfamily N, member 4) in vitro as well as in vivo. In vitro we replaced potassium by rubidium (Rb+) and determined Rb+ fluxes evoked by 10 mum of the calcium ionophore A23187 on C6BU1 rat glioma cells. Compared with known KCNN4 blockers, such as clotrimazole (IC50 = 360 +/- 12 nm) and charybdotoxin (IC50 = 3.3 +/- 1.9 nm), the triazole and cyclohexadiene were considerably more potent than clotrimazole and displayed similar potencies (IC50 = 12.1 +/- 8.8 and 13.3 +/- 4.7 nm, respectively). In the rat acute subdural haematoma model, both the triazole and cyclohexadiene displayed reduction of brain water content (-26% at 0.3 mg/kg and -24% at 0.01 mg/kg) and reduction of the intracranial pressure (-46% at 0.1 mg/kg and -60% at 0.003 mg/kg) after 24 h when administered as a 4-h infusion immediately after brain injury. When infarct volumes were determined after 7 days, the triazole as well as the cyclohexadiene displayed strong neuroprotective efficacy (-52% infarct volume reduction at 1.2 mg/kg and -43% at 0.04 mg/kg, respectively). It is concluded that blockade of KCNN4 channels is a new pharmacological approach to attenuate acute brain damage caused by traumatic brain injury.	Bayer HealthCare, CNS Res, D-42096 Wuppertal, Germany; Bayer HealthCare, Inst Pharmacokinet, D-42096 Wuppertal, Germany		Mauler, F (corresponding author), Bayer HealthCare, CNS Res, Aprather Weg 18a, D-42096 Wuppertal, Germany.	Frank.Mauler@bayerhealthcare.com	Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X			ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; Asbun J, 1998, P W PHARMACOL SOC, V41, P145; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; BRUGNARA C, 1993, J BIOL CHEM, V268, P8760; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; BRUGNARA C, 1993, J CLIN INVEST, V92, P520, DOI 10.1172/JCI116597; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DOUKAS J, 1994, AM J PATHOL, V145, P211; Eilig I, 2001, ANESTH ANALG, V92, P669, DOI 10.1213/00000539-200103000-00023; ELLORY JC, 1994, BRIT J PHARMACOL, V111, P903, DOI 10.1111/j.1476-5381.1994.tb14823.x; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hastie LE, 1997, FREE RADICAL BIO MED, V22, P955, DOI 10.1016/S0891-5849(96)00482-0; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Horvath E., 1997, Society for Neuroscience Abstracts, V23, P1923; Isaev NK, 2002, NEUROSCIENCE, V113, P47, DOI 10.1016/S0306-4522(02)00164-1; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kawai N, 2000, ACT NEUR S, V76, P529; Kayser ST, 1998, EUR J CELL BIOL, V76, P119, DOI 10.1016/S0171-9335(98)80024-1; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Malek AM, 1996, J CELL SCI, V109, P713; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; MORLEY NCD, 2004, COCHRANE LIB; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Rittenhouse AR, 1997, J MEMBRANE BIOL, V157, P177, DOI 10.1007/s002329900227; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Schuhmacher J, 2003, RAPID COMMUN MASS SP, V17, P1950, DOI 10.1002/rcm.1139; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; SCHWAB A, 1996, PFLUEGERS ARCH, V432, P87; SCHWAB A, 1998, CURR RES ION CHANNEL, V3, P126; TAS PWL, 1988, NEUROSCI LETT, V94, P279, DOI 10.1016/0304-3940(88)90031-6; Urbahns K, 2003, BIOORG MED CHEM LETT, V13, P2637, DOI 10.1016/S0960-894X(03)00560-2; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Xi GH, 2001, STROKE, V32, P162, DOI 10.1161/01.STR.32.1.162; Xiao F, 2002, ACAD EMERG MED, V9, P933, DOI 10.1111/j.1553-2712.2002.tb02196.x; Zwienenberg M, 1999, J NEUROTRAUM, V16, P1095, DOI 10.1089/neu.1999.16.1095	43	53	54	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	OCT	2004	20	7					1761	1768		10.1111/j.1460-9568.2004.03615.x			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855TJ	WOS:000223996900008	15379997				2022-02-06	
J	Hu, BR; Liu, CL; Bramlett, T; Sick, TJ; Alonso, TF; Chen, SY; Dietrich, WD				Hu, BR; Liu, CL; Bramlett, T; Sick, TJ; Alonso, TF; Chen, SY; Dietrich, WD			Changes in TrkB-ERK1/2-CREB/Elk-1 pathways in hippocampal mossy fiber organization after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						traumatic brain injury; mossy fiber; seizure and epilepsy; hippocampus; TrkB-ERK1/2-CREB/Elk-1	SEIZURE-INDUCED ACTIVATION; SIGNAL-REGULATED KINASE; ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; FLUID PERCUSSION; NEUROTROPHIC FACTOR; DENTATE GYRUS; IMMUNOHISTOCHEMICAL EVIDENCE; CEREBRAL-ISCHEMIA; ADULT HIPPOCAMPUS	Traumatic brain injury (TBI) leads to mossy fiber reorganization, which is considered to be a causative factor in the development of temporal lobe epilepsy. However, the underlying mechanism is not fully understood. Emerging evidence suggests that TrkB-ERK1/2-CREB/Elk-1 pathways are highly related to synaptic plasticity. This study used the rat fluid-percussion injury model to investigate activation of TrkB-ERK1/2-CREB/Elk-1 signaling pathways after TBI. Rats were subjected to 2.0-atm parasagittal TBf followed by 30 minutes, 4 hours, 24 hours, and 72 hours of recovery. After TBI, striking activation of TrkB-ERK 1/2-CREB/Elk-1 signaling pathways in mossy fiber organization were observed with confocal microscopy and Western blot analysis. ERK1/2 was highly phosphorylated predominantly in hippocampal mossy fibers, whereas TrkB was phosphorylated both in the mossy fibers and the dentate gyrus region at 30 minutes and 4 hours of recovery after TBI. CREB was also activated at 30 minutes, peaked at 24 hours of recovery, and returned to the control level at 72 hours of recovery in dentate gyrus granule cells. Elk-1 phosphorylation was seen in CA3 neurons at 4 hours after TBI. The results suggest that the signaling pathways of TrkBERK1/2-CREB/Elk-1 are highly activated in mossy fiber organization, which may contribute to mossy fiber reorganization seen after TBI.	Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA; Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA		Hu, BR (corresponding author), Univ Miami, Sch Med, Dept Neurol, POB 16960, Miami, FL 33136 USA.	bhu@med.miami.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291, NS36810] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS036810, R29NS036810, R56NS036810] Funding Source: NIH RePORTER		Bender RA, 2001, EUR J NEUROSCI, V13, P679, DOI 10.1046/j.1460-9568.2001.01432.x; Binder DK, 1999, J NEUROSCI, V19, P4616; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cavazos JE, 2003, J COMP NEUROL, V458, P272, DOI 10.1002/cne.10581; Croll SD, 1999, NEUROSCIENCE, V93, P1491, DOI 10.1016/S0306-4522(99)00296-1; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; He XP, 2002, J NEUROSCI, V22, P7502; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Hu BR, 1999, NEUROSCIENCE, V89, P437, DOI 10.1016/S0306-4522(98)00352-2; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Li S, 2003, NEUROSCIENCE, V119, P1147, DOI 10.1016/S0306-4522(03)00239-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Ouyang YB, 2001, NEUROSCI LETT, V298, P159, DOI 10.1016/S0304-3940(00)01721-3; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Povlishock J T, 1992, Hum Cell, V5, P345; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scharfman HE, 1999, J NEUROSCI, V19, P5619; Scharfman HE, 2002, J COMP NEUROL, V454, P424, DOI 10.1002/cne.10449; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thiels E, 2002, J NEUROSCI, V22, P2054, DOI 10.1523/JNEUROSCI.22-06-02054.2002; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Wenzel HJ, 2000, HIPPOCAMPUS, V10, P244, DOI 10.1002/1098-1063(2000)10:3<244::AID-HIPO5>3.0.CO;2-7; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	52	53	60	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2004	24	8					934	943		10.1097/01.WCB.0000125888.56462.A1			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	844CA	WOS:000223133600012	15362724	Bronze			2022-02-06	
J	Moseley, AM; Lanzarone, S; Bosman, JM; van Loo, MA; de Bie, RA; Hassett, L				Moseley, AM; Lanzarone, S; Bosman, JM; van Loo, MA; de Bie, RA; Hassett, L			Ecological validity of walking speed assessment after traumatic brain injury - A pilot study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; brain injuries; functional assessment; gait; physical therapy; walking	GAIT CHARACTERISTICS; OLDER PEDESTRIANS; RELIABILITY; STREET; TASKS; SEX	Objective: To assess the ecological validity of walking speed measurement after traumatic brain injury (FBI). Participants: Ten people with TBI who could walk independently and were participating in a rehabilitation program. Design: Walking speed on 3 clinical gait tests (comfortable and fast pace over a 10-m distance and a 6-minute walk test) in 3 "natural" environments (a corridor in a brain injury rehabilitation unit, a car park of a metropolitan shopping center, and inside a metropolitan shopping center). Normative data were collected for 275 able-bodied pedestrians as they walked in the 3 natural environments. Results: For subjects with TBI, agreement between the speeds used in the clinical gait tests and the natural environments was poor (intraclass correlation coefficient [ICC] values ranged from -0.24 to 0.63). The closest speed match was the comfortable paced 10-m walk test and walking in a corridor of a brain injury rehabilitation unit (ICC 0.63). Able-bodied pedestrians walked at significantly faster speeds than did subjects with TBI in all 3 natural environments. Conclusions: Comfortable walking speed appears to have the highest ecological validity of the clinical gait tests investigated. Practice in natural and more complex environments should be incorporated into walking rehabilitation programs for people with TBI.	Univ Sydney, Fac Med, Rehabil Studies Unit, Ryde, NSW 1680, Australia; Univ Maastricht, Maastricht, Netherlands; Liverpool Hlth Serv, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Moseley, AM (corresponding author), Univ Sydney, Fac Med, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	amoseley@mail.usyd.edu.au		Hassett, Leanne/0000-0002-3546-1822			Carr J., 2003, STROKE REHABILITATIO; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dean CM, 2001, CLIN REHABIL, V15, P415, DOI 10.1191/026921501678310216; EKEOKORO ST, 1984, J HUM MOVEMENT STUD, V10, P107; FINLAY O, 1993, PHYSIOTHERAPY, V79, P845; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Gentile A, 2000, MOVEMENT SCI FDN PHY, P111; Gifford R, 1977, J HUM MOVEMENT STUD, V3, P66; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Hangland A, 1997, PERCEPT MOTOR SKILL, V85, P845, DOI 10.2466/pms.1997.85.3.845; HOXIE RE, 1994, J AM GERIATR SOC, V42, P241, DOI 10.1111/j.1532-5415.1994.tb01745.x; Langlois JA, 1997, AM J PUBLIC HEALTH, V87, P393, DOI 10.2105/AJPH.87.3.393; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; ROBINETT CS, 1988, PHYS THER, V68, P1371, DOI 10.1093/ptj/68.9.1371; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Sun J, 1996, ERGONOMICS, V39, P677, DOI 10.1080/00140139608964489; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; VANLOO MA, 2004, BRAIN INJURY, P18; Wade D, 1992, MEASUREMENT NEUROLOG; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]; WELKOWITZ J, 1972, INTRO STAT BEHAV SCI, P112; [No title captured]	25	53	53	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2004	19	4					341	348		10.1097/00001199-200407000-00008			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	839CB	WOS:000222759800008	15263861				2022-02-06	
J	Davis, GA; Coelho, CA				Davis, GA; Coelho, CA			Referential cohesion and logical coherence of narration after closed head injury	BRAIN AND LANGUAGE			English	Article						discourse; narrative; language production; coherence; cohesion; closed head injury	TRAUMATIC BRAIN-INJURY; DISCOURSE PRODUCTION; CAUSAL RELATEDNESS; ELICITATION TASK; CONNECTED SPEECH; ADULTS; DISORDERS; PATTERNS; MILD	A group with closed head injury was compared to neurologically intact controls regarding the referential cohesion and logical coherence of narrative production. A sample of six stories was obtained with tasks of cartoon-elicited story-telling and auditory-oral retelling. We found deficits in the clinical group with respect to referential cohesion, logical coherence, and accuracy of narration. The occurrence of deficits depended on the condition of narrative production and, to some extent, on the particular story used. The primary implications of this study pertain to the attention given by researchers to the feature of discourse production being studied and processing demands of the task. (C) 2004 Elsevier Inc. All rights reserved.	Univ Massachusetts, Amherst, MA 01003 USA; Univ Connecticut, Storrs, CT 06269 USA		Davis, GA (corresponding author), Univ Massachusetts, Arnold House,Box 30410, Amherst, MA 01003 USA.	albyn@comdis.umass.edu					Bloom Ronald L., 1994, DISCOURSE ANAL APPL, P81; Britton B.K., 1994, HDB PSYCHOLINGUISTIC, P641; BROWNELL HH, 1988, APHASIOLOGY, V2, P247, DOI 10.1080/02687038808248918; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C.A., 1993, CLIN APHASIOLOGY, V21, P183; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Damico J. S., 1985, COMMUNICATION SKILLS, P165; Davis GA, 1997, BRAIN LANG, V56, P183; Davis GA, 2000, APHASIOLOGY DISORDER; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; FLETCHER CR, 1988, J MEM LANG, V27, P235, DOI 10.1016/0749-596X(88)90052-6; FREDERIKSEN CH, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P239; GARDNER H, 1983, COGNITIVE PROCESSING, P169; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; GORDON PC, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P23; HAGEN C, 1980, REHABILITATION HEAD; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Halliday M. A. K., 1985, INTRO FUNCTIONAL GRA; Haravon A., 1994, DISCOURSE ANAL APPL, P47; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; HUBER W, 1982, BRAIN LANG, V16, P1, DOI 10.1016/0093-934X(82)90069-4; KINTSCH W, 1994, HDB PSYCHOLINGUISTIC, P00721; Kintsch W., 1998, COMPREHENSION PARADI; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Lorch R. F., 1995, SOURCES COHERENCE RE, P263; LUZZATTI C, 1989, APHASIOLOGY, V3, P643, DOI 10.1080/02687038908249030; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MENN L, 1994, APHASIOLOGY, V8, P343, DOI 10.1080/02687039408248664; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MYERS JL, 1987, J MEM LANG, V26, P453, DOI 10.1016/0749-596X(87)90101-X; Myers P.S., 1999, RIGHT HEMISPHERE DAM; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; NORUSIS MJ, 1993, SPSS WINDOWS BASE SY; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; RIVERS DL, 1980, BRAIN LANG, V10, P348, DOI 10.1016/0093-934X(80)90061-9; Shadden B.B., 1991, CLIN APHASIOLOGY, V20, P327; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; SINGER M, 1992, J MEM LANG, V31, P507, DOI 10.1016/0749-596X(92)90026-T; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1997, BRAIN INJURY, V11, P409; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; TRABASSO T, 1985, J MEM LANG, V24, P595, DOI 10.1016/0749-596X(85)90048-8; TRABASSO T, 1985, J MEM LANG, V24, P612, DOI 10.1016/0749-596X(85)90049-X; Trabasso T., 1984, LEARNING COMPREHENSI; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; van den Broek P., 1994, HDB PSYCHOLINGUISTIC, P539; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; WYCKOFF LH, 1984, THESIS U FLORIDA; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27	62	53	53	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	JUN	2004	89	3					508	523		10.1016/j.bandl.2004.01.003			16	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	820TO	WOS:000221412500010	15120542				2022-02-06	
J	Levack, W; McPherson, K; McNaughton, H				Levack, W; McPherson, K; McNaughton, H			Success in the workplace following traumatic brain injury: are we evaluating what is most important?	DISABILITY AND REHABILITATION			English	Article							COMMUNITY INTEGRATION; REHABILITATION; EMPLOYMENT; PREDICTORS	Purpose: Vocational outcome, and in particular full-time paid work, is considered an important indicator of successful rehabilitation following traumatic brain injury (TBI). However it has not been established that these outcomes adequately or accurately represent the values of the people with TBI. This paper describes a study exploring the experiences of individuals who attempted returning to work following TBI, with emphasis on factors that related to perceptions of 'success' or 'failure'. Method: A phenomenological study, interviewing seven people with moderate to severe TBI was conducted. The interview data were analysed for themes relating to experiences of success or failure in the workplace. Community consultation provided additional perspectives in the interpretation and validation of results. Results: The results of this study support in part the assumption that paid employment is indicative of success following TBI. Equally prevalent were findings that challenged this assumption, including situations where: (1) return to employment contributed to catastrophic personal events, (2) feelings of success were achieved even though paid employment was not, and (3) success in the workplace was associated with factors other than hours worked or pay earned. Conclusions: This research suggests that the use of work placement as a measure of successful rehabilitation might misrepresent the perspective of individuals with TBI. A multifactorial approach to evaluating vocational rehabilitation is recommended, which incorporates the subjective experience of work.	Univ Otago, Wellington Sch Med & Hlth Sci, Rehabil Teaching & Res Unit, Wellington, New Zealand; Univ Southampton, Sch Hlth Profess & Rehabil Sci, Southampton SO17 1BJ, Hants, England; Med Res Inst New Zealand, Wellington, New Zealand		Levack, W (corresponding author), Univ Otago, Wellington Sch Med & Hlth Sci, Rehabil Teaching & Res Unit, POB 7343, Wellington, New Zealand.	wlevack@wnmeds.ac.nz	McNaughton, Harry/AAC-6556-2020; Levack, William Mark Magnus/F-9607-2018	Levack, William Mark Magnus/0000-0001-6631-908X; McPherson, Kathryn/0000-0003-1240-8882; McPherson, Kath/0000-0003-0487-8497			*ACC NAT HLTH COMM, 1998, TRAUM BRAIN INJ REH; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P356; Crotty M., 1998, FDN SOCIAL RES MEANI; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Karlovits T, 1999, BRAIN INJURY, V13, P845; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; McColl MA, 2000, ARCH PHYS MED REHAB, V81, P817, DOI 10.1016/S0003-9993(00)90117-5; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; McPherson KM, 2001, DISABIL REHABIL, V23, P706; Morse J.M., 2002, READ ME 1 USERS GUID; Rice P., 1999, QUALITATIVE RES METH; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Ville I, 1998, DISABIL REHABIL, V20, P127, DOI 10.3109/09638289809166072; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wehman P, 2000, AM J PHYS MED REHAB, V79, P161, DOI 10.1097/00002060-200003000-00009; Zasler ND, 1997, J HEAD TRAUMA REHAB, V12, P42, DOI 10.1097/00001199-199710000-00005	23	53	55	0	10	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1464-5165			DISABIL REHABIL	Disabil. Rehabil.	MAR 4	2004	26	5					290	298		10.1080/09638280310001647615			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	801WV	WOS:000220126900005	15200244				2022-02-06	
J	Nagdyman, N; Fleck, T; Barth, S; Abdul-Khaliq, H; Stiller, B; Ewert, P; Huebler, M; Kuppe, H; Lange, PE				Nagdyman, N; Fleck, T; Barth, S; Abdul-Khaliq, H; Stiller, B; Ewert, P; Huebler, M; Kuppe, H; Lange, PE			Relation of cerebral tissue oxygenation index to central venous oxygen saturation in children	INTENSIVE CARE MEDICINE			English	Article						near-infrared spectroscopy; tissue oxygenation index; cerebral oxygenation; central venous oxygen saturation; congenital heart defects; children	NEAR-INFRARED SPECTROSCOPY; HYPOTHERMIC CIRCULATORY ARREST; EXTRACRANIAL BLOOD OXYGENATION; CLOSED-HEAD INJURY; BULB OXIMETRY; SURGERY; SPECTROPHOTOMETRY; INFANTS; BYPASS	Objective: To evaluate the relationship between the cerebral tissue oxygenation index measured by near-infrared spectroscopy and central venous oxygen saturation (SvO(2)) after corrective surgery of congenital heart defects in children. Design: Prospective observational clinical study. Setting: A tertiary neonatal and paediatric intensive care unit for paediatric cardiology. Patients: Neonates and children consecutively admitted to the paediatric cardiology intensive care unit after corrective surgery of non-cyanotic congenital heart defects. Measurements and results: Forty-three children were studied. Cerebral tissue oxygenation index, measured non-invasively by near-infrared spectroscopy, was compared to SvO(2), measured by a catheter placed in the right atrium, and to haemodynamic and respiratory parameters. Pearson's correlation coefficients and p values were calculated. Simultaneously measured values for SvO(2) (62.2+/-9.8%, 39.8-80.4%) and cerebral tissue oxygenation index (56.7+/-8.8%, 35.8-71.2%) showed a significant correlation (r=0.52, p<0.001). Conclusion: Cerebral tissue oxygenation index and SvO(2) are not interchangeable parameters, but cerebral tissue oxygenation index reflects the haemodynamic influence on cerebral oxygenation after cardiovascular surgery. Further work is necessary to confirm the clinical role of continuous non-invasive measurement of cerebral tissue oxygenation index with regard to the variations of global systemic oxygen consumption after cardiac surgery in children.	German Heart Inst, Dept Intens Care & Paediat Cardiol, D-13353 Berlin, Germany; German Heart Inst, Dept Cardiothorac & Vasc Surg, D-13353 Berlin, Germany; German Heart Inst, Dept Anaesthesiol, D-13353 Berlin, Germany		Nagdyman, N (corresponding author), German Heart Inst, Dept Intens Care & Paediat Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany.	nagdyman@dhzb.de	Fleck, Thilo Pierre Karl/H-9073-2019; huebler, michael/AAS-4063-2020	Fleck, Thilo Pierre Karl/0000-0003-4531-5930; 			Abdul-Khaliq H, 2002, THORAC CARDIOV SURG, V50, P77, DOI 10.1055/s-2002-26698; Abdul-Khaliq H, 2000, BIOMED TECH, V45, P328, DOI 10.1515/bmte.2000.45.11.328; Adcock LM, 1999, CLIN PERINATOL, V26, P893, DOI 10.1016/S0095-5108(18)30026-5; Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Ali MS, 2001, CAN J ANAESTH, V48, P497, DOI 10.1007/BF03028317; Ali MS, 2001, ANAESTHESIA, V56, P24; Chan MTV, 1997, ANAESTHESIA, V52, P705; Daubeney PEF, 1996, ANN THORAC SURG, V61, P930, DOI 10.1016/0003-4975(95)01186-2; Du Plessis Adre J., 1995, Current Opinion in Pediatrics, V7, P632; Fearn SJ, 1997, ANAESTHESIA, V52, P704; Fortune PM, 2001, INTENS CARE MED, V27, P1401, DOI 10.1007/s001340100994; GERMON TJ, 1995, J NEUROL NEUROSUR PS, V58, P477, DOI 10.1136/jnnp.58.4.477; Grubhofer G, 1997, ANAESTHESIA, V52, P116, DOI 10.1111/j.1365-2044.1997.20-az020.x; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; Lewis SB, 1996, CRIT CARE MED, V24, P1334, DOI 10.1097/00003246-199608000-00011; MATCHER SJ, 1995, P SOC PHOTO-OPT INS, V2359, P486; MILLER HC, 1974, BRIT HEART J, V36, P446; Nollert G, 1998, THORAC CARDIOV SURG, V46, P167, DOI 10.1055/s-2007-1010220; Nollert G, 2000, THORAC CARDIOV SURG, V48, P247, DOI 10.1055/s-2000-6895; Quaresima V, 2000, J BIOMED OPT, V5, P201, DOI 10.1117/1.429987; Rigg CD, 1997, ANAESTHESIA, V52, P356, DOI 10.1111/j.1365-2044.1997.98-az0094a.x; Schulz G, 2002, INTENS CARE MED, V28, P184, DOI 10.1007/s00134-001-1182-5; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3579, P144; Ter Minassian A, 1999, ANESTHESIOLOGY, V91, P985; Tweddell James S, 2002, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V5, P187; VONSIEBENTHAL K, 1992, BRAIN DEV-JPN, V14, P135; Wahr JA, 1996, J CARDIOTHOR VASC AN, V10, P406, DOI 10.1016/S1053-0770(96)80107-8; Weiss M, 2002, CAN J ANAESTH, V49, P824, DOI 10.1007/BF03017416	29	53	53	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAR	2004	30	3					468	471		10.1007/s00134-003-2101-8			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780GQ	WOS:000189364300018	14722637				2022-02-06	
J	Roncadin, C; Guger, S; Archibald, J; Barnes, M; Dennis, M				Roncadin, C; Guger, S; Archibald, J; Barnes, M; Dennis, M			Working memory after mild, moderate, or severe childhood closed head injury	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	28th Annual Meeting of the International-Neuropsychological-Society	FEB 09-12, 2000	DENVER, CO	Int Neuropsychol Soc			TRAUMATIC BRAIN-INJURY; INHIBITORY CONTROL; EXECUTIVE FUNCTION; FRONTAL LOBES; CHILDREN; DISCOURSE; ABILITY; AGE; COMPREHENSION; ADOLESCENTS	Children with closed head injury (CHI) perform poorly on complex tasks requiring working memory (WM). It is unclear to what extent WM itself is compromised, and whether WM varies with factors related to the CHI, such as injury severity, age at injury, and time since injury. We studied verbal WM in 126 school-age children with CHI, divided into mild, moderate, and severe injury severity groups. WM distributions were significantly skewed toward lower scores in the moderate and severe groups, although the distribution in the mild group was normal. Age at injury and time since injury predicted WM components only for the moderate group. Survivors of moderate or severe childhood CHI have persisting WM deficits limiting the computational workspace required for many cognitive tasks.	Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada		Dennis, M (corresponding author), Hosp Sick Children, Dept Psychol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2R01NS21889-16] Funding Source: Medline		Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Awh E, 1995, ANN NY ACAD SCI, V769, P97, DOI 10.1111/j.1749-6632.1995.tb38134.x; Baddeley A.D., 1986, WORKING MEMORY; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Barrouillet P, 2001, J MEM LANG, V45, P1, DOI 10.1006/jmla.2001.2767; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Case R., 1985, INTELLECTUAL DEV BIR; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cowan N., 1997, DEV MEMORY CHILDHOOD, P163; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P89; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; GOLDMAN R, 1974, TECHNICAL MANUAL GOL; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; HULME C, 1995, J CHILD PSYCHOL PSYC, V36, P373, DOI 10.1111/j.1469-7610.1995.tb01297.x; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Logie RH, 1996, WORKING MEMORY HUMAN, P31, DOI DOI 10.1093/ACPROF:OSO/9780195100990.003.0002; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MONTGOMERY JW, 1995, J SPEECH HEAR RES, V38, P187, DOI 10.1044/jshr.3801.187; Palmer HM, 2000, BRAIN COGNITION, V44, P103; Passolunghi MC, 2001, J EXP CHILD PSYCHOL, V80, P44, DOI 10.1006/jecp.2000.2626; Petrides M, 2000, J NEUROSCI, V20, P7496; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Proctor A, 2000, BRAIN INJURY, V14, P633; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RICHARDSON JTE, 1996, WORKING MEMORY HUMAN, P3; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; RONCADIN C, 2003, UNPUB DEV RELATIONS; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Swanson HL, 2001, J EXP CHILD PSYCHOL, V79, P294, DOI 10.1006/jecp.2000.2587; SWANSON HL, 1993, J EXP CHILD PSYCHOL, V56, P87, DOI 10.1006/jecp.1993.1027; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81; Verger K, 2000, BRAIN INJURY, V14, P495; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeo RA, 2000, DEV NEUROPSYCHOL, V17, P143, DOI 10.1207/S15326942DN1702_01	65	53	53	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2004	25	1-2					21	36					16	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology	774CG	WOS:000188961700003	14984327				2022-02-06	
J	Evered, L; Ruff, R; Baldo, J; Isomura, A				Evered, L; Ruff, R; Baldo, J; Isomura, A			Emotional risk factors and postconcussional disorder	ASSESSMENT			English	Article						mild traumatic brain injury (MTBI); postconcussional disorder (PCD); emotional factors; forensic evaluation	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; MILD; SYMPTOMS; MODERATE; SPECTRUM	Emotional risk factors were examined in 129 litigant and nonlitigant patients diagnosed with Postconcussional Disorder (PCD) following Mild Traumatic Brain Injury (MTBI). According to Millon Clinical Multiaxial Inventorv (MCMI) criteria, four subgroups emerged: (a) 14.7% met criteria for an Axis I disorder, (b) 24.8% for an Axis II disorder (c) threshold for 24.0% for bout Axis I and II disorders, and (d) 36.4% fell below psychopathology. Thus, 63.5% endorsed emotional pathology. Of the four groups, those with both Axis I and II psychopathology presented the greatest number of emotional complaints in a clinical interview and manifested the lowest neurocognitive test scores. Motor skills. verbal abilities, memory functioning, and IQ were primarily affected. With the exception of post-morbid emotional complaints, no significant differences were identified between litigants and nonlitigants. Our analysis suggests that the combination of both Axis I and II psychopathology is associated with greater impairment following MTBI.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Scripps Coll, Claremont, CA 91711 USA; Brown Univ, Providence, RI 02912 USA								ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baser C A, 1987, Arch Clin Neuropsychol, V2, P13, DOI 10.1016/0887-6177(87)90031-X; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Chapman EH, 1999, J HEAD TRAUMA REHAB, V14, P521, DOI 10.1097/00001199-199912000-00002; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Groth-Marnat G, 1997, HDB PSYCHOL ASSESSME; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; IVERSON GL, 2001, J FORENSIC NEUROPSYC, V2, P19, DOI DOI 10.1300/J151v02n01_02; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LUCAS JA, 1998, CLIN NEUROPSYCHOLOGY, P243; Millon T., 1996, DISORDERS PERSONALIT; MILLON T, 1987, MCMI 2 MANUAL; MILLON T, 1997, MANUAL MILLON CLIN M, V3; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; *NIH, 2000, NIH CONS STAT REH PE; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RUFF R, IN PRESS RUFF NEUROB; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUFF RM, 1991, HDB CLIN TRIALS NEUR, P89; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tombaugh T.N., 1996, TEST MEMORY MALINGER; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340	36	53	53	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	DEC	2003	10	4					420	427		10.1177/1073191103259539			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	750GU	WOS:000186983600013	14682488				2022-02-06	
J	Cifu, DX; Kreutzer, JS; Kolakowsky-Hayner, SA; Marwitz, JH; Englander, J				Cifu, DX; Kreutzer, JS; Kolakowsky-Hayner, SA; Marwitz, JH; Englander, J			The relationship between therapy intensity and rehabilitative outcomes after traumatic brain injury: A multicenter analysis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; rehabilitation; treatment outcome	STROKE	Objectives: To identify factors relating to the intensity of rehabilitation services received and to ascertain the relation between injury outcomes, demographics, types of therapy, and the intensity of rehabilitation services provided. Design: A multicenter, prospective, nonrandomized study with inpatient rehabilitation data collected between 1989 and 1996. Setting: Three medical centers in the federally sponsored Traumatic Brain Injury Model Systems. In each setting, the continuum of care includes emergency medical services, intensive and acute medical care, and inpatient rehabilitation. Participants: A total of 491 consecutively enrolled patients with a mean age +/- standard deviation of 34.3 +/- 15.88 years recruited from 3 medical centers. To be included in the study, patients must have been at least 16 years of age, have presented to the emergency department within 24 hours of injury, and have received acute care and inpatient rehabilitation. Interventions: Patients received comprehensive medical care along with a combination of rehabilitative therapies, including physical, occupational, psychologic, and speech therapy. Main Outcome Measures: Therapy intensity; levels of functional independence, cognitive function, functional gain, and treatment efficiency, as indicated by the FIM(TM) instrument; rehabilitation length of stay (LOS); and charges. Results: Age predicted the intensity of both psychologic (P < .001) and total therapy (P < .01) services. Acute care LOS was also a significant predictor of psychologic services (P < .01). Only admission motor FIM was relevant in predicting speech services intensity (P < .01). Therapy intensity was predictive of motor functioning at discharge (P < .001). However, therapy intensity did not predict cognitive gain (P < .05). Conclusions: This study is among the first multicenter efforts to examine the potential benefits of individual therapy services. Findings support assertions that increased therapy intensity, particularly physical and psychologic therapies, enhances functional outcomes.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Santa Clara Valley Med Ctr, Rehabil Res Ctr Traumat Brain Injury & Spinal Cor, Santa Clara, CA USA		Kreutzer, JS (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, 1200 E Broad St,Rm 3-102,Box 980542, Richmond, VA 23298 USA.	jskreutz@hsc.vcu.edu	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Cifu, David/0000-0003-1600-9387			ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; BASMAJIAN JV, 1987, ARCH PHYS MED REHAB, V68, P267; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; CAREY LM, 1993, ARCH PHYS MED REHAB, V74, P602, DOI 10.1016/0003-9993(93)90158-7; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Hall KM, 1994, ARCH PHYS MED REHABI, V75, pSC; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HESSE SA, 1994, STROKE, V25, P1999, DOI 10.1161/01.STR.25.10.1999; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Keith RA, 1997, ARCH PHYS MED REHAB, V78, P1298, DOI 10.1016/S0003-9993(97)90300-2; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lorenze EJ, 1962, ARCH PHYS MED, V43, P514; Macdonell R A, 1994, J Stroke Cerebrovasc Dis, V4, P155, DOI 10.1016/S1052-3057(10)80178-8; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; *STAT U NEW YORK, 1995, GUID UN DAT SYST MED; Stern PH, 1971, STROKE, V2, P213, DOI 10.1161/01.STR.2.3.213	25	53	54	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2003	84	10					1441	1448		10.1016/S0003-9993(03)00272-7			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	731JG	WOS:000185880100004	14586910				2022-02-06	
J	Greve, KW; Bianchini, KJ; Mathias, CW; Houston, RJ; Crouch, JA				Greve, KW; Bianchini, KJ; Mathias, CW; Houston, RJ; Crouch, JA			Detecting malingered performance on the Wechsler Adult Intelligence Scale Validation of Mittenberg's approach in traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; response bias; WAIS; TBI	INCOMPLETE EFFORT; HEAD-INJURY; IDENTIFICATION	This study assesses the effectiveness of the Wechsler Adult Intelligence Scale (WAIS) performance validity markers devised by Mittenberg et al. [Prof. Psychol.: Res. Pract. 26 (1995) 491] in the detection of malingered neurocognitive dysfunction (MND). Subjects were 65 traumatic brain injury (TBI) patients referred for neuropsychological evaluation. Twenty-eight met the Slick et al. [Clin. Neuropsychol. 13 (1999) 545] criteria for at least probable MND. The control group was comprised of 37 patients without external incentive and who thus did not meet the Slick et al. criteria. All subjects completed the Wechsler Adult Intelligence Scale-Revised (WAIS-R or WAIS-III). The discriminant function score (DFS) and the vocabulary-digit span (VDS) difference score were calculated and sensitivity, specificity, and predictive power were examined for several cut-offs for each marker individually and the two combined. Classification accuracy for the DFS was acceptable and better than for VDS. The use of the two markers in combination resulted in no incremental increase in classification accuracy. Issues related to the clinical application of these techniques are discussed. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd. All rights reserved.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Jefferson Neurobehav Grp, Metairie, LA USA; Inst Living, Hartford, CT USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu		Mathias, Charles/0000-0003-1902-673X			American Psychiatric Association, 1994, DIAGN STAT MAN; Axelrod B. N., 1999, J FORENSIC NEUROPSYC, V1, P15; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BIANCHINI KB, IN PRESS CLIN NEUROP; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Guilmette T J, 1990, Arch Clin Neuropsychol, V5, P373, DOI 10.1016/0887-6177(90)90016-I; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Hartlage LC, 1998, CRIT ISS NE, P239; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Heubrock D, 1998, EUR J PSYCHOL ASSESS, V14, P211, DOI 10.1027/1015-5759.14.3.211; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; MITTENBERG W, IN PRESS CLIN NEUROP; Pankratz L., 1988, CLIN ASSESSMENT MALI, P169; Reynolds CR, 1998, CRIT ISS NE, P261; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS RW, 1999, AM J FORENSIC PSYCH, V17, P35; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	35	53	53	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2003	18	3					245	260	PII S0887-6177(02)00137-3	10.1016/S0887-6177(02)00137-3			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	666FJ	WOS:000182166200002	14591458	Bronze			2022-02-06	
J	Bushnik, T; Hanks, RA; Kreutzer, J; Rosenthal, M				Bushnik, T; Hanks, RA; Kreutzer, J; Rosenthal, M			Etiology of traumatic brain injury: Characterization of differential outcomes up to 1 year postinjury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; outcome assessment (health care); rehabilitation; violence	PENETRATING HEAD-INJURY; UNITED-STATES; COMMUNITY INTEGRATION; SUBSTANCE-ABUSE; PREDICTORS; VIOLENCE; EMPLOYMENT; SEVERITY; SCALE; COMA	Objective: To characterize outcomes after traumatic brain injury (TBI) resulting from vehicular crashes, violence, falls, or other causes. Design: Prospective, multicenter, longitudinal. Setting: Seventeen Traumatic Brain Injury Model Systems. Participants: A total of 1170 individuals with moderate to severe TBI with data from initial medical and rehabilitation stays and 1-year follow-up. Interventions: Not applicable. Main Outcome Measures: At rehabilitation discharge, FIMTM instrument, Disability Rating Scale (DRS), and Rancho Los Amigo Levels of Cognitive Functioning Scale. At 1 year postinjury, FIM, DRS, Community Integration Questionnaire (CIQ), employment, residence, marital status, and seizure occurrence. Results: The 4 etiology groups could be distinguished based on premorbid characteristics. Severity of injury indices indicated that individuals in vehicular crashes showed a trend toward incurring more severe injuries than the other 3 groups. At rehabilitation discharge, there were no functional differences between groups. At 1 year postinjury, the groups could be differentiated: individuals in violence-related TBI had higher unemployment rates and lower CIQ scores; persons in vehicular crashes reported the best functional and psychosocial outcomes; and individuals in the falls and other groups had outcomes lying between the vehicular and violence groups. Conclusion: This study elucidated important differences between persons with violence-related TBI and those with non-violence-related TBI. Further research is needed to find effective interventions to address these differences.	Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; Santa Clara Valley Med Ctr, Dept PM&R, San Jose, CA 95128 USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; Rehabilitat Inst Michigan, Detroit, MI USA; Virginia Commonwealth Univ, Richmond, CA USA; Virginia Commonwealth Univ Med Coll Virginia, Richmond, VA USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA		Bushnik, T (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA.			Bushnik, Tamara/0000-0003-3328-257X			Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; ENGLANDER J, 1999, REHABILITATION ADULT, P453; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hagen C., 1972, LEVELS COGNITIVE FUN; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; JENNETT B, 1981, MANAGEMENT HEAD INJU, P77; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kraus JF, 1993, HEAD INJURY, P1; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wehman P, 1999, REHABILITATION ADULT, P326; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, BRAIN INJURY REHABIL, P355; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955; Zafonte RD, 1997, BRAIN INJURY, V11, P403; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226; [No title captured]; 2000, TRAUMATIC BRAIN INJ, V6, P8	43	53	53	0	12	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					255	262		10.1053/apmr.2003.50092			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700016	12601658				2022-02-06	
J	Yeates, KO; Taylor, HG; Woodrome, SE; Wade, SL; Stancin, T; Drotar, D				Yeates, KO; Taylor, HG; Woodrome, SE; Wade, SL; Stancin, T; Drotar, D			Race as a moderator of parent and family outcomes following pediatric traumatic brain injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						traumatic brain injury; children; race	INITIAL YEAR; HEALTH; RELIABILITY; CHILDREN; BURDEN	Objective: To use data from a prospective, longitudinal study to determine whether race moderates parent and family outcomes during the first year following pediatric traumatic brain injuries (TBI). Method: Participants included 73 white and 18 black children with moderate to severe TBI and their families, and 32 white and 23 black children with orthopedic injuries only (OI) and their families. Assessments of parent and family functioning occurred shortly after injury (baseline) and at 6- and 12-month follow-ups. Results: Race was a significant moderator of group differences in parental psychological distress and perceived family burden, by and large independent of socioeconomic status. The negative consequences of TBI were relatively less pronounced for parents of black children than for parents of white children at baseline, but became more pronounced at the two follow-ups. Black and white parents differed in preferred coping strategies, which may partially account for their different reactions to their children's injuries. Conclusions: The sociocultural factors associated with race may moderate the effects of pediatric TBI and OI on parents and families.	Childrens Hosp, Dept Psychol, Columbus, OH 43205 USA; Ohio State Univ, Columbus, OH 43210 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Indianapolis Univ, Indianapolis, IN USA; Purdue Univ, Indianapolis, IN USA; Univ Cincinnati, Cincinnati, OH 45221 USA		Yeates, KO (corresponding author), Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43205 USA.	yeates.1@osu.edu	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5 R01 NS36335] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ 390611] Funding Source: Medline		Boyd-Franklin N., 1993, NORMAL FAMILY PROCES, P361; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Coll CG, 1996, CHILD DEV, V67, P1891, DOI 10.2307/1131600; CULVER JL, 2001, UNPUB COPING DISTRES; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; DRESSLER WW, 1993, MED ANTHROPOL Q, V7, P325, DOI 10.1525/maq.1993.7.4.02a00030; Greco P, 1996, J CLIN PSYCHOL MED S, V3, P337, DOI 10.1007/BF01994018; HU XH, 1993, CAN MED ASSOC J, V149, P421; KESSLER RC, 1986, J HEALTH SOC BEHAV, V27, P107, DOI 10.2307/2136310; KETCHUM KM, 2000, THESIS ST LOUIS U; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; NAVARRO V, 1991, INT J HEALTH SERV, V21, P229, DOI 10.2190/5WXM-QK9K-PTMQ-T1FG; NEIGHBORS HW, 1983, PREVENTION HUMAN SER, V2, P125; Ren XS, 1996, J EPIDEMIOL COMMUN H, V50, P269, DOI 10.1136/jech.50.3.269; STEIN REK, 1989, PUBLIC HEALTH REP, V104, P377; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; ULBRICH PM, 1989, J HEALTH SOC BEHAV, V30, P131, DOI 10.2307/2136918; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Weitzman M, 1999, PEDIATRICS, V104, P151; WETHINGTON E, 1986, J HEALTH SOC BEHAV, V27, P78, DOI 10.2307/2136504; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	34	53	53	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUN	2002	27	4					393	403		10.1093/jpepsy/27.4.393			11	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	556PY	WOS:000175859200009	11986362	Bronze			2022-02-06	
J	Green, A; Felmingham, K; Baguley, IJ; Slewa-Younan, S; Simpson, S				Green, A; Felmingham, K; Baguley, IJ; Slewa-Younan, S; Simpson, S			The clinical utility of the Beck Depression Inventory after traumatic brain injury	BRAIN INJURY			English	Article							COMPONENTS; MOOD	Primary objective: To examine the psychometric properties of the Beck Depression Inventory (BDI) in traumatic brain injury (TBI) and to determine the relative endorsement of somatic-performance and cognitive-affective items in this group. Research design: Prospective 2 year follow up assessment. Methods: 117 patients discharged from an inpatient TBI rehabilitation service completed the BDI as part of a 24 month follow up assessment. Demographic and injury related data were obtained from patient files and significant others. Main outcomes: A principal components analysis revealed three factors describing affective and performance items, negative attitudes towards oneself and somatic disturbance. The reliability estimate was high (coefficient alpha =0.92). A dependent sample t-test revealed higher endorsement of the cognitive-affective subscale with more clients classified as at least moderately depressed using the cognitive-affective rather than the total BDI score. Conclusion: This study provides preliminary evidence suggesting that the BDI may be an effective screening tool for self reported depression in TBI.	Westmead Hosp, Brain Injury Rehabil Serv, Westmead, NSW 2145, Australia		Green, A (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, Westmead, NSW 2145, Australia.	alisag@biru.wsahs.nsw.gov.au	Baguley, Ian/AAM-5828-2021; Baguley, Ian J/K-6878-2013	Baguley, Ian J/0000-0001-5650-3705			BECK AT, 1973, J PSYCHOL, V85, P257, DOI 10.1080/00223980.1973.9915655; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT., 1979, COGNITIVE THERAPY DE; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROWN C, 1995, PSYCHOL ASSESSMENT, V7, P59; CHRISTENSEN BK, 1995, J INT NEUROPSYCH SOC, V1, P122; CLARK CD, 1984, J NERV MENT DIS, V171, P705; CLARK CD, 1984, J NERV MENT DIS, V173, P482; COAKES JS, 1997, SPSS ANAL ANGUISH; DEGAGNEBROWN A, 1998, JOEM, V40, P862; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOWELL C, 1997, STAT METHODS PSYCHOL; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; PIOTROWSKI C, 1985, J PERS ASSESS, V49, P115, DOI 10.1207/s15327752jpa4902_1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROSS ED, 1981, ARCH GEN PSYCHIAT, V54, P343; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; *SPSS, 1999, SPSS BASE 9 0 US GUI; STARTUP M, 1992, J AFFECT DISORDERS, V26, P251, DOI 10.1016/0165-0327(92)90103-D; STEER RA, 1987, J PSYCHOPATHOL BEHAV, V9, P327, DOI 10.1007/BF00964561; WILLIAMS ACD, 1993, PAIN, V55, P259, DOI 10.1016/0304-3959(93)90155-I; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	25	53	53	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2001	15	12					1021	1028		10.1080/02699050110074187			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	493CM	WOS:000172204500001	11712948				2022-02-06	
J	Cernak, I; O'Connor, C; Vink, R				Cernak, I; O'Connor, C; Vink, R			Activation of cyclo-oxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article; Proceedings Paper	34th Annual Meeting of the Australasian-Society-of-Clinical-and-Experimental-Pharmacologists-and-Toxicologists	DEC 03-06, 2000	NEWCASTLE, AUSTRALIA	Australasian Soc Clin & Exptl Pharmacologists & Toxicologists		diffuse axonal injury; neurological outcome; neurotrauma; nimesulide	CEREBRAL-ISCHEMIA; ARACHIDONIC-ACID; CYCLOOXYGENASE-2; DAMAGE; INHIBITION; INDOMETHACIN; HIPPOCAMPUS; EXPRESSION; INDUCTION; MODEL	1. Post-traumatic inflammation may play a significant role in the development of delayed secondary brain damage following traumatic brain injury. 2. During post-traumatic inflammation, metabolic products of arachidonic acid, known as prostanoids (prostaglandins and thromboxanes) are released and aggravate the injury process. Prostanoid synthesis is regulated by the enzyme cyclo-oxygenase (COX), which is present in at least two isoforms, COX-1 (the constitutive form) and COX-2 (the inducible form). 3. In the present study, we examine the temporal and spatial profiles of COX-2 expression and the effects of the COX-2 inhibitor nimesulide on motor and cognitive outcome following diffuse traumatic brain injury in rats. 4. Adult male Sprague-Dawley rats were injured using the 2 m impact acceleration model of diffuse traumatic brain injury. At preselected time points after injury, animals were killed and the expression of COX-2 was measured in the cortex and hippocampus by western blotting techniques. 5. Increased expression of COX-2 was found in the cortex at 3 days and in the hippocampus as early as 3 h postinjury and this persisted for at least 12 days. 6. Administration of nimesulide (6 mg/kg, i.p.) at 30 min after injury and daily over a 10 day post-traumatic neurological assessment period resulted in a significant improvement compared with vehicle (2% dimethylsulphoxide diluted in isotonic saline)-treated controls in cognitive deficits, as assessed by the Barnes circular maze. There was also a significant improvement in motor dysfunction as assessed by the rotarod test on days 1 and 2 post-trauma compared with vehicle-treated controls. 7. These results implicate the involvement of COX-2 in cognitive and motor dysfunction following diffuse traumatic brain injury.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia		Cernak, I (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Res Bld Room EP04,3970 Reservoir Rd NW, Washington, DC 20001 USA.	ifc@georgetown.edu	Cernak, Ibolja/A-6399-2008; Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ibolja, Cernak/0000-0003-3214-698X			BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BAZAN NG, 1989, ANN NY ACAD SCI, V559, P1; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BENEDEK G, 1987, CAN J NEUROL SCI, V14, P145; Buccellati C, 1998, NEUROSCI LETT, V257, P123, DOI 10.1016/S0304-3940(98)00745-9; Candelario-Jalil E, 2000, EUR J PHARMACOL, V390, P295, DOI 10.1016/S0014-2999(99)00908-5; CollacoMoraes Y, 1996, J CEREBR BLOOD F MET, V16, P1366, DOI 10.1097/00004647-199611000-00035; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; KATSUKI H, 1995, PROG NEUROBIOL, V46, P607, DOI 10.1016/0301-0082(95)00016-O; KIM HJ, 1989, J NEUROSURG, V71, P565, DOI 10.3171/jns.1989.71.4.0565; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1996, LAB INVEST, V74, P315; Parsadaniantz SM, 2000, J NEUROENDOCRINOL, V12, P766, DOI 10.1046/j.1365-2826.2000.00517.x; Sandhya TL, 1998, BRAIN RES, V788, P223, DOI 10.1016/S0006-8993(97)01552-7; Sastry PS, 2000, J NEUROCHEM, V74, P1, DOI 10.1046/j.1471-4159.2000.0740001.x; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wakita H, 1999, NEUROREPORT, V10, P1461, DOI 10.1097/00001756-199905140-00013; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	24	53	54	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	NOV	2001	28	11					922	925		10.1046/j.1440-1681.2001.03549.x			4	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pharmacology & Pharmacy; Physiology	548PA	WOS:000175396000014	11703397				2022-02-06	
J	Marklund, N; Lewander, T; Clausen, F; Hillered, L				Marklund, N; Lewander, T; Clausen, F; Hillered, L			Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						4-hydroxybenzoic acid; nitrone PBN radical; rats; reactive oxygen species; S-PBN; traumatic brain injury	TERT-BUTYL-NITRONE; COMPRESSION CONTUSION TRAUMA; FOCAL CEREBRAL-ISCHEMIA; FLUID PERCUSSION INJURY; NERVOUS-SYSTEM TRAUMA; NITRIC-OXIDE SYNTHASE; ALPHA-PHENYLNITRONE; LIPID-PEROXIDATION; OXIDATIVE STRESS; SUPEROXIDE-PRODUCTION	In previous studies, the authors showed that the nitrone radical scavenger alpha -phenyl-N-tert-butyl nitrone (PBN) and its sulfo-derivative, 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN), attenuated cognitive disturbance and reduced tissue damage after traumatic brain injury (TBI) in rats. In the current study, the production of reactive oxygen species (ROS) after TBI was monitored with microdialysis and the 4-hydroxybenzoic acid (4-HBA) trapping method. A single dose of PBN (30 mg/kg) or an equimolar dose of S-PBN (47 mg/kg) was administered intravenously 30 minutes before a controlled cortical contusion injury in rats. Plasma and brain tissue drug concentrations were analyzed at the end of the microdialysis experiment (3 hours after injury) and, in a separate experiment with S-PBN, at 30 and 60 minutes after injury. Traumatic brain injury caused a significant increase in ROS formation that lasted for 60 minutes after the injury as evidenced by increased 3,4-dihydroxybenzoic acid (3,4-DHBA) concentrations in the dialysate. PBN and S-PBN equally and significantly attenuated the posttraumatic increase in 3,4-DHBA formation. High PBN concentrations were found bilaterally in brain tissue up to 3 hours after injury. In contrast, S-PBN was rapidly cleared from the circulation and was not detectable in brain at 30 minutes after injury or at any later time point. The results suggest that scavenging of ROS after TBI may contribute to the neuroprotective properties observed with nitrone spin-trapping agents. S-PBN, which remained undetectable even in traumatized brain tissue, reduced ROS production to the same extent as PBN that readily crossed the blood-brain barrier. This finding supports an important role for ROS production at the blood-endothelial interface in TBI.	Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Psychiat, Ulleraker, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden		Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden.			Clausen, Fredrik/0000-0003-3592-4417; Marklund, Niklas/0000-0002-9797-5626			Althaus JS, 2000, FREE RADICAL BIO MED, V29, P1085, DOI 10.1016/S0891-5849(00)00350-6; ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; ANDERSON DE, 1993, BIOCHEM BIOPH RES CO, V193, P878, DOI 10.1006/bbrc.1993.1707; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Beckman JS, 1996, ADV NEUROL, V71, P339; BETZ AL, 1985, J NEUROCHEM, V44, P574, DOI 10.1111/j.1471-4159.1985.tb05451.x; Bogdanov MB, 1999, NEUROSCI LETT, V262, P33, DOI 10.1016/S0304-3940(99)00047-6; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; CARNEY JM, 1991, J MOL NEUROSCI, V3, P47, DOI 10.1007/BF02896848; CHEN GM, 1990, FREE RADICAL RES COM, V9, P317, DOI 10.3109/10715769009145690; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Floyd RA, 1999, LIFE SCI, V65, P1893, DOI 10.1016/S0024-3205(99)00443-9; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gidday JM, 1999, J NEUROTRAUM, V16, P27, DOI 10.1089/neu.1999.16.27; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOULD TJ, 1994, BRAIN RES, V660, P333, DOI 10.1016/0006-8993(94)91308-0; GRAMMAS P, 1993, FREE RADICAL BIO MED, V14, P553, DOI 10.1016/0891-5849(93)90113-9; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; Hall ED, 1995, J NEUROL SCI, V134, P79, DOI 10.1016/0022-510X(95)00211-J; Hall ED, 1997, NEUROSURG CLIN N AM, V8, P195; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; HILLERED L, 1983, J CEREBR BLOOD F MET, V3, P207, DOI 10.1038/jcbfm.1983.28; Imaizumi S, 1996, NEUROCHEM INT, V29, P205, DOI 10.1016/0197-0186(95)00120-4; JOSEPH JA, 1995, BRAIN RES, V671, P73, DOI 10.1016/0006-8993(94)01320-H; Kawamata T, 1997, ACT NEUR S, V70, P191; Keller JN, 1998, J NEUROSCI, V18, P687; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1987, AM REV RESPIR DIS, V136, P474, DOI 10.1164/ajrccm/136.2.474; Kotake Y, 1998, BBA-MOL CELL RES, V1448, P77, DOI 10.1016/S0167-4889(98)00126-8; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Kuroda S, 1996, NEUROBIOL DIS, V3, P149, DOI 10.1006/nbdi.1996.0015; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Maples KR, 2001, FREE RADICAL RES, V34, P417, DOI 10.1080/10715760100300351; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MARKLUND N, 2001, IN PRESS J NEUROTRAU; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MIYAJIMA T, 1995, BIOCHEM BIOPH RES CO, V215, P114, DOI 10.1006/bbrc.1995.2440; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Pazos AJ, 1999, BRAIN RES, V846, P186, DOI 10.1016/S0006-8993(99)02010-7; Peeling J, 1998, BRAIN RES, V795, P63, DOI 10.1016/S0006-8993(98)00253-4; POGREBNIAK HW, 1992, SURGERY, V112, P130; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; SCHINETTI ML, 1989, CARDIOVASC RES, V23, P76, DOI 10.1093/cvr/23.1.76; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SCHULZ JB, 1995, J CEREBR BLOOD F MET, V15, P948, DOI 10.1038/jcbfm.1995.120; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; SteMarie L, 1996, ANAL BIOCHEM, V241, P67, DOI 10.1006/abio.1996.0379; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Whalen MJ, 1998, ACT NEUR S, V71, P212; Yang Y, 2000, EXP NEUROL, V163, P39, DOI 10.1006/exnr.2000.7364; YOSHIKAWA T, 1996, FREE RADICALS BRAIN, P45	66	53	54	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2001	21	11					1259	1267		10.1097/00004647-200111000-00002			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	491AZ	WOS:000172087000002	11702041	Bronze			2022-02-06	
J	Meythaler, JM; Depalma, L; Devivo, MJ; Guin-Renfroe, S; Novack, TA				Meythaler, JM; Depalma, L; Devivo, MJ; Guin-Renfroe, S; Novack, TA			Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes	BRAIN INJURY			English	Article							SEROTONIN UPTAKE INHIBITORS; HEAD-INJURY; RECEPTORS; SYSTEM; SCALE; PHARMACOKINETICS; PHARMACOLOGY; FLUVOXAMINE; ORIENTATION; RECOVERY	Objective: To establish whether or not the serotonin reuptake inhibitor (SSRI) sertraline can improve arousal and alertness of patients with traumatic brain injury (TBI) and associated diffuse axonal injury (DAI). Serotonin is a major inhibitory as well an excitatory neurotransmitter, and serotonergic neurons modulate the activity of brain regions responsible for motor control, arousal, attention, and emotional regulation. Setting: Tertiary care inpatient rehabilitation centre directly attached to a university hospital level-one trauma centre. Design: Prospective placebo-controlled randomized trial utilizing sertraline on admission to acute rehabilitation. Data set: Eleven subjects, post-high speed motor vehicle crash and post-severe TBI (GCS less than or equal to 8) with presumed DAI randomized to receive either sertraline 100 mg per day or placebo for 2 weeks. All subjects were within 2 weeks of acute injury. Outcome measures recorded were the Orientation Log (daily), Agitated Behaviour Scale (daily), and the Galveston Orientation and Amnesia Test (weekly). Results: Both placebo and active medication groups demonstrated similar rates of improvement on all three scales. There was no difference in the rates of recovery for either study group (p > 0.05, ANOVA with repeated measures). The groups did not demonstrate a statistically significant negative effect on recovery either, although the size is too small for a statistically reliable beta-effect. Conclusion: This pilot study fails to establish whether the early use of sertraline may improve alertness, decrease agitation or improve cognitive recall of material. This may be due to the small size of the study group, the brief duration of treatment or by a skewed placebo group. Larger studies will be required to prove any efficacy. There were no complications with its use and sertraline did not demonstrate a detrimental effect on recovery. This indicates that sertraline may be safe to use in the treatment of psychiatric or behavioural complications attributable to TBI.	Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr, Birmingham, AL 35233 USA		Meythaler, JM (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr, 1717 6th Ave S, Birmingham, AL 35233 USA.	jmeythal@uab.com					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V5, P459; AZMITIA EC, 1990, ANN NY ACAD SCI, V600, P343, DOI 10.1111/j.1749-6632.1990.tb16894.x; AZMITIA EC, 1978, HDB PSYCHOPHARMACOLO, V9, P233; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; Chandler M C, 1988, Brain Inj, V2, P309; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; FULLER RW, 1987, J CLIN PSYCHOPHARM, V7, pS36; GOLDSTEIN LB, 1990, STROKE, V21, P139; GOLDSTEIN LB, 1991, J NEUROL REHABIL, V5, P129; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HRDINA PD, 1991, J PSYCHIATR NEUROSCI, V16, P10; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JACOBS BL, 1990, ANN NY ACAD SCI, V600, P260, DOI 10.1111/j.1749-6632.1990.tb16888.x; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, MANAGEMENT HEAD INJU, P90; LAUDER JM, 1990, ANN NY ACAD SCI, V600, P297, DOI 10.1111/j.1749-6632.1990.tb16891.x; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LIPPER S, 1976, J NERV MENT DIS, V162, P366, DOI 10.1097/00005053-197605000-00008; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; Minderhoud JM., 1990, PHYS MED REHABILITAT, V4, P447; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Novack T A, 1993, NeuroRehabilitation, V3, P79, DOI 10.3233/NRE-1993-3309; OVERMARS H, 1983, EUR J DRUG METAB PH, V8, P269, DOI 10.1007/BF03188757; PALACIOS JM, 1990, ANN NY ACAD SCI, V600, P36, DOI 10.1111/j.1749-6632.1990.tb16871.x; PEROUTKA SJ, 1990, ANN NY ACAD SCI, V600, P104, DOI 10.1111/j.1749-6632.1990.tb16876.x; PRESKORN SH, 1993, J CLIN PSYCHIAT, V54, P14; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1992, J NEUROSURG, V76, pA399; SANDEL ME, 1993, AM J PHYS MED REHAB, V72, P325, DOI 10.1097/00002060-199310000-00013; SCOTT DE, 1995, EXP NEUROL, V131, P23, DOI 10.1016/0014-4886(95)90004-7; SELIGER G M, 1992, Brain Injury, V6, P267, DOI 10.3109/02699059209029668; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; VANHARTEN J, 1993, CLIN PHARMACOKINET, V24, P203, DOI 10.2165/00003088-199324030-00003; WAGNER JC, 1986, ACCOMPLISHMENT ONCOL, V1, P1; Wagner W, 1992, Drugs, V43 Suppl 2, P48; WESTER P, 1990, J NEUROCHEM, V54, P1148, DOI 10.1111/j.1471-4159.1990.tb01942.x; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V600, P315, DOI 10.1111/j.1749-6632.1990.tb16892.x; WHITAKERAZMITIA PM, 1992, NEUROPHARMACOLOGY SE; Whyte J, 1993, REHABILITATION MED P, P825; WHYTE J, 1988, REHABILITATION MED P, P585; WONG DT, 1983, BIOCHEM PHARMACOL, V32, P1287, DOI 10.1016/0006-2952(83)90284-8	49	53	55	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2001	15	4					321	331		10.1080/026990501750111274			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	420ZK	WOS:000168035000004	11299133				2022-02-06	
J	Miller, LJ; Donders, J				Miller, LJ; Donders, J			Subjective symptomatology after traumatic head injury	BRAIN INJURY			English	Article							MMPI-2 VALIDITY SCALES; FAKE BAD SCALE; BRAIN-INJURY; IMPAIRMENT; RECOVERY	Background: Controversy persists regarding the reasons for persistent subjective complaints after mild traumatic head injury (THI). Statement of purpose: To evaluate the influence of injury severity, psychological factors, and financial contingencies on symptomatology after THI. Methods: Subjective complaints about cognitive, emotional, and somatic symptoms, as assessed by a standardized self-report inventory (Minnesota Multiphasic Personality Inventory-2; MMPI-2) were evaluated in 150 patients with THI. Results: Individuals with mild THI demonstrated paradoxically greater symptomatology on the MMPI-2 than patients with moderate-to-severe THI. Furthermore, specific actuarial criteria for possible symptom magnification (Fake Bad Scale) were met about twice as often in patients with mild THI who were seeking financial compensation for alleged acquired dysfunction than in patients with mild THI without such external contingencies. Conclusion: The evaluation of persistent subjective complaints after THI should consider injury severity in concert with psychological and financial/motivational factors. Great caution should be taken in attributing persistent symptomatology after mild THI to cerebral dysfunction.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jdonders@mfbrc.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BUTCHER J, 1989, MINNESOTA MULTIPHASI, V2; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GASS CS, 2000, CLIN GUIDE NEUROPSYC, P55; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Hoffman R. G., 1999, J FORENSIC NEUROPSYC, V1, P3, DOI DOI 10.1300/J151V01N02_02; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; Millis Scott R., 1996, P481; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V41, P611; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Stevens J.P., 1992, APPL MULTIVARIATE ST, V2nd; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOUNGQUIST RC, 1984, OPT LETT, V9, P177, DOI 10.1364/OL.9.000177	30	53	53	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2001	15	4					297	304		10.1080/026990501750111238			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	420ZK	WOS:000168035000002	11299131				2022-02-06	
J	McCarron, MO; Muir, KW; Nicoll, JAR; Stewart, J; Currie, Y; Brown, K; Bone, I				McCarron, MO; Muir, KW; Nicoll, JAR; Stewart, J; Currie, Y; Brown, K; Bone, I			Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke	ARCHIVES OF NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; E EPSILON-2 ALLELE; CEREBROVASCULAR-DISEASE; E POLYMORPHISM; APOE GENOTYPE; CEREBRAL INFARCTION; ALZHEIMERS-DISEASE; NEURONAL DAMAGE; GLOBAL-ISCHEMIA; ANIMAL-MODELS	Background: The apolipoprotein E (APOE) epsilon 4 allele is a marker of adverse outcome following head injury and intracerebral hemorrhage. Transgenic animal data in a focal cerebral ischemia model suggest that the epsilon 4 allele increases infarct size and functional impairment. Objective: To determine if APOE genotype is associated with functional recovery from ischemic stroke. Design: Prospective study. Setting: Stroke service at a university teaching hospital. Patients: Patients with clinical and neuroimaging findings (computed tomography or magnetic resonance imaging) compatible with an acute ischemic stroke. Main Outcome: Functional outcome by Barthel index (BI) and modifed Rankin scale (mRS) was compared fur epsilon 3/epsilon 3 patients vs epsilon 4 carriers and vs epsilon 2 carriers at 1 and 3 months. Univariate predictors of 3-month outcome were examined in a multivariate analysis. Results: One hundred eighty nine patients were enrolled: 100 women, 89 men (mean+/-SD age, 69.4+/-11.0 years). There were 25 epsilon 2 alleles (frequency, 0.07), 292 epsilon 3 alleles (0.77), and 61 epsilon 4 alleles (0.16). Baseline National Institutes of Health Stroke Scale scores and Oxfordshire Community Stroke Project classifications were similar in all groups (epsilon 3/epsilon 3. epsilon 4, and epsilon 2 carriers). One-month (BI, P=.64; mRS, P=.59) and 3-month (BI, P=.87; mRS, P=.73) outcomes were not associated with possession of either epsilon 4 or the epsilon 2 allele. Baseline National Institutes of Health Stroke Scale scores (P<.001) and age (P=.002) were significant predictors of 3-month BI and mRS outcomes in multivariate analyses. Conclusions: Although there: is a robust influence of APOE polymorphism on functional recovery after some types of brain injury in humans, it does not exert a major influence on injury severity or functional recovery following ischemic stroke.	So Gen Hosp, Inst Neurol Sci, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland; So Gen Hosp, Inst Neurol Sci, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland		Muir, KW (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland.		Muir, Keith W/A-7670-2011; Nicoll, James/I-9253-2017	Muir, Keith W/0000-0001-9535-022X; Nicoll, James/0000-0002-9444-7246			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; CORIA F, 1995, STROKE, V26, P2375; COUDERC R, 1993, STROKE, V24, P661, DOI 10.1161/01.STR.24.5.661; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Ferrucci L, 1997, STROKE, V28, P2410, DOI 10.1161/01.STR.28.12.2410; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fullerton SM, 1998, EXP NEUROL, V153, P156, DOI 10.1006/exnr.1998.6872; Hachinski V, 1996, ARCH NEUROL-CHICAGO, V53, P303, DOI 10.1001/archneur.1996.00550040031011; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Horsburgh K, 1996, NEUROPATH APPL NEURO, V22, P342, DOI 10.1111/j.1365-2990.1996.tb01113.x; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kessler C, 1997, ARTERIOSCL THROM VAS, V17, P2880, DOI 10.1161/01.ATV.17.11.2880; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1998, NEUROREPORT, V9, P615, DOI 10.1097/00001756-199803090-00010; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; MAHIEUX F, 1990, STROKE, V21, P1; MAHONEY F I, 1965, Md State Med J, V14, P61; Margaglione M, 1998, STROKE, V29, P399, DOI 10.1161/01.STR.29.2.399; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McCarron MO, 1998, STROKE, V29, P1882, DOI 10.1161/01.STR.29.9.1882; McCarron MO, 1998, NEUROSCI LETT, V247, P45, DOI 10.1016/S0304-3940(98)00286-9; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Muller W, 1998, BRAIN PATHOL, V8, P641; Nakata Y, 1997, AM J HYPERTENS, V10, P1391, DOI 10.1016/S0895-7061(97)00315-4; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; PEDROBOTET J, 1992, STROKE, V23, P1556, DOI 10.1161/01.STR.23.11.1556; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; RANKIN J, 1957, Scott Med J, V2, P200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TOMIMOTO H, 1995, ACTA NEUROPATHOL, V90, P608; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WIEBERS DO, 1990, STROKE, V21, P1; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250	44	53	56	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	OCT	2000	57	10					1480	1484		10.1001/archneur.57.10.1480			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	363EB	WOS:000089821200011	11030801	Bronze			2022-02-06	
J	Engelborghs, K; Haseldonckx, M; Van Reempts, J; Van Rossem, K; Wouters, L; Borgers, M; Verlooy, J				Engelborghs, K; Haseldonckx, M; Van Reempts, J; Van Rossem, K; Wouters, L; Borgers, M; Verlooy, J			Impaired autoregulation of cerebral blood flow in an experimental model of traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebral blood flow; closed head injury; hypotension; rat; traumatic brain injury	CLOSED-HEAD-INJURY; INTRACRANIAL-PRESSURE; CEREBROVASCULAR RESPONSES; ACUTE HYPERTENSION; ANESTHETIZED RATS; AUTO-REGULATION; ISOFLURANE; CATS; HYPOTENSION; CIRCULATION	In order to study the pathophysiology and the intracranial hemodynamics of traumatic brain injury, we have developed a modified closed-head injury model of impact-acceleration that expresses several features of severe head injury in humans, including acute and long-lasting intracranial hypertension, diffuse axonal injury, neuronal necrosis, bleeding, and edema. In view of the clinical relevance of impaired autoregulation of cerebral blood flow after traumatic brain injury, and aiming at further characterization of the model, we investigated the autoregulation efficiency 24 h after experimental closed-head injury. Cortical blood flow was continuously monitored with a laser-Doppler flowmeter, and the mean arterial blood pressure was progressively decreased by controlled hemorrhage. Relative laser-Doppler flow was plotted against the corresponding mean arterial blood pressure, and a two-line segmented model was applied to determine the break point and slopes of the autoregulation curves. The slope of the curve at the right hand of the break point was significantly increased in the closed head injury group (0.751 +/- 0.966%/mm Hg versus -0.104 +/- 0.425%/mm Hg,p = 0.028). The break point tended towards higher values in the closed head injury group (62.2 +/- 20.8 mm Hg versus 46.9 +/- 12.7 mm Hg; mean a SD, p = 0.198). It is concluded that cerebral autoregulation in this modified closed head injury model is impaired 24 h after traumatic brain injury. This finding, in addition to other characteristic features of severe head injury established earlier in this model, significantly contributes to its clinical relevance.	Janssen Res Fdn, Dept Life Sci, B-2340 Beerse, Belgium; Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium		Van Rossem, K (corresponding author), Janssen Res Fdn, Dept Life Sci, Turnhoutseweg 30, B-2340 Beerse, Belgium.	kvrossem@janbe.jnj.com					Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bullock MR, 1996, J NEUROTRAUM, V13, P711; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; FITCH W, 1975, CIRC RES, V37, P550, DOI 10.1161/01.RES.37.5.550; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GOLDING EM, 1999, J CEREB BLOOD FLO S1, V19, pS624; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HARDEBO JE, 1977, ACTA NEUROL SCAND, V56, P92; HEIMANN A, 1994, J CEREBR BLOOD F MET, V14, P1100, DOI 10.1038/jcbfm.1994.144; HEISTAD DD, 1979, CIRC RES, V45, P331, DOI 10.1161/01.RES.45.3.331; HOFFMAN WE, 1991, ANESTH ANALG, V73, P753; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202, DOI 10.1152/ajpheart.1995.268.6.H2202; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; JOHANSSON BB, 1979, ACTA NEUROL SCAND, V60, P193; LEE JG, 1994, ANESTH ANALG, V79, P58; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MACKENZIE ET, 1976, CIRC RES, V39, P33, DOI 10.1161/01.RES.39.1.33; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; MCPHERSON RW, 1988, ANESTHESIOLOGY, V69, P493, DOI 10.1097/00000542-198810000-00008; MILETICH DJ, 1976, ANESTH ANALG, V55, P100; MORITA Y, 1995, ACTA PHYSIOL SCAND, V154, P121, DOI 10.1111/j.1748-1716.1995.tb09894.x; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Preckel MP, 1996, INT J MICROCIRC, V16, P277, DOI 10.1159/000179186; RAICHLE ME, 1971, EUR NEUROL, V6, P1, DOI 10.1159/000114443; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1994, INTRACRANIAL PRESSUR, V9, P222; SCHMIDT JF, 1990, J CARDIOVASC PHARM, V15, P983, DOI 10.1097/00005344-199006000-00017; SEBER GAF, 1989, NONLINEAR REGRESSION, P447; STRAUSS CC, 1992, J ANXIETY DISORD, V6, P89, DOI 10.1016/0887-6185(92)90029-7; TODD MM, 1984, ANESTHESIOLOGY, V60, P276, DOI 10.1097/00000542-198404000-00002; TOMIDA S, 1989, J CEREBR BLOOD F MET, V9, P79, DOI 10.1038/jcbfm.1989.11; Toyoda K, 1997, J CEREBR BLOOD F MET, V17, P680; TSAI ML, 1989, NEUROPHARMACOLOGY, V28, P1075, DOI 10.1016/0028-3908(89)90120-2; VEHAEGEN MJ, 1993, STROKE, V24, P407; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Yamamoto S, 1998, BRAIN RES, V782, P194, DOI 10.1016/S0006-8993(97)01278-X	51	53	53	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2000	17	8					667	677		10.1089/089771500415418			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	347WF	WOS:000088951600004	10972243				2022-02-06	
J	Otto, VI; Heinzel-Pleines, UE; Gloor, SM; Trentz, O; Kossmann, T; Morganti-Kossmann, MC				Otto, VI; Heinzel-Pleines, UE; Gloor, SM; Trentz, O; Kossmann, T; Morganti-Kossmann, MC			sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; adhesion molecules; chemokines; astrocytes; microvascular endothelial cells	INTERCELLULAR-ADHESION MOLECULE-1; TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; CLOSED-HEAD INJURY; SOLUBLE ICAM-1; PNEUMOCOCCAL MENINGITIS; GENE-EXPRESSION; GLIAL-CELLS; IN-VITRO; CYTOKINES	The dysfunction of the blood-brain barrier (BBB) occurring after traumatic brain injury (TBI) is mediated by intracerebral neutrophil accumulation, chemokine release (e.g., interleukin (IL)-8) and upregulation of adhesion molecules (e.g., intercellular adhesion molecule (ICAM)-1). In patients with severe TBI, we previously found that elevated cerebrospinal fluid (CSF) IL-8 and soluble (s)ICAM-1 correlate with BBB dysfunction, and this prompted us to concomitantly monitor IL-8, sICAM-1 and their stimulator tumor necrosis factor (TNF)-alpha in CSF. Potential mechanisms for upregulation of the IL-8 analogue, murine macrophage inflammatory protein (MIP)-2, and sICAM-1 at the BBB were studied using cultured mouse astrocytes and brain microvascular endothelial cells (MVEC). In CSF of seven patients, IL-8 and sICAM-1 were elevated for 19 days after severe TBI, whereas TNF-alpha exceeded normal values on 9 days. Stimulation of MVEC and astrocytes with TNF-alpha simultaneously induced the release of MIP-2 reaching saturation by 4-8 hr and of sICAM-1 increasing continuously from 2-4 hr to 12 hr. Augmented sICAM-1 production correlated with enhanced membrane-bound (m)ICAM-1 expression in both cell types (r(s) = 0.96 and 0.90, P < 0.0001), but was markedly higher in astrocytes. The release of sICAM-1 was not influenced by IL-8 or MIP-2, although astrocytes and MVEC expressed the IL-8/MIP-2 receptor (CXCR-2) as determined by FAGS analysis. Instead, we found that sICAM-1 strongly induced MIP-2 secretion by both cell types with kinetics differing from those evoked by TNF-alpha. If added together, sICAM-1 and TNF-alpha synergistically induced MIP-2 production suggesting the involvement of two different pathways for MIP-2 regulation. J. Neurosci. Res. 60:733-742, 2000. (C) 2000 Wiley-Liss, Inc.	Univ Zurich Hosp, Dept Surg, Div Res, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Surg, Div Trauma Surg, Zurich, Switzerland; Univ Tubingen Hosp, Dept Internal Med, Tubingen, Germany; ETH Zentrum, Fed Inst Technol, Inst Biochem, Zurich, Switzerland		Otto, VI (corresponding author), Univ Zurich Hosp, Dept Surg, Div Res, CH-8091 Zurich, Switzerland.			Otto, Vivianne/0000-0002-1157-0186; Morganti-Kossmann, Cristina/0000-0002-0807-2063			ALOISI F, 1992, J IMMUNOL, V149, P2358; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; BOWMAN PD, 1983, ANN NEUROL, V14, P396, DOI 10.1002/ana.410140403; Budnik A, 1996, EXP HEMATOL, V24, P352; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; DUFF GW, 1982, J IMMUNOL METHODS, V52, P333, DOI 10.1016/0022-1759(82)90005-9; HALSTENSEN A, 1993, J INFECT DIS, V167, P471, DOI 10.1093/infdis/167.2.471; HASKARD D, 1986, J IMMUNOL, V137, P2901; Hellerbrand C, 1998, AM J PHYSIOL-GASTR L, V275, pG269, DOI 10.1152/ajpgi.1998.275.2.G269; HERNANDEZ LA, 1987, AM J PHYSIOL, V253, P699; Ikeda M, 1996, CYTOKINE, V8, P109, DOI 10.1006/cyto.1996.0015; KING PD, 1995, J IMMUNOL, V154, P6080; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; Komatsu S, 1997, AM J PATHOL, V151, P205; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; KUBY J, 1997, IMMUNOLOGY, P357; Kusterer K, 1998, AM J PHYSIOL-GASTR L, V275, pG377; LACY M, 1995, J NEUROIMMUNOL, V61, P71, DOI 10.1016/0165-5728(95)00075-D; Lakshminarayanan V, 1997, J BIOL CHEM, V272, P32910, DOI 10.1074/jbc.272.52.32910; LUKACS NW, 1994, BLOOD, V83, P1174; Lyons PD, 1998, GLIA, V22, P103, DOI 10.1002/(SICI)1098-1136(199802)22:2<103::AID-GLIA1>3.0.CO;2-8; MCCABE SM, 1993, CELL IMMUNOL, V150, P364, DOI 10.1006/cimm.1993.1204; MEYER DM, 1995, J IMMUNOL, V155, P3578; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORGANTIKOSSMAN.MC, 1995, IMMUNE RESPONSES NER, P159; MullerLadner U, 1996, J NEUROL SCI, V144, P135, DOI 10.1016/S0022-510X(96)00217-1; Paolieri F, 1997, ALLERGY, V52, P521, DOI 10.1111/j.1398-9995.1997.tb02595.x; Perry VH, 1997, MOL MED TODAY, V3, P335, DOI 10.1016/S1357-4310(97)01077-0; PETZELBAUER P, 1995, CYTOKINE, V7, P267, DOI 10.1006/cyto.1995.0031; PIGOTT R, 1992, BIOCHEM BIOPH RES CO, V187, P584, DOI 10.1016/0006-291X(92)91234-H; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; RIECKMANN P, 1995, J NEUROIMMUNOL, V60, P9, DOI 10.1016/0165-5728(95)00047-6; Rot A, 1996, J LEUKOCYTE BIOL, V59, P39, DOI 10.1002/jlb.59.1.39; Schmal H, 1998, J IMMUNOL, V161, P3685; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; SCHONBECK U, 1995, J IMMUNOL, V154, P2375; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SHRIKANT P, 1994, J NEUROIMMUNOL, V51, P209, DOI 10.1016/0165-5728(94)90083-3; SHRIKANT P, 1995, J IMMUNOL, V155, P1489; Shrikant P, 1996, J IMMUNOL, V157, P1819; SOBEL RA, 1990, AM J PATHOL, V136, P1309; SPELLERBERG B, 1994, ANN MED, V26, P411, DOI 10.3109/07853899409148362; STOCKER R, 1995, INTEGRATED APPROACH, P196; Taub Dennis D., 1996, Cytokine and Growth Factor Reviews, V7, P355, DOI 10.1016/S1359-6101(97)89237-4; Tomita M, 1996, ACT NEUR S, V66, P32; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Vastag M, 1999, MICROVASC RES, V57, P52, DOI 10.1006/mvre.1998.2115; Wedi B, 1996, ALLERGY, V51, P676; Xiao YQ, 1999, BBA-MOL CELL RES, V1450, P155, DOI 10.1016/S0167-4889(99)00042-7	52	53	54	0	4	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	JUN 15	2000	60	6					733	742		10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	321TE	WOS:000087470100005	10861785				2022-02-06	
J	Shohami, E; Kaufer, D; Chen, Y; Seidman, S; Cohen, O; Ginzberg, D; Melamed-Book, N; Yirmiya, R; Soreq, H				Shohami, E; Kaufer, D; Chen, Y; Seidman, S; Cohen, O; Ginzberg, D; Melamed-Book, N; Yirmiya, R; Soreq, H			Antisense prevention of neuronal damages following head injury in mice	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						antisense; oligonucleotides; head injury; acetylcholinesterase; emergency medicine	ACETYLCHOLINESTERASE-TRANSGENIC MICE; TRAUMATIC BRAIN INJURY; GENE-EXPRESSION; STRESS; HIPPOCAMPUS; DETERIORATION; STRATEGIES; PATHOLOGY; PROTEIN; CORTEX	Closed head injury (CHI) is an important cause of death among young adults and a prominent risk factor for nonfamilial Alzheimer's disease. Emergency intervention following CHI should therefore strive to improve survival, promote recovery, and prevent delayed neuropathologies. We employed high-resolution nonradioactive in situ hybridization to determine whether a single intracerebroventricular injection of 500 ng 2'-O-methyl RNA-capped antisense oligonucleotide (AS-ODN) against acetylcholinesterase (AChE) mRNA blocks overexpression of the stress-related readthrough AChE (AChE-R) mRNA splicing variant in head-injured mice. Silver-based Golgi staining revealed pronounced dendrite outgrowth in somatosensory cortex of traumatized mice 14 days postinjury that was associated with sites of AChE-R mRNA overexpression and suppressed by anti-AChE AS-ODNs. Furthermore, antisense treatment reduced the number of dead CA3 hippocampal neurons in injured mice, and facilitated neurological recovery as determined by performance in tests of neuromotor coordination. In trauma-sensitive transgenic mice overproducing AChE, antisense treatment reduced mortality from 50% to 20%, similar to that displayed by head-injured control mice. These findings demonstrate the potential of antisense therapeutics in treating acute injury, and suggest antisense prevention of AChE-R overproduction to mitigate the detrimental consequences of various traumatic brain insults.	Hebrew Univ Jerusalem, Fac Social Sci, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Fac Social Sci, Sch Pharm, Dept Pharmacol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Fac Social Sci, Dept Psychol, IL-91904 Jerusalem, Israel		Soreq, H (corresponding author), Hebrew Univ Jerusalem, Fac Social Sci, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.		Yirmiya, Raz/D-1090-2014	Yirmiya, Raz/0000-0002-4009-7316; Soreq, Hermona/0000-0002-0955-526X			Andres C, 1997, P NATL ACAD SCI USA, V94, P8173, DOI 10.1073/pnas.94.15.8173; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Beeri R, 1997, J NEUROCHEM, V69, P2441; BEERI R, 1995, CURR BIOL, V5, P1063, DOI 10.1016/S0960-9822(95)00211-9; CASCERES A, 1983, J COMP NEUROL, V214, P387; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Crooke ST, 1998, ANTISENSE NUCLEIC A, V8, P115, DOI 10.1089/oli.1.1998.8.115; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Gattoni R, 1996, NUCLEIC ACIDS RES, V24, P2535, DOI 10.1093/nar/24.13.2535; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; Grifman M, 1997, ANTISENSE NUCLEIC A, V7, P351, DOI 10.1089/oli.1.1997.7.351; Grisaru D, 1999, MOL CELL BIOL, V19, P788; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Imai Y, 1998, MOL BRAIN RES, V53, P33, DOI 10.1016/S0169-328X(97)00262-3; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kaufer D, 1999, NEUROSCIENTIST, V5, P173, DOI 10.1177/107385849900500314; Kreutz MR, 1998, J NEUROSCI, V18, P8278; McCarthy MM, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P283; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Morrow BA, 1999, J NEUROSCI, V19, P5666; PERRY E, 2000, IN PRESS EUR J PHARM; Robinson RG, 1997, ANNU REV MED, V48, P217; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Seidman S, 1999, ANTISENSE NUCLEIC A, V9, P333, DOI 10.1089/oli.1.1999.9.333; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SOREQ H, 2000, ANTISENSE DRUG TECHN; Sternfeld M, 1998, J NEUROSCI, V18, P1240; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767	37	53	56	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0946-2716			J MOL MED-JMM	J. Mol. Med.		2000	78	4					228	236		10.1007/s001090000104			9	Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Research & Experimental Medicine	333VH	WOS:000088151100007	10933585				2022-02-06	
J	Callahan, CD; Hinkebein, J				Callahan, CD; Hinkebein, J			Neuropsychological significance of anosmia following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							HEAD TRAUMA; COMMUNITY	Objectives: To investigate the incidence of anosmia following traumatic brain injury (TBI) using a standardized instrument and to test hypotheses that post-TBI anosmics perform significantly more poorly than do post-TBI normosmics on measures of executive skills and functional outcome. Design: Prospective quasi-experimental between-groups design. Participants: Sixty-eight adults diagnosed with TBI. Setting: Brain injury rehabilitation program based at a Midwestern medical center. Main Outcome Measures: University of Pennsylvania Smell Identification Test (UPSIT), selected neuropsychological measures of executive skills, the Disability Rating Scale (DRS), and the Community Integration Questionnaire (CIQ). Results: Forty-four subjects (65%) demonstrated impaired olfaction; only 13 (30%) acknowledged smell dysfunction. Anosmic and normosmic groups did not differ in demographics, IQ, chronicity, or admis- sion Glasgow Coma Scale (GCS). Anosmics had longer coma (P = .01), more severe deficits in complex attention (Trailmaking Test, Part B, P = .01), new learning/memory (California Verbal Learning Test Trial V [CVLT-V], P = .001), and problem solving (Wiconsin Card Sorting Test [WCST], P = .001), leading to greater functional impairment (Disability Rating Scale [DRS], P = .003). No differences emerged on the CIQ. Conclusions: Anosmia is a common sequela of TBI, although only a minority of patients are aware of this deficit. Further, anosmics demonstrated greater impairment in a variety of frontal-lobe mediated executive functions, as well as greater functional disability.	Mem Med Ctr, Ctr Neuromuscular Sci, Brain Injury Program, Springfield, IL 62781 USA		Callahan, CD (corresponding author), Mem Med Ctr, Ctr Neuromuscular Sci, Brain Injury Program, 701 N 1st St, Springfield, IL 62781 USA.						BERROL S, 1989, TRAUMATIC BRAIN INJU, V3, P85; CONSTANZO RM, 1992, J HEAD TRAUMA REHAB, V7, P15; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Doty RL, 1995, SMELL IDENTIFICATION, Vthird; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HENDRIKS A P J, 1988, Rhinology (Utrecht), V26, P229; JENNET B, 1981, MANAGEMENT HEAD INJU; Leigh AD, 1943, LANCET, V1, P38; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P455; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; SULLIVAN TE, 1995, BRAIN INJURY, V9, P641, DOI 10.3109/02699059509008222; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; VARNEY NR, 1995, S COND 15 ANN M NAT; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; ZASLER ND, 1992, J HEAD TRAUMA REHAB, V7, P66	19	53	56	0	7	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1999	14	6					581	587		10.1097/00001199-199912000-00006			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	269AV	WOS:000084454300005	10671703				2022-02-06	
J	Stamatakis, EA; Glabus, MF; Wyper, DJ; Barnes, A; Wilson, JTL				Stamatakis, EA; Glabus, MF; Wyper, DJ; Barnes, A; Wilson, JTL			Validation of statistical parametric mapping (SPM) in assessing cerebral lesions: A simulation study	NEUROIMAGE			English	Article							ARTIFICIAL NEURAL-NETWORK; TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; BLOOD-FLOW; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; 99TCM-HMPAO SPECT; HEAD-INJURY; QUANTIFICATION; PERFUSION	Simulated abnormalities were introduced in a normal SPECT with known and controllable characteristics (abnormality size and depth) in an attempt to provide validation for the analysis of SPECT lesion studies using SPM. Two simulations were carried out. The first determined the minimum hypoperfusion depth detectable using SPM by altering mean local intensity while keeping the size of the lesion constant. This was done by changing the mean local intensity in percentile increments of 10 down to -100 and up to 50. The second simulation determined the cluster size that SPM can detect by keeping the mean intensity of the lesion constant while altering its size from 4 voxels to 63,000 voxels in a total brain volume of 300,000 voxels. Both simulations determined which method of normalization is most appropriate, what level of grey matter thresholding should be used, and at what statistical probability peak threshold (u) the results should be determined. Proportional scaling was found to be the most appropriate normalization method. ANCOVA was useful where very large abnormalities were present and normalization external to SPM was not available. In those cases, ANCOVA was used in conjunction with measurement of an unaffected part of the brain (in this case medial occipital lobe). For better results statistical probability peak threshold was set to p(u) = 0.01 and grey matter threshold was set to a value below 0.5. SPM produced best results when the abnormality represented a decrease of about -50% from the normal or more and detected other decreases in an acceptable manner. (C) 1999 Academic Press.	Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Univ Edinburgh, Dept Phys Med, Edinburgh, Midlothian, Scotland; Royal Edinburgh & Associated Hosp, MRC, Brain Metab Unit, Edinburgh, Midlothian, Scotland; So Gen Hosp, NHS Trust, Inst Neurol Sci, Dept Clin Phys, Glasgow G51 4TF, Lanark, Scotland		Stamatakis, EA (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.		Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019; Barnes, Anna/AAV-8780-2021	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Barnes, Anna/0000-0002-6902-214X; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Acton PD, 1998, EUR J NUCL MED, V25, P663; ADLER RJ, 1996, NEUROLOGY, V46, P278; ARLIG A, 1994, NUCL MED COMMUN, V15, P814; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; BUTLER RE, 1995, INT J GERIATR PSYCH, V10, P121, DOI 10.1002/gps.930100207; CHAN KH, 1994, J NUCL MED, V35, P771; CHANG L, 1993, ARCH NEUROL-CHICAGO, V50, P917, DOI 10.1001/archneur.1993.00540090024006; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P6, DOI 10.1136/jnnp.54.1.6; Ebmeier KP, 1998, NEUROIMAGE, V7, P199, DOI 10.1006/nimg.1998.0321; FLOYD CE, 1992, INVEST RADIOL, V27, P667, DOI 10.1097/00004424-199209000-00001; Friston K. J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON RJ, 1994, FUNCTIONAL NEUROIMAG, P79; GRAY BG, 1992, J NUCL MED, V33, P52; HOUSTON AS, 1994, J NUCL MED, V35, P239; JACOBS A, 1994, J NUCL MED, V35, P942; JACOBS A, 1993, NUCL MED COMMUN, V14, P702, DOI 10.1097/00006231-199308000-00011; JOHNSON KA, 1993, J NUCL MED, V34, P2044; KARBE H, 1994, NEURORADIOLOGY, V36, P1, DOI 10.1007/BF00599183; LONG DT, 1992, MED PHYS, V19, P483, DOI 10.1118/1.596837; LOUFTI I, 1995, INVEST RADIOL, V30, P588; MARKUS HS, 1993, NUCL MED COMMUN, V14, P628, DOI 10.1097/00006231-199308000-00002; MIGNECO O, 1994, COMPUT MED IMAG GRAP, V18, P413, DOI 10.1016/0895-6111(94)90078-7; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Page MPA, 1996, J NUCL MED, V37, P195; PEARLSON GD, 1992, ARCH GEN PSYCHIAT, V49, P402; ROSENTHAL MS, 1995, J NUCL MED, V36, P1489; SYED GMS, 1992, NUCL MED COMMUN, V13, P811, DOI 10.1097/00006231-199211000-00007; TOURASSI GD, 1995, COMPUT BIOMED RES, V28, P257, DOI 10.1006/cbmr.1995.1017; Weeks RA, 1997, J CEREBR BLOOD F MET, V17, P943, DOI 10.1097/00004647-199709000-00003	31	53	53	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT	1999	10	4					397	407		10.1006/nimg.1999.0477			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	243CP	WOS:000082979800005	10493898				2022-02-06	
S	Hall, ED; Kupina, NC; Althaus, JS		Trembly, B; Slikker, W		Hall, ED; Kupina, NC; Althaus, JS			Peroxynitrite scavengers for the acute treatment of traumatic brain injury	NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	4th International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	NOV 15-19, 1998	ANNAPOLIS, MARYLAND	US FDA, Natl Ctr Toxicol Res, Dept Vet Affairs Med Ctr			NITRIC-OXIDE	Recent evidence has suggested that the superoxide and nitric oxide-derived reactive oxygen species peroxynitrite (ONOO-) may play a significant role in the acute pathophysiology of brain injury. One pharmacological mechanism by which ONOO--mediated damage might be interrupted is by the administration of scavenging compounds such as the thiol-containing compound penicillamine. In the present study, we examined the ability of either penicillamine (Pen) or the more brain penetrable penicillamine methyl ester (PenME) (0.01, 0.1, 1.0 or 10.0 mg/kg i.v. 5 min post-injury) to improve the early (1 hr) neurological recovery (grip score) of male CF-1 mice after a severe (900 g-cm; 50 g x 18 cm) injury. Pen produced a dose-related improvement in grip score. At 1.0 mg/kg, a +112% improvement was observed compared to vehicle-treated mice, and at 10.0 mg/kg, the increase was +168% (both, p < 0.05), PenME more potently improved the l-hr grip score, but the magnitude of the optimal effect (+96% at 0.1 mg/kg; p < 0.02) was no greater than that observed with Pen, which largely remains in the cerebral microvasculature. These results are consistent with a role of ONOO- in acute head injury, but suggest that microvascular scavenging may be of primary therapeutic importance during the early post-traumatic period.	Parke Davis Pharmaceut Res, Neurosci Therapeut, Ann Arbor, MI 48105 USA		Hall, ED (corresponding author), Parke Davis Pharmaceut Res, Neurosci Therapeut, 2800 Plymouth Rd, Ann Arbor, MI 48105 USA.		Hall, Edward D/F-8930-2013				ALTHAUS JS, 1994, RES COMMUN CHEM PATH, V83, P243; AUDUS KL, 1991, FREE RADICAL BIO MED, V11, P361, DOI 10.1016/0891-5849(91)90152-S; Beckman J. S., 1996, METHODS NITRIC OXIDE, P61; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; Coeroli L, 1998, J NEUROCHEM, V70, P2516; Hall E.D., 1995, CENTRAL NERVOUS SYST, P213; Hall ED, 1997, NEUROSCIENTIST, V3, P42, DOI 10.1177/107385849700300114; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MESENGE C, IN PRESS EUR J PHARM; Ohnishi S. T., 1995, CENTRAL NERVOUS SYST, P437	10	53	54	0	1	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-222-3	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1999	890						462	468		10.1111/j.1749-6632.1999.tb08025.x			7	Biochemistry & Molecular Biology; Multidisciplinary Sciences; Clinical Neurology; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BP50F	WOS:000085330700042	10668450				2022-02-06	
J	Groom, KN; Shaw, TG; O'Connor, ME; Howard, NI; Pickens, A				Groom, KN; Shaw, TG; O'Connor, ME; Howard, NI; Pickens, A			Neurobehavioral symptoms and family functioning in traumatically brain-injured adults	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; PSYCHOSOCIAL ADJUSTMENT; FOLLOW-UP; RELATIVES; STROKE; IMPACT	Traumatic brain injury (TBI) often results in a myriad of symptoms across physical, cognitive, and neurobehavioral domains. Despite inherent limitations associated with physical or cognitive impairments, the extant literature suggests that neurobehavioral symptoms tend to be the most distressing symptoms for the family and are more strongly related to poor outcome for the patient. The Neuropsychology Behavior and Affect Profile (NBAP) along with the General Functioning subscale of the Family Assessment Device (FAD-GF) and the Perceived Stress Scale were administered to 153 family members of persons who had sustained a TBI. The results provide new normative data and statistical support for the NBAP as a promising measure of neurobehavioral symptomatology following TBI. The correlation of .54 (p < .01) between FAD-GF and Full Scale NBAP scores provides powerful support for the hypothesis that family dysfunction is related to the presence of neurobehavioral symptoms in the patient. NBAP domains of Depression, Inappropriateness, Pragnosia, and indifference appear most strongly related to family functioning and also bar a significant relationship to caregiver stress level and patient unemployment, whereas injury severity had little impact on either family functioning or neurobehavioral symptoms. The findings reinforce the significance of neurobehavioral symptoms and fortify their proposed link to family dysfunction post-TBI. (C) 1998 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Tulsa, Tulsa, OK 74104 USA		Groom, KN (corresponding author), 7146 S Braden,Suite 500, Tulsa, OK 74136 USA.						ALEXANDER MP, 1987, NEUROBEHAVIORAL RECO; Alfano D. P., 1987, CLIN NEUROPSYCHOL, V1, P105; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; Anderson-Parente JK., 1990, COGN REHABIL, V8, P22; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; Bond M R, 1975, Ciba Found Symp, P141; BROOKS N, 1984, CLOSED HEAD INJURY P; Brown E.W., 1985, FAMILY SYSTEMS MED, V3, P440, DOI 10.1037/h0089672; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DELORTO A, 1994, HEAD INJURY FAMILY L; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EVANS RL, 1987, ARCH PHYS MED REHAB, V68, P508; GRANT I, 1987, NEUROBEHAVIORAL RECO; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NELSON L, 1994, NEUROPSYCHOLOGY BEHA; NELSON LD, 1993, PSYCHOL ASSESSMENT, V5, P374; NOVACK TA, 1987, ARCH PHYS MED REHAB, V68, P729; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PATTERSON JM, 1990, SOC SCI MED, V31, P159, DOI 10.1016/0277-9536(90)90057-Y; RAIT DS, 1992, FAM PROCESS, V31, P383, DOI 10.1111/j.1545-5300.1992.00383.x; Reitan R, 1985, HALSTEAD REITAN NEUR; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Satz P, 1993, NEUROPSYCHOLOGY, V7, P553, DOI DOI 10.1037/0894-4105.7.4.553; STAMBROOK M, 1989, CANADIAN J REHABILIT, V3, P87; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1974, SCANDINAVIAN J REHAB, V6, P1; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31; [No title captured]; [No title captured]	42	53	55	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	1998	13	8					695	711		10.1016/S0887-6177(98)00005-5			17	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	133DY	WOS:000076672200003	14590629	Bronze			2022-02-06	
J	Mahalick, DM; Carmel, PW; Greenberg, JP; Molofsky, W; Brown, JA; Heary, RF; Marks, D; Zampella, E; Hodosh, R; von der Schmidt, E				Mahalick, DM; Carmel, PW; Greenberg, JP; Molofsky, W; Brown, JA; Heary, RF; Marks, D; Zampella, E; Hodosh, R; von der Schmidt, E			Psychopharmacologic treatment of acquired attention disorders in children with brain injury	PEDIATRIC NEUROSURGERY			English	Article						attention; children; traumatic brain injury; head injury; closed head injury; psychostimulant; ritalin; methylphenidate; neuropsychological assessment	CLOSED-HEAD-INJURY; ADOLESCENTS; DEFICIT	This investigation examined the efficacy of psychostimulant therapy in alleviating neurobehavioral dysfunction attendant to pediatric brain injury. The most commonly reported neurobehavioral sequelae associated with head injury in the pediatric population involve deficits along the attentional matrix. This is also the most common objectively documented neurobehavioral finding among children as well as adults. There are several investigations in the adult literature which have employed the use of psychostimulants in treating both psychiatric and neuropsychological residua associated with head injury. Overall, the results of these studies are equivocal, but suggest a beneficial impact on general functioning. The present prospective investigation utilized a double-blind, placebo-controlled, cross-over experimental design to examine the efficacy of methylphenidate in treating children with acquired attentional disorders secondary to brain injury. A cohort of 14 children with varying degrees of head injury were recruited for participation. As expected, differences between drug and placebo conditions uniformly achieved statistical significance, Additionally, there were no differences in performance between baseline and placebo conditions on neurobehavioral tasks of attention and concentration. Current findings suggest that methylphenidate (and probably other psychostimulants such as Cylert, Adderal, Wellbutrin and dextroamphetamine sulfate) is an extremely effective agent in treating attentional disorders secondary to brain injury in children.	UMDNJ, Dept Surg, Neurosurg Sect, Sch Med, Newark, NJ USA; UMDNJ, Dept Psychiat, Sch Med, Newark, NJ USA; UMDNJ, Dept Pediat, Sch Med, Newark, NJ USA; UMDNJ, Dept Neurosci, Sch Med, Newark, NJ USA; Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ USA; Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ USA; Robert Wood Johnson Med Sch, Dept Surg Neurosurg, New Brunswick, NJ USA; Neurobehav Inst NJ, Somerville, NJ USA; Beth Israel Hosp, New York, NY USA		Mahalick, DM (corresponding author), Univ Med & Dent New Jersey, Sch Med, Div Neurol Surg, Doctors Off Ctr, 90 Bergen St,Suite 7300, Newark, NJ 07103 USA.						ALEXANDER MP, 1982, PSYCHIAT ASPECTS NEU, V3, P219; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; DOUGLAS VI, 1995, J AM ACAD CHILD PSY, V34, P877, DOI 10.1097/00004583-199507000-00011; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; GAULTIERI CT, 1988, BRAIN INJURY, V2, P273; GORDON M, 1982, GORDON DIAGNOSTIC SY; GORDON M, 1983, UNPUB ASSESSMENT ADD; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LIPPER S, 1976, J NERV MENT DIS, V162, P366, DOI 10.1097/00005053-197605000-00008; Luria A.R., 1966, HIGHER CORTICAL FUNC; MAHALICK DM, 1996, TRAUMA, V38, P39; Mather N., 1990, WOODCOCK JOHNSON PSY; MESULAM MM, 1985, PRINCIPLES BEHAV NEU, P124; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Parmelee D X, 1987, Brain Inj, V1, P41, DOI 10.3109/02699058709034443; RUFF RM, 1986, PERCEPT MOTOR SKILL, V62, P407, DOI 10.2466/pms.1986.62.2.407; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; STERN JM, 1978, SCAND J REHABIL MED, V10, P7; [No title captured]	27	53	53	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	SEP	1998	29	3					121	126		10.1159/000028705			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	148RD	WOS:000077545000004	9838263				2022-02-06	
J	Xiong, Y; Peterson, PL; Verweij, BH; Vinas, FC; Muizelaar, JP; Lee, CP				Xiong, Y; Peterson, PL; Verweij, BH; Vinas, FC; Muizelaar, JP; Lee, CP			Mitochondrial dysfunction after experimental traumatic brain injury: Combined efficacy of SNX-111 and U-101033E	JOURNAL OF NEUROTRAUMA			English	Article						antioxidants, brain mitochondria; calcium channel blockers; oxidative phosphorylation; rats; traumatic brain injury	SEVERE HEAD-INJURY; LIPID-PEROXIDATION; FOREBRAIN MITOCHONDRIA; FOCAL ISCHEMIA; FREE-RADICALS; CALCIUM; DAMAGE; TRIAL; MULTICENTER; NEURONS	We recently demonstrated that posttraumatic administration of the N-type calcium channel blocker SNX-111 (S) and a novel blood-brain barrier penetrating antioxidant U-101033E (U), significantly alleviated mitochondrial dysfunction induced by traumatic brain injury (TBI) in rats. The present study was designed to determine whether a combination of S and U, which act on different biochemical mechanisms of secondary brain injury, would be more efficacious than either drug alone. Brain mitochondria from injured and uninjured hemispheres were isolated and examined at 12 h post TBI induced by a severe controlled cortical impact injury. S at 1.0 mg/kg significantly increased both State 3 and 4 rates and produced a slight increase in P/O ratio, and there was virtually no change in RCI, U at 1.0 mg/kg did not show any protection. However, the combined treatment of S at 1.0 mg/kg and U at 1.0 mg/kg eliminated the uncoupling effect of S, and restored not only State 3 rates and P/O ratios but also RCI to near sham values. These results provide further evidence that both reactive oxygen species and perturbation of cellular calcium homeostasis participate in the pathogenesis of TBI-induced mitochondrial dysfunction, and support the idea of using combined therapy with lower drug doses.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA		Lee, CP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.			Xiong, Ye/0000-0001-9770-6031			BERMAN RF, 1997, J NEUROTRAUM, V14, P800; BRAUGHLER JM, 1985, J NEUROCHEM, V45, P1288, DOI 10.1111/j.1471-4159.1985.tb05555.x; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; BUCHAN AM, 1994, J CEREBR BLOOD F MET, V14, P903, DOI 10.1038/jcbfm.1994.121; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; CASTILHO RF, 1994, ARCH BIOCHEM BIOPHYS, V308, P158, DOI 10.1006/abbi.1994.1022; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; DYKENS JA, 1994, J NEUROCHEM, V63, P584; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall ED, 1996, ACT NEUR S, V66, P107; Hall ED, 1997, J PHARMACOL EXP THER, V281, P895; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HOVDA DA, 1994, ACTA NEUROCHIR, P521; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Lee C. P., 1993, V2, P41; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALIS CD, 1986, J BIOL CHEM, V261, P14201; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; PACKER L, 1996, FREE RADICALS BRAIN, pR29; PETERSON PL, 1997, J NEUROSURG, V36, P375; SCHUTZ H, 1973, ARCH NEUROL-CHICAGO, V29, P408, DOI 10.1001/archneur.1973.00490300070009; SCHUTZ H, 1973, ARCH NEUROL-CHICAGO, V29, P417, DOI 10.1001/archneur.1973.00490300079010; SCIAMANNA MA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P223, DOI 10.1016/0167-4889(92)90180-J; SCIAMANNA MA, 1993, ARCH BIOCHEM BIOPHYS, V305, P215, DOI 10.1006/abbi.1993.1414; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Smith SL, 1996, EXP NEUROL, V141, P304, DOI 10.1006/exnr.1996.0165; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V150, P459, DOI 10.1111/j.1748-1716.1994.tb09713.x	40	53	55	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	1998	15	7					531	544		10.1089/neu.1998.15.531			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZY374	WOS:000074614700007	9674556				2022-02-06	
J	Grzybicki, D; Moore, SA; Schelper, R; Glabinski, AR; Ransohoff, RM; Murphy, S				Grzybicki, D; Moore, SA; Schelper, R; Glabinski, AR; Ransohoff, RM; Murphy, S			Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma	ACTA NEUROPATHOLOGICA			English	Article						astrocyte; cerebral trauma; chemokine; edema; nitric oxide synthase	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FIBRILLARY ACIDIC PROTEIN; NADPH-DIAPHORASE ACTIVITY; NERVOUS-SYSTEM; MESSENGER-RNA; RAT-BRAIN; ACTIVATED ASTROCYTES; MECHANICAL INJURY; INTERLEUKIN-1; MICROGLIA	Traumatic injury to the brain initiates multiple interrelated processes that involve parenchymal, vascular, and infiltrating inflammatory cells. Nitric oxide (NO) and chemokines have been implicated as regulators of the central nervous system ir?jury response, Following a cryogenic lesion of the cerebral cortex in mice, mRNA for NO synthase (NOS)-2 was detected by reverse transcriptase polymerase chain reaction ipsilaterally 12 h after injury and persisted for 2 weeks. While mRNA was also detected contralaterally, the time course of expression was shorter (1 week). By immunohistochemistry, NOS-2 protein was initially detected ipsilaterally 12 h after injury in infiltrating inflammatory cells. Astroglial cells expressed NOS-2 from 24 to 72 h after injury. The expression of monocyte chemoattractant protein (MCP-1) mRNA peaked at 6 h on the lesion side, remained for 24 h and then declined by 48 h. On the unlesioned side, MCP-1 mRNA was expressed to a much lesser extent and had declined by 24 h. The up-regulation of MCP-1 was relatively specific as a closely related mRNA encoding IP-10 was not significantly increased. These findings implicate a role for NOS-2 and MCP-I as potential regulators of cellular events following cryogenic cerebral trauma.	Univ Iowa, Coll Med, Dept Pharmacol, BSB, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA		Murphy, S (corresponding author), Univ Iowa, Coll Med, Dept Pharmacol, BSB, Iowa City, IA 52242 USA.			Moore, Steven/0000-0002-6353-7900	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029226] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29226, NS07294] Funding Source: Medline		BAKER RN, 1971, J NEUROPATH EXP NEUR, V30, P668, DOI 10.1097/00005072-197110000-00010; CANCILLA PA, 1992, J NEUROPATH EXP NEUR, V51, P560, DOI 10.1097/00005072-199209000-00011; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; FILEP JG, 1993, BRIT J PHARMACOL, V108, P323, DOI 10.1111/j.1476-5381.1993.tb12803.x; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P2485; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Glabinski AR, 1995, BRAIN BEHAV IMMUN, V9, P315, DOI 10.1006/brbi.1995.1030; Grzybicki D, 1996, J CHEM NEUROANAT, V10, P221, DOI 10.1016/0891-0618(96)00139-1; Grzybicki DM, 1997, J NEUROIMMUNOL, V73, P15, DOI 10.1016/S0165-5728(96)00159-2; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; KITCHENER PD, 1993, NEUROSCIENCE, V53, P613, DOI 10.1016/0306-4522(93)90610-R; Klatzo I, 1980, Adv Neurol, V28, P359; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; LOTAN M, 1994, FASEB J, V8, P1026, DOI 10.1096/fasebj.8.13.7926367; Malhotra Sudarshan K., 1994, Biomedical Letters, V49, P273; MCCALL TB, 1992, BIOCHEM BIOPH RES CO, V186, P680, DOI 10.1016/0006-291X(92)90800-Z; MCELHANEY MR, 1994, NEUROSCI LETT, V180, P67, DOI 10.1016/0304-3940(94)90915-6; MURPHY S, 1996, NEUROSCIENTIST, V2, P91; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; OURY TD, 1993, J BIOL CHEM, V268, P15394; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; REGIDOR J, 1993, BRAIN RES, V631, P171, DOI 10.1016/0006-8993(93)91206-8; ROJAS A, 1993, BIOCHEM BIOPH RES CO, V196, P274, DOI 10.1006/bbrc.1993.2245; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; SVENSSON M, 1993, J NEUROSCI RES, V35, P373, DOI 10.1002/jnr.490350404; Tani M, 1996, AM J PATHOL, V148, P889; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; WALLACE MN, 1994, NEUROSCIENCE, V59, P905, DOI 10.1016/0306-4522(94)90294-1; WALLACE MN, 1992, NEUROREPORT, V3, P953, DOI 10.1097/00001756-199211000-00001; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAMANAKA K, 1995, NEUROSCI LETT, V194, P124, DOI 10.1016/0304-3940(95)11715-9; ZEIHER AM, 1995, CIRC RES, V76, P980, DOI 10.1161/01.RES.76.6.980; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213	35	53	53	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	JAN	1998	95	1					98	103		10.1007/s004010050770			6	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	YM855	WOS:000071108400012	9452827				2022-02-06	
J	Cherian, L; Goodman, JC; Robertson, CS				Cherian, L; Goodman, JC; Robertson, CS			Hyperglycemia increases brain injury caused by secondary ischemia after cortical impact injury in rats	CRITICAL CARE MEDICINE			English	Article						hyperglycemia; traumatic brain injury; cortical impact injury; cerebral ischemia; secondary insult; glucose	ENERGY PHOSPHATE-METABOLISM; TOTAL PARENTERAL-NUTRITION; SEVERE HEAD-INJURY; FOREBRAIN ISCHEMIA; CEREBRAL-ISCHEMIA; VASOGENIC EDEMA; INSULTS; BIOCHEMISTRY; HYPOTENSION; ADENOSINE	Objective: To examine the effects of glucose infusion on the histologic brain damage caused by controlled cortical impact in jury alone and by cortical impact injury complicated by secondary ischemia. Design: Prospective, randomized study. Setting: University laboratory. Subjects: Male Long Evans rats. Interventions: Three experimental conditions were studied: a) 2.5-mm deformation impact (velocity 4 m/sec) injury followed by 40 mins of bilateral carotid occlusion; b) sham impact injury followed by 40 mins of bilateral carotid occlusion; and c) 2.5-mm deformation impact (velocity 4 m/sec) injury followed by sham carotid occlusion, For each experimental condition, animals were randomized to receive either glucose solution or saline solution before the induced injury and the sham impact injury, Contusion volume and neuron density in the CA1 and CA3 regions of the hippocampus were measured 2 wks after the injury. Measurements and Main Results: Parenteral administration of 2.2 g/kg glucose solution increased the blood glucose concentra- tion from 6.7 +/- 3.3 to 17.9 +/- 10.6 mmol/L before the impact injury, and to 12.3 +/- 5.6 mmol/L before carotid occlusion, Hyperglycemia had the greatest effect on the consequences of the impact injury complicated by secondary ischemia, increasing contusion volume from 1 to 30.6 mm(3) in the animals that received saline or glucose solution, respectively (p =.005), and reducing the density of normal appearing neurons in the CA1 area of the hippocampus from 201 to 144 cells/mm(2) in the animals that received saline solution and glucose solution, respectively (p =.038). The impact injury alone and bilateral carotid occlusion alone caused minimal neuronal loss in the hippocampus and minimal contusion or infarction at the impact site, Individually, these mild injuries were not adversely affected by infusion of glucose solution. Conclusion: Hyperglycemia increases brain damage when traumatic brain injury is complicated by secondary ischemia.	BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030		Cherian, L (corresponding author), BAYLOR COLL MED,DEPT NEUROSURG,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; COMBS DJ, 1989, J NEUROSURG, V70, P623, DOI 10.3171/jns.1989.70.4.0623; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; EISENBERG HM, 1983, INTRACRANIAL PRESSUR, V5, P549; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GISSELSSON L, 1992, J CEREBR BLOOD F MET, V12, P809, DOI 10.1038/jcbfm.1992.112; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; HOFFMAN WE, 1990, ANESTHESIOLOGY, V32, P1045; HOFFMAN WE, 1988, ANESTHESIOLOGY REV, V15, P92; HSU SSF, 1991, AM J PHYSIOL, V261, pH398, DOI 10.1152/ajpheart.1991.261.2.H398; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LUNDGREN J, 1991, J CEREBR BLOOD F MET, V11, P587, DOI 10.1038/jcbfm.1991.108; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; PHILLIS JW, 1990, BRAIN RES, V524, P336, DOI 10.1016/0006-8993(90)90712-K; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; ROSNER MJ, 1993, INTRACRANIAL PRESSUR, V8, P686; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SILBERMAN H, 1986, JPEN-PARENTER ENTER, V10, P151, DOI 10.1177/0148607186010002151; WATERS DC, 1986, J NEUROSURG, V64, P460, DOI 10.3171/jns.1986.64.3.0460; WELSH FA, 1987, J NEUROCHEM, V49, P846, DOI 10.1111/j.1471-4159.1987.tb00971.x; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	35	53	54	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0090-3493			CRIT CARE MED	Crit. Care Med.	AUG	1997	25	8					1378	1383		10.1097/00003246-199708000-00027			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XQ994	WOS:A1997XQ99400027	9267953				2022-02-06	
J	Snow, P; Douglas, J; Ponsford, J				Snow, P; Douglas, J; Ponsford, J			Conversational assessment following traumatic brain injury: A comparison across two control groups	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; SOCIAL SKILL; VALIDATION; DISCOURSE; LISTENER; ABILITY	Although changes in discourse are frequently referred to in the traumatic brain injury (TBI) literature, they are difficult to objectify and measure. It is not always easy, therefore, for clinicians to differentiate between discourse behaviours which may have been present premorbidly, and those which are uniquely associated with TBI. The major aim of this study was to systematically examine and describe the nature of conversational impairment following severe TBI, with particular reference to the premorbid sociolinguistic characteristics of the TBI population. A second aim of the study was to examine the relationship between discourse impairment following TBI and severity of injury. Twenty-six TBI participants were compared with 26 non-brain-injured orthopaedic patients, and 26 university students, using Damico's Clinical Discourse Analysis (CDA). As predicted, global measures derived from the CDA did not differentiate the groups. The TBI group was, however, found to differ significantly from both control groups on a modified measure (CDA-M) which removes discourse errors that occurred with similar frequency across the three groups. Performance on this measure correlated significantly with severity of injury. Further, it was found that there were quantitative and qualitative differences between two severity subgroups in the TBI group with respect to their CDA-M profiles. While nearly all members of the TBI group made errors associated with information transfer, only the more severely injured TBI participants made errors in parameters which seem to be associated with more fundamental 'rules' of conversational interaction. The results are discussed in relation to the psychosocial implications of the findings, together with issues in sampling and measuring conversational discourse in the TBI population.	LA TROBE UNIV,MELBOURNE,VIC,AUSTRALIA; BETHSDA HOSP,MELBOURNE,FL				Douglas, Jacinta M/C-2380-2009	Douglas, Jacinta/0000-0003-0940-6624; Snow, Pamela/0000-0002-2426-8349			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BELLACK AS, 1983, BEHAV RES THER, V21, P29, DOI 10.1016/0005-7967(83)90123-7; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Burke WH, 1988, HEAD INJURY REHABILI; CAMPBELL TF, 1992, TOP LANG DISORD, V12, P42, DOI 10.1097/00011363-199202000-00006; COEHLO CA, 1994, DISCOURSE ANAL APPL, P95; COEHLO CA, 1991, J HEAD TRAUMA REHAB, V6, P92; COEHLO CA, 1995, BRAIN INJURY, V9, P471; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; Damico J. S., 1985, COMMUNICATION SKILLS, P165; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Grice H. P., 1975, SYNTAX SEMANTICS, P41; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hartley L. L, 1995, COGNITIVE COMMUNICAT; HUDSON RA, 1980, SOCIOLINGUISTICS; JORDAN F, 1990, AUSTR J HUMAN COMMUN, V18, P69; KEARNS KJ, TREATMENT EFFICACY R, P79; KEPPELL G, 1991, DESIGN ANAL RES HDB; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MALKMUS DD, 1989, TOP LANG DISORD, V9, P50, DOI 10.1097/00011363-198903000-00006; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MILTON SB, 1981, P CLIN APH C, P114; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; PARSONS CL, 1989, AUSTR J HUMAN COMMUN, V17, P37; Patry R., 1990, DISCOURSE ABILITY BR, P3, DOI 10.1007/978-1-4612-3262-9_1; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1991, J CLIN EXPT NEUROPSY, V14, P822; POOLE ME, 1976, SOCIAL CLASS LANGUAG; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rimel RW, 1990, REHABILITATION ADULT, P8; Ruff R, 1991, COGNITIVE REHABILITA, P23; SARNO MT, 1984, FUNCTIONAL ASSESSMEN, P210; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; SNOW P, 1995, TRAUMATIC BRAIN INJU, P137; Snow P, 1995, TRAUMATIC BRAIN INJU, P33; STUBBS M, 1983, DISCOURSE ANAL; Trudgill P. J., 1983, SOCIOLINGUISTICS INT; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Wilson John, 1989, BOUNDARIES CONVERSAT	51	53	55	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1997	11	6					409	429					21	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WZ726	WOS:A1997WZ72600003	9171927				2022-02-06	
J	King, NS; Crawford, S; Wenden, FJ; Moss, NEG; Wade, DT				King, NS; Crawford, S; Wenden, FJ; Moss, NEG; Wade, DT			Interventions and service need following mild and moderate head injury: The Oxford Head Injury Service	CLINICAL REHABILITATION			English	Article							QUESTIONNAIRE; CONCUSSION; SCALE	Objective: To describe the interventions given by the Oxford Head injury Service (OXHIS) to patients seen after head injury, predominantly mild or moderate, over the first six months after their injuries. Design: Descriptive data of the amounts of early intervention provided by OXHIS in relation to severity of head injury and the amount of service need identified at six month follow-up. Setting: OXHIS aimed to register all patients aged 16-65 with a head injury of any severity, resident in Oxfordshire. it contacted and provided interventions for a random half of those registered at 7-10 days post-injury as part of a randomized controlled trial to investigate the effectiveness of early follow-up, Al six months post-injury, independent assessment of all those registered was undertaken to evaluate outcome and identify continuing service needs. Subjects: The data come from the 579 patients (of the 1156 registered), randomized to receive the new service at 7-10 days post-injury. All but eight of these received some form of service, and 252 of the randomized patients were available for interview at six months post-injury to assess their continuing service need. Results: in the first five months after head injury: 240 patients received postal information alone and were not otherwise in contact with the service; 127 had telephone contact, advice and information; 93 were seen in person, assessed and given advice and information; 78 needed more help and support from the OXHIS team over the telephone; and 33 required further face-to-face contact either from OXHIS or other services. Extensive use was made of standardized leaflets but only accompanied by individualized assessment and advice. At six months 252 of the 579 patients were interviewed: 101 had no problems; 136 needed further reassurance; and 15 required further intervention. Patients with longer periods of post-traumatic amnesia (PTA) were more likely to receive a higher level of service, but the majority of patients who received the more extensive services were those with 'mild' and 'moderate' head injuries. Conclusions: Although the amount of service provided at 7-10 days post- injury increased with severity of head injury, most service was in fact given to patients with milder head injuries:which were much more common. The majority of patients seen at six months post-injury needed reassurance, advice or other services;and monitoring of patients for some time after their head injuries does seem warranted. A population of 560 000 people could receive service from three whole-time equivalent (WTE) staff using these assessment and management protocols.			King, NS (corresponding author), RIVERMEAD REHABIL CTR,OXFORD HEAD INJURY SERV,ABINGDON RD,OXFORD OX1 4XD,ENGLAND.			Wade, Derick/0000-0002-1188-8442			Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GRONWALL D, 1980, J CLIN NEUROPSYCHOL, V2, P147; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KATZMAN R, 1983, AM J PSYCHIAT, V140, P737; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KING NS, 1997, IN PRESS BR J CLIN P; KING NS, 1997, IN PRESS J NEUROL NE; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moss NE, 1996, DISABIL REHABIL, V18, P169, DOI 10.3109/09638289609166296; Moss NE., 1994, CLIN REHABIL, V8, P149; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; SALKOVSKIS PM, COGNITIVE BEHAV THER; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; WADE DT, 1997, WADERESS; WADE DT, 1997, IN PRESS J NEUROL NE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	20	53	53	0	1	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON, ENGLAND NW1 3BH	0269-2155			CLIN REHABIL	Clin. Rehabil.	FEB	1997	11	1					13	27		10.1177/026921559701100104			15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XA307	WOS:A1997XA30700003	9065356				2022-02-06	
J	Lewen, A; Soderstrom, S; Hillered, L; Ebendal, T				Lewen, A; Soderstrom, S; Hillered, L; Ebendal, T			Expression of serine/threonine kinase receptors in traumatic brain injury	NEUROREPORT			English	Article						activin; ActR-1; ALK; BMPR-II; bone morphogenetic protein; in situ hybridization; mRNA; neuronal plasticity; osteogenic protein; rat; receptors; serine-threonine protein kinase receptors; transforming growth factor beta superfamily; traumatic brain injury	SERINE THREONINE KINASE; NERVE GROWTH-FACTOR; BETA-SUPERFAMILY; MESSENGER-RNA; II RECEPTOR; CLONING; GLUTAMATE; NEURONS; FAMILY; MEMBER	THE aim of this study was to investigate the expression of serine/threonine kinase receptors in the brain following traumatic brain injury. We report here that, the recently cloned and characterized bone morphogenetic protein (BMP) receptor type II (BMPR-II) and the activin receptor type IA (ActR-1) Act: mRNAs were simultaneously up-regulated in neurones in the dentate gyrus 6 h after a mild cerebral contusion injury. This finding was specific for these receptors since other investigated genes (i.e. ActR-II; ActR-IB, trkB and c-fos) showed other temporal patterns. These data suggest that type I and type II receptors act together in signal transduction in vivo and that BMPs may be involved in neuronal plasticity after traumatic brain injury.	UNIV UPPSALA HOSP,DEPT NEUROSURG,S-75185 UPPSALA,SWEDEN; UNIV UPPSALA HOSP,DEPT CLIN CHEM,S-75185 UPPSALA,SWEDEN; UNIV UPPSALA HOSP,DEPT DEV NEUROSCI,S-75185 UPPSALA,SWEDEN; BIOMED CTR,S-75185 UPPSALA,SWEDEN				Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348			ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Bengtsson H, 1995, NEUROREPORT, V7, P113, DOI 10.1097/00001756-199512000-00027; CUNNINGHAM NS, 1995, GROWTH FACTORS, V12, P99, DOI 10.3109/08977199509028956; HOVDA DA, 1990, ACT NEUR S, V51, P331; KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; LAI M, 1995, NEUROSCIENCE, V70, P1013; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEWEN A, 1996, SOC NEUR ABSTR, V22; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LYONS KM, 1991, TRENDS GENET, V7, P408, DOI 10.1016/0168-9525(91)90265-R; MABLE PC, 1995, SOC NEUR ABSTR, V21; MANESS LM, 1994, NEUROSCI BIOBEHAV R, V18, P143, DOI 10.1016/0149-7634(94)90043-4; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PREHN JHM, 1993, J NEUROCHEM, V60, P1665, DOI 10.1111/j.1471-4159.1993.tb13389.x; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; SODERSTROM S, 1995, DEV BRAIN RES, V85, P96, DOI 10.1016/0165-3806(94)00199-A; SODERSTROM S, 1996, IN PRESS CELL TISSUE; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; TOMIZAWA K, 1995, MOL BRAIN RES, V28, P122, DOI 10.1016/0169-328X(94)00199-O; WILHERS G, 1995, SOC NEUR ABSTR, V21; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	29	53	55	0	1	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	JAN 20	1997	8	2					475	479		10.1097/00001756-199701200-00020			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WX340	WOS:A1997WX34000021	9080432				2022-02-06	
J	Ikonomidou, C; Turski, L				Ikonomidou, C; Turski, L			Prevention of trauma-induced neurodegeneration in infant and adult rat brain: Glutamate antagonists	METABOLIC BRAIN DISEASE			English	Article; Proceedings Paper	Symposium on Neuroactive Amino Acids in CNS Disorders, at the 2nd International Congress of the Polish-Neuroscience-Society	SEP 13-16, 1995	KRAKOW, POLAND	Polish Neurosci Soc		traumatic brain injury; glutamate antagonists; AMPA antagonist; NMDA antagonists	METHYL-D-ASPARTATE; EXCITATORY AMINO-ACIDS; ISCHEMIC NEURONAL DEGENERATION; CENTRAL-NERVOUS-SYSTEM; NON-NMDA RECEPTORS; KAINIC-ACID; CEREBRAL-ISCHEMIA; INJURY; NEUROTOXICITY; DAMAGE	The mechanisms of neuronal degeneration following traumatic head injury are not well understood and no adequate treatment is currently available for the prevention of traumatic brain damage in humans. Seven day old rat pups were subjected to mechanical percussion of the head. Cortical damage in infant rats was reduced by pre-treatment with the N-methyl-D-aspartate (NMDA) antagonists dizocilpine (MK-801) or 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate (CPP). The AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) did not significantly suppress cortical damage in infant rats. In adult rats, traumatic head injury leads to primary (at impact-cortex) and secondary (distant- hippocampus) damage to the brain. Morphometric analysis demonstrated that both cortical and hippocampal damage was mitigated by pre-treatment with either the NMDA antagonist CPP or the non-NMDA antagonist NBQX. Neither treatment prevented primary damage in the cortex when therapy was started after trauma. Delayed treatment of rats with NBQX, but not with CPP, beginning between 1 and 7 h after trauma prevented the hippocampal damage. No protection was seen when therapy with NBQX was started 10 h after trauma. These data indicate that NMDA antagonists may possess better neuroprotective properties against excitotoxic processes triggered by traumatic brain injury in young individuals whereas AMPA antagonists may be more beneficial in adults.	SCHERING AG,RES LABS,D-13342 BERLIN,GERMANY; HUMBOLDT UNIV BERLIN,CLIN CHARITE,DEPT PEDIAT NEUROL,D-10098 BERLIN,GERMANY								Adams JH, 1992, GREENFIELDS NEUROPAT, P106; ALBALA BJ, 1984, DEV BRAIN RES, V13, P139, DOI 10.1016/0165-3806(84)90085-3; BENARI Y, 1984, DEV BRAIN RES, V14, P284, DOI 10.1016/0165-3806(84)90314-6; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERNDT RS, 1994, J EXP PSYCHOL LEARN, V20, P977, DOI 10.1037/0278-7393.20.4.977; BONDOLI A, 1981, RESUSCITATION, V9, P119, DOI 10.1016/0300-9572(81)90021-6; CAMPOCHIARO P, 1978, P NATL ACAD SCI USA, V75, P2025, DOI 10.1073/pnas.75.4.2025; CAVALHEIRO EA, 1983, ELECTROEN CLIN NEURO, V56, P480, DOI 10.1016/0013-4694(83)90232-8; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farber N. B., 1992, Society for Neuroscience Abstracts, V18, P1148; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; GRAFE MR, 1994, BRAIN RES, V653, P161, DOI 10.1016/0006-8993(94)90385-9; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hagberg H., 1992, Biology of the Neonate, V62, P299; HU BR, 1995, J NEUROCHEM, V64, P277; Ikonomidou C, 1995, CURR OPIN NEUROL, V8, P487, DOI 10.1097/00019052-199512000-00017; IKONOMIDOU C, 1989, J NEUROSCI, V9, P2809; IKONOMIDOU C, 1989, J NEUROSCI, V9, P1693; IKONOMIDOU C, 1989, Society for Neuroscience Abstracts, V15, P767; IKONOMIDOU C, 1994, NEUROPSYCHOPHARMACOL, V10, pS448; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAUFMAN BA, 1994, PEDIATR ANN, V23, P18, DOI 10.3928/0090-4481-19940101-07; LEHMANN J, 1987, J PHARMACOL EXP THER, V240, P737; LI H, 1993, J CEREBR BLOOD F MET, V13, P933, DOI 10.1038/jcbfm.1993.116; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MCDONALD JW, 1987, EUR J PHARMACOL, V140, P359, DOI 10.1016/0014-2999(87)90295-0; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; McGeer P, 1978, KAINIC ACID TOOL NEU, P1; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MONAGHAN DT, 1991, EXCITATORY AMINO ACI, P1; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1991, Society for Neuroscience Abstracts, V17, P184; MOSINGER JL, 1991, EXP NEUROL, V113, P10, DOI 10.1016/0014-4886(91)90140-8; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Olney J W, 1986, Adv Neurol, V44, P857; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OLNEY JW, 1971, J NEUROPATH EXP NEUR, V30, P75, DOI 10.1097/00005072-197101000-00008; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; OLNEY JW, 1989, J NEUROSCI, V9, P1701; OLNEY JW, 1972, J NEUROPATH EXP NEUR, V31, P464, DOI 10.1097/00005072-197207000-00006; OLNEY JW, 1991, NEUROBIOLOGY NMDA RE, P187; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PEARL TM, 1990, NEW ENGL J MED, V322, P1775; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Povlishock John T., 1993, P185; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; TEITELBAUM JS, 1990, NEW ENGL J MED, V322, P1781, DOI 10.1056/NEJM199006213222505; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; TURSKI L, 1988, NEUROL NEUR, V46, P343; WRATHALL JR, 1992, BRAIN RES, V586, P140, DOI 10.1016/0006-8993(92)91384-Q	56	53	56	1	1	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0885-7490			METAB BRAIN DIS	Metab. Brain Dis.	JUN	1996	11	2					125	141		10.1007/BF02069500			17	Endocrinology & Metabolism; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	UP556	WOS:A1996UP55600003	8776715				2022-02-06	
J	SempleRowland, SL; Mahatme, A; Popovich, PG; Green, DA; Hassler, G; Stokes, BT; Streit, WJ				SempleRowland, SL; Mahatme, A; Popovich, PG; Green, DA; Hassler, G; Stokes, BT; Streit, WJ			Analysis of TGF-beta 1 gene expression in contused rat spinal cord using quantitative RT-PCR	JOURNAL OF NEUROTRAUMA			English	Article						cytokine; cyclophilin; inflammation; reactive gliosis; regeneration; spinal cord injury; transforming growth factor beta	TRANSFORMING GROWTH FACTOR-BETA-1; INTERLEUKIN-1-BETA MESSENGER-RNA; TRANSIENT FOREBRAIN ISCHEMIA; FACTOR-BETA; DIFFERENTIAL EXPRESSION; MONONUCLEAR PHAGOCYTES; TRAUMATIC INJURY; NERVOUS-SYSTEM; BRAIN; MICROGLIA	We have used northern blot analysis and quantitative reverse transcription polymerase chain reaction (RT-PCR) to determine the postinjury expression profile of the transforming growth factor-beta 1 (TGF-beta 1) gene in the contused rat spinal cord, Spectrophotometric estimates of total sample RNA and quantitative analyses of cyclophilin mRNA using RT-PCR served as controls for comparisons between samples, No changes in cyclophilin gene expression were found at any postinjury survival times, The results of the TGF-beta 1 analyses, which were carried out on spinal cord samples taken at postinjury intervals ranging from 6 h to 10 days, show that the amount of TGF-beta 1 mRNA present in spinal cord increases rapidly following injury, reaching maximum levels 7 days postinjury. Unoperated control samples contained approximately 2 x 10(8) molecules of TGF-beta 1 mRNA/0.5 mu g total RNA. By 1 day postinjury, the amount of TGF-beta 1 mRNA in the cord had increased by a factor of 2.5 to 5 x 10(8) molecules/0.5 mu g total RNA, At 7 days postinjury, there were approximately 15 x 10(8) molecules of TGF-beta 1 mRNA/0.5 mu g total RNA. By 10 days postinjury the amount of TGF-beta 1 mRNA present in the spinal cord had declined to 8 x 10(8) molecules of TGF-beta 1 mRNA/0.5 mu g total RNA, a value similar to that observed at 3 days postinjury, The roles that TGF-beta 1 might play in modifying cellular responses in injured spinal cord are discussed.	OHIO STATE UNIV, COLL MED, SPINAL CORD INJURY RES CTR, DEPT PHYSIOL, COLUMBUS, OH 43210 USA		SempleRowland, SL (corresponding author), UNIV FLORIDA, DEPT NEUROSCI, INST BRAIN, POB 100244 JHMHC, GAINESVILLE, FL 32610 USA.		Popovich, Phillip/C-9187-2009	Popovich, Phillip/0000-0003-1329-7395	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS NS-10165 (BTS), T32 NS07291-05 (PGP)] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007291, P50NS010165] Funding Source: NIH RePORTER		BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BLIGHT AR, 1993, BRAIN RES, V632, P314, DOI 10.1016/0006-8993(93)91167-Q; BUTTINI M, 1994, MOL BRAIN RES, V23, P126, DOI 10.1016/0169-328X(94)90218-6; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONSTAM DB, 1992, J IMMUNOL, V148, P1404; DACUNHA A, 1993, J NEUROIMMUNOL, V42, P71, DOI 10.1016/0165-5728(93)90214-J; DACUNHA A, 1992, J NEUROIMMUNOL, V36, P157; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DING A, 1990, J IMMUNOL, V145, P940; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; FONTANA A, 1989, J IMMUNOL, V143, P3230; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HORNER PJ, 1994, NEURAL TRANSPLANTATI, P119; KIEFER R, 1995, INT J DEV NEUROSCI, V13, P331; KIEFER R, 1993, EUR J NEUROSCI, V5, P775, DOI 10.1111/j.1460-9568.1993.tb00929.x; KLEMPT ND, 1992, MOL BRAIN RES, V13, P93, DOI 10.1016/0169-328X(92)90048-G; KORSHINAGA M, 1995, J NEUROTRAUM, V12, P209; Lindholm D, 1990, Neuroreport, V1, P9; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU T, 1993, STROKE, V24, P1746, DOI 10.1161/01.STR.24.11.1746; LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; MERRILL JE, 1991, GLIA, V4, P327, DOI 10.1002/glia.440040311; MILNER RJ, 1983, NUCLEIC ACIDS RES, V11, P5497, DOI 10.1093/nar/11.16.5497; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; NICHOLS NR, 1991, J NEUROSCI RES, V28, P134, DOI 10.1002/jnr.490280114; PASINETTI GM, 1993, NEUROSCIENCE, V54, P893, DOI 10.1016/0306-4522(93)90583-2; POPOVICH PG, 1993, J NEUROTRAUM, V10, P37, DOI 10.1089/neu.1993.10.37; POPOVICH PG, 1994, BRAIN RES, V633, P348, DOI 10.1016/0006-8993(94)91560-1; QIAN SW, 1990, NUCLEIC ACIDS RES, V18, P3059, DOI 10.1093/nar/18.10.3059; Sambrook J., 1989, MOL CLONING LAB MANU; SEMPLEROWLAND SL, 1994, INVEST OPHTH VIS SCI, V35, P2550; STOKES BT, 1992, J NEUROTRAUM, V9, P187, DOI 10.1089/neu.1992.9.187; STREILEIN JW, 1992, J NEUROIMMUNOL, V39, P185, DOI 10.1016/0165-5728(92)90253-H; SUZUMURA A, 1993, J IMMUNOL, V151, P2150; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WIESSNER C, 1993, ACTA NEUROPATHOL, V86, P439; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131	47	53	54	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	1995	12	6					1003	1014		10.1089/neu.1995.12.1003			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TU518	WOS:A1995TU51800001	8742129				2022-02-06	
J	KELLY, DF				KELLY, DF			ALCOHOL AND HEAD-INJURY - AN ISSUE REVISITED	JOURNAL OF NEUROTRAUMA			English	Article						ALCOHOL; COAGULOPATHY; EXCITOTOXICITY; HEAD INJURY; N-METHYL-D-ASPARTATE RECEPTOR	ETHANOL WITHDRAWAL; BRAIN INJURY; CORTICAL-NEURONS; CEREBRAL-CORTEX; TRAUMA; INTOXICATION; FIBRINOLYSIS; HIPPOCAMPAL; INHIBITION; DRINKING	The pathophysiologic changes associated with acute and chronic alcohol exposure in the setting of traumatic brain injury are complex, Experimental data indicate that ethanol intoxication can exacerbate brain injury through several mechanisms including hemodynamic and respiratory depression, blood-brain barrier disruption, and derangements in hemostasis. Alcohol, however, is also a potent inhibitor of N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity, and thus is neuroprotective. In contrast to the effects of acute intoxication, chronic alcohol exposure appears to result in upregulation of NMDA receptor activity and downregulation of gamma-aminobutyric acid (GABA) receptor function. This imbalance, it is hypothesized, can result in a surge of exitotoxicity following alcohol withdrawal. Trauma-related excitotoxic cell damage may be significantly potentiated by this alcohol-induced receptor imbalance that is unmasked as withdrawal occurs. Clinical and epidemiologic investigations of alcohol and outcome after head injury have not consistently demonstrated a measurable effect from either acute or chronic alcohol use. Multiple factors including the timing of intoxication in relation to time of injury, the degree and chronicity of intoxication, as well as the influence of other secondary injury processes appear to determine the net effect of alcohol in a given individual. Further clinical and experimental investigations aimed at defining the impact of alcohol use on outcome after head injury are warranted.			KELLY, DF (corresponding author), UNIV CALIF LOS ANGELES,HLTH SCI CTR,DIV NEUROSURG,BOX 956901,LOS ANGELES,CA 90095, USA.						AGUAYO LG, 1990, EUR J PHARMACOL, V187, P127, DOI 10.1016/0014-2999(90)90349-B; ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ALLAN AM, 1987, PHARMACOL BIOCHEM BE, V27, P665, DOI 10.1016/0091-3057(87)90192-4; BENGMARK S, 1980, THROMB HAEMOSTASIS, V43, P203; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; BUNEGIN L, 1986, CRIT CARE MED, V14, P387, DOI 10.1097/00003246-198604000-00151; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; DECRESCITO V, 1974, SURG FORUM, V15, P438; DEYKIN D, 1982, NEW ENGL J MED, V306, P852, DOI 10.1056/NEJM198204083061406; DILDYMAYFIELD JE, 1991, J NEUROCHEM, V56, P1536, DOI 10.1111/j.1471-4159.1991.tb02048.x; ELMER O, 1984, HAEMOSTASIS, V14, P223; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GERSHMAN H, 1991, Journal of Emergency Medicine, V9, P307, DOI 10.1016/0736-4679(91)90371-L; GONZALES RA, 1991, TRENDS PHARMACOL SCI, V12, P1, DOI 10.1016/0165-6147(91)90478-B; GRANT KA, 1990, EUR J PHARMACOL, V176, P289, DOI 10.1016/0014-2999(90)90022-X; GULYA K, 1991, BRAIN RES, V547, P129; HAUT MJ, 1974, AM J MED, V56, P2; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; INGLIS FM, 1990, ACT NEUR S, V51, P277; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KELLY DF, 1995, CRIT CARE MED, V23, pA245; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kraus JF, 1993, HEAD INJURY, P1; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; LESLIE SW, 1983, J PHARMACOL EXP THER, V225, P571; LINDENBA.J, 1969, NEW ENGL J MED, V281, P333, DOI 10.1056/NEJM196908142810701; LITTLE HJ, 1986, LIFE SCI, V39, P2059, DOI 10.1016/0024-3205(86)90356-5; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; LOVINGER DM, 1993, ALCOHOL CLIN EXP RES, V17, P19, DOI 10.1111/j.1530-0277.1993.tb00720.x; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; McQueen J D, 1975, Surg Neurol, V4, P375; MODELL JG, 1990, NEW ENGL J MED, V323, P455, DOI 10.1056/NEJM199008163230706; MONTPIED P, 1991, MOL PHARMACOL, V39, P157; MORROW AL, 1988, J PHARMACOL EXP THER, V246, P158; NESTOROS JN, 1980, SCIENCE, V209, P708, DOI 10.1126/science.7394531; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PERSSON L, 1977, ACTA NEUROL SCAND, V56, P7; PERSSON LI, 1978, ACTA NEUROL SCAND, V57, P405; PIKAAR NA, 1987, METABOLISM, V36, P538, DOI 10.1016/0026-0495(87)90163-6; RIDKER PM, 1994, JAMA-J AM MED ASSOC, V272, P929, DOI 10.1001/jama.272.12.929; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENGREN LE, 1979, ACTA NEUROL SCAND, V59, P119; RYBACK R, 1970, ARCH INTERN MED, V125, P475, DOI 10.1001/archinte.125.3.475; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; TAKADERA T, 1990, BRAIN RES, V537, P109, DOI 10.1016/0006-8993(90)90346-D; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1981, J NEUROSURG, V55, P718, DOI 10.3171/jns.1981.55.5.0718; WALKER DW, 1974, ELECTROEN CLIN NEURO, V36, P233, DOI 10.1016/0013-4694(74)90164-3; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; WHITTINGTON MA, 1991, BRIT J PHARMACOL, V103, P1677, DOI 10.1111/j.1476-5381.1991.tb09846.x; ZINC BJ, 1995, J NEUROSURGF, V82, P822; ZINC BJ, 1993, J NEUROTRAUM, V10, P275; 1994, 1994 OCCUPANT PROTEC	62	53	54	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1995	12	5					883	890		10.1089/neu.1995.12.883			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TE646	WOS:A1995TE64600012	8594215				2022-02-06	
J	NADLER, V; BIEGON, A; BEITYANNAI, E; ADAMCHIK, J; SHOHAMI, E				NADLER, V; BIEGON, A; BEITYANNAI, E; ADAMCHIK, J; SHOHAMI, E			CA-45 ACCUMULATION IN RAT-BRAIN AFTER CLOSED-HEAD INJURY - ATTENUATION BY THE NOVEL NEUROPROTECTIVE AGENT HU-211	BRAIN RESEARCH			English	Article						CALCIUM ACCUMULATION; (45)CALCIUM; CANNABINOID; CLOSED HEAD INJURY; HEAD TRAUMA; HU-211	CALCIUM ACCUMULATION; CEREBRAL-ISCHEMIA; NEURONAL DAMAGE; AMINO-ACIDS; NEUROTOXICITY; RECEPTORS; POTASSIUM; BLOCKADE; TRAUMA	Ca-45 accumulation was studied autoradiographically as a marker for lethally injured brain tissue following closed head injury (CHI), and applied to an investigation of the neuroprotective effect of the non-psychoactive cannabinoid(+)-(3S,4S)-7-hydroxy-D-6 tetrahydro-cannabinol 1,1-dimethylheptyl (HU-211). Amassment of Ca-45 in rat brain was examined 24 or 72 h after induction of CHI in the left hemisphere by a weight-drop device. Concentration of Ca-45 within 15 different brain regions was assessed by relative optical density. There was increased Ca-45 accumulation in the hemisphere ipsilateral to the side of the insult as compared with the contralateral hemisphere. The highest density of radioactive labeling was found in the anterior cortex and in the frontal parts of the parietal cortex, with accumulation expanding as a function of time post injury. On the third day following trauma the amount of accumulated Ca-45 was higher than that at 24 h after CHI, with more distant Ca-45-accumulating structures involved: the ventral posterolateral nucleus of the thalamus and the substantia nigra. Histological examination revealed necrotic tissue in the regions accumulating Ca-45. HU-211, a stereoselective inhibitor of the N-methyl-D-aspartate (NMDA) receptor, was injected immediately after induction of trauma. One day after trauma, HU-211 had significantly decreased both the volume of the Ca-45 accumulating zone and the concentration of the amassed radioisotope. In the HU-211 treated rats a considerable reduction in radioactive labeling was also found 72 h after trauma. The ability of HU-211 to decrease Ca-45 accumulation after head trauma is probably due to its ability to attenuate Ca2+ fluxes through the NMDA receptor-mediated calcium channels and to reduce the depolarization evoked Ca2+ fluxes. On the basis of our results, HU-211 seems to be a promising therapeutic agent for head trauma in humans.	HEBREW UNIV JERUSALEM, DEPT PHARMACOL, JERUSALEM, ISRAEL		NADLER, V (corresponding author), PHARMOS LTD, KIRYAT WEIZMANN, IL-76326 REHOVOT, ISRAEL.		Beit-Yannai, Elie/F-2141-2012	Beit-Yannai, Elie/0000-0001-9347-822X			ARAKI T, 1990, BRAIN RES, V528, P114, DOI 10.1016/0006-8993(90)90202-M; Bar-Joseph Avi, 1994, Society for Neuroscience Abstracts, V20, P186; BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; Biegon A., 1993, Society for Neuroscience Abstracts, V19, P1485; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, J NEUROSCI, V10, P2493; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; DIENEL GA, 1984, J NEUROCHEM, V43, P913, DOI 10.1111/j.1471-4159.1984.tb12825.x; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; Eshhar N., 1994, Society for Neuroscience Abstracts, V20, P1046; ESHHAR N, 1994, J NEUROCHEM, V63, pS79; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GRAMSBERGEN JBP, 1988, J NEUROCHEM, V50, P1798, DOI 10.1111/j.1471-4159.1988.tb02481.x; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HOVDA DA, 1994, ACTA NEUROCHIR, P521; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; NADLER V, 1993, NEUROSCI LETT, V162, P43, DOI 10.1016/0304-3940(93)90555-Y; NADLER V, 1993, BRAIN RES, V622, P79, DOI 10.1016/0006-8993(93)90804-V; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; SAJI M, 1987, SCIENCE, V235, P66, DOI 10.1126/science.3798095; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; SHAPIRA Y, 1989, Neurological Research, V11, P169; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; STEIN DT, 1988, J CEREBR BLOOD F MET, V8, P834, DOI 10.1038/jcbfm.1988.140; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1	36	53	55	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 10	1995	685	1-2					1	11		10.1016/0006-8993(95)00367-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RJ201	WOS:A1995RJ20100001	7583233				2022-02-06	
J	ASGEIRSSON, B; GRANDE, PO; NORDSTROM, CH; BERNTMAN, L; MESSETER, K; RYDING, E				ASGEIRSSON, B; GRANDE, PO; NORDSTROM, CH; BERNTMAN, L; MESSETER, K; RYDING, E			EFFECTS OF HYPOTENSIVE TREATMENT WITH ALPHA(2)-AGONIST AND BETA(1)-ANTAGONIST ON CEREBRAL HEMODYNAMICS IN SEVERELY HEAD-INJURED PATIENTS	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						ADRENERGIC ALPHA RECEPTOR AGONISTS; ADRENERGIC BETA RECEPTOR ANTAGONISTS; BRAIN EDEMA; BRAIN INJURIES; CEREBRAL HEMODYNAMICS; CEREBRAL PERFUSION PRESSURE; CLONIDINE; INTRACRANIAL PRESSURE, METOPROLOL	BLOOD-BRAIN-BARRIER; FLOW; CIRCULATION; ANESTHESIA; CLONIDINE; PRESSURE	Therapy of post-traumatic brain oedema often includes preservation of high arterial blood pressure to avoid secondary ischaemic injuries to the brain. This practice can be questioned since high arterial blood pressure may aggravate brain oedema through raised hydrostatic capillary pressure, causing fluid filtration across the damaged blood-brain barrier. This latter view is in agreement with our clinical experience and therefore hypotensive therapy with an alpha(2)-adrenergic agonist (clonidine) and a beta(1)-adrenergic antagonist (metoprolol) has become part of our treatment protocol for severely head injured patients to decrease the post-traumatic brain oedema. The present study is an attempt to analyse whether there are any direct local cerebrovascular effects of the hypotensive agents used, which also might influence intracranial pressure. Severely head injured patients were investigated. Heart rate, mean arterial blood pressure, intracranial pressure, cerebral blood flow and arteriovenous difference in oxygen content were measured before and after a bolus dose of clonidine (six patients) and metoprolol (nine patients). Clonidine decreased mean arterial blood pressure and cerebrovascular resistance without affecting other parameters measured. Metoprolol decreased heart rate and mean arterial pressure, but had no effect on the cerebrovascular parameters. The results show that clonidine and metoprolol have no, or only minor, direct influence on local cerebral haemodynamics in severely brain injured patients. This implies that if there is an intracranial pressure reducing effect of these drugs, as suggested, this must be due to other mechanisms, namely a reduction in capillary hydrostatic pressure secondary to decreased arterial blood pressure and heart rate.	UNIV LUND HOSP,DEPT PHYSIOL & BIOPHYS,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT CLIN NEUROPHYSIOL,S-22185 LUND,SWEDEN		ASGEIRSSON, B (corresponding author), UNIV LUND HOSP,DEPT ANAESTHESIA & INTENS CARE,S-22185 LUND,SWEDEN.						ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, IN PRESS INTENSIVE C; ASGEIRSSON B, 1994, 9TH INT S INT PRESS; BOREL C, 1990, CHEST, V98, P180, DOI 10.1378/chest.98.1.180; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLGAN FJ, 1983, CRIT CARE MED, V11, P368, DOI 10.1097/00003246-198305000-00010; CRIUCKSHANK JM, 1987, LANCET, V2, P585; DAHLGREN N, 1981, J CEREBR BLOOD F MET, V1, P429, DOI 10.1038/jcbfm.1981.47; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; EDVINSSON L, 1978, J PHYSIOL-LONDON, V274, P149, DOI 10.1113/jphysiol.1978.sp012140; EDVINSSON L, 1976, PHARMACOL REV, V2, P275; FENSTERMACHER JD, 1984, EDEMA, P383; HAYASHI Y, 1993, BRIT J ANAESTH, V71, P108, DOI 10.1093/bja/71.1.108; HEISTAD DD, 1983, HDB PHYSL 2, V0003, P00137; JENSEN K, 1989, BRIT J ANAESTH, V62, P321, DOI 10.1093/bja/62.3.321; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; LASSEN N A, 1987, Nuclear Medicine Communications, V8, P535; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P483, DOI 10.1152/ajplegacy.1976.231.2.483; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; OLESEN J, 1986, CEPHALALGIA, V6, P41, DOI 10.1177/03331024860060S505; PAPPIUS HM, 1989, IMPLICATIONS BLOOD B, V1, P293; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; REID JL, 1981, BRIT J CLIN PHARMACO, V12, P295, DOI 10.1111/j.1365-2125.1981.tb01217.x; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; TODD NV, 1990, ACT NEUR S, V51, P296	28	53	54	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	APR	1995	39	3					347	351		10.1111/j.1399-6576.1995.tb04075.x			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	RH062	WOS:A1995RH06200014	7793214				2022-02-06	
J	YAZBAK, PA; MCCOMB, JG; RAFFEL, C				YAZBAK, PA; MCCOMB, JG; RAFFEL, C			PEDIATRIC TRAUMATIC INTRACRANIAL ANEURYSMS	PEDIATRIC NEUROSURGERY			English	Article						ANEURYSM, TRAUMATIC INTRACRANIAL	INTERNAL CAROTID-ARTERY; STAB WOUNDS; CHILDHOOD; BRAIN	During the past 17 years, 7 children have been treated at Children's Hospital Los Angeles (CHLA) for traumatic intracranial aneurysms. These patients presented with subarachnoid or intraparenchymal hemorrhage (5 cases), growing fracture (1 case), and behavioral change (1 case). All patients were managed with surgery, and no patient died or was made neurologically worse as a result of such management. The existence of a traumatic aneurysm should be considered when new neurological symptoms develop in a patient with a history of head injury.	UNIV SO CALIF,CHILDRENS HOSP LOS ANGELES,SCH MED,DIV PEDIAT NEUROSURG,LOS ANGELES,CA		YAZBAK, PA (corresponding author), DARTMOUTH HITCHCOCK MED CTR,NEUROSURG SECT,1 MED CTR DR,LEBANON,NH 03756, USA.						AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; ALMEIDA GM, 1977, CHILD BRAIN, V3, P193; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BOUSQUET C, 1989, SURG NEUROL, V31, P319, DOI 10.1016/0090-3019(89)90059-1; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; DIAL DL, 1937, AM J SURG, V35, P2; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Endo S, 1974, No Shinkei Geka, V2, P329; FELDGES A, 1989, INTENS CARE MED, V15, P400; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; FOX JL, 1983, INTRACRANIAL ANEURYS, V3, P1453; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; KOMIYAMA M, 1991, SURG NEUROL, V36, P126, DOI 10.1016/0090-3019(91)90230-7; LASSMAN LP, 1974, VASCULAR SURG, V8, P1; LEE JP, 1990, J TRAUMA, V30, P619, DOI 10.1097/00005373-199005000-00017; MENEZES AH, 1974, J NEUROSURG, V40, P544, DOI 10.3171/jns.1974.40.4.0544; MORARD M, 1991, NEUROSURGERY, V29, P438, DOI 10.1227/00006123-199109000-00018; NAKSTAD P, 1984, J NEURORADIOLOGY, V11, P3; NOV AA, 1984, J NEURORADIOLOGY, V11, P3; OVERTON MC, 1966, J NEUROSURG, V24, P672, DOI 10.3171/jns.1966.24.3.0672; PATEL AN, 1971, J NEUROSURG, V35, P571, DOI 10.3171/jns.1971.35.5.0571; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; POZATTI E, 1982, J NEUROSURG, V57, P418; SCHARFETTER F, 1976, ACTA NEUROCHIR, V33, P123, DOI 10.1007/BF01405749; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SHUCART WA, 1974, AM J DIS CHILD, V127, P288, DOI 10.1001/archpedi.1974.02110210138022; SHULMAN K, 1982, PEDIATRIC NEUROSURGE, P617; SMITH KR, 1968, J NEUROSURG, V29, P551, DOI 10.3171/jns.1968.29.5.0551; TEAL JS, 1973, J NEUROSURG, V38, P568, DOI 10.3171/jns.1973.38.5.0568; THOMPSON JR, 1973, AM J ROENTGENOL, V118, P163, DOI 10.2214/ajr.118.1.163; Tsubokawa T, 1975, No Shinkei Geka, V3, P663; WEINSTEIN JM, 1991, ARCH NEUROL-CHICAGO, V48, P490, DOI 10.1001/archneur.1991.00530170050020; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016; [No title captured]; [No title captured]	39	53	54	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	JAN	1995	22	1					15	19		10.1159/000121294			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PY968	WOS:A1995PY96800003	7888388				2022-02-06	
J	MITTENBERG, W; BURTON, DB				MITTENBERG, W; BURTON, DB			A SURVEY OF TREATMENTS FOR POST-CONCUSSION SYNDROME	BRAIN INJURY			English	Article							BLUNT HEAD-INJURY; SYMPTOMS; SEQUELAE	A survey of the members of the National Academy of Neuropsychology and the International Neuropsychological Society was conducted on current treatment approaches for post-concussion syndrome. The interventions that were found useful most frequently included education about the effects of head injury, reassurance that the symptoms are part of the normal recovery process, and support in coping with reactions to the symptoms. Graded resumption of activity, antidepressant medication, and cognitive restructuring were also regarded as useful. The relations.hips between type of treatment, factors contributing to the syndrome, ratings of treatment effectiveness, and duration of treatment were discussed.			MITTENBERG, W (corresponding author), NOVA UNIV,SCH PSYCHOL,FT LAUDERDALE,FL 33314, USA.						Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BECK AT, 1979, COGNITIVE THERAPY DE; BECK AT, ANXIETY DISORDERS PH; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CYTOWIC RE, 1987, NEUROPSYCHOLOGICAL S, P226; DIKMEN SS, MILD HEAD INJURY, P229; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GLISKY EL, 1986, J HEAD TRAUMA REHABI, V1, P81; GODFREY HPD, 1987, BRIT J CLIN PSYCHOL, V26, P83, DOI 10.1111/j.2044-8260.1987.tb00735.x; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; KERLINGER F, 1973, F BEHAV RES, P414; Levin H.S., 1989, MILD HEAD INJURY; Levin H. S., 1987, NEUROBEHAVIORAL RECO, P262; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1990, J CLIN EXPT NEUROPSY, V12, P120; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; LONG CJ, 1986, SOUTHERN MED J, V79, P728, DOI 10.1097/00007611-198606000-00020; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MEIER MJ, 1986, NEUROPSYCHOL REHABIL; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Philips HC, 1988, PSYCHOL MANAGEMENT C; Ruff R. M., 1989, MILD HEAD INJURY, P176; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1977, LANCET, V1, P1; SCHATZBERG AF, MANUAL CLIN PSYCHOPH; Uzzell B., 1986, CLIN NEUROPSYCHOLOGY; WRIGHTSON P, 1989, MILD HEAD INJURY, P245; 1978, MENTAL DISORDERS GLO	35	53	53	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1994	8	5					429	437		10.3109/02699059409150994			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	NW122	WOS:A1994NW12200004	7951205				2022-02-06	
J	SWAINE, BR; SULLIVAN, SJ				SWAINE, BR; SULLIVAN, SJ			RELIABILITY OF THE SCORES FOR THE FINGER-TO-NOSE TEST IN ADULTS WITH TRAUMATIC BRAIN INJURY	PHYSICAL THERAPY			English	Article						COORDINATION; RELIABILITY; TESTS AND MEASUREMENTS; TRAUMATIC BRAIN INJURY	AGREEMENT; SCALES; SYSTEM	Background and Purpose. The Purpose of this study was to determine the intrarater and interrater reliability of measurements of three clinical features of coordination based on the performance of the ''finger-to-nose'' test. Subjects. Thirty-seven Persons with traumatic brain injury (26 male, 11 female), aged 17 to 64 years (XBAR = 29.1, SD = 9.9), participated in the study. Methods. Each subject's performance was videotaped and evaluated for the right and left upper extremities (UEs) (two trials each) with respect to the following variables: time of execution, degree of dysmetria, and degree of tremor (four-point ordinal ratings). One year later, five experienced physical therapists (including the original investigator) independently rated each patient''s videotaped performance in the same manner as described above. Results. Intraclass correlation coefficients (ICC[3,1]) for intrarater reliability were .971 and .986 and ICCs for interrater reliability were .920 and .913 for right and left UEs, respectively, for the time of execution. A generalized Kappa statistic of .54 was calculated for the scoring of dysmetria (both UEs) and Kappa statistics calculated for the scoring of tremor were .18 and .31 for right and left UEs, respectively. Interrater reliability was lower for the scoring of these variables and varied from .36 to .40 for dysmetria and from .27 to .26 for tremor (right and left UEs, respectively). Conclusion and Discussion. These results indicate that physical therapist demonstrate low reliability in assessment of the presence of dysmetria and tremor using videotaped performances of the finger-to-nose test. The results suggest, however, that therapists reliably measure the time of execution of this test. If the limitations associated with therapists' capacity for objective measurement of subjective phenomena cannot be overcome (eg, by establishment of more definitive scoring criteria for the measures of dysmetria and tremor), then therapy should seek alternative methods of evaluation of UE coordination.	UNIV MONTREAL,FAC MED,ECOLE READAPTAT,BIOMED SCI PROGRAM,MONTREAL H3C 3J7,QUEBEC,CANADA; CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL H3G 1M8,QUEBEC,CANADA								Adams RD, 1989, PRINCIPLES NEUROLOGY; BEHBEHANI K, 1990, ARCH PHYS MED REHAB, V71, P106; CARONNA JJ, 1984, REHABILITATION ADULT, P59; COHADON F, 1983, NEUROCHIRURGIE, V29, P303; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; EASTLACK ME, 1991, PHYS THER, V71, P465, DOI 10.1093/ptj/71.6.465; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; GRINKER RR, 1966, NEUROLOGY, P40; HELD JP, 1975, ANN MED PHYS, V18, P337; HENDERSON L, 1991, J NEUROL NEUROSUR PS, V54, P18, DOI 10.1136/jnnp.54.1.18; Jennett B, 1972, Scand J Rehabil Med, V4, P16; Jones R D, 1981, Int Rehabil Med, V3, P71; KONDRASKE GV, 1984, IEEE T BIO-MED ENG, V31, P401, DOI 10.1109/TBME.1984.325279; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MAYO NE, 1991, AM J PHYS MED REHAB, V70, P118, DOI 10.1097/00002060-199106000-00002; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; RINEHART MA, 1983, PHYS THER, V63, P1975, DOI 10.1093/ptj/63.12.1975; ROSECRANCE JC, 1991, PHYS THER, V71, P334, DOI 10.1093/ptj/71.4.334; ROTHSTEIN JM, 1985, MEASUREMENT PHYSICAL, P8; SCHMITZ TJ, 1988, PHYSICAL REHABILITAT, P121; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SMITH SS, 1987, PHYS THER, V67, P1860, DOI 10.1093/ptj/67.12.1860; SULLIVAN SJ, 1989, P EVALUATION MESURAB; SWAINE BR, 1992, ARCH PHYS MED REHAB, V73, P55; TURTON A J, 1987, Physiotherapy Practice, V3, P117, DOI 10.3109/09593988709044173; WHYTE J, 1988, REHABILITATION MED P, P585	26	53	53	0	5	AMER PHYS THER ASSN	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314	0031-9023			PHYS THER	Phys. Ther.	FEB	1993	73	2					71	78		10.1093/ptj/73.2.71			8	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	KJ866	WOS:A1993KJ86600004	8421720				2022-02-06	
J	BEERS, SR				BEERS, SR			COGNITIVE EFFECTS OF MILD HEAD-INJURY IN CHILDREN AND ADOLESCENTS	NEUROPSYCHOLOGY REVIEW			English	Article						NEUROPSYCHOLOGICAL ASSESSMENT; MILD HEAD INJURY; DEVELOPMENT; INFORMATION PROCESSING	NEUROPSYCHOLOGICAL SEQUELAE; INTELLECTUAL ABILITY; REACTION-TIME; TRAUMA; PERFORMANCE; CONCUSSION; RECOVERY; CHILDHOOD; SYMPTOMS; MEMORY	A comprehensive review of recent neuropsychological studies of mild head injury (MHI) involving children and adolescents is presented. The seminal work of Rutter and his colleagues is reviewed. An alternative conceptualization of MHI as proposed by various researchers is elaborated and further research investigating the cognitive sequelae of MHI is reviewed. MHI is discussed within the context of development and information processing models. Finally, the sequelae of MHI are reviewed with respect to academic functioning. Methodological problems inherent in studies of MHI are identified and discussed. The studies reviewed here support the conclusion that both the cognitive and emotional consequences of MHI should receive serious evaluation.	VET ADM MED CTR,PITTSBURGH,PA; WESTERN PSYCHIAT INST & CLIN,PITTSBURGH,PA 15261								ADAMS KM, 1991, J CLIN EXP NEUROPSYC, V13, P388, DOI 10.1080/01688639108401053; ADAMS W, 1990, MAY N COAST SOC PED; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; ALVS WM, 1985, CENTRAL NERVOUS SYST, P255; ARMSTRONG CL, 1987, NEUROPSYCHOLOGY, V4, P15; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BARTH JT, 1986, J HEAD TRAUMA REHABI, V1, P62; BARTH JT, 1986, J HEAD TRAUMA REHABI, V1, pR9; BARTH JT, 1990, 10TH ANN C NAT AC NE; BARTH JT, 1989, MILD HEAD INJURY, P255; BARTHOLOMEUSZ FDL, 1989, J GASTROEN HEPATOL, V4, P81, DOI 10.1111/j.1440-1746.1989.tb00810.x; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Benton A. L, 1989, MILD HEAD INJURY, P3; BIGLER ED, 1987, J LEARN DISABIL, V20, P516, DOI 10.1177/002221948702000902; BIGLER ED, 1987, J LEARN DISABIL, V20, P454, DOI 10.1177/002221948702000803; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1989, ASSESSMENT BEHAV CON, P37; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; BOLL TJ, 1981, HDB CLIN NEUROPSYCHO, V1, P418; BOLLOK I, 1983, NEUROPEPTIDES, V3, P263; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CASEY R, 1986, PEDIATRICS, V78, P497; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHADWICK O, 1981, PSYCHOL MED, V11, P46; CHADWICK O, 1985, DEV MED CHILD NEUROL, V27, P69; Colohan A. R. T., 1986, J HEAD TRAUMA REHAB, V1, P13; CONBOY TJ, 1986, REHABIL PSYCHOL, V31, P203, DOI 10.1037//0090-5550.31.4.203; DICKER BG, 1989, J HEAD TRAUMA REHAB, V4, P73; DIKMEN S, 1989, REHABIL PSYCHOL, V34, P101; DIKMEN SS, 1989, MILD HEAD INJURY, P229; EAMES P, 1986, LANCET, V2, P164; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P71; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; FLETCHER JM, 1990, 10TH ANN C NAT AC NE; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; GENNARELLI TA, 1987, STAPP CAR CRASH C, P49; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTILINI M, 1989, MILD HEAD INJURY, P163; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; GOUVIER WD, 1986, AM PSYCHOL, V41, P483; GRAHAM P, 1968, BRIT J PSYCHIAT, V114, P581, DOI 10.1192/bjp.114.510.581; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HANNAY HJ, 1988, J CLIN EXPT NEUROPSY, V11, P444; HYND GW, 1990, 10TH ANN C NAT AC NE; HYND GW, 1988, NEUROPSYCHOLOGICAL A, P12; JANE JA, 1982, OUTCOME PATHOLOGY HE, P229; Jennett B, 1978, Practitioner, V221, P77; Jennett B, 1989, MILD HEAD INJURY, P23; KALSBECK WD, 1980, J NEUROSURG, V53, P1931; KANE RL, 1992, NEUROPSYCHOL REV, V2, P281; KAY T, 1986, MINOR HEAD INJURY IN; KLAUBER MR, 1986, PREV MED, V15, P139, DOI 10.1016/0091-7435(86)90084-8; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KLVOE H, 1972, SCANDINAVIAN J REHAB, V4, P55; KRAUS JF, 1989, MILD HEAD INJURY, P8; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin H.S., 1989, MILD HEAD INJURY; Levin H. S., 1987, NEUROBEHAVIORAL RECO, P262; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIDVALL HF, 1975, LANCET, V1, P100; Lidvall HF, 1974, ACTA NEUROLOGICA S56, V50, P7; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MARGULIES SS, 1989, J BIOCH ENG, V111, P241; Marshall L. F., 1985, CENTRAL NERVOUS SYST, P45; Marshall LF, 1989, MILD HEAD INJURY, P276; MARTINI DR, 1990, MAY N COAST SOC PED; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Miller WG, 1986, NEUROPSYCHOLOGY HDB, P347; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Paris R., 1974, CLIN NEUROPSYCHOLOGY, P179; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL M, 1986, J HEAD TRAUMA REHABI, V1, pR8; Ruff R. M., 1989, MILD HEAD INJURY, P176; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1966, SOC PSYCHIATR, V1, P38, DOI 10.1007/BF00583828; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; RUTTER M, 1982, AM J PSYCHIAT, V139, P21; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; SALAZAR AM, 1992, CHALLENGES NEUROLOGY, P55; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SCHOENHUBER R, 1989, MILD HEAD INJURY, P142; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; SLATER EJ, 1989, J ADOLESCENT HEALTH, V10, P237, DOI 10.1016/0197-0070(89)90240-4; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; SYMONDS C, 1962, LANCET, V1, P1; TEASDALE G, 1974, LANCET, V2, P81; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; WINOGRON HW, 1984, J CLIN ENUROPSYCHOLO, V6, P268; ZAPPALA G, 1992, ARCH CLIN NEUROPSYCH, V7, P145, DOI 10.1016/0887-6177(92)90008-B; [No title captured]	115	53	53	0	6	PLENUM PUBL CORP	NEW YORK	CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013	1040-7308			NEUROPSYCHOL REV	Neuropsychol. Rev.	DEC	1992	3	4					281	320		10.1007/BF01108414			40	Psychology, Clinical; Neurosciences	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	LE058	WOS:A1992LE05800001	1284851				2022-02-06	
J	SHEPARD, SR; GHAJAR, JBG; GIANNUZZI, R; KUPFERMAN, S; HARIRI, RJ				SHEPARD, SR; GHAJAR, JBG; GIANNUZZI, R; KUPFERMAN, S; HARIRI, RJ			FLUID PERCUSSION BAROTRAUMA CHAMBER - A NEW INVITRO MODEL FOR TRAUMATIC BRAIN INJURY	JOURNAL OF SURGICAL RESEARCH			English	Article							CEREBRAL MISSILE INJURY; HEAD-INJURY; RAT				SHEPARD, SR (corresponding author), CORNELL UNIV,MED CTR,NEW YORK HOSP,AITKEN NEUROSURG LAB,1300 YORK AVE,NEW YORK,NY 10021, USA.						BERGREN DR, 1975, J TRAUMA, V15, P336, DOI 10.1097/00005373-197504000-00010; CHASON JL, 1958, J NEUROSURG, V15, P135, DOI 10.3171/jns.1958.15.2.0135; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; CROCKARD HA, 1977, J NEUROSURG, V46, P784, DOI 10.3171/jns.1977.46.6.0784; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Gennarelli T, 1982, ADV NEUROTRAUMATOLOG, P31; Gennarelli T, 1982, HEAD INJURY BASIC CL, V1982, P129; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Gennarelli T. A., 1972, 16 STAPP CAR CRASH C, P296; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1971, 15TH P STAPP CAR CRA, P797; GENNARELLI TA, 1980, APPL NEUROBIOL, V6, P234; GENNARELLI TA, 1985, NIH CENTRAL NERVOUS, P103; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; Gurdjian E. S., 1967, MED SCI, V18, P45; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; HARIRI RJ, 1989, J TRAUMA, V29, P1203, DOI 10.1097/00005373-198909000-00003; HAYES RL, 1989, HEAD INJURY; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Kobrine A I, 1973, Surg Neurol, V1, P34; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; LINDGREN S, 1965, BIOPHYSIK, V3, P320; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1966, HEAD INJURY, P260; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TSUBOKAWA T, 1975, Neurologia Medico-Chirurgica, V15, P57, DOI 10.2176/nmc.15pt1.57	30	53	56	0	1	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0022-4804			J SURG RES	J. Surg. Res.	NOV	1991	51	5					417	424		10.1016/0022-4804(91)90144-B			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GK450	WOS:A1991GK45000011	1758175				2022-02-06	
J	SIEGEL, JH; GENS, DR; MAMANTOV, T; GEISLER, FH; GOODARZI, S; MACKENZIE, EJ				SIEGEL, JH; GENS, DR; MAMANTOV, T; GEISLER, FH; GOODARZI, S; MACKENZIE, EJ			EFFECT OF ASSOCIATED INJURIES AND BLOOD-VOLUME REPLACEMENT ON DEATH, REHABILITATION NEEDS, AND DISABILITY IN BLUNT TRAUMATIC BRAIN INJURY	CRITICAL CARE MEDICINE			English	Article						BRAIN INJURIES; BLUNT INJURIES; COST-BENEFIT ANALYSIS; BRAIN DEATH; DISABILITY; REHABILITATION; NEUROLOGIC EXAMINATION; SEVERITY OF ILLNESS INDEX; GLASGOW COMA SCALE	HEAD-INJURY; MULTIPLE TRAUMA; ORGAN INJURY; MANAGEMENT	Objective: To examine the effects of associated injuries on death, disability, rehabilitation needs, and cost in patients with blunt traumatic brain injury. Design: A retrospective case series analysis of 1,709 patients with blunt traumatic brain injury, or 37.2% of 4,590 consecutive blunt trauma patients, was combined with a prospective study of a subset of 202 of the 1,709 brain-injured patients obtained during the same time period with regard to need for rehabilitation services, residual disability, and costs at 1 yr after discharge from the acute trauma center. Setting. A level I regional trauma center that is also the statewide neurotrauma and multiple trauma unit serving a population of more than 3 million persons. Results: Contingency table analysis showed the Glasgow Coma Scale to be highly predictive (p < .0001) of likelihood of mortality, need for postacute inpatient rehabilitation, or discharge home. Of the blunt traumatic brain injury patients, 40.4% (691) had an isolated brain injury and 59.6% (1,018) had brain plus at least one other systemic injury. The mortality rate of the isolated brain injury group was 11.1% compared with 21.8% in all brain plus systemic injury groups (p < .0001). Spine, lung, visceral, pelvis, or extremity injuries in blunt traumatic brain injury all increased mortality rate to > 25% (all simultaneously significant, p < .0001). Analysis of the interaction of brain injury (quantified by Glasgow Coma Scale) with blood replacement in the initial 24 hrs showed that at any Glasgow Coma Scale range, percent mortality increased as the volume of blood increased. Hypovolemic shock increased the mortality rate from 12.8% to 62.1% (p < .0001). The need for postacute inpatient rehabilitation in survivors also increased as blood replacement increased, and shock increased the percent of patients requiring post-acute inpatient rehabilitation from 39.7% to 60.3%. In 202 consecutive surviving brain trauma patients followed for 1 yr, isolated brain-injured patients with moderate brain injuries had a 4% need for posttrauma, postacute inpatient rehabilitation with a total cost per case of $12,489 compared with the brain plus extremity injury group, who had a 23% postacute inpatient rehabilitation rate and a total cost per case of $36,177 at 1 yr. With severe brain injury, isolated brain injury increased postacute inpatient rehabilitation to 29% and 1-yr cost to $59,274, but with the brain plus extremity injury group, postacute inpatient rehabilitation increased to 49% and cost to $84,950. Conclusions: In blunt traumatic brain injury, the addition of major visceral or extremity injuries, with need for blood replacement or shock, increases the risk of death, the need for rehabilitation, and the costs of disability.	UNIV MARYLAND,SCH MED,MARYLAND INST EMERGENCY MED SERVICES SYST,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,DEPT SURG,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,DEPT NEUROSURG,BALTIMORE,MD 21201; JOHNS HOPKINS UNIV,SCH PUBL HLTH & HYG,BALTIMORE,MD 21218								ANNEGERS JF, 1979, CENTRAL NERVOUS SYST, P1; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; COOPER PJ, 1987, HEAD INJURY, P1; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; Dunham C M, 1989, Md Med J, V38, P227; DUNHAM CM, 1991, RESUSCITATION, V21, P207, DOI 10.1016/0300-9572(91)90047-3; Geisler F.H., 1987, TRAUMA EMERGENCY SUR, P919; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Jennett B, 1981, MANAGEMENT HEAD INJU; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; MACKENZIE EJ, 1988, JAMA-J AM MED ASSOC, V260, P3290, DOI 10.1001/jama.260.22.3290; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; RIVKIND AI, 1989, J TRAUMA, V29, P1398, DOI 10.1097/00005373-198910000-00019; SACHS L, 1982, APPLIED STATISTICS H; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Turney SZ, 1990, MANAGEMENT CARDIOTHO, P229; 1985, ABBREVIATED INJURY S	18	53	53	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0090-3493			CRIT CARE MED	Crit. Care Med.	OCT	1991	19	10					1252	1265		10.1097/00003246-199110000-00007			14	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK390	WOS:A1991GK39000007	1914482				2022-02-06	
J	WOOLF, PD; LEE, LA; HAMILL, RW; MCDONALD, JV				WOOLF, PD; LEE, LA; HAMILL, RW; MCDONALD, JV			THYROID TEST ABNORMALITIES IN TRAUMATIC BRAIN INJURY - CORRELATION WITH NEUROLOGIC IMPAIRMENT AND SYMPATHETIC NERVOUS-SYSTEM ACTIVATION	AMERICAN JOURNAL OF MEDICINE			English	Article											WOOLF, PD (corresponding author), UNIV ROCHESTER, MED CTR, DEPT MED, ENDOCRINE METAB UNIT, ROCHESTER, NY 14642 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA007066] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA07066] Funding Source: Medline		AHREN B, 1985, ACTA ENDOCRINOL-COP, V108, P184, DOI 10.1530/acta.0.1080184; AHREN B, 1986, ENDOCR REV, V7, P149, DOI 10.1210/edrv-7-2-149; BACCI V, 1982, J CLIN ENDOCR METAB, V54, P1229, DOI 10.1210/jcem-54-6-1229; BECKER RA, 1980, ARCH SURG-CHICAGO, V115, P439; BRENT GA, 1986, J CLIN ENDOCR METAB, V63, P1; CHOPRA IJ, 1980, J CLIN ENDOCR METAB, V51, P135, DOI 10.1210/jcem-51-1-135; COLTON T, 1974, STATISTICS MED; COOPER DS, 1983, CLIN ENDOCRINOL, V18, P265, DOI 10.1111/j.1365-2265.1983.tb03211.x; CRYER PE, 1980, NEW ENGL J MED, V303, P436; DIEGUEZ C, 1984, ENDOCRINOLOGY, V114, P957, DOI 10.1210/endo-114-3-957; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; JENNETT B, 1975, LANCET, V1, P480; KAHANA L, 1983, CLIN ENDOCRINOL, V19, P131, DOI 10.1111/j.1365-2265.1983.tb00751.x; KAPTEIN EM, 1982, CLIN ENDOCRINOL, V16, P565, DOI 10.1111/j.1365-2265.1982.tb03173.x; KAPTEIN EM, 1982, J CLIN INVEST, V69, P526, DOI 10.1172/JCI110478; KRULICH L, 1982, ENDOCRINOLOGY, V110, P796, DOI 10.1210/endo-110-3-796; KRULICH L, 1982, NEUROENDOCRINOLOGY, V35, P139, DOI 10.1159/000123369; LEE LA, 1986, CLIN CHEM, V32, P797; LEEBAW WF, 1978, J CLIN ENDOCR METAB, V47, P480, DOI 10.1210/jcem-47-3-480; MANNISTO PT, 1981, ACTA ENDOCRINOL-COP, V97, P213, DOI 10.1530/acta.0.0970213; MURAKI T, 1982, ENDOCRINOLOGY, V110, P51, DOI 10.1210/endo-110-1-51; PEULER JD, 1977, LIFE SCI, V21, P625, DOI 10.1016/0024-3205(77)90070-4; PITTMAN CS, 1979, METABOLISM, V28, P333, DOI 10.1016/0026-0495(79)90103-3; ROGOL AD, 1979, NEUROENDOCRINOLOGY, V29, P413, DOI 10.1159/000122952; RUDMAN D, 1977, J CLIN ENDOCR METAB, V45, P747, DOI 10.1210/jcem-45-4-747; SAVDIE E, 1978, CLIN NEPHROL, V9, P68; SHANNON N, 1984, CLIN CHEM, V30, P1770; SMITH PJ, 1984, ENDOCR REV, V5, P514, DOI 10.1210/edrv-5-4-514; TEASDALE G, 1974, LANCET, V2, P81; WARTOFSKY L, 1982, ENDOCR REV, V3, P164, DOI 10.1210/edrv-3-2-164; WEHMANN RE, 1985, NEW ENGL J MED, V312, P546, DOI 10.1056/NEJM198502283120904; WIERSINGA WM, 1981, CLIN ENDOCRINOL, V14, P367, DOI 10.1111/j.1365-2265.1981.tb00622.x; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; WOOLF PD, 1972, J CLIN ENDOCR METAB, V35, P616, DOI 10.1210/jcem-35-4-616; ZALOGA GP, 1985, ANN SURG, V201, P456, DOI 10.1097/00000658-198504000-00010	37	53	55	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	FEB	1988	84	2					201	208		10.1016/0002-9343(88)90414-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	M0068	WOS:A1988M006800003	3407649				2022-02-06	
J	SARAN, AS				SARAN, AS			DEPRESSION AFTER MINOR CLOSED HEAD-INJURY - ROLE OF DEXAMETHASONE SUPPRESSION TEST AND ANTIDEPRESSANTS	JOURNAL OF CLINICAL PSYCHIATRY			English	Article									CASE WESTERN RESERVE UNIV, SCH MED, DEPT PSYCHIAT, CLEVELAND, OH 44106 USA								American Psychiatric Association, 1980, DIAGN STAT MAN MENT; AMSTERDAM JD, 1982, AM J PSYCHIAT, V139, P287; BOISMARE F, 1977, PSYCHOPHARMACOLOGY, V55, P251, DOI 10.1007/BF00497856; BROWN WA, 1979, AM J PSYCHIAT, V136, P230; BROWN WA, 1981, PSYCHIAT RES, V4, P115, DOI 10.1016/0165-1781(81)90015-9; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; DAVIDSON J, 1984, ARCH GEN PSYCHIAT, V41, P506; DAVIDSON JRT, 1982, ARCH GEN PSYCHIAT, V39, P527; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; GEORGOTAS A, 1981, J CLIN PSYCHOPHARM, V1, P27, DOI 10.1097/00004714-198101000-00006; GOLD MS, 1980, LANCET, V1, P1190; GROSSMAN R, 1975, 5TH P ANN M SOC NEUR, V76, P506; Guy W., 1976, CLIN GLOBAL IMPRESSI; HAMILTON M, 1980, J NEUROL NEUROSUR PS, V27, P56; JENNETT B, 1976, ARCH NEUROL-CHICAGO, V33, P595, DOI 10.1001/archneur.1976.00500090001001; KLEIN DF, 1980, DIAGNOSIS DRUG TREAT; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LIEBOWITZ MR, 1984, J CLIN PSYCHIAT, V45, P22; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAXSON CL, 1976, PEDIATRICS, V57, P893; QUITKIN F, 1979, ARCH GEN PSYCHIAT, V36, P749; RUTHERFORD WH, 1977, LANCET, V1, P1; SCHATZBERG AF, 1983, AM J PSYCHIAT, V140, P88; SCHLESSER MA, 1980, ARCH GEN PSYCHIAT, V37, P737; VANWOERKOM TCAM, 1977, LANCET, V1, P812; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	30	53	53	0	0	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry		1985	46	8					335	338					4	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	APJ36	WOS:A1985APJ3600008	4019422				2022-02-06	
J	PHILLIPS, G				PHILLIPS, G			TRAUMATIC EPILEPSY AFTER CLOSED HEAD INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article																	BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P348; ECCLES JC, 1953, NEUROPHYSIOLOGICAL B; JEFFERSON G, 1942, GLASGOW MED J, V20, P77; PICKERING GW, 1951, LANCET, V2, P845; RUSSELL WR, 1952, J NEUROL NEUROSUR PS, V15, P93, DOI 10.1136/jnnp.15.2.93; SCA, 1952, COMMUNICATION; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107	8	53	53	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1954	17	1					1	10		10.1136/jnnp.17.1.1			10	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	YD072	WOS:A1954YD07200001	13131074	Green Published, Bronze			2022-02-06	
J	KUNKLE, EC; MULLER, JC; ODOM, GL				KUNKLE, EC; MULLER, JC; ODOM, GL			TRAUMATIC BRAIN-STEM THROMBOSIS - REPORT OF A CASE AND ANALYSIS OF THE MECHANISM OF INJURY	ANNALS OF INTERNAL MEDICINE			English	Article																	ALAJOUANINE T, 1948, REV NEUROL, V80, P321; Alexander L, 1937, ARCH NEURO PSYCHIATR, V38, P1243, DOI 10.1001/archneurpsyc.1937.02260240123010; BAUER W, 1942, DISEASES METABOLISM, P609; Blaine ES, 1925, J AMER MED ASSOC, V85, P1356, DOI 10.1001/jama.1925.02670180012003; Brock S., 1943, INJURIES SKULL BRAIN; Corner EM, 1907, J ANAT PHYSIOL, V41, P149; DEKLEYN A, 1933, DTSCH Z NERVENHEILKD, V132, P157; deKleyn Nieuwenhuyse, 1927, ACTA OTOLARYNG STOCK, V11, P155, DOI 10.3109/00016482709120074; Foix C, 1925, REV NEUROL-FRANCE, V43, P160; FUTCHER TB, 1907, MODERN MED, V1, P808; Grinker RR, 1927, J AMER MED ASSOC, V88, P1140, DOI 10.1001/jama.1927.02680410016007; Hall AJ, 1934, LANCET, V2, P975; MOOLTEN SE, 1949, ARCH INTERN MED, V84, P667, DOI 10.1001/archinte.1949.00230050003001; PERRY TT, 1943, P STAFF M MAYO CLIN, V18, P19; PRATTTHOMAS HR, 1947, JAMA-J AM MED ASSOC, V133, P600, DOI 10.1001/jama.1947.02880090022005; Rigdon RH, 1944, J LAB CLIN MED, V29, P28; Sheehan D, 1937, LANCET, V2, P614; SUGAR O, 1949, AM J ROENTGENOL, V61, P166; Yaskin HE, 1944, ARCH NEURO PSYCHIATR, V51, P271, DOI 10.1001/archneurpsyc.1944.02290270060008; 1937, J A M A, V109, P233	20	53	53	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.		1952	36	5					1329	1335		10.7326/0003-4819-36-5-1329			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UE138	WOS:A1952UE13800016	14924467				2022-02-06	
J	Nath, ND; Behzadan, AH; Paal, SG				Nath, Nipun D.; Behzadan, Amir H.; Paal, Stephanie G.			Deep learning for site safety: Real-time detection of personal protective equipment	AUTOMATION IN CONSTRUCTION			English	Article						Personal protective equipment (PPE); Construction safety; Deep learning; Transfer learning; Image dataset; Real-time object detection	CONVOLUTIONAL NEURAL-NETWORKS; CONSTRUCTION; OBJECTS; MODEL	The leading causes of construction fatalities include traumatic brain injuries (resulted from fall and electrocution) and collisions (resulted from struck by objects). As a preventive step, the U.S. Occupational Safety and Health Administration (OSHA) requires that contractors enforce and monitor appropriate usage of personal protective equipment (PPE) of workers (e.g., hard hat and vest) at all times. This paper presents three deep learning (DL) models built on You-Only-Look-Once (YOLO) architecture to verify PPE compliance of workers; i.e., if a worker is wearing hard hat, vest, or both, from image/video in real-time. In the first approach, the algorithm detects workers, hats, and vests and then, a machine learning model (e.g., neural network and decision tree) verifies if each detected worker is properly wearing hat or vest. In the second approach, the algorithm simultaneously detects individual workers and verifies PPE compliance with a single convolutional neural network (CNN) framework. In the third approach, the algorithm first detects only the workers in the input image which are then cropped and classified by CNN-based classifiers (i.e., VGG-16, ResNet-50, and Xception) according to the presence of PPE attire. All models are trained on an in-house image dataset that is created using crowd-sourcing and web-mining. The dataset, named Pictor-v3, contains similar to 1,500 annotated images and similar to 4,700 instances of workers wearing various combinations of PPE components. It is found that the second approach achieves the best performance, i.e., 72.3% mean average precision (mAP), in real-world settings, and can process 11 frames per second (FPS) on a laptop computer which makes it suitable for real-time detection, as well as a good candidate for running on light-weight mobile devices. The closest alternative in terms of performance (67.93% mAP) is the third approach where VGG-16, ResNet-50, and Xception classifiers are assembled in a Bayesian framework. However, the first approach is the fastest among all and can process 13 FPS with 63.1% mAP. The crowed-sourced Pictor-v3 dataset and all trained models are publicly available to support the design and testing of other innovative applications for monitoring safety compliance, and advancing future research in automation in construction.	[Nath, Nipun D.; Paal, Stephanie G.] Texas A&M Univ, Zachry Dept Civil Engn, 3136 TAMU, College Stn, TX 77843 USA; [Behzadan, Amir H.] Texas A&M Univ, Dept Construct Sci, 3137 TAMU, College Stn, TX 77843 USA		Behzadan, AH (corresponding author), Texas A&M Univ, Dept Construct Sci, 3137 TAMU, College Stn, TX 77843 USA.	nipundebnath@tamu.edu; abehzadan@tamu.edu; spaal@tamu.edu			U.S. National Science Foundation (NSF)National Science Foundation (NSF) [CMMI 1800957]	The authors gratefully acknowledge the U.S. National Science Foundation (NSF) for supporting this project through grant CMMI 1800957, as well as Mr. Yalong Pi for assisting in data preparation. Any opinions, findings, conclusions, and recommendations expressed in this paper are those of the authors and do not necessarily represent the views of the NSF or the individual named above.	Akbar-Khanzadeh F, 1998, J Hum Ergol (Tokyo), V27, P70; Barro-Torres S, 2012, COMPUT COMMUN, V36, P42, DOI 10.1016/j.comcom.2012.01.005; Bishop CM., 2006, PATTERN RECOGN; Bureau of Labor Statistics, IND GLANC CONSTR; Bureau of Labor Statistics, FAT OCC INJ COUNTS R; Castelvecchi D, 2016, NATURE, V537, P20, DOI 10.1038/538020a; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONS; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Ding LY, 2018, AUTOMAT CONSTR, V86, P118, DOI 10.1016/j.autcon.2017.11.002; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Fang Q, 2018, AUTOMAT CONSTR, V85, P1, DOI 10.1016/j.autcon.2017.09.018; Fergus R, 2005, IEEE I CONF COMP VIS, P1816; Friedman S, 2001, IND REL RES, P1, DOI 10.1097/00054725-200102000-00001; GIRSHICK R, 2014, PROC CVPR IEEE, P580, DOI DOI 10.1109/CVPR.2014.81; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Han S, 2013, AUTOMAT CONSTR, V35, P131, DOI 10.1016/j.autcon.2013.05.001; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI 10.1109/ICCV.2017.322; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735; Huang XY, 2003, J CONSTR ENG M ASCE, V129, P262, DOI 10.1061/(ASCE)0733-9364(2003)129:3(262); Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kelm A, 2013, AUTOMAT CONSTR, V36, P38, DOI 10.1016/j.autcon.2013.08.009; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Kolar Z, 2018, AUTOMAT CONSTR, V89, P58, DOI 10.1016/j.autcon.2018.01.003; Kosala R., 2000, SIGKDD EXPLOR NEWSL, V2, P1, DOI DOI 10.1145/360402.360406; Krizhevsky A., 2012, ADV NEURAL INFORM PR, P1097, DOI DOI 10.1145/3065386; Kyrkou C, 2018, DES AUT TEST EUROPE, P967, DOI 10.23919/DATE.2018.8342149; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lin TY, 2020, IEEE T PATTERN ANAL, V42, P318, DOI [10.1109/ICCV.2017.324, 10.1109/TPAMI.2018.2858826]; Liu W, 2016, LECT NOTES COMPUT SC, V9905, P21, DOI 10.1007/978-3-319-46448-0_2; Mneymneh BE, 2019, J COMPUT CIVIL ENG, V33, DOI 10.1061/(ASCE)CP.1943-5487.0000813; Murphy K.P., 2012, MACHINE LEARNING PRO; Nath N., 2018, P 18 INT C CONSTR AP, P1; Nath ND, 2019, J INF TECHNOL CONSTR, V24, P511, DOI 10.36680/j.itcon.2019.028; Naticchia B, 2013, AUTOMAT CONSTR, V29, P148, DOI 10.1016/j.autcon.2012.09.016; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; OSHA, TOP 10 MOST FREQ CIT; OSHA, WORK SAF SER CONSTR; OSHA, COMM US STAT; OSHA, CIT STAND CONSTR; OSHA, EMPL PAYM PERS PROT; OSHA, SAF VEST REQ PROT FL; OSHA, SAF HLTH REG CONSTR; Park MW, 2015, J CONSTR ENG M, V141, DOI 10.1061/(ASCE)CO.1943-7862.0000974; Park MW, 2012, AUTOMAT CONSTR, V28, P15, DOI 10.1016/j.autcon.2012.06.001; Perez L, 2017, EFFECTIVENESS DATA A; Redmon J, 2018, ARXIV PREPRINT ARXIV; Redmon J, 2017, PROC CVPR IEEE, P6517, DOI 10.1109/CVPR.2017.690; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Ren SQ, 2015, ADV NEUR IN, V28; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Seo J, 2015, ADV ENG INFORM, V29, P239, DOI 10.1016/j.aei.2015.02.001; Shan Du, 2011, 2011 3rd International Conference on Computer Research and Development (ICCRD 2011), P25, DOI 10.1109/ICCRD.2011.5763846; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Shrestha K., 2015, J CONSTRUCTION ENG, V2015, P1; Siddula M, 2016, PROCEDIA ENGINEER, V145, P428, DOI 10.1016/j.proeng.2016.04.010; Simonyan K., 2014, ARXIV, DOI DOI 10.1109/CVPR.2015.7298594; Szegedy C., 2013, ADV NEURAL INF PROCE, V26, P2553, DOI DOI 10.5555/2999792.2999897; Turpin A., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P11, DOI 10.1145/1148170.1148176; United States Census Bureau, CONSTR SPEND; Vedantam R., 2015, CORR; WESTON J, 1998, CSDTR9804 U LOND DEP; Wu JX, 2019, AUTOMAT CONSTR, V106, DOI 10.1016/j.autcon.2019.102894; Xie ZP, 2018, PR IEEE I C PROGR IN, P430, DOI 10.1109/PIC.2018.8706269; Yuen M.-C., 2011, P 3 IEEE INT C SOC C, P766, DOI DOI 10.1109/PASSAT/SOCIALCOM.2011.203; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang YB, 2011, IEEE T IMAGE PROCESS, V20, P3291, DOI 10.1109/TIP.2011.2158226; Zivkovic Z, 2004, INT C PATT RECOG, P28, DOI 10.1109/ICPR.2004.1333992	68	52	52	20	54	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0926-5805	1872-7891		AUTOMAT CONSTR	Autom. Constr.	APR	2020	112								103085	10.1016/j.autcon.2020.103085			20	Construction & Building Technology; Engineering, Civil	Science Citation Index Expanded (SCI-EXPANDED)	Construction & Building Technology; Engineering	LE5UJ	WOS:000526785600018		Bronze			2022-02-06	
J	Kheiri, G; Dolatshahi, M; Rahmani, F; Rezaei, N				Kheiri, Ghazaleh; Dolatshahi, Mahsa; Rahmani, Farzaneh; Rezaei, Nima			Role of p38/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapy	REVIEWS IN THE NEUROSCIENCES			English	Article						autophagy; mitogen-activated protein kinase (MAPK); neuroinflammation; oxidative stress; receptor for advanced glycation end products	ACTIVATED PROTEIN-KINASE; GLYCATION END-PRODUCTS; P38 MAP KINASE; (+)-2-(1-HYDROXYL-4-OXOCYCLOHEXYL) ETHYL CAFFEATE; IMPROVES COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; A-BETA; TAU PHOSPHORYLATION; N-BENZYLCINNAMIDE; OXIDATIVE STRESS	A myriad of environmental and genetic factors, as well as the physiologic process of aging, contribute to Alzheimer's disease (AD) pathology. Neuroinflammation is and has been a focus of interest, as a common gateway for initiation of many of the underlying pathologies of AD. Amyloid beta (A beta) toxicity, increasing RAGE expression, tau hyperphosphorylation, induction of apoptosis, and deregulated autophagy are among other mechanisms, partly entangled and being explained by activation of mitogen-activated protein kinase (MAPK) and MAPK signaling. p38 MAPK is the most essential regulator of A beta induced toxicity from this family. p38 induces NF-kappa B activation, glutamate excitotoxicity, and disruption of synaptic plasticity, which are other implications of all justifying the p38 MAPK as a potential target to break the vicious AP toxicity cycle. Until recently, many in vivo and in vitro studies have investigated the effects of p38 MAPK inhibitors in AD. The pyridinyl imidazole compounds SB202190 and SB203580 have shown promising anti-apoptotic results in vivo. MW108 inhibits activation of p38 and is able to postpone cognitive decline in animal models. The PD169316, with anti-inflammatory, anti-oxidative, and anti-apoptotic features, has improved spatial memory in vivo. Natural compounds from Camellia sinensis (green tea), polyphenols from olive oil, pinocembrin from propolis, and the puerarine extract isoflavones, have shown strong antiapoptotic features, mediated by p38 MAPK inhibition. Use of these drug targets is limited due to central nervous system side effects or cross-reactivity with other kinases, predicting the low efficacy of these drugs in clinical trials.	[Kheiri, Ghazaleh; Dolatshahi, Mahsa; Rahmani, Farzaneh; Rezaei, Nima] USERN, NeuroImaging Network NIN, Tehran 19166, Iran; [Rezaei, Nima] Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies, Dr Qarib St,Keshavarz Blvd, Tehran 14194, Iran; [Kheiri, Ghazaleh; Dolatshahi, Mahsa; Rahmani, Farzaneh] Univ Tehran Med Sci, SSRC, Tehran 1416753955, Iran		Rezaei, N (corresponding author), USERN, NeuroImaging Network NIN, Tehran 19166, Iran.; Rezaei, N (corresponding author), Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies, Dr Qarib St,Keshavarz Blvd, Tehran 14194, Iran.	rezaei_nima@tums.ac.ir	Rezaei, Nima/B-4245-2008; Dolatshahi, Mahsa/AAL-5273-2021	Rezaei, Nima/0000-0002-3836-1827; 	Tehran University of Medical SciencesTehran University of Medical Sciences	Tehran University of Medical Sciences supported this study.	Abdoulaye IA, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5012341; Alam J, 2016, AUTOPHAGY, V12, P2516, DOI 10.1080/15548627.2016.1238555; Arunsundar M, 2015, NEUROTOX RES, V27, P143, DOI 10.1007/s12640-014-9492-x; Ashabi G, 2013, BASIC CLIN PHARMACOL, V112, P145, DOI 10.1111/bcpt.12000; Ashabi G, 2012, BEHAV BRAIN RES, V232, P165, DOI 10.1016/j.bbr.2012.04.006; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Bachstetter AD, 2014, J NEUROIMMUNE PHARM, V9, P454, DOI 10.1007/s11481-014-9543-3; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bartus RT, 2009, PSYCHOPHARMACOLOGY, V202, P15, DOI 10.1007/s00213-008-1365-7; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blum S, 1999, J NEUROSCI, V19, P3535; Bodles AM, 2005, NEUROBIOL AGING, V26, P9, DOI 10.1016/j.neurobiolaging.2004.02.022; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023; BURNS A, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B158; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; Cai YF, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00027; Cao GY, 2015, J ETHNOPHARMACOL, V168, P31, DOI 10.1016/j.jep.2015.03.041; Cardaci S, 2010, BIOCHEM J, V430, P439, DOI 10.1042/BJ20100503; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chan SHH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-17; Chang CH, 2010, J MED FOOD, V13, P548, DOI 10.1089/jmf.2009.1291; Chang KH, 2010, J NEUROCHEM, V113, P1221, DOI 10.1111/j.1471-4159.2010.06687.x; Chen LL, 2017, AUTOPHAGY, V13, P1969, DOI 10.1080/15548627.2017.1371393; Chicca A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0307-7; Choi IS, 2011, J ALZHEIMERS DIS, V27, P127, DOI 10.3233/JAD-2011-110545; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chueh FS, 2004, J PHARMACOL SCI, V96, P420, DOI 10.1254/jphs.FP0040424; Colie S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45306; Correa SAL, 2012, J NEUROSCI, V32, P13039, DOI 10.1523/JNEUROSCI.0930-12.2012; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; CZQP Technology, 2016, PHAS 2 STUD PIN INJ; Daniels WMU, 2001, METAB BRAIN DIS, V16, P175, DOI 10.1023/A:1012541011123; Dehghani R, 2018, REV NEUROSCIENCE, V29, P161, DOI 10.1515/revneuro-2017-0042; Delgado M, 2008, GLIA, V56, P1091, DOI 10.1002/glia.20681; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Desideri E, 2014, AUTOPHAGY, V10, P1652, DOI 10.4161/auto.29456; Devi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032792; Djordjevic S, 2002, TRENDS BIOCHEM SCI, V27, P426, DOI 10.1016/S0968-0004(02)02136-9; Dong WG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0646-z; Dorostkar MM, 2015, ACTA NEUROPATHOL, V130, P1, DOI 10.1007/s00401-015-1449-5; Emamian ES, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00033; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Fang F, 2018, HUM MOL GENET, V27, P1002, DOI 10.1093/hmg/ddy017; Fernandez F, 2012, CELL ADHES MIGR, V6, P333, DOI 10.4161/cam.20892; Ferrer I, 1990, Arch Neurobiol (Madr), V53, P222; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gabr AA, 2017, BBA-MOL BASIS DIS, V1863, P2942, DOI 10.1016/j.bbadis.2017.06.020; Genheden M, 2015, J NEUROSCI, V35, P972, DOI 10.1523/JNEUROSCI.2641-14.2015; Ghasemi R, 2014, NEUROPHARMACOLOGY, V85, P113, DOI 10.1016/j.neuropharm.2014.01.036; Ghidoni R, 2008, J NEURAL TRANSM, V115, P1047, DOI 10.1007/s00702-008-0069-9; Giraldo E, 2014, REDOX BIOL, V2, P873, DOI 10.1016/j.redox.2014.03.002; Haghshomar M., 2017, NEUROSCIENCE; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Ho DT, 1997, J NEUROCHEM, V68, P106; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hu WC, 2014, CHEM-BIOL INTERACT, V224, P108, DOI 10.1016/j.cbi.2014.10.011; Huai YP, 2013, NEURAL REGEN RES, V8, P1733, DOI 10.3969/j.issn.1673-5374.2013.19.001; Hyun S, 2015, MICROBIOL BIOTECHN L, V25, P334, DOI 10.4014/jmb.1411.11073; Imbimbo BP, 2005, NEUROIMAG CLIN N AM, V15, P727, DOI 10.1016/j.nic.2005.09.009; Jeong K, 2014, APOPTOSIS, V19, P1399, DOI 10.1007/s10495-014-1013-0; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jung YY, 2014, BIOMOL THER, V22, P232, DOI 10.4062/biomolther.2014.030; Kano Y, 2007, BRAIN RES, V1154, P1, DOI 10.1016/j.brainres.2007.03.087; Kanungo Jyotshna, 2017, Brain Disord Ther, V6, DOI 10.4172/2168-975X.1000232; Karelina K, 2012, LEARN MEMORY, V19, P550, DOI 10.1101/lm.025775.112; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Kennedy DO, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121332; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim EJ, 2013, J ETHNOPHARMACOL, V146, P294, DOI 10.1016/j.jep.2012.12.047; Kim HS, 2015, ARCH PHARM RES, V38, P813, DOI 10.1007/s12272-014-0456-8; Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Kim YH, 2010, INT IMMUNOPHARMACOL, V10, P1560, DOI 10.1016/j.intimp.2010.09.007; Knight ZA, 2011, CURR TOP MICROBIOL, V347, P263, DOI 10.1007/82_2010_44; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kuang X, 2008, PHARMACOL BIOCHEM BE, V88, P213, DOI 10.1016/j.pbb.2007.08.006; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kurz A, 2011, PROG NEURO-PSYCHOPH, V35, P373, DOI 10.1016/j.pnpbp.2010.07.018; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lan X, 2016, MOL NEUROBIOL, V53, P1794, DOI 10.1007/s12035-015-9125-2; Lauretti E, 2015, AGING CELL, V14, P1067, DOI 10.1111/acel.12381; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee YK, 2011, J NUTR BIOCHEM, V22, P476, DOI 10.1016/j.jnutbio.2010.04.002; Lee YJ, 2011, FREE RADICAL BIO MED, V50, P66, DOI 10.1016/j.freeradbiomed.2010.10.698; Lee YJ, 2012, J ALZHEIMERS DIS, V29, P677, DOI 10.3233/JAD-2012-111835; Lei H, 2014, J ASIAN NAT PROD RES, V16, P854, DOI 10.1080/10286020.2014.939586; Leung KW, 2010, CHINESE MED, V5, P20, DOI DOI 10.1186/1749-8546-5-20; Li W, 2012, LIFE SCI, V91, P809, DOI 10.1016/j.lfs.2012.08.028; Li X, 2004, NEUROREPORT, V15, P2237, DOI 10.1097/00001756-200410050-00019; Li XH, 2015, CLIN INTERV AGING, V10, P549, DOI 10.2147/CIA.S74042; Li YK, 2003, J NEUROSCI, V23, P1605; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lim DY, 2014, CANCER PREV RES, V7, P856, DOI 10.1158/1940-6207.CAPR-13-0286; Liu R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-105; Liu RX, 2016, AM J TRANSL RES, V8, P4082; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Ma L, 2003, BRAIN RES, V966, P167, DOI 10.1016/S0006-8993(02)04149-5; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Maphis N, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0221-y; Sabogal-Guaqueta AM, 2016, NEUROPHARMACOLOGY, V102, P111, DOI 10.1016/j.neuropharm.2015.11.002; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moghaddam HS, 2017, REV NEUROSCIENCE, V28, P509, DOI 10.1515/revneuro-2016-0068; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Nai Y, 2018, HUM EXP TOXICOL, V37, P929, DOI 10.1177/0960327117745693; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Ning B, 2013, J MOL NEUROSCI, V49, P380, DOI 10.1007/s12031-012-9893-3; Nobre AC, 2008, ASIA PAC J CLIN NUTR, V17, P167; Ojala JO, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050055; Ojala JO, 2008, J NEUROIMMUNOL, V205, P86, DOI 10.1016/j.jneuroim.2008.09.012; Omata Yasuhiro, 2014, Am J Neurodegener Dis, V3, P134; Onyango IG, 2005, MOL CELL NEUROSCI, V29, P333, DOI 10.1016/j.mcn.2005.02.012; Ossoukhova A, 2015, HUM PSYCHOPHARM CLIN, V30, P108, DOI 10.1002/hup.2463; Pan YX, 2013, J CLIN NEUROSCI, V20, P726, DOI 10.1016/j.jocn.2012.09.012; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Pei JJ, 2001, J ALZHEIMERS DIS, V3, P41, DOI 10.3233/JAD-2001-3107; Peng Y, 2012, J ALZHEIMERS DIS, V29, P379, DOI 10.3233/JAD-2011-111577; Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010; Penzes P, 2011, BRAIN RES REV, V67, P184, DOI 10.1016/j.brainresrev.2011.01.003; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Polotow TG, 2015, MAR DRUGS, V13, P6117, DOI 10.3390/md13106117; Puangmalai N, 2017, NEURAL REGEN RES, V12, P1492, DOI 10.4103/1673-5374.215262; Qi QQ, 2018, NEUROSCI LETT, V672, P59, DOI 10.1016/j.neulet.2017.11.051; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; REINIKAINEN KJ, 1990, J NEUROSCI RES, V27, P576, DOI 10.1002/jnr.490270419; RICH JB, 1995, NEUROLOGY, V45, P51, DOI 10.1212/WNL.45.1.51; Rivera-Cervantes MC, 2015, J MOL NEUROSCI, V55, P596, DOI 10.1007/s12031-014-0398-0; Robinson KA, 1999, J NEUROSCI RES, V55, P724, DOI 10.1002/(SICI)1097-4547(19990315)55:6<724::AID-JNR7>3.0.CO;2-9; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Sasaki N, 2002, NEUROSCI LETT, V326, P117, DOI 10.1016/S0304-3940(02)00310-5; Scheff SW, 1996, DEMENTIA, V7, P226, DOI 10.1159/000106884; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Scholey A, 2010, PSYCHOPHARMACOLOGY, V212, P345, DOI 10.1007/s00213-010-1964-y; Schuehly W, 2011, CHEM BIOL, V18, P1053, DOI 10.1016/j.chembiol.2011.05.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shen JN, 2015, CURR ALZHEIMER RES, V12, P892, DOI 10.2174/156720501209151019111244; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Singh S, 2003, J BIOL CHEM, V278, P36410, DOI 10.1074/jbc.M306428200; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Song YS, 2004, NEUROSCI RES, V49, P69, DOI 10.1016/j.neures.2004.01.010; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Stein IS, 2015, J NEUROSCI, V35, P12303, DOI 10.1523/JNEUROSCI.4289-14.2015; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Sun AY, 2003, EXP NEUROL, V183, P394, DOI 10.1016/S0014-4886(03)00180-8; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Tan MS, 2012, NEUROSCI LETT, V516, P226, DOI 10.1016/j.neulet.2012.03.093; Tang SC, 2017, NEUROMOL MED, V19, P579, DOI 10.1007/s12017-017-8471-9; Thangnipon W, 2016, NEUROSCI LETT, V610, P6, DOI 10.1016/j.neulet.2015.10.050; Thangnipon W, 2015, ARCH PHARM RES, V38, P1380, DOI 10.1007/s12272-015-0593-8; Thangnipona W, 2013, NEUROSCI LETT, V556, P20, DOI 10.1016/j.neulet.2013.09.071; Torres M, 2015, APOPTOSIS, V20, P712, DOI 10.1007/s10495-015-1099-z; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; de la Torre AV, 2013, PHARMACOL RES, V70, P116, DOI 10.1016/j.phrs.2013.01.007; Vignini A, 2013, CURR DIABETES REV, V9, P218, DOI 10.2174/1573399811309030003; Wang G, 2012, PROG NEUROBIOL, V98, P207, DOI 10.1016/j.pneurobio.2012.06.003; Wang HM, 2010, THIRTEENTH NATIONAL CONFERENCE ON PACKAGING ENGINEERING, TNCPE 13, P1; Wang S, 2014, J CLIN NEUROSCI, V21, P810, DOI 10.1016/j.jocn.2013.08.017; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Watterson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066226; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Wu ZF, 2014, MOL NEUROBIOL, V50, P986, DOI 10.1007/s12035-014-8675-z; Xiang J, 2014, INT J CLIN EXP MED, V7, P1706; Xiong ZL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00238; Xu J, 2012, NEUROPHARMACOLOGY, V62, P2424, DOI 10.1016/j.neuropharm.2012.02.014; Xu W, 2016, NEUROCHEM INT, V100, P44, DOI 10.1016/j.neuint.2016.08.012; Yamagishi S, 2003, J BIOCHEM, V133, P719, DOI 10.1093/jb/mvg092; Yan HQ, 2017, NEUROL RES, V39, P337, DOI 10.1080/01616412.2016.1268775; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan Shirley ShiDu, 2012, Front Biosci (Schol Ed), V4, P240; Yang S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/215798; Yang ZH, 2012, J ASIAN NAT PROD RES, V14, P14, DOI 10.1080/10286020.2011.620393; Yasuda S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P45; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Yu Y, 2008, EXP BRAIN RES, V184, P307, DOI 10.1007/s00221-007-1100-3; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zhang CH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007257; Zhang HY, 2011, EXP GERONTOL, V46, P30, DOI 10.1016/j.exger.2010.09.013; Zhang L, 2010, NEUROCHEM INT, V57, P547, DOI 10.1016/j.neuint.2010.06.021; Zheng L, 2011, AUTOPHAGY, V7, P1528, DOI 10.4161/auto.7.12.18051; Zheng QH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005803; Zhou W, 2013, FUTURE MED CHEM, V5, P1559, DOI 10.4155/fmc.13.125; Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880	202	52	56	4	30	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	JAN	2019	30	1					9	30		10.1515/revneuro-2018-0008			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF3HI	WOS:000454125700002	29804103				2022-02-06	
J	DePadilla, L; Miller, GF; Jones, SE; Peterson, AB; Breiding, MJ				DePadilla, Lara; Miller, Gabrielle F.; Jones, Sherry Everett; Peterson, Alexis B.; Breiding, Matthew J.			Self-Reported Concussions from Playing a Sport or Being Physically Active Among High School Students - United States, 2017	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article									[DePadilla, Lara; Peterson, Alexis B.; Breiding, Matthew J.] CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Miller, Gabrielle F.] CDC, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Jones, Sherry Everett] CDC, Div Adolescent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Jones, Sherry Everett] CDC, Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA		DePadilla, L (corresponding author), CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	ldepadilla@cdc.gov					Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Brener ND, 2013, MMWR RECOMM REP, V62, P1; CDC, 2015, FACT SHEET YOUTH SPO; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; DePadilla L, 2018, 4 FED INT C TRAUM BR; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; JOBE JB, 1993, APPL COGNITIVE PSYCH, V7, P567, DOI 10.1002/acp.2350070703; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774	10	52	52	0	3	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	JUN 22	2018	67	24					682	685		10.15585/mmwr.mm6724a3			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GK5VO	WOS:000436247500003	29927909	Green Submitted, Green Published, Bronze			2022-02-06	
J	Geeraerts, T; Velly, L; Abdennour, L; Asehnoune, K; Audibert, G; Bouzat, P; Bruder, N; Carrillon, R; Cottenceau, V; Cotton, F; Courtil-Teyssedre, S; Dahyot-Fizelier, C; Dailler, F; David, JS; Engrand, N; Fletcher, D; Francony, G; Gergele, L; Ichai, C; Javouhey, E; Leblanc, PE; Lieutaud, T; Meyer, P; Mirek, S; Orliaguet, G; Proust, F; Quintard, H; Ract, C; Srairi, M; Tazarourte, K; Vigue, B; Payen, JF				Geeraerts, Thomas; Velly, Lionel; Abdennour, Lamine; Asehnoune, Karim; Audibert, Gerard; Bouzat, Pierre; Bruder, Nicolas; Carrillon, Romain; Cottenceau, Vincent; Cotton, Francois; Courtil-Teyssedre, Sonia; Dahyot-Fizelier, Claire; Dailler, Frederic; David, Jean-Stephane; Engrand, Nicolas; Fletcher, Dominique; Francony, Gilles; Gergele, Laurent; Ichai, Carole; Javouhey, Etienne; Leblanc, Pierre-Etienne; Lieutaud, Thomas; Meyer, Philippe; Mirek, Sebastien; Orliaguet, Gilles; Proust, Francois; Quintard, Herve; Ract, Catherine; Srairi, Mohamed; Tazarourte, Karim; Vigue, Bernard; Payen, Jean-Francois		French Soc Anaesthesia Intensive C; Assoc Neuro Anesthesie Reanimation; French Soc Emergency Med; Soc Francaise Neurochirurgie; Grp Francophone Reanimation Urgenc; Assoc Anesthesistes Reanimateurs P	Management of severe traumatic brain injury (first 24 hours)	ANAESTHESIA CRITICAL CARE & PAIN MEDICINE			English	Article							CEREBRAL PERFUSION-PRESSURE; GLASGOW-COMA-SCALE; SEVERE HEAD-INJURY; SIMPLIFIED MOTOR SCORE; INTENSIVE INSULIN THERAPY; SYSTOLIC BLOOD-PRESSURE; INTRA-CRANICAL PRESSURE; REFRACTORY INTRACRANIAL HYPERTENSION; EARLY DECOMPRESSIVE CRANIECTOMY; RANDOMIZED CONTROLLED-TRIALS	The latest French Guidelines for the management in the first 24 hours of patients with severe traumatic brain injury (TBI) were published in 1998. Due to recent changes (intracerebral monitoring, cerebral perfusion pressure management, treatment of raised intracranial pressure), an update was required. Our objective has been to specify the significant developments since 1998. These guidelines were conducted by a group of experts for the French Society of Anesthesia and Intensive Care Medicine (Societe francaise d'anesthesie et de reanimation [SFAR]) in partnership with the Association de neuro-anesthesie-reanimation de langue francaise (ANARLF), The French Society of Emergency Medicine (Societe francaise de medecine d'urgence (SFMU), the Societe francaise de neurochirurgie (SFN), the Groupe francophone de reanimation et d'urgences pediatriques (GFRUP) and the Association des anesthesistes-reanimateurs pediatriques d'expression francaise (ADARPEF). The method used to elaborate these guidelines was the Grade (R) method. After two Delphi rounds, 32 recommendations were formally developed by the experts focusing on the evaluation the initial severity of traumatic brain injury, the modalities of prehospital management, imaging strategies, indications for neurosurgical interventions, sedation and analgesia, indications and modalities of cerebral monitoring, medical management of raised intracranial pressure, management of multiple trauma with severe traumatic brain injury, detection and prevention of post-traumatic epilepsia, biological homeostasis (osmolarity, glycaemia, adrenal axis) and paediatric specificities. (C) 2017 The Authors. Published by Elsevier Masson SAS on behalf of Societe francaise d'anesthesie et de reanimation (Sfar).	[Geeraerts, Thomas; Srairi, Mohamed] Univ Toulouse 3, Paul Sabatier, CHU Toulouse,Pole Anesthesie Reanimat, ToNIC,Toulouse Neuroimaging Ctr,UMR 1214,Inserm, F-31059 Toulouse, France; [Velly, Lionel; Bruder, Nicolas] Univ Aix Marseille, CHU Timone, AP HM, Serv Anesthesie Reanimat, F-13005 Marseille, France; [Abdennour, Lamine] Grp Hosp Pitie Salpetriere, AP HP, Dept Anesthesie Reanimat, F-75013 Paris, France; [Asehnoune, Karim] CHU Nantes, Hotel Dieu, Serv Anesthesie & Reanimat Chirurgicale, F-44093 Nantes 1, France; [Audibert, Gerard] CHU Nancy, Hop Cent, Dept Anesthesie & Reanimat, F-54000 Nancy, France; [Bouzat, Pierre; Francony, Gilles; Payen, Jean-Francois] CHU Grenoble Alpes, Pole Anesthesie Reanimat, F-38043 Grenoble 9, France; [Carrillon, Romain; Dailler, Frederic] Hosp civils Lyon, Grp Hosp Est, Hop Neurol Pierre Wertheimer, Serv Anesthesie & Reanimat, F-69677 Bron, France; [Cottenceau, Vincent] CHU Bordeaux, Hop Pellegrin, SAR 1, Serv Reanimat Cirurgicale & Traumatol, Bordeaux, France; [Cotton, Francois] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Imagerie, F-69495 Pierre Benite, France; [Courtil-Teyssedre, Sonia; Javouhey, Etienne] Hosp Civils Lyon, Hop Femme Mere Enfant, Serv Reanimat Pediat, F-69677 Bron, France; [Dahyot-Fizelier, Claire] CHU Poitiers, Dept Anesthesie & Reanimat, F-86021 Poitiers, France; [David, Jean-Stephane] Ctr Hosp Lyon Sud, Hospices Civils Lyon, Serv Anesthesie Reanimat, F-69495 Pierre Benite, France; [Engrand, Nicolas] Fdn Ophtalmol Adolphe Rothschild, Serv Anesthesie Reanimat, F-75940 Paris 19, France; [Fletcher, Dominique] Univ Versailles St Quentin, Hop Raymond Poincare, AP HP, Serv Anesthesie Reanimat Chirurgicale, Garches, France; [Gergele, Laurent] CHU St Etienne, Dept Anesthesie & Reanimat, F-42055 St Etienne, France; [Ichai, Carole; Quintard, Herve] CHU Nice, Hop Pasteur, CNRS, UMR 7275,Serv Anesthesie Reanimat Med Chirurgical, F-06000 Nice, France; [Leblanc, Pierre-Etienne; Ract, Catherine; Vigue, Bernard] Hop Univ Paris Sud, Hop Bicetre, AP HP, Dept Anesthesie & Reanimat, Le Kremlin Bicetre, France; [Leblanc, Pierre-Etienne; Ract, Catherine; Vigue, Bernard] Ctr Rech Neurosci, Ctr Hosp Bourg Bresse, Serv Anesthesie, Inserm 5288,CNRS 1072,Equipe TIGER, Lyon, France; [Lieutaud, Thomas] Univ Claude Bernard Lyon, IFSTTAR, UMR T9405, UMRESTTE, Lyon, France; [Lieutaud, Thomas] Univ Paris 05, Hop Univ Necker Enfants Malades, Serv Anesthesie Reanimat, AP HP, Paris, France; [Meyer, Philippe; Orliaguet, Gilles] Serv Pharmacol & Evaluat Therapeut Chez Enfant En, EA Paris Descartes 08, F-75743 Paris 15, France; [Mirek, Sebastien] CHU Dijon, Serv Anesthesie Reanimat, Dijon, France; [Proust, Francois] CHU Strasbourg, Serv Neurochirurgie, Hop Hautepierre, F-67098 Strasbourg, France; [Tazarourte, Karim] Hop Edouard Herriot, Hosp civils Lyon, SAMU SMUR Serv Urgences, F-69437 Lyon 03, France		Geeraerts, T (corresponding author), CHU Toulouse, Pole Anesthesie Reanimat, F-31059 Toulouse 9, France.	geeraerts.t@chu-toulouse.fr	Payen, Jean-Francois/L-6667-2014; Meyer, Philippe/ABE-4242-2020; Bouzat, Pierre/L-6881-2014; Bouzat, Pierre/AAC-4105-2019; cotton, francois/F-4762-2013; David, Jean Stephane/H-9399-2019	Meyer, Philippe/0000-0002-3829-6631; Bouzat, Pierre/0000-0003-4667-6738; cotton, francois/0000-0003-0046-2478; David, Jean Stephane/0000-0001-6274-7044; Orliaguet, Gilles/0000-0003-0930-2251; GERGELE, Laurent/0000-0002-7283-6793; tazarourte, karim/0000-0002-3376-1258; Srairi, Mohamed/0000-0001-7219-501X			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS5; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Algarra NN, 2016, J NEUROSURG ANESTHES; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Ananda A, 1999, ACTA NEUROCHIR SUPPL, V73, P99; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 1999, Ann Fr Anesth Reanim, V18, P15; [Anonymous], 2008, GUIDELINES MILD TRAU; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Augustes R, 2011, ANAESTH INTENS CARE, V39, P401, DOI 10.1177/0310057X1103900310; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 1999, DEV MED CHILD NEUROL, V41, P220, DOI 10.1017/S0012162299000481; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bechir M, 2010, MINERVA ANESTESIOL, V76, P896; Behrens A, 2011, NEUROSURGERY, V69, pE1033, DOI 10.1227/NEU.0b013e31822999b7; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Caballero G Christina, 2013, Hosp Pharm, V48, P757, DOI 10.1310/hpj4809-757; Caputo ND, 2014, J TRAUMA ACUTE CARE, V77, P534, DOI 10.1097/TA.0000000000000414; Cariou A, 2017, ANAESTH CRIT CARE PA; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Caterino JM, 2012, EMERG MED J, V29, P492, DOI 10.1136/emj.2010.110437; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cinotti R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0498-9; CLARK WC, 1989, NEUROSURGERY, V25, P20; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; Densmore JC, 2006, J PEDIATR SURG, V41, P92, DOI 10.1016/j.jpedsurg.2005.10.013; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Duranteau J, 2015, ANESTH REANIM, V1, P62, DOI 10.1016/j.anrea.2014.12.007; Egerod I, 2010, CRIT CARE, V14, DOI 10.1186/cc8978; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Flierl MA, 2010, J ORTHOP TRAUMA, V24, P107, DOI 10.1097/BOT.0b013e3181b6bdfc; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Ghajar J, 1995, New Horiz, V3, P395; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; GIULIONI M, 1988, NEUROSURGERY, V22, P807, DOI 10.1227/00006123-198805000-00001; Goyal A, 2012, J NEUROTRAUMA; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Gura M, 2011, TURK NEUROSURG, V21, P210, DOI 10.5137/1019-5149.JTN.3574-10.1; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Hara M, 1998, NEUROL RES, V20, P225, DOI 10.1080/01616412.1998.11740510; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; HUANG MS, 1995, J TRAUMA, V38, P154, DOI 10.1097/00005373-199501000-00035; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Huang YH, 2015, SEIZURE-EUR J EPILEP, V25, P150, DOI 10.1016/j.seizure.2014.10.008; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hulka F, 1997, J TRAUMA, V42, P514, DOI 10.1097/00005373-199703000-00020; Hutchinson PJ, 2016, N ENGL J MED; Ilves P, 2010, ACTA PAEDIATR, V99, P1329, DOI 10.1111/j.1651-2227.2010.01820.x; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jakola AS, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.08.021; Javouhey E, 2009, PEDIATR CRIT CARE ME, V10, P472, DOI 10.1097/PCC.0b013e318198b1cb; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jiang LB, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0054-2; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kapapa T, 2010, J CHILD NEUROL, V25, P274, DOI 10.1177/0883073809332699; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Kim DR, 2014, J KOREAN NEUROSURG S, V55, P26, DOI 10.3340/jkns.2014.55.1.26; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kosty JA, 2013, ANESTH ANALG, V117, P694, DOI 10.1213/ANE.0b013e31829cc765; Kouvarellis AJ, 2011, CHILD NERV SYST, V27, P1139, DOI 10.1007/s00381-011-1464-3; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Ma CY, 2010, CHIN J TRAUMATOL, V13, P293, DOI 10.3760/cma.j.issn.1008-1275.2010.05.008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maguire M, 2010, J TRAUMA, V68, P250, DOI 10.1097/TA.0b013e3181c45479; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Matsushima K, 2012, J CRIT CARE, V27, P125, DOI 10.1016/j.jcrc.2011.08.012; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; Mondello S, 2011, NEUROSURG; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mrozek S, 2013, ANN FR ANESTH, V32, P510, DOI 10.1016/j.annfar.2013.07.010; Mrozek S, 2014, CRIT CARE, V18, DOI 10.1186/cc13841; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; NAKAYAMA DK, 1992, J PEDIATR SURG, V27, P427, DOI 10.1016/0022-3468(92)90328-5; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; NICE, 2014, HEAD INJ ASS EARL MA; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Orliaguet G, 2001, INTENS CARE MED, V27, P743, DOI 10.1007/s001340100905; Osler TM, 2001, J TRAUMA, V50, P96, DOI 10.1097/00005373-200101000-00017; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; Oyetunji TA, 2011, AM J SURG, V201, P445, DOI 10.1016/j.amjsurg.2010.10.006; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; Parks Nancy A, 2012, Adv Surg, V46, P205; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Paulus EM, 2014, J TRAUMA ACUTE CARE, V76, P279, DOI 10.1097/TA.0000000000000101; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pepe Paul E, 2004, Crit Care Med, V32, pS414, DOI 10.1097/01.CCM.0000134264.88332.37; Pepe PE, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0808-x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Poca MA, 1998, ACT NEUR S, V71, P27; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Pracht EE, 2008, J PEDIATR SURG, V43, P212, DOI 10.1016/j.jpedsurg.2007.09.047; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Ramakrishnan Vivek, 2015, Surg Neurol Int, V6, P8, DOI 10.4103/2152-7806.149613; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Ratanalert S, 2002, J CLIN NEUROSCI, V9, P640, DOI 10.1054/jocn.2002.1085; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; REYNOLDS MA, 1995, ANN SURG, V222, P470; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roberts DJ, 2013, ANN SURG, V257, P621, DOI 10.1097/SLA.0b013e318288c514; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rossi-Mossuti F, 2016, J NEUROL SURG PART A, V77, P36, DOI 10.1055/s-0035-1563556; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; SADHU VK, 1979, RADIOLOGY, V133, P507, DOI 10.1148/133.2.507; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shea Kenneth, 2012, Emerg Med Pract, V14, P1; Sierink JC, 2012, BRIT J SURG, V99, P52, DOI 10.1002/bjs.7760; Sigurta A, 2013, INTENS CARE MED, V39, P129, DOI 10.1007/s00134-012-2748-0; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Sonneville R, 2015, INTENS CARE MED, V41, P192, DOI 10.1007/s00134-014-3577-0; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1983, LANCET, V2, P678; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; THOMAS D G T, 1978, Lancet, V1, P113; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vernon DD, 2005, PEDIATR EMERG CARE, V21, P18, DOI 10.1097/01.pec.0000150983.96357.83; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wakerley BR, 2015, J NEUROIMAGING, V25, P111, DOI 10.1111/jon.12100; Wang NE, 2013, J TRAUMA ACUTE CARE, V75, P704, DOI 10.1097/TA.0b013e31829a0a65; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Wells DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11678; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; Yu A, 2013, CRIT CARE MED, V41, P2002, DOI 10.1097/CCM.0b013e31828e96c0; Yuan Q, 2013, BRAIN INJURY, V27, P664, DOI 10.3109/02699052.2013.775497; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30; Zhao HX, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0100-7	304	52	55	3	15	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2352-5568			ANAESTH CRIT CARE PA	Anaesth. Crit. Care Pain Med.	APR	2018	37	2					171	186		10.1016/j.accpm.2017.12.001			16	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	GA8WW	WOS:000428623300015	29288841	Green Published, hybrid			2022-02-06	
J	Mouzon, BC; Bachmeier, C; Ojo, JO; Acker, CM; Ferguson, S; Paris, D; Ait-Ghezala, G; Crynen, G; Davies, P; Mullan, M; Stewart, W; Crawford, F				Mouzon, Benoit C.; Bachmeier, Corbin; Ojo, Joseph O.; Acker, Christopher M.; Ferguson, Scott; Paris, Daniel; Ait-Ghezala, Ghania; Crynen, Gogce; Davies, Peter; Mullan, Michael; Stewart, William; Crawford, Fiona			Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							FOOTBALL LEAGUE PLAYERS; MOUSE MODEL; COGNITIVE DYSFUNCTION; HIPPOCAMPAL-LESIONS; RECOGNITION MEMORY; HEAD-INJURY; OBJECT RECOGNITION; SILENT EPIDEMIC; ENCEPHALOPATHY; TAU	Objective Exposure to repetitive concussion, or mild traumatic brain injury (mTBI), has been linked with increased risk of long-term neurodegenerative changes, specifically chronic traumatic encephalopathy (CTE). To date, preclinical studies largely have focused on the immediate aftermath of mTBI, with no literature on the lifelong consequences of mTBI in these models. This study provides the first account of lifelong neurobehavioral and histological consequences of repetitive mTBI providing unique insight into the constellation of evolving and ongoing pathologies with late survival. Methods Male C57BL/6J mice (aged 2-3months) were exposed to either single or repetitive mild TBI or sham procedure. Thereafter, animals were monitored and assessed at 24months post last injury for measures of motor coordination, learning deficits, cognitive function, and anxiety-like behavior prior to euthanasia and preparation of the brains for detailed neuropathological and protein biochemical studies. Results At 24months survival animals exposed to r-mTBI showed clear evidence of learning and working memory impairment with a lack of spatial memory and vestibule-motor vestibulomotor deficits compared to sham animals. Associated with these late behavioral deficits there was evidence of ongoing axonal degeneration and neuroinflammation in subcortical white matter tracts. Notably, these changes were also observed after a single mTBI, albeit to a lesser degree than repetitive mTBI. Interpretation In this context, our current data demonstrate, for the first time, that rather than an acute, time limited event, mild TBI can precipitate a lifelong degenerative process. These data therefore suggest that successful treatment strategies should consider both the acute and chronic nature of mTBI.	[Mouzon, Benoit C.; Bachmeier, Corbin; Ojo, Joseph O.; Ferguson, Scott; Paris, Daniel; Ait-Ghezala, Ghania; Crynen, Gogce; Mullan, Michael; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Mouzon, Benoit C.; Bachmeier, Corbin; Ojo, Joseph O.; Ferguson, Scott; Paris, Daniel; Ait-Ghezala, Ghania; Crynen, Gogce; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Mouzon, Benoit C.; Bachmeier, Corbin; Paris, Daniel; Ait-Ghezala, Ghania; Crynen, Gogce; Crawford, Fiona] Open Univ, Milton Keynes, Bucks, England; [Acker, Christopher M.; Davies, Peter] Feinstein Inst Med Res, Manhasset, NY USA; [Stewart, William] Queen Elizabeth Glasgow Univ Hosp, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Glasgow, Lanark, Scotland		Mouzon, BC (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	bmouzon@roskampinstitute.org		Stewart, William/0000-0003-2199-2582; Ait-Ghezala, Ghania/0000-0002-9836-8617; Crynen, Gogce/0000-0001-6066-9900	Department of Defense awardUnited States Department of Defense [W81XWH-10-1-0759]; Roskamp Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS094003]; DODUnited States Department of Defense [PT110785]; NHS Research Scotland Career Researched Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS038104] Funding Source: NIH RePORTER	This research was funded by a Department of Defense award (W81XWH-10-1-0759) to Dr. Fiona Crawford, and by the Roskamp Foundation. Dr. Crawford is a VA Research Career Scientist. Dr. Stewart is supported by NIH grants NS038104 & NS094003, DOD grant PT110785 and an NHS Research Scotland Career Researched Fellowship. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Clark RE, 2000, J NEUROSCI, V20, P8853; DE BL, 2009, BRAIN 3, V132, P695; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Forwood SE, 2005, HIPPOCAMPUS, V15, P347, DOI 10.1002/hipo.20059; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Good MA, 2007, BEHAV NEUROSCI, V121, P218, DOI 10.1037/0735-7044.121.1.218; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Paris D, 2014, J BIOL CHEM, V289, P33927, DOI 10.1074/jbc.M114.608091; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Roberts G, 1969, BRAIN DAMAGE BOXERS; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134	51	52	52	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JAN	2018	5	1					64	80		10.1002/acn3.510			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS8LX	WOS:000422664400007	29376093	Green Published, Green Accepted, gold			2022-02-06	
J	McGlinchey, RE; Milberg, WP; Fonda, JR; Fortier, CB				McGlinchey, Regina E.; Milberg, William P.; Fonda, Jennifer R.; Fortier, Catherine Brawn			A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: The TRACTS longitudinal prospective cohort study	INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH			English	Article						blast; co-morbidity; concussion; neuroimaging; post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; REDUCED CORTICAL THICKNESS; MENTAL-HEALTH PROBLEMS; BRAIN-INJURY; BLAST EXPOSURE; BOSTON ASSESSMENT; PTSD; COMBAT; SYMPTOMS	Many US veterans of Afghanistan and Iraq have multiple physical and psychiatric problems. A major focus of research has been on determining the effects of mild Traumatic Brain Injury (mTBI), but mTBI is rarely diagnosed in the absence of co-occurring conditions such as blast exposure, post-traumatic stress disorder (PTSD), depression, substance abuse, etc. These potentially interactive psychological and physical conditions produce complex patterns of cognitive, psychological, and physical symptoms that impede civilian reintegration and complicate efficient and effective treatment planning. The Translational Research Center for TBI and Stress Disorders (TRACTS) has developed a multidisciplinary approach to the assessment of deployment trauma and its consequences in veterans of these wars. The prospective TRACTS longitudinal cohort study conducts state-of-the-art assessments in the domains of biomedical function, lifetime head trauma, psychological function encompassing deployment experience and lifetime exposure to traumatic events, neuropsychological function, and structural and functional neuroimaging. The TRACTS longitudinal cohort study is the first of its kind to comprehensively evaluate lifetime incidence of TBI and PTSD in these veterans, in addition to those incurred during military deployment. The protocol has begun to reveal information that will help improve understanding of the complex pathophysiology associated with co-occurring mTBI and related stress disorders.	[McGlinchey, Regina E.; Milberg, William P.; Fonda, Jennifer R.; Fortier, Catherine Brawn] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [McGlinchey, Regina E.; Milberg, William P.; Fonda, Jennifer R.; Fortier, Catherine Brawn] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [McGlinchey, Regina E.; Milberg, William P.; Fortier, Catherine Brawn] Harvard Med Sch, Dept Psychiat, Boston, MA USA		McGlinchey, RE (corresponding author), VA Boston Healthcare Syst, GRECC TRACTS 182 JP, 150 South Huntington Ave, Boston, MA 02130 USA.	regina_mcglinchey@hms.harvard.edu	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B9254-C]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AT009430] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I50RX003001, I01CX001327] Funding Source: NIH RePORTER	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (B9254-C)	Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Benedict R., 1997, BRIEF VISUOSPATIAL M; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis D., 2001, D KEFS EXAMINERS TEC; Delis D.C., 2000, CALIFORNIA VERBAL LE; Esterman M, 2013, J INT NEUROPSYCH SOC, V19, P835, DOI 10.1017/S135561771300057X; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gibbon M., 1997, USERS GUIDE STRUCTUR; Green P, 2004, GREENS MED SYMPTOM V; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Henry GK, 2005, CLIN NEUROPSYCHOL, V19, P121, DOI 10.1080/13854040490516604; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kansagara D., 2013, COMPLICATIONS MILD T; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Maksimovskiy Arkadiy L, 2014, J Alcohol Drug Depend, V2, P144; McGlinchey R. E., 2016, 11 WORLD C BRAIN INJ; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Miller MW, 2015, PSYCHONEUROENDOCRINO, V62, P359, DOI 10.1016/j.psyneuen.2015.09.003; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Pickering TG, 2005, HYPERTENSION, V45, P142, DOI 10.1161/01.HYP.0000150859.47929.8e; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Sadeh N, 2016, MOL PSYCHIATR, V21, P357, DOI 10.1038/mp.2015.134; Sadeh N, 2016, Mol Psychiatry, V21, P299, DOI 10.1038/mp.2016.10; Sadeh N, 2015, HUM BRAIN MAPP, V36, P3076, DOI 10.1002/hbm.22829; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tiffen J., 1968, PURDUE PEGBOARD EXAM; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun T, 2010, MEASURING HLTH DISAB; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Warrington E. K., 1991, VISUAL OBJECT SPACE; Weathers FW, 1991, PCL C FOR DSM 4; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Wolf EJ, 2016, BIOL PSYCHIAT, V80, P363, DOI 10.1016/j.biopsych.2015.11.023; Wolf EJ, 2016, PSYCHONEUROENDOCRINO, V63, P155, DOI 10.1016/j.psyneuen.2015.09.020; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	64	52	53	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8931	1557-0657		INT J METH PSYCH RES	Int. J. Methods Psychiatr. Res.	SEP	2017	26	3							e1556	10.1002/mpr.1556			15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FI2RF	WOS:000411789400010	28211592	Green Accepted, Green Published			2022-02-06	
J	Ganpule, S; Daphalapurkar, NP; Ramesh, KT; Knutsen, AK; Pham, DL; Bayly, PV; Prince, JL				Ganpule, Shailesh; Daphalapurkar, Nitin P.; Ramesh, Kaliat T.; Knutsen, Andrew K.; Pham, Dzung L.; Bayly, Philip V.; Prince, Jerry L.			A Three-Dimensional Computational Human Head Model That Captures Live Human Brain Dynamics	JOURNAL OF NEUROTRAUMA			English	Article						computational head model; DAI; human brain deformation	SPORTS-RELATED CONCUSSION; MATERIAL POINT METHOD; WHITE-MATTER; MECHANICAL-PROPERTIES; SOLID MECHANICS; AXONAL DAMAGE; FE MODEL; INJURY; TISSUE; IMPACT	Diffuse axonal injury (DAI) is a debilitating consequence of traumatic brain injury (TBI) attributed to abnormal stretching of axons caused by blunt head trauma or acceleration of the head. We developed an anatomically accurate, subjectspecific, three-dimensional (3D) computational model of the human brain, and used it to study the dynamic deformations in the substructures of the brain when the head is subjected to rotational accelerations. The computational head models use anatomy and morphology of the white matter fibers obtained using MRI. Subject-specific full-field shearing motions in live human brains obtained through a recently developed tagged MRI imaging technique are then used to validate the models by comparing the measured and predicted heterogeneous dynamic mechanical response of the brain. These results are used to elucidate the dynamics of local shearing deformations in the brain substructures caused by rotational acceleration of the head. Our work demonstrates that the rotational dynamics of the brain has a timescale of similar to 100 ms as determined by the shearing wave speeds, and thus the injuries associated with rotational accelerations likely occur over these time scales. After subject-specific validation using the live human subject data, a representative subject-specific head model is used to simulate a real life scenario that resulted in a concussive injury. Results suggest that regions of the brain, in the form of a toroid, encompassing the white matter, the cortical gray matter, and outer parts of the limbic system have a higher susceptibility to injury under axial rotations of the head.	[Ganpule, Shailesh; Daphalapurkar, Nitin P.; Ramesh, Kaliat T.] Johns Hopkins Univ, Hopkins Extreme Mat Inst, Baltimore, MD 21218 USA; [Knutsen, Andrew K.; Pham, Dzung L.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Bayly, Philip V.] Washington Univ, Dept Mech Engn, St Louis, MO 63130 USA; [Prince, Jerry L.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA		Ganpule, S (corresponding author), Johns Hopkins Univ, Hopkins Extreme Mat Inst, Baltimore, MD 21218 USA.	sganpull@jhu.edu	Pham, Dzung/AAR-8263-2020; Ramesh, KT/D-5451-2009; Daphalapurkar, Nitin/B-4397-2011	Ramesh, KT/0000-0003-2659-4698; Daphalapurkar, Nitin/0000-0001-5523-8874	National Institute of Neurological Disorders and Strokes, National Institutes of Health [R01NS055951]; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	S.G. acknowledges Dr. Fangxu Xing for useful discussions regarding the HARP algorithm, and Amy Dagro for assistance in proofreading the manuscript. The authors acknowledge funding from the National Institute of Neurological Disorders and Strokes, National Institutes of Health (Project # R01NS055951). This work was partially supported by the Department of Defense in the Center for Neuroscience and Regenerative Medicine.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bardenhagen SG, 2002, J COMPUT PHYS, V180, P383, DOI 10.1006/jcph.2002.7103; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazin PL, 2008, MED IMAGE ANAL, V12, P616, DOI 10.1016/j.media.2008.06.008; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cole RH, 1948, PHYS TODAY, V1, P35, DOI [10.1063/1.3066176, DOI 10.1063/1.3066176]; Daphalapurkar NP, 2008, MECH ADV MATER STRUC, V15, P594, DOI 10.1080/15376490802470523; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fung Y.C., 2013, BIOMECHANICS MECH PR; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Garo A, 2007, BIORHEOLOGY, V44, P51; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Guilkey JE, 2006, J BIOMECH, V39, P2074, DOI 10.1016/j.jbiomech.2005.06.017; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ionescu I, 2006, J BIOMECH ENG-T ASME, V128, P917, DOI 10.1115/1.2372490; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nairn JA, 2003, CMES-COMP MODEL ENG, V4, P649; Newman J A, 2000, Stapp Car Crash J, V44, P215; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; PIERPAOLI C, 2010, ISMRM P, V18, P1597; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Sadeghirad A, 2011, INT J NUMER METH ENG, V86, P1435, DOI 10.1002/nme.3110; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stalnaker R. L, 1969, THESIS; Sulsky D, 2004, EUR J MECH A-SOLID, V23, P423, DOI 10.1016/j.euromechsol.2004.02.007; SULSKY D, 1995, COMPUT PHYS COMMUN, V87, P236, DOI 10.1016/0010-4655(94)00170-7; Takhounts EG, 2008, STAPP CAR C, V52, P1; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Willmott CJ, 2012, INT J CLIMATOL, V32, P2088, DOI 10.1002/joc.2419; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	71	52	53	2	28	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2017	34	13					2154	2166		10.1089/neu.2016.4744			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ2HM	WOS:000404530400454	28394205	Green Published			2022-02-06	
J	Hazeldine, J; Naumann, DN; Toman, E; Davies, D; Bishop, JRB; Su, ZJ; Hampson, P; Dinsdale, RJ; Crombie, N; Duggal, NA; Harrison, P; Belli, A; Lord, JM				Hazeldine, Jon; Naumann, David N.; Toman, Emma; Davies, David; Bishop, Jonathan R. B.; Su, Zhangjie; Hampson, Peter; Dinsdale, Robert J.; Crombie, Nicholas; Duggal, Niharika Arora; Harrison, Paul; Belli, Antonio; Lord, Janet M.			Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study	PLOS MEDICINE			English	Article							MAJOR TRAUMA; BRAIN-INJURY; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; INFLAMMATORY RESPONSE; OXIDASE COMPONENTS; MOLECULAR-PATTERNS; SUPPRESSOR-CELLS; BURN INJURY; LATE-ONSET	Background Almost all studies that have investigated the immune response to trauma have analysed blood samples acquired post-hospital admission. Thus, we know little of the immune status of patients in the immediate postinjury phase and how this might influence patient outcomes. The objective of this study was therefore to comprehensively assess the ultra-early, within 1-hour, immune response to trauma and perform an exploratory analysis of its relationship with the development of multiple organ dysfunction syndrome (MODS). Methods and findings The immune and inflammatory response to trauma was analysed in 89 adult trauma patients (mean age 41 years, range 18-90 years, 75 males) with a mean injury severity score (ISS) of 24 (range 9-66), from whom blood samples were acquired within 1 hour of injury (mean time to sample 42 minutes, range 17-60 minutes). Within minutes of trauma, a comprehensive leukocytosis, elevated serum pro-and anti-inflammatory cytokines, and evidence of innate cell activation that included neutrophil extracellular trap generation and elevated surface expression of toll-like receptor 2 and CD11b on monocytes and neutrophils, respectively, were observed. Features consistent with immune compromise were also detected, notably elevated numbers of immune suppressive CD16(BRIGHT) CD62L(DIM) neutrophils (82.07 x 10(6)/l +/- 18.94 control versus 1,092 x 10(6)/l +/- 165 trauma, p < 0.0005) and CD14(+)HLA-DRlow/- monocytes (34.96 x 10(6)/l +/- 4.48 control versus 95.72 x 10(6)/l +/- 8.0 trauma, p < 0.05) and reduced leukocyte cytokine secretion in response to lipopolysaccharide stimulation. Exploratory analysis via binary logistic regression found a potential association between absolute natural killer T (NKT) cell numbers and the subsequent development of MODS. Study limitations include the relatively small sample size and the absence of data relating to adaptive immune cell function. Conclusions Our study highlighted the dynamic and complex nature of the immune response to trauma, with immune alterations consistent with both activation and suppression evident within 1 hour of injury. The relationship of these changes, especially in NKT cell numbers, to patient outcomes such as MODS warrants further investigation.	[Hazeldine, Jon; Hampson, Peter; Dinsdale, Robert J.; Crombie, Nicholas; Duggal, Niharika Arora; Harrison, Paul; Belli, Antonio; Lord, Janet M.] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Hazeldine, Jon; Naumann, David N.; Toman, Emma; Davies, David; Bishop, Jonathan R. B.; Su, Zhangjie; Belli, Antonio; Lord, Janet M.] Queen Elizabeth Hosp Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Hampson, Peter; Dinsdale, Robert J.; Harrison, Paul] Scar Free Fdn, Birmingham Ctr Burns Res, Birmingham, W Midlands, England; [Crombie, Nicholas] Midlands Air Ambulance, Unit 16 Enterprise Trading Estate, Brierley Hill, W Midlands, England		Hazeldine, J (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England.; Hazeldine, J (corresponding author), Queen Elizabeth Hosp Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England.	j.hazeldine@bham.ac.uk	Harrison, Paul/AAN-1916-2021; Naumann, David/S-9917-2019; Belli, Antonio/I-3799-2015; Hazeldine, Jon/T-5725-2019	Harrison, Paul/0000-0003-4610-8909; Naumann, David/0000-0003-2243-2325; Belli, Antonio/0000-0002-3211-9933; Bishop, Jonathan/0000-0003-1789-5886; Lord, Janet/0000-0003-1030-6786; A Duggal, Niharika/0000-0003-4459-4632	National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre; Department of Health and Ministry of Defence; Scar Free Foundation Birmingham Burns Research Centre, which is part of the Burns Collective within the Scar Free Foundation; RoseTrees TrustRosetrees Trust [DTAA.RDBU18237]; Medical Neuroscience Teaching and Research Fund [DTAA.RCLG19305]; Queen Elizabeth Hospital Birmingham Charity; Rosetrees TrustRosetrees Trust [M382] Funding Source: researchfish	For funding this research, the authors acknowledge the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre, which is joint funded by the Department of Health and Ministry of Defence (http://www.nihr.ac.uk; JH, DNN, ET, DD, JRBB, ZS, NC, AB, and JML), the Scar Free Foundation Birmingham Burns Research Centre, which is part of the Burns Collective within the Scar Free Foundation (www.scarfree.org.uk; PHam, RJD, and PHar), the RoseTrees Trust (www.rosetreestrust.co.uk; JH, AB, and JML; grant number, DTAA.RDBU18237), and the Medical Neuroscience Teaching and Research Fund (https://sites.google.com/site/mntrfund/; JH, AB, and JML; grant number, DTAA.RCLG19305). The authors would also like to acknowledge the Queen Elizabeth Hospital Birmingham Charity for funding the purchase of the Sysmex XN-1000 haematology analyser (https://www.qehb.org; PHar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja R, 2006, J IMMUNOL, V177, P7184, DOI 10.4049/jimmunol.177.10.7184; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Cheron A, 2010, CRIT CARE, V14, DOI 10.1186/cc9331; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Cuschieri J, 2010, SHOCK, V34, P346, DOI 10.1097/SHK.0b013e3181d8e687; Drifte G, 2013, CRIT CARE MED, V41, P820, DOI 10.1097/CCM.0b013e318274647d; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Giannoudis PV, 2003, INJURY, V34, P397, DOI 10.1016/S0020-1383(02)00416-3; Gouel-Cheron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033095; Hampson P., 2016, ANN SURG; Hazeldine J, 2016, BURNS TRAUMA, V4, DOI 10.1186/s41038-016-0059-3; Hietbrink F, 2013, SHOCK, V40, P21, DOI 10.1097/SHK.0b013e318295a40a; Hirose T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111755; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Huang H, 2015, HEPATOLOGY, V62, P600, DOI 10.1002/hep.27841; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Junger WG, 2013, SHOCK, V40, P366, DOI 10.1097/SHK.0000000000000038; Kasten KR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-4; Kirchhoff C, 2009, CRIT CARE, V13, DOI 10.1186/cc7914; Kraft R, 2015, SHOCK, V43, P222, DOI 10.1097/SHK.0000000000000294; Laborde RR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00147; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; Li HP, 2015, J TRAUMA ACUTE CARE, V78, P272, DOI 10.1097/TA.0000000000000509; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Manson J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1341-2; Marks W, 2013, CENT EUR J IMMUNOL, V38, P494, DOI 10.5114/ceji.2013.39767; Muszynski JA, 2014, SHOCK, V42, P313, DOI 10.1097/SHK.0000000000000217; Nakagawa M, 1998, CIRCULATION, V98, P2307, DOI 10.1161/01.CIR.98.21.2307; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; Orr SK, 2015, CRIT CARE MED, V43, P2642, DOI 10.1097/CCM.0000000000001312; Perez-Barcena J, 2010, ANN SURG, V251, P521, DOI 10.1097/SLA.0b013e3181cc8f84; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rainer TH, 2001, RESUSCITATION, V51, P139, DOI 10.1016/S0300-9572(01)00409-9; Rosenthal J, 1996, BLOOD, V88, P4321; Sauce D, 2017, J GERONTOL A-BIOL, V72, P163, DOI 10.1093/gerona/glw062; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tarlowe MH, 2003, J IMMUNOL, V171, P2066, DOI 10.4049/jimmunol.171.4.2066; Timmermans K, 2016, INTENS CARE MED, V42, P551, DOI 10.1007/s00134-015-4205-3; Torrance HDT, 2015, ANN SURG, V261, P751, DOI 10.1097/SLA.0000000000000653; Torrance HDT, 2015, J TRAUMA ACUTE CARE, V78, P535, DOI 10.1097/TA.0000000000000534; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Visser T, 2011, EUR J TRAUMA EMERG S, V37, P177, DOI 10.1007/s00068-010-0041-x; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; West SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052406; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Xiu B, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.56	59	52	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1676			PLOS MED	PLos Med.	JUL	2017	14	7							e1002338	10.1371/journal.pmed.1002338			29	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1QA	WOS:000406611200008	28719602	Green Published, Green Submitted, gold, Green Accepted			2022-02-06	
J	Zemek, RL; Grool, AM; Duque, DR; DeMatteo, C; Rothman, L; Benchimol, EI; Guttmann, A; Macpherson, AK				Zemek, Roger L.; Grool, Anne M.; Duque, Daniel Rodriguez; DeMatteo, Carol; Rothman, Linda; Benchimol, Eric I.; Guttmann, Astrid; Macpherson, Alison K.			Annual and Seasonal Trends in Ambulatory Visits for Pediatric Concussion in Ontario between 2003 and 2013	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURIES; EMERGENCY-DEPARTMENTS; SPORTS; CHILDREN; EPIDEMIOLOGY; STATEMENT; SYMPTOMS; SCHOOL; RISK; HEAD	Objective To investigate annual and seasonal trends in physician office and emergency department (ED) visit rates for pediatric concussion in Ontario between 2003 and 2013. Study design A retrospective, population-based study was conducted using linked health administrative data from all concussion-related visits to ED and physician office by children aged 5 through 18 years. Time series analysis was used to assess whether periodic components exist in the monthly number of concussion-related visits. Results Over the 11-year study period, there were 176 685 pediatric visits for concussion in EDs and physician offices in Ontario. Standardized concussion-related visits showed a 4.4-fold (95% CI 4.37-4.45) increase per 100 000 from 2003 to 2013, with nearly 35 000 total visits in 2013. Concussion-related visits demonstrated a steep increase from 2010 onward. The greatest increases in standardized visits were in females (6.3-fold, 95% CI 6.236.46 vs 3.6-fold, 95% CI 3.56-3.64 in males) and 13-18.99 year olds (5.0-fold, 95% CI 4.93-5.08 vs 4.1- fold, 95% CI 3.99-4.27 in 9-12 years and 2.3-fold, 95% CI 2.23-2.42 in 5-8 years). A strong seasonal variability (R(2)autoreg = 0.87, P < .01) in the number of concussion-related visits was present, with most occurring in fall and winter. Conclusions Pediatric concussion-related ED and physician office visit rates have greatly increased in the last decade, particularly since 2010. Prevention strategies may be targeted at those most at risk and at seasonalrelated activities carrying the greatest risk of concussion.	[Zemek, Roger L.] Univ Ottawa, Dept Pediat, Div Pediat Emergency Med, Ottawa, ON, Canada; [Zemek, Roger L.; Grool, Anne M.; Benchimol, Eric I.] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Duque, Daniel Rodriguez; Benchimol, Eric I.; Guttmann, Astrid; Macpherson, Alison K.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Rothman, Linda; Macpherson, Alison K.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Benchimol, Eric I.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Ottawa, ON, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada		Zemek, RL (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Benchimol, Eric/A-7711-2010; Zemek, Roger/H-1039-2018	Benchimol, Eric/0000-0001-8855-3598; 	CIHRCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; BEST DJ, 1974, ROY STAT SOC C-APP, V23, P98; Carroll L J, 2011, CONCUSSION CRISIS AN; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Ghysels E., 2001, ECONOMETRIC ANAL SEA; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod AI, 2011, Kendall: Kendall rank correlation and Mann-Kendall trend test; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; MOINEDDIN R, 2003, POPUL HEALTH METR, V1, DOI DOI 10.1186/1478-7954-1-10; Morrissey D, 2014, J TRAUMA ACUTE CARE, V77, pS8, DOI 10.1097/TA.0000000000000331; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	30	52	52	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2017	181						222	+		10.1016/j.jpeds.2016.10.067			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	EN8KL	WOS:000396249200035	27843008				2022-02-06	
J	Molet, J; Maras, PM; Kinney-Lang, E; Harris, NG; Rashid, F; Ivy, AS; Solodkin, A; Obenaus, A; Baram, TZ				Molet, Jenny; Maras, Pamela M.; Kinney-Lang, Eli; Harris, Neil G.; Rashid, Faisal; Ivy, Autumn S.; Solodkin, Ana; Obenaus, Andre; Baram, Tallie Z.			MRI uncovers disrupted hippocampal microstructure that underlies memory impairments after early-life adversity	HIPPOCAMPUS			English	Article						early-life stress; cognitive vulnerabilities; brain networks; magnetic resonance imaging (MRI); diffusion tensor imaging (DTI)	CORTICOTROPIN-RELEASING HORMONE; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MOUSE-BRAIN; CHILDHOOD MALTREATMENT; AMYGDALA VOLUMES; DENDRITIC SPINES; TEMPORAL-LOBE; SEXUAL-ABUSE; IN-VIVO	Memory and related cognitive functions are progressively impaired in a subgroup of individuals experiencing childhood adversity and stress. However, it is not possible to identify vulnerable individuals early, a crucial step for intervention. In this study, high-resolution magnetic resonance imaging (MRI) and intra-hippocampal diffusion tensor imaging (DTI) were employed to examine for structural signatures of cognitive adolescent vulnerabilities in a rodent model of early-life adversity. These methods were complemented by neuroanatomical and functional assessments of hippocampal network integrity during adolescence, adulthood and middle-age. The high-resolution MRI identified selective loss of dorsal hippocampal volume, and intra-hippocampal DTI uncovered disruption of dendritic structure, consistent with disrupted local connectivity, already during late adolescence in adversity-experiencing rats. Memory deteriorated over time, and stunting of hippocampal dendritic trees was apparent on neuroanatomical analyses. Thus, disrupted hippocampal neuronal structure and connectivity, associated with cognitive impairments, are detectable via non-invasive imaging modalities in rats experiencing early-life adversity. These high-resolution imaging approaches may constitute promising tools for prediction and assessment of at-risk individuals in the clinic. (c) 2016 Wiley Periodicals, Inc.	[Molet, Jenny; Ivy, Autumn S.; Solodkin, Ana; Baram, Tallie Z.] UC Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Maras, Pamela M.; Kinney-Lang, Eli; Baram, Tallie Z.] UC Irvine, Dept Pediat, Irvine, CA 92697 USA; [Kinney-Lang, Eli; Rashid, Faisal; Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA; [Harris, Neil G.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Solodkin, Ana; Baram, Tallie Z.] UC Irvine, Dept Neurol, Irvine, CA 92697 USA		Molet, J (corresponding author), Univ Calif Irvine, Dept Anat, Med Sci 1,ZOT 4475, Irvine, CA 92697 USA.; Molet, J (corresponding author), Univ Calif Irvine, Dept Neurobiol, Med Sci 1,ZOT 4475, Irvine, CA 92697 USA.	jenny.molet@gmail.com		Ivy, Autumn/0000-0003-1775-6253; Harris, Neil/0000-0002-1965-6750	 [MH73136];  [NS29012];  [P50MH096889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH096889, R01MH073136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS028912] Funding Source: NIH RePORTER	Grant numbers: MH73136, NS29012, P50MH096889.	Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Ayling E, 2012, CURR PSYCHIAT REP, V14, P197, DOI 10.1007/s11920-012-0273-z; Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; Baram TZ, 2012, AM J PSYCHIAT, V169, P907, DOI 10.1176/appi.ajp.2012.11091347; Bourgin J, 2015, EUR NEUROPSYCHOPHARM, V25, P828, DOI 10.1016/j.euroneuro.2015.02.010; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Dere E, 2010, BEHAV BRAIN RES, V215, P162, DOI 10.1016/j.bbr.2010.03.017; Everson-Rose SA, 2003, AM J EPIDEMIOL, V158, P1083, DOI 10.1093/aje/kwg263; Goubran M, 2015, ANN NEUROL, V77, P237, DOI 10.1002/ana.24318; Hayes K, 2014, J NEUROSCI METH, V221, P103, DOI 10.1016/j.jneumeth.2013.09.014; Hodel AS, 2015, NEUROIMAGE, V105, P112, DOI 10.1016/j.neuroimage.2014.10.020; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Ivy AS, 2008, NEUROSCIENCE, V154, P1132, DOI 10.1016/j.neuroscience.2008.04.019; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Kantarci K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00316; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Kehoe P, 1999, HIPPOCAMPUS, V9, P651, DOI 10.1002/(SICI)1098-1063(1999)9:6<651::AID-HIPO6>3.0.CO;2-P; Keller SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046791; Kerchner GA, 2010, NEUROLOGY, V75, P1381, DOI 10.1212/WNL.0b013e3181f736a1; Kim CH, 2010, EPILEPSY RES, V90, P21, DOI 10.1016/j.eplepsyres.2010.03.002; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Lyons DM, 2001, ARCH GEN PSYCHIAT, V58, P1145, DOI 10.1001/archpsyc.58.12.1145; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Maras PM, 2014, MOL PSYCHIATR, V19, P811, DOI 10.1038/mp.2014.12; McEwen BS, 2012, DEV NEUROBIOL, V72, P878, DOI 10.1002/dneu.20968; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Molet J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.200; Molet J, 2014, DEV PSYCHOBIOL, V56, P1675, DOI 10.1002/dev.21230; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Norris FC, 2013, MAGN RESON MED, V70, P1380, DOI 10.1002/mrm.24573; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; PYCH JC, 2008, ALZHEIMERS DEMENT, V4, pT71; Qiu AQ, 2015, ANNU REV PSYCHOL, V66, P853, DOI 10.1146/annurev-psych-010814-015340; Radley JJ, 2008, J COMP NEUROL, V507, P1141, DOI 10.1002/cne.21588; Regev L, 2014, FRONT NEUROENDOCRIN, V35, P171, DOI 10.1016/j.yfrne.2013.10.001; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Schoemaker D, 2016, NEUROIMAGE, V129, P1, DOI 10.1016/j.neuroimage.2016.01.038; Segal M, 2010, HIPPOCAMPUS, V20, P1332, DOI 10.1002/hipo.20751; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHOLL DA, 1953, J ANAT, V87, P387; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; T Paus., 2009, HDB ADOLESCENT PSYCH, P95, DOI DOI 10.1002/9780470479193; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Trivedi R, 2009, NEURORADIOLOGY, V51, P567, DOI 10.1007/s00234-009-0533-8; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Haren NEM, 2004, BIOL PSYCHIAT, V56, P454, DOI 10.1016/j.biopsych.2004.06.033; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Wang XD, 2012, EUR J NEUROSCI, V36, P2360, DOI 10.1111/j.1460-9568.2012.08148.x; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Wilson RS, 2005, EXP AGING RES, V31, P393, DOI 10.1080/03610730500206683; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Zalsman G, 2015, EUR NEUROPSYCHOPHARM, V25, P2075, DOI 10.1016/j.euroneuro.2015.08.006; Zhang JY, 2002, NEUROIMAGE, V15, P892, DOI 10.1006/nimg.2001.1012	69	52	52	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	DEC	2016	26	12					1618	1632		10.1002/hipo.22661			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC9YX	WOS:000388501300013	27657911	Green Accepted, Green Submitted			2022-02-06	
J	Bhattacharya, B; Maung, A; Schuster, K; Davis, KA				Bhattacharya, Bishwajit; Maung, Adrian; Schuster, Kevin; Davis, Kimberly A.			The older they are the harder they fall: Injury patterns and outcomes by age after ground level falls	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Ground level fall; Geriatric; Outcome; Mortality	TRAUMATIC BRAIN-INJURY; GERIATRIC TRAUMA; PREINJURY WARFARIN; MORTALITY; CARE; METAANALYSIS; PREVENTION; ADULTS; IMPACT; RISK	Background: Trauma centers are seeing an increasing number of geriatric patients that are more susceptible to injuries even from relatively minor insults such as a ground level fall (GLF). As life expectancy increases, people are living in the geriatric age bracket for decades and often use anticoagulation agents for various comorbidities. We hypothesize that this patient population is not homogenous and we investigated the injury patterns and outcomes after GLF as a function of age and anticoagulation use. We also sought to identify injury patterns and patient characteristics of GLF patients. Methods: A retrospective review of a Level I trauma center's database identified all adult (age >18) trauma patients admitted after GLFs between 1/2003 and 12/2013. Demographics, injury patterns, antiplatelet use, anticoagulation use (including warfarin, enoxaparin, and rivaroxaban) and outcomes were abstracted. Results: The cohort included 5088 patients. 3990 patients were >60 years and 38.2% were male. With each decade, although the mean ISS did not considerably change (range 7.0-8.6), mortality increased (0.9% at <60 years vs. 5.5% at >90 years), and the likelihood of home discharge decreased dramatically (73.7% at <60 years vs. 18.2% at >90 years). Abdominal solid organ injuries were rare (0.8%). Age was associated with an increased incidence of cervical spine (p = 0.002), rib (p = 0.009) and pelvic fractures (p <0.001). Only aspirin use was significantly associated with intracranial bleed (p = 0.001). Aspirin (p = 0.049) or warfarin (p <0.001) use was associated with increased overall mortality. Conclusion: GLF patients are not homogenous as certain injury patterns change with increasing age. Aspirin use was associated with an increased incidence of intracranial bleeds, whereas other antiplatelet or anticoagulation agents were not. GLF is also associated with significant morbidity and mortality that increases dramatically with age. Both aspirin and warfarin are independently associated with increased mortality. These patient differences have implications for their evaluation and management. Level of evidence: Epidemiological/prognostic study level IV. Published by Elsevier Ltd.	[Bhattacharya, Bishwajit; Maung, Adrian; Schuster, Kevin; Davis, Kimberly A.] Yale Sch Med, Sect Gen Surg Trauma & Surg Crit Care, Dept Surg, New Haven, CT 06510 USA		Bhattacharya, B (corresponding author), 330 Cedar St,POB 208062, New Haven, CT 06520 USA.	bishwajit.bhattacharya@yale.edu; adrian.maung@yale.edu; kevin.schuster@yale.edu; kimberly.davis@yale.edu		Bhattacharya, Bishwajit/0000-0002-7118-7621			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Bradburn E, 2012, J TRAUMA ACUTE CARE, V73, P435, DOI 10.1097/TA.0b013e31825c7cf4; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Garwe T, 2012, AM J SURG, V204, P921, DOI 10.1016/j.amjsurg.2012.05.020; GOTTSDANKER R, 1982, J GERONTOL, V37, P342, DOI 10.1093/geronj/37.3.342; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Grove R. D., 1968, VITAL STAT RATES US; Healy DA, 2014, EMERG MED J, V31, P101, DOI 10.1136/emermed-2012-201892; Hwabejire JO, 2014, JAMA SURG, V149, P1054, DOI 10.1001/jamasurg.2014.473; Ichwan B, 2015, ANN EMERG MED, V65, P92, DOI 10.1016/j.annemergmed.2014.04.019; Mandavia D, 1998, EMERG MED CLIN N AM, V16, P257, DOI 10.1016/S0733-8627(05)70358-8; Mangram AJ, 2012, J TRAUMA ACUTE CARE, V72, P119, DOI 10.1097/TA.0b013e318241f0ba; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; National Trauma Data Bank, 2012, ANN REP AM COLL SURG; Peden M., 2002, INJURY CHART BOOK GR; Rodriguez RM, 2013, JAMA SURG, V148, P940, DOI 10.1001/jamasurg.2013.2757; Schoene D, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-107; Shaw JA, 2014, QUAL HEALTH RES, V24, P901, DOI 10.1177/1049732314539194; Sierink Joanne C, 2012, Ned Tijdschr Geneeskd, V156, pA4897; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Vincent GK., 2010, NEXT 4 DECADES OLDER, P25; Vlaeyen E, 2015, J AM GERIATR SOC, V63, P211, DOI 10.1111/jgs.13254; Yoshida G, 2014, SPINE, V39, P1121, DOI 10.1097/BRS.0000000000000360; Zafar SN, 2015, J TRAUMA ACUTE CARE, V78, P852, DOI 10.1097/TA.0000000000000557	26	52	52	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2016	47	9					1955	1959		10.1016/j.injury.2016.06.019			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DU5QG	WOS:000382265800016	27346422				2022-02-06	
J	Helmy, A; Guilfoyle, MR; Carpenter, KLH; Pickard, JD; Menon, DK; Hutchinson, PJ				Helmy, Adel; Guilfoyle, Mathew R.; Carpenter, Keri L. H.; Pickard, John D.; Menon, David K.; Hutchinson, Peter J.			Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Chemokines; brain trauma; microglia; inflammation; neurochemistry	ACUTE ISCHEMIC-STROKE; PHASE-II; MACROPHAGE ACTIVATION; HEAD-INJURY; MICE; POLARIZATION; INFLAMMATION; MCP-1; NEUROINFLAMMATION; NEUTRALIZATION	Interleukin-1 receptor antagonist (IL1ra) has demonstrated efficacy in a wide range of animal models of neuronal injury. We have previously published a randomised controlled study of IL1ra in human severe TBI, with concomitant microdialysis and plasma sampling of 42 cytokines and chemokines. In this study, we have used partial least squares discriminant analysis to model the effects of drug administration and time following injury on the cytokine milieu within the injured brain. We demonstrate that treatment with rhIL1ra causes a brain-specific modification of the cytokine and chemokine response to injury, particularly in samples from the first 48 h following injury. The magnitude of this response is dependent on the concentration of IL1ra achieved in the brain extracellular space. Chemokines related to recruitment of macrophages from the plasma compartment (MCP-1) and biasing towards a M1 microglial phenotype (GM-CSF, IL1) are increased in patient samples in the rhIL1ra-treated patients. In control patients, cytokines and chemokines biased to a M2 microglia phenotype (IL4, IL10, MDC) are relatively increased. This pattern of response suggests that a simple classification of IL1ra as an 'anti-inflammatory' cytokine may not be appropriate and highlights the importance of the microglial response to injury.	[Helmy, Adel; Guilfoyle, Mathew R.; Carpenter, Keri L. H.; Pickard, John D.; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Carpenter, Keri L. H.; Pickard, John D.; Menon, David K.; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge Biomed Campus, Cambridge, England; [Menon, David K.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge Biomed Campus, Cambridge, England		Helmy, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	adelhelmy@cantab.net	Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Hutchinson, Peter/0000-0002-2796-1835	joint Medical Research Council/Royal College of Surgeons of England Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; Raymond and Beverly Sackler Fellowships; Royal College of Surgeons of England Research Fellowship; National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); National Institute for Health Research Senior Investigator Awards; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; National Institute for Health Research Brain Repair Centre Collaborative; National Institute for Health Research Professorship; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, 79068]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025, G9439390, G1002277, G0600986, G0802251] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G9439390, G0001354, G0001354B, G1000183B, G0802251, G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, ACF-2006-14-004, NF-SI-0512-10090, NF-SI-0508-10327] Funding Source: researchfish	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: AH is supported by a joint Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (G0802251). AH and MRG are supported by Raymond and Beverly Sackler Fellowships. MRG is supported by the Royal College of Surgeons of England Research Fellowship. KLHC is supported by the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). DKM and JDP are supported by National Institute for Health Research Senior Investigator Awards. PJH is supported by the Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship, the National Institute for Health Research Brain Repair Centre Collaborative and the National Institute for Health Research Professorship. Study Support was provided by the Medical Research Council (grant number G0600986 ID 79068) and the National Institute for Health Research Brain Repair Centre Collaborative.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Babcock AA, 2003, J NEUROSCI, V23, P7922; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Cagnin A, 2007, NEUROTHERAPEUTICS, V4, P443, DOI 10.1016/j.nurt.2007.04.006; Chu HX, 2015, STROKE, V46, P1929, DOI 10.1161/STROKEAHA.115.009426; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Desforges Nicole M, 2012, Int J Alzheimers Dis, V2012, P345472, DOI 10.1155/2012/345472; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Miro-Mur F, 2015, BRAIN BEHAV IN PRESS; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; Price CJS, 2006, STROKE, V37, P1749, DOI 10.1161/01.STR.0000226980.95389.0b; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwartz M, 2009, NEUROSCIENCE, V158, P1133, DOI 10.1016/j.neuroscience.2008.12.013; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Singh N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-1; Smith CJ, 2015, EXPERT OPIN INV DRUG, V24, P623, DOI 10.1517/13543784.2015.1020110; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Stowe AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-33; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Weiclenbusch M, 2012, J INNATE IMMUN, V4, P463, DOI 10.1159/000336717; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	43	52	54	1	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2016	36	8					1434	1448		10.1177/0271678X15620204			15	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	DU3ED	WOS:000382092700010	26661249	Green Published, Green Accepted, Bronze			2022-02-06	
J	Heyer, GL; Schaffer, CE; Rose, SC; Young, JA; McNally, KA; Fischer, AN				Heyer, Geoffrey L.; Schaffer, Caroline E.; Rose, Sean C.; Young, Julie A.; McNally, Kelly A.; Fischer, Anastasia N.			Specific Factors Influence Postconcussion Symptom Duration among Youth Referred to a Sports Concussion Clinic	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; COGNITIVE IMPAIRMENT; HEAD-INJURY; RECOVERY; PREDICTORS; CHILDREN; EPIDEMIOLOGY; MANAGEMENT	Objective To identify the clinical factors that influence the duration of postconcussion symptoms among youth referred to a sports concussion clinic. Study design A retrospective cohort study was conducted to evaluate several potential predictors of symptom duration via a Cox proportional hazards analyses. The individual postconcussion symptom scores were highly correlated, so these symptoms were analyzed in the statistical model as coefficients derived from principal component analyses. Results Among 1953 youth with concussion, 1755 (89.9%) had dates of reported symptom resolution. The remainder (10.1%) were lost to follow-up and censored. The median time to recovery was 18 days (range 1-353 days). By 30 days, 72.6% had recovered; by 60 days, 91.4% had recovered; and by 90 days, 96.8% had recovered. Several variables in a multivariate Cox model predicted postconcussion symptom duration: female sex (P < .001, hazard ratio [HR] = 1.28), continued activity participation (P = .02, HR = 1.13), loss of consciousness (P = .03, HR = 1.18), anterograde amnesia (P = .04, HR = 1.15), premorbid headaches (P = .03, HR = 1.15), symptom components from the day of concussion (emotion, P = .03, HR = 1.08), and the day of clinic evaluation (cognitive-fatigue, P < .001, HR = 1.22; cephalalgic, P < .001, HR = 1.27; emotional, P = .05, HR = 1.08; arousal-stimulation, P = .003, HR = 1.1). In univariate analyses, greater symptom scores generally predicted longer symptom durations. Worsening of symptoms from the day of concussion to the day of clinic evaluation also predicted longer recovery (P < .001, HR = 1.59). Conclusions Several factors help to predict protracted postconcussion symptom durations among youth referred to a sports concussion clinic.	[Heyer, Geoffrey L.; Rose, Sean C.] Ohio State Univ, Div Pediat Neurol, Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Heyer, Geoffrey L.; Rose, Sean C.] Ohio State Univ, Dept Neurol, Columbus, OH 43205 USA; [Schaffer, Caroline E.] Clemson Univ, Dept Hlth Sci, Clemson, SC USA; [Young, Julie A.; Fischer, Anastasia N.] Ohio State Univ, Div Sports Med, Columbus, OH 43205 USA; [McNally, Kelly A.] Ohio State Univ, Div Pediat Psychol & Neuropsychol, Nationwide Childrens Hosp, Columbus, OH 43205 USA; [McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA		Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Neurol, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Ohio State Univ, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org		Rose, Sean/0000-0001-5177-7715; Heyer, Geoffrey/0000-0001-9334-3739; McNally, Kelly/0000-0001-9278-9413			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Falk AC, 2006, ACTA PAEDIATR, V95, P1533, DOI 10.1080/08035250600731957; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	39	52	52	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUL	2016	174						33	+		10.1016/j.jpeds.2016.03.014			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DP6PX	WOS:000378620800009	27056449				2022-02-06	
J	McAllister, TW; Zafonte, R; Jain, S; Flashman, LA; George, MS; Grant, GA; He, F; Lohr, JB; Andaluz, N; Summerall, L; Paulus, MP; Raman, R; Stein, MB				McAllister, Thomas W.; Zafonte, Ross; Jain, Sonia; Flashman, Laura A.; George, Mark S.; Grant, Gerald A.; He, Feng; Lohr, James B.; Andaluz, Norberto; Summerall, Lanier; Paulus, Martin P.; Raman, Rema; Stein, Murray B.			Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury	NEUROPSYCHOPHARMACOLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DEPLOYED MILITARY PERSONNEL; POSTCONCUSSIVE SYMPTOMS; PSYCHIATRIC-DISORDERS; SUICIDE RISK; DEPRESSION; IRAQ; SYMPTOMATOLOGY; AFGHANISTAN; VETERANS	We report findings from a 12-week randomized double-blinded placebo-controlled trial of methylphenidate or galantamine to treat emotional and cognitive complaints in individuals (n=32) with a history of PTSD, TBI, or both conditions. In this small pilot study, methylphenidate treatment was associated with clinically meaningful and statistically significant improvement compared with placebo on the primary outcome, a measure of cognitive complaints (Ruff Neurobehavioral Inventory-Postmorbid Cognitive Scale), as well as on the secondary outcomes reflecting post-concussive (Rivermead Post Concussive Symptom Questionnaire) and post-traumatic stress symptoms (Posttraumatic Stress Disorder Checklist). Treatment was well tolerated. These results suggest the need for a larger RCT to replicate and confirm these findings. Design considerations for such a trial should include the need for multiple sites to facilitate adequate recruitment and extension of the treatment and follow-up periods.	[McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, 355W,16th St,Suite 4800, Indianapolis, IN 46202 USA; [Zafonte, Ross] Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Boston, MA USA; [Jain, Sonia; He, Feng; Raman, Rema] Univ Calif San Diego, Biostat Res Ctr, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Flashman, Laura A.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Program, Lebanon, NH 03766 USA; [George, Mark S.] Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA; [Grant, Gerald A.] Stanford Univ, Lucile Packard Childrens Hosp, Dept Neurosurg, Stanford, CA 94305 USA; [Lohr, James B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Andaluz, Norberto] Univ Cincinnati, Mayfield Clin, Neurosci Inst, Dept Neurosurg,Coll Med, Cincinnati, OH USA; [Summerall, Lanier] Ralph H Johnson VA Med Ctr, Dept Psychiat, Charleston, SC USA; [Paulus, Martin P.] Laureate Inst Brain Res, Tulsa, OK USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA		McAllister, TW (corresponding author), Indiana Univ Sch Med, Dept Psychiat, 355W,16th St,Suite 4800, Indianapolis, IN 46202 USA.	twmcalli@iupui.edu		George, Mark/0000-0003-1767-1815	United States Department of Defense grant [W81XWH08-2-0159]; Janssen PharmaceuticaJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; PfizerPfizer; Tonix Pharmaceuticals; Biological Psychiatry; UpToDate	This study was funded by the United States Department of Defense grant W81XWH08-2-0159. MBS reports consulting income in the past 3 years from Janssen Pharmaceutica, Pfizer, and Tonix Pharmaceuticals; and income for editorial work for Biological Psychiatry and UpToDate. RZ has received compensation from Demos Medical Publishing, as well as Oakstone Institute for educational products. The remaining authors declare no conflict of interest.	Abraham AD, 2012, LEARN MEMORY, V19, P67, DOI 10.1101/lm.024752.111; Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Aga-Mizrachi S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.82; Arciniegas D, 2007, GUIDE NEUROPSYCHIATR, P24; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Dawson DA, 2005, COMPR PSYCHIAT, V46, P405, DOI 10.1016/j.comppsych.2005.01.006; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; Hankin CS, 1999, AM J PSYCHIAT, V156, P1924; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howlett JR, 2015, NEUROBIOLOGY OF PTSD; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Koontz Jennifer, 2005, Am J Alzheimers Dis Other Demen, V20, P295, DOI 10.1177/153331750502000502; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Loy C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001747.pub3; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Parker G, 2013, J AFFECT DISORDERS, V151, P360, DOI 10.1016/j.jad.2013.05.093; Ruff R. M., 2003, RNBI RUFF NEUROBEHAV; Schilstrom B, 2007, NEUROPSYCHOPHARMACOL, V32, P43, DOI 10.1038/sj.npp.1301087; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seeman P, 1998, MOL PSYCHIATR, V3, P386, DOI 10.1038/sj.mp.4000421; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thompson Sarah, 2004, Expert Opin Drug Saf, V3, P425, DOI 10.1517/14740338.3.5.425; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	43	52	52	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	APR	2016	41	5					1191	1198		10.1038/npp.2015.282			8	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	DG1BW	WOS:000371801200002	26361060	Green Published, Bronze			2022-02-06	
J	Dash, PK; Zhao, J; Kobori, N; Redell, JB; Hylin, MJ; Hood, KN; Moore, AN				Dash, Pramod K.; Zhao, Jing; Kobori, Nobuhide; Redell, John B.; Hylin, Michael J.; Hood, Kimberly N.; Moore, Anthony N.			Activation of Alpha 7 Cholinergic Nicotinic Receptors Reduce Blood-Brain Barrier Permeability following Experimental Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						blood-brain barrier breakdown; controlled cortical impact brain injury; inflammatory cytokines; secondary TBI pathology	VAGUS NERVE-STIMULATION; NEURONAL CELL-DEATH; IMMUNE-RESPONSE; SYSTEMIC INFLAMMATION; ALLOSTERIC MODULATION; COGNITIVE DYSFUNCTION; CEREBROSPINAL-FLUID; HEAD-INJURY; MICE; RAT	Traumatic brain injury (TBI) is a major human health concern that has the greatest impact on young men and women. The breakdown of the blood-brain barrier (BBB) is an important pathological consequence of TBI that initiates secondary processes, including infiltration of inflammatory cells, which can exacerbate brain inflammation and contribute to poor outcome. While the role of inflammation within the injured brain has been examined in some detail, the contribution of peripheral/systemic inflammation to TBI pathophysiology is largely unknown. Recent studies have implicated vagus nerve regulation of splenic cholinergic nicotinic acetylcholine receptor alpha 7 (nAChRa7) signaling in the regulation of systemic inflammation. However, it is not known whether this mechanism plays a role in TBI-triggered inflammation and BBB breakdown. Following TBI, we observed that plasma TNF-alpha and IL-1 beta levels, as well as BBB permeability, were significantly increased in nAChRa7 null mice (Chrna7(-/-)) relative to wild-type mice. The administration of exogenous IL-1 beta and TNF-alpha to brain-injured animals worsened Evans Blue dye extravasation, suggesting that systemic inflammation contributes to TBI-triggered BBB permeability. Systemic administration of the nAChRa7 agonist PNU-282987 or the positive allosteric modulator PNU-120596 significantly attenuated TBI-triggered BBB compromise. Supporting a role for splenic nAChRa7 receptors, we demonstrate that splenic injection of the nicotinic receptor blocker alpha-bungarotoxin increased BBB permeability in brain-injured rats, while PNU-282987 injection decreased such permeability. These effects were not seen when alpha-bungarotoxin or PNU-282987 were administered to splenectomized, brain-injured rats. Together, these findings support the short-term use of nAChRa7-activating agents as a strategy to reduce TBI-triggered BBB permeability.	[Dash, Pramod K.; Zhao, Jing; Kobori, Nobuhide; Redell, John B.; Hylin, Michael J.; Hood, Kimberly N.; Moore, Anthony N.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurobiol & Anat, POB 20036, Houston, TX 77030 USA		Dash, PK (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurobiol & Anat, POB 20036, Houston, TX 77030 USA.	p.dash@uth.tmc.edu	Hylin, Michael/U-2878-2019		Senator Lloyd and B.A. Bentsen Center for Stroke Research; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-087149, NS-088298]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087149, R01NS088298] Funding Source: NIH RePORTER	This research was supported by the Senator Lloyd and B.A. Bentsen Center for Stroke Research, and National Institutes of Health Grants NS-087149 and NS-088298.	Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BENNETT BR, 1989, J TRAUMA, V29, P556, DOI 10.1097/00005373-198905000-00003; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bruchfeld A, 2008, MOL MED, V14, P109, DOI 10.2119/2007-00107.Bruchfeld; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; DIXON CE, 1991, J NEUROSCI METH, V39, P253; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Gray E, 2008, BRAIN PATHOL, V18, P86, DOI 10.1111/j.1750-3639.2007.00110.x; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hijioka M, 2012, NEUROSCIENCE, V222, P10, DOI 10.1016/j.neuroscience.2012.07.024; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; KINKADE JM, 1983, BIOCHEM BIOPH RES CO, V114, P296, DOI 10.1016/0006-291X(83)91627-3; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kox M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0667-5; Kumaria A, 2012, BRIT J NEUROSURG, V26, P316, DOI 10.3109/02688697.2012.663517; Levine YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104530; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Mazurov A, 2006, CURR MED CHEM, V13, P1567, DOI 10.2174/092986706777442011; McCrory P, 2002, J SCI MED SPORT, V5, P169, DOI 10.1016/S1440-2440(02)80002-0; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Moreno A, 1998, NMR BIOMED, V11, P93, DOI 10.1002/(SICI)1099-1492(199805)11:3<93::AID-NBM520>3.0.CO;2-H; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shi C, 2013, NEUROL RES, V35, P263, DOI 10.1179/1743132813Y.0000000167; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stuckenholz V, 2013, J PARKINSON DIS, V3, P161, DOI 10.3233/JPD-120157; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	60	52	56	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 2	2016	36	9					2809	2818		10.1523/JNEUROSCI.3197-15.2016			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF2BV	WOS:000371145400022	26937017	Bronze, Green Published			2022-02-06	
J	Cruz, LJ; Stammes, MA; Que, I; van Beek, ER; Knol-Blankevoort, VT; Snoeks, TJA; Chan, A; Kaijzel, EL; Lowik, CWGM				Cruz, Luis J.; Stammes, Marieke A.; Que, Ivo; van Beek, Ermond R.; Knol-Blankevoort, Vicky T.; Snoeks, Thomas J. A.; Chan, Alan; Kaijzel, Eric L.; Lowik, Clemens W. G. M.			Effect of PLGA NP size on efficiency to target traumatic brain injury	JOURNAL OF CONTROLLED RELEASE			English	Article						Imaging; Targeting; Contrast agents; Nanoparticles; PLGA; Brain injury	IN-VITRO; NANOPARTICLES; CELLS	Necrotic cell death occurs exclusively under pathological conditions, such as ischemic diseases. Necrosis imaging is of diagnostic value and enables early measurement of treatment efficiency in ischemic patients. Here we explored the targeted delivery of particles, with diameters of approximately 100 nm, 200 nm and 800 nm, consisting of a poly(lactic-co-glycolic acid) (PLGA) nanoparticle (NP) core coated with a polyethylene glycollipid (PEG) layer. Targeted delivery was facilitated by coupling the amino end group of the polyethylene glycol-layer to 800CW imaging agent, which specifically binds to intracellular proteins of cells that have lost membrane integrity, thus revealing the extent of the damaged area. We found that smaller NPs (100 nm), with an appropriate coating, diffuse throughout the traumatic brain injury (TBI) in mice. Optical imaging revealed that smaller (100-nm) PEG-coated NPs carrying 800CW penetrated deeper into the mouse brain than large 800CW containing NPs (800 nm). The importance of the 800CW as a ligand to target the necrotic tissue was further confirmed in living mice. The ability to achieve brain penetration with smaller NPs is expected to allow more uniform, longer-lasting, and effective delivery of drugs within the brain, and may find application in the treatment of stroke, brain tumors, neuroinflammation, and other brain diseases where the blood-brain barrier is compromised or where local delivery strategies are feasible. (C) 2015 Elsevier B.V. All rights reserved.	[Cruz, Luis J.; Que, Ivo; Knol-Blankevoort, Vicky T.; Snoeks, Thomas J. A.; Kaijzel, Eric L.; Lowik, Clemens W. G. M.] Leiden Univ, Med Ctr, Dept Radiol, Nanomed & Mol Imaging, Albinusdreef 2, NL-2300 RC Leiden, Netherlands; [Stammes, Marieke A.; van Beek, Ermond R.; Chan, Alan] Percuros, Enschede, Netherlands		Cruz, LJ (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Nanomed & Mol Imaging, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.; Lowik, CWGM (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Expt Mol Imaging, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	l.j.cruz_ricondo@lumc.nl; C.W.G.M.Lowik@lumc.nl		Chan, Alan/0000-0001-6949-9274; Kaijzel, Eric/0000-0003-3118-9910	VIDI personal grant [723.012.110]; European UnionEuropean Commission [612360]; CTMM project Cancer Vaccine Tracking [03O-302]	The authors wish to thank the technicians of the LUMC Radiology Department for assistance. This work was financially supported by the VIDI personal grant (project number 723.012.110) L.J.C, the FP7 European Union Marie Curie IAPP program, BRAINPATH, under grant number 612360 and the CTMM project Cancer Vaccine Tracking (03O-302).	Barichello JM, 1999, DRUG DEV IND PHARM, V25, P471, DOI 10.1081/DDC-100102197; BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420; CHIGNELL CF, 1970, MOL PHARMACOL, V6, P1; Cruz LJ, 2014, MOL PHARMACEUT, V11, P4299, DOI 10.1021/mp400717r; Cruz LJ, 2011, MOL PHARMACEUT, V8, P520, DOI 10.1021/mp100356k; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Ishii T, 2013, BIOCHEM BIOPH RES CO, V430, P1201, DOI 10.1016/j.bbrc.2012.12.080; Ishii T, 2010, BRAIN RES, V1321, P164, DOI 10.1016/j.brainres.2010.01.039; Jain S, 2012, BRIT J RADIOL, V85, P101, DOI 10.1259/bjr/59448833; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Langer R, 1998, NATURE, V392, P5; Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w; Mc Carthy DJ, 2015, PHARM RES-DORDR, V32, P1161, DOI 10.1007/s11095-014-1545-6; Mosqueira VCF, 2001, BIOMATERIALS, V22, P2967, DOI 10.1016/S0142-9612(01)00043-6; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2; Panagiotou S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00182; Pogue B.W., 2015, P SPIE INT SOC OPT E, V9311; Ruozi B, 2015, MOL NEUROBIOL, V52, P899, DOI 10.1007/s12035-015-9235-x; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Tassa C, 2010, BIOCONJUGATE CHEM, V21, P14, DOI 10.1021/bc900438a; Togashi DM, 2008, J FLUORESC, V18, P519, DOI 10.1007/s10895-007-0294-x; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Xie B., 2015, ONCOTARGET; Zehendner CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016760; Zhang P.L., 2015, CELL BIOCH BIOPHYS	29	52	53	1	48	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	FEB 10	2016	223						31	41		10.1016/j.jconrel.2015.12.029			11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	DB8TG	WOS:000368788900004	26708021				2022-02-06	
J	Johnson, VE; Stewart, W; Weber, MT; Cullen, DK; Siman, R; Smith, DH				Johnson, Victoria E.; Stewart, William; Weber, Maura T.; Cullen, D. Kacy; Siman, Robert; Smith, Douglas H.			SNTF immunostaining reveals previously undetected axonal pathology in traumatic brain injury	ACTA NEUROPATHOLOGICA			English	Article						Traumatic brain injury; TBI; Concussion; Mild TBI; Diffuse axonal injury; Spectrin breakdown; SNTF; Axonal pathology; Amyloid precursor protein; Neurofilaments	AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD INJURY; INTRAAXONAL NEUROFILAMENT COMPACTION; DYNAMIC STRETCH INJURY; CALPAIN ACTIVATION; CORPUS-CALLOSUM; CYCLOSPORINE-A; HIPPOCAMPAL DAMAGE; SURROGATE MARKERS; FORENSIC PRACTICE	Diffuse axonal injury (DAI) is a common feature of severe traumatic brain injury (TBI) and may also be a predominant pathology in mild TBI or "concussion". The rapid deformation of white matter at the instant of trauma can lead to mechanical failure and calcium-dependent proteolysis of the axonal cytoskeleton in association with axonal transport interruption. Recently, a proteolytic fragment of alpha-II spectrin, "SNTF", was detected in serum acutely following mild TBI in patients and was prognostic for poor clinical outcome. However, direct evidence that this fragment is a marker of DAI has yet to be demonstrated in either humans following TBI or in models of mild TBI. Here, we used immunohistochemistry (IHC) to examine for SNTF in brain tissue following both severe and mild TBI. Human severe TBI cases (survival < 7d; n = 18) were compared to age-matched controls (n = 16) from the Glasgow TBI archive. We also examined brains from an established model of mild TBI at 6, 48 and 72 h post-injury versus shams. IHC specific for SNTF was compared to that of amyloid precursor protein (APP), the current standard for DAI diagnosis, and other known markers of axonal pathology including non-phosphorylated neurofilament-H (SMI-32), neurofilament-68 (NF-68) and compacted neurofilament-medium (RMO-14) using double and triple immunofluorescent labeling. Supporting its use as a biomarker of DAI, SNTF immunoreactive axons were observed at all time points following both human severe TBI and in the model of mild TBI. Interestingly, SNTF revealed a subpopulation of degenerating axons, undetected by the gold-standard marker of transport interruption, APP. While there was greater axonal co-localization between SNTF and APP after severe TBI in humans, a subset of SNTF positive axons displayed no APP accumulation. Notably, some co-localization was observed between SNTF and the less abundant neurofilament subtype markers. Other SNTF positive axons, however, did not co-localize with any other markers. Similarly, RMO-14 and NF-68 positive axonal pathology existed independent of SNTF and APP. These data demonstrate that multiple pathological axonal phenotypes exist post-TBI and provide insight into a more comprehensive approach to the neuropathological assessment of DAI.	[Johnson, Victoria E.; Stewart, William; Weber, Maura T.; Cullen, D. Kacy; Siman, Robert; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Penn Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Stewart, William] Queen Elizabeth Glasgow Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; [Stewart, William] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland		Smith, DH (corresponding author), Univ Penn, Perelman Sch Med, Penn Ctr Brain Injury & Repair, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@upenn.edu		Stewart, William/0000-0003-2199-2582	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS056202, NS038104, NS092389]; US Department of DefenseUnited States Department of Defense [PT110785]; NHS Research Scotland Career Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R01NS092398, R01NS038104] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants NS056202 (D. H. Smith and R. Siman), NS038104 (D. H. Smith), NS092389 (D. H. Smith), the US Department of Defense Grant PT110785 (D. H. Smith) and the NHS Research Scotland Career Research Fellowship (W. Stewart). We would like to thank Dr. John Wolf and Michael Grovola for their assistance with confocal imaging.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; MAXWELL WL, 1991, J ANAT, V176, P71; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Povlishock JT, 1999, ACT NEUR S, V73, P15; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; SIMAN R, 1989, J NEUROSCI, V9, P1579; Siman R., 2015, J NEUROTRAU IN PRESS; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yamazaki T, 1997, J NEUROSCI, V17, P1004	83	52	53	1	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JAN	2016	131	1					115	135		10.1007/s00401-015-1506-0			21	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	DA2CB	WOS:000367601800008	26589592	Green Accepted			2022-02-06	
J	Young, JC; Roper, BL; Arentsen, TJ				Young, J. Christopher; Roper, Brad L.; Arentsen, Timothy J.			Validity testing and neuropsychology practice in the VA healthcare system: results from recent practitioner survey	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity test; performance validity test; response bias; malingering; neuropsychology	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; RESPONSE BIAS SCALE; TEST-PERFORMANCE; REPEATABLE BATTERY; DIGIT SPAN; BASE RATES; VETERANS; SOLDIERS; INDEXES	Objective: A survey of neuropsychologists in the Veterans Health Administration examined symptom/performance validity test (SPVT) practices and estimated base rates for patient response bias. Method: Invitations were emailed to 387 psychologists employed within the Veterans Affairs (VA), identified as likely practicing neuropsychologists, resulting in 172 respondents (44.4% response rate). Practice areas varied, with 72% at least partially practicing in general neuropsychology clinics and 43% conducting VA disability exams. Results: Mean estimated failure rates were 23.0% for clinical outpatient, 12.9% for inpatient, and 39.4% for disability exams. Failure rates were the highest for mTBI and PTSD referrals. Failure rates were positively correlated with the number of cases seen and frequency and number of SPVT use. Respondents disagreed regarding whether one (45%) or two (47%) failures are required to establish patient response bias, with those administering more measures employing the more stringent criterion. Frequency of the use of specific SPVTs is reported. Conclusions: Base rate estimates for SPVT failure in VA disability exams are comparable to those in other medicolegal settings. However, failure in routine clinical exams is much higher in the VA than in other settings, possibly reflecting the hybrid nature of the VA's role in both healthcare and disability determination. Generally speaking, VA neuropsychologists use SPVTs frequently and eschew pejorative terms to describe their failure. Practitioners who require only one SPVT failure to establish response bias may overclassify patients. Those who use few or no SPVTs may fail to identify response bias. Additional clinical and theoretical implications are discussed.	[Young, J. Christopher] Siskin Hosp Phys Rehabil, Chattanooga, TN USA; [Roper, Brad L.; Arentsen, Timothy J.] Memphis Vet Affairs Med Ctr, Memphis, TN USA		Young, JC (corresponding author), Siskin Hosp Phys Rehabil, Chattanooga, TN USA.	jcyoung@siskinrehab.org					Arbisi P.A, 2004, PSYCHOL SERV, V1, P56, DOI DOI 10.1037/1541-1559.1.1.56; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boone K. B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brewin B., 2012, NATL J; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Congressional Budget Office, 2014, VET DIS COMP TRENDS; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Goldstein G, 2010, CLIN NEUROPSYCHOL, V24, P401, DOI 10.1080/13854040903313597; Green P., 2005, WORD MEMORY TEST WIN; Green P, 2004, GREENS MED SYMPTOM V; Guilmette T.J., 2013, MILD TRAUMATIC BRAIN, P31; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jackson JC, 2011, J TRAUMA STRESS, V24, P609, DOI 10.1002/jts.20688; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith GE, 2008, Textbook of clinical neuropsychology, P38; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sullivan K., 2006, J FORENSIC NEUROPSYC, V4, P49, DOI [10.1300/J151v04n04_04, DOI 10.1300/J151V04N04_04]; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; United States Department of Veterans Affairs, 2014, VET COMP BEN RAT TAB; United States Government Accountability Office, 2010, VET DIS BEN FURTH EV; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	50	52	52	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	4					497	514		10.1080/13854046.2016.1159730			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO6YO	WOS:000377929600002	27032437				2022-02-06	
J	Kang, M; Min, K; Jang, J; Kim, SC; Kang, MS; Jang, SJ; Lee, JY; Kim, SH; Kim, MK; An, SA; Kim, M				Kang, Mino; Min, Kyunghoon; Jang, Joonyoung; Kim, Seung Chan; Kang, Myung Seo; Jang, Su Jin; Lee, Ji Young; Kim, Sang Heum; Kim, Moon Kyu; An, SeongSoo A.; Kim, MinYoung			Involvement of Immune Responses in the Efficacy of Cord Blood Cell Therapy for Cerebral Palsy	STEM CELLS AND DEVELOPMENT			English	Article							LONG PENTRAXIN PTX3; ACUTE MYOCARDIAL-INFARCTION; TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTORS; MONONUCLEAR-CELLS; INNATE IMMUNITY; INFLAMMATION; TRANSPLANTATION; RATS; MECHANISMS	This study evaluated the efficacy of umbilical cord blood (UCB) cell for patients with cerebral palsy (CP) in a randomized, placebo-controlled, double-blind trial and also assessed factors and mechanisms related to the efficacy. Thirty-six children (ages 6 months to 20 years old) with CP were enrolled and treated with UCB or a placebo. Muscle strength and gross motor function were evaluated at baseline and 1, 3, and 6 months after treatment. Along with function measurements, each subject underwent F-18-fluorodeoxyglucose positron emission tomography at baseline and 2 weeks after treatment. Cytokine and receptor levels were quantitated in serial blood samples. The UCB group showed greater improvements in muscle strength than the controls at 1 (0.94 vs. -0.35, respectively) and 3 months (2.71 vs. 0.65) after treatment (Ps<0.05). The UCB group also showed greater improvements in gross motor performance than the control group at 6 months (8.54 vs. 2.60) after treatment (P<0.01). Additionally, positron emission tomography scans revealed decreased periventricular inflammation in patients administered UCB, compared with those treated with a placebo. Correlating with enhanced gross motor function, elevations in plasma pentraxin 3 and interleukin-8 levels were observed for up to 12 days after treatment in the UCB group. Meanwhile, increases in blood cells expressing Toll-like receptor 4 were noted at 1 day after treatment in the UCB group, and they were correlated with increased muscle strength at 3 months post-treatment. In this trial, treatment with UCB alone improved motor outcomes and induced systemic immune reactions and anti-inflammatory changes in the brain. Generally, motor outcomes were positively correlated with the number of UCB cells administered: a higher number of cells resulted in better outcomes. Nevertheless, future trials are needed to confirm the long-term efficacy of UCB therapy, as the follow-up duration of the present trial was short.	[Kang, Mino; Kim, Seung Chan; An, SeongSoo A.] Gachon Univ, Dept Bionanotechnol, Gachon Med Res Inst, Songnam 461701, Gyeonggi Do, South Korea; [Min, Kyunghoon; Jang, Joonyoung; Kim, MinYoung] CHA Univ, Dept Rehabil Med, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kang, Myung Seo] CHA Univ, Dept Lab Med, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kang, Myung Seo] CHA Med Ctr Cord Blood Bank, Songnam, South Korea; [Jang, Su Jin; Lee, Ji Young] CHA Univ, Dept Nucl Med, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kim, Sang Heum] CHA Univ, Dept Radiol, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kim, Moon Kyu] CHA Univ, CHA Bundang Med Ctr, Div Hematol Oncol, Dept Pediat, Songnam 463712, Gyeonggi Do, South Korea		An, SA (corresponding author), Gachon Univ, Dept Bionanotechnol, Gachon Med Res Inst, 65 San, Songnam 461701, Gyeonggi Do, South Korea.	kmin@cha.ac.kr; seongaan@gachon.ac.kr		Moon Kyu, Kim/0000-0001-6186-3991	CHA Bundang Medical Center; Korean Health Industry Development Institute [HI3C1204]; HSLee Welfare Foundation; Gachon University Gil Medical Center [2013-52]	UCB units used in this study were provided by "CHA Medical Center Cord Blood Bank." This study was supported by CHA Bundang Medical Center, a grant of the Korean Health Industry Development Institute (HI3C1204), HSLee Welfare Foundation, and Gachon University Gil Medical Center (grant number: 2013-52). We appreciate Sunhee Lee R.N. for devoted assistance for conduction of the study and Anthony Thomas Milliken for his help with the editing of this article.	Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Bayley N., 2006, BAYLEY SCALES INFANT, V3rd; Bottazzi B, 2006, J LEUKOCYTE BIOL, V79, P909, DOI 10.1189/jlb.1005557; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; Brain, 2000, AIDS EX PER NERV SYS; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Entok E, 2014, MOL BIOL REP, V41, P2827, DOI 10.1007/s11033-014-3137-2; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Haley S, 1992, PEDIAT EVALUATION DI; Han B, 2011, INTENS CARE MED, V37, P334, DOI 10.1007/s00134-010-2067-2; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Inforzato A, 2011, TISSUE ANTIGENS, V77, P271, DOI 10.1111/j.1399-0039.2011.01645.x; Jeon H, 2010, J NEUROIMMUNOL, V229, P63, DOI 10.1016/j.jneuroim.2010.07.001; Kalluri Hari Varun, 2012, World J Transplant, V2, P51, DOI 10.5500/wjt.v2.i4.51; Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Ko J, 2012, ANN REHABIL MED-ARM, V36, P233, DOI 10.5535/arm.2012.36.2.233; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kunes P, 2013, PERFUSION-UK, V28, P377, DOI 10.1177/0267659113483799; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Lee JH, 2013, ANN REHABIL MED-ARM, V37, P167, DOI 10.5535/arm.2013.37.2.167; Lin CY, 2010, ANN NEUROL, V68, P204, DOI 10.1002/ana.22049; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Mantovani A, 2003, VACCINE, V21, pS43, DOI 10.1016/S0264-410X(03)00199-3; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; Min K, 2013, STEM CELLS, V31, P581, DOI 10.1002/stem.1304; Moalli F, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/830421; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Norrby K, 1996, CELL PROLIFERAT, V29, P315, DOI 10.1111/j.1365-2184.1996.tb01583.x; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Uniform Data System for Medical Rehabilitation, 2006, WEEFIMII CLIN GUID V; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Wu CX, 2013, THERANOSTICS, V3, P448, DOI 10.7150/thno.6592; Yuen CM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-141; Zhu HF, 2014, TRANSPL INT, V27, P87, DOI 10.1111/tri.12197	46	52	53	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	OCT 1	2015	24	19					2259	2268		10.1089/scd.2015.0074			10	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	CR5PP	WOS:000361395900004	25977995				2022-02-06	
J	Kroshus, E; Baugh, CM; Daneshvar, DH; Stamm, JM; Laursen, RM; Austin, SB				Kroshus, Emily; Baugh, Christine M.; Daneshvar, Daniel H.; Stamm, Julie M.; Laursen, R. Mark; Austin, S. Bryn			Pressure on Sports Medicine Clinicians to Prematurely Return Collegiate Athletes to Play After Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						conflict of interest; organizational structure; sex; college	ICE HOCKEY; TRAINERS; MANAGEMENT; DISEASE; PROFILE; POLICY; SCHOOL	Context: Anecdotal and qualitative evidence has suggested that some clinicians face pressure from coaches and other personnel in the athletic environment to prematurely return athletes to participation after a concussion. This type of pressure potentially can result in compromised patient care. Objective: To quantify the extent to which clinicians in the collegiate sports medicine environment experience pressure when caring for concussed athletes and whether this pressure varies by the supervisory structure of the institution's sports medicine department, the clinician's sex, and other factors. Design: Cross-sectional study. Setting: Web-based survey of National College Athletic Association member institutions. Patients or Other Participants: A total of 789 athletic trainers and 111 team physicians from 530 institutions. Main Outcome Measure(s): We asked participants whether they had experienced pressure from 3 stakeholder populations (other clinicians, coaches, athletes) to prematurely return athletes to participation after a concussion. Modifying variables that we assessed were the position (athletic trainer, physician) and sex of the clinicians, the supervisory structure of their institutions' sports medicine departments, and the division of competition in which their institutions participate. Results: We observed that 64.4% (n = 580) of responding clinicians reported having experienced pressure from athletes to prematurely clear them to return to participation after a concussion, and 53.7% (n = 483) reported having experienced this pressure from coaches. Only 6.6% (n = 59) reported having experienced pressure from other clinicians to prematurely clear an athlete to return to participation after a concussion. Clinicians reported greater pressure from coaches when their departments were under the supervisory purview of the athletic department rather than a medical institution. Female clinicians reported greater pressure from coaches than male clinicians did. Conclusions: Most clinicians reported experiencing pressure to prematurely return athletes to participation after a concussion. Identifying factors that are associated with variability in pressure on clinicians during concussion recovery can inform potential future strategies to reduce these pressures.	[Kroshus, Emily; Austin, S. Bryn] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Kroshus, Emily] Natl Coll Athletic Assoc, Sport Sci Inst, Indianapolis, IN USA; [Kroshus, Emily; Baugh, Christine M.] Harvard Univ, Edmond J Safra Ctr Eth, Boston, MA 02115 USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Baugh, Christine M.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Austin, S. Bryn] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA; [Daneshvar, Daniel H.; Stamm, Julie M.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02215 USA; [Stamm, Julie M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02215 USA; [Daneshvar, Daniel H.] Sports Legacy Inst, Boston, MA USA; [Laursen, R. Mark] Boston Univ, Sargent Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; [Austin, S. Bryn] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA		Kroshus, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 677 Huntington Ave, Boston, MA 02115 USA.	emk329@mail.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513	National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	Christine M. Baugh was supported by the National Institute of Mental Health of the National Institutes of Health under award number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta RV, 1977, WOMEN INTERCOLLEGIAT; Anderson LC, 2005, J MED ETHICS, V31, P88, DOI 10.1136/jme.2002.000836; [Anonymous], 2013, 2013 14 NCAA SPORTS, P56; [Anonymous], MEMB STAT; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Beale D, 2011, WORK EMPLOY SOC, V25, P5, DOI 10.1177/0950017010389228; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Cleveland JN, 2005, ORGANIZATIONAL FRONT, P149; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Drummond JL, 2007, J ATHL TRAINING, V42, P106; Hoel H., 2001, EUR J WORK ORGAN PSY, V10, P443, DOI [10.1080/13594320143000780, DOI 10.1080/13594320143000780]; Howard B, HIGH SCH SPORTS PART; Irick E., 2011, NCAA SPORTS SPONSORS; Irick E, 2009, RACE GENDER DEMOGRAP; Kahanov L, 2010, J ATHL TRAINING, V45, P459, DOI 10.4085/1062-6050-45.5.459; Kania ML, 2009, J ATHL TRAINING, V44, P58, DOI 10.4085/1062-6050-44.1.58; King NMP, 2013, AM J BIOETHICS, V13, P13, DOI 10.1080/15265161.2013.828126; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Laursen M, 2010, COLL HLTH ACTION, V49, p[29, 1]; Laursen RM, 2010, ATHLET THER TODAY, V15, P1; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Mazerolle SM, 2012, J ATHL TRAINING, V47, P694, DOI 10.4085/1062-6050-47.6.04; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; O'Connor C, 2010, J ATHL TRAINING, V45, P386, DOI 10.4085/1062-6050-45.4.386; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sailors PR, 2013, AM J BIOETHICS, V13, P22, DOI 10.1080/15265161.2013.828118; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Testoni D, 2013, AM J BIOETHICS, V13, P4, DOI 10.1080/15265161.2013.828114; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Waddington I, 2005, ETHICS SPORT, P182; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Wolverton B, COACH MAKES CALL ATH; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	40	52	52	1	27	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2015	50	9					944	951		10.4085/1062-6050-50.6.03			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CW7MQ	WOS:000365183700007	26207440	Green Published			2022-02-06	
J	Molina, DK; DiMaio, VJM				Molina, D. Kimberley; DiMaio, Vincent J. M.			Normal Organ Weights in Women Part II-The Brain, Lungs, Liver, Spleen, and Kidneys	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						brain; female; forensic; kidney; liver; lung; normal; organ; spleen; weight	NORMAL JAPANESE; POPULATION; HEART; SIZE; AGE	Organomegaly can be a sign of disease and pathology, although standard tables defining organomegaly have yet to be established and universally accepted. This study was designed to address the issue and to determine a normal weight for the major organs in adult human females. A prospective study was undertaken of healthy females who had sudden, traumatic deaths at age 18 to 35 years. Cases were excluded if there was a history of medical illness including illicit drug use, prolonged medical treatment was performed, there was a prolonged period between the time of injury and death, body length and weight could not be accurately assessed, or if any illness or intoxication was identified after gross and microscopic analysis including evidence of systemic disease. Individual organs were excluded if there was significant injury to the organ that could have affected the weight. A total of 102 cases met criteria for inclusion in the study during the approximately 10-year period of data collection from 2004 to 2014. The decedents had an average age of 24.4 years and ranged in length from 141 to 182 cm (56.4-72.8 inches) with an average length of 160 cm (64 inches). The weight ranged from 35.9 to 152 kg (79-334 lb) with an average weight of 65.3 kg (143 lb). The majority of the decedents (86%) died of either ballistic or blunt force (including craniocerebral) injuries. The mean brain weight was 1233 g (range, 1000-1618 g); liver mean weight, 1288 g (range, 775-2395 g); spleen mean weight, 115 g (range, 51-275 g); right lung mean weight, 340 g (range, 142-835 g); left lung mean, 299 g (range, 108-736 g); right kidney mean weight, 108 g (range, 67-261 g); and the left kidney mean weight, 116 g (range, 55-274 g). Regression analysis was performed and showed that there were insufficient associations between organ weight and body length, body weight, and body mass index to allow for predictability. The authors therefore propose establishing a reference range for organ weights in women, much like those in use for other laboratory tests. Reference ranges (95% inclusion) are proposed: brain, 1033 to 1404 g; liver, 603 to 1767 g; spleen, less than 230 g; right lung, 101 to 589 g; left lung, 105 to 515 g; right kidney, 38 to 174 g; and left kidney, 35 to 192 g.	[Molina, D. Kimberley; DiMaio, Vincent J. M.] BCMEO, San Antonio, TX 78229 USA		Molina, DK (corresponding author), BCMEO, 7337 Louis Pasteur Dr, San Antonio, TX 78229 USA.	kmolina@bexar.org					[Anonymous], 1997, 11622AIE A D CO LTD; Boyd E, 1933, ARCH PATHOL, V16, P350; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; DELAND FH, 1968, RADIOLOGY, V91, P1195, DOI 10.1148/91.6.1195; DELAND FH, 1970, RADIOLOGY, V97, P589, DOI 10.1148/97.3.589; GARBY L, 1993, AM J HUM BIOL, V5, P291, DOI 10.1002/ajhb.1310050307; KASISKE BL, 1986, ARCH PATHOL LAB MED, V110, P55; Lindboe CF, 2003, CLIN NEUROPATHOL, V22, P263; MOAR JJ, 1988, AM J PHYS ANTHROPOL, V76, P105, DOI 10.1002/ajpa.1330760109; Molina DK, 2012, AM J FOREN MED PATH, V33, P368, DOI 10.1097/PAF.0b013e31823d29ad; MYERS J, 1974, ARCH PATHOL, V98, P33; Ogiu N, 1997, HEALTH PHYS, V72, P368, DOI 10.1097/00004032-199703000-00004; Sanchez R, 1997, Invest Clin, V38, P83; Smith HL, 1928, AM HEART J, V4, P79, DOI 10.1016/S0002-8703(29)90099-5; SprogoeJakobsen S, 1997, FORENSIC SCI INT, V88, P215, DOI 10.1016/S0379-0738(97)00103-5; TANAKA GI, 1979, HEALTH PHYS, V36, P333, DOI 10.1097/00004032-197903000-00011; WHIMSTER WF, 1971, AM REV RESPIR DIS, V103, P85; WHIMSTER WF, 1974, AM REV RESPIR DIS, V110, P478	18	52	53	2	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2015	36	3					182	187		10.1097/PAF.0000000000000175			6	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	CQ3UX	WOS:000360530200013	26108038				2022-02-06	
J	Munce, TA; Dorman, JC; Thompson, PA; Valentine, VD; Bergeron, MF				Munce, Thayne A.; Dorman, Jason C.; Thompson, Paul A.; Valentine, Verle D.; Bergeron, Michael F.			Head Impact Exposure and Neurologic Function of Youth Football Players	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article							SPORTS-RELATED CONCUSSION; HIGH-SCHOOL FOOTBALL; UNITED-STATES; RELIABILITY; INJURY; DIAGNOSIS; LOCATION; BRAIN	Football players are subjected to repetitive impacts that may lead to brain injury and neurologic dysfunction. Knowledge about head impact exposure (HIE) and consequent neurologic function among youth football players is limited. Purpose This study aimed to measure and characterize HIE of youth football players throughout one season and explore associations between HIE and changes in selected clinical measures of neurologic function. Methods Twenty-two youth football players (11-13 yr) wore helmets outfitted with a head impact telemetry (HIT) system to quantify head impact frequency, magnitude, duration, and location. Impact data were collected for each practice (27) and game (9) in a single season. Selected clinical measures of balance, oculomotor performance, reaction time, and self-reported symptoms were assessed before and after the season. Results The median individual head impacts per practice, per game, and throughout the entire season were 9, 12, and 252, respectively. Approximately 50% of all head impacts (6183) had a linear acceleration between 10g and 20g, but nearly 2% were greater than 80g. Overall, the head impact frequency distributions in this study population were similar in magnitude and location as in high school and collegiate football, but total impact frequency was lower. Individual changes in neurologic function were not associated with cumulative HIE. Conclusion This study provides a novel examination of HIE and associations with short-term neurologic function in youth football and notably contributes to the limited HIE data currently available for this population. Whereas youth football players can experience remarkably similar head impact forces as high school players, cumulative subconcussive HIE throughout one youth football season may not be detrimental to short-term clinical measures of neurologic function.	[Munce, Thayne A.; Dorman, Jason C.; Valentine, Verle D.; Bergeron, Michael F.] Sanford Hlth, Sanford Sports Sci Inst, Sioux Falls, SD 57104 USA; [Munce, Thayne A.; Dorman, Jason C.; Valentine, Verle D.; Bergeron, Michael F.] Sanford Res, Sioux Falls, SD USA; [Munce, Thayne A.; Valentine, Verle D.; Bergeron, Michael F.] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA; [Thompson, Paul A.] Sanford Res, Methodol & Data Anal Div, Sioux Falls, SD USA		Munce, TA (corresponding author), Sanford Sports Sci Inst, 1210 W 18th St,Suite 204, Sioux Falls, SD 57104 USA.	thayne.munce@sanfordhealth.org			Sanford Research, Sioux Falls, SD; South Dakota Junior Football, Inc.	Sanford Research, Sioux Falls, SD, provided financial support for this work.; The authors thank Shanna Kindt, MS, Hannah Nelson, MS, Tryg Odney, MS, and Caitlin Pearl, MS, for their assistance with data collection. The authors also sincerely thank the research volunteers and their parents for their participation in this study, and they greatly appreciate the support of this project by South Dakota Junior Football, Inc.	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Valentine VD, 2012, MED SCI SPORTS EXERC, p[44, S264]; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	36	52	53	0	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	AUG	2015	47	8					1567	1576		10.1249/MSS.0000000000000591			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CM8IF	WOS:000357942200003	25437194				2022-02-06	
J	Theadom, A; Cropley, M; Parmar, P; Barker-Collo, S; Starkey, N; Jones, K; Feigin, VL				Theadom, Alice; Cropley, Mark; Parmar, Priya; Barker-Collo, Suzanne; Starkey, Nicola; Jones, Kelly; Feigin, Valery L.		BIONIC Res Grp	Sleep difficulties one year following mild traumatic brain injury in a population-based study	SLEEP MEDICINE			English	Article						Epidemiology; Mild traumatic brain injury; Sleep; Recovery; Adult	QUALITY INDEX; HEAD-INJURY; DEPRESSION SCALE; HOSPITAL ANXIETY; DISTURBANCE; DISORDERS; INSOMNIA; VALIDITY; RELIABILITY; EPIDEMIOLOGY	Background: Sleep quality affects all aspects of daily functioning, and it is vital for facilitating recovery from illness and injury. Sleep commonly becomes disrupted following moderate to severe brain injury, yet little is known about the prevalence of sleep disruption over time and how it impacts on recovery following mild injury. Methods: This was a longitudinal study of 346 adults who experienced a mild brain injury (aged >= 16 years) identified within a population-based incidence sample in New Zealand. The prevalence of sleep difficulties was assessed at baseline (within two weeks), one, six and 12 months, alongside other key outcomes. Results: One year post injury, 41.4% of people were identified as having clinically significant sleep difficulties, with 21.0% at a level indicative of insomnia. Poor sleep quality at baseline was significantly predictive of poorer post-concussion symptoms, mood, community integration, and cognitive ability one year post injury. The prevalence of insomnia following mild traumatic brain injury (TBI) was more than three times the rate found in the general population. Of those completing a sleep assessment at six and 12 months, 44.9% of the sample showed improvements in sleep quality, 16.2% remained stable, and 38.9% worsened. Conclusions: Screening for sleep difficulties should occur routinely following a mild brain injury to identify adults potentially at risk of poor recovery. Interventions to improve sleep are needed to facilitate recovery from injury, and to prevent persistent sleep difficulties emerging. (C) 2015 Elsevier B.V. All rights reserved.	[Theadom, Alice; Parmar, Priya; Jones, Kelly; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland 1142, New Zealand; [Cropley, Mark] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Private Bag 92006, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Cropley, Mark/V-2296-2019; Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; Ameratunga, Shanthi/0000-0001-8042-2251; Parmar, Priya/0000-0001-6001-9326; McPherson, Kath/0000-0003-0487-8497; Theadom, Alice/0000-0003-0351-6216; McPherson, Kathryn/0000-0003-1240-8882; Te Ao, Braden/0000-0002-1050-200X	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192]	This study was funded by the Health Research Council of New Zealand (09/063A, 11/192). We thank the research team for their dedication and performance, in addition to staff at the Coroner's office in Hamilton; New Zealand Accident Compensation Corporation, New Zealand Health Information Service; Waikato District Health Board; Spring Hill Correctional Facility, Waikato University Staff. We thank the many doctors, nurses and rehabilitation professionals and service providers such as ABI Management and administrative staff within and outside Hamilton who referred patients into the study. Additionally, we would like to thank the BIONIC participants and their families and friends. We thank Helen McDonald for her administrative support for the study, and CNS Vital Signs for their support with the neuropsychological assessment.	Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Daley M, 2009, SLEEP MED, V10, P427, DOI 10.1016/j.sleep.2008.04.005; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Gualtieri CT, 2004, AM NEUR ASS ANN M BA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; Novak M, 2004, J PSYCHOSOM RES, V56, P527, DOI 10.1016/j.jpsychores.2004.02.007; Ohayon MM, 1997, J PSYCHIATR RES, V31, P333, DOI 10.1016/S0022-3956(97)00002-2; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Smolensky MH, 2011, ACCIDENT ANAL PREV, V43, P533, DOI 10.1016/j.aap.2009.12.004; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	48	52	52	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	AUG	2015	16	8					926	932		10.1016/j.sleep.2015.04.013			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CN0EO	WOS:000358087000005	26138280				2022-02-06	
J	Kitchen, P; Day, RE; Taylor, LHJ; Salman, MM; Bill, RM; Conner, MT; Conner, AC				Kitchen, Philip; Day, Rebecca E.; Taylor, Luke H. J.; Salman, Mootaz M.; Bill, Roslyn M.; Conner, Matthew T.; Conner, Alex C.			Identification and Molecular Mechanisms of the Rapid Tonicity-induced Relocalization of the Aquaporin 4 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER PERMEABILITY; COLLECTING DUCT; MEMBRANE TRAFFICKING; PLASMA-MEMBRANE; PHOSPHORYLATION; CALMODULIN; AQP4; TRANSLOCATION; CELLS; INVOLVEMENT	The aquaporin family of integral membrane proteins is composed of channels that mediate cellular water flow. Aquaporin 4 (AQP4) is highly expressed in the glial cells of the central nervous system and facilitates the osmotically driven pathological brain swelling associated with stroke and traumatic brain injury. Here we show that AQP4 cell surface expression can be rapidly and reversibly regulated in response to changes of tonicity in primary cortical rat astrocytes and in transfected HEK293 cells. The translocation mechanism involves PKA activation, influx of extracellular calcium, and activation of calmodulin. We identify five putative PKA phosphorylation sites and use site-directed mutagenesis to show that only phosphorylation at one of these sites, serine 276, is necessary for the translocation response. We discuss our findings in the context of the identification of new therapeutic approaches to treating brain edema.	[Kitchen, Philip; Taylor, Luke H. J.] Univ Warwick, Mol Org & Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Day, Rebecca E.; Salman, Mootaz M.; Conner, Matthew T.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Bill, Roslyn M.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England		Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk; m.conner@shu.ac.uk; a.c.conner@bham.ac.uk	Bill, Roslyn M/D-4554-2012; Kitchen, Philip/J-6936-2019; Salman, Mootaz M./J-3111-2019	Bill, Roslyn M/0000-0003-1331-0852; Kitchen, Philip/0000-0002-1558-4673; Salman, Mootaz M./0000-0002-5683-1706	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick [EP/F500378/1]; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [1091578] Funding Source: researchfish	This work was supported by the Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick, Grant EP/F500378/1 (to P. K. and L. H. J. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Assentoft M, 2014, AM J PHYSIOL-CELL PH, V307, pC957, DOI 10.1152/ajpcell.00182.2014; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carmosino M, 2007, BIOL CELL, V99, P25, DOI 10.1042/BC200600068; Conner AC, 2013, MOL MEMBR BIOL, V30, P101, DOI 10.3109/09687688.2012.743194; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; De Bellis M, 2014, MOL BIOL CELL, V25, P470, DOI 10.1091/mbc.E13-06-0331; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P411, DOI 10.1016/j.bmc.2007.12.040; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kalman K, 2008, J BIOL CHEM, V283, P21278, DOI 10.1074/jbc.M801740200; Kato J, 2013, BIOCHEM J, V454, P275, DOI 10.1042/BJ20130046; Katsura T, 1997, Am J Physiol, V272, pF817; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nicchia GP, 2008, GLIA, V56, P1755, DOI 10.1002/glia.20724; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rabaud NE, 2009, BIOCHEM BIOPH RES CO, V383, P54, DOI 10.1016/j.bbrc.2009.03.128; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Song YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034936; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	35	52	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16873	16881		10.1074/jbc.M115.646034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	WOS:000357572800032	26013827	Green Published, hybrid, Green Accepted			2022-02-06	
J	Tam, S; Mckay, A; Sloan, S; Ponsford, J				Tam, Sammi; McKay, Adam; Sloan, Sue; Ponsford, Jennie			The experience of challenging behaviours following severe TBI: A family perspective	BRAIN INJURY			English	Article						Community integration; coping; family experience; thematic analysis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AGGRESSIVE-BEHAVIOR; SCALE; MANAGEMENT; CAREGIVERS; PEOPLE; ADULTS; CARE	Primary objective: Family caregivers play an important role in managing challenging behaviours after TBI. The aims of this study were to understand how family caregivers of individuals with TBI perceive challenging behaviours and their impact on the TBI individual's community integration and family functioning. Research design: A qualitative research design was employed to capture the lived experience of family caregivers of individuals with TBI. Methods and procedures: Face-to-face interviews were conducted on six female family caregivers of individuals with severe TBI (sustained an average of 17 years earlier) and long-standing challenging behaviours. Main outcomes and results: The results revealed that family caregivers adopted a broader definition of challenging behaviour than that used by professionals and these behaviours impacted on the community integration of the individual with TBI, most notably leading to poor social relationships. Challenging behaviours were viewed as a key source of distress and burden for family caregivers and they used many different strategies to manage the behaviours. Conclusion: Greater understanding of challenging behaviours from the perspectives of family caregivers may help provide more effective support and interventions to improve quality-of-life for individuals with challenging behaviours after TBI and their families.	[Tam, Sammi; McKay, Adam; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [McKay, Adam; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Sloan, Sue] Osborn Sloan & Associates, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Mckay, A (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	adam.mckay@monash.edu	McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681			Albaugh JA, 2003, ONCOLOGY NURSING FOR, V30, P592; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; EMERSON E, 1995, J INTELL DISABIL RES, V39, P388, DOI 10.1111/j.1365-2788.1995.tb00543.x; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Liamputtong P., 2005, QUALITATIVE RES METH; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McCubin M. A., 1991, FAMILY ASSESSMENT IN, P3; Ponsford J., 2013, TRAUMATIC BRAIN INJU, P164; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P1; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Smeets SM, 2012, ARCH PHYS MED REHAB, V93, P834, DOI 10.1016/j.apmr.2011.10.029; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Willis TJ, 2003, J HEAD TRAUMA REHAB, V18, P75, DOI 10.1097/00001199-200301000-00008; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	33	52	52	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					813	821		10.3109/02699052.2015.1005134			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800004	25914927				2022-02-06	
J	Lourbopoulos, A; Erturk, A; Hellal, F				Lourbopoulos, Athanasios; Ertuerk, Ali; Hellal, Farida			Microglia in action: how aging and injury can change the brain's guardians	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						microglia; stroke; traumatic brain injury; inflammation; aging	ACTIVATED MICROGLIA; RESIDENT MICROGLIA; HEMATOPOIETIC STEM; COMMON VARIANTS; CELL-DEATH; IN-VITRO; CNS; REVEALS; MECHANISM; FATE	Neuroinflarnmation, the inflammatory response in the central nervous system (CNS), is a major determinant of neuronal function and survival during aging and disease progression. Microglia, as the resident tissue-macrophages of the brain, provide constant support to surrounding neurons in healthy brain. Upon any stress signal (such as trauma, ischemia, inflammation) they are one of the first cells to react. Local and/or peripheral signals determine microglia stress response, which can vary within a continuum of states from beneficial to detrimental for neuronal survival, and can be shaped by aging and previous insults. In this review, we discuss the roles of microglia upon an ischemic or traumatic injury, and give our perspective how aging may contribute to microglia behavior in the injured brain. We speculate that a deeper understanding of specific microglia identities will pave the way to develop more potent therapeutics to treat the diseases of aging brain.	[Lourbopoulos, Athanasios; Hellal, Farida] Univ Munich, Sch Med, Inst Stroke & Dementia Res ISD, Lab Expt Stroke Res, D-81377 Munich, Germany; [Ertuerk, Ali] Univ Munich, Sch Med, Inst Stroke & Dementia Res ISD, Lab Acute Brain Injury, D-81377 Munich, Germany		Hellal, F (corresponding author), Univ Munich, Sch Med, Inst Stroke & Dementia Res ISD, Lab Expt Stroke Res, Campus Grosshadern,Feodor Lynen Str 17, D-81377 Munich, Germany.	farida.hellal@med.uni-muenchen.de	Hellal, Farida/D-1834-2015	Hellal, Farida/0000-0002-9344-1846			Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Duering M, 2012, NEUROLOGY, V79, P2025, DOI 10.1212/WNL.0b013e3182749f39; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013; Famakin BM, 2014, AGING DIS, V5, P307, DOI 10.14336/AD.2014.0500307; Flanary BE, 2007, REJUV RES, V10, P61, DOI 10.1089/rej.2006.9096; Floden AM, 2011, J ALZHEIMERS DIS, V25, P279, DOI 10.3233/JAD-2011-101014; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; GEHRMANN J, 1995, J NEUROPATH EXP NEUR, V54, P680, DOI 10.1097/00005072-199509000-00010; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hefendehl JK, 2014, AGING CELL, V13, P60, DOI 10.1111/acel.12149; Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; HU XM, 2012, STROKE, V43, P3063, DOI DOI 10.1161/STR0KEAHA.112.659656; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Ito U, 2007, STROKE, V38, P2577, DOI 10.1161/STROKEAHA.107.484394; Jacquin A, 2014, J ALZHEIMERS DIS, V40, P1029, DOI 10.3233/JAD-131580; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Lee Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/297241; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Miller KR, 2007, NEURON GLIA BIOL, V3, P245, DOI 10.1017/S1740925X08000136; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nakanishi H, 2009, BEHAV BRAIN RES, V201, P1, DOI 10.1016/j.bbr.2009.02.001; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Narantuya D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011746; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Neumann J, 2015, ACTA NEUROPATHOL, V129, P259, DOI 10.1007/s00401-014-1355-2; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; Perego C, 2013, JOVE-J VIS EXP, DOI 10.3791/50605; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perez-de-Puig I, 2015, ACTA NEUROPATHOL, V129, P239, DOI 10.1007/s00401-014-1381-0; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Radlinska BA, 2009, ANN NEUROL, V66, P825, DOI 10.1002/ana.21796; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rozovsky I, 1998, NEUROBIOL AGING, V19, P97, DOI 10.1016/S0197-4580(97)00169-3; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Takeuchi H, 2006, NEUROBIOL DIS, V22, P33, DOI 10.1016/j.nbd.2005.09.014; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang JP, 2013, INT J MOL MED, V31, P172, DOI 10.3892/ijmm.2012.1179; Weinstein JR, 2010, FUTUR NEUROL, V5, P227, DOI 10.2217/FNL.10.1; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu LJ, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/586426; Wynne AM, 2010, BRAIN BEHAV IMMUN, V24, P1190, DOI 10.1016/j.bbi.2010.05.011; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yan BC, 2014, J NEUROL SCI, V337, P129, DOI 10.1016/j.jns.2013.11.034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	108	52	53	1	24	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	FEB 23	2015	9								54	10.3389/fncel.2015.00054			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB9MT	WOS:000349956500001	25755635	gold, Green Published			2022-02-06	
J	Sisniega, A; Zbijewski, W; Xu, J; Dang, H; Stayman, JW; Yorkston, J; Aygun, N; Koliatsos, V; Siewerdsen, JH				Sisniega, A.; Zbijewski, W.; Xu, J.; Dang, H.; Stayman, J. W.; Yorkston, J.; Aygun, N.; Koliatsos, V.; Siewerdsen, J. H.			High-fidelity artifact correction for cone-beam CT imaging of the brain	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						cone beam CT; Monte Carlo; scatter correction; traumatic brain injury; variance reduction; artifact correction; soft-tissue brain imaging	X-RAY SCATTER; FLAT-PANEL DETECTOR; MONTE-CARLO SIMULATIONS; EMPIRICAL CUPPING CORRECTION; DIFFUSE AXONAL INJURY; DEDICATED BREAST CT; COMPUTED-TOMOGRAPHY; LAG CORRECTION; CORRECTION ALGORITHM; HARDENING CORRECTION	CT is the frontline imaging modality for diagnosis of acute traumatic brain injury (TBI), involving the detection of fresh blood in the brain (contrast of 30-50 HU, detail size down to 1 mm) in a non-contrast-enhanced exam. A dedicated point-of-care imaging system based on cone-beam CT (CBCT) could benefit early detection of TBI and improve direction to appropriate therapy. However, flat-panel detector (FPD) CBCT is challenged by artifacts that degrade contrast resolution and limit application in soft-tissue imaging. We present and evaluate a fairly comprehensive framework for artifact correction to enable soft-tissue brain imaging with FPD CBCT. The framework includes a fast Monte Carlo (MC)-based scatter estimation method complemented by corrections for detector lag, veiling glare, and beam hardening. The fast MC scatter estimation combines GPU acceleration, variance reduction, and simulation with a low number of photon histories and reduced number of projection angles (sparse MC) augmented by kernel de-noising to yield a runtime of similar to 4 min per scan. Scatter correction is combined with two-pass beam hardening correction. Detector lag correction is based on temporal deconvolution of the measured lag response function. The effects of detector veiling glare are reduced by deconvolution of the glare response function representing the long range tails of the detector point-spread function. The performance of the correction framework is quantified in experiments using a realistic head phantom on a testbench for FPD CBCT. Uncorrected reconstructions were non-diagnostic for soft-tissue imaging tasks in the brain. After processing with the artifact correction framework, image uniformity was substantially improved, and artifacts were reduced to a level that enabled visualization of similar to 3 mm simulated bleeds throughout the brain. Non-uniformity (cupping) was reduced by a factor of 5, and contrast of simulated bleeds was improved from similar to 7 to 49.7 HU, in good agreement with the nominal blood contrast of 50 HU. Although noise was amplified by the corrections, the contrast-to-noise ratio (CNR) of simulated bleeds was improved by nearly a factor of 3.5 (CNR = 0.54 without corrections and 1.91 after correction). The resulting image quality motivates further development and translation of the FPD-CBCT system for imaging of acute TBI.	[Sisniega, A.; Zbijewski, W.; Xu, J.; Dang, H.; Stayman, J. W.; Siewerdsen, J. H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Yorkston, J.] Carestream Hlth, Rochester, NY 14615 USA; [Aygun, N.; Siewerdsen, J. H.] Johns Hopkins Univ, Russel H Morgan Dept Radiol, Baltimore, MD 21205 USA; [Koliatsos, V.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA		Sisniega, A (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu	Dang, Hao/U-4865-2018	Dang, Hao/0000-0001-5861-6535; Sisniega, Alejandro/0000-0003-2030-2711; Stayman, Joseph/0000-0003-4358-378X	Carestream Health (Rochester NY)	This work was supported by academic-industry research collaboration with Carestream Health (Rochester NY). Collaboration and useful discussions regarding the MC-GPU package with Dr Andreu Badal and Dr Iacovos Kyprianou (US FDA CDRH, Bethesda MD) are gratefully acknowledged. The authors thank Joshua Levy and colleagues at The Phantom Laboratory (Greenwich NY) for development of the anthropomorphic head phantom and Dr Adam S Wang and Nicholas Uebele (Johns Hopkins University, Baltimore MD) for assistance with the low-contrast simulated brain and bleed formulations.	ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; Badal A, 2009, MED PHYS, V36, P4878, DOI 10.1118/1.3231824; Baer M, 2012, PHYS MED BIOL, V57, P6849, DOI 10.1088/0031-9155/57/21/6849; Bertram M, 2005, P SOC PHOTO-OPT INS, V5745, P259, DOI 10.1117/12.595032; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; Bootsma GJ, 2013, MED PHYS, V40, DOI 10.1118/1.4822484; Carrino JA, 2014, RADIOLOGY, V270, P816, DOI 10.1148/radiol.13130225; Carton AK, 2009, MED PHYS, V36, P920, DOI 10.1118/1.3077922; Cho YB, 2005, MED PHYS, V32, P968, DOI 10.1118/1.1869652; COURVILLE C B, 1950, Bull Los Angel Neuro Soc, V15, P72; Dang H, 2014, P SPIE MED IN PRESS; De Man B, 2001, IEEE T MED IMAGING, V20, P999, DOI 10.1109/42.959297; Dong X, 2012, MED PHYS, V39, P5901, DOI 10.1118/1.4750054; Elbakri IA, 2003, PHYS MED BIOL, V48, P2453, DOI 10.1088/0031-9155/48/15/314; Fahrig R, 2006, MED PHYS, V33, P4541, DOI 10.1118/1.2370508; Gang GJ, 2010, MED PHYS, V37, P1948, DOI 10.1118/1.3352586; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GLOVER GH, 1982, MED PHYS, V9, P860, DOI 10.1118/1.595197; Greenberg M, 2006, HDB NEUROSURGERY; Grills IS, 2008, INT J RADIAT ONCOL, V70, P1045, DOI 10.1016/j.ijrobp.2007.07.2352; Grimmer R, 2012, MED PHYS, V39, P825, DOI 10.1118/1.3676180; Hernandez AM, 2014, MED PHYS, V41, DOI 10.1118/1.4866216; Hsieh J, 2000, PROC SPIE, V3977, P298, DOI 10.1117/12.384505; Hsieh J, 2000, MED PHYS, V27, P23, DOI 10.1118/1.598853; Hsieh J., 2009, COMPUTED TOMOGRAPHY; Hubbell J. H., 1996, TABLES XRAY MASS ATT; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; Jarry G, 2006, MED PHYS, V33, P4320, DOI 10.1118/1.2358324; Jia X, 2012, MED PHYS, V39, P7368, DOI 10.1118/1.4766436; Joseph PM, 1997, MED PHYS, V24, P1629, DOI 10.1118/1.597970; JOSEPH PM, 1978, J COMPUT ASSIST TOMO, V2, P100, DOI 10.1097/00004728-197801000-00017; Kachelriess M, 2006, MED PHYS, V33, P1269, DOI 10.1118/1.2188076; KIJEWSKI P K, 1978, Medical Physics (Woodbury), V5, P209, DOI 10.1118/1.594429; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; Kyriakou Y, 2006, PHYS MED BIOL, V51, P4567, DOI 10.1088/0031-9155/51/18/008; Kyriakou Y, 2010, MED PHYS, V37, P5179, DOI 10.1118/1.3477088; La Riviere PJ, 2006, IEEE T MED IMAGING, V25, P1022, DOI 10.1109/TMI.2006.875429; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lazos D, 2012, MED PHYS, V39, P5639, DOI 10.1118/1.4747260; Liu X, 2005, MED PHYS, V32, P2093, DOI 10.1118/1.1998386; LOVE LA, 1987, MED PHYS, V14, P178, DOI 10.1118/1.596126; Luhta R P, 2003, US Patent Number, Patent No. [10/256,059, 10256059]; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mail N, 2008, MED PHYS, V35, P5187, DOI 10.1118/1.2977759; Mainegra-Hing E, 2010, PHYS MED BIOL, V55, P4495, DOI 10.1088/0031-9155/55/16/S05; Mainegra-Hing E, 2008, J PHYS CONF SER, V102, DOI 10.1088/1742-6596/102/1/012017; Maltz JS, 2008, IEEE T MED IMAGING, V27, P1791, DOI 10.1109/TMI.2008.928922; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miracle AC, 2009, AM J NEURORADIOL, V30, P1285, DOI 10.3174/ajnr.A1654; Mori S, 2006, PHYS MED BIOL, V51, P3953, DOI 10.1088/0031-9155/51/16/005; NALCIOGLU O, 1979, PHYS MED BIOL, V24, P330, DOI 10.1088/0031-9155/24/2/009; NEITZEL U, 1992, MED PHYS, V19, P475, DOI 10.1118/1.596836; Ning R, 2004, MED PHYS, V31, P1195, DOI 10.1118/1.1711475; Nuyts J, 2013, PHYS MED BIOL, V58, pR63, DOI 10.1088/0031-9155/58/12/R63; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Poludniowski G, 2011, PHYS MED BIOL, V56, P1837, DOI 10.1088/0031-9155/56/6/019; Poludniowski G, 2009, PHYS MED BIOL, V54, P3847, DOI 10.1088/0031-9155/54/12/016; Prakash P, 2011, MED PHYS, V38, P5612, DOI 10.1118/1.3633937; Ruhrnschopf EP, 2011, MED PHYS, V38, P5186, DOI 10.1118/1.3589140; Ruhrnschopf EP, 2011, MED PHYS, V38, P4296, DOI 10.1118/1.3599033; Samei E, 1998, MED PHYS, V25, P102, DOI 10.1118/1.598165; Schneider W, 2000, PHYS MED BIOL, V45, P459, DOI 10.1088/0031-9155/45/2/314; SEIBERT JA, 1988, MED PHYS, V15, P567, DOI 10.1118/1.596208; Siewerdsen JH, 2011, NUCL INSTRUM METH A, V648, pS241, DOI 10.1016/j.nima.2010.11.088; Siewerdsen JH, 1999, MED PHYS, V26, P1624, DOI 10.1118/1.598657; Siewerdsen JH, 2006, MED PHYS, V33, P187, DOI 10.1118/1.2148916; Siewerdsen JH, 2005, MED PHYS, V32, P241, DOI 10.1118/1.1836331; Siewerdsen JH, 1999, MED PHYS, V26, P2635, DOI 10.1118/1.598803; Siewerdsen JH, 2000, MED PHYS, V27, P1903, DOI 10.1118/1.1286590; Siewerdsen JH, 2001, MED PHYS, V28, P220, DOI 10.1118/1.1339879; Sisniega A, 2013, MED PHYS, V40, DOI 10.1118/1.4801895; Starman J, 2012, MED PHYS, V39, P6035, DOI 10.1118/1.4752087; Starman J, 2012, MED PHYS, V39, P18, DOI 10.1118/1.3664004; Starman J, 2011, MED PHYS, V38, P2398, DOI 10.1118/1.3574873; Sun M, 2010, PHYS MED BIOL, V55, P6695, DOI 10.1088/0031-9155/55/22/007; Tang XY, 2005, PHYS MED BIOL, V50, P3889, DOI 10.1088/0031-9155/50/16/016; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; TUY HK, 1983, SIAM J APPL MATH, V43, P546, DOI 10.1137/0143035; Tward DJ, 2007, MED PHYS, V34, P4459, DOI 10.1118/1.2790586; Van Gompel G, 2011, MED PHYS, V38, pS36, DOI 10.1118/1.3577758; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Weisfield RL, 1999, PROC SPIE, V3659, P307, DOI 10.1117/12.349505; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805; Yang K, 2007, MED PHYS, V34, P2059, DOI 10.1118/1.2737263; Yang K, 2012, PROC SPIE, V8313, DOI 10.1117/12.911093; Yang WT, 2007, AM J ROENTGENOL, V189, P1312, DOI 10.2214/AJR.07.2403; Yu LF, 2010, AM J ROENTGENOL, V194, pW193, DOI 10.2214/AJR.09.2951; Zbijewski W, 2011, MED PHYS, V38, P4700, DOI 10.1118/1.3611039; Zbijewski W, 2009, P SPIE MED IMAGING, V7258; Zeng K, 2004, MED PHYS, V31, P3206, DOI 10.1118/1.1809792; Zhao W, 2005, MED PHYS, V32, P488, DOI 10.1118/1.1843353; Zhu L, 2005, P SOC PHOTO-OPT INS, V5745, P251, DOI 10.1117/12.594699; Zhu L, 2006, IEEE T MED IMAGING, V25, P1573, DOI 10.1109/TMI.2006.884636; Zhu L, 2009, MED PHYS, V36, P2258, DOI 10.1118/1.3130047; Zoumalan RA, 2009, OTOLARYNG HEAD NECK, V140, P841, DOI 10.1016/j.otohns.2009.01.010	95	52	54	0	15	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	FEB 21	2015	60	4					1415	1439		10.1088/0031-9155/60/4/1415			25	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	CB3LK	WOS:000349529100003	25611041				2022-02-06	
J	Laredo, SA; Steinman, MQ; Robles, CF; Ferrer, E; Ragen, BJ; Trainor, BC				Laredo, Sarah A.; Steinman, Michael Q.; Robles, Cindee F.; Ferrer, Emilio; Ragen, Benjamin J.; Trainor, Brian C.			Effects of defeat stress on behavioral flexibility in males and females: modulation by the mu-opioid receptor	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						Barnes maze; orbitofrontal cortex; Peromyscus californicus; sex differences; social defeat	TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; BETA-FUNALTREXAMINE; GENDER-DIFFERENCES; PREFRONTAL CORTEX; ANXIETY DISORDERS; CORTICAL-LESIONS; CALIFORNIA MICE; MESSENGER-RNA; COPING STYLES	Behavioral flexibility is a component of executive functioning that allows individuals to adapt to changing environmental conditions. Independent lines of research indicate that the mu opioid receptor (MOR) is an important mediator of behavioral flexibility and responses to psychosocial stress. The current study bridges these two lines of research and tests the extent to which social defeat and MOR affect behavioral flexibility and whether sex moderates these effects in California mice (Peromyscus californicus). Males and females assigned to social defeat or control conditions were tested in a Barnes maze. In males, defeat impaired behavioral flexibility but not acquisition. Female performance was unaffected by defeat. MOR binding in defeated and control mice in the orbitofrontal cortex (OFC), striatum and hippocampus was examined via autoradiography. Stressed males had reduced MOR binding in the OFC whereas females were unaffected. The MOR antagonist beta-funaltrexamine (1mg/kg) impaired performance in males naive to defeat during the reversal phase but had no effect on females. Finally, we examined the effects of the MOR agonist morphine (2.5 and 5mg/kg) on stressed mice. As expected, morphine improved behavioral flexibility in stressed males. The stress-induced deficits in behavioral flexibility in males are consistent with a proactive coping strategy, including previous observations that stressed male California mice exhibit strong social approach and aggression. Our pharmacological data suggest that a down-regulation of MOR signaling in males may contribute to sex differences in behavioral flexibility following stress. This is discussed in the framework of coping strategies for individuals with mood disorders.	[Laredo, Sarah A.; Steinman, Michael Q.; Robles, Cindee F.; Ferrer, Emilio; Ragen, Benjamin J.; Trainor, Brian C.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Laredo, Sarah A.; Trainor, Brian C.] Univ Calif Davis, Anim Behav Grad Grp, Davis, CA 95616 USA; [Steinman, Michael Q.; Trainor, Brian C.] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Grp, Davis, CA 95616 USA; [Ragen, Benjamin J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA		Laredo, SA (corresponding author), Univ Calif Davis, One Shields Ave, Davis, CA 95616 USA.	salaredo@scripps.edu; bctrainor@ucdavis.edu	Trainor, Brian C./L-3618-2016	Trainor, Brian C./0000-0002-4627-5478	NSFNational Science Foundation (NSF); NIH National Research Service from NIMH [F31 MH095253-01, R01MH085069]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085069, F31MH095253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007456] Funding Source: NIH RePORTER	The authors thank Karen Bales, Robert Berman, Simona Ghetti and Charles Heyser for thoughtful comments on the manuscript, Andrea Silva for technical assistance and Cindy Clayton for animal care. This research was funded by a Graduate Research Fellowship awarded by the NSF to S.A.L., an NIH National Research Service Award F31 MH095253-01 from NIMH to M.Q.S., and R01MH085069 to B.C.T.	Bales KL, 2007, NEUROSCIENCE, V144, P38, DOI 10.1016/j.neuroscience.2006.09.009; Bernal SA, 2007, BEHAV BRAIN RES, V177, P126, DOI 10.1016/j.bbr.2006.10.028; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bissonette GB, 2012, NEUROPHARMACOLOGY, V62, P1168, DOI 10.1016/j.neuropharm.2011.03.011; Bond AB, 2007, J COMP PSYCHOL, V121, P372, DOI 10.1037/0735-7036.121.4.372; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Channon S, 1996, J AFFECT DISORDERS, V39, P107, DOI 10.1016/0165-0327(96)00027-4; Cook CD, 2000, PSYCHOPHARMACOLOGY, V150, P430, DOI 10.1007/s002130000453; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Davis RN, 2000, COGNITIVE THER RES, V24, P699, DOI 10.1023/A:1005591412406; DeRubeis RJ, 1999, AM J PSYCHIAT, V156, P1007; Dickstein DP, 2010, PSYCHOL MED, V40, P1089, DOI 10.1017/S0033291709991462; Farahmandfar M, 2010, BEHAV BRAIN RES, V211, P156, DOI 10.1016/j.bbr.2010.03.013; Garety P, 1997, BRIT J PSYCHIAT, V171, P420, DOI 10.1192/bjp.171.5.420; GAULIN SJC, 1989, ANIM BEHAV, V37, P322, DOI 10.1016/0003-3472(89)90121-8; GAULIN SJC, 1986, AM NAT, V127, P74, DOI 10.1086/284468; Ghods-Sharifi S, 2008, NEUROBIOL LEARN MEM, V89, P567, DOI 10.1016/j.nlm.2007.10.007; Goel N, 2009, J NEUROENDOCRINOL, V21, P415, DOI 10.1111/j.1365-2826.2009.01843.x; Gonzales Keith L, 2011, Front Endocrinol (Lausanne), V2; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Greenberg GD, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00223; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Isovich E, 2001, EUR J NEUROSCI, V13, P1254, DOI 10.1046/j.0953-816x.2001.01492.x; Jamot L, 2003, GENES BRAIN BEHAV, V2, P80, DOI 10.1034/j.1601-183X.2003.00013.x; Jasarevic E, 2012, ANIM BEHAV, V84, P1141, DOI 10.1016/j.anbehav.2012.08.015; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; Kanagaratnam P, 2007, J ANXIETY DISORD, V21, P510, DOI 10.1016/j.janxdis.2006.06.008; KAVALIERS M, 1987, PHARMACOL BIOCHEM BE, V27, P477, DOI 10.1016/0091-3057(87)90351-0; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lapiz-Bluhm MDS, 2010, INT J NEUROPSYCHOPH, V13, P997, DOI 10.1017/S1461145710000039; Liberzon I, 2007, BIOL PSYCHIAT, V61, P1030, DOI 10.1016/j.biopsych.2006.06.021; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; LIUCHEN LY, 1987, MOL PHARMACOL, V32, P321; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; MARTIN TJ, 1995, J PHARMACOL EXP THER, V272, P1135; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McArdle J. J, 1990, HDB PSYCHOL AGING; Meilandt WJ, 2004, J NEUROSCI, V24, P2953, DOI 10.1523/JNEUROSCI.5569-03.2004; Milner TA, 2013, SYNAPSE, V67, P757, DOI 10.1002/syn.21683; Murmu MS, 2006, EUR J NEUROSCI, V24, P1477, DOI 10.1111/j.1460-9568.2006.05024.x; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Nikulina EM, 1999, NEUROREPORT, V10, P3015, DOI 10.1097/00001756-199909290-00026; OLSON GA, 1979, PHARMACOL BIOCHEM BE, V11, P341, DOI 10.1016/0091-3057(79)90146-1; Quednow BB, 2008, INT J NEUROPSYCHOPH, V11, P655, DOI 10.1017/S1461145707008322; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; RIBBLE DO, 1991, BEHAV ECOL SOCIOBIOL, V29, P161, DOI 10.1007/BF00166397; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; Silva AL, 2010, BEHAV BRAIN RES, V208, P528, DOI 10.1016/j.bbr.2009.12.038; Stafford K, 2001, PHARMACOL BIOCHEM BE, V69, P233, DOI 10.1016/S0091-3057(01)00525-1; Steinman MQ, 2015, PSYCHONEUROENDOCRINO, V51, P122, DOI 10.1016/j.psyneuen.2014.09.009; Steinman MQ, 2011, EUR J NEUROSCI, V33, P361, DOI 10.1111/j.1460-9568.2010.07528.x; Taylor S, 1996, J BEHAV THER EXP PSY, V27, P1, DOI 10.1016/0005-7916(95)00058-5; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; Trainor BC, 2013, HORM BEHAV, V63, P543, DOI 10.1016/j.yhbeh.2013.01.011; Trainor BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017405	63	52	52	0	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2015	41	4					434	441		10.1111/ejn.12824			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC0UW	WOS:000350054000004	25615538	Green Accepted			2022-02-06	
J	Yuan, WH; Wade, SL; Babcock, L				Yuan, Weihong; Wade, Shari L.; Babcock, Lynn			Structural Connectivity Abnormality in Children with Acute Mild Traumatic Brain Injury using Graph Theoretical Analysis	HUMAN BRAIN MAPPING			English	Article						acute; mTBI; structural connectivity; graph theoretical analysis; DTI; small-worldness; network	SMALL-WORLD; CORTICAL THICKNESS; FUNCTIONAL NETWORK; COGNITIVE DECLINE; WORKING-MEMORY; ORGANIZATION; ADOLESCENTS; TRACTOGRAPHY; ASSOCIATION; MODERATE	The traumatic biomechanical forces associated with mild traumatic brain injury (mTBI) typically impart diffuse, as opposed to focal, brain injury potentially disrupting the structural connectivity between neural networks. Graph theoretical analysis using diffusion tensor imaging was used to assess injury-related differences in structural connectivity between 23 children (age 11-16 years) with mTBI and 20 age-matched children with isolated orthopedic injuries (OI) scanned within 96 h postinjury. The distribution of hub regions and the associations between alterations in regional network measures and symptom burden, as assessed by the postconcussion symptom scale score (PCSS), were also examined. In comparison to the OI group, the mTBI group was found to have significantly higher small-worldness (P<0.0001), higher normalized clustering coefficients (P<0.0001), higher normalized characteristic path length (P=0.007), higher modularity (P=0.0005), and lower global efficiency (P<0.0001). A series of hub regions in the mTBI group were found to have significant alterations in regional network measures including nodal degree, nodal clustering coefficient, and nodal between-ness centrality. Correlation analysis showed that PCSS total score acquired at the time of imaging was significantly associated with the nodal degree of two hubs, the superior frontal gyrus at orbital section and the middle frontal gyrus. These findings provide new evidence of acute white matter alteration at both global and regional network level following mTBI in children furthering our understanding of underlying mechanisms of acute neurological insult associated with mTBI. Hum Brain Mapp 36:779-792, 2015. (c) 2014 Wiley Periodicals, Inc.	[Yuan, Weihong] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Div Radiol, Cincinnati, OH 45229 USA; [Yuan, Weihong; Wade, Shari L.; Babcock, Lynn] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA; [Babcock, Lynn] Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Dept Pediat, Cincinnati, OH 45229 USA		Yuan, WH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, 3333 Burnet Ave,ML 5033, Cincinnati, OH 45229 USA.	weihong.yuan@cchmc.org		Babcock, Lynn/0000-0002-2658-6893	KL2 Mentored Career Award from the University of Cincinnati Center for Clinical and Translational Science and Training; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR026315] Funding Source: NIH RePORTER	Contract grant sponsor: KL2 Mentored Career Award (PI: Babcock) from the University of Cincinnati Center for Clinical and Translational Science and Training.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achenbach T, 1983, MANUAL CHILD BEHAV C; Ajilore O, 2014, AM J GERIAT PSYCHIAT, V22, P102, DOI 10.1016/j.jagp.2013.10.004; Baria AT, 2013, NEUROIMAGE, V73, P144, DOI 10.1016/j.neuroimage.2013.01.072; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Betzel R.F., 2013, NETW, V1, P353, DOI DOI 10.1017/NWS.2013.19; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Cook LG, 2013, J INT NEUROPSYCH SOC, V19, P508, DOI 10.1017/S1355617712001452; Correa DD, 2013, BRAIN IMAGING BEHAV, V7, P478, DOI 10.1007/s11682-013-9221-8; Daianu M, 2013, BRAIN CONNECT, V3, P407, DOI 10.1089/brain.2012.0137; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim DJ, 2011, BRAIN CONNECT, V1, P473, DOI 10.1089/brain.2011.0053; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Lipszyc J, 2014, ARCH CLIN NEUROPSYCH, V29, P289, DOI 10.1093/arclin/acu004; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048846; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Onoda K, 2013, NEUROSCI LETT, V556, P104, DOI 10.1016/j.neulet.2013.10.023; Ottet MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00402; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Reijmer YD, 2013, NEUROLOGY, V80, P1370, DOI 10.1212/WNL.0b013e31828c2ee5; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Shi F, 2012, NEUROIMAGE, V62, P1622, DOI 10.1016/j.neuroimage.2012.05.026; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; Vecchio F, 2014, J ALZHEIMERS DIS, V41, P113, DOI 10.3233/JAD-132087; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zuo NM, 2012, NEUROSCI BULL, V28, P375, DOI 10.1007/s12264-012-1245-3	64	52	53	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	FEB	2015	36	2					779	792		10.1002/hbm.22664			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AZ7DN	WOS:000348378800029	25363671	Green Published, Green Accepted			2022-02-06	
J	Carlozzi, NE; Kratz, AL; Sander, AM; Chiaravalloti, ND; Brickell, TA; Lange, RT; Hahn, EA; Austin, A; Miner, JA; Tulsky, DS				Carlozzi, Noelle E.; Kratz, Anna L.; Sander, Angelle M.; Chiaravalloti, Nancy D.; Brickell, Tracey A.; Lange, Rael T.; Hahn, Elizabeth A.; Austin, Amy; Miner, Jennifer A.; Tulsky, David S.			Health-Related Quality of Life in Caregivers of Individuals With Traumatic Brain Injury; Development of a Conceptual Model	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Caregivers; Outcome assessment (health care); Quality of life; Rehabilitation	PATIENT-REPORTED OUTCOMES; SOCIAL SUPPORT; ISSUES RELEVANT; HEAD-INJURY; FAMILY; BURDEN; REHABILITATION; IDENTIFICATION; INSTRUMENT; PREDICTORS	Objectives: To identify aspects of health-related quality of life (HRQOL) that are relevant to caregivers of individuals with traumatic brain injury (TBI) and to propose an integrated conceptual framework based on this information. Design: Nine focus groups with caregivers of individuals with moderate-to-severe TBI were qualitatively analyzed to ascertain the effect that caring for an individual with a TBI has on caregiver HRQOL. Setting: University hospitals and rehabilitation treatment centers. Participants: Caregivers (N=55) of individuals with moderate-to-severe TBI. Interventions: Not applicable. Main Outcome Measures: Not applicable. Results: Qualitative analysis indicated that caregivers were most concerned about their social health (42% of comments). Other important issues were emotional health (34%), physical health (11%), cognitive health (3%), and feelings of loss (9%; feelings of loss related to changes in the future/potential of the care recipient or related to the caregiver). Areas of concern that were discussed that were specific to the caregiver and not fully evaluated by existing patient-reported outcomes (PROs) included feelings of loss, anxiety related to the caregiver role (reinjury concerns, worry about leaving the person alone, etc), and caregiver strain (burden, stress, feeling overwhelmed, etc). Conclusions: Although existing PROs capture relevant aspects of HRQOL for caregivers, there are HRQOL domains that are not addressed. A validated and sensitive HRQOL tool for caregivers of individuals with TBI will facilitate initiatives to improve outcomes in this underserved group. (C) 2015 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Kratz, Anna L.; Austin, Amy; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Sander, Angelle M.] Mem Hermann Res Ctr, Inst Rehabil Res, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, Houston, TX 77030 USA; [Chiaravalloti, Nancy D.] Kessler Fdn Res Ctr, Traumat Brain Injury Lab, Neuropsychol & Neurosci Lab, W Orange, NJ USA; [Brickell, Tracey A.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Hahn, Elizabeth A.] Northwestern Univ, Dept Med Social Sci, Chicago, IL 60611 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Kessler Fdn, Neuropsychol & Neurosci Lab, Spinal Cord Injury Lab, W Orange, NJ USA		Carlozzi, NE (corresponding author), Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu		Chiaravalloti, Nancy/0000-0003-2943-7567; Tulsky, David/0000-0002-4335-4509	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [05R01NR013658]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K01AR064275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health (grant no. 05R01NR013658).	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; BASCH CE, 1987, HEALTH EDUC QUART, V14, P411, DOI 10.1177/109019818701400404; Brouwer WBF, 2006, QUAL LIFE RES, V15, P1005, DOI 10.1007/s11136-005-5994-6; Carlozzi NE, 2013, ARCH PHYS MED REHAB, V94, P1721, DOI 10.1016/j.apmr.2013.02.024; Carlozzi NE, 2013, J HEALTH PSYCHOL, V18, P212, DOI 10.1177/1359105312438109; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Glaser B., 1967, DISCOVERY GROUNDED T; Goldberg D., 1978, MANUAL GEN HLTH QUES; Grad FP, 2002, B WORLD HEALTH ORGAN, V80, P981; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Knight RG, 1997, J CLIN EXP NEUROPSYC, V19, P7, DOI 10.1080/01688639708403832; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rapport LJ, 2006, J HEAD TRAUMA REHAB, V21, P432, DOI 10.1097/00001199-200609000-00055; Rothman ML, 2007, VALUE HEALTH, V10, pS66, DOI 10.1111/j.1524-4733.2007.00269.x; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Smith A M, 1998, Rehabil Nurs, V23, P252; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thurman D, 2007, BRAIN INJURY MED PRI, P373; Traumatic Brain Injury Model Systems, TRAUM BRAIN INJ MOD; Turner RR, 2007, VALUE HEALTH, V10, pS86, DOI 10.1111/j.1524-4733.2007.00271.x; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Zarit SH., 1985, HIDDEN VICTIMS ALZHE; Zemke R., 1985, FIGURING THINGS OUT	58	52	53	1	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2015	96	1					105	113		10.1016/j.apmr.2014.08.021			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AY6EW	WOS:000347661100015	25239281	Green Accepted			2022-02-06	
J	Abdullah, L; Evans, JE; Ferguson, S; Mouzon, B; Montague, H; Reed, J; Crynen, G; Emmerich, T; Crocker, M; Pelot, R; Mullan, M; Crawford, F				Abdullah, Laila; Evans, James E.; Ferguson, Scott; Mouzon, Benoit; Montague, Hannah; Reed, Jon; Crynen, Gogce; Emmerich, Tanja; Crocker, Madison; Pelot, Robert; Mullan, Michael; Crawford, Fiona			Lipidomic analyses identify injury-specific phospholipid changes 3 mo after traumatic brain injury	FASEB JOURNAL			English	Article						controlled cortical impact; mass spectrometry; phosphatidylcholine; phosphatidylethanolamine; phosphatidylinositol; sphingomyelin	CORTICAL IMPACT INJURY; FREE FATTY-ACIDS; SIGNAL-TRANSDUCTION; MEMORY DEFICITS; SPATIAL MEMORY; AXONAL INJURY; RAT-BRAIN; MEDIATORS; LIPOPROTEINS; ACTIVATION	Phospholipid (PL) abnormalities are observed in the cerebrospinal fluid of patients with traumatic brain injury (TBI), suggesting their role in TBI pathology. Therefore, PL levels were examined in a TBI mouse model that received 1.8 mm deep controlled cortical impact injury or craniectomy only (control). The rotarod and Barnes maze acquisition and probe tests were performed within 2 wk after injury, with another probe test performed 3 mo postinjury. Liquid chromatography/mass spectrometry analyses were performed on lipid extracts from several brain regions and plasma from injured and control mice collected at 3 mo postinjury. Compared to controls, injured mice with sensorimotor and learning deficits had decreased levels of cortical and cerebellar phosphatidylcholine (PC) and phosphatidylethanolamine (PE) levels, while hippocampal PC, sphingomyelin and PE levels were elevated. Ether PE levels were lower in the cortices and plasma of injured animals. Polyunsaturated fatty acid-containing PC and PE species, particularly ratios of docosahexaenoic acid (DHA) to arachidonic acid, were lower in the hippocampi and cortices and plasma of injured mice. Given the importance of DHA in maintaining neuronal function and resolving inflammation and of peroxisomes in synthesis of ether PLs, normalizing these PLs may be a useful strategy for treating the chronic pathology of TBI.	[Abdullah, Laila; Evans, James E.; Ferguson, Scott; Mouzon, Benoit; Montague, Hannah; Reed, Jon; Crynen, Gogce; Emmerich, Tanja; Crocker, Madison; Pelot, Robert; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Abdullah, Laila; Evans, James E.; Ferguson, Scott; Mouzon, Benoit; Reed, Jon; Crynen, Gogce; Emmerich, Tanja; Pelot, Robert; Crawford, Fiona] James A Haley Vet Affairs Hosp, Tampa, FL USA		Abdullah, L (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	labdullah@rfdn.org		Emmerich, Tanja/0000-0001-5064-7150	Congressionally Directed Medical Research Program award [W81XWH-10-1-0759]; U.S. Department of Veterans Affairs Merit awardUS Department of Veterans Affairs	This work is made possible through a Congressionally Directed Medical Research Program award (W81XWH-10-1-0759) and a U.S. Department of Veterans Affairs Merit award to F.C. The authors also thank Ariel Gonzalez for his contribution to lipidomic analyses. The contents do not represent the views of the Department of Veterans Affairs or the U.S. Government.	Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Ando S, 2005, MASS SPECTROM REV, V24, P865, DOI 10.1002/mas.20045; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; da Silva TF, 2012, BBA-MOL BASIS DIS, V1822, P1501, DOI 10.1016/j.bbadis.2012.05.014; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; Driskell JA, 2007, SPORTS NUTR FATS PRO; Erdman J., 2011, NUTR TRAUMATIC BRAIN; FADEN AI, 1992, AM J PHYSIOL, V263, pR909, DOI 10.1152/ajpregu.1992.263.4.R909; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Finkelstein E., 2006, INCIDENCE EC BURDEN; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Fujimoto S, 2004, HEART VESSELS, V19, P19, DOI 10.1007/s00380-003-0725-9; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; King JA, 2004, NEUROPSYCHOLOGY, V18, P405, DOI 10.1037/0894-4105.18.3.405; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Lohner K, 1996, CHEM PHYS LIPIDS, V81, P167, DOI 10.1016/0009-3084(96)02580-7; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meyer U, 2010, PSYCHOPHARMACOLOGY, V208, P531, DOI 10.1007/s00213-009-1754-6; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Polozova A, 2007, J MOL NEUROSCI, V33, P56, DOI 10.1007/s12031-007-0039-y; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Purdon AD, 2002, NEUROCHEM RES, V27, P1641, DOI 10.1023/A:1021635027211; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sawada Masato, 2013, Keio Journal of Medicine, V62, P13, DOI 10.2302/kjm.2012-0005-RE; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Taber KH, 2010, PTSD RES Q, V21, P1; U.S. Centers for Disease Control and Prevention National Institutes of Health Department of Defense and Department of Veterans Affairs Leadership Panel, 2013, REP C TRAUM BRAIN IN; Vance DE, 2008, N COMP BIOC, P1; VANCE JE, 1994, J NEUROCHEM, V62, P329; Wallace D, 2012, J MIL VETERANS HEALT, V20, P10; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu GF, 2013, CLIN CHIM ACTA, V421, P7, DOI 10.1016/j.cca.2013.02.030; Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8	69	52	53	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5311	5321		10.1096/fj.14-258228			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	WOS:000345894500025	25208845				2022-02-06	
J	Dienel, GA				Dienel, Gerald A.			Lactate shuttling and lactate use as fuel after traumatic brain injury: metabolic considerations	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						astrocyte; lactate; microdialysis; neuron; pyruvate; traumatic brain injury	CONCENTRATION-GRADIENT MISINTERPRETATION; INTRACRANIAL HYPERTENSIVE EPISODES; CEREBROSPINAL-FLUID TRANSPORT; CEREBRAL ENERGY-METABOLISM; INTRACELLULAR PH INDICATOR; COMBINED MICRODIALYSIS; OXIDATIVE-METABOLISM; GLUCOSE-UTILIZATION; NEURONAL-ACTIVITY; GLUTAMATE UPTAKE	Lactate is proposed to be generated by astrocytes during glutamatergic neurotransmission and shuttled to neurons as 'preferred' oxidative fuel. However, a large body of evidence demonstrates that metabolic changes during activation of living brain disprove essential components of the astrocyte-neuron lactate shuttle model. For example, some glutamate is oxidized to generate ATP after its uptake into astrocytes and neuronal glucose phosphorylation rises during activation and provides pyruvate for oxidation. Extension of the notion that lactate is a preferential fuel into the traumatic brain injury (TBI) field has important clinical implications, and the concept must, therefore, be carefully evaluated before implementation into patient care. Microdialysis studies in TBI patients demonstrate that lactate and pyruvate levels and lactate/pyruvate ratios, along with other data, have important diagnostic value to distinguish between ischemia and mitochondrial dysfunction. Results show that lactate release from human brain to blood predominates over its uptake after TBI, and strong evidence for lactate metabolism is lacking; mitochondrial dysfunction may inhibit lactate oxidation. Claims that exogenous lactate infusion is energetically beneficial for TBI patients are not based on metabolic assays and data are incorrectly interpreted.	Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA		Dienel, GA (corresponding author), Univ Arkansas Med Sci, Dept Neurol, Slot 500,4301 W Markham St, Little Rock, AR 72205 USA.	gadienel@uams.edu					ADACHI K, 1995, J CEREBR BLOOD F MET, V15, P97, DOI 10.1038/jcbfm.1995.11; Alessandri B, 2009, FUTUR NEUROL, V4, P209, DOI 10.2217/14796708.4.2.209; Ball KK, 2010, J CEREBR BLOOD F MET, V30, P162, DOI 10.1038/jcbfm.2009.206; Bauer DE, 2012, NEUROCHEM INT, V61, P566, DOI 10.1016/j.neuint.2012.01.013; Baxter P, 2014, TRANSL STROKE RES, V5, P136, DOI 10.1007/s12975-013-0283-0; BELT JA, 1979, BIOCHEMISTRY-US, V18, P3506, DOI 10.1021/bi00583a011; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, INTENS CARE MED, V40, P920, DOI 10.1007/s00134-014-3312-x; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Boyko M, 2014, J NEURAL TRANSM, V121, P971, DOI 10.1007/s00702-014-1181-7; Boyko M, 2012, NEUROTHERAPEUTICS, V9, P649, DOI 10.1007/s13311-012-0129-6; Bradbury MW, 1985, EXPT BIOL LYMPHATIC, P355; Cahill George F Jr, 2003, Trans Am Clin Climatol Assoc, V114, P149; CAHILL GF, 2003, T AM CLIN CLIMAT ASS, V114, P162; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; CREMER JE, 1982, J CEREBR BLOOD F MET, V2, P394, DOI 10.1038/jcbfm.1982.45; Cruz NF, 2007, J NEUROSCI RES, V85, P3254, DOI 10.1002/jnr.21193; Cruz NF, 2013, J NEUROCHEM, V125, P247, DOI 10.1111/jnc.12166; Cruz NF, 1999, J CEREBR BLOOD F MET, V19, P380, DOI 10.1097/00004647-199904000-00004; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; Desagher S, 1997, J NEUROSCI, V17, P9060; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Dienel GA, 2004, NEUROCHEM INT, V45, P321, DOI 10.1016/j.neuint.2003.10.011; DIENEL GA, 1991, J CEREBR BLOOD F MET, V11, P25, DOI 10.1038/jcbfm.1991.3; Dienel GA, 2014, METAB BRAIN DIS, Vdoi:, DOI [10.1007/811011-014-9493-8, DOI 10.1007/811011-014-9493-8]; Dienel GA, 2007, J NEUROCHEM, V102, P466, DOI 10.1111/j.1471-4159.2007.04595.x; Dienel GA, 2013, NEUROCHEM INT, V63, P244, DOI 10.1016/j.neuint.2013.06.015; Dienel GA, 2012, ASN NEURO, V4, P267, DOI 10.1042/AN20120021; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Dohmen C, 2005, BRAIN RES, V1037, P43, DOI 10.1016/j.brainres.2004.12.046; Dohmen C, 2001, J CEREBR BLOOD F MET, V21, P503, DOI 10.1097/00004647-200105000-00004; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; ERIKSSON G, 1995, GLIA, V15, P152, DOI 10.1002/glia.440150207; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gandhi GK, 2009, J NEUROCHEM, V111, P522, DOI 10.1111/j.1471-4159.2009.06333.x; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; HALPERIN ML, 1969, J BIOL CHEM, V244, P384; Haspel HC, 1999, J MEMBRANE BIOL, V169, P45, DOI 10.1007/PL00005900; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 2008, CRIT CARE MED, V36, P2952, DOI 10.1097/CCM.0b013e3181872178; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; HOLDEN JE, 1991, J CEREBR BLOOD F MET, V11, P171, DOI 10.1038/jcbfm.1991.50; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hu YB, 1997, J NEUROCHEM, V68, P1745; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Jalloh I, 2014, J NEUROTRAUM, V31, P1529, DOI 10.1089/neu.2013.3316; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Johnston M, 2002, NEWS PHYSIOL SCI, V17, P227, DOI 10.1152/nips.01400.2002; Johnston M, 2003, LYMPHAT RES BIOL, V1, P45; Johnston Miles, 2003, Lymphat Res Biol, V1, P41, DOI 10.1089/15396850360495682; Jolivet R, 2010, J CEREBR BLOOD F MET, V30, P1982, DOI 10.1038/jcbfm.2010.132; Koh L, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-6; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kumura E, 1999, J CEREBR BLOOD F MET, V19, P788, DOI 10.1097/00004647-199907000-00009; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; LIEBOWITZ MR, 1986, AM J PSYCHIAT, V143, P495; Madsen PL, 1999, J CEREBR BLOOD F MET, V19, P393, DOI 10.1097/00004647-199904000-00005; MADSEN PL, 1995, J CEREBR BLOOD F MET, V15, P485, DOI 10.1038/jcbfm.1995.60; Madsen PL, 1998, J CEREBR BLOOD F MET, V18, P742, DOI 10.1097/00004647-199807000-00005; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Mangia S, 2011, J CEREBR BLOOD F MET, V31, P1346, DOI 10.1038/jcbfm.2011.29; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marklund N, 2009, J NEUROTRAUM, V26, P1281, DOI [10.1089/neu.2008.0827, 10.1089/neu.2008-0827]; McKenna Mary C, 2013, Front Endocrinol (Lausanne), V4, P191, DOI 10.3389/fendo.2013.00191; McKenna MC, 1996, J NEUROCHEM, V66, P386; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Morgenthaler FD, 2006, NEUROCHEM INT, V48, P616, DOI 10.1016/j.neuint.2005.12.034; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Nagra G, 2006, AM J PHYSIOL-REG I, V291, pR1383, DOI 10.1152/ajpregu.00235.2006; Nakanishi H, 1996, J CEREBR BLOOD F MET, V16, P439, DOI 10.1097/00004647-199605000-00010; NEDERGAARD M, 1993, AM J PHYSIOL, V265, pR282, DOI 10.1152/ajpregu.1993.265.2.R282; Nehlig A, 2004, PROSTAG LEUKOTR ESS, V70, P265, DOI 10.1016/j.plefa.2003.07.006; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nordstrom CH, 2014, J NEUROTRAUM, V31, P1528, DOI 10.1089/neu.2013.3229; Nordstrom CH, 2014, INTENS CARE MED, V40, P919, DOI 10.1007/s00134-014-3297-5; Nordstrom CH, 2013, J REHABIL MED, V45, P710, DOI 10.2340/16501977-1157; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Okada Y, 2007, BRAIN ENERGETICS INT, P17, DOI [10.1007/978-0-387-30411-3_2, DOI 10.1007/978-0-387-30411-3_2]; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; Pellerin L, 2010, DIABETES METAB, V36, pS59, DOI 10.1016/S1262-3636(10)70469-9; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2008, CURR OPIN CLIN NUTR, V11, P701, DOI 10.1097/MCO.0b013e328312c368; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Prieto R, 2011, BRAIN RES, V1404, P39, DOI 10.1016/j.brainres.2011.06.006; Purins K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00064; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; ROMIJN JA, 1994, AM J PHYSIOL, V266, pE334, DOI 10.1152/ajpendo.1994.266.3.E334; Ronald Zielke H, 2009, J NEUROCHEM, V109, P24, DOI 10.1111/j.1471-4159.2009.05941.x; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; SAVAKI HE, 1980, J NEUROCHEM, V35, P495, DOI 10.1111/j.1471-4159.1980.tb06293.x; Schurr A, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00096; Siesj? BK., 1978, BRAIN ENERGY METABOL; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stephenson KN, 2000, BIOCHEM PHARMACOL, V60, P651, DOI 10.1016/S0006-2952(00)00377-4; Thoresen M, 1998, PEDIATR RES, V44, P746, DOI 10.1203/00006450-199811000-00018; Tian JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095777; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; TUCEK S, 1974, J NEUROCHEM, V22, P893, DOI 10.1111/j.1471-4159.1974.tb04314.x; Ugbode CI, 2014, J NEUROCHEM, V130, P668, DOI 10.1111/jnc.12759; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; VEECH RL, 1991, NMR BIOMED, V4, P53, DOI 10.1002/nbm.1940040204; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; WOLFE RR, 1988, AM J PHYSIOL, V254, pE532, DOI 10.1152/ajpendo.1988.254.4.E532	146	52	54	1	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2014	34	11					1736	1748		10.1038/jcbfm.2014.153			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AS7HZ	WOS:000344428800002	25204393	Green Published, Bronze			2022-02-06	
J	Spira, JL; Lathan, CE; Bleiberg, J; Tsao, JW				Spira, James L.; Lathan, Corinna E.; Bleiberg, Joseph; Tsao, Jack W.			The Impact of Multiple Concussions on Emotional Distress, Post-Concussive Symptoms, and Neurocognitive Functioning in Active Duty United States Marines Independent of Combat Exposure or Emotional Distress	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; behavioral assessments; cognitive function; head trauma; military injury	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; RECURRENT CONCUSSION; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSION SYNDROME; STRESS; PERFORMANCE; DEPLOYMENT; INDEX; TIME	Controversy exists as to whether the lingering effects of concussion on emotional, physical, and cognitive symptoms is because of the effects of brain trauma or purely to emotional factors such as post-traumatic stress disorder or depression. This study examines the independent effects of concussion on persistent symptoms. The Defense Automated Neurobehavioral Assessment, a clinical decision support tool, was used to assess neurobehavioral functioning in 646 United States Marines, all of whom were fit for duty. Marines were assessed for concussion history, post-concussive symptoms, emotional distress, neurocognitive functioning, and deployment history. Results showed that a recent concussion or ever having experienced a concussion was associated with an increase in emotional distress, but not with persistent post-concussive symptoms (PPCS) or neurocognitive functioning. Having had multiple lifetime concussions, however, was associated with greater emotional distress, PPCS, and reduced neurocognitive functioning that needs attention and rapid discrimination, but not for memory-based tasks. These results are independent of deployment history, combat exposure, and symptoms of post-traumatic stress disorder and depression. Results supported earlier findings that a previous concussion is not generally associated with post-concussive symptoms independent of covariates. In contrast with other studies that failed to find a unique contribution for concussion to PPCS, however, evidence of recent and multiple concussion was seen across a range of emotional distress, post-concussive symptoms, and neurocognitive functioning in this study population. Results are discussed in terms of implications for assessing concussion on return from combat.	[Spira, James L.] US Dept Vet Affairs, Natl Ctr PTSD, Pacific Isl Div, Honolulu, HI 96819 USA; [Spira, James L.] Univ Hawaii, John A Burns Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Lathan, Corinna E.] AnthroTronix Inc, Silver Spring, MD USA; [Bleiberg, Joseph] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence Psychol Hlth & Traum, Bethesda, MD USA; [Tsao, Jack W.] US Navy Bur Med & Surg Falls Church, Traumat Brain Injury Program, Wounded Ill & Injured Directorate, Falls Church, VA USA		Spira, JL (corresponding author), US Dept Vet Affairs, Natl Ctr PTSD, 3375 Koapaka St,I-560, Honolulu, HI 96819 USA.	James.Spira@va.gov		Bleiberg, Joseph/0000-0003-0867-5494	U.S. Navy Bureau of Medicine and Surgery, Wounded, Ill, and Injured Directorate	This work was supported by the U.S. Navy Bureau of Medicine and Surgery, Wounded, Ill, and Injured Directorate, as well as with resources and the use of facilities at the US Department of Veterans Affairs, National Center for PTSD, Pacific Islands Health Care System.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chard K.M., 2012, REHABIL PSYCHOL, V57, P13; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Spira J., 2013, P MIL HLTH SYST RES; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2010, MILITARY NEUROPSYCHO, P321; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wesensten N., 2010, MILITARY NEUROPSYCHO, P297	56	52	52	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2014	31	22					1823	1834		10.1089/neu.2014.3363			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB4ZO	WOS:000349637400002	25003552	Green Published, Bronze			2022-02-06	
J	Choudhary, AK; Ishak, R; Zacharia, TT; Dias, MS				Choudhary, Arabinda K.; Ishak, Ramsay; Zacharia, Thomas T.; Dias, Mark S.			Imaging of spinal injury in abusive head trauma: a retrospective study	PEDIATRIC RADIOLOGY			English	Article						Abusive head trauma; Spine trauma; Spinal subdural hemorrhage; Infant; Magnetic resonance imaging; Nuchal ligament injury	SHAKEN BABY SYNDROME; CLINICAL ARTICLE; DURA-MATER; CONNECTIVE-TISSUE; LIGAMENTUM NUCHAE; ANATOMIC RELATION; MYODURAL BRIDGE; POSTERIOR MINOR; BRAIN INJURY; CHILDREN	Spinal imaging has been a neglected part of abusive head trauma (AHT) imaging. As most of the radiographs and CT spine are negative in AHT in infants, the cervical spine is assumed to be normal. There is increasing evidence in the role of injury to brainstem and cervical cord in the pathogenesis of AHT. In addition, in courts of law, there is fierce debate about AHT, its mimics and other disparate nontraumatic diagnoses explaining the neuroradiological and skeletal findings. However, this discussion ignores the evidence and significance of spinal injury. We sought to study the cervical spine in an AHT cohort to understand the true prevalence of spinal injuries in AHT and contrast it with cohorts of accidental and nontraumatic groups to give the clinicians a robust diagnostic tool in evaluating AHT. The purpose of this study is to compare the relative incidence of spinal ligamentous and soft-tissue abnormalities on spinal MRI among three groups of children ages < 48 months: 1) those with AHT, 2) those with accidental trauma, and 3) those with nontraumatic conditions. This comparative study included 183 children who underwent spine MRI: 67 with AHT, 46 with accidental trauma and a clinical suspicion of spinal injury, and 70 with nontraumatic conditions. Clinical and radiographic findings were collected in all cases and were analyzed retrospectively to identify MRI evidence of traumatic spinal injuries. The incidence of spinal injuries among the three groups was compared. The incidence of spinal ligamentous injuries was calculated for those with and without radiographic evidence of hypoxic-ischemic encephalopathy. All comparisons were performed using Fisher exact test with P < 0.05 considered statistically significant. Cervical spine ligamentous injuries (predominantly the nuchal, atlanto-occipital and atlanto-axial ligaments) were present in 78% of the AHT group, 46% of the accidental trauma group and 1% of the nontraumatic group; all of these differences were statistically significant. Among the AHT group, ligamentous injuries were statistically correlated with evidence of brain ischemia. Injury to the cervical spinal posterior ligamentous complex is common in AHT and even more prevalent than in clinically symptomatic traumatic cases. The high correlation between the radiographic findings of occipitocervical ligamentous injuries and hypoxic-ischemic brain injury is consistent with an interpretation that transient upper occipitocervical spinal cord injury in AHT leads to disordered breathing and results in hypoxic-ischemic encephalopathy. We recommend imaging the entire spine in AHT to properly identify and classify these injuries.	[Choudhary, Arabinda K.] Nemours AI DuPont Children Hosp, Dept Radiol, Wilmington, DE 19803 USA; [Ishak, Ramsay; Zacharia, Thomas T.] Hershey Med Ctr, Dept Radiol, Hershey, PA USA; [Dias, Mark S.] Hershey Med Ctr, Dept Neurosurg, Hershey, PA USA		Choudhary, AK (corresponding author), Nemours AI DuPont Children Hosp, Dept Radiol, 1600 Rockland Rd, Wilmington, DE 19803 USA.	arabinda.choudhary@nemours.org	choudhary, arabinda/AAP-1220-2021; Zacharia, Thomas/AAZ-4762-2021	choudhary, arabinda/0000-0002-2338-5906; Zacharia, Thomas/0000-0002-6908-9440			Anderson RCE, 2010, J NEUROS-PEDIATR, V5, P292, DOI 10.3171/2009.10.PEDS09159; Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; Dean NA, 2002, CLIN ANAT, V15, P182, DOI 10.1002/ca.10001; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Johnson GM, 2000, SPINE, V25, P5, DOI 10.1097/00007632-200001010-00003; Judkins AR, 2004, AM J FOREN MED PATH, V25, P29, DOI 10.1097/01.paf.0000113811.85110.54; Kadri PAS, 2007, NEUROSURGERY, V61, P301, DOI 10.1227/01.neu.0000303985.65117.ea; Kahkeshani K, 2012, CLIN ANAT, V25, P415, DOI 10.1002/ca.21261; Katz JS, 2010, J NEUROSURG-PEDIATR, V5, P470, DOI 10.3171/2009.11.PEDS09291; Kemp AM, 2010, ARCH DIS CHILD, V95, P355, DOI 10.1136/adc.2009.169110; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Matshes EW, 2011, ACAD FOR PATHOL, V1, P82; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Mulcahey MJ, 2007, SPINAL CORD, V45, P452, DOI 10.1038/sj.sc.3101987; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; Polk-Williams A, 2008, J PEDIATR SURG, V43, P1718, DOI 10.1016/j.jpedsurg.2008.06.002; Pontell ME, 2013, CLIN ANAT, V26, P450, DOI 10.1002/ca.22134; Shannon P, 2001, LANCET, V358, P686, DOI 10.1016/S0140-6736(01)05849-4; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Takeshita K, 2004, SPINE, V29, pE388, DOI 10.1097/01.brs.0000138309.11926.72; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	31	52	52	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	SEP	2014	44	9					1130	1140		10.1007/s00247-014-2959-3			11	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	AN8RA	WOS:000340870400012	24687620				2022-02-06	
J	Gressot, LV; Chamoun, RB; Patel, AJ; Valadka, AB; Sum, D; Robertson, CS; Gopinath, SP				Gressot, Loyola V.; Chamoun, Roukoz B.; Patel, Akash J.; Valadka, Alex B.; Sum, Dima; Robertson, Claudia S.; Gopinath, Shankar P.			Predictors of outcome in civilians with gunshot wounds to the head upon presentation	JOURNAL OF NEUROSURGERY			English	Article						gunshot wound to the head; Glasgow Coma Scale; outcome; penetrating head injury; traumatic brain injury	INJURIES; BRAIN; MANAGEMENT; PROGNOSIS	Object. Prediction of outcome from initial presentation after a gunshot wound to the head (GSWH) is essential to further clinical decision making. The authors' goals are to report the survival and functional outcomes of these patients, to identify prognostic factors, and to propose a scoring system that can predict their outcome. Methods. The records of 199 patients admitted with a GSWH with dural penetration between 1990 and 2008 were retrospectively reviewed. The inclusion criterion was a CT scan available for review. Patients declared brain dead on presentation were excluded, which yielded a series of 119 patients. Statistical analysis was performed using a logistic regression model. Results. Fifty-eight (49%) of the 119 patients died. Twenty-three patients (19%) had a favorable outcome defined as a 6-month Glasgow Outcome Scale (GOS) score of moderate disability or good recovery, 35 (29%) had a poor outcome (GOS of persistent vegetative state or severe disability), and 3 (3%) were lost to follow-up. Significant prognostic factors for mortality were age older than 35 years, nonreactive pupils, bullet trajectory. of bihemispheric (excluding bifrontal), and posterior fossa involvement compared with unihemispheric and bifrontal. Factors that were moderately associated with higher mortality included intracranial pressure (ICP) above 20 mm Hg and Glasgow Coma Scale (GCS) score at presentation of 3 or 4. Upon multivariate analysis, the significant factors for mortality were bullet trajectory and pupillary response. Variables found to be significant for good functional outcome were admission GCS score greater than or equal to 5, pupillary reactivity, and bullet trajectory of unihemispheric or bifrontal. Factors moderately associated with good outcome included age of 35 years or younger, initial ICP 20 mm Hg or lower, and lack of transventricular trajectory. In the multivariate analysis, significant factors for good functional outcome were bullet trajectory and pupillary response, with age moderately associated with improved functional outcomes. The authors also propose a scoring system to estimate survival and functional outcome. Conclusions. Age, pupils, GCS score, and bullet trajectory on CT scan can be used to determine likelihood of survival and good functional outcome. The authors advocate assessing patients based on these parameters rather than pronouncing a poor prognosis and withholding aggressive resuscitation based upon low GCS score alone.	[Gressot, Loyola V.; Patel, Akash J.; Robertson, Claudia S.; Gopinath, Shankar P.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Chamoun, Roukoz B.] Univ Kansas, Dept Neurosurg, Kansas City, KS USA; [Valadka, Alex B.] Seton Brain & Spine Inst Neurosurg, Austin, TX USA; [Sum, Dima] Univ Texas Houston, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA		Gopinath, SP (corresponding author), Baylor Coll Med, Dept Neurosurg, 6501 Fannin St NC-100, Houston, TX 77030 USA.	shankarg@bcm.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-NS38660]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG017604] Funding Source: NIH RePORTER	This Study is supported by NIH Grant P01-NS38660. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	[Anonymous], 2001, J TRAUMA S, V51, pS44; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; JACOBS DG, 1995, AM SURGEON, V61, P647; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; Khan MB, 2013, WORLD NEURO IN PRESS; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Murano T, 2005, AM SURGEON, V71, P1009; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Nathoo N, 2002, SURG NEUROL, V58, P225, DOI 10.1016/S0090-3019(02)00828-5; Ozkan U, 2002, NEUROSURG REV, V25, P231, DOI 10.1007/s101430100173; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Sustic A, 2001, MIL MED, V166, P331, DOI 10.1093/milmed/166.4.331	24	52	54	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2014	121	3					645	652		10.3171/2014.5.JNS131872			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AN6EW	WOS:000340688700020	24995781				2022-02-06	
J	Kadom, N; Khademian, Z; Vezina, G; Shalaby-Rana, E; Rice, A; Hinds, T				Kadom, Nadja; Khademian, Zarir; Vezina, Gilbert; Shalaby-Rana, Eglal; Rice, Amy; Hinds, Tanya			Usefulness of MRI detection of cervical spine and brain injuries in the evaluation of abusive head trauma	PEDIATRIC RADIOLOGY			English	Article						Cervical spine; Brain; Child abuse; Magnetic resonance imaging; Pediatric	HYPOXIC-ISCHEMIC INJURY; YOUNG-CHILDREN; SUBDURAL HEMORRHAGE; INFANTS	In the evaluation of children younger than 3 years with intracranial hemorrhage it can be difficult to determine whether the cause of hemorrhage was traumatic, and if so, whether abusive head trauma (AHT) is a possibility. Cervical spine MRI is not a routine part of the nationally recommended imaging workup for children with suspected abusive head trauma. There is increasing evidence that spinal injuries are found at autopsy or MRI in abused children. However the prevalence of cervical spine injuries in children evaluated for abusive head trauma is unknown. We sought to determine both the incidence and the spectrum of cervical spine and brain injuries in children being evaluated for possible abusive head trauma. We also examined the relationship between cervical and brain MRI findings and selected study outcome categories. This study is a 3-year retrospective review of children evaluated for abusive head trauma. Inclusion criteria were: children with head trauma seen at our institution between 2008 and 2010, age younger than 36 months, availability of diagnostic-quality brain and cervical spine MRI, and child abuse team involvement because abusive head trauma was a possibility. A child abuse pediatrician and pediatric radiologists, all with board certification, were involved in data collection, image interpretation and data analysis. Statistical analysis was performed using Stata v12.1. The study included 74 children (43 boys, 31 girls) with a mean age of 164 days (range, 20-679 days). Study outcomes were categorized as: n = 26 children with accidental head trauma, n = 38 with abusive head trauma (n = 18 presumptive AHT, n = 20 suspicious for AHT), and n = 10 with undefined head trauma. We found cervical spine injuries in 27/74 (36%) children. Most cervical spine injuries were ligamentous injuries. One child had intrathecal spinal blood and two had spinal cord edema; all three of these children had ligamentous injury. MRI signs of cervical injury did not show a statistically significant relationship with a study outcome of abusive head trauma or help discriminate between accidental and abusive head trauma. Of the 30 children with supratentorial brain injury, 16 (53%) had a bilateral hypoxic-ischemic pattern. There was a statistically significant relationship between bilateral hypoxic-ischemic brain injury pattern and abusive head trauma (P < 0.05). In addition, the majority (81%) of children with bilateral hypoxic-ischemic brain injuries had cervical injuries. Although detection of cervical spine injuries by MRI does not discriminate between accidental and abusive head trauma, it can help to distinguish a traumatic from non-traumatic intracranial subdural hemorrhage. Cervical MRI should be considered in children with acute intracranial bleeds and otherwise non-contributory history, physical examination and ophthalmological findings. There is a statistically significant relationship between diffuse hypoxic-ischemic brain injury patterns and abusive head trauma. The high incidence of cervical injuries in children with hypoxic-ischemic injuries suggests a causal relationship. Overall, increased utilization of brain and spine MRI in children being evaluated for abusive head trauma can be helpful.	[Kadom, Nadja; Khademian, Zarir; Vezina, Gilbert; Shalaby-Rana, Eglal] Childrens Natl Med Ctr, Dept Diagnost Imaging & Radiol, Washington, DC 20010 USA; [Hinds, Tanya] Childrens Natl Med Ctr, Child & Adolescent Protect Ctr, Washington, DC 20010 USA; [Kadom, Nadja] Boston Univ, Med Ctr, Boston, MA 02118 USA		Kadom, N (corresponding author), Boston Univ, Med Ctr, 820 Harrison Ave,FGH Bldg,3rd Floor, Boston, MA 02118 USA.	nkpiano@gmail.com		Hinds, Tanya/0000-0003-2308-9143			Anderson SE, 2012, RADIOLOGY, V262, P567, DOI 10.1148/radiol.11102115; Boos SC, 2011, CHILD ABUSE NEGLECT, P396; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Brockmeyer DL, 2012, CHILD NERV SYST, V28, P699, DOI 10.1007/s00381-012-1696-x; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Chan YL, 2003, PEDIATR RADIOL, V33, P574, DOI 10.1007/s00247-003-0949-y; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Goradia D, 2007, AM J NEURORADIOL, V28, P209; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Hymel Kent P, 2002, Child Maltreat, V7, P329, DOI 10.1177/107755902237263; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kemp AM, 2010, ARCH DIS CHILD, V95, P355, DOI 10.1136/adc.2009.169110; Kemp AM, 2002, ARCH DIS CHILD, V86, P98, DOI 10.1136/adc.86.2.98; Koumellis P, 2009, ARCH DIS CHILD, V94, P216, DOI 10.1136/adc.2008.141671; McKinney AM, 2008, PEDIATR RADIOL, V38, P164, DOI 10.1007/s00247-007-0673-0; Schoenwaelder M, 2009, EMERG RADIOL, V16, P129, DOI 10.1007/s10140-008-0749-7; Zimmerman RA, 2007, J NEURORADIOLOGY, V34, P109, DOI 10.1016/j.neurad.2007.01.124	21	52	52	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	JUL	2014	44	7					839	848		10.1007/s00247-014-2874-7			10	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	AK1XW	WOS:000338213600009	24557483				2022-02-06	
J	Koenig, CJ; Maguen, S; Monroy, JD; Mayott, L; Seal, KH				Koenig, Christopher J.; Maguen, Shira; Monroy, Jose D.; Mayott, Lindsay; Seal, Karen H.			Facilitating culture-centered communication between health care providers and veterans transitioning from military deployment to civilian life	PATIENT EDUCATION AND COUNSELING			English	Article						Patient-centered care; Health communication; Culture; Post-deployment health; Readjustment experience; Military veterans; USA	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; AFGHANISTAN VETERANS; MENTAL-HEALTH; DISCOURSE ANALYSIS; COMBAT; BARRIERS; WOMEN; IRAQ; HOME	Objective: To describe returning veterans' transition experience from military to civilian life and to educate health care providers about culture-centered communication that promotes readjustment to civilian life. Methods: Qualitative, in-depth, semi-structured interviews with 17 male and 14 female Iraq and Afghanistan veterans were audio recorded, transcribed verbatim, and analyzed using Grounded Practical Theory. Results: Veterans described disorientation when returning to civilian life after deployment. Veterans' experiences resulted from an underlying tension between military and civilian identities consistent with reverse culture shock. Participants described challenges and strategies for managing readjustment stress across three domains: intrapersonal, professional/educational, and interpersonal. Conclusions: To provide patient-centered care to returning Iraq and Afghanistan veterans, health care providers must be attuned to medical, psychological, and social challenges of the readjustment experience, including reverse culture shock. Cultufe-centered communication may help veterans integrate positive aspects of military and civilian identities, which may promote full reintegration into civilian life. Practice implications: Health care providers may promote culture-centered interactions by asking veterans to reflect about their readjustment experiences. By actively eliciting challenges and helping veterans' to identify possible solutions, health care providers may help veterans integrate military and civilian identities through an increased therapeutic alliance and social support throughout the readjustment process. Published by Elsevier Ireland Ltd.	[Koenig, Christopher J.; Maguen, Shira; Monroy, Jose D.; Mayott, Lindsay; Seal, Karen H.] San Francisco Vet Adm Med Ctr, San Francisco, CA 94121 USA; [Koenig, Christopher J.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Maguen, Shira; Seal, Karen H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Koenig, Christopher J.; Mayott, Lindsay; Seal, Karen H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Monroy, Jose D.] San Francisco State Univ, Dept Psychol, San Francisco, CA 94132 USA		Koenig, CJ (corresponding author), San Francisco Vet Adm Med Ctr, Dept Med, 4150 Clement St,111-A1, San Francisco, CA 94121 USA.	Christopher.Koenig@va.gov	Koenig, Christopher J./AAA-2831-2020	Koenig, Christopher J./0000-0003-0884-4120	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0106]	Department of Defense award W81XWH-08-2-0106 funded this study. The funders had no role in the design, data analysis, writing or approval of the manuscript.	Abramson CM, 2012, J THEOR SOC BEHAV, V42, P155, DOI 10.1111/j.1468-5914.2011.00484.x; ADLER PS, 1975, J HUMANIST PSYCHOL, V15, P13; Ames GM, 2007, J STUD ALCOHOL DRUGS, V68, P336, DOI 10.15288/jsad.2007.68.336; Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8; Arthur N., 2000, CAN J COUNS, V34, P204; Beder J, 2011, SOC WORK HEALTH CARE, V50, P515, DOI 10.1080/00981389.2011.554279; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Brinkmann S., 2009, INTERVIEWS LEARNING; Brown WV, 2011, J CLIN LIPIDOL, V5, P1, DOI 10.1016/j.jacl.2010.11.010; Butler CW, 2010, SOC PSYCHOL QUART, V73, P265, DOI 10.1177/0190272510379838; Chretien JP, 2013, J GEN INTERN MED, V28, P953, DOI 10.1007/s11606-013-2359-7; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Crabtree B. F., 1999, DOING QUALITATIVE RE; CRAIG RT, 1995, COMMUN THEOR, V5, P248, DOI 10.1111/j.1468-2885.1995.tb00108.x; Cuber BJF, 2012, MARRIAGE FAM LIVING, V7, P28; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; Dutta MJ, 2007, COMMUN THEOR, V17, P304, DOI 10.1111/j.1468-2885.2007.00297.x; FAULKNER RR, 1977, URBAN LIFE, V6, P303, DOI 10.1177/089124167700600303; GALBRAITH H M, 1945, J Okla State Med Assoc, V38, P481; Gaw KF, 2000, INT J INTERCULT REL, V24, P83, DOI 10.1016/S0147-1767(99)00024-3; Goldsmith DJ, 1997, HUM COMMUN RES, V23, P454, DOI 10.1111/j.1468-2958.1997.tb00406.x; Halfon N, 2002, MILBANK Q, V80, P433, DOI 10.1111/1468-0009.00019; Hall LK, 2011, SOC WORK HEALTH CARE, V50, P4, DOI 10.1080/00981389.2010.513914; Heritage J, 1992, DILEMMAS ADVICE ASPE, P359; Hinojosa R, 2010, J AM BOARD FAM MED, V23, P770, DOI 10.3122/jabfm.2010.06.100094; Hobbs K, 2008, AAOHN J, V56, P337, DOI 10.3928/08910162-20080801-07; Koenig CJ, 2012, HEALTH COMMUN, V27, P818, DOI 10.1080/10410236.2011.651708; Kuehner CA, 2013, J AM ACAD NURSE PRAC, V25, P77, DOI 10.1111/j.1745-7599.2012.00810.x; Lannin DR, 2002, AM J SURG, V184, P418, DOI 10.1016/S0002-9610(02)01009-7; Lapp CA, 2010, J FAM NURS, V16, P45, DOI 10.1177/1074840709357347; Lomsky-Feder E, 2008, ARMED FORCES SOC, V34, P593, DOI 10.1177/0095327X07312090; Maguen S, 2006, J LOSS TRAUMA, V11, P373, DOI 10.1080/15325020600672004; Maguen S, 2010, PROF PSYCHOL-RES PR, V41, P135, DOI 10.1037/a0018835; Mattocks KM, 2012, SOC SCI MED, V74, P537, DOI 10.1016/j.socscimed.2011.10.039; McLean, 2002, CANADIAN J COUNSELLI, V36; Muhr T, 1999, ATLAS TI 6 X; Nayback AM, 2008, J PSYCHOSOC NURS MEN, V46, P43; Ouimette P, 2011, PSYCHOL SERV, V8, P212, DOI 10.1037/a0024360; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ray SL, 2011, J PSYCHIATR MENT HLT, V18, P198, DOI 10.1111/j.1365-2850.2010.01652.x; Roberts C, 2005, MED EDUC, V39, P632, DOI 10.1111/j.1365-2929.2005.02171.x; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Saha S, 2008, J NATL MED ASSOC, V100, P1275, DOI 10.1016/S0027-9684(15)31505-4; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Sayers SL, 2009, J CLIN PSYCHIAT, V8, pe1; Schegloff EA, 2005, SOC PROBL, V52, P449, DOI 10.1525/sp.2005.52.4.449; Schuetz A, 1945, AM J SOCIOL, V50, P369, DOI 10.1086/219654; Seal KH, 2011, J GEN INTERN MED, V26, P1160, DOI 10.1007/s11606-011-1746-1; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Sewell WH, 1999, STUD HIST SOC CULT, V34, P35; Shaw SE, 2009, FAM PRACT, V26, P413, DOI 10.1093/fampra/cmp038; Shuy RW, 2002, IN PERSON VERSUS TEL, P537; Silverstein R, 1996, J GENET PSYCHOL, V157, P169, DOI 10.1080/00221325.1996.9914855; SOLOMON Z, 1988, PSYCHIATRY, V51, P323, DOI 10.1080/00332747.1988.11024407; Sorsdahl MN, 2010, REENTRY TRANSITION F; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Stachyra A., 2011, BEING BECOMING US IR; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Teal CR, 2009, SOC SCI MED, V68, P533, DOI 10.1016/j.socscimed.2008.10.015; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Walsh JME, 2004, J GEN INTERN MED, V19, P156, DOI 10.1111/j.1525-1497.2004.30263.x; WOLFE J, 1993, J TRAUMA STRESS, V6, P179, DOI 10.1002/jts.2490060203	66	52	53	0	41	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0738-3991			PATIENT EDUC COUNS	Patient Educ. Couns.	JUN	2014	95	3					414	420		10.1016/j.pec.2014.03.016			7	Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Public, Environmental & Occupational Health; Social Sciences - Other Topics	AI3QD	WOS:000336776100017	24742536				2022-02-06	
J	McCauley, SR; Wilde, EA; Barnes, A; Hanten, G; Hunter, JV; Levin, HS; Smith, DH				McCauley, Stephen R.; Wilde, Elisabeth A.; Barnes, Amanda; Hanten, Gerri; Hunter, Jill V.; Levin, Harvey S.; Smith, Douglas H.			Patterns of Early Emotional and Neuropsychological Sequelae after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						post-traumatic stress disorder; memory; mild traumatic brain injury; post-concussion syndrome; processing speed	CONCUSSION SYMPTOMS QUESTIONNAIRE; MINOR HEAD-INJURY; IDENTIFICATION TEST AUDIT; ABUSE SCREENING-TEST; HIGH-SCHOOL; PSYCHOMETRIC PROPERTIES; PRACTICAL SCALE; RECOVERY; SPORTS; RELIABILITY	Although mild traumatic brain injury (mTBI) is now recognized as a major health issue, there have been relatively few studies of its acute effects. Previous studies of mTBI assessed at 1 week or less post-injury have produced inconsistent results, spanning reports of no ill effects to findings of robust dysfunction. These gross disparities reflect study differences such as the criteria for mTBI diagnosis and selection of comparison groups. In consideration of these issues, this study investigated outcome in the first 96 hours after injury in adolescents and adults ages 12-30 years with mTBI (n=73) compared with orthopedically injured (OI, n=65) and typically developing controls (TDC, n=40). The mTBI group reported significantly greater general psychological distress, post-concussion symptom severity, and post-traumatic stress severity than OI (all p<0.0001) and TDC (all p<0.0001); the OI and TDC groups responded similarly on these variables. There was a significant GroupxAge interaction on the Total score (p<0.009), and the Cognitive (p=0.01) and Somatic (p<0.032) subscales of the Rivermead Post Concussion Symptoms Questionnaire where increasing symptom severity was associated with increasing age in the mTBI group. On neuropsychological assessment, the mTBI group performed significantly more poorly compared with OI for Verbal Selective Reminding Test (delayed recall, p=0.0003) and Symbol-Digit Modalities Test (SDMT written p=0.03; oral, p=0.001). The TDC group more robustly outperformed the mTBI group on these measures and also on the Brief Visuospatial Memory Test (delayed recall, p<0.04), Letter Fluency (p<0.02), and Category Switching (p<0.04). The TDC group outperformed the OI group on SDMT and Letter Fluency. These findings are consistent with previous reports of acute deficits in episodic memory and processing speed acutely after mTBI. Notably, however, these data also demonstrate the challenges of comparison group selection because differences were also found between the TDC and OI groups.	[McCauley, Stephen R.; Wilde, Elisabeth A.; Barnes, Amanda; Hanten, Gerri; Levin, Harvey S.] Baylor Coll Med, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Barnes, Amanda; Hanten, Gerri; Levin, Harvey S.] Univ Texas Houston, Sch Med, Houston, TX USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Smith, Douglas H.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mccauley@bcm.edu	Meijer, Anna/K-5118-2016		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 NS056202]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202] Funding Source: NIH RePORTER	This work was supported by NIH grant P01 NS056202 (Smith, PI). The information in this manuscript and the manuscript itself has never been published either electronically or in print. None of the authors have any financial or other relationship(s) that could be construed as a conflict of interest with respect to the content of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute for Neurological Disorders and Stroke or the National Institutes of Health.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benedict R.H., 1995, BRIEF VISUOSPATIAL M; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bohn M, 1991, VALIDITY DRUG ABUSE; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cato MA, 2002, CLIN NEUROPSYCHOL, V16, P524, DOI 10.1076/clin.16.4.524.13901; Committee on Injury Scaling, 1998, ABBR INJ SCAL; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lidvall H F, 1974, Acta Neurol Scand Suppl, V56, P3; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miller L, 2001, NEUROREHABILITATION, V16, P109; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smith A., 1982, SYMBOL DIGIT MODALIT; Sosin DM, 1996, BRAIN INJURY, V10, P47; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sunderland A., 1983, J VERB LEARN VERB BE, V22, P727, DOI [10.1016/S0022-5371(83)90229-3, DOI 10.1093/BRAIN/AWU207]; TEASDALE G, 1974, LANCET, V2, P81; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Weathers F. W., 1993, 9 ANN CONV INT SOC T; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	66	52	52	0	35	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					914	925		10.1089/neu.2012.2826			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200004	24344952	Green Published			2022-02-06	
J	Mosquera, L; Colon, JM; Santiago, JM; Torrado, AI; Melendez, M; Segarra, AC; Rodriguez-Orengo, JF; Miranda, JD				Mosquera, Laurivette; Colon, Jennifer M.; Santiago, Jose M.; Torrado, Aranza I.; Melendez, Margarita; Segarra, Annabel C.; Rodriguez-Orengo, Jose F.; Miranda, Jorge D.			Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: Their antioxidant effect and role of estrogen receptor alpha	BRAIN RESEARCH			English	Article						Trauma; Neuroprotection; Selective estrogen receptor modulators; 17 beta-estradiol; Locomotor recovery; Estrogen receptor expression	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; BREAST-CANCER; FEMALE RAT; 17-BETA-ESTRADIOL; NEUROPROTECTION; ISCHEMIA; ACTIVATION	17 beta-Estradiol is a multi-active steroid that imparts neuroprotection via diverse mechanisms of action. However, its role as a neuroprotective agent after spinal cord injury (SCI), or the involvement of the estrogen receptor-alpha (ER-a) in locomotor recovery, is still a subject of much debate. In this study, we evaluated the effects of estradiol and of Tamoxifen (an estrogen receptor mixed agonist/antagonist) on locomotor recovery following SCI. To control estradiol cyclical variability, ovariectomized female rats received empty or estradiol filled implants, prior to a moderate contusion to the spinal cord. Estradiol improved locomotor function at 7, 14, 21, and 28 days post injury (DPI), when compared to control groups (measured with the BBB open field test). This effect was ER-a mediated, because functional recovery was blocked with an ER-a antagonist. We also observed that ER-a was up-regulated after SCI. Long-term treatment (28 DPI) with estradiol and Tamoxifen reduced the extent of the lesion cavity, an effect also mediated by ER-a. The antioxidant effects of estradiol were seen acutely at 2 DPI but not at 28 DPI, and this acute effect was not receptor mediated. Rats treated with Tamoxifen recovered some locomotor activity at 21 and 28 DPI, which could be related to the antioxidant protection seen at these time points. These results show that estradiol improves functional outcome, and these protective effects are mediated by the ER-a dependent and independent-mechanisms. Tamoxifen's effects during late stages of SCI support the use of this drug as a long-term alternative treatment for this condition. (C) 2014 Elsevier B.V. All rights reserved.	[Mosquera, Laurivette; Colon, Jennifer M.; Torrado, Aranza I.; Segarra, Annabel C.; Miranda, Jorge D.] Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA; [Santiago, Jose M.] Univ Puerto Rico, Dept Nat Sci, Carolina, PR 00984 USA; [Melendez, Margarita] Inst Forens Sci, San Juan, PR USA; [Rodriguez-Orengo, Jose F.] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA		Miranda, JD (corresponding author), Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA.	jorge.miranda3@upr.edu		Colon-Mercado, Jennifer/0000-0002-2912-554X	COBRE [P20-GM103642]; MBRS-RISE Program [R25-GM061838]; MBRS-SCORE [S06-GM008224]; RCMI Program [G12RR03051]; Division of Biomedical Sciences of the UPR School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM061838, P20GM103642, R01GM068138, S06GM008224] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [G12MD007600] Funding Source: NIH RePORTER	Special thanks to Yvonne Torres for her support during the radioimmunoassay experiment and Nildris Cruz for her unconditional help with the oxidative stress analysis. Thanks to Luz C. Arocho, Odrick Rosas and the staff of the Animal Resource Center at the UPR-MSC, for their surgical and technical support. Special thanks to the Institute of Forensic Sciences for the standardization and analysis of tamoxifen in the samples. Finally, our appreciation to Dr. Anne Etgen for her editorial support, critiques, suggestions and recommendations in the preparation of the manuscript. This research project is in partial fulfillment of Mrs. Laurivette Mosquera and Ms. Jennifer Colon doctoral dissertations. This study was supported by COBRE (P20-GM103642), MBRS-RISE Program (R25-GM061838), MBRS-SCORE (S06-GM008224), RCMI Program (G12RR03051) and the Division of Biomedical Sciences of the UPR School of Medicine.	Amtul Z, 2010, NEUROSCIENCE, V169, P781, DOI 10.1016/j.neuroscience.2010.05.031; [Anonymous], 2012, J Spinal Cord Med, V35, P480, DOI 10.1179/1079026812Z.000000000124; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Baker KA, 2005, J NEUROTRAUM, V22, P415, DOI 10.1089/neu.2005.22.415; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Biegon A, 1996, CANCER RES, V56, P4328; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Breckwoldt M, 2000, EXP CLIN ENDOCR DIAB, V108, P243, DOI 10.1055/s-2000-7751; Bydon M., 2013, WORLD NEUROSURG, P1; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Crespo MJ, 2008, J CARDIOVASC PHARM T, V13, P64, DOI 10.1177/1074248407307854; Cummings SR, 2002, JAMA-J AM MED ASSOC, V287, P216, DOI 10.1001/jama.287.2.216; Cuzzocrea S, 2008, SHOCK, V29, P362, DOI 10.1097/shk.0b013e31814545dc; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; DonCarlos LL, 2009, PSYCHONEUROENDOCRINO, V34, P113; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; DZIUK PJ, 1966, ENDOCRINOLOGY, V78, P208, DOI 10.1210/endo-78-1-208; Elkabes S., 2014, EXP NEUROL; Etgen AM, 2011, FRONT NEUROENDOCRIN, V32, P336, DOI 10.1016/j.yfrne.2010.12.005; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Febo M, 2002, BRAIN RES, V943, P151, DOI 10.1016/S0006-8993(02)02748-8; Feng YZ, 2004, EUR J PHARMACOL, V484, P65, DOI 10.1016/j.ejphar.2003.10.048; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 2009, FRONT NEUROENDOCRIN, V30, pV, DOI 10.1016/j.yfrne.2009.04.006; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Hauben E, 2002, EUR J NEUROSCI, V16, P1731, DOI 10.1046/j.1460-9568.2002.02241.x; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Ismailoglu O, 2010, J CLIN NEUROSCI, V17, P1306, DOI 10.1016/j.jocn.2010.01.049; Ismailoglu O, 2013, AM J MED SCI, V345, P39, DOI 10.1097/MAJ.0b013e3182522651; JORDAN VC, 1991, J NATL CANCER I, V83, P492, DOI 10.1093/jnci/83.7.492; Kachadroka S, 2010, J NEUROTRAUM, V27, P611, DOI 10.1089/neu.2009.1069; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Laliberte F, 2011, MENOPAUSE, V18, P1052, DOI 10.1097/gme.0b013e3182175e5c; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; LEGAN SJ, 1975, ENDOCRINOLOGY, V96, P571, DOI 10.1210/endo-96-3-571; Leon RL, 2012, ENDOCRINOLOGY, V153, P3386, DOI 10.1210/en.2011-1859; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Mead R, 1988, DESIGN EXPT, P587; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Osuka K, 2001, J NEUROCHEM, V76, P1842, DOI 10.1046/j.1471-4159.2001.00198.x; Oudega M, 1800, Handb Clin Neurol, V109, P617, DOI 10.1016/B978-0-444-52137-8.00038-3; Prokai L, 2007, PHARMACOL THERAPEUT, V114, P1, DOI 10.1016/j.pharmthera.2007.01.006; Rau SW, 2003, J NEUROSCI, V23, P11420; Ritz MF, 2008, BRAIN RES, V1203, P177, DOI 10.1016/j.brainres.2008.01.091; Samantaray S, 2011, NEUROCHEM RES, V36, P1809, DOI 10.1007/s11064-011-0498-y; Santiago JM, 2009, J NEUROTRAUM, V26, P1783, DOI 10.1089/neu.2007.0502; Sare GM, 2008, EUR HEART J, V29, P2031, DOI 10.1093/eurheartj/ehn299; Scott E, 2012, FRONT NEUROENDOCRIN, V33, P85, DOI 10.1016/j.yfrne.2011.10.001; Segarra AC, 2004, PRINCIPLES GENDER SP, P96; Siriphorn A, 2012, J COMP NEUROL, V520, P2630, DOI 10.1002/cne.23056; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Sribnick EA, 2006, NEUROSCIENCE, V137, P197, DOI 10.1016/j.neuroscience.2005.08.074; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; Sribnick EA, 2010, J NEUROSCI RES, V88, P1738, DOI 10.1002/jnr.22337; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0; Sugishita K, 2003, J MOL CELL CARDIOL, V35, P331, DOI 10.1016/S0022-2828(03)00017-8; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Traynor BJ, 2006, NEUROLOGY, V67, P20, DOI 10.1212/01.wnl.0000223353.34006.54; VanderHorst VGJM, 2005, J COMP NEUROL, V488, P152, DOI 10.1002/cne.20569; Winterle JS, 2001, ARCH BIOCHEM BIOPHYS, V392, P233, DOI 10.1006/abbi.2001.2431; WISE PM, 1981, BIOL REPROD, V24, P820, DOI 10.1095/biolreprod24.4.820; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yune TY, 2008, J NEUROTRAUM, V25, P1121, DOI 10.1089/neu.2008.0544; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	75	52	54	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 2	2014	1561						11	22		10.1016/j.brainres.2014.03.002			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH3GU	WOS:000336012500002	24637260	Green Accepted			2022-02-06	
J	Sinclair, KL; Ponsford, JL; Taffe, J; Lockley, SW; Rajaratnam, SMW				Sinclair, Kelly L.; Ponsford, Jennie L.; Taffe, John; Lockley, Steven W.; Rajaratnam, Shantha M. W.			Randomized Controlled Trial of Light Therapy for Fatigue Following Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; light therapy; fatigue; excessive daytime sleepiness; sleep disturbance; depression	EXCESSIVE DAYTIME SLEEPINESS; PSYCHOMOTOR VIGILANCE; INTERINDIVIDUAL DIFFERENCES; BRIGHT LIGHT; ALERTNESS; SENSITIVITY; DISTURBANCE; WAVELENGTH; DEPRESSION; DISORDERS	Background. Fatigue is a common, persistent complaint following traumatic brain injury (TBI). Effective treatment is not well established. Objective. The current study aimed to investigate the efficacy of 4 weeks of light therapy for fatigue in patients with TBI. Methods. We undertook a randomized, placebo-controlled study of 4-week, 45 min/morning, home-based treatment with short wavelength (blue) light therapy ((max) = 465 nm, 84.8 mu W/cm(2), 39.5 lux, 1.74 x 10(14) photons/cm(2)/s) compared with yellow light therapy ((max) = 574 nm, 18.5 mu W/cm(2), 68 lux, 1.21 x 10(12) photons/cm(2)/s) containing less photons in the short wavelength range and a no treatment control group (n = 10 per group) in patients with TBI who self-reported fatigue and/or sleep disturbance. Assessments of fatigue and secondary outcomes (self-reported daytime sleepiness, depression, sleep quality, and sustained attention) were conducted over 10 weeks at baseline (week -2), midway through and at the end of light therapy (weeks 2 and 4), and 4 weeks following cessation of light therapy (week 8). Results. After controlling age, gender, and baseline depression, treatment with high-intensity blue light therapy resulted in reduced fatigue and daytime sleepiness during the treatment phase, with evidence of a trend toward baseline levels 4 weeks after treatment cessation. These changes were not observed with lower-intensity yellow light therapy or no treatment control conditions. There was also no significant treatment effect observed for self-reported depression or psychomotor vigilance performance. Conclusions. Blue light therapy appears to be effective in alleviating fatigue and daytime sleepiness following TBI and may offer a noninvasive, safe, and nonpharmacological alternative to current treatments.	[Sinclair, Kelly L.; Ponsford, Jennie L.; Taffe, John; Lockley, Steven W.; Rajaratnam, Shantha M. W.] Monash Univ, Clayton, Vic 3800, Australia; [Ponsford, Jennie L.] Epworth Med Fdn, Richmond, Vic, Australia; [Lockley, Steven W.; Rajaratnam, Shantha M. W.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lockley, Steven W.; Rajaratnam, Shantha M. W.] Harvard Univ, Sch Med, Boston, MA USA		Rajaratnam, SMW (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17,Clayton Campus, Clayton, Vic 3800, Australia.	shantha.rajaratnam@monash.edu		Lockley, Steven/0000-0001-5209-2881; Rajaratnam, Shantha/0000-0001-7527-8558	Transport Accident Commission; Jack Brockhoff Foundation; Centre for Integrated Research and Understanding of Sleep (CIRUS); University of SydneyUniversity of Sydney; RACV Sir Edmund Herring Memorial Scholarship	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by funding from Transport Accident Commission, Jack Brockhoff Foundation, Centre for Integrated Research and Understanding of Sleep (CIRUS), The University of Sydney, and RACV Sir Edmund Herring Memorial Scholarship. goLITE devices were donated by Apollo Health, since bought by Philips Lighting.	Anderson JL, 2009, ACTA PSYCHIAT SCAND, V120, P203, DOI 10.1111/j.1600-0447.2009.01345.x; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Brainard GC, 2005, J BIOL RHYTHM, V20, P314, DOI 10.1177/0748730405278951; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Delis D.C., 2000, CALIFORNIA VERBAL LE; DINGES DF, 1987, SLEEP, V10, P313; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Eastman CI, 1998, ARCH GEN PSYCHIAT, V55, P883, DOI 10.1001/archpsyc.55.10.883; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Field A., 2017, DISCOVERING STAT USI, V5th; Glickman G, 2006, BIOL PSYCHIAT, V59, P502, DOI 10.1016/j.biopsych.2005.07.006; Goel N, 2010, NEUROLOGY, V75, P1509, DOI 10.1212/WNL.0b013e3181f9615d; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Jeste N, 2013, QUAL LIFE RES, V22, P1239, DOI 10.1007/s11136-012-0243-2; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kim H, 2007, SLEEP, V30, P1309, DOI 10.1093/sleep/30.10.1309; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Liu LQ, 2005, SUPPORT CARE CANCER, V13, P1010, DOI 10.1007/s00520-005-0824-5; Lockley SW, 2006, CURR BIOL, V16, pR795, DOI 10.1016/j.cub.2006.08.039; Lockley SW, 2006, SLEEP, V29, P161; Mills Peter R, 2007, J Circadian Rhythms, V5, P2, DOI 10.1186/1740-3391-5-2; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Phipps-Nelson J, 2003, SLEEP, V26, P695, DOI 10.1093/sleep/26.6.695; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; *STATACORP LP, 2009, STAT STAT SOFTW REL; Van Dongen HPA, 2004, SLEEP, V27, P423; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Wood Angela M, 2004, Clin Trials, V1, P368; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; [No title captured]	46	52	53	0	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2014	28	4					303	313		10.1177/1545968313508472			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AE8QB	WOS:000334265300002	24213962				2022-02-06	
J	Alosco, ML; Fedor, AF; Gunstad, J				Alosco, Michael L.; Fedor, Andrew F.; Gunstad, John			Attention deficit hyperactivity disorder as a risk factor for concussions in NCAA division-I athletes	BRAIN INJURY			English	Article						ADHD; NCAA athletes; risk factors; sports-related concussion	TRAUMATIC BRAIN-INJURY; MEDICINE POSITION STATEMENT; FOOTBALL PLAYERS; CHILDREN; SPORT; HISTORY; SOCIETY; IMPACT	Objective: Sports-related concussions are associated with both acute and long-term consequences. Past work has identified novel risk factors and modifiers for concussions, including mood and neuropsychiatric disorders. Attention Deficit Hyperactivity Disorder (ADHD) is a common neuropsychiatric disorder that may also contribute to concussion risk, although no study has examined this possibility. Methods: One hundred and thirty-nine NCAA Division-I athletes at Kent State University (KSU) self-reported a history of prior concussion and diagnostic history of ADHD as part of a larger concussion management programme at KSU. Results: ADHD was prevalent (10.1%) and 18.0% of the sample reported a prior history of at least one concussion injury. 50.4% of athletes with ADHD reported a history of at least one prior concussion vs 14.4% of athletes without ADHD, which represented a significant difference (p<0.01). Analyses showed that athletes with ADHD were more likely to report a past history of concussions than those without ADHD (F (1,133) = 4.31, p = 0.04). Conclusion: ADHD is prevalent in NCAA Division-I athletes and associated with history of past concussions. If replicated, these findings could have important implications in the prevention and management of concussions in athletes with ADHD.	[Alosco, Michael L.; Fedor, Andrew F.; Gunstad, John] Kent State Univ, Dept Psychol, Kent, OH 44242 USA		Alosco, ML (corresponding author), Kent State Univ, Dept Psychol, Kent, OH 44242 USA.	malosco@kent.edu	Meijer, Anna/K-5118-2016		National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK075119, HL089311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL089311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R56DK075119, R01DK075119] Funding Source: NIH RePORTER	Indirect support for this work included National Institutes of Health (NIH) grants DK075119 and HL089311. The authors report no conflicts of interest.	Alosco ML, 2012, INT J ATHL THER TRAI, V17, P22, DOI 10.1123/ijatt.17.5.22; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Chuang TC, 2013, PSYCHIAT RES-NEUROIM, V211, P186, DOI 10.1016/j.pscychresns.2012.11.008; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; FAIGEL HC, 1995, J ADOLESCENT HEALTH, V16, P174, DOI 10.1016/1054-139X(94)00049-K; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey WJ, 1997, ADAPT PHYS ACT Q, V14, P189, DOI 10.1123/apaq.14.3.189; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1	17	52	52	0	22	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					472	474		10.3109/02699052.2014.887145			3	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900011	24564766				2022-02-06	
J	Di Pietro, V; Lazzarino, G; Amorini, AM; Tavazzi, B; D'Urso, S; Longo, S; Vagnozzi, R; Signoretti, S; Clementi, E; Giardina, B; Lazzarino, G; Belli, A				Di Pietro, Valentina; Lazzarino, Giacomo; Amorini, Angela Maria; Tavazzi, Barbara; D'Urso, Serafina; Longo, Salvatore; Vagnozzi, Roberto; Signoretti, Stefano; Clementi, Elisabetta; Giardina, Bruno; Lazzarino, Giuseppe; Belli, Antonio			Neuroglobin expression and oxidant/antioxidant balance after graded traumatic brain injury in the rat	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Brain antioxidants; Neuroglobin; Neuroprotection; Nitrosative stress; Oxidative stress; Traumatic brain injury; Free radicals	OXYGEN-GLUCOSE DEPRIVATION; MOUSE CORTICAL-NEURONS; OXIDATIVE STRESS; GENE-EXPRESSION; IN-VITRO; MODEL; APOPTOSIS; SAMPLES; PATHOPHYSIOLOGY; NEUROPROTECTION	Neuroglobin is a neuron-specific hexacoordinated globin capable of binding various ligands, including 02, NO, and CO, the biological function of which is still uncertain. Various studies seem to indicate that neuroglobin is a neuroprotective agent when overexpressed, acting as a potent inhibitor of oxidative and nitrosative stress. In this study, we evaluated the pathophysiological response of the neuroglobin gene and protein expression in the cerebral tissue of rats sustaining traumatic brain injury of differing severity, while simultaneously measuring the oxidant/antioxidant balance. Two levels of trauma (mild and severe) were induced in anesthetized animals using the weight-drop model of diffuse axonal injury. Rats were then sacrificed at 6, 12, 24, 48, and 120 h after traumatic brain injury, and the gene and protein expression of neuroglobin and the concentrations of malondialdehyde (as a parameter representative of reactive oxygen species-mediated damage), nitrite nitrate (indicative of NO metabolism), ascorbate, and glutathione (GSH) were determined in the brain tissue. Results indicated that mild traumatic brain injury, although causing a reversible increase in oxidative/nitrosative stress (increase in malondialdehyde and nitrite nitrate) and an imbalance in antioxidants (decrease in ascorbate and GSH), did not induce any change in neuroglobin. Conversely, severe traumatic brain injury caused an over nine- and a fivefold increase in neuroglobin gene and protein expression, respectively, as well as a remarkable increase in oxidative/nitrosative stress and depletion of antioxidants. The results of this study, showing a lack of effect in mild traumatic brain injury as well as asynchronous time course changes in neuroglobin expression, oxidative/nitrosative stress, and antioxidants in severe traumatic brain injury, do not seem to support the role of neuroglobin as an endogenous neuroprotective antioxidant agent, at least under pathophysiological conditions.(c) 2014 The Authors. Published by Elsevier Inc	[Di Pietro, Valentina; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Neurotrauma & Neurodegenerat Sect, Birmingham, W Midlands, England; [Lazzarino, Giacomo; Amorini, Angela Maria; Tavazzi, Barbara; Longo, Salvatore; Giardina, Bruno] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Rome, Italy; [D'Urso, Serafina; Lazzarino, Giuseppe] Univ Catania, Div Biochem & Mol Biol, Dept Biol Geol & Environm Sci, I-95125 Catania, Italy; [Vagnozzi, Roberto] Univ Roma Tor Vergata, Neurosurg Sect, Dept Biomed & Prevent, Rome, Italy; [Signoretti, Stefano] San Camillo Hosp, Div Neurosurg, Dept Neurosci Head & Neck Surg, Rome, Italy; [Clementi, Elisabetta] Univ Cattolica Sacro Cuore, CNR Inst Chim Riconoscimento Mol, Rome, Italy		Lazzarino, G (corresponding author), Univ Catania, Div Biochem & Mol Biol, Dept Biol Geol & Environm Sci, I-95125 Catania, Italy.	lazzarig@unict.it	Clementi, Maria Elisabetta/AAA-1450-2022; Clementi, Maria Elisabetta/E-5936-2017; Signoretti, stefano/AAL-5631-2020; Belli, Antonio/I-3799-2015; TAVAZZI, BARBARA/AAB-9830-2019; lazzarino, giuseppe/K-2277-2015	Clementi, Maria Elisabetta/0000-0002-4615-7826; Clementi, Maria Elisabetta/0000-0002-4615-7826; Signoretti, stefano/0000-0002-8086-1622; Belli, Antonio/0000-0002-3211-9933; TAVAZZI, BARBARA/0000-0001-8743-0895; Di Pietro, Valentina/0000-0001-9430-4723; Lazzarino, Giacomo/0000-0003-1639-0966; lazzarino, giuseppe/0000-0002-5917-7279; AMORINI, Angela Maria/0000-0003-3525-9955	Catholic University of Rome; University of Birmingham; University of Catania	This work has been supported, in part, by funds from the Catholic University of Rome, the University of Catania, and the University of Birmingham.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Bonding SH, 2008, INT J BIOL MACROMOL, V43, P295, DOI 10.1016/j.ijbiomac.2008.07.003; Brittain T, 2010, IUBMB LIFE, V62, P878, DOI 10.1002/iub.405; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Giza CC, 2001, J ATHL TRAINING, V36, P228; Haines B, 2013, NEUROSCI LETT, V549, P3, DOI 10.1016/j.neulet.2013.04.039; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hua S, 2010, CURR MED CHEM, V17, P160; Hundahl CA, 2012, BIOCHEM BIOPH RES CO, V425, P100, DOI 10.1016/j.bbrc.2012.07.061; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P183, DOI 10.1159/000135617; Jin KL, 2011, PHARMACOLOGY, V87, P81, DOI 10.1159/000322998; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kiger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020478; Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013; LAZZARINO G, 1991, ANAL BIOCHEM, V197, P191, DOI 10.1016/0003-2697(91)90378-7; LAZZARINO G, 1989, ANAL BIOCHEM, V181, P239, DOI 10.1016/0003-2697(89)90236-4; Lechauve C, 2012, BBA-MOL CELL RES, V1823, P2261, DOI 10.1016/j.bbamcr.2012.09.009; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li SQ, 2013, MOL NEUROBIOL, V47, P197, DOI 10.1007/s12035-012-8373-7; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusardi TA, 2012, EXP NEUROL, V234, P161, DOI 10.1016/j.expneurol.2011.12.026; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Raida Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076565; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Romitelli F, 2007, J CHROMATOGR B, V851, P257, DOI 10.1016/j.jchromb.2007.02.003; Shang AJ, 2012, NEUROL RES, V34, P588, DOI 10.1179/1743132812Y.0000000052; Shang AJ, 2012, NEUROL SCI, V33, P551, DOI 10.1007/s10072-011-0772-4; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Singh S, 2013, NITRIC OXIDE-BIOL CH, V32, P21, DOI 10.1016/j.niox.2013.03.008; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Van Leuven W, 2013, BBA-PROTEINS PROTEOM, V1834, P1764, DOI 10.1016/j.bbapap.2013.04.015; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yu Z, 2012, NEUROSCIENCE, V218, P235, DOI 10.1016/j.neuroscience.2012.05.054; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995	56	52	52	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	APR	2014	69						258	264		10.1016/j.freeradbiomed.2014.01.032			7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AD8BC	WOS:000333490500027	24491879	hybrid, Green Published			2022-02-06	
J	Gao, S; Zhao, P; Lin, C; Sun, YX; Wang, YL; Zhou, ZC; Yang, DJ; Wang, XL; Xu, HZ; Zhou, F; Cao, LM; Zhou, W; Ning, K; Chen, X; Xu, J				Gao, Shane; Zhao, Peng; Lin, Chao; Sun, Yuxi; Wang, Yilei; Zhou, Zhichong; Yang, Danjing; Wang, Xianli; Xu, Hongzhen; Zhou, Fei; Cao, Limei; Zhou, Wei; Ning, Ke; Chen, Xu; Xu, Jun			Differentiation of Human Adipose-Derived Stem Cells into Neuron-Like Cells Which Are Compatible with Photocurable Three-Dimensional Scaffolds	TISSUE ENGINEERING PART A			English	Article							MARROW STROMAL CELLS; HUMAN BONE-MARROW; IN-VITRO DIFFERENTIATION; MURINE; TISSUE; PROTEIN; PROGENITORS; INCREASE; RAT	Multipotent human adipose-derived stromal/stem cells (hADSCs) hold a great promise for cell-based therapy for many devastating human diseases, such as spinal cord injury and stroke. If exogenous hADSCs can be cultured in a three-dimensional (3D) scaffold with effective proliferation and differentiation capacity, it will better mimic the in vivo environment, which will have profound impact on the therapeutic application of hADSCs. In this study, a group of elastic-dominant, porous bioscaffolds from photocurable chitosan and gelatin were fabricated and proven to be biocompatible with both hADSCs and hADSC-derived neuron-like cells (hADSC-NLCs) in vitro. The identity of harvested hADSCs was confirmed by their positive immunostaining of mesenchymal stem cell surface markers, CD29, CD44, and CD105, and also positive expression of stem markers, Sox-2, Oct-4, c-Myc, Nanog, and Klf4. Their multipotency was further confirmed by trilineage differentiation of hADSCs toward adipocyte, osteoblast, and chondrocyte. It was found that hADSCs could be conditioned to differentiate into neurons in vitro as determined by immunostaining the markers of Tuj1, MAP2, NeuN, and Synapsin. The hADSCs and hADSC-NLCs were proven to be biocompatible with 3D scaffold, which actually facilitated the proliferation and differentiation of hADSCs in vitro, by MTT assay and their neuronal gene expression profiling. Moreover, hADSC-NLCs, which were mixed with 3D scaffold and transplanted into traumatic brain injury mouse model, survived in vivo and led to the better repair of the damaged brain area. The immunohistochemical studies revealed that 3D scaffold indeed improved the viability of transplanted cells, their ability to incorporate into the in vivo neural circuit, and their capacity for tissue repair. This study indicates that hADSCs would have great therapeutic application potential as seeding cells for in vivo transplantation to treat various neurological diseases when co-applied with porous chitosan/gelatin bioscaffolds.	[Gao, Shane; Sun, Yuxi; Wang, Yilei; Zhou, Zhichong; Yang, Danjing; Wang, Xianli; Ning, Ke; Xu, Jun] Tongji Univ, Sch Med, East Hosp, Shanghai 200092, Peoples R China; [Zhao, Peng; Lin, Chao; Xu, Hongzhen; Zhou, Wei] Tongji Univ, Sch Med, Inst Biomed Engn & Nano Sci, Shanghai 200092, Peoples R China; [Zhou, Fei; Cao, Limei; Chen, Xu] Jiangsu Univ, Shanghai Peoples Hosp 8, Shanghai 200233, Peoples R China; [Ning, Ke] Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci SITranN, Sheffield, S Yorkshire, England		Chen, X (corresponding author), Jiangsu Univ, Shanghai Peoples Hosp 8, Shanghai 200233, Peoples R China.	cxwp65@163.com; xunymc2000@yahoo.com	Ning, Ke/B-4561-2009	Ning, Ke/0000-0002-0771-1134	Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2010CB945200, 2012CB966300, 2011CB966200]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271369, 81070910]; National program for support of Top-notch young professionals; New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-10-0606]; Shanghai Rising-Star program [11QA1407100]; Projects of International Cooperation and Exchanges NSFC [81261130318]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities	This study is supported by the following grants: the Ministry of Science and Technology of China (2010CB945200, 2012CB966300, 2011CB966200); the National Natural Science Foundation of China (81271369, 81070910); National program for support of Top-notch young professionals; New Century Excellent Talents in University (NCET-10-0606); Shanghai Rising-Star program (11QA1407100); Projects of International Cooperation and Exchanges NSFC (81261130318); and the Fundamental Research Funds for the Central Universities.	Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05; Case J, 2005, ANN NY ACAD SCI, V1044, P183, DOI 10.1196/annals.1349.024; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Figueroa MP, 2007, MICRON, V38, P668, DOI 10.1016/j.micron.2006.08.004; Fujimura J, 2005, BIOCHEM BIOPH RES CO, V333, P116, DOI 10.1016/j.bbrc.2005.05.096; Gao S, 2009, INT J MED MUSHROOMS, V11, P1, DOI 10.1615/IntJMedMushr.v11.i1.10; Germain N, 2010, J CELL BIOCHEM, V111, P535, DOI 10.1002/jcb.22747; Gong HP, 2000, J BIOMED MATER RES, V52, P285; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta AN, 2007, J PHYS CHEM B, V111, P10137, DOI 10.1021/jp070745s; Cardozo AJ, 2011, J MOL NEUROSCI, V44, P186, DOI 10.1007/s12031-011-9503-9; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Pemg CK, 2008, J BIOMED MATER RES A, V84A, P622, DOI 10.1002/jbm.a.31291; Ribeiro D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015786; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schmitt C, 1998, CRIT REV FOOD SCI, V38, P689, DOI 10.1080/10408699891274354; Schwartz Z, 2011, AM J VET RES, V72, P42, DOI 10.2460/ajvr.72.1.42; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Suon S, 2004, STEM CELLS DEV, V13, P625, DOI 10.1089/scd.2004.13.625; Takeuchi S, 2013, TURK NEUROSURG, V23, P349, DOI 10.5137/1019-5149.JTN.7023-12.1; Welstead G Grant, 2008, J Vis Exp, DOI 10.3791/734; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yaghoobi MM, 2005, NEUROSCI LETT, V390, P81, DOI 10.1016/j.neulet.2005.08.011; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Yang LQ, 2011, NEUROREPORT, V22, P370, DOI 10.1097/WNR.0b013e3283469615; Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029; ZEMAN L, 1972, MACROMOLECULES, V5, P513, DOI 10.1021/ma60028a030; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	41	52	54	1	32	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	APR 1	2014	20	7-8					1271	1284		10.1089/ten.tea.2012.0773			14	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering; Materials Science	AE6NG	WOS:000334110000015	24251600	Green Published			2022-02-06	
J	Pugh, KR; Frost, SJ; Rothman, DL; Hoeft, F; Del Tufo, SN; Mason, GF; Molfese, PJ; Mencl, WE; Grigorenko, EL; Landi, N; Preston, JL; Jacobsen, L; Seidenberg, MS; Fulbright, RK				Pugh, Kenneth R.; Frost, Stephen J.; Rothman, Douglas L.; Hoeft, Fumiko; Del Tufo, Stephanie N.; Mason, Graeme F.; Molfese, Peter J.; Mencl, W. Einar; Grigorenko, Elena L.; Landi, Nicole; Preston, Jonathan L.; Jacobsen, Leslie; Seidenberg, Mark S.; Fulbright, Robert K.			Glutamate and Choline Levels Predict Individual Differences in Reading Ability in Emergent Readers	JOURNAL OF NEUROSCIENCE			English	Article						decoding; individual differences; MRS; phonological processing; reading; reading disability	MAGNETIC-RESONANCE-SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; TRAUMATIC BRAIN-INJURY; WHITE-MATTER; GABA CONCENTRATION; FUNCTIONAL CONNECTIVITY; DEVELOPMENTAL DYSLEXIA; AUDITORY-CORTEX; ANGULAR GYRUS; ATTENTION	Reading disability is a brain-based difficulty in acquiring fluent reading skills that affects significant numbers of children. Although neuroanatomical and neurofunctional networks involved in typical and atypical reading are increasingly well characterized, the underlying neurochemical bases of individual differences in reading development are virtually unknown. The current study is the first to examine neurochemistry in children during the critical period in which the neurocircuits that support skilled reading are still developing. In a longitudinal pediatric sample of emergent readers whose reading indicators range on a continuum from impaired to superior, we examined the relationship between individual differences in reading and reading-related skills and concentrations of neurometabolites measured using magnetic resonance spectroscopy. Both continuous and group analyses revealed that choline and glutamate concentrations were negatively correlated with reading and related linguistic measures in phonology and vocabulary (such that higher concentrations were associated with poorer performance). Correlations with behavioral scores obtained 24 months later reveal stability for the relationship between glutamate and reading performance. Implications for neurodevelopmental models of reading and reading disability are discussed, including possible links of choline and glutamate to white matter anomalies and hyperexcitability. These findings point to new directions for research on gene-brain-behavior pathways in human studies of reading disability.	[Pugh, Kenneth R.; Frost, Stephen J.; Hoeft, Fumiko; Del Tufo, Stephanie N.; Molfese, Peter J.; Mencl, W. Einar; Grigorenko, Elena L.; Landi, Nicole; Preston, Jonathan L.; Jacobsen, Leslie; Seidenberg, Mark S.; Fulbright, Robert K.] Haskins Labs Inc, New Haven, CT 06511 USA; [Pugh, Kenneth R.; Rothman, Douglas L.; Mason, Graeme F.; Fulbright, Robert K.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA; [Pugh, Kenneth R.; Del Tufo, Stephanie N.; Landi, Nicole] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Hoeft, Fumiko] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Grigorenko, Elena L.; Landi, Nicole] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Preston, Jonathan L.] So Connecticut State Univ, Dept Commun Disorders, New Haven, CT 06515 USA; [Seidenberg, Mark S.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA		Pugh, KR (corresponding author), Haskins Labs Inc, 300 George St,Suite 900, New Haven, CT 06511 USA.	pugh@haskins.yale.edu	Grigorenko, Elena/V-2418-2019; landi, nicole/ABG-5374-2020; Landi, Nicole/P-2954-2014; Preston, Jonathan/E-9310-2010	Landi, Nicole/0000-0003-2890-2519; Preston, Jonathan/0000-0001-9971-6321; Del Tufo, Stephanie/0000-0002-2463-1785	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD001994, R01 HD048830]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); NIHM; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-HD02-3343, N01-MH9-0002, N01-NS-9-2314, N01-NS-9-2315, N01-NS-9-2316, N01-NS-9-2317, N01-NS-9-2319, N01-NS-9-2320]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD065794, P01HD001994] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [N01HD023343, R01HD048830] Funding Source: NIH RePORTER	This study is supported by NICHD P01 HD001994 to Haskins Laboratories (Carol Fowler) and NICHD R01 HD048830 to Yale University (K.R.P.). The 4T MR system was partially purchased by a generous gift from the W.M. Keck Foundation. Data used in the preparation of this article were obtained from the NIH Pediatric MRI Data Repository created by the NIH MRI Study of Normal Brain Development. This is a multisite, longitudinal study of typically developing children from ages newborn through young adulthood conducted by the Brain Development Cooperative Group and supported by NICHD, NIDA, NIHM, and NINDS (Contract nos. N01-HD02-3343, N01-MH9-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319, -2320). This paper reflects the views of the authors and may not reflect the opinions or views of the NIH.	Baruth JM, 2013, AUTISM RES, V6, P119, DOI 10.1002/aur.1273; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Braze D, 2007, J LEARN DISABIL-US, V40, P226, DOI 10.1177/00222194070400030401; Brennan BP, 2013, BIOL PSYCHIAT, V73, P24, DOI 10.1016/j.biopsych.2012.06.023; Brown MS, 2013, AUTISM RES, V6, P1, DOI 10.1002/aur.1260; Bruno JL, 2013, NEUROIMAGE, V67, P175, DOI 10.1016/j.neuroimage.2012.10.092; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Carrey N, 2002, J CHILD ADOL PSYCHOP, V12, P331, DOI 10.1089/104454602762599871; Carrey NJ, 2007, J CHILD ADOL PSYCHOP, V17, P11, DOI 10.1089/cap.2006.0008; Centanni T, 2013, CEREB CORTE IN PRESS; Che A, 2014, BIOL PSYCHI IN PRESS; Courvoisie H, 2004, J NEUROPSYCH CLIN N, V16, P63, DOI 10.1176/appi.neuropsych.16.1.63; de Diego-Adelino J, 2013, J PSYCHIATR NEUROSCI, V38, P107, DOI 10.1503/jpn.110185; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; Essa MM, 2012, NEUROCHEM RES, V37, P1829, DOI 10.1007/s11064-012-0799-9; Fletcher J. M., 2012, LEARNING LEARNING DI; Frye RE, 2010, CEREB CORTEX, V20, P2625, DOI 10.1093/cercor/bhq010; Gallinat J, 2006, PSYCHOPHARMACOLOGY, V187, P103, DOI 10.1007/s00213-006-0397-0; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gass A, 2013, NEUROLOGY, V80, P17, DOI 10.1212/WNL.0b013e31827b1b4c; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Henry PG, 2001, MAGNET RESON MED, V45, P517, DOI 10.1002/1522-2594(200103)45:3<517::AID-MRM1068>3.0.CO;2-6; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Kalia M, 2008, METABOLISM, V57, pS2, DOI 10.1016/j.metabol.2008.07.009; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Landi N, 2013, DEVELOPMENTAL SCI, V16, P13, DOI 10.1111/j.1467-7687.2012.01180.x; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1409, DOI 10.1016/j.neubiorev.2008.04.008; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Maisog JM, 2008, ANN NY ACAD SCI, V1145, P237, DOI 10.1196/annals.1416.024; Mason GF, 1997, J MAGN RESON, V126, P18, DOI 10.1006/jmre.1997.1143; Mason GF, 2002, MAGN RESON IMAGING, V20, P431, DOI 10.1016/S0730-725X(02)00510-6; Michael N, 2009, PSYCHIAT RES-NEUROIM, V172, P78, DOI 10.1016/j.pscychresns.2009.01.002; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Niogi SN, 2006, NEUROPSYCHOLOGIA, V44, P2178, DOI 10.1016/j.neuropsychologia.2006.01.011; Perlov E, 2009, WORLD J BIOL PSYCHIA, V10, P355, DOI 10.1080/15622970802176032; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Pignatelli M, 2012, J PHYSIOL-PARIS, V106, P81, DOI 10.1016/j.jphysparis.2011.09.007; Poelmans G, 2011, AM J PSYCHIAT, V168, P365, DOI 10.1176/appi.ajp.2010.10070948; Pugh KR, 2013, BRAIN LANG, V125, P173, DOI 10.1016/j.bandl.2012.04.004; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Pugh KR, 2010, NEURAL BASIS READING, P281, DOI DOI 10.1093/ACPROF:OSO/9780195300369.003.0011; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; Rashotte C.A., 1999, TEST WORD READING EF; Richardson AJ, 1997, NMR BIOMED, V10, P309, DOI 10.1002/(SICI)1099-1492(199710)10:7<309::AID-NBM484>3.0.CO;2-0; Richlan F, 2013, HUM BRAIN MAPP, V34, P3055, DOI 10.1002/hbm.22127; Richlan F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012073; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rojas DC, 2014, NEUROIMAGE, V86, P28, DOI 10.1016/j.neuroimage.2013.01.045; Ross AJ, 2004, BRAIN RES REV, V44, P83, DOI 10.1016/j.brainresrev.2003.11.001; ROTHMAN DL, 1993, P NATL ACAD SCI USA, V90, P5662, DOI 10.1073/pnas.90.12.5662; Rothman DL, 1994, NMR PHYSL BIOMEDICIN, P353; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Sagvolden T, 2009, NEUROPHARMACOLOGY, V57, P619, DOI 10.1016/j.neuropharm.2009.08.004; Sanacora G, 2003, ANN NY ACAD SCI, V1003, P292, DOI 10.1196/annals.1300.018; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; SHAYWITZ BA, 1992, J LEARN DISABIL, V25, P639, DOI 10.1177/002221949202501003; Shen J, 2004, J MAGN RESON, V170, P290, DOI 10.1016/j.jmr.2004.05.022; Shen J, 1997, MAGNET RESON MED, V38, P834, DOI 10.1002/mrm.1910380521; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Singh KD, 2012, NEUROIMAGE, V62, P1121, DOI 10.1016/j.neuroimage.2012.01.028; SNOWLING MJ, 1981, PSYCHOL RES-PSYCH FO, V43, P219, DOI 10.1007/BF00309831; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; Valentine GW, 2011, PSYCHIAT RES-NEUROIM, V191, P122, DOI 10.1016/j.pscychresns.2010.10.009; Wagner RK., 1999, COMPREHENSIVE TEST P; Wechsler D., 2011, WECHSLER ABBREVIATED; Woodcock R, 2003, WOODCOCK JOHNSON 3 S; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427	80	52	53	0	20	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 12	2014	34	11					4082	4089		10.1523/JNEUROSCI.3907-13.2014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC9UG	WOS:000332879500028	24623786	Green Published, Bronze			2022-02-06	
J	Lim, MM; Elkind, J; Xiong, GX; Galante, R; Zhu, JX; Zhang, L; Lian, J; Rodin, J; Kuzma, NN; Pack, AI; Cohen, AS				Lim, Miranda M.; Elkind, Jaclynn; Xiong, Guoxiang; Galante, Ray; Zhu, Jingxu; Zhang, Lin; Lian, Jie; Rodin, Julianna; Kuzma, Nicholas N.; Pack, Allan I.; Cohen, Akiva S.			Dietary Therapy Mitigates Persistent Wake Deficits Caused by Mild Traumatic Brain Injury	SCIENCE TRANSLATIONAL MEDICINE			English	Article							CHAIN AMINO-ACIDS; SLEEP-DEPRIVATION; SUSTAINED ATTENTION; PREVALENCE; METABOLISM; DISORDERS; DYNAMICS; LEUCINE; POWER; RATS	Sleep disorders are highly prevalent in patients with traumatic brain injury (TBI) and can significantly impair cognitive rehabilitation. No proven therapies exist to mitigate the neurocognitive consequences of TBI. We show that mild brain injury in mice causes a persistent inability to maintain wakefulness and decreases orexin neuron activation during wakefulness. We gave mice a dietary supplement of branched-chain amino acids (BCAAs), precursors for de novo glutamate synthesis in the brain. BCAA therapy reinstated activation of orexin neurons and improved wake deficits in mice with mild brain injury. Our data suggest that dietary BCAA intervention, acting in part through orexin, can ameliorate injury-induced sleep disturbances and may facilitate cognitive rehabilitation after brain injury.	[Lim, Miranda M.; Pack, Allan I.] Univ Penn, Perelman Sch Med, Dept Med, Div Sleep Med, Philadelphia, PA 19104 USA; [Lim, Miranda M.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Lim, Miranda M.; Galante, Ray; Zhu, Jingxu; Zhang, Lin; Lian, Jie; Rodin, Julianna; Pack, Allan I.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Elkind, Jaclynn; Xiong, Guoxiang; Cohen, Akiva S.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Kuzma, Nicholas N.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA		Lim, MM (corresponding author), Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Div Hosp & Specialty Med, Sleep Disorders Lab, Portland, OR 92739 USA.	lmir@ohsu.edu		Pack, Allan/0000-0002-2879-0484	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HL007713, R01HL111725-01A1, R01NS069629, R01HD059288]; University of Pennsylvania Department of Medicine/Measey Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD059288, R37HD059288] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL111725, T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER	Supported by NIH T32 HL007713 and University of Pennsylvania Department of Medicine/Measey Research Fellowship to M. M. L., NIH R01HL111725-01A1 to A.I P., and NIH R01NS069629 and R01HD059288 to A.S.C.	Acuna-Goycolea C, 2004, J NEUROSCI, V24, P3013, DOI 10.1523/JNEUROSCI.5416-03.2004; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Colas D, 2005, NEUROBIOL AGING, V26, P265, DOI 10.1016/j.neurobiolaging.2004.03.004; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; FRANKEN P, 1991, NEUROSCI LETT, V130, P141, DOI 10.1016/0304-3940(91)90382-4; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Harada M, 1976, Kumamoto Med J, V29, P110; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McDermott CM, 2003, J NEUROSCI, V23, P9687; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Moretti Davide V, 2011, Front Psychiatry, V1, P152, DOI 10.3389/fpsyt.2010.00152; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0; Naidoo N, 2011, AGING CELL, V10, P640, DOI 10.1111/j.1474-9726.2011.00699.x; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Perouansky M, 2010, ANESTHESIOLOGY, V113, P1299, DOI 10.1097/ALN.0b013e3181f90ccc; R Core Team, 2012, R LANG ENV STAT COMP; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Ruskin DN, 2004, EUR J NEUROSCI, V19, P3121, DOI 10.1111/j.0953-816X.2004.03426.x; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yudkoff M, 1997, GLIA, V21, P92, DOI 10.1002/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W	51	52	56	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	DEC 11	2013	5	215							215ra173	10.1126/scitranslmed.3007092			12	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	275OA	WOS:000328685500004	24337480	Green Accepted			2022-02-06	
J	Kou, ZF; Gattu, R; Kobeissy, F; Welch, RD; O'Neil, BJ; Woodard, JL; Ayaz, SI; Kulek, A; Kas-Shamoun, R; Mika, V; Zuk, C; Tomasello, F; Mondello, S				Kou, Zhifeng; Gattu, Ramtilak; Kobeissy, Firas; Welch, Robert D.; O'Neil, Brian J.; Woodard, John L.; Ayaz, Syed Imran; Kulek, Andrew; Kas-Shamoun, Robert; Mika, Valerie; Zuk, Conor; Tomasello, Francesco; Mondello, Stefania			Combining Biochemical and Imaging Markers to Improve Diagnosis and Characterization of Mild Traumatic Brain Injury in the Acute Setting: Results from a Pilot Study	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE; WHITE-MATTER INJURY; DIFFUSE AXONAL INJURY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL LESIONS; BREAKDOWN PRODUCTS; SERUM-LEVELS; BIOMARKERS; CONCUSSION	Background: Mild traumatic brain injury (mTBI) is a significant healthcare burden and its diagnosis remains a challenge in the emergency department. Serum biomarkers and advanced magnetic resonance imaging (MRI) techniques have already demonstrated their potential to improve the detection of brain injury even in patients with negative computed tomography (CT) findings. The objective of this study was to determine the clinical value of a combinational use of both blood biomarkers and MRI in mTBI detection and their characterization in the acute setting (within 24 hours after injury). Methods: Nine patients with mTBI were prospectively recruited from the emergency department. Serum samples were collected at the time of hospital admission and every 6 hours up to 24 hours post injury. Neuronal (Ubiquitin C-terminal Hydrolase-L1 [UCH-L1]) and glial (glial fibrillary acidic protein [GFAP]) biomarker levels were analyzed. Advanced MRI data were acquired at 9 +/- 6.91 hours after injury. Patients' neurocognitive status was assessed by using the Standard Assessment of Concussion (SAC) instrument. Results: The median serum levels of UCH-L1 and GFAP on admission were increased 4.9 folds and 10.6 folds, respectively, compared to reference values. Three patients were found to have intracranial hemorrhages on SWI, all of whom had very high GFAP levels. Total volume of brain white matter (WM) with abnormal fractional anisotropy (FA) measures of diffusion tensor imaging (DTI) were negatively correlated with patients' SAC scores, including delayed recall. Both increased and decreased DTI-FA values were observed in the same subjects. Serum biomarker level was not correlated with patients' DTI data nor SAC score. Conclusions: Blood biomarkers and advanced MRI may correlate or complement each other in different aspects of mTBI detection and characterization. GFAP might have potential to serve as a clinical screening tool for intracranial bleeding. UCH-L1 complements MRI in injury detection. Impairment at WM tracts may account for the patients' neurocognitive symptoms.	[Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [Kou, Zhifeng; Gattu, Ramtilak; Zuk, Conor] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Kobeissy, Firas] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Welch, Robert D.; O'Neil, Brian J.; Ayaz, Syed Imran; Kulek, Andrew; Kas-Shamoun, Robert; Mika, Valerie] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Welch, Robert D.; O'Neil, Brian J.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA; [Woodard, John L.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Tomasello, Francesco; Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy		Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	zhifeng_kou@wayne.edu	Mika, Valerie H./AAO-2816-2020; Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Woodard, John/0000-0001-9196-3336	International Society for Magnetic Resonance in Medicine; Department of DefenseUnited States Department of Defense; Banyan Biomarkers, Inc.	This work was supported by a Seed Grant from the International Society for Magnetic Resonance in Medicine (PI: Zhifeng Kou) and a research grant from the Department of Defense. Drs. Mondello and Kobeissy were employees and received salaries from Banyan Biomarkers, Inc. Dr. Welch is a site PI of a clinical trial from Banyan Biomarkers, Inc., supported by the Department of Defense. Dr. O'Neil is a site PI for BrainScope Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; CDC, 2003, REP C MILD TRAUM BRA; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2012, BIOMARKERS TRAUMATIC; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kou Z, 2010, CLIN MR NEUROIMAGING; Kou Z, 2008, REGION INTEREST ANAL; Kou Z, 2007, JOINT ANN M ISMRM ES; Kou ZF, 2012, RSC DRUG DISCOV, V24, P19, DOI 10.1039/9781849734745-00019; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M., 2000, STANDARDIZED ASSESSM; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; National Academy of Neuropsychology, 2002, MILD TRAUM BRAIN INJ; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Papa L, ANN EMER MED    1108; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Unden J, 2009, J NEUROL, V256, P72, DOI 10.1007/s00415-009-0054-8; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	77	52	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80296	10.1371/journal.pone.0080296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	WOS:000327311900061	24260364	Green Submitted, Green Published, gold			2022-02-06	
J	Kim, J; Kim, TY; Cho, KS; Kim, HN; Koh, JY				Kim, Jean; Kim, Tae-Youn; Cho, Kyung-Sook; Kim, Ha Na; Koh, Jae-Young			Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis	NEUROBIOLOGY OF DISEASE			English	Article						Steroid hormone; Spinal cord; hSOD1; LC3; ALS	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; MITOCHONDRIAL DYSFUNCTION; ALZHEIMER-DISEASE; MUTANT MICE; ALS MODEL; SOD1; PROGRESSION; TOXICITY; TRIAL	Progesterone (PG) exerts neuroprotective effects under conditions such as brain ischemia, traumatic brain injury, and spinal cord injury. Previously, we reported that PG activates autophagy, a potential neuroprotective mechanism, in cortical astrocytes. In the present study, we explored the possibility that PG, by activating autophagy in spinal cord cells, protects against motoneuron degeneration in transgenic (Tg) mice expressing the human G93A-SOD1 (superoxide dismutase 1) mutant, a model of amyotrophic lateral sclerosis. PG treatment increased autophagic flux in G93A-SOD1 Tg spinal cord astrocyte cultures and mice. In addition, PG treatment reduced mutant SOD1 protein levels and motoneuronal death. Inhibition of autophagy with 3-methyladenine (3MA) reversed these PG effects, indicating that activation of autophagy contributed to the PG neuroprotection. PG effects in vivo were tested by intraperitoneally injecting male G93A-SOD1 Tg mice with different doses of PG (2, 4, or 8 mg/kg) or vehicle from 70 days of age until death. Measurements of motor functions using rota-rod tests showed that the onset of symptoms was not different among groups, but the progression of motor dysfunction was significantly delayed in the PG-treated group compared with the vehicle control group. The average lifespan was also prolonged in the PG-injected group. Histological examinations revealed that PG treatment substantially reduced the death of spinal motoneurons at 14 weeks of age with a concomitant decrease in mutant SOD1 levels. Our results demonstrated that PG delays neurodegenerative progress in G93A-SOD1 transgenic mice, possibly through activation of autophagy in the spinal cord. (C) 2013 Elsevier Inc All rights reserved.	[Kim, Jean; Kim, Tae-Youn; Cho, Kyung-Sook; Kim, Ha Na; Koh, Jae-Young] Univ Ulsan, Coll Med, Neural Injury Res Lab, Seoul 138736, South Korea; [Koh, Jae-Young] Univ Ulsan, Coll Med, Dept Neurol, Seoul 138736, South Korea		Koh, JY (corresponding author), Univ Ulsan, Coll Med, Dept Neurol, 388-1 Poongnap Dong, Seoul 138736, South Korea.	jkko@amc.seoul.kr	Koh, Jae-Young/C-9014-2011	Koh, Jae-Young/0000-0002-4318-495X	National Research Foundation of KoreaNational Research Foundation of Korea [2009-0081487, 2005-0093836]; Asan Institute for Life Sciences [2012-193]	This work was supported by the National Research Foundation of Korea (2009-0081487, 2005-0093836), and by Asan Institute for Life Sciences (2012-193).	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Arciello M, 2010, J NEUROCHEM, V112, P183, DOI 10.1111/j.1471-4159.2009.06441.x; Beretta S, 2003, NEUROBIOL DIS, V13, P213, DOI 10.1016/S0969-9961(03)00043-3; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Deniselle MCG, 2012, J NEUROCHEM, V122, P185, DOI 10.1111/j.1471-4159.2012.07753.x; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kim HN, 2012, NEUROCHEM INT, V60, P125, DOI 10.1016/j.neuint.2011.11.015; Kim J, 2009, NEUROBIOL DIS, V34, P221, DOI 10.1016/j.nbd.2009.01.004; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Maitra R, 1998, CAN J PHYSIOL PHARM, V76, P909, DOI 10.1139/cjpp-76-9-909; Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Song CY, 2012, INT J NEUROSCI, V122, P695, DOI 10.3109/00207454.2012.714430; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P557, DOI 10.1136/jnnp-2011-302021; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541	49	52	53	0	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	NOV	2013	59						80	85		10.1016/j.nbd.2013.07.011			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221MV	WOS:000324663900008	23891729				2022-02-06	
J	Veitch, DP; Friedl, KE; Weiner, MW				Veitch, Dallas P.; Friedl, Karl E.; Weiner, Michael W.			Military Risk Factors for Cognitive Decline, Dementia and Alzheimer's Disease	CURRENT ALZHEIMER RESEARCH			English	Article						Alzheimer's disease; armed forces; combat; depression; gulf war illness; post-traumatic stress disorder; risk factors; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; GULF-WAR VETERANS; MENTAL-HEALTH PROBLEMS; QUALITY-OF-LIFE; PERSISTENT ORGANIC POLLUTANTS; AMYLOID PROTEIN DEPOSITION; MAJOR DEPRESSIVE DISORDER; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE	Delayed neurological health consequences of environmental exposures during military service have been generally underappreciated. The rapidly expanding understanding of Alzheimer's disease (AD) pathogenesis now makes it possible to quantitate some of the likely long-term health risks associated with military service. Military risk factors for AD include both factors elevated in military personnel such as tobacco use, traumatic brain injury (TBI), depression, and post-traumatic stress disorder (PTSD) and other nonspecific risk factors for AD including, vascular risk factors such as obesity and obesity-related diseases (e.g., metabolic syndrome), education and physical fitness. The degree of combat exposure, Vietnam era Agent Orange exposure and Gulf War Illness may also influence risk for AD. Using available data on the association of AD and specific exposures and risk factors, the authors have conservatively estimated 423,000 new cases of AD in veterans by 2020, including 140,000 excess cases associated with specific military exposures. The cost associated with these excess cases is approximately $5.8 billion to $7.8 billion. Mitigation of the potential impact of military exposures on the cognitive function of veterans and management of modifiable risk factors through specifically designed programs will be instrumental in minimizing the impact of AD in veterans in the future decades.	[Veitch, Dallas P.; Weiner, Michael W.] Univ Calif San Francisco, Ctr Imaging Neurodegenerat Dis, Ctr Vet Med, San Francisco, CA 94143 USA; [Friedl, Karl E.] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA		Weiner, MW (corresponding author), Univ Calif San Francisco, Ctr Imaging Neurodegenerat Dis, Ctr Vet Med, San Francisco, CA 94143 USA.	michael.weiner@ucsf.edu	Friedl, Karl/M-1803-2019	Friedl, Karl/0000-0002-3134-8427; Veitch, Dallas/0000-0002-9918-0640			Abouzeid M, 2012, J PSYCHOSOM RES, V72, P33, DOI 10.1016/j.jpsychores.2011.08.002; Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Ahmadi N, 2011, AM J CARDIOL, V108, P29, DOI 10.1016/j.amjcard.2011.02.340; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Almond N, 2008, MIL MED, V173, P544, DOI 10.7205/MILMED.173.6.544; Ambrus J L, 2004, J Med, V35, P265; Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; [Anonymous], 1988, JAMA, V259, P2701; [Anonymous], 1998, JAMA-J AM MED ASSOC, V259, P2708; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arora P, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-4; Association As, 2011, ALZH DIS FACTS FIG; Babic D, 2007, PSYCHIAT DANUB, V19, P68; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barber Robert, 2011, Cleve Clin J Med, V78 Suppl 1, pS47, DOI 10.3949/ccjm.78.s1.08; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bendlin BB, 2010, MATURITAS, V65, P131, DOI 10.1016/j.maturitas.2009.12.014; Bentley S, 1991, SHORT HIST PTSD THER; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Bilbul M, 2011, CAN J NEUROL SCI, V38, P580, DOI 10.1017/S0317167100012129; Blanchard MS, 2006, AM J EPIDEMIOL, V163, P66, DOI 10.1093/aje/kwj008; BOSCARINO JA, 1995, J TRAUMA STRESS, V8, P317, DOI 10.1007/BF02109567; Bray RM., 2009, DEP DEFENSE; Bremner J. Douglas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P503; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bridger R, 2009, OCCUP MED-OXFORD, V59, P195, DOI 10.1093/occmed/kqp028; Brown DW, 2010, J GEN INTERN MED, V25, P147, DOI 10.1007/s11606-009-1160-0; Buis LR, 2011, J REHABIL RES DEV, V48, P901, DOI 10.1682/JRRD.2010.08.0144; Bunegin L, 2001, TOXICOL IND HEALTH, V17, P128, DOI 10.1191/0748233701th100oa; Bureau USC, 2010, CENS 2010; Bureau USC, 2012, STAT ABSTR; Byers AL, 2012, AM J GERIAT PSYCHIAT, V20, P664, DOI 10.1097/JGP.0b013e31822001c1; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Carrion-Baralt JR, 2010, J AM GERIATR SOC, V58, P798, DOI 10.1111/j.1532-5415.2010.02789.x; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chang JW, 2010, CHEMOSPHERE, V81, P1027, DOI 10.1016/j.chemosphere.2010.08.050; Chao LDL, 2011, NEUROTOXICOLOGY, V32, P814, DOI 10.1016/j.neuro.2011.06.006; Chao LL, 2010, NEUROTOXICOLOGY, V31, P493, DOI 10.1016/j.neuro.2010.05.006; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cheng D, 2011, DEMENT GERIATR COGN, V31, P424, DOI 10.1159/000324134; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Chwastiak LA, 2011, PSYCHOSOMATICS, V52, P230, DOI 10.1016/j.psym.2010.12.009; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Coughlin Steven S, 2011, Open Epidemiol J, V4, P140; Coughlin SS, 2011, OPEN CARDIOVASC MED, V5, P164, DOI 10.2174/1874192401105010164; Cranmer M, 2000, TOXICOL SCI, V56, P431, DOI 10.1093/toxsci/56.2.431; Cypel Y, 2010, ANN EPIDEMIOL, V20, P339, DOI 10.1016/j.annepidem.2010.02.003; Das SR, 2005, AM J PREV MED, V28, P291, DOI 10.1016/j.amepre.2004.12.007; David AS, 2002, PSYCHOL MED, V32, P1357, DOI 10.1017/S0033291702006359; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Alves TCDF, 2010, J ALZHEIMERS DIS, V20, P749, DOI 10.3233/JAD-2010-091561; Defense Do, 2012, STATISTICS; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dlugosz LJ, 1999, J CLIN EPIDEMIOL, V52, P1267, DOI 10.1016/S0895-4356(99)00131-6; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Enache D, 2011, CURR OPIN PSYCHIATR, V24, P461, DOI 10.1097/YCO.0b013e32834bb9d4; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiedler N, 2006, BRIT J PSYCHIAT, V188, P453, DOI 10.1192/bjp.188.5.453; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FLESCHJANYS D, 1995, AM J EPIDEMIOL, V142, P1165, DOI 10.1093/oxfordjournals.aje.a117575; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Freiberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P247, DOI 10.1097/QAI.0b013e3181c6c4b7; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gibson TB, 2009, MIL MED, V174, P936, DOI 10.7205/MILMED-D-03-7808; Gizlice Z., 2002, 133 N CAR CTR HLTH S; Goh C, 2010, PSYCHIAT DANUB, V22, P198; GOLDBERG J, 1990, JAMA-J AM MED ASSOC, V263, P1227, DOI 10.1001/jama.263.9.1227; Goldstein L.E., 2012, SCI TRANSL MED, V4; Graham DI, 1999, ACT NEUR S, V73, P89; Granado NS, 2009, HYPERTENSION, V54, P966, DOI 10.1161/HYPERTENSIONAHA.109.132555; Greenberg N, 2008, Emerg Health Threats J, V1, pe10, DOI 10.3134/ehtj.08.010; Guillamondegui OD, 2011, 11EHC017EF AHRQ; Haddock CK, 2007, MIL MED, V172, P527, DOI 10.7205/MILMED.172.5.527; Haley RW, 2000, RADIOLOGY, V215, P807, DOI 10.1148/radiology.215.3.r00jn48807; Hamilton JD, 1998, J TRAUMA STRESS, V11, P763, DOI 10.1023/A:1024449517730; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hankin CS, 2006, J AMBUL CARE MANAG, V29, P51, DOI 10.1097/00004479-200601000-00006; Hankin CS, 1999, AM J PSYCHIAT, V156, P1924; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Health status of Vietnam veterans. III, 1988, JAMA-J AM MED ASSOC, V259, P2715; Heaton KJ, 2007, NEUROTOXICOLOGY, V28, P761, DOI 10.1016/j.neuro.2007.03.006; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Henriksen GL, 1997, EPIDEMIOLOGY, V8, P252, DOI 10.1097/00001648-199705000-00005; Heppner PS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; Huber A, 1993, 2 INT NEUTR S; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Hunt SC, 2006, AM J EPIDEMIOL, V164, DOI 10.1093/aje/kwj297; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Institute of Medicine, 2009, GULF WAR HLTH; Ismail K, 2006, PHILOS T R SOC B, V361, P543, DOI 10.1098/rstb.2006.1815; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jakovjevic M, 2007, PSYCHIAT DANUB, V19, P76; Jakovljevic Miro, 2006, Psychiatr Danub, V18, P169; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Johnson AM, 2010, ANN EPIDEMIOL, V20, P143, DOI 10.1016/j.annepidem.2009.10.006; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kang HK, 2006, AM J IND MED, V49, P875, DOI 10.1002/ajim.20385; Kang HK, 2006, ANN EPIDEMIOL, V16, P381, DOI 10.1016/j.annepidem.2005.03.004; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P70; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Kern PA, 2004, J CLIN ENDOCR METAB, V89, P4665, DOI 10.1210/jc.2004-0250; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim JS, 2003, IND HEALTH, V41, P149, DOI 10.2486/indhealth.41.149; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; Kimm H, 2011, ARCH GERONTOL GERIAT, V52, pE117, DOI 10.1016/j.archger.2010.09.004; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Kizer KW, 2012, JAMA-J AM MED ASSOC, V307, P789, DOI 10.1001/jama.2012.196; Koepsell TD, 2009, PREV MED, V48, P267, DOI 10.1016/j.ypmed.2009.01.008; Kogevinas M, 1997, AM J EPIDEMIOL, V145, P1061, DOI 10.1093/oxfordjournals.aje.a009069; Kopf PG, 2008, CARDIOVASC TOXICOL, V8, P181, DOI 10.1007/s12012-008-9027-x; Kopf PG, 2010, TOXICOL SCI, V117, P537, DOI 10.1093/toxsci/kfq218; Kress AA, 2005, PREV MED, V41, P63, DOI 10.1016/j.ypmed.2004.10.012; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krishnan LL, 2005, DEMENT GERIATR COGN, V20, P245, DOI 10.1159/000087345; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Lahiri DK, 2010, EXP GERONTOL, V45, P291, DOI 10.1016/j.exger.2010.01.001; LeardMann CA, 2011, PUBLIC HEALTH REP, V126, P371, DOI 10.1177/003335491112600311; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; Lee HK, 2010, BBA-GEN SUBJECTS, V1800, P282, DOI 10.1016/j.bbagen.2009.11.010; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Levine J, 2008, DEPRESS ANXIETY, V25, pE154, DOI 10.1002/da.20400; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Li B, 2011, AM J EPIDEMIOL, V174, P761, DOI 10.1093/aje/kwr154; Lim S, 2010, ANN NY ACAD SCI, V1201, P166, DOI 10.1111/j.1749-6632.2010.05622.x; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Littman AJ, 2009, MED SCI SPORT EXER, V41, P1006, DOI 10.1249/MSS.0b013e3181943826; Luchsinger JA, 2009, J ALZHEIMERS DIS, V16, P693, DOI 10.3233/JAD-2009-1022; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McAuley P, 2007, AM J MED, V120, P518, DOI 10.1016/j.amjmed.2006.07.032; McDonald ML, 2003, ADMIN SCI QUART, V48, P1, DOI 10.2307/3556617; McGraw LK, 2008, J CARDIOVASC NURS, V23, P338, DOI 10.1097/01.JCN.0000317437.75081.e7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer JS, 1999, INT J GERIATR PSYCH, V14, P1050, DOI 10.1002/(SICI)1099-1166(199912)14:12<1050::AID-GPS56>3.0.CO;2-Z; Milionis HJ, 2008, CNS SPECTRUMS, V13, P606, DOI 10.1017/S1092852900016886; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Nation DA, 2011, MED HYPOTHESES, V76, P847, DOI 10.1016/j.mehy.2011.02.034; Nelson KM, 2006, J GEN INTERN MED, V21, P915, DOI 10.1007/BF02743137; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; OToole BI, 1996, INT J EPIDEMIOL, V25, P331, DOI 10.1093/ije/25.2.331; Ouseph R, 2007, CLIN NEPHROL, V68, P373; Panza F, 2010, J ALZHEIMERS DIS, V21, P691, DOI 10.3233/JAD-2010-091669; Peckerman A, 2000, PSYCHOSOM MED, V62, P509, DOI 10.1097/00006842-200007000-00009; Pelclova D, 2009, NEUROENDOCRINOL LETT, V30, P219; Peters Ruth, 2008, BMC Geriatr, V8, P36, DOI 10.1186/1471-2318-8-36; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Pinder RJ, 2012, INT J EPIDEMIOL, V41, P1272, DOI 10.1093/ije/dyr096; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Proctor SP, 2001, MIL MED, V166, P510, DOI 10.1093/milmed/166.6.510; Proctor SP, 2006, NEUROTOXICOLOGY, V27, P931, DOI 10.1016/j.neuro.2006.08.001; Puga A, 2011, TOXICOL SCI, V120, P256, DOI 10.1093/toxsci/kfq393; Qureshi SU, 2010, J AM GERIATR SOC, V58, P1627, DOI 10.1111/j.1532-5415.2010.02977.x; Reiber GE, 2004, DIABETES CARE, V27, pB3, DOI 10.2337/diacare.27.suppl_2.B3; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; RICHLIE DG, 1991, ARCH INTERN MED, V151, P1433, DOI 10.1001/archinte.151.7.1433; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Savica R, 2011, PSYCHIAT CLIN N AM, V34, P127, DOI 10.1016/j.psc.2010.11.006; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Schuff N, 1997, ANN NY ACAD SCI, V821, P516, DOI 10.1111/j.1749-6632.1997.tb48319.x; Schuff N, 2008, PSYCHIAT RES-NEUROIM, V162, P147, DOI 10.1016/j.pscychresns.2007.04.011; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sierksma ASR, 2010, EUR J PHARMACOL, V626, P72, DOI 10.1016/j.ejphar.2009.10.021; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Singh JA, 2005, J AM GERIATR SOC, V53, P108, DOI 10.1111/j.1532-5415.2005.53020.x; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith B, 2008, AM J PREV MED, V35, P539, DOI 10.1016/j.amepre.2008.07.009; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Smith TC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-69; Smith TC, 2009, PUBLIC HEALTH REP, V124, P90, DOI 10.1177/003335490912400112; Sperling W, 2011, J NERV MENT DIS, V199, P196, DOI 10.1097/NMD.0b013e31820c71e0; Spira AP, 2012, AM J GERIAT PSYCHIAT, V20, P1006, DOI 10.1097/JGP.0b013e318235b611; SPIRO A, 1994, PSYCHOL AGING, V9, P17, DOI 10.1037/0882-7974.9.1.17; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Stimpson NJ, 2003, BRIT J PSYCHIAT, V182, P391, DOI 10.1192/bjp.182.5.391; Sundstrom A, 2007, INT PSYCHOGERIATR, V19, P159, DOI 10.1017/S1041610206003498; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas HV, 2006, PSYCHOL MED, V36, P735, DOI 10.1017/S0033291705006975; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tsai J, 2011, PREV CHRONIC DIS, V8; Uemura H, 2009, ENVIRON HEALTH PERSP, V117, P568, DOI 10.1289/ehp.0800012; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Voelker MD, 2002, AM J EPIDEMIOL, V155, P899, DOI 10.1093/aje/155.10.899; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Weiner MW, 2011, MIL MED, V176, P896, DOI 10.7205/MILMED-D-10-00332; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; Wint Dylan, 2011, Cleve Clin J Med, V78 Suppl 1, pS44, DOI 10.3949/ccjm.78.s1.07; Woodward SH, 2009, ARCH GEN PSYCHIAT, V66, P1373, DOI 10.1001/archgenpsychiatry.2009.160; Xu WL, 2009, DIABETES, V58, P71, DOI 10.2337/db08-0586; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yoon J, 2011, POPUL HEALTH MANAG, V14, P293, DOI 10.1089/pop.2010.0079; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011	251	52	53	0	49	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050	1875-5828		CURR ALZHEIMER RES	Curr. Alzheimer Res.	NOV	2013	10	9					907	930		10.2174/15672050113109990142			24	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	241GO	WOS:000326154600001	23906002				2022-02-06	
J	Baxter, D; Sharp, DJ; Feeney, C; Papadopoulou, D; Ham, TE; Jilka, S; Hellyer, PJ; Patel, MC; Bennett, AN; Mistlin, A; McGilloway, E; Midwinter, M; Goldstone, AP				Baxter, David; Sharp, David J.; Feeney, Claire; Papadopoulou, Debbie; Ham, Timothy E.; Jilka, Sagar; Hellyer, Peter J.; Patel, Maneesh C.; Bennett, Alexander N.; Mistlin, Alan; McGilloway, Emer; Midwinter, Mark; Goldstone, Anthony P.			Pituitary Dysfunction after Blast Traumatic Brain Injury: The UK BIOSAP Study	ANNALS OF NEUROLOGY			English	Article							GLUCAGON STIMULATION TESTS; GROWTH-HORMONE; AXONAL INJURY; HYPOPITUITARISM; PREVALENCE; SECRETION; MILITARY; TIME	ObjectivePituitary dysfunction is a recognized consequence of traumatic brain injury (TBI) that causes cognitive, psychological, and metabolic impairment. Hormone replacement offers a therapeutic opportunity. Blast TBI (bTBI) from improvised explosive devices is commonly seen in soldiers returning from recent conflicts. We investigated: (1) the prevalence and consequences of pituitary dysfunction following moderate to severe bTBI and (2) whether it is associated with particular patterns of brain injury. MethodsNineteen male soldiers with moderate to severe bTBI (median age = 28.3 years) and 39 male controls with moderate to severe nonblast TBI (nbTBI; median age = 32.3 years) underwent full dynamic endocrine assessment between 2 and 48 months after injury. In addition, soldiers had structural brain magnetic resonance imaging, including diffusion tensor imaging (DTI), and cognitive assessment. ResultsSix of 19 (32.0%) soldiers with bTBI, but only 1 of 39 (2.6%) nbTBI controls, had anterior pituitary dysfunction (p = 0.004). Two soldiers had hyperprolactinemia, 2 had growth hormone (GH) deficiency, 1 had adrenocorticotropic hormone (ACTH) deficiency, and 1 had combined GH/ACTH/gonadotrophin deficiency. DTI measures of white matter structure showed greater traumatic axonal injury in the cerebellum and corpus callosum in those soldiers with pituitary dysfunction than in those without. Soldiers with pituitary dysfunction after bTBI also had a higher prevalence of skull/facial fractures and worse cognitive function. Four soldiers (21.1%) commenced hormone replacement(s) for hypopituitarism. InterpretationWe reveal a high prevalence of anterior pituitary dysfunction in soldiers suffering moderate to severe bTBI, which was more frequent than in a matched group of civilian moderate to severe nbTBI subjects. We recommend that all patients with moderate to severe bTBI should routinely have comprehensive assessment of endocrine function. Ann Neurol 2013;74:527-536	[Baxter, David; Sharp, David J.; Feeney, Claire; Ham, Timothy E.; Jilka, Sagar; Hellyer, Peter J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London W12 0NN, England; [Baxter, David; Midwinter, Mark] Acad Dept Mil Surg & Trauma, Royal Ctr Def Med, Birmingham, W Midlands, England; [Feeney, Claire; Papadopoulou, Debbie; Goldstone, Anthony P.] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Imperial Ctr Endocrinol, London, England; [Patel, Maneesh C.] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Imaging, London, England; [Bennett, Alexander N.; Mistlin, Alan; McGilloway, Emer] Def Med Rehabil Ctr, Epsom, Surrey, England; [Midwinter, Mark] Univ Leeds, Chapel Allerton Hosp, Acad Sect Musculoskeletal Dis, Leeds, W Yorkshire, England; [Goldstone, Anthony P.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, Metab & Mol Imaging Grp, London W12 0NN, England		Goldstone, AP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, Metab & Mol Imaging Grp, Du Cane Rd, London W12 0NN, England.	tony.goldstone@imperial.ac.uk	Midwinter, Mark/AAB-6527-2019; Sharp, David J/A-2119-2013; Hellyer, Peter J/F-7112-2013; Midwinter, Mark J/P-6264-2015	Midwinter, Mark/0000-0003-1836-7137; Hellyer, Peter J/0000-0002-5139-3401; Midwinter, Mark J/0000-0003-1836-7137; Goldstone, Anthony/0000-0001-8179-7071	UK Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [NIHR-RP-011-048]; Imperial College Healthcare Charity [7006/R21U]; Royal Centre for Defence Medicine; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [1110783, G0701951, MR/K023926/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-011-048] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K023926/1, G0701951] Funding Source: UKRI	This study was supported by the UK Medical Research Council (MRC), National Institute for Health Research (NIHR, ref. NIHR-RP-011-048), Imperial College Healthcare Charity (ref. 7006/R21U), and the Royal Centre for Defence Medicine. D.J.S. is supported by the MRC (Clinician Scientist Fellowship) and NIHR, A. P. G. by the MRC, and C. F. by Imperial College Healthcare Charity.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Cegla J, 2013, CLIN ENDOCRINOL, V78, P738, DOI 10.1111/cen.12043; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cherrier MM, 2009, FRONT HORM RES, V37, P150, DOI 10.1159/000176051; Chesser GS, 2012, AFGHANISTAN CASUALTI; Colao A, 2009, J CLIN ENDOCR METAB, V94, P4414, DOI 10.1210/jc.2009-1134; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grossman AB, 2010, J CLIN ENDOCR METAB, V95, P4855, DOI 10.1210/jc.2010-0982; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Leong KS, 2001, CLIN ENDOCRINOL, V54, P463, DOI 10.1046/j.1365-2265.2001.01169.x; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Pervanidou P, 2010, PROG BRAIN RES, V182, P149, DOI 10.1016/S0079-6123(10)82005-9; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Salvatori R, 2005, JAMA-J AM MED ASSOC, V294, P2481, DOI 10.1001/jama.294.19.2481; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanielian T., 2008, INVISIBLE WOUNDS WAR; van Dam PS, 2005, HORM RES, V64, P109, DOI 10.1159/000089326; van Liempt S, 2011, PSYCHONEUROENDOCRINO, V36, P1361, DOI 10.1016/j.psyneuen.2011.03.009; Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009; Webb S M, 2008, J Endocrinol Invest, V31, P52; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	35	52	53	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	OCT	2013	74	4					527	536		10.1002/ana.23958			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257FN	WOS:000327369100007	23794460	Green Published, hybrid			2022-02-06	
J	Kruer, RM; Harris, LH; Goodwin, H; Kornbluth, J; Thomas, KP; Slater, LA; Haut, ER				Kruer, Rachel M.; Harris, Lindsay H.; Goodwin, Haley; Kornbluth, Joshua; Thomas, Katherine P.; Slater, Leigh A.; Haut, Elliott R.			Changing trends in the use of seizure prophylaxis after traumatic brain injury: A shift from phenytoin to levetiracetam	JOURNAL OF CRITICAL CARE			English	Article						Seizure; Seizure prophylaxis; Levetiracetam; Phenytoin; Traumatic brain injury	INTRAVENOUS LEVETIRACETAM	Purpose: Current guidelines for traumatic brain injury (TBI) recommend antiepileptic drugs (AEDs) for 7 days after injury to decrease posttraumatic seizure risk. Phenytoin decreases seizure risk 73% vs placebo during this time. Levetiracetam (LEV) is an alternative; however, no published data validate comparable efficacy. Our objective was to evaluate seizure incidence 7 days after TBI in patients treated with phenytoin (PHT) vs LEV and to characterize practice of AED selection. Methods: A retrospective observational study was conducted using a Trauma Registry (Collector Trauma Registry; Digital Innovation, Inc, Forrest Hill, Md) to evaluate patients with TBI. Patients with an initial Head/Neck Abbreviated Injury Scale score of 3 or higher and a Glasgow Coma Scale of 8 or less were included. Results: Of 109 patients, 89 received PHT, and 20, LEV. Two patients experienced posttraumatic seizure, 1 in each group. Sixty-eight patients survived to hospital discharge; 65% received prophylactic AED greater than 7 days. Ninety-eight percent of 81 patients admitted between 2000 and 2007 received PHT, whereas 64% of 28 patients admitted between 2008 and 2010 received LEV. Conclusion: Only 2 patients experienced posttraumatic seizure after receiving AED, indicating low incidence. Most surviving to hospital discharge received AED prophylaxis greater than 7 days despite guideline recommendations. After approval of intravenous LEV, a trend favoring LEV was observed. (C) 2013 Elsevier Inc. All rights reserved.	[Kruer, Rachel M.; Harris, Lindsay H.; Goodwin, Haley] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Kornbluth, Joshua] Johns Hopkins Univ Hosp, Div Neurocrit Care, Dept Neurol, Baltimore, MD 21287 USA; [Thomas, Katherine P.] Intermt Med Ctr, Dept Med, Div Neurol, Murray, UT 84107 USA; [Slater, Leigh A.; Haut, Elliott R.] Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA; [Slater, Leigh A.; Haut, Elliott R.] Johns Hopkins Univ Hosp, Dept Anesthesiol Crit Care Med ACCM, Baltimore, MD 21287 USA; [Slater, Leigh A.; Haut, Elliott R.] Johns Hopkins Univ Hosp, Dept Emergency Med, Baltimore, MD 21287 USA		Kruer, RM (corresponding author), Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA.	rkruer1@jhmi.edu	Kornbluth, Joshua/U-7807-2019; Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X			Bratton SL, 2007, J NEUROTRAUM, V24, P83; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2007, TRAUMATIC BRAIN INJU; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kazerooni R, 2010, CLINICOECONOMIC OUTC, V2, P15; Paton L, 2007, AVOIDING COMMON ICU, P458; Pieracci FM, 2012, J TRAUMA ACUTE CARE, V72, P276, DOI 10.1097/TA.0b013e31823df31f; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Winter ME, 2008, CLIN PHARMACOKINET, P247	11	52	53	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	OCT	2013	28	5							883.e9	10.1016/j.jcrc.2012.11.020			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	217QM	WOS:000324374700061	23566730				2022-02-06	
J	Nakase-Richardson, R; Sherer, M; Barnett, SD; Yablon, SA; Evans, CC; Kretzmer, T; Schwartz, DJ; Modarres, M				Nakase-Richardson, Risa; Sherer, Mark; Barnett, Scott D.; Yablon, Stuart A.; Evans, Clea C.; Kretzmer, Tracy; Schwartz, Daniel J.; Modarres, Mo			Prospective Evaluation of the Nature, Course, and Impact of Acute Sleep Abnormality After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Delirium; Length of stay; Outcome assessment (health care); Rehabilitation; Sleep	CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; ISCHEMIC-STROKE; ACUTE CONFUSION; WAKE DISTURBANCES; DEPRIVATION; MEMORY; REHABILITATION; INSOMNIA; COGNITION	Objective: To prospectively characterize the prevalence, course, and impact of acute sleep abnormality among traumatic brain injury (TBI) neurorehabilitation admissions. Design: Prospective observational study. Setting: Freestanding rehabilitation hospital. Participants: Primarily severe TBI (median emergency department Glasgow Coma Scale [GCS] score =7; N=205) patients who were mostly men (71%) and white (68%) were evaluated during acute neurorehabilitation. Interventions: None. Main Outcome Measure: Delirium Rating Scale-Revised-98 (DelRS-R98) was administered weekly throughout rehabilitation hospitalization. De1RS-R98 item 1 was used to classify severity of sleep-wake cycle disturbance (SWCD) as none, mild, moderate, or severe. SWCD ratings were analyzed both serially and at 1 month postinjury. Results: For the entire sample, 66% (mild to severe) had SWCD at 1 month postinjury. The course of the SWCD using a subset (n=152) revealed that 84% had SWCD on rehabilitation admission, with 63% having moderate to severe ratings (median, 24d postinjury). By the third serial exam (median, 35d postinjury), 59% remained with SWCD, and 28% had moderate to severe ratings. Using general linear modeling and adjusting for age, emergency department GCS score, and days postinjury, presence of moderate to severe SWCD at 1 month postinjury made significant contributions in predicting duration of posttraumatic amnesia (P<.01) and rehabilitation hospital length of stay (P<.01). Conclusions: Results suggest that sleep abnormalities after TBI are prevalent and decrease over time. However, a high percent remained with SWCD throughout the course of rehabilitation intervention. Given the brevity of inpatient neurorehabilitation, future studies may explore targeting SWCD to improve early outcomes, such as cognitive functioning and economic impact, after TBI. Archives of Physical Medicine and Rehabilitation 2013;94:875-82 (C) 2013 by the American Congress of Rehabilitation Medicine	[Nakase-Richardson, Risa; Kretzmer, Tracy] James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Barnett, Scott D.] Res Ctr Excellence Maximizing Rehabil Outcomes, Tampa, FL USA; [Nakase-Richardson, Risa; Barnett, Scott D.; Kretzmer, Tracy; Schwartz, Daniel J.] Univ S Florida, Tampa, FL USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Houston, TX 77030 USA; [Yablon, Stuart A.] Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Yablon, Stuart A.] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Evans, Clea C.] Methodist Rehabil Ctr, Jackson, MS USA; [Evans, Clea C.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Schwartz, Daniel J.] James A Haley Vet Hosp, Dept Med, Tampa, FL 33612 USA; [Modarres, Mo] Charles Stark Draper Lab Inc, Tampa, FL USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd 116-B, Tampa, FL 33612 USA.	Risa.Richardson@va.gov			National Institute on Disability and Rehabilitation Research, Department of Education [H133A060038, H133B090023, H133A070043]; Health Services Research and Development (HSR&D)/Rehabilitation Research and Development (RR&D) Center of Excellence for Maximizing Rehabilitation Outcomes [COE - HFP 09-156]	Supported by the National Institute on Disability and Rehabilitation Research, Department of Education (grant nos. H133A060038 [TEE Model System National Data and Statistical Center], H133B090023 [Rehabilitation Research and Training Center on Developing Strategies to Foster Community Integration and Participation for Individuals With Traumatic Brain Injury], and H133A070043 [Texas TBI Model System of TIRR]) and the Health Services Research and Development (HSR&D)/Rehabilitation Research and Development (RR&D) Center of Excellence for Maximizing Rehabilitation Outcomes (grant no. COE - HFP 09-156).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Basetti CL, 2011, HDB CLIN NEUROL, V99, P1051; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Bloomfield IL, 2009, J INTERN NEUROPSYCH, V2, P1; Burke DT, 2004, J APPL RES, V4, P239; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dinges DF, 1997, SLEEP, V20, P267; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hermann DM, 2009, NEUROLOGY, V73, P1313, DOI 10.1212/WNL.0b013e3181bd137c; HORNE JA, 1985, ANN CLIN RES, V17, P199; Johnson EO, 1998, SLEEP, V21, P178, DOI 10.1093/sleep/21.2.178; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Leppavuori A, 2002, CEREBROVASC DIS, V14, P90, DOI 10.1159/000064737; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Massicotte-Marquez J, 2008, NEUROLOGY, V70, P1250, DOI 10.1212/01.wnl.0000286943.79593.a6; McDermott CM, 2003, J NEUROSCI, V23, P9687; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nowell Peter D., 1997, JAMA (Journal of the American Medical Association), V278, P2170, DOI 10.1001/jama.278.24.2170; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Siccoli MM, 2008, EUR J NEUROL, V15, P565, DOI 10.1111/j.1468-1331.2008.02119.x; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Tomfohr LM, 2011, SLEEP, V34, P121, DOI 10.1093/sleep/34.1.121; Traumatic Brain Injury Model Systems National Data and Statistical Center, SYLL; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Van Someren EJW, 2007, SLEEP MED REV, V11, P465, DOI 10.1016/j.smrv.2007.07.003; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	49	52	53	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2013	94	5					875	882		10.1016/j.apmr.2013.01.001			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	134HX	WOS:000318202100012	23296143				2022-02-06	
J	Nichols, JE; Niles, JA; DeWitt, D; Prough, D; Parsley, M; Vega, S; Cantu, A; Lee, E; Cortiella, J				Nichols, Joan E.; Niles, Jean A.; DeWitt, Douglas; Prough, Donald; Parsley, Margaret; Vega, Stephanie; Cantu, Andrea; Lee, Eric; Cortiella, Joaquin			Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ABCG2+CXCR4+mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury	STEM CELL RESEARCH & THERAPY			English	Article							CENTRAL-NERVOUS-SYSTEM; RETINOIC ACID; INFLAMMATORY RESPONSE; CHONDROITIN SULFATE; CORD BLOOD; DIFFERENTIATION; SURVIVAL; EXPRESSION; APOPTOSIS; FLUID	Introduction: Nervous system injuries comprise a diverse group of disorders that include traumatic brain injury (TBI). The potential of mesenchymal stem cells (MSCs) to differentiate into neural cell types has aroused hope for the possible development of autologous therapies for central nervous system injury. Methods: In this study we isolated and characterized a human peripheral blood derived (HPBD) MSC population which we examined for neural lineage potential and ability to migrate in vitro and in vivo. HPBD CD133+, ATP-binding cassette sub-family G member 2 (ABCG2)+, C-X-C chemokine receptor type 4 (CXCR4)+ MSCs were differentiated after priming with beta-mercaptoethanol (beta-ME) combined with trans-retinoic acid (RA) and culture in neural basal media containing basic fibroblast growth factor (FGF2) and epidermal growth factor (EGF) or co-culture with neuronal cell lines. Differentiation efficiencies in vitro were determined using flow cytometry or fluorescent microscopy of cytospins made of FACS sorted positive cells after staining for markers of immature or mature neuronal lineages. RA-primed CD133+ABCG2+CXCR4+ human MSCs were transplanted into the lateral ventricle of male Sprague-Dawley rats, 24 hours after sham or traumatic brain injury (TBI). All animals were evaluated for spatial memory performance using the Morris Water Maze (MWM) Test. Histological examination of sham or TBI brains was done to evaluate MSC survival, migration and differentiation into neural lineages. We also examined induction of apoptosis at the injury site and production of MSC neuroprotective factors. Results: CD133+ABCG2+CXCR4+ MSCs consistently expressed markers of neural lineage induction and were positive for nestin, microtubule associated protein-1 beta (MAP-1 beta), tyrosine hydroxylase (TH), neuron specific nuclear protein (NEUN) or type III beta-tubulin (Tuj1). Animals in the primed MSC treatment group exhibited MWM latency results similar to the uninjured (sham) group with both groups showing improvements in latency. Histological examination of brains of these animals showed that in uninjured animals the majority of MSCs were found in the lateral ventricle, the site of transplantation, while in TBI rats MSCs were consistently found in locations near the injury site. We found that levels of apoptosis were less in MSC treated rats and that MSCs could be shown to produce neurotropic factors as early as 2 days following transplantation of cells. In TBI rats, at 1 and 3 months post transplantation cells were generated which expressed markers of neural lineages including immature as well as mature neurons. Conclusions: These results suggest that PBD CD133+ABCG2+CXCR4+ MSCs have the potential for development as an autologous treatment for TBI and neurodegenerative disorders and that MSC derived cell products produced immediately after transplantation may aid in reducing the immediate cognitive defects of TBI.	[Nichols, Joan E.; Niles, Jean A.; Vega, Stephanie; Cantu, Andrea; Lee, Eric; Cortiella, Joaquin] Univ Texas Med Branch, Lab Tissue Engn & Regenerat Med, Galveston, TX 77555 USA; [Nichols, Joan E.; Niles, Jean A.; Vega, Stephanie] Univ Texas Med Branch, Div Infect Dis, Dept Internal Med, Galveston, TX 77555 USA; [DeWitt, Douglas; Prough, Donald; Parsley, Margaret; Lee, Eric; Cortiella, Joaquin] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Nichols, JE (corresponding author), Univ Texas Med Branch, Lab Tissue Engn & Regenerat Med, 301 Univ Blvd,Mail Route 0435, Galveston, TX 77555 USA.	jnichols@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X; Cantu, Andrea/0000-0002-1466-2510	Moody Center for Brain and Spinal Cord Research/Mission Connect (The Moody Center)	This research was supported by The Moody Center for Brain and Spinal Cord Research/Mission Connect (The Moody Center). We would like to thank Dr Gerald Campbell MD PhD from the UTMB Dept of Pathology, Division of Neuropathology for his invaluable support in data analysis. We would like to thank Kenneth D Frohne for his help with images and publishing software. We also need to thank Tatsuo Uchida for doing the statistical analysis of the MWM data. We are indebted to Joe and Nina Brown for their constant support and their belief in the potential of stem cell therapies.	Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Caldwell MA, 2005, EUR J NEUROSCI, V22, P2965, DOI 10.1111/j.1460-9568.2005.04504.x; Canas N, 2011, NEUROCHEM INT, V58, P676; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Christopherson GT, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt81; Conti AC, 1998, J NEUROSCI, V18, P5663; Cortiella J, 2006, TISSUE ENG, V12, P1213, DOI 10.1089/ten.2006.12.1213; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Curry DJ, 2004, J NEUROSURG, V101, P91, DOI 10.3171/ped.2004.101.2.0091; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Egea J, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.01.016; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Habich A, 2006, EXP HEMATOL, V34, P914, DOI 10.1016/j.exphem.2006.03.010; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; HENION PD, 1994, DEV BIOL, V161, P243, DOI 10.1006/dbio.1994.1024; Islam MO, 2005, NEUROSCI RES, V52, P75, DOI 10.1016/j.neures.2005.01.013; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jang YK, 2004, J NEUROSCI RES, V75, P573, DOI 10.1002/jnr.10789; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Khattak SF, 2005, TISSUE ENG, V11, P974, DOI 10.1089/ten.2005.11.974; Kim S, 2006, BRAIN RES, V1123, P27, DOI 10.1016/j.brainres.2006.09.044; Kuci S, 2008, CELL PROLIFERAT, V41, P12, DOI 10.1111/j.1365-2184.2007.00502.x; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Li LL, 2011, BIOMATERIALS, V32, P4489, DOI 10.1016/j.biomaterials.2011.03.019; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McGuckin C, 2008, NAT PROTOC, V3, P1046, DOI 10.1038/nprot.2008.69; Miller RH, 2010, DISCOV MED, V9, P236; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Morando S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt94; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399; Parish Christopher R, 2009, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0409s84; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pozzobon M, 2009, STEM CELLS DEV, V18, P497, DOI 10.1089/scd.2008.0003; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Ross HH, 2008, STEM CELLS, V26, P3218, DOI 10.1634/stemcells.2008-0299; SAS Institute Inc, 2004, SAS 9 1 3 ETL STUD U; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schurman WT, 1999, J AEROSOL MED, V10, P1; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Stumm RK, 2002, J NEUROSCI, V22, P5865; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Ukai R, 2007, J NEUROTRAUM, V24, P508, DOI 10.1089/neu.2006.0161; Wang SP, 2012, MOL MED REP, V6, P848, DOI 10.3892/mmr.2012.997; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Willerth SM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt58; Xiong Y, 2010, DISCOV MED, V10, P434	60	52	55	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	JAN 6	2013	4								3	10.1186/scrt151			23	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	086XI	WOS:000314722400001	23290300	Green Published, gold			2022-02-06	
J	Barbosa, RR; Jawa, R; Watters, JM; Knight, JC; Kerwin, AJ; Winston, ES; Barraco, RD; Tucker, B; Bardes, JM; Rowell, SE				Barbosa, Ronald R.; Jawa, Randeep; Watters, Jennifer M.; Knight, Jennifer C.; Kerwin, Andrew J.; Winston, Eleanor S.; Barraco, Robert D.; Tucker, Brian; Bardes, James M.; Rowell, Susan E.			Evaluation and management of mild traumatic brain injury: An Eastern Association for the Surgery of Trauma practice management guideline	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Mild traumatic brain injury; concussion; guidelines	MINOR HEAD-INJURY; COLLEGIATE FOOTBALL PLAYERS; POST-CONCUSSION SYMPTOMS; COMPUTED-TOMOGRAPHY SCAN; DIFFUSE AXONAL INJURY; NEW-ORLEANS CRITERIA; OF-THE-LITERATURE; COGNITIVE REHABILITATION; INTRACRANIAL INJURY; RANDOMIZED-TRIAL	BACKGROUND: An estimated 1.1 million people sustain a mild traumatic brain injury (MTBI) annually in the United States. The natural history of MTBI remains poorly characterized, and its optimal clinical management is unclear. The Eastern Association for the Surgery of Trauma had previously published a set of practice management guidelines for MTBI in 2001. The purpose of this review was to update these guidelines to reflect the literature published since that time. METHODS: The PubMed and Cochrane Library databases were searched for articles related to MTBI published between 1998 and 2011. Selected older references were also examined. RESULTS: A total of 112 articles were reviewed and used to construct a series of recommendations. CONCLUSION: The previous recommendation that brain computed tomographic (CT) should be performed on patients that present acutely with suspected brain trauma remains unchanged. A number of additional recommendations were added. Standardized criteria that may be used to determine which patients receive a brain CT in resource-limited environments are described. Patients with an MTBI and negative brain CT result may be discharged from the emergency department if they have no other injuries or issues requiring admission. Patients taking warfarin who present with an MTBI should have their international normalized ratio (INR) level determined, and those with supratherapeutic INR values should be admitted for observation. Deficits in cognition and memory usually resolve within 1 month but may persist for longer periods in 20% to 40% of cases. Routine use of magnetic resonance imaging, positron emission tomography, nuclear magnetic resonance, or biochemical markers for the clinical management of MTBI is not supported at the present time. (J Trauma Acute Care Surg. 2012;73: S307-S314. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Barbosa, Ronald R.] Legacy Emanuel Hosp & Hlth Ctr, Portland, OR USA; [Watters, Jennifer M.; Rowell, Susan E.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Jawa, Randeep] Nebraska Med Ctr, Dept Surg, Omaha, NE USA; [Knight, Jennifer C.; Bardes, James M.] W Virginia Univ, Div Acute Care Surg, Dept Surg, Sch Med, Morgantown, WV 26506 USA; [Kerwin, Andrew J.] Univ Florida, Coll Med, Dept Surg, Jacksonville, FL USA; [Winston, Eleanor S.] Baystate Med Ctr, Dept Surg, Div Trauma Crit Care & Emergency Surg Serv, Springfield, MA 01107 USA; [Barraco, Robert D.] Lehigh Valley Hlth Network, Dept Surg, Allentown, PA USA; [Tucker, Brian] Univ Kentucky, Dept Surg, Lexington, KY USA		Barbosa, RR (corresponding author), Legacy Emanuel Hosp, 2801 N Gantenbein,MOB 130, Portland, OR 97227 USA.	Rbarbosa91@yahoo.com	Rowell, Susan/S-7480-2019	Bardes, James/0000-0002-9361-6263			af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KA, 2009, ARCH PHYS MED REHAB, V90, pS52, DOI 10.1016/j.apmr.2009.05.019; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Committee on Trauma American College of Surgeons, 2008, ATLS ADV TRAUM LIF S, V8th; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dutton RP, 2011, J TRAUMA, V70, P554, DOI 10.1097/TA.0b013e31820d1062; Faul M, 2010, TRAUMATIC BRAIN INJU; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Fiedler ER, 2001, ASSESSMENT HEAD INJU; Fisk GD, 1998, BRAIN INJURY, V12, P683; Gamache PL, 2011, BRAIN INJURY, V25, P416, DOI 10.3109/02699052.2011.558039; Gerberding J.L., 2003, C MILD TRAUM BRAIN I; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lange RT, 2010, J TRAUMA, V68, P1065, DOI 10.1097/TA.0b013e3181bb9890; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; The Management of Concussion/mTBI Work Group, VA DOD CLIN PRACT GU; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; World Health Organization, 2008, ICD 10 INT STAT CLAS; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	80	52	53	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2012	73			4			S307	S314		10.1097/TA.0b013e3182701885			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	043VO	WOS:000311578300006	23114486	Bronze			2022-02-06	
J	Semple, BD; Canchola, SA; Noble-Haeusslein, LJ				Semple, Bridgette D.; Canchola, Sandra A.; Noble-Haeusslein, Linda J.			Deficits in Social Behavior Emerge during Development after Pediatric Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; cognitive function; outcome measures; pediatric brain injury; social behavior	MORRIS WATER MAZE; SEX-DIFFERENCES; MOUSE MODEL; NEUROPSYCHOLOGICAL SEQUELAE; SOCIOEMOTIONAL BEHAVIOR; AGGRESSIVE-BEHAVIOR; PREFRONTAL CORTEX; ANIMAL-MODEL; HEAD-INJURY; SHORT-TERM	The pediatric brain may be particularly vulnerable to social deficits after traumatic brain injury (TBI) due to the protracted nature of psychosocial development through adolescence. However, the majority of pre-clinical studies fail to assess social outcomes in experimental pediatric TBI. The current study evaluated social behavior in mice subjected to TBI at postnatal day (p)21. Social behaviors were assessed by a partition test, resident-intruder, three-chamber, and tube dominance tasks during adolescence (p35-42) and again during early adulthood (p60-70), during encounters with unfamiliar, naive stimulus mice. Despite normal olfactory function and normal social behaviors during adolescence, brain-injured mice showed impaired social investigation by adulthood, evidenced by reduced ano-genital sniffing and reduced following of stimulus mice in the resident-intruder task, as well as a loss of preference for sociability in the three-chamber task. TBI mice also lacked a preference for social novelty, suggestive of a deficit in social recognition or memory. By adulthood, brain-injured mice exerted more frequent dominance in the tube task compared to sham-operated controls, a finding suggestive of aggressive tendencies. Together these findings reveal reduced social interaction and a tendency towards increased aggression, which evolves across development to adulthood. This emergence of aberrant social behavior, which parallels the development of other cognitive deficits in this model and behaviors seen in brain-injured children, is consistent with the hypothesis that the full extent of deficits is not realized until the associated skills reach maturity. Thus, efficacy of therapeutics for pediatric TBI should take into account the time-dependent emergence of abnormal behavioral patterns.	[Semple, Bridgette D.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Canchola, Sandra A.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA		Semple, BD (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 513 Parnassus Ave,Room HSE 722, San Francisco, CA 94143 USA.	Bridgette.Semple@ucsf.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS050159]; Core Exploratory Award from the UCSF Resource Allocation Program; Sir Keith Murdoch Fellowship from the American Australian Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050159, R01NS077767] Funding Source: NIH RePORTER	This study was supported by an NIH/NINDS R01 grant (NS050159) and a Core Exploratory Award from the UCSF Resource Allocation Program. The research was conducted in the Neurobehavioral Core for Rehabilitation Research at UCSF. B.D. Semple was also supported by a Sir Keith Murdoch Fellowship from the American Australian Association.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; An XL, 2011, EXP ANIM TOKYO, V60, P111, DOI 10.1538/expanim.60.111; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Bachevalier J, 2001, BEHAV NEUROSCI, V115, P545, DOI 10.1037//0735-7044.115.3.545; Bannerman DM, 2002, EXP BRAIN RES, V142, P395, DOI 10.1007/s00221-001-0938-z; Barker LA, 2010, NEUROPSYCHOLOGIA, V48, P2550, DOI 10.1016/j.neuropsychologia.2010.05.001; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Braga LW, 2007, J CHILD NEUROL, V22, P1084, DOI 10.1177/0883073807306246; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Duval J, 2008, J CHILD NEUROL, V23, P663, DOI 10.1177/0883073808314161; Duvoisin RM, 2011, BEHAV BRAIN RES, V221, P50, DOI 10.1016/j.bbr.2011.02.049; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Engelmann M, 2006, HORM BEHAV, V50, P496, DOI 10.1016/j.yhbeh.2006.04.009; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Ferriero DM, 2010, J ANAT, V217, P429, DOI 10.1111/j.1469-7580.2010.01226.x; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Greve KW, 2001, BRAIN INJURY, V15, P255; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jacobs R, 2011, CORTEX, V47, P808, DOI 10.1016/j.cortex.2010.06.002; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; Kaidanovich-Beilin Oksana, 2011, J Vis Exp, DOI 10.3791/2473; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kudryavtseva N N, 2003, Neurosci Behav Physiol, V33, P461, DOI 10.1023/A:1023411217051; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Maaswinkel H, 1996, PHYSIOL BEHAV, V60, P55, DOI 10.1016/0031-9384(95)02233-3; Malkova L, 2010, BEHAV NEUROSCI, V124, P742, DOI 10.1037/a0021622; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Molina J, 2008, HUM MOL GENET, V17, P2486, DOI 10.1093/hmg/ddn148; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pietropaolo S, 2004, PHYSIOL BEHAV, V81, P443, DOI 10.1016/j.physbeh.2004.02.022; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan BC, 2008, BEHAV BRAIN RES, V193, P235, DOI 10.1016/j.bbr.2008.06.002; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Terranova ML, 2005, CURR PROT TOXICOL; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; VANDEPOLL NE, 1982, J COMP PHYSIOL PSYCH, V96, P893, DOI 10.1037/0735-7036.96.6.893; Verger K, 2001, BRAIN INJURY, V15, P211; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yang M, 2011, CURR PROT NEUROSCI, V8; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.001.2007, 10.3389/neuro.08/001.2007]; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	77	52	53	1	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2672	2683		10.1089/neu.2012.2595			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400008	22888909	Green Published			2022-02-06	
J	Saykally, JN; Rachmany, L; Hatic, H; Shaer, A; Rubovitch, V; Pick, CG; Citron, BA				Saykally, J. N.; Rachmany, L.; Hatic, H.; Shaer, A.; Rubovitch, V.; Pick, C. G.; Citron, B. A.			THE NUCLEAR FACTOR ERYTHROID 2-LIKE 2 ACTIVATOR, TERT-BUTYLHYDROQUINONE, IMPROVES COGNITIVE PERFORMANCE IN MICE AFTER MILD TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						traumatic brain injury; transcription factors; Nrf2; HSP70	OXIDATIVE STRESS; HEAD-INJURY; MEMORY; NEURONS; ASTROCYTES; DEFICITS; DAMAGE; MODEL; IDENTIFICATION; VULNERABILITY	Traumatic Brain injury affects at least 1.7 million people in the United States alone each year. The majority of injuries are categorized as mild but these still produce lasting symptoms that plague the patient and the medical field. Currently treatments are aimed at reducing a patient's symptoms, but there is no effective method to combat the source of the problem, neuronal loss. We tested a mild, closed head traumatic brain injury model for the effects of modulation of the antioxidant transcription factor Nrf2 by the chemical activator, tert-butylhydroquinone (tBHQ). We found that post-injury visual memory was improved by a 7 day course of treatment and that the level of activated caspase-3 in the hippocampus was reduced. The injury-induced memory loss was also reversed by a single injection at 30 min after injury. Since the protective stress response molecule, HSP70, can be upregulated by Nrf2, we examined protein levels in the hippocampus, and found that HSP70 was elevated by the injury and then further increased by the treatment. To test the possible role of HSP70, model neurons in culture exposed to a mild injury and treated with the Nrf2 activator displayed improved survival that was blocked by the HSP70 inhibitor, VER155008. Following mild traumatic brain injury, there may be a partial protective response and patients could benefit from directed enhancement of regulatory pathways such as Nrf2 for neuroprotection. Published by Elsevier Ltd. on behalf of IBRO.	[Saykally, J. N.; Hatic, H.; Citron, B. A.] Mol Biol Lab, Bay Pines, FL 33744 USA; [Saykally, J. N.; Hatic, H.; Citron, B. A.] USF Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Rachmany, L.; Shaer, A.; Rubovitch, V.; Pick, C. G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel		Citron, BA (corresponding author), Mol Biol Lab, Res & Dev 151,Bldg 22,Room 123,POB 4125, Bay Pines, FL 33744 USA.	bruce.citron@va.gov	Pick, Chaim/D-4789-2009		Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development)US Department of Veterans Affairs; Florida Department of Health James and Esther King Biomedical Research Program; Bay Pines Foundation; University of South Florida Signature Interdisciplinary Program in Neuroscience	Acknowledgments-The authors thank Andrea Smith for expert assistance with animal studies. This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development), the Florida Department of Health James and Esther King Biomedical Research Program, the Bay Pines Foundation, and the University of South Florida Signature Interdisciplinary Program in Neuroscience.	Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kane MJ, 2011, BRAIN RES, V1425, P123, DOI 10.1016/j.brainres.2011.09.047; Kane Michael J, 2009, Recent Pat CNS Drug Discov, V4, P190; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; RempelClower NL, 1996, J NEUROSCI, V16, P5233; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shih AY, 2007, J NEUROCHEM, V101, P109, DOI 10.1111/j.1471-4159.2006.04345.x; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	56	52	54	1	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT 25	2012	223						305	314		10.1016/j.neuroscience.2012.07.070			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	018VM	WOS:000309694700031	22890082				2022-02-06	
J	Rafaels, KA; Bass, CR; Panzer, MB; Salzar, RS; Woods, WA; Feldman, SH; Walilko, T; Kent, RW; Capehart, BP; Foster, JB; Derkunt, B; Toman, A				Rafaels, Karin A.; Bass, Cameron R. 'Dale'; Panzer, Matthew B.; Salzar, Robert S.; Woods, William A.; Feldman, Sanford H.; Walilko, Tim; Kent, Richard W.; Capehart, Bruce P.; Foster, Jonathan B.; Derkunt, Burcu; Toman, Amanda			Brain injury risk from primary blast	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Primary blast; brain injury; injury risk; ferret	ADULT-RAT BRAIN; IMPULSE NOISE; HEAD-INJURY; NEURONS; OVERPRESSURE; NEUROTRAUMA; EXPOSURE	BACKGROUND: Military service members are often exposed to at least one explosive event, and many blast-exposed veterans present with symptoms of traumatic brain injury. However, there is little information on the intensity and duration of blast necessary to cause brain injury. METHODS: Varying intensity shock tube blasts were focused on the head of anesthetized ferrets, whose thorax and abdomen were protected. Injury evaluations included physiologic consequences, gross necropsy, and histologic diagnosis. The resulting apnea, meningeal bleeding, and fatality were analyzed using logistic regressions to determine injury risk functions. RESULTS: Increasing severity of blast exposure demonstrated increasing apnea immediately after the blast. Gross necropsy revealed hemorrhages, frequently near the brain stem, at the highest blast intensities. Apnea, bleeding, and fatality risk functions from blast exposure to the head were determined for peak overpressure and positive-phase duration. The 50% risk of apnea and moderate hemorrhage were similar, whereas the 50% risk of mild hemorrhage was independent of duration and required lower overpressures (144 kPa). Another fatality risk function was determined with existing data for scaled positive-phase durations from 1 millisecond to 20 milliseconds. CONCLUSION: The first primary blast brain injury risk assessments for mild and moderate/severe injuries in a gyrencephalic animal model were determined. The blast level needed to cause a mild/moderate brain injury may be similar to or less than that needed for pulmonary injury. The risk functions can be used in future research for blast brain injury by providing realistic injury risks to guide the design of protection or evaluate injury. (J Trauma Acute Care Surg. 2012;73:895-901. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Woods, William A.] Univ Virginia, Dept Emergency Med, Charlottesville, VA USA; [Rafaels, Karin A.; Salzar, Robert S.; Kent, Richard W.; Foster, Jonathan B.; Derkunt, Burcu] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA USA; [Feldman, Sanford H.] Univ Virginia, Ctr Comparat Med, Charlottesville, VA USA; [Toman, Amanda] Tech Support Working Grp, Arlighton, VA USA; [Bass, Cameron R. 'Dale'; Panzer, Matthew B.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Capehart, Bruce P.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Capehart, Bruce P.] Durham VA Med Ctr, Operat Enduring Freedom Operat Iraqi Freedom Vet, Durham, NC USA; [Capehart, Bruce P.] Durham VA Med Ctr, Mental Hlth Serv Line, Durham, NC USA; [Walilko, Tim] Appl Res Associates, Rocky Mt Div, Littleton, CO USA		Rafaels, KA (corresponding author), USA, Res Lab, ATTN RDRL SLB W, 328 Hopkins Rd, Aberdeen Proving Ground, MD 21005 USA.	kar3k@virginia.edu	Feldman, Sanford/AAH-7070-2021		TSWG [W91CRB-09-C-0015]; University of Virginia School of Engineering and Applied Sciences; UVA Center for Applied Biomechanics; UVA Center for Comparative Medicine; Duke University Pratt School of Engineering; Department of Biomedical Engineering	We gratefully acknowledge support from TSWG under contract W91CRB-09-C-0015, the University of Virginia School of Engineering and Applied Sciences, the UVA Center for Applied Biomechanics, the UVA Center for Comparative Medicine for animal support, the Duke University Pratt School of Engineering and the Department of Biomedical Engineering.	Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; Axelsson H, 1996, J TRAUMA, V40, pS31, DOI 10.1097/00005373-199603001-00006; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bogo V, 1971, DASA2659 DEF NUCL AG; Bowen I G, 1968, DASA2113 DEP DEF; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; CLEMEDSON CJ, 1953, AM J PHYSIOL, V174, P316, DOI 10.1152/ajplegacy.1953.174.2.316; Clemedson CJ, 1949, ACTA PHYSL SCAND, V18, P1; DODD KT, 1990, J OCCUP ENVIRON MED, V32, P260, DOI 10.1097/00043764-199003000-00015; Eppinger R., 1984, 840885 SAE; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; Hooker DR, 1924, AM J PHYSIOL, V67, P219; Hosmer D, 1989, APPL LOGISTIC REGRES; Hutsler JJ, 2005, BRAIN RES, V1052, P71, DOI 10.1016/j.brainres.2005.06.015; Hyde D., 2004, CONWEP 2 1 0 8 COMPU; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; JAFFIN JH, 1987, J TRAUMA, V27, P349, DOI 10.1097/00005373-198704000-00002; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Krohn PL, 1941, 249 RC MIN HOM SEC C; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rasband W.S, 1997, IMAGEJ US; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; Risling M, 2005, FOIR0756SE SWED DEF; Romba J, 1959, 1159 HUM ENG LAB; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; SMART IHM, 1986, J ANAT, V146, P141; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; Wood GW, 2010, PERS ARM SYST S QUEB; Yelverton JT, 1997, SCI FDN TRAUMA, P189; Zhu F, 2010, P STAPP CAR CRASH C	40	52	52	1	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2012	73	4					895	901		10.1097/TA.0b013e31825a760e			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	029OL	WOS:000310505100017	22836001				2022-02-06	
J	Lu, CW; Czosnyka, M; Shieh, JS; Smielewska, A; Pickard, JD; Smielewski, P				Lu, Cheng-Wei; Czosnyka, Marek; Shieh, Jiann-Shing; Smielewska, Anna; Pickard, John D.; Smielewski, Peter			Complexity of intracranial pressure correlates with outcome after traumatic brain injury	BRAIN			English	Article						complexity; intracranial pressure; multiscale entropy; traumatic brain injury; outcome	MULTISCALE ENTROPY ANALYSIS; HEART-RATE-VARIABILITY; APPROXIMATE ENTROPY; BLOOD-PRESSURE; PLATEAU WAVES; TIME-SERIES; AUTOREGULATION; HYPERTENSION; DYNAMICS; SYSTEM	This study applied multiscale entropy analysis to investigate the correlation between the complexity of intracranial pressure waveform and outcome after traumatic brain injury. Intracranial pressure and arterial blood pressure waveforms were low-pass filtered to remove the respiratory and pulse components and then processed using a multiscale entropy algorithm to produce a complexity index. We identified significant differences across groups classified by the Glasgow Outcome Scale in intracranial pressure, pressure-reactivity index and complexity index of intracranial pressure (P < 0.0001; P = 0.001; P < 0.0001, respectively). Outcome was dichotomized as survival/death and also as favourable/unfavourable. The complexity index of intracranial pressure achieved the strongest statistical significance (F = 28.7; P < 0.0001 and F = 17.21; P < 0.0001, respectively) and was identified as a significant independent predictor of mortality and favourable outcome in a multivariable logistic regression model (P < 0.0001). The results of this study suggest that complexity of intracranial pressure assessed by multiscale entropy was significantly associated with outcome in patients with brain injury.	[Lu, Cheng-Wei; Czosnyka, Marek; Pickard, John D.; Smielewski, Peter] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge CB0 2QQ, England; [Lu, Cheng-Wei] Far Eastern Mem Hosp, Dept Anaesthesiol, Taipei 220, Taiwan; [Lu, Cheng-Wei; Shieh, Jiann-Shing] Yuan Ze Univ, Dept Mech Engn, Tao Yuan 220, Taiwan; [Smielewska, Anna] Addenbrookes Hosp, Publ Hlth Lab, Dept Virol, Cambridge CB0 2QQ, England		Smielewski, P (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Level 4,A Block, Cambridge CB0 2QQ, England.	ps10011@cam.ac.uk		Smielewski, Peter/0000-0001-5096-3938; Smielewska, Anna/0000-0002-6200-6876	National Institute of Health Research, Biomedical Research Centre (Neuroscience Theme); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390]; NIHRNational Institute for Health Research (NIHR); Center for Dynamical Biomarkers and Translational Medicine; National Science CouncilMinistry of Science and Technology, Taiwan [NSC 100-2911-I-008-001]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0001354, G0001354B, G1000183B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G0001237] Funding Source: UKRI	This work was supported by the National Institute of Health Research, Biomedical Research Centre (Neuroscience Theme), the Medical Research Council (grants G0600986 and G9439390), NIHR Senior Investigator Awards (J.D.P.). This research was also supported by the Center for Dynamical Biomarkers and Translational Medicine which is sponsored by National Science Council (grant number: NSC 100-2911-I-008-001).	Angelini L, 2007, ARTIF INTELL MED, V41, P237, DOI 10.1016/j.artmed.2007.07.012; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; AUER LM, 1983, ACTA NEUROCHIR, V68, P93, DOI 10.1007/BF01406205; Balestreri M, 2005, ACT NEUR S, V95, P25; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Catarino A, 2011, CLIN NEUROPHYSIOL, V122, P2375, DOI 10.1016/j.clinph.2011.05.004; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hornero R, 2007, MED BIOL ENG COMPUT, V45, P617, DOI 10.1007/s11517-007-0194-x; Hu X, 2006, IEEE T BIO-MED ENG, V53, P195, DOI 10.1109/TBME.2005.862546; Hu X, 2008, MED ENG PHYS, V30, P631, DOI 10.1016/j.medengphy.2007.07.002; JENNETT B, 1975, LANCET, V1, P480; LEMAIRE JJ, 1994, COMPUT METH PROG BIO, V42, P1, DOI 10.1016/0169-2607(94)90133-3; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Protzner AB, 2010, ARCH ITAL BIOL, V148, P289; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riordan WP, 2009, J SURG RES, V156, P283, DOI 10.1016/j.jss.2009.03.086; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Santamarta D, 2010, CHILD NERV SYST, V26, P1683, DOI 10.1007/s00381-010-1244-5; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Trunkvalterova Z, 2008, PHYSIOL MEAS, V29, P817, DOI 10.1088/0967-3334/29/7/010; Turianikova Z, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/9/006; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256	42	52	55	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	AUG	2012	135		8				2399	2408		10.1093/brain/aws155			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	984DQ	WOS:000307170300019	22734128	Green Published, Bronze			2022-02-06	
J	Mabry, RL; Apodaca, A; Penrod, J; Orman, JA; Gerhardt, RT; Dorlac, WC				Mabry, Robert L.; Apodaca, Amy; Penrod, Jason; Orman, Jean A.; Gerhardt, Robert T.; Dorlac, Warren C.			Impact of critical care-trained flight paramedics on casualty survival during helicopter evacuation in the current war in Afghanistan	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Advanced Technology Applications for Combat Casualty Care Conference (ATACCC)	AUG 15-18, 2011	Fort Lauderdale, FL			Helicopter; military; trauma; flight medic; Afghanistan; emergency medical services	TRAUMATIC BRAIN-INJURY; EMERGENCY CARE; SERVICES; TRANSPORT; MORTALITY; INTUBATION; OUTCOMES; VICTIMS; PATIENT; ILL	BACKGROUND: The US Army pioneered medical evacuation (MEDEVAC) by helicopter, yet its system remains essentially unchanged since the Vietnam era. Care is provided by a single combat medic credentialed at the Emergency Medical Technician - Basic level. Treatment protocols, documentation, medical direction, and quality improvement processes are not standardized and vary significantly across US Army helicopter evacuation units. This is in contrast to helicopter emergency medical services that operate within the United States. Current civilian helicopter evacuation platforms are routinely staffed by critical care-trained flight paramedics (CCFP) or comparably trained flight nurses who operate under trained EMS physician medical direction using formalized protocols, standardized patient care documentation, and rigorous quality improvement processes. This study compares mortality of patients with injury from trauma between the US Army's standard helicopter evacuation system staffed with medics at the Emergency Medical Technician - Basic level (standard MEDEVAC) and one staffed with experienced CCFP using adopted civilian helicopter emergency medical services practices. METHODS: This is a retrospective study of a natural experiment. Using data from the Joint Theater Trauma Registry, 48-hour mortality for severely injured patients (injury severity score >= 16) was compared between patients transported by standard MEDEVAC units and CCFP air ambulance units. RESULTS: The 48-hour mortality for the CCFP-treated patients was 8% compared to 15% for the standard MEDEVAC patients. After adjustment for covariates, the CCFP system was associated with a 66% lower estimated risk of 48-hour mortality compared to the standard MEDEVAC system. CONCLUSIONS: These findings demonstrate that using an air ambulance system based on modern civilian helicopter EMS practice was associated with a lower estimated risk of 48-hour mortality among severely injured patients in a combat setting. (J Trauma Acute Care Surg. 2012;73: S32-S37. Copyright (c) 2012 by Lippincott Williams & Wilkins) LEVEL OF EVIDENCE: Therapeutic study, level II.	[Mabry, Robert L.] USA, Inst Surg Res, MCMR SRJ, San Antonio, TX 78234 USA		Mabry, RL (corresponding author), USA, Inst Surg Res, MCMR SRJ, 3400 Rawley E Chambers Ave, San Antonio, TX 78234 USA.	robert.mabry@us.army.mil	Gerhardt, Robert/ABI-5668-2020	Gerhardt, Robert/0000-0002-7714-119X			Air Medical Physician Association, 2003, Air Med J, V22, P14; BAXT WG, 1985, ANN EMERG MED, V14, P859, DOI 10.1016/S0196-0644(85)80634-X; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Berry J, 2010, NEWSWEEK        0313; Bledsoe Bryan E, 2003, Emerg Med Serv, V32, P88; BURNEY RE, 1986, ANN EMERG MED, V15, P1491, DOI 10.1016/S0196-0644(86)80950-7; Burney RE, 1987, ANN EMERG MED, V16, P54; COWLEY RA, 1973, J TRAUMA, V13, P1029, DOI 10.1097/00005373-197312000-00001; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; DeLorenzo RA, 1997, AVIAT SPACE ENVIR MD, V68, P56; Driscoll RS, 2001, MIL MED, V166, P290, DOI 10.1093/milmed/166.4.290; Eastridge Brian J, 2009, Am J Surg, V198, P852, DOI 10.1016/j.amjsurg.2009.04.029; FALLON MJ, 1990, ANN EMERG MED, V19, P914, DOI 10.1016/S0196-0644(05)81570-7; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; FREILICH DA, 1990, NEW YORK STATE J MED, V90, P358; Gearhart PA, 1997, ANN EMERG MED, V30, P500, DOI 10.1016/S0196-0644(97)70010-6; Gerhardt R T, 2000, Prehosp Emerg Care, V4, P136, DOI 10.1080/10903120090941407; Higgins RA, 2010, AACN ADV CRIT CARE, V21, P288, DOI 10.1097/NCI.0b013e3181e6741f; Iirola TT, 2006, EUR J EMERG MED, V13, P335, DOI 10.1097/01.mej.0000224429.51623.fb; JACOBS LM, 1989, J NATL MED ASSOC, V81, P1157; Lehmann R, 2009, J TRAUMA, V66, pS31, DOI 10.1097/TA.0b013e31819d9575; McCowan CL, 2007, PREHOSP EMERG CARE, V11, P383, DOI 10.1080/10903120701536867; McCowan Christy L, 2008, Air Med J, V27, P78, DOI 10.1016/j.amj.2007.10.001; MEIER DR, 1989, SOUTHERN MED J, V82, P885, DOI 10.1097/00007611-198907000-00022; MOYLAN JA, 1988, ANN SURG, V208, P673, DOI 10.1097/00000658-198812000-00001; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; Parker Paul J, 2006, J R Army Med Corps, V152, P202; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; WHITE MS, 1971, AEROSPACE MED, V42, P780; Zoroya G, 2009, US TODAY        0120	35	52	52	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73			1			S32	S37		10.1097/TA.0b013e3182606001			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	992VP	WOS:000307808500006	22847091				2022-02-06	
J	Meyer, DL; Davies, DR; Barr, JL; Manzerra, P; Forster, GL				Meyer, Danielle L.; Davies, Daniel R.; Barr, Jeffrey L.; Manzerra, Pasquale; Forster, Gina L.			Mild traumatic brain injury in the rat alters neuronal number in the limbic system and increases conditioned fear and anxiety-like behaviors	EXPERIMENTAL NEUROLOGY			English	Article						Mild traumatic brain injury; Concussive injury; Apoptosis; Hippocampus; Amygdala; Anxiety; Posttraumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; EXPERIMENTAL-MODELS; AMYGDALA RESPONSE; CELL-DEATH; NEUROGENESIS; EXTINCTION; PTSD; CA1	Recent reports suggest that experiencing a mild closed head trauma or mild traumatic brain injury (mTBI) is associated with a greater incidence of anxiety disorders. Dysfunction of limbic structures, such as the medial prefrontal cortex, amygdala and hippocampus, is associated with the symptoms of anxiety disorders. Therefore, the goal of the current studies was to characterize the consequences of closed mTBI on these limbic structures and associated fear and anxiety-related behaviors. A weight-drop procedure was employed to induce mTBI in male rats. Rats were transcardically perfused 4 or 9 days following exposure to mTBI or control procedures, and neuronal number, brain region area, and the number of apoptotic cells in each region were determined. In separate groups of rats, the effects of mTBI on anxiety-like behaviors, motor function, nociception, and acquisition, retention and extinction of contextual fear were also assessed. Findings suggest that mTBI was associated with significant neuronal cell loss in the CA1 region of the dorsal hippocampus and increased cell number in subregions of the amygdala, both of which appear to be related to alterations to apoptosis in these regions following mTBI. Furthermore, mTBI increased expression of anxiety-like behaviors and conditioned fear, with no effect on motor performance or nociception. Overall, a single impact to the skull to mimic mTBI in rats produces discrete alterations to neuronal numbers within the limbic system and specific emotional deficits, providing a potential neurobiological link between mTBI and anxiety disorders. (c) 2012 Elsevier Inc. All rights reserved.	[Meyer, Danielle L.; Davies, Daniel R.; Barr, Jeffrey L.; Manzerra, Pasquale; Forster, Gina L.] Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, Neurosci Grp, Vermillion, SD 57069 USA; [Barr, Jeffrey L.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA		Forster, GL (corresponding author), Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, Neurosci Grp, 414 E Clark St, Vermillion, SD 57069 USA.	gforster@usd.edu			South Dakota Board of Regents, Department of Defense [W81XWH-10-1-0578]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20 RR015567]; USD; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015567] Funding Source: NIH RePORTER	This work was supported by a South Dakota Board of Regents Competitive Research Grant, Department of Defense Grant W81XWH-10-1-0578, NIH P20 RR015567 which is a designated Center of Biomedical Research Excellence (COBRE), and a USD Undergraduate Research Grant to D.D. We thank Jamie Scholl, Emily Reinbold, Dr. Michael Watt, Michael Olson and Dr. Fran Day for their assistance with these experiments.	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Armony JL, 2005, AM J PSYCHIAT, V162, P1961, DOI 10.1176/appi.ajp.162.10.1961; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barr JL, 2010, NEUROPHARMACOLOGY, V59, P395, DOI 10.1016/j.neuropharm.2010.05.011; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Bryant RA, 2008, PSYCHOL MED, V38, P555, DOI 10.1017/S0033291707002231; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Clark RSB, 1997, J NEUROSCI, V17, P9172; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Feng N, 2009, HORM BEHAV, V56, P149, DOI 10.1016/j.yhbeh.2009.03.023; Forster GL, 2006, NEUROSCIENCE, V141, P1047, DOI 10.1016/j.neuroscience.2006.04.006; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031, DOI 10.1152/jn.2000.83.2.1031; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Lukkes JL, 2009, HORM BEHAV, V55, P248, DOI 10.1016/j.yhbeh.2008.10.014; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Malherbe P, 2009, BRIT J PHARMACOL, V156, P1326, DOI 10.1111/j.1476-5381.2009.00127.x; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Okuda H, 2009, J NEUROSCI RES, V87, P3546, DOI 10.1002/jnr.22160; Ooba Satomi, 2009, Kurume Medical Journal, V56, P49; Paxinos CW, 1998, RAT BRAIN STEREOTAXI; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Schienle A, 2011, EUR ARCH PSY CLIN N, V261, P303, DOI 10.1007/s00406-010-0147-5; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Sook-Kyung CK, 2011, FRONT NEUROL, V2, P1; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vuong SM, 2010, BEHAV BRAIN RES, V208, P278, DOI 10.1016/j.bbr.2009.11.036; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Yoshino A, 1996, J CEREB BLOOD FLOW M, V12, P996; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238	78	52	52	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2012	235	2			SI		574	587		10.1016/j.expneurol.2012.03.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944DE	WOS:000304177800021	22498103				2022-02-06	
J	Renison, B; Ponsford, J; Testa, R; Richardson, B; Brownfield, K				Renison, Belinda; Ponsford, Jennie; Testa, Renee; Richardson, Barry; Brownfield, Kylie			The Ecological and Construct Validity of a Newly Developed Measure of Executive Function: The Virtual Library Task	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Executive function; Brain injuries; Neuropsychological tests; Validation studies; Cognitive function; Virtual systems	TRAUMATIC BRAIN-INJURY; MULTIPLE ERRANDS TEST; CARD SORTING TEST; DYSEXECUTIVE SYNDROME; SIMPLIFIED VERSION; REHABILITATION; DYSFUNCTION; DEFICITS; RELIABILITY; PERFORMANCE	Virtual reality (VR) assessment paradigms have the potential to address the limited ecological validity of pen and paper measures of executive function (EF) and the pragmatic and reliability issues associated with functional measures. To investigate the ecological validity and construct validity of a newly developed VR measure of EF, the Virtual Library Task (VLT); a real life analogous task-the Real Library Task (RLT); and five neuropsychological measures of EF were administered to 30 patients with traumatic brain injury (TBI) and 30 healthy Controls. Significant others for each participant also completed the Dysexecutive Questionnaire (DEX), which is a behavioral rating scale of everyday EF. Performances on the VLT and the RLT were significantly positively correlated indicating that VR performance is similar to real world performance. The TBI group performed significantly worse than the Control group on the VLT and the Modified Six Elements Test (MSET) but the other four neuropsychological measures of EF failed to differentiate the groups. Both the MSET and the VLT significantly predicted everyday EF suggesting that they are both ecologically valid tools for the assessment of EF. The VLT has the advantage over the MSET of providing objective measurement of individual components of EF. (JINS, 2012, 18, 440-450)	[Renison, Belinda; Ponsford, Jennie; Testa, Renee; Brownfield, Kylie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie] MERRC, Melbourne, Vic, Australia; [Testa, Renee] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Richardson, Barry] Monash Univ, Sch Human Commun & Social Sci, Melbourne, Vic 3004, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu			Jack Brockhoff Foundation; Monash University's Faculty of Medicine, Nursing and Health Sciences	We thank the participants in this study, who generously donated their time. We also thank Johnathan Wells for programming the virtual library environment. The development of the virtual library environment was supported by a grant from the Jack Brockhoff Foundation and completion of the study was supported by a grant from Monash University's Faculty of Medicine, Nursing and Health Sciences. There are no conflicts of interest relating to this manuscript.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Brownfield K., 2008, VIRTUAL LIB TASK; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2009, RESTOR NEUROL NEUROS, V27, P493, DOI 10.3233/RNN-2009-0511; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 1996, HAYLING BRIXTON TEST; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chan RCK, 2002, J INT NEUROPSYCH SOC, V8, P771, DOI 10.1017/S1355617702860052; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Coakes SJ, 2003, SPSS ANAL ANGUISH; Crawford J.R., 2005, ASSESSMENT EXECUTIVE; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; Duncan J, 2005, CORTEX, V41, P215, DOI 10.1016/S0010-9452(08)70896-7; Elkind JS, 2001, CYBERPSYCHOL BEHAV, V4, P489, DOI 10.1089/109493101750527042; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Greve KW, 1997, BRIT J CLIN PSYCHOL, V36, P283, DOI 10.1111/j.2044-8260.1997.tb01414.x; HEATON RK, 2005, WISCONSIN CARD SORTI; Jansari A., 2004, S NEUR REH SAT S JOI; Jovanovski D., 2004, COGNITIVE SET SHIFTI; Joyner KB, 2009, J PSYCHOEDUC ASSESS, V27, P452, DOI 10.1177/0734282909333945; Katz N, 2007, OTJR-OCCUP PART HEAL, V27, P44, DOI 10.1177/153944920702700202; Klinger E, 2006, CYBERPSYCHOL BEHAV, V9, P342, DOI 10.1089/cpb.2006.9.342; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LONG CJ, 1997, CRIT ISS NE, P153; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Matheis R.J., 2004, THESIS FAIRLEIGH DIC; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Monis R.G., 2002, INT C DIS VIRT REAL; Morganti F., 2004, CYBERTHERAPY INTERNE; Moriyama Y, 2002, ALCOHOL CLIN EXP RES, V26, P1239, DOI 10.1097/01.ALC.0000026103.08053.86; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stuss D. T., 2007, HUMAN FRONTAL LOBES, V2, P292; Testa R., 2011, ARCH CLIN N IN PRESS; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; Tyson PJ, 2008, INT J PSYCHIAT CLIN, V12, P112, DOI 10.1080/13651500701687133; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; [No title captured]	60	52	55	1	44	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2012	18	3					440	450		10.1017/S1355617711001883			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	937VG	WOS:000303690500006	22339816				2022-02-06	
J	Bisschops, LLA; Hoedemaekers, CWE; Mollnes, TE; van der Hoeven, JG				Bisschops, Laurens L. A.; Hoedemaekers, Cornelia W. E.; Mollnes, Tom E.; van der Hoeven, Johannes G.			Rewarming after hypothermia after cardiac arrest shifts the inflammatory balance	CRITICAL CARE MEDICINE			English	Article						brain; cardiac arrest; complement activation; cytokine; hypoxia-ischemia; induced; inflammation; mild hypothermia	TRAUMATIC BRAIN-INJURY; SUCCESSFUL CARDIOPULMONARY-RESUSCITATION; ENDOTHELIAL ADHESION MOLECULES; MILD HYPOTHERMIA; BLOOD-BRAIN; INTERLEUKIN-8; COMPLEMENT; REPERFUSION; ACTIVATION; HEMORRHAGE	Objectives: The aim of this study was to simultaneously analyze the key components of the cerebral and systemic inflammatory response over time in cardiac arrest patients during mild therapeutic hypothermia and rewarming. Design and Setting: Clinical observational study in a tertiary care university hospital. Patients: Ten comatose patients after out-of-hospital cardiac arrest. Interventions: All patients were cooled to 32-34 degrees C for 24 hrs. After 24 hrs patients were passively rewarmed to normothermia. Measurements and Main Results: On admission and at 3, 6, 12, 24, and 48 hrs blood samples were taken from the arterial and jugular bulb catheter. Proinflammatory and anti-inflammatory cytokines and chemokines (interleukin-1ra, interleukin-1 beta, interleukin-6, interleukin-8, interleukin-10, interleukin-18, monocyte chemotactic protein-1, high-mobility group box-1 and tumor necrosis factor-alpha), complement activation products (C4d, Bb, C3a, and terminal complement complex), and the adhesion molecule soluble intercellular adhesion molecule were measured. Mean temperatures at the start of the study and at 12 and 24 hrs were 33.7 +/- 0.9 degrees C, 32.7 +/- 0.92 degrees C, and 34.5 +/- 1.5 degrees C, respectively. Passive rewarming resulted in a temperature of 37.8 +/- 0.5 degrees C at 48 hrs. The proinflammatory cytokine interleukin-6 increased from 12 to 24 hrs and returned to baseline levels after 48 hrs. In contrast, the chemokines interleukin-8 and monocyte chemotactic protein-1 stayed relatively high from the start and during the hypothermia period, decreasing to baseline levels after 48 hrs. The anti-inflammatory cytokines interleukin-10 and interleukin-1ra did not significantly change during mild therapeutic hypothermia and rewarming, although low values of interleukin-10 were observed after rewarming. A significant increase after rewarming was demonstrated on high-mobility group box-1 concentrations in the jugular bulb, whereas soluble intercellular adhesion molecule increased significantly during hypothermia and remained at this level after rewarming. Complement activation was increased on admission and decreased after induction of hypothermia, followed by a secondary increase during rewarming. No significant differences between any of the biomarkers were found between samples from the arterial and jugular bulb catheter. Conclusions: Complement activation occurs during rewarming from mild therapeutic hypothermia after cardiac arrest. Interleukin-6 increased already from 12 to 24 hrs, concomitantly with a significant increase in the temperature seen during this period of mild therapeutic hypothermia. The optimal rate of rewarming is unknown. Additional clinical studies are needed to determine the optimal rewarming rate and strategy. (Crit Care Med 2012; 40:1136-1142)	[Bisschops, Laurens L. A.; Hoedemaekers, Cornelia W. E.; van der Hoeven, Johannes G.] Radboud Univ Nijmegen, Dept Intens Care, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Mollnes, Tom E.] Oslo Univ Hosp, Inst Immunol, Oslo, Norway; Univ Oslo, N-0316 Oslo, Norway; [Mollnes, Tom E.] Nordlandssykehuset, Res Lab, Bodo, Norway; Univ Tromso, N-9001 Tromso, Norway		Bisschops, LLA (corresponding author), Radboud Univ Nijmegen, Dept Intens Care, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	L.Bisschops@ic.umcn.nl	Hoedemaekers, C.W.E./L-4375-2015; Mollnes, Tom/ABI-5183-2020; van der Hoeven, J.G./H-8048-2014				Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aibiki M, 1999, RESUSCITATION, V41, P263, DOI 10.1016/S0300-9572(99)00052-0; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bottiger BW, 2002, CRIT CARE MED, V30, P2473, DOI 10.1097/01.CCM.0000034689.78033.E2; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; Gando S, 2000, INTENS CARE MED, V26, P38, DOI 10.1007/s001340050009; GOETTING MG, 1990, CRIT CARE MED, V18, P1220, DOI 10.1097/00003246-199011000-00006; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Hildebrand F, 2005, CYTOKINE, V31, P382, DOI 10.1016/j.cyto.2005.06.008; Holzer M, 2002, NEW ENGL J MED, V346, P549; Inoue K, 2003, TRANSPLANTATION, V76, P409, DOI 10.1097/01.TP.0000076095.51697.5E; Izeboud CA, 1999, INFLAMM RES, V48, P497, DOI 10.1007/s000110050493; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Meybohm P, 2010, CRIT CARE, V14, DOI 10.1186/cc8879; Mizushima H, 1999, LIFE SCI, V65, P2127, DOI 10.1016/S0024-3205(99)00477-4; Mizushima Y, 2000, ARCH SURG-CHICAGO, V135, P175, DOI 10.1001/archsurg.135.2.175; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Shyu KG, 1997, AM HEART J, V134, P551, DOI 10.1016/S0002-8703(97)70094-2; Vaagenes P, 2003, RESUSCITATION, V58, P103, DOI 10.1016/S0300-9572(03)00102-3; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VIDEM V, 1992, ANN THORAC SURG, V54, P725, DOI 10.1016/0003-4975(92)91018-5; Youngquist ST, 2009, RESUSCITATION, V80, P249, DOI 10.1016/j.resuscitation.2008.08.018	33	52	52	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2012	40	4					1136	1142		10.1097/CCM.0b013e3182377050			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912QC	WOS:000301813700012	22020246				2022-02-06	
J	McAllister, TW; Tyler, AL; Flashman, LA; Rhodes, CH; McDonald, BC; Saykin, AJ; Tosteson, TD; Tsongalis, GJ; Moore, JH				McAllister, Thomas W.; Tyler, Anna L.; Flashman, Laura A.; Rhodes, C. Harker; McDonald, Brenna C.; Saykin, Andrew J.; Tosteson, Tor D.; Tsongalis, Gregory J.; Moore, Jason H.			Polymorphisms in the Brain-Derived Neurotrophic Factor Gene Influence Memory and Processing Speed One Month after Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; genetic factors; head trauma; neuropsychology; traumatic brain injury	RAT HIPPOCAMPUS; UNITED-STATES; PROGESTERONE; POPULATION; EXPRESSION; HAPLOTYPES; PLASTICITY; TRAUMA; BDNF	Brain-derived neurotrophic factor (BDNF) plays a role in cognition, as well as neural survival and plasticity. There are several common polymorphisms in the BDNF gene, one of which (rs6265) is an extensively studied non-synonymous coding polymorphism (Val66Met) which has been linked to cognitive performance in healthy controls and some clinical populations. We hypothesized that the Met allele of rs6265 would be associated with poorer cognitive performance in individuals with mild-to-moderate traumatic brain injury, and that other polymorphisms in the BDNF gene would also affect cognition. Genotype at 9 single-nucleotide polymorphisms (SNPs) in the BDNF gene, and measures of speed of information processing, learning, and memory were assessed in 75 patients with mTBI and 38 healthy subjects. Consistent with previous reports, the Met allele of rs6265 was associated with cognition (slower processing speed) in the entire group. Two other SNPs were associated with processing speed in the mTBI group, but both are in linkage disequilibrium with rs6265, and neither remained significant after adjustment for rs6265 status. Within the mTBI group, but not the controls, 4 SNPs, but not rs6265, were associated with memory measures. These associations were not affected by adjustment for rs6265 status. Polymorphisms in BDNF influence cognitive performance shortly after mTBI. The results raise the possibility that a functional polymorphism other than rs6265 may contribute to memory function after mTBI.	[McAllister, Thomas W.; Flashman, Laura A.; McDonald, Brenna C.; Saykin, Andrew J.] Dartmouth Med Sch, Sect Neuropsychiat, Dept Psychiat, Lebanon, NH USA; [Tyler, Anna L.; Moore, Jason H.] Dartmouth Med Sch, Computat Genet Lab, Lebanon, NH USA; [Rhodes, C. Harker] Dartmouth Med Sch, Sect Mol Pathol, Lebanon, NH USA; [Tosteson, Tor D.] Dartmouth Med Sch, Sect Biostat & Epidemiol, Lebanon, NH USA; [Tosteson, Tor D.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [McDonald, Brenna C.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN USA		McAllister, TW (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Neuropsychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	thomas.w.mcallister@dartmouth.edu	Moore, Jason H./AAV-9645-2021; Saykin, Andrew/A-1318-2007	Moore, Jason H./0000-0002-5015-1099; Saykin, Andrew/0000-0002-1376-8532	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048176]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055020]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048176] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055020] Funding Source: NIH RePORTER	This work was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R01HD048176), and the National Institute of Neurological Disorders and Stroke (R01NS055020). The authors would like to thank Reid Kehoe, Ph.D., and Ashlee Robbins, B.A., who assisted with some of the analyses in this work.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; First M., 1997, STRUCTURED CLIN INTE; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Gordon M., 1986, GORDON DIAGNOSTIC SY; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LONG JC, 1995, AM J HUM GENET, V56, P799; Lu B, 2000, PROG BRAIN RES, V128, P231; McAllister T., 2005, TXB TRAUMATIC BRAIN, P279; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pritchard JK, 2000, GENETICS, V155, P945; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	37	52	53	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1111	1118		10.1089/neu.2011.1930			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100011	22188054	Green Published			2022-02-06	
J	Seli, P; Cheyne, JA; Smilek, D				Seli, Paul; Cheyne, James Allan; Smilek, Daniel			Attention failures versus misplaced diligence: Separating attention lapses from speed-accuracy trade-offs	CONSCIOUSNESS AND COGNITION			English	Article						Sustained attention; Speed accuracy trade-off; Attention lapses; Alerts; Vigilance	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; TASK UNRELATED THOUGHT; SUSTAINED-ATTENTION; DEFICIT/HYPERACTIVITY DISORDER; RESPONSE VARIABILITY; EXECUTIVE FUNCTION; PERFORMANCE; ADHD; MIND	In two studies of a GO-NOGO task assessing sustained attention, we examined the effects of (1) altering speed-accuracy trade-offs through instructions (emphasizing both speed and accuracy or accuracy only) and (2) auditory alerts distributed throughout the task. Instructions emphasizing accuracy reduced errors and changed the distribution of GO trial RTs. Additionally, correlations between errors and increasing RTs produced a U-function; excessively fast and slow RTs accounted for much of the variance of errors. Contrary to previous reports, alerts increased errors and RT variability. The results suggest that (1) standard instructions for sustained attention tasks, emphasizing speed and accuracy equally, produce errors arising from attempts to conform to the misleading requirement for speed, which become conflated with attention-lapse produced errors and (2) auditory alerts have complex, and sometimes deleterious, effects on attention. We argue that instructions emphasizing accuracy provide a more precise assessment of attention lapses in sustained attention tasks. (C) 2011 Elsevier Inc. All rights reserved.	[Seli, Paul; Cheyne, James Allan; Smilek, Daniel] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada		Seli, P (corresponding author), Univ Waterloo, Dept Psychol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	pseli@uwaterloo.ca					Beilock SL, 2008, J EXP PSYCHOL-APPL, V14, P340, DOI 10.1037/a0012859; Beilock SL, 2004, PSYCHON B REV, V11, P373, DOI 10.3758/BF03196585; Bellgrove MA, 2006, CORTEX, V42, P838, DOI 10.1016/S0010-9452(08)70426-X; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chan RCK, 2009, COGN BEHAV NEUROL, V22, P180, DOI 10.1097/WNN.0b013e3181b7ef84; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050110034325; Cheyne D. O., 2009, NCM ANN M WAIK HAW A; Cheyne J. A., 2006, CONSCIOUS COGN, V18, P481; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Cheyne JA, 2011, COGNITION, V121, P437, DOI 10.1016/j.cognition.2011.07.010; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Davies DR., 1982, PSYCHOL VIGILANCE; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; EDWARDS W, 1961, PSYCHOL REV, V68, P275, DOI 10.1037/h0044699; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Greene CM, 2009, NEUROPSYCHOLOGIA, V47, P591, DOI 10.1016/j.neuropsychologia.2008.10.003; Helton WS, 2011, CONSCIOUS COGN, V20, P1732, DOI 10.1016/j.concog.2011.02.011; Helton WS, 2010, CONSCIOUS COGN, V19, P77, DOI 10.1016/j.concog.2010.01.006; Helton WS, 2009, CONSCIOUS COGN, V18, P600, DOI 10.1016/j.concog.2009.06.002; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Helton WS, 2005, BRIT J PSYCHOL, V96, P249, DOI 10.1348/000712605X38369; HOWELL WC, 1963, J EXP PSYCHOL, V65, P39, DOI 10.1037/h0038982; Imbo I, 2010, EUR J COGN PSYCHOL, V22, P964, DOI 10.1080/09541440903150196; James W., 1890, PRINCIPLES PSYCHOL; Johnson KA, 2008, NEUROPSYCHOLOGIA, V46, P1532, DOI 10.1016/j.neuropsychologia.2008.01.002; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Juncos-Rabadan O, 2008, ACTA PSYCHOL, V127, P237, DOI 10.1016/j.actpsy.2007.05.003; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P211, DOI 10.1111/1469-7610.00712; MACKAY DG, 1971, AM J PSYCHOL, V84, P35, DOI 10.2307/1421223; MACKAY DG, 1982, PSYCHOL REV, V89, P483, DOI 10.1037/0033-295X.89.5.483; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Matthews Gerald, 2000, HUMAN PERFORMANCE CO; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Molenberghs P, 2009, NEUROPSYCHOLOGIA, V47, P2866, DOI 10.1016/j.neuropsychologia.2009.06.012; Mullins C, 2005, J AM ACAD CHILD PSY, V44, P169, DOI 10.1097/00004583-200502000-00009; NEWELL KM, 1980, TUTORIALS MOTOR BEHA; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; O'Connell RG, 2006, NEUROPSYCHOL REHABIL, V16, P653, DOI 10.1080/09602010500200250; O'Connell RG, 2004, NEUROREPORT, V15, P2535, DOI 10.1097/00001756-200411150-00021; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Prinz W, 2009, OXFORD HDB HUMAN ACT; REASON J, 1979, ASPECTS CONSCIOUSNES, P67; Reason J.T., 1977, ADULT LEARNING; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Ridderinkhof KR, 2002, ATTENTION PERFORM, V19, P494; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rupp H., 1932, PSYCHOTECHNISCHES Z, V7, P161; SALTHOUSE TA, 1979, ERGONOMICS, V22, P811, DOI 10.1080/00140137908924659; Schneider W., 2002, E PRIME REFERENCE GU; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; Seli P, 2012, CAN J EXP PSYCHOL, V66, P44, DOI 10.1037/a0025111; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Smallwood J, 2004, CONSCIOUS COGN, V13, P789, DOI 10.1016/j.concog.2004.07.004; Smallwood J, 2003, CONSCIOUS COGN, V12, P169, DOI 10.1016/S1053-8100(02)00003-X; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Smith-Chant BL, 2003, MEM COGNITION, V31, P516, DOI 10.3758/BF03196093; Stevenson H., 2011, BRAIN COGNITION, V20, P1732; STINS JF, 2007, ADV COGN PSYCHOL, V3, P389; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; Van der Linden D, 2005, WORK STRESS, V19, P23, DOI 10.1080/02678370500065275; Warm J. S., 1984, SUSTAINED ATTENTION; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Woodworth R. S., 1899, PSYCHOL MONOGRAPHS, V3; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P1844, DOI 10.1016/j.neuropsychologia.2009.02.025	81	52	52	0	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	MAR	2012	21	1					277	291		10.1016/j.concog.2011.09.017			15	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	911YZ	WOS:000301761900027	22001770				2022-02-06	
J	Smith, DW; Bailes, JE; Fisher, JA; Robles, J; Turner, RC; Mills, JD				Smith, David W.; Bailes, Julian E.; Fisher, Joseph A.; Robles, Javier; Turner, Ryan C.; Mills, James D.			Internal Jugular Vein Compression Mitigates Traumatic Axonal Injury in a Rat Model by Reducing the Intracranial Slosh Effect	NEUROSURGERY			English	Article						Amyloid precursor protein (APP); Concussion; Intracranial compliance; Slosh; Traumatic brain injury	INTRAOCULAR-PRESSURE; BRAIN-INJURY; DOCOSAHEXAENOIC ACID; REBOUND TONOMETER; SUPPLEMENTATION	BACKGROUND: Traumatic brain injury (TBI) remains a devastating condition for which extracranial protection traditionally has been in the form of helmets, which largely fail to protect against intracranial injury. OBJECTIVE: To determine whether the pathological outcome after traumatic brain injury can be improved via slosh mitigation by internal jugular vein (IJV) compression. METHODS: Two groups of 10 adult male Sprague-Dawley rats were subjected to impact-acceleration traumatic brain injury. One group underwent IJV compression via application of a collar before injury; the second group did not. Intracranial pressure and intraocular pressure were measured before and after IJV compression to assess collar performance. All rats were killed after a 7-day recovery period, and brainstem white matter tracts underwent fluorescent immunohistochemical processing and labeling of beta-amyloid precursor protein, a marker of axonal injury. Digital imaging and statistical analyses were used to determine whether IJV compression resulted in a diminished number of injured axons. RESULTS: Compression of the IJV resulted in an immediate 30% increase in intraocular and intracranial pressures. Most notably, IJV compression resulted in. 80% reduction in the number of amyloid precursor protein-positive axons as indicated by immunohistochemical analysis. CONCLUSION: Using a standard acceleration-deceleration laboratory model of mild traumatic brain injury, we have shown successful prevention of axonal injury after IJV compression as indicated by immunohistochemical staining of amyloid precursor protein. We argue that IJV compression reduces slosh-mediated brain injury by increasing intracranial blood volume, which can be indirectly measured by intracranial and intraocular pressures.	[Bailes, Julian E.] NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL 60201 USA; [Smith, David W.; Robles, Javier; Turner, Ryan C.; Mills, James D.] W Virginia Univ, Dept Neurosurg, Morgantown, WV 26506 USA; [Fisher, Joseph A.] Univ Toronto, Dept Anesthesiol, Toronto, ON, Canada; [Fisher, Joseph A.] Univ Hlth Network, Toronto, ON, Canada		Bailes, JE (corresponding author), NorthShore Univ Hlth Syst, Dept Neurosurg, 2650 Ridge Ave, Evanston, IL 60201 USA.	jbailes@northshore.org		Turner, Ryan/0000-0001-5523-0645			Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Faul M, 2010, TRAUMATIC BRAIN INJU; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Lee EJ, 2008, JPN J OPHTHALMOL, V52, P500, DOI 10.1007/s10384-008-0591-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Mills JD, 2003, J BIOMED OPT, V8, P347, DOI 10.1117/1.1584443; Ohashi M, 2008, JPN J OPHTHALMOL, V52, P399, DOI 10.1007/s10384-008-0532-z; Rai R, 2008, CLINICS, V63, P521, DOI 10.1590/S1807-59322008000400018; RAPHAEL JH, 1994, ANAESTHESIA, V49, P437; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Teng C, 2003, BRIT J OPHTHALMOL, V87, P946, DOI 10.1136/bjo.87.8.946; Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781	18	52	52	0	14	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2012	70	3					740	746		10.1227/NEU.0b013e318235b991			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	898ZU	WOS:000300781700032	21904255				2022-02-06	
J	Larney, S; Topp, L; Indig, D; O'Driscoll, C; Greenberg, D				Larney, Sarah; Topp, Libby; Indig, Devon; O'Driscoll, Colman; Greenberg, David			A cross-sectional survey of prevalence and correlates of suicidal ideation and suicide attempts among prisoners in New South Wales, Australia	BMC PUBLIC HEALTH			English	Article							TRAUMATIC BRAIN-INJURY; SELF-HARM; PSYCHIATRIC-DISORDERS; MENTAL-HEALTH; RISK-FACTORS; BEHAVIOR; WOMEN	Background: We aimed to estimate the prevalence of suicidal ideation and suicide attempt among prisoners in New South Wales, Australia; and, among prisoners reporting suicidal ideation, to identify factors associated with suicide attempt. Methods: A cross-sectional design was used. Participants were a random, stratified sample of 996 inmates who completed a telephone survey. The estimated population prevalence of suicidal ideation and suicide attempt were calculated and differences by sex and Aboriginality were tested using chi(2) tests. Correlates of suicidal ideation and suicide attempt were tested using logistic regression. Results: One-third of inmates reported lifetime suicidal ideation and one-fifth had attempted suicide. Women and Aboriginal participants were significantly more likely than men and non-Aboriginal participants, respectively, to report attempting suicide. Correlates of suicidal ideation included violent offending, traumatic brain injury, depression, self-harm, and psychiatric hospitalisation. Univariate correlates of suicide attempt among ideators were childhood out-of-home care, parental incarceration and psychiatric hospitalization; however, none of these remained significant in a multivariate model. Conclusions: Suicidal ideation and attempts are highly prevalent among prisoners compared to the general community. Assessment of suicide risk is a critical task for mental health clinicians in prisons. Attention should be given to ensuring assessments are gender-and culturally sensitive. Indicators of mental illness may not be accurate predictors of suicide attempt. Indicators of childhood trauma appear to be particularly relevant to risk of suicide attempt among prisoners and should be given attention as part of risk assessments.	[Larney, Sarah; Indig, Devon] Justice Hlth & Forens Mental Hlth Network, Ctr Hlth Res Criminal Justice, Sydney, NSW, Australia; [Larney, Sarah] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Topp, Libby] Univ New S Wales, Kirby Inst, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Indig, Devon] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [O'Driscoll, Colman; Greenberg, David] Justice Hlth & Forens Mental Hlth Network, Statewide Forens Mental Hlth, Sydney, NSW, Australia; [O'Driscoll, Colman; Greenberg, David] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia		Larney, S (corresponding author), Justice Hlth & Forens Mental Hlth Network, Ctr Hlth Res Criminal Justice, Sydney, NSW, Australia.	s.larney@unsw.edu.au	Larney, Sarah L/B-1900-2008; Larney, Sarah/AAR-1372-2020	Larney, Sarah L/0000-0002-5602-4963; Larney, Sarah/0000-0002-5602-4963; Indig, Devon/0000-0002-6741-5062	Hunter New England Population Health; IHS investigator team; Corrective Services NSW; NSW Health and Justice Health; Inmate Health Survey	Thank you to the IHS Clinical Co-ordinator, Shalin Kumar; Belinda Border of Hunter New England Population Health; the IHS investigator team; and Corrective Services NSW for supporting the conduct of the IHS. The IHS was originally developed by Professor Tony Butler. Funding for the IHS was provided by NSW Health and Justice Health. The funding bodies had no role in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.; SL, DI and DG are current employees, and LT and CO are past employees, of Justice Health, which funded the Inmate Health Survey.	Australian Bureau of Statistics, 2010, CAUS DEATH 2008; Australian Bureau of Statistics, 2010, PRIS AUSTR; Babor TF., 2001, ALCOHOL USE DISORDER, V2a ed.; Baillargeon J, 2009, J AM ACAD PSYCHIATRY, V37, P188; Bebbington PE, 2010, EUR PSYCHIAT, V25, P427, DOI 10.1016/j.eurpsy.2009.12.004; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Blaauw E, 2005, SUICIDE LIFE-THREAT, V35, P63, DOI 10.1521/suli.35.1.63.59268; Borges G, 2010, CURR OPIN PSYCHIATR, V23, P195, DOI 10.1097/YCO.0b013e3283386322; Butler T, 2006, AUST NZ J PSYCHIAT, V40, P272, DOI 10.1111/j.1440-1614.2006.01785.x; Butler T, 2007, AUST NZ J PSYCHIAT, V41, P429, DOI 10.1080/00048670701261210; Clements-Nolle K, 2009, WOMEN HEALTH ISS, V19, P185, DOI 10.1016/j.whi.2009.02.002; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Elliott-Farrelly T, 2004, ADV MENTAL HLTH, V3, P138, DOI DOI 10.5172/jamh.3.3.138; Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107; Fazel S, 2011, SOC PSYCH PSYCH EPID, V46, P191, DOI 10.1007/s00127-010-0184-4; Fruehwald S, 2004, BRIT J PSYCHIAT, V185, P494, DOI 10.1192/bjp.185.6.494; Hall GJ, 2006, PREVENTING SUICIDE O, P29; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hunter Ernest, 2006, Arch Suicide Res, V10, P141, DOI 10.1080/13811110600556889; Indig D, 2010, 2009 INM HLTH SURV; Jenkins R, 2005, PSYCHOL MED, V35, P257, DOI 10.1017/S0033291704002958; Johnston AK, 2009, AUST NZ J PSYCHIAT, V43, P635, DOI 10.1080/00048670902970874; Joukamaa M, 1997, FORENSIC SCI INT, V89, P167, DOI 10.1016/S0379-0738(97)00119-9; Konrad N, 2007, CRISIS, V28, P113, DOI 10.1027/0227-5910.28.3.113; Lekka NP, 2006, EUR ARCH PSY CLIN N, V256, P87, DOI 10.1007/s00406-005-0606-6; Liebling A., 2006, PREVENTING SUICIDE O, P16; Marzano L, 2011, SOC SCI MED, V72, P874, DOI 10.1016/j.socscimed.2010.12.028; Marzano L, 2010, BRIT J PSYCHIAT, V197, P219, DOI 10.1192/bjp.bp.109.075424; Naud H, 2010, J PSYCHOPATHOL BEHAV, V32, P333, DOI 10.1007/s10862-009-9159-8; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock Matthew K., 2000, INT HDB SUICIDE ATTE, P437, DOI DOI 10.1002/9780470698976.CH24; O'Driscoll C, 2007, AUST NZ J PSYCHIAT, V41, P519, DOI 10.1080/00048670701341863; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Perry AE, 2010, INT J OFFENDER THER, V54, P803, DOI 10.1177/0306624X09359757; SAS Institute, 2008, SAS 9 2; Shaw J, 2004, BRIT J PSYCHIAT, V184, P263, DOI 10.1192/bjp.184.3.263; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Western Australia Department of Justice Suicide Prevention Taskforce, 2002, SUIC PRIS; [No title captured]	41	52	54	0	34	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	JAN 6	2012	12								14	10.1186/1471-2458-12-14			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	892MG	WOS:000300289700001	22225627	Green Published, gold			2022-02-06	
J	Scheibel, RS; Newsome, MR; Troyanskaya, M; Lin, XD; Steinberg, JL; Radaideh, M; Levin, HS				Scheibel, Randall S.; Newsome, Mary R.; Troyanskaya, Maya; Lin, Xiaodi; Steinberg, Joel L.; Radaideh, Majdi; Levin, Harvey S.			Altered Brain Activation in Military Personnel with One or More Traumatic Brain Injuries Following Blast	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain concussion; Brain mapping; Executive function; fMRI; Post-concussion syndrome; PTSD	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-CONTROL; FUNCTIONAL MRI; HEAD-INJURY; VETERANS; MEMORY; IRAQ; CONCUSSION; SYMPTOMS; SCALE	Explosive blast is a frequent cause of traumatic brain injury (TBI) among personnel deployed to Afghanistan and Iraq. Functional magnetic resonance imaging (fMRI) with an event-related stimulus-response compatibility task was used to compare 15 subjects with mild, chronic blast-related TBI with 15 subjects who had not experienced a TBI or blast exposure during deployment. Six TBI subjects reported multiple injuries. Relative to the control group, TBI subjects had slightly slower responses during fMRI and increased somatic complaints and symptoms of post-traumatic stress disorder (PTSD) and depression. A between-group analysis indicated greater activation during stimulus-response incompatibility in TBI subjects within the anterior cingulate gyrus, medial frontal cortex, and posterior cerebral areas involved in visual and visual-spatial functions. This activation pattern was more extensive after statistically controlling for reaction time and symptoms of PTSD and depression. There was also a negative relationship between symptoms of PTSD and activation within posterior brain regions. These results provide evidence for increased task-related activation following mild, blast-related TBI and additional changes associated with emotional symptoms. Limitations of this study include no matching for combat exposure and different recruitment strategies so that the control group was largely a community-based sample, while many TBI subjects were seeking services. (JINS, 2012, 18, 89-100)	[Scheibel, Randall S.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Scheibel, Randall S.; Newsome, Mary R.; Troyanskaya, Maya; Lin, Xiaodi; Radaideh, Majdi; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Steinberg, Joel L.] Univ Texas Houston, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Houston, TX 77225 USA; [Radaideh, Majdi] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA		Scheibel, RS (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	scheibel@bcm.tmc.edu			Department of Veterans Affairs Center of ExcellenceUS Department of Veterans Affairs [B6812C]; Department of Veterans AffairsUS Department of Veterans Affairs [B4596R]	The authors report no conflicts of interest. This work was supported by a Department of Veterans Affairs Center of Excellence grant (H. S. L., grant number B6812C), Neurorehabilitation: Neurons to Networks Center for Rehabilitation Research; and by a Department of Veterans Affairs Merit Review grant (H. S. L., grant number B4596R). The Michael E. DeBakey Veterans Affairs Medical Center in Houston, TX, and the South Central Mental Illness Research, Education, and Clinical Center (MIRECC) provided access to equipment and facilities used for the analysis of the image data. We thank Xiaoqi Li for assisting with statistical analysis and Drs. Helene K. Henson and David P. Graham for assisting with the screening and recruitment of subjects.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; CERNAK I, 2005, RESTORATIVE NEUROLOG, V23, P139; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Derogatis L.R., 1975, BRIEF SYMPTOM INVENT; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Galati G, 2010, EXP BRAIN RES, V206, P109, DOI 10.1007/s00221-010-2168-8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Morey RA, 2008, PSYCHIAT RES-NEUROIM, V162, P59, DOI 10.1016/j.pscychresns.2007.07.007; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Ware J., 2004, SCORE VERSION 2 SF 1	46	52	52	1	32	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2012	18	1					89	100		10.1017/S1355617711001433			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	874LL	WOS:000298958800009	22132942				2022-02-06	
J	Kontos, AP; Dolese, A; Elbin, RJ; Covassin, T; Warren, BL				Kontos, Anthony P.; Dolese, Angela; Elbin, R. J., III; Covassin, Tracey; Warren, Barbara L.			Relationship of soccer heading to computerized neurocognitive performance and symptoms among female and male youth soccer players	BRAIN INJURY			English	Article						neurocognitive test; sex differences; soccer; soccer heading; symptoms; youth	HIGH-SCHOOL; CONCUSSION; RECOVERY; INJURIES; BRAIN; FREQUENCY	Primary objective: The purpose of this study was to investigate the relationship between soccer heading and computerized neurocognitive performance and symptoms in female and male youth soccer players. Research design: Cross-sectional and prospective design. Methods and procedures: A total of 63 (27 females, 36 males) youth soccer players aged 13-18 years (M == 15.89, SD == 1.17) participated in the study. Participants completed the Immediate Post-concussion Assessment and Cognitive Test (ImPACT) and symptom report. Main outcomes: Computerized neurocognitive performance (e.g., verbal and visual memory, motor processing, and reaction time) and symptoms. Results: There were no differences in neurocognitive performance or symptoms among low-, moderate-, and high-exposure header groups. The current sample outperformed the 10th percentile norms for neurocognitive and symptom scores. Males headed the ball more frequently and reported lower verbal and visual memory and motor processing speed scores than females. Conclusion: The current findings did not support a relationship between soccer heading and computerized neurocognitive performance and symptoms. The researchers suggest that any purported effects of soccer heading in youth are subtle and may affect only a small number of athletes. The reported sex differences in heading exposure warrant further attention.	[Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Sch Med, UPMC Ctr Sports Med,Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Dolese, Angela] Univ New Orleans, Athlet Dept, New Orleans, LA 70148 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Warren, Barbara L.] Univ Puget Sound, Tacoma, WA 98416 USA		Kontos, AP (corresponding author), Univ Pittsburgh, UPMC Sports Med Concuss Program, Sch Med, UPMC Ctr Sports Med,Dept Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA.	mail-akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310			Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; COLLINS M, 2004, CURR OPIN ORTHOP, V15, P100; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lees K., 1988, SCI FOOTBALL, P385; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Lovell MR, 2006, IMPACT CONCUSSION MA; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schmitt DM, 2003, BRIT J SPORT MED, V37, P233; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	31	52	52	2	29	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1234	1241		10.3109/02699052.2011.608209			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200010	21902552				2022-02-06	
J	Adelson, PD; Srinivas, R; Chang, Y; Bell, M; Kochanek, PM				Adelson, P. David; Srinivas, Ravi; Chang, Yuefang; Bell, Michael; Kochanek, Patrick M.			Cerebrovascular response in children following severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Pediatric; Head trauma; Cerebral blood flow; Autoregulation; Vasoreactivity; Xenon CT	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; METABOLISM; AUTOREGULATION; ADOLESCENTS; INFANTS; CIRCULATION; TOMOGRAPHY; SCORE; AGE	To describe the pathophysiologic response in cerebral blood flow (CBF) and autoregulation after severe traumatic brain injury (TBI), Glasgow Coma Score (GCS) a parts per thousand currency sign8 on admission, in children, defining a baseline for future studies. Retrospective chart review of 95 patients following TBI, ages 0.1-18.4 years (< 5 years (n = 44), < 2 years (n = 17)) for CBF using Xenon Computerized Tomography (XeCT) over a 10-year period and 6-month Glasgow Outcome Scores (GOS). A total of 140 CBF studies were performed variably from admission up to post injury day (PID) 9; 27 patients underwent repeat CBF study after PaCO2 was manipulated to determine CO2 vasoreactivity (CO2VR). Mean CBF on admission (PID 0, n = 26) was 32.05 +/- 21.45 ml/100 g/min (mean +/- SEM) and was a parts per thousand currency sign20 ml/100 g/min in eight patients. At PID 1-2, mean CBF increased to 55.36 +/- 23.11 ml/100 g/min. There was significant differences in mean CBF of "favorable" outcomes (GOS a parts per thousand yenaEuro parts per thousand 4) versus "unfavorable" outcome (GOS a parts per thousand currency signaEuro parts per thousand 3) (61.74 +/- 18.27 vs. 46.54 +/- 26.26, respectively (P = 0.01)). "Unfavorable" outcomes were seen in all patients with CBF a parts per thousand currency sign20 ml/100 mg/min during PID 0-2 and in 76.5% of children < 2 years. CO2VR < 2%/Torr PaCO2 within PID 0-2 was significantly associated with "unfavorable" outcome (P = 0.029). Younger age, early or later low CBF, and CO2VR < 2%/Torr PaCO2 were correlated with poorer outcomes in children. This represents the largest experience with XeCT CBF in children and confirms our preliminary report of low early CBF after TBI in children, disturbed CO2VR, and relationship of low CBF and unfavorable outcome.	[Adelson, P. David] Phoenix Childrens Neurosci Inst & Pediat Neurosur, Phoenix, AZ 85016 USA; [Srinivas, Ravi; Chang, Yuefang; Bell, Michael; Kochanek, Patrick M.] Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Srinivas, Ravi; Chang, Yuefang; Bell, Michael; Kochanek, Patrick M.] Univ Pittsburgh, Pittsburgh, PA USA		Adelson, PD (corresponding author), Phoenix Childrens Neurosci Inst & Pediat Neurosur, 4th Floor,Bldg B,1919 E Thomas Rd, Phoenix, AZ 85016 USA.	dadelson@phoenixchildrens.com	Kochanek, Patrick M/D-2371-2015; Adelson, David/W-2083-2019	Kochanek, Patrick M/0000-0002-2627-913X; 	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS01809, NS052478]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS052478, K08NS001809] Funding Source: NIH RePORTER	The authors would like to thank Ms. Christina Casanova for the preparation of this manuscript and S. Danielle Brown, MSN, who served as the honest broker. The author (PDA) was supported in part for this study by the National Institute of Health (NS01809, NS052478). The authors have no personal or institutional financial interest in drugs, materials, or devices described in this submission.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; BEYDA DH, 1996, CRIT CARE MED, V24, P134; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; CHIRON C, 1992, J NUCL MED, V33, P696; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; GUR D, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P68; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; JENNETT B, 1975, LANCET, V1, P480; KASOFF SS, 1972, J NEUROSURG, V36, P463, DOI 10.3171/jns.1972.36.4.0463; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KOCHANEK PK, 1995, CURRENT CONCEPTS PED; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1996, P 10 INT BRAIN ED S, P90; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1993, J CEREB BLOOD FLOW M, V13, P571; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; PIETRINI D, 2004, MINERVA ANESTESIOL, V70, P545; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	37	52	54	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2011	27	9					1465	1476		10.1007/s00381-011-1476-z			12	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	807KY	WOS:000293897800017	21559825				2022-02-06	
J	Kurowski, BG; Taylor, HG; Yeates, KO; Walz, NC; Stancin, T; Wade, SL				Kurowski, Brad G.; Taylor, H. Gerry; Yeates, Keith Owen; Walz, Nicolay C.; Stancin, Terry; Wade, Shari L.			Caregiver Ratings of Long-term Executive Dysfunction and Attention Problems After Early Childhood Traumatic Brain Injury: Family Functioning Is Important	PM&R			English	Article							DEFICIT HYPERACTIVITY DISORDER; OUTCOME 30 MONTHS; YOUNG-CHILDREN; HEAD-INJURY; DEFICIT/HYPERACTIVITY DISORDER; ASSESSMENT DEVICE; BEHAVIOR PROBLEMS; FOLLOW-UP; PREDICTORS; RECOVERY	Objective: To evaluate the relationship of family and parenting factors to long-term executive dysfunction and attention problems after early childhood traumatic brain injury (TBI). We hypothesized that the magnitude of executive dysfunction and attention problems would be moderated by family and parenting factors. Design: A multicenter, prospective cohort study that included an orthopedic injury (01) reference group. Setting: Three tertiary academic children's hospital medical centers and one general medical center. Participants: Children, ages 3-7 years, hospitalized for 01, moderate TBI, or severe TBI. Methods and Outcome Measurements: Parental ratings of family functioning and parenting styles were obtained 18 months after the injury occurred. The main outcome measurements, which were parental ratings of children's executive function and attention, were performed at least 24 months after the injury occurred (mean, 39 months; range, 25-63 months). Analysis: Group comparisons were conducted with use of t-tests, chi(2) analysis, analysis of variance, and Pearson and Spearman correlations. Regression analysis was used to examine associations of the outcomes with family functioning and parenting styles and to test moderating effects of these factors on group differences. Results: Participants with severe TBI demonstrated increased executive dysfunction and attention problems compared with those who sustained moderate TBI or OI. Lower levels of family dysfunction were associated with better executive function and attention across groups but did not moderate group differences. However, attention deficits after severe TBI were exacerbated under conditions of more permissive parenting relative to attention deficits after OIs. Conclusions: Executive function and attention problems persisted on a long-term basis (>24 months) after early childhood TBI, and positive global family functioning and nonpermissive parenting were associated with better outcomes. Better characterization of the optimal family environment for recovery from early childhood TBI could help target future interventions. PM R 2011;3:836-845	[Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Walz, Nicolay C.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH USA; [Kurowski, Brad G.; Walz, Nicolay C.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Psychiat, Div Pediat Psychol, Cleveland, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human Development, Rehabilitation Medicine Scientist Training Program (RMSTP) [R01 HD42729, 7K12 H0001097-14]; United States Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; Trauma Research grants from State of Ohio Emergency Medical Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	Funding for this study was provided through grant R01 HD42729 from the National Institute of Child Health and Human Development, Rehabilitation Medicine Scientist Training Program (RMSTP) grant 7K12 H0001097-14, in part by United States Public Health Service National Institutes of Health grant M01 RR 08084, and by Trauma Research grants from the State of Ohio Emergency Medical Services.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Faul M, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Josie KL, 2008, J HEAD TRAUMA REHAB, V23, P357, DOI 10.1097/01.HTR.0000341431.29133.a8; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RIVARA JB, 1994, PEDIATR ANN, V23, P38, DOI 10.3928/0090-4481-19940101-09; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	56	52	52	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2011	3	9					836	845		10.1016/j.pmrj.2011.05.016			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	961BE	WOS:000305438100008	21944301	Green Accepted			2022-02-06	
J	Schonberger, M; Ponsford, J; Gould, KR; Johnston, L				Schoenberger, Michael; Ponsford, Jennie; Gould, Kate R.; Johnston, Lisa			The Temporal Relationship Between Depression, Anxiety, and Functional Status after Traumatic Brain Injury: A Cross-lagged Analysis	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Depression; Anxiety; Functional status; Prospective studies; Longitudinal studies	STRUCTURED INTERVIEWS; HEALTH; MODEL; REHABILITATION; DISORDERS; MODERATE; OUTCOMES; ASSOCIATION; MULTICENTER; IMPAIRMENT	Poor functional status and high rates of anxiety and depression have been reported in individuals who have sustained a traumatic brain injury (TBI). However, it is unclear whether psychiatric disorders after TBI are a cause or a consequence of functional limitations. The current study aimed to investigate the temporal relationship between anxiety, depression and functional impairment following TBI. The study has a prospective, longitudinal single-group design. Anxiety and depression, assessed using the Structured Clinical Interview for DSM-IV, and functional changes, assessed with the Glasgow Outcome Scale-Extended, were measured six and 12 months post-injury in 122 individuals who had sustained a TBI (79% male, mean age 35 years, mean duration of post-traumatic amnesia 24 days, mean Glasgow Coma Scale score 9.2). Cross-lagged analyses were conducted within a structural equation modelling framework. Functional changes six months post-injury predicted depression and anxiety one year after the injury. Anxiety and depression, in turn, were not predictive of later functional status. This study adds to our understanding of the temporal relationship between depression, anxiety and functional status after TBI. The results indicate the importance of supporting brain injured individuals in coping with the functional consequences of their injury in order promote psychological well-being. (JINS, 2011, 17, 781-787)	[Schoenberger, Michael; Ponsford, Jennie; Gould, Kate R.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Schoenberger, Michael; Ponsford, Jennie; Gould, Kate R.; Johnston, Lisa] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Schonberger, M (corresponding author), Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, Engelberger Str 41, D-79106 Freiburg, Germany.	michael.schoenberger@psychologie.uni-freiburg.de	Gould, Kate Rachel/AAA-5511-2020	Gould, Kate Rachel/0000-0002-3564-7408	Victorian Neurotrauma Initiative	Funding for this study was provided by the Victorian Neurotrauma Initiative. The authors have no financial involvement or interests.	Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; First M., 1995, STRUCTURED CLIN INTE, V9, P92; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; GOULD KR, 2011, PSYCHOL MED; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Muthen B., 1997, ROBUST INFERENCE USI; Muthen B., 2010, MPLUS VERSION 6; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; PELZ DC, 1964, AM SOCIOL REV, V29, P836, DOI 10.2307/2090866; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; POPPER K, 1963, CONJECTURES REFITTAT; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Stuss D. T., 1999, COGNITIVE NEUROREHAB, P188; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; VONKORFF M, 1992, ARCH GEN PSYCHIAT, V49, P91; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	47	52	53	1	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2011	17	5					781	787		10.1017/S1355617711000701			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	821KV	WOS:000294974800003	21729404				2022-02-06	
J	Folkersma, H; Dingley, JCF; van Berckel, BNM; Rozemuller, A; Boellaard, R; Huisman, MC; Lammertsma, AA; Vandertop, WP; Molthoff, CFM				Folkersma, Hedy; Dingley, Jessica C. Foster; van Berckel, Bart N. M.; Rozemuller, Annemieke; Boellaard, Ronald; Huisman, Marc C.; Lammertsma, Adriaan A.; Vandertop, W. Peter; Molthoff, Carla F. M.			Increased cerebral (R)-[C-11]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study	JOURNAL OF NEUROINFLAMMATION			English	Article							LAYER HIGH-RESOLUTION; NEURONAL INJURY; AMINO-ACIDS; HEAD-INJURY; MICROGLIA; HIPPOCAMPUS; ACTIVATION; RECEPTORS; REPAIR; PET	Background: The aim of the present study was to investigate microglia activation over time following traumatic brain injury (TBI) and to relate these findings to glutamate release. Procedures: Sequential dynamic (R)-[C-11]PK11195 PET scans were performed in rats 24 hours before (baseline), and one and ten days after TBI using controlled cortical impact, or a sham procedure. Extracellular fluid (ECF) glutamate concentrations were measured using cerebral microdialysis. Brains were processed for histopathology and (immuno)-histochemistry. Results: Ten days after TBI, (R)-[C-11]PK11195 binding was significantly increased in TBI rats compared with both baseline values and sham controls (p < 0.05). ECF glutamate values were increased immediately after TBI (27.6 +/- 14.0 mu mol.L-1) as compared with the sham procedure (6.4 +/- 3.6 mu mol.L-1). Significant differences were found between TBI and sham for ED-1, OX-6, GFAP, Perl's, and Fluoro-Jade B. Conclusions: Increased cerebral uptake of (R)-[C-11]PK11195 ten days after TBI points to prolonged and ongoing activation of microglia. This activation followed a significant acute posttraumatic increase in ECF glutamate levels.	[Folkersma, Hedy; Vandertop, W. Peter] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Dingley, Jessica C. Foster; van Berckel, Bart N. M.; Boellaard, Ronald; Huisman, Marc C.; Lammertsma, Adriaan A.; Molthoff, Carla F. M.] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med, NL-1081 HV Amsterdam, Netherlands; [Dingley, Jessica C. Foster; van Berckel, Bart N. M.; Boellaard, Ronald; Huisman, Marc C.; Lammertsma, Adriaan A.; Molthoff, Carla F. M.] Vrije Univ Amsterdam Med Ctr, PFT Res, NL-1081 HV Amsterdam, Netherlands; [Rozemuller, Annemieke] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands		Folkersma, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	h.folkersma@amc.nl	Rozemuller, Annemieke/C-2084-2008; Vandertop, William P./K-9288-2018	Boellaard, Ronald/0000-0002-0313-5686; Lammertsma, Adriaan/0000-0003-1237-2891; Vandertop, William/0000-0001-5417-0265	Dutch Brain Foundation [9F01.21]; Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [016.066.309]	The authors thank M. van Gelder for expert technical assistance in the animal experiments and P. Kostense from the Department of Epidemiology & Biostatistics for statistical support. This study was funded by the Dutch Brain Foundation (Grant-ID 9F01.21) and by the Netherlands Organization for Scientific Research (NWO, Grant-ID 016.066.309).	Boellaard R, 2003, PHYS MED BIOL, V48, P429, DOI 10.1088/0031-9155/48/4/302; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cho BP, 2006, GLIA, V53, P92, DOI 10.1002/glia.20265; de Jong HWAM, 2007, PHYS MED BIOL, V52, P1505, DOI 10.1088/0031-9155/52/5/019; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Fei Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-96; Folkersma H, 2009, J NUCL MED, V50, P1975, DOI 10.2967/jnumed.109.067512; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Heiss WD, 2004, J NUCL MED, V45, P1811; Hume SP, 1998, EUR J NUCL MED, V25, P173, DOI 10.1007/s002590050211; Ito F, 2010, ANN NUCL MED, V24, P163, DOI 10.1007/s12149-009-0339-0; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; Kropholler MA, 2006, J CEREBR BLOOD F MET, V26, P1431, DOI 10.1038/sj.jcbfm.9600289; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Liu GJ, 2009, EUR J NEUROSCI, V29, P1108, DOI 10.1111/j.1460-9568.2009.06659.x; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; OLNEY JW, 1970, NATURE, V227, P609, DOI 10.1038/227609b0; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745; Takeuchi H, 2008, EXP NEUROL, V214, P144, DOI 10.1016/j.expneurol.2008.08.001; Toyama H, 2008, ANN NUCL MED, V22, P417, DOI 10.1007/s12149-008-0136-1; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196	32	52	54	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUN 14	2011	8								67	10.1186/1742-2094-8-67			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	790EK	WOS:000292571100001	21672189	gold, Green Published			2022-02-06	
J	Bouzat, P; Francony, G; Declety, P; Genty, C; Kaddour, A; Bessou, P; Brun, J; Jacquot, C; Chabardes, S; Bosson, JL; Payen, JF				Bouzat, Pierre; Francony, Gilles; Declety, Philippe; Genty, Celine; Kaddour, Affif; Bessou, Pierre; Brun, Julien; Jacquot, Claude; Chabardes, Stephan; Bosson, Jean-Luc; Payen, Jean-Francois			Transcranial Doppler to Screen on Admission Patients With Mild to Moderate Traumatic Brain Injury	NEUROSURGERY			English	Article						Computed tomographic scan; Mild traumatic brain injury; Minor head injury; Moderate head injury; Neuroworsening; Outcome; Transcranial Doppler	CRANIAL COMPUTED-TOMOGRAPHY; MINIMAL HEAD-INJURY; EMERGENCY-DEPARTMENT; NEUROLOGICAL DETERIORATION; INTRACRANIAL-PRESSURE; DECISION-MAKING; FLOW-VELOCITY; MANAGEMENT; TALK; RISK	BACKGROUND: Detecting patients at risk for secondary neurological deterioration (SND) after mild to moderate traumatic brain injury is challenging. OBJECTIVE: To assess the diagnostic accuracy of transcranial Doppler (TCD) on admission in screening these patients. METHODS: This prospective, observational cohort study enrolled 98 traumatic brain injury patients with an initial Glasgow Coma Scale score of 9 to 15 whose initial computed tomography (CT) scan showed either absent or mild lesions according to the Trauma Coma Data Bank (TCDB) classification, ie, TCDB I and TCDB II, respectively. TCD measurements of the 2 middle cerebral arteries were obtained on admission under stable conditions in all patients. Neurological outcome was reassessed on day 7. RESULTS: Of the 98 patients, 21 showed SND, ie, a decrease of >= 2 points from the initial Glasgow Coma Scale or requiring any treatment for neurological deterioration. Diastolic cerebral blood flow velocities and pulsatility index measurements were different between patients with SND and patients with no SND. Using receiver-operating characteristic analysis, we found the best threshold limits to be 25 cm/s (sensitivity, 92%; specificity, 76%; area under curve, 0.93) for diastolic cerebral blood flow velocity and 1.25 (sensitivity, 90%; specificity, 91%; area under curve, 0.95) for pulsatility index. According to a recursive-partitioning analysis, TCDB classification and TCD measurements were the most discriminative among variables to detect patients at risk for SND. CONCLUSION: In patients with no severe brain lesions on CT after mild to moderate traumatic brain injury, TCD on admission, in complement with brain CT scan, could accurately screen patients at risk for SND.	[Bouzat, Pierre; Francony, Gilles; Declety, Philippe; Brun, Julien; Jacquot, Claude; Payen, Jean-Francois] Hop Albert Michallon, Dept Anesthesia & Crit Care, F-38043 Grenoble, France; [Genty, Celine; Bosson, Jean-Luc] Hop Albert Michallon, Div Biostat, F-38043 Grenoble, France; [Kaddour, Affif] Hop Albert Michallon, Dept Emergency Med, F-38043 Grenoble, France; [Bessou, Pierre] Hop Albert Michallon, Dept Radiol, F-38043 Grenoble, France; [Chabardes, Stephan] Hop Albert Michallon, Dept Neurosurg, F-38043 Grenoble, France		Payen, JF (corresponding author), Hop Albert Michallon, Dept Anesthesia & Crit Care, BP 217, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	Bouzat, Pierre/L-6881-2014; Payen, Jean-Francois/L-6667-2014; bosson, jean-luc/AAP-5163-2020; Bouzat, Pierre/AAC-4105-2019	bosson, jean-luc/0000-0003-0967-6026; Bouzat, Pierre/0000-0003-4667-6738			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bouzat P, 2010, INTENS CARE MED, V36, P1514, DOI 10.1007/s00134-010-1919-0; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; de Andrade AF, 2006, SURG NEUROL, V65, pS10, DOI 10.1016/j.surneu.2005.11.034; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Gennarelli TA, 2005, ABBREVIATED INJURY S; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL RJ, 1986, STAT MED, V5, P517, DOI 10.1002/sim.4780050516; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shafe M, 2004, ACAD EMERG MED, V11, P774, DOI 10.1197/j.aem.2004.02.518; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y	39	52	54	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2011	68	6					1603	1609		10.1227/NEU.0b013e31820cd43e			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	760CK	WOS:000290299700059	21311381				2022-02-06	
